FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Yiamsawas, D
   Baier, G
   Thines, E
   Landfester, K
   Wurm, FR
AF Yiamsawas, Doungporn
   Baier, Grit
   Thines, Eckhard
   Landfester, Katharina
   Wurm, Frederik R.
TI Biodegradable lignin nanocontainers
SO RSC ADVANCES
LA English
DT Article
ID MINIEMULSION POLYMERIZATION; CONTROLLED-RELEASE; NANOCAPSULES
AB The abundant biomaterial lignin was used to prepare hollow nanocapsules by interfacial polyaddition in inverse miniemulsions. These cross-linked lignin nanocontainers can be loaded with hydrophilic substances which can be released by an enzymatic trigger from natural plant extracts revealing them as potential nanocontainers for agricultural applications.
C1 [Yiamsawas, Doungporn; Baier, Grit; Landfester, Katharina; Wurm, Frederik R.] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Thines, Eckhard] IBWF eV, Inst Biotechnol & Drug Res, D-67663 Kaiserslautern, Germany.
   [Thines, Eckhard] Johannes Gutenberg Univ Mainz, Inst Biotechnol, D-55128 Mainz, Germany.
RP Wurm, FR (reprint author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
EM wurm@mpip-mainz.mpg.de
RI Mainz, EMZ-M/E-3619-2016; Wurm, Frederik/A-2522-2010; Landfester,
   Katharina/F-9449-2011
OI Wurm, Frederik/0000-0002-6955-8489; Landfester,
   Katharina/0000-0001-9591-4638; Thines, Eckhard/0000-0002-4003-2272
CR Baier G, 2010, BIOMACROMOLECULES, V11, P960, DOI 10.1021/bm901414k
   Ciolacu D, 2012, MAT SCI ENG C-MATER, V32, P452, DOI 10.1016/j.msec.2011.11.018
   Nghi DH, 2012, APPL ENVIRON MICROB, V78, P4893, DOI 10.1128/AEM.07588-11
   Faria FAC, 2012, POLYM INT, V61, P788, DOI 10.1002/pi.4140
   Fernandez-Perez M, 2011, CARBOHYD POLYM, V83, P1672, DOI 10.1016/j.carbpol.2010.10.024
   Flores-Cespedes F, 2012, J AGR FOOD CHEM, V60, P1042, DOI 10.1021/jf2037483
   Gao GZ, 2012, BIOMACROMOLECULES, V13, P3602, DOI 10.1021/bm301039f
   Calvo-Flores FG, 2010, CHEMSUSCHEM, V3, P1227, DOI 10.1002/cssc.201000157
   Hatakeyama H, 2010, ADV POLYM SCI, V232, P1, DOI 10.1007/12_2009_12
   Landfester K, 2010, ADV POLYM SCI, V229, P1, DOI 10.1007/12_2009_43
   Lora JH, 2002, J POLYM ENVIRON, V10, P39, DOI 10.1023/A:1021070006895
   Malzahn K, 2014, ACS MACRO LETT, V3, P40, DOI 10.1021/mz400578e
   Rosenbauer EM, 2010, MACROMOLECULES, V43, P5083, DOI 10.1021/ma100481s
   Stewart D, 2008, IND CROP PROD, V27, P202, DOI 10.1016/j.indcrop.2007.07.008
   Tiarks F, 2001, LANGMUIR, V17, P908, DOI 10.1021/la001276n
NR 15
TC 46
Z9 48
U1 10
U2 47
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 23
BP 11661
EP 11663
DI 10.1039/c3ra47971d
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA AC4DE
UT WOS:000332470000019
OA Other Gold
DA 2018-10-20
ER

PT J
AU Thrivikraman, G
   Madras, G
   Basu, B
AF Thrivikraman, Greeshma
   Madras, Giridhar
   Basu, Bikramjit
TI In vitro/In vivo assessment and mechanisms of toxicity of bioceramic
   materials and its wear particulates
SO RSC ADVANCES
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE; ARTIFICIAL HIP JOINTS; TITANIUM-DIOXIDE
   NANOPARTICLES; CELL-BIOMATERIAL INTERACTION; MESSENGER-RNA EXPRESSION;
   MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE; OXIDATIVE STRESS;
   HYDROXYAPATITE NANOPARTICLES; BIOLOGICAL-PROPERTIES
AB With the progress in modern technological research, novel biomaterials are being largely developed for various biomedical applications. Over the past two decades, most of the research focuses on the development of a new generation of bioceramics as substitutes for hard tissue replacement. In reference to their application in different anatomical locations of a patient, newly developed bioceramic materials can potentially induce a toxic/harmful effect to the host tissues. Therefore, prior to clinical testing, relevant biochemical screening assays are to be performed at the cellular and molecular level, to address the issues of biocompatibility and long term performance of the implants. Along with testing strategies in the bulk material toxicity, a detailed evaluation should also be conducted to determine the toxicity of the wear products of the potential bioceramics. This is important as the bioceramics are intended to be implanted in patients with longer life expectancy and notwithstanding, the material will eventually release finer (mostly nanosized) sized debris particles due to continuous wear at articulating surfaces in the hostile corrosive environment of the human body. The wear particulates generated from a biocompatible bioceramic may act in a different way, inducing early/late aseptic loosening at the implant site, resulting in osteolysis and inflammation. Hence, a study on the chronic effects of the wear particulates, in terms of local and systemic toxicity becomes the major criteria in the toxicity evaluation of implantable bioceramics. In this broad perspective, this article summarizes some of the currently used techniques and knowledge in assessing the in vitro and in vivo cytotoxicity and genotoxicity of bioceramic implant materials. It also addresses the need to conduct a broad evaluation before claiming the biocompatibility and clinical feasibility of any new biomaterial. This review also emphasizes some of the case studies based on the experimental designs that are currently followed and its importance in the context of clinical applications.
C1 [Thrivikraman, Greeshma; Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
   [Thrivikraman, Greeshma; Madras, Giridhar] Indian Inst Sci, Ctr Nano Sci & Engn, Bangalore 560012, Karnataka, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
RI Madras, Giridhar/A-1257-2007; Madras, Giridhar/K-8468-2015
OI Madras, Giridhar/0000-0003-2211-5055; Madras,
   Giridhar/0000-0003-2211-5055; T, Greeshma/0000-0002-0870-5369
FU Department of Science and Technology (DST); Department of Biotechnology
   (DBT); Council for Scientific and Industrial Research (CSIR), Government
   of India
FX The research results reviewed in this paper are obtained from the
   projects sponsored by Department of Science and Technology (DST),
   Department of Biotechnology (DBT) and Council for Scientific and
   Industrial Research (CSIR), Government of India. The authors are
   grateful for their financial support in the recent past. One of the
   authors, BB is thankful to his collaborators, including Sushma Kalmodia
   (currently at Shankar Nethralaya, India), Alok Kumar and Krishanu Biswas
   (IIT Kanpur, India), Thomas J. Webster (Northeastern University, USA),
   David Stout (formerly at Brown University, USA) and the toxicologists
   from Indian Institute for Toxicological Research, Lucknow, India (Alok
   Pandey, Vyom Sharma and Alok Dhawan).
CR Abarrategi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034117
   Afzal MAF, 2013, J BIOMATER APPL, V27, P967, DOI 10.1177/0885328211431856
   Afzal MAF, 2012, MAT SCI ENG C-MATER, V32, P1164, DOI 10.1016/j.msec.2012.03.003
   Agrawal CM, 1998, JOM-J MIN MET MAT S, V50, P31, DOI 10.1007/s11837-998-0064-5
   Ahamed M, 2013, CURR PHARM DESIGN, V19, P6681, DOI 10.2174/1381612811319370011
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   AMES BN, 1973, P NATL ACAD SCI USA, V70, P2281, DOI 10.1073/pnas.70.8.2281
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Ben-Nissan B, 2002, J CERAM SOC JPN, V110, P601, DOI 10.2109/jcersj.110.601
   Benazzo F., 2006, BIOCERAMICS ALTERNAT, P171
   Berube P, 2005, J PERIODONTOL, V76, P1697, DOI 10.1902/jop.2005.76.10.1697
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Black J., 1988, ORTHOPAEDIC BIOMATER
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Catelas I, 1999, J BONE JOINT SURG BR, V81B, P516, DOI 10.1302/0301-620X.81B3.8737
   Chang CK, 2001, J BIOMED MATER RES, V56, P17, DOI 10.1002/1097-4636(200107)56:1<17::AID-JBM1063>3.0.CO;2-T
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   Chesnutt BM, 2007, J BIOMED MATER RES A, V82A, P343, DOI 10.1002/jbm.a.31070
   Christmann M, 2013, NUCLEIC ACIDS RES, V41, P8403, DOI 10.1093/nar/gkt635
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   CORY AH, 1991, CANCER COMMUN, V3, P207
   DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802
   Dasarathy H, 1996, J BIOMED MATER RES, V31, P81, DOI 10.1002/(SICI)1097-4636(199605)31:1<81::AID-JBM10>3.0.CO;2-P
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   DELCERRO M, 1980, MICROSC ACTA, V83, P117
   DICARLO E F, 1992, Clinical Materials, V9, P235, DOI 10.1016/0267-6605(92)90104-2
   Dinescu S, 2013, BIOMED RES INT, DOI 10.1155/2013/598056
   Doostmohammadi A, 2011, J MATER SCI-MATER M, V22, P2293, DOI 10.1007/s10856-011-4400-x
   DORLOT JM, 1989, J BIOMED MATER RES-A, V23, P299, DOI 10.1002/jbm.820231405
   Drouet C., 2006, Advances in Science and Technology, V49, P54, DOI 10.4028/www.scientific.net/AST.49.45
   Dubey AK, 2013, J MATER SCI-MATER M, V24, P1789, DOI 10.1007/s10856-013-4921-6
   Egermann M, 2005, OSTEOPOROSIS INT, V16, pS129, DOI 10.1007/s00198-005-1859-7
   ELIA MC, 1993, MUTAT RES, V291, P193, DOI 10.1016/0165-1161(93)90159-W
   Elshahawy W, 2011, ADV CERAMICS ELECT M
   Fabbri N, 2011, EUR J RADIOL, V77, P43, DOI 10.1016/j.ejrad.2010.08.015
   Fadeel B, 2010, ADV DRUG DELIVER REV, V62, P362, DOI 10.1016/j.addr.2009.11.008
   Falez F., 2006, BIOCERAMICS ALTERNAT, V171
   Fielding GA, 2012, ACTA BIOMATER, V8, P3144, DOI 10.1016/j.actbio.2012.04.004
   FIELDS RD, 1993, AM BIOTECHNOL LAB, V11, P48
   Filova E, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3509112
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Fruh HJ, 1997, BIOMATERIALS, V18, P873, DOI 10.1016/S0142-9612(97)00005-7
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   Genies C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078356
   GRISS P, 1977, ARCH ORTHOP TRAUM SU, V90, P29, DOI 10.1007/BF00415892
   Gu YW, 2002, BIOMATERIALS, V23, P37, DOI 10.1016/S0142-9612(01)00076-X
   Han YJ, 2007, BIOFACTORS, V30, P205, DOI 10.1002/biof.5520300402
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Hansen DC, 2008, ELECTROCHEM SOC INTE, V17, P31
   Hatton A, 2003, BIOMATERIALS, V24, P1193, DOI 10.1016/S0142-9612(02)00510-0
   Hatton A, 2002, BIOMATERIALS, V23, P3429, DOI 10.1016/S0142-9612(02)00047-9
   Heil J, 1996, MUTAT RES-GENET TOX, V368, P181, DOI 10.1016/S0165-1218(96)90060-9
   HELLMAN KB, 1994, J CELL BIOCHEM, V56, P210, DOI 10.1002/jcb.240560216
   Helmus MN, 2008, TOXICOL PATHOL, V36, P70, DOI 10.1177/0192623307310949
   HENCH L, 1993, INTRO BIOCERAMICS
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENSSGE EJ, 1994, J MATER SCI-MATER M, V5, P657, DOI 10.1007/BF00120351
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Homaeigohar SSH, 2005, J BIOMED MATER RES A, V75A, P14, DOI 10.1002/jbm.a.30333
   Hu J, 2007, WORLD J GASTROENTERO, V13, P2798
   Imbert L., 2011, WORKING PRINCIPLE DU
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Iyer R, 1996, TOXICOL APPL PHARM, V141, P84, DOI 10.1006/taap.1996.0263
   Jain S, 2013, J BIOMED MATER RES B, V101B, P520, DOI 10.1002/jbm.b.32852
   Jantova S, 2008, MUTAT RES-GEN TOX EN, V652, P139, DOI 10.1016/j.mrgentox.2008.01.010
   Jayaswal Gaurav P, 2010, J Indian Prosthodont Soc, V10, P8, DOI 10.1007/s13191-010-0002-4
   Jun C., 2005, J WUHAN UNIV TECHNOL, V20, P57
   Kalmodia S, 2013, J BIOMATER APPL, V27, P891, DOI 10.1177/0885328211430422
   Kalmodia S, 2011, J BIOMED NANOTECHNOL, V7, P74, DOI 10.1166/jbn.2011.1208
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kang YQ, 2013, ACTA BIOMATER, V9, P4906, DOI 10.1016/j.actbio.2012.08.008
   Kang YQ, 2011, EUR POLYM J, V47, P1569, DOI 10.1016/j.eurpolymj.2011.05.004
   Kang YQ, 2011, BIOMATERIALS, V32, P6119, DOI 10.1016/j.biomaterials.2011.05.015
   Kannan TP, 2006, ARCH OROFAC SCI, V1, P15
   Kasper C., 2012, TISSUE ENG 3 CELL SU, V126, P317
   Kato S, 1998, BIOMATERIALS, V19, P821, DOI 10.1016/S0142-9612(97)00240-8
   Katzer A, 2003, TOXICOLOGY, V190, P145, DOI 10.1016/S03000-483X(03)00147-1
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kinikoglu B, 2009, BIOMATERIALS, V30, P6418, DOI 10.1016/j.biomaterials.2009.08.010
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kohn D. H., 2003, BIOCERAMICS STANDARD
   Kroll A, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-9
   Kumar A, 2013, J BIOMED MATER RES A, V101, P2925, DOI 10.1002/jbm.a.34603
   Laquerriere P, 2001, J BIOMED MATER RES, V58, P238, DOI 10.1002/1097-4636(2001)58:3<238::AID-JBM1012>3.3.CO;2-9
   Larson EM, 1997, INVEST OPHTH VIS SCI, V38, P1929
   Lee BT, 2006, MAT SCI ENG A-STRUCT, V429, P348, DOI 10.1016/j.msea.2006.05.090
   LEPOCK JR, 1988, J CELL PHYSIOL, V137, P14, DOI 10.1002/jcp.1041370103
   Lerouge S, 1997, J BONE JOINT SURG BR, V79B, P135, DOI 10.1302/0301-620X.79B1.6621
   Li J., 1993, Clinical Materials, V12, P197, DOI 10.1016/0267-6605(93)90073-G
   Liagre B, 2002, J BONE JOINT SURG BR, V84B, P920, DOI 10.1302/0301-620X.84B6.12457
   Liu XC, 2012, INT J NANOMED, V7, P1239, DOI 10.2147/IJN.S28098
   Liu X, 2010, BIOMATERIALS, V31, P8198, DOI 10.1016/j.biomaterials.2010.07.069
   Maccauro G., 2011, BIOMATERIALS APPL NA
   Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003
   Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0
   MARTIN A, 1988, J BONE JOINT SURG AM, V70A, P1561, DOI 10.2106/00004623-198870100-00017
   MATSUDA T, 1995, ASAIO J, V41, pM398, DOI 10.1097/00002480-199507000-00039
   McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3
   Mocchegiani E, 2000, TRENDS PHARMACOL SCI, V21, P205, DOI 10.1016/S0165-6147(00)01476-0
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murakami T, 1997, MAT SCI ENG A-STRUCT, V240, P672, DOI 10.1016/S0921-5093(97)00651-5
   Murray Peter E, 2007, Med Oral Patol Oral Cir Bucal, V12, pE258
   Nakada H, 2008, J HARD TISSUE BIOL, V17, P99, DOI 10.2485/jhtb.17.99
   Narayan R, 2010, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-1-4419-1395-1
   Nath S, 2013, J BIOMATER APPL, V27, P497, DOI 10.1177/0885328211412206
   Nath S, 2010, J MATER SCI-MATER M, V21, P1273, DOI 10.1007/s10856-009-3939-2
   Nazir NM, 2012, J ENG SCI TECHNOL, V7, P169
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Nevelos J, 2000, J ARTHROPLASTY, V15, P793, DOI 10.1054/arth.2000.8100
   Nevelos JE, 2001, J MATER SCI-MATER M, V12, P141, DOI 10.1023/A:1008970027306
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Ning CQ, 2004, BIOMATERIALS, V25, P3379, DOI 10.1016/j.biomaterials.2003.10.017
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Olofsson J., 2011, THESIS ACTA U UPSALI, P841
   Ong JL, 2006, JOM-US, V58, P67, DOI 10.1007/s11837-006-0145-2
   Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268
   Ostman P.O., 2007, VARIOUS PROTOCOLS DI
   Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004
   Palmquist A., 2008, NOVEL TECHNIQUE PREP
   Palsson BO, 2009, TISSUE ENG
   Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869
   PARK JB, 1980, J BIOMED MATER RES, V14, P269, DOI 10.1002/jbm.820140308
   PARK JB, 1977, BIOMATER ARTIF CELL, V5, P267, DOI 10.3109/10731197709118677
   Park JC, 2002, YONSEI MED J, V43, P518, DOI 10.3349/ymj.2002.43.4.518
   Patel N. R., 2012, INT J EMERGING TECHN, V2, P91
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Piattelli A., 1993, INT J ORAL MAXILLOF, V8, P69
   Pikner S. S., 2008, SWED DENT J S, V194, P2
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Poitout DG, 2004, BIOMECHANICS BIOMATE
   PRENTO P, 1993, HISTOCHEMISTRY, V99, P163, DOI 10.1007/BF00571877
   Quan RF, 2013, MAT SCI ENG C-MATER, V33, P1332, DOI 10.1016/j.msec.2012.12.033
   Radu A, 2008, ROM BIOTECH LETT, V13, P3863
   Rahman H. S. A., 2013, J CERAM SOC JPN, V121, P382
   Rasekh M, 2013, ACTA BIOMATER, V9, P5052, DOI 10.1016/j.actbio.2012.09.032
   Revell P. A., 2006, Nanotechnology Perceptions, V2, P283
   Rieger W., 2009, DITAL DENT NEWS, V3, P6
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rosengren A, 2005, J BIOMED MATER RES A, V75A, P115, DOI 10.1002/jbm.a.30431
   Roy M, 2012, ACS APPL MATER INTER, V4, P1341, DOI 10.1021/am201610q
   Saha N, 2012, J BIOMED MATER RES B, V100B, P256, DOI 10.1002/jbm.b.31948
   Saha N, 2010, J BIOMED MATER RES B, V95B, P430, DOI 10.1002/jbm.b.31734
   Saquib Q, 2012, TOXICOL IN VITRO, V26, P351, DOI 10.1016/j.tiv.2011.12.011
   Saraste A, 1999, HERZ, V24, P189, DOI 10.1007/BF03044961
   Schouten C, 2010, CLIN ORAL IMPLAN RES, V21, P414, DOI 10.1111/j.1600-0501.2009.01872.x
   Sharma V, 2009, TOXICOL LETT, V185, P211, DOI 10.1016/j.toxlet.2009.01.008
   Shukla RK, 2011, TOXICOL IN VITRO, V25, P231, DOI 10.1016/j.tiv.2010.11.008
   Siddiqui MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069534
   Singh B, 2011, MAT SCI ENG C-MATER, V31, P1320, DOI 10.1016/j.msec.2011.04.015
   Skorokhod VV, 2010, POWDER METALL MET C+, V49, P324, DOI 10.1007/s11106-010-9239-z
   Song YH, 2013, INT J NANOMED, V8, P2745, DOI 10.2147/IJN.S44885
   Stea S, 2000, BIOMATERIALS, V21, P1393, DOI 10.1016/S0142-9612(00)00041-7
   STEVENS MG, 1993, J IMMUNOL METHODS, V157, P225, DOI 10.1016/0022-1759(93)90091-K
   Stoppie N, 2005, CLIN IMPLANT DENT R, V7, P87, DOI 10.1111/j.1708-8208.2005.tb00051.x
   Sun J, 2009, J BIOMED MATER RES A, V88A, P673, DOI 10.1002/jbm.a.31892
   Suner S, 2012, TRIBOL-MATER SURF IN, V6, P39, DOI 10.1179/1751584X12Y.0000000005
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7
   Tavakoli Mohammad, 2012, Dent Res J (Isfahan), V9, P314
   Tayebi L., 2012, CURRENT MICROSCOPY C
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Thamaraiselvi T. V., 2004, TRENDS BIOMATER ARTI, V18, P9
   Theiszova M, 2008, NEOPLASMA, V55, P312
   Thrivikraman G, 2013, BIOMATERIALS, V34, P7073, DOI 10.1016/j.biomaterials.2013.05.076
   Tipper JL, 2002, BIOMATERIALS, V23, P3441, DOI 10.1016/S0142-9612(02)00048-0
   Topaktas M, 2012, TURK J BIOL, V36, P568, DOI 10.3906/biy-1112-20
   Totten G.E., 2004, MECH TRIBOLOGY MAT C
   Tripathi G, 2013, J BIOMED MATER RES A, V101, P1539, DOI 10.1002/jbm.a.34452
   Tripathi G, 2012, CERAM INT, V38, P341, DOI 10.1016/j.ceramint.2011.07.012
   Vallet-Regi M., 2001, J CHEM SOC DA, V97
   Vallet-Regi M, 2010, CR CHIM, V13, P174, DOI 10.1016/j.crci.2009.03.004
   Van Tienhoven EAE, 2006, J BIOMED MATER RES A, V78A, P175, DOI 10.1002/jbm.a.30679
   Vielreicher M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0263
   Vilches J., 2007, MODERN RES ED TOPICS
   Vivanco J, 2012, J MECH BEHAV BIOMED, V9, P137, DOI 10.1016/j.jmbbm.2012.02.003
   Wakayama S, 2006, JSME INT J A-SOLID M, V49, P11, DOI 10.1299/jsmea.49.11
   Wang MO, 2013, BIOMACROMOLECULES, V14, P1321, DOI 10.1021/bm301962f
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0
   Wataha JC, 2001, J PROSTHET DENT, V86, P203, DOI 10.1067/mpr.2001.117056
   WIESLANDER AP, 1993, BIOMAT ARTIF CELL IM, V21, P63, DOI 10.3109/10731199309118297
   Wilhelmi V, 2012, TOXICOL IN VITRO, V26, P323, DOI 10.1016/j.tiv.2011.12.006
   Willmann G, 1996, BIOMATERIALS, V17, P2157, DOI 10.1016/0142-9612(96)00042-7
   Wilson Judy R, 2005, Adv Skin Wound Care, V18, P373, DOI 10.1097/00129334-200509000-00011
   Wise DL, 2000, BIOMATERIALS ENG DEV, V2
   Xu LM, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-16
   Xu ZL, 2012, J APPL TOXICOL, V32, P429, DOI 10.1002/jat.1745
   Yamaki K, 2012, DENT MATER J, V31, P427, DOI 10.4012/dmj.2011-051
   Yang YZ, 2003, J BIOMED MATER RES A, V64A, P509, DOI 10.1002/jbm.a.10431
   Yuan Y, 2010, BIOMATERIALS, V31, P730, DOI 10.1016/j.biomaterials.2009.09.088
   Zhang X, 1997, J MATER SCI, V32, P235, DOI 10.1023/A:1018568308926
   Zhao JS, 2009, J TOXICOL ENV HEAL A, V72, P1141, DOI 10.1080/15287390903091764
   Zhao XX, 2013, ARCH TOXICOL, V87, P1037, DOI 10.1007/s00204-012-0827-1
NR 201
TC 24
Z9 25
U1 5
U2 38
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 25
BP 12763
EP 12781
DI 10.1039/c3ra44483j
PG 19
WC Chemistry, Multidisciplinary
SC Chemistry
GA AC4IQ
UT WOS:000332485000019
OA Bronze
DA 2018-10-20
ER

PT J
AU Xu, HC
   Luan, YF
   Wu, ZQ
   Li, XM
   Yuan, YL
   Liu, XL
   Yuan, L
   Li, D
   Chen, H
AF Xu, Haichao
   Luan, Yafei
   Wu, Zhaoqiang
   Li, Xinming
   Yuan, Yuling
   Liu, Xiaoli
   Yuan, Lin
   Li, Dan
   Chen, Hong
TI Incorporation of Lysine-Containing Copolymer with Polyurethane Affording
   Biomaterial with Specific Adsorption of Plasminogen
SO CHINESE JOURNAL OF CHEMISTRY
LA English
DT Article
DE plasminogen; protein adsorption; hemocompatibility; blending; lysine
ID SEGMENTED POLYURETHANE; BIOMEDICAL APPLICATIONS; PHOSPHOLIPID POLYMER;
   FIBRINOLYTIC SYSTEM; BLOOD COMPATIBILITY; SURFACES; PROTEINS; ADHESION;
   BLENDS
AB A novel biomaterial based on polyurethane (PU) was prepared through physical incorporation of lysine-containing copolymer to improve its hemocompatibility and surface recognition of plasminogen. The lysine-containing copolymer was synthesized via the copolymerization of 2-ethylhexyl methacrylate (EHMA), oligo (ethylene glycol) methyl ether methacrylate (OEGMA) and 6-tert-butoxycarbonyl amino-2-(2-methyl-acryloylamino)-hexanoic acid tert-butyl ester (Lys(P)MA), followed by the deprotection of COOH and epsilon-NH2 groups on lysine residues in the copolymer. The composition of the copolymer can be adjusted by varying the monomer feed ratio. The three components contribute to improving the compatibility with PU, resistance to nonspecific protein adsorption and specific binding of plasminogen, respectively. The binding capacity towards plasminogen increased with the lysine content in the copolymer. This approach illustrates a simple way for the generation of novel biomaterials with improved hemocompatibility and surface recognition of specific biomolecules.
C1 [Xu, Haichao; Luan, Yafei; Wu, Zhaoqiang; Li, Xinming; Yuan, Yuling; Liu, Xiaoli; Yuan, Lin; Li, Dan; Chen, Hong] Soochow Univ, Dept Polymer Sci & Engn, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Jiangsu, Peoples R China.
RP Li, D (reprint author), Soochow Univ, Dept Polymer Sci & Engn, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Jiangsu, Peoples R China.
EM lidan@suda.edu.cn; chenh@suda.edu.cn
RI chen, Hong/L-6932-2013; Liu, Xiaoli/M-5410-2013; Li, Dan/R-8422-2016
OI Li, Dan/0000-0002-1141-8838; , Lin/0000-0001-6966-8584; Liu,
   Xiaoli/0000-0003-1686-3292
FU National Natural Science Foundation of China [21204055, 21344002,
   21174098, 21304062]; Natural Science Foundation of Jiangsu Province
   [13KJA430006, 13KJB430020]
FX This work was supported by the National Natural Science Foundation of
   China (Nos. 21204055, 21344002, 21174098 and 21304062) and the Natural
   Science Foundation of Jiangsu Province (Nos. 13KJA430006 and
   13KJB430020).
CR ANGLESCANO E, 1994, CHEM PHYS LIPIDS, V67-8, P353, DOI 10.1016/0009-3084(94)90157-0
   Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   Chen H, 2009, J BIOMED MATER RES A, V90A, P940, DOI 10.1002/jbm.a.32152
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   Lamba NMK, 2000, J BIOMAT SCI-POLYM E, V11, P1227, DOI 10.1163/156856200744174
   Li D, 2011, COLLOID SURFACE B, V86, P1, DOI 10.1016/j.colsurfb.2011.04.003
   Li D, 2011, ACTA BIOMATER, V7, P954, DOI 10.1016/j.actbio.2010.10.021
   Li D, 2009, ACTA BIOMATER, V5, P1864, DOI 10.1016/j.actbio.2009.03.001
   Liu XL, 2012, CHINESE J POLYM SCI, V30, P235, DOI 10.1007/s10118-012-1118-2
   MAYER M, 1990, CLIN BIOCHEM, V23, P197, DOI 10.1016/0009-9120(90)90601-P
   McClung WG, 2003, J BIOMED MATER RES A, V66A, P795, DOI 10.1002/jdm.a.10017
   Moon JH, 1997, LANGMUIR, V13, P4305, DOI 10.1021/la9705118
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   Ogawa R, 2002, J BIOMED MATER RES, V62, P214, DOI 10.1002/jbm.10339
   Ogawa R, 2003, SCI TECHNOL ADV MAT, V4, P523, DOI 10.1016/j.stam.2003.10.030
   Sask K. N., 2011, LANGMUIR, V28, P2099
   Sask KN, 2012, J BIOMED MATER RES A, V100A, P2821, DOI 10.1002/jbm.a.34218
   Tan DS, 2012, J BIOMED MATER RES A, V100A, P380, DOI 10.1002/jbm.a.33191
   Tan J, 2013, J BIOMAT SCI-POLYM E, V24, P497, DOI 10.1080/09205063.2012.690286
   Tan J, 2009, J BIOMED MATER RES A, V90A, P196, DOI 10.1002/jbm.a.32074
   Tang ZC, 2013, POLYM CHEM-UK, V4, P1583, DOI 10.1039/c2py20944f
   Tong WF, 2013, CHINESE J POLYM SCI, V31, P495, DOI 10.1007/s10118-013-1210-2
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Wang HW, 2012, CHINESE J POLYM SCI, V30, P893, DOI 10.1007/s10118-012-1181-8
   Wu ZQ, 2012, POLYM ADVAN TECHNOL, V23, P1500, DOI 10.1002/pat.2072
   Wu ZQ, 2012, MACROMOL BIOSCI, V12, P126, DOI 10.1002/mabi.201100211
   Wu ZQ, 2009, MACROMOL BIOSCI, V9, P1165, DOI 10.1002/mabi.200900221
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhang Q, 2013, COLLOID SURFACE B, V102, P354, DOI 10.1016/j.colsurfb.2012.07.037
NR 30
TC 3
Z9 3
U1 2
U2 25
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1001-604X
EI 1614-7065
J9 CHINESE J CHEM
JI Chin. J. Chem.
PD JAN
PY 2014
VL 32
IS 1
SI SI
BP 44
EP 50
DI 10.1002/cjoc.201300735
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA AB6LI
UT WOS:000331899600007
DA 2018-10-20
ER

PT J
AU Daghighi, S
   Sjollema, J
   Dijkstra, RJB
   Jaspers, V
   Zaat, SAJ
   van der Mei, HC
   Busscher, HJ
AF Daghighi, Seyedmojtaba
   Sjollema, Jelmer
   Dijkstra, Rene J. B.
   Jaspers, Valery
   Zaat, Sebastian A. J.
   van der Mei, Henny C.
   Busscher, Henk J.
TI REAL-TIME QUANTIFICATION OF MATRIX METALLOPROTEINASE AND INTEGRIN alpha
   v beta 3 EXPRESSION DURING BIOMATERIAL-ASSOCIATED INFECTION IN A MURINE
   MODEL
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Immune response; bioluminescence; matrix metalloproteinase;
   fluorescence; integrin; infection; Staphylococcus aureus; implant
ID FOREIGN-BODY REACTION; STAPHYLOCOCCUS-AUREUS INFECTION; IN-VIVO; MICE;
   BIOLUMINESCENT; INFLAMMATION; EPIDERMIDIS; TISSUE;
   MATRIX-METALLOPROTEINASE-9; MACROPHAGES
AB Biomaterial implants and devices increase the risk of microbial infections due to the biofilm mode of growth of infecting bacteria on implant materials, in which bacteria are protected against antibiotic treatment and the local immune system. Matrix-metalloproteinases (MMPs) and cell surface integrin receptors facilitate transmigration of inflammatory cells toward infected or inflamed tissue. This study investigates the relationship between MMP- and integrin-expression and the clearance of infecting Staphylococcus aureus around implanted biomaterials in a murine model. MMP- and integrin alpha v beta 3 expression were monitored in mice, with and without subcutaneously implanted biomaterial samples, in the absence and presence of bioluminescent S. aureus Xen36. Staphylococcal persistence was imaged longitudinally over time using bioluminescence imaging. The activatable MMPSense (R) 680 and integrin-targeted IntegriSense (R) 750 probes were injected on different days after implantation and their signal intensity and localisation monitored using fluorescence imaging. After sacrifice 7 or 16 days post-implantation, staphylococci from biomaterial samples and surrounding tissues were cultured on agar-plates and presence of host inflammatory cells was histologically evaluated. MMP- and integrin-expression were equally enhanced in presence of staphylococci or biomaterials up to 7 days post-implantation, but their localisation along the biomaterial samples differed. Bacterial clearance from tissue was higher in the absence of biomaterials. It is of clinical relevance that MMP- and integrin-expression were enhanced in presence of both staphylococci and biomaterials, although the immune system in the presence of biomaterials remained hampered in eradicating bacteria during the first 7 days post-implantation.
C1 [Daghighi, Seyedmojtaba; Sjollema, Jelmer; Dijkstra, Rene J. B.; van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.
   [Daghighi, Seyedmojtaba; Sjollema, Jelmer; Dijkstra, Rene J. B.; van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   [Jaspers, Valery; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, CINIMA Ctr Infect & Immun Amsterdam, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
RP Sjollema, J (reprint author), Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, POB 196, NL-9700 AD Groningen, Netherlands.
EM j.sjollema@umcg.nl
FU BioMedical Materials institute [P4.01 NANTICO]; Dutch Ministry of
   Economic Affairs
FX The authors would like to thank Martijn Riool and Leonie de Boer for
   histological evaluations and Peter Plomp for assistance in animal
   experiments. This research forms part of the Project P4.01 NANTICO of
   the research program of the BioMedical Materials institute, co-funded by
   the Dutch Ministry of Economic Affairs.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bernthal NM, 2011, J ORTHOP RES, V29, P1621, DOI 10.1002/jor.21414
   Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580
   Boelens JJ, 2000, INFECT IMMUN, V68, P6924, DOI 10.1128/IAI.68.12.6924-6931.2000
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Brand AM, 2010, LETT APPL MICROBIOL, V51, P645, DOI 10.1111/j.1472-765X.2010.02948.x
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Chen XY, 2004, CANCER RES, V64, P8009, DOI 10.1158/0008-5472.CAN-04-1956
   Clapper ML, 2011, NEOPLASIA, V13, P685, DOI 10.1593/neo.11400
   Daghighi S, 2012, ACTA BIOMATER, V8, P3991, DOI 10.1016/j.actbio.2012.07.017
   DAMJANOVICH L, 1992, AM J RESP CELL MOL, V6, P197, DOI 10.1165/ajrcmb/6.2.197
   de Souza LF, 2009, MOL IMMUNOL, V46, P937, DOI 10.1016/j.molimm.2008.09.012
   Deguchi J, 2006, CIRCULATION, V114, P55, DOI 10.1161/CIRCULATIONAHA.106.619056
   Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9
   Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158
   Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104
   Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gooz M, 2001, AM J PHYSIOL-GASTR L, V281, pG823
   Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Hwang JY, 2012, MOL IMAGING BIOL, V14, P431, DOI 10.1007/s11307-011-0517-z
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jones EF, 2012, MOL IMAGING BIOL, V14, P32, DOI 10.1007/s11307-011-0480-8
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kerr J. R., 1999, Molecular Pathology, V52, P220
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kossodo S, 2010, MOL IMAGING BIOL, V12, P488, DOI 10.1007/s11307-009-0279-z
   Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515
   Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   Medina C, 2005, INFLAMM BOWEL DIS, V11, P99, DOI 10.1097/00054725-200502000-00002
   Ntziachristos Vasilis, 2002, Nature Medicine, V8, P757, DOI 10.1038/nm729
   Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418
   Peterson JD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3038
   Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5
   Singh B, 2000, DRUGS, V59, P278, DOI 10.2165/00003495-200059020-00017
   Snoeks TJA, 2010, ANGIOGENESIS, V13, P135, DOI 10.1007/s10456-010-9168-y
   Alvarado MVY, 2011, J VASC INTERV RADIOL, V22, P1758, DOI 10.1016/j.jvir.2011.08.025
   van der Loos CM, 2010, J HISTOTECHNOL, V33, P31, DOI 10.1179/his.2010.33.1.31
   Wang Q, 2004, AM J PHYSIOL-HEART C, V286, pH806, DOI 10.1152/ajpheart.00291.2003
   Wang YY, 2005, SHOCK, V24, P214, DOI 10.1097/01.shk.0000174935.13786.6c
   Waschkau B, 2013, CONTRAST MEDIA MOL I, V8, P1, DOI 10.1002/cmmi.1486
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
NR 51
TC 3
Z9 3
U1 4
U2 20
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2014
VL 27
BP 26
EP 38
DI 10.22203/eCM.v027a03
PG 13
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA AC3YI
UT WOS:000332457100003
PM 24464726
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhang, XF
   Han, PP
   Jaiprakash, A
   Wu, CT
   Xiao, Y
AF Zhang, Xufang
   Han, Pingping
   Jaiprakash, Anjali
   Wu, Chengtie
   Xiao, Yin
TI A stimulatory effect of Ca3ZrSi2O9 bioceramics on
   cementogenic/osteogenic differentiation of periodontal ligament cells
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MARROW STROMAL CELLS; TRICALCIUM PHOSPHATE CERAMICS; CALCIUM-SILICATE;
   OSTEOGENIC DIFFERENTIATION; STEM-CELLS; BIOLOGICAL-PROPERTIES;
   ATTACHMENT PROTEIN; BIOACTIVE CERAMICS; SIGNALING PATHWAY; IONIC
   PRODUCTS
AB The regeneration of periodontal tissues to cure periodontitis remains a medical challenge. Therefore, it is of great importance to develop a novel biomaterial that could induce cementogenesis and osteogenesis in periodontal tissue engineering. Calcium silicate (Ca-Si) based ceramics have been found to be potential bioactive materials due to their osteostimulatory effect. Recently, it is reported that zirconium modified calcium-silicate-based (Ca3ZrSi2O9) ceramics stimulate cell proliferation and osteogenic differentiation of osteoblasts. However, it is unknown whether Ca3ZrSi2O9 ceramics possess specific cementogenic stimulation for human periodontal ligament cells (hPDLCs) in periodontal tissue regeneration in vitro. The purpose of this study was to investigate whether Ca3ZrSi2O9 ceramic disks and their ionic extracts could stimulate cell growth and cementogenic/osteogenic differentiation of hPDLCs; the possible molecular mechanism involved in this process was also explored by investigating the Wnt/beta-catenin signalling pathway of hPDLCs. Our results showed that Ca3ZrSi2O9 ceramic disks supported cell adhesion, proliferation and significantly up-regulated relative alkaline phosphatase (ALP) activity, cementogenic/osteogenic gene expression (CEMP1, CAP, ALP and OPN) and Wnt/beta-catenin signalling pathway-related genes (AXIN2 and CTNNB) for hPDLCs, compared to that of beta-tricalcium phosphate (beta-TCP) bioceramic disks and blank controls. The ionic extracts from Ca3ZrSi2O9 powders also significantly enhanced relative ALP activity, cementogenic/osteogenic and Wnt/beta-catenin-related gene expression of hPDLCs. The present results demonstrate that Ca3ZrSi2O9 ceramics are capable of stimulating cementogenic/osteogenic differentiation of hPDLCs possibly via activation of the Wnt/beta-catenin signalling pathway, suggesting that Ca3ZrSi2O9 ceramics have the potential to be used for periodontal tissue regeneration.
C1 [Zhang, Xufang; Han, Pingping; Jaiprakash, Anjali; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Xiao, Y (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
EM chengtiewu@mail.sic.ac.cn; yin.xiao@qut.edu.au
OI zhang, xufang/0000-0003-0182-6755; Han, Pingping/0000-0001-7546-1635;
   Xiao, Yin/0000-0003-1785-3491
FU ARC [DP120103697]; Recruitment Program of Global Young Talent, China;
   Natural Science Foundation of China [31370963, 81201202, 81190132]; SIC,
   CAS
FX Funding for this study was provided by ARC Discovery (DP120103697), the
   Recruitment Program of Global Young Talent, China (Dr Wu), Natural
   Science Foundation of China (Grant 31370963, 81201202 and 81190132) and
   innovative project of SIC, CAS.
CR Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017
   Alvarez-Perez MA, 2006, BONE, V38, P409, DOI 10.1016/j.bone.2005.09.009
   Alves NM, 2010, J MATER CHEM, V20, P2911, DOI 10.1039/b910960a
   [Anonymous], 109935 ISOEN
   Bar-Kana I, 1998, EUR J ORAL SCI, V106, P357, DOI 10.1111/j.1600-0722.1998.tb02198.x
   Bosshardt DD, 2009, PERIODONTOL 2000, V51, P208, DOI 10.1111/j.1600-0757.2009.00317.x
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Galler KM, 2010, J MATER CHEM, V20, P8730, DOI 10.1039/c0jm01207f
   Gu HJ, 2011, BIOMATERIALS, V32, P7023, DOI 10.1016/j.biomaterials.2011.06.003
   Han PP, 2013, BIOMATER SCI-UK, V1, P379, DOI 10.1039/c2bm00108j
   Han PP, 2012, BIOMATERIALS, V33, P6370, DOI 10.1016/j.biomaterials.2012.05.061
   Hench L. L., 2010, J R SOC INTERFACE, V4, pS379
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Liu HW, 1997, J BONE MINER RES, V12, P1691, DOI 10.1359/jbmr.1997.12.10.1691
   Liu L, 2009, J ENDODONT, V35, P1368, DOI 10.1016/j.joen.2009.07.005
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   Peng WW, 2011, J ENDODONT, V37, P1240, DOI 10.1016/j.joen.2011.05.035
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006
   Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Silverio KG, 2010, J PERIODONTOL, V81, P1207, DOI 10.1902/jop.2010.090729
   Singh A, 2010, J MATER CHEM, V20, P8832, DOI 10.1039/c0jm01613f
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Wu CT, 2008, J BIOMED MATER RES B, V87B, P346, DOI 10.1002/jbm.b.31109
   Wu CT, 2008, J BIOMED MATER RES A, V86A, P402, DOI 10.1002/jbm.a.31623
   Wu C, 2007, J BIOMED MATER RES B, V83B, P153, DOI 10.1002/jbm.b.30779
   Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002
   Wu CT, 2014, ACTA BIOMATER, V10, P428, DOI 10.1016/j.actbio.2013.10.013
   Wu CT, 2013, J AM CERAM SOC, V96, P928, DOI 10.1111/jace.12059
   Wu CT, 2013, J MATER CHEM B, V1, P876, DOI 10.1039/c2tb00391k
   Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhang ML, 2012, J MATER CHEM, V22, P21686, DOI 10.1039/c2jm34395a
   Zhou YH, 2012, ACTA BIOMATER, V8, P2307, DOI 10.1016/j.actbio.2012.03.012
   Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2
NR 43
TC 7
Z9 7
U1 4
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 10
BP 1415
EP 1423
DI 10.1039/c3tb21663b
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AC0QN
UT WOS:000332199900015
DA 2018-10-20
ER

PT J
AU Giljean, S
   Bigerelle, M
   Anselme, K
AF Giljean, Sylvain
   Bigerelle, Maxence
   Anselme, Karine
TI Roughness Statistical Influence on Cell Adhesion Using Profilometry and
   Multiscale Analysis
SO SCANNING
LA English
DT Article
DE surface analysis; metrology; life sciences; polishing technique;
   computer simulation
ID OSTEOBLAST-LIKE CELLS; SURFACE-ROUGHNESS; STAINLESS-STEEL;
   TITANIUM-ALLOY; TOPOGRAPHY; ABRASION; MG63; TI-6AL-4V; GUIDANCE;
   PROLIFERATION
AB In this study, two series of 11 samples of TiAl6V4 titanium alloy and 316L stainless steel have been polished in an isotropic manner at different levels in order to quantify the influence of biomaterial roughness on cell behavior. Topography was measured by a tactile profilometer and a multiscale analysis has been carried out. Human osteoblasts have been cultured on those samples. It appears that roughness has no reproducible effect on the cell behavior except an influence on cell orientation on the wider grooves. As a conclusion, biomaterial surface damage, in the roughness range between R-a = 0.01 and 0.1 m, has no influence on cell-adhesion mechanisms when roughness is isotropic and groove width is inferior to a critical value. SCANNING 36:2-10, 2014. (c) 2012 Wiley Periodicals, Inc.
C1 [Giljean, Sylvain] Univ Haute Alsace, LPMT, EA 4365, F-68057 Mulhouse, France.
   [Bigerelle, Maxence] Univ Valenciennes & Hainaut Cambresis, LAMIH TEMPO, Le Mont Houy, Valenciennes, France.
   [Anselme, Karine] Univ Haute Alsace, Inst Sci Mat Mulhouse IS2M, CNRS, LRC7228, F-68057 Mulhouse, France.
RP Anselme, K (reprint author), Univ Haute Alsace, Inst Sci Mat Mulhouse IS2M, CNRS, LRC7228, 15 Rue Jean Starcky,BP 2488, F-68057 Mulhouse, France.
EM karine.anselme@uha.fr
OI Anselme, Karine/0000-0002-6669-205X; Maxence,
   Bigerelle/0000-0002-4144-245X; Giljean, Sylvain/0000-0002-8262-345X
FU Centre Technique des Industries Mecaniques
FX Contract grant sponsor: Centre Technique des Industries Mecaniques.
CR Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   Anselme K, 2002, TISSUE ENG, V8, P941, DOI 10.1089/107632702320934047
   Bigerelle M, 2011, ACTA BIOMATER, V7, P3302, DOI 10.1016/j.actbio.2011.05.013
   Bigerelle M, 2011, TRIBOL INT, V44, P63, DOI 10.1016/j.triboint.2010.08.002
   Bigerelle M, 2001, COMPUT MATH APPL, V42, P241, DOI 10.1016/S0898-1221(01)00148-1
   Bigerelle M, 2008, TRIBOL INT, V41, P992, DOI 10.1016/j.triboint.2008.03.015
   Bigerelle M, 2012, WEAR, V286, P124, DOI 10.1016/j.wear.2011.08.006
   Chen J, 2007, J BIOMED MATER RES B, V82B, P360, DOI 10.1002/jbm.b.30741
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1992, J CELL SCI, V103, P287
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Giljean S, 2008, SURF ENG, V24, P8, DOI 10.1179/174329408X271426
   Giljean S, 2007, P I MECH ENG B-J ENG, V221, P1407, DOI 10.1243/09544054JEM746
   Giljean S, 2010, J BIOMED MATER RES A, V94A, P1111, DOI 10.1002/jbm.a.32793
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Kim HJ, 2005, J BIOMED MATER RES A, V74A, P366, DOI 10.1002/jbm.a.30327
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Loesberg WA, 2005, J BIOMED MATER RES A, V75A, P723, DOI 10.1002/jbm.a.30480
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Sinnett-Jones PE, 2005, WEAR, V259, P898, DOI 10.1016/j.wear.2005.02.045
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Zhang H, 2009, WEAR, V266, P566, DOI 10.1016/j.wear.2008.04.076
NR 29
TC 5
Z9 6
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0161-0457
EI 1932-8745
J9 SCANNING
JI Scanning
PD JAN
PY 2014
VL 36
IS 1
SI SI
BP 2
EP 10
DI 10.1002/sca.21061
PG 9
WC Instruments & Instrumentation; Microscopy
SC Instruments & Instrumentation; Microscopy
GA AA7FA
UT WOS:000331261600002
PM 23165936
DA 2018-10-20
ER

PT J
AU Anselme, K
   Bigerelle, M
AF Anselme, K.
   Bigerelle, M.
TI On the Relation Between Surface Roughness of Metallic Substrates and
   Adhesion of Human Primary Bone Cells
SO SCANNING
LA English
DT Article
DE surface analysis; metrology; computer simulation; life sciences
ID LONG-TERM ADHESION; OSTEOBLAST ADHESION; MACHINED SURFACES; GRINDING
   PROCESS; TOPOGRAPHY; PARAMETERS; CHEMISTRY; SCALE; BIOMATERIALS;
   TITANIUM
AB Surface characteristics of materials, whether their topography, chemistry, or surface energy, play an essential part in osteoblast adhesion on biomaterials. Thus, the quality of cell adhesion will influence the cell's capacity to proliferate and differentiate in contact with a biomaterial. We have developed for more than ten years numerous studies on the influence of topography and chemistry of metallic substrates on the response of primary human bone cells. The originality of our approach is that contrary to most of other authors, we quantified the adhesion of primary human bone cells on metallic substrates with perfectly characterized surface topography after some hours but also over 21 days. Moreover, we have developed original statistical approaches for characterizing the relation between surface roughness and cell-adhesion parameters. In this article, we will illustrate different studies we did these last ten years concerning the development of a new adhesion parameter, the adhesion power; the correlation between short-term adhesion, long-term adhesion, and proliferation; the influence of roughness organization on cell adhesion and the development of the order parameter; our modeling approach of cell adhesion on surface topography; the relative influence of surface chemistry and topography on cell adhesion and contact angle; the relation between surface features dimensions and cell adhesion. Further, some considerations will be given on the methods for scanning surface topography for cell-adhesion studies. Finally, perspectives will be given to elucidate these intracellular mechanotransduction mechanisms induced by the deformation of cells on model sinusoidal peaks-or-valleys surfaces. SCANNING 36:11-20, 2014. (c) 2012 Wiley Periodicals, Inc.
C1 [Anselme, K.] Univ Haute Alsace, Inst Sci Mat Mulhouse, F-68057 Mulhouse, France.
   [Bigerelle, M.] Univ Valenciennes & Hainaut Cambresis, Lab LAMIH TEMPO, Le Mont Houy, Valenciennes, France.
RP Anselme, K (reprint author), Univ Haute Alsace, Inst Sci Mat Mulhouse, CNRS, LRC7228, F-68057 Mulhouse, France.
EM karine.anselme@uha.fr
OI Maxence, Bigerelle/0000-0002-4144-245X; Anselme,
   Karine/0000-0002-6669-205X
FU Cetim (Centre Technique des Industries Mecaniques)
FX Contract grant sponsor: Cetim (Centre Technique des Industries
   Mecaniques).
CR Anselme K, 2006, SURF COAT TECH, V200, P6325, DOI 10.1016/j.surfcoat.2005.11.001
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   ANSELME K, 1994, CELL MATER, V4, P113
   Bigerelle M, 2005, ACTA BIOMATER, V1, P499, DOI 10.1016/j.actbio.2005.06.001
   Bigerelle M, 2005, WEAR, V258, P232, DOI 10.1016/j.wear.2004.09.025
   Bigerelle M, 2005, J BIOMED MATER RES A, V75A, P530, DOI 10.1002/jbm.a.30473
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Bigerelle M, 2011, ACTA BIOMATER, V7, P3302, DOI 10.1016/j.actbio.2011.05.013
   Bigerelle M, 2003, J MATER SCI, V38, P2525, DOI 10.1023/A:1023929807546
   Bigerelle M, 2011, TRIBOL INT, V44, P63, DOI 10.1016/j.triboint.2010.08.002
   Bigerelle M, 2002, BIOMOL ENG, V19, P79, DOI 10.1016/S1389-0344(02)00048-5
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Bigerelle M, 2008, POLYM ENG SCI, V48, P1725, DOI 10.1002/pen.21131
   Bigerelle M, 2008, TRIBOL INT, V41, P992, DOI 10.1016/j.triboint.2008.03.015
   Bigerelle M, 2007, SENSOR ACTUAT B-CHEM, V126, P126, DOI 10.1016/j.snb.2006.11.006
   Brown CA, 2001, INT J MACH TOOL MANU, V41, P1927, DOI 10.1016/S0890-6955(01)00057-8
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalla Costa M, 2007, MICROELECTRON ENG, V84, P424, DOI 10.1016/j.mee.2006.10.068
   Emerson RJ, 2006, LANGMUIR, V22, P11311, DOI 10.1021/la061984u
   Giljean S, 2011, APPL SURF SCI, V7, P3302
   Jouini N, 2009, INT J SURF SCI ENG, V3, P310, DOI 10.1504/IJSURFSE.2009.027418
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Najjar D, 2003, WEAR, V254, P450, DOI 10.1016/S0043-1648(03)00140-6
   Nebe JGB, 2007, MACROMOL BIOSCI, V7, P567, DOI 10.1002/mabi.200600293
   Van Gorp A, 2007, MAT SCI ENG C-BIO S, V27, P1434, DOI 10.1016/j.msec.2006.09.041
   Van Gorp A, 2010, INT J MATER PROD TEC, V38, P16, DOI 10.1504/IJMPT.2010.031892
NR 32
TC 10
Z9 11
U1 1
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0161-0457
EI 1932-8745
J9 SCANNING
JI Scanning
PD JAN
PY 2014
VL 36
IS 1
SI SI
BP 11
EP 20
DI 10.1002/sca.21067
PG 10
WC Instruments & Instrumentation; Microscopy
SC Instruments & Instrumentation; Microscopy
GA AA7FA
UT WOS:000331261600003
PM 23203601
DA 2018-10-20
ER

PT J
AU Rochford, ETJ
   Poulsson, AHC
   Varela, JS
   Lezuo, P
   Richards, RG
   Moriarty, TF
AF Rochford, E. T. J.
   Poulsson, A. H. C.
   Salavarrieta Varela, J.
   Lezuo, P.
   Richards, R. G.
   Moriarty, T. F.
TI Bacterial adhesion to orthopaedic implant materials and a novel oxygen
   plasma modified PEEK surface
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Bacterial adhesion; Infection; Polyetheretherketone (PEEK); Surface
   roughness; Surface treatment; Titanium
ID STAPHYLOCOCCUS-AUREUS ADHESION; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   CLUMPING FACTOR; PROTEIN ADSORPTION; BIOFILM FORMATION; BIOMATERIAL;
   EPIDERMIDIS; FIBRINOGEN; INFECTIONS; RETENTION
AB Despite extensive use of polyetheretherketone (PEEK) in biomedical applications, information about bacterial adhesion to this biomaterial is limited. This study investigated Staphylococcus aureus and Staphylococcus epidermidis adhesion to injection moulded and machined PEEK OPTIMA (R) using a custom-built adhesion chamber with medical grade titanium and Thermanox for comparison. Additionally, bacterial adhesion to a novel oxygen plasma modified PEEK was also investigated in both a pre-operative model in physiological saline, and additionally in a post-operative model in human blood plasma.
   In the pre-operative model, the rougher machined PEEK had a significantly greater number of adherent bacteria compared to injection moulded PEEK. Bacterial adhesion to titanium and Thermanox was similar. Oxygen plasma surface modification of PEEK did not lead to a significant change in bacterial adhesion in the pre-operative contamination model, despite observed changes in surface characteristics. In the post-operative contamination model, S. aureus adhesion was increased from 5 x 10(5) CFU cm(-2) to approximately 1.3 x 10(7) CFU cm(-2) on the modified surfaces due to differential protein adhesion during the conditioning period. However, S. epidermidis adhesion to modified PEEK was less than to unmodified PEEK in the post-operative model. These results illustrate the importance of testing bacterial adhesion of several strains in both a pre-operative and post-operative, clinically relevant bacterial contamination model. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Rochford, E. T. J.; Poulsson, A. H. C.; Salavarrieta Varela, J.; Lezuo, P.; Richards, R. G.; Moriarty, T. F.] AO Res Inst Davos, Davos, Switzerland.
   [Rochford, E. T. J.; Richards, R. G.] Aberystwyth Univ, IBERS, Aberystwyth, Dyfed, Wales.
   [Salavarrieta Varela, J.] Hosp Univ Fdn Santa Fe Bogota, Bogota, Colombia.
   [Richards, R. G.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.
RP Moriarty, TF (reprint author), AO Fdn, AO Res Inst Davos, Clavadelerstr 8,Davos Pl, CH-7270 Davos, Switzerland.
EM fintan.moriarty@aofoundation.org
RI Richards, Robert/I-8235-2015
OI Richards, Robert/0000-0002-7778-2480; Moriarty,
   Fintan/0000-0003-2307-0397
FU Invibio Biomaterial Solutions, UK
FX Financial contribution and PEEK discs from Invibio Biomaterial
   Solutions, UK. Dr. Schulzki, RBSD SRK GR, Switzerland for fresh frozen
   plasma bags. Synthes Inc., Switzerland, provided Titanium discs. CCE,
   Glasgow University, UK and especially Dr N. Gadegaard for kind use of
   AFM. Robert Mathys Foundation, Bettlach, Switzerland for XPS
   measurements.
CR ABBEY DM, 1995, J SPINAL DISORD, V8, P278, DOI 10.1097/00002517-199508040-00003
   Amanatides E, 2006, SURF COAT TECH, V200, P6331, DOI 10.1016/j.surfcoat.2005.11.002
   [Anonymous], 1996, J BONE JOINT SURG BR, V78, P647
   Awaja F, 2012, PLASMA PROCESS POLYM, V9, P355, DOI 10.1002/ppap.201100034
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Baumgartner JN, 1998, J BIOMED MATER RES, V40, P660, DOI 10.1002/(SICI)1097-4636(19980615)40:4<660::AID-JBM18>3.0.CO;2-J
   Beiner John M, 2003, Neurosurg Focus, V15, pE14
   Bichler C, 1999, SURF COAT TECH, V112, P373, DOI 10.1016/S0257-8972(98)00780-4
   BODEN MK, 1989, INFECT IMMUN, V57, P2358
   BRENNAN WJ, 1991, POLYMER, V32, P1527, DOI 10.1016/0032-3861(91)90436-M
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   Deirmengian C, 2003, J ARTHROPLASTY, V18, P22, DOI 10.1054/S0883-5403(03)00288-2
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   Donlan RM, 2004, APPL ENVIRON MICROB, V70, P4980, DOI 10.1128/AEM.70.8.4980-4988.2004
   ESPERSEN F, 1990, APMIS, V98, P471, DOI 10.1111/j.1699-0463.1990.tb01059.x
   FLETCHER M, 1976, J GEN MICROBIOL, V94, P400, DOI 10.1099/00221287-94-2-400
   Flint SH, 2000, J FOOD ENG, V43, P235, DOI 10.1016/S0260-8774(99)00157-0
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7
   Gao LC, 2007, LANGMUIR, V23, P3762, DOI 10.1021/la062634a
   Gorth DJ, 2012, INT J NANOMED, V7, P4829, DOI 10.2147/IJN.S35190
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Greene S. L., 2001, Plant Genetic Resources Newsletter, P1
   Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006
   Kinnari TJ, 2010, CLIN MICROBIOL INFEC, V16, P1036, DOI 10.1111/j.1469-0691.2009.02995.x
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   Levi ADO, 1997, J NEUROSURG, V86, P975, DOI 10.3171/jns.1997.86.6.0975
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   McKenzie DR, 2004, SURF COAT TECH, V186, P239, DOI 10.1016/j.surfcoat.2004.04.093
   Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X
   MOREILLON P, 1995, INFECT IMMUN, V63, P4738
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   Nilsdotter-Augustinsson A, 2005, APMIS, V113, P361, DOI 10.1111/j.1600-0463.2005.apm_113508.x
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   Poulsson A.H.C., 2009, Patent No. [WO 2009/149827 A1, 2009149827, W02009/149827A1]
   Poulsson AHC, 2012, PDL HANDB SER, P145, DOI 10.1016/B978-1-4377-4463-7.10010-7
   Rivard CH, 2002, J BIOMED MATER RES, V62, P488, DOI 10.1002/jbm.10159
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   SLACK SM, 1987, ANN NY ACAD SCI, V516, P223, DOI 10.1111/j.1749-6632.1987.tb33044.x
   Tang HY, 2006, COLLOID SURFACE B, V51, P16, DOI 10.1016/j.colsurfb.2006.04.011
   Tant M.R., 1995, ACS SYM SER, P1
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   van der Mei HC, 1997, MICROBIOL-UK, V143, P3861, DOI 10.1099/00221287-143-12-3861
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   VAUDAUX PE, 1995, INFECT IMMUN, V63, P585
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   Weinstein MA, 2000, J SPINAL DISORD, V13, P422, DOI 10.1097/00002517-200010000-00009
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
NR 57
TC 31
Z9 32
U1 4
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2014
VL 113
BP 213
EP 222
DI 10.1016/j.colsurfb.2013.09.012
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AB3CZ
UT WOS:000331670200027
PM 24103502
DA 2018-10-20
ER

PT J
AU Antonini, V
   Torrengo, S
   Marocchi, L
   Minati, L
   Serra, MD
   Bao, G
   Speranza, G
AF Antonini, V.
   Torrengo, S.
   Marocchi, L.
   Minati, L.
   Serra, M. Dalla
   Bao, G.
   Speranza, G.
TI Combinatorial plasma polymerization approach to produce thin films for
   testing cell proliferation
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Cell proliferation; Combinatorial plasma polymerization; C-based thin
   films; XPS; Contact angle
ID SURFACE-CHEMISTRY; OXIDE NANOPARTICLES; PROTEIN ADSORPTION; INTEGRIN
   BINDING; ADHESION; FIBRONECTIN; CHARGE; INTERFACES; BIOCOMPATIBILITY;
   INTERNALIZATION
AB Plasma enhanced physical vapor depositions are extensively used to fabricate substrates for cell culture applications. One peculiarity of the plasma processes is the possibility to deposit thin films with reproducible chemical and physical properties. In the present work, a combinatorial plasma polymerization process was used to deposit thin carbon based films to promote cell adhesion, in the interest of testing cell proliferation as a function of the substrate chemical properties. Peculiarity of the combinatorial approach is the possibility to produce in just one deposition experiment, a set of surfaces of varying chemical moieties by changing the precursor composition. A full characterization of the chemical, physical and thermodynamic properties was performed for each set of the synthesized surfaces. X-ray photoelectron spectroscopy was used to measure the concentration of carboxyl, hydroxyl and amine functional groups on the substrate surfaces. A perfect linear trend between polar groups' density and precursors' concentration was found. Further analyses reveled that also contact angles and the correspondent surface energies of all deposited thin films are linearly dependent on the precursor concentration. To test the influence of the surface composition on the cell adhesion and proliferation, two cancer cell lines were utilized. The cell viability was assessed after 24 h and 48 h of cell culture. Experiments show that we are able to control the cell adhesion and proliferation by properly changing the thin film deposition conditions i.e. the concentration and the kind of chemical moiety on the substrate surface. The results also highlight that physical and chemical factors of biomaterial surface, including surface hydrophobicity and free energy, chemical composition, and topography, can altered cell attachment. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Antonini, V.; Serra, M. Dalla] Ist Biofis, Consiglio Nazl Ric, I-38123 Trento, Italy.
   [Torrengo, S.; Marocchi, L.; Minati, L.; Speranza, G.] Fdn Bruno Kessler, I-38123 Trento, Italy.
   [Minati, L.; Speranza, G.] Ist Foton Nanotecnol, Consiglio Nazl Ric, I-38123 Trento, Italy.
   [Bao, G.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Bao, G.] Emory Univ, Atlanta, GA 30332 USA.
RP Speranza, G (reprint author), Fdn Bruno Kessler, V Sommarie 18, I-38123 Trento, Italy.
EM speranza@fbk.eu
RI Dalla Serra, Mauro/A-6218-2010; Speranza, Giorgio/G-6275-2011
OI Dalla Serra, Mauro/0000-0003-1048-2739; Speranza,
   Giorgio/0000-0003-1478-0995
CR Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Carre A, 2010, J ADHES SCI TECHNOL, V24, P815, DOI 10.1163/016942409X12598231567862
   CARTER HB, 1988, J UROLOGY, V140, P173
   Chisholm BJ, 2007, J COAT TECHNOL RES, V4, P1, DOI 10.1007/s11998-007-9000-9
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   Dash BC, 2010, BIOMATERIALS, V31, P8188, DOI 10.1016/j.biomaterials.2010.07.067
   Ercole F, 2003, J APPL POLYM SCI, V89, P3371, DOI 10.1002/app.12574
   Ganzevles RA, 2007, ROY SOC CH, P195, DOI 10.1039/9781847557698-00195
   Grinnell F., 1981, MAT RES, V15, P338
   Gugutkov D, 2010, J BIOMED MATER RES A, V92A, P322, DOI 10.1002/jbm.a.32374
   Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n
   Horbett TA, 1995, ACS SYM SER, V602, P1
   Jager M, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/69036
   Jandeleit B., 1999, ANGEW CHEM INT EDIT, V38, P2494
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   Katainen J, 2006, J COLLOID INTERF SCI, V304, P524, DOI 10.1016/j.jcis.2006.09.015
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kwok DY, 1998, POLYM ENG SCI, V38, P1675, DOI 10.1002/pen.10338
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LOPEZ LC, 2008, ADV PLASMA TECHNOL, P269
   Lutol F M.P., 2005, NAT BIOTECHNOL, V23, P47
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Osaka T, 2009, COLLOID SURFACE B, V71, P325, DOI 10.1016/j.colsurfb.2009.03.004
   Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   PHILLIPS HJ, 1973, TISSUE CULTURE METHO, P406
   Pistillo BR, 2009, PLASMA PROCESS POLYM, V6, pS61, DOI 10.1002/ppap.200930308
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Sardella E., 2005, PLASMA PROCESS POLYM, P373
   Sardella E, 2008, PLASMA PROCESS POLYM, V5, P540, DOI 10.1002/ppap.200800005
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Seong I.W., 2005, QSAR COMB SCI, V24, P138
   Siboni S, 2004, J COLLOID INTERF SCI, V271, P454, DOI 10.1016/j.jcis.2003.09.050
   Takeuchi I, 2002, APPL SURF SCI, V189, P353, DOI 10.1016/S0169-4332(01)01027-3
   Takeuchi I, 2005, MATER TODAY, V8, P18, DOI 10.1016/S1369-7021(05)71121-4
   TATOULIAN M, 1998, PLASMAS POLYM, V3, P211
   Thelakkat M, 2004, MACROMOL RAPID COMM, V25, P204, DOI 10.1002/marc.200300254
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Wang L, 2010, J BIOMED MATER RES A, V93A, P1260, DOI 10.1002/jbm.a.32621
   WEISS L, 1971, J CELL PHYSIOL, V77, P179, DOI 10.1002/jcp.1040770208
   Xu Y, 2009, BIOMATERIALS, V30, P4930, DOI 10.1016/j.biomaterials.2009.06.005
   Yamada K, 2006, JPN J APPL PHYS 1, V45, P4259, DOI 10.1143/JJAP.45.4259
   Yool Y.K., 2002, J PHYS CONDENS MATT, V14, pR49
   Zenkiewicz M.J., 2007, ACHIEVEMENTS MAT MAN, V24, P137
   Zhang Y, 2009, SMALL, V5, P1990, DOI 10.1002/smll.200900520
NR 52
TC 8
Z9 9
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2014
VL 113
BP 320
EP 329
DI 10.1016/j.colsurfb.2013.09.020
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AB3CZ
UT WOS:000331670200041
PM 24121075
DA 2018-10-20
ER

PT J
AU Kikuchi, S
   Kameyama, Y
   Mizutani, M
   Komotori, J
AF Kikuchi, Shoichi
   Kameyama, Yutaka
   Mizutani, Masayoshi
   Komotori, Jun
TI Effects of Fine Particle Peening on Oxidation Behavior of
   Nickel-Titanium Shape Memory Alloy
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shot peening; oxidation; amorphous; nickel-titanium shape memory alloy;
   biomaterial
ID IMMERSION ION-IMPLANTATION; SURFACE-LAYER; IRON
AB The effects of fine particle peening (FPP) on oxidation behavior of nickel titanium shape memory alloy (Ni-Ti alloy) were evaluated. After FPP treatment, oxidation process was performed at 300, 400 and 500 degrees C for 30 min in N-2-20 vol%O-2 atmosphere. Surface microstructures of oxidized specimens pre-treated with FPP were characterized using scanning electron microscope (SEM), glow discharge optical emission spectroscopy (GD-OES), X-ray photoelectron spectroscopy (XPS) and X-ray diffraction analysis (XRD). Oxide layers formed on the specimens pre-treated with FPP were thinner than those on the un-peened ones. Amorphous titanium oxides (TiO and TiO2) were formed on the un-peened specimens by oxidation process, whereas a nickel oxide (NiO) was created on the FPP-treated surface oxidized at temperature greater than 400 degrees C as well as titanium oxides. This was because an amorphous structure created by FPP accelerated the outward growth of nickel oxide during the subsequent oxidation process. Moreover, the effects of surface oxide layers on the biocompatibility of Ni-Ti alloy were investigated. Due to the formation of a thin oxide layer which contains nickel element, the oxidized specimen pre-treated with FPP showed higher amount of nickel ion elution than that of the oxidized one during the cell culture tests. These results suggest that microstructural feature of surface oxide layer strongly affects the biocompatibility of Ni-Ti alloy.
C1 [Kikuchi, Shoichi] Ritsumeikan Univ, Coll Sci & Engn, Dept Mech Engn, Kusatsu 5258577, Japan.
   [Kameyama, Yutaka] Tokyo City Univ, Dept Mech Engn, Fac Engn, Tokyo 1588557, Japan.
   [Mizutani, Masayoshi] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan.
   [Komotori, Jun] Keio Univ, Fac Sci & Technol, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan.
RP Komotori, J (reprint author), Keio Univ, Fac Sci & Technol, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan.
EM komotori@mech.keio.ac.jp
FU Light Metal Educational Foundation, Inc.
FX The authors would like to thank The Light Metal Educational Foundation,
   Inc. for the support.
CR Armitage DA, 2003, MAT SCI ENG A-STRUCT, V349, P89, DOI 10.1016/S0921-5093(02)00818-3
   Heumann T., 2005, DIFFUSION METALLEN, P299
   Ito T, 2010, J JPN I MET, V74, P533, DOI 10.2320/jinstmet.74.533
   Kikuchi Shoichi, 2012, Journal of Solid Mechanics and Materials Engineering, V6, P431, DOI 10.1299/jmmp.6.431
   Kikuchi S., 2008, J SOLID MECH MAT ENG, V2, P1330
   Kikuchi S., 2008, J SOLID MECH MAT ENG, V2, P1444
   Kikuchi S., 2013, J JPN ABRAS TECHNOL, V57, P530
   Kikuchi S, 2009, J MATER PROCESS TECH, V209, P6156, DOI 10.1016/j.jmatprotec.2009.04.024
   Kikuchi S, 2010, INT J FATIGUE, V32, P403, DOI 10.1016/j.ijfatigue.2009.07.019
   Michiardi A, 2007, SURF COAT TECH, V201, P6484, DOI 10.1016/j.surfcoat.2006.12.023
   Mizutani M., 2011, T JPN SOC MECH ENG, V77, P2144
   Poon RWY, 2006, NUCL INSTRUM METH B, V242, P270, DOI 10.1016/j.nimb.2005.08.045
   Poon RWY, 2005, BIOMATERIALS, V26, P2265, DOI 10.1016/j.biomaterials.2004.07.056
   Sasago A., J JAPAN I METALS, V72, P347
   Sugawara H., 2006, Journal of the Society of Materials Science, Japan, V55, P965, DOI 10.2472/jsms.55.965
   Sui JH, 2006, NUCL INSTRUM METH B, V248, P67, DOI 10.1016/j.nimb.2006.04.054
   Taniguchi S., 2007, B IRON STEEL I JPN, V12, P695
   Tong WP, 2007, SCRIPTA MATER, V57, P533, DOI 10.1016/j.scriptamat.2007.05.017
   Tong WP, 2003, SCIENCE, V299, P686, DOI 10.1126/science.1080216
   Wang ZB, 2003, ACTA MATER, V51, P4319, DOI 10.1016/S1359-6454(03)00260-X
   Wroblewski G, 2006, SURF ENG, V22, P138, DOI 10.1179/174329406X85010
NR 21
TC 4
Z9 4
U1 0
U2 13
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JAN
PY 2014
VL 55
IS 1
BP 176
EP 181
DI 10.2320/matertrans.M2013336
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AB5UW
UT WOS:000331855200031
OA Bronze
DA 2018-10-20
ER

PT J
AU Magda, J
   Cho, SH
   Streitmatter, S
   Jevremovic, T
AF Magda, Jules
   Cho, Seung-Hei
   Streitmatter, Seth
   Jevremovic, Tatjana
TI Effects of gamma rays and neutron irradiation on the glucose response of
   boronic acid-containing "smart" hydrogels
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Hydrogels; Gamma rays; Stimuli-responsive; Boron neutron capture
   therapy; Nuclear reactor; Glucose
ID STERILIZATION; SENSORS
AB If a biomaterial is to be implanted in the body, it must be subjected to a sterilization procedure which often involves gamma irradiation. We report results for the effects of gamma-irradiation on the glucose response of a hydrogel with glucose-binding boronic acid moieties. This 'smart" hydrogel is of a type suitable for use in non-enzymatic glucose sensors. In addition, the effect of neutron irradiation on the glucose response of these hydrogels is also of interest, because the hydrogels could be used with minor modification to deliver boron to tumors during boron neutron capture therapy (BNCT). We show that the glucose response of the smart hydrogels is unaffected by exposure to neutrons in the dose range typical for BNCT. The effect of gamma rays on the glucose response depends on the method used to cure the smart hydrogel. If the hydrogel is cured with a thermal free-radical-initiator, then the hydrogel can be sterilized by gamma irradiation with no adverse effects upon the glucose response. However, if the hydrogel is cured with a UV-initiated free radical initiator, then the glucose response decreases in magnitude with increase in the gamma radiation dose. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Magda, Jules; Cho, Seung-Hei; Jevremovic, Tatjana] Univ Utah, Dept Chem Engn, Salt Lake City, UT 84112 USA.
   [Streitmatter, Seth; Jevremovic, Tatjana] Univ Utah, Nucl Engn Program UNEP, Salt Lake City, UT 84112 USA.
RP Magda, J (reprint author), Univ Utah, 50 S Cent Campus Dr,Rm 3290, Salt Lake City, UT 84112 USA.
EM jj.magda@utah.edu
OI Magda, Jules/0000-0002-1063-6526
FU Neopanora Institute Network of Energy Technologies; University of Utah
   Nuclear Engineering Program (UNEP)
FX This research was supported by the Neopanora Institute Network of Energy
   Technologies, and the University of Utah Nuclear Engineering Program
   (UNEP).
CR Bio-process Systems Alliance Irradiation and Sterilization Subcommittee, 2008, BIOPROC INT      MAY
   Cambre JN, 2011, POLYMER, V52, P4631, DOI 10.1016/j.polymer.2011.07.057
   Elijarrat-Binstock E, 2007, POLYM ADVAN TECHNOL, V18, P720
   Fedorovich NE, 2007, TISSUE ENG, V13, P1904
   Fernandez-Carballido A, 2006, INT J PHARM, V313, P129, DOI 10.1016/j.ijpharm.2006.01.034
   GEHRKE SH, 1993, ADV POLYM SCI, V110, P81
   Guenther M, 2010, P SOC PHOTO-OPT INS, V7642
   Horkay F, 2011, SENSOR ACTUAT B-CHEM, V160, P1363, DOI 10.1016/j.snb.2011.09.079
   Kanjickal D, 2008, J BIOMED MATER RES A, V88A, P409
   Kanjickal D, 2008, J BIOMED MATER RES A, V87A, P608, DOI 10.1002/jbm.a.31811
   Lin G, 2010, SENSOR ACTUAT B-CHEM, V144, P332, DOI 10.1016/j.snb.2009.07.054
   Lin G, 2009, SENSOR ACTUAT B-CHEM, V136, P186, DOI 10.1016/j.snb.2008.11.001
   Morris GM, 2012, TXB NEUTRON CAPTURE
   Park SE, 2004, J APPL POLYM SCI, V91, P636, DOI 10.1002/app.13211
   Pelowitz BD, LACP1100438 LOS AL N
   Stringer RC, 2011, ANAL CHIM ACTA, V703, P239, DOI 10.1016/j.aca.2011.07.034
   Tse J.R., 2010, CURRENT PROTOCOLS CE
   Tyan YC, 2003, J BIOMED MATER RES A, V67A, P1033, DOI 10.1002/jbm.a.10024
NR 18
TC 5
Z9 5
U1 1
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
EI 1873-2321
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD JAN
PY 2014
VL 99
BP 219
EP 222
DI 10.1016/j.polymdegradstab.2013.11.002
PG 4
WC Polymer Science
SC Polymer Science
GA AB9RV
UT WOS:000332134300027
DA 2018-10-20
ER

PT J
AU Tan, YH
   Terrill, SE
   Paranjape, GS
   Stine, KJ
   Nichols, MR
AF Tan, Yih Horng
   Terrill, Shana E.
   Paranjape, Geeta S.
   Stine, Keith J.
   Nichols, Michael R.
TI The influence of gold surface texture on microglia morphology and
   activation
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID SCANNING-ELECTRON-MICROSCOPY; SELF-ASSEMBLED MONOLAYERS;
   TUMOR-NECROSIS-FACTOR; NANOPOROUS GOLD; PROTEIN IMMOBILIZATION;
   NERVOUS-SYSTEM; DRUG-DELIVERY; CELL-CULTURE; BIOMATERIALS; BRAIN
AB Microglial cells play a critical role in the propagation of neuroinflammation in the central nervous system. Microglia sense and respond to environmental signals including chemical, physical and biological cues from the surrounding cell/tissue components. In this project, our goal was to examine the effects of surface texture on BV-2 microglia morphology and function by comparing flat and nanoporous gold (np-Au) surfaces to the more conventional glass. The biocompatibility of np-Au with microglia was evaluated using functional cell assays and high resolution imaging with scanning electron microscopy (SEM). Microglia seeded on glass, ultra-flat gold (UF-Au), ultra-thin (UT) np-Au and np-Au monolith were adherent to all surfaces and their viability was not compromised as assessed by multiple toxicity assays. SEM revealed detailed morphological characteristics of adherent microglia and indicated few dramatic changes as a result of the different surfaces. Microglia proliferation was hampered by np-Au monolith but less by UT np-Au and not at all on UF-Au or glass. Microglial activation, measured by tumor necrosis factor a (TNF alpha) production, was fully functional (and equivalent) on all gold surfaces compared to glass. The present findings should help further the understanding of basic microglia biology on textured surfaces and more fully evaluate np-Au as a multi-functional biocompatible material. The knowledge obtained and technology developed will have a significant impact in the fabrication of nanoelectronic devices, chemical sensor development, porous nanostructured materials for BioMEMs/NEMs integration, and functional biomaterial coatings for drug delivery.
C1 [Tan, Yih Horng] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA.
   Univ Missouri, Ctr Nanosci, St Louis, MO 63121 USA.
RP Tan, YH (reprint author), Univ Missouri, Dept Chem & Biochem, 1 Univ Blvd, St Louis, MO 63121 USA.
EM nicholsmic@umsl.edu
FU Australian Research Council [DP110902183]; National Health and Medical
   Research Council [APP1024723]; University of New South Wales
FX The authors thank the Australian Research Council (DP110902183) and the
   National Health and Medical Research Council (APP1024723) and the
   University of New South Wales for financial support for different
   aspects of this work.
CR Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
   Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h
   Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831
   Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997
   HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4
   Huang JH, 2010, SOFT MATTER, V6, P3395, DOI 10.1039/b927168f
   Hutter E, 2010, ACS NANO, V4, P2595, DOI 10.1021/nn901869f
   Jans H, 2012, CHEM SOC REV, V41, P2849, DOI 10.1039/c1cs15280g
   Kloss CUA, 2001, EXP NEUROL, V168, P32, DOI 10.1006/exnr.2000.7575
   KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6
   Leung BK, 2008, BIOMATERIALS, V29, P3289, DOI 10.1016/j.biomaterials.2008.03.045
   Motta PS, 2005, IEEE T BIO-MED ENG, V52, P923, DOI 10.1109/TBME.2005.845225
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Mrksich M, 2009, ACTA BIOMATER, V5, P832, DOI 10.1016/j.actbio.2009.01.016
   Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Pandey B, 2012, J CARBOHYD CHEM, V31, P466, DOI 10.1080/07328303.2012.683909
   Paranjape GS, 2012, ACS CHEM NEUROSCI, V3, P302, DOI 10.1021/cn2001238
   Park TH, 2003, BIOTECHNOL PROGR, V19, P243, DOI 10.1021/bp020143k
   Persheyev S, 2011, J BIOMED MATER RES A, V99A, P135, DOI 10.1002/jbm.a.33159
   Seker E, 2012, ADV HEALTHC MATER, V1, P172, DOI 10.1002/adhm.201200002
   Shulga OV, 2008, ANALYST, V133, P319, DOI 10.1039/b712760j
   Shulga OV, 2007, CHEM MATER, V19, P3902, DOI 10.1021/cm070238n
   Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a
   Syed MM, 2007, J NEUROCHEM, V103, P1461, DOI 10.1111/j.1471-4159.2007.04838.x
   Tan YH, 2013, NEW J CHEM, V37, P2150, DOI 10.1039/c3nj00253e
   Tan YH, 2012, J MATER CHEM, V22, P6733, DOI 10.1039/c2jm16633j
   Tan YH, 2011, NANOSCALE, V3, P3395, DOI 10.1039/c1nr10427f
   Tan YH, 2008, ACS NANO, V2, P2374, DOI 10.1021/nn800508f
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6
   Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919
   Wei MY, 2011, J COLLOID INTERF SCI, V356, P182, DOI 10.1016/j.jcis.2010.12.079
   Wittstock A, 2010, SCIENCE, V327, P319, DOI 10.1126/science.1183591
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 36
TC 14
Z9 14
U1 1
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 1
BP 110
EP 120
DI 10.1039/c3bm60096c
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA 296HX
UT WOS:000330177000012
DA 2018-10-20
ER

PT J
AU Kijenska, E
   Prabhakaran, MP
   Swieszkowski, W
   Kurzydlowski, KJ
   Ramakrishna, S
AF Kijenska, Ewa
   Prabhakaran, Molamma P.
   Swieszkowski, Wojciech
   Kurzydlowski, Krzysztof J.
   Ramakrishna, Seeram
TI Interaction of Schwann cells with laminin encapsulated PLCL core-shell
   nanofibers for nerve tissue engineering
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Co-axial electrospinning; Laminin; Nerve regeneration; Schwann cells;
   S-100 protein
ID PERIPHERAL-NERVE; STEM-CELLS; ELECTROSPUN NANOFIBERS;
   MECHANICAL-PROPERTIES; REGENERATION; SCAFFOLDS; DIFFERENTIATION;
   MYELINATION; FABRICATION; AUTOGRAFTS
AB Nerve tissue engineering (TE) is a rapidly expanding area of research advancing towards the repair and regeneration of non-union peripheral nerve defects caused by injuries. The current challenge for researchers is to develop a biomimetic scaffold that is capable of stimulating the re-growth of the native tissue, thus structurally mimicking the extracellular matrix (ECM), providing chemical guidance cues and mechanical support for re-enervation of the damaged region. Laminin is a glycoprotein naturally occurring in nerves and it plays a significant role towards the migration of nerve cells and axonal outgrowth. In this study, laminin incorporated scaffolds were produced by co-axial electrospinning and blend electrospinning techniques, in order to develop suitable biomaterial constructs for peripheral nerve tissue regeneration. Core-shell and blend nanofibers of laminin incorporated poly(L-lactic acid)-co-poly(epsilon-caprolactone) (PLCL) with diameters of 316 +/- 110 nm and 350 +/- 112 nm were respectively, fabricated and the morphology, surface hydrophilicity, chemical and mechanical properties were investigated. The ability of attachment and proliferation of Schwann cells on the electrospun nanofibrous scaffolds was investigated by cell proliferation assay and their phenotype was evaluated by immunocytochemical staining using specific S100 antibody. The cells were found to attach and proliferate on core-shell PLCL-laminin scaffolds, expressing bi- and tri-polar elongations retaining their typical phenotype. Results of 7 days of in vitro culture of Schwann cells, showed 78% increase in cell proliferation on core-shell structured nanofibers compared to blend PLCL-laminin scaffolds, which confirmed the potential application of these constructs as substrates for peripheral nerve regeneration. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Kijenska, Ewa; Prabhakaran, Molamma P.; Ramakrishna, Seeram] Natl Univ Singapore, Fac Engn, Ctr Nanofibers & Nanotechnol, Nanosci & Nanotechnol Initiat, Singapore 117576, Singapore.
   [Kijenska, Ewa; Swieszkowski, Wojciech; Kurzydlowski, Krzysztof J.] Warsaw Univ Technol, Fac Mat Sci & Engn, Mat Design Div, PL-02507 Warsaw, Poland.
   [Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
RP Prabhakaran, MP (reprint author), Natl Univ Singapore, Fac Engn, Ctr Nanofibers & Nanotechnol, Nanosci & Nanotechnol Initiat, E3-05-14,2 Engn Dr 3, Singapore 117576, Singapore.
EM nnimpp@nus.edu.sg
OI Kijenska-Gawronska, Ewa/0000-0002-2614-2838
FU European Union; Academic Research from the National University of
   Singapore; NUS Nanoscience and Nanotechnology Initiative
FX This work has been supported by the European Union in the framework of
   European Social Fund through the Warsaw University of Technology
   Development Programme, realized by Center of Advanced Studies. This
   study was supported by the Academic Research from the National
   University of Singapore and NUS Nanoscience and Nanotechnology
   Initiative.
CR ALBERTS B, 1994, MOL BIOL CELL
   Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Borschel GH, 2003, J SURG RES, V114, P133, DOI 10.1016/S0022-4804(03)00255-5
   Chan JR, 2007, J CELL BIOL, V177, P953, DOI 10.1083/jcb.200705105
   Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068
   ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001
   FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43
   Feltri ML, 2005, J PERIPHER NERV SYST, V10, P128, DOI 10.1111/j.1085-9489.2005.0010204.x
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   He LM, 2010, ACTA BIOMATER, V6, P2960, DOI 10.1016/j.actbio.2010.02.039
   Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029
   Ide C, 1998, EXP NEUROL, V154, P99, DOI 10.1006/exnr.1998.6921
   Keilhoff G, 2006, TISSUE ENG, V12, P1451, DOI 10.1089/ten.2006.12.1451
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kijenska E, 2012, J BIOMED MATER RES B, V100B, P1093, DOI 10.1002/jbm.b.32676
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5
   Li XQ, 2010, COLLOID SURFACE B, V75, P418, DOI 10.1016/j.colsurfb.2009.09.014
   Mercurio AM, 1990, CURR OPIN CELL BIOL, V2, P845, DOI 10.1016/0955-0674(90)90082-P
   MILLESI H, 1995, CLIN ORTHOP RELAT R, P76
   Myckatyn TM, 2004, NEUROL RES, V26, P124, DOI 10.1179/016164104225013743
   Neal RA, 2012, J BIOMED MATER RES A, V100A, P406, DOI 10.1002/jbm.a.33204
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Nishiura Y, 2004, TISSUE ENG, V10, P157, DOI 10.1089/107632704322791808
   Norouzi M, POLYM INT, DOI DOI 10.1002/PIA416
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P876, DOI 10.1002/jbm.a.10074
   Rodrigues MCO, 2012, SCI WORLD J, DOI 10.1100/2012/413091
   SCHITTNY JC, 1988, J CELL BIOL, V107, P1599, DOI 10.1083/jcb.107.4.1599
   Slutsky D.J., 2005, ATLAS HAND CLIN, V10, P73
   Su Y, 2012, ACTA BIOMATER, V8, P763, DOI 10.1016/j.actbio.2011.11.002
   Tan SH, 2005, POLYMER, V46, P6128, DOI 10.1016/j.polymer.2005.05.068
   Wang C, 2011, WOODHEAD PUBL MATER, P168
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yan S, 2009, POLYMER, V50, P4212, DOI DOI 10.1016/J.POLYMER.2009.06.058
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yu XJ, 2003, TISSUE ENG, V9, P421, DOI 10.1089/107632703322066606
   Zhu N, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045002
NR 40
TC 25
Z9 25
U1 1
U2 72
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD JAN
PY 2014
VL 50
BP 30
EP 38
DI 10.1016/j.eurpolymj.2013.10.021
PG 9
WC Polymer Science
SC Polymer Science
GA AA0XZ
UT WOS:000330822000003
DA 2018-10-20
ER

PT J
AU Hu, Q
   Chen, XF
   Zhao, NR
   Li, YL
   Mao, C
AF Hu, Qing
   Chen, Xiaofeng
   Zhao, Naru
   Li, Yuli
   Mao, Cong
TI Fabrication and characterization of dodecylamine derived monodispersed
   mesoporous bioactive glass sub-micron spheres
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Sol-gel preparation; Bioactive glass; Monodispersed; Mesoporous
   sub-micron spheres; Apatite formation
ID IN-VITRO BIOACTIVITY; SILICA; CELLS; MICROSPHERES; SURFACTANTS;
   PARTICLES; GROWTH; SIZE
AB This paper reports a facile method for fabricating monodispersed mesoporous bioactive glass submicron spheres (MBGS) using dodecylamine (DDA) as a catalyst and template agent in sol-gel process. The effects of synthesis conditions including the amount of DDA, temperature of hydrolysis and the volume ratio of alcohol to water (AW ratio) on the resulting particle size, morphology, monodispersity and pore size distribution of MBGS are investigated and discussed. The results indicate that the particle size, morphology, monodispersity and pore size distribution of MBGS depend on the amount of DDA, the temperature of hydrolysis and the AW ratio. Meanwhile, using DDA as the structure directing agent and hydrolysis catalyst under optimal synthesis conditions (e. g. 4 g DDA, hydrolysis temperature at 40 degrees C and AW ratio at 4) is in favor of obtaining MBGS with mesoporous surface structure, large specific surface area (362.073 m(2) g(-1)), relatively homogeneous particle size (similar to 560 nm) as well as good apatite-forming activity. The unique structure and properties may turn MBGS into a good candidate as a drug delivery carrier or an injectable biomaterial for bone tissue regeneration.
C1 [Hu, Qing; Chen, Xiaofeng; Zhao, Naru; Li, Yuli; Mao, Cong] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
   [Hu, Qing; Chen, Xiaofeng; Zhao, Naru; Li, Yuli; Mao, Cong] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China.
RP Chen, XF (reprint author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
EM chenxf@scut.edu.cn
FU National Natural Science Foundation of China [50830101, 51072055,
   51172073, 51202069]; National 973 project of China [2011CB606204];
   Research Fund for the Doctoral Program of Higher Education of China
   [20110172110002]; Fundamental Research Funds for the Central University
   [2012ZP0001]
FX This work was supported by the Key Project of the National Natural
   Science Foundation of China (Grant No. 50830101), National Natural
   Science Foundation of China (Grant No. 51072055, Grant No. 51172073,
   Grant No. 51202069), the National 973 project of China (2011CB606204),
   Research Fund for the Doctoral Program of Higher Education of China
   (20110172110002) and the Fundamental Research Funds for the Central
   University (2012ZP0001).
CR BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Bellucci D, 2010, MATER LETT, V64, P203, DOI 10.1016/j.matlet.2009.10.054
   Bo L., 2010, BIOMED MATER, V5
   Branda F, 2007, COLLOID SURFACE A, V299, P252, DOI 10.1016/j.colsurfa.2006.11.048
   Chen XF, 2009, J NON-CRYST SOLIDS, V355, P791, DOI 10.1016/j.jnoncrysol.2009.02.005
   Coleman NJ, 2000, CERAM INT, V26, P171, DOI 10.1016/S0272-8842(99)00037-1
   Di Renzo F, 1999, MICROPOR MESOPOR MAT, V28, P437, DOI 10.1016/S1387-1811(98)00315-1
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hong ZK, 2008, ACTA BIOMATER, V4, P1297, DOI 10.1016/j.actbio.2008.03.007
   Hong ZK, 2010, J BIOMED MATER RES A, V95A, P747, DOI 10.1002/jbm.a.32898
   Hu Q, 2013, MATER LETT, V106, P452, DOI 10.1016/j.matlet.2013.04.075
   Hum J, 2012, J MATER SCI-MATER M, V23, P2317, DOI 10.1007/s10856-012-4580-z
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Labbaf S, 2011, BIOMATERIALS, V32, P1010, DOI 10.1016/j.biomaterials.2010.08.082
   Lei B, 2011, J MATER CHEM, V21, P12725, DOI 10.1039/c1jm11547b
   Lei B, 2011, J SOL-GEL SCI TECHN, V58, P656, DOI 10.1007/s10971-011-2441-8
   Lei B, 2010, J BIOMED MATER RES A, V94A, P1091, DOI 10.1002/jbm.a.32776
   Lei B, 2009, MATER LETT, V63, P1719, DOI 10.1016/j.matlet.2009.04.041
   Liu SQ, 2003, J PHYS CHEM B, V107, P10405, DOI 10.1021/jp034410w
   Lossdorfer S, 2004, BIOMATERIALS, V25, P2547, DOI 10.1016/j.biomaterials.2003.09.094
   Macquarrie DJ, 2001, J MATER CHEM, V11, P1843, DOI 10.1039/b100957p
   Meseguer-Olmo L, 2008, ACTA BIOMATER, V4, P1104, DOI 10.1016/j.actbio.2007.11.001
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Ryoo R, 2001, J AM CHEM SOC, V123, P1650, DOI 10.1021/ja0038326
   Shi XT, 2008, J MATER SCI-MATER M, V19, P2933, DOI 10.1007/s10856-008-3424-3
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   TANEV PT, 1995, SCIENCE, V267, P865, DOI 10.1126/science.267.5199.865
   Valerio P, 2005, J MATER SCI-MATER M, V16, P851, DOI 10.1007/s10856-005-3582-5
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Wang CC, 1999, CHEM MATER, V11, P3113, DOI 10.1021/cm990180f
   Yu JG, 2006, J SOLID STATE CHEM, V179, P226, DOI 10.1016/j.jssc.2005.10.036
   Yun HS, 2010, MATER LETT, V64, P1850, DOI 10.1016/j.matlet.2010.04.053
   Zhao H, 2011, J INORG ORGANOMET P, V21, P925, DOI 10.1007/s10904-011-9541-3
NR 36
TC 12
Z9 12
U1 2
U2 50
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
EI 1573-4846
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD JAN
PY 2014
VL 69
IS 1
BP 9
EP 16
DI 10.1007/s10971-013-3167-6
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA AA3DW
UT WOS:000330974100002
DA 2018-10-20
ER

PT J
AU Kong, HJ
   Wong, JY
AF Kong, Hyunjoon
   Wong, Joyce Y.
TI Materials for biological modulation, sensing, and imaging
SO MRS BULLETIN
LA English
DT Editorial Material
DE Biomedical; cellular (material form); surface chemistry; biomimetic
   (assembly); tissue; polymer; biological; biomaterial
ID SMOOTH-MUSCLE-CELLS; ON-A-CHIP; STEM-CELLS; REGENERATIVE MEDICINE;
   EXTRACELLULAR-MATRIX; SUBSTRATE STIFFNESS; GENE DELIVERY; HYDROGELS;
   DRUG; FIBROBLASTS
AB Biological cells are major building blocks of tissues and organs of living organisms. These cells are also being used as biomarkers for diagnosis and sources for regenerative medicine. To better understand and even regulate diverse activities of cells, materials capable of interacting with cells have been designed by integrating various material chemistry, characterization, and processing techniques. These materials are often integrated with various nano- and microscale engineering devices. In this article, we provide an overview of materials for biological modulation, sensing, and imaging and also discuss opportunities for the future development of multifunctional materials for sensing and therapies.
C1 [Kong, Hyunjoon] Univ Illinois, Urbana, IL 61801 USA.
   [Wong, Joyce Y.] Boston Univ, Boston, MA 02215 USA.
RP Kong, HJ (reprint author), Univ Illinois, Urbana, IL 61801 USA.
EM hjkong06@illinois.edu; jywong@bu.edu
RI Wong, Joyce/F-3732-2011
OI Wong, Joyce/0000-0002-3526-6381
CR Addis RC, 2013, NAT MED, V19, P829, DOI 10.1038/nm.3225
   Alberts B., 2008, MOL BIOL CELL
   Brown XQ, 2010, J CELL PHYSIOL, V225, P115, DOI 10.1002/jcp.22202
   Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031
   Chien KR, 2008, NATURE, V453, P302, DOI 10.1038/nature07037
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]
   Ghassemi S, 2012, P NATL ACAD SCI USA, V109, P5328, DOI 10.1073/pnas.1119886109
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Isenberg BC, 2012, J BIOMECH, V45, P756, DOI 10.1016/j.jbiomech.2011.11.015
   Jeong JH, 2012, ADV MATER, V24, P58, DOI 10.1002/adma.201103207
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kircher MF, 2003, CANCER RES, V63, P6838
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Kong HJ, 2007, NAT REV DRUG DISCOV, V6, P455, DOI 10.1038/nrd2309
   Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472
   Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897
   Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   Saint-Michel E, 2009, BIOPHYS J, V97, P480, DOI 10.1016/j.bpj.2009.04.044
   Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008
   Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852
   Sazonova OV, 2011, BIOPHYS J, V101, P622, DOI 10.1016/j.bpj.2011.06.051
   Schmidt JJ, 2008, J BIOMED MATER RES A, V87A, P1113, DOI 10.1002/jbm.a.32287
   Singhal R, 2011, NAT NANOTECHNOL, V6, P57, DOI [10.1038/nnano.2010.241, 10.1038/NNANO.2010.241]
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Sniadecki NJ, 2007, P NATL ACAD SCI USA, V104, P14553, DOI 10.1073/pnas.0611613104
   Sun YF, 2011, J CANCER RES CLIN, V137, P1151, DOI 10.1007/s00432-011-0988-y
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442
   Williamson A, 2013, LAB CHIP, V13, P3471, DOI 10.1039/c3lc50237f
   Wong JY, 2012, NANO TODAY, V7, P488, DOI 10.1016/j.nantod.2012.09.001
   Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045
   Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314
   Zorlutuna P, 2011, ADV FUNCT MATER, V21, P3642, DOI 10.1002/adfm.201101023
   Zrazhevskiy P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2635
NR 47
TC 0
Z9 0
U1 1
U2 17
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2014
VL 39
IS 1
BP 12
EP 17
DI 10.1557/mrs.2013.317
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AA1CF
UT WOS:000330833200010
DA 2018-10-20
ER

PT J
AU Kuo, CK
   Smith, ML
AF Kuo, Catherine K.
   Smith, Michael L.
TI Biomaterial design motivated by characterization of natural
   extracellular matrices
SO MRS BULLETIN
LA English
DT Article
DE Biomaterial; biological; biomimetic (assembly)
ID STEM-CELL FATE; EMBRYONIC TENDON DEVELOPMENT; GREEN FLUORESCENT PROTEIN;
   I COLLAGEN FIBRILS; MECHANICAL-PROPERTIES; VISCOELASTIC PROPERTIES;
   ACTIN CYTOSKELETON; FIBRONECTIN MATRIX; SINGLE CELLS; FIBERS
AB A growing trend in tissue engineering and regenerative medicine is to view cells, matrices, and whole tissues from a materials science perspective. The rationale behind this novel approach to considering biological problems is that the material properties at these different length scales both define their physical stability and also provide instructive cues. These cues can maintain homeostasis in healthy tissues or drive dynamic events during development, wound healing, and disease progression. However, one must map and characterize the physical properties of the natural extracellular matrix environment found in vivo in order to guide the design of synthetic or naturally derived materials to control cell function. This article reviews the study of natural tissues as materials, and sheds light on the use of this information to develop novel synthetic materials that guide cell function.
C1 [Kuo, Catherine K.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Smith, Michael L.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Kuo, CK (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM catherinek.kuo@tufts.edu; msmith@bu.edu
FU Basil O'Connor Starter Scholar Research Award from the March of Dimes
   Foundation [5-FY11-153]; National Institute of Arthritis and
   Musculoskeletal and Skin Diseases of the NIH [R03AR061036]; NSF CBET
   [1150467]; NSF CMMI [1031139]
FX Supported, in part, by a Basil O'Connor Starter Scholar Research Award
   Grant No. 5-FY11-153 from the March of Dimes Foundation (to C.K.K.),
   Award Number R03AR061036 from the National Institute of Arthritis and
   Musculoskeletal and Skin Diseases of the NIH (to C.K.K.), NSF CBET Grant
   1150467 (to M.L.S.), and NSF CMMI 1031139 (to M.L.S.).
CR Andreasson-Ochsner M, 2011, LAB CHIP, V11, P2876, DOI 10.1039/c1lc20067d
   Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6
   Banos Charles C., 2008, Birth Defects Research, V84, P228, DOI 10.1002/bdrc.20130
   Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x
   Bradshaw M. J., 2012, PLOS COMPUT BIOL, V8
   Bradshaw MJ, 2011, BIOPHYS J, V101, P1740, DOI 10.1016/j.bpj.2011.08.029
   Bradshaw MJ, 2013, ACTA BIOMATER
   Brown J, 2012, PLOS ONE, V7
   Brown J. P., 2013, J BIOMECH
   Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Burute M, 2012, CURR OPIN CELL BIOL, V24, P628, DOI 10.1016/j.ceb.2012.07.003
   Cao LZ, 2012, P NATL ACAD SCI USA, V109, P7251, DOI 10.1073/pnas.1118088109
   Carlisle CR, 2010, ACTA BIOMATER, V6, P2997, DOI 10.1016/j.actbio.2010.02.050
   Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135
   Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Deravi LF, 2012, NANO LETT, V12, P5587, DOI 10.1021/nl302643g
   DeVolder R., 2012, REV SYST BIOL MED, V4, P351, DOI 10.1002/wsbm.117422615143
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dusseiller MR, 2006, BIOINTERPHASES, V1, pP1, DOI 10.1116/1.2190698
   Dusseiller MR, 2005, BIOMATERIALS, V26, P5917, DOI 10.1016/j.biomaterials.2005.02.032
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   George EL, 1997, BLOOD, V90, P3073
   GEORGE EL, 1993, DEVELOPMENT, V119, P1079
   Graham JS, 2004, EXP CELL RES, V299, P335, DOI 10.1016/j.yexcr.2004.05.022
   Guthold M, 2007, CELL BIOCHEM BIOPHYS, V49, P165, DOI 10.1007/s12013-007-9001-4
   Guvendiren M, 2013, ADV HEALTHC MATER, V2, P155, DOI 10.1002/adhm.201200105
   Hay ED, 1993, CURR OPIN CELL BIOL, V5, P1029, DOI 10.1016/0955-0674(93)90088-8
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021
   Kim IL, 2013, BIOMATERIALS, V34, P5571, DOI 10.1016/j.biomaterials.2013.04.004
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kubow KE, 2009, INTEGR BIOL, V1, P635, DOI 10.1039/b914996a
   Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415
   Kuo CK, 2008, DEV DYNAM, V237, P1477, DOI 10.1002/dvdy.21547
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Leckband DE, 2011, CURR OPIN CELL BIOL, V23, P523, DOI 10.1016/j.ceb.2011.08.003
   Lee J, 2013, BIOMATERIALS, V34, P8140, DOI 10.1016/j.biomaterials.2013.07.074
   Li GN, 2007, TISSUE ENG, V13, P1035, DOI 10.1089/ten.2006.0251
   Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003
   Little WC, 2009, NANO LETT, V9, P4158, DOI 10.1021/nl902365z
   Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/nmat3361, 10.1038/NMAT3361]
   Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317
   Liu W., 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.274573317614616
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0
   Marturano J. E., 2013, ACTA BIOMATER, V13, ps1742
   Marturano JE, 2013, P NATL ACAD SCI USA, V110, P6370, DOI 10.1073/pnas.1300135110
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Nii M, 2013, ACTA BIOMATER, V9, P5475, DOI 10.1016/j.actbio.2012.11.002
   Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f
   Ochsner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009445
   Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153
   Ohashi T, 2002, J CELL SCI, V115, P1221
   Parekh A, 2011, BIOPHYS J, V100, P573, DOI 10.1016/j.bpj.2010.12.3733
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Peleg O, 2012, BIOPHYS J, V103, P1909, DOI 10.1016/j.bpj.2012.09.028
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064
   Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/NNANO.2012.167, 10.1038/nnano.2012.167]
   Plummer ST, 2003, LANGMUIR, V19, P7528, DOI 10.1021/la030075r
   Robins SP, 2007, BIOCHEM SOC T, V35, P849, DOI 10.1042/BST0350849
   Rowlands A. S., 2008, CELL PHYSL, V295, pC1037
   Roy P, 1999, ANN BIOMED ENG, V27, P721, DOI 10.1114/1.227
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Salib IG, 2011, LANGMUIR, V27, P3991, DOI 10.1021/la104609t
   Schiele NR, 2013, CURR OPIN BIOTECH, V24, P834, DOI 10.1016/j.copbio.2013.07.003
   Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716
   Sharma R., 2012, PLOS ONE, V7
   Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Silver FH, 2002, CONNECT TISSUE RES, V43, P569, DOI 10.1080/03008200290001302
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Walpita D, 2002, NAT REV MOL CELL BIO, V3, P137, DOI 10.1038/nrm727
   Wan AMD, 2013, BBA-GEN SUBJECTS, V1830, P4314, DOI 10.1016/j.bbagen.2013.03.033
   WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576
   Yang L, 2012, J MECH BEHAV BIOMED, V6, P148, DOI 10.1016/j.jmbbm.2011.11.008
   Yang L, 2008, BIOPHYS J, V94, P2204, DOI 10.1529/biophysj.107.111013
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Young DA, 2013, BIOMATERIALS, V34, P8581, DOI 10.1016/j.biomaterials.2013.07.103
NR 90
TC 2
Z9 2
U1 2
U2 18
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2014
VL 39
IS 1
BP 18
EP 24
DI 10.1557/mrs.2013.311
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AA1CF
UT WOS:000330833200011
DA 2018-10-20
ER

PT J
AU Lewis, JS
   Roy, K
   Keselowsky, BG
AF Lewis, Jamal S.
   Roy, Krishnendu
   Keselowsky, Benjamin G.
TI Materials that harness and modulate the immune system
SO MRS BULLETIN
LA English
DT Article
DE biological; biomaterial; biomedical; biomimetic (assembly)
ID DENDRITIC CELL ACTIVATION; REGULATORY T-CELLS; VACCINE ADJUVANTS;
   DELIVERY-SYSTEMS; ANTIGEN DELIVERY; INNATE IMMUNITY; DRUG-DELIVERY;
   ANTIBODY-RESPONSES; GENE DELIVERY; MICROPARTICLES
AB Recently, biomaterial scientists have married materials engineering and immunobiology to conceptualize new immunomodulatory materials. This special class of biomaterials can modulate and harness the innate properties of immune functionality for enhanced therapeutic efficacy. Generally, two fundamental strategies are followed in the design of immunomodulatory biomaterials: (1) immuno-evasive (immuno-mimetic, immuno-suppressing, or immuno-inert) biomaterials and (2) immuno-activating or immuno-enhancing biomaterials. This article highlights the development and application of a number of immunomodulatory materials, categorized by these two general approaches.
C1 [Lewis, Jamal S.] Univ Florida, Gainesville, FL 32610 USA.
   [Roy, Krishnendu] Univ Texas Austin, Austin, TX 78712 USA.
   [Keselowsky, Benjamin G.] Univ Florida, Gainesville, FL 32611 USA.
RP Lewis, JS (reprint author), Univ Florida, Gainesville, FL 32610 USA.
EM jamalslewis@ufl.edu; kroy@mail.utexas.edu; bkeselowsky@bme.ufl.edu
RI Lewis, Jamal/B-1734-2013
FU National Institutes of Health [R01DK091658, R21A1094360]
FX This work was supported in part by grants from the National Institutes
   of Health, R01DK091658 and R21A1094360.
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   Ali Omar A., 2007, Proceedings of the American Association for Cancer Research Annual Meeting, V48, P652
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Bandyopadhyay A, 2011, BIOMATERIALS, V32, P3094, DOI 10.1016/j.biomaterials.2010.12.054
   Bayramoglu G, 2008, J APPL POLYM SCI, V109, P749, DOI 10.1002/app.28062
   Benoit MA, 1999, INT J PHARMACEUT, V184, P73, DOI 10.1016/S0378-5173(99)00109-X
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chen YZ, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/565643
   CLAASSEN E, 1992, RES IMMUNOL, V143, P478, DOI 10.1016/0923-2494(92)80057-R
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Doehn C, 2008, BIODRUGS, V22, P71, DOI 10.2165/00063030-200822020-00001
   EDELMAN R, 1980, REV INFECT DIS, V2, P370
   Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032
   Fadilah S A W, 2007, Malays J Pathol, V29, P1
   Foster S, 2010, BIOCONJUGATE CHEM, V21, P2205, DOI 10.1021/bc100204m
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Girard M P, 2009, Ann Pharm Fr, V67, P203, DOI 10.1016/j.pharma.2009.02.004
   Gregoriadis G, 1995, TRENDS BIOTECHNOL, V13, P527, DOI 10.1016/S0167-7799(00)89017-4
   Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   Haining WN, 2004, J IMMUNOL, V173, P2578, DOI 10.4049/jimmunol.173.4.2578
   Hirosue S, 2010, VACCINE, V28, P7897, DOI 10.1016/j.vaccine.2010.09.077
   Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213
   Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009
   Ianaro A, 2009, MINI-REV MED CHEM, V9, P306, DOI 10.2174/1389557510909030306
   Ioannou XP, 2003, VACCINE, V21, P4368, DOI 10.1016/S0264-410X(03)00437-7
   Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021
   Jhunjhunwala S, 2009, J CONTROL RELEASE, V133, P191, DOI 10.1016/j.jconrel.2008.10.011
   Jiang WL, 2005, ADV DRUG DELIVER REV, V57, P391, DOI 10.1016/j.addr.2004.09.003
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Jones KS, 2008, BIOTECHNOL PROGR, V24, P807, DOI [10.1002/btpr.10, 10.1021/bp.10]
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Kaul D, 1998, Dev Biol Stand, V95, P141
   Keselowsky BG, 2011, HUM VACCINES, V7, P37, DOI 10.4161/hv.7.1.12916
   Kim DH, 2007, BIOMATERIALS, V28, P3369, DOI 10.1016/j.biomaterials.2007.04.010
   Kostina NY, 2012, BIOMACROMOLECULES, V13, P4164, DOI 10.1021/bm301441x
   Lee PY, 2003, PHARM RES, V20, P1995, DOI 10.1023/B:PHAM.0000008048.58777.da
   Leleux J, 2013, ADV HEALTHC MATER, V2, P72, DOI 10.1002/adhm.201200268
   Lemoine D, 1998, INT J PHARMACEUT, V176, P9, DOI 10.1016/S0378-5173(98)00303-2
   Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049
   Li XY, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-89
   Lin CC, 2010, J CONTROL RELEASE, V142, P384, DOI 10.1016/j.jconrel.2009.11.022
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   Makela PH, 2000, FEMS MICROBIOL REV, V24, P9, DOI 10.1111/j.1574-6976.2000.tb00530.x
   Mallapragada SK, 2008, INT J PHARMACEUT, V364, P265, DOI 10.1016/j.ijpharm.2008.06.030
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   Matsue Hiroyuki, 1999, Journal of Dermatology (Tokyo), V26, P757
   McIntyre JA, 2005, DRUG FUTURE, V30, P892, DOI 10.1358/dof.2005.030.09.941847
   Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5
   Mohammadi G, 2010, COLLOID SURFACE B, V80, P34, DOI 10.1016/j.colsurfb.2010.05.027
   Morris S, 2011, J IMMUNOL, V187, P3953, DOI 10.4049/jimmunol.1100524
   Motornov M, 2010, PROG POLYM SCI, V35, P174, DOI 10.1016/j.progpolymsci.2009.10.004
   Mountziaris PM, 2011, PHARM RES-DORDR, V28, P1370, DOI 10.1007/s11095-010-0354-9
   Novak MT, 2009, BIOMATERIALS, V30, P1989, DOI 10.1016/j.biomaterials.2008.11.025
   OHAGAN DT, 1991, IMMUNOLOGY, V73, P239
   Ott G, 1995, Pharm Biotechnol, V6, P277
   Phillips B, 2008, DIABETES, V57, P1544, DOI 10.2337/db07-0507
   Prichard HL, 2008, STEM CELLS, V26, P2691, DOI 10.1634/stemcells.2008-0140
   Prichard HL, 2007, BIOMATERIALS, V28, P936, DOI 10.1016/j.biomaterials.2006.09.012
   Quintilio W, 2009, VACCINE, V27, P4219, DOI 10.1016/j.vaccine.2009.04.047
   Rajapaksa Thejani E., 2010, Current Immunology Reviews, V6, P29
   Roy D, 2010, PROG POLYM SCI, V35, P278, DOI 10.1016/j.progpolymsci.2009.10.008
   Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041
   Ruedl C, 1996, VACCINE, V14, P792, DOI 10.1016/0264-410X(95)00231-O
   Ryan EJ, 2001, TRENDS BIOTECHNOL, V19, P293, DOI 10.1016/S0167-7799(01)01670-5
   Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009
   Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x
   Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001
   Torres MP, 2011, ACTA BIOMATER, V7, P2857, DOI 10.1016/j.actbio.2011.03.023
   Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015
   Waeckerle-Men Y, 2005, ADV DRUG DELIVER REV, V57, P475, DOI 10.1016/j.addr.2004.09.007
   Webster DM, 2013, EUR J PHARM BIOPHARM, V84, P1, DOI 10.1016/j.ejpb.2012.12.009
   Yi DH, 2013, SCAND J IMMUNOL, V78, P167, DOI 10.1111/sji.12060
NR 80
TC 15
Z9 16
U1 2
U2 28
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2014
VL 39
IS 1
BP 25
EP 34
DI 10.1557/mrs.2013.310
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AA1CF
UT WOS:000330833200012
PM 26997752
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mastria, E
   Chilkoti, A
AF Mastria, Eric
   Chilkoti, Ashutosh
TI Genetically encoded "smart" peptide polymers for biomedicine
SO MRS BULLETIN
LA English
DT Article
DE biomaterial; nanostructure; self-assembly; biological synthesis
   (assembly); chemical composition
ID ELASTIN-LIKE POLYPEPTIDES; TARGETED DRUG-DELIVERY; HUMAN TUMOR
   XENOGRAFT; MILD HYPERTHERMIA; MOLECULAR-WEIGHT; CELLULAR UPTAKE;
   CANCER-THERAPY; NANOPARTICLES; MODEL; TEMPERATURE
AB Drug delivery systems are becoming increasingly sophisticated, with the ability to target and penetrate specific tissues and release drugs based upon the local environment. While these advanced systems often offer advantages over their less sophisticated counterparts, the final product may be more complex and require additional manufacturing steps. In this article, we review a body of work based on genetically encoded elastin-like polypeptides (ELPs) that offer a route to modular, multifunctional delivery systems that are simple to manufacture. ELPs are temperature-sensitive biopolymers that can be designed on the genetic level and expressed in cell-based protein production systems. The tools of molecular biology and versatility of proteins are used to engineer polymers with precise composition and molecular weight that self-assemble to form drug delivery systems with an impressive variety of features and functions. Due to their versatility and ease of production, ELPs are likely to contribute to the goal of designing simple and effective smart delivery systems.
C1 [Mastria, Eric] Duke Univ, Durham, NC 27710 USA.
   [Chilkoti, Ashutosh] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
RP Mastria, E (reprint author), Duke Univ, Durham, NC 27710 USA.
EM eric.mastria@duke.edu; chilkoti@duke.edu
OI Mastria, Eric/0000-0002-5112-4543
CR Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377
   Bao LL, 2011, AM J PATHOL, V178, P838, DOI 10.1016/j.ajpath.2010.10.029
   Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652
   Callahan DJ, 2012, NANO LETT, V12, P2165, DOI 10.1021/nl300630c
   Chen XY, 2005, J MED CHEM, V48, P1098, DOI 10.1021/jm049165z
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbt1340, 10.1038/nbtl340]
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Dreher MR, 2007, CANCER RES, V67, P4418, DOI 10.1158/0008-5472.CAN-06-4444
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Forssen E, 1998, ADV DRUG DELIVER REV, V29, P249, DOI 10.1016/S0169-409X(97)00083-5
   GABIZON A, 1985, BRIT J CANCER, V51, P681, DOI 10.1038/bjc.1985.103
   Gregoriadis G, 1978, Ann N Y Acad Sci, V308, P343, DOI 10.1111/j.1749-6632.1978.tb22034.x
   Karanth H, 2007, J PHARM PHARMACOL, V59, P469, DOI 10.1211/jpp.59.4.0001
   Kim B, 2008, J AM CHEM SOC, V130, P17867, DOI 10.1021/ja8059057
   Koo OM, 2005, NANOMED-NANOTECHNOL, V1, P193, DOI 10.1016/j.nano.2005.06.004
   Lammers T, 2008, BRIT J CANCER, V99, P392, DOI 10.1038/sj.bjc.6604483
   Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6
   Lian T, 2001, J PHARM SCI-US, V90, P667, DOI 10.1002/jps.1023
   Liu WE, 2006, J CONTROL RELEASE, V116, P170, DOI 10.1016/j.jconrel.2006.06.026
   MacEwan SR, 2012, NANO LETT, V12, P3322, DOI 10.1021/nl301529p
   MacEwan SR, 2010, NANOMEDICINE-UK, V5, P793, DOI 10.2217/NNM.10.50
   MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327
   MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/nmat2569, 10.1038/NMAT2569]
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   McDaniel JR, 2013, BIOMACROMOLECULES, V14, P2866, DOI 10.1021/bm4007166
   McDaniel JR, 2013, ANGEW CHEM INT EDIT, V52, P1683, DOI 10.1002/anie.201200899
   McDaniel JR, 2012, J CONTROL RELEASE, V159, P362, DOI 10.1016/j.jconrel.2012.02.030
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x
   Na K, 2002, PHARMACEUT RES, V19, P681, DOI 10.1023/A:1015370532543
   Needham D, 2000, CANCER RES, V60, P1197
   Pasqualini R, 2000, CANCER RES, V60, P722
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Ponce AM, 2006, INT J HYPERTHER, V22, P205, DOI 10.1080/02656730600582956
   RAHMAN A, 1980, CANCER RES, V40, P1532
   Sallach RE, 2009, BIOTECHNOL PROGR, V25, P1810, DOI 10.1002/btpr.208
   SEYMOUR LW, 1995, EUR J CANCER, V31A, P766, DOI 10.1016/0959-8049(94)00514-6
   SEYMOUR LW, 1987, J BIOMED MATER RES, V21, P1341, DOI 10.1002/jbm.820211106
   Simnick AJ, 2011, J CONTROL RELEASE, V155, P144, DOI 10.1016/j.jconrel.2011.06.044
   Simnick AJ, 2010, ACS NANO, V4, P2217, DOI 10.1021/nn901732h
   Straube WL, 2001, INT J HYPERTHER, V17, P48, DOI 10.1080/02656730150201598
   Tian B, 2012, J MATER CHEM, V22, P17404, DOI 10.1039/c2jm31806g
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006/1211
   Webster R, 2007, DRUG METAB DISPOS, V35, P9, DOI 10.1124/dmd.106.012419
   Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003
   Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5
   YUAN F, 1995, CANCER RES, V55, P3752
   Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020
NR 53
TC 2
Z9 2
U1 1
U2 37
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2014
VL 39
IS 1
BP 35
EP 43
DI 10.1557/mrs.2013.313
PG 9
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AA1CF
UT WOS:000330833200013
DA 2018-10-20
ER

PT J
AU Hwang, SR
   Ku, SH
   Joo, MK
   Kim, SH
   Kwon, IC
AF Hwang, Seung Rim
   Ku, Sook Hee
   Joo, Min Kyung
   Kim, Sun Hwa
   Kwon, Ick Chan
TI Theranostic nanomaterials for image-guided gene therapy
SO MRS BULLETIN
LA English
DT Article
DE biomedical; biomaterial; nanoscale
ID MESOPOROUS SILICA NANOPARTICLES; OVERCOME DRUG-RESISTANCE; IN-VIVO; GOLD
   NANOPARTICLES; SIRNA DELIVERY; ANTISENSE OLIGONUCLEOTIDES;
   FUNCTIONALIZED GRAPHENE; BIOMEDICAL APPLICATIONS; MAGNETIC
   NANOPARTICLES; PHOTOTHERMAL THERAPY
AB Theranostics was proposed as a combined process of therapeutics and diagnostics methodology for increasing treatment efficacy and safety with simultaneous monitoring of the response to treatment. In the past two decades, nanotechnology has been the focus of developing strategies for drug delivery and imaging functions, and it has expanded to the design of multifunctional nanoparticles and the creation of nanotheranostics (i.e., theranostic nanomedicines). Nanotheranostics also shows potential in gene therapy; however, nanoparticle-mediated delivery of genes still faces major obstacles related to (1) the uptake by the reticuloendothelial system, (2) the ability to get across the target cell membranes through endocytosis, and (3) the ability to accumulate in organs with permeable vasculature. Here, we review the development and application of nanotheranostics, highlighting their relevance to gene therapy as well as molecular imaging.
C1 [Hwang, Seung Rim] Chosun Univ, Coll Pharm, Kwangju, South Korea.
   [Ku, Sook Hee; Joo, Min Kyung; Kim, Sun Hwa; Kwon, Ick Chan] Korea Inst Sci & Technol, Ctr Theragnosis, Biomed Res Inst, Seoul, South Korea.
RP Hwang, SR (reprint author), Chosun Univ, Coll Pharm, Kwangju, South Korea.
EM srhwang@chosun.ac.kr; kusookhee@gmail.com; minkyjoo@gmail.com;
   sunkim@kist.re.kr; ikwon@kist.re.kr
FU KIST; Global Innovative Research Center (GiRC) Program through the
   National Research Foundation of Korea (NRF)
FX This study was funded by the Intramural Research Program (Theragnosis,
   Global RNAi Carrier Initiative, and KIST Young Fellow) of KIST and the
   Global Innovative Research Center (GiRC) Program through the National
   Research Foundation of Korea (NRF).
CR Alhasan A. H., 2013, SMALL, DOI 10.1002/smll.201302143
   Aryal S, 2009, J NANOSCI NANOTECHNO, V9, P5701, DOI 10.1166/jnn.2009.1227
   Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191
   Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104
   Bryson JM, 2009, P NATL ACAD SCI USA, V106, P16913, DOI 10.1073/pnas.0904860106
   Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016
   Chen Yuxiang, 2003, Current Gene Therapy, V3, P273, DOI 10.2174/1566523034578339
   Fattal E, 2008, INT J PHARMACEUT, V364, P237, DOI 10.1016/j.ijpharm.2008.06.011
   Feng LZ, 2011, NANOSCALE, V3, P1252, DOI 10.1039/c0nr00680g
   Fernandez-Fernandez A, 2011, APPL BIOCHEM BIOTECH, V165, P1628, DOI 10.1007/s12010-011-9383-z
   Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Han G, 2006, CHEM BIOL DRUG DES, V67, P78, DOI 10.1111/j.1747-0285.2005.00324.x
   Han G, 2005, BIOCONJUGATE CHEM, V16, P1356, DOI 10.1021/bc050173j
   Harada-Shiba M, 2002, GENE THER, V9, P407, DOI 10.1038/sj.gt/3301665
   Jain TK, 1998, J AM CHEM SOC, V120, P11092, DOI 10.1021/ja973849x
   Juliano R, 2009, MOL PHARMACEUT, V6, P686, DOI 10.1021/mp900093r
   Jyoti A, 2011, J BIOMED NANOTECHNOL, V7, P170, DOI 10.1166/jbn.2011.1254
   Kawano T, 2006, J CONTROL RELEASE, V111, P382, DOI 10.1016/j.jconrel.2005.12.022
   Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005
   Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821
   Lee JH, 2009, ANGEW CHEM INT EDIT, V48, P4174, DOI 10.1002/anie.200805998
   Lee LJ, 2006, ANN BIOMED ENG, V34, P75, DOI 10.1007/s10439-005-9011-6
   Lee SJ, 2012, ANGEW CHEM INT EDIT, V51, P7203, DOI 10.1002/anie.201201390
   Li C, 2010, ACS NANO, V4, P6707, DOI 10.1021/nn102187v
   Li SD, 2010, J CONTROL RELEASE, V145, P178, DOI 10.1016/j.jconrel.2010.03.016
   Liu L, 2009, CHEM COMMUN, P6759, DOI 10.1039/b912659g
   Lu W, 2010, CANCER RES, V70, P3177, DOI 10.1158/0008-5472.CAN-09-3379
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   Medarova Z, 2007, NAT MED, V13, P372, DOI 10.1038/nm1486
   Meng H, 2013, ACS NANO, V7, P994, DOI 10.1021/nn3044066
   Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m
   Mudd SR, 2010, BIOCONJUGATE CHEM, V21, P1183, DOI 10.1021/bc900558z
   Namiki Y, 2009, NAT NANOTECHNOL, V4, P598, DOI [10.1038/NNANO.2009.202, 10.1038/nnano.2009.202]
   Nie SM, 2010, NANOMEDICINE-UK, V5, P523, DOI [10.2217/nnm.10.23, 10.2217/NNM.10.23]
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]
   Peng C, 2010, SMALL, V6, P1686, DOI 10.1002/smll.201000560
   Prabhu P, 2012, J BIOMED NANOTECHNOL, V8, P859, DOI 10.1166/jbn.2012.1459
   Que-Gewirth NS, 2007, GENE THER, V14, P283, DOI 10.1038/sj.gt.3302900
   Rana S, 2012, ADV DRUG DELIVER REV, V64, P200, DOI 10.1016/j.addr.2011.08.006
   Roy I, 2005, P NATL ACAD SCI USA, V102, P279, DOI 10.1073/pnas.0408039101
   Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c
   Sokolov K, 2003, CANCER RES, V63, P1999
   Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8
   Svenson S, 2013, MOL PHARMACEUT, V10, P848, DOI 10.1021/mp300644n
   Takahashi H., 2005, CHEM COMMUN, V2247
   Tang LAL, 2010, J AM CHEM SOC, V132, P10976, DOI 10.1021/ja104017y
   Thomas M, 2003, P NATL ACAD SCI USA, V100, P9138, DOI 10.1073/pnas.1233634100
   Toscano MG, 2011, GENE THER, V18, P117, DOI 10.1038/gt.2010.138
   Tseng YC, 2009, ADV DRUG DELIVER REV, V61, P721, DOI 10.1016/j.addr.2009.03.003
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   van Beijnum JR, 2006, TRENDS MOL MED, V12, P44, DOI 10.1016/j.molmed.2005.11.005
   van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983
   Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0
   Wang H, 2007, MOL PHARM, V4, P189, DOI 10.1021/mp060045s
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Wen YQ, 2010, CHEM COMMUN, V46, P2596, DOI 10.1039/b924832c
   Wojtoniszak M, 2012, COLLOID SURFACE B, V89, P79, DOI 10.1016/j.colsurfb.2011.08.026
   Wolff JA, 2008, MOL THER, V16, P8, DOI 10.1038/sj.mt.6300326
   Yang K, 2012, ADV MATER, V24, P1868, DOI 10.1002/adma.201104964
   Yang K, 2011, ACS NANO, V5, P516, DOI 10.1021/nn1024303
   Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u
   Zhang SA, 2011, CARBON, V49, P4040, DOI 10.1016/j.carbon.2011.05.056
   Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79
   Zhu SG, 2004, BIOTECHNOL APPL BIOC, V39, P179, DOI 10.1042/BA20030077
NR 65
TC 1
Z9 1
U1 1
U2 32
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2014
VL 39
IS 1
BP 44
EP 50
DI 10.1557/mrs.2013.312
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AA1CF
UT WOS:000330833200014
DA 2018-10-20
ER

PT J
AU Lee, H
   Chung, M
   Jeon, NL
AF Lee, Hyunjae
   Chung, Minhwan
   Jeon, Noo Li
TI Microvasculature: An essential component for organ-on-chip systems
SO MRS BULLETIN
LA English
DT Article
DE Biological; biomaterial; tissue; biomedical; devices
ID BLOOD-BRAIN-BARRIER; ENDOTHELIAL-CELL MONOLAYERS; IN-VITRO MODEL;
   MICROFLUIDIC DEVICES; TUMOR VASCULATURE; TRANSENDOTHELIAL MIGRATION;
   CANCER-IMMUNOTHERAPY; INFLAMMATORY DISEASE; ANGIOCRINE SIGNALS;
   ANGIOGENESIS
AB Improving the biological relevance of organs-on-chips is one of the main issues in biomedical engineering. The microvascular system is related to numerous biological phenomena throughout the life of organs. Although many in vitro microvascular systems have been developed, current organ-on-chip systems fail to fully integrate three-dimensional microvasculature, which results in decreased similarity of the systems with in vivo conditions. In this review, we propose that the microvascular system is an essential component for engineering organs-on-chips to achieve greater biological relevance. Various methods for engineering microvessels in vitro are reviewed, as well as recent representative efforts to engineer vascularized organs-on-chips. Material considerations for designing organs-on-chips are also reviewed.
C1 [Lee, Hyunjae; Chung, Minhwan; Jeon, Noo Li] Seoul Natl Univ, Seoul 151, South Korea.
RP Lee, H (reprint author), Seoul Natl Univ, Seoul 151, South Korea.
EM ummae3@snu.ac.kr; wireless0426@naver.com; njeon@snu.ac.kr
FU Pioneer Project [2013-041859]; National Research Foundation; Ministry of
   Education, Science and Technology of Korea
FX This work was supported by the Pioneer Project (2013-041859) and the
   global PhD Fellowship Program (NRF-2012-Global Ph.D. Fellowship Program)
   through the National Research Foundation funded by the Ministry of
   Education, Science and Technology of Korea.
CR Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522
   Auger FA, 2013, ANNU REV BIOMED ENG, V15, P177, DOI 10.1146/annurev-bioeng-071812-152428
   Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093
   Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005
   Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d
   Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287
   Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115
   Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006
   Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109
   Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005
   Chung S, 2010, ANN BIOMED ENG, V38, P1164, DOI 10.1007/s10439-010-9899-3
   Cracowski JL, 2006, TRENDS PHARMACOL SCI, V27, P503, DOI 10.1016/j.tips.2006.07.008
   Cutolo M, 2010, NAT REV RHEUMATOL, V6, P578, DOI 10.1038/nrrheum.2010.104
   Davis GE, 2000, IN VITRO CELL DEV-AN, V36, P513
   de Jongh RT, 2004, CIRCULATION, V109, P2529, DOI 10.1161/01.CIR.0000129772.26647.6F
   Deban L, 2008, AM J PATHOL, V172, P1457, DOI 10.2353/ajpath.2008.070593
   Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003
   Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493
   Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]
   Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483
   Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300
   FOLKMAN J, 1990, J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4
   Friedl J, 2002, BLOOD, V100, P1334
   Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767
   Goel S, 2012, P NATL ACAD SCI USA, V109, pE1214, DOI 10.1073/pnas.1203794109
   Grammas P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001918
   Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006
   Hsu YH, 2013, LAB CHIP, V13, P2990, DOI 10.1039/c3lc50424g
   Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819
   Kazakoff PW, 1995, IN VITRO CELL DEV-AN, V31, P846
   Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a
   Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177
   KRAMER RH, 1979, P NATL ACAD SCI USA, V76, P5704, DOI 10.1073/pnas.76.11.5704
   Lai CH, 2005, BRAIN RES REV, V50, P258, DOI 10.1016/j.brainreserv.2005.07.004
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   Li YH, 1999, CLIN EXP METASTAS, V17, P423, DOI 10.1023/A:1006614232388
   Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149
   Long DA, 2012, NAT REV NEPHROL, V8, P244, DOI 10.1038/nrneph.2011.219
   Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965
   Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   MONTESANO R, 1993, J CELL SCI, V105, P1013
   Mukhopadhyay R, 2007, ANAL CHEM, V79, P7249, DOI 10.1021/ac071972t
   Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961
   Nachman RL, 2012, J CLIN INVEST, V122, P796, DOI 10.1172/JCI62589
   Naiyer AJ, 1999, BLOOD, V94, P4011
   Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017
   Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258
   Pirtskhalaishvili G, 2000, PROSTATE, V44, P77
   Raghavan S, 2010, TISSUE ENG PT A, V16, P2255, DOI 10.1089/ten.TEA.2009.0584
   Ren K., 2013, ACC CHEM RES, DOI 10.1021/ar300314s
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724
   Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229
   Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013
   Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008
   Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703
   STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   TOOKE JE, 1995, DIABETES, V44, P721, DOI 10.2337/diabetes.44.7.721
   Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628
   Voura EB, 1998, CELL TISSUE RES, V293, P375, DOI 10.1007/s004410051129
   Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e
   WEIDNER N, 1995, AM J PATHOL, V147, P9
   WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101
   Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151
   Yeon JH, 2012, LAB CHIP, V12, P2815, DOI [10.1039/c2lc40131b, 10.1039/C2LC40131B]
   Yin XL, 2010, AM J PATHOL, V176, P1600, DOI 10.2353/ajpath.2010.090406
   Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109
   Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109
NR 83
TC 14
Z9 15
U1 5
U2 42
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2014
VL 39
IS 1
BP 51
EP 59
DI 10.1557/mrs.2013.286
PG 9
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AA1CF
UT WOS:000330833200015
DA 2018-10-20
ER

PT J
AU Gomes, CP
   Lopes, CDF
   Moreno, PMD
   Varela-Moreira, A
   Alonso, MJ
   Pego, AP
AF Gomes, Carla Pereira
   Ferreira Lopes, Catia Daniela
   Duarte Moreno, Pedro Miguel
   Varela-Moreira, Aida
   Jose Alonso, Maria
   Pego, Ana Paula
TI Translating chitosan to clinical delivery of nucleic acid-based drugs
SO MRS BULLETIN
LA English
DT Review
DE Chitosan; nucleic acid delivery; biomaterial; biomedical; nanostructure;
   biomimetic
ID MEDIATED GENE DELIVERY; SYNCYTIAL VIRUS-INFECTION; N-ACETYLATED
   CHITOSANS; IN-VITRO; SIRNA DELIVERY; TRANSFECTION EFFICIENCY; DNA
   NANOPARTICLES; PLASMID DNA; MOLECULAR-WEIGHT; ANTISENSE OLIGONUCLEOTIDE
AB A number of systems based on synthetic molecules, among them cationic liposomes and poly(ethylene imine)-based polymers, have been proposed as delivery vehicles for nucleic acids. Some of these systems have even reached the market, ensuring efficient and transient transfection levels in a variety of cell types. However, toxicity issues have limited their application in vivo. In this context, chitosan, a biocompatible and biodegradable polysaccharide, has been proposed as a promising alternative for the delivery of nucleic acid-based molecules. Here we present an overview of the state of the art of chitosan-based vectors for nucleic acid delivery and the most recent data on the in vivo testing of the proposed systems. We additionally express our view on the barriers that might be hampering the translation of this knowledge into clinical practice and the challenges that need to be fulfilled for these promising vehicles to reach patients.
C1 [Gomes, Carla Pereira; Ferreira Lopes, Catia Daniela; Duarte Moreno, Pedro Miguel; Varela-Moreira, Aida; Pego, Ana Paula] Univ Porto, Inst Biomed Engn, Oporto, Portugal.
   [Jose Alonso, Maria] Univ Santiago de Compostela, CIMUS Res Ctr, Sch Pharm, Santiago De Compostela, Spain.
RP Gomes, CP (reprint author), Univ Porto, Inst Biomed Engn, Rua Campo Alegre, Oporto, Portugal.
EM carla.gomes@ineb.up.pt; catia.lopes@ineb.up.pt; pedro.moreno@ineb.up.pt;
   aida.moreira@ineb.up.pt; mariaj.alonso@usc.es; apego@ineb.up.pt
RI Moreno, Pedro/J-9382-2013; Lopes, Catia/O-1090-2013; Pego, Ana
   Paula/C-6942-2012; Alonso, Maria Jose/K-3893-2014
OI Moreno, Pedro/0000-0002-3773-3262; Lopes, Catia/0000-0002-7467-6498;
   Pego, Ana Paula/0000-0001-5169-328X; Gomes, Carla/0000-0002-1483-4079
FU FEDER funds through the Programa Operacional Factores de
   Competitividade-COMPETE; Portuguese funds through FCT-Fundacao para a
   Ciencia e a Tecnologia [PTDC/CTM-NAN/115124/2009,
   PEst-C/SAU/LA0002/2011]; FCT [SFRH/BD/79930/2011, SFRH/BD/77933/2011];
   European Union [PIEF-GA-2011-300485]
FX The authors would like to acknowledge the FEDER funds through the
   Programa Operacional Factores de Competitividade-COMPETE and the
   Portuguese funds through FCT-Fundacao para a Ciencia e a Tecnologia
   (PTDC/CTM-NAN/115124/2009 and PEst-C/SAU/LA0002/2011) that supported
   this work. C. P. G. and C. D. F. L. acknowledge FCT for their PhD
   scholarships (SFRH/BD/79930/2011 and SFRH/BD/77933/2011). P. M. D. M. is
   supported by a Marie Curie Actions grant within the framework of the
   European Union's Seventh Framework Program (PIEF-GA-2011-300485). The
   authors would like to thank A. Nunes (IBMC-INEB) for her contribution to
   the graphic design of Figure 2.
CR Alameh M, 2012, INT J NANOMED, V7, P1399, DOI 10.2147/IJN.S26571
   [Anonymous], 2012, F2260 ASTM
   [Anonymous], 2008, F2602 ASTM INT
   [Anonymous], 2011, F2103 ASTM INT
   Azizi E, 2010, INT J NANOMED, V5, P455
   Bansal V., 2011, ADV BIOL RES, V5, P28
   Barbosa M. A., 2011, COMPREHENSIVE BIOMAT, P221
   Bivas-Benita M, 2004, VACCINE, V22, P1609, DOI 10.1016/j.vaccine.2003.09.044
   Bivas-Benita M, 2003, INT J PHARM, V266, P17, DOI 10.1016/S0378-5173(03)00377-6
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Bowman K, 2008, J CONTROL RELEASE, V132, P252, DOI 10.1016/j.jconrel.2008.06.019
   Buschmann M. D., 2013, ADV DRUG DE IN PRESS
   Buschmann MD, 2013, ADV DRUG DELIVER REV, V65, P1234, DOI 10.1016/j.addr.2013.07.005
   Chan P, 2007, BIOMATERIALS, V28, P540, DOI 10.1016/j.biomaterials.2006.08.046
   Chellat F, 2000, J BIOMED MATER RES, V53, P592, DOI 10.1002/1097-4636(200009)53:5<592::AID-JBM20>3.0.CO;2-P
   Cheng MR, 2011, J BIOMED MATER RES B, V99B, P70, DOI 10.1002/jbm.b.31873
   Chew JL, 2003, VACCINE, V21, P2720, DOI 10.1016/S0264-410X(03)00228-7
   *COUNC EUR, 2002, EUR PHARM
   Csaba N, 2004, EUR J PHARM SCI, V23, pS55
   Csaba N, 2009, INT J PHARMACEUT, V382, P205, DOI 10.1016/j.ijpharm.2009.07.028
   Csaba N, 2009, J BIOMED NANOTECHNOL, V5, P162, DOI 10.1166/jbn.2009.1017
   Dass CR, 2007, BIOMATERIALS, V28, P3026, DOI 10.1016/j.biomaterials.2007.03.016
   de la Fuente M, 2008, GENE THER, V15, P668, DOI 10.1038/gt.2008.16
   de la Fuente M., 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/07510521817630
   de la Fuente M, 2008, INVEST OPHTH VIS SCI, V49, P2016, DOI 10.1167/iovs.07-1077
   Dehousse V, 2010, INT J BIOL MACROMOL, V46, P342, DOI 10.1016/j.ijbiomac.2010.01.010
   Dung TH, 2007, J NANOSCI NANOTECHNO, V7, P3695, DOI 10.1166/jnn.2007.041
   Feng S, 2010, ENDOCR-RELAT CANCER, V17, P1021, DOI 10.1677/ERC-10-0073
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Food and Drug Administration, 2007, GUID IND
   Gan Q, 2005, COLLOID SURFACE B, V44, P65, DOI 10.1016/j.colsurfb.2005.06.001
   Gao SY, 2005, EUR J PHARM BIOPHARM, V60, P327, DOI 10.1016/j.ejpb.2005.02.011
   Gazori T., 2010, CARBOHYD POLYM, V80, P6
   Gazori T, 2009, CARBOHYD POLYM, V77, P599, DOI 10.1016/j.carbpol.2009.02.019
   Han HD, 2011, CANCER BIOL THER, V11, P839, DOI 10.4161/cbt.11.9.15185
   He BB, 2009, BIOLOGIA, V64, P819, DOI 10.2478/s11756-009-0117-4
   Holzerny P, 2012, J CONTROL RELEASE, V157, P297, DOI 10.1016/j.jconrel.2011.08.023
   Hong HJ, 2008, BIOMATERIALS, V29, P4831, DOI 10.1016/j.biomaterials.2008.08.023
   Howard KA, 2009, MOL THER, V17, P162, DOI 10.1038/mt.2008.220
   Hu FQ, 2006, INT J PHARM, V315, P158, DOI 10.1016/j.ijpharm.2006.02.026
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Huang Z, 2012, LIFE SCI, V91, P1207, DOI 10.1016/j.lfs.2012.09.015
   Iqbal M, 2003, VACCINE, V21, P1478, DOI 10.1016/S0264-410X(02)00662-X
   Jean M, 2011, GENE THER, V18, P807, DOI 10.1038/gt.2011.25
   Jiang HL, 2009, BIOMATERIALS, V30, P5844, DOI 10.1016/j.biomaterials.2009.07.017
   Jiang X, 2006, J GENE MED, V8, P477, DOI 10.1002/jgm.868
   Johnston SA, 2002, ARCH MED RES, V33, P325, DOI 10.1016/S0188-4409(02)00383-1
   Kai E, 2004, PHARM RES, V21, P838, DOI 10.1023/B:PHAM.0000026437.32238.6f
   Kannan M, 2010, ADV BIOL RES, V4, P10
   Katas H, 2006, J CONTROL RELEASE, V115, P216, DOI 10.1016/j.jconrel.2006.07.021
   Kim HS, 2011, CLIN CANCER RES, V17, P1713, DOI 10.1158/1078-0432.CCR-10-2081
   Kim ST, 2007, BIOMATERIALS, V28, P3360, DOI 10.1016/j.biomaterials.2007.03.029
   Kim TH, 2003, J CONTROL RELEASE, V93, P389, DOI 10.1016/j.jconrel.2003.08.016
   Kong Xiaoyuan, 2007, Genet Vaccines Ther, V5, P4, DOI 10.1186/1479-0556-5-4
   Koping-Hoggard M, 2004, GENE THER, V11, P1441, DOI 10.1038/sj.gt.3302312
   Kumar M, 2002, HUM GENE THER, V13, P1415, DOI 10.1089/10430340260185058
   KUMAR M, 2003, GENETIC VACCINES THE, V1
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Lee D, 2007, PHARM RES, V24, P157, DOI 10.1007/s11095-006-9136-9
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   Lee SJ, 2012, ANGEW CHEM INT EDIT, V51, P7203, DOI 10.1002/anie.201201390
   LI GP, 2009, CELL MOL IMMUNOL, V6, P45
   Liu L, 2013, APPL MICROBIOL BIOT, V97, P6149, DOI 10.1007/s00253-013-4995-6
   Liu XD, 2007, BIOMATERIALS, V28, P1280, DOI 10.1016/j.biomaterials.2006.11.004
   Malmo J, 2012, J CONTROL RELEASE, V158, P261, DOI 10.1016/j.jconrel.2011.11.012
   Mansouri S, 2004, EUR J PHARM BIOPHARM, V57, P1, DOI 10.1016/s0939-641(03)00155-3
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004
   Moreira C, 2009, ACTA BIOMATER, V5, P2995, DOI 10.1016/j.actbio.2009.04.021
   Mourya VK, 2009, J MATER SCI-MATER M, V20, P1057, DOI 10.1007/s10856-008-3659-z
   Noh SM, 2011, BIOMATERIALS, V32, P849, DOI 10.1016/j.biomaterials.2010.09.027
   Oliveira C. R., 2012, SCI WORLD J, V2012
   Oliveira H, 2010, J BIOMED MATER RES A, V95A, P801, DOI 10.1002/jbm.a.32874
   Ozbas-Turan S, 2010, OLIGONUCLEOTIDES, V20, P147, DOI 10.1089/oli.2009.0222
   Pego A. P., 2013, DRUG DELIVERY SYSTEM
   Perez-Martinez FC, 2011, PHARM RES-DORDR, V28, P1843, DOI 10.1007/s11095-010-0364-7
   Pille JY, 2006, HUM GENE THER, V17, P1019, DOI 10.1089/hum.2006.17.1019
   Pires LR, 2011, NANOMEDICINE-UK, V6, P1499, DOI [10.2217/nnm.11.51, 10.2217/NNM.11.51]
   Ragelle H, 2013, J CONTROL RELEASE, V172, P207, DOI 10.1016/j.jconrel.2013.08.005
   Raghuwanshi D, 2012, MOL PHARMACEUT, V9, P946, DOI 10.1021/mp200553x
   Ravina M, 2010, PHARM RES-DORDR, V27, P2544, DOI 10.1007/s11095-010-0263-y
   Remaut K, 2006, J CONTROL RELEASE, V115, P335, DOI 10.1016/j.jconrel.2006.08.009
   Rojanarata T, 2008, PHARM RES-DORDR, V25, P2807, DOI 10.1007/s11095-008-9648-6
   Roy K, 1999, NAT MED, V5, P387
   Shaji J., 2010, INT J PHARM APPL SCI, V1, P11
   Skaugrud O, 1999, BIOTECHNOL GENET ENG, V16, P23, DOI 10.1080/02648725.1999.10647970
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Straarup EM, 2010, NUCLEIC ACIDS RES, V38, P7100, DOI 10.1093/nar/gkq457
   Struszczyk M. H., 2006, MONOGRAPH POLISH CHI, VXI
   Talaei F, 2011, INT J NANOMED, V6, P1963, DOI 10.2147/IJN.S22731
   Teijeiro-Osorio D, 2009, EUR J PHARM BIOPHARM, V71, P257, DOI 10.1016/j.ejpb.2008.09.020
   Uherek C, 2000, ADV DRUG DELIVER REV, V44, P153, DOI 10.1016/S0169-409X(00)00092-2
   United States Pharmacopeia and the National Formulary, 2011, US PHARM CONV, V29, P5361
   US Food and Drug Administration, 2012, GUID IND PRY END TES
   Varkouhi AK, 2010, BIOCONJUGATE CHEM, V21, P2339, DOI 10.1021/bc1003789
   Varma AJ, 2004, CARBOHYD POLYM, V55, P77, DOI 10.1016/j.carbpol.2003.08.005
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Varum KM, 1996, BBA-GEN SUBJECTS, V1291, P5, DOI 10.1016/0304-4165(96)00038-4
   VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2
   Wang BQ, 2011, BIOMATERIALS, V32, P4630, DOI 10.1016/j.biomaterials.2011.03.003
   Wong K, 2006, BIOCONJUGATE CHEM, V17, P152, DOI 10.1021/bc0501597
   Xu W, 2004, VACCINE, V22, P3603, DOI 10.1016/j.vaccine.2004.03.033
   ZAMECNIK PC, 1978, P NATL ACAD SCI USA, V75, P280, DOI 10.1073/pnas.75.1.280
   Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174
   Zhao QQ, 2012, INT J NANOMED, V7, P3191, DOI 10.2147/IJN.S30909
NR 105
TC 18
Z9 18
U1 1
U2 44
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2014
VL 39
IS 1
BP 60
EP 70
DI 10.1557/mrs.2013.314
PG 11
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AA1CF
UT WOS:000330833200016
DA 2018-10-20
ER

PT J
AU You, J
   Shin, DS
   Patel, D
   Gao, YD
   Revzin, A
AF You, Jungmok
   Shin, Dong-Sik
   Patel, Dipali
   Gao, Yandong
   Revzin, Alexander
TI Multilayered Heparin Hydrogel Microwells for Cultivation of Primary
   Hepatocytes
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE hepatocytes; hybrid hydrogel; liver; microwells; tissue engineering
ID MESENCHYMAL STEM-CELLS; POLY(ETHYLENE GLYCOL); SANDWICH CONFIGURATION;
   SUSTAINED-RELEASE; MATRIX STIFFNESS; LIVER STIFFNESS; CULTURE-SYSTEM;
   GROWTH-FACTOR; IN-VITRO; DIFFERENTIATION
AB The biomaterial scaffolds for regenerative medicine need to be rationally designed to achieve the desired cell fate and function. This paper describes the development of hydrogel microstructures for cultivation of primary hepatocytes. Four different micropatterned surfaces are tested: 1) poly(ethyelene glycol) (PEG) microwells patterned on glass, 2) heparin hydrogel microwells patterned on glass, 3) PEG microwells patterned on heparin hydrogel-coated substrates, and 4) heparin hydrogel microwells patterned on heparin hydrogel-coated substrates. The latter surfaces are constructed by a combination of micromolding and microcontact printing techniques to create microwells with both walls and floor composed of heparin hydrogel. Individual microwell dimensions are 200 m diameter and 20 m in height. In all cases, the floor of the microwells is modified with collagen I to promote cell adhesion. Cultivation of hepatocytes followed by analysis of hepatic markers (urea production, albumin synthesis, and E-cadherin expression) reveals that the all-heparin gel microwells are most conducive to hepatic phenotype maintenance. For example, ELISA analysis shows 2.3 to 13.1 times higher levels of albumin production in all-heparin gel wells compared with other micropatterned surfaces. Importantly, hepatic phenotype expression can be further enhanced by culturing fibroblasts on the heparin gel walls of the microwells. In the future, multicomponent all-heparin gel microstructures may be employed in designing hepatic niche for liver-specific differentiation of stem cells.
C1 [You, Jungmok; Shin, Dong-Sik; Patel, Dipali; Gao, Yandong; Revzin, Alexander] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
RP Revzin, A (reprint author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
EM arevzin@ucdavis.edu
RI Shin, Dong-Sik/E-4606-2011
OI Shin, Dong-Sik/0000-0001-8101-0793
FU NIH [DK073901]
FX The authors thank Prof. Tae for providing heparin thiol and also Profs.
   Marcu and Louie for use of their microscopy facilities. Financial
   support for this work was provided by the NIH grants DK073901.
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Bastard C, 2011, WORLD J GASTROENTERO, V17, P968, DOI 10.3748/wjg.v17.i8.968
   Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183
   Beamish JA, 2009, BIOMATERIALS, V30, P6286, DOI 10.1016/j.biomaterials.2009.08.004
   Bhatia SN, 1998, J BIOMAT SCI-POLYM E, V9, P1137, DOI 10.1163/156856298X00695
   Charnley M, 2009, INTEGR BIOL-UK, V1, P625, DOI 10.1039/b918172p
   Chen AA, 2009, BIOMATERIALS, V30, P1113, DOI 10.1016/j.biomaterials.2008.10.055
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   DUNN JCY, 1989, FASEB J, V3, P174
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   Dusseiller MR, 2005, BIOMATERIALS, V26, P5917, DOI 10.1016/j.biomaterials.2005.02.032
   Fukuda J, 2006, BIOMATERIALS, V27, P1061, DOI 10.1016/j.biomaterials.2005.07.031
   Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044
   Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550
   Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880
   GOSEY LL, 1985, J CLIN MICROBIOL, V22, P803
   Guillame-Gentil O, 2010, ADV MATER, V22, P5443, DOI 10.1002/adma.201001747
   Guvendiren M., 2012, NAT COMMUN, V3, P1269
   Kane BJ, 2006, ANAL CHEM, V78, P4291, DOI 10.1021/ac051856v
   Kim M, 2010, BIOMATERIALS, V31, P3596, DOI 10.1016/j.biomaterials.2010.01.068
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Lee JA, 2009, AEOLIAN RES, V1, P1, DOI 10.1016/j.aeolia.2009.06.001
   Lee JY, 2009, LANGMUIR, V25, P3880, DOI [10.1021/la803635r, 10.1021/1a803635r]
   Mederacke I, 2009, LIVER INT, V29, P1500, DOI 10.1111/j.1478-3231.2009.02100.x
   Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030
   Mori R, 2008, J BIOSCI BIOENG, V106, P237, DOI 10.1263/jbb.106.237
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Otsuka H, 2004, CHEMBIOCHEM, V5, P850, DOI 10.1002/cbic.200300822
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   Revzin A, 2004, LANGMUIR, V20, P2999, DOI 10.1021/la035827w
   Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328
   Shah SS, 2011, SOFT MATTER, V7, P3133, DOI 10.1039/c0sm00771d
   Suh KY, 2004, ADV MATER, V16, P584, DOI 10.1002/adma.200306180
   Tae G, 2006, J BIOMAT SCI-POLYM E, V17, P187, DOI 10.1163/156856206774879090
   Tae G, 2005, BIOMATERIALS, V26, P5259, DOI 10.1016/j.biomaterials.2005.01.042
   Tae G, 2007, BIOMACROMOLECULES, V8, P1979, DOI 10.1021/bm0701189
   Tang MD, 2003, J AM CHEM SOC, V125, P12988, DOI 10.1021/ja037677h
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   Tuleuova N, 2010, BIOMATERIALS, V31, P9221, DOI 10.1016/j.biomaterials.2010.08.050
   Wang WJ, 2009, BIOMATERIALS, V30, P2705, DOI 10.1016/j.biomaterials.2009.01.030
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   WISSE E, 1977, MED CHIR DIG, V6, P409
   Wong SF, 2011, BIOMATERIALS, V32, P8087, DOI 10.1016/j.biomaterials.2011.07.028
   Xia L, 2012, BIOMATERIALS, V33, P2165, DOI 10.1016/j.biomaterials.2011.12.006
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1921, DOI 10.1021/bm050003+
   You J., TISSUE ENG PART A, DOI [10.1089/ten.TEA.20120681, DOI 10.1089/TEN.TEA.20120681]
   Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631
NR 56
TC 25
Z9 27
U1 4
U2 53
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JAN
PY 2014
VL 3
IS 1
BP 126
EP 132
DI 10.1002/adhm.201300054
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 302HT
UT WOS:000330595400014
PM 23828859
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, YC
   Tsai, LK
   Wang, JH
   Young, TH
AF Li, Yi-Chen
   Tsai, Li-Kai
   Wang, Jyh-Horng
   Young, Tai-Horng
TI A neural stem/precursor cell monolayer for neural tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Neural stem/precursor cells (NSPCs); Differentiation; Monolayer;
   Epidermal growth factor (EGF); Fibronectin
ID CENTRAL-NERVOUS-SYSTEM; FIBROBLAST-GROWTH-FACTOR; CORTICAL STEM-CELLS;
   EXTRACELLULAR-MATRIX PROTEINS; ADULT-MOUSE BRAIN; IN-VITRO;
   DIFFERENTIATION; PROLIFERATION; NEURONS; SURVIVAL
AB The purpose of this study was to prepare a monolayer of neural stem/precursor cells (NSPCs) for neural tissue engineering applications. Two components present in serum, fibronectin and epidermal growth factor (EGF) were added into DMEM/F12 medium (termed medium B) to examine the effect of the migration-, proliferation- and differentiation-promoting potential on the cultured NSPCs, isolated from embryonic rat cerebral cortex. Compared with the serum effect, medium B also permitted neurosphere attachment onto the substrate surface and cell migration out of neurospheres extensively, but enhanced more extensive cell division and slowed down NSPC differentiation to generate a confluent NSPC monolayer. It was found the medium B-treated NSPCs possessed the capability to form typical neurospheres or to undergo differentiation into neuron-related cell types on various biomaterial surfaces. Therefore, we proposed a two-stage process for wound healing or nerve conduit preparation. Extensive NSPC division and MAP2-positive neuron differentiation were manipulated in NSPCs cultured in the medium B followed by the neuronal differentiation-favorable medium. These results should be useful for controlling the proliferation and differentiation of NSPCs on various biomaterials and conduits in neuroscience research. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Li, Yi-Chen; Young, Tai-Horng] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan.
   [Li, Yi-Chen; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Wang, Jyh-Horng] Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan.
   [Tsai, Li-Kai] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.
   [Tsai, Li-Kai] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.
   [Tsai, Li-Kai] Coll Med, Taipei, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan.
EM jhwang@ntuh.gov.tw; thyoung@ntu.edu.tw
OI Tsai, Li-Kai/0000-0001-8420-6951; Wang, Jyh- Horng/0000-0002-1531-5297
FU National Science Council of Taiwan, the Republic of China
FX The authors thank the National Science Council of Taiwan, the Republic
   of China for their financial support of this research.
CR AHMED S, 1995, J NEUROSCI, V15, P5765
   AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x
   BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8
   Bobis-Wozowicz S, 2011, EXP HEMATOL, V39, P686, DOI 10.1016/j.exphem.2011.03.004
   BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514
   Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158
   Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E
   Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098
   CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0
   Ceriotti L, 2009, SOFT MATTER, V5, P1406, DOI 10.1039/b814616k
   Chen CR, 2009, ACTA BIOMATER, V5, P2610, DOI 10.1016/j.actbio.2009.03.037
   Choi KC, 2008, J KOREAN NEUROSURG S, V44, P375, DOI 10.3340/jkns.2008.44.6.375
   Cooke MJ, 2010, J BIOMED MATER RES A, V93A, P824, DOI 10.1002/jbm.a.32585
   Goetsch KP, 2011, ANAL BIOCHEM, V411, P158, DOI 10.1016/j.ab.2010.12.012
   Gritti A, 1996, J NEUROSCI, V16, P1091
   Harper MM, 2010, J MOL NEUROSCI, V40, P269, DOI 10.1007/s12031-009-9211-x
   Hung CH, 2006, BIOMATERIALS, V27, P4461, DOI 10.1016/j.biomaterials.2006.04.021
   Hung CH, 2006, BIOMATERIALS, V27, P5901, DOI 10.1016/j.biomaterials.2006.08.009
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Kiryushko D, 2003, J BIOL CHEM, V278, P12325, DOI 10.1074/jbc.M211628200
   Kokuzawa J, 2003, MOL CELL NEUROSCI, V24, P190, DOI 10.1016/S1044-7431(03)00160-X
   Kuai XL, 2009, DIFFERENTIATION, V77, P229, DOI 10.1016/j.diff.2008.10.014
   Kuwada SK, 2000, MOL BIOL CELL, V11, P2485, DOI 10.1091/mbc.11.7.2485
   Leker RR, 2009, J NEURAL TRANSM, V116, P1397, DOI 10.1007/s00702-009-0329-3
   Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396
   Li YC, 2012, ACTA BIOMATER, V8, P3035, DOI 10.1016/j.actbio.2012.04.036
   Lin DJ, 2009, J BIOMAT SCI-POLYM E, V20, P1943, DOI 10.1163/156856208X396047
   LOEBER CP, 1990, DEV BIOL, V140, P401, DOI 10.1016/0012-1606(90)90089-2
   McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Rao MS, 1999, ANAT REC, V257, P137
   Reid AJ, 2013, NEUROSCI LETT, V544, P125, DOI 10.1016/j.neulet.2013.04.001
   Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085
   SANTAOLALLA J, 1995, J NEUROSCI RES, V42, P172, DOI 10.1002/jnr.490420204
   Shao HJ, 2010, J BIOMED MATER RES A, V93A, P1297, DOI 10.1002/jbm.a.32629
   Sun M, 2010, J BIOMED MATER RES A, V93A, P1470, DOI 10.1002/jbm.a.32681
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Suzuki Y, 2010, J BIOL CHEM, V285, P18443, DOI 10.1074/jbc.M110.114645
   Tsai LK, 2011, STROKE, V42, P2932, DOI 10.1161/STROKEAHA.110.612788
   Tsai RYL, 2000, J NEUROSCI, V20, P3725
   Tureyen K, 2005, NEUROSURGERY, V57, P1254, DOI 10.1227/01.NEU.0000186040.96929.8A
   Wang JH, 2006, BIOMATERIALS, V27, P3441, DOI 10.1016/j.biomaterials.2006.02.002
   WECLEWICZ K, 1993, J NEUROSCI RES, V36, P173, DOI 10.1002/jnr.490360207
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   Young TH, 2005, BIOMATERIALS, V26, P4291, DOI 10.1016/j.biomaterials.2004.10.043
NR 48
TC 16
Z9 16
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2014
VL 35
IS 4
BP 1192
EP 1204
DI 10.1016/j.biomaterials.2013.10.066
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA0WF
UT WOS:000330817400008
PM 24225085
DA 2018-10-20
ER

PT J
AU Torielli, RM
   Cannon, FS
   Voigt, RC
   Considine, TJ
   Furness, JC
   Fox, JT
   Goudzwaard, JE
   Huang, H
AF Torielli, Rose M.
   Cannon, Fred S.
   Voigt, Robert C.
   Considine, Timothy J.
   Furness, James C.
   Fox, John T.
   Goudzwaard, Jeff E.
   Huang, He
TI THE ENVIRONMENTAL PERFORMANCE AND COST OF INNOVATIVE TECHNOLOGIES FOR
   DUCTILE IRON FOUNDRY PRODUCTION
SO INTERNATIONAL JOURNAL OF METALCASTING
LA English
DT Article
DE metalcasting; foundry; cupola; advanced oxidation; coke; energy;
   materials; volatile organic compound emissions; anthracite; ultrasonics;
   life cycle; sustainability
ID ADVANCED OXIDATION; ANALYTICAL PYROLYSIS; BINDER; EMISSIONS
AB The authors and collaborators have devised innovative technologies that decrease foundry costs, pollution, materials use, and energy. These include: (a) applying advanced oxidation to green sand and baghouse dust to diminish clay, coal, sand, volatile organic compounds (VOCs), and costs; (b) replacing phenolic urethane core binders with collagen-alkali silicate binders to diminish VOCs; (c) replacing coke with anthracite fines held together with biomaterial to reduce energy and costs. It is proposed by the authors that if a foundry were to concurrently employ all these innovative technologies (with 50% anthracite bricks), it could potentially diminish overall costs by 6.6%, life cycle energy costs by 15%, VOC pollution by 57%, sand by 85%, clay and coal by 50%, and iron scrap by 9%. These computations are per full-scale operations for advanced oxidation; and R&D results for replacing binders and coke. This paper also notes that when electricity comes primarily from coal fired power plants, electric induction furnaces consumes more life cycle energy than do cupolas for melting iron.
C1 [Torielli, Rose M.; Cannon, Fred S.; Voigt, Robert C.] Penn State Univ, University Pk, PA 16802 USA.
   [Considine, Timothy J.] Univ Wyoming, Laramie, WY 82071 USA.
   [Furness, James C.] Furness Newburge Inc, Versailles, KY USA.
   [Fox, John T.] Lehigh Univ, Bethlehem, PA 18015 USA.
   [Goudzwaard, Jeff E.] Neenah Ind Inc, Neenah, WI USA.
   [Huang, He] URS Corp, Philadelphia, PA USA.
RP Torielli, RM (reprint author), Penn State Univ, University Pk, PA 16802 USA.
FU National Science Foundation (NSF); U.S. Department of Agriculture [AFRI
   2011-67009-20049]; Department of Energy (Consortium for Premium Carbon
   Products from Coal); Environmental Protection Agency; Ben Franklin
   Technology Partners of Pennsylvania; NSF [9816232, 0070183, 0524940,
   0700759, 0824406, 0927967, 0906271, 1127817]
FX The research and development regarding these innovative technologies
   that is chronicled herein has been funded through numerous grants from
   the National Science Foundation (NSF), U.S. Department of Agriculture
   (AFRI 2011-67009-20049), Department of Energy (Consortium for Premium
   Carbon Products from Coal), the Environmental Protection Agency, the Ben
   Franklin Technology Partners of Pennsylvania, and numerous industrial
   sources. The NSF grants include: 9816232, 0070183, 0524940, 0700759,
   0824406, 0927967, 0906271, 1127817.
CR ALSEMA EA, 1995, ENV LIFE CYCLE ASSES
   Andrews J., 2000, MODERN CASTING   SEP, p[40, 43]
   [Anonymous], AP 42 COMP AIR POLL
   Baumel C.P., 1985, ESTIMATES TOTAL FUEL
   Cannon F.S., 2004, CHEM PROCESS POLLUTI
   Cannon F.S., 2006, ADAPTING ANTHRACITE
   Considine T. J., 2001, ENV NEW TECHNOLOGY A
   Davis S.C., 2009, ORNL6984 US DEP EN
   Facanha C, 2006, INT J LIFE CYCLE ASS, V11, P229, DOI 10.1065/lca2006.02.244
   Fox J. T., 2007, AM FOUNDRY SOC T, V115, P367
   Fox J. T., 2008, AM FOUNDRY SOC T, V116, P539
   Fox J.T., 2008, AFS T, V116, P523
   Fox JT, 2012, INT J ADHES ADHES, V34, P38, DOI 10.1016/j.ijadhadh.2011.11.011
   Glowacki C. R., 2003, AM FOUNDRY SOC T, V111, P579
   Goudzwaard J. . E., 2003, AM FOUNDRY SOC T, V111, P1191
   Huang H, 2011, ENVIRON SCI TECHNOL, V45, P3062, DOI 10.1021/es102684k
   Huang H, 2011, CERAM INT, V37, P1063, DOI 10.1016/j.ceramint.2010.11.022
   Huang H, 2009, FUEL PROCESS TECHNOL, V90, P1183, DOI 10.1016/j.fuproc.2009.05.015
   Jones A.J., 2007, THESIS MIT
   Land J.D., 2004, AM FOUNDRY SOC T, V112, P1075
   Land J.D., 2002, AM FOUNDRY SOC T, V110, P705
   Lumadue MR, 2012, FUEL, V97, P869, DOI 10.1016/j.fuel.2012.02.061
   Milan-Segovia N, 2007, OZONE-SCI ENG, V29, P461, DOI 10.1080/01919510701615433
   Neill D.A., 2001, AM FOUNDRY SOC T, V109, P937
   Rodrigue J. P., 2009, GEOGRAPHY TRANSPORT
   U.S. Energy Information Administration, COAL TRANSP RAT TREN
   U.S. Energy Information Administration, STAT EN PROF WISC
   U.S. Energy Information Administration, VOL REP GREENH GAS P
   US Energy Information Administration, GAS DIES FUEL UPD
   US EPA C.C.D. U.S., GREENH GAS INV REP
   Wang Y., 2004, AM FOUNDRY SOC T, V112, P635
   Wang YJ, 2006, ENVIRON SCI TECHNOL, V40, P3095, DOI 10.1021/es060013y
   Wang YJ, 2005, ENVIRON SCI TECHNOL, V39, P7712, DOI 10.1021/es0480015
   Wang Y, 2007, ENVIRON SCI TECHNOL, V41, P7922, DOI 10.1021/es071657o
   Wang YJ, 2007, ENVIRON SCI TECHNOL, V41, P2957, DOI 10.1021/es0628295
   Wang YJ, 2011, ENVIRON SCI TECHNOL, V45, P8529, DOI 10.1021/es2023048
   Wang YJ, 2009, ENVIRON SCI TECHNOL, V43, P1559, DOI 10.1021/es8024929
NR 37
TC 2
Z9 2
U1 0
U2 17
PU AMER FOUNDRY SOC INC
PI SCHAUMBURG
PA 1695 N PENNY LN, SCHAUMBURG, IL 60173-4555 USA
SN 1939-5981
EI 2163-3193
J9 INT J METALCAST
JI Int. J. Met.
PY 2014
VL 8
IS 1
BP 37
EP 48
DI 10.1007/BF03355570
PG 12
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA AA2IC
UT WOS:000330917300005
DA 2018-10-20
ER

PT J
AU Li, J
   Yang, HL
   Wang, HF
   Ruan, JM
AF Li, Jing
   Yang, Hailin
   Wang, Huifeng
   Ruan, Jianming
TI Low elastic modulus titanium-nickel scaffolds for bone implants
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Porous TiNi alloy; Slurry immersing with polymer sponge and sintering
   method; Pore structural properties; Compressing properties; Biological
   evaluation in vitro; Cancellous bone substitute
ID SHAPE-MEMORY ALLOYS; POROUS NITI; MECHANICAL-PROPERTIES; BIOMECHANICS;
   HYDROXYAPATITE; BIOCOMPATIBILITY; BIOMATERIAL; COMBINATION; FABRICATION;
   METALLURGY
AB The superelastic nature of repeating the human bones is crucial to the ideal artificial biomedical implants to ensure smooth load transfer and foster the ingrowth of new bone tissues. Three dimensional interconnected porous TiNi scaffolds, which have the tailorable porous structures with micro-hole, were fabricated by slurry immersing with polymer sponge and sintering method. The crystallinity and phase composition of scaffolds were studied by X-ray diffraction. The pore morphology, size and distribution in the scaffolds were characterized by scanning electron microscopy. The porosity ranged from 65 to 72%, pore size was 250-500 mu m. Compressive strength and elastic modulus of the scaffolds were similar to 73 MPa and similar to 3GPa respectively. The above pore structural and mechanical properties are similar to those of cancellous bone. In the initial cell culture test, osteoblasts adhered well to the scaffold surface during a short time, and then grew smoothly into the interconnected pore channels. These results indicate that the porous TiNi scaffolds fabricated by this method could be bone substitute materials. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Li, Jing; Yang, Hailin; Wang, Huifeng; Ruan, Jianming] Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
RP Ruan, JM (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
EM jianming@csu.edu.cn
FU Fundamental Research Funds for the Central Universities of Central South
   University [2012zztsa012]; National Natural Science Foundation of China
   [51274247]; National High Technology Research and Development Program
   [2012BAE06B00]
FX The authors would like to acknowledge the Fundamental Research Funds for
   the Central Universities of Central South University (No. 2012zztsa012),
   the National Natural Science Foundation of China (No. 51274247) and the
   National High Technology Research and Development Program (No.
   2012BAE06B00) for their financial support.
CR Bansiddhi A, 2008, ACTA BIOMATER, V4, P773, DOI 10.1016/j.actbio.2008.02.009
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   FLATLEY TJ, 1983, CLIN ORTHOP RELAT R, P246
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Greiner C, 2005, ACTA BIOMATER, V1, P705, DOI 10.1016/j.actbio.2005.07.005
   Haugen H, 2004, J EUR CERAM SOC, V24, P661, DOI 10.1016/S0955-2219(03)00255-3
   Hoh DJ, 2009, NEUROSURGERY, V64, P199, DOI 10.1227/01.NEU.0000330392.09889.99
   Hosseini SA, 2009, MAT SCI ENG C-MATER, V29, P2203, DOI 10.1016/j.msec.2009.05.006
   Ismail MH, 2012, MAT SCI ENG C-MATER, V32, P1480, DOI 10.1016/j.msec.2012.04.028
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kohl M, 2009, ADV ENG MATER, V11, P959, DOI 10.1002/adem.200900168
   Likibi F, 2005, ANN CHIR, V130, P235, DOI 10.1016/j.anchir.2004.12.006
   LINDE F, 1991, J BIOMECH, V24, P803, DOI 10.1016/0021-9290(91)90305-7
   Liu XM, 2011, BIOMATERIALS, V32, P330, DOI 10.1016/j.biomaterials.2010.08.102
   Livingston T.L., 1999, BIOACTIVE FOAM BONE
   Nakas C.I., 2011, J MECH BEHAV BIOMED, V4, P2017
   Peters MC, 1997, MATER SCI FORUM, V250, P43, DOI 10.4028/www.scientific.net/MSF.250.43
   Prymak O, 2005, BIOMATERIALS, V26, P5801, DOI 10.1016/j.biomaterials.2005.02.029
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Sahin S, 2002, J DENT, V30, P271, DOI 10.1016/S0300-5712(02)00065-9
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Tosun G, 2012, MATER LETT, V66, P138, DOI 10.1016/j.matlet.2011.08.023
   Tripathi G, 2012, CERAM INT, V38, P341, DOI 10.1016/j.ceramint.2011.07.012
   Turner CH, 2002, OSTEOPOROSIS INT, V13, P97, DOI 10.1007/s001980200000
   Vacanti CA, 1999, CLIN ORTHOP RELAT R, pS375
   Wu SL, 2007, ACTA MATER, V55, P3437, DOI 10.1016/j.actamat.2007.01.045
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 30
TC 15
Z9 15
U1 2
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2014
VL 34
BP 110
EP 114
DI 10.1016/j.msec.2013.08.043
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA 300UM
UT WOS:000330489500014
PM 24268239
DA 2018-10-20
ER

PT J
AU Yang, JM
   Yang, JH
   Huang, HT
AF Yang, Jen Ming
   Yang, Jhe-Hao
   Huang, Huei Tsz
TI Chitosan/polyanion surface modification of styrene-butadiene-styrene
   block copolymer membrane for wound dressing
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Layer-by-layer; Chitosan; Polyanion; Wound dressing; Bactericidal
   activity; Cell culture
ID SBS-G-VP; POLYELECTROLYTE MULTILAYER FILMS; BY-LAYER DEPOSITION;
   WATER-VAPOR TRANSMISSION; POLY-L-LYSINE; HYALURONIC-ACID; THIN-FILMS;
   IN-VITRO; BIOMEDICAL APPLICATIONS; BIOMATERIAL USAGE
AB The surface of styrene-butadiene-styrene block copolymer (SBS) membrane is modified with tri-steps in this study. At first, two step modified SBS membrane (MSBS) was prepared with epoxidation and ring opening reaction with maleated ionomer. Then chitosan was used as the polycation electrolyte and sodium alginate, poly(gamma-glutamic acid) (PGA) and poly(aspartic acid) (PAsp) were selected as polyanion electrolytes to deposit on the surfaces of MSBS membrane by the layer-by-layer self-assembly (LbL) deposition technique to get three [chitosan/polyanion] LbL modified SBS membranes, ([CS/Alg], [CS/PGA] and [CS/PAsp]). From the quantitative XPS analysis and water contact angle measurement, it is found that the order of wettability and the content of functional group percentages of COO- and -O=C-N- on the three [CS/polyanion] systems are [CS/Alg] > [CS/PGA] > [CS/PAsp]. Performances of water vapor transmission rates, fibronectin adsorption, antibacterial assessment and 3T3 fibroblast cell growth on [CS/Alg], [CS/PGA] and [CS/PAsp] membranes were also evaluated. With the evaluation of water vapor transmission rate, these [CS/Alg], [CS/PGA] and [CS/PAsp] membranes are sterile semipermeable with water evaporation at about 82 +/- 8 g/day.m(2). It is found that the amount of fibronectin adsorption on the three [CS/polyanion] systems is significantly determined by the sum of the functional group of COO- and -O=C-N- on the surfaces of [CS/Alg], [CS/PGA] and [CS/PAsp] systems. The results are inverse with the sum of the functional group of COO- and -O=C-N- on the three [CS/polyanion]. From the cytotoxicity test and cell adhesion and proliferation assay of 3T3 fibroblasts on the three [CS/polyanion] systems, it revealed that the cells not only remained viable but they also proliferated on the surfaces of [CS/Alg], [CS/PGA] and [CS/PAsp]. The bactericidal activity was found on [CS/Alg], [CS/PGA] and [CS/PAsp]. The transport of bacterial through these [CS/polyanion] membranes was also conducted. No bacterial transport was found. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Yang, Jen Ming; Huang, Huei Tsz] Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
   [Yang, Jhe-Hao] Chang Gung Univ, Dept Elect Engn, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
EM jmyang@mail.cgu.edu.tw
FU National Science Council of the Republic of China; Chang Gung Memorial
   Hospital
FX This research work was supported by the National Science Council of the
   Republic of China and from the partial financial support of the Chang
   Gung Memorial Hospital.
CR Abdelghany SM, 2013, BIOMACROMOLECULES, V14, P302, DOI 10.1021/bm301858a
   Adusumilli M, 2009, LANGMUIR, V25, P7478, DOI 10.1021/la900391q
   Ai H, 2011, ADV DRUG DELIVER REV, V63, P772, DOI 10.1016/j.addr.2011.03.013
   Baba A, 2006, J PHYS CHEM B, V110, P42, DOI 10.1021/jp056201c
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Campbell VE, 2005, CHEM MATER, V17, P186, DOI 10.1021/cm048905p
   Chiarelli PA, 2002, LANGMUIR, V18, P168, DOI 10.1021/la011333s
   Crouzier T., 2011, ADV MATER, V23, P111
   Crouzier T, 2011, BIOMATERIALS, V32, P7543, DOI 10.1016/j.biomaterials.2011.06.062
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Detzel CJ, 2011, TISSUE ENG PART B-RE, V17, P101, DOI [10.1089/ten.teb.2010.0548, 10.1089/ten.TEB.2010.0548]
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Hu XF, 2010, LANGMUIR, V26, P2624, DOI 10.1021/la902719k
   Izquierdo A, 2005, LANGMUIR, V21, P7558, DOI 10.1021/la047407s
   Japanese Industrial Standard Community, 2002, L19022002 JIS JAP ST
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   Lefaux CJ, 2004, J POLYM SCI POL PHYS, V42, P3654, DOI 10.1002/polb.20209
   Lin HY, 2007, INT J HYDROGEN ENERG, V32, P86, DOI 10.1016/j.ijhydene.2006.04.007
   Lu OY, 2008, J MEMBRANE SCI, V310, P76, DOI 10.1016/j.memsci.2007.10.031
   LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020
   LVOV Y, 1993, MACROMOLECULES, V26, P5396, DOI 10.1021/ma00072a016
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Mohammed JS, 2004, BIOMACROMOLECULES, V5, P1745, DOI 10.1021/bm0498631
   Moskowitz JS, 2010, BIOMATERIALS, V31, P6019, DOI 10.1016/j.biomaterials.2010.04.011
   Nogueira GM, 2010, LANGMUIR, V26, P8953, DOI 10.1021/la904741h
   Pavlukhina S, 2011, ADV DRUG DELIVER REV, V63, P822, DOI 10.1016/j.addr.2011.03.017
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Saha N, 2013, BIOMACROMOLECULES, V14, P520, DOI 10.1021/bm301774a
   Salloum DS, 2004, BIOMACROMOLECULES, V5, P1089, DOI 10.1021/bm034522t
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   Schlenoff JB, 2000, LANGMUIR, V16, P9968, DOI 10.1021/la001312i
   Schneider A, 2007, LANGMUIR, V23, P2655, DOI 10.1021/la062163s
   Suh KY, 2005, J BIOMED MATER RES B, V72B, P292, DOI 10.1002/jbm.b.30152
   Suh KY, 2004, ADV MATER, V16, P584, DOI 10.1002/adma.200306180
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x
   Vazquez E, 2002, J AM CHEM SOC, V124, P13992, DOI 10.1021/ja026405w
   Watanabe J, 2008, ACTA BIOMATER, V4, P1255, DOI 10.1016/j.actbio.2008.03.009
   Wong SY, 2010, BIOMATERIALS, V31, P4079, DOI 10.1016/j.biomaterials.2010.01.119
   Wu P, 1996, BIOMATERIALS, V17, P1373, DOI 10.1016/0142-9612(96)87277-2
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
   Yang JM, 2012, MAT SCI ENG C-MATER, V32, P1578, DOI 10.1016/j.msec.2012.04.046
   Yang JM, 2010, MAT SCI ENG C-MATER, V30, P1151, DOI 10.1016/j.msec.2010.06.014
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   Yang JM, 2003, J BIOMED MATER RES A, V64A, P138, DOI 10.1002/jbm.a.10245
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
   Zahn R, 2012, BIOMATERIALS, V33, P3421, DOI 10.1016/j.biomaterials.2012.01.019
   Zhou DJ, 2004, LANGMUIR, V20, P9089, DOI 10.1021/la048619s
NR 56
TC 8
Z9 8
U1 1
U2 74
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2014
VL 34
BP 140
EP 148
DI 10.1016/j.msec.2013.09.001
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 300UM
UT WOS:000330489500018
PM 24268243
DA 2018-10-20
ER

PT J
AU Chen, HY
   Zhang, EL
   Yang, K
AF Chen, Haiyan
   Zhang, Erlin
   Yang, Ke
TI Microstructure, corrosion properties and bio-compatibility of calcium
   zinc phosphate coating on pure iron for biomedical application
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterials; Coatings; Surfaces; Corrosion; Pure iron
ID IN-VITRO; CELL COMPATIBILITY; BIOMATERIAL; MAGNESIUM; STENTS;
   BIOCOMPATIBILITY; DEGRADATION; BIOACTIVITY; SCAFFOLDS; ALLOYS
AB In order to improve the biocompatibility and the corrosion resistance in the initial stage of implantation, a phosphate (CaZn2(PO4)(2)center dot 2H(2)O) coating was obtained on the surface of pure iron by a chemical reaction method. The anti-corrosion property, the blood compatibility and the cell toxicity of the coated pure iron specimens were investigated. The coating was composed of some fine phosphate crystals and the surface of coating was flat and dense enough. The electrochemical data indicated that the corrosion resistance of the coated pure iron was improved with the increase of phosphating time. When the specimen was phosphated for 30 min, the corrosion resistance (R-p) increased to 8006 Omega. Compared with that of the naked pure iron, the anti-hemolysis property and cell compatibility of the coated specimen was improved significantly, while the anti-coagulant property became slightly worse due to the existence of element calcium. It was thought that phosphating treatment might be an effective method to improve the biocompatibility of pure iron for biomedical application. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Chen, Haiyan] Harbin Inst Technol, State Key Lab Adv Welding & Joining, Harbin 150001, Peoples R China.
   [Zhang, Erlin] Northeastern Univ, Educ Minist China, Key Lab Anisotropy & Texture Mat, Shenyang 110819, Peoples R China.
   [Yang, Ke] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RP Zhang, EL (reprint author), Northeastern Univ, Educ Minist China, Key Lab Anisotropy & Texture Mat, Shenyang 110819, Peoples R China.
EM zhangerlin2009@163.com
RI Zhang, Erlin/N-6608-2014
OI Zhang, Erlin/0000-0002-6152-6546
FU National Key Basic Research Program of China (973) [2012CB619100];
   National Natural Science Foundation [81071262/H1820]; Heilongjiang
   Universities' Science and Technology Innovation Team program
   [2012TD010]; Nature Science Foundation of Heilongjiang Province for
   Distinguished Young Scholars [JC201205]
FX The authors would like to acknowledge the financial support from
   National Key Basic Research Program of China (973) (2012CB619100),
   National Natural Science Foundation (81071262/H1820), Heilongjiang
   Universities' Science and Technology Innovation Team program (2012TD010)
   and Nature Science Foundation of Heilongjiang Province for Distinguished
   Young Scholars (JC201205).
CR [Anonymous], 2002, ISO1099312 ANSIAAMI
   Bal KE, 2012, MATER LETT, V79, P238, DOI 10.1016/j.matlet.2012.04.036
   Cai KY, 2007, ACTA BIOMATER, V3, P597, DOI 10.1016/j.actbio.2006.12.005
   Cai S, 2011, MATER CHEM PHYS, V131, P462, DOI 10.1016/j.matchemphys.2011.10.005
   Cu X.N., 2009, BIOMATERIALS, V30, P484
   Du H, 2011, COLLOID SURFACE B, V83, P96, DOI 10.1016/j.colsurfb.2010.11.003
   Durnelie N, 2008, MATER CHARACT, V59, P129, DOI 10.1016/j.matchar.2006.11.030
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gurappa I, 2002, MATER CHARACT, V49, P73, DOI 10.1016/S1044-5803(02)00320-0
   ISO 10993-5, 1999, 109935 ISO
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Liu GY, 2011, MATER CHEM PHYS, V130, P1118, DOI 10.1016/j.matchemphys.2011.08.043
   Lu X, 2007, MAT SCI ENG C-BIO S, V27, P700, DOI 10.1016/j.msec.2006.06.030
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Otsuka M, 2003, BIO-MED MATER ENG, V13, P103
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016
   Siah CW, 2005, CLIN CHIM ACTA, V358, P24, DOI 10.1016/j.cccn.2005.02.022
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Sun RX, 2006, MATER CHARACT, V56, P250, DOI 10.1016/j.matchar.2005.11.012
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Xu LP, 2009, J MATER SCI-MATER M, V20, P859, DOI 10.1007/s10856-008-3648-2
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   YAMAGUCHI M, 1994, PEPTIDES, V15, P1367, DOI 10.1016/0196-9781(94)90110-4
   Yang F, 2008, CHEM ENG J, V137, P154, DOI 10.1016/j.cej.2007.07.076
   Yang SL, 2008, POLYM TEST, V27, P957, DOI 10.1016/j.polymertesting.2008.08.009
   Yanovska A, 2011, SURF COAT TECH, V205, P5324, DOI 10.1016/j.surfcoat.2011.05.040
   Zhang EL, 2010, J MATER SCI-MATER M, V21, P2151, DOI 10.1007/s10856-010-4070-0
   Zheng CY, 2007, MAT SCI ENG C-BIO S, V27, P824, DOI 10.1016/j.msec.2006.09.021
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 33
TC 23
Z9 23
U1 3
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2014
VL 34
BP 201
EP 206
DI 10.1016/j.msec.2013.09.010
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 300UM
UT WOS:000330489500025
PM 24268250
DA 2018-10-20
ER

PT J
AU Low, YKA
   Zou, X
   Fang, YM
   Wang, JL
   Lin, WS
   Boey, FYC
   Ng, KW
AF Low, Y. K. A.
   Zou, X.
   Fang, Y. M.
   Wang, J. L.
   Lin, W. S.
   Boey, F. Y. C.
   Ng, K. W.
TI beta-Phase poly(vinylidene fluoride) films encouraged more homogeneous
   cell distribution and more significant deposition of fibronectin towards
   the cell-material interface compared to alpha-phase poly(vinylidene
   fluoride) films
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly(vinylidene fluoride); Polymorphism; Cell-material interaction;
   Biomaterial
ID CRYSTALLINE PHASES; PVDF FILMS; POLYMERS; PIEZOELECTRICITY;
   PROLIFERATION; ORIENTATION; OSTEOBLAST; MORPHOLOGY; MEMBRANES; ADHESION
AB The piezoelectric response from beta-phase poly(vinylidene fluoride) (PVDF) can potentially be exploited for biomedical application. We hypothesized that alpha and beta-phase PVDF exert direct but different influence on cellular behavior, alpha- and beta-phase PVDF films were synthesized through solution casting and characterized with FT-IR, XRD, AFM and PPM to ensure successful fabrication of alpha and beta-phase PVDF films. Cellular evaluation with L929 mouse fibroblasts over one-week was conducted with AlamarBlue (R) metabolic assay and PicoGreen (R) proliferation assay. Immunostaining of fibronectin investigated the extent and distribution of extracellular matrix deposition. Image saliency analysis quantified differences in cellular distribution on the PVDF films. Our results showed that beta-phase PVDF films with the largest area expressing piezoelectric effect elicited highest cell metabolic activity at day 3 of culture. Increased fibronectin adsorption towards the cell-material interface was shown on beta-phase PVDF films. Image saliency analysis showed that fibroblasts on beta-phase PVDF films were more homogeneously distributed than on alpha-phase PVDF films. Taken collectively, the different molecular packing of alpha and beta-phase PVDF resulted in differing physical properties of films, which in turn induced differences in cellular behaviors. Further analysis of how alpha and beta-phase PVDF may evoke specific cellular behavior to suit particular application will be intriguing. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Low, Y. K. A.; Zou, X.; Wang, J. L.; Boey, F. Y. C.; Ng, K. W.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Fang, Y. M.; Lin, W. S.] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore.
RP Ng, KW (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, N4-1 50 Nanyang Ave, Singapore 639798, Singapore.
EM kwng@ntu.edu.sg
RI Ng, Kee Woei/B-7242-2008; WANG, Junling/B-3596-2009; Boey, Freddy Yin
   Chiang/G-2618-2017
OI Ng, Kee Woei/0000-0002-7276-3563; WANG, Junling/0000-0003-3663-7081; 
CR Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006
   Benz M, 2003, J APPL POLYM SCI, V89, P1093, DOI 10.1002/app.12267
   Chen RS, 2007, J BIOMED MATER RES A, V83A, P241, DOI 10.1002/jbm.a.31475
   Eggleton R.C., 1979, P 24 ANN CONV AM I U, P123
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fukada E, 2000, IEEE T ULTRASON FERR, V47, P1277, DOI 10.1109/58.883516
   Gregorio R, 2006, J APPL POLYM SCI, V100, P3272, DOI 10.1002/app.23137
   Gregorio R, 1999, J MATER SCI, V34, P4489
   GUTHNER P, 1992, APPL PHYS LETT, V61, P1137, DOI 10.1063/1.107693
   HASEGAWA R, 1972, POLYM J, V3, P600, DOI 10.1295/polymj.3.600
   Kakoei Shahla, 2010, Iran Endod J, V5, P69
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Lin DJ, 2006, EUR POLYM J, V42, P1581, DOI 10.1016/j.eurpolymj.2006.01.027
   Lovell CS, 2011, J POLYM SCI POL PHYS, V49, P1555, DOI 10.1002/polb.22345
   Low YKA, 2011, J BIOMAT SCI-POLYM E, V22, P1651, DOI 10.1163/092050610X519471
   Low Y.K.A., 2012, J APPL POLYM SCI, V128, P2902
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Mago Gaurav, 2008, J NANOMATER, V2008, P8
   NEWMAN BA, 1979, J APPL PHYS, V50, P6095, DOI 10.1063/1.325778
   OSAKI S, 1975, J POLYM SCI POL PHYS, V13, P1071, DOI 10.1002/pol.1975.180130602
   Park A, 1996, J BIOMED MATER RES, V31, P117
   Park YJ, 2005, EUR POLYM J, V41, P1002, DOI 10.1016/j.eurpolymj.2004.11.022
   Ribeiro C., 2012, BIOMED MAT, V7
   Rodrigues MT, 2008, MATER SCI FORUM, V587-588, P72, DOI 10.4028/www.scientific.net/MSF.587-588.72
   Salgado AJ, 2006, MATER SCI FORUM, V514-516, P1020, DOI 10.4028/www.scientific.net/MSF.514-516.1020
   Salimi A, 2003, POLYM TEST, V22, P699, DOI 10.1016/S0142-9418(03)00003-5
   Sencadas V, 2004, THERMOCHIM ACTA, V424, P201, DOI 10.1016/j.tca.2004.06.006
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Teng HX, 2012, APPL SCI-BASEL, V2, P496, DOI 10.3390/app2020496
   Wang T, 2007, DENT MATER, V23, P450, DOI 10.1016/j.dental.2006.02.016
   Wang ZY, 2008, POLYMER, V49, P2542, DOI 10.1016/j.polymer.2008.03.043
   Weber N, 2010, ACTA BIOMATER, V6, P3550, DOI 10.1016/j.actbio.2010.03.035
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
NR 33
TC 10
Z9 10
U1 3
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2014
VL 34
BP 345
EP 353
DI 10.1016/j.msec.2013.09.029
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 300UM
UT WOS:000330489500043
PM 24268268
DA 2018-10-20
ER

PT J
AU Zhu, CH
   Fan, DD
   Wang, YY
AF Zhu, Chenhui
   Fan, Daidi
   Wang, Yaoyu
TI Human-like collagen/hyaluronic acid 3D scaffolds for vascular tissue
   engineering
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Vascular scaffold; Hyaluronic acid; Human-like collagen;
   Biocompatibility
ID SIGNALING PATHWAYS; HYALURONAN; HYDROGELS; COLLAGEN; CD44; ANGIOGENESIS;
   RECEPTORS; GROWTH; BIOMATERIAL; INVOLVEMENT
AB Following the previous work of media layer and adventitia layer construction for vascular scaffold, we developed a suitable intima layer scaffold for endothelialization using novel human-like collagen/hyaluronic acid composite at different mass ratios of 40/1, 20/1 and 10/1 (HLC to HA) by freeze-drying process. The structure, mechanical strength, degradation and biocompatibility of the vascular HLC/HA scaffold were evaluated. The results showed that the 10/1 HLC/HA composited an optimal scaffold with (1) an interconnected porous network with a pore diameter of 12 2 pm and porosity of 89.3%, (2) better mechanical properties with higher stress of 321.7 +/- 15 kPa and strain of 45.5 +/- 0.2% than 40/1,20/1 and pure HLC scaffolds, (3) only 9% degradation upon immersion in PBS for 45 days at 37 degrees C in vitro, and (4) excellent biocompatibility. This study suggests that the 10/1 HLC/HA composite has a broad prospect of application as luminal vascular scaffold in the tissue engineering. Crown Copyright (C) 2013 Published by Elsevier B.V. All rights reserved.
C1 [Zhu, Chenhui; Fan, Daidi] NW Univ Xian, Sch Chem Engn, Shaanxi Key Lab Degradable Biomed Mat, Xian 710069, Shaanxi, Peoples R China.
   [Zhu, Chenhui; Fan, Daidi] NW Univ Xian, Sch Chem Engn, Shaanxi R&D Ctr Biomat & Fermentat Engn, Xian 710069, Shaanxi, Peoples R China.
   [Wang, Yaoyu] Minist Educ, Key Lab Synthet & Nat Funct Mol Chem, Xian H710069, Shaanxi, Peoples R China.
RP Fan, DD (reprint author), NW Univ Xian, Sch Chem Engn, Shaanxi Key Lab Degradable Biomed Mat, Xian 710069, Shaanxi, Peoples R China.
EM fandaidi@nwu.edu.cn
RI Fan, daidi/J-1128-2017
FU National Natural Science Foundation of China [21076119, 31000019,
   21106112, 21106111, 21106114, 21276210, 21206135]; Shaanxi Provincial
   Scientific Technology Research and Development Program [2007K06-03];
   Scientific Research Program of Shaanxi Provincial Department of
   Education [12JK0449]; Xi'an Research and Development Program [YF07078];
   Shaanxi Biochemical Engineering Key Discipline Program, China
FX This study was financially supported the National Natural Science
   Foundation of China (21076119 and 31000019; 21106112, 21106111,
   21106114; 21276210, 21206135); Shaanxi Provincial Scientific Technology
   Research and Development Program (2007K06-03), Scientific Research
   Program of Shaanxi Provincial Department of Education (12JK0449), Xi'an
   Research and Development Program (YF07078), and Shaanxi Biochemical
   Engineering Key Discipline Program, China.
CR Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Fan DD, 2005, BIOTECHNOL LETT, V27, P865, DOI 10.1007/s10529-005-6720-8
   Gendler E., 2004, J BIOMED MATER RES, V18, P727
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   Hirai J, 1994, ASAIO J, V40, pM383, DOI 10.1097/00002480-199407000-00027
   HOFFMAN D, 1992, CIRCULATION, V86, P75
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kang TY, 2013, ACTA BIOMATER, V9, P4716, DOI 10.1016/j.actbio.2012.08.042
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee SJ, 2007, J BIOMED MATER RES B, V82B, P506, DOI 10.1002/jbm.b.30756
   Leukauf C, 1993, J Heart Valve Dis, V2, P230
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   Rahmanian M, 2002, INT J CANCER, V97, P601, DOI 10.1002/ijc.10087
   RAO J, 1992, ANAL BIOCHEM, V207, P186, DOI 10.1016/0003-2697(92)90521-8
   Rath SN, 2012, J BIOMATER APPL, V27, P277, DOI 10.1177/0885328211402243
   Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200
   Seidlits SK, 2011, ACTA BIOMATER, V7, P2401, DOI 10.1016/j.actbio.2011.03.024
   Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200
   Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629
   Vara DS, 2005, PATHOL BIOL, V53, P599, DOI 10.1016/j.patbio.2004.12.006
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhu C., 2009, CHINESE J BIOTECHNOL, V25, P1225
   Zhu CH, 2009, J BIOMED MATER RES A, V89A, P829, DOI 10.1002/jbm.a.32256
   Zilla P, 1997, J HEART VALVE DIS, V6, P510
NR 35
TC 17
Z9 17
U1 2
U2 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2014
VL 34
BP 393
EP 401
DI 10.1016/j.msec.2013.09.044
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 300UM
UT WOS:000330489500049
PM 24268274
DA 2018-10-20
ER

PT J
AU Wang, JT
   Li, LL
   Zhang, MY
   Liu, SL
   Jiang, LH
   Shen, Q
AF Wang, Jun-Ting
   Li, Lu-Lu
   Zhang, Meng-Yuan
   Liu, Si-Lu
   Jiang, Lin-Hai
   Shen, Qing
TI Directly obtaining high strength silk fiber from silkworm by feeding
   carbon nanotubes
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Silk fiber; Silkworm; Carbon nanotubes; Feeding; Strength
ID BOMBYX-MORI SILK; CHITOSAN FIBER; CROSS-LINKING; FIBROIN; BIOMATERIAL;
   NANOFIBERS; SCAFFOLDS; CELLULOSE; GLYOXAL; C-13
AB By feeding silkworm with the carbon nanotube, CNT, we directly obtained high strength silk fiber, SF, from silkworm. The CNT-based SF, SF/CNT, has a stress at 1.69GPa and a strain at about 24% both higher than those of the SF and are capable to compare with the super SF and even the spider fiber. Morphology comparison showed that the presence of CNT in SF caused the cross-section changed from triangle to ellipse. X-ray diffraction and infrared analysis indicated that the embedded CNT in SF caused an increase in silk-I structure. Specifically the amide-II structure reduced by about 5% and the amide-III structure increased by about 10%. Thermogravimetric analyses indicated that the presence of CNT in SF enhanced the thermal stability. Additionally, the presence of CNT in SF also enhanced the electrical property. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Shen, Qing] Donghua Univ, State Key Lab Modificat Chem Fiber & Polymers, Shanghai 201620, Peoples R China.
   Donghua Univ, Polymer Dept, Shanghai 201620, Peoples R China.
RP Shen, Q (reprint author), Donghua Univ, State Key Lab Modificat Chem Fiber & Polymers, 2999 N Renmin Rd Songjiang, Shanghai 201620, Peoples R China.
EM sqing@dhu.edu.cn
CR Asakura T, 2002, BIOCHEMISTRY-US, V41, P4415, DOI 10.1021/bi0119013
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Ayutsede J.E., 2005, THESIS DREXEL U US
   Blond D, 2007, BIOMACROMOLECULES, V8, P3973, DOI 10.1021/bm700971g
   Domachuk P, 2010, ADV MATER, V22, P249, DOI 10.1002/adma.200900821
   Dong JQ, 2009, J POLYM SCI POL PHYS, V47, P2036, DOI 10.1002/polb.21802
   Feng XX, 2007, INT J BIOL MACROMOL, V40, P105, DOI 10.1016/j.ijbiomac.2006.06.011
   Fraser R.D.B., 1973, CONFORMATONS FIBROUS
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kang M, 2009, CURR APPL PHYS, V9, pS95, DOI 10.1016/j.cap.2008.08.014
   Kim D. Y., 2009, APPL PHYS LETT, P95
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Li DL, 2006, J APPL POLYM SCI, V101, P2810, DOI 10.1002/app.22612
   Lucas F., 1956, ADV PROTEIN CHEM, V13
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Martel A, 2007, BIOMACROMOLECULES, V8, P3548, DOI 10.1021/bm700935w
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Taddei P, 2007, BIOMACROMOLECULES, V8, P1200, DOI 10.1021/bm061017y
   Tansil NC, 2011, BIOMATERIALS, V32, P9576, DOI 10.1016/j.biomaterials.2011.08.081
   Tansil NC, 2011, ADV MATER, V23, P1463, DOI 10.1002/adma.201003860
   Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v
   Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860
   Um IC, 2004, INT J BIOL MACROMOL, V34, P89, DOI 10.1016/j.ijbiomac.2004.03.007
   Urn I.C., 2004, INT J BIOL MACROMOL, V34, P107
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang ZX, 2004, CARBOHYD POLYM, V57, P415, DOI 10.1016/j.carbpol.2004.05.017
   Yang Q, 2005, CARBOHYD POLYM, V61, P393, DOI 10.1016/j.carbpol.2005.04.017
   Yang Q, 2005, CARBOHYD POLYM, V59, P205, DOI 10.1016/j.carbpol.2004.09.013
   Yao JM, 2002, MACROMOLECULES, V35, P6, DOI 10.1021/ma011335j
   YAO N, 2005, HDB MICROSCOPY NANOT
   Yoon SH, 2006, BIOMACROMOLECULES, V7, P1280, DOI 10.1021/bm050597g
   Zhou L, 2005, J PHYS CHEM B, V109, P16937, DOI 10.1021/jp050883m
NR 38
TC 10
Z9 10
U1 9
U2 110
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2014
VL 34
BP 417
EP 421
DI 10.1016/j.msec.2013.09.041
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA 300UM
UT WOS:000330489500052
PM 24268277
DA 2018-10-20
ER

PT J
AU Kulaga, E
   Ploux, L
   Balan, L
   Schrodj, G
   Roucoules, V
AF Kulaga, Emilia
   Ploux, Lydie
   Balan, Lavinia
   Schrodj, Gautier
   Roucoules, Vincent
TI Mechanically Responsive Antibacterial Plasma Polymer Coatings for
   Textile Biomaterials
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE antibacterial coating; controlled release; maleic anhydride; plasma
   polymerization; responsive materials; silver particles
ID SILVER-COATED MEGAPROSTHESES; PLANAR MAGNETRON DEPOSITION; HEAVY-METAL
   RESISTANCE; BACTERIAL ADHESION; CONTROLLED-RELEASE; MALEIC-ANHYDRIDE;
   NANOPARTICLES; SURFACES; FILMS; EPIDEMIOLOGY
AB We have developed a new type of mechanically responsive material on the basis of a plasma-modified soft biomaterial substrate (polypropylene surgical mesh). A first plasma deposited layer, enriched in a bioactive agent (silver nanoparticles), has been covered by a second plasma polymer layer that acts as a barrier to spontaneous release. The release of the active agent in a controlled manner was achieved by the presence of mechanically reversible fragmentations in the top-layer of deposited plasma polymer, induced by mechanical stimuli. Characterization of the material was performed by Scanning Electron Microscopy, Transmission Electron Microscopy, Attenuated Total Reflexion-Fourier Transform Infra-Red, X-ray Photoelectron, and Ultra Violet-Visible Spectroscopies. The antibacterial properties of the material have been verified.
C1 [Kulaga, Emilia; Ploux, Lydie; Balan, Lavinia; Schrodj, Gautier; Roucoules, Vincent] UHA, IS2M, CNRS, UMR 7361, F-68057 Mulhouse, France.
RP Roucoules, V (reprint author), UHA, IS2M, CNRS, UMR 7361, 15 Rue Jean Starcky, F-68057 Mulhouse, France.
EM Vincent.Roucoules@uha.fr
RI Balan, Lavinia/L-5866-2016
OI Balan, Lavinia/0000-0003-0144-401X
FU Region Alsace in France
FX The authors gratefully acknowledge the financial support from Region
   Alsace in France. The authors would like to thank Cousin Biotech for
   providing polypropylene mesh substrates. Florent Kuntz and Ludovic
   Frechard from Aerial are kindly acknowledged for their expertise and
   assistance in the electron beam sterilization process.
CR Airoudj A, 2011, ADV ENG MATER, V13, pB360, DOI 10.1002/adem.201080075
   Bagshaw SM, 2006, CURR OPIN INFECT DIS, V19, P67, DOI 10.1097/01.qco.0000200292.37909.e0
   Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7
   Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12
   Beier O, 2013, PLASMA PROCESS POLYM, V10, P77, DOI 10.1002/ppap.201200059
   Boening H. V., 1988, FUNDAMENTAL PLASMA C, P75
   Boldyryeva H, 2003, THIN SOLID FILMS, V442, P86, DOI 10.1016/S0040-6090(03)00950-7
   Boonkaew B., 2013, BURNS, V39, P1341
   Bruins MR, 2000, ECOTOX ENVIRON SAFE, V45, P198, DOI 10.1006/eesa.1999.1860
   Callegari A, 2003, NANO LETT, V3, P1565, DOI 10.1021/nl034757a
   Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001
   Chopra I, 2007, J ANTIMICROB CHEMOTH, V59, P587, DOI 10.1093/jac/dkm006
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Chung CJ, 2008, J BIOMED MATER RES B, V85B, P220, DOI 10.1002/jbm.b.30939
   Dietz HP, 2003, INT UROGYNECOL J PEL, V14, P239, DOI 10.1007/s00192-003-1041-8
   Dirani A, 2010, PLASMA PROCESS POLYM, V7, P571, DOI 10.1002/ppap.200900162
   Ducel G, 2002, PREVENTION HOSP ACQU
   Eichler M, 2011, BIOMATERIALS, V32, P9168, DOI 10.1016/j.biomaterials.2011.08.063
   France RM, 1998, LANGMUIR, V14, P4827, DOI 10.1021/la9713053
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Contreras RG, 2010, IN VIVO, V24, P513
   Geissler A, 2008, LANGMUIR, V24, P4874, DOI 10.1021/la703633k
   Geissler A, 2010, PLASMA PROCESS POLYM, V7, P64, DOI 10.1002/ppap.200900098
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Hardes J, 2007, BIOMATERIALS, V28, P2869, DOI 10.1016/j.biomaterials.2007.02.033
   Hardes J, 2010, J SURG ONCOL, V101, P389, DOI 10.1002/jso.21498
   Hegemann D, 2007, PLASMA PROCESS POLYM, V4, P229, DOI 10.1002/ppap.200600169
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395
   Hlidek P, 2008, THIN SOLID FILMS, V516, P4581, DOI 10.1016/j.tsf.2007.05.085
   HUDA MN, 1984, COLLOID POLYM SCI, V262, P110
   Jradi S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/9/095605
   Korner E, 2010, PLASMA PROCESS POLYM, V7, P619, DOI 10.1002/ppap.200900163
   Lan SF, 2013, DENT MATER, V29, P656, DOI 10.1016/j.dental.2013.03.014
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Miao H, 2009, J MICROBIOL METH, V76, P111, DOI 10.1016/j.mimet.2008.09.015
   Mishra G, 2010, LANGMUIR, V26, P9645, DOI 10.1021/la100236c
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457
   Page K, 2009, J MATER CHEM, V19, P3819, DOI 10.1039/b818698g
   Paladini F, 2013, J MATER SCI-MATER M, V24, P2461, DOI 10.1007/s10856-013-4986-2
   Palmer AC, 2013, NAT REV GENET, V14, P243, DOI 10.1038/nrg3351
   Parashar UK, 2008, DIG J NANOMATER BIOS, V3, P81
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014
   Ploux L, 2010, J ADHES SCI TECHNOL, V24, P2165, DOI 10.1163/016942410X511079
   Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795
   Ross SS, 2012, J MICROBIOL METH, V90, P9, DOI 10.1016/j.mimet.2012.04.008
   Roucoules V, 2007, LANGMUIR, V23, P13136, DOI 10.1021/la701460f
   Roucoules V, 2003, J PHYS CHEM B, V107, P3496, DOI 10.1021/jp0212621
   Roucoules V, 2007, J ADHESION, V83, P875, DOI 10.1080/00218460701699732
   Samore MH, 2004, JAMA-J AM MED ASSOC, V291, P325, DOI 10.1001/jama.291.3.325
   Siffer F, 2005, ANAL CHIM ACTA, V539, P289, DOI 10.1016/j.aca.2005.02.072
   Taha M., 2013, MAT SCI ENG C, V3, P2639
   Teitzel GM, 2003, APPL ENVIRON MICROB, V69, P2313, DOI 10.1128/AEM.69.4.2313-2320.2003
   van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X
   Vasilev K, 2008, J PHYS CHEM B, V112, P10915, DOI 10.1021/jp803678w
   Vasilev K, 2010, NANO LETT, V10, P202, DOI 10.1021/nl903274q
   Vidal O, 1998, J BACTERIOL, V180, P2442
   Woodward IS, 2006, PLASMA CHEM PLASMA P, V26, P507, DOI 10.1007/s11090-006-9032-4
   Yasuda H., 1985, PLASMA POLYM
   Zanna S, 2010, APPL SURF SCI, V256, P6499, DOI 10.1016/j.apsusc.2010.03.132
   Zimmermann AK, 2007, J BIOMED MATER RES B, V80B, P433, DOI 10.1002/jbm.b.30614
NR 62
TC 9
Z9 9
U1 3
U2 47
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1612-8850
EI 1612-8869
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD JAN
PY 2014
VL 11
IS 1
BP 63
EP 79
DI 10.1002/ppap.201300091
PG 17
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 302FW
UT WOS:000330588800007
DA 2018-10-20
ER

PT J
AU Jang, HL
   Jin, K
   Lee, J
   Kim, Y
   Nahm, SH
   Hong, KS
   Nam, KT
AF Jang, Hae Lin
   Jin, Kyoungsuk
   Lee, Jaehun
   Kim, Younghye
   Nahm, Seung Hoon
   Hong, Kug Sun
   Nam, Ki Tae
TI Revisiting Whitlockite, the Second Most Abundant Biomineral in Bone:
   Nanocrystal Synthesis in Physiologically Relevant Conditions and
   Biocompatibility Evaluation
SO ACS NANO
LA English
DT Article
DE biomineralization; bone growth; whitlockite; nanoparticle; calcium
   phosphate; inorganic synthesis; biomaterial
ID MG-CONTAINING BETA-CA3(PO4)2; CALCIUM PHOSPHATES; MAGNESIUM WHITLOCKITE;
   ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; PRECIPITATION; ENAMEL;
   OSTEOCLASTS; PHOSPHORUS; CA3(PO4)2
AB The synthesis of pure whitlockite (WH: Ca18Mg2(HPO4)(2)(PO4)(12)) has remained a challenge even though it is the second most abundant inorganic in living bone. Although a few reports about the precipitation of WH in heterogeneous phases have been published, to date, synthesizing WH without utilizing any effects of a buffer or various other ions remains difficult. Thus, the related research fields have encountered difficulties and have not been fully developed. Here, we developed a large-scale synthesis method for pure WH nanoparticles in a ternary Ca(OH)(2)-Mg(OH)(2)-H3PO4 system based on a systematic approach. We used excess Mg2+ to impede the growth of hydroxyapatite (HAP: Ca-10(PO4)(6)(OH)(2)) and the formation of other kinetically favored calcium phosphate intermediate phases. In addition, we designed and investigated the synthesis conditions of WH under the acidic pH conditions required to dissolve HAP, which is the most thermodynamically stable phase above pH 4.2, and to incorporate the HPO42- group into the chemical structure of WH. We demonstrated that pure WH nanoparticles can be precipitated under Mg2+-rich and acidic pH conditions without any intermediate phases. Interestingly, this synthesized nano-WH showed comparable biocompatibility with HAP. Our methodology for determining the synthesis conditions of WH could provide a new platform for investigating other important precipitants in aqueous systems.
C1 [Jang, Hae Lin; Jin, Kyoungsuk; Lee, Jaehun; Kim, Younghye; Hong, Kug Sun; Nam, Ki Tae] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151744, South Korea.
   [Nahm, Seung Hoon] Korea Res Inst Stand & Sci, Taejon 305340, South Korea.
RP Nam, KT (reprint author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151744, South Korea.
EM nkitae@snu.ac.kr
OI Jin, Kyoungsuk/0000-0003-3009-6691; Nam, Ki Tae/0000-0001-6353-8877
FU Basic Science Research Program of the National Research Foundation of
   Korea (NRF) [2011-0011225]; Global Frontier R&D Program on Center for
   Multiscale Energy System of the National Research Foundation of Korea
   (NRF) [0420-20130104]; Pioneer Research Center Program of the National
   Research Foundation of Korea (NRF) [2011-0027888]; Fusion Research
   Program for Green Technologies of the National Research Foundation of
   Korea (NRF) [2012M3C1A1048863]; International Research & Development
   Program of the National Research Foundation of Korea (NRF)
   [2013K1A3A1A32035536]; Ministry of Science, ICT & Future Planning
FX This research was supported by the Basic Science Research Program (grant
   number 2011-0011225), the Global Frontier R&D Program on Center for
   Multiscale Energy System (grant number 0420-20130104), the Pioneer
   Research Center Program (grant number 2011-0027888), the Fusion Research
   Program for Green Technologies (grant number 2012M3C1A1048863), and the
   International Research & Development Program (grant number
   2013K1A3A1A32035536) of the National Research Foundation of Korea (NRF)
   funded by the Ministry of Science, ICT & Future Planning.
CR Ben Abdelkader S, 2004, J THERM ANAL CALORIM, V77, P863, DOI 10.1023/B:JTAN.0000041665.41225.c3
   Bracci B, 2009, J INORG BIOCHEM, V103, P1666, DOI 10.1016/j.jinorgbio.2009.09.009
   CALVO C, 1975, AM MINERAL, V60, P120
   Cashman KD, 1999, P NUTR SOC, V58, P477, DOI 10.1017/S0029665199000622
   Colfen H, 2010, NAT MATER, V9, P960, DOI 10.1038/nmat2911
   Driessens FCM, 1990, BIOMINERALS
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003
   GEE A, 1955, J AM CHEM SOC, V77, P2961, DOI 10.1021/ja01616a009
   GOPAL R, 1972, NATURE-PHYS SCI, V237, P30
   GOPAL R, 1974, CAN J CHEM, V52, P1155, DOI 10.1139/v74-181
   Hannig M, 2010, NAT NANOTECHNOL, V5, P565, DOI [10.1038/NNANO.2010.83, 10.1038/nnano.2010.83]
   Hayashi Y, 1996, J ELECTRON MICROSC, V45, P501, DOI 10.1093/oxfordjournals.jmicro.a023475
   JACKSON S F, 1956, Nature, V178, P798
   Jalota S, 2006, J BIOMED MATER RES A, V78A, P481, DOI 10.1002/jbm.a.30851
   KOUTSOUKOS P, 1980, J AM CHEM SOC, V102, P1553, DOI 10.1021/ja00525a015
   Lagier R, 2003, PATHOL RES PRACT, V199, P329, DOI 10.1078/0344-0338-00425
   LeGeros R, 1989, MAGNESIUM HLTH DIS
   LEGEROS RZ, 1975, C INT CNRS, V230, P105
   MARTENS CS, 1970, GEOCHIM COSMOCHIM AC, V34, P621, DOI 10.1016/0016-7037(70)90020-7
   MEINKE DK, 1979, CALCIFIED TISSUE INT, V28, P37, DOI 10.1007/BF02441216
   NANCOLLAS GH, 1976, CROAT CHEM ACTA, V48, P431
   OKAZAKI M, 1986, CARIES RES, V20, P324, DOI 10.1159/000260952
   PALAMARA J, 1980, ARCH ORAL BIOL, V25, P715, DOI 10.1016/0003-9969(80)90125-9
   QUINT P, 1980, CALCIFIED TISSUE INT, V32, P257, DOI 10.1007/BF02408549
   ROTHWELL WP, 1980, J AM CHEM SOC, V102, P2637, DOI 10.1021/ja00528a020
   ROWLES SL, 1968, B SOC CHIM FR, P1797
   Ryan LM, 1999, CALCIFIED TISSUE INT, V65, P374, DOI 10.1007/s002239900716
   Sader MS, 2009, J MATER SCI-MATER M, V20, P521, DOI 10.1007/s10856-008-3610-3
   SCHROEDER LW, 1977, J SOLID STATE CHEM, V22, P253, DOI 10.1016/0022-4596(77)90002-0
   SCOTCHFORD CA, 1995, OSTEOARTHR CARTILAGE, V3, P79, DOI 10.1016/S1063-4584(05)80041-X
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   SUGIYAMA K, 1987, PHYS CHEM MINER, V15, P125, DOI 10.1007/BF00308774
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   TERPSTRA RA, 1986, CALCIFIED TISSUE INT, V39, P348, DOI 10.1007/BF02555203
   TRAUTZ OR, 1964, J DENT RES, V43, P751
   VERBEECK RMH, 1986, B SOC CHIM BELG, V95, P455
   WALSER M, 1961, J CLIN INVEST, V40, P723, DOI 10.1172/JCI104306
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
NR 40
TC 29
Z9 30
U1 3
U2 47
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JAN
PY 2014
VL 8
IS 1
BP 634
EP 641
DI 10.1021/nn405246h
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 301OX
UT WOS:000330542900065
PM 24299655
DA 2018-10-20
ER

PT J
AU Critchfield, A
   McCabe, R
   Klebanov, N
   Richey, L
   Socrate, S
   Norwitz, E
   Kaplan, D
   House, M
AF Critchfield, Agatha
   McCabe, Reid
   Klebanov, Nikolai
   Richey, Lauren
   Socrate, Simona
   Norwitz, Errol
   Kaplan, David
   House, Michael
TI An injectable silk-based biomaterial as an alternative to cervical
   cerclage: a pilot study in a pregnant rabbit model
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 34th Annual Scientific Pregnancy Meeting of the
   Society-for-Maternal-Fetal-Medicine
CY FEB 03-08, 2014
CL New Orleans, LA
SP Soc Maternal Fetal Med
C1 [Critchfield, Agatha; Norwitz, Errol; House, Michael] Tufts Med Ctr, Boston, MA USA.
   [McCabe, Reid; Klebanov, Nikolai; Kaplan, David] Tufts Univ, Medford, MA 02155 USA.
   [Richey, Lauren] Tufts Univ, Lab Anim Med, Boston, MA 02111 USA.
   [Socrate, Simona] MIT, Cambridge, MA 02139 USA.
OI Klebanov, Nikolai/0000-0001-8310-3029; McCabe, Reid/0000-0003-1046-0740
NR 0
TC 0
Z9 0
U1 1
U2 7
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2014
VL 210
IS 1
SU S
BP S348
EP S348
DI 10.1016/j.ajog.2013.10.741
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 298KK
UT WOS:000330322600708
DA 2018-10-20
ER

PT J
AU Payne, KFB
   Balasundaram, I
   Deb, S
   Di Silvio, L
   Fan, KFM
AF Payne, Karl F. B.
   Balasundaram, Indran
   Deb, Sanjukta
   Di Silvio, Lucy
   Fan, Kathleen F. M.
TI Tissue engineering technology and its possible applications in oral and
   maxillofacial surgery
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Review
DE Tissue engineering; Maxillofacial surgery; Reconstructive surgery; Head
   and neck surgery
ID BONE MORPHOGENETIC PROTEIN-2; TEMPOROMANDIBULAR-JOINT DISC; ARTIFICIAL
   SALIVARY-GLAND; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; MANDIBULAR
   CONTINUITY DEFECTS; CULTURED SKIN SUBSTITUTES; SINUS FLOOR AUGMENTATION;
   STEM-CELLS; CONDYLAR RECONSTRUCTION; LIP RECONSTRUCTION
AB Tissue engineering is a rapidly advancing discipline that combines the attributes of biochemical and biomaterial engineering with cell transplantation to create bio-artificial tissues and organs. For the oral and maxillofacial surgeon, the reconstruction of maxillofacial defects in hard and soft tissues is an ongoing challenge. While autologous grafts and vascularised free flaps are the current gold standard, they are not without complications at both the donor and reconstructed sites. Tissue engineering, which aims to create tissue-matched, prefabricated, prevascularised bony or soft tissue composite grafts, or both, therefore has the potential to revolutionise practice in maxillofacial surgery. We review the technology of tissue engineering and its current and future applications within the specialty, and discuss contemporary obstacles yet to be overcome. (C) 2013 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Payne, Karl F. B.; Fan, Kathleen F. M.] Kings Coll Hosp London, Dept Oral & Maxillofacial Surg, London, England.
   [Balasundaram, Indran] Royal London Hosp, Dept Oral & Maxillofacial Surg, London, England.
   [Deb, Sanjukta; Di Silvio, Lucy] Guys Hosp, Kings Coll London Dent Inst, Dept Biomat Tissue Engn & Imaging, London SE1 9RT, England.
RP Payne, KFB (reprint author), Kings Coll Hosp London, Dept Oral & Maxillofacial Surg, London, England.
EM karlpayne@nhs.net; indranb@hotmail.com; Sanjukta.deb@kcl.ac.uk;
   lucy.di_silvio@kcl.ac.uk; kfan@nhs.net
OI Di Silvio, Lucy/0000-0003-2554-2052
CR Aframian DJ, 2002, TISSUE ENG, V8, P871, DOI 10.1089/10763270260424231
   Aframian DJ, 2008, TISSUE ENG PART B-RE, V14, P187, DOI 10.1089/ten.teb.2008.0044
   Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556
   Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104
   Allen KD, 2008, J DENT RES, V87, P180, DOI 10.1177/154405910808700205
   Allen KD, 2006, TISSUE ENG, V12, P1183, DOI 10.1089/ten.2006.12.1183
   Almarza AJ, 2005, ANN BIOMED ENG, V33, P943, DOI 10.1007/s10439-005-3311-8
   Alonso N, 2010, TISSUE ENG PART C-ME, V16, P1183, DOI [10.1089/ten.tec.2009.0824, 10.1089/ten.TEC.2009.0824]
   Anderson JM, 2006, J MATER SCI-MATER M, V17, P1025, DOI 10.1007/s10856-006-0439-5
   Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x
   Bell RB, 2009, J ORAL MAXIL SURG, V67, P2673, DOI 10.1016/j.joms.2009.07.085
   Betz VM, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2724
   Black AF, 1998, FASEB J, V12, P1331
   Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018
   Boyne PJ, 1997, INT J PERIODONT REST, V17, P10
   Bramfeldt H, 2010, CURR MED CHEM, V17, P3944, DOI 10.2174/092986710793205327
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Carter TG, 2008, J ORAL MAXIL SURG, V66, P1417, DOI 10.1016/j.joms.2008.01.058
   Caruso DM, 1999, BURNS, V25, P771, DOI 10.1016/S0305-4179(99)00083-2
   Chao MM, 2006, J CRANIOFAC SURG, V17, P405, DOI 10.1097/00001665-200605000-00004
   Chin M, 2005, J CRANIOFAC SURG, V16, P778, DOI 10.1097/01.scs.0000166802.49021.01
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Deb S, 2010, J MATER SCI-MATER M, V21, P893, DOI 10.1007/s10856-009-3936-5
   Depprich R, 2008, BRIT J ORAL MAX SURG, V46, P349, DOI 10.1016/j.bjoms.2008.01.012
   Detamore MS, 2005, ANN BIOMED ENG, V33, P383, DOI 10.1007/s10439-005-1741-y
   Di Silvio L, 2007, WOODHEAD PUBL MATER, P319, DOI 10.1533/9781845693817.2.319
   di Summa PG, 2011, NEUROSCIENCE, V181, P278, DOI 10.1016/j.neuroscience.2011.02.052
   Dickinson BP, 2008, PLAST RECONSTR SURG, V121, P209, DOI 10.1097/01.prs.0000293870.64781.12
   Dormer NH, 2011, J ORAL MAXIL SURG, V69, pE50, DOI 10.1016/j.joms.2010.12.049
   Esposito M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003607.pub3
   Eweida Ahmad M, 2011, Ann Surg Innov Res, V5, P2, DOI 10.1186/1750-1164-5-2
   Fallucco MA, 2009, J CRANIOFAC SURG, V20, P1759, DOI 10.1097/SCS.0b013e3181b5d08e
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Glied Allen N, 2010, N Y State Dent J, V76, P32
   Goessler UR, 2007, EUR ARCH OTO-RHINO-L, V264, P1343, DOI 10.1007/s00405-007-0369-y
   Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Heliotis M, 2006, INT J ORAL MAX SURG, V35, P265, DOI 10.1016/j.ijom.2005.07.013
   Herford AS, 2008, J ORAL MAXIL SURG, V66, P616, DOI 10.1016/j.joms.2007.11.021
   Herford AS, 2007, J ORAL MAXIL SURG, V65, P2136, DOI 10.1016/j.jams.2007.06.670
   Herford AS, 2010, J CRANIOFAC SURG, V21, P1970, DOI 10.1097/SCS.0b013e3181f502fa
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Izumi K, 2003, INT J ORAL MAX SURG, V32, P188, DOI 10.1054/ijom.2002.0365
   Joraku A, 2005, LARYNGOSCOPE, V115, P244, DOI 10.1097/01.mlg.0000154726.77915.cc
   Joraku A, 2007, DIFFERENTIATION, V75, P318, DOI 10.1111/j.1432-0436.2006.00138.x
   Junior GD, 2006, CURR OPIN ONCOL, V18, P266
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Khadka A, 2012, INT J ORAL MAX SURG, V41, P94, DOI 10.1016/j.ijom.2011.10.018
   Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu J, 2010, ORTHOD CRANIOFAC RES, V13, P11, DOI 10.1111/j.1601-6343.2009.01475.x
   Liu YF, 2011, J ZHEJIANG UNIV-SC B, V12, P769, DOI 10.1631/jzus.B1000323
   MacFarlane Deborah F, 2006, Adv Dermatol, V22, P125, DOI 10.1016/j.yadr.2006.07.002
   Maenpaa K, 2010, J R SOC INTERFACE, V7, P177, DOI 10.1098/rsif.2009.0117
   Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031
   Molsted K, 1999, CRIT REV ORAL BIOL M, V10, P225, DOI 10.1177/10454411990100020801
   Nahmias Y, 2005, BIOTECHNOL BIOENG, V92, P129, DOI 10.1002/bit.20585
   Naujoks Christian, 2008, Head Face Med, V4, P3, DOI 10.1186/1746-160X-4-3
   Orringer JS, 1999, PLAST RECONSTR SURG, V104, P793, DOI 10.1097/00006534-199909030-00028
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Peramo A, 2012, TISSUE ENG PART C-ME, V18, P273, DOI [10.1089/ten.tec.2011.0406, 10.1089/ten.TEC.2011.0406]
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   PUELACHER WC, 1994, J ORAL MAXIL SURG, V52, P1172, DOI 10.1016/0278-2391(94)90538-X
   Rawashdeh MA, 2008, BRIT J ORAL MAX SURG, V46, P665, DOI 10.1016/j.bjoms.2008.07.184
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Ripamonti U, 2011, BRIT J ORAL MAX SURG, V49, P507, DOI 10.1016/j.bjoms.2010.07.020
   Salih V, 2009, WOODHEAD PUBL MATER, P185, DOI 10.1533/9781845695477.2.185
   Sauerbier S, 2006, CLIN ORAL IMPLAN RES, V17, P625, DOI 10.1111/j.1600-0501.2006.01229.x
   Scaglione S, 2008, CELLULAR RESPONSE BI
   Schek R M, 2005, Orthod Craniofac Res, V8, P313, DOI 10.1111/j.1601-6343.2005.00354.x
   Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009
   Seo S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/806891
   Sheridan RL, 2001, BURNS, V27, P421, DOI 10.1016/S0305-4179(00)00156-X
   Sterodimas A, 2009, ANN PLAS SURG, V62, P97, DOI 10.1097/SAP.0b013e3181788ec9
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com
   Supp Dorothy M., 2002, Journal of Burn Care & Rehabilitation, V23, P10, DOI 10.1097/00004630-200201000-00004
   Susarla SM, 2011, ANN PLAS SURG, V67, P655, DOI 10.1097/SAP.0b013e31822c00e6
   Swope VB, 1997, J INVEST DERMATOL, V109, P289, DOI 10.1111/1523-1747.ep12335766
   Szabo G, 2005, INT J ORAL MAX IMPL, V20, P371
   THOMAS M, 1991, J ORAL MAXIL SURG, V49, P854, DOI 10.1016/0278-2391(91)90015-E
   Tran SD, 2005, TISSUE ENG, V11, P172, DOI 10.1089/ten.2005.11.172
   Tran SD, 2006, TISSUE ENG, V12, P2939, DOI 10.1089/ten.2006.12.2939
   Triplett RG, 2009, J ORAL MAXIL SURG, V67, P1947, DOI 10.1016/j.joms.2009.04.085
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van Hout WMMT, 2011, CLIN ORAL INVEST, V15, P297, DOI 10.1007/s00784-011-0547-6
   Voss P, 2010, BRIT J ORAL MAX SURG, V48, P121, DOI 10.1016/j.bjoms.2009.04.032
   Wang KH, 2011, CURR OPIN OTOLARYNGO, V19, P119, DOI 10.1097/MOO.0b013e328344a569
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Woo EJ, 2012, J ORAL MAXIL SURG, V70, P765, DOI 10.1016/j.joms.2011.09.008
   Xiao CW, 2010, INT J MOL MED, V26, P517, DOI 10.3892/ijmm_00000494
   Zhang Zhiyuan, 2011, Front Med, V5, P401, DOI 10.1007/s11684-011-0161-7
   Zhou GD, 2006, TISSUE ENG, V12, P3209, DOI 10.1089/ten.2006.12.3209
NR 98
TC 16
Z9 17
U1 1
U2 36
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
EI 1532-1940
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD JAN
PY 2014
VL 52
IS 1
BP 7
EP 15
DI 10.1016/j.bjoms.2013.03.005
PG 9
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 297MV
UT WOS:000330260500003
PM 23601833
DA 2018-10-20
ER

PT J
AU Gunduz, O
   Sahin, YM
   Agathopoulos, S
   Ben-Nissan, B
   Oktar, FN
AF Gunduz, O.
   Sahin, Y. M.
   Agathopoulos, S.
   Ben-Nissan, B.
   Oktar, F. N.
TI A New Method for Fabrication of Nanohydroxyapatite and TCP from the Sea
   Snail Cerithium vulgatum
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID ENAMEL-DERIVED HYDROXYAPATITE; MECHANICAL-PROPERTIES; NANO-POWDERS;
   THIN-FILMS; BONE; PHOSPHATE; MICROSTRUCTURE; BIOMATERIAL; COMPOSITES;
   COATINGS
AB Biphasic bioceramic nanopowders of hydroxyapatite (HA) and beta-tricalcium phosphate (TCP) were prepared from shells of the sea snail Cerithium vulgatum (Bruguiere, 1792) using a novel chemical method. Calcination of the powders produced was carried out at varying temperatures, specifically at 400 degrees C and 800 degrees C, in air for 4 hours. When compared to the conventional hydrothermal transformation method, this chemical method is very simple, economic, due to the fact that it needs inexpensive and safe equipment, because the transformation of the aragonite and calcite of the shells into the calcium phosphate phases takes place at 80 degrees C under the atmospheric pressure. The powders produced were determined using infrared spectroscopy (FT-IR), X-ray diffraction, and scanning electron microscopy (SEM). The features of the powders produced along with the fact of their biological origin qualify these powders for further consideration and experimentation to fabricate nanoceramic biomaterials.
C1 [Gunduz, O.] Marmara Univ, Fac Tech Educ, Dept Met Educ, TR-34722 Istanbul, Turkey.
   [Gunduz, O.; Oktar, F. N.] Marmara Univ, Ctr Nanotechnol & Biomat Appl & Res, TR-34722 Istanbul, Turkey.
   [Sahin, Y. M.] Istanbul Arel Univ, Dept Biomed Engn, Fac Engn & Architecture, TR-34537 Istanbul, Turkey.
   [Agathopoulos, S.] Univ Ioannina, Dept Mat Sci & Engn, GR-45110 Ioannina, Greece.
   [Ben-Nissan, B.] Univ Technol Sydney, Dept Chem & Forens Sci, Sydney, NSW 2007, Australia.
   [Oktar, F. N.] Marmara Univ, Dept Bioengn, Fac Engn, TR-34722 Istanbul, Turkey.
   [Oktar, F. N.] Marmara Univ, Sch Hlth Related Profess, Dept Med Imaging Tech, TR-34688 Istanbul, Turkey.
RP Gunduz, O (reprint author), Marmara Univ, Fac Tech Educ, Dept Met Educ, TR-34722 Istanbul, Turkey.
EM oguzhan@marmara.edu.tr; foktar@marmara.edu.tr
OI Gunduz, Oguzhan/0000-0002-9427-7574
FU Turkish Republic Government Planning Organization in the framework of
   the Project [2003K120810]; Metallurgical and Materials Engineering
   Department, Istanbul Technical University, Turkey
FX This study was carried out partly with the equipment furnished (between
   2007 and 2008) to Marmara University with the support of the Turkish
   Republic Government Planning Organization in the framework of the
   Project 2003K120810 "Manufacturing and Characterization of
   Electro-Conductive Bioceramics." The authors also acknowledge the very
   valuable support of the Metallurgical and Materials Engineering
   Department, Istanbul Technical University, Turkey.
CR Agaogullari D, 2012, ACTA PHYS POL A, V121, P23
   Agathopoulos S., 2012, Key Engineering Materials, V493-494, P775, DOI 10.4028/www.scientific.net/KEM.493-494.775
   Akyurt N, 2011, INT J ARTIF ORGANS, V34, P700
   Ates A. Suat, 2007, Turkish Journal of Zoology, V31, P13
   Baciut M, 2007, J OPTOELECTRON ADV M, V9, P2547
   Balthasar U., 2012, P 22 VM GOLDSCHM C E
   Boyd AR, 2006, SURF COAT TECH, V200, P6002, DOI [10.1016/j.surfcoat.2005.09.032, 10.1016/j.surfcoat.09.032]
   Demirkol N, 2012, ACTA PHYS POL A, V121, P274, DOI 10.12693/APhysPolA.121.274
   Demirkol N, 2010, INT J ARTIF ORGANS, V33, P468
   Duta L, 2013, APPL SURF SCI, V265, P41, DOI 10.1016/j.apsusc.2012.10.077
   En-Nissan B, 2004, United States Patent, Patent No. [US2004/0091547 A1, 20040091547]
   Foroughi MR, 2012, J POROUS MAT, V19, P667, DOI 10.1007/s10934-011-9518-1
   Goller G, 2004, MATER LETT, V58, P2599, DOI 10.1016/j.matlet.2004.03.032
   Goller G, 2002, MATER LETT, V56, P142
   Hernigou P, 2010, INT ORTHOP, V34, P191, DOI 10.1007/s00264-009-0875-1
   Kel D., 2012, Key Engineering Materials, V493-494, P287, DOI 10.4028/www.scientific.net/KEM.493-494.287
   KEL D, 2011, INT J ARTIF ORGANS, V34, P700
   Lahiri D, 2012, MAT SCI ENG C-MATER, V32, P1727, DOI 10.1016/j.msec.2012.05.010
   Lemos AF, 2006, J EUR CERAM SOC, V26, P3639, DOI 10.1016/j.jeurceramsoc.2005.12.011
   Lewis K, 2006, KEY ENG MAT, V309-311, P15, DOI 10.4028/www.scientific.net/KEM.309-311.15
   Macha IJ, 2013, J AUST CERAM SOC, V49, P122
   Oktar FN, 2007, CERAM INT, V33, P1309, DOI 10.1016/j.ceramint.2006.05.022
   Oktar FN, 2010, INT J ARTIF ORGANS, V33, P467
   Oktar FN, 2006, KEY ENG MAT, V309-311, P49, DOI 10.4028/www.scientific.net/KEM.309-311.49
   Ozyegin L. S., 2012, Key Engineering Materials, V493-494, P781, DOI 10.4028/www.scientific.net/KEM.493-494.781
   Ozyegin LS, 2004, MATER LETT, V58, P2605, DOI 10.1016/j.matlet.2004.03.033
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Roll S. J., 2006, THESIS NATL I TECHNO
   Sai Shigaku, 2005, Jikeikai Medical Journal, V52, P47
   Samur R, 2013, METALURGIJA, V52, P375
   Song J. J., 2010, THESIS U TORONTO
   Tamasan M, 2013, MAT SCI ENG C-MATER, V33, P2569, DOI 10.1016/j.msec.2013.02.019
   Tuyel A. U., 2007, J BIOTECHNOLOGY S, V131S, pS65
   Tuyel A. U., 2008, THESIS TC MARMARA U
   ZDUN VI, 1980, PARAZITOLOGIYA+, V14, P345
NR 35
TC 6
Z9 6
U1 2
U2 28
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2014
AR 382861
DI 10.1155/2014/382861
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 301DQ
UT WOS:000330513400001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yang, TT
   Ni, YX
   Zhai, JJ
   Li, Q
   Zheng, L
   Qin, J
   Sun, XL
   Zhou, YM
AF Yang, Tingting
   Ni, Yuxin
   Zhai, Jingjie
   Li, Qi
   Zheng, Ling
   Qin, Jie
   Sun, Xiaolin
   Zhou, Yanmin
TI Microstructure, Mechanical Properties, In Vitro Degradation and
   Cytotoxicity of Mg-4Zn-3HA Alloy for Biodegradable Implant Materials
SO JOURNAL OF HARD TISSUE BIOLOGY
LA English
DT Article
DE Biocompatibility; Biodegradable; Biomaterial; Magnesium alloy
ID MAGNESIUM ALLOYS; PURE MAGNESIUM; CORROSION; BONE; COMPOSITES; BEHAVIOR;
   CA
AB In this study, a kind of Mg-4Zn-3HA alloy was investigated as a biodegradable material. Magnesium alloys can be totally degraded in the body, and their corrosion products are not deleterious to the surrounding tissues. We conducted a comprehensive investigation of the microstructure, mechanical properties, in vitro degradation assessments, and in vitro cytotoxicity evaluations of Mg-4Zn-3HA alloy. Our observations of the microstructure show that the Mg-4Zn-3HA alloy is porous, and its structural characteristic resembling nature bone make this alloy suitable for use in implants. The results of in vitro degradation indicate that the corrosion resistance is improved with the extension of immersion time, and XRD and EDS analysis proves that the corrosion products on the surface of Mg-4Zn-3HA alloy contain hydroxyapatite (HA), Mg (OH)(2) and other magnesium-substituted calcium phosphate, which could reduce the degradation rate. The degradation process of magnesium alloy and the formation of corrosion layer are also discussed in this work. The corrosion products contain HA and Mg (OH)(2), which can promote good biocompatibility. No significant cytotoxicity to MC3T3-E1 cells is detected in the extraction medium, and MC3T3-E1 cells are able to adhere and spread on the corrosion layer of the Mg-4Zn-3HA alloy. Mg-4Zn-3HA alloys have the potential to be used for biomedical applications.
C1 [Yang, Tingting; Ni, Yuxin; Zhai, Jingjie; Zheng, Ling; Qin, Jie; Sun, Xiaolin; Zhou, Yanmin] Jilin Univ, Stomatol Hosp, Implant Ctr, Changchun 130021, Jilin Province, Peoples R China.
   [Li, Qi] Inner Mongolia Med Univ, Affiliated Hosp, Inner Mongolia, Inner Mongolia, Peoples R China.
RP Zhou, YM (reprint author), Jilin Univ, Stomatol Hosp, Implant Ctr, Changchun 130021, Jilin Province, Peoples R China.
EM zhouym62@126.com
FU Jilin University Stomatological Hospital; Harbin Institute of
   Technology; national natural science foundation of China [81070855]
FX This work was supported by Jilin University Stomatological Hospital and
   Harbin Institute of Technology. This study was financially supported by
   funds from the national natural science foundation of China (NO.
   81070855).
CR [Anonymous], 2009, 109935 ISO
   [Anonymous], 2004, G3172 ASTM
   COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   He WW, 2010, MAT SCI ENG C-MATER, V30, P167, DOI 10.1016/j.msec.2009.09.014
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Li SS, 2007, J ALLOY COMPD, V437, P317, DOI 10.1016/j.jallcom.2006.07.117
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Mordike B., 2006, MAGNESIUM TECHNOLOGY, P76
   Nakamura Y, 1997, FUND APPL TOXICOL, V37, P106, DOI 10.1006/faat.1997.2322
   Rahman EI- SSA, 2003, PHARMACOLOG RES, V47, P189
   Song G, 1997, CORROS SCI, V39, P855, DOI 10.1016/S0010-938X(96)00172-2
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Yu K, 2012, ACTA BIOMATER, V8, P2845, DOI 10.1016/j.actbio.2012.04.009
   Zhang E, 2008, MAT SCI ENG A-STRUCT, V488, P102, DOI 10.1016/j.msea.2007.10.056
NR 21
TC 1
Z9 2
U1 1
U2 13
PU JOURNAL HARD TISSUE BIOLOGY
PI MINATO KU
PA NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO
   106-0031, JAPAN
SN 1341-7649
J9 J HARD TISSUE BIOL
JI J. Hard Tissue Biol.
PD JAN
PY 2014
VL 23
IS 1
BP 111
EP 117
DI 10.2485/jhtb.23.111
PG 7
WC Engineering, Biomedical
SC Engineering
GA 298VF
UT WOS:000330351900015
OA Bronze
DA 2018-10-20
ER

PT J
AU Lin, TH
   Tamaki, Y
   Pajarinen, J
   Waters, HA
   Woo, DK
   Yao, ZY
   Goodman, SB
AF Lin, Tzu-hua
   Tamaki, Yasunobu
   Pajarinen, Jukka
   Waters, Heather A.
   Woo, Deanna K.
   Yao, Zhenyu
   Goodman, Stuart B.
TI Chronic inflammation in biomaterial-induced periprosthetic osteolysis:
   NF-kappa B as a therapeutic target
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Biomaterials; Periprosthetic osteolysis; Chronic inflammation; NF-kappa
   B
ID TOTAL HIP-ARTHROPLASTY; MESENCHYMAL STEM-CELLS; CROSS-LINKED
   POLYETHYLENE; WEAR-DEBRIS PARTICLES; OXYGEN RADICAL PRODUCTION;
   FOREIGN-BODY REACTION; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; DECOY
   OLIGODEOXYNUCLEOTIDES; TITANIUM PARTICLES
AB Biomaterial-induced tissue responses in patients with total joint replacement are associated with the generation of wear particles, which may lead to chronic inflammation and local bone destruction (peri-prosthetic osteolysis). Inflammatory reactions associated with wear particles are mediated by several important signaling pathways, the most important of which involves the transcription factor NF-kappa B. NF-kappa B activation is essential for macrophage recruitment and maturation, as well as the production of pro-inflammatory cytokines and chemokines such as TNF-alpha, IL-1 beta, IL-6 and MCP1. In addition, NF-kappa B activation contributes to osteoclast differentiation and maturation via RANK/RANKL signaling, which increases bone destruction and reduces bone formation. Targeting individual downstream cytokines directly (such as TNF-alpha or IL-1 beta) may not effectively prevent wear particle induced osteolysis. A more logical upstream therapeutic approach may be provided by direct modulation of the core I kappa B/IKK alpha/beta/NF-kappa B signaling pathway in the local environment. However, the timing, dose and strategy for administration should be considered. Suppression of chronic inflammation via inhibition of NF-kappa B activity in patients with malfunctioning joint replacements may be an effective strategy to mitigate wear particle induced periprosthetic osteolysis. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lin, Tzu-hua; Tamaki, Yasunobu; Pajarinen, Jukka; Waters, Heather A.; Woo, Deanna K.; Yao, Zhenyu; Goodman, Stuart B.] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA.
   [Goodman, Stuart B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
RP Goodman, SB (reprint author), Stanford Univ, Sch Med, Dept Orthopaed Surg, 450 Broadway St, Redwood City, CA 94063 USA.
EM goodbone@stanford.edu
FU NIAMS NIH HHS [R01 AR055650, R01 AR063717]
CR Akisue T, 2002, J BIOMED MATER RES, V59, P507, DOI 10.1002/jbm.1264
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Baumann B, 2005, J ORTHOP RES, V23, P1241, DOI 10.1016/j.orthres.2005.02.017
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521
   Bukata SV, 2004, J ORTHOPAED RES, V22, P6, DOI 10.1016/S0736-0266(03)00153-0
   Burton L, 2013, J ORTHOP RES, V31, P73, DOI 10.1002/jor.22190
   Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200
   Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110
   Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954
   Chen F, 2002, ATLAS GENET CYTOGEN, V6, P156
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cheng T, 2008, MED HYPOTHESES, V71, P727, DOI 10.1016/j.mehy.2008.07.003
   Childs LM, 2001, J BONE MINER RES, V16, P338, DOI 10.1359/jbmr.2001.16.2.338
   Childs LM, 2001, J BONE JOINT SURG AM, V83A, P1789, DOI 10.2106/00004623-200112000-00004
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Clohisy JC, 2006, J ORTHOP RES, V24, P1358, DOI 10.1002/jor.20184
   Clohisy JC, 2004, J ORTHOPAED RES, V22, P13, DOI 10.1016/S0736-0266(03)00156-6
   Crotti TN, 2004, BIOMATERIALS, V25, P565, DOI 10.1016/S0142-9612(03)00556-8
   de Poorter JJ, 2005, J GENE MED, V7, P1421, DOI 10.1002/jgm.795
   Desmet C, 2004, J IMMUNOL, V173, P5766, DOI 10.4049/jimmunol.173.9.5766
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Engh CA, 2012, J ARTHROPLASTY, V27, P2, DOI 10.1016/j.arth.2012.03.048
   Fabre C, 2012, CLIN CANCER RES, V18, P4669, DOI 10.1158/1078-0432.CCR-12-0779
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Fujii J, 2011, HIP INT, V21, P231, DOI 10.5301/HIP.2011.7977
   Gallo J, 2013, INNATE IMMUN-LONDON, V19, P213, DOI 10.1177/1753425912451779
   Gibon E, 2012, TISSUE ENG PT A, V18, P968, DOI [10.1089/ten.tea.2011.0545, 10.1089/ten.TEA.2011.0545]
   Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982
   Goodman S, 2005, ORTHOP CLIN N AM, V36, P41, DOI 10.1016/j.ocl.2004.06.015
   Goodman Stuart B, 2013, Instr Course Lect, V62, P201
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Greenfield EM, 2010, J BIOL CHEM, V285, P32378, DOI 10.1074/jbc.M110.136895
   Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150
   Haleem-Smith H, 2012, J ORTHOP RES, V30, P853, DOI 10.1002/jor.22002
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   Hirayama T, 2011, J ORTHOP RES, V29, P984, DOI 10.1002/jor.21369
   Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490
   Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147
   Huang L, 2000, AM J PATHOL, V156, P761, DOI 10.1016/S0002-9440(10)64942-5
   Huang ZN, 2010, J BIOMED MATER RES A, V94A, P1264, DOI 10.1002/jbm.a.32803
   Ilchmann T, 1998, J BONE JOINT SURG BR, V80B, P377, DOI 10.1302/0301-620X.80B3.8455
   James MA, 1993, CARDIOVASC PATHOL, V4, P2
   Jazrawi L M, 1998, J Am Acad Orthop Surg, V6, P198
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Joon P, 2002, METALLIC BIOMATERIAL, P1
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kido A, 2004, CLIN ORTHOP RELAT R, P230
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   Kong YY, 1999, NATURE, V397, P315
   Konttinen YT, 2013, NAT REV RHEUMATOL, V9, P5, DOI 10.1038/nrrheum.2012.218
   Konttinen YT, 2001, J BONE MINER RES, V16, P1780, DOI 10.1359/jbmr.2001.16.10.1780
   Koulouvaris P, 2008, J ORTHOP RES, V26, P106, DOI 10.1002/jor.20486
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Laird RK, 2006, HISTOL HISTOPATHOL, V21, P1277, DOI 10.14670/HH-21.1277
   Lavon I, 2000, NAT MED, V6, P573
   Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Love RJ, 2011, COMPR BIOMATER, P37
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MacDonald SJ, 2004, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000150309.48474.8b
   Maitra R, 2008, PLOS ONE, V3
   Maitra R, 2009, MOL IMMUNOL, V47, P175, DOI 10.1016/j.molimm.2009.09.023
   MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107
   Mao X, 2012, INFLAMMATION, V35, P905, DOI 10.1007/s10753-011-9392-7
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Miyake T, 2006, GENE THER, V13, P695, DOI 10.1038/sj.gt.3302704
   Miyake T, 2008, CARDIOVASC RES, V79, P706, DOI 10.1093/cvr/cvn139
   Miyake T, 2011, MOL THER, V19, P181, DOI 10.1038/mt.2010.208
   Nakamura H, 2002, GENE THER, V9, P1221, DOI 10.1038/sj.gt.3301724
   Nakashima H, 2004, CIRCULATION, V109, P132, DOI 10.1161/01.CIR.0000105725.61763.A2
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Nalepka JL, 2006, CLIN ORTHOP RELAT R, P229, DOI 10.1097/01.blo.0000224050.94248.38
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nimeri G, 2003, J BIOMED MATER RES A, V67A, P439, DOI 10.1002/jbm.a.10081
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   Novitskiy G, 2004, J BIOL CHEM, V279, P15639, DOI 10.1074/jbc.M311499200
   O'Connell MA, 1998, J BIOL CHEM, V273, P30410, DOI 10.1074/jbc.273.46.30410
   O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002
   Ogushi I, 2003, HEPATOLOGY, V38, P335, DOI 10.1053/jhep.2003.50298
   Ollivere B, 2012, J BONE JOINT SURG BR, V94B, P10, DOI 10.1302/0301-620X.94B1.28047
   Osako MK, 2012, CURR TOP MED CHEM, V12, P1603
   Pajarinen J, 2013, ACTA BIOMATER, V9, P9229, DOI 10.1016/j.actbio.2013.06.027
   Pajarinen J, 2010, J BIOMED MATER RES A, V92A, P1528, DOI 10.1002/jbm.a.32495
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P381, DOI 10.1002/jbm.a.30907
   Pearl JI, 2011, BIOMATERIALS, V32, P5535, DOI 10.1016/j.biomaterials.2011.04.046
   Potnis PA, 2013, CELL IMMUNOL, V282, P53, DOI 10.1016/j.cellimm.2013.04.003
   Punt IM, 2009, BIOMATERIALS, V30, P2079, DOI 10.1016/j.biomaterials.2008.12.071
   Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b
   Purdue P Edward, 2006, HSS J, V2, P102, DOI 10.1007/s11420-006-9003-6
   Rakshit DS, 2006, J BONE JOINT SURG AM, V88A, P788, DOI 10.2106/JBJS.E.00711
   Rao AJ, 2012, ACTA BIOMATER, V8, P2815, DOI 10.1016/j.actbio.2012.03.042
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Reynolds SE, 2012, J ARTHROPLASTY, V27, P1064, DOI 10.1016/j.arth.2012.01.006
   Rogers TH, 2010, BIOMATERIALS, V31, P594, DOI 10.1016/j.biomaterials.2009.09.077
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   Schwarz EM, 2003, J ORTHOPAED RES, V21, P1049, DOI 10.1016/S0736-0266(03)00093-7
   Schwarz EM, 2000, J ORTHOPAED RES, V18, P472, DOI 10.1002/jor.1100180321
   Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44
   Shida J, 2000, CALCIFIED TISSUE INT, V67, P151, DOI 10.1007/s00223001125
   Shimizu H, 2009, ANTIOXID REDOX SIGN, V11, P2065, DOI [10.1089/ars.2008.2355, 10.1089/ARS.2008.2355]
   Sochart DH, 1999, CLIN ORTHOP RELAT R, P135
   Soloviev A, 2002, J ORTHOPAED RES, V20, P714, DOI 10.1016/S0736-0266(01)00180-2
   STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x
   Sun KN, 2013, INT J ARTIF ORGANS, V36, P522, DOI 10.5301/ijao.5000218
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   TAKAGI M, 1995, J RHEUMATOL, V22, P2285
   TAKAGI M, 1994, ACTA ORTHOP SCAND, V65, P281, DOI 10.3109/17453679408995454
   Takagi M, 2007, J BIOMED MATER RES A, V81A, P1017, DOI 10.1002/jbm.a.31235
   Takei I, 2000, J RHEUMATOL, V27, P894
   Talmo CT, 2006, CLIN ORTHOP RELAT R, P254, DOI 10.1097/01.blo.0000246531.59876.a8
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Tas SW, 2009, CURR GENE THER, V9, P160, DOI 10.2174/156652309788488569
   Tatro JM, 2007, J ORTHOP RES, V25, P361, DOI 10.1002/jor.20289
   THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5
   Thomas GER, 2011, J BONE JOINT SURG AM, V93A, P716, DOI 10.2106/JBJS.J.00287
   Thuy DD, 2011, PHARM RES-DORDR, V28, P742, DOI 10.1007/s11095-011-0366-0
   Tsao AK, 2008, J AM ACAD ORTHOP SUR, V16, pS7, DOI 10.5435/00124635-200800001-00004
   Tunyogi-Csapo M, 2007, J ORTHOP RES, V25, P1378, DOI 10.1002/jor.20449
   Tyson-Capper AJ, 2013, ANN RHEUM DIS, V72, P460, DOI 10.1136/annrheumdis-2012-202468
   Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0
   Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   XIA ZD, 1994, CHINESE MED J-PEKING, V107, P845
   Xing S, 2002, BIOMATERIALS, V23, P3595, DOI 10.1016/S0142-9612(02)00088-1
   Xing ZQ, 2006, J ORTHOP RES, V24, P959, DOI 10.1002/jor.20038
   Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178
   Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914
   Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200
   Yang SY, 2004, GENE THER, V11, P483, DOI 10.1038/sj.gt.3302192
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
NR 147
TC 66
Z9 70
U1 2
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2014
VL 10
IS 1
BP 1
EP 10
DI 10.1016/j.actbio.2013.09.034
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 292HR
UT WOS:000329893300001
PM 24090989
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Siegismund, D
   Undisz, A
   Germerodt, S
   Schuster, S
   Rettenmayr, M
AF Siegismund, Daniel
   Undisz, Andreas
   Germerodt, Sebastian
   Schuster, Stefan
   Rettenmayr, Markus
TI Quantification of the interaction between biomaterial surfaces and
   bacteria by 3-D modeling
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bacterial adhesion; Surface topography; Computer simulation;
   Biomaterial-centered infection; Biomaterials
ID DLVO INTERACTION; BIOFILM FORMATION; ROUGH SURFACES; COLLOIDAL
   PARTICLES; TISSUE INTEGRATION; STAINLESS-STEEL; CELL RESPONSE; IN-VITRO;
   ADHESION; TOPOGRAPHY
AB It is general knowledge that bacteria/surface interactions depend on the surface topography. However, this well-known dependence has so far not been included in the modeling efforts. We propose a model for calculating interaction energies between spherical bacteria and arbitrarily structured 3-D surfaces, combining the Derjaguin, Landau, Verwey, Overbeek theory and an extended surface element integration method. The influence of roughness on the interaction (for otherwise constant parameters, e.g. surface chemistry, bacterial hydrophobicity) is quantified, demonstrating that common experimental approaches which consider amplitude parameters of the surface topography but which ignore spacing parameters fail to adequately describe the influence of surface roughness on bacterial adhesion. The statistical roughness profile parameters arithmetic average height (representing an amplitude parameter) and peak density (representing a spacing parameter) both exert a distinct influence on the interaction energy. The influence of peak density on the interaction energy increases with decreasing arithmetic average height and contributes significantly to the total interaction energy with an arithmetic average height below 70 nm. With the aid of the proposed model, different sensitivity ranges of the interaction between rough surfaces and bacteria are identified. On the nanoscale, the spacing parameter of the surface dominates the interaction, whereas on the microscale the amplitude parameter adopts the governing role. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Siegismund, Daniel; Undisz, Andreas; Rettenmayr, Markus] Univ Jena, Inst Mat Sci & Technol, D-07743 Jena, Germany.
   [Siegismund, Daniel; Germerodt, Sebastian; Schuster, Stefan] Univ Jena, Dept Bioinforrnat, D-07743 Jena, Germany.
RP Rettenmayr, M (reprint author), Univ Jena, Inst Mat Sci & Technol, Lobdergraben 32, D-07743 Jena, Germany.
EM M.Rettenmayr@uni-jena.de
FU Jena School for Microbial Communication (JSMC/MikroInter); DFG; State of
   Thuringia
FX This work was supported by the Jena School for Microbial Communication
   (JSMC/MikroInter) funded by the DFG and the State of Thuringia.
   Stimulating discussions with A. Schroeter and M. Foge are gratefully
   acknowledged.
CR Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Arnold JW, 2000, POULTRY SCI, V79, P1839, DOI 10.1093/ps/79.12.1839
   Bendersky M, 2011, J COLLOID INTERF SCI, V353, P87, DOI 10.1016/j.jcis.2010.09.058
   Bhattacharjee S, 1997, J COLLOID INTERF SCI, V193, P273, DOI 10.1006/jcis.1997.5076
   Bhattacharjee S, 1998, LANGMUIR, V14, P3365, DOI 10.1021/la971360b
   Bhattacharjee S, 1998, CROAT CHEM ACTA, V71, P883
   BISNO AL, 1995, INFECT CONT HOSP EP, V16, P648
   Busscher H.J., 2012, SCI TRANSL MED, V4
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Busscher HJ, 2010, CURR OPIN COLLOID IN, V15, P510, DOI 10.1016/j.cocis.2010.05.014
   Charman KM, 2009, LETT APPL MICROBIOL, V48, P472, DOI 10.1111/j.1472-765X.2008.02551.x
   Coriand L, 2011, APPL OPTICS, V50, pC257, DOI 10.1364/AO.50.00C257
   Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015
   Duparre A, 2002, APPL OPTICS, V41, P154, DOI 10.1364/AO.41.000154
   Edwards KJ, 2001, CHEM GEOL, V180, P19, DOI 10.1016/S0009-2541(01)00303-5
   Engelsman AF, 2010, BIOFOULING, V26, P761, DOI 10.1080/08927014.2010.515027
   Fernandez ICS, 2010, ACTA BIOMATER, V6, P1119, DOI 10.1016/j.actbio.2009.08.040
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   Gallardo-Moreno AM, 2009, ACTA BIOMATER, V5, P181, DOI 10.1016/j.actbio.2008.07.028
   GARCIA N, 1984, PHYS REV LETT, V52, P1798, DOI 10.1103/PhysRevLett.52.1798
   Giraldez MJ, 2010, OPTOMETRY VISION SCI, V87, pE426, DOI 10.1097/OPX.0b013e3181da8656
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hoek EMV, 2006, J COLLOID INTERF SCI, V298, P50, DOI 10.1016/j.jcis.2005.12.031
   Huang XF, 2010, LANGMUIR, V26, P2528, DOI 10.1021/la9028113
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kemps JAL, 2005, LANGMUIR, V21, P11710, DOI 10.1021/la051292q
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Loskill P, 2012, LANGMUIR, V28, P7242, DOI 10.1021/la3004323
   Martines E, 2008, COLLOID SURFACE A, V318, P45, DOI 10.1016/j.colsurfa.2007.11.035
   Medilanski E, 2002, BIOFOULING, V18, P193, DOI 10.1080/08927010290011370
   Missirlis YF, 2007, MATERIALWISS WERKST, V38, P983, DOI 10.1002/mawe.200700240
   Mitik-Dineva N, 2009, BIOFOULING, V25, P621, DOI 10.1080/08927010903012773
   Pawel P, 2008, WEAR, V264, P457
   Ploux L, 2010, J ADHES SCI TECHNOL, V24, P2165, DOI 10.1163/016942410X511079
   Ponche A, 2010, P I MECH ENG H, V224, P1471, DOI 10.1243/09544119JEIM900
   Shao W, 2010, COLLOID SURFACE B, V76, P98, DOI 10.1016/j.colsurfb.2009.10.018
   Siegismund D, 2013, CELL MOL BIOENG, V6, P210, DOI 10.1007/s12195-012-0266-3
   Singh AV, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025001
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   van der Mei HC, 2012, PLOS PATHOG, V8
   van Loosdrecht M C, 1990, J Biomater Appl, V5, P91, DOI 10.1177/088532829000500202
   van Oss C. J., 2006, INTERFACIAL FORCES A
   Verran J, 2010, LETT APPL MICROBIOL, V50, P258, DOI 10.1111/j.1472-765X.2009.02784.x
   Webb HK, 2013, BIOFOULING, V29, P163, DOI 10.1080/08927014.2012.757697
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
NR 55
TC 24
Z9 24
U1 3
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2014
VL 10
IS 1
BP 267
EP 275
DI 10.1016/j.actbio.2013.09.016
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 292HR
UT WOS:000329893300028
PM 24071002
DA 2018-10-20
ER

PT J
AU Hayden, RS
   Vollrath, M
   Kaplan, DL
AF Hayden, Rebecca S.
   Vollrath, Moritz
   Kaplan, David L.
TI Effects of clodronate and alendronate on osteoclast and osteoblast
   co-cultures on silk-hydroxyapatite films
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Osteoporosis; Co-culture; Bisphosphonates; Silk
ID IN-VITRO; SPECTROPHOTOMETRIC DETERMINATION; BISPHOSPHONATES ACT;
   BREAST-CANCER; BONE; CELLS; FRACTURES; RAT; NANOCOMPOSITES; OSTEOPOROSIS
AB The goal of this study was to explore the effects of osteoporosis-related therapeutics on bone remodeling in vitro. A previously established bone-tissue mimetic system consisting of silk protein biomaterials in combination with hydroxyapatite and human cells was used for the study. Silk-hydroxyapatite films were pre-complexed with the non-nitrogenous bisphosphonate clodronate or the nitrogenous bisphosphonate alendronate and cultured with THP-1 human acute monocytic leukemia cell line-derived osteoclasts, human mesenchymal stem cell derived osteoblasts or a direct co-culture of the two cell types. Metabolic activity, calcium deposition and alkaline phosphatase activity were assessed over 12 weeks, and reconstructed remodeled biomaterial surfaces were also evaluated for quantitative morphological changes. Increased metabolic activity and increased roughness were found on the clodronate-complexed biomaterial substrates remodeled by osteoblasts and co-cultures of osteoblasts with osteoclasts, even at doses high enough to cause a 90% decrease in osteoclast metabolic activity. Films complexed with low doses of alendronate resulted in increased metabolic activity and calcium deposition by osteoblasts, while higher doses were similarly toxic among osteoclasts, osteoblasts and co-cultures. These results point to the utility of these well-defined bone-mimetic in vitro cultures as useful screens for therapeutics for bone-related diseases, particularly with the ability to conduct studies for extended duration (here for 12 weeks) and with pre-complexed drugs to mimic conditions found in vivo. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hayden, Rebecca S.; Vollrath, Moritz; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [P41 EB002520]
FX This work was funded by NIH grant number P41 EB002520 for the Tissue
   Engineering Resource Center. The funding source had no role in study
   design; in the collection, analysis and interpretation of data; in the
   writing of the report; or in the decision to submit the paper for
   publication.
CR Abrahamsen B., 2012, OSTEOPOROSIS INT, P10
   Altman Greg, 2002, FASEB Journal, V16, P270
   Bellido T, 2011, BONE, V49, P50, DOI 10.1016/j.bone.2010.08.008
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Black DM, 2012, NEW ENGL J MED, V366, P2051, DOI 10.1056/NEJMp1202623
   Boanini E, 2008, BIOMATERIALS, V29, P790, DOI 10.1016/j.biomaterials.2007.10.040
   Boanini E, 2013, ADV MATER, V25, P4605, DOI 10.1002/adma.201301129
   Boanini E, 2012, BONE, V51, P944, DOI 10.1016/j.bone.2012.07.020
   Boanini E, 2012, BIOMATERIALS, V33, P722, DOI 10.1016/j.biomaterials.2011.09.092
   Boonen S, 2005, OSTEOPOROSIS INT, V16, P1291, DOI 10.1007/s00198-005-1945-x
   Cartsos VM, 2008, J AM DENT ASSOC, V139, P23, DOI 10.14219/jada.archive.2008.0016
   Chen X, 2010, ANAL BIOCHEM, V403, P63, DOI 10.1016/j.ab.2010.04.003
   Duque G, 2007, J BONE MINER RES, V22, P1603, DOI 10.1359/JBMR.070701
   Garcia-Moreno C, 1998, BONE, V22, P233, DOI 10.1016/S8756-3282(97)00270-6
   Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254
   Hayden RS, 2013, ADV FUNCT MAT
   Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y
   Idris AI, 2009, ENDOCRINOLOGY, V150, P5, DOI 10.1210/en.2008-0998
   Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   KASTING GB, 1992, J BONE MINER RES, V7, P513
   Kellinsalmi M, 2005, BASIC CLIN PHARMACOL, V97, P382, DOI 10.1111/j.1742-7843.2005.pto_176.x
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kimmel DB, 2007, J DENT RES, V86, P1022, DOI 10.1177/154405910708601102
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kuljanin J, 2002, J PHARMACEUT BIOMED, V28, P1215, DOI 10.1016/S0731-7085(02)00021-3
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Mills OP, 2010, GEOSPHERE, V6, P805, DOI 10.1130/GES00558.1
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Nishikawa M, 1996, BONE, V18, P9, DOI 10.1016/8756-3282(95)00426-2
   Ohe JY, 2012, CLIN ORAL INVEST, V16, P1153, DOI 10.1007/s00784-011-0614-z
   Ostadi H, 2009, MICROELECTRON ENG, V86, P1021, DOI 10.1016/j.mee.2009.01.056
   Petersson IU, 2009, BIOMATERIALS, V30, P4471, DOI 10.1016/j.biomaterials.2009.05.042
   Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800
   Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722
   Rogers MJ, 2004, CALCIFIED TISSUE INT, V75, P451, DOI 10.1007/s00223-004-0024-1
   SAHNI M, 1993, J CLIN INVEST, V91, P2004, DOI 10.1172/JCI116422
   Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650
   Sengupta S, 2010, BIOMACROMOLECULES, V11, P3592, DOI 10.1021/bm101054q
   Silverman SL, 2007, OSTEOPOROSIS INT, V18, P25, DOI 10.1007/s00198-006-0274-z
   Sun L, 2011, BIOMATERIALS, V32, P5581, DOI 10.1016/j.biomaterials.2011.04.028
   Taha EA, 2003, CHEM PHARM BULL, V51, P1444, DOI 10.1248/cpb.51.1444
   TENENBAUM HC, 1992, BONE, V13, P249, DOI 10.1016/8756-3282(92)90205-B
   Viereck V, 2002, BIOCHEM BIOPH RES CO, V291, P680, DOI 10.1006/bbrc.2002.6510
   Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619
NR 46
TC 16
Z9 17
U1 4
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2014
VL 10
IS 1
BP 486
EP 493
DI 10.1016/j.actbio.2013.09.028
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 292HR
UT WOS:000329893300048
PM 24096150
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Nelson, DM
   Hashizume, R
   Yoshizumi, T
   Blakney, AK
   Ma, ZW
   Wagner, WR
AF Nelson, Devin M.
   Hashizume, Ryotaro
   Yoshizumi, Tomo
   Blakney, Anna K.
   Ma, Zuwei
   Wagner, William R.
TI Intramyocardial Injection of a Synthetic Hydrogel with Delivery of bFGF
   and IGF1 in a Rat Model of Ischemic Cardiomyopathy
SO BIOMACROMOLECULES
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; MYOCARDIAL-INFARCTION; SEQUENTIAL DELIVERY;
   VENTRICULAR-FUNCTION; CARDIAC-FUNCTION; EXTRACELLULAR-MATRIX; INJECTABLE
   HYDROGEL; ANGIOGENESIS; DEGRADATION; MACROPHAGES
AB It is increasingly appreciated that the properties of a biomaterial used in intramyocardial injection therapy influence the outcomes of infarcted hearts that are treated. In this report the extended in vivo efficacy of a thermally responsive material that can deliver dual growth factors while providing a slow degradation time and high mechanical stiffness is examined. Copolymers consisting of N-isopropylacrylamide, 2-hydroxyethyl methacrylate, and degradable methacrylate polylactide were synthesized. The release of bioactive basic fibroblast growth factor (bFGF) and insulin-like growth factor 1 (IGF1) from the gel and loaded poly(lactide-co-glycolide) microparticles was assessed. Hydrogel with or without loaded growth factors was injected into 2 week-old infarcts in Lewis rats and animals were followed for 16 weeks. The hydrogel released bioactive bFGF and IGF1 as shown by mitogenic effects on rat smooth muscle cells in vitro. Cardiac function and geometry were improved for 16 weeks after hydrogel injection compared to saline injection. Despite demonstrating that left ventricular levels of bFGF and IGF1 were elevated for two weeks after injection of growth factor loaded gels, both functional and histological assessment showed no added benefit to inclusion of these proteins. This result points to the complexity of designing appropriate materials for this application and suggests that the nature of the material alone, without exogenous growth factors, has a direct ability to influence cardiac remodeling.
C1 [Nelson, Devin M.; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Hashizume, Ryotaro; Yoshizumi, Tomo; Blakney, Anna K.; Ma, Zuwei; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
FU National Institutes of Health (NIH) [HL105911, T32-HL076124]
FX This work was supported by the National Institutes of Health (NIH),
   Grant No. HL105911. D.M.N. was supported by NIH Training Grant No.
   T32-HL076124.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Aoki M, 2000, GENE THER, V7, P417, DOI 10.1038/sj.gt.3301104
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Cheng K, 2012, J AM COLL CARDIOL, V59, P256, DOI 10.1016/j.jacc.2011.10.858
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013
   Fujimoto KL, 2012, J CARD FAIL, V18, P585, DOI 10.1016/j.cardfail.2012.05.006
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hashizume R, 2013, BIOMATERIALS, V34, P7353, DOI 10.1016/j.biomaterials.2013.06.020
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Hughes GC, 2004, ANN THORAC SURG, V77, P812, DOI 10.1016/j.athorasur.2003.09.060
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Laham RJ, 2000, J PHARMACOL EXP THER, V292, P795
   Ma ZW, 2010, BIOMACROMOLECULES, V11, P1873, DOI 10.1021/bm1004299
   Nelson DM, 2012, J BIOMED MATER RES A, V100A, P776, DOI 10.1002/jbm.a.34015
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Peng H, 2010, POLYM DEGRAD STABIL, V95, P643, DOI 10.1016/j.polymdegradstab.2009.12.005
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Shao ZQ, 2006, CIRC J, V70, P471, DOI 10.1253/circj.70.471
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Suleiman MS, 2007, PHARMACOL THERAPEUT, V114, P278, DOI 10.1016/j.pharmthera.2007.03.001
   Sun Y, 2000, J LAB CLIN MED, V135, P316, DOI 10.1067/mlc.2000.105971
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   Tengood JE, 2011, TISSUE ENG PT A, V17, P1181, DOI [10.1089/ten.TEA.2010.0551, 10.1089/ten.tea.2010.0551]
   Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Wenk J. F., 2009, J BIOMECH ENG, V131, P10111
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
NR 45
TC 20
Z9 21
U1 2
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2014
VL 15
IS 1
BP 1
EP 11
DI 10.1021/bm4010639
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 292CO
UT WOS:000329879800001
PM 24345287
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, HQ
   Frith, J
   Cooper-White, JJ
AF Li, Haiqing
   Frith, Jessica
   Cooper-White, Justin J.
TI Modulation of Stem Cell Adhesion and Morphology via Facile Control over
   Surface Presentation of Cell Adhesion Molecules
SO BIOMACROMOLECULES
LA English
DT Article
ID BETA-CYCLODEXTRIN; INCLUSION COMPLEX; COPOLYMER; IMMOBILIZATION;
   INTEGRINS; PEPTIDES; BEHAVIOR
AB To encourage cell adhesion on biomaterial surfaces in a more facile, safe, and low-cost fashion, we have demonstrated a noncovalent approach to spatially conjugate beta-cyclodextrin (beta-CD) modified peptide sequences onto self-assembled adamantane-terminated polystyrene-b-poly(ethylene oxide) (PS-PEO-Ada) films through inclusion complexing interactions between beta-CDs and adamantane. By simply blending various ratios of unmodified PS-PEO with a newly synthesized PS-PEO-Ada, we produced PS polymer films that displayed well-organized adamantine-decorated cylindrical PEO domains with varying average interdomain spacings ranging from 29 to 47 nm. The presence of the adamantane moiety at the terminal end of the PEO chain permitted rapid, and importantly, oriented attachment of beta-CD functionalized peptides onto these surfaces. This one-step process not only converted these proven nonadherent PS-PEO surfaces into adherent surfaces, but also permitted precisely controlled presentation and surface distribution of the conjugated peptides. The utility of these surfaces as cell culture substrates was confirmed with human mesenchymal stem cells (hMSCs). We observed that with increasing PS-PEO-Ada content in the PEO cylindrical domains, these novel polymer films displayed improved cell attachment and spreading, with notable differences in hMSC morphology. We further confirmed that this novel PS-PEO-Ada surface provides a flexible platform for facile conjugation of mixtures of beta-CDs functionalized with different peptides, specifically RGD and IKVAV peptides. The cell adhesion and spreading assays on these surfaces indicated that the morphologies of hMSCs can be easily manipulated, while no significant changes in cell attachment were observed. The lock-and-key peptide conjugation technique presented in this work is applicable to any substrate that incorporates a moiety capable of forming inclusion complexes with alpha-, beta-, and gamma-CDs, providing a facile and flexible method by which to construct peptide-conjugated biomaterial substrates for a multitude of applications in fields ranging from cell bioprocessing and regenerative medicine to cell-based assays.
C1 [Li, Haiqing; Frith, Jessica; Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Tissue Engn & Microfluid Lab, Brisbane, Qld 4072, Australia.
   [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, Brisbane, Qld 4072, Australia.
   [Cooper-White, Justin J.] CSIRO, Div Mat Sci & Engn, Clayton, Vic 3169, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Tissue Engn & Microfluid Lab, Corner Cooper & Coll Rd, Brisbane, Qld 4072, Australia.
EM j.cooperwhite@uq.edu.au
RI Frith, Jessica/J-6873-2017; McKenzie, Warren/J-2137-2014
OI Frith, Jessica/0000-0002-6558-5412; Cooper-White,
   Justin/0000-0002-1920-8229
FU Australian Research Council [DP1095429]
FX We would like to acknowledge the financial support provided by the
   Australian Research Council Discovery Grant Scheme (DP1095429). This
   work was performed in part at the Queensland node of the Australian
   National Fabrication Facility, a company established under the National
   Collaborative Research Infrastructure Strategy to provide nano- and
   microfabrication facilities for Australian researchers.
CR Bae JW, 2009, MACROMOLECULES, V42, P3437, DOI 10.1021/ma900185x
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Figuelras A, 2007, EUR J PHARM BIOPHARM, V67, P531, DOI 10.1016/j.ejpb.2007.03.005
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   George PA, 2009, BIOMATERIALS, V30, P4732, DOI 10.1016/j.biomaterials.2009.05.039
   George PA, 2009, EUR POLYM J, V45, P1065, DOI 10.1016/j.eurpolymj.2008.11.039
   George PA, 2009, BIOMATERIALS, V30, P2449, DOI 10.1016/j.biomaterials.2009.01.012
   Ghaemi SR, 2013, BIOMATERIALS, V34, P7601, DOI 10.1016/j.biomaterials.2013.06.022
   HABUS I, 1995, BIOCONJUGATE CHEM, V6, P327, DOI 10.1021/bc00034a001
   Hirschfeld-Warneken VC, 2008, EUR J CELL BIOL, V87, P743, DOI 10.1016/j.ejcb.2008.03.011
   Hudalla GA, 2010, LANGMUIR, V26, P6449, DOI 10.1021/la1008208
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Joddar B, 2011, J MATER CHEM, V21, P13737, DOI 10.1039/c1jm10984g
   Lin ZQ, 2002, ADV MATER, V14, P1373, DOI 10.1002/1521-4095(20021002)14:19<1373::AID-ADMA1373>3.0.CO;2-F
   Loftsson T, 2007, INT J PHARM, V329, P1, DOI 10.1016/j.ijpharm.2006.10.044
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Rangelov S, 2007, J PHYS CHEM B, V111, P11127, DOI 10.1021/jp074485q
   Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588
   Serro AP, 2012, SURF INTERFACE ANAL, V44, P426, DOI 10.1002/sia.3820
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tang W, 2008, NAT PROTOC, V3, P691, DOI 10.1038/nprot.2008.37
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Valle EMD, 2004, PROCESS BIOCHEM, V39, P1033
   Williams RO, 1998, EUR J PHARM BIOPHARM, V46, P355, DOI 10.1016/S0939-6411(98)00033-2
   Yoon JJ, 2004, BIOMATERIALS, V25, P5613, DOI 10.1016/j.biomaterials.2004.01.014
   Zhang GR, 2000, TALANTA, V51, P1019, DOI 10.1016/S0039-9140(00)00287-3
NR 26
TC 26
Z9 26
U1 4
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2014
VL 15
IS 1
BP 43
EP 52
DI 10.1021/bm4012562
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 292CO
UT WOS:000329879800005
PM 24274693
DA 2018-10-20
ER

PT J
AU Zhang, QC
   Tan, K
   Zhang, Y
   Ye, ZY
   Tan, WS
   Lang, MD
AF Zhang, Qingchun
   Tan, Ke
   Zhang, Yan
   Ye, Zhaoyang
   Tan, Wen-Song
   Lang, Meidong
TI In Situ Controlled Release of rhBMP-2 in Gelatin-Coated 3D Porous
   Poly(epsilon-caprolactone) Scaffolds for Homogeneous Bone Tissue
   Formation
SO BIOMACROMOLECULES
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; GROWTH-FACTORS;
   CLINICAL-APPLICATIONS; SUSTAINED-RELEASE; STROMAL CELLS; REGENERATION;
   DELIVERY; HYDROGEL; FABRICATION
AB In tissue engineering, incorporation of bone morphogenetic protein-2 (BMP-2) into biomaterial scaffolds is an attractive strategy to stimulate bone repair. However, suboptimal release of BMP-2 remains a great concern, which may cause unfavorable bone formation as well as severe inflammation. In this study, genipin-cross-linked gelatin entrapped with recombinant human BMP-2 (rhBMP-2) was exploited to decorate the interior surface of three-dimensional porous poly(epsilon-caprolactone) (PCL) scaffolds. With gelatin-coating, PCL scaffolds demonstrated enhanced water uptake and improved compressive moduli. Intriguingly, a unique release profile of rhBMP-2 composed of a transient burst release followed by a sustained release was achieved in coated scaffolds. These coated scaffolds well supported growth and osteogenesis of human mesenchymal stem cells (hMSCs) in vitro, indicating the retaining of rhBMP-2 bioactivity. When hMSCs-seeded scaffolds were implanted subcutaneously in nude mice for 4 weeks, better bone formation was observed in gelatin/rhBMP-2-coated scaffolds. Specifically, the spatial distribution of newly formed bone was more uniform in gelatin-coated scaffolds than in uncoated scaffolds, which displayed preferential bone formation at the periphery. These results collectively demonstrated that gelatin-coating of porous PCL scaffolds is a promising approach for delivering rhBMP-2 to stimulate improved bone regeneration.
C1 [Zhang, Qingchun; Zhang, Yan; Lang, Meidong] E China Univ Sci & Technol, Sch Mat Sci & Engn, Minist Educ, Key Lab Ultrafine Mat, Shanghai 200237, Peoples R China.
   [Tan, Ke; Ye, Zhaoyang; Tan, Wen-Song] E China Univ Sci & Technol, Sch Bioengn, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.
RP Ye, ZY (reprint author), E China Univ Sci & Technol, Sch Bioengn, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.
EM zhaoyangye@ecust.edu.cn; mdlang@ecust.edu.cn
OI Lang, Meidong/0000-0003-2053-9284
FU Fundamental Research Funds for the Central Universities; National
   Natural Science Foundation of China [20804015, 31000424]; Specialized
   Research Fund for the Doctoral Program of Higher Education
   [200802511021, 20100074120009]; Shanghai Municipal Education Commission;
   Program for Changjiang Scholars and Innovative Research Team in
   University [IRT0825]
FX This research was supported by the Fundamental Research Funds for the
   Central Universities, the National Natural Science Foundation of China
   (20804015, 31000424), Specialized Research Fund for the Doctoral Program
   of Higher Education (200802511021, 20100074120009), "Shu Guang" Project
   of Shanghai Municipal Education Commission, and Program for Changjiang
   Scholars and Innovative Research Team in University (IRT0825).
CR Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Brown KV, 2011, TISSUE ENG PT A, V17, P1735, DOI 10.1089/ten.tea.2010.0446
   Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513
   De Biase P, 2005, INJURY, V36, P43, DOI 10.1016/j.injury.2005.07.034
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Geuze R., 2012, TISSUE ENG, V18, P2052
   Geuze RE, 2012, TISSUE ENG PT A, V18, P2052, DOI [10.1089/ten.tea.2011.0560, 10.1089/ten.TEA.2011.0560]
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099
   Jo S, 2013, J BIOMED MATER RES A, V101, P892, DOI 10.1002/jbm.a.34354
   Kang JM, 2010, J BIOMED MATER RES A, V93A, P666, DOI 10.1002/jbm.a.32282
   Kang SW, 2012, BIOTECHNOL LETT, V34, P1375, DOI 10.1007/s10529-012-0900-0
   Kempen DHR, 2009, TISSUE ENG PT A, V15, P587, DOI 10.1089/ten.tea.2007.0376
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Li B, 2009, BIOMATERIALS, V30, P6768, DOI 10.1016/j.biomaterials.2009.08.038
   Liu XH, 2005, J BIOMED MATER RES A, V74A, P84, DOI 10.1002/jbm.a.30367
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Mwangi JW, 2004, INT J PHARM, V278, P319, DOI 10.1016/j.ijpharm.2004.03.024
   Na K, 2007, BIOMATERIALS, V28, P2631, DOI 10.1016/j.biomaterials.2007.02.008
   Polak SJ, 2011, ACTA BIOMATER, V7, P1760, DOI 10.1016/j.actbio.2010.12.030
   Reichert J. C., 2012, SCI TRANSL MED, V4
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P258, DOI [10.1089/ten.teb.2011.0440, 10.1089/ten.TEB.2011.0440]
   Tadokoro M, 2012, J TISSUE ENG REGEN M, V6, P253, DOI 10.1002/term.427
   Vo TN, 2012, ADV DRUG DELIVER REV, V64, P1292, DOI 10.1016/j.addr.2012.01.016
   Wang M, 2010, BIOTECHNOL BIOPROC E, V15, P1047, DOI 10.1007/s12257-009-3147-4
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wu LB, 2005, TISSUE ENG, V11, P1105, DOI 10.1089/ten.2005.11.1105
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yan JL, 2011, BIOMACROMOLECULES, V12, P2562, DOI 10.1021/bm200375x
   Yang HS, 2011, TISSUE ENG PT A, V17, P2153, DOI [10.1089/ten.tea.2010.0702, 10.1089/ten.TEA.2010.0702]
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zhang HN, 2010, TISSUE ENG PT A, V16, P3441, DOI [10.1089/ten.tea.2010.0132, 10.1089/ten.TEA.2010.0132]
   Zhang QC, 2013, MAT SCI ENG C-MATER, V33, P2094, DOI 10.1016/j.msec.2013.01.025
   Zhang QC, 2013, POLYM DEGRAD STABIL, V98, P209, DOI 10.1016/j.polymdegradstab.2012.10.008
NR 43
TC 21
Z9 23
U1 1
U2 64
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2014
VL 15
IS 1
BP 84
EP 94
DI 10.1021/bm401309u
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 292CO
UT WOS:000329879800010
PM 24266740
DA 2018-10-20
ER

PT J
AU Lee, JS
   Shin, J
   Park, HM
   Kim, YG
   Kim, BG
   Oh, JW
   Cho, SW
AF Lee, Jung Seung
   Shin, Jisoo
   Park, Hae-Min
   Kim, Yun-Gon
   Kim, Byung-Gee
   Oh, Jong-Won
   Cho, Seung-Woo
TI Liver Extracellular Matrix Providing Dual Functions of Two-Dimensional
   Substrate Coating and Three-Dimensional Injectable Hydrogel Platform for
   Liver Tissue Engineering
SO BIOMACROMOLECULES
LA English
DT Article
ID ADULT-RAT HEPATOCYTES; MARROW-DERIVED CELLS; STEM-CELLS; IN-VITRO;
   ORTHOTOPIC TRANSPLANTATION; MECHANICAL-PROPERTIES; VIVO; SCAFFOLDS;
   FAILURE; GROWTH
AB Decellularization of tissues or organs can provide an efficient strategy for preparing functional scaffolds for tissue engineering. Microstructures of native extracellular matrices and their biochemical compositions can be retained in the decellularized matrices, providing tissue-specific microenvironments for efficient tissue regeneration. Here, we report the versatility of liver extracellular matrix (LEM) that can be used for two-dimensional (2D) coating and three-dimensional (3D) hydrogel platforms for culture and transplantation of primary hepatocytes. Collagen type I (Col I) has typically been used for hepatocyte culture and transplantation. In this study, LEM was compared with Col I in terms of biophysical and mechanical characteristics and biological performance for enhancing cell viability, differentiation, and hepatic functions. Surface properties of LEM coating and mechanical properties and gelation kinetics of LEM hydrogel could be manipulated by adjusting the LEM concentration. In addition, LEM hydrogel exhibited improved elastic properties, rapid gelation, and volume maintenance compared to Col I hydrogel. LEM coating significantly improved hepatocyte functions such as albumin secretion and urea synthesis. More interestingly, LEM coating upregulated hepatic gene expression of human adipose-derived stem cells, indicating enhanced hepatic differentiation of these stem cells. The viability and hepatic functions of primary hepatocytes were also significantly improved in LEM hydrogel compared to Col I hydrogel both in vitro and in vivo. Albumin and hepatocyte transcription factor expression was upregulated in hepatocytes transplanted in LEM hydrogels. In conclusion, LEM can provide functional biomaterial platforms for diverse applications in liver tissue engineering by promoting survival and maturation of hepatocytes and hepatic commitment of stem cells. This study demonstrates the feasibility of decellularized matrix for both 2D coating and 3D hydrogel in liver tissue engineering.
C1 [Lee, Jung Seung; Shin, Jisoo; Oh, Jong-Won; Cho, Seung-Woo] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.
   [Park, Hae-Min; Kim, Byung-Gee] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151742, South Korea.
   [Kim, Yun-Gon] Soongsil Univ, Dept Chem Engn, Seoul 156743, South Korea.
RP Cho, SW (reprint author), Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.
EM seungwoocho@yonsei.ac.kr
FU National Research Foundation of Korea (NRF) [NRF-2010-0025982,
   NRF-2013R1A1A2A10061422]; Translational Research Center for Protein
   Function Control (TRCP) [2009-0083522]; Ministry of Science, ICT and
   Future Planning (MSIP), Republic of Korea; Korea Health Technology RD
   Project [A110552]; Ministry of Health and Welfare, Republic of Korea
FX This work was supported by grants (NRF-2010-0025982 and
   NRF-2013R1A1A2A10061422) from the National Research Foundation of Korea
   (NRF) and a grant (2009-0083522) from the Translational Research Center
   for Protein Function Control (TRCP) funded by the Ministry of Science,
   ICT and Future Planning (MSIP), Republic of Korea. This work was also
   supported by a grant (A110552) from the Korea Health Technology R&D
   Project funded by the Ministry of Health and Welfare, Republic of Korea.
   We thank Jin Kim for her assistance in preparing the schematic
   illustration in Figure 1.
CR Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Berthiaume F, 1996, FASEB J, V10, P1471
   Cho SW, 2009, TISSUE ENG PT A, V15, P901, DOI 10.1089/ten.tea.2008.0172
   Cho SW, 2005, ANN SURG, V241, P506, DOI 10.1097/01.sla.0000154268.12239.ed
   Chu XH, 2009, BIOTECHNOL LETT, V31, P347, DOI 10.1007/s10529-008-9892-1
   Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   DeQuach JA, 2012, EUR CELLS MATER, V23, P400, DOI 10.22203/eCM.v023a31
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Freytes DO, 2008, J BIOMED MATER RES A, V87A, P862, DOI 10.1002/jbm.a.31821
   HABIBULLAH CM, 1994, TRANSPLANTATION, V58, P951, DOI 10.1097/00007890-199410270-00016
   Hou YT, 2010, J BIOSCI BIOENG, V110, P208, DOI 10.1016/j.jbiosc.2010.01.016
   Ishii T, 2008, AM J PHYSIOL-GASTR L, V295, pG313, DOI 10.1152/ajpgi.00072.2008
   Kim SS, 2006, ARTIF ORGANS, V30, P554, DOI 10.1111/j.1525-1594.2006.00258.x
   KOIDE N, 1990, EXP CELL RES, V186, P227, DOI 10.1016/0014-4827(90)90300-Y
   Lee C, 2013, BIOMACROMOLECULES, V14, P2004, DOI 10.1021/bm400352d
   Lee JS, 2012, BIOTECHNOL BIOPROC E, V17, P427, DOI 10.1007/s12257-012-0047-9
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Okura H, 2009, TISSUE ENG PART C-ME, V16, P761
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108
   Raeder RH, 2002, TRANSPL IMMUNOL, V10, P15, DOI 10.1016/S0966-3274(01)00044-2
   RUBIN K, 1981, CELL, V24, P463, DOI 10.1016/0092-8674(81)90337-8
   Ruiz JC, 2010, J CELL PHYSIOL, V225, P429, DOI 10.1002/jcp.22216
   SCHUETZ EG, 1988, J CELL PHYSIOL, V134, P309, DOI 10.1002/jcp.1041340302
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Seif-Naraghi S.B., 2013, SCI TRANSL MED, V5
   Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]
   Sharma NS, 2010, FASEB J, V24, P2364, DOI 10.1096/fj.09-135095
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154
   Soto-Gutierrez A, 2011, MOL PATHOL LIB, V5, P17, DOI 10.1007/978-1-4419-7107-4_3
   Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014
   Stuart K, 2008, BIOPOLYMERS, V89, P841, DOI 10.1002/bip.21024
   Syedain ZH, 2013, TISSUE ENG PT A, V19, P759, DOI [10.1089/ten.tea.2012.0365, 10.1089/ten.TEA.2012.0365]
   Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wang T, 2013, J MATER CHEM B, V1, P339, DOI 10.1039/c2tb00195k
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Wang YF, 2011, HEPATOLOGY, V53, P293, DOI 10.1002/hep.24012
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
   Yeh WC, 2002, ULTRASOUND MED BIOL, V28, P467, DOI 10.1016/S0301-5629(02)00489-1
   Zhang WX, 2010, ADV DRUG DELIVER REV, V62, P814, DOI 10.1016/j.addr.2010.02.005
   Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005
NR 53
TC 48
Z9 50
U1 9
U2 87
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2014
VL 15
IS 1
BP 206
EP 218
DI 10.1021/bm4015039
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 292CO
UT WOS:000329879800023
PM 24350561
DA 2018-10-20
ER

PT J
AU Ambrogi, V
   Panzella, L
   Persico, P
   Cerruti, P
   Lonz, CA
   Carfagna, C
   Verotta, L
   Caneva, E
   Napolitano, A
   d'Ischia, M
AF Ambrogi, Veronica
   Panzella, Lucia
   Persico, Paola
   Cerruti, Pierfrancesco
   Lonz, Carlo A.
   Carfagna, Cosimo
   Verotta, Luisella
   Caneva, Enrico
   Napolitano, Alessandra
   d'Ischia, Marco
TI An Antioxidant Bioinspired Phenolic Polymer for Efficient Stabilization
   of Polyethylene
SO BIOMACROMOLECULES
LA English
DT Article
ID CAFFEIC ACID; NATURAL ANTIOXIDANTS; POLYPROPYLENE; FILMS; OXIDATION;
   CHEMILUMINESCENCE; DEGRADATION; FLAVONOIDS; MECHANISM; NITRITE
AB The synthesis, structural characterization and properties of a new bioinspired phenolic polymer (polyCAME) produced by oxidative polymerization of caffeic acid methyl ester (CAME) with horseradish peroxidase (HRP)-H2O2 is reported as a new sustainable stabilizer toward polyethylene (PE) thermal and photo-oxidative degradation. PolyCAME exhibits high stability toward decarboxylation and oxidative degradation during the thermal processes associated with PE film preparation. Characterization of PE films by thermal methods, photo-oxidative treatments combined with chemiluminescence, and FTIR spectroscopy and mechanical tests indicate a significant effect of polyCAME on PE durability. Data from antioxidant capacity tests suggest that the protective effects of polyCAME are due to the potent scavenging activity on aggressive OH radicals, the efficient H-atom donor properties inducing free radical quenching, and the ferric ion reducing ability. PolyCAME is thus proposed as a novel easily accessible, eco-friendly, and biocompatible biomaterial for a sustainable approach to the stabilization of PE films in packaging and other applications.
C1 [Ambrogi, Veronica; Lonz, Carlo A.] Univ Naples Federico II, Dept Mat & Prod Engn, I-80125 Naples, Italy.
   [Panzella, Lucia; Napolitano, Alessandra; d'Ischia, Marco] Univ Naples Federico II, Dept Chem Sci, I-80126 Naples, Italy.
   [Persico, Paola; Cerruti, Pierfrancesco; Carfagna, Cosimo] CNR, Inst Polymer Chem & Technol ICTP, I-80078 Pozzuoli, Na, Italy.
   [Verotta, Luisella] Univ Milan, Dept Chem, I-20133 Milan, Italy.
   [Caneva, Enrico] Interdept Ctr Large Instrumentat CIGA, I-20133 Milan, Italy.
RP Cerruti, P (reprint author), CNR, Inst Polymer Chem & Technol ICTP, Via Campi Flegrei 34, I-80078 Pozzuoli, Na, Italy.
EM cerruti@ictp.cnr.it; dischia@unina.it
RI Verotta, Luisella/O-5953-2016; Napolitano, Alessandra/E-9761-2011;
   d'Ischia, Marco/C-9837-2011; cerruti, pierfrancesco/P-4534-2014;
   Socaciu, Carmen/P-8358-2014
OI Verotta, Luisella/0000-0002-5739-6291; d'Ischia,
   Marco/0000-0002-7184-0029; Socaciu, Carmen/0000-0002-7352-5057; Cerruti,
   Pierfrancesco/0000-0003-0822-2866; Panzella, Lucia/0000-0002-2662-8205
FU Italian MIUR [2010PFLRJR, PRIN 2010-11-PROxi]
FX This work was supported by grants from Italian MIUR (PRIN 2010-2011-
   2010PFLRJR project and PRIN 2010-11-PROxi project).
CR Allen N. S., 1992, FUNDAMENTALS POLYM D
   Ambrogi V, 2011, POLYM DEGRAD STABIL, V96, P2152, DOI 10.1016/j.polymdegradstab.2011.09.015
   Andjelkovic M, 2006, FOOD CHEM, V98, P23, DOI 10.1016/j.foodchem.2005.05.044
   Bahr M, 2012, GREEN CHEM, V14, P1447, DOI 10.1039/c2gc35099h
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   BIGGER SW, 1987, J POLYM SCI POL CHEM, V25, P3311, DOI 10.1002/pola.1987.080251211
   BILLINGHAM NC, 1991, POLYM DEGRAD STABIL, V34, P263, DOI 10.1016/0141-3910(91)90122-8
   Brocca D, 2002, WATER RES, V36, P3675, DOI 10.1016/S0043-1354(02)00084-2
   Cash JJ, 2013, POLYM CHEM-UK, V4, P3859, DOI 10.1039/c3py00438d
   Lopez MDC, 2013, J AGR FOOD CHEM, V61, P8462, DOI 10.1021/jf402670a
   Cerruti P, 2005, POLYMER, V46, P4571, DOI 10.1016/j.polymer.2005.03.065
   Cerruti P, 2009, POLYM DEGRAD STABIL, V94, P2095, DOI 10.1016/j.polymdegradstab.2009.07.023
   CHEW CH, 1977, EUR POLYM J, V13, P361, DOI 10.1016/0014-3057(77)90095-7
   Clough R. L., 1996, POLYM DURABILITY DEG
   Colin-Chavez C, 2013, PACKAG TECHNOL SCI, V26, P267, DOI 10.1002/pts.1982
   Corrales T, 2002, J PHOTOCH PHOTOBIO A, V147, P213, DOI 10.1016/S1010-6030(01)00629-3
   d'Ischia M, 2011, CHEM RES TOXICOL, V24, P2071, DOI 10.1021/tx2003118
   Daquino C, 2009, EUR J ORG CHEM, P6289, DOI 10.1002/ejoc.200900804
   De Lucia M, 2008, CHEM RES TOXICOL, V21, P2407, DOI 10.1021/tx800283d
   Fearon PK, 2004, J THERM ANAL CALORIM, V76, P75, DOI 10.1023/B:JTAN.0000027805.48648.c2
   Foley S, 1999, FREE RADICAL BIO MED, V26, P1202, DOI 10.1016/S0891-5849(98)00313-X
   Foti MC, 2004, J ORG CHEM, V69, P2309, DOI 10.1021/jo035758q
   Calvo-Flores FG, 2010, CHEMSUSCHEM, V3, P1227, DOI 10.1002/cssc.201000157
   Goupy P, 2003, J AGR FOOD CHEM, V51, P615, DOI 10.1021/jf025938l
   Gubbels E, 2013, J POLYM SCI POL CHEM, V51, P890, DOI 10.1002/pola.26446
   Gugumus F, 1998, POLYM DEGRAD STABIL, V62, P245, DOI 10.1016/S0141-3910(98)00003-2
   Hollmann F, 2012, POLYMERS-BASEL, V4, P759, DOI 10.3390/polym4010759
   Jain A, 2002, J MATER SCI, V37, P2623, DOI 10.1023/A:1015837312634
   Kikuzaki H, 2002, J AGR FOOD CHEM, V50, P2161, DOI 10.1021/jf011348w
   Kono Y, 1997, BBA-GEN SUBJECTS, V1335, P335, DOI 10.1016/S0304-4165(96)00151-1
   Koontz JL, 2010, J APPL POLYM SCI, V117, P2299, DOI 10.1002/app.32044
   Koutny M, 2008, POLYM DEGRAD STABIL, V93, P1515, DOI 10.1016/j.polymdegradstab.2008.05.007
   Kyriakou SA, 1999, POLYM DEGRAD STABIL, V66, P49, DOI 10.1016/S0141-3910(99)00051-8
   Law A, 2008, POLYM ENG SCI, V48, P627, DOI 10.1002/pen.20987
   Lligadas G, 2013, J POLYM SCI POL CHEM, V51, P2111, DOI 10.1002/pola.26620
   Lopez-de-Dicastillo C, 2010, J AGR FOOD CHEM, V58, P10958, DOI 10.1021/jf1022324
   Masuda T, 2008, J AGR FOOD CHEM, V56, P5947, DOI 10.1021/jf800781b
   Meylemans HA, 2013, BIOMACROMOLECULES, V14, P771, DOI 10.1021/bm3018438
   Monien BH, 2006, BIOORGAN MED CHEM, V14, P7988, DOI 10.1016/j.bmc.2006.07.066
   Moussouni S, 2011, TETRAHEDRON LETT, V52, P1165, DOI 10.1016/j.tetlet.2011.01.004
   Napolitano A, 2002, J ORG CHEM, V67, P803, DOI 10.1021/jo015965v
   NERI C, 1995, POLYM DEGRAD STABIL, V49, P65, DOI 10.1016/0141-3910(95)00057-S
   Noordover BAJ, 2007, BIOMACROMOLECULES, V8, P3860, DOI 10.1021/bm700775e
   NOUROOZZADEH J, 1995, J AGR FOOD CHEM, V43, P17, DOI 10.1021/jf00049a005
   Ozyurek M, 2008, ANAL CHIM ACTA, V616, P196, DOI 10.1016/j.aca.2008.04.033
   Pannala A, 1998, FREE RADICAL BIO MED, V24, P594, DOI 10.1016/S0891-5849(97)00321-3
   Panzella L, 2002, BIOORG MED CHEM LETT, V12, P3547, DOI 10.1016/S0960-894X(02)00795-3
   Persico P, 2012, INT J BIOL MACROMOL, V51, P1151, DOI 10.1016/j.ijbiomac.2012.08.036
   Persico P, 2009, POLYM ENG SCI, V49, P1447, DOI 10.1002/pen.21191
   Phua SL, 2013, ACS APPL MATER INTER, V5, P1302, DOI 10.1021/am3024405
   Rabello MS, 1997, POLYMER, V38, P6379, DOI 10.1016/S0032-3861(97)00213-9
   Ravichandran S, 2012, GREEN CHEM, V14, P819, DOI 10.1039/c2gc16192c
   Saliu F, 2011, TETRAHEDRON LETT, V52, P3856, DOI 10.1016/j.tetlet.2011.05.072
   Samper MD, 2013, J APPL POLYM SCI, V129, P1707, DOI 10.1002/app.38871
   Schwarzenbach K., 2001, PLASTIC ADDITIVES HD, P29
   Shanmuganathan K, 2011, MACROMOLECULES, V44, P9499, DOI 10.1021/ma202170n
   Shin J, 2012, BIOMACROMOLECULES, V13, P3833, DOI 10.1021/bm3012852
   Smith PB, 2011, ACS SYM SER, V1063, P1
   Stanzione JF, 2012, GREEN CHEM, V14, P2346, DOI 10.1039/c2gc35672d
   Tatraaljai D, 2013, EUR POLYM J, V49, P1196, DOI 10.1016/j.eurpolymj.2013.02.018
   Thakkar JN, 2010, BIOMACROMOLECULES, V11, P1412, DOI 10.1021/bm100161u
   Thi TH, 2008, J BIOMAT SCI-POLYM E, V19, P75, DOI 10.1163/156856208783227668
   Xin ML, 2013, POLYM BULL, V70, P2755, DOI 10.1007/s00289-013-0985-1
   Xu P, 2005, J AM CHEM SOC, V127, P11745, DOI 10.1021/ja051637r
   Yu LL, 2002, FOOD CHEM, V78, P457, DOI 10.1016/S0308-8146(02)00156-5
   Zhu Y, 2010, FOOD CHEM, V118, P228, DOI 10.1016/j.foodchem.2009.04.112
   Ziaja P, 2012, POLYM CHEM-UK, V3, P93, DOI 10.1039/c1py00494h
NR 67
TC 19
Z9 19
U1 1
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2014
VL 15
IS 1
BP 302
EP 310
DI 10.1021/bm4015478
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 292CO
UT WOS:000329879800033
PM 24313867
DA 2018-10-20
ER

PT J
AU Sun, JY
   Ling, MZ
   Wang, YM
   Chen, DH
   Zhang, SJ
   Tong, J
   Wang, S
AF Sun, Jiyu
   Ling, Mingze
   Wang, Yueming
   Chen, Donghui
   Zhang, Shujun
   Tong, Jin
   Wang, Shuang
TI Quasi-Static and Dynamic Nanoindentation of Some Selected Biomaterials
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE biomaterial; dynamic nanoindentation; viscoelasticity; nacre; bovine
   horn; beetle elytra
ID MOLECULAR-WEIGHT POLYETHYLENE; VISCOELASTIC PROPERTIES;
   MECHANICAL-PROPERTIES; BIOLOGICAL-MATERIALS; INSTRUMENTED INDENTATION;
   POLYMERIC MATERIALS; BONE; ROUGHNESS; FRACTURE; NACRE
AB This study details an investigation of the viscoelastic behavior of some biomaterials (nacre, cattle horn and beetle cuticle) at lamellar length scales using quasi-static and dynamic nanoindentation techniques in the materials' Transverse Direction (TD) and Longitudinal Direction (LD). Our results show that nacre exhibits high fracture toughness moving towards a larger campaniform as the stress frequency varies from 10 Hz to 200 Hz. Elytra cuticle exhibits the least fracture toughness presenting little energy dissipation in TD. It was initially speculated that the fracture toughness of the subject materials would be directly related to energy-dissipating mechanisms (mechanical hysteresis), but not the maximum value of the loss tangent tan delta. However, it was found that the materials' elastic modulus and hardness are similar in both the TD and LD when assessed using the quasi-static nanoindentation method, but not dynamic nanoindentation. It is believed that the reported results can be useful in the design of new crack arrest and damping materials based on biological counterparts.
C1 [Sun, Jiyu; Ling, Mingze; Wang, Yueming; Chen, Donghui; Tong, Jin] Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun 130025, Peoples R China.
   [Zhang, Shujun] Gloucestershire Univ, Dept Multimedia & Comp, Cheltenham GL50 2HR, Glos, England.
   [Wang, Shuang] Jilin Univ, China Japan Union Hosp, Dept Ophthalmol, Changchun 130031, Peoples R China.
RP Sun, JY (reprint author), Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun 130025, Peoples R China.
EM sjy@jlu.edu.cn
FU National Natural Science Foundation of China [31172144]; National
   Science & Technology Pillar Program of China in the Twelfth Five-Year
   Plan Period [2014BAD06B03]; Development Program of Science and
   Technology of Jilin Province of China [201303040NY, 20130522 034311]
FX This work was supported by the National Natural Science Foundation of
   China (31172144), the National Science & Technology Pillar Program of
   China in the Twelfth Five-Year Plan Period (2014BAD06B03), the
   Development Program of Science and Technology of Jilin Province of China
   (201303040NY, 20130522 034311), and the "Project 985" of Jilin
   University.
CR Ahearne M, 2007, ANN BIOMED ENG, V35, P1608, DOI 10.1007/s10439-007-9323-9
   Asif SAS, 1998, MATER RES SOC SYMP P, V505, P103
   Bhushan B., 2012, BIOMIMETICS BIOINSPI
   Bhushan B., 2010, SPRINGER HDB NANOTEC
   Bobji MS, 1997, APPL PHYS LETT, V71, P1059, DOI 10.1063/1.119727
   Bouaita N, 2006, POLYM ENG SCI, V46, P1160, DOI 10.1002/pen.20596
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   Chen Q, 2013, J MECH BEHAV BIOMED, V19, P3, DOI 10.1016/j.jmbbm.2012.10.012
   Donnelly E, 2006, J BIOMED MATER RES A, V77A, P426, DOI 10.1002/jbm.a.30633
   Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9
   Enders S, 2004, J MATER RES, V19, P880, DOI 10.1557/jmr.2004.19.3.880
   Faingold A, 2012, J MECH BEHAV BIOMED, V9, P198, DOI 10.1016/j.jmbbm.2012.01.014
   Franke O, 2008, JOM-US, V60, P49, DOI 10.1007/s11837-008-0071-6
   Fratzl P., 2005, LEARNING NATURE DESI, P15
   Hayes SA, 2004, J MATER RES, V19, P3298, DOI 10.1557/JMR.2004.0437
   Hu K, 2001, J STRUCT BIOL, V136, P46, DOI 10.1006/jsbi.2001.4417
   Jeng YR, 2013, J BIONIC ENG, V10, P522, DOI 10.1016/S1672-6529(13)60239-5
   Katti KS, 2010, BIOMIMETICS, LEARNING FROM NATURE, P193
   Lee CS, 2004, MACROMOL RES, V12, P141, DOI 10.1007/BF03219007
   Loubet JL, 2000, J MATER RES, V15, P1195, DOI 10.1557/JMR.2000.0169
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Mohanty B, 2006, J MATER RES, V21, P2045, DOI 10.1557/JMR.2006.0247
   Odegard GM, 2005, EXP MECH, V45, P130, DOI 10.1177/0014485105052320
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Park K, 2004, BIOMATERIALS, V25, P2427, DOI 10.1016/j.biomaterials.2003.09.014
   Pathak S, 2011, J MECH BEHAV BIOMED, V4, P34, DOI 10.1016/j.jmbbm.2010.09.002
   PETHICA JB, 1987, PHYS SCRIPTA, VT19A, P61, DOI 10.1088/0031-8949/1987/T19A/010
   Rettler E, 2013, J MATER CHEM B, V1, P2789, DOI 10.1039/c3tb20120a
   Richter BI, 2011, ARCH ORTHOP TRAUM SU, V131, P191, DOI 10.1007/s00402-010-1118-z
   Stempfle P, 2007, INT J NANOTECHNOL, V4, P712, DOI 10.1504/IJNT.2007.015466
   Sun JY, 2006, IEE P-NANOBIOTECHNOL, V153, P129, DOI [10.1049/ip-nbt:20050050, 10.1049/jp-nbt:20050050]
   Sun JY, 2007, J BIONIC ENG, V4, P11, DOI 10.1016/S1672-6529(07)60007-9
   Tang B, 2007, J MATER SCI-MATER M, V18, P1875, DOI 10.1007/s10856-007-3031-8
   Yamashita J, 2001, J BIOMED MATER RES, V58, P47, DOI 10.1002/1097-4636(2001)58:1<47::AID-JBM70>3.0.CO;2-U
   Yourdkhani M, 2011, J BIONIC ENG, V8, P357, DOI 10.1016/S1672-6529(11)60041-3
   Zhang YF, 2009, J POLYM SCI POL PHYS, V47, P1030, DOI 10.1002/polb.21709
NR 36
TC 14
Z9 16
U1 5
U2 39
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD JAN
PY 2014
VL 11
IS 1
BP 144
EP 150
DI 10.1016/S1672-6529(14)60029-9
PG 7
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 294XQ
UT WOS:000330081600015
DA 2018-10-20
ER

PT J
AU Ge, YY
   Xiao, D
   Li, ZL
   Cui, XM
AF Ge, Yuanyuan
   Xiao, Duo
   Li, Zhili
   Cui, Xuemin
TI Dithiocarbamate functionalized lignin for efficient removal of metallic
   ions and the usage of the metal-loaded bio-sorbents as potential free
   radical scavengers
SO JOURNAL OF MATERIALS CHEMISTRY A
LA English
DT Article
ID SUGAR-CANE BAGASSE; AQUEOUS-SOLUTIONS; MODEL COMPOUNDS; RICE HUSK;
   ADSORPTION; COPPER; WATER; EQUILIBRIUM; PARAMETERS; SORPTION
AB Lignin-based dithiocarbamate (LDTC) was synthesized by anchoring the chelating agent of dithiocarbamate to the ortho sites of phenol hydroxyl groups in the alkaline lignin matrix. The LDTC biomaterial was characterized by Fourier transform infrared spectroscopy, X-ray photoelectron spectroscopy and elemental analysis. Due to the cross-linked polymer matrix, high content of dithiocarbamate groups and excellent complex ability, the LDTC was used as a new bio-adsorbent for the removal of metallic ions from aqueous solution. The influences of pH, LDTC dosage, contact time, and initial metallic ion concentration on adsorption capacity and competitive adsorption of multi metallic ions have been investigated. The regeneration of LDTC was also studied. The results demonstrated that LDTC showed fast adsorption, higher adsorption capacity and feasible regeneration compared to other lignin-based bio-adsorbents even activated carbon. The adsorption kinetics and adsorption isotherms were fitted well by a pseudo second-order model and D-R model, respectively. Moreover, the resultant metal-loaded solid bio-sorbents (LDTC-M) were firstly estimated as free radical scavengers due to the inherent merits of naturally occurring polyphenols which therefore could provide a potential way for value-added usage of the LDTC-M.
C1 [Ge, Yuanyuan; Xiao, Duo; Li, Zhili; Cui, Xuemin] Guangxi Univ, Sch Chem & Chem Engn, Guangxi Key Lab Petrochem Resource Proc Intensifi, Nanning 530004, Peoples R China.
RP Li, ZL (reprint author), Guangxi Univ, Sch Chem & Chem Engn, Guangxi Key Lab Petrochem Resource Proc Intensifi, Nanning 530004, Peoples R China.
EM cezli@foxmail.com
FU National Natural Science Foundation of China [21264002]; Scientific
   Research Foundation of Guangxi University [XJZ120279]; Guangxi Key
   Laboratory of Petrochemical Resource Processing and Process
   Intensification Technology [2012Z07]
FX We greatly acknowledge the support from the National Natural Science
   Foundation of China (21264002), Scientific Research Foundation of
   Guangxi University (XJZ120279), and Guangxi Key Laboratory of
   Petrochemical Resource Processing and Process Intensification Technology
   (2012Z07).
CR Alslaibi TM, 2014, ENVIRON PROG SUSTAIN, V33, P1074, DOI 10.1002/ep.11877
   Asmadi M, 2011, J ANAL APPL PYROL, V92, P88, DOI 10.1016/j.jaap.2011.04.011
   Azarpira A., 2013, ABSTR PAP AM CHEM SO, V245
   Bai L, 2011, J HAZARD MATER, V195, P261, DOI 10.1016/j.jhazmat.2011.08.038
   Bansal M, 2009, J HAZARD MATER, V171, P83, DOI 10.1016/j.jhazmat.2009.05.124
   BATTISTONI C, 1984, J CHEM SOC DALTON, P1293, DOI 10.1039/dt9840001293
   Chang Q, 2008, J HAZARD MATER, V159, P548, DOI 10.1016/j.jhazmat.2008.02.053
   Choi J, 2013, J MATER CHEM A, V1, P5847, DOI 10.1039/c3ta00030c
   Crist RH, 2002, ENVIRON SCI TECHNOL, V36, P1485, DOI 10.1021/es011136f
   Demirbas A, 2004, J HAZARD MATER, V109, P221, DOI 10.1016/j.jhazmat.2004.04.002
   Deutsch KL, 2012, APPL CATAL A-GEN, V447, P144, DOI 10.1016/j.apcata.2012.09.047
   Dikici H, 2010, B ENVIRON CONTAM TOX, V84, P147, DOI 10.1007/s00128-009-9899-x
   Dlamini DS, 2012, MATER CHEM PHYS, V133, P369, DOI 10.1016/j.matchemphys.2012.01.040
   FURLANI C, 1983, INORG CHIM A-ARTICLE, V73, P105, DOI 10.1016/S0020-1693(00)90833-8
   Gich M, 2013, J MATER CHEM A, V1, P11410, DOI 10.1039/c3ta12190a
   Gupta VK, 2009, CRIT REV ENV SCI TEC, V39, P783, DOI 10.1080/10643380801977610
   Harmita H, 2009, BIORESOURCE TECHNOL, V100, P6183, DOI 10.1016/j.biortech.2009.06.093
   Hergert H. L., 1971, LIGNINS OCCUSSENCE F
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Hutson ND, 1997, ADSORPTION, V3, P189, DOI 10.1007/BF01650130
   Javaid A, 2011, BIOMASS BIOENERG, V35, P1675, DOI 10.1016/j.biombioe.2010.12.035
   Jiang T., 2009, LIGNIN
   Kardam A., 2013, CLEAN TECHNOL ENVIR, P1
   Li ZL, 2012, INT J BIOL MACROMOL, V51, P1116, DOI 10.1016/j.ijbiomac.2012.09.004
   Li ZL, 2011, J BRAZIL CHEM SOC, V22, P1866, DOI 10.1590/S0103-50532011001000006
   [李志礼 LI Zhili], 2008, [化工学报, Journal of Chemical Industry and Engineering (China)], V59, P2127
   Liu Y, 2006, J HAZARD MATER, V137, P1149, DOI 10.1016/j.jhazmat.2006.03.057
   Lopretti M, 1998, PROCESS BIOCHEM, V33, P657, DOI 10.1016/S0032-9592(98)00028-4
   Lu QF, 2012, BIORESOURCE TECHNOL, V104, P111, DOI 10.1016/j.biortech.2011.10.055
   Ma HY, 2012, ACS MACRO LETT, V1, P213, DOI 10.1021/mz200047q
   Mahajan G, 2013, J ENVIRON CHEM ENG, V1, P1020, DOI 10.1016/j.jece.2013.08.013
   Maldhure AV, 2011, CHEM ENG J, V168, P1103, DOI 10.1016/j.cej.2011.01.091
   Matlock MM, 2001, J HAZARD MATER, V82, P55, DOI 10.1016/S0304-3894(00)00353-8
   McBride M., 1994, ENV CHEM SOILS
   McCloskey JT, 1996, ENVIRON TOXICOL CHEM, V15, P1730, DOI 10.1897/1551-5028(1996)015<1730:PTRTOM>2.3.CO;2
   Mohan D, 2006, J COLLOID INTERF SCI, V297, P489, DOI 10.1016/j.jcis.2005.11.023
   Niemenmaa O, 2008, BIODEGRADATION, V19, P555, DOI 10.1007/s10532-007-9161-3
   Onyango MS, 2004, J COLLOID INTERF SCI, V279, P341, DOI 10.1016/j.jcis.2004.06.038
   Ozcan A, 2005, J HAZARD MATER, V124, P200, DOI 10.1016/j.hazmat.2005.05.007
   Patil N. D., 2013, ABSTR PAP AM CHEM SO, V245
   Pehlivan E, 2006, J HAZARD MATER, V134, P149, DOI 10.1016/j.jhazmat.2005.10.052
   Peternele WS, 1999, BIORESOURCE TECHNOL, V68, P95, DOI 10.1016/S0960-8524(98)00083-2
   Rao GP, 2007, SEP PURIF TECHNOL, V58, P224, DOI 10.1016/j.seppur.2006.12.006
   Robertson AP, 1999, ENVIRON SCI TECHNOL, V33, P786, DOI 10.1021/es9807237
   Roy PK, 2003, TALANTA, V59, P239, DOI 10.1016/S0039-9140(02)00497-6
   Salanti A, 2010, J AGR FOOD CHEM, V58, P10049, DOI 10.1021/jf102188k
   Say R, 2008, J HAZARD MATER, V150, P560, DOI 10.1016/j.jhazmat.2007.03.089
   Srivastava VC, 2006, J HAZARD MATER, V134, P257, DOI 10.1016/j.jhazmat.2005.11.052
   Suhas P.J.M., 2007, BIORESOURCE TECHNOL, V98, P2301, DOI DOI 10.1016/J.BIORTECH.2006.08.008
   Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009
   Tavares DS, 2013, J MATER CHEM A, V1, P8134, DOI 10.1039/c3ta10914c
   Tomasevic DD, 2013, CHEMOSPHERE, V92, P1490, DOI 10.1016/j.chemosphere.2013.03.063
   Unlu N, 2007, SEP PURIF TECHNOL, V52, P461, DOI 10.1016/j.seppur.2006.05.026
   Vinardell MP, 2008, IND CROP PROD, V27, P220, DOI 10.1016/j.indcrop.2007.07.011
   Wu Y, 2008, BIORESOURCE TECHNOL, V99, P7709, DOI 10.1016/j.biortech.2008.01.069
   YU XR, 1990, J ELECTRON SPECTROSC, V50, P159, DOI 10.1016/0368-2048(90)87059-W
   Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u
NR 57
TC 47
Z9 49
U1 5
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-7488
EI 2050-7496
J9 J MATER CHEM A
JI J. Mater. Chem. A
PY 2014
VL 2
IS 7
BP 2136
EP 2145
DI 10.1039/c3ta14333c
PG 10
WC Chemistry, Physical; Energy & Fuels; Materials Science,
   Multidisciplinary
SC Chemistry; Energy & Fuels; Materials Science
GA 294LS
UT WOS:000330048400017
DA 2018-10-20
ER

PT J
AU Connell, LS
   Romer, F
   Suarez, M
   Valliant, EM
   Zhang, ZY
   Lee, PD
   Smith, ME
   Hanna, JV
   Jones, JR
AF Connell, Louise S.
   Romer, Frederik
   Suarez, Marta
   Valliant, Esther M.
   Zhang, Ziyu
   Lee, Peter D.
   Smith, Mark E.
   Hanna, John V.
   Jones, Julian R.
TI Chemical characterisation and fabrication of chitosan-silica hybrid
   scaffolds with 3-glycidoxypropyl trimethoxysilane
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID SOL-GEL METHOD; IN-VITRO; BIOACTIVE GLASS; MECHANICAL-PROPERTIES; BONE
   REGENERATION; MEMBRANES; ACID; CYTOCOMPATIBILITY; SOLUBILIZATION;
   BIOMATERIAL
AB Chitosan has been explored as a potential component of biomaterials and scaffolds for many tissue engineering applications. Hybrid materials, where organic and inorganic networks interpenetrate at the molecular level, have been a particular focus of interest using 3-glycidoxypropyl trimethoxysilane (GPTMS) as a covalent crosslinker between the networks in a sol-gel process. GPTMS contains both an epoxide ring that can undergo a ring opening reaction with the primary amine of chitosan and a trimethoxysilane group that can co-condense with silica precursors to form a silica network. While many researchers have exploited this ring-opening reaction, it is not yet fully understood and thus the final product is still a matter of some dispute. Here, a detailed study of the reaction of GPTMS with chitosan under different pH conditions was carried out using a combination of solution state and solid state MAS NMR techniques. The reaction of GPTMS with chitosan at the primary amine to form a secondary amine was confirmed and the rate was found to increase at lower pH. However, a side-reaction was identified between GPTMS and water producing a diol species. The relative amounts of diol and chitosan-GPTMS species were 80 and 20% respectively and this ratio did not vary with pH. The functionalisation pH had an effect on the mechanical properties of 65 wt% organic monoliths where the properties of the organic component became more dominant. Scaffolds were fabricated by freeze drying and had pore diameters in excess of 140 mm, and tailorable by altering freezing temperature, which were suitable for tissue engineering applications. In both monoliths and scaffolds, increasing the organic content disrupted the inorganic network, leading to an increase in silica dissolution in SBF. However, the dissolution of silica and chitosan was congruent up to 4 weeks in SBF, illustrating the true hybrid nature resulting from covalent bonding between the networks.
C1 [Connell, Louise S.; Valliant, Esther M.; Zhang, Ziyu; Jones, Julian R.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Romer, Frederik; Smith, Mark E.; Hanna, John V.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.
   [Suarez, Marta] Fdn ITMA, Llanera 33428, Asturias, Spain.
   [Suarez, Marta] Ctr Invest Nanomat & Nanotecnol, Dept Nanostruct Mat, Llanera 33428, Spain.
   [Lee, Peter D.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England.
   [Smith, Mark E.] Univ Lancaster, Vice Chancellors Off, Lancaster LA1 4YW, England.
RP Jones, JR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, South Kensington Campus, London SW7 2AZ, England.
EM julian.r.jones@imperial.ac.uk
RI Jones, Julian/B-1007-2012; Renold, Ria/K-7051-2018; Connell,
   Louise/H-2581-2014; Lee, Peter/R-2323-2016
OI Jones, Julian/0000-0002-2647-8024; Connell, Louise/0000-0002-1809-7686;
   Lee, Peter/0000-0002-3898-8881; Suarez, Marta/0000-0001-9764-0861
FU EPSRC [EP/E057098/1, EP/E051669/1, EP/I020861/1, EP/I004688/1];
   Department of Materials, Imperial College London; Ficyt under the Argo
   program; University of Warwick; Birmingham Science City projects;
   Advantage West Midlands (AWM); European Regional Development Fund
   (ERDF); solid-state NMR facilities at Warwick; Engineering and Physical
   Sciences Research Council [EP/I020861/1, EP/E051669/1, EP/E057098/1]
FX The authors would like to thank Mr Peter Haycock, Department of
   Chemistry, Imperial College London, for carrying out the quantitative
   HSQC experiments. This research has been funded by the EPSRC
   (EP/E057098/1, EP/E051669/1 and EP/I020861/1) and the Department of
   Materials, Imperial College London. EMV was a Natural Sciences and
   Engineering Research Council of Canada (NSERC), Canadian Centennial
   Scholar, MS was supported by Ficyt under the Argo program. JVH and MES
   acknowledge support for the solid-state NMR facilities at Warwick used
   in this research which were funded by EPSRC and the University of
   Warwick. NMR was also partially funded through the Birmingham Science
   City projects which were supported by Advantage West Midlands (AWM) and
   the European Regional Development Fund (ERDF). JVH and MES acknowledge
   EPSRC support for FR via project EP/I004688/1.
CR Al-Sagheer F, 2010, J NANOMATER, DOI 10.1155/2010/490679
   Amado S, 2008, BIOMATERIALS, V29, P4409, DOI 10.1016/j.biomaterials.2008.07.043
   Atwood RC, 2004, SCRIPTA MATER, V51, P1029, DOI 10.1016/j.scriptamat.2004.08.014
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Chao AC, 2008, J MEMBRANE SCI, V311, P306, DOI 10.1016/j.memsci.2007.12.032
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Gabrielli L, 2014, RSC ADV, V4, P1841, DOI 10.1039/c3ra44748k
   Gabrielli L, 2013, CHEM-EUR J, V19, P7856, DOI 10.1002/chem.201204326
   Gao CX, 2013, J APPL POLYM SCI, V127, P2588, DOI 10.1002/app.37946
   Heikkinen S, 2003, J AM CHEM SOC, V125, P4362, DOI 10.1021/ja029035k
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   Innocenzi P, 2005, J SOL-GEL SCI TECHN, V35, P225, DOI 10.1007/s10971-005-2290-4
   Jones JR, 2007, BIOMATERIALS, V28, P1404, DOI 10.1016/j.biomaterials.2006.11.014
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Jones JR, 2009, J EUR CERAM SOC, V29, P1275, DOI 10.1016/j.jeurceramsoc.2008.08.003
   Koh MY, 2011, J BIOMATER APPL, V25, P581, DOI 10.1177/0885328209357111
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lin S, 2009, J MATER CHEM, V19, P1276, DOI 10.1039/b814292k
   Liu YL, 2004, POLYMER, V45, P6831, DOI 10.1016/j.polymer.2004.08.006
   MacKenzie K. J. D., 2002, MULTINUCLEAR SOLID S
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mahony O, 2010, ADV FUNCT MATER, V20, P3835, DOI 10.1002/adfm.201000838
   Minami S., 2006, MAT SCI CHITIN CHITO, P191
   NOVAK BM, 1993, ADV MATER, V5, P422, DOI 10.1002/adma.19930050603
   Osaka A., 2005, J R SOC INTERFACE, V2, P335
   Pakula M, 2008, J ACOUST SOC AM, V123, P2415, DOI 10.1121/1.2839016
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   Poologasundarampillai G, 2012, SOFT MATTER, V8, P4822, DOI 10.1039/c2sm00033d
   Poologasundarampillai G, 2010, J MATER CHEM, V20, P8952, DOI 10.1039/c0jm00930j
   Prochazkova S, 1999, CARBOHYD POLYM, V38, P115, DOI 10.1016/S0144-8617(98)00108-8
   Rashidova SS, 2004, J CHROMATOGR B, V800, P49, DOI 10.1016/j.jchromb.2003.10.015
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   Rhee SH, 2002, BIOMATERIALS, V23, P4915, DOI 10.1016/S0142-9612(02)00251-X
   Rinaudo M, 1999, INT J POLYM ANAL CH, V5, P267, DOI 10.1080/10236669908009742
   Rinaudo M, 1999, POLYMER, V40, P7029, DOI 10.1016/S0032-3861(99)00056-7
   Shirosaki Y, 2005, BIOMATERIALS, V26, P485, DOI 10.1016/j.biomaterials.2004.02.056
   Shirosaki Y., 2009, BIOCERAMICS DEV APPL, V22, P217
   Shirosaki Y, 2008, CHEM ENG J, V137, P122, DOI 10.1016/j.cej.2007.10.012
   Shirosaki Y, 2010, J CERAM SOC JPN, V118, P989, DOI 10.2109/jcersj2.118.989
   Shirosaki Y, 2009, J NANOSCI NANOTECHNO, V9, P3714, DOI 10.1166/jnn.2009.NS56
   Shirosaki Y, 2009, ACTA BIOMATER, V5, P346, DOI 10.1016/j.actbio.2008.07.022
   Simoes MJ, 2011, ACTA MEDICA PORT, V24, P43
   Toskas G, 2013, CARBOHYD POLYM, V94, P713, DOI 10.1016/j.carbpol.2013.01.068
   Tsuru K, 1997, J MATER SCI-MATER M, V8, P157, DOI 10.1023/A:1018523203667
   Valliant EM, 2013, ACTA BIOMATER, V9, P7662, DOI 10.1016/j.actbio.2013.04.037
   Valliant EM, 2011, SOFT MATTER, V7, P5083, DOI 10.1039/c0sm01348j
   Varghese JG, 2010, J CHEM ENG DATA, V55, P2084, DOI 10.1021/je9003993
   Wright J.D., 2000, SOL GEL MAT CHEM APP
   Yue S, 2011, ACTA BIOMATER, V7, P2637, DOI 10.1016/j.actbio.2011.02.009
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 54
TC 46
Z9 46
U1 6
U2 79
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 6
BP 668
EP 680
DI 10.1039/c3tb21507e
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA 292XQ
UT WOS:000329936400010
DA 2018-10-20
ER

PT J
AU Ponomarenko, EA
   Kopylov, AT
   Lisitsa, AV
   Radko, SP
   Kiseleva, YY
   Kurbatov, LK
   Ptitsyn, KG
   Tikhonova, OV
   Moisa, AA
   Novikova, SE
   Poverennaya, EV
   Ilgisonis, EV
   Filimonov, AD
   Bogolubova, NA
   Averchuk, VV
   Karalkin, PA
   Vakhrushey, IV
   Yarygin, KN
   Moshkovskii, SA
   Zgoda, VG
   Sokolov, AS
   Mazur, AM
   Prokhortchouck, EB
   Skryabin, KG
   Ilina, EN
   Kostrjukova, ES
   Alexeev, DG
   Tyakht, AV
   Gorbachev, AY
   Govorun, VM
   Archakov, AI
AF Ponomarenko, Elena A.
   Kopylov, Arthur T.
   Lisitsa, Andrey V.
   Radko, Sergey P.
   Kiseleva, Yana Yu.
   Kurbatov, Leonid K.
   Ptitsyn, Konstantin G.
   Tikhonova, Olga V.
   Moisa, Alexander A.
   Novikova, Svetlana E.
   Poverennaya, Ekaterina V.
   Ilgisonis, Ekaterina V.
   Filimonov, Alexey D.
   Bogolubova, Nadezhda A.
   Averchuk, Valentina V.
   Karalkin, Pavel A.
   Vakhrushey, Igor V.
   Yarygin, Konstantin N.
   Moshkovskii, Sergei A.
   Zgoda, Victor G.
   Sokolov, Alexey S.
   Mazur, Alexander M.
   Prokhortchouck, Egor B.
   Skryabin, Konstantin G.
   Ilina, Elena N.
   Kostrjukova, Elena S.
   Alexeev, Dmitry G.
   Tyakht, Alexander V.
   Gorbachev, Alexey Yu.
   Govorun, Vadim M.
   Archakov, Alexander I.
TI Chromosome 18 Transcriptoproteome of Liver Tissue and HepG2 Cells and
   Targeted Proteome Mapping in Depleted Plasma: Update 2013
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE mRNA sequencing; quantitative PCR; selected reaction monitoring; human
   proteome project; transcriptome; proteome; transcriptoproteome;
   chromosome 18
ID HUMAN PROTEINS; COPY-NUMBER; QUANTITATION; SYSTEM
AB We report the results obtained in 2012-2013 by the Russian Consortium for the Chromosome-centric Human Proteome Project (C-HPP). The main scope of this work was the transcriptome profiling of genes on human chromosome 18 (Chr 18), as well as their encoded proteome, from three types of biomaterials: liver tissue, the hepatocellular carcinoma-derived cell line HepG2, and blood plasma The transcriptome profiling for liver tissue was independently performed using two RNaseq platforms (SOLiD and Illumina) and also by droplet digital PCR (ddPCR) and quantitative RT-PCR. The proteome profiling of Chr 18 was accomplished by quantitatively measuring protein copy numbers in the three types of biomaterial (the lowest protein concentration measured was 10(-13) M) using selected reaction monitoring (SRM). In total, protein copy numbers were estimated for 228 master proteins, including quantitative data on 164 proteins in plasma, 171 in the HepG2 cell line, and 186 in liver tissue. Most proteins were present in plasma at 10(8) copies/mu L, while the median abundance was 10(4) and 10(5) protein copies per cell in HepG2 cells and liver tissue, respectively. In summary, for liver tissue and HepG2 cells a "transcriptoproteome" was produced that reflects the relationship between transcript and protein copy numbers of the genes on Chr 18. The quantitative data acquired by RNaseq, PCR, and SRM were uploaded into the "Update_2013" data set of our knowledgebase (www.kb18.ru) and investigated for linear correlations.
C1 [Ponomarenko, Elena A.; Kopylov, Arthur T.; Lisitsa, Andrey V.; Radko, Sergey P.; Kiseleva, Yana Yu.; Kurbatov, Leonid K.; Ptitsyn, Konstantin G.; Tikhonova, Olga V.; Moisa, Alexander A.; Novikova, Svetlana E.; Poverennaya, Ekaterina V.; Ilgisonis, Ekaterina V.; Filimonov, Alexey D.; Bogolubova, Nadezhda A.; Averchuk, Valentina V.; Karalkin, Pavel A.; Vakhrushey, Igor V.; Yarygin, Konstantin N.; Moshkovskii, Sergei A.; Zgoda, Victor G.; Archakov, Alexander I.] Russian Acad Med Sci, Orekhovich Inst Biomed Chem, Moscow 119121, Russia.
   [Sokolov, Alexey S.; Prokhortchouck, Egor B.; Skryabin, Konstantin G.] Natl Res Ctr Kurchatov Inst, Moscow 123182, Russia.
   [Prokhortchouck, Egor B.; Skryabin, Konstantin G.] Russian Acad Sci, Ctr Bioengn, Moscow 117312, Russia.
   [Ilina, Elena N.; Kostrjukova, Elena S.; Alexeev, Dmitry G.; Tyakht, Alexander V.; Gorbachev, Alexey Yu.; Govorun, Vadim M.] Fed Med Biol Agcy Russian Federat, Sci Res Inst Phys Chem Med, Moscow 119828, Russia.
RP Archakov, AI (reprint author), 10 Pogodinskaya St, Moscow 119121, Russia.
EM alexander.archakov@ibmc.msk.ru
RI Alexeev, Dmitry/A-6167-2013; Novikova, Svetlana/F-5107-2017; Yarygin,
   Konstantin/C-4047-2009; Ilina, Elena/N-8190-2015
OI Alexeev, Dmitry/0000-0003-0783-1176; Novikova,
   Svetlana/0000-0003-2777-2476; Yarygin, Konstantin/0000-0002-2261-851X;
   Ilina, Elena/0000-0003-0130-5079; Kostryukova,
   Elena/0000-0002-0457-6803; Filimonov, Aleksey/0000-0002-8895-142X;
   Gorbachev, Alexey/0000-0002-2743-5835; Tyakht,
   Alexander/0000-0002-7358-2537
FU Ministry of Education and Science of the Russian Federation [8781, 8274]
FX This work was done in accordance with the Human Proteome Program of the
   Russian Academy of Medical Science and was funded by the Ministry of
   Education and Science of the Russian Federation (Agreements 8781 and
   8274).
CR Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d
   Archakov A, 2012, EXPERT REV PROTEOMIC, V9, P667, DOI [10.1586/EPR.12.54, 10.1586/epr.12.54]
   Archakov A, 2011, PROTEOMICS, V11, P1853, DOI 10.1002/pmic.201000540
   Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001
   Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h
   Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56
   Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236
   Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.014050
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Kopylov AT, 2013, PROTEOMICS, V13, P727, DOI 10.1002/pmic.201100460
   Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179
   Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303
   Poverennaya EV, 2014, BBA-PROTEINS PROTEOM, V1844, P77, DOI 10.1016/j.bbapap.2013.08.006
   Roth MJ, 2005, MOL CELL PROTEOMICS, V4, P1002, DOI 10.1074/mcp.M500064-MCP200
   Rubin A., 2013, STAT EVIDENCE BASED, P144
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Sherwood CA, 2009, J PROTEOME RES, V8, P4396, DOI 10.1021/pr900010h
   Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002
   Zgoda VG, 2013, J PROTEOME RES, V12, P123, DOI [10.1021/pr300821n1, 10.1021/pr300821n]
NR 19
TC 16
Z9 22
U1 1
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD JAN
PY 2014
VL 13
IS 1
SI SI
BP 183
EP 190
DI 10.1021/pr400883x
PG 8
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 286MF
UT WOS:000329472700019
PM 24328317
DA 2018-10-20
ER

PT J
AU Albertson, AE
   Teule, F
   Weber, W
   Yarger, JL
   Lewis, RV
AF Albertson, Amy E.
   Teule, Florence
   Weber, Warner
   Yarger, Jeffery L.
   Lewis, Randolph V.
TI Effects of different post-spin stretching conditions on the mechanical
   properties of synthetic spider silk fibers
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Synthetic spider silk fibers; Mechanical properties; Post-spinning;
   Dragline; Argiope aurantia
ID DRAGLINE SILK; NEPHILA-CLAVIPES; ARGIOPE-AURANTIA; BETA-SHEETS;
   PROTEINS; FLAGELLIFORM; ORIENTATION; NMR; BIOMATERIALS; SEQUENCES
AB Spider silk is a biomaterial with impressive mechanical properties, resulting in various potential applications. Recent research has focused on producing synthetic spider silk fibers with the same mechanical properties as the native fibers. For this study, three proteins based on the Argiope aurantia Major ampullate Spidroin 2 consensus repeat sequence were expressed, purified and spun into fibers. A number of post-spin draw conditions were tested to determine the effect of each condition on the mechanical properties of the fiber. In all cases, post-spin stretching improved the mechanical properties of the fibers. Aqueous isopropanol was the most effective solution for increasing extensibility, while other solutions worked best for each fiber type for increasing tensile strength. The strain values of the stretched fibers correlated with the length of the proline-rich protein sequence. Structural analysis, including X-ray diffraction and Raman spectroscopy, showed surprisingly little change in the initial as-spun fibers compared with the post-spin stretched fibers. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Albertson, Amy E.; Teule, Florence; Lewis, Randolph V.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.
   [Weber, Warner; Yarger, Jeffery L.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA.
RP Albertson, AE (reprint author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.
EM aalberts@uwyo.edu
RI Yarger, Jeff/L-8748-2014
OI Yarger, Jeff/0000-0002-7385-5400
FU National Institute of Health (NIH) [EB000490]; Department of Energy
   (DOE) [DE-SC0004791]; Department of Defense Air Force Office of
   Scientific Research (AFOSR) [FA9550-09-1-0717]; Department of Defense
   AFOSR [FA9550-10-1-0275]; National Science Foundation (NSF), Division of
   Materials Research [DMR-0805197]; U.S. Department of Energy, Basic
   Energy Sciences, Office of Science [DE-ACO206CH11357]; National Center
   for Research Resources [5P41RR007707]; National Institute of General
   Medical Sciences from the National Institutes of Health [8P41GM103543]
FX The authors would like to acknowledge support for the work done in the
   Lewis laboratory from the National Institute of Health (NIH) Award no.
   EB000490, the Department of Energy (DOE) Award no. DE-SC0004791, and the
   Department of Defense Air Force Office of Scientific Research (AFOSR)
   Award no. FA9550-09-1-0717. Jeffery Yarger would like to acknowledge
   support from the Department of Defense AFOSR under Award no.
   FA9550-10-1-0275 and the National Science Foundation (NSF), Division of
   Materials Research under Award no. DMR-0805197. Use of the Advanced
   Photon Source was supported by the U.S. Department of Energy, Basic
   Energy Sciences, Office of Science, under Contract no. DE-ACO206CH11357.
   Use of the BioCARS Sector 14 was also supported by grants from the
   National Center for Research Resources (5P41RR007707) and the National
   Institute of General Medical Sciences (8P41GM103543) from the National
   Institutes of Health. The authors would also like to thank Dr. Michael
   Hinman for help with mechanical testing data analysis and valuable
   advice on this manuscript and Dr. Kenneth Gerow for providing insight
   into the statistical analysis of the data. Any opinions, findings, or
   conclusions presented in this publication are those of the author(s) and
   do not necessarily reflect the views of the NIH, DOE, NSF or AFOSR.
CR Adrianos SL, 2013, BIOMACROMOLECULES, V14, P1751, DOI 10.1021/bm400125w
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   An B, 2011, BIOMACROMOLECULES, V12, P2375, DOI 10.1021/bm200463e
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Brooks AE, 2005, BIOMACROMOLECULES, V6, P3095, DOI 10.1021/bm050421e
   Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p
   Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Gorb SN, 2006, NATURE, V443, P407, DOI 10.1038/443407a
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5
   Hinman M., 1992, Results and Problems in Cell Differentiation, V19, P227
   Holland GP, 2008, J AM CHEM SOC, V130, P9871, DOI 10.1021/ja8021208
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Jelinski LW, 1999, INT J BIOL MACROMOL, V24, P197, DOI 10.1016/S0141-8130(98)00085-3
   Jenkins JE, 2010, CHEM COMMUN, V46, P6714, DOI 10.1039/c0cc00829j
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Teule F, 2007, J MATER SCI, V42, P8974, DOI 10.1007/s10853-007-1642-6
   Teule F, 2012, BIOPOLYMERS, V97, P418, DOI 10.1002/bip.21724
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Urrry D.W., 1995, P CIB FDN S, V192, P30
   Urry D.W., 1995, P CIB FDN S, V192, P4922
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
NR 38
TC 23
Z9 23
U1 1
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JAN
PY 2014
VL 29
SI SI
BP 225
EP 234
DI 10.1016/j.jmbbm.2013.09.002
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 294ZF
UT WOS:000330085700021
PM 24113297
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Narita, K
   Niinomi, M
   Nakai, M
AF Narita, Kengo
   Niinomi, Mitsuo
   Nakai, Masaaki
TI Effects of micro- and nano-scale wave-like structures on fatigue
   strength of a beta-type titanium alloy developed as a biomaterial
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Metallic biomaterials; Beta-type titanium alloy; Fatigue strength; Nano
   structure
ID SPINAL FIXATION APPLICATIONS; ALPHA-PHASE PRECIPITATION; CHANGEABLE
   YOUNGS MODULUS; ZR SYSTEM ALLOYS; BIOMEDICAL APPLICATIONS; TENSILE
   PROPERTIES; MECHANICAL-PROPERTIES; PLASTIC-DEFORMATION; ELASTIC-MODULUS;
   TI-MO
AB Some newly developed p-type titanium alloys, for biomedical applications exhibit distinctive heterogeneous structures. The formation mechanisms for these structures have not been completely revealed; however, understanding these mechanisms could lead to improving their properties. In this study, the heterogeneous structures of a Ti-29Nb-13Ta-4.6Zr alloy (TNTZ), which is a candidate for next-generation metallic biomaterials, were analyzed. Furthermore, the effects of such heterogeneous structures on the mechanical strength of this alloy, including fatigue strength, were revealed by comparing its strength to that of homogenous TNTZ. The heterogeneous structures were characterized micro-, submicro- and nano-scale wave-like structures. The formation mechanisms of these wavelike structures are found to be different from each other even though their morphologies are similar. It is revealed that the micro-, submicro- and nano-scale wave-like structures are caused by elemental segregation, crystal distortion related to kink band and phase separation into beta and beta', respectively. However, these structures have no significant effect on both tensile properties and fatigue strength comparison with homogeneous structure in this study. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Narita, Kengo; Niinomi, Mitsuo; Nakai, Masaaki] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Narita, K (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM narita@imr.tohoku.ac.jp
RI Niinomi, Mitsuo/B-5965-2011; Nakai, Masaaki/C-1919-2009; Narita,
   Kengo/C-4332-2015
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Banerjee D, 2013, ACTA MATER, V61, P844, DOI 10.1016/j.actamat.2012.10.043
   Conrado R.M.A., 2010, ACTA BIOMATER, V6, P1625
   HANADA S, 1986, T JPN I MET, V27, P496, DOI 10.2320/matertrans1960.27.496
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   Ikeda M., 2002, METALL MATER TRANS A, V33, P4
   Kuramoto S, 2005, J JPN I MET, V69, P953, DOI 10.2320/jinstmet.69.953
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Liu JP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02156
   Min XH, 2011, MAT SCI ENG A-STRUCT, V528, P4569, DOI 10.1016/j.msea.2011.02.071
   Min XH, 2010, MAT SCI ENG A-STRUCT, V527, P1480, DOI 10.1016/j.msea.2009.10.033
   Nakai M, 2009, MATER TRANS, V50, P423, DOI 10.2320/matertrans.MRP2008380
   Narita K, 2011, J JPN I MET, V75, P198, DOI 10.2320/jinstmet.75.198
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niinomi M, 2008, MAT SCI ENG C-BIO S, V28, P406, DOI 10.1016/j.msec.2007.04.028
   OKA M, 1978, J JPN I MET, V42, P814, DOI 10.2320/jinstmet1952.42.8_814
   Okazaki Y, 2011, MAT SCI ENG C-MATER, V31, P325, DOI 10.1016/j.msec.2010.09.015
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P363, DOI 10.1016/j.msec.2004.12.014
   Sakaguchi N, 2004, J JPN I MET, V68, P1076, DOI 10.2320/jinstmet.68.1076
   Sakaguchi N, 2003, J JPN I MET, V67, P681, DOI 10.2320/jinstmet1952.67.11_681
   Takesue N, 2009, J CRYST GROWTH, V311, P3319, DOI 10.1016/j.jcrysgro.2009.03.052
   Yang Y, 2010, ACTA MATER, V58, P2778, DOI 10.1016/j.actamat.2010.01.015
   Zhao XF, 2012, ACTA BIOMATER, V8, P2392, DOI 10.1016/j.actbio.2012.02.010
   Zhao XF, 2012, ACTA BIOMATER, V8, P1990, DOI 10.1016/j.actbio.2012.02.004
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 26
TC 12
Z9 12
U1 0
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JAN
PY 2014
VL 29
SI SI
BP 393
EP 402
DI 10.1016/j.jmbbm.2013.09.017
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 294ZF
UT WOS:000330085700036
PM 24184863
DA 2018-10-20
ER

PT J
AU Pinheiro, ALB
   Aciole, GTS
   Ramos, TA
   Gonzalez, TA
   da Silva, LN
   Soares, LGP
   Aciole, JMS
   dos Santos, JN
AF Pinheiro, Antonio L. B.
   Santos Aciole, Gilberth Tadeu
   Ramos, Thais Andrade
   Gonzalez, Tayna Assuncao
   da Silva, Lais Nogueira
   Soares, Luiz G. Pinheiro
   Santos Aciole, Jouber Mateus
   dos Santos, Jean Nunes
TI The efficacy of the use of IR laser phototherapy associated to biphasic
   ceramic graft and guided bone regeneration on surgical fractures treated
   with miniplates: a histological and histomorphometric study on rabbits
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Biomaterials; Bone repair; Guided bone regeneration; Internal rigid
   fixation; Phototherapy
ID RODENT MODEL; MORPHOGENETIC PROTEINS; IN-VIVO; RAMAN-SPECTROSCOPY;
   DENTAL IMPLANTS; BOVINE BONE; REPAIR; LIGHT; PHOTOBIOMODULATION; THERAPY
AB The aim of the present study was to assess, by light microscopy and histomorphometry, the repair of surgical fractures fixed with internal rigid fixation (IRF) treated or not with IR laser (lambda 780 nm, 50 mW, 4 x 4 J/cm(2) = 16 J/cm(2), I center dot = 0.5cm(2), CW) associated or not to the use of hydroxyapatite and guided bone regeneration. Surgical tibial fractures were created under general anesthesia on 15 rabbits that were divided into 5 groups, maintained on individual cages, at day/night cycle, fed with solid laboratory pelted diet, and had water ad libidum. The fractures in groups II, III, IV, and V were fixed with miniplates. Animals in groups III and V were grafted with hydroxyapatite and GBR technique used. Animals in groups IV and V were irradiated at every other day during two weeks (4 x 4 J/cm(2), 16 J/cm(2) = 112 J/cm(2)). Observation time was that of 30 days. After animal death, specimens were taken, routinely processed to wax, cut and stained with HA and Sirius red, and used for histological assessment. The results of both analyses showed a better bone repair on all irradiated subjects especially when the biomaterial and GBR were used. In conclusion, the results of the present investigation are important clinically as they are suggestive that the association of hydroxyapatite, and laser light resulted in a positive and significant repair of complete tibial fractures treated with miniplates.
C1 [Pinheiro, Antonio L. B.; Santos Aciole, Gilberth Tadeu; Ramos, Thais Andrade; Gonzalez, Tayna Assuncao; da Silva, Lais Nogueira; Soares, Luiz G. Pinheiro; Santos Aciole, Jouber Mateus] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio L. B.] Univ Camilo Castelo Branco, BR-12245230 Sao Jose Dos Campos, SP, Brazil.
   [Pinheiro, Antonio L. B.] Inst Nacl Ciencia & Tecnol Opt & Foton, BR-13560970 Sao Carlos, SP, Brazil.
   [dos Santos, Jean Nunes] Univ Fed Bahia, Sch Dent, Lab Surg Pathol, BR-40110150 Salvador, BA, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, Av Araujo Pinho,62,Canela, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br; gilberthaciole@hotmail.com;
   thais_andraderamos@hotmail.com; tayna_gonzalez@yahoo.com.br;
   lay_lica@hotmail.com; luizguilherme_@hotmail.com;
   jouber_aciole@hotmail.com
RI Pinheiro, Antonio Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX The authors gratefully acknowledge the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) for the financial
   support and PhD Grant.
CR Carvalho FB, 2011, P SPIE, V7887
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Oliveira M. A. M., 2001, REV FOUFBA, V22, P12
   Pinheiro AL, 2010, PHOTOMED LASER SURG, V28, P89
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   PINHEIRO ALB, 2001, LASER THER, V13, P73
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinheiro Antonio Luiz Barbosa, 2003, Braz. Dent. J., V14, P177, DOI 10.1590/S0103-64402003000300007
   Soares LES, 2003, J CLIN LASER MED SUR, V21, P357, DOI 10.1089/104454703322650167
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
NR 19
TC 4
Z9 4
U1 0
U2 6
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD JAN
PY 2014
VL 29
IS 1
BP 279
EP 288
DI 10.1007/s10103-013-1339-9
PG 10
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA 291NA
UT WOS:000329834200037
PM 23649614
DA 2018-10-20
ER

PT J
AU Chen, CJ
   Luo, JJ
   Qin, W
   Tong, ZF
AF Chen, Congjin
   Luo, Jianju
   Qin, Wen
   Tong, Zhangfa
TI Elemental analysis, chemical composition, cellulose crystallinity, and
   FT-IR spectra of Toona sinensis wood
SO MONATSHEFTE FUR CHEMIE
LA English
DT Article; Proceedings Paper
CT 2nd International Congress on Advanced Materials (ICAM)
CY MAY 16-19, 2013
CL Jiangsu Univ, Zhejiang, PEOPLES R CHINA
HO Jiangsu Univ
DE Chemical composition; Trace elements; Extraction; ICP-AES; FT-IR
   spectroscopy; X-ray diffraction
ID INFRARED-SPECTROSCOPY; STRUCTURAL-ANALYSIS; CELL-WALL; LIGNIN;
   MELIACEAE; DEGRADATION; MISCANTHUS; APOPTOSIS; HARDWOOD; SOFT
AB Toona sinensis wood was analyzed for main chemical composition, trace element content, and wood cellulose crystallinity by FT-IR spectroscopy and X-ray diffraction of its native and extracted forms. The results showed that the ash and the extractives content of Toona sinensis wood were higher than for other leafy trees. The holo-cellulose, cellulose, and lignin content of the wood were 722.2, 458.3, and 213.1 mg g(-1), respectively. Trace element content was: Ca 3.05 x 10(3), Mg 3.34 x 10(2), Fe 1.38 x 10(2), K 1.30 x 10(2), Na 58.0, Al 25.7, Zn 5.91, Cu 4.06, Mn 3.21, and Pb 0.534 mu g g(-1). Extraction of Toona sinensis wood resulted in no significant chemical changes but the band at 1,736 cm(-1) of C=O in lignin and hemicelluloses disappeared and a band at 1,245 cm(-1) of CO-OR in hemicelluloses and C-O in lignin shifted to 1,234 cm(-1) and weakened only in the spectrum of the sample extracted with 1 % (w/w) aqueous sodium hydroxide. The FT-IR crystallinity index of the sample extracted with 1 % (w/w) aqueous sodium hydroxide was less than that of the original wood. The X-ray diffraction crystallinity indices of nitric acid-ethanol cellulose in T. sinensis wood was 0.786. These results indicate that T. sinensis wood probably has good flexibility and strength, and has the potential for use as a biomaterial and/or a bioenergy feedstock.
C1 [Chen, Congjin; Qin, Wen; Tong, Zhangfa] Guangxi Univ, Sch Chem & Chem Engn, Guangxi Key Lab Petrochem Resource Proc & Proc In, Nanning 530004, Peoples R China.
   [Luo, Jianju] Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China.
RP Chen, CJ (reprint author), Guangxi Univ, Sch Chem & Chem Engn, Guangxi Key Lab Petrochem Resource Proc & Proc In, Nanning 530004, Peoples R China.
EM gxdxccj@163.com
CR Abdelkafi F, 2011, BIOMACROMOLECULES, V12, P3895, DOI 10.1021/bm2008179
   Adel AM, 2010, BIORESOURCE TECHNOL, V101, P4446, DOI 10.1016/j.biortech.2010.01.047
   ANDERSON EL, 1991, APPL SPECTROSC, V45, P641, DOI 10.1366/0003702914336930
   Batista BL, 2009, FORENSIC SCI INT, V192, P88, DOI 10.1016/j.forsciint.2009.08.003
   Bauer S, 2012, J AGR FOOD CHEM, V60, P8203, DOI 10.1021/jf302409d
   Bjarnestad S, 2002, ANAL CHEM, V74, P5851, DOI 10.1021/ac025926z
   Chang HL, 2006, GYNECOL ONCOL, V102, P309, DOI 10.1016/j.ygyno.2005.12.023
   Chen CongJin, 2006, Chemistry and Industry of Forest Products, V26, P69
   Chen Congjin, 2010, Journal of Chinese Institute of Food Science and Technology, V10, P233
   Colom X, 2003, POLYM DEGRAD STABIL, V80, P543, DOI 10.1016/S0141-3910(03)00051-X
   Faix O, 1992, METHODS LIGNIN CHEM, V83
   Fan S, 2007, FOOD CHEM TOXICOL, V45, P2228, DOI 10.1016/j.fct.2007.05.022
   Fan ZF, 2003, SUBTROPICAL PLANT SC, V32, P35
   Gao RL, 2003, ACTA AGR U JIANGXIEN, V25, P124
   Hergert H. L., 1971, LIGNINS OCCURRENCE F, P267
   HORN BA, 1994, APPL SPECTROSC, V48, P662, DOI 10.1366/000370294774369072
   Hseu YC, 2008, FOOD CHEM TOXICOL, V46, P105, DOI 10.1016/j.fct.2007.07.003
   Hsieh TJ, 2004, FOOD CHEM TOXICOL, V42, P843, DOI 10.1016/j.fct.2004.01.008
   Hu G, 2012, ENERG FUEL, V26, P740, DOI 10.1021/ef201477p
   Huang G.Q., 2000, J S CHINA U TECHNOLO, V28, P95
   Huang Y, 2013, J WOOD CHEM TECHNOL, V32, P294
   Inagaki T, 2010, BIOMACROMOLECULES, V11, P2300, DOI 10.1021/bm100403y
   Ioannidou MD, 2005, TALANTA, V65, P92, DOI 10.1016/j.talanta.2004.05.018
   Kataoka Y, 1998, MACROMOLECULES, V31, P760, DOI 10.1021/ma970768c
   [赖玉荣 LAI Yutong], 2007, [中国造纸学报, Transaction of China Pulp and Paper], V22, P54
   Lebo SE, 1990, J PULP PAP SCI, V16, P139
   Leiviska T, 2009, WATER RES, V43, P3199, DOI 10.1016/j.watres.2009.04.051
   Li GY, 2011, CARBOHYD POLYM, V85, P560, DOI 10.1016/j.carbpol.2011.03.014
   Li J, 2003, TIMBER SPECTROSCOPY
   Li JH, 2009, SPECTROSC SPECT ANAL, V129, P797
   [李贤军 LI Xianjun], 2008, [林产工业, China Forest Products Industry], V35, P32
   Lu WD, 2008, ANHUI AGR SCI B, V14, P61
   [骆嘉言 Luo Jiayan], 2003, [西北林学院学报, Journal of Northwest Forestry College], V18, P77
   Lv J.B., 2008, CHEM IND FOREST PROD, V28, P66
   Moore AK, 2001, APPL SPECTROSC REV, V36, P65, DOI 10.1081/ASR-100103090
   Muller U, 2003, J PHOTOCH PHOTOBIO B, V69, P97, DOI 10.1016/S1011-1344(02)00412-8
   Obernberger I, 1997, BIOMASS BIOENERG, V12, P211, DOI 10.1016/S0961-9534(96)00051-7
   OWEN NL, 1989, APPL SPECTROSC, V43, P451, DOI 10.1366/0003702894202760
   Pandey KK, 2003, INT BIODETER BIODEGR, V52, P151, DOI 10.1016/S0964-8305(03)00052-0
   Pandey KK, 1999, J APPL POLYM SCI, V71, P1969, DOI 10.1002/(SICI)1097-4628(19990321)71:12<1969::AID-APP6>3.0.CO;2-D
   Pei-Hwei W, 2008, FOOD CHEM TOXICOL, V46, P2554, DOI 10.1016/j.fct.2008.04.011
   Popescu CM, 2007, CELL CHEM TECHNOL, V40, P649
   Popescu CM, 2007, APPL SPECTROSC, V61, P1168, DOI 10.1366/000370207782597076
   Porbatzki D, 2011, BIOMASS BIOENERG, V35, pS79, DOI 10.1016/j.biombioe.2011.04.001
   Rodrigues J, 1998, HOLZFORSCHUNG, V52, P46, DOI 10.1515/hfsg.1998.52.1.46
   Schwanninger M, 2004, VIB SPECTROSC, V36, P23, DOI 10.1016/j.vibspec.2004.02.003
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Shi S, 2008, PULP PAPER ANAL DETE
   SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033
   Wang K. J., 2007, FOOD CHEM, V101, P265
   Yang HL, 2006, FOOD CHEM TOXICOL, V44, P1978, DOI 10.1016/j.fct.2006.06.027
   Yang S, 2001, PLANT FIBER CHEM
NR 52
TC 11
Z9 11
U1 4
U2 44
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0026-9247
EI 1434-4475
J9 MONATSH CHEM
JI Mon. Chem.
PD JAN
PY 2014
VL 145
IS 1
BP 175
EP 185
DI 10.1007/s00706-013-1077-5
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA 293LY
UT WOS:000329974300026
DA 2018-10-20
ER

PT J
AU Xiong, Y
   Ren, C
   Zhang, B
   Yang, HS
   Lang, Y
   Min, L
   Zhang, WL
   Pei, FX
   Yan, YG
   Li, H
   Mo, AC
   Tu, CQ
   Duan, H
AF Xiong, Yan
   Ren, Cheng
   Zhang, Bin
   Yang, Hongsheng
   Lang, Yun
   Min, Li
   Zhang, Wenli
   Pei, Fuxing
   Yan, Yonggang
   Li, Hong
   Mo, Anchun
   Tu, Chongqi
   Duan, Hong
TI Analyzing the behavior of a porous nano-hydroxyapatite/polyamide 66
   (n-HA/PA66) composite for healing of bone defects
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE biomaterial; artificial bone materials; porous n-HA/PA66 composite
   (n-HA/PA66); bone defects healing; bone grafting
ID ENGINEERING SCAFFOLD MATERIAL; GRAFT SUBSTITUTES
AB The aim of this study was to analyze the behavior of the porous nano-hydroxyapatite/polyamide 66 (n-HA/PA66) composite grafted for bone defect repair through a series of biological safety experiments, animal experiments, and a more than 5-year long clinical follow-up. The biological safety experiments, carried out in accordance with the Chinese Guo Biao and Tolerancing (GB/T) 16886 and GB/T16175, revealed that porous n-HA/PA66 composite had no cytotoxicity, no sensitization effect, no pyrogenic reaction, and that its hemolysis rate was 0.59% (less than 5%). Rabbit models of tibia defects with grafted porous n-HA/PA66 composite were established. After 2 weeks, the experiment showed that osteogenesis was detected in the porous n-HA/PA66 composite; the density of new bone formation was similar to the surrounding host bone at 12 weeks. After 26 weeks, the artificial bone rebuilt to lamellar bone completely. In the clinical study, a retrospective review was carried out for 21 patients who underwent serial radiographic assessment after treatment with porous n-HA/PA66 composite grafts following bone tumor resection. All wounds healed to grade A. No postoperative infections, delayed deep infection, nonspecific inflammation, rejection, or fractures were encountered. At a mean follow-up of 5.3 years, the mean Musculoskeletal Tumor Society's (MSTS) 93 score was 29.3 points (range: 28-30 points) and mean radiopaque density ratio was 0.77 +/- 0.10. The radiologic analysis showed that porous n-HA/PA66 composite had been completely incorporated with the host bone about 1.5 years later. In conclusion, this study indicated that the porous n-HA/PA66 composite had biological safety, and good biocompatibility, osteoinduction, and osseointegration. Thus, the porous n-HA/PA66 composite is an ideal artificial bone substitute and worthy of promotion in the field.
C1 [Xiong, Yan; Ren, Cheng; Zhang, Bin; Yang, Hongsheng; Lang, Yun; Min, Li; Pei, Fuxing; Tu, Chongqi; Duan, Hong] Sichuan Univ, West China Hosp, Dept Orthoped, Chengdu 610064, Sichuan, Peoples R China.
   [Yan, Yonggang; Li, Hong] Sichuan Univ, Sch Phys Sci & Technol, Chengdu 610064, Sichuan, Peoples R China.
   [Mo, Anchun] Sichuan Univ, West China Coll Stomatol, Dept Oral Implant, Chengdu 610064, Sichuan, Peoples R China.
RP Duan, H (reprint author), Sichuan Univ, West China Hosp, Dept Orthoped, 37 Guo Xue Lane, Chengdu 610064, Sichuan, Peoples R China.
EM tuchongqitucq@163.com; duanhong1970@126.com
FU National Science and Technology Support Program of the People's Republic
   of China [2007BAE131304]
FX The work described in this paper was supported by the National Science
   and Technology Support Program of the People's Republic of China
   (2007BAE131304).
CR Black J, 2006, BIOL PERFORMANCE MAT
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241
   Fleming JE, 2000, ORTHOP CLIN N AM, V31, P357, DOI 10.1016/S0030-5898(05)70156-5
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   Jie W, 2004, EUR POLYM J, V40, P509, DOI 10.1016/j.eurpolymj.2003.10.028
   Kaveh K, 2010, J ANIM VET ADV, V9, P1055
   Kim HM, 2001, KEY ENG MATER, V218-220, P621
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   Lane JM, 1999, CLIN ORTHOP RELAT R, pS107
   Li Hong, 2008, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V25, P1126
   Li J, 2010, J BIOMATER SCI POLYM
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   Milosevski M, 1999, CERAM INT, V25, P693, DOI 10.1016/S0272-8842(99)00003-6
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Morrison R., 2012, BONE GRAFTS BONE GRA, P75
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P162
   Rosen PS, 2000, PERIODONTOL 2000, V22, P88, DOI 10.1034/j.1600-0757.2000.2220107.x
   Su B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068342
   Tsuchiya T, 1994, J Biomater Appl, V9, P138
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Vaz L, 1999, J MATER SCI-MATER M, V10, P239, DOI 10.1023/A:1008910213166
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Wu L, 2006, MATER SCI FORUM, V510-511, P938, DOI 10.4028/www.scientific.net/MSF.510-511.938
   Xu QA, 2010, INT J NANOMED, V5, P331
   Yang AP, 2007, KEY ENG MATER, V330, P321
   Yang X, 2012, ORTHOPEDICS, V35, pE66, DOI 10.3928/01477447-20111122-10
   Zhang X, 2006, POLYM DEGRAD STABIL, V91, P1202, DOI 10.1016/j.polymdegradstab.2005.02.006
NR 34
TC 29
Z9 37
U1 3
U2 50
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 485
EP 494
DI 10.2147/IJN.S52990
PG 10
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 291BE
UT WOS:000329801800001
PM 24531621
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Cox, SC
   Jamshidi, P
   Grover, LM
   Mallick, KK
AF Cox, Sophie C.
   Jamshidi, Parastoo
   Grover, Liam M.
   Mallick, Kajal K.
TI Low temperature aqueous precipitation of needle-like nanophase
   hydroxyapatite
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM PHOSPHATES; THERMAL-STABILITY; CARBONATED HYDROXYAPATITE;
   NANOSIZED HYDROXYAPATITE; GEL TECHNIQUE; BONE; POWDERS; NANOPARTICLES;
   APATITES; FTIR
AB The use of tissue engineered biodegradable porous scaffolds has become an important focus of the biomedical research field. The precursor materials used to form these structures play a vital role in their overall performance thus making the study and synthesis of these selected materials imperative. The authors present a comparison and characterisation of hydroxyapatite (HA), a popular calcium phosphate (CaP) biomaterial, synthesised by an aqueous precipitation (AP) method. The influence of various reaction conditions on the phase, crystallinity, particle size as well as morphology, molecular structure, potential in-vivo bioactivity and cell viability were assessed by XRD, SEM and TEM, FTIR, a simulated body fluid (SBF) test and a live/dead assay using MC3T3 osteoblast precursor cells, respectively. Naturally carbonated nanoparticles of HA with typically needle-like morphology were synthesised by the reported AP method. Initial pH was found to influence the crystallisation process and determine the CaP phase formed as well as the resultant particle and crystallite sizes. A marked change in particle morphology was also observed above pH 9. The use of toluene as a replacement solvent for water up to 60 % was found to reduce the crystallinity of as-synthesised HA. This has marked influence on the effect of ethanolamine (5 wt%), which was found to improve HA crystallinity. SEM and EDS were used to confirm the growth of carbonated apatite on the surface of HA pellets immersed in SBF for up to 28 days. Cell culture results revealed viable cells on all samples where pH was controlled and maintained at 10-11 during precipitation, including those that used ethanolamine and toluene in preparation. When the initial alkali pH was not maintained non-viable cells were observed on HA substrates.
C1 [Cox, Sophie C.; Mallick, Kajal K.] Univ Warwick, WMG, Coventry CV4 7AL, W Midlands, England.
   [Jamshidi, Parastoo; Grover, Liam M.] Univ Birmingham, Sch Chem Engn, Coventry B15 2TT, W Midlands, England.
RP Mallick, KK (reprint author), Univ Warwick, WMG, Coventry CV4 7AL, W Midlands, England.
EM s.cox.3@warwick.ac.uk; k.k.mallick@warwick.ac.uk
RI Grover, Liam/F-2713-2011
OI Grover, Liam/0000-0002-9774-7412; Cox, Sophie/0000-0003-4746-0322
CR Afshar A, 2003, MATER DESIGN, V24, P197, DOI 10.1016/S0261-3069(03)00003-7
   AOKI H, 1991, SCI MED APPL HYDROXY
   Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C
   BARRALET JE, 1993, BIOCERAMICS, V6, P179
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bohner M, 2000, INJURY, V31, pS37
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   Cao LY, 2005, CERAM INT, V31, P1041, DOI 10.1016/j.ceramint.2004.11.002
   Cardoso DA, 2012, J BIOMED MATER RES B, V100B, P2316, DOI 10.1002/jbm.b.32794
   Chen LA, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/10/105708
   Cunniffe GM, 2010, J BIOMED MATER RES A, V95A, P1142, DOI 10.1002/jbm.a.32931
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   DRIESSENS FCM, 1983, BIOCERAMICS CALCIUM, P1
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Girija EK, 2012, POWDER TECHNOL, V225, P190, DOI 10.1016/j.powtec.2012.04.007
   Gross KA, 1991, INT CERAMIC C AUSTCE, V90, P124
   Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf
   Jha LJ, 1997, J MATER SCI-MATER M, V8, P185, DOI 10.1023/A:1018531505484
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kong LB, 2002, J MATER SCI, V37, P1131, DOI 10.1023/A:1014355103125
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   LEGEROS RZ, 1978, CALC TISS RES, V26, P111, DOI 10.1007/BF02013245
   LeGeros RZ, 1999, AM J DENT, V12, P65
   Lim GK, 1997, BIOMATERIALS, V18, P1433, DOI 10.1016/S0142-9612(97)00081-1
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Liu DM, 1997, J MATER SCI-MATER M, V8, P227, DOI 10.1023/A:1018591724140
   Liu YK, 2009, J BIOMED MATER RES A, V90A, P1083, DOI 10.1002/jbm.a.32192
   Niu JL, 2007, BIOCERAMICS, V19, P247
   Panda RN, 2003, J PHYS CHEM SOLIDS, V64, P193, DOI 10.1016/S0022-3697(02)00257-3
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Pramanik S, 2007, CERAM INT, V33, P419, DOI 10.1016/j.ceramint.2005.10.025
   Rao RR, 1997, J MATER SCI-MATER M, V8, P511, DOI 10.1023/A:1018586412270
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Salimi MN, 2012, POWDER TECHNOL, V218, P109, DOI 10.1016/j.powtec.2011.11.049
   Santos Maria Helena, 2004, Mat. Res., V7, P625, DOI 10.1590/S1516-14392004000400017
   Shepherd JH, 2011, JOM-US, V63, P83, DOI 10.1007/s11837-011-0063-9
   Slosarczyk A, 2005, J MOL STRUCT, V744, P657, DOI 10.1016/j.molstruc.2004.11.078
   Wang PP, 2010, POWDER TECHNOL, V203, P315, DOI 10.1016/j.powtec.2010.05.023
   Wang YJ, 2006, NANOTECHNOLOGY, V17, P4405, DOI 10.1088/0957-4484/17/17/020
   Yang JH, 2011, J BIOMED MATER RES B, V99B, P150, DOI 10.1002/jbm.b.31882
   Yin G, 2002, CHEM ENG J, V87, P181, DOI 10.1016/S1385-8947(01)00248-0
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 48
TC 11
Z9 11
U1 2
U2 51
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2014
VL 25
IS 1
BP 37
EP 46
DI 10.1007/s10856-013-5042-y
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289CB
UT WOS:000329657900004
PM 24006049
DA 2018-10-20
ER

PT J
AU Blanquer, A
   Pellicer, E
   Hynowska, A
   Barrios, L
   Ibanez, E
   Baro, MD
   Sort, J
   Nogues, C
AF Blanquer, A.
   Pellicer, E.
   Hynowska, A.
   Barrios, L.
   Ibanez, E.
   Baro, M. D.
   Sort, J.
   Nogues, C.
TI In vitro biocompatibility assessment of Ti40Cu38Zr10Pd12 bulk metallic
   glass
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OSTEOBLASTIC CELLS; TITANIUM; CYTOTOXICITY; PROLIFERATION; ADHESION;
   BEHAVIOR; ALLOYS; FIBROBLASTS; MODULATION; MONOCYTES
AB The use of biocompatible materials has attained an increasing importance for tissue regeneration and transplantation. The excellent mechanical and corrosion properties of Ti40Cu38Zr10Pd12 bulk metallic glass (BMG) turn it into a potential candidate for its use in orthopaedic implants. Before being considered as a biomaterial, some biological parameters must be taken into account. In this study, mouse preosteoblasts were cultured in the presence or absence of the alloy at different times (24 h, 7 and 21 days) and no differences in cell viability were detected. Moreover, cells were able to adhere to the alloy surface by establishing focal contacts, and displayed a flattened polygonal morphology. After 14 days in culture, differentiation into osteoblasts was observed. Besides, the amount of Cu ions released and their potential toxic effects were analyzed, showing that the amount of Cu released did not increase cell death. Finally, the low levels of inflammatory cytokines secreted by THP-1 differentiated macrophages exposed to the alloy suggest the absence of an immunogenic response to the alloy. In conclusion, in vitro studies indicate that the Ti40Cu38Zr10Pd12 BMG could be considered as a biomaterial to be used in orthopaedic implants.
C1 [Blanquer, A.; Barrios, L.; Ibanez, E.; Nogues, C.] Univ Autonoma Barcelona, Dept Biol Cel Lular Fisiol & Immunol, Bellaterra 08193, Spain.
   [Pellicer, E.; Hynowska, A.; Baro, M. D.; Sort, J.] Univ Autonoma Barcelona, Dept Fis, Bellaterra 08193, Spain.
   [Sort, J.] Univ Autonoma Barcelona, ICREA, Bellaterra 08193, Spain.
RP Nogues, C (reprint author), Univ Autonoma Barcelona, Dept Biol Cel Lular Fisiol & Immunol, Edifici C, Bellaterra 08193, Spain.
EM eva.pellicer@uab.cat; carme.nogues@uab.cat
RI Sort, Jordi/F-6582-2014; Pellicer, Eva/G-2917-2014; Ibanez,
   Elena/K-4320-2014; Baro, Maria Dolors/A-2096-2009; Nogues,
   Carme/A-2339-2009; Barrios, Leonardo/L-3315-2014
OI Sort, Jordi/0000-0003-1213-3639; Pellicer, Eva/0000-0002-8901-0998;
   Ibanez, Elena/0000-0002-0275-6958; Baro, Maria
   Dolors/0000-0002-8636-1063; Nogues, Carme/0000-0002-6361-8559; Barrios,
   Leonardo/0000-0002-6151-8503; Blanquer, Andreu/0000-0002-3551-1885
FU Spanish Ministerio de Ciencia e Innovacion [TEC2011-29140-C03-03];
   Generalitat de Catalunya [2009-SGR-282, 2009-SGR-1292]; BioTiNet
   [FP7-PEOPLE-2010-ITN-264635]; Universitat Autonoma de Barcelona; ICREA
   ACADEMIA award; ICREA
FX This work has been partially financed by the Spanish Ministerio de
   Ciencia e Innovacion (TEC2011-29140-C03-03), the Generalitat de
   Catalunya (2009-SGR-282 and 2009-SGR-1292) and the
   FP7-PEOPLE-2010-ITN-264635 (BioTiNet). A. Blanquer was supported by a
   predoctoral grant from the Universitat Autonoma de Barcelona. M. D. Baro
   was partially supported by an ICREA ACADEMIA award.
CR Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051
   Bacakova L, 2008, CELL GROWTH PROCESSE, P5
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Blaine TA, 1997, J BONE JOINT SURG AM, V79A, P1519, DOI 10.2106/00004623-199710000-00009
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Dahotre NB, 2010, PHILOS T R SOC A, V368, P1863, DOI 10.1098/rsta.2010.0003
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Fornell J, 2011, J MECH BEHAV BIOMED, V4, P1709, DOI 10.1016/j.jmbbm.2011.05.028
   Contreras RG, 2010, IN VIVO, V24, P507
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gonzalez S, 2012, J MECH BEHAV BIOMED, V6, P53, DOI 10.1016/j.jmbbm.2011.09.014
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Huang L, 2011, ACTA BIOMATER, V7, P395, DOI 10.1016/j.actbio.2010.08.002
   Li L, 2012, J BIOMED MATER RES B, V100B, P934, DOI 10.1002/jbm.b.32655
   McGinley EL, 2011, DENT MATER, V27, P1295, DOI 10.1016/j.dental.2011.09.013
   Morita A, 2000, MAT SCI ENG A-STRUCT, V280, P208, DOI 10.1016/S0921-5093(99)00668-1
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Oak J.-J., 2009, J BIOMECHANICAL SCI, V4, P384, DOI DOI 10.1299/JBSE.4.384
   Pellicer E, 2013, J BIOMED MATER RES A, V101, P502, DOI 10.1002/jbm.a.34347
   Percy ME, 2011, J INORG BIOCHEM, V105, P1505, DOI 10.1016/j.jinorgbio.2011.08.001
   Pizzoferrato A, 2002, INTEGRATED BIOMATERIALS SCIENCE, P735, DOI 10.1007/0-306-47583-9_26
   Popp JR, 2011, J TISSUE ENG REGEN M, V5, P780, DOI 10.1002/term.376
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   Shimojo N, 2007, BIO-MED MATER ENG, V17, P127
   Thyssen JP, 2009, CHEM RES TOXICOL, V23, P309
   Valles G, 2006, BIOMATERIALS, V27, P5199, DOI 10.1016/j.biomaterials.2006.05.045
   Wang YB, 2011, J BIOMED MATER RES B, V96B, P34, DOI 10.1002/jbm.b.31725
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Wataha JC, 2004, J BIOMED MATER RES B, V69B, P11, DOI 10.1002/jbm.b.20029
   WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yamazaki T, 2006, IN VIVO, V20, P605
   Yamazaki T, 2012, IN VIVO, V26, P651
NR 34
TC 11
Z9 11
U1 0
U2 28
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2014
VL 25
IS 1
BP 163
EP 172
DI 10.1007/s10856-013-5041-z
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289CB
UT WOS:000329657900016
PM 24022801
DA 2018-10-20
ER

PT J
AU Liang, JI
   Lin, PC
   Chen, MY
   Hsieh, TH
   Chen, JJJ
   Yeh, ML
AF Liang, Jen-I
   Lin, Ping-Chia
   Chen, Meng-Yi
   Hsieh, Tsung-Hsun
   Chen, Jia-Jin Jason
   Yeh, Ming-Long
TI The effect of tenocyte/hyaluronic acid therapy on the early recovery of
   healing Achilles tendon in rats
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID AUTOLOGOUS TENOCYTE THERAPY; MESENCHYMAL STEM-CELLS; GAIT ANALYSIS;
   REPAIR; DEFECT; MODEL; TENDINOPATHY; HYALURONAN; RUPTURE; BIOMECHANICS
AB The aim of this study was to explore the potential for a better recovery outcome for the Achilles tendon at an early healing stage when a mixed biomaterial-tenocyte injection is used. The experimental animals underwent single limb Achilles tendon transection followed by suturing repair. A solution of either hyaluronic acid with or without tenocytes or normal saline was randomly chosen to be injected around the injury site after surgery. To obtain the comprehensive recovery condition of the rats on different management protocols, the animals were evaluated histologically, mechanically, and functionally. A significant difference in the recovery condition was found in the injured tendon injected with the hyaluronic acid solution with tenocytes compared with the other groups. Tendon stiffness and the locomotion abilities of the rats with healing Achilles tendons were improved in the hyaluronic acid with tenocyte transplantation group. The acceleration of the inflammatory phase in rats with the hyaluronic acid with tenocyte injections might be the major reason for the better functional outcomes.
C1 [Liang, Jen-I; Lin, Ping-Chia; Chen, Meng-Yi; Chen, Jia-Jin Jason; Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
   [Chen, Meng-Yi] China Med Univ, Beigang Hosp, Dept Orthoped, Yunlin, Taiwan.
   [Hsieh, Tsung-Hsun] Taipei Med Univ, Grad Inst Neural Regenerat Med, Taipei, Taiwan.
   [Chen, Jia-Jin Jason; Yeh, Ming-Long] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan.
RP Yeh, ML (reprint author), Natl Cheng Kung Univ, Dept Biomed Engn, 1 Univ Rd, Tainan 701, Taiwan.
EM mlyeh@mail.ncku.edu.tw
CR Ahmed Z, 2000, CELL MOTIL CYTOSKEL, V46, P6
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Chen JM, 2011, TISSUE ENG PT A, V17, P2037, DOI [10.1089/ten.tea.2010.0492, 10.1089/ten.TEA.2010.0492]
   Chen JM, 2007, TISSUE ENG, V13, P1479, DOI 10.1089/ten.2006.0266
   Chong AKS, 2007, J BONE JOINT SURG AM, V89A, P74, DOI 10.2106/JBJS.E.01396
   Clarke AW, 2011, AM J SPORT MED, V39, P614, DOI 10.1177/0363546510387095
   Clarke KA, 1999, PHYSIOL BEHAV, V66, P723, DOI 10.1016/S0031-9384(98)00343-6
   Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/036354650427689
   Gouwanda D, 2011, J BIOMECH, V44, P972, DOI 10.1016/j.jbiomech.2010.12.013
   HESS GP, 1989, SPORTS MED, V8, P371, DOI 10.2165/00007256-198908060-00005
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P369, DOI 10.1089/ten.2006.12.369
   Kirkendall DT, 1997, SCAND J MED SCI SPOR, V7, P62
   Krahe MA, 2009, FOOT ANKLE CLIN, V14, P247, DOI 10.1016/j.fcl.2009.04.003
   Kutty JK, 2007, BIOMATERIALS, V28, P4928, DOI 10.1016/j.biomaterials.2007.08.007
   Lee HY, 2012, MED BIOL ENG COMPUT, V50, P937, DOI 10.1007/s11517-012-0933-5
   Li R, 2012, J ORTHOP TRAUMA, V26, P689, DOI 10.1097/BOT.0b013e318266eb7e
   Liang JI, 2012, ANN BIOMED ENG, V40, P2532, DOI 10.1007/s10439-012-0619-z
   Liu W, 2006, TISSUE ENG, V12, P775, DOI 10.1089/ten.2006.12.775
   Machner A, 2003, ARTHRITIS RES THER, V5, pR253, DOI 10.1186/ar789
   MURRELL GAC, 1992, J ORTHOPAED RES, V10, P398, DOI 10.1002/jor.1100100313
   Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6
   OBRIEN M, 1992, CLIN SPORT MED, V11, P505
   OBrien M, 1997, SCAND J MED SCI SPOR, V7, P55
   Oshiro W, 2003, J HAND SURG-AM, V28A, P814, DOI 10.1053/S0363-5023(03)00366-6
   ROBINSON RO, 1987, J MANIP PHYSIOL THER, V10, P172
   See EKN, 2004, BRIT J SPORT MED, V38, P597, DOI 10.1136/bjsm.2003.007120
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Soldatis JJ, 1997, AM J SPORT MED, V25, P90, DOI 10.1177/036354659702500118
   Stoll C, 2011, BIOMATERIALS, V32, P4806, DOI 10.1016/j.biomaterials.2011.03.026
   WILLIAMS JGP, 1986, SPORTS MED, V3, P114, DOI 10.2165/00007256-198603020-00003
   Yeung CK, 2006, J ORTHOP RES, V24, P193, DOI 10.1002/jor.20020
   Yuan J, 2002, J ORTHOPAED RES, V20, P1372, DOI 10.1016/S0736-0266(02)00075-X
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 33
TC 7
Z9 7
U1 3
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2014
VL 25
IS 1
BP 217
EP 227
DI 10.1007/s10856-013-5036-9
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289CB
UT WOS:000329657900021
PM 24072390
DA 2018-10-20
ER

PT J
AU Fragoso, AS
   Silva, MB
   de Melo, CP
   Aguiar, JLA
   Rodrigues, CG
   de Medeiros, PL
   Branco, JF
   Andrade, CAS
   Oliveira, MDL
AF Fragoso, A. S.
   Silva, M. B.
   de Melo, C. P.
   Aguiar, J. L. A.
   Rodrigues, C. G.
   de Medeiros, P. L.
   Branco Junior, J. F.
   Andrade, C. A. S.
   Oliveira, M. D. L.
TI Dielectric study of the adhesion of mesenchymal stem cells from human
   umbilical cord on a sugarcane biopolymer
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; GROWTH; BIOMATERIALS;
   MECHANISMS; TISSUES
AB It is of current interest the identification of appropriate matrices for growing mesenchymal stem cells (MSC). These cells are able not only to regenerate themselves but also to differentiate into other type of functional cells, and so they have been extensively used in tissue engineering. In this work, we have evaluated the use of electric impedance spectroscopy (EIS) to follow the adhesion of MSC from Wharton's jelly of the human umbilical cord (hWJMSC) on sugarcane biopolymers (SCB). Impedance spectra of the systems were obtained in the frequency range of 10(2)-10(5) Hz. An EIS investigation showed that when deposited on a metallic electrode SCB films prevent the passage of electrons between the solution and the metallic interface. The impedance spectra of hWJMSCs adhered on SCB revealed that there is a significant increase in the magnitude of the impedance when compared to that of pure SCB. The corresponding resistance (real part of the impedance) was even higher for the SCB-hWJMSC system than for SCB without cells on their surface, in an indication of an increased blockage to the electron transfers. The resistance charge transfer is extracted by curve-fitting the impedance spectra to an equivalent circuit model. Also, a shift of the phase angle to higher frequencies was obtained for SCB-hWJMSC system as a result from hWJMSC adhesion. Our study demonstrates that EIS is an appropriate method to evaluate the adhesion of MSC. SCB can be considered as a promising biomaterial for tissue engineering.
C1 [Fragoso, A. S.; Oliveira, M. D. L.] Univ Fed Pernambuco, Programa Posgrad Ciencias Biol, BR-50670901 Recife, PE, Brazil.
   [Silva, M. B.; Rodrigues, C. G.; Branco Junior, J. F.] Univ Fed Pernambuco, Dept Biofis & Radiobiol, BR-50670901 Recife, PE, Brazil.
   [de Melo, C. P.] Univ Fed Pernambuco, Dept Fis, BR-50670901 Recife, PE, Brazil.
   [Aguiar, J. L. A.] Univ Fed Pernambuco, Dept Cirurgia, BR-50670901 Recife, PE, Brazil.
   [de Medeiros, P. L.] Univ Fed Pernambuco, Dept Histol & Embriol, BR-50670901 Recife, PE, Brazil.
   [Andrade, C. A. S.; Oliveira, M. D. L.] Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
RP Oliveira, MDL (reprint author), Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
EM m_danielly@yahoo.com.br
FU FACEPE; CNPq [310305/2012-8, 310361/2012-5]
FX We dedicated this work to Prof. Oleg V. Krasilnikov (in memoriam).
   Fragoso would like to thank FACEPE for a graduate scholarship. Andrade
   and Oliveira are also gratefully for CNPq financial support (Grant
   310305/2012-8 and 310361/2012-5, respectively). We thank the Hospital de
   Avila (Recife, PE) for providing human umbilical cord samples.
CR Aguiar José Lamartine de Andrade, 2007, Acta Cir. Bras., V22, P77, DOI 10.1590/S0102-86502007000700015
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Bacakova L, 2000, J BIOMED MATER RES, V49, P369, DOI 10.1002/(SICI)1097-4636(20000305)49:3<369::AID-JBM10>3.0.CO;2-W
   Bacakova L, 2000, BIOMATERIALS, V21, P1173, DOI 10.1016/S0142-9612(00)00009-0
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   BOUKAMP BA, 1986, SOLID STATE IONICS, V18-9, P136, DOI 10.1016/0167-2738(86)90100-1
   Chamberlain JR, 2004, SCIENCE, V303, P1198, DOI 10.1126/science.1088757
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Chung TW, 2011, CARBOHYD POLYM, V85, P726, DOI 10.1016/j.carbpol.2011.03.025
   Coelho Maria Cristina de Oliveira Cardoso, 2002, Acta Cir. Bras., V17, P11, DOI 10.1590/S0102-86502002000700003
   Collazos-Castro JE, 2010, BIOMATERIALS, V31, P9244, DOI 10.1016/j.biomaterials.2010.08.057
   Albuquerque Paulo Cezar Vidal Carneiro de, 2011, Rev. bras. ortop., V46, P577, DOI [10.1016/S2255-4971(15)30415-8, 10.1590/S0102-36162011000500016]
   de Carvalho AM, 2012, INT BRAZ J UROL, V38, P544, DOI 10.1590/S1677-55382012000400015
   Demetrescu I, 2010, BIOELECTROCHEMISTRY, V79, P122, DOI 10.1016/j.bioelechem.2010.02.001
   Gheorghe M, 2003, BIOSENS BIOELECTRON, V19, P95, DOI 10.1016/S0956-5663(03)00179-9
   Grinnemo KH, 2004, J THORAC CARDIOV SUR, V127, P1293, DOI 10.1016/j.jtcvs.2003.07.037
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Guo ML, 2006, BBA-GEN SUBJECTS, V1760, P432, DOI 10.1016/j.bbagen.2005.11.011
   Hou YX, 2006, BIOSENS BIOELECTRON, V21, P1393, DOI 10.1016/j.bios.2005.06.002
   Jiang XF, 2010, SENSOR ACTUAT B-CHEM, V149, P87, DOI 10.1016/j.snb.2010.06.026
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   Luna DMN, 2011, COLLOID SURFACE A, V373, P22, DOI 10.1016/j.colsurfa.2010.10.003
   Malmivuo JA, 1995, BIOELECTROMAGNETISM
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Navratilova I, 2004, BIOELECTROCHEMISTRY, V62, P11, DOI 10.1016/j.bioelechem.2003.10.004
   RANDLES JEB, 1947, DISCUSS FARADAY SOC, V1, P11, DOI 10.1039/df9470100011
   Reininger-Mack A, 2002, TRENDS BIOTECHNOL, V20, P56, DOI 10.1016/S0167-7799(01)01880-7
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2003, EUR CELLS MATER, V5, P39
   Sarro E, 2012, BIOSENS BIOELECTRON, V31, P257, DOI 10.1016/j.bios.2011.10.028
   SCHWAN HP, 1993, MED PROG TECHNOL, V19, P163
   Sengupta D, 2010, TISSUE ENG PART B-RE, V16, P285, DOI 10.1089/ten.teb.2009.0591
   Sharon N, 2002, CRIT REV FOOD SCI, V42, P267, DOI 10.1080/10408390209351914
   Silverstein R.M., 2006, IDENTIFICACAO ESPECT
   TRINKAUS JP, 1969, CELLS ORGANS
   Xue YD, 2011, ANAL BIOCHEM, V410, P92, DOI 10.1016/j.ab.2010.11.019
   YAMADA KM, 1989, FIBRONECTIN
NR 38
TC 10
Z9 11
U1 1
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2014
VL 25
IS 1
BP 229
EP 237
DI 10.1007/s10856-013-5056-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289CB
UT WOS:000329657900022
PM 24072391
DA 2018-10-20
ER

PT J
AU Kang, R
   Luo, YL
   Zou, LJ
   Xie, L
   Lysdahl, H
   Jiang, XM
   Chen, CY
   Bolund, L
   Chen, ML
   Besenbacher, F
   Bunger, C
AF Kang, Ran
   Luo, Yonglun
   Zou, Lijin
   Xie, Lin
   Lysdahl, Helle
   Jiang, Xiumei
   Chen, Chunying
   Bolund, Lars
   Chen, Menglin
   Besenbacher, Flemming
   Buenger, Cody
TI Osteogenesis of human induced pluripotent stem cells derived mesenchymal
   stem cells on hydroxyapatite contained nanofibers
SO RSC ADVANCES
LA English
DT Article
ID NANOPHASE HYDROXYAPATITE; SCAFFOLDS; DIFFERENTIATION; REGENERATION;
   BIOMATERIAL; MEMBRANE; GROWTH
AB Biomimetic nanofibrous scaffolds combined with stem cells are promising for bone tissue engineering. In the present study, we have employed nano-hydroxyapatite (nHAp) contained polycaprolactone (PCL) nanofibers as a biomimetic nanofibrous scaffold, and mesenchymal stem cells derived from human induced pluripotent stem cells (hiPS-MSCs) as the novel stem cells sources. The response of hiPS-MSCs on the nanofibrous scaffolds in terms of cell proliferation and differentiation into the osteoblastic phenotype was investigated by XTT assay, scanning electron microscopy (SEM), osteogenic genes expression (runt-related transcription factor 2 (RUNX2), alkaline phosphatase (ALP), collagen I (COL1A1), and osteocalcin (OC)), ALP activity, and calcium deposition. It is clearly shown that the hiPS-MSCs attached, and proliferated on the nanofibrous scaffolds. Compared with PCL nanofibers without nHAp, the cells on the nHAp contained nanofibers demonstrated superior capabilites to differentiate to form calcified extracellular matrix. Together with gene expression, all of the results indicate the great potential of the hiPS-MSCs seeded biomimetic nanofibrous scaffolds for bone regeneration in the future.
C1 [Kang, Ran; Zou, Lijin; Lysdahl, Helle; Buenger, Cody] Aarhus Univ Hosp, Orthopaed Res Lab, DK-8000 Aarhus C, Denmark.
   [Kang, Ran; Chen, Menglin; Besenbacher, Flemming] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.
   [Luo, Yonglun; Chen, Chunying; Bolund, Lars] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark.
   [Kang, Ran; Xie, Lin] Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing 210028, Jiangsu, Peoples R China.
   [Jiang, Xiumei] Natl Ctr Nanosci & Technol China, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
RP Kang, R (reprint author), Aarhus Univ Hosp, Orthopaed Res Lab, DK-8000 Aarhus C, Denmark.
EM alun@hum-gen.au.dk; menglin@inano.au.dk
OI Chen, Menglin/0000-0002-2721-651X
FU Danish Strategic Research Foundation on Project ElectroMed [11-115313];
   Velux [25906]; Lundberk Foundation; International cooperation; Natural
   Science Foundation of Jiansu province of PRC [BZ2011046, BK2012490]
FX The authors would like to thank Anette Baatrup for her great technical
   assistance. This project is supported by grants from Danish Strategic
   Research Foundation on Project ElectroMed (11-115313), Velux (25906),
   Lundberk Foundation, International cooperation and Natural Science
   Foundation of Jiansu province of PRC (BZ2011046, BK2012490).
CR Abdal-haya A, 2013, COLLOID SURFACE B, V102, P635, DOI 10.1016/j.colsurfb.2012.09.017
   Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503
   Bilousova G, 2011, STEM CELLS, V29, P206, DOI 10.1002/stem.566
   Carlson AL, 2012, FASEB J, V26, P3240, DOI 10.1096/fj.11-192732
   D'Anto V, 2016, J TISSUE ENG REGEN M, V10, pE147, DOI 10.1002/term.1768
   Diederichs S, 2013, BIOESSAYS, V35, P220, DOI 10.1002/bies.201200068
   Fox K, 2012, CHEMPHYSCHEM, V13, P2495, DOI 10.1002/cphc.201200080
   Fukunaga N, 2010, CELL REPROGRAM, V12, P369, DOI [10.1089/cell.2009.0097, 10.1089/cell.2009.0086]
   Giuliani M, 2011, BLOOD, V118, P3254, DOI 10.1182/blood-2010-12-325324
   Guo XY, 2007, J BIOMED MATER RES A, V82A, P1022, DOI 10.1002/jbm.a.31200
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6
   Keyser KA, 2007, CELL TRANSPLANT, V16, P555, DOI 10.3727/000000007783464939
   Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553
   Kuznetsov SA, 2011, STEM CELLS DEV, V20, P269, DOI 10.1089/scd.2009.0501
   Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5
   Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312
   Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033225
   Ozdemir T, 2013, CURR PHARM DESIGN, V19, P3446, DOI 10.2174/1381612811319190010
   Peng HJ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/48/485102
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Shafiee A, 2011, J BIOMED MATER RES A, V99A, P467, DOI 10.1002/jbm.a.33206
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   Sui G, 2007, J BIOMED MATER RES A, V82A, P445, DOI 10.1002/jbm.a.31166
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   van Manen E. H., 2012, ODONTOLOGY, V93, P1539
   Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084
   Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497
   Yen ML, 2011, CELL TRANSPLANT, V20, P1529, DOI 10.3727/096368910X564067
   Zakaria SM, 2013, TISSUE ENG PART B-RE, V19, P431, DOI [10.1089/ten.teb.2012.0624, 10.1089/ten.TEB.2012.0624]
   Zou LJ, 2013, SCI REP-UK, V3, DOI [10.1038/srep02243, 10.1038/srep03108]
NR 33
TC 15
Z9 15
U1 0
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 11
BP 5734
EP 5739
DI 10.1039/c3ra44181d
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 287ZA
UT WOS:000329579900058
DA 2018-10-20
ER

PT J
AU Kon, E
   Filardo, G
   Di Martino, A
   Busacca, M
   Moio, A
   Perdisa, F
   Marcacci, M
AF Kon, Elizaveta
   Filardo, Giuseppe
   Di Martino, Alessandro
   Busacca, Maurizio
   Moio, Antonio
   Perdisa, Francesco
   Marcacci, Maurilio
TI Clinical Results and MRI Evolution of a Nano-Composite Multilayered
   Biomaterial for Osteochondral Regeneration at 5 Years
SO AMERICAN JOURNAL OF SPORTS MEDICINE
LA English
DT Article
DE knee; articular cartilage; articular cartilage resurfacing; magnetic
   resonance imaging; osteochondral scaffold
ID CARTILAGE REPAIR; HYDROXYAPATITE SCAFFOLD; DEFECT REPAIR; SHEEP MODEL;
   FOLLOW-UP; DESIGN; TISSUE; PLUG; KNEE; SYSTEMS
AB Background: Several cartilage lesions involve the subchondral bone, and there is a need for biphasic scaffolds to treat the entire osteochondral unit to reproduce the different biological and functional requirements and guide the growth of the 2 tissues.
   Purpose: To evaluate the results of a cell-free collagen-hydroxyapatite osteochondral scaffold at midterm, and to use magnetic resonance imaging (MRI) analysis to document the imaging evolution of the tissue regeneration process through 5 years of follow-up.
   Study Design: Case series; Level of evidence, 4.
   Methods: Twenty-seven patients (9 women, 18 men; mean age, 34.9 10.2 years) treated for knee chondral or osteochondral lesions (size, 1.5-6 cm(2)) were followed for 2 and 5 years and were clinically evaluated using the International Knee Documentation Committee (IKDC) and Tegner scores. An MRI evaluation was performed at both follow-ups in 23 lesions, and the magnetic resonance observation of cartilage repair tissue (MOCART) score and specific subchondral bone parameters (bone regeneration, bone signal quality, osteophytes or upcoming bone front, sclerotic areas, and edema) were analyzed.
   Results: A statistically significant improvement in all clinical scores was observed from the initial evaluation to the 2- and 5-year follow-ups, and the results were stable over time. The mean IKDC subjective score improved from 40.0 +/- 15.0 to 76.5 +/- 14.5 (2-year follow-up) and 77.1 +/- 18.0 (5-year follow-up) and the mean Tegner score from 1.6 +/- 1.1 to 4.0 +/- 1.8 (2-year follow-up) and 4.1 +/- 1.9 (5-year follow-up). The MRI evaluation showed a significant improvement in both the MOCART score and subchondral bone status from 2 to 5 years. At 5 years, complete filling of the cartilage was shown in 78.3% of the lesions, complete integration of the graft was detected in 69.6% of cases, the repair tissue surface was intact in 60.9%, and the structure of the repair tissue was homogeneous in 60.9% of the cases. No correlation was found between MRI findings and clinical outcome.
   Conclusion: This osteochondral scaffold was used for the treatment of chondral and osteochondral knee defects with a single-step procedure. The study results highlighted the safety and potential of this procedure, which offered a good clinical outcome with stable results at midterm follow-up. Although the MRI findings improved over time, some abnormalities persisted, but no correlation was found between the imaging and clinical results.
C1 [Kon, Elizaveta; Filardo, Giuseppe; Di Martino, Alessandro; Busacca, Maurizio; Moio, Antonio; Perdisa, Francesco; Marcacci, Maurilio] Rizzoli Orthopaed Inst, I-40136 Bologna, Italy.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Biomech Lab, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it
OI Filardo, Giuseppe/0000-0002-8136-0977
FU European Union [278807]
FX The authors thank B. Di Matteo, G. Altadonna, L. Andriolo, S. Bassini,
   E. Ferretti, A. Montaperto, and F. Balboni (III Clinic, Biomechanics
   Laboratory, Rizzoli Orthopaedic Institute) and E. Pignotti and K. Smith
   (Task Force, Rizzoli Orthopaedic Institute). The research leading to
   these results has received funding from the European Union's Seventh
   Framework Programme (FP/2007-2013) under grant agreement number 278807.
CR Barber FA, 2011, ARTHROSCOPY, V27, P60, DOI 10.1016/j.arthro.2010.06.023
   Bedi A, 2010, CARTILAGE, V1, P20, DOI 10.1177/1947603509355970
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   de Windt TS, 2013, AM J SPORT MED, V41, P1695, DOI 10.1177/0363546512473258
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Filardo G, 2012, CARTILAGE, V3, P288, DOI 10.1177/1947603512436371
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Getgood AMJ, 2012, KNEE, V19, P422, DOI 10.1016/j.knee.2011.03.011
   Gille J, 2010, KNEE SURG SPORT TR A, V18, P1456, DOI 10.1007/s00167-010-1042-3
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   International Cartilage Repair Society, 2000, ICRS CART INJ EV PAC
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Joshi N, 2012, AM J SPORT MED, V40, P1289, DOI 10.1177/0363546512441585
   Khanarian NT, 2012, BIOMATERIALS, V33, P5247, DOI 10.1016/j.biomaterials.2012.03.076
   Kon E, 2011, EUR J RADIOL, V79, P382, DOI 10.1016/j.ejrad.2010.04.002
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2012, CURR REV MUSCULOSKE, V5, P236, DOI 10.1007/s12178-012-9135-x
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-220
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Marcacci M, 2013, KNEE SURG SPORTS TRA, DOI 10.1007/s00167-013-2388-0
   Marlovits S, 2006, EUR J RADIOL, V57, P1, DOI 10.1016/j.ejrad.2005.08.004
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   Melton JTK, 2010, EXPERT REV MED DEVIC, V7, P333, DOI 10.1586/ERD.10.15
   Panni AS, 2011, INT J IMMUNOPATH PH, V24, P149, DOI 10.1177/03946320110241S228
   Pape D, 2010, KNEE SURG SPORT TR A, V18, P448, DOI 10.1007/s00167-010-1052-1
   Pascarella A, 2010, KNEE SURG SPORT TR A, V18, P509, DOI 10.1007/s00167-009-1007-6
   Patrascu JM, 2010, J BONE JOINT SURG BR, V92B, P1160, DOI 10.1302/0301-620X.92B8.24341
   Reyes R., 2012, J TISSUE ENG REGEN M, DOI 10.1002/term.1549
   Schumann Detlef, 2007, V140, P101
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43
   Williams Riley J, 2008, Instr Course Lect, V57, P563
NR 38
TC 51
Z9 51
U1 1
U2 12
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0363-5465
EI 1552-3365
J9 AM J SPORT MED
JI Am. J. Sports Med.
PD JAN
PY 2014
VL 42
IS 1
BP 158
EP 165
DI 10.1177/0363546513505434
PG 8
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA 284NI
UT WOS:000329325600026
PM 24114751
DA 2018-10-20
ER

PT J
AU Wu, J
   Zheng, YD
   Yang, Z
   Lin, QH
   Qiao, K
   Chen, XH
   Peng, Y
AF Wu, Jian
   Zheng, Yudong
   Yang, Zhou
   Lin, Qinhua
   Qiao, Kun
   Chen, Xiaohua
   Peng, Yan
TI Influence of dialdehyde bacterial cellulose with the nonlinear
   elasticity and topology structure of ECM on cell adhesion and
   proliferation
SO RSC ADVANCES
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; MECHANICAL STIMULATION; SCAFFOLDS;
   DIFFERENTIATION; COMPOSITES; CONSTRUCTS; STIFFNESS; NETWORKS
AB Bacterial cellulose (BC) has attracted much attention as a novel biomaterial recently. In this work, the special chemical structure, topology structure and mechanical behavior of C2, 3-oxidized dialdehyde BC (DBC) were investigated. The DBC was prepared from the selective-oxidation of BC with sodium periodate. DBC membranes show obvious shrinkage in 2D direction with no significant changes in thickness. Similar to elastins, DBC exhibits a typical nonlinear elasticity, it can return to its original shape as soon as the deformation force is removed. Similarly to elastin, DBC exhibits a typical nonlinear elastic behavior. It can return to its original shape as soon as the deformation force is removed, and this nonlinear elastic behavior is typical for fiber networks in general. DBC has a nano-fiber network topology structure that is similar to the extracellular matrix. Moreover, the reaction between cell-surface proteins and aldehydes of DBC is conducive to the adhesion and proliferation of cells within the DBC networks. In general, the nonlinear elasticity, topology structure and cell adhesion of DBC were similar to the extracellular matrix. This demonstrates the potential of using DBC as a material in the repair process of injured tissues.
C1 [Wu, Jian; Zheng, Yudong; Yang, Zhou; Lin, Qinhua; Qiao, Kun] Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
   [Chen, Xiaohua] Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Beijing 100083, Peoples R China.
   [Peng, Yan] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China.
RP Zheng, YD (reprint author), Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
EM zhengyudong@mater.ustb.edu.cn
RI Yang, Zhou/H-9169-2017
OI Yang, Zhou/0000-0003-1229-3739
FU National Natural Science Foundation of China [51073024, 51273021];
   National Science and Technology Support Project of China [2011BAK15B04]
FX This study is financially supported by National Natural Science
   Foundation of China Project (Grant no. 51073024 and Grant no. 51273021),
   and the National Science and Technology Support Project of China (Grant
   no. 2011BAK15B04).
CR Alberts B., 2008, MOL BIOL CELL
   Brown A. J., 1886, J CHEM SOC, V49, P172, DOI DOI 10.1039/CT8864900172
   Chen SY, 2010, J APPL POLYM SCI, V117, P8, DOI 10.1002/app.31477
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   D'Amore A, 2010, BIOMATERIALS, V31, P5345, DOI 10.1016/j.biomaterials.2010.03.052
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Erk KA, 2010, BIOMACROMOLECULES, V11, P1358, DOI 10.1021/bm100136y
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gea S, 2010, MATER LETT, V64, P901, DOI 10.1016/j.matlet.2010.01.042
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Hu WL, 2011, CARBOHYD POLYM, V83, P1575, DOI 10.1016/j.carbpol.2010.10.016
   ISOGAI A, 1989, MACROMOLECULES, V22, P3168, DOI 10.1021/ma00197a045
   Jian W., 2013, CHEM J CHINESE U, V34, P210
   Joseleau JP, 2008, BIOMACROMOLECULES, V9, P767, DOI 10.1021/bm7011339
   KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim UJ, 2000, BIOMACROMOLECULES, V1, P488, DOI 10.1021/bm0000337
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Koch J. R., 1977, PLAST RECONSTR SURG, V99, P1094
   Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004
   Kuo YC, 2012, BIOMATERIALS, V33, P8955, DOI 10.1016/j.biomaterials.2012.08.073
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Li J, 2009, MAT SCI ENG C-BIO S, V29, P1635, DOI 10.1016/j.msec.2009.01.006
   MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425
   Mancini R., 1963, PLAST RECONSTR SURG, V32, P579
   Muangman Pornprom, 2011, J Am Col Certif Wound Spec, V3, P16, DOI 10.1016/j.jcws.2011.04.001
   Nirmalanandhan VS, 2007, J BIOMECH ENG-T ASME, V129, P919, DOI 10.1115/1.2800828
   Quero F, 2010, ACS APPL MATER INTER, V2, P321, DOI 10.1021/am900817f
   SANDERSO.CJ, 1971, IMMUNOLOGY, V20, P1061
   Schlufter K, 2010, MACROMOL SY, V294-II, P117, DOI 10.1002/masy.200900054
   Shearn JT, 2007, J BIOMECH ENG-T ASME, V129, P848, DOI 10.1115/1.2800769
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Varavinit S, 2001, WORLD J MICROB BIOT, V17, P721, DOI 10.1023/A:1012984802624
   Wang G, 2010, ACTA BIOMATER, V6, P3630, DOI 10.1016/j.actbio.2010.03.039
   Ward I. M., 2012, MECH PROPERTIES SOLI
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   YOSHINO K, 1990, J APPL PHYS, V68, P1720, DOI 10.1063/1.346600
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
   Zhang HJ, 2011, BIOMATERIALS, V32, P1906, DOI 10.1016/j.biomaterials.2010.11.027
NR 39
TC 22
Z9 23
U1 1
U2 46
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 8
BP 3998
EP 4009
DI 10.1039/c3ra45407j
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA 280ON
UT WOS:000329040500042
DA 2018-10-20
ER

PT J
AU Zeng, Y
   Li, W
   Zhang, HH
   Wu, X
   Sun, W
   Zhu, ZH
   Yu, Y
AF Zeng, Yan
   Li, Wei
   Zhang, Huanhuan
   Wu, Xu
   Sun, Wei
   Zhu, Zhihong
   Yu, Ying
TI Application of flower-like SnS2 nanoparticles for direct
   electrochemistry of hemoglobin and its electrocatalysis
SO ANALYTICAL METHODS
LA English
DT Article
ID IONIC LIQUID ELECTRODE; AGAROSE HYDROGEL FILMS; CARBON NANOTUBES;
   MULTILAYER FILMS; GLUCOSE-OXIDASE; COMPOSITE FILM; MYOGLOBIN;
   TETRAFLUOROBORATE; NANOCOMPOSITES; FABRICATION
AB Flower-like SnS2 nanoparticles were synthesized through a hydrothermal process. By combing with hemoglobin (Hb) and the ionic liquid (IL) 1-butyl-3-methyl-imidazolium tetrafluoroborate ([BMIM]BF4), a composite biomaterial was fabricated and further used to modify a carbon ionic liquid electrode (CILE) with Nafion as a film-forming material. FT-IR and UV-Vis spectroscopic results showed that Hb retained its native structure in the composite. With the synergistic effects of the SnS2 nanoflower and IL, a couple of well-defined redox peaks of Hb appeared in the cyclic voltammogram of Nafion/Hb-SnS2-IL/CILE, which indicated that direct electron transfer between Hb and the underlying electrode was realized. The electrochemical behavior of Hb on the modified electrode was investigated by cyclic voltammetry with the electrochemical parameters such as electron transfer coefficient (a), electron transfer number (n) and heterogeneous electron transfer rate constant (k(s)) calculated. The fabricated electrode showed good electrocatalytic ability for the reduction of trichloroacetic acid (TCA) with a wider linear range from 0.8 to 21.0 mM and a lower detection limit of 0.27 mM (S/N-3), indicating its potential application for the construction of a novel third-generation electrochemical biosensor.
C1 [Zeng, Yan; Li, Wei; Zhang, Huanhuan; Wu, Xu; Zhu, Zhihong; Yu, Ying] Cent China Normal Univ, Coll Phys Sci & Technol, Inst Nanosci & Nanotechnol, Wuhan 430079, Peoples R China.
   [Sun, Wei] Hainan Normal Univ, Coll Chem & Chem Engn, Haikou 571158, Peoples R China.
RP Zhu, ZH (reprint author), Cent China Normal Univ, Coll Phys Sci & Technol, Inst Nanosci & Nanotechnol, Wuhan 430079, Peoples R China.
EM zhzhu@phy.ccnu.cn; yuying@phy.ccnu.edu.cn
FU CCNU from the colleges' basic research and operation of MOE
   [CCNU12A05021]; Key Laboratory of Analytical Chemistry for Biology and
   Medicine (Wuhan University) of the Ministry of Education [ACBM2010006];
   Key Project of Natural Science Foundation of Hubei Province
   [2011CDA092]; Natural Science Foundation of Hainan Province [213015]
FX We are grateful for the financial support of the self-determined
   research funds of CCNU from the colleges' basic research and operation
   of MOE (CCNU12A05021), the Key Laboratory of Analytical Chemistry for
   Biology and Medicine (Wuhan University) of the Ministry of Education
   (ACBM2010006), the National Natural Science Foundation of China (no.
   50802032), the Key Project of Natural Science Foundation of Hubei
   Province (no. 2011CDA092) and the Natural Science Foundation of Hainan
   Province (213015).
CR Cape JN, 2006, ENVIRON SCI POLLUT R, V13, P276, DOI 10.1065/espr2005.12.286
   Ding SF, 2007, ELECTROCHEM COMMUN, V9, P216, DOI 10.1016/j.elecom.2006.09.007
   Fan CH, 2000, ELECTROANAL, V12, P1156, DOI 10.1002/1521-4109(200010)12:14<1156::AID-ELAN1156>3.0.CO;2-4
   Feher E, 2007, BIOCHEM SOC T, V35, P1624, DOI 10.1042/BST0351624
   Galinski M, 2006, ELECTROCHIM ACTA, V51, P5567, DOI 10.1016/j.electacta.2006.03.016
   Gao YC, 2011, ANAL METHODS-UK, V3, P2387, DOI 10.1039/c1ay05378g
   Guo CX, 2011, CHEM COMMUN, V47, P2652, DOI 10.1039/c0cc04542j
   Guo CX, 2010, ELECTROCHEM COMMUN, V12, P1237, DOI 10.1016/j.elecom.2010.06.028
   KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634
   Ke Y, 2012, RSC ADV, V2, P5676, DOI 10.1039/c2ra20362f
   KUHN R, 1990, WATER RES, V24, P31, DOI 10.1016/0043-1354(90)90061-A
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Lei YQ, 2009, J PHYS CHEM C, V113, P1280, DOI 10.1021/jp8079974
   Li J, 2013, BIOSENS BIOELECTRON, V41, P698, DOI 10.1016/j.bios.2012.09.059
   Li MF, 2008, BIOELECTROCHEMISTRY, V74, P217, DOI 10.1016/j.bioelechem.2008.08.004
   Li R, 2013, ELECTROCHIM ACTA, V95, P71, DOI 10.1016/j.electacta.2013.02.048
   Liu GD, 2007, ELECTROANAL, V19, P777, DOI 10.1002/elan.200603787
   Liu H, 2013, J MOL CATAL A-CHEM, V378, P285, DOI 10.1016/j.molcata.2013.06.021
   Liu KP, 2010, ELECTROCHEM COMMUN, V12, P402, DOI 10.1016/j.elecom.2010.01.004
   Lu HY, 2006, J PHYS CHEM B, V110, P23710, DOI 10.1021/jp063550d
   Pan Y, 2013, J APPL POLYM SCI, V128, P647, DOI 10.1002/app.38216
   Pan ZQ, 2012, SENSOR ACTUAT B-CHEM, V174, P421, DOI 10.1016/j.snb.2012.08.069
   RUSLING JF, 1993, J AM CHEM SOC, V115, P11891, DOI 10.1021/ja00078a030
   Sun P, 2010, ANAL CHIM ACTA, V661, P1, DOI 10.1016/j.aca.2009.12.007
   Sun W, 2008, ELECTROCHIM ACTA, V53, P8217, DOI 10.1016/j.electacta.2008.06.021
   Sun W, 2013, COLLOID SURFACE B, V101, P177, DOI 10.1016/j.colsurfb.2012.06.010
   Tan SW, 2011, ANAL METHODS-UK, V3, P110, DOI 10.1039/c0ay00505c
   Umar A, 2013, TALANTA, V114, P183, DOI 10.1016/j.talanta.2013.03.050
   Wang B, 2012, MAT SCI ENG C-MATER, V32, P2280, DOI 10.1016/j.msec.2012.06.015
   Wang GF, 2011, ANAL METHODS-UK, V3, P2475, DOI 10.1039/c1ay05404j
   Wang J, 2005, ANALYST, V130, P421, DOI 10.1039/b414248a
   Wang SF, 2005, LANGMUIR, V21, P9260, DOI 10.1021/la050947k
   Wang SF, 2007, ELECTROCHEM COMMUN, V9, P1709, DOI 10.1016/j.elecom.2007.03.018
   Wang Y. H., 2008, MICROCHIM ACTA, V164, P41
   Wright JM, 2004, ENVIRON HEALTH PERSP, V112, P920, DOI 10.1289/ehp.6779
   Xiao YH, 2008, ELECTROANAL, V20, P648, DOI 10.1002/elan.200704125
   Yang ZJ, 2011, BIOSENS BIOELECTRON, V26, P4337, DOI 10.1016/j.bios.2011.04.031
   Zhao YD, 2005, TALANTA, V65, P489, DOI 10.1016/j.talanta.2004.06.028
   Zhu ZH, 2011, J PHYS CHEM C, V115, P12547, DOI 10.1021/jp202500n
   Zhu ZH, 2011, BIOSENS BIOELECTRON, V26, P2119, DOI 10.1016/j.bios.2010.09.017
   Zhu ZH, 2010, BIOSENS BIOELECTRON, V25, P2313, DOI 10.1016/j.bios.2010.03.019
NR 41
TC 10
Z9 10
U1 7
U2 79
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9660
EI 1759-9679
J9 ANAL METHODS-UK
JI Anal. Methods
PY 2014
VL 6
IS 2
BP 404
EP 409
DI 10.1039/c3ay41644e
PG 6
WC Chemistry, Analytical; Food Science & Technology; Spectroscopy
SC Chemistry; Food Science & Technology; Spectroscopy
GA 281AP
UT WOS:000329072200011
DA 2018-10-20
ER

PT J
AU Janssen, NG
   Weijs, WLJ
   Koole, R
   Rosenberg, AJWP
   Meijer, GJ
AF Janssen, Nard G.
   Weijs, Willem L. J.
   Koole, Ronald
   Rosenberg, Antoine J. W. P.
   Meijer, Gert J.
TI Tissue engineering strategies for alveolar cleft reconstruction: a
   systematic review of the literature
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Review
DE Alveolar cleft grafting; Tissue engineering; Bone substitute;
   Biomaterial
ID BONE MORPHOGENETIC PROTEIN-2; AUTOGENOUS BONE; PALATE PATIENTS; ILIAC
   CREST; DONOR SITE; RESIDUAL ALVEOLAR; REDUCED MORBIDITY; UNILATERAL
   CLEFTS; MAXILLARY GROWTH; SECONDARY
AB To date, a great number of tissue engineering strategies have been suggested for alveolar cleft reconstruction; however, autologous bone grafting seems to remain the golden standard.
   A systematic review of the literature was conducted in order to evaluate the clinical evidence pertaining to enhancement or replacement of the autologous bone graft in the alveolar cleft by means of tissue-engineered substitutes; 16 articles were selected for analysis.
   Tissue engineering strategies for alveolar cleft grafting included enhancing the autologous bone graft by means of platelet-rich plasma addition, the use of barrier membranes and fibrin glue, extension of the autologous graft with calcium phosphate scaffolds, and replacement of the graft using bone morphogenetic protein-2, mesenchymal stem cells, or calcium phosphate scaffolds.
   Selected articles showed a vast heterogeneity in data acquisition and patient selection. Therefore, a meta-analysis could not be performed. Future publications concerning this topic should be methodologically sound and preferably use three-dimensional radiological imaging for pre- and postoperative results.
   Bypassing or enhancing autologous bone grafting by means of tissue engineering solutions has become an important topic in alveolar cleft grafting. Replacement of the autologous bone graft will result in absence of donor site morbidity in this predominantly young population.
C1 [Janssen, Nard G.; Koole, Ronald; Rosenberg, Antoine J. W. P.] Univ Utrecht, Med Ctr, Dept Oral & Maxillofacial Surg, Utrecht, Netherlands.
   [Weijs, Willem L. J.; Meijer, Gert J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands.
   [Meijer, Gert J.] Radboud Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, NL-6525 ED Nijmegen, Netherlands.
RP Janssen, NG (reprint author), Univ Utrecht, Med Ctr, Dept Oral & Maxillofacial Surg, Utrecht, Netherlands.
EM n.g.janssen-2@umcutrecht.nl
RI Weijs, W.L.J./L-4749-2015; Meijer, G.J./H-8073-2014
CR Alonso N, 2010, TISSUE ENG PART C-ME, V16, P1183, DOI [10.1089/ten.tec.2009.0824, 10.1089/ten.TEC.2009.0824]
   Beirne JC, 1996, INT J ORAL MAX SURG, V25, P268, DOI 10.1016/S0901-5027(06)80053-6
   Benlidayi ME, 2012, J ORAL MAXIL SURG, V70, pE95, DOI 10.1016/j.joms.2011.08.041
   BERGLAND O, 1986, CLEFT PALATE J, V23, P175
   Booij A, 2005, CLEFT PALATE-CRAN J, V42, P533, DOI 10.1597/03-158.1
   BOYNE PJ, 1976, AM J ORTHOD DENTOFAC, V70, P20, DOI 10.1016/0002-9416(76)90258-X
   BOYNE PJ, 1972, J ORAL SURG, V30, P87
   BRATTSTROM V, 1991, SCAND J PLAST RECONS, V25, P259, DOI 10.3109/02844319109020630
   CANADY JW, 1993, CLEFT PALATE-CRAN J, V30, P579, DOI 10.1597/1545-1569(1993)030<0579:SOTICA>2.3.CO;2
   Clavijo-Alvarez JA, 2010, CLEFT PALATE-CRAN J, V47, P116, DOI 10.1597/09-029.1
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Dempf R, 2002, CLEFT PALATE-CRAN J, V39, P18, DOI 10.1597/1545-1569(2002)039<0018:ABGIPW>2.0.CO;2
   Dickinson BP, 2008, PLAST RECONSTR SURG, V121, P209, DOI 10.1097/01.prs.0000293870.64781.12
   Duskova M, 2006, J CRANIOFAC SURG, V17, P1153, DOI 10.1097/01.scs.0000236435.90097.7b
   ENEMARK H, 1987, J ORAL MAXIL SURG, V45, P913, DOI 10.1016/0278-2391(87)90439-3
   Enemark H, 2001, CLEFT PALATE-CRAN J, V38, P155, DOI 10.1597/1545-1569(2001)038<0155:MBGMFR>2.0.CO;2
   Feichtinger M, 2007, CLEFT PALATE-CRAN J, V44, P142, DOI 10.1597/06-047.1
   FREIHOFER HPM, 1993, J CRANIO MAXILL SURG, V21, P143, DOI 10.1016/S1010-5182(05)80102-7
   Gimbel M, 2007, J CRANIOFAC SURG, V18, P895, DOI 10.1097/scs.0b013e3180a771af
   Herford AS, 2007, J ORAL MAXIL SURG, V65, P2136, DOI 10.1016/j.jams.2007.06.670
   HOPPENREIJS TJM, 1992, J CRANIO MAXILL SURG, V20, P119, DOI 10.1016/S1010-5182(05)80093-9
   KOOLE R, 1994, CLEFT PALATE-CRAN J, V31, P217, DOI 10.1597/1545-1569(1994)031<0217:EMSBGA>2.3.CO;2
   Koong B, 2010, CLIN ORAL IMPLAN RES, V21, P1201, DOI 10.1111/j.1600-0501.2010.01996.x
   Lee C, 2009, INT J ORAL MAX SURG, V38, P117, DOI 10.1016/j.ijom.2008.11.019
   Luaces-Rey R, 2010, MED ORAL PATOL ORAL, V15, pE619, DOI 10.4317/medoral.15.e619
   Marukawa E, 2010, J CRANIOMAXILLOFAC S, V39, P278
   Matic DB, 2008, PLAST RECONSTR SURG, V121, P1343, DOI 10.1097/01.prs.0000304604.89450.ae
   Meazzini MC, 2007, PLAST RECONSTR SURG, V119, P1527, DOI 10.1097/01.prs.0000256064.74938.72
   Mendez R, 2006, Cir Pediatr, V19, P23
   Mikoya T, 2010, CLEFT PALATE-CRAN J, V47, P454, DOI 10.1597/09-172
   Newlands LC, 2000, BRIT J ORAL MAX SURG, V38, P488, DOI 10.1054/bjom.2000.0300
   O'Hara C, 2004, 73 ANN M AM SOC PLAS
   Oyama T, 2004, J ORAL MAXIL SURG, V62, P555, DOI 10.1016/j.joms.2003.08.023
   Peled M, 2005, CLEFT PALATE-CRAN J, V42, P344, DOI 10.1597/03-141.1
   Sato Y, 2008, PLAST RECONSTR SURG, V121, P1356, DOI 10.1097/01.prs.0000302461.56820.c9
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Segura-Castillo JL, 2005, J CRANIOFAC SURG, V16, P105, DOI 10.1097/00001665-200501000-00020
   SEMB G, 1988, CLEFT PALATE J, V25, P288
   Stellmach R, 1993, Fortschr Kiefer Gesichtschir, V38, P11
   Swan MC, 2006, BRIT J ORAL MAX SURG, V44, P129, DOI 10.1016/j.bjoms.2005.04.015
   THILANDER B, 1974, SCAND J PLAST RECONS, V8, P52, DOI 10.3109/02844317409084371
   Thuaksuban N, 2010, INT J ORAL MAX SURG, V39, P1175, DOI 10.1016/j.ijom.2010.07.008
   Weibull L, 2009, CLIN IMPLANT DENT R, V11, P149, DOI 10.1111/j.1708-8208.2008.00102.x
   Weijs WLJ, 2010, INT J ORAL MAX SURG, V39, P424, DOI 10.1016/j.ijom.2010.02.004
   Williams A, 2003, EUR J ORTHODONT, V25, P205, DOI 10.1093/ejo/25.2.205
   Woo EJ, 2012, J ORAL MAXIL SURG, V70, P765, DOI 10.1016/j.joms.2011.09.008
NR 46
TC 17
Z9 18
U1 1
U2 26
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD JAN
PY 2014
VL 18
IS 1
BP 219
EP 226
DI 10.1007/s00784-013-0947-x
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 281IP
UT WOS:000329094500024
PM 23430342
DA 2018-10-20
ER

PT J
AU Bedouet, L
   Moine, L
   Pascale, F
   Nguyen, VN
   Labarre, D
   Laurent, A
AF Bedouet, Laurent
   Moine, Laurence
   Pascale, Florentina
   Van-Nga Nguyen
   Labarre, Denis
   Laurent, Alexandre
TI Synthesis of hydrophilic intra-articular microspheres conjugated to
   ibuprofen and evaluation of anti-inflammatory activity on articular
   explants
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article; Proceedings Paper
CT Public Engagement Workshop on How to Improve Medicines for Older People
CY JUL 02-02, 2013
CL London, ENGLAND
DE DDS; Hydrogel; Ibuprofen; Microspheres; Osteoarthritis; Prodrug
ID BIOMATERIAL SURFACE-CHEMISTRY; IN-VITRO; DRUG-DELIVERY; HYDROGEL
   MICROSPHERES; VIVO EVALUATION; SYNOVIAL-FLUID; RELEASE; OSTEOARTHRITIS;
   DEGRADATION; POLYESTERS
AB The main limitation of current microspheres for intra-articular delivery of non-steroidal anti-inflammatory drugs (NSAIDs) is a significant initial burst release, which prevents a long-term drug delivery. In order to get a sustained delivery of NSAIDs without burst, hydrogel degradable microspheres were prepared by co-polymerization of a methacrylic derivative of ibuprofen with oligo(ethylene-glycol) methacrylate and poly(PLGA-PEG) dimethacrylate as degradable crosslinker. Microspheres (40-100 mu m) gave a low yield of ibuprofen release in saline buffer (approximate to 2% after 3 months). Mass spectrometry analysis confirmed that intact ibuprofen was regenerated indicating that ester hydrolysis occurred at the carboxylic acid position of ibuprofen. Dialysis of release medium followed by alkaline hydrolysis show that in saline buffer ester hydrolysis occurred at other positions in the polymer matrix leading to the release of water-soluble polymers (>6-8000 Da) conjugated with ibuprofen showing that degradation and drug release are simultaneous. By considering the free and conjugated ibuprofen, 13% of the drug is released in 3 months. In vitro, ibuprofen-loaded MS inhibited the synthesis of prostaglandin E2 in articular cartilage and capsule explants challenged with lipopolysaccharides. Covalent attachment of ibuprofen to PEG-hydrogel MS suppresses the burst release and allows a slow drug delivery for months and the cyclooxygenase-inhibition property of regenerated ibuprofen is preserved. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Bedouet, Laurent; Laurent, Alexandre] Archimed, Occlugel, F-78350 Jouy En Josas, France.
   [Moine, Laurence; Van-Nga Nguyen; Labarre, Denis] Univ Paris 11, Fac Pharm, UMR CNRS 8612, IFR ITFM 141, F-92296 Chatenay Malabry, France.
   [Pascale, Florentina; Laurent, Alexandre] INRA, Ctr Res Intervent Imaging CR2i, AP HP, F-78352 Jouy En Josas, France.
   [Laurent, Alexandre] Hop Lariboisiere, AP HP, Dept Intervent Neuroradiol, F-75475 Paris 10, France.
RP Laurent, A (reprint author), Univ Paris 07, Hop Lariboisiere, AP HP, Fac Med, 2 Rue Ambroise Pare, F-75010 Paris, France.
EM alex.laurent@lrb.aphp.fr
OI Moine, Laurence/0000-0003-3306-9795
CR Amin S, 2009, SCI RES ESSAYS, V4, P1175
   Babazadeh M, 2008, INT J PHARMACEUT, V356, P167, DOI 10.1016/j.ijpharm.2008.01.003
   Babazadeh M, 2007, J APPL POLYM SCI, V104, P2403, DOI 10.1002/app.25913
   Babazadeh M, 2006, INT J PHARMACEUT, V316, P68, DOI 10.1016/j.ijpharm.2006.02.032
   Bedouet L, 2013, INT J PHARMACEUT, V456, P536, DOI 10.1016/j.ijpharm.2013.08.016
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Butoescu N, 2009, EUR J PHARM BIOPHARM, V73, P205, DOI 10.1016/j.ejpb.2009.06.009
   Censi R, 2010, BIOMACROMOLECULES, V11, P2143, DOI 10.1021/bm100514p
   Dajani EZ, 2008, J PHYSIOL PHARMACOL, V59, P117
   Fernandez-Carballido A, 2004, INT J PHARMACEUT, V279, P33, DOI 10.1016/j.ijpharm.2004.04.003
   Gerwin N, 2006, ADV DRUG DELIVER REV, V58, P226, DOI 10.1016/j.addr.2006.01.018
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Inoue A, 2006, ARTHRITIS RHEUM-US, V54, P264, DOI 10.1002/art.21561
   Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742
   Larsen C, 2008, J PHARM SCI-US, V97, P4622, DOI 10.1002/jps.21346
   Li B, 2007, BIOCHEM PHARMACOL, V70, P1673
   Lu Y, 2007, J MICROENCAPSUL, V24, P515, DOI 10.1080/02652040701433479
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   MAKELA AL, 1981, SCAND J RHEUMATOL, P15
   Martel-Pelletier J, 2003, SEMIN ARTHRITIS RHEU, V33, P155, DOI 10.1016/S0049-0172(03)00134-3
   MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693
   Mizrahi B, 2009, AAPS PHARMSCITECH, V10, P453, DOI 10.1208/s12249-009-9228-z
   Moodley I, 2008, CARDIOVASC J AFR, V19, P102
   NETTER P, 1989, CLIN PHARMACOKINET, V17, P145, DOI 10.2165/00003088-198917030-00002
   Panusa A, 2007, J PHARMACEUT BIOMED, V43, P1221, DOI 10.1016/j.jpba.2006.10.012
   Peng YS, 2006, EUR J PHARM SCI, V29, P60, DOI 10.1016/j.ejps.2006.05.010
   Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886
   Rimoli MG, 1999, J CONTROL RELEASE, V58, P61, DOI 10.1016/S0168-3659(98)00129-1
   Rosario-Melendez R, 2013, BIOMACROMOLECULES, V14, P3542, DOI 10.1021/bm400889a
   Thakkar H, 2004, J DRUG TARGET, V12, P549, DOI 10.1080/10611860400010630
   Thompson CJ, 2008, DRUG DEV IND PHARM, V34, P877, DOI [10.1080/03639040801929075, 10.1080/03639040801929075 ]
   Thompson CJ, 2009, J MICROENCAPSUL, V26, P676, DOI 10.3109/02652040802656333
   Tuncay M, 2000, INT J PHARM, V195, P179, DOI 10.1016/S0378-5173(99)00394-4
   Nguyen VN, 2013, SOFT MATTER, V9, P1929, DOI 10.1039/c2sm27066h
   Wang HY, 2010, BIOMACROMOLECULES, V11, P3290, DOI 10.1021/bm100712k
NR 35
TC 19
Z9 20
U1 0
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD JAN 1
PY 2014
VL 459
IS 1-2
BP 51
EP 61
DI 10.1016/j.ijpharm.2013.11.004
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 281ST
UT WOS:000329122000007
PM 24231051
DA 2018-10-20
ER

PT J
AU Ramavandi, B
   Farjadfard, S
AF Ramavandi, Bahman
   Farjadfard, Sima
TI Removal of chemical oxygen demand from textile wastewater using a
   natural coagulant
SO KOREAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Biomaterial; Coagulation; Plantago ovata; Pretreatment; Textile
   Wastewater
ID MORINGA-OLEIFERA SEED; SALT SOLUTION; FLOCCULATION; PRETREATMENT;
   PARTICLES; TURBIDITY; EFFLUENT; CHITOSAN; COLOR; PULP
AB A biomaterial was successfully synthesized from Plantago ovata by using an FeCl3-induced crude extract (FCE). The potential of FCE to act as a natural coagulant was tested for the pretreatment of real textile wastewater. Tests were performed to evaluate the effects of FCE quantity, salt concentration, and wastewater pH on chemical oxygen demand (COD) reduction during a coagulation/flocculation process. Experimental results indicated that the wastewater could be effectively treated by using a coagulation/flocculation process, where the BOD5/COD ratio of the effluent was improved to 0.48. A low coagulant dose, 1.5mg/L, achieved a high COD removal percentage, 89%, at operational conditions of neutral pH and room temperature. The experimental data revealed that the maximum COD removal occurred at water pH < 8. Increasing the salt promoted the COD removal. The settling and filterability characteristics of the sludge were also studied. Scanning electron microscopy and energy dispersive spectroscopy studies were conducted to determine the sludge structure and composition, respectively. Overall, FCE as an eco-friendly biomaterial was revealed to be a very efficient coagulant and a promising option for the removal of COD from wastewaters.
C1 [Ramavandi, Bahman] Bushehr Univ Med Sci, Environm Hlth Engn Dept, Fac Hlth, Bushehr, Iran.
   [Farjadfard, Sima] Islamic Azad Univ, Dept Environm Engn, Grad Sch Environm & Energy, Sci & Res Branch, Tehran, Iran.
RP Ramavandi, B (reprint author), Bushehr Univ Med Sci, Environm Hlth Engn Dept, Fac Hlth, Bushehr, Iran.
EM ramavandi_b@yahoo.com
RI Ramavandi, Bahman/D-5523-2017
OI Ramavandi, Bahman/0000-0002-4823-2113
FU Bushehr University of Medical Sciences
FX Authors acknowledge the Bushehr University of Medical Sciences for
   providing the technical and financial support for this research.
CR Al-Degs Y, 2000, WATER RES, V34, P927, DOI 10.1016/S0043-1354(99)00200-6
   Altaher H, 2012, J HAZARD MATER, V233, P97, DOI 10.1016/j.jhazmat.2012.06.061
   Anastasakis K, 2009, DESALINATION, V249, P786, DOI 10.1016/j.desal.2008.09.013
   APHA (American Public Health Association), 1998, STANDARD METHODS EXA
   Asgari G, 2014, DESALIN WATER TREAT, V52, P7354, DOI 10.1080/19443994.2013.823358
   Barnes D., 1981, WATER WASTEWATER SYS
   Bratskaya S, 2004, WATER RES, V38, P2955, DOI 10.1016/j.watres.2004.03.033
   Brigante M, 2007, COLLOID SURFACE A, V294, P64, DOI 10.1016/j.colsurfa.2006.07.045
   Chadho K. L., 1995, ADV HORTICULTURE MED, V11
   Cheng WP, 2008, COLLOID SURFACE A, V312, P238, DOI 10.1016/j.colsurfa.2007.06.060
   Churchley J. H., 1993, P 66 ANN M TEXT EFFL
   Diaz A, 1999, PROCESS BIOCHEM, V35, P391, DOI 10.1016/S0032-9592(99)00085-0
   EDZWALD JK, 1975, CLAY CLAY MINER, V23, P39, DOI 10.1346/CCMN.1975.0230106
   Garg A, 2005, IND ENG CHEM RES, V44, P2016, DOI 10.1021/ie048990a
   Gauthier E, 2000, ENVIRON RES, V84, P232, DOI 10.1006/enrs.2000.4101
   Hilal N, 2008, DESALINATION, V220, P85, DOI 10.1016/j.desal.2007.01.024
   Mahesh S, 2006, IND ENG CHEM RES, V45, P5766, DOI 10.1021/ie0603969
   McCabe W. L., 2001, UNIT OPERATIONS CHEM, P1008
   Meric S, 2005, WATER RES, V39, P1147, DOI 10.1016/j.watres.2004.12.021
   Mishra A, 2005, J HAZARD MATER, V118, P213, DOI 10.1016/j.jhazmat.2004.11.003
   NELSON DL, 2008, LEHNINGER PRINCIPLES
   Okuda T, 1999, WATER RES, V33, P3373, DOI 10.1016/S0043-1354(99)00046-9
   Okuda T, 2001, WATER RES, V35, P405, DOI 10.1016/S0043-1354(00)00290-6
   Okuda T, 2001, WATER RES, V35, P830, DOI 10.1016/S0043-1354(00)00296-7
   Ramakrishna KR, 1997, WATER SCI TECHNOL, V36, P189, DOI 10.1016/S0273-1223(97)00387-9
   Raychaudhuri S. P., 1993, GLIMPSES PLANT RES T, V10, P247
   Richardson J. F., 2003, COULSON RICHARDSONS, P254
   Sanchez-Martin J, 2010, BIORESOURCE TECHNOL, V101, P6259, DOI 10.1016/j.biortech.2010.02.072
   Sanghi R, 2002, GREEN CHEM, V4, P252, DOI 10.1039/b200067a
   Schintu M, 2000, ECOTOX ENVIRON SAFE, V46, P29, DOI 10.1006/eesa.1999.1887
   Sciban M., 2005, ACTA PERIOD TECHNOL, V36, P81, DOI DOI 10.2298/APT0536081S
   Trefalt G, 2013, J COLLOID INTERF SCI, V406, P111, DOI 10.1016/j.jcis.2013.05.071
   Verma AK, 2012, J ENVIRON MANAGE, V93, P154, DOI 10.1016/j.jenvman.2011.09.012
   Verrna S, 2010, J HAZARD MATER, V178, P1055, DOI 10.1016/j.jhazmat.2010.02.047
   VOET D, 1990, BIOCHEMISTRY
   Wang JP, 2013, WATER RES, V47, P2643, DOI 10.1016/j.watres.2013.01.050
   Zagorodni A., 2006, ION EXCHANGE MAT PRO
   Zhang PY, 2008, SEP PURIF TECHNOL, V63, P642, DOI 10.1016/j.seppur.2008.07.008
NR 38
TC 19
Z9 20
U1 2
U2 26
PU KOREAN INSTITUTE CHEMICAL  ENGINEERS
PI SEOUL
PA F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA
SN 0256-1115
EI 1975-7220
J9 KOREAN J CHEM ENG
JI Korean J. Chem. Eng.
PD JAN
PY 2014
VL 31
IS 1
BP 81
EP 87
DI 10.1007/s11814-013-0197-2
PG 7
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 281MN
UT WOS:000329105800013
DA 2018-10-20
ER

PT J
AU Nayyer, L
   Birchall, M
   Seifalian, AM
   Jell, G
AF Nayyer, Leila
   Birchall, Martin
   Seifalian, Alexander M.
   Jell, Gavin
TI Design and development of nanocomposite scaffolds for auricular
   reconstruction
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Auricle; Nanocomposite; POSS-PCU; Medpor (R)
ID HIGH-DENSITY POLYETHYLENE; POROUS POLYETHYLENE; EAR RECONSTRUCTION;
   ENDOTHELIAL-CELLS; IMPLANTS; GROWTH; MICROTIA; GRAFTS; COMPLICATIONS;
   FABRICATION
AB Auricular reconstruction using sculpted autologous costal cartilage is effective, but complex and time consuming and may incur donor site sequelae and morbidity. Conventional synthetic alternatives are associated with infection and extrusion in up to about 15% of cases. We present a novel POSS-PCU nanocomposite auricular scaffold, which aims to reduce extrusion rates by mimicking the elastic modulus of human ears and by encouraging desirable cellular interactions. The fabrication, physicochemical properties (including nanoscale topography) and cellular interactions of these scaffolds were compared to Medpor (R), the current synthetic standard. Our scaffold had a more similar elastic modulus (5.73 +/- 0.17 MPa) to ear cartilage (5.02 +/- 0.17 MPa) compared with Medpor (R), which was much stiffer (140.9 +/- 0.04 MPa). POSS-PCU supported fibroblast ingrowth and proliferation; significantly higher collagen production was also produced by cells on the POSS-PCU than those on Medpor (R). This porous POSS-PCU nanocomposite scaffold is therefore a promising alternative biomaterial for auricular surgical reconstruction.
   From the Clinical Editor: In this paper, a novel POSS-PCU nanocomposite auricular scaffold is described to reduce extrusion rates by having a much closer elastic modulus of human ears than the currently available synthetic standard. Enabling desirable cellular interactions may lead to the successful clinical application of these novel scaffolds. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Nayyer, Leila; Seifalian, Alexander M.; Jell, Gavin] UCL, UCL Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London, England.
   [Birchall, Martin] UCL, UCL Ear Inst, London, England.
   [Birchall, Martin] UCL, Royal Natl Throat Nose & Ear Hosp, London, England.
   [Seifalian, Alexander M.] Royal Free London NHS Fdn Trust Hosp, Dept Plast & Reconstruct Surg, London, England.
RP Seifalian, AM (reprint author), UCL, UCL Div Surg & Intervent Sci, London, England.
EM a.seifalian@ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013; Jell, Gavin/C-4893-2009
OI Seifalian, Alexander/0000-0002-1180-3322; 
FU Medical Research Council [G1001539, MR/K026453/1]
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Bigham WJ, 1999, OPHTHALMIC PLAST REC, V15, P317, DOI 10.1097/00002341-199909000-00004
   Brent B, 1999, PLAST RECONSTR SURG, V104, P319, DOI 10.1097/00006534-199908000-00001
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   COX NH, 1987, Q J MED, V64, P661
   Dalby MJ, 2002, IEEE T NANOBIOSCI, V1, P12, DOI 10.1109/TNB.2002.806930
   Desai M, 2012, J VASC SURG, V55, P77
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Hansen JC, 2007, J BIOMECH, V40, P2865, DOI 10.1016/j.jbiomech.2007.03.018
   Harris J, 1996, J MED GENET, V33, P809, DOI 10.1136/jmg.33.10.809
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Hou QP, 2003, BIOMATERIALS, V24, P1937, DOI 10.1016/S0142-9612(02)00562-8
   Jell G, 2009, FUNDAMENTALS TISSUE, P469
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Kawanabe Y, 2006, PLAST RECONSTR SURG, V117, P2011, DOI 10.1097/01.prs.0000210015.28620.1c
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI 10.2217/NNM.10.54
   Luquetti DV, 2011, BIRTH DEFECTS RES A, V91, P813, DOI 10.1002/bdra.20836
   MURPHY EF, 1973, J BIOMED MATER RES, V7, P275, DOI 10.1002/jbm.820070319
   NEEL HB, 1983, ARCH OTOLARYNGOL, V109, P427
   OSGUTHORPE JD, 1991, ARCH OTOLARYNGOL, V117, P969
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Punshon G, 2005, BIOMATERIALS, V26, P6271, DOI 10.1016/j.biomaterials.2005.03.034
   REMULLA HD, 1995, OPHTHALMOLOGY, V102, P586
   Schenke-Layland K, 2009, BIOMATERIALS, V30, P4665, DOI 10.1016/j.biomaterials.2009.05.033
   Sclafani AP, 1997, PLAST RECONSTR SURG, V99, P41, DOI 10.1097/00006534-199701000-00007
   SHANBHAG A, 1990, ANN PLAS SURG, V24, P32, DOI 10.1097/00000637-199001000-00006
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   WALSH BJ, 1992, ANAL BIOCHEM, V203, P187, DOI 10.1016/0003-2697(92)90301-M
   Walton RL, 2002, PLAST RECONSTR SURG, V110, P234, DOI 10.1097/00006534-200207000-00041
   Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821
   Wang YL, 2009, IEEE ENG MED BIO, P3339, DOI 10.1109/IEMBS.2009.5333200
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zhang Q, 2009, PLAST RECONSTR SURG, V123, P849, DOI 10.1097/PRS.0b013e318199f057
NR 44
TC 24
Z9 28
U1 3
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD JAN
PY 2014
VL 10
IS 1
BP 235
EP 246
DI 10.1016/j.nano.2013.06.006
PG 12
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA 281LR
UT WOS:000329103500025
PM 23792331
DA 2018-10-20
ER

PT J
AU Das, SK
   Dey, T
   Kundu, SC
AF Das, Saroj Kumar
   Dey, Tuli
   Kundu, S. C.
TI Fabrication of sericin nanoparticles for controlled gene delivery
SO RSC ADVANCES
LA English
DT Article
ID CELLULAR UPTAKE; PROTEIN; STABILITY; MECHANISM; THERAPY; RELEASE; SYSTEM
AB Protein based nanoparticles are functionally efficient for drug or gene delivery due to their biodegradable nature and easy elimination from the body. Silk, a natural biomaterial, is being used extensively as drug/ biomolecule delivery system. Silk protein sericin (glue protein) coates the silk fibers and is discarded as a waste product in the textile industry. As a potential biomaterial, sericin has multiple advantages due to its hydrophilic and cytocompatible nature. In this study, sericin based nanoparticles were prepared by a protein de-solvation method with a diameter of 100-150 nm. The structural morphology, surface charge and cytocompatibility were measured against mouse fibroblast. Modification of the surface charge (from anionic to cationic) was done to achieve optimum DNA binding. The cellular uptake of the FITC conjugated nanoparticles is analyzed and followed up by the delivery of extracellular genes within the fibroblasts. The successful expression of the green fluorescence protein confirms the prospective use of natural silk protein sericin based nanoparticles as a therapeutic DNA delivery system.
C1 [Das, Saroj Kumar; Dey, Tuli; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Das, SK (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijili.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291; Das, Saroj Kumar/0000-0002-0766-2192
FU Department of Biotechnology, Govt. of India
FX The authors would like to thank the Department of Biotechnology, Govt.
   of India for funding. The authors wish to express their gratitude to Dr.
   R. Chaturvedi (University of Massachusetts, USA), Dr. Felix Engel and
   Dr. C. Patra (Max Planck Institute for Lung and Heart research, Germany)
   for the generous gift of the pEGFP-C1 plasmid.
CR Abbasi S, 2011, CELL BIOCHEM BIOPHYS, V61, P277, DOI 10.1007/s12013-011-9201-9
   Albanese A, 2011, ACS NANO, V5, P5478, DOI 10.1021/nn2007496
   ALTON EWFW, 1993, NAT GENET, V5, P135, DOI 10.1038/ng1093-135
   Aramwit P., 2002, PHARM RES, V19, P1488
   Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y
   Cho KC, 2005, MACROMOL BIOSCI, V5, P512, DOI 10.1002/mabi.200500018
   Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z
   Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104
   DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L
   Guarnieri D, 2011, J NANOPART RES, V13, P4295, DOI 10.1007/s11051-011-0375-2
   Harris TJ, 2010, BIOMATERIALS, V31, P998, DOI 10.1016/j.biomaterials.2009.10.012
   Huang J, 2010, ACS NANO, V4, P7151, DOI 10.1021/nn101643u
   Huang M, 2002, PHARM RES-DORDR, V19, P1488, DOI 10.1023/A:1020404615898
   Jahanshahi Mohsen, 2004, Iranian Journal of Biotechnology, V2, P1
   Jahanshahi M, 2008, AFR J BIOTECHNOL, V7, P4926
   Kay MA, 1997, P NATL ACAD SCI USA, V94, P12744, DOI 10.1073/pnas.94.24.12744
   Kim EY, 2012, GENE THER, V19, P347, DOI 10.1038/gt.2011.95
   Kundu B, 2012, BIOMATERIALS, V33, P7456, DOI 10.1016/j.biomaterials.2012.06.091
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595
   Liao ZX, 2012, BIOMATERIALS, V33, P3306, DOI 10.1016/j.biomaterials.2012.01.013
   Nayak S, 2012, CELL TISSUE RES, V347, P783, DOI 10.1007/s00441-011-1269-4
   Numata K, 2012, MACROMOL BIOSCI, V12, P75, DOI 10.1002/mabi.201100274
   Numata K, 2011, BIOCONJUGATE CHEM, V22, P1605, DOI 10.1021/bc200170u
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Parra-Guillen ZP, 2010, PHARM RES-DORDR, V27, P1487, DOI 10.1007/s11095-010-0136-4
   Quaak SGL, 2009, J CONTROL RELEASE, V139, P153, DOI 10.1016/j.jconrel.2009.06.033
   Rhaese S, 2003, J CONTROL RELEASE, V92, P199, DOI 10.1016/S0168-3659(03)00302-X
   Salata O.V., 2004, J NANOBIOTECHNOL, V2, P3, DOI DOI 10.1186/1477-3155-2-3
   Singh HD, 2010, ACTA BIOMATER, V6, P4277, DOI 10.1016/j.actbio.2010.06.017
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Subia B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035103
   Tervonen T., 2008, J NANOPART RES, V11, P757, DOI 10.1007/s11051-008-9546-1
   Treuel L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0939
   Verma M., 1997, NATURE, V389, P239
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   Zhang ZL, 2000, BIOSEPARATION, V13
NR 40
TC 11
Z9 11
U1 5
U2 39
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 5
BP 2137
EP 2142
DI 10.1039/c3ra44990d
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 280MV
UT WOS:000329035400007
DA 2018-10-20
ER

PT J
AU Kojima, K
   Vacanti, CA
AF Kojima, Koji
   Vacanti, Charles A.
TI Tissue Engineering in the Trachea
SO ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY
   BIOLOGY
LA English
DT Article
DE tissue engineering; stem cell; trachea
ID NASAL CHONDROCYTES; RECONSTRUCTION; CARTILAGE; REPLACEMENT; CELLS;
   ALLOGRAFTS; SCAFFOLDS; MATRIX
AB This review summarizes efforts to generate an autologous tissue-engineered trachea (TET) using various biomaterial or cell sources to make tracheal cartilage to form the structural components of a functional tracheal replacement. Biomechanical assessments of the TET showed that the cartilage stiffness was excellent in the nude models; however, the sheep autologous TET did not provide sufficient support and collapsed easily. As a result, tissue engineering technology is still far from allowing the functional recovery of patients who suffer from severe tracheal disease. On the other hand, there are several clinical reports seeding cells to decellularized tissue using tissue engineering techniques. However, the working mechanisms of the tissue-engineered trachea remain unclear. Nevertheless, we believe that the field of tissue engineering has great potential for surmounting these obstacles and allowing us to generate functional tracheal replacements in the near future. Anat Rec, 297:44-50. 2014. (c) 2013 Wiley Periodicals, Inc.
C1 [Kojima, Koji; Vacanti, Charles A.] Harvard Univ, Sch Med, Dept Anesthesiol, Lab Tissue Engn & Regenerat Med,Brigham & Womens, Boston, MA 02115 USA.
RP Kojima, K (reprint author), Harvard Univ, Sch Med, Dept Anesthesiol, Lab Tissue Engn & Regenerat Med,Brigham & Womens, 75 Francis St,Thorn 703, Boston, MA 02115 USA.
EM kojima@zeus.bwh.harvard.edu
CR Banis JC, 1996, PLAST RECONSTR SURG, V98, P1046, DOI 10.1097/00006534-199611000-00019
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Canseco JA, 2012, TISSUE ENG PT A, V18, P2549, DOI [10.1089/ten.tea.2012.0030, 10.1089/ten.TEA.2012.0030]
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Cavadas PC, 1998, PLAST RECONSTR SURG, V101, P937, DOI 10.1097/00006534-199804040-00008
   Delaere P, 2010, NEW ENGL J MED, V362, P138, DOI 10.1056/NEJMoa0810653
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Fuchs JR, 2002, J PEDIATR SURG, V37, P1000, DOI 10.1043/jpsu.2002.33829
   Graziano J L, 1967, Ann Thorac Surg, V4, P1
   Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kojima K, 2003, ANN THORAC SURG, V76, P1884, DOI 10.1016/S0003-4975(03)01193-7
   Kojima K, 2002, J THORAC CARDIOV SUR, V123, P1177, DOI 10.1067/mtc.2002.121161
   Kojima K, 2004, J THORAC CARDIOV SUR, V128, P147, DOI 10.1016/j.jtcvs.2004.02.038
   Kojima K, 2003, FASEB J, V17, P823, DOI 10.1096/fj.02-0462com
   Kushibe K, 2000, ANN THORAC SURG, V70, P1876, DOI 10.1016/S0003-4975(00)01854-3
   Lee CJ, 2002, J CARDIOVASC SURG, V43, P275
   LETANG E, 1990, ANN THORAC SURG, V49, P955, DOI 10.1016/0003-4975(90)90875-7
   Lin CH, 2008, TISSUE ENG PART C-ME, V14, P69, DOI 10.1089/tec.2007.0336
   Luo XS, 2013, BIOMATERIALS, V34, P3336, DOI 10.1016/j.biomaterials.2013.01.060
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   MESSINEO A, 1994, J PEDIATR SURG, V29, P697, DOI 10.1016/0022-3468(94)90744-7
   Okumura N, 1991, ASAIO Trans, V37, pM317
   OSADA H, 1994, J CARDIOVASC SURG, V35, P165
   Osada H, 2000, ANN THORAC SURG, V70, P1886, DOI 10.1016/S0003-4975(00)01847-6
   VACANTI CA, 1994, J PEDIATR SURG, V29, P201, DOI 10.1016/0022-3468(94)90318-2
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Zang MQ, 2012, PLAST RECONSTR SURG, V130, P532, DOI 10.1097/PRS.0b013e31825dc084
   Zani BG, 2008, P NATL ACAD SCI USA, V105, P7046, DOI 10.1073/pnas.0802463105
NR 30
TC 31
Z9 37
U1 0
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-8486
EI 1932-8494
J9 ANAT REC
JI Anat. Rec.
PD JAN
PY 2014
VL 297
IS 1
SI SI
BP 44
EP 50
DI 10.1002/ar.22799
PG 7
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 273SG
UT WOS:000328556000007
PM 24293389
OA Bronze
DA 2018-10-20
ER

PT J
AU Sicari, BM
   Dearth, CL
   Badylak, SF
AF Sicari, Brian M.
   Dearth, Christopher L.
   Badylak, Stephen F.
TI Tissue Engineering and Regenerative Medicine Approaches to Enhance the
   Functional Response to Skeletal Muscle Injury
SO ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY
   BIOLOGY
LA English
DT Article
DE tissue engineering; stem cells; regenerative medicine; biologic
   scaffolds
ID MESENCHYMAL STEM-CELLS; DUCHENNE MUSCULAR-DYSTROPHY; SMALL-INTESTINAL
   SUBMUCOSA; UMBILICAL-CORD BLOOD; MARROW-DERIVED CELLS; XENOGENEIC
   EXTRACELLULAR-MATRIX; ACELLULAR DERMAL MATRIX; NORMAL MYOGENIC CELLS;
   HUMAN ADIPOSE-TISSUE; ROTATOR CUFF TEARS
AB The well-recognized ability of skeletal muscle for functional and structural regeneration following injury is severely compromised in degenerative diseases and in volumetric muscle loss. Tissue engineering and regenerative medicine strategies to support muscle reconstruction have typically been cell-centric with approaches that involve the exogenous delivery of cells with myogenic potential. These strategies have been limited by poor cell viability and engraftment into host tissue. Alternative approaches have involved the use of biomaterial scaffolds as substrates or delivery vehicles for exogenous myogenic progenitor cells. Acellular biomaterial scaffolds composed of mammalian extracellular matrix (ECM) have also been used as an inductive niche to promote the recruitment and differentiation of endogenous myogenic progenitor cells. An acellular approach, which activates or utilizes endogenous cell sources, obviates the need for exogenous cell administration and provides an advantage for clinical translation. The present review examines the state of tissue engineering and regenerative medicine therapies directed at augmenting the skeletal muscle response to injury and presents the pros and cons of each with respect to clinical translation. Anat Rec, 297:51-64. 2014. (c) 2013 Wiley Periodicals, Inc.
C1 [Sicari, Brian M.; Dearth, Christopher L.; Badylak, Stephen F.] McGowan Inst Regenerat Med, Pittsburgh, PA USA.
   [Sicari, Brian M.] Univ Pittsburgh, Cellular & Mol Pathol Grad Program, Sch Med, Pittsburgh, PA 15219 USA.
   [Dearth, Christopher L.; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Sch Med, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr,Suite 300, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
CR Adams JE, 2006, ARTHROSCOPY, V22, P700, DOI 10.1016/j.arthro.2006.03.016
   Agrawal V, 2012, TISSUE ENG PT A, V18, P1454, DOI [10.1089/ten.tea.2011.0550, 10.1089/ten.TEA.2011.0550]
   Agrawal V, 2011, TISSUE ENG PT A, V17, P2435, DOI [10.1089/ten.TEA.2011.0036, 10.1089/ten.tea.2011.0036]
   Agrawal V, 2011, TISSUE ENG PT A, V17, P3033, DOI [10.1089/ten.TEA.2011.0257, 10.1089/ten.tea.2011.0257]
   Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106
   Agrawal V, 2009, J TISSUE ENG REGEN M, V3, P590, DOI 10.1002/term.200
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592
   Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Ayyildiz A, 2008, ANZ J SURG, V78, P82, DOI 10.1111/j.1445-2197.2007.04361.x
   Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101
   Badhe SP, 2008, J SHOULDER ELB SURG, V17, p35S, DOI 10.1016/j.jse.2007.08.005
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak SF, 2006, CELL TRANSPLANT, V15, pS29, DOI 10.3727/000000006783982368
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI 10.1089/ten.tea.2010.0739
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Balaban B, 2005, AM J PHYS MED REHAB, V84, P843, DOI 10.1097/01.phm.0000184156.98671.d0
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237
   Borschel GH, 2004, PLAST RECONSTR SURG, V113, P595, DOI 10.1097/01.PRS.0000101064.62289.2F
   Brazelton TR, 2003, DEV BIOL, V262, P64, DOI 10.1016/S0012-1606(03)00357-9
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   Brennan EP, 2008, J TISSUE ENG REGEN M, V2, P491, DOI 10.1002/term.123
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Burchfield JS, 2008, CIRC RES, V103, P203, DOI 10.1161/CIRCRESAHA.108.178475
   Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   CARLSON BM, 1968, J MORPHOL, V125, P447, DOI 10.1002/jmor.1051250405
   CARLSON BM, 1983, MED SCI SPORT EXER, V15, P187
   Carnio S, 2011, J TISSUE ENG REGEN M, V5, P1, DOI 10.1002/term.282
   Carpenter CP, 2012, CAN J UROL, V19, P6207
   Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Cheng A, 2012, CLIN PLAST SURG, V39, P167, DOI 10.1016/j.cps.2012.02.004
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Cizkova D, 2011, FOLIA BIOL-PRAGUE, V57, P232
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Corona BT, 2012, TISSUE ENG PT A, V18, P1213, DOI [10.1089/ten.tea.2011.0614, 10.1089/ten.TEA.2011.0614]
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Pinheiro CHD, 2012, STEM CELL REV REP, V8, P363, DOI 10.1007/s12015-011-9304-0
   Dai WD, 2009, REGEN MED, V4, P387, DOI 10.2217/RME.09.2
   Daly KA, 2011, TISSUE ENG PART C-ME, V17, P631, DOI 10.1089/ten.tec.2010.0699
   Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1
   Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136
   Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508
   Derwin KA, 2010, J SHOULDER ELB SURG, V19, P467, DOI 10.1016/j.jse.2009.10.020
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Di Rocco G, 2006, J CELL SCI, V119, P2945, DOI 10.1242/jcs.03029
   Doede T, 2009, ARTIF ORGANS, V33, P328, DOI 10.1111/j.1525-1594.2009.00727.x
   Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3
   Drowley L, 2010, MOL THER, V18, P1865, DOI 10.1038/mt.2010.160
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Fan CY, 2008, MICROSURG, V28, P71, DOI 10.1002/micr.20449
   Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8
   Feng SW, 2008, CYTOTHERAPY, V10, P254, DOI 10.1080/14653240802020381
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Gang EJ, 2009, EXP CELL RES, V315, P2624, DOI 10.1016/j.yexcr.2009.05.009
   Gharaibeh B, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt72
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022
   Glimm H, 2000, BLOOD, V96, P4185
   Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797
   Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4
   Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058
   Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007
   Guerette B, 1997, CELL TRANSPLANT, V6, P101, DOI 10.1016/S0963-6897(96)00230-8
   GUERETTE B, 1994, TRANSPLANT P, V26, P3461
   Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43922
   GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0
   Han JG, 2010, DIS COLON RECTUM, V53, P219, DOI 10.1007/DCR.0b013e3181b715b5
   HARDIMAN O, 1993, NEUROLOGY, V43, P1432, DOI 10.1212/WNL.43.7.1432
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534
   Heckmann L, 2008, BIOTECHNOL APPL BIOC, V49, P185, DOI 10.1042/BA20070071
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hong F, 2002, FASEB J, V16, P1633, DOI 10.1096/fj.02-0060fje
   Hope WW, 2012, PLAST SURT INT, V2012
   Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022
   HUARD J, 1991, CLIN SCI, V81, P287, DOI 10.1042/cs0810287
   HUARD J, 1994, HUM GENE THER, V5, P949, DOI 10.1089/hum.1994.5.8-949
   HUARD J, 1992, MUSCLE NERVE, V15, P550, DOI 10.1002/mus.880150504
   Iannotti JP, 2006, J BONE JOINT SURG AM, V88A, P1238, DOI 10.2106/JBJS.E.00524
   in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kang Y, 2010, MICROVASC RES, V80, P310, DOI 10.1016/j.mvr.2010.05.006
   KARPATI G, 1993, ANN NEUROL, V34, P8, DOI 10.1002/ana.410340105
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   KHAN MA, 1993, J NEUROL SCI, V120, P8, DOI 10.1016/0022-510X(93)90017-S
   Kinoshita I, 1996, J NEUROPATH EXP NEUR, V55, P687, DOI 10.1097/00005072-199606000-00002
   KINOSHITA I, 1994, MUSCLE NERVE, V17, P1407, DOI 10.1002/mus.880171210
   Kissane NA, 2012, PLAST RECONSTR SURG, V130, p194S, DOI 10.1097/PRS.0b013e318265a5ec
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Kong KY, 2004, STEM CELLS, V22, P981, DOI 10.1634/stemcells.22-6-981
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   Koponen JK, 2007, MOL THER, V15, P2172, DOI 10.1038/sj.mt.6300302
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Lavasani M, 2006, HUM GENE THER, V17, P180, DOI 10.1089/hum.2006.17.180
   Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x
   Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085
   Li F, 2004, ENDOTHELIUM-J ENDOTH, V11, P199, DOI 10.1080/10623320490512390
   Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC370, DOI 10.1152/ajpcell.00453.2002
   Lin SH, 2004, J RECONSTR MICROSURG, V20, P227
   Liu Q, 2009, VASC ENDOVASC SURG, V43, P433, DOI 10.1177/1538574409335158
   Lullove E, 2012, J AM PODIAT MED ASSN, V102, P233, DOI 10.7547/1020233
   Ma JQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/812135
   Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.tea.2010.0682, 10.1089/ten.TEA.2010.0682]
   Manzur A. Y., 2008, COCHRANE DATABASE SY
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303
   Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]
   Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.0.CO;2-U
   Mofid MM, 2012, EUR J PLAST SURG, V35, P717, DOI 10.1007/s00238-012-0736-9
   Momoh AO, 2010, J PLAST RECONSTR AES, V63, P2185, DOI 10.1016/j.bjps.2010.03.010
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Moon DG, 2008, TISSUE ENG PT A, V14, P473, DOI 10.1089/tea.2007.0104
   MUIR AR, 1965, J ANAT, V99, P435
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Negroni E, 2009, MOL THER, V17, P1771, DOI 10.1038/mt.2009.167
   Nieponice A, 2012, J SURG RES IN PRESS
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   Ota S, 2011, AM J SPORT MED, V39, P1912, DOI 10.1177/0363546511415239
   Ota T, 2008, J THORAC CARDIOV SUR, V136, P1309, DOI 10.1016/j.jtcvs.2008.07.008
   PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0
   Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145
   Perez-Ilzarbe M, 2008, EUR J HEART FAIL, V10, P1065, DOI 10.1016/j.ejheart.2008.08.002
   Pesce M, 2003, CIRC RES, V93, pE51, DOI 10.1161/01.RES.0000090624.04507.45
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001
   Pu LLQ, 2005, PLAST RECONSTR SURG, V115, P2127, DOI 10.1097/01.PRS.0000168883.65715.2F
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Riederer I, 2012, MOL THER, V20, P146, DOI 10.1038/mt.2011.193
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Rossi CA, 2010, ORGANOGENESIS, V6, P167, DOI 10.4161/org.6.3.12419
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Saxena AK, 1999, TISSUE ENG, V5, P525, DOI 10.1089/ten.1999.5.525
   Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565
   Shah R, 2005, BIOMATERIALS, V26, P1497, DOI 10.1016/j.biomaterials.2004.04.049
   Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406
   Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Sicari B., 2011, TISSUE ENG REGENERAT
   Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017
   Skuk D, 1999, EXP NEUROL, V155, P22, DOI 10.1006/exnr.1998.6973
   Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023
   Skuk D, 2007, NEUROMUSCULAR DISORD, V17, P38, DOI 10.1016/j.nmd.2006.10.003
   Skuk D, 2006, J NEUROPATH EXP NEUR, V65, P371, DOI 10.1097/01.jnen.0000218443.45782.81
   Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709
   Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje
   Springer ML, 2003, MOL THER, V7, P441, DOI 10.1016/S1525-0016(03)00010-8
   Springer ML, 1998, MOL CELL, V2, P549, DOI 10.1016/S1097-2765(00)80154-9
   Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Thorrez L, 2008, BIOMATERIALS, V29, P75, DOI 10.1016/j.biomaterials.2007.09.014
   Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   Torrente Y, 2007, CELL TRANSPLANT, V16, P563, DOI 10.3727/000000007783465064
   Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325
   Tottey S, 2011, TISSUE ENG PT A, V17, P37, DOI [10.1089/ten.tea.2010.0188, 10.1089/ten.TEA.2010.0188]
   Tottey S, 2011, BIOMATERIALS, V32, P128, DOI 10.1016/j.biomaterials.2010.09.006
   TREMBLAY JP, 1993, NEUROMUSCULAR DISORD, V3, P583, DOI 10.1016/0960-8966(93)90121-Y
   TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Turner NJ, 2010, ARCH HISTOL CYTOL, V73, P103, DOI 10.1679/aohc.73.103
   Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274
   Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Vekris MD, 2008, INJURY, V39, pS15, DOI 10.1016/j.injury.2008.06.008
   Voytik-Harbin SL, 1998, IN VITRO CELL DEV-AN, V34, P239
   Walton JR, 2007, J BONE JOINT SURG AM, V89A, P786, DOI 10.2106/JBJS.F.00315
   Wang W, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025011
   Weiser AC, 2003, J UROLOGY, V170, P1593, DOI 10.1097/01.ju.0000083863.01634.e1
   Winkler T, 2009, TISSUE ENG PT A, V15, P487, DOI 10.1089/ten.tea.2007.0426
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Wong Ivan, 2010, J Shoulder Elbow Surg, V19, P104, DOI 10.1016/j.jse.2009.12.017
   Wood JD, 2005, JAVMA-J AM VET MED A, V226, P1095, DOI 10.2460/javma.2005.226.1095
   Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C
   Wozniak AC, 2005, MUSCLE NERVE, V31, P283, DOI 10.1002/mus.20263
   Zalavras CG, 2006, J SHOULDER ELB SURG, V15, P224, DOI 10.1016/j.jse.2005.06.007
   Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006
   Zantop T, 2006, J ORTHOP RES, V24, P1299, DOI 10.1002/jor.20071
   Zhang Y, 2008, CIRC-CARDIOVASC IMAG, V1, P197, DOI 10.1161/CIRCIMAGING.108.781120
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 209
TC 17
Z9 18
U1 1
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-8486
EI 1932-8494
J9 ANAT REC
JI Anat. Rec.
PD JAN
PY 2014
VL 297
IS 1
SI SI
BP 51
EP 64
DI 10.1002/ar.22794
PG 14
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 273SG
UT WOS:000328556000008
PM 24293290
DA 2018-10-20
ER

PT J
AU Krishnan, R
   Arora, RP
   Alexander, M
   White, SM
   Lamb, MW
   Foster, CE
   Choi, B
   Lakey, JRT
AF Krishnan, Rahul
   Arora, Rajan P.
   Alexander, Michael
   White, Sean M.
   Lamb, Morgan W.
   Foster, Clarence E., III
   Choi, Bernard
   Lakey, Jonathan R. T.
TI Noninvasive evaluation of the vascular response to transplantation of
   alginate encapsulated islets using the dorsal skin-fold model
SO BIOMATERIALS
LA English
DT Article
DE Islet; Transplantation; Diabetes; Angiogenesis; In vivo test; Alginate;
   Encapsulation
ID MICROENCAPSULATED PORCINE ISLETS; HUMAN PANCREATIC-ISLETS; BLOOD-FLOW;
   IN-VITRO; WINDOW CHAMBER; INTRAVITAL MICROSCOPY; PERMEABILITY FACTOR;
   INSULIN-SECRETION; OXYGEN-SATURATION; CELLS
AB Alginate encapsulation reduces the risk of transplant rejection by evading immune-mediated cell injury and rejection; however, poor vascular perfusion results in graft failure. Since existing imaging models are incapable of quantifying the vascular response to biomaterial implants after transplantation, in this study, we demonstrate the use of in vivo laser speckle imaging (LSI) and wide-field functional imaging (WiFI) to monitor the microvascular environment surrounding biomaterial implants. The vascular response to two islet-containing biomaterial encapsulation devices, alginate microcapsules and a high-guluronate alginate sheet, was studied and compared after implantation into the mouse dorsal window chamber (N = 4 per implant group). Images obtained over a 14-day period using LSI and WiFI were analyzed using algorithms to quantify blood flow, hemoglobin oxygen saturation and vascular density. Using our method, we were able to monitor the changes in the pen-implant microvasculature non-invasively without the use of fluorescent dyes. Significant changes in blood flow, hemoglobin oxygen saturation and vascular density were noted as early as the first week post-transplant. The dorsal window chamber model enables comparison of host responses to transplanted biomaterials. Future experiments will study the effect of changes in alginate composition on the vascular and immune responses. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Krishnan, Rahul; Alexander, Michael; Lamb, Morgan W.; Foster, Clarence E., III; Choi, Bernard; Lakey, Jonathan R. T.] Univ Calif Irvine, Dept Surg, Orange, CA 92868 USA.
   [Arora, Rajan P.; White, Sean M.; Choi, Bernard] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92617 USA.
   [White, Sean M.; Choi, Bernard; Lakey, Jonathan R. T.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92617 USA.
RP Lakey, JRT (reprint author), 333 City Blvd West,Suite 700, Orange, CA 92868 USA.
EM jlakey@uci.edu
FU Department of Surgery, University of California Irvine; Hanuman Medical
   Foundation, San Francisco; Arnold and Mabel Beckman Foundation; National
   Institutes of Health [P41 EB015890, R01 HD065536]
FX The authors would like to acknowledge Dr. Rick Storrs from the Hanuman
   Medical Foundation and Mr. Ouwen Liang, junior specialist at the Islet
   Lab at UC Irvine, for providing the Islet sheets and alginate
   microcapsules (respectively) that were used in various experiments. We
   acknowledge our students Nhat Truong, Maria Morkos and Risha Shukla for
   helping with manuscript editing before submission. Finally, the authors
   gratefully acknowledge financial and institutional support from
   Department of Surgery, University of California Irvine; the Hanuman
   Medical Foundation, San Francisco; the Arnold and Mabel Beckman
   Foundation; and the National Institutes of Health (P41 EB015890 and R01
   HD065536).
CR Agarwal Avinash, 2012, Semin Intervent Radiol, V29, P90, DOI 10.1055/s-0032-1312569
   Algire GH, 1943, J NATL CANCER I, V4, P1
   Arifin DR, 2011, DIABETES-METAB RES, V27, P761, DOI 10.1002/dmrr.1248
   Arifin DR, 2011, RADIOLOGY, V260, P790, DOI 10.1148/radiol.11101608
   ASHCROFT SJ, 1971, LANCET, V1, P888
   Avgoustiniatos ES, 1997, ANN NY ACAD SCI, V831, P145
   Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063
   Beger C, 1997, TRANSPLANTATION, V63, P577, DOI 10.1097/00007890-199702270-00016
   Benedict KA, 2013, AM J TRANSPLANT, V13, P2207, DOI 10.1111/ajt.12323
   Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504
   Borg DJ, 2011, CURR DIABETES REP, V11, P434, DOI 10.1007/s11892-011-0210-2
   BRIERS JD, 1982, INVEST OPHTH VIS SCI, V22, P255
   Bruno G, 2011, TRANSPL P, V43, P327, DOI 10.1016/j.transproceed.2010.09.098
   Bucher P, 2004, TRANSPLANT P, V36, P1119, DOI 10.1016/j.transproceed.2004.04.022
   Candiello Joseph E., 2011, Critical Reviews in Biomedical Engineering, V39, P535
   Caumo A, 2011, TRANSPLANTATION, V92, P815, DOI 10.1097/TP.0b013e31822ca79b
   Chhabra P, 2011, J TRANSPLANT, DOI 10.1155/2011/637692
   Choe SW, 2010, ACTA BIOMATER, V6, P3491, DOI 10.1016/j.actbio.2010.03.006
   Choi B, 2004, MICROVASC RES, V68, P143, DOI 10.1016/j.mvr.2004.04.003
   Choi H, 2012, OPT EXPRESS, V20, P26219, DOI 10.1364/OE.20.026219
   Cormode DP, 2011, RADIOLOGY, V258, P1, DOI 10.1148/radiol.102011
   Cornolti R, 2009, CELL TRANSPLANT, V18, P195, DOI 10.3727/096368909788341252
   Cowan PJ, 2010, TRANSPLANTATION, V90, P1050, DOI 10.1097/TP.0b013e3181f6e286
   de Vos P, 2010, ADV EXP MED BIOL, V670, P38
   Dellian M, 1996, AM J PATHOL, V149, P59
   Dellian M, 1996, BRIT J CANCER, V74, P1206, DOI 10.1038/bjc.1996.518
   Deng C, 2011, J CONTROL RELEASE, V152, pE196, DOI 10.1016/j.jconrel.2011.09.005
   DeVos P, 1996, TRANSPLANTATION, V62, P893, DOI 10.1097/00007890-199610150-00004
   Dewhirst MW, 2000, INT J CANCER, V90, P237, DOI 10.1002/1097-0215(20001020)90:5<237::AID-IJC1>3.3.CO;2-K
   Dufrane D, 2010, TRANSPLANTATION, V90, P1054, DOI 10.1097/TP.0b013e3181f6e267
   Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541
   Duvivier-Kali VF, 2001, DIABETES, V50, P1698, DOI 10.2337/diabetes.50.8.1698
   Emamaullee JA, 2006, TRANSPLANTATION, V82, P945, DOI 10.1097/01.tp.0000238677.00750.32
   Franz MJ, 2002, J AM DIET ASSOC, V102, P109, DOI 10.1016/S0002-8223(02)90031-3
   Gala-Lopez B, 2013, CURR DIABETES REP, V13, P713, DOI 10.1007/s11892-013-0414-8
   Gao Q, 2010, AM J TRANSPLANT, V10, P1588, DOI 10.1111/j.1600-6143.2010.03151.x
   Hathout E, 2003, ARCH DIS CHILD, V88, P591, DOI 10.1136/adc.88.7.591
   Hilling DE, 2013, CELL TRANSPLANT
   Japee SA, 2004, MICROCIRCULATION, V11, P39, DOI 10.1080/10739680490266171
   Jones KS, 2004, TRANSPLANTATION, V78, P1454, DOI 10.1097/01.TP.0000142094.63083.FB
   King A, 2003, TRANSPLANTATION, V76, P275, DOI 10.1097/01.TP.0000078625.29988.0A
   Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649
   Krishnamurthy N. V., 2011, Critical Reviews in Biomedical Engineering, V39, P473, DOI 10.1615/CritRevBiomedEng.v39.i6.10
   Lamb M, 2011, TRANSPL P, V43, P3265, DOI 10.1016/j.transproceed.2011.10.028
   Lamb M, 2013, CELL TRANSPLANT
   Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12
   Laschke M. W., 2011, EUR CELLS MATER, V22, P147
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   Liu XY, 2010, ASAIO J, V56, P241, DOI 10.1097/MAT.0b013e3181d7b8e3
   Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412
   MARCHETTI P, 1994, DIABETES, V43, P827, DOI 10.2337/diabetes.43.6.827
   Marzorati S, 2009, TRANSPL P, V41, P352, DOI 10.1016/j.transproceed.2008.09.057
   Mazhar A, 2011, BIOMED OPT EXPRESS, V2, P1553, DOI 10.1364/BOE.2.001553
   MENGER MD, 1992, J CLIN INVEST, V90, P1361, DOI 10.1172/JCI116002
   Meyer T, 2008, PEDIATR SURG INT, V24, P1375, DOI 10.1007/s00383-008-2267-9
   Moy AJ, 2011, MICROVASC RES, V82, P199, DOI 10.1016/j.mvr.2011.07.004
   Mueller KR, 2013, XENOTRANSPLANTATION, V20, P75, DOI 10.1111/xen.12022
   O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8
   Omer A, 2003, XENOTRANSPLANTATION, V10, P240, DOI 10.1034/j.1399-3089.2003.01150.x
   Oye KS, 2008, MICROVASC RES, V75, P179, DOI 10.1016/j.mvr.2007.06.009
   Perez VL, 2011, DIABETOLOGIA, V54, P1121, DOI 10.1007/s00125-011-2091-y
   Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124
   Qi M, 2008, ARTIF CELL BLOOD SUB, V36, P403, DOI 10.1080/10731190802369755
   Qi MRG, 2011, J SURG RES, V168, pE117, DOI 10.1016/j.jss.2011.01.040
   Roche E, 2005, TRANSPL IMMUNOL, V15, P113, DOI 10.1016/j.trim.2005.09.008
   Sabat M, 2003, TRANSPLANT P, V35, P2343, DOI 10.1016/S0041-1345(03)00793-0
   Sabek O, 2010, TRANSPL P, V42, P2112, DOI 10.1016/j.transproceed.2010.05.080
   SCHERNTHANER G, 1993, DIABETES CARE, V16, P155, DOI 10.2337/diacare.16.3.155
   SCHMIDSCHOENBEIN GW, 1977, MICROVASC RES, V14, P303, DOI 10.1016/0026-2862(77)90028-0
   SIEBERS U, 1993, INT J ARTIF ORGANS, V16, P96
   Song C, 2009, TRANSPL P, V41, P1789, DOI 10.1016/j.transproceed.2009.01.079
   Song Y, 2012, PHARMAZIE, V67, P394, DOI 10.1691/ph.2012.1697
   Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369
   Storrs R, 2001, ANN NY ACAD SCI, V944, P252
   SUN AM, 1988, METHOD ENZYMOL, V137, P575
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   Thompson P, 2011, AM J TRANSPLANT, V11, P947, DOI 10.1111/j.1600-6143.2011.03509.x
   Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744
   Vaithilingam V, 2011, J MICROENCAPSUL, V28, P499, DOI 10.3109/02652048.2011.586067
   Veriter S, 2010, TISSUE ENG PT A, V16, P1503, DOI [10.1089/ten.tea.2009.0286, 10.1089/ten.TEA.2009.0286]
   Wang P, 2013, RADIOLOGY, V266, P822, DOI 10.1148/radiol.12121129
   WEBER CJ, 1990, HORM METAB RES, V25, P219
   White SM, 2012, TISSUE ENG PART C-ME, V18, P697, DOI [10.1089/ten.tec.2011.0744, 10.1089/ten.TEC.2011.0744]
   White SM, 2011, MICROVASC RES, V82, P92, DOI 10.1016/j.mvr.2011.03.006
   Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765
NR 85
TC 11
Z9 11
U1 1
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2014
VL 35
IS 3
BP 891
EP 898
DI 10.1016/j.biomaterials.2013.10.012
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 277GL
UT WOS:000328806900002
PM 24176195
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Raic, A
   Rodling, L
   Kalbacher, H
   Lee-Thedieck, C
AF Raic, Annamarija
   Roedling, Lisa
   Kalbacher, Hubert
   Lee-Thedieck, Cornelia
TI Biomimetic macroporous PEG hydrogels as 3D scaffolds for the
   multiplication of human hematopoietic stem and progenitor cells
SO BIOMATERIALS
LA English
DT Article
DE Biomimetic material; Bone marrow; Co-culture; Stem cell;
   Three-dimensional scaffolds; Stem cell niche
ID BONE-MARROW NICHE; LONG-TERM; 3-DIMENSIONAL SCAFFOLDS; ARTIFICIAL
   NICHES; UMBILICAL-CORD; STROMAL CELLS; N-CADHERIN; EXPANSION;
   DIFFERENTIATION; ADHESION
AB Multiplication of hematopoietic stem cells (HSCs) in vitro with current standard methods is limited and mostly insufficient for clinical applications of these cells. They quickly lose their multipotency in culture because of the fast onset of differentiation. In contrast, HSCs efficiently self-renew in their natural microenvironment (their niche) in the bone marrow. Therefore, engineering artificial bone marrow analogs is a promising biomaterial-based approach for culturing these cells. In the current study, a straight-forward, easy-to-use method for the production of biofunctionalized, macroporous hydrogel scaffolds that mimic the spongy architecture of trabecular bones was developed. As surrogates for cellular components of the niche, mesenchymal stem cells (MSCs) from different sources (bone marrow and umbilical cord) and osteoblast-like cells were tested. MSCs from bone marrow had the strongest pro-proliferative effect on freshly isolated human hematopoietic stem and progenitor cells (HSPCs) from umbilical cord blood. Co-culture in the pores of the three-dimensional hydrogel scaffold showed that the positive effect of MSCs on preservation of HSPC sternness was more pronounced in 3D than in standard 2D cell culture systems. Thus, the presented biomimetic scaffolds revealed to meet the basic requirements for creating artificial HSC niches. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Raic, Annamarija] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany.
   [Roedling, Lisa; Lee-Thedieck, Cornelia] Karlsruhe Inst Technol, Inst Funct Interfaces, D-76344 Eggenstein Leopoldshafen, Germany.
   [Kalbacher, Hubert] Univ Tubingen, Intezfac Inst Biochem, D-72076 Tubingen, Germany.
RP Lee-Thedieck, C (reprint author), Karlsruhe Inst Technol, Inst Funct Interfaces, Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.
EM cornelia.lee-thedieck@kit.edu
RI Lee-Thedieck, Cornelia/H-2835-2013
OI Lee-Thedieck, Cornelia/0000-0001-8863-5403
FU BioInterfaces programme of the Helmholtz-Association; Brigitte
   Schlieben-Lange-Programm; kathe und Josef Klinz-Stiftung
FX We thank Aftin Ross (Karlsruhe Institute of Technology, Karlsruhe,
   Germany) for critically reviewing and editing the manuscript. We are
   grateful to Prof. W. Aicher (University Hospital of Tubingen, Tubingen,
   Germany) and Prof. Eissner (Munich University Medical Centre, Munich,
   Germany) for kindly providing us with mesenchymal stem cells. The
   project was supported by the BioInterfaces programme of the
   Helmholtz-Association, the 'Brigitte Schlieben-Lange-Programm' and the
   'kathe und Josef Klinz-Stiftung'.
CR Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004
   ARMEANU S, 1995, J CELL BIOL, V131, P243, DOI 10.1083/jcb.131.1.243
   Aydin D, 2010, LANGMUIR, V26, P15472, DOI 10.1021/la103065x
   Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709
   Betz MW, 2010, BIOMACROMOLECULES, V11, P1160, DOI 10.1021/bm100061z
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Chiu YC, 2010, TISSUE ENG PART C-ME, V16, P905, DOI [10.1089/ten.tec.2009.0646, 10.1089/ten.TEC.2009.0646]
   Choi JS, 2012, BIOMATERIALS, V33, P4460, DOI 10.1016/j.biomaterials.2012.03.010
   Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003
   Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041
   Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783
   Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132
   Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829
   Ferreira MSV, 2012, BIOMATERIALS, V33, P6987, DOI 10.1016/j.biomaterials.2012.06.029
   Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433
   Guitart AV, 2010, EXP HEMATOL, V38, P847, DOI 10.1016/j.exphem.2010.06.002
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hines M, 2008, J CHEM TECHNOL BIOT, V83, P421, DOI 10.1002/jctb.1856
   Isern J, 2013, CELL REP, V3, P1714, DOI 10.1016/j.celrep.2013.03.041
   Kadereit S, 2002, STEM CELLS, V20, P573, DOI 10.1634/stemcells.20-6-573
   Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   KNAPP W, 1995, ANN HEMATOL, V70, P281, DOI 10.1007/s002770050070
   Kurth I, 2011, MACROMOL BIOSCI, V11, P739, DOI 10.1002/mabi.201000432
   Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4
   Lee J, 2009, SMALL, V5, P1008, DOI 10.1002/smll.200801242
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Lee-Thedieck C, 2012, MACROMOL RAPID COMM, V33, P1432, DOI 10.1002/marc.201200219
   Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034
   Lu LL, 2006, HAEMATOL-HEMATOL J, V91, P1017
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Mortera-Blanco T, 2011, BIOMATERIALS, V32, P9263, DOI 10.1016/j.biomaterials.2011.08.051
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Nichols JE, 2009, BIOMATERIALS, V30, P1071, DOI 10.1016/j.biomaterials.2008.10.041
   OGAWA M, 1993, BLOOD, V81, P2844
   Puch S, 2001, J CELL SCI, V114, P1567
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Rao M, 2012, STEM CELLS, V30, P55, DOI 10.1002/stem.770
   Rochet N, 2003, EUR J HAEMATOL, V70, P43, DOI 10.1034/j.1600-0609.2003.02766.x
   Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Snoeck HW, 2013, CURR OPIN HEMATOL, V20, P355, DOI 10.1097/MOH.0b013e3283623c77
   Taichman RS, 1996, BLOOD, V87, P518
   Thomas E D, 1999, Biol Blood Marrow Transplant, V5, P341, DOI 10.1016/S1083-8791(99)70010-8
   Umemoto T, 2008, BIOCHEM BIOPH RES CO, V365, P176, DOI 10.1016/j.bbrc.2007.10.168
   Wagers AJ, 2006, STEM CELLS, V24, P1087, DOI 10.1634/stemcells.2005-0396
   Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280
   Wagner W, 2008, EXP GERONTOL, V43, P974, DOI 10.1016/j.exger.2008.04.007
   Walasek MA, 2012, ANN NY ACAD SCI, V1266, P138, DOI 10.1111/j.1749-6632.2012.06549.x
   Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081
   Zaidi N, 2007, FEBS J, V274, P3138, DOI 10.1111/j.1742-4658.2007.05846.x
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
NR 55
TC 57
Z9 58
U1 4
U2 112
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2014
VL 35
IS 3
BP 929
EP 940
DI 10.1016/j.biomaterials.2013.10.038
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 277GL
UT WOS:000328806900006
PM 24176196
DA 2018-10-20
ER

PT J
AU Hu, P
   Hu, XL
   Chen, CJ
   Hou, DF
   Huang, YH
AF Hu, Pei
   Hu, Xianluo
   Chen, Chaoji
   Hou, Dongfang
   Huang, Yunhui
TI Biomaterial-assisted synthesis of AgCl@Ag concave cubes with efficient
   visible-light-driven photocatalytic activity
SO CRYSTENGCOMM
LA English
DT Article
ID HIGHLY EFFICIENT; FACILE SYNTHESIS; PLASMONIC PHOTOCATALYST;
   COMPOSITE-MATERIALS; MECHANISM; NANOCOMPOSITES; PERFORMANCE; NANOSHEETS;
   WATER; FILM
AB A facile biomaterial-assisted method has been developed to fabricate AgCl@Ag concave cubes. The biomaterial agar gel was used to moderate the reaction process by providing a reaction matrix to mediate the diffusion of reactants and confine the growth of AgCl@Ag concave cubes. The whole reaction process was performed under mild conditions without heat treatment or organic additives. The as-formed AgCl@Ag concave cubes as a photocatalyst exhibit effective activity for photocatalytic degradation of methyl orange (MO) under visible-light irradiation, which is mainly attributed to the surface plasmon resonance (SPR) of Ag nanoparticles.
C1 [Hu, Pei; Hu, Xianluo; Chen, Chaoji; Hou, Dongfang; Huang, Yunhui] Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
RP Hu, XL (reprint author), Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
EM huxl@mail.hust.edu.cn; huangyh@mail.hust.edu.cn
RI Hu, Xianluo/E-6442-2010; Chen, Chaoji/G-7577-2017; Huang,
   Yunhui/C-3752-2014
OI Hu, Xianluo/0000-0002-5769-167X; Chen, Chaoji/0000-0001-9553-554X; 
FU Natural Science Foundation of China [21271078, 51002057]; PCSIRT
   (Program for Changjiang Scholars and Innovative Research Team in
   University); NCET (Program for New Century Excellent Talents in
   University) [NECT-12-0223]
FX This work was supported by Natural Science Foundation of China (grant
   nos. 21271078 and 51002057), PCSIRT (Program for Changjiang Scholars and
   Innovative Research Team in University), and NCET (Program for New
   Century Excellent Talents in University, no. NECT-12-0223).
CR Ai LH, 2013, APPL CATAL B-ENVIRON, V142, P744, DOI 10.1016/j.apcatb.2013.05.053
   An CH, 2010, ADV MATER, V22, P2570, DOI 10.1002/adma.200904116
   Bi YP, 2009, CHEM COMMUN, P6551, DOI 10.1039/b913725d
   Chen DL, 2012, CHEM-EUR J, V18, P5192, DOI 10.1002/chem.201103787
   Estroff LA, 2001, CHEM MATER, V13, P3227, DOI 10.1021/cm010110k
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Glaus S, 2003, PHOTOCH PHOTOBIO SCI, V2, P398, DOI 10.1039/b211678b
   Han L, 2013, CHEM COMMUN, V49, P4953, DOI 10.1039/c3cc41798k
   Han L, 2011, NANOSCALE, V3, P2931, DOI 10.1039/c1nr10247h
   Hou DF, 2013, NANOSCALE, V5, P9764, DOI [10.1039/c3nr02458j, 10.1039/c2nr33750a]
   Hu XL, 2010, LANGMUIR, V26, P3031, DOI 10.1021/la902142b
   Jiang J, 2011, CHEM-EUR J, V17, P3710, DOI 10.1002/chem.201002951
   Khan SUM, 2002, SCIENCE, V297, P2243, DOI 10.1126/science.1075035
   Li YY, 2010, J PHYS CHEM C, V114, P3175, DOI 10.1021/jp911678q
   Liu WJ, 2012, APPL CATAL B-ENVIRON, V123, P78, DOI 10.1016/j.apcatb.2012.04.033
   Lou ZZ, 2011, DALTON T, V40, P4104, DOI 10.1039/c0dt01795g
   Maeda K, 2007, J PHYS CHEM C, V111, P18264, DOI 10.1021/jp0765188
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Matos R. A. D., 2013, COLLOID SURF A, V423, P58
   Shalom M, 2013, J AM CHEM SOC, V135, P7118, DOI 10.1021/ja402521s
   Shukla MK, 2012, BIORESOURCE TECHNOL, V107, P295, DOI 10.1016/j.biortech.2011.11.092
   Takezawa Y, 2006, SMALL, V2, P390, DOI [10.1002/smll.200500343, 10.1002/50111.200500343]
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wang P, 2008, ANGEW CHEM INT EDIT, V47, P7931, DOI 10.1002/anie.200802483
   Wang P, 2010, CHEM-EUR J, V16, P538, DOI 10.1002/chem.200901954
   Wang P, 2009, CHEM-EUR J, V15, P1821, DOI 10.1002/chem.200802327
   Wang WG, 2012, CHEM-ASIAN J, V7, P1902, DOI 10.1002/asia.201200197
   Wang XF, 2011, CHEM-EUR J, V17, P7777, DOI 10.1002/chem.201101032
   Ye LQ, 2012, ACS CATAL, V2, P1677, DOI 10.1021/cs300213m
   Yu JC, 2005, ENVIRON SCI TECHNOL, V39, P1175, DOI 10.1021/es035374h
   Zhang H, 2008, CHEM MATER, V20, P6543, DOI 10.1021/cm801796q
   Zhang H, 2011, ENVIRON SCI TECHNOL, V45, P5731, DOI 10.1021/es2002919
   Zhu MS, 2011, ACS NANO, V5, P4529, DOI 10.1021/nn200088x
NR 33
TC 19
Z9 19
U1 3
U2 56
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1466-8033
J9 CRYSTENGCOMM
JI Crystengcomm
PY 2014
VL 16
IS 4
BP 649
EP 653
DI 10.1039/c3ce41925h
PG 5
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA 273QO
UT WOS:000328551400020
DA 2018-10-20
ER

PT J
AU Liu, RY
   Qin, JQ
   Zhao, L
   Zhang, XZ
   Xue, XK
AF Liu, Ruoyan
   Qin, Jianqiang
   Zhao, Li
   Zhang, Xianzuo
   Xue, Xukai
TI The Microstructures and Materials of Nerve Conduits Used in Peripheral
   Nerve Regeneration
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Neural Scaffold; Peripheral Nerve Injuries; Nerve Tissue Engineering;
   Regenerative Medicine; Biomaterial; Microstructure; Clinical
   Applications.
ID RAT SCIATIC-NERVE; CILIARY NEUROTROPHIC FACTOR; SCHWANN-CELL BEHAVIOR;
   AUTOGENOUS VEIN GRAFT; NEURITE OUTGROWTH; IN-VITRO;
   EXTRACELLULAR-MATRIX; HYALURONIC-ACID; SILICONE TUBES; ULNAR NERVE
AB The curing of nerve injuries by bridging nerve gaps remains not only a pressing medical need, but also a great operative challenge for surgeons. Autologous nerve grafting have long been considered the gold standard of repairing injured nerves for its outcomes, but nevertheless it can be made better by eliminating its drawbacks. Advances in the field of tissue engineering have led to the development of artificial nerve guidance conduits (NGCs), each striving to be viable alternatives to autograft. There is now a diverse array of biomaterials, either of natural or synthetic origin, that when combined with well-defined fabrication techniques, have produced neural scaffolds with different structures and properties. This article critically reviews the requirements of an ideal nerve guidance conduit (NGC), by analyzing available materials, structures and suitability for clinical application as conduits for peripheral nerve repair. Their characteristics, benefits and drawbacks will be compared with respect to their development history and future development potential.
C1 [Liu, Ruoyan; Qin, Jianqiang; Zhao, Li; Zhang, Xianzuo; Xue, Xukai] Southern Med Univ, Dept Anat, Guangzhou 510515, Guangdong, Peoples R China.
RP Qin, JQ (reprint author), Southern Med Univ, Dept Anat, Guangzhou 510515, Guangdong, Peoples R China.
OI Zhang, Xianzuo/0000-0002-6432-7745
FU Science and Technology Development Fund of Macau [016/2009/A1]
FX Author contributions: Ruoyan Liu and Jianqiang Qin contributed to the
   design and conception of the manuscript. Ruoyan Liu, Li Zhao, Xianzuo
   Zhang, Xukai Xue conducted the literature search. Ruoyan Liu prepared
   the primary manuscript and table. Jianqiang Qin critically revised the
   primary manuscript. All authors approved the final version of the
   manuscript. Funding: The Science and Technology Development Fund of
   Macau, No. 01 6/2009/A1
CR AEBISCHER P, 1990, BRAIN RES, V531, P211, DOI 10.1016/0006-8993(90)90776-8
   Ahmed Z, 1999, CELL MOTIL CYTOSKEL, V42, P331
   Alhosseini SN, 2012, INT J NANOMED, V7, P25, DOI 10.2147/IJN.S25376
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Alluin O, 2009, BIOMATERIALS, V30, P363, DOI 10.1016/j.biomaterials.2008.09.043
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   Ayhan S, 2003, MICROSURG, V23, P49, DOI 10.1002/micr.10088
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Barcelos AS, 2003, MICROSURG, V23, P66, DOI 10.1002/micr.10083
   Barnes CA, 2011, BIOMATERIALS, V32, P137, DOI 10.1016/j.biomaterials.2010.09.007
   Bax DV, 2012, ACTA BIOMATER, V8, P2538, DOI 10.1016/j.actbio.2012.03.023
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Bian YZ, 2009, BIOMATERIALS, V30, P217, DOI 10.1016/j.biomaterials.2008.09.036
   Biazar E, 2010, INT J NANOMED, V5, P839, DOI 10.2147/IJN.S11883
   Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Bozkurt A, 2012, BIOMATERIALS, V33, P1363, DOI 10.1016/j.biomaterials.2011.10.069
   Brandt J, 2002, SCAND J PLAST RECONS, V36, P2, DOI 10.1080/028443102753478309
   Brooks DN, 2012, MICROSURG, V32, P1, DOI 10.1002/micr.20975
   Bushnell BD, 2008, J HAND SURG-AM, V33A, P1081, DOI 10.1016/j.jhsa.2008.03.015
   Cao JI, 2011, BIOMATERIALS, V32, P3939, DOI 10.1016/j.biomaterials.2011.02.020
   Chamberlain LJ, 1998, BIOMATERIALS, V19, P1393, DOI 10.1016/S0142-9612(98)00018-0
   Chiriac S, 2012, J HAND SURG-EUR VOL, V37E, P342, DOI 10.1177/1753193411422685
   CHIU DTW, 1982, SURGERY, V91, P226
   Collazos-Castro JE, 2010, BIOMATERIALS, V31, P9244, DOI 10.1016/j.biomaterials.2010.08.057
   Crouzier T, 2009, J BIOMED MATER RES A, V89A, P818, DOI 10.1002/jbm.a.32103
   Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004
   Dahlin LB, 2001, SCAND J PLAST RECONS, V35, P29, DOI 10.1080/02844310151032510
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   Deal DN, 2012, J AM ACAD ORTHOP SUR, V20, P63, DOI 10.5435/JAAOS-20-02-063
   DIAZFLORES L, 1995, HISTOL HISTOPATHOL, V10, P937
   Donoghoe N, 2007, MICROSURG, V27, P595, DOI 10.1002/micr.20408
   Ehashi T, 2011, J BIOMAT SCI-POLYM E, V22, P627, DOI 10.1163/092050610X488250
   Frattini F, 2012, TISSUE ENG PT A, V18, P2030, DOI [10.1089/ten.TEA.2011.0496, 10.1089/ten.tea.2011.0496]
   Gamez E, 2003, CELL TRANSPLANT, V12, P481, DOI 10.3727/000000003108747046
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Ghaznavi AM, 2011, ANN PLAS SURG, V66, P273, DOI 10.1097/SAP.0b013e3181e6cff7
   Griffin J, 2011, J BIOMED MATER RES A, V97A, P230, DOI 10.1002/jbm.a.33049
   Gu JH, 2012, J TISSUE ENG REGEN M, V6, P163, DOI 10.1002/term.407
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Guarino V, 2013, ADV HEALTHC MATER, V2, P218, DOI 10.1002/adhm.201200152
   Hafeman AE, 2011, BIOMATERIALS, V32, P419, DOI 10.1016/j.biomaterials.2010.08.108
   Hashimoto T, 2002, EXP BRAIN RES, V146, P356, DOI 10.1007/s00221-002-1173-y
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Hill PS, 2011, TISSUE ENG PT A, V17, P1499, DOI 10.1089/ten.tea.2010.0184
   Hozumi K, 2012, BIOMATERIALS, V33, P4241, DOI 10.1016/j.biomaterials.2012.02.055
   Hsu SH, 2011, BIOMATERIALS, V32, P3764, DOI 10.1016/j.biomaterials.2011.01.065
   Huang LH, 2008, BIOMACROMOLECULES, V9, P850, DOI 10.1021/bm7011828
   Huang LH, 2007, BIOMATERIALS, V28, P1741, DOI 10.1016/j.biomaterials.2006.12.007
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Hudson TW, 2004, TISSUE ENG, V10, P1346, DOI 10.1089/ten.2004.10.1346
   Ichihara S, 2009, TISSUE ENG PART C-ME, V15, P387, DOI 10.1089/ten.tec.2008.0508
   Ignazio M, 2010, J HAND SURG-AM, V35A, P1418, DOI 10.1016/j.jhsa.2010.05.019
   Jansen K, 2004, J BIOMED MATER RES A, V69A, P334, DOI 10.1002/jbm.a.30004
   JENO CB, 1985, BRAIN RES, V361, P233
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jung SY, 2012, BIOMATERIALS, V33, P3967, DOI 10.1016/j.biomaterials.2012.02.002
   Junka R, 2013, J BIOMATER TISS ENG, V3, P494, DOI 10.1166/jbt.2013.1110
   Karabekmez Furkan E, 2009, Hand (N Y), V4, P245, DOI 10.1007/s11552-009-9195-6
   KAUPPILA T, 1993, EXP NEUROL, V123, P181, DOI 10.1006/exnr.1993.1151
   Kaw A. K., 2006, MECH COMPOSITE MAT, P2
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kijenska E, 2012, J BIOMED MATER RES B, V100B, P1093, DOI 10.1002/jbm.b.32676
   Kim BS, 2004, J BIOMED MATER RES A, V68A, P201, DOI 10.1002/jbm.a.10045
   Kim SW, 2006, MACROMOL RES, V14, P94, DOI 10.1007/BF03219074
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Lee YS, 2011, ACTA BIOMATER, V7, P3877, DOI 10.1016/j.actbio.2011.07.013
   Lee Y, 2008, MICROSURG, V28, P436, DOI 10.1002/micr.20517
   Lee YH, 2005, BIOMATERIALS, V26, P3165, DOI 10.1016/j.biomaterials.2004.08.018
   Li LH, 2012, BIOMATERIALS, V33, P3428, DOI 10.1016/j.biomaterials.2012.01.038
   Lu MC, 2009, J MATER SCI-MATER M, V20, P1175, DOI 10.1007/s10856-008-3646-4
   Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007
   LUNDBORG G, 1991, SCAND J PLAST RECONS, V25, P79, DOI 10.3109/02844319109034927
   LUNDBORG G, 1981, J NEUROSCI RES, V6, P265, DOI 10.1002/jnr.490060302
   LUNDBORG G, 1982, J NEUROPATH EXP NEUR, V41, P412, DOI 10.1097/00005072-198207000-00004
   Lundborg G, 2004, J HAND SURG-BRIT EUR, V29B, P100, DOI 10.1016/j.jhsb.2003.09.018
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Man AJ, 2011, TISSUE ENG PT A, V17, P2931, DOI 10.1089/ten.tea.2011.0030
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813
   Masand SN, 2012, BIOMATERIALS, V33, P790, DOI 10.1016/j.biomaterials.2011.10.013
   Matsumine H., 2012, J TISSUE EN IN PRESS
   Meek MF, 2004, TISSUE ENG, V10, P1027, DOI 10.1089/ten.2004.10.1027
   Meek MF, 2002, J ORAL MAXIL SURG, V60, P1095, DOI 10.1053/joms.2002.35627
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   Mihai R, 2011, J Med Life, V4, P250
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   MOLANDER H, 1982, MUSCLE NERVE, V5, P54, DOI 10.1002/mus.880050110
   Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015
   Neal RA, 2012, J BIOMED MATER RES A, V100A, P406, DOI 10.1002/jbm.a.33204
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Odian G., 2004, PRINCIPLES POLYM, P135
   Polyganics BV (Netherlands), POL BV NETH NEUR 4 1
   Polyganics BV (Netherlands), POL BV NETH SPEC 510
   Prabhakaran MP, 2011, J NANOSCI NANOTECHNO, V11, P3039, DOI 10.1166/jnn.2011.3753
   Raimondo S, 2005, J COMP NEUROL, V489, P249, DOI 10.1002/cne.20625
   Rinker B, 2011, J HAND SURG-AM, V36A, P775, DOI 10.1016/j.jhsa.2011.01.030
   Risitano G, 2002, Chir Main, V21, P194, DOI 10.1016/S1297-3203(02)00109-9
   Rosson GD, 2009, MICROSURG, V29, P107, DOI 10.1002/micr.20580
   Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5
   Runge MB, 2010, BIOMATERIALS, V31, P5916, DOI 10.1016/j.biomaterials.2010.04.012
   Sailer M, 2012, BIOMATERIALS, V33, P5841, DOI 10.1016/j.biomaterials.2012.05.001
   SCHALLER E, 1988, Handchirurgie Mikrochirurgie Plastische Chirurgie, V20, P7
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Scott JB, 2011, BIOMATERIALS, V32, P4830, DOI 10.1016/j.biomaterials.2011.03.037
   SECKEL BR, 1995, J NEUROSCI RES, V40, P318, DOI 10.1002/jnr.490400305
   Sedaghati T, 2011, BIOTECHNOL APPL BIOC, V58, P288, DOI 10.1002/bab.51
   Shen H, 2010, J BIOMED MATER RES B, V95B, P161, DOI 10.1002/jbm.b.31696
   Shi GX, 2008, BIOMATERIALS, V29, P3792, DOI 10.1016/j.biomaterials.2008.06.010
   Smith RM, 2004, J INVEST SURG, V17, P339, DOI 10.1080/08941930490524417
   Soller EC, 2012, BIOMATERIALS, V33, P4783, DOI 10.1016/j.biomaterials.2012.03.068
   Spivey EC, 2012, BIOMATERIALS, V33, P4264, DOI 10.1016/j.biomaterials.2012.02.043
   Stanec S, 1998, BRIT J PLAST SURG, V51, P637, DOI 10.1054/bjps.1998.9996
   Stanec S, 1998, J RECONSTR MICROSURG, V14, P227, DOI 10.1055/s-2007-1000173
   Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024
   Tantuwaya VS, 1997, BRAIN RES, V759, P58, DOI 10.1016/S0006-8993(97)00247-3
   Taras JS, 2011, J HAND SURG-AM, V36A, P1441, DOI 10.1016/j.jhsa.2011.06.009
   Terada N, 1997, SCAND J PLAST RECONS, V31, P1
   Thompson BC, 2011, BIOMATERIALS, V32, P3822, DOI 10.1016/j.biomaterials.2011.01.053
   Thompson BC, 2010, J CONTROL RELEASE, V141, P161, DOI 10.1016/j.jconrel.2009.09.016
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Timnak A, 2011, J MATER SCI-MATER M, V22, P1555, DOI 10.1007/s10856-011-4316-5
   U. S. National Institutes of Health, COMP POSTM STUD COMM
   WALTON RL, 1989, PLAST RECONSTR SURG, V84, P944, DOI 10.1097/00006534-198912000-00013
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wang KK, 1998, MICROSURG, V18, P270, DOI 10.1002/(SICI)1098-2752(1998)18:4<270::AID-MICR11>3.0.CO;2-V
   Wang S, 2001, BIOMATERIALS, V22, P1157, DOI 10.1016/S0142-9612(00)00356-2
   Wangensteen Kirk J, 2010, Hand (N Y), V5, P273, DOI 10.1007/s11552-009-9245-0
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   WHITWORTH IH, 1995, J HAND SURG-BRIT EUR, V20B, P429, DOI 10.1016/S0266-7681(05)80148-2
   WILLIAMS LR, 1993, EXP NEUROL, V120, P49, DOI 10.1006/exnr.1993.1039
   Xu HX, 2011, BIOMATERIALS, V32, P4506, DOI 10.1016/j.biomaterials.2011.02.023
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006
   Yoshii S, 2003, J BIOMED MATER RES A, V67A, P467, DOI 10.1002/jbm.a.10103
   Yoshii S, 2002, BRAIN RES, V949, P202, DOI 10.1016/S0006-8993(02)03149-9
   Yu WW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-68
   Yue ZL, 2011, BIOMATERIALS, V32, P4714, DOI 10.1016/j.biomaterials.2011.03.032
   ZHAO Q, 1993, RESTOR NEUROL NEUROS, V5, P197, DOI 10.3233/RNN-1993-5304
   Zhu JX, 2012, INT J BIOL MACROMOL, V51, P105, DOI 10.1016/j.ijbiomac.2012.04.022
NR 144
TC 6
Z9 6
U1 0
U2 56
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD JAN
PY 2014
VL 4
IS 1
BP 65
EP 83
DI 10.1166/jbt.2014.1138
PG 19
WC Cell & Tissue Engineering
SC Cell Biology
GA 272FT
UT WOS:000328446400009
DA 2018-10-20
ER

PT J
AU Lensing, R
   Behrens, P
   Muller, PP
   Lenarz, T
   Stieve, M
AF Lensing, Rebecca
   Behrens, Peter
   Mueller, Peter Paul
   Lenarz, Thomas
   Stieve, Martin
TI In vivo testing of a bioabsorbable magnesium alloy serving as total
   ossicular replacement prostheses
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Animal model; magnesium alloy; biodegradation; osteoinduction; middle
   ear
ID IMPLANTS; SCAFFOLDS; CORROSION; SURFACE; HYDROXYAPATITE; OSTEOGENESIS;
   DEGRADATION; TECHNOLOGY; MECHANISMS; ADHESION
AB Magnesium alloys have been investigated in different fields of medicine and represent a promising biomaterial for implants due to characteristics like bioabsorbability and osteoinduction. The objective of this study was to evaluate the usability of magnesium as implant material in middle ear surgery. Magnesium implants were placed into the right middle ear of eighteen New Zealand White rabbits. Nine animals were euthanized after four weeks and nine animals after three month. The petrous bones were removed and embedded in epoxy resin. The specimens were then polished, stained and evaluated with the aid of a light microscope. The histological examination revealed a good biocompatibility. After four weeks, a beginning corrosion of the implant's surface and low amount of trabecular bone formation in the area of the stapes base plate was observed. A considerable degradation of implants and obvious bone formation was found three month after implantation. The magnesium alloy used in the present study partly corroded too fast, so that a complete bone reconstruction could not be established in time. The increased osteoinduction on the stapes base plate resulted in a tight bone-implant bonding. Thus, a promising application of magnesium could be a coating of biomaterials in order to improve the bony integration of implants.
C1 [Lensing, Rebecca; Lenarz, Thomas; Stieve, Martin] Hannover Med Sch, Dept Otolaryngol, D-30625 Hannover, Germany.
   [Behrens, Peter] Leibniz Univ Hannover, Inst Inorgan Chem, Hannover, Germany.
   [Mueller, Peter Paul] Helmholtz Ctr Infect Res, Braunschweig, Germany.
RP Lensing, R (reprint author), Hannover Med Sch, Dept Otolaryngol, Carl Neubergstr 1, D-30625 Hannover, Germany.
EM Lensing.Rebecca@mh-hannover.de
OI Mueller, Peter/0000-0002-1209-7546
CR Ashammakhi N, 2003, J CRANIOFAC SURG, V14, P247, DOI 10.1097/00001665-200303000-00021
   Beck A, 2001, MAGNESIUM SEINE LEGI
   Erbel R, 2007, HERZ, V32, P308, DOI 10.1007/s00059-007-2995-y
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Huehnerschulte TA, 2011, MATERIALS, V4, P1144, DOI 10.3390/ma4061144
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kontakis GM, 2007, ACTA ORTHOP BELG, V73, P159
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Lueers JC, 2010, LARYNGO RHINO OTOL, V89, P172, DOI 10.1055/s-0030-1248308
   Pietak A, 2008, J MATER SCI-MATER M, V19, P407, DOI 10.1007/s10856-007-3172-9
   Revell PA, 2004, KEY ENG MAT, V254-2, P447, DOI 10.4028/www.scientific.net/KEM.254-256.447
   Shaw B.A., 2003, ASM HDB A, V13, P692
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, MATERIALWISS WERKST, V37, P504, DOI 10.1002/mawe.200600027
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2004, FERTIGUNG MAGNESIUM, P692
   Witte F, 2008, J BIOMED MATER RES A, V86A, P1041, DOI 10.1002/jbm.a.31713
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zeng R, 2008, ADV ENG MAT, V10
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 29
TC 5
Z9 5
U1 3
U2 18
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2014
VL 28
IS 5
BP 688
EP 696
DI 10.1177/0885328212472246
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 278HT
UT WOS:000328880600005
PM 23292719
DA 2018-10-20
ER

PT J
AU Sabbatini, M
   Boccafoschi, F
   Bosetti, M
   Cannas, M
AF Sabbatini, Maurizio
   Boccafoschi, Francesca
   Bosetti, Michela
   Cannas, Mario
TI Adhesion and differentiation of neuronal cells on Zn-doped bioactive
   glasses
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE GAP-43; neuronal cell line; protein adsorption; bioactive glass;
   biocompatibility
ID NEUROBLASTOMA-CELLS; RETINOIC ACID; SERINE 41; GAP-43; ZINC; DYNAMICS;
   APOPTOSIS; BEHAVIOR; CONTACT; MATRIX
AB To verify the compatibility of rigid supports with neuronal cells for biomechanical application, we have evaluated the biocompatibility of Zn-doped bioglasses versus neuronal cell line SKNBE. Undifferentiated and retinoic acid-differentiated cells were used. We have observed that bioglasses doped with low concentration of Zn favored cell adhesion and proliferation of undifferentiated SKNBE neuronal cells, while the high Zn concentration strongly interfered with cell proliferation. Instead the high Zn concentration lightly stimulates the adhesive and strongly stimulates the phenotype characterization of differentiated SKNBE cells. Focal contact sites were observed in cells performing spread adhesive morphology, while they were down-regulated in cells performing differentiation behavior. GAP-43 and neurofilament were expressed in differentiated cells. However, GAP-43 was also found to be expressed in undifferentiated cells, where its expression seems related to proliferative behavior of cells. This work evidenced the importance of the biomaterial chemical structure in influencing proliferation or differentiation pathways of neuronal cells.
C1 [Sabbatini, Maurizio; Boccafoschi, Francesca; Cannas, Mario] Res Ctr Biocompatibil & Tissue Engn, Dept Hlth Sci, Novara, Italy.
   [Bosetti, Michela] Univ Piemonte Orientale, Dept Pharmaceut Sci, Novara, Italy.
RP Sabbatini, M (reprint author), Univ Piemonte Orientale, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy.
EM maurizio.sabbatini@med.unipmn.it
OI Bosetti, Michela/0000-0002-3682-8702; Boccafoschi,
   Francesca/0000-0002-6734-5447
FU Italian Ministero dell'Istruzione, del'Universita e della Ricerca (MIUR)
   [20003032158_004]
FX This work was supported by grant from Italian Ministero dell'Istruzione,
   del'Universita e della Ricerca (MIUR): project PRIN 2006, Prot. No
   20003032158_004.
CR Aina V, 2009, ACTA BIOMATER, V5, P1211, DOI 10.1016/j.actbio.2008.10.020
   Aina V, 2007, CHEM-BIOL INTERACT, V167, P207, DOI 10.1016/j.cbi.2007.03.002
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Bozzo C, 1997, EXP CELL RES, V237, P326, DOI 10.1006/excr.1997.3777
   Bunting S, 2005, J HAND SURG-BRIT EUR, V30B, P242, DOI 10.1016/j.jhsh.2004.11.003
   Chambaut-Guerin AM, 2000, J NEUROCHEM, V74, P508, DOI 10.1046/j.1471-4159.2000.740508.x
   Deb S, 2010, J MATER SCI-MATER M, V21, P893, DOI 10.1007/s10856-009-3936-5
   Fromherz P, 2006, ANN NY ACAD SCI, V1093, P143, DOI 10.1196/annals.1382.011
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   He Q, 1997, J NEUROSCI, V17, P3515
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31
   Kontonasaki E, 2008, DENT MATER, V24, P1362, DOI 10.1016/j.dental.2008.03.002
   Linati L, 2005, J PHYS CHEM B, V109, P4989, DOI 10.1021/jp046631n
   Lusvardi G, 2008, J BIOMATER APPL, V22, P505, DOI 10.1177/0885328207079731
   Lusvardi G, 2002, J PHYS CHEM B, V106, P9753, DOI 10.1021/jp020321s
   Mani S, 2001, MOL CELL NEUROSCI, V17, P54, DOI 10.1006/mcne.2000.0931
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Mishra R, 2008, CELL CYCLE, V7, P348, DOI 10.4161/cc.7.3.5235
   Nguyen L, 2009, MOL CELL NEUROSCI, V41, P62, DOI 10.1016/j.mcn.2009.01.011
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rozzo C, 1997, CELL DEATH DIFFER, V4, P713, DOI 10.1038/sj.cdd.4400304
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Silvagno F, 2002, FEBS LETT, V532, P153, DOI 10.1016/S0014-5793(02)03667-0
   Truong-Tran AQ, 2001, BIOMETALS, V14, P315, DOI 10.1023/A:1012993017026
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
NR 26
TC 3
Z9 3
U1 3
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2014
VL 28
IS 5
BP 708
EP 718
DI 10.1177/0885328212474944
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 278HT
UT WOS:000328880600007
PM 23413232
DA 2018-10-20
ER

PT J
AU Yang, YW
   Wu, JY
   Liu, CT
   Liao, GC
   Huang, HY
   Hsu, RQ
   Chiang, MH
   Wu, JS
AF Yang, Yi-Wei
   Wu, Jane-Yii
   Liu, Chih-Tung
   Liao, Guo-Chun
   Huang, Hsuan-Yu
   Hsu, Ray-Quen
   Chiang, Ming-Hung
   Wu, Jong-Shinn
TI Fast incorporation of primary amine group into polylactide surface for
   improving C2C12 cell proliferation using nitrogen-based
   atmospheric-pressure plasma jets
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE atmospheric-pressure; plasma; DBD; tissue engineering; biomaterial; PLA;
   cell proliferation
ID LOW-DENSITY POLYETHYLENE; MECHANICAL-PROPERTIES; FUNCTIONAL-GROUPS;
   FREE-ENERGY; POLYMERS; ADHESION; FILM; BIOMATERIALS; WETTABILITY;
   MEMBRANES
AB In this article, we report the development of the fast incorporation of primary amine functional groups into a polylactide (PLA) surface using the post-discharge jet region of an atmospheric-pressure nitrogen-based dielectric barrier discharge (DBD). Plasma treatments were carried out in two sequential steps: (1) nitrogen with 0.1% oxygen addition, and (2) nitrogen with 5% ammonia addition. The analyses show that the concentration of N/C ratio, surface energy, contact angle, and surface roughness of the treated PLA surface can reach 19.1%, 70.5 mJ/m(2), 38 degrees and 73.22 nm, respectively. In addition, the proposed two-step plasma treatment procedure can produce a PLA surface exhibiting almost the same C2C12 cell attachment and proliferation performance as that of the conventional gelatin coating method. Most importantly, the processing/preparation time is reduced from 13-15 h (gelatin coating method) to 5-15 min (two-step plasma treatment), which is very useful in practical applications. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 160-169, 2014.
C1 [Yang, Yi-Wei; Liu, Chih-Tung; Liao, Guo-Chun; Huang, Hsuan-Yu; Hsu, Ray-Quen; Chiang, Ming-Hung; Wu, Jong-Shinn] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan.
   [Wu, Jane-Yii] Da Yeh Univ, Dept Bioind Technol, Changhua, Taiwan.
RP Wu, JS (reprint author), Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan.
EM chongsin@faculty.nctu.edu.tw
FU National Science of Council of Taiwan [NSC-101-2221-E-009-041-MY3]
FX Contract grant sponsor: National Science of Council of Taiwan; contract
   grant number: NSC-101-2221-E-009-041-MY3
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   Comelles J, 2010, NANOMED-NANOTECHNOL, V6, P44, DOI 10.1016/j.nano.2009.05.006
   Crist B.V., 2000, HDB MONOCHROMATIC XP
   EVERHART DS, 1981, ANAL CHEM, V53, P665, DOI 10.1021/ac00227a022
   Gupta AP, 2007, EUR POLYM J, V43, P4053, DOI 10.1016/j.eurpolymj.2007.06.045
   Hou X, 2003, CHINESE J POLYM SCI, V21, P227
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Kazuaki N, 2005, JSME INT J C-DYN CON, V48, P411
   Klages CP, 2008, PLASMA PROCESS POLYM, V5, P368, DOI 10.1002/ppap.200700142
   Kostov KG, 2010, SURF COAT TECH, V204, P3064, DOI 10.1016/j.surfcoat.2010.02.008
   Kwon OJ, 2005, SURF COAT TECH, V192, P1, DOI 10.1016/j.surfcoat.2004.09.018
   Lahaye J, 1999, CARBON, V37, P585, DOI 10.1016/S0008-6223(98)00225-5
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   Mortensen H, 2006, JPN J APPL PHYS 1, V45, P8506, DOI 10.1143/JJAP.45.8506
   Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Quirk RA, 2000, MACROMOLECULES, V33, P258, DOI 10.1021/ma9916133
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Socrates G., 2001, INFRARED RAMAN CHARA
   Soradech S, 2012, J FOOD ENG, V108, P94, DOI 10.1016/j.jfoodeng.2011.07.019
   Steen ML, 2001, J MEMBRANE SCI, V188, P97, DOI 10.1016/S0376-7388(01)00375-1
   Tadmor R, 2004, LANGMUIR, V20, P7659, DOI 10.1021/la049410h
   Tang CYY, 2007, J MEMBRANE SCI, V287, P146, DOI 10.1016/j.memsci.2006.10.038
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   WU S, 1973, J ADHESION, V5, P39, DOI 10.1080/00218467308078437
   Yildirim E. D., 2007, PLASMA PROCESS POLYM, V4, P58
NR 32
TC 5
Z9 5
U1 1
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2014
VL 102
IS 1
BP 160
EP 169
DI 10.1002/jbm.a.34681
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256MB
UT WOS:000327313400017
PM 23613278
DA 2018-10-20
ER

PT J
AU Togami, W
   Sei, A
   Okada, T
   Taniwaki, T
   Fujimoto, T
   Nakamura, T
   Tahata, S
   Nakanishi, Y
   Mizuta, H
AF Togami, Wakana
   Sei, Akira
   Okada, Tatsuya
   Taniwaki, Takuya
   Fujimoto, Toru
   Nakamura, Takayuki
   Tahata, Shogo
   Nakanishi, Yoshitaka
   Mizuta, Hiroshi
TI Effects of water-holding capability of the PVF sponge on the adhesion
   and differentiation of rat bone marrow stem cell culture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE coated polyvinyl formal sponge; high water-holding capability; bone
   marrow stem cells; osteogenic ability
ID IN-VITRO; CYTOSKELETAL ORGANIZATION; SURFACE; SCAFFOLDS; WETTABILITY;
   POLYSACCHARIDE; ATTACHMENT; GROWTH; GRAFT; GLASS
AB The aim of the study is to estimate the effects of the water-holding capability of the polyvinyl formal (PVF) sponges on osteogenic response in vitro experiments. The rat bone marrow stem cells (BMCs) were seeded and cultured for up to 4 weeks under static conditions in osteogenic media to evaluate the adhesion, proliferation, differentiation, and mineralization on the Dextran-coated PVF sponges with or without water-holding capability. The BMCs seeded onto the PVF sponges with water-holding capability showed more significant increases in DNA content, alkaline phosphatase (ALP) activity, osteocalcin content, and calcium deposition than those without water-holding capability. These results suggest that the Dextran-coated PVF sponges with high water-holding capability would have potential uses as both a new scaffold to bone tissue engineering and as a new biomaterial. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 247-253, 2014.
C1 [Togami, Wakana; Sei, Akira; Okada, Tatsuya; Taniwaki, Takuya; Fujimoto, Toru; Nakamura, Takayuki; Tahata, Shogo; Mizuta, Hiroshi] Kumamoto Univ, Dept Orthopaed Surg, Fac Life Sci, Chuo Ku, Kumamoto 8608556, Japan.
   [Nakanishi, Yoshitaka] Kumamoto Univ, Grad Sch Sci & Technol, Dept Adv Mech Syst, Chuo Ku, Kumamoto 8608556, Japan.
RP Togami, W (reprint author), Kumamoto Univ, Dept Orthopaed Surg, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.
EM a1203ki@fc.kuh.kumamoto-u.ac.jp
CR Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Chen R, 2007, J MATER CHEM, V17, P3974, DOI 10.1039/b706765h
   CHENU C, 1993, GEODERMA, V56, P143, DOI 10.1016/0016-7061(93)90106-U
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   Flory PJ, 1939, J AM CHEM SOC, V61, P1518, DOI 10.1021/ja01875a053
   FLORY PJ, 1950, J AM CHEM SOC, V72, P5052, DOI 10.1021/ja01167a064
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Gerritsen M, 2000, BIOMATERIALS, V21, P71, DOI 10.1016/S0142-9612(99)00136-2
   Huang W, 2010, BIOMATERIALS, V31, P4278, DOI 10.1016/j.biomaterials.2010.01.059
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Lee SJ, 2003, J COLLOID INTERF SCI, V259, P228, DOI 10.1016/S0021-9797(02)00163-7
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Nakanishi Y, 2009, J BIOMECH SCI ENG, V4, P249, DOI DOI 10.1299/JBSE.4.249
   Nodarian T, 2010, ORTHOP TRAUMATOL-SUR, V96, P593, DOI 10.1016/j.otsr.2010.03.016
   Ohgushi H, 1999, J BIOMED MATER RES, V44, P381, DOI 10.1002/(SICI)1097-4636(19990315)44:4<381::AID-JBM3>3.0.CO;2-E
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   Panagiotis M, 2005, INJURY, V36, pS30, DOI 10.1016/j.injury.2005.10.008
   Quezada Gallo J, 2004, ACTA HORTIC, V682, P1709
   Satriano C, 2001, LANGMUIR, V17, P2243, DOI 10.1021/la001321r
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Tohma Y, 2006, J ORTHOP RES, V24, P595, DOI 10.1002/jor.20085
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   YAMAGUCHI M, 2004, J ARTIF ORGANS, V7, P187
   Yoshikawa Masataka, 2010, Journal of Biomedical Science & Engineering, V3, P751, DOI 10.4236/jbise.2010.38100
   Yoshikawa M, 2009, WORLD ACAD SCI ENG T, V54, P580
   Zhu J, 2005, J POLYM SCI A, V44, P192
NR 34
TC 5
Z9 5
U1 1
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2014
VL 102
IS 1
BP 247
EP 253
DI 10.1002/jbma.34695
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256MB
UT WOS:000327313400025
PM 23657866
DA 2018-10-20
ER

PT J
AU Vulpoi, A
   Simon, V
   Ylanen, H
   Simon, S
AF Vulpoi, A.
   Simon, V.
   Ylanen, H.
   Simon, S.
TI Development and in vitro assessment of bioactive glass/polymer
   nanostructured composites with silver
SO JOURNAL OF COMPOSITE MATERIALS
LA English
DT Article
DE Composite biomaterials; silver; invitro bioactivity; antibacterial
   effect
ID DYNAMIC THERMOGRAVIMETRIC CONDITIONS; POLY(VINYL ALCOHOL);
   THERMOXIDATIVE DEGRADATION; MECHANICAL-PROPERTIES; HYDROLYSIS DEGREE;
   BIOGLASS(R); BLENDS; GLASS; ANTIBACTERIAL; BIOMATERIAL
AB Two composites consisting of non-woven poly-96L/4D-lactide copolymer meshes and a bioactive glass containing silver and silver free were obtained in polyvinyl-alcohol solutions by slurry dipping method under slow mechanical stirring. The development of hydroxyapatite type nanocrystals on samples surface in simulated body fluid proved for both composites the tendency for high level of bioactivity. Their antibacterial effect was evaluated against Gram-negative Escherichia coli and Gram-positive Staphylococcus epidermidis. Both composites showed inhibitory effect on bacterial growth, but only the composite with silver containing bioactive glass proved to have bactericidal effect. The AgCl nanocrystals and Ag3PO4 particles self-assembled on the surface of this composite proved the release of silver ions into simulated body fluid.
C1 [Vulpoi, A.; Simon, V.; Simon, S.] Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania.
   [Vulpoi, A.; Simon, V.; Simon, S.] Univ Babes Bolyai, Inst Interdisciplinary Res Bionanosci, Cluj Napoca 400084, Romania.
   [Vulpoi, A.; Ylanen, H.] Tampere Univ Technol, FIN-33101 Tampere, Finland.
RP Simon, S (reprint author), Univ Babes Bolyai, Fac Phys, M Kogalniceanu 1, Cluj Napoca 400084, Romania.
EM simons@phys.ubbcluj.ro
RI Vulpoi, Adriana/D-3890-2012
OI Vulpoi, Adriana/0000-0001-5334-4980
FU Romanian National University Research Council CNCSIS Romania
   [PCCE-129/2008];  [POSDRU6/1.5/S/3]
FX AV wishes to thank for the financial support provided from programs
   co-financed by The Sectoral Operational Programme Human Resources
   Development, Contract POSDRU6/1.5/S/3 - "Doctoral studies: through
   science towards society''. This work was accomplished in the framework
   of PNII Idei PCCE-129/2008 project granted by the Romanian National
   University Research Council CNCSIS Romania.
CR Alkan M, 2009, J APPL POLYM SCI, V112, P3764, DOI 10.1002/app.29830
   Balamurugan A, 2008, DENT MATER, V24, P1343, DOI 10.1016/j.dental.2008.02.015
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Bellantone M, 2000, J BIOMED MATER RES, V51, P484, DOI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
   Bjorklund TG, 2004, SYNTHETIC MET, V142, P195, DOI 10.1016/j.synthmet.2003.09.007
   Blaker JJ, 2005, J BIOMATER APPL, V20, P81, DOI 10.1177/0885328205054264
   Boccaccini A. R., 2002, Ceramic Engineering and Science Proceedings, V23, P805
   Brizzolara D, 1996, MACROMOLECULES, V29, P191, DOI 10.1021/ma951144e
   Buckley JJ, 2010, J MATER CHEM, V20, P8056, DOI 10.1039/c0jm01500h
   Clupper DC, 2001, J MATER SCI-MATER M, V12, P917, DOI 10.1023/A:1012836426866
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   Hench L.L., 2002, FUTURE STRATEGIES TI, P3
   Homaeigohar SS, 2006, J EUR CERAM SOC, V26, P273, DOI 10.1016/j.jeurceramsoc.2004.10.003
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Ignjatovic N, 2004, APPL SURF SCI, V238, P314, DOI 10.1016/j.apsusc.2004.05.227
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Jung Y, 2005, BIOMATERIALS, V26, P6314, DOI 10.1016/j.biomaterials.2005.04.007
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Newby PJ, 2011, J MATER SCI-MATER M, V22, P557, DOI 10.1007/s10856-011-4240-8
   Niemela T, 2004, KEY ENG MAT, V254-2, P509, DOI 10.4028/www.scientific.net/KEM.254-256.509
   Niiranen N, 2004, J BIOMED MAT RES A, V69, P699
   Olsen-Claire J, 2006, MATERIALWISS WERKST, V37, P577, DOI 10.1002/mawe.200500942
   POPA M, 1972, J POLYM SCI POL CHEM, V10, P3679, DOI 10.1002/pol.1972.170101221
   Ray SS, 2005, PROG MATER SCI, V50, P962, DOI 10.1016/j.pmatsci.2005.05.002
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Sedlarik V, 2010, J BIOMAT SCI-POLYM E, V21, P1421, DOI 10.1163/092050609X12517858243742
   Simon V, 2008, J NON-CRYST SOLIDS, V354, P1751, DOI 10.1016/j.jnoncrysol.2007.08.063
   Suljovrujic E., 2003, RADIAT PHYS CHEM, V67, P375
   VASILE C, 1981, J POLYM SCI POL CHEM, V19, P897, DOI 10.1002/pol.1981.170190405
   Vijayalakshmi SP, 2006, J APPL POLYM SCI, V101, P233, DOI 10.1002/app.23246
   Vulpoi A, 2012, J BIOMED MATER RES A, V100A, P1179, DOI 10.1002/jbm.a.34060
   Vulpoi A, 2012, MAT SCI ENG C-MATER, V32, P178, DOI 10.1016/j.msec.2011.10.015
   Yeh JT, 2008, POLYM-PLAST TECHNOL, V47, P1289, DOI 10.1080/03602550802497958
   Zhou ZH, 2008, J MACROMOL SCI B, V47, P847, DOI 10.1080/00222340802122764
NR 36
TC 7
Z9 7
U1 0
U2 45
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0021-9983
EI 1530-793X
J9 J COMPOS MATER
JI J. Compos Mater.
PD JAN
PY 2014
VL 48
IS 1
BP 63
EP 70
DI 10.1177/0021998312468186
PG 8
WC Materials Science, Composites
SC Materials Science
GA 274HZ
UT WOS:000328598700005
DA 2018-10-20
ER

PT J
AU Rossi, AL
   Moldovan, S
   Querido, W
   Rossi, A
   Werckmann, J
   Ersen, O
   Farina, M
AF Rossi, Andre L.
   Moldovan, Simona
   Querido, William
   Rossi, Alexandre
   Werckmann, Jacques
   Ersen, Ovidiu
   Farina, Marcos
TI Effect of strontium ranelate on bone mineral: Analysis of nanoscale
   compositional changes
SO MICRON
LA English
DT Article
DE Strontium ranelate; Hydroxyapatite; Bone mineral; Biomaterial;
   Biomineralization
ID HIP-REPLACEMENT; IN-VITRO; HYDROXYAPATITE; OSTEOPOROSIS; CARBONATE;
   APATITES; TEMPERATURE; OSTEOBLAST; PHOSPHATE; CRYSTALS
AB Strontium ranelate has been used to prevent bone loss and stimulate bone regeneration. Although strontium may integrate into the bone crystal lattice, the chemical and structural modifications of the bone when strontium interacts with the mineral phase are not completely understood. The objective of this study was to evaluate apatite from the mandibles of rats treated with strontium ranelate in the drinking water and compare its characteristics with those from untreated rats and synthetic apatites with and without strontium. Electron energy loss near edge structures from phosphorus, carbon, calcium and strontium were obtained by electron energy loss spectroscopy in a transmission electron microscope. The strontium signal was detected in the biological and synthetic samples containing strontium. The relative quantification of carbon by analyzing the C-K edge at an energy loss of Delta E = 284 eV showed an increase in the number of carbonate groups in the bone mineral of treated rats. A synthetic strontium-containing sample used as control did not exhibit a carbon signal. This study showed physicochemical modifications in the bone mineral at the nanoscale caused by the systemic administration of strontium ranelate. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Rossi, Andre L.; Rossi, Alexandre] Ctr Brasileiro Pesquisas Fis, BR-22290180 Rio De Janeiro, Brazil.
   [Moldovan, Simona; Ersen, Ovidiu] Inst Phys & Chim Mat Strasbourg, F-67081 Strasbourg, France.
   [Querido, William; Farina, Marcos] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, BR-21941599 Rio De Janeiro, Brazil.
   [Werckmann, Jacques] Inst Nacl Metrol Normalizacao & Qualidade Ind, BR-25245390 Rio De Janeiro, Brazil.
RP Farina, M (reprint author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Av Carlos Chagas Filho,373,Bloco F,Sala F2-027, BR-21941599 Rio De Janeiro, Brazil.
EM mfarina@icb.ufrj.br
RI Querido, William/I-4130-2014; Farina, Marcos/I-3744-2014; Ersen,
   Ovidiu/I-1983-2016
OI Querido, William/0000-0002-1484-2415; Rossi, Andre/0000-0002-9920-4411;
   ERSEN, Ovidiu/0000-0002-1553-0915
FU CNPq; CAPES; FAPERJ; INMETRO Brazilian institutions; French-Brazilian
   cooperation (CAPES-COFECUB)
FX We thank CNPq, CAPES, FAPERJ and INMETRO Brazilian institutions for
   financial support and/or facilities. This work is part of a
   French-Brazilian cooperation (CAPES-COFECUB).
CR Ammann P, 2004, J BONE MINER RES, V19, P2012, DOI 10.1359/JBMR.040906
   Ammann P, 2007, J BONE MINER RES, V22, P1419, DOI 10.1359/jbmr.070607
   Baig AA, 1999, CALCIFIED TISSUE INT, V64, P437, DOI 10.1007/PL00005826
   Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022
   Bazin D, 2011, J SYNCHROTRON RADIAT, V18, P912, DOI 10.1107/S0909049511032651
   Benhayoune H, 2001, J PHYS D APPL PHYS, V34, P141, DOI 10.1088/0022-3727/34/1/321
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Boivin G, 1996, J BONE MINER RES, V11, P1302
   Boivin G., 2003, Osteoporosis International, V14, P19
   Boivin G, 2010, OSTEOPOROSIS INT, V21, P667, DOI 10.1007/s00198-009-1005-z
   Boivin G, 2012, J TRACE ELEM MED BIO, V26, P153, DOI 10.1016/j.jtemb.2012.03.013
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Bunger MH, 2010, CALCIFIED TISSUE INT, V86, P294, DOI 10.1007/s00223-010-9341-8
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Carter DH, 2002, BONE, V31, P389, DOI 10.1016/S8756-3282(02)00840-2
   Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   COLLIEX C, 1991, PHYS REV B, V44, P11402, DOI 10.1103/PhysRevB.44.11402
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Farlay D, 2005, J BONE MINER RES, V20, P1569, DOI 10.1359/JBMR.050405
   GARVIE LAJ, 1994, AM MINERAL, V79, P411
   Gregori G, 2006, J EUR CERAM SOC, V26, P1473, DOI 10.1016/j.jeurceramsoc.2005.02.007
   HARRIES JE, 1987, CALCIFIED TISSUE INT, V41, P346, DOI 10.1007/BF02556675
   Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006
   Li CH, 2010, J BONE MINER RES, V25, P968, DOI 10.1359/jbmr.091038
   Li YF, 2010, BIOMATERIALS, V31, P9006, DOI 10.1016/j.biomaterials.2010.07.112
   Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001
   Li ZY, 2010, J BONE MINER METAB, V28, P25, DOI 10.1007/s00774-009-0109-z
   Liou SC, 2004, BIOMATERIALS, V25, P189, DOI 10.1016/S0142-9612(03)00479-4
   Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105
   Mansot JL, 2003, J MICROSC-OXFORD, V210, P110, DOI 10.1046/j.1365-2818.2003.01171.x
   Marie PJ, 2006, CURR OPIN RHEUMATOL, V18, pS11, DOI 10.1097/01.bor.0000229522.89546.7b
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Meunier PJ, 2009, OSTEOPOROSIS INT, V20, P1663, DOI 10.1007/s00198-008-0825-6
   Ni GX, 2010, J MATER SCI-MATER M, V21, P377, DOI 10.1007/s10856-009-3866-2
   Ni GX, 2006, J BIOMED MATER RES B, V77B, P409, DOI 10.1002/jbm.b.30417
   Oliveira J.P., 2012, CALCIFIED TISSUE INT, V18, P18
   Reginster JY, 2008, ARTHRITIS RHEUM-US, V58, P1687, DOI 10.1002/art.23461
   Roschger P, 2010, J BONE MINER RES, V25, P891, DOI 10.1359/jbmr.091028
   Terra J, 2009, PHYS CHEM CHEM PHYS, V11, P568, DOI 10.1039/b802841a
   Verberckmoes SC, 2004, CALCIFIED TISSUE INT, V75, P405, DOI 10.1007/s00223-004-0260-4
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Williams D. B., 2009, TRANSMISSION ELECT M
   Yao F, 2009, ACTA BIOMATER, V5, P2169, DOI 10.1016/j.actbio.2009.02.007
NR 45
TC 14
Z9 14
U1 3
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD JAN
PY 2014
VL 56
BP 29
EP 36
DI 10.1016/j.micron.2013.09.008
PG 8
WC Microscopy
SC Microscopy
GA 273HT
UT WOS:000328526600004
PM 24207060
DA 2018-10-20
ER

PT J
AU Chinga-Carrasco, G
   Averianova, N
   Kondalenko, O
   Garaeva, M
   Petrov, V
   Leinsvang, B
   Karlsen, T
AF Chinga-Carrasco, Gary
   Averianova, Natalia
   Kondalenko, Olga
   Garaeva, Milyausha
   Petrov, Vladimir
   Leinsvang, Bent
   Karlsen, Trond
TI The effect of residual fibres on the micro-topography of cellulose
   nanopaper
SO MICRON
LA English
DT Article
DE MFC; Nanocellulose; Biomaterial; Surface roughness; Characterization;
   Microscopy
ID MICROFIBRILLATED CELLULOSE; HIGHLY TRANSPARENT; NATIVE CELLULOSE; FILMS;
   NANOFIBRILS; OXIDATION
AB Nanopaper is a new material concept composed of nanocellulose, which has been proposed for a series of applications. Recently, the surface of nanopapers has also been emphasized as an important structure to control. This is due to the potential of nanopaper structures as a substrate for printing functionality, which could expand the applicability of nanopaper as a functionalized biomaterial. In this study, we demonstrate how the roughness of nanopaper is affected by the fraction of residual fibres that were not fibrillated into nanofibrils after a homogenization procedure. The topography and morphology were assessed with laser profilometry, atomic force microscopy and scanning (transmission) electron microscopy. The results show a linear correlation between the estimated fraction of residual fibres and the roughness of the assessed nanopapers. Furthermore, the fraction of residual fibres can be reduced by fractionating the nanocellulose, which is demonstrated in the present work. Such knowledge will be valuable for designing nanopaper surfaces with specific structural characteristics. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Chinga-Carrasco, Gary; Leinsvang, Bent; Karlsen, Trond] Paper & Fibre Res Inst PFI, NO-7491 Trondheim, Norway.
   [Averianova, Natalia; Kondalenko, Olga; Garaeva, Milyausha; Petrov, Vladimir] Kazan Natl Res Technol Univ, Kazan 420015, Russia.
RP Chinga-Carrasco, G (reprint author), Paper & Fibre Res Inst PFI, Flegskoleringen 6B, NO-7491 Trondheim, Norway.
EM gary.chinga.carrasco@pfi.no
RI Galblaub, Olga/L-5298-2017; Chinga-Carrasco, Gary/J-1661-2014
OI Galblaub, Olga/0000-0001-9374-9368; Chinga-Carrasco,
   Gary/0000-0002-6183-2017
FU Kazan National Research Technological University (KNRTU); Research
   Council of Norway (NanoHeal project) [219733]
FX The authors thank Ingebjorg Leirset and Mirjana Filipovic (PFI) for good
   collaboration in the preparation of the nanocellulose samples. Gurvinder
   Singh, Vidar Fauske and Ida Noddeland at the NTNU NanoLab are thanked
   for valuable cooperation and assistance in the acquisition of the AFM
   and S(T)EM images. The Kazan National Research Technological University
   (KNRTU) and The Research Council of Norway (NanoHeal project, grant no.
   219733) are acknowledged for funding part of this work.
CR Ahola S, 2008, BIOMACROMOLECULES, V9, P1273, DOI 10.1021/bm701317k
   Aulin C, 2010, CELLULOSE, V17, P559, DOI 10.1007/s10570-009-9393-y
   Chinga-Carrasco G., 2012, J NANOPART RES, V14, P213
   Chinga-Carrasco G, 2013, MICRON, V48, P42, DOI 10.1016/j.micron.2013.02.005
   Chinga-Carrasco G, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1280-z
   Chinga-Carrasco G, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-417
   Chinga-Carrasco G, 2010, J NANOPART RES, V12, P841, DOI 10.1007/s11051-009-9710-2
   Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u
   Henriksson M, 2008, BIOMACROMOLECULES, V9, P1579, DOI 10.1021/bm800038n
   Him U., 2006, LENZINGER BERICHTE, V86, P96
   Huang J, 2013, ACS NANO, V7, P2106, DOI 10.1021/nn304407r
   Orelma H., 2012, BIOINTERPHASES, V7, P1
   Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s
   Siro I, 2011, J APPL POLYM SCI, V119, P2652, DOI 10.1002/app.32831
   Stone J. E., 1966, Pulp and Paper in Canada, V67, pT263
   Syverud K, 2009, CELLULOSE, V16, P75, DOI 10.1007/s10570-008-9244-2
   Tanaka A, 2012, NORD PULP PAP RES J, V27, P689
   Tekin E, 2008, SOFT MATTER, V4, P703, DOI 10.1039/b711984d
   Tobjork D, 2011, ADV MATER, V23, P1935, DOI 10.1002/adma.201004692
   Wagberg L, 2008, LANGMUIR, V24, P784, DOI 10.1021/la702481v
NR 20
TC 18
Z9 18
U1 0
U2 36
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD JAN
PY 2014
VL 56
BP 80
EP 84
DI 10.1016/j.micron.2013.09.002
PG 5
WC Microscopy
SC Microscopy
GA 273HT
UT WOS:000328526600012
PM 24183789
DA 2018-10-20
ER

PT J
AU Mei, L
   Jiang, YY
   Feng, SS
AF Mei, Lin
   Jiang, Yuyang
   Feng, Si-Shen
TI Star-shaped block polymers as a molecular biomaterial for nanomedicine
   development
SO NANOMEDICINE
LA English
DT Editorial Material
DE anticancer drug; biodegradable polymer; cancer nanotechnology; drug
   delivery; drug targeting; pharmaceutical nanotechnology
ID VITAMIN-E TPGS; DRUG-DELIVERY; COPOLYMER; MICELLES; CANCER; CORE;
   NANOPARTICLES; DOXORUBICIN; CARRIERS; GLYCOL)
C1 [Mei, Lin] Tsinghua Univ, Shenzhen Grad Sch, Shenzhen Key Lab Gene & Antibody Therapy, Shenzhen 518055, Peoples R China.
   [Jiang, Yuyang] Tsinghua Univ, Shenzhen Grad Sch, Shenzhen Key Lab Chem Biol, Minist Prov Jointly Constructed Base State Key La, Shenzhen 518055, Peoples R China.
   [Feng, Si-Shen] Natl Univ Singapore, Dept Chem & Biomol Engn, Dept Bioengn, Singapore 117576, Singapore.
   [Feng, Si-Shen] Natl Univ Singapore, Nanosci & Nanotechnol Initiat NUSNNI NanoCore, Singapore 117576, Singapore.
RP Feng, SS (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Dept Bioengn, Block E3,05-29,2 Engn Dr 3, Singapore 117576, Singapore.
EM chefess@nus.edu.sg
CR Dai FY, 2010, BIOMATERIALS, V31, P559, DOI 10.1016/j.biomaterials.2009.09.055
   Dong PW, 2010, COLLOID SURFACE A, V358, P128, DOI 10.1016/j.colsurfa.2010.01.037
   Feng SS, 2006, NANOMEDICINE-UK, V1, P297, DOI 10.2217/17435889.1.3.297
   Gao X, 2013, INT J NANOMED, V8, P971, DOI 10.2147/IJN.S39532
   Li XJ, 2011, BIOMATERIALS, V32, P6595, DOI 10.1016/j.biomaterials.2011.05.049
   Nemoto Y, 2008, BIOCONJUGATE CHEM, V19, P2513, DOI 10.1021/bc800003t
   Cuong NV, 2012, J MATER CHEM, V22, P1006, DOI 10.1039/c1jm13588k
   Ouyang CP, 2012, POLYM BULL, V68, P27, DOI 10.1007/s00289-011-0516-x
   Pafiti KS, 2012, EUR POLYM J, V48, P1422, DOI 10.1016/j.eurpolymj.2012.05.008
   Peng CL, 2008, BIOMATERIALS, V29, P3599, DOI 10.1016/j.biomaterials.2008.05.018
   Schramm OG, 2009, MACROMOLECULES, V42, P1808, DOI 10.1021/ma8024738
   Wang F, 2008, BIOCONJUGATE CHEM, V19, P1423, DOI 10.1021/bc7004285
   Wang G, 2012, CHEM-EUR J, V18, P9705, DOI 10.1002/chem.201200849
   Wang JL, 2012, BIOMATERIALS, V33, P6877, DOI 10.1016/j.biomaterials.2012.06.019
   Xu FJ, 2009, BIOMACROMOLECULES, V10, P285, DOI 10.1021/bm8010165
   Zeng XW, 2013, BIOMATERIALS, V34, P6058, DOI 10.1016/j.biomaterials.2013.04.052
   Zhang LZ, 2012, MACROMOL BIOSCI, V12, P83, DOI 10.1002/mabi.201100197
   Zhang ZP, 2012, BIOMATERIALS, V33, P4889, DOI 10.1016/j.biomaterials.2012.03.046
   Zou P, 2012, POLYMER, V53, P1245, DOI 10.1016/j.polymer.2012.01.044
NR 19
TC 13
Z9 13
U1 2
U2 30
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PD JAN
PY 2014
VL 9
IS 1
BP 9
EP 12
DI 10.2217/nnm.13.180
PG 4
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 275MX
UT WOS:000328682500003
PM 24354810
DA 2018-10-20
ER

PT J
AU Kim, MS
   Son, J
   Lee, H
   Hwang, H
   Choi, CH
   Kim, G
AF Kim, Min Seong
   Son, JoonGon
   Lee, HyeongJin
   Hwang, Heon
   Choi, Chang Hyun
   Kim, GeunHyung
TI Highly porous 3D nanofibrous scaffolds processed with an
   electrospinning/laser process
SO CURRENT APPLIED PHYSICS
LA English
DT Article
DE Nanofiber; Electrospinning; Laser process; Biomaterial
ID PORE-SIZE; TISSUE; BONE; MATRIX; DIFFERENTIATION; REGENERATION;
   FABRICATION
AB Electrospinning has been widely used to produce micro/nanosized fibres. Although the method is very simple, easy, and effective for obtaining nanosized material, the fabrication of three dimensional (3D) shapes comprised of micro/nanofibres has been a major obstacle for use in tissue engineering. In this study, a new electrospinning method to fabricate controllable 3D micro/nanofibrous structure (with thickness over 3 mm) is suggested. The fabricated 3D fibrous structure was fully porous and successfully consisted of submicron-sized fibres. However, the pores in the 3D fibrous structure were too small (5 -10 mu m), so we used a femtosecond laser process to achieve enough cell infiltration and proliferation in the thickness direction of the 3D structure. By controlling appropriate processing conditions, we can successfully fabricate a highly porous 3D micro/nanofibrous structure with various pore sizes ranging from 189 + 28 mu m to 380 + 21 mu m. The fabricated 3D fibrous scaffolds were assessed for in vitro biological capabilities by culturing osteoblast like cells (MG63). Compared with the rapid-prototyped PCL scaffold, the 3D fibrous scaffold exhibited significantly higher biological activities (initial cell attachment and cell proliferation) due to the topographical structure of micro/nanofibres. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Kim, Min Seong; Lee, HyeongJin; Hwang, Heon; Choi, Chang Hyun; Kim, GeunHyung] Sungkyunkwan Univ, Tissue Engn Lab, Dept Biomechatron Engn, Coll Biotechnol & Bioengn, Suwon, South Korea.
   [Son, JoonGon] GIST, Dept Phys & Photon Sci, Kwangju, South Korea.
RP Kim, G (reprint author), GIST, Dept Phys & Photon Sci, Kwangju, South Korea.
EM gkimbme@skku.edu
FU National Research Foundation of Korea; Ministry of Education, Science,
   and Technology (MEST) [NRF-2012R1A2A2A01017435]; Ministry of Health &
   Welfare, Republic of Korea [A120942]
FX This research was financially supported by the National Research
   Foundation of Korea grant funded by the Ministry of Education, Science,
   and Technology (MEST) (Grant No. NRF-2012R1A2A2A01017435) and also was
   partially supported by a grant of the Korean Health Technology R&D
   Project, Ministry of Health & Welfare, Republic of Korea (Grant no.
   A120942).
CR Balasundaram G, 2006, NANOMEDICINE-UK, V1, P169, DOI 10.2217/17435889.1.2.169
   Dong B, 2009, MACROMOL RAPID COMM, V30, P539, DOI 10.1002/marc.200800634
   Geun Hyung Kim, 2009, MACROMOL RAPID COMM, V29, P1577
   HINES AL, 1985, MASS TRANSFER FUNDAM
   Hong JK, 2010, ACTA BIOMATER, V6, P4734, DOI 10.1016/j.actbio.2010.07.003
   Hong S, 2011, APPL PHYS A-MATER, V103, P1009, DOI 10.1007/s00339-011-6381-5
   Hu J, 2008, BIOMATERIALS, V29, P3815, DOI 10.1016/j.biomaterials.2008.06.015
   Kai D, 2013, J MATER CHEM B, V1, P2305, DOI 10.1039/c3tb00151b
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Kim G, 2006, EUR POLYM J, V42, P2031, DOI 10.1016/j.eurpolymj.2006.01.026
   Lee J, 2013, MATER LETT, V93, P397, DOI 10.1016/j.matlet.2012.11.124
   Luoa Y., 2013, CARBOHYD POLYM, V91, P419
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Meng LH, 2012, J MATER CHEM, V22, P19412, DOI 10.1039/c2jm31618h
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Roosa SMM, 2010, J BIOMED MATER RES A, V92A, P359, DOI 10.1002/jbm.a.32381
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Srouji S, 2008, J MATER SCI-MATER M, V19, P1249, DOI 10.1007/s10856-007-3218-z
   Tutak W, 2013, BIOMATERIALS, V34, P2389, DOI 10.1016/j.biomaterials.2012.12.020
   Tzezana R, 2008, TISSUE ENG PART C-ME, V14, P281, DOI 10.1089/ten.tec.2008.0201
   Wang J., 2012, J BIOMED MATER RES, V93, P753
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yokoyama Y, 2009, MATER LETT, V63, P754, DOI 10.1016/j.matlet.2008.12.042
NR 24
TC 24
Z9 25
U1 3
U2 68
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
EI 1878-1675
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JAN
PY 2014
VL 14
IS 1
BP 1
EP 7
DI 10.1016/j.cap.2013.10.008
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 272RM
UT WOS:000328477900001
DA 2018-10-20
ER

PT J
AU Brochu, ABW
   Evans, GA
   Reichert, WM
AF Brochu, Alice B. W.
   Evans, Gregory A.
   Reichert, William M.
TI Mechanical and cytotoxicity testing of acrylic bone cement embedded with
   microencapsulated 2-octyl cyanoacrylate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE self-healing; cytotoxicity; bone cement; mechanical properties;
   biomaterial
ID FATIGUE-CRACK PROPAGATION; OSTEOSARCOMA CELL-LINES; SELF-HEALING
   POLYMERS; OSTEOBLAST-LIKE CELLS; FRACTURE-TOUGHNESS; TISSUE ADHESIVE;
   STERILIZATION METHOD; PHYSICAL-PROPERTIES; HEART-VALVE; COMPOSITE
AB The water-reactive tissue adhesive 2-octyl cyanoacrylate (OCA) was microencapsulated in polyurethane shells and incorporated into Palacos R bone cement. The tensile and compressive properties of the composite material were investigated in accordance with commercial standards, and fracture toughness of the capsule-embedded bone cement was measured using the tapered double-cantilever beam geometry. Viability and proliferation of MG63 human osteosarcoma cells after culture with extracts from Palacos R bone cement, capsule-embedded Palacos R bone cement, and OCA were also analyzed. Incorporating up to 5 wt % capsules had little effect on the compressive and tensile properties of the composite, but greater than 5 wt % capsules reduced these values below commercial standards. Fracture toughness was increased by 13% through the incorporation of 3 wt % capsules and eventually decreased below the toughness of the capsule-free controls at capsule contents of 15 wt % and higher. The effect on cell proliferation and viability in response to extracts prepared from capsule-embedded and commercial bone cements were not significantly different from each other, whereas extracts from OCA were moderately toxic to cells. Overall, the addition of lower wt % of OCA-containing microcapsules to commercial bone cement was found to moderately increase static mechanical properties without increasing the toxicity of the material. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 181-189, 2014.
C1 [Brochu, Alice B. W.; Evans, Gregory A.; Reichert, William M.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Brochu, Alice B. W.; Reichert, William M.] Duke Univ, Ctr Biomol & Tissue Engn, Durham, NC 27708 USA.
RP Reichert, WM (reprint author), Duke Univ, Dept Biomed Engn, 136 Hudson Hall,Box 90281, Durham, NC 27708 USA.
EM reichert@duke.edu
FU National Institutes of Health [T32-GM8555, R21 EB 013874-01]
FX Contract grant sponsor: National Institutes of Health; contract grant
   numbers: T32-GM8555 (to A. B. W. B.); R21 EB 013874-01 (to W.M.R.)
CR Ahmed AM, 2003, JOINT REPLACEMENT AR, P7
   Almeida T, 2011, MAT SCI ENG C-MATER, V31, P658, DOI 10.1016/j.msec.2010.12.020
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Andersson HM, 2007, SPRINGER SER MATER S, V100, P19, DOI 10.1007/978-1-4020-6250-6_2
   [Anonymous], 2012, 10993122012 ISO
   Bergman SD, 2007, SPRINGER SER MATER S, V100, P45, DOI 10.1007/978-1-4020-6250-6_3
   Biggs PL, 2009, SELF HEALING PMMA BO, P147
   Brochu ABW, 2012, J BIOMED MATER RES B, V100B, P1764, DOI 10.1002/jbm.b.32743
   Brochu ABW, 2011, J BIOMED MATER RES A, V96A, P492, DOI 10.1002/jbm.a.32987
   Brown EN, 2006, J MATER SCI, V41, P6266, DOI 10.1007/s10853-006-0512-y
   Brown EN, 2011, J STRAIN ANAL ENG, V46, P167, DOI 10.1177/0309324710396018
   Brown EN, 2004, J MATER SCI, V39, P1703, DOI 10.1023/B:JMSC.0000016173.73733.dc
   Brown EN, 2003, J MICROENCAPSUL, V20, P719, DOI 10.1080/0265204031000154160
   Brown EN, 2002, EXP MECH, V42, P372, DOI 10.1177/001448502321548193
   Caruso MM, 2010, ACS APPL MATER INTER, V2, P1195, DOI 10.1021/am100084k
   CIAPETTI G, 1994, BIOMATERIALS, V15, P92, DOI 10.1016/0142-9612(94)90256-9
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   Coulthard P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004287.pub3
   Dabagh M, 2005, J APPL POLYM SCI, V98, P758, DOI 10.1002/app.22132
   DAVIES JP, 1987, J BIOMED MATER RES, V21, P719, DOI 10.1002/jbm.820210604
   Edidin AA, 2000, J ARTHROPLASTY, V15, P321, DOI 10.1016/S0883-5403(00)90647-8
   Evans CE, 1999, J HAND SURG-BRIT EUR, V24B, P658, DOI 10.1054/jhsb.1999.0279
   Giddings VL, 2001, BIOMATERIALS, V22, P1875, DOI 10.1016/S0142-9612(00)00372-0
   Graham J, 2000, J ARTHROPLASTY, V15, P1028, DOI 10.1054/arth.2000.8188
   GRANCHI D, 1995, BIOMATERIALS, V16, P1187, DOI 10.1016/0142-9612(95)93585-2
   Harper EJ, 2000, J MATER SCI-MATER M, V11, P491, DOI 10.1023/A:1013057724268
   Hoey D, 2009, ACTA BIOMATER, V5, P719, DOI 10.1016/j.actbio.2008.08.024
   Jackson AC, 2011, MACROMOL RAPID COMM, V32, P82, DOI 10.1002/marc.201000468
   Jyoti MA, 2011, J MATER SCI-MATER M, V22, P1333, DOI 10.1007/s10856-011-4311-x
   Kaplan M, 2005, HEART SURG FORUM, V8, pE169, DOI 10.1532/HSF98.20041126
   Kessler MR, 2007, P I MECH ENG G-J AER, V221, P479, DOI 10.1243/09544100JAERO172
   Kessler MR, 2003, COMPOS PART A-APPL S, V34, P743, DOI 10.1016/S1359-835X(03)00138-6
   Kessler MR, 2001, COMPOS PART A-APPL S, V32, P683, DOI 10.1016/S1359-835X(00)00149-4
   Kidane AG, 2009, J BIOMED MATER RES B, V88B, P290, DOI 10.1002/jbm.b.31151
   Kim HS, 2001, INT ORTHOP, V25, P343, DOI 10.1007/s002640100293
   Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022
   Kuehn KD, 2005, ORTHOP CLIN N AM, V36, P29, DOI 10.1016/j.ocl.2004.06.011
   Kurtz SM, 2005, BIOMATERIALS, V26, P3699, DOI 10.1016/j.biomaterials.2004.09.055
   LEONARD F., 1967, J BIOMED MAT RES, V1, P3, DOI 10.1002/jbm.820010103
   Lewis G, 2007, J MATER SCI-MATER M, V18, P1649, DOI 10.1007/s10856-007-3042-5
   Lewis G, 1999, BIOMATERIALS, V20, P69, DOI 10.1016/S0142-9612(98)00145-8
   Lewis G, 1998, BIOMATERIALS, V19, P117, DOI 10.1016/S0142-9612(97)00165-8
   Lewis G, 2000, BIOMATERIALS, V21, P775, DOI 10.1016/S0142-9612(99)00226-4
   Lewis G, 2009, J APPL BIOMATER BIOM, V7, P90
   Linder L., 1982, BIOCOMPATIBILITY ORT, P1
   Lopes MA, 1998, J BIOMED MATER RES, V41, P649, DOI 10.1002/(SICI)1097-4636(19980915)41:4<649::AID-JBM17>3.0.CO;2-9
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MATSUMOTO T, 1967, ARCH SURG-CHICAGO, V94, P861
   Nayab SN, 2007, BIOMATERIALS, V28, P38, DOI 10.1016/j.biomaterials.2006.08.032
   Palacos R., 2012, INSTRUCTIONS USE
   PEREK J, 1992, J MATER SCI-MATER M, V3, P333, DOI 10.1007/BF00705365
   Perez MA, 2009, ANN BIOMED ENG, V37, P454, DOI 10.1007/s10439-008-9616-7
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   Singer AJ, 2004, AM J SURG, V187, P238, DOI 10.1016/j.amjsurg.2003.11.017
   Thumwanit V, 1999, AUST DENT J, V44, P248, DOI 10.1111/j.1834-7819.1999.tb00228.x
   VINTERS HV, 1985, NEURORADIOLOGY, V27, P279, DOI 10.1007/BF00339559
   WEBER SC, 1984, CLIN ORTHOP RELAT R, P249
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
   Yang JL, 2008, MACROMOLECULES, V41, P9650, DOI 10.1021/ma801718v
NR 59
TC 6
Z9 7
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2014
VL 102
IS 1
BP 181
EP 189
DI 10.1002/jbm.b.32994
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 268EX
UT WOS:000328153100020
PM 23913367
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ming, JF
   Zuo, BQ
AF Ming, Jinfa
   Zuo, Baoqi
TI A Novel Silk Fibroin/Sodium Alginate Hybrid Scaffolds
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article
ID SODIUM ALGINATE; POROUS SCAFFOLDS; CELLS
AB Porous silk fibroin/sodium alginate hybrid scaffolds were prepared through lyophilization method. Hybrid scaffolds were characterized for morphological and functional properties related to different mixture ratios between silk fibroin and sodium alginate. The silk fibroin/sodium alginate hybrid scaffolds showed a thin-layer structure and much more irregular rod-like structure appeared at the layer surface after adding 50% sodium alginate. The results of wide-angle X-ray diffraction and Fourier transform infrared analysis confirmed that the crystal structure of silk fibroin was not influenced by adding the different contents of sodium alginate, exhibiting the random coil structure in the hybrid scaffolds. The thermal behavior of the hybrid scaffolds exhibited major change with containing 30% sodium alginate or more. The porosity of the scaffolds varied between 92 and 94% with a favorable compressive modulus and stress. The mechanical properties results depicted the hybrid scaffolds containing 10% sodium alginate, with a porosity of 94.0 +/- 0.10%, attained the highest compressive modulus and stress for 41 +/- 6 and 44 +/- 3 kPa, respectively. In addition, mineralization results showed hydroxyapatite crystal growing on the surface of the scaffold. This hybrid biomaterial should offer new and important options to the needs related to biomineralization and tissue engineering, in general. POLYM. ENG. SCI., 54:129-136, 2014. (c) 2013 Society of Plastics Engineers
C1 [Ming, Jinfa; Zuo, Baoqi] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Ming, Jinfa; Zuo, Baoqi] Soochow Univ, Coll Text & Clothing Engn, Suzhou 215021, Peoples R China.
RP Zuo, BQ (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM bqzuo@suda.edu.cn
FU First Phase of Jiangsu Universities' Distinctive Discipline Development
   Program for Textile Science and Engineering of Soochow University;
   National Science Foundation of China [81271723]; Soochow University
   [5832003611]; Jiangsu Province Ordinary Universities; Colleges Graduate
   Scientific and Innovation Plan [CXLX12_0815]; National Engineering
   Laboratory for Modern Silk
FX Contract grant sponsor: The First Phase of Jiangsu Universities'
   Distinctive Discipline Development Program for Textile Science and
   Engineering of Soochow University; contract grant sponsor: National
   Science Foundation of China; contract grant number: 81271723; contract
   grant sponsor: Doctoral Candidate Academic Award Project of Soochow
   University; contract grant number: 5832003611; contract grant sponsor:
   Jiangsu Province Ordinary Universities; contract grant sponsor: Colleges
   Graduate Scientific and Innovation Plan; contract grant number:
   CXLX12_0815; contract grant sponsor: National Engineering Laboratory for
   Modern Silk.
CR Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Cao Y, 2005, BIOMACROMOLECULES, V6, P2189, DOI 10.1021/bm0501510
   Chhatbar MU, 2012, SOFT MATTER, V8, P1837, DOI 10.1039/c2sm06947d
   Chung EJ, 2012, TISSUE ENG PART C-ME, V18, P113, DOI [10.1089/ten.tec.2011.0289, 10.1089/ten.TEC.2011.0289]
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Ma GP, 2012, CARBOHYD POLYM, V87, P737, DOI 10.1016/j.carbpol.2011.08.055
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Ming JF, 2012, J APPL POLYM SCI, V125, P2148, DOI 10.1002/app.36354
   MORRIS ER, 1980, CARBOHYD RES, V81, P305, DOI 10.1016/S0008-6215(00)85661-X
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Papageorgiou SK, 2010, CARBOHYD RES, V345, P469, DOI 10.1016/j.carres.2009.12.010
   Sen G, 2010, J APPL POLYM SCI, V115, P63, DOI 10.1002/app.30596
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
   Xia Y, 2012, J BIOMED MATER RES A, V100A, P1044, DOI 10.1002/jbm.a.33232
   Yang LQ, 2007, CARBOHYD POLYM, V68, P218, DOI 10.1016/j.carbpol.2006.12.020
   Yu YJ, 2006, LANGMUIR, V22, P3899, DOI 10.1021/la051911v
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
NR 26
TC 10
Z9 11
U1 6
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0032-3888
EI 1548-2634
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PD JAN
PY 2014
VL 54
IS 1
BP 129
EP 136
DI 10.1002/pen.23542
PG 8
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 263QR
UT WOS:000327823600015
DA 2018-10-20
ER

PT J
AU Li, X
   Fan, DD
   Ma, XX
   Zhu, CH
   Luo, Y
   Liu, BW
   Chen, L
AF Li, Xian
   Fan, Daidi
   Ma, Xiaoxuan
   Zhu, Chenhui
   Luo, Yane
   Liu, Bowen
   Chen, Lan
TI A Novel Injectable pH/Temperature Sensitive CS-HLC/beta-GP Hydrogel: The
   Gelation Mechanism and Its Properties
SO SOFT MATERIALS
LA English
DT Article
DE Injectable hydrogel; pH/temperature-sensitive hydrogel; Sol-gel
   transition
ID HUMAN-LIKE COLLAGEN; CHITOSAN; COPOLYMER; SCAFFOLD; PH; HYDROXYAPATITE;
   DELIVERY; MATRICES; GROWTH; BONE
AB The chitosan-human-like collagen/beta-sodium glycerophosphate (CS-HLC/beta-GP) hydrogel, is sensitive to pH and temperature changes and has proved to be a potential candidate as an injectable filling biomaterial in plastic and reconstruction surgery. The formation and pH/temperature-sensitivity mechanism of the novel CS-HLC/beta-GP hydrogel were explored by Fourier transform infrared spectroscopy (FTIR) and swelling tests. Our results showed that an amide bond (-CONH) is formed between the carbonyl (CO) of HLC and the amino of CS and -NRH2+ is formed between the amide bond and beta-GP; the temperature sensitivity depended on the hydrophobic-hydrophilic interaction of molecular chains, and the pH sensitivity depended on the electrostatic interaction of ionic groups (-NRH2+ and -OPO32-). The properties of the novel CS-HLC/beta-GP hydrogel were also examined using the tube inverting method, the swelling test, the liquid displacement method, and mechanical testing. The gelling time before and after addition of HLC is 30 min and 8 min, respectively, at 37 degrees C. Compared with conventional CS/beta-GP hydrogels, such as CS-AC (animal-derived collagen)/beta-GP hydrogel, the CS-HLC/beta-GP hydrogel showed a desirable porosity level, swelling ratio, pH/temperature sensitivity, a smooth surface, regular porous networks, and adequate mechanical strength and cross-linking densities. Therefore, the CS-HLC/beta-GP hydrogels are excellent candidates for use in biomedical fields, such as in soft tissue defect filling and drug delivery.
C1 [Li, Xian; Fan, Daidi; Ma, Xiaoxuan; Zhu, Chenhui; Luo, Yane] NW Univ Xian, Dept Chem Engn, Xian 710069, Shaanxi, Peoples R China.
   [Ma, Xiaoxuan; Zhu, Chenhui; Luo, Yane; Liu, Bowen] NW Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Dept Chem Engn, Xian 710069, Shaanxi, Peoples R China.
   [Chen, Lan] NW Univ Xian, Fac Life Sci, Xian 710069, Shaanxi, Peoples R China.
RP Fan, DD (reprint author), NW Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Taibai North Rd 229, Xian 710069, Shaanxi, Peoples R China.
EM fandaidi@nwu.edu.cn
RI Fan, daidi/J-1128-2017
FU National High Technology Research and Development Program of China (863
   Program) [2007AA03Z456]; National Natural Science Foundation of China
   [20606026, 20776119, 31000019]; Xi'an Research and Development Program
   [YF07078, NC08005]; Shaanxi Provincial Department of Education, China
   [08JK452, 2010JC21]; Shaanxi Provincial Scientific Technology Research
   and Development Program [2007K06-03]; Specialized Research Fund for the
   Doctoral Program of Higher Education of China [20096101110014,
   20096101120023]; NWU Graduate Innovation and Creativity Funds
   [YZZ12037]; Shaanxi Key Subject Program, China
FX This study was financially supported by the National High Technology
   Research and Development Program of China (863 Program, 2007AA03Z456),
   the National Natural Science Foundation of China (20606026, 20776119,
   and 31000019), Xi'an Research and Development Program (YF07078 and
   NC08005), the Scientific Research Program of Shaanxi Provincial
   Department of Education, China (08JK452, 2010JC21), Shaanxi Provincial
   Scientific Technology Research and Development Program (2007K06-03), the
   Specialized Research Fund for the Doctoral Program of Higher Education
   of China (20096101110014 and 20096101120023), the NWU Graduate
   Innovation and Creativity Funds (YZZ12037), and Shaanxi Key Subject
   Program, China.
CR Aamer KA, 2004, BIOMATERIALS, V25, P1087, DOI 10.1016/S0142-9612(03)00632-X
   Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Chen LY, 2004, BIOMATERIALS, V25, P3725, DOI 10.1016/j.biomaterials.2003.09.100
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   Fan DD, 2002, CHEM IND ENG CHINA, V53, P752
   Ganji F, 2007, J SOL-GEL SCI TECHN, V42, P47, DOI 10.1007/s10971-006-9007-1
   Hua XF, 2006, CHINESE J CHEM ENG, V14, P242, DOI 10.1016/S1004-9541(06)60065-7
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   In-Yong K, 2008, BIOTECHNOLOGY ADV, V26, P1
   Jatuporn N, 2010, INT J PHARMACEUT, V391, P115
   Kim S, 2010, BIOMATERIALS, V31, P4157, DOI 10.1016/j.biomaterials.2010.01.139
   Lee WF, 2001, J APPL POLYM SCI, V82, P2487, DOI 10.1002/app.2099
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Li Y. S., 2009, CHIN J COLLOID POLYM, V27, P9
   Lin YH, 2005, BIOMATERIALS, V26, P2105, DOI 10.1016/j.biomaterials.2004.06.011
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   Radhakumary C, 2011, CARBOHYD POLYM, V83, P705, DOI 10.1016/j.carbpol.2010.08.042
   SANTOS PM, 1991, OTOLARYNG HEAD NECK, V105, P12, DOI 10.1177/019459989110500103
   Sashiwa H, 2002, BIOMACROMOLECULES, V3, P1126, DOI 10.1021/bm0200480
   Seo SJ, 2006, BIOMATERIALS, V27, P1487, DOI 10.1016/j.biomaterials.2005.09.018
   Shim WS, 2005, BIOMACROMOLECULES, V6, P2930, DOI 10.1021/bm050521k
   Simone S.S., 2009, ACTA BIOMATER, V5, P1911
   Tang YF, 2008, PROG CHEM, V20, P239
   Wang Y, 2006, MAT SCI ENG C-BIO S, V26, P635, DOI 10.1016/j.msec.2005.07.019
   Yan H, 2005, COLLOID SURFACE B, V46, P142, DOI 10.1016/j.colsurfb.2005.10.007
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhai Y, 2005, CURR APPL PHYS, V5, P429, DOI 10.1016/j.cap.2005.01.004
   Zhang KP, 2007, SOFT MATER, V5, P183, DOI 10.1080/15394450701539008
   Zhu CH, 2009, J BIOMED MATER RES A, V89A, P829, DOI 10.1002/jbm.a.32256
NR 31
TC 23
Z9 23
U1 8
U2 93
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1539-445X
EI 1539-4468
J9 SOFT MATER
JI Soft Mater.
PY 2014
VL 12
IS 1
BP 1
EP 11
DI 10.1080/1539445X.2011.584269
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 273BX
UT WOS:000328509300001
DA 2018-10-20
ER

PT S
AU Singh, KV
   Khan, F
AF Singh, Kumar Vikram
   Khan, Fazeel
GP ASEE
TI Interactive Module for Biomaterial Modeling and Characterization
SO 2014 ASEE ANNUAL CONFERENCE
SE ASEE Annual Conference & Exposition
LA English
DT Proceedings Paper
CT ASEE Annual Conference
CY JUN 15-18, 2014
CL Indianapolis, IN
SP ASEE
ID PATTERNS
AB The burgeoning field of biocompatible polymers (biomaterials) presents many avenues for exploring the applications of material modeling and simulation techniques within an undergraduate and/or graduate curriculum. The instrument created for achieving this has been the development of a set of online interactive Matlab-GUI based learning modules which demonstrate the characterization of the mechanical properties of biocompatible polymers through material modeling and simulation. These learning modules can be utilized in a range of materials science and mechanics of materials courses. Few polymeric materials, which are used in load bearing prosthetics and in more flexible applications, such as tissue repair, were selected to demonstrate the large variations in deformation characteristics that might be encountered even in one category of materials. These modules feature experimental data libraries which enable students to understand the process of tuning material model parameters by juxtaposing simulation and experimental data in various applications. This is preceded by a detailed account of the mathematical basis of the various rheological models and a consideration of their respective limitations. A dedicated website has been created for this project. Measures to ensure ease of use and broad utilization include packaging of the interactive Matlab programs in the form of downloadable apps. Furthermore, the provision of downloadable experimental data files also broadens the scope of future analysis and presents the potential for lecture-only courses to feature a lab based activity to engage students in greater depth. This format enables the learning modules as well as the developed simulation apps, which are also available at the Mathworks website, to be used by external users and other institutes. The collection of pre-post questionnaire and summary survey data has been undertaken towards the assessment of the project learning outcomes. A summary of this data will be made available on the project website.
C1 [Singh, Kumar Vikram] Miami Univ, Dept Mech & Mfg Engn, Oxford, OH 45056 USA.
   [Khan, Fazeel] Miami Univ, Oxford, OH 45056 USA.
RP Singh, KV (reprint author), Miami Univ, Dept Mech & Mfg Engn, Oxford, OH 45056 USA.
RI Singh, Kumar/D-5183-2015
OI Singh, Kumar/0000-0002-9868-5583
CR Balamuralithara B, 2009, COMPUT APPL ENG EDUC, V17, P108, DOI 10.1002/cae.20186
   Hoic-Bozic N., 2009, ED IEEE T, V52, P19, DOI DOI 10.1109/TE.2007.914945
   Khan F., 2013, P ASME INT MECH ENG
   Khan F, 2012, J MECH BEHAV BIOMED, V6, P174, DOI 10.1016/j.jmbbm.2011.10.009
   Maiorana C, 2008, COMPUT APPL ENG EDUC, V16, P189, DOI 10.1002/cae.20167
   Nistor N, 2010, COMPUT EDUC, V55, P663, DOI 10.1016/j.compedu.2010.02.026
   Prince MJ, 2006, J ENG EDUC, V95, P123, DOI 10.1002/j.2168-9830.2006.tb00884.x
   Rogers N., 2013, FRONT ED C FIE IEEE, P553
   Singh K. V., 2012, P ASME INT MECH ENG, P1
   Steif PS, 2009, J ENG EDUC, V98, P321, DOI 10.1002/j.2168-9830.2009.tb01030.x
NR 10
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC ENGINEERING EDUCATION
PI WASHINGTON
PA 1818 N STREET, NW SUITE 600, WASHINGTON, DC 20036 USA
SN 2153-5965
J9 ASEE ANNU CONF EXPO
PY 2014
PG 13
WC Education & Educational Research; Education, Scientific Disciplines;
   Engineering, Multidisciplinary
SC Education & Educational Research; Engineering
GA BF6XU
UT WOS:000383779802061
DA 2018-10-20
ER

PT B
AU Itami, G
   Akiyama, T
   Sakai, O
   Harada, Y
AF Itami, G.
   Akiyama, T.
   Sakai, O.
   Harada, Y.
GP IEEE
TI Localized electromagnetic distortion in 2D metal hole array and its
   application to imaging of permittivity distribution
SO 2014 ASIA-PACIFIC MICROWAVE CONFERENCE (APMC)
SE Asia Pacific Microwave Conference-Proceedings
LA English
DT Proceedings Paper
CT Asia-Pacific Microwave Conference Proceedings
CY NOV 04-07, 2014
CL Sendai, JAPAN
SP Inst Elect Informat Commun Engineers IEICE, IEEE MTT-S, IEEE AP-S, EuMA, URSI, IEEE MTT-S Japan/Kansai/Nagoya Chapters, Tech Comm Microwaves, Elect Soc, IEICE, Tech Comm Elect Simulat Technol, Elect Soc, IEICE, Tech Comm Microwave Photon, Elect Soc, IEICE, IEEE Sendai Sect, Japan Inst Elect Packaging, Japan Soc Electromagnet Wave Energy Applicat, IEEJ Invest Comm Innovat Electromagnet Technol Their Appl Dev
DE Metamaterial; spoof surface plasmon; metal hole array; surface wave;
   millimeter wave; electromagnetic distortion; two-dimensional imaging
ID METAMATERIAL
AB We performed two-dimensional imaging of conductive and dielectric samples above a metal plate with a two-dimensional array of subwavelength holes (metal hole array) with electromagnetic distortion formed by inserting a needle-like conductive probe into holes in it. A metal hole array has a special electromagnetic response such as localization of electromagnetic waves at a specific frequency near it. Generally, the phenomenon described above is called "spoof surface plasmon resonance." And such special media can be regarded as "metamaterial" from a point of view that it realizes a macroscopically uniform medium by the subwavelength-size holes in the metal plate. We conducted numerical analyses of electric field profiles in order to clarify how electric field distributions near the metamaterial change by the electromagnetic distortion, and confirmed the phenomenon that these uniform electric fields around the "metamaterial" are distorted locally by using the needle-like conductive probe. Electromagnetic waves response to the permittivity at the space, so that it is considered that the change of the permittivity at the space is reflected as that of the electromagnetic distribution at the space. Based on the above, the formation of the electromagnetic distortion can be a detecting method of samples which have dielectric responses. Therefore, we consider that this two-dimensional imaging system is applicable to detecting something which has abnormal permittivity inside bulk material, such as a cancer in biomaterial tissues.
C1 [Itami, G.; Akiyama, T.; Sakai, O.] Kyoto Univ, Elect Sci & Engn, Kyoto Daigaku Katsura, Nishigyo Ku, Kyoto 6158530, Japan.
   [Harada, Y.] Kyoto Prefectural Univ Med, Grad Sch Med, Kamigyo Ku, Kyoto 6020841, Japan.
RP Itami, G (reprint author), Kyoto Univ, Elect Sci & Engn, Kyoto Daigaku Katsura, Nishigyo Ku, Kyoto 6158530, Japan.
CR Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031
   Gao Z., 2009, J APPL PHYS, V48, P91
   Lee D. S., 2009, JPN J APPL PHYS, V48
   Pendry JB, 2004, SCIENCE, V305, P847, DOI 10.1126/science.1098999
   Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628
   Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356
NR 6
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-4-9023-3931-4
J9 ASIA PACIF MICROWAVE
PY 2014
BP 1253
EP 1255
PG 3
WC Engineering, Electrical & Electronic
SC Engineering
GA BF1OG
UT WOS:000380417700055
DA 2018-10-20
ER

PT B
AU Nasir, NFM
   Gan, E
   Shukla, R
   Istivan, T
   Pirogova, E
   Tanner, P
   Holland, AS
AF Nasir, N. F. Mohd
   Gan, E.
   Shukla, R.
   Istivan, T.
   Pirogova, E.
   Tanner, P.
   Holland, A. S.
GP IEEE
TI The Effect of Micromachining Process to the Biocompatibility of 3C-SiC
   Membranes
SO 2014 IEEE CONFERENCE ON BIOMEDICAL ENGINEERING AND SCIENCES (IECBES)
LA English
DT Proceedings Paper
CT IEEE INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND SCIENCES
CY DEC 08-10, 2014
CL MIRI, MALAYSIA
SP IEEE, EMB, Sarawak, MARA, DanMedik, SSILTERRA, Minist Hlth Malaysia, TME, Univ Malaya
ID BIOMEDICAL APPLICATIONS; COLORIMETRIC ASSAY; CYTO-TOXICITY; GROWTH
AB 3C-Silicon Carbide (SiC) has been identified as a potential biomaterial for implantable devices. The prospect of 3C-SiC membrane as the working component for BioMEMS in in-vitro blood pressure sensing could be a new challenge for biomedical engineers. Although, 3C-SiC is known to be biocompatible, but the micromachining process normally used in semiconductor industry might alter the biocompatibility of 3C-SiC. In this study, we investigate the biocompatibility of 3C-SiC which had been subjected to Potassium Hydroxide (KOH) wet etching and reactive ion etching (RIE) using tetrafluoromethane (CF4). The Chinese Hamster Ovary (CHO) cells were directly cultured onto the prepared samples of 3C-SiC, Si and controls to investigate 3C-SiC biocompatibility. The cells were detached from the substrates and grown further in 6 well plates for another 24 hours at 37 degrees C with 5% CO2 and 95% relative humidity for further testing. Cell viability percentage was determined by Trypan Blue exclusion technique which revealed the preference of the cells to grow and to proliferate on the treated SiC samples. However, the results could be inaccurate due to the nature of the testing which compromises the further ability of the cells to proliferate. Thus, a comparison was made by using Methylthiazolyldiphenyltetrazolium bromide (MTT) assay, a typical cytotoxicity assay, and also PrestoBlueTM reagent (which is the state-of-the-art assay for biocompatibility determination) to confirm the cell viability on the treated and untreated SiC. Thus, the results showed that the cells proliferated better on surface of the 3C-SiC treated with halogenated plasma which indicate the enhancement of biocompatibility of the semiconductor material due to the RIE.
C1 [Nasir, N. F. Mohd] Univ Malaysia Perlis, Biomed Elect Engn, Arau 02600, Perlis, Malaysia.
   [Gan, E.] RMIT Univ, Vocat Hlth & Sci, Bundoora, Vic, Australia.
   [Shukla, R.; Istivan, T.] RMIT Univ, Sch Appl Sci, Bundoora, Vic, Australia.
   [Pirogova, E.; Holland, A. S.] RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia.
   [Tanner, P.] Griffith Univ, Queensland Micro & Nanotechnol Ctr, Brisbane, Qld, Australia.
RP Nasir, NFM (reprint author), Univ Malaysia Perlis, Biomed Elect Engn, Arau 02600, Perlis, Malaysia.
EM nashrul@unimap.edu.my; emily.gan@rmit.edu.au; ravi.shukla@rmit.edu.au;
   taghrid.istivan@rmit.edu.au; elena.pirogova@nnit.edu.au;
   p.tanner@griffith.edu.au; anthony.holland@nnit.edu.au
RI Griffith University, QMNC/I-5498-2013
CR Angelescu A, 2003, REV ADV MATER SCI, V5, P440
   Cimalla I, 2007, SENSOR ACTUAT B-CHEM, V123, P740, DOI 10.1016/j.snb.2006.10.030
   Coletti C., 2006, CULTURE MAMMALIAN CE, P46
   Coletti C., 2007, BIOCOMPATIBILITY WET, P5849
   Doerge T., 2009, NOVEL METHOD FLEXIBL
   Edmondson J, 1988, J TISSUE CULT METHOD, V11, P15, DOI 10.1007/BF01404408
   Ee Lim Tan B. D. P., 2008, SENSORS, V8, P6396
   Frewin CL, 2011, IEEE ENG MED BIO, P2957, DOI 10.1109/IEMBS.2011.6090582
   Gabriel G, 2007, MICROELECTRON J, V38, P406, DOI 10.1016/j.mejo.2006.11.008
   Gomez R, 2006, BIOMED MICRODEVICES, V8, P43, DOI 10.1007/s10544-006-6381-y
   Hierold C, 1998, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE ELEVENTH ANNUAL INTERNATIONAL WORKSHOP PROCEEDINGS, P568, DOI 10.1109/MEMSYS.1998.659820
   Iliescu C, 2008, SENSOR ACTUAT B-CHEM, V129, P404, DOI 10.1016/j.snb.2007.08.043
   Kalnins U., MED SCI MONITOR, V8, pPI16
   Machleidt T, 2011, J BIOMOL SCREEN, V16, P1236, DOI 10.1177/1087057111422943
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69
   Masoodzadehgan N. H., 2012, SUPERPARAMAGNETIC IR
   Mohd N. F. Nasir, 2012, MRS SPRING M SAN FRA, P99
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nasir N. F. M., 2012, 2012 International Conference on Biomedical Engineering (ICoBE), P589, DOI 10.1109/ICoBE.2012.6178985
   Newman RA, 2011, IN VITRO CELL DEV-AN, V47, pS32
   PAGE M, 1988, INT J IMMUNOPHARMACO, V10, P785, DOI 10.1016/0192-0561(88)90001-X
   PALMOUR JW, 1986, J VAC SCI TECHNOL A, V4, P590, DOI 10.1116/1.573854
   Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519
   Rosenbloom AJ, 2004, BIOMED MICRODEVICES, V6, P261, DOI 10.1023/B:BMMD.0000048558.91401.1d
   Strober W., 2001, CURRENT PROTOCOLS IM
   Tanajura Luiz Fernando Leite, 2004, Arq. Bras. Cardiol., V83, P59, DOI 10.1590/S0066-782X2004001900011
   Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011
   WAN H, 1994, J MATER SCI-MATER M, V5, P154, DOI 10.1007/BF00053336
   Wang L, 2011, THIN SOLID FILMS, V519, P6443, DOI 10.1016/j.tsf.2011.04.224
   Zorman CA, 2009, DTIP 2009: SYMPOSIUM ON DESIGN, TEST, INTEGRATION AND PACKAGING OF MEMS/MOEMS, P1
NR 31
TC 0
Z9 0
U1 1
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-4084-4
PY 2014
BP 360
EP 364
PG 5
WC Engineering, Biomedical
SC Engineering
GA BF2GY
UT WOS:000380466700063
DA 2018-10-20
ER

PT B
AU Chu, HK
   Huan, ZJ
   Mills, JK
   Yang, J
   Sun, D
AF Chu, Henry K.
   Huan, Zhijie
   Mills, James K.
   Yang, Jie
   Sun, Dong
GP IEEE
TI Conductive, multilayer scaffold with micro-porous structure for tissue
   engineering
SO 2014 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS
   IEEE-ROBIO 2014
LA English
DT Proceedings Paper
CT 2014 IEEE International Conference on Robotics and Biomimetics (ROBIO)
CY DEC 05-10, 2014
CL Bali, INDONESIA
SP IEEE Robot & Automat Soc, State Key Lab Robot & Syst, Harbin Inst Technol, Natl Univ Def Technol, Shenzhen Inst Adv Technol
ID TWEEZERS; HYDROGEL; CELLS; POLYDIMETHYLSILOXANE; MANIPULATION; SYSTEM
AB Polymeric materials have been used extensively for the fabrication of various biomedical devices. In this paper, polydimethylsiloxane (PDMS) was adopted as the biomaterial to construct a porous, conductive nanocomposite scaffold for tissue regeneration. This proposed conductive scaffold will incorporate dielectrophoresis to manipulate cells towards the scaffold body for efficient cell seeding. In order to enhance the cell attachment onto the scaffold, microscale pores were also integrated throughout the scaffold surface in addition to the existing porous architecture from the scaffold geometry. Experiments were conducted to characterize the material properties of the proposed scaffold material and examine the improvement on the cell seeding process.
C1 [Chu, Henry K.; Huan, Zhijie; Sun, Dong] City Univ Hong Kong, Dept Mech & Biomed Engn, Hong Kong, Hong Kong, Peoples R China.
   [Huan, Zhijie; Yang, Jie] Univ Sci & Technol China, Dept Precis Machinery & Instrumentat, Hefei, Anhui, Peoples R China.
   [Mills, James K.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
RP Chu, HK (reprint author), City Univ Hong Kong, Dept Mech & Biomed Engn, Hong Kong, Hong Kong, Peoples R China.
EM henrychu@cityu.edu.hk; hzjxb@mail.ustc.edu.cn; mills@mie.utoronto.ca;
   jieyang@ustc.edu.cn; medsun@cityu.edu.hk
OI CHU, Henry Kar Hang/0000-0001-7225-6927; SUN, Dong/0000-0003-3945-4037
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Cheah CC, 2014, IEEE T ROBOT, V30, P68, DOI 10.1109/TRO.2013.2289593
   Chen HY, 2012, IEEE T ROBOT, V28, P1069, DOI 10.1109/TRO.2012.2196309
   Chen QS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02433
   Choi SJ, 2011, ACS APPL MATER INTER, V3, P4552, DOI 10.1021/am201352w
   Chu HK, 2014, IEEE INT C INT ROBOT, P2003, DOI 10.1109/IROS.2014.6942829
   Dai L, 2004, INTELLIGENT MACROMOL, P41
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011, P19, DOI DOI 10.1155/2011/290602
   Grogan SP, 2012, TISSUE ENG PART C-ME, V18, P496, DOI [10.1089/ten.tec.2011.0525, 10.1089/ten.TEC.2011.0525]
   Han JW, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4790437
   Ho CT, 2006, LAB CHIP, V6, P724, DOI 10.1039/b60203d
   Joly P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073545
   Lantada A. D., 2014, ADV MATER SCI ENG, V2014, DOI DOI 10.1155/2014/612976
   Leclerc E, 2003, BIOMED MICRODEVICES, V5, P109, DOI 10.1023/A:1024583026925
   Martins AM, 2014, BIOMACROMOLECULES, V15, P635, DOI 10.1021/bm401679q
   Mata A, 2009, BIOMATERIALS, V30, P4610, DOI 10.1016/j.biomaterials.2009.05.023
   Murphy MB, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P309, DOI 10.1016/B978-012370615-7/50026-3
   Ramon-Azcon J, 2012, LAB CHIP, V12, P2959, DOI 10.1039/c2lc40213k
   Schrand Amanda M., 2009, P159, DOI 10.1007/978-0-387-78608-7_8
   Seidi A, 2012, INTEGRATED BIOMATERI, P1, DOI DOI 10.1007/S00420-012-0822-0
   Shahini A, 2014, INT J NANOMED, V9, P167, DOI 10.2147/IJN.S54668
   Suzuki M, 2007, LANGMUIR, V23, P4088, DOI 10.1021/la063075a
   Tang V. L., 2004, ADV DRUG DELIVERY RE, V56, P1635
   Villalona GA, 2010, TISSUE ENG PART B-RE, V16, P341, DOI 10.1089/ten.TEB.2009.0527
   Wang XL, 2011, LAB CHIP, V11, P3656, DOI 10.1039/c1lc20653b
   Yan X, 2013, IEEE INT C INT ROBOT, P490, DOI 10.1109/IROS.2013.6696396
   Yang W, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.06GM01
   You JO, 2011, NANO LETT, V11, P3643, DOI 10.1021/nl201514a
   Yuen PK, 2011, LAB CHIP, V11, P1541, DOI 10.1039/c0lc00660b
   Yui N., 2002, SUPRAMOLECULAR DESIG, P2
NR 30
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-7397-2
PY 2014
BP 1886
EP 1891
PG 6
WC Automation & Control Systems; Engineering, Biomedical; Engineering,
   Electrical & Electronic; Robotics
SC Automation & Control Systems; Engineering; Robotics
GA BF1IH
UT WOS:000380399500314
DA 2018-10-20
ER

PT B
AU Tregubov, V
   Krivovichev, G
AF Tregubov, Vladimir
   Krivovichev, Gerasim
BE Veremey, EI
TI Mathematical Modelling of Biological Mobility
SO 2014 INTERNATIONAL CONFERENCE ON COMPUTER TECHNOLOGIES IN PHYSICAL AND
   ENGINEERING APPLICATIONS (ICCTPEA)
LA English
DT Proceedings Paper
CT International Conference on Computer Technologies in Physical and
   Engineering Applications (ICCTPEA)
CY JUN 30-JUL 04, 2014
CL Saint Petersburg, RUSSIA
SP Saint Petersburg State Univ, IEEE Russia NW Sect
AB The paper is devoted to the mathematical modelling of conformational rearrangement in biomaterial and to the formation of biological mobility at the micro level. For this purpose the actin-myosin interaction in muscle sarcomere and alpha - beta tubulin interaction in the cilium and flagellum inner structure were considered.
C1 [Tregubov, Vladimir; Krivovichev, Gerasim] St Petersburg State Univ, St Petersburg 198504, Russia.
RP Tregubov, V (reprint author), St Petersburg State Univ, Univ Skiy Prosp 35, St Petersburg 198504, Russia.
EM tregoubov@apmath.spbu.ru; gera1983k@bk.ru
RI Krivovichev, Gerasim/K-9000-2013; Krivovichev, Gerasim/R-1930-2017
OI Krivovichev, Gerasim/0000-0002-1135-1469; Krivovichev,
   Gerasim/0000-0002-1135-1469; Tregubov, Vladimir/0000-0001-7830-7035
CR DESHCHEREVSKII V I, 1971, Biorheology, V7, P147
   Krivovichev GV, 2011, ACTA BIOENG BIOMECH, V13, P73
   Tregoubov V. P., 2003, ACTA BIOENGINEERI S1, V5, P512
NR 3
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-5317-2
PY 2014
BP 189
EP 190
PG 2
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary
SC Computer Science; Engineering
GA BE0PW
UT WOS:000366571300108
DA 2018-10-20
ER

PT J
AU Guan, GP
   Wang, L
   Li, MZ
   Bai, L
AF Guan, Guoping
   Wang, Lu
   Li, Mingzhong
   Bai, Lun
TI In vivo biodegradation of porous silk fibroin films implanted beneath
   the skin and muscle of the rat(1)
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Biomedical Engineering and Biotechnology
   (iCBEB)
CY OCT 11-13, 2013
CL Wuhan, PEOPLES R CHINA
DE biodegradation; porous biomaterials; silk fibroin; in vivo
ID DEGRADATION; SCAFFOLDS; VITRO
AB Since the bioresorption process has a strong impact not only on the mechanical properties of the biomaterial but also on the extent of tissue regeneration, in vivo biodegradation of absorbable porous biomaterials plays a key role in tissue repair and wound healing. In the present work, porous silk fibroin films (PSFFs) were prepared by a freeze-drying method and then implanted beneath the dorsal skin and the femoral skeletal muscle of the rat. The objective was to study the rate of biodegradation of the PSFFs in different tissues, each with its distinct metabolic rate. In addition we examined the relationship between the biodegradation rate and tissue-regeneration rate semi-quantitatively by incorporating histology, microscopy and image analysis methods. Furthermore, based on our previous findings, we also explored the relationship between in vitro and in vivo rates of biodegradation. The results suggest that the PSFFs experience a similar biodegradation process regardless of the type of tissue in which they are implanted, in spite of the higher metabolic rate of the skeletal muscle. In addition, the in vitro biodegradation rate of the PSFFs was comparable to that of both skin and skeletal muscle, suggesting that an in vitro biodegradation test could be used to predict in vivo performance.
C1 [Guan, Guoping; Wang, Lu] Donghua Univ, Coll Text, Minist Educ, Key Lab Text Sci & Technol, Shanghai, Peoples R China.
   [Li, Mingzhong; Bai, Lun] Text & Clothing Engn Coll, Suzhou, Jiangsu, Peoples R China.
RP Wang, L (reprint author), Donghua Univ, Coll Text, Minist Educ, Key Lab Text Sci & Technol, 2999 North Renmin Rd, Shanghai, Peoples R China.
EM wanglu@dhu.edu.cn
CR Boyd M, 2007, REGEN MED, V2, P363, DOI 10.2217/17460751.2.4.363
   Cao Y, 2006, BIOMATERIALS, V27, P2854, DOI 10.1016/j.biomaterials.2005.12.015
   Guan GP, 2010, INT CONF BIOMED, P1668, DOI 10.1109/BMEI.2010.5639621
   Guan GP, 2010, BIO-MED MATER ENG, V20, P295, DOI 10.3233/BME-2010-0643
   Guan GP, 2009, MATER SCI FORUM, V610-613, P1113, DOI 10.4028/www.scientific.net/MSF.610-613.1113
   Hedberg EL, 2005, BIOMATERIALS, V26, P3215, DOI 10.1016/j.biomaterials.2004.09.012
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yoshioka T, 2008, BIOMATERIALS, V29, P3438, DOI 10.1016/j.biomaterials.2008.04.011
NR 10
TC 4
Z9 6
U1 1
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 1
BP 789
EP 797
DI 10.3233/BME-130870
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256LU
UT WOS:000327312600091
PM 24211965
DA 2018-10-20
ER

PT J
AU Dinjaski, N
   Fernandez-Gutierrez, M
   Selvam, S
   Parra-Ruiz, FJ
   Lehman, SM
   Roman, JS
   Garcia, E
   Garcia, JL
   Garcia, AJ
   Prieto, MA
AF Dinjaski, Nina
   Fernandez-Gutierrez, Mar
   Selvam, Shivaram
   Parra-Ruiz, Francisco J.
   Lehman, Susan M.
   Roman, Julio San
   Garcia, Ernesto
   Garcia, Jose L.
   Garcia, Andres J.
   Auxiliadora Prieto, Maria
TI PHACOS, a functionalized bacterial polyester with bactericidal activity
   against methicillin-resistant Staphylococcus aureus
SO BIOMATERIALS
LA English
DT Article
DE Functionalized polyhydroxyalkanoate; Antimicrobial polymers;
   Methicillin-resistant Staphylococcus aureus; Biofilm; Biomaterial
   infection
ID MEDIUM-CHAIN-LENGTH; ANTIMICROBIAL POLYMERS; BIOFILM FORMATION;
   N-ACETYLCYSTEINE; IN-VIVO; INFECTIONS; POLYHYDROXYALKANOATES; SURFACES;
   TISSUE; ACIDS
AB Biomaterial-associated infections represent a significant clinical problem, and treatment of these microbial infections is becoming troublesome due to the increasing number of antibiotic-resistant strains. Here, we report a naturally functionalized bacterial polyhydroxyalkanoate (PHACOS) with antibacterial properties. We demonstrate that PHACOS selectively and efficiently inhibits the growth of methicillin-resistant Staphylococcus aureus (MRSA) both in vitro and in vivo. This ability has been ascribed to the functionalized side chains containing thioester groups. Significantly less (3.2-fold) biofilm formation of S. aureus was detected on PHACOS compared to biofilms formed on control poly(3-hydroxyoctanoate-co-hydroxyhexanoate) and poly(ethylene terephthalate), but no differences were observed in bacterial adhesion among these polymers. PHACOS elicited minimal cytotoxic and inflammatory effects on murine macrophages and supported normal fibroblast adhesion. In vivo fluorescence imaging demonstrated minimal inflammation and excellent antibacterial activity for PHACOS compared to controls in an in vivo model of implant-associated infection. Additionally, reductions in neutrophils and macrophages in the vicinity of sterile PHACOS compared to sterile PHO implant were observed by immunohistochemistry. Moreover, a similar percentage of inflammatory cells was found in the tissue surrounding sterile PHACOS and S. aureus pre-colonized PHACOS implants, and these levels were significantly lower than S. aureus pre-colonized control polymers. These findings support a contact active surface mode of antibacterial action for PHACOS and establish this functionalized polyhydroxyalkanoate as an infection-resistant biomaterial. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Dinjaski, Nina; Garcia, Ernesto; Garcia, Jose L.; Auxiliadora Prieto, Maria] CSIC, Ctr Invest Biol, Madrid 28040, Spain.
   [Fernandez-Gutierrez, Mar; Parra-Ruiz, Francisco J.; Roman, Julio San] CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
   [Selvam, Shivaram; Lehman, Susan M.; Garcia, Andres J.] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Selvam, Shivaram; Lehman, Susan M.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Garcia, Ernesto] CIBER Enfermedades Resp CIBERES, Madrid, Spain.
   [Fernandez-Gutierrez, Mar; Parra-Ruiz, Francisco J.; Roman, Julio San] Ctr Invest Biomed Red Bioingn Biomat & Nanomed, CIBER BBN, Madrid, Spain.
RP Prieto, MA (reprint author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain.
EM auxi@cib.csic.es
RI Prieto, Maria Auxiliadora/I-8092-2015; Fernandez-Gutierrez,
   Mar/D-3860-2014
OI Fernandez-Gutierrez, Mar/0000-0003-1739-1987; Prieto Jimenez, M.
   Auxiliadora/0000-0002-8038-1223; Prieto, Martin/0000-0002-8841-0543;
   Selvam, Shivaram/0000-0002-0005-7707; /0000-0002-3991-7305; Garcia
   Lopez, Jose Luis/0000-0002-9238-2485
FU program JAE DOC of the CSIC; Ministerio of Economia y Competitividad
   [BIO2010-21049]; U.S.A. National Institutes of Health [R21 AI094624];
   Georgia Tech/Emory Center for the Engineering of Living Tissues; Atlanta
   Clinical and Translational Science Institute under PHS from the Clinical
   and Translational Science Award Program [UL RR025008]; CIBER-BBN
FX N.D. is a fellow of JAE Pre-doc Program of CSIC. M.F.-G. and F.P-R thank
   the program JAE DOC of the CSIC for financial support. The technical
   works of A. Valencia and F. de la Pena are greatly appreciated. We are
   indebted to Biopolis S.L. for the supplied polymers. This work was
   supported by the Ministerio of Economia y Competitividad
   (BIO2010-21049), the U.S.A. National Institutes of Health grant R21
   AI094624 (A.J.G.), the Georgia Tech/Emory Center for the Engineering of
   Living Tissues, the Atlanta Clinical and Translational Science Institute
   under PHS Grant UL RR025008 from the Clinical and Translational Science
   Award Program. Financial support from the CIBER-BBN is acknowledged.
   CIBER de Enfermedades Respiratorias (CIBERES) is an initiative of
   Instituto de Salud Carlos III (ISCIII).
CR [Anonymous], 2008, M07A8 CLSI
   Butler MS, 2011, J ANTIBIOT, V64, P413, DOI 10.1038/ja.2011.44
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   CORNELL RJ, 1965, J MED CHEM, V8, P388, DOI 10.1021/jm00327a025
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226
   Epand RF, 2009, BIOPHYS J, V97, P2250, DOI 10.1016/j.bpj.2009.08.006
   Escapa IF, 2011, APPL MICROBIOL BIOT, V89, P1583, DOI 10.1007/s00253-011-3099-4
   FDA, 1987, GUID VAL LIM AM LYS
   Furrer P, 2007, J MICROBIOL METH, V69, P206, DOI 10.1016/j.mimet.2007.01.002
   Gibney KA, 2012, MACROMOL BIOSCI, V12, P1279, DOI 10.1002/mabi.201200052
   Gomes ME, 2004, INT MATER REV, V49, P261, DOI 10.1179/095066004225021918
   Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Hazer DB, 2012, MAT SCI ENG C-MATER, V32, P637, DOI 10.1016/j.msec.2012.01.021
   Hernandez MD, 2009, INFECT CONT HOSP EP, V30, P190, DOI 10.1086/593205
   Kiedrowski MR, 2011, ANN NY ACAD SCI, V1241, P104, DOI 10.1111/j.1749-6632.2011.06281.x
   Klein E, 2009, EMERG INFECT DIS, V15, P1925, DOI 10.3201/eid1512.081341
   Kojima M, 2000, ONCOGENE, V19, P1225, DOI 10.1038/sj.onc.1203427
   Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851
   Kuroda K, 2013, WIRES NANOMED NANOBI, V5, P49, DOI 10.1002/wnan.1199
   Lejars M, 2012, CHEM REV, V112, P4347, DOI 10.1021/cr200350v
   Lienkamp K, 2008, J AM CHEM SOC, V130, P9836, DOI 10.1021/ja801662y
   Lin PW, 2009, FREE RADICAL BIO MED, V47, P1205, DOI 10.1016/j.freeradbiomed.2009.07.033
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Mauclaire L, 2010, COLLOID SURFACE B, V76, P104, DOI 10.1016/j.colsurfb.2009.10.021
   Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   National Research Council, 1985, NIH PUBLICATION, V85-23
   Olofsson AC, 2003, APPL ENVIRON MICROB, V69, P4814, DOI 10.1128/AEM.69.8.4814-4822.2003
   Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2
   PerezGiraldo C, 1997, J ANTIMICROB CHEMOTH, V39, P643, DOI 10.1093/jac/39.5.643
   Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08
   Reusch RN, 2000, BIOCHEMISTRY-MOSCOW+, V65, P280
   Ruth K, 2007, BIOMACROMOLECULES, V8, P279, DOI 10.1021/bm060585a
   Sambrook J, 2001, MOL CLONING LAB MANU
   Sandoval A, 2005, APPL MICROBIOL BIOT, V67, P97, DOI 10.1007/s00253-004-1752-x
   SCHMIDT HHH, 1996, METHODS NITRIC OXIDE, P491
   Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Timofeeva L, 2011, APPL MICROBIOL BIOT, V89, P475, DOI 10.1007/s00253-010-2920-9
   Tortajada M, 2013, INT MICROBIOL, V16, P1, DOI 10.2436/20.1501.01.175
   Wang SY, 2008, PHYTOTHER RES, V22, P213, DOI 10.1002/ptr.2289
   Wang Y, 2013, LANGMUIR, V29, P10635, DOI 10.1021/la4012263
   Wiggam MI, 1997, DIABETES CARE, V20, P137
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 49
TC 19
Z9 25
U1 2
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2014
VL 35
IS 1
BP 14
EP 24
DI 10.1016/j.biomaterials.2013.09.059
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 266EL
UT WOS:000328006100002
PM 24094939
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Huang, GS
   Hsieh, PS
   Tseng, CS
   Hsu, SH
AF Huang, Guo-Shiang
   Hsieh, Pai-Shan
   Tseng, Ching-Shiow
   Hsu, Shan-hui
TI The substrate-dependent regeneration capacity of mesenchymal stem cell
   spheroids derived on various biomaterial surfaces
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID HUMAN GINGIVAL FIBROBLASTS; IN-VITRO; CHITOSAN MEMBRANES; BONE-MARROW;
   CARTILAGE REGENERATION; CULTURE METHODS; CHONDROGENESIS;
   DIFFERENTIATION; TISSUE; MATRIX
AB Mesenchymal stem cells (MSCs) are widely used for their self-renewal and multipotent abilities, which can be further enhanced by growing MSCs as three-dimensional (3D) cellular spheroids on certain substrates. Although various surfaces have been used to generate 3D MSC spheroids, the answer to whether all these spheroids have similar in vitro and in vivo properties remains unclear. In this study, adipose-derived adult stem cells (ADSCs) were cultured on a non-adherent Petri dish, polyvinyl alcohol, chitosan (CS), or chitosan-hyaluronan (CS-HA) to form 3D spheroids. The expression of the cell adhesion molecule, N-cadherin, was analyzed by qRT-PCR and Western blotting. The functional migration ability was tested using the transwell assay. The capacity for chondral regeneration of various ADSC spheroids was further evaluated in a rabbit model. We demonstrated that ADSC spheroids derived on the CS or CS-HA surface had the greater expression of N-cadherin and better migration ability. The latter was consistent with the higher expression levels of chemokine/receptor SDF-1/CXCR4 for the spheroids derived on CS or CS-HA. Animal studies also revealed significantly better cartilage repair in defects loaded with CS- or CS-HA-derived spheroids. In particular, CS-HA-derived spheroids gave rise to the best regeneration when combined with a 3D printed scaffold. This study suggested that MSC spheroids derived on different surfaces may have distinct in vitro and in vivo properties, which appeared to be associated with the surface-bound calcium as well as the calcium-dependent N-cadherin and CXCR4 signaling. The substrate-dependent properties may eventually lead to different regeneration capacities of various MSC spheroids in vivo.
C1 [Huang, Guo-Shiang; Hsieh, Pai-Shan; Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan.
   [Tseng, Ching-Shiow] Natl Cent Univ, Dept Mech Engn, Taoyuan, Taiwan.
RP Huang, GS (reprint author), Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan.
EM shhsu@ntu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
FU National Science Council of Taiwan [NSC102-2321-B-002-033]
FX This research was supported by the National Science Council of Taiwan
   (NSC102-2321-B-002-033).
CR Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Chang CH, 2008, ARTIF ORGANS, V32, P561, DOI 10.1111/j.1525-1594.2008.00575.x
   Chen RS, 2007, J BIOMED MATER RES A, V83A, P241, DOI 10.1002/jbm.a.31475
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI [10.1089/ten.tec.2009.0432, 10.1089/ten.TEC.2009.0432]
   Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6
   Guang LG, 2012, INT J BIOCHEM CELL B, V44, P1825, DOI 10.1016/j.biocel.2012.06.033
   Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013
   Hsu SH, 2012, TISSUE ENG PT A, V18, P67, DOI [10.1089/ten.tea.2011.0157, 10.1089/ten.TEA.2011.0157]
   Hsu SH, 2013, MACROMOL BIOSCI, V13, P1100, DOI 10.1002/mabi.201200472
   Hsu SH, 2012, BIOMATERIALS, V33, P2642, DOI 10.1016/j.biomaterials.2011.12.032
   Huang GS, 2013, EUR CELLS MATER, V26, P179, DOI 10.22203/eCM.v026a13
   Huang GS, 2011, BIOMATERIALS, V32, P6929, DOI 10.1016/j.biomaterials.2011.05.092
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Katagiri H, 2013, BIOCHEM BIOPH RES CO, V435, P603, DOI 10.1016/j.bbrc.2013.05.026
   Kuraitis D, 2011, EUR CELLS MATER, V22, P109, DOI 10.22203/eCM.v022a09
   Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338
   Lee J I, 2011, Eur Cell Mater, V22, P275
   Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007
   Mendelson A, 2011, FASEB J, V25, P3496, DOI 10.1096/fj.10-176305
   POTTEN CS, 1990, DEVELOPMENT, V110, P1001
   Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329
   Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466
   Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271
   Su GN, 2013, BIOMATERIALS, V34, P3215, DOI 10.1016/j.biomaterials.2013.01.044
   Sukegawa A, 2012, TISSUE ENG PT A, V18, P934, DOI [10.1089/ten.TEA.2011.0380, 10.1089/ten.tea.2011.0380]
   Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869
   Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003
   Yeh HY, 2012, BIOMATERIALS, V33, P8943, DOI 10.1016/j.biomaterials.2012.08.069
   Yen HJ, 2009, TISSUE ENG PT A, V15, P965, DOI 10.1089/ten.tea.2008.0090
   Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191
   Ziane S, 2012, EUR CELLS MATER, V23, P147, DOI 10.22203/eCM.v023a11
NR 34
TC 13
Z9 13
U1 1
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 11
BP 1652
EP 1660
DI 10.1039/c4bm00053f
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7XR
UT WOS:000343034200010
DA 2018-10-20
ER

PT S
AU Pernisova, V
   Capova, K
   Smetana, M
   Strapacova, T
AF Pernisova, Viera
   Capova, Klara
   Smetana, Milan
   Strapacova, Tatiana
BE Capova, K
   Udpa, L
   Janousek, L
   Rao, BPC
TI Biomaterial Real Defects Evaluation Using Advanced Detection Sensors
SO ELECTROMAGNETIC NONDESTRUCTIVE EVALUATION (XVII)
SE Studies in Applied Electromagnetics and Mechanics
LA English
DT Proceedings Paper
CT 18th International Workshop on Electromagnetic Non-Destructive
   Evaluation (ENDE)
CY JUN 25-28, 2013
CL Bratislava, SLOVAKIA
SP Univ Zilina, Fac Elect Engn, Univ Zilina, Fac Elect Engn, Alumni Club, Japan Soc Maintenol, Japan Soc Appl Electromagnet & Mech
DE biomaterial; eddy current testing; magnetic sensors; GMR; fluxgate;
   stress corrosion crack
AB The paper deals with biomaterial electromagnetic non-destructive testing with an emphasis on real defects identification. Various modifications of eddy current testing (ECT) detection sensors will be compared and discussed from the desired detected signal characteristics points of view. Advanced magnetic sensors such as giant magneto-resistance (GMR) sensors and fluxgate sensors and probe coils are presented in the paper. These advanced sensors are characterized by their sensitivity, frequency range and sensors dimensions. The measurements for detection of stress corrosion cracks (SCC) in implants materials using magnetic sensors will be presented and their responses will be compared.
C1 [Pernisova, Viera; Capova, Klara; Smetana, Milan; Strapacova, Tatiana] Univ Zilina, Fac Eletr Engn, Dept Electromagnet & Biomed Engn, Univ 1, Zilina 01026, Slovakia.
RP Capova, K (reprint author), Univ Zilina, Fac Eletr Engn, Dept Electromagnet & Biomed Engn, Univ 1, Zilina 01026, Slovakia.
EM klara.capova@fel.uniza.sk
FU Slovak Grant Agency Vega [1/0927/11]
FX This work was supported by grant of the Slovak Grant Agency Vega,
   project No. 1/0927/11.
CR Betta G, 2012, IEEE T INSTRUM MEAS, V61, P505, DOI 10.1109/TIM.2011.2161923
   REIG C., 2009, TECHNOLOGY APPL ELEC, P7920
   Ripka P, 2003, SENSOR ACTUAT A-PHYS, V106, P8, DOI 10.1016/S0924-4247(03)00094-3
   SMETANA M., 2012, ELECTROMAGNETIC NOND, V36, P227
NR 4
TC 0
Z9 0
U1 2
U2 2
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1383-7281
BN 978-1-61499-407-7; 978-1-61499-406-0
J9 STUD APPL ELECTROMAG
PY 2014
VL 39
BP 19
EP 26
DI 10.3233/978-1-61499-407-7-19
PG 8
WC Engineering, Electrical & Electronic; Mechanics; Physics, Applied
SC Engineering; Mechanics; Physics
GA BJ6NY
UT WOS:000426883200003
DA 2018-10-20
ER

PT J
AU An, B
   Kaplan, DL
   Brodsky, B
AF An, Bo
   Kaplan, David L.
   Brodsky, Barbara
TI Engineered recombinant bacterial collagen as an alternative
   collagen-based biomaterial for tissue engineering
SO FRONTIERS IN CHEMISTRY
LA English
DT Editorial Material
DE collagen; triple helix; recombinant expression; biomaterials; tissue
   engineering
C1 [An, Bo; Kaplan, David L.; Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu; barbara.brodsky@tufts.edu
RI An, Bo/N-3466-2014
OI An, Bo/0000-0002-1031-3380
FU NIBIB NIH HHS [R01 EB011620]
CR An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200
   Chan SWP, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-51
   Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002
   Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241
   Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200
   Jalan AA, 2013, J AM CHEM SOC, V135, P6014, DOI 10.1021/ja402187t
   JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1
   KADLER K, 1994, PROTEIN PROFILE, V1, P519
   Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017
   Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001
   Merrett K, 2008, INVEST OPHTH VIS SCI, V49, P3887, DOI 10.1167/iovs.07-1348
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Myllyharju Johanna, 2009, V522, P51, DOI 10.1007/978-1-59745-413-1_3
   NAUTIYAL S, 1995, BIOCHEMISTRY-US, V34, P11645, DOI 10.1021/bi00037a001
   Peng YY, 2014, J BIOMED MATER RES A, V102, P2189, DOI 10.1002/jbm.a.34898
   Peng YY, 2014, APPL MICROBIOL BIOT, V98, P1807, DOI 10.1007/s00253-013-5475-8
   Peng YY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-146
   Peng YY, 2010, BIOMATERIALS, V31, P2755, DOI 10.1016/j.biomaterials.2009.12.040
   Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200
   Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   Ruggiero F, 2008, METHODS, V45, P75, DOI 10.1016/j.ymeth.2008.01.003
   Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357
   Shilo S, 2013, TISSUE ENG PT A, V19, P1519, DOI [10.1089/ten.tea.2012.0345, 10.1089/ten.TEA.2012.0345]
   Shoseyov O, 2014, BIOENGINEERED, V5, P49, DOI 10.4161/bioe.26002
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   Xu X, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-69
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
   Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003
   Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979
   Yu ZX, 2011, J BIOL CHEM, V286, P18960, DOI 10.1074/jbc.M110.217422
NR 36
TC 14
Z9 14
U1 2
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
EI 2296-2646
J9 FRONT CHEM
JI Front. Chem.
PY 2014
VL 2
AR 40
DI 10.3389/fchem.2014.00040
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA V43JV
UT WOS:000209678600043
PM 25003103
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lomakin, J
   Sprouse, PA
   Detamore, MS
   Gehrke, SH
AF Lomakin, J.
   Sprouse, P. A.
   Detamore, M. S.
   Gehrke, S. H.
TI Effect of Pre-Stress on the Dynamic Tensile Behavior of the TMJ Disc
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE TMJ; dynamic mechanical analysis; strain-rate frequency superposition;
   viscoelasticity; biomechanics
ID TEMPOROMANDIBULAR-JOINT DISC; FINITE-ELEMENT-ANALYSIS; VISCOELASTIC
   PROPERTIES; ARTICULAR-CARTILAGE; COMPRESSIVE PROPERTIES; RESONANCE
   FREQUENCY; SHEAR PROPERTIES; STRAIN; TISSUES; SYSTEM
AB Previous dynamic analyses of the temporomandibular joint (TMJ) disc have not included a true preload, i.e., a step stress or strain beyond the initial tare load. However, due to the highly nonlinear stress-strain response of the TMJ disc, we hypothesized that the dynamic mechanical properties would greatly depend on the preload, which could then, in part, account for the large variation in the tensile stiffnesses reported for the TMJ disc in the literature. This study is the first to report the dynamic mechanical properties as a function of prestress. As hypothesized, the storage modulus (E') of the disc varied by a factor of 25 in the mediolateral direction and a factor of 200 in the anteroposterior direction, depending on the prestress. Multiple constant strain rate sweeps were extracted and superimposed via strain-rate frequency superposition (SRFS), which demonstrated that the strain rate amplitude and strain rate were both important factors in determining the TMJ disc material properties, which is an effect not typically seen with synthetic materials. The presented analysis demonstrated, for the first time, the applicability of viscoelastic models, previously applied to synthetic polymer materials, to a complex hierarchical biomaterial such as the TMJ disc, providing a uniquely comprehensive way to capture the viscoelastic response of biological materials. Finally, we emphasize that the use of a preload, preferably which falls within the linear region of the stress-strain curve, is critical to provide reproducible results for tensile analysis of musculoskeletal tissues. Therefore, we recommend that future dynamic mechanical analyses of the TMJ disc be performed at a controlled prestress corresponding to a strain range of 5- 10%.
C1 [Lomakin, J.; Detamore, M. S.; Gehrke, S. H.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA.
   [Sprouse, P. A.; Detamore, M. S.; Gehrke, S. H.] Univ Kansas, Bioengn Program, Lawrence, KS 66045 USA.
RP Gehrke, SH (reprint author), Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA.
EM shgehrke@ku.edu
RI Gehrke, Stevin/A-5265-2014
FU National Science Foundation [IOS 0726412]
FX Sincere thanks to Dr. Milind Singh for his advice and for providing
   tissue samples for this work. This material is based on work supported
   by the National Science Foundation under Grant No. IOS 0726412. Any
   opinions, findings, and conclusions or recommendations expressed in this
   article are those of the authors and do not necessarily reflect the
   views of the National Science Foundation.
CR Allen KD, 2005, ANN BIOMED ENG, V33, P951, DOI 10.1007/s10439-005-3872-6
   Athanasiou KA, 2009, TISSUE ENG TEMPOROMA
   Beatty MW, 2003, J OROFAC PAIN, V17, P160
   Beatty MW, 2001, J BIOMED MATER RES, V57, P25, DOI 10.1002/1097-4636(200110)57:1<25::AID-JBM1137>3.0.CO;2-H
   Beek M, 2000, J BIOMECH, V33, P307, DOI 10.1016/S0021-9290(99)00168-2
   Beek M, 2001, J DENT RES, V80, P876, DOI 10.1177/00220345010800030601
   Chin LPY, 1996, J ORAL MAXIL SURG, V54, P315, DOI 10.1016/S0278-2391(96)90751-X
   Detamore MS, 2003, TISSUE ENG, V9, P1065, DOI 10.1089/10763270360727991
   Detamore MS, 2003, J BIOMECH ENG-T ASME, V125, P558, DOI 10.1115/1.1589778
   Detamore MS, 2003, J ORAL MAXIL SURG, V61, P494, DOI 10.1053/joms.2003.50096
   Donzelli PS, 2004, J BIOMECH, V37, P1787, DOI 10.1016/j.jbiomech.2004.01.029
   Fernandez P, 2011, STRAIN, V47, P188, DOI 10.1111/j.1475-1305.2008.00502.x
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102
   Herring S. W., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P391
   Herring S. W., 2003, J MUSCULOSKEL NEURON, V3, P406
   Hoffman B. D., 2005, B AM PHYS SOC, V1, P31003
   Inman D. J., 2000, ENG VIBRATION
   Lamela MJ, 2013, J MECH BEHAV BIOMED, V23, P62, DOI 10.1016/j.jmbbm.2013.04.006
   Klemuk SA, 2004, LARYNGOSCOPE, V114, P1597, DOI 10.1097/00005537-200409000-00018
   Koenderink GH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysLettRev.96.138307
   Kong HJ, 2003, MACROMOLECULES, V36, P4582, DOI 10.1021/ma034137w
   Koolstra JH, 2007, J BIOMECH, V40, P2330, DOI 10.1016/j.jbiomech.2006.10.019
   Koolstra JH, 2003, J DENT RES, V82, P672, DOI 10.1177/154405910308200903
   Kuboki T, 1997, J DENT RES, V76, P1760, DOI 10.1177/00220345970760110701
   Mavrilas D, 2005, J BIOMECH, V38, P761, DOI 10.1016/j.jbiomech.2004.05.019
   Menard K. P., 1999, DYNAMIC MECH ANAL PR
   Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x
   Mohan P. H., 2008, PHYS REV E, V77, P7
   OLOYEDE A, 1992, CONNECT TISSUE RES, V27, P211, DOI 10.3109/03008209209006997
   Park S, 2006, J BIOMECH ENG-T ASME, V128, P623, DOI 10.1115/1.2206201
   Rees LA., 1954, BRIT DENT J, V96, P125
   Scapino RP, 2006, CELLS TISSUES ORGANS, V182, P201, DOI 10.1159/000093969
   SCHWARTZ MH, 1994, J BIOMECH, V27, P865, DOI 10.1016/0021-9290(94)90259-3
   Singh M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838062
   Snider GR, 2008, J DENT RES, V87, P1053, DOI 10.1177/154405910808701112
   Stokes JR, 2008, SOFT MATTER, V4, P1133, DOI 10.1039/b719677f
   Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406
   Tanaka E, 2004, J DENT RES, V83, P476, DOI 10.1177/154405910408300608
   Tanaka E, 2004, MED ENG PHYS, V26, P503, DOI 10.1016/j.medengphy.2004.03.001
   Tanaka E, 2003, CRIT REV ORAL BIOL M, V14, P138, DOI 10.1177/154411130301400207
   Tanaka E, 2003, EUR J ORAL SCI, V111, P434, DOI 10.1034/j.1600-0722.2003.00066.x
   Tanaka E, 2003, EUR J ORAL SCI, V111, P353, DOI 10.1034/j.1600-0722.2003.00049.x
   Tanaka E, 2003, J BIOMED MATER RES A, V65A, P386, DOI 10.1002/jbm.a.10496
   Tanaka E, 2003, J DENT RES, V82, P228, DOI 10.1177/154405910308200315
   Tanaka E, 2002, J DENT RES, V81, P618, DOI 10.1177/154405910208100908
   Tanaka E, 2002, ARCH ORAL BIOL, V47, P139, DOI 10.1016/S0003-9969(01)00096-6
   TANNE K, 1991, J DENT RES, V70, P1545, DOI 10.1177/00220345910700121401
   Teng S, 1991, J Craniomandib Disord, V5, P107
   Wang TG, 2007, SCAND J MED SCI SPOR, V17, P535, DOI 10.1111/j.1600-0838.2006.00618.x
   Wyss HM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238303
NR 51
TC 2
Z9 2
U1 1
U2 14
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
EI 1528-8951
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD JAN
PY 2014
VL 136
IS 1
AR 011001
DI 10.1115/1.4025775
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 269ST
UT WOS:000328262900001
PM 24141522
DA 2018-10-20
ER

PT J
AU Silva, R
   Singh, R
   Sarker, B
   Papageorgiou, DG
   Juhasz, JA
   Roether, JA
   Cicha, I
   Kaschta, J
   Schubert, DW
   Chrissafis, K
   Detsch, R
   Boccaccini, AR
AF Silva, Raquel
   Singh, Raminder
   Sarker, Bapi
   Papageorgiou, Dimitrios G.
   Juhasz, Judith A.
   Roether, Judith A.
   Cicha, Iwona
   Kaschta, Joachim
   Schubert, Dirk W.
   Chrissafis, Konstantinos
   Detsch, Rainer
   Boccaccini, Aldo R.
TI Hybrid hydrogels based on keratin and alginate for tissue engineering
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PHYSICOCHEMICAL PROPERTIES; REGENERATIVE MEDICINE; ENDOTHELIAL-CELLS;
   SPONGE SCAFFOLDS; PORE-SIZE; FABRICATION; BIOMATERIAL; ULTRASOUND;
   APOPTOSIS; WOOL
AB Novel hybrid hydrogels based on alginate and keratin were successfully produced for the first time. The self-assembly properties of keratin, and its ability to mimic the extracellular matrix were combined with the excellent chemical and mechanical stability and biocompatibility of alginate to produce 2D and 3D hybrid hydrogels. These hybrid hydrogels were prepared using two different approaches: sonication, to obtain 2D hydrogels, and a pressure-driven extrusion technique to produce 3D hydrogels. All results indicated that the composition of the hydrogels had a significant effect on their physical properties, and that they can easily be tuned to obtain materials suitable for biological applications. The cell-material interaction was assessed through the use of human umbilical vein endothelial cells, and the results demonstrated that the alginate/keratin hybrid biomaterials supported cell attachment, spreading and proliferation. The results proved that such novel hybrid hydrogels might find applications as scaffolds for soft tissue regeneration.
C1 [Silva, Raquel; Sarker, Bapi; Juhasz, Judith A.; Detsch, Rainer; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
   [Singh, Raminder] Univ Hosp Erlangen, Med Clin 2, Lab Mol Cardiol, D-91054 Erlangen, Germany.
   [Papageorgiou, Dimitrios G.; Detsch, Rainer] Aristotle Univ Thessaloniki, Dept Phys, Solid State Phys Sect, Thessaloniki 54124, Greece.
   [Roether, Judith A.; Kaschta, Joachim; Schubert, Dirk W.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Polymer Mat, D-91058 Erlangen, Germany.
   [Singh, Raminder; Cicha, Iwona] Univ Hosp Erlangen, ENT Dept, Sect Expt Oncol & Nanomed, Cardiovasc Nanomed Unit, D-91054 Erlangen, Germany.
RP Boccaccini, AR (reprint author), Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
EM aldo.boccaccini@ww.uni-erlangen.de
RI Boccaccini, Aldo/C-7905-2013
OI Papageorgiou, Dimitrios/0000-0001-5558-5040; Chrissafis,
   Konstantinos/0000-0003-1546-8565; Silva, Raquel/0000-0001-7648-9146
FU Emerging Fields project "TOPbiomat" of the University of
   Erlangen-Nuremberg (Germany)
FX This study was supported by the Emerging Fields project "TOPbiomat" of
   the University of Erlangen-Nuremberg (Germany). The authors thank Nina
   Jaziri for help with HUVEC isolation and Dr. Menti Goudouri for FTIR
   measurements.
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Astbury WT, 1934, PHILOS T R SOC LOND, V232, P333, DOI 10.1098/rsta.1934.0010
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Balaji S, 2012, POLYM ADVAN TECHNOL, V23, P500, DOI 10.1002/pat.1905
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   Bang JH, 2010, ADV MATER, V22, P1039, DOI 10.1002/adma.200904093
   Bogun M, 2011, J THERM ANAL CALORIM, V106, P953, DOI 10.1007/s10973-011-1594-6
   BUCHANAN JH, 1977, BIOCHEM J, V167, P489, DOI 10.1042/bj1670489
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   Caridade SG, 2013, J MECH BEHAV BIOMED, V20, P173, DOI 10.1016/j.jmbbm.2012.11.012
   Chavakis E., 2002, J AM HEART ASS, V22, P887
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022
   EARLAND C, 1956, BIOCHIM BIOPHYS ACTA, V22, P405, DOI 10.1016/0006-3002(56)90048-8
   Elisseeff J, 2005, Orthod Craniofac Res, V8, P150, DOI 10.1111/j.1601-6343.2005.00335.x
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Feughelman M., 1985, KERATIN ENCY POLYM S, P566
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gao CM, 2009, POLYM DEGRAD STABIL, V94, P1405, DOI 10.1016/j.polymdegradstab.2009.05.011
   Goddard DR, 1934, J BIOL CHEM, V106, P605
   Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682
   Hamasaki S, 2008, MAT SCI ENG C-BIO S, V28, P1250, DOI 10.1016/j.msec.2007.11.008
   Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Ioannou YA, 1996, NUCLEIC ACIDS RES, V24, P992
   Joshi C., 2012, CURR MICROSC CONTRIB, P756
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   Katoh K, 2004, BIOMATERIALS, V25, P2265, DOI 10.1016/j.biomaterials.2003.09.021
   Kidoaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078067
   Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341
   Leadsham JE, 2010, CELL DEATH DIFFER, V17, P754, DOI 10.1038/cdd.2009.196
   Leal-Egana A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-24
   Li HB, 2006, BIOMED MATER, V1, P42, DOI 10.1088/1748-6041/1/1/007
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACLAREN JA, 1962, AUST J CHEM, V15, P824, DOI 10.1071/CH9620824
   Mason TJ, 2007, ULTRASON SONOCHEM, V14, P476, DOI 10.1016/j.ultsonch.2006.10.008
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Ming J., 2013, POLYM ENG SCI, P1
   ODONNELL IJ, 1969, AUST J BIOL SCI, V22, P471, DOI 10.1071/BI9690471
   Park JB, 2011, MED ORAL PATOL ORAL, V16, pE115, DOI 10.4317/medoral.16.e115
   PAULING L, 1953, NATURE, V171, P59, DOI 10.1038/171059a0
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P729, DOI 10.1073/pnas.37.11.729
   Paulusse JMJ, 2006, J POLYM SCI POL CHEM, V44, P5445, DOI 10.1002/pola.21646
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Rae J, 2005, ULTRASON SONOCHEM, V12, P325, DOI 10.1016/j.ultsonch.2004.06.007
   Rippon J., 1992, SOC DYERS COLOURISTS, P1
   Sarker B, 2014, J MATER CHEM B, V2, P1470, DOI 10.1039/c3tb21509a
   Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969
   Silva R, 2010, ULTRASON SONOCHEM, V17, P628, DOI 10.1016/j.ultsonch.2009.10.010
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Song SJ, 2011, ARTIF ORGANS, V35, P1132, DOI 10.1111/j.1525-1594.2011.01377.x
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   SUSLICK KS, 1990, J AM CHEM SOC, V112, P7807, DOI 10.1021/ja00177a058
   Suslick S., 1999, ACOUSTIC CAVITATION, P335
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tham WL, 2010, EXPRESS POLYM LETT, V4, P517, DOI 10.3144/expresspolymlett.2010.66
   Varghese S, 2006, ADV POLYM SCI, P95, DOI 10.1007/12_072
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Wang L, 2012, TISSUE ENG PT A, V18, P2000, DOI [10.1089/ten.tea.2011.0663, 10.1089/ten.TEA.2011.0663]
   Wen YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053147
   Zeng Q., 2013, J BIOMED MATER RES B, P1
   Zhou CS, 2006, J AGR FOOD CHEM, V54, P2223, DOI 10.1021/jf052763h
NR 66
TC 23
Z9 24
U1 3
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 33
BP 5441
EP 5451
DI 10.1039/c4tb00776j
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AM9ME
UT WOS:000340204900013
OA Bronze, Green Published
DA 2018-10-20
ER

PT S
BE Piel, M
   Thery, M
TI Methods in Cell Biology Micropatterning in Cell Biology Part C
SO MICROPATTERNING IN CELL BIOLOGY, PT C
SE Methods in Cell Biology
LA English
DT Review; Book Chapter
AB This 317-page book in English titled "Micropatterning in Cell Biology-Part C" is volume 121 in the series "Methods in Cell Biology". This book contains 15 individually-authored chapters divided among two sections. Each chapter is extensively referenced. Topics covered include preparation of a micropatterned rigid-soft composite substrate for probing cellular rigidity sensing, micropatterning on micropost arrays, microfluidic patterning of protein gradients on biomimetic hydrogel substrates, micropatterning of poly(ethylene glycol) diacrylate hydrogels, curved and folded micropatterns in 3D cell culture and tissue engineering and cell migration in confined environments. Also discussed are micropatterned porous membranes for combinatorial cell-based assays, micropatterning cells on permeable membrane filters, microfabrication of a platform to measure and manipulate the mechanics of engineered microtissues, methods for two-dimensional cell confinement and benzophenone-based photochemical micropatterning of biomolecules to create model substrates and instructive biomaterials. This book includes a list of the contributors and their respective institutions. This book will be of interest to all those working or studying in the fields of biomaterial science and tissue engineering.
NR 0
TC 0
Z9 0
U1 1
U2 10
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-679X
BN 978-0-12-800281-0
J9 METHOD CELL BIOL
JI Methods Cell Biol.
PY 2014
VL 121
BP COVER1
EP U3
D2 10.1007/978-3-8349-6619-3
PG 3
WC Cell Biology
SC Cell Biology
GA BA2GL
UT WOS:000333375700016
DA 2018-10-20
ER

PT J
AU Choi, YC
   Choi, JS
   Jung, YJ
   Cho, YW
AF Choi, Young Chan
   Choi, Ji Suk
   Jung, Yeon Jae
   Cho, Yong Woo
TI Human gelatin tissue-adhesive hydrogels prepared by enzyme-mediated
   biosynthesis of DOPA and Fe3+ ion crosslinking
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID HUMAN ADIPOSE-TISSUE; GECKO FOOT-HAIR; MECHANICAL-PROPERTIES; MUSHROOM
   TYROSINASE; THORACIC-SURGERY; MUSSEL ADHESION; HUMAN COLLAGEN;
   AMINO-ACID; COMPONENTS; SEALANTS
AB Gelatin is extensively used as a biomaterial for diverse pharmaceutical and medical applications due to its excellent biocompatibility and biodegradability. Here we present bio-inspired tissue-adhesive gelatin hydrogels prepared by the enzyme-mediated synthesis of L-3,4-dihydroxyphenylalanine (L-DOPA) and Fe3+ ion crosslinking. Gelatin of human origin was obtained through two major steps, extracellular matrix (ECM) extraction from human adipose tissue and gelatin isolation from the ECM. The tyrosine residues in human gelatin were converted into DOPA by enzymatic reaction with tyrosinase. Upon the addition of Fe3+ ions, the DOPA-modified gelatin formed a sticky hydrogel within seconds through complexation between the DOPA molecules and Fe3+ ions. The final DOPA-modified, Fe3+ ion-crosslinked gelatin hydrogels retained their hydrogel stability well at body temperature in an aqueous environment and exhibited appropriate mechanical properties. The hemostatic ability of the DOPA-Fe3+ gelatin hydrogels was explored using a hemorrhaging liver rat model. Shortly after the injection of the DOPA-Fe3+ gelatin hydrogel, the bleeding was arrested in the hemorrhaging site of the liver. Overall results suggest that the DOPA-Fe3+ gelatin hydrogel, with its good elastic and hemostatic properties, is a promising tissue adhesive for use in a wide variety of surgical operations.
C1 [Choi, Young Chan; Choi, Ji Suk; Jung, Yeon Jae; Cho, Yong Woo] Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
   [Cho, Yong Woo] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea.
RP Cho, YW (reprint author), Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
EM ywcho7@hanyang.ac.kr
FU Basic Research Program [2012-008294]; Bio & Medical Technology
   Development Program through the National Research Foundation of Korea
   (NRF) [2011-0019774]; Korean government (MEST); Seoul RBD Program
   [SS110011]
FX This work was supported by the Basic Research Program (Grant no.
   2012-008294) and the Bio & Medical Technology Development Program (Grant
   no. 2011-0019774) through the National Research Foundation of Korea
   (NRF) funded by the Korean government (MEST). This work was also
   supported by Seoul R&BD Program (Grant no. SS110011).
CR Arnow LE, 1937, J BIOL CHEM, V118, P531
   Autumn K, 2000, NATURE, V405, P681
   Baez J, 2005, APPL MICROBIOL BIOT, V69, P245, DOI 10.1007/s00253-005-0180-x
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Burzio LA, 2000, COMP BIOCHEM PHYS B, V126, P383, DOI 10.1016/S0305-0491(00)00188-7
   Cardillo G, 2012, EUR J CARDIO-THORAC, V41, P657, DOI 10.1093/ejcts/ezr083
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Choi JS, 2010, TISSUE ENG PART C-ME, V16, P387, DOI [10.1089/ten.tec.2009.0276, 10.1089/ten.TEC.2009.0276]
   Choi JS, 2011, CELL TISSUE RES, V345, P415, DOI 10.1007/s00441-011-1223-5
   Choi JS, 2011, J BIOMED MATER RES A, V97A, P292, DOI 10.1002/jbm.a.33056
   Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034
   Duarte AP, 2012, PROG POLYM SCI, V37, P1031, DOI 10.1016/j.progpolymsci.2011.12.003
   EASTOE JE, 1955, BIOCHEM J, V61, P589, DOI 10.1042/bj0610589
   Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917
   Gomez-Guillen MC, 2002, FOOD HYDROCOLLOID, V16, P25, DOI 10.1016/S0268-005X(01)00035-2
   Guvendiren M, 2008, BIOMACROMOLECULES, V9, P122, DOI 10.1021/bm700886b
   Hamming LM, 2008, COMPOS SCI TECHNOL, V68, P2042, DOI 10.1016/j.compscitech.2008.02.036
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hoffmann B, 2009, J MATER SCI-MATER M, V20, P2001, DOI 10.1007/s10856-009-3782-5
   Hong S, 2013, ADV FUNCT MATER, V23, P1774, DOI 10.1002/adfm.201202365
   Hornykiewicz O, 2002, AMINO ACIDS, V23, P65, DOI 10.1007/s00726-001-0111-9
   Hwang DS, 2012, SOFT MATTER, V8, P5640, DOI 10.1039/c2sm25173f
   Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157
   Kim BS, 2012, BIOTECHNOL PROGR, V28, P973, DOI 10.1002/btpr.1555
   Krogsgaard M, 2013, BIOMACROMOLECULES, V14, P297, DOI 10.1021/bm301844u
   Laulicht B, 2012, MACROMOL BIOSCI, V12, P1555, DOI 10.1002/mabi.201200179
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lee C, 2013, BIOMACROMOLECULES, V14, P2004, DOI 10.1021/bm400352d
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   McDermott MK, 2004, BIOMACROMOLECULES, V5, P1270, DOI 10.1021/bm034529a
   Min K, 2010, J BIOTECHNOL, V146, P40, DOI 10.1016/j.jbiotec.2010.01.002
   Monahan J, 2003, CHEM COMMUN, P1672, DOI 10.1039/b301052j
   Nezhadi SH, 2009, J DRUG TARGET, V17, P731, DOI 10.3109/10611860903096540
   Ninan G, 2010, J FOOD SCI, V75, pE620, DOI 10.1111/j.1750-3841.2010.01851.x
   Oh DX, 2013, BIOTECHNOL PROGR, V29, P505, DOI 10.1002/btpr.1691
   Panke S, 2002, CURR OPIN BIOTECH, V13, P111, DOI 10.1016/S0958-1669(02)00302-6
   Passage J, 2005, ANZ J SURG, V75, P315, DOI 10.1111/j.1445-2197.2005.03350.x
   Pollak JS, 2001, J VASC INTERV RADIOL, V12, P907, DOI 10.1016/S1051-0443(07)61568-1
   Pursifull NF, 2007, CURR OPIN UROL, V17, P396, DOI 10.1097/MOU.0b013e3282f0d683
   Reece TB, 2001, AM J SURG, V182, p40S, DOI 10.1016/S0002-9610(01)00742-5
   Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x
   Schonauer C, 2004, EUR SPINE J, V13, pS89, DOI 10.1007/s00586-004-0727-z
   Seo SY, 2003, J AGR FOOD CHEM, V51, P2837, DOI 10.1021/jf020826f
   Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759
   SILVER FH, 1995, BIOMATERIALS, V16, P891, DOI 10.1016/0142-9612(95)93113-R
   Spotnitz WD, 2008, TRANSFUSION, V48, P1502, DOI 10.1111/j.1537-2995.2008.01703.x
   Thalmann CR, 2002, EUR FOOD RES TECHNOL, V214, P276, DOI 10.1007/s00217-001-0455-0
   Wilker JJ, 2010, CURR OPIN CHEM BIOL, V14, P276, DOI 10.1016/j.cbpa.2009.11.009
   You I, 2011, BIOCONJUGATE CHEM, V22, P1264, DOI 10.1021/bc2000534
   Zaks A, 1997, DRUG DISCOV TODAY, V2, P513, DOI 10.1016/S1359-6446(97)01078-7
   Zaupa A, 2011, BIOMACROMOLECULES, V12, P75, DOI 10.1021/bm101029k
NR 52
TC 34
Z9 35
U1 11
U2 93
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 2
BP 201
EP 209
DI 10.1039/c3tb20696c
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 264AL
UT WOS:000327849200006
DA 2018-10-20
ER

PT J
AU Li, Y
   Ng, HP
   Jung, HD
   Kim, HE
   Estrin, Y
AF Li, Yuanlong
   Ng, Hoi Pang
   Jung, Hyun-Do
   Kim, Hyoun-Ee
   Estrin, Yuri
TI Enhancement of mechanical properties of grade 4 titanium by equal
   channel angular pressing with billet encapsulation
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Titanium; Equal-channel angular pressing; Metal forming and
   shaping; Structural
ID TENSILE DUCTILITY; MICROSTRUCTURE; REGENERATION; TEMPERATURE; PRESSURE;
   ALLOYS; METAL; TI
AB Commercial purity titanium (Grade 4) was processed by encapsulation-aided equal-channel angular pressing. Encapsulation in a copper cartridge made it possible to carry out the process repeatedly, up to 8 passes, at a relatively low temperature of 300 degrees C. Extremely high values of yield strength and tensile strength close to record literature values for this titanium grade and matching, or even surpassing, the levels for conventional Ti-6Al-4V alloy were obtained. A hi-modal grain structure observed may be responsible for a favorable combination of strength and ductility the processed material exhibits. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Li, Yuanlong; Jung, Hyun-Do; Kim, Hyoun-Ee] Seoul Natl Univ, Dept Mat Sci & Engn, WCU Hybrid Mat Program, Seoul, South Korea.
   [Ng, Hoi Pang; Estrin, Yuri] Monash Univ, Dept Mat Engn, Ctr Adv Hybrid Mat, Clayton, Vic 3168, Australia.
   [Estrin, Yuri] NITU MISiS, Lab Hybrid Nanostruct Mat, Moscow, Russia.
RP Kim, HE (reprint author), Seoul Natl Univ, Dept Mat Sci & Engn, WCU Hybrid Mat Program, Seoul, South Korea.
EM kimhe@snu.ac.kr
OI Estrin, Yuri/0000-0001-7784-5704
FU World Class University (WCU) program of National Research Foundation of
   Korea; Ministry of Education, Science and Technology
   [R31-2008-000-10075]; Russian Ministry for Education and Science
   [14.A12.31.0001]
FX Support of this research through the World Class University (WCU)
   program of National Research Foundation of Korea funded by the Ministry
   of Education, Science and Technology (R31-2008-000-10075) as well as
   Grant #14.A12.31.0001 of the Russian Ministry for Education and Science
   is gratefully acknowledged. Useful discussions with Dr. Sung Min Chung
   (Dentium Co. Ltd.) and Prof. Hyoung-Seop Kim (Postech) as well as
   technical assistance of Mingzhe Bian are gratefully appreciated. The
   authors acknowledge the use of facilities in the Monash Centre for
   Electron Microscopy (MCEM).
CR Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   Chen CC, 2005, J MATER SCI, V40, P4053, DOI 10.1007/s10853-005-2802-1
   Cornwell LR, 1996, MATER CHARACT, V37, P295, DOI 10.1016/S1044-5803(97)80018-6
   Estrin Y, 2013, BIOMEDICAL RES INT
   Islamgaliev RK, 2008, MAT SCI ENG A-STRUCT, V493, P190, DOI 10.1016/j.msea.2007.08.084
   Kim I, 2003, MAT SCI ENG A-STRUCT, V342, P302, DOI 10.1016/S0921-5093(02)00318-0
   Ko YG, 2006, SCRIPTA MATER, V54, P1785, DOI 10.1016/j.scriptamat.2006.01.034
   Liu YG, 2012, COMPOS PART B-ENG, V43, P249, DOI 10.1016/j.compositesb.2011.11.048
   Lopovok R, 2008, ADV ENG MATER, V10, P429, DOI 10.1002/adem.200700363
   Ma E, 2006, JOM-US, V58, P49, DOI 10.1007/s11837-006-0215-5
   Quang P, 2006, KEY ENG MATER, V326-328, P325
   Raab GI, 2010, RUSSIAN METALLURGY M, V2009, P416
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Salem AA, 2006, METALL MATER TRANS A, V37A, P259, DOI 10.1007/s11661-006-0171-2
   Salem AA, 2002, SCRIPTA MATER, V46, P419, DOI 10.1016/S1359-6462(02)00005-2
   Shin DH, 2003, ACTA MATER, V51, P983, DOI 10.1016/S1359-6454(02)00501-3
   Valiev RZ, 2006, PROG MATER SCI, V51, P881, DOI 10.1016/j.pmatsci.2006.02.003
   Valley RZ, 2008, ADV ENG MATER, V10, pB15
   Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133
   Yang XR, 2009, RARE METAL MAT ENG, V38, P955
   Zebardast M, 2011, J MATER PROCESS TECH, V211, P1034, DOI 10.1016/j.jmatprotec.2011.01.004
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 22
TC 11
Z9 13
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JAN 1
PY 2014
VL 114
BP 144
EP 147
DI 10.1016/j.matlet.2013.09.118
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 261TI
UT WOS:000327687100039
DA 2018-10-20
ER

PT J
AU Li, D
   Zheng, Q
   Wang, YW
   Chen, H
AF Li, Dan
   Zheng, Qing
   Wang, Yanwei
   Chen, Hong
TI Combining surface topography with polymer chemistry: exploring new
   interfacial biological phenomena
SO POLYMER CHEMISTRY
LA English
DT Review
ID TRANSFER-RADICAL POLYMERIZATION; STIMULI-RESPONSIVE POLYMERS;
   CIRCULATING TUMOR-CELLS; SILICON NANOWIRE ARRAYS; PROTEIN ADSORPTION;
   EFFICIENT CAPTURE; INITIATED POLYMERIZATIONS; NANOSTRUCTURED SURFACES;
   COMPUTER-SIMULATION; RELATIVE INFLUENCE
AB The review focuses on the combination of surface topography and surface chemical modification with the grafting of polymer chains to develop optimal material interfaces for biological and biomedical applications. Understanding how surface chemistry and topography correlate with the interfacial properties and biological functions of a material is important for the development of biomaterials. Synergies between these two properties are known to exist, but have not been exploited extensively for biomaterial design. Preliminary studies suggest that the combination of surface topography and chemistry may not only enhance surface properties, but may also give biological properties that are opposite to those of the corresponding smooth surface, and even other unexpected biological properties. This review summarizes some recent studies in this area, mostly carried out in our own laboratory, as examples to illustrate how synergistic properties and functions may be obtained by combining surface topography with polymer chemistry. It is hoped that this review will stimulate a more thorough exploration of the topography-chemistry synergy as a means of injecting "new life" into efforts to develop novel bio-functional surfaces.
C1 [Li, Dan; Zheng, Qing; Wang, Yanwei; Chen, Hong] Soochow Univ, Jiangsu Key Lab Adv Funct Polymer Design & Applic, Dept Polymer Sci & Engn, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
RP Wang, YW (reprint author), Soochow Univ, Jiangsu Key Lab Adv Funct Polymer Design & Applic, Dept Polymer Sci & Engn, Coll Chem Chem Engn & Mat Sci, 199 Renai Rd, Suzhou 215123, Peoples R China.
EM ywwang@suda.edu.cn; chenh@suda.edu.cn
RI chen, Hong/L-6932-2013; Li, Dan/R-8422-2016; Wang, Yanwei/B-9590-2008
OI Li, Dan/0000-0002-1141-8838; Wang, Yanwei/0000-0002-8488-9833
FU National Natural Science Foundation of China [21204055, 21204061];
   National Science Fund for Distinguished Young Scholars [21125418];
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD); Project of Scientific and Technological
   Infrastructure of Suzhou [SZS201207]
FX This work was supported by the National Natural Science Foundation of
   China (21204055, 21204061), the National Science Fund for Distinguished
   Young Scholars (21125418), the Priority Academic Program Development of
   Jiangsu Higher Education Institutions (PAPD), and the Project of
   Scientific and Technological Infrastructure of Suzhou (SZS201207).
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Assender H, 2002, SCIENCE, V297, P973, DOI 10.1126/science.1074955
   Ayres N, 2010, POLYM CHEM-UK, V1, P769, DOI 10.1039/b9py00246d
   Bai HJ, 2009, LANGMUIR, V25, P10402, DOI 10.1021/la900944c
   Bain ED, 2013, MACROMOL THEOR SIMUL, V22, P8, DOI 10.1002/mats.201200030
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Barth JV, 2005, NATURE, V437, P671, DOI 10.1038/nature04166
   BENNETT JM, 1992, MEAS SCI TECHNOL, V3, P1119, DOI 10.1088/0957-0233/3/12/001
   Bigerelle M, 2008, POLYM ENG SCI, V48, P1725, DOI 10.1002/pen.21131
   Brittain WJ, 2007, J POLYM SCI POL CHEM, V45, P3505, DOI 10.1002/pola.22180
   Calvo A, 2009, J AM CHEM SOC, V131, P10866, DOI 10.1021/ja9031067
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen D, 2007, J PHYS CHEM C, V111, P2351, DOI 10.1021/jp065099w
   Chen H, 2009, COLLOID SURFACE B, V71, P275, DOI 10.1016/j.colsurfb.2009.02.018
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Chen L, 2011, ADV MATER, V23, P4376, DOI 10.1002/adma.201102435
   Chen L, 2009, J AM CHEM SOC, V131, P10467, DOI 10.1021/ja9019935
   Chen T, 2012, CHEM SOC REV, V41, P3280, DOI 10.1039/c2cs15225h
   COSGROVE T, 1994, LANGMUIR, V10, P3500, DOI 10.1021/la00022a024
   COSGROVE T, 1987, MACROMOLECULES, V20, P2879, DOI 10.1021/ma00177a040
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Czanderna A., 2002, BEAM EFFECTS SURFACE, V5, P275
   Dan L., 2012, PROTEINS INTERFACES, V1120, P301
   Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m
   Ferhan AR, 2013, ANAL CHEM, V85, P4094, DOI 10.1021/ac4001817
   Fristrup CJ, 2012, POLYM CHEM-UK, V3, P198, DOI 10.1039/c1py00347j
   Fristrup CJ, 2009, SOFT MATTER, V5, P4623, DOI 10.1039/b821815c
   Gan JB, 2010, COLLOID SURFACE B, V76, P381, DOI 10.1016/j.colsurfb.2009.11.013
   Gao X, 2010, MACROMOL REACT ENG, V4, P235, DOI 10.1002/mren.200900063
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Gulati K, 2012, ACTA BIOMATER, V8, P449, DOI 10.1016/j.actbio.2011.09.004
   HAIR ML, 1991, MACROMOLECULES, V24, P341, DOI 10.1021/ma00001a057
   Han LL, 2013, COLLOID SURFACE B, V111, P1, DOI 10.1016/j.colsurfb.2013.05.011
   Han LL, 2013, BIOMATERIALS, V34, P975, DOI 10.1016/j.biomaterials.2012.10.041
   Han LL, 2012, LANGMUIR, V28, P193, DOI 10.1021/la2040533
   Huber DL, 2003, SCIENCE, V301, P352, DOI 10.1126/science.1080759
   Jain P, 2007, LANGMUIR, V23, P11360, DOI 10.1021/la701735q
   Kanazawa H, 2011, J CHROMATOGR A, V1218, P8738, DOI 10.1016/j.chroma.2011.04.015
   Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k
   Koegler P, 2012, ADV DRUG DELIVER REV, V64, P1820, DOI 10.1016/j.addr.2012.06.001
   Kulangara K, 2009, SOFT MATTER, V5, P4072, DOI 10.1039/b910132m
   Li CY, 2013, BIOMACROMOLECULES, V14, P1278, DOI 10.1021/bm4000597
   Lin M, 2012, ANAL CHIM ACTA, V746, P63, DOI 10.1016/j.aca.2012.08.017
   Liu KS, 2011, NANO TODAY, V6, P155, DOI 10.1016/j.nantod.2011.02.002
   Liu XL, 2013, MACROMOL BIOSCI, V13, P147, DOI 10.1002/mabi.201200269
   Mann DGJ, 2008, ACS NANO, V2, P69, DOI 10.1021/nn700198y
   Matsuda N, 2007, ADV MATER, V19, P3089, DOI 10.1002/adma.200701978
   McKnight TE, 2004, NANO LETT, V4, P1213, DOI 10.1021/nl049504b
   McKnight TE, 2003, NANOTECHNOLOGY, V14, P551, DOI 10.1088/0957-4484/14/5/313
   Mendes PM, 2008, CHEM SOC REV, V37, P2512, DOI 10.1039/b714635n
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   Minko S, 2006, POLYM REV, V46, P397, DOI 10.1080/15583720600945402
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   Nath N, 2002, ADV MATER, V14, P1243, DOI 10.1002/1521-4095(20020903)14:17<1243::AID-ADMA1243>3.0.CO;2-M
   Orski SV, 2011, J MATER CHEM, V21, P14135, DOI 10.1039/c1jm11039j
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Park S, 2009, NANO LETT, V9, P1325, DOI 10.1021/nl802962t
   PARSONAGE E, 1991, MACROMOLECULES, V24, P1987, DOI 10.1021/ma00008a041
   Ponche A, 2010, P I MECH ENG H, V224, P1471, DOI 10.1243/09544119JEIM900
   Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Roy P, 2002, NAT CELL BIOL, V4, pE91, DOI 10.1038/ncb0402-e91
   Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107
   Shi XJ, 2012, LANGMUIR, V28, P17011, DOI 10.1021/la303042d
   Simovic S, 2010, CHEM COMMUN, V46, P1317, DOI 10.1039/b919840g
   Song W, 2007, CHINESE SCI BULL, V52, P3169, DOI 10.1007/s11434-007-0504-6
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sun TL, 2006, ACCOUNTS CHEM RES, V39, P487, DOI 10.1021/ar068150n
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Sun TL, 2005, SMALL, V1, P959, DOI 10.1002/smll.200500095
   Tawfick S, 2012, ADV MATER, V24, P1628, DOI 10.1002/adma.201103796
   Telford AM, 2012, BIOMACROMOLECULES, V13, P2989, DOI 10.1021/bm3010534
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Turgman-Cohen S, 2012, MACROMOLECULES, V45, P2128, DOI 10.1021/ma202679r
   Turgman-Cohen S, 2011, J AM CHEM SOC, V133, P17567, DOI 10.1021/ja2081636
   Wang HW, 2013, ACS APPL MATER INTER, V5, P1800, DOI 10.1021/am3031322
   Wang HW, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/10/105101
   Wang HW, 2013, LANGMUIR, V29, P3, DOI 10.1021/la304378w
   Wang HW, 2011, COLLOID SURFACE B, V83, P355, DOI 10.1016/j.colsurfb.2010.12.009
   Wang L, 2011, J MATER CHEM, V21, P13920, DOI 10.1039/c1jm12148k
   Wang ST, 2011, ANGEW CHEM INT EDIT, V50, P3084, DOI 10.1002/anie.201005853
   Wang ST, 2009, ANGEW CHEM INT EDIT, V48, P8970, DOI 10.1002/anie.200901668
   Wang YY, 2013, ACS APPL MATER INTER, V5, P3816, DOI 10.1021/am400469g
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Wu JD, 2012, INTERFACE FOCUS, V2, P337, DOI 10.1098/rsfs.2011.0124
   Xia F, 2008, ADV MATER, V20, P2842, DOI 10.1002/adma.200800836
   Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002
   Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2
   Yameen B, 2013, CHEM-ASIAN J, V8, P1736, DOI 10.1002/asia.201300149
   Yu Q, 2011, RSC ADV, V1, P262, DOI 10.1039/c1ra00201e
   Yu QA, 2011, ACTA BIOMATER, V7, P1550, DOI 10.1016/j.actbio.2010.12.021
   Yu QA, 2010, LANGMUIR, V26, P17812, DOI 10.1021/la103647s
   Yu Q, 2010, COLLOID SURFACE B, V76, P468, DOI 10.1016/j.colsurfb.2009.12.006
   Yuan L, 2011, J MATER CHEM, V21, P6148, DOI 10.1039/c1jm10734h
   Yuan L, 2011, MACROMOL BIOSCI, V11, P1031, DOI 10.1002/mabi.201000464
   Yuan SJ, 2009, ACS APPL MATER INTER, V1, P640, DOI 10.1021/am800182d
   Zhai GQ, 2005, MACROMOL BIOSCI, V5, P974, DOI 10.1002/mabi.200500079
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
   Zheng J, 2010, COLLOID SURFACE B, V77, P234, DOI 10.1016/j.colsurfb.2010.01.032
   Zhou F, 2012, MACROMOL BIOSCI, V12, P1391, DOI 10.1002/mabi.201200129
   Zhou F, 2012, ANALYST, V137, P1779, DOI 10.1039/c2an16257a
   Zhou F, 2011, CHINESE SCI BULL, V56, P977, DOI 10.1007/s11434-010-4173-5
   Zhou F, 2011, LANGMUIR, V27, P2155, DOI 10.1021/la1049937
   Zhou XZ, 2011, SMALL, V7, P2273, DOI 10.1002/smll.201002381
NR 112
TC 34
Z9 35
U1 3
U2 131
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2014
VL 5
IS 1
BP 14
EP 24
DI 10.1039/c3py00739a
PG 11
WC Polymer Science
SC Polymer Science
GA 261MT
UT WOS:000327669900002
DA 2018-10-20
ER

PT J
AU Skilling, KJ
   Citossi, F
   Bradshaw, TD
   Ashford, M
   Kellam, B
   Marlow, M
AF Skilling, Kathryn J.
   Citossi, Francesca
   Bradshaw, Tracey D.
   Ashford, Marianne
   Kellam, Barrie
   Marlow, Maria
TI Insights into low molecular mass organic gelators: a focus on drug
   delivery and tissue engineering applications
SO SOFT MATTER
LA English
DT Review
ID AMINO-ACID-DERIVATIVES; ASSEMBLING PEPTIDE SCAFFOLDS;
   NUCLEAR-MAGNETIC-RESONANCE; SUGAR-INTEGRATED GELATORS; WEIGHT GELATORS;
   MECHANICAL-PROPERTIES; FMOC-DIPHENYLALANINE; SUPRAMOLECULAR HYDROGEL;
   FUNCTIONAL MATERIALS; CONTROLLED-RELEASE
AB In recent years low molecular mass organic gelators (LMOGs) have gained increasing interest as an alternative biomaterial to polymer derived gels, with potential applications in drug delivery and tissue engineering. LMOGs are small organic molecules which self-assemble in water or organic solvents forming a 3D network that entraps the liquid phase resulting in gel formation. In this review, we report the classification of LMOGs into hydrogelators and gelators of organic solvents and we discuss the techniques commonly used to characterise the gels of these gelators with particular reference to specific applications of LMOGs in drug delivery and tissue engineering.
C1 [Skilling, Kathryn J.; Citossi, Francesca; Bradshaw, Tracey D.; Kellam, Barrie; Marlow, Maria] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Ashford, Marianne] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England.
RP Marlow, M (reprint author), Univ Nottingham, Sch Pharm, Univ Pk, Nottingham NG7 2RD, England.
EM maria.marlow@nottingham.ac.uk
OI Marlow, Maria/0000-0002-0333-5290
FU Engineering and Physical Sciences Research Council (EPSRC); AstraZeneca;
   University of Nottingham, School of Pharmacy; Engineering and Physical
   Sciences Research Council [1226164]
FX The authors thank the Engineering and Physical Sciences Research Council
   (EPSRC), AstraZeneca and The University of Nottingham, School of
   Pharmacy for funding.
CR Abdallah DJ, 2000, J BRAZIL CHEM SOC, V11, P209, DOI 10.1590/S0103-50532000000300002
   Abdallah DJ, 2000, LANGMUIR, V16, P7558, DOI 10.1021/la000730k
   Abdallah DJ, 2000, ADV MATER, V12, P1237
   Adams DJ, 2010, SOFT MATTER, V6, P1971, DOI 10.1039/b921863g
   Adams DJ, 2009, SOFT MATTER, V5, P1856, DOI 10.1039/b901556f
   Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Amin S, 2009, SCI RES ESSAYS, V4, P1175
   Araki K, 2005, TOP CURR CHEM, V256, P133, DOI 10.1007/b107173
   Babu P, 2006, MACROMOL SYMP, V241, P60, DOI 10.1002/masy.200650909
   Banerjee S, 2013, J MATER CHEM C, V1, P3305, DOI 10.1039/c3tc30104d
   Bastiat G, 2010, BIOMATERIALS, V31, P6031, DOI 10.1016/j.biomaterials.2010.04.009
   Bastiat G, 2009, J MATER CHEM, V19, P3867, DOI 10.1039/b822657a
   Berthier D, 2002, J AM CHEM SOC, V124, P13486, DOI 10.1021/ja027660j
   Bhuniya S, 2006, TETRAHEDRON LETT, V47, P7153, DOI 10.1016/j.tetlet.2006.08.002
   Bildstein L, 2011, EUR J PHARM BIOPHARM, V79, P612, DOI 10.1016/j.ejpb.2011.07.003
   Braun HG, 2012, COLLOID SURFACE B, V97, P43, DOI 10.1016/j.colsurfb.2012.03.028
   Brizard A, 2005, TOP CURR CHEM, V256, P167, DOI 10.1007/b107174
   Brosse N, 2004, TETRAHEDRON LETT, V45, P9521, DOI 10.1016/j.tetlet.2004.10.139
   BROTIN T, 1991, J CHEM SOC CHEM COMM, P416, DOI 10.1039/c39910000416
   Buerkle LE, 2012, CHEM SCI, V3, P564, DOI 10.1039/c1sc00729g
   CAPITANI D, 1993, LANGMUIR, V9, P685, DOI 10.1021/la00027a013
   Celis S, 2013, ORG BIOMOL CHEM, V11, P2839, DOI 10.1039/c3ob27347d
   Chen L, 2011, SOFT MATTER, V7, P9721, DOI 10.1039/c1sm05827d
   Chen L, 2010, LANGMUIR, V26, P13466, DOI 10.1021/la102059x
   Couffin-Hoarau AC, 2004, PHARM RES-DORDR, V21, P454, DOI 10.1023/B:PHAM.0000019299.01265.05
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Daniel J, 2003, J AM OIL CHEM SOC, V80, P417, DOI 10.1007/s11746-003-0714-0
   Dastidar P, 2008, CHEM SOC REV, V37, P2699, DOI 10.1039/b807346e
   de Loos M, 2005, EUR J ORG CHEM, P3615, DOI 10.1002/ejoc.200400723
   de Loos M, 2000, EUR J ORG CHEM, P3675
   de Loos M, 2001, ANGEW CHEM INT EDIT, V40, P613, DOI 10.1002/1521-3773(20010202)40:3<613::AID-ANIE613>3.0.CO;2-K
   Debnath S, 2008, CHEM-EUR J, V14, P6870, DOI 10.1002/chem.200800731
   Segarra-Maset MD, 2013, CHEM SOC REV, V42, P7086, DOI 10.1039/c2cs35436e
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Engelkamp H, 1999, SCIENCE, V284, P785, DOI 10.1126/science.284.5415.785
   Escuder B, 2006, J ORG CHEM, V71, P7747, DOI 10.1021/jo0612731
   Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049
   FLORY PJ, 1975, FARADAY DISCUSS, V57, P7
   Friggeri A, 2005, CHEM-EUR J, V11, P5353, DOI 10.1002/chem.200500007
   Friggeri A, 2002, J AM CHEM SOC, V124, P10754, DOI 10.1021/ja012585i
   FUHRHOP JH, 1987, J AM CHEM SOC, V109, P3387, DOI 10.1021/ja00245a032
   Ganji F, 2009, IRAN POLYM J, V18, P63
   Gao J, 2009, J AM CHEM SOC, V131, P11286, DOI 10.1021/ja9042142
   Gao Y, 2009, J AM CHEM SOC, V131, P13576, DOI 10.1021/ja904411z
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelbart WM, 1996, J PHYS CHEM-US, V100, P13169, DOI 10.1021/jp9606570
   GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013
   George M, 2005, CHEM-EUR J, V11, P3243, DOI 10.1002/chem.200401066
   George M, 2003, LANGMUIR, V19, P8168, DOI 10.1021/la0343829
   George M, 2006, ACCOUNTS CHEM RES, V39, P489, DOI 10.1021/ar0500923
   Godeau G, 2009, LANGMUIR, V25, P8447, DOI 10.1021/la900140b
   Goyal N, 2010, TETRAHEDRON, V66, P5962, DOI 10.1016/j.tet.2010.05.071
   GRAHAM T, 1861, PHILOS T R SOC LONDO, V151, P183, DOI DOI 10.1098/RSTL.1861.0011
   Gronwald O, 2001, CHEM-EUR J, V7, P4328, DOI 10.1002/1521-3765(20011015)7:20<4328::AID-CHEM4328>3.0.CO;2-S
   Haines SR, 2002, CHEM COMMUN, P2846, DOI 10.1039/b203462j
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hanabusa K, 2000, J COLLOID INTERF SCI, V224, P231, DOI 10.1006/jcis.1999.6672
   Hanabusa K, 1998, COLLOID POLYM SCI, V276, P252, DOI 10.1007/s003960050236
   Hanabusa K, 1996, ANGEW CHEM INT EDIT, V35, P1949, DOI 10.1002/anie.199619491
   Hanabusa K, 1999, TETRAHEDRON LETT, V40, P2385, DOI 10.1016/S0040-4039(99)00195-1
   Heeres A, 2003, J AM CHEM SOC, V125, P14252, DOI 10.1021/ja036954h
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hirst AR, 2008, J AM CHEM SOC, V130, P9113, DOI 10.1021/ja801804c
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Huang YD, 2013, J MOL STRUCT, V1031, P43, DOI 10.1016/j.molstruc.2012.07.040
   Iqbal S, 2010, SOFT MATTER, V6, P1875, DOI 10.1039/b926785a
   Ishi-i T, 2001, LANGMUIR, V17, P5825, DOI 10.1021/la0107749
   ISRAELACHVILI JN, 1992, J PHYS CHEM-US, V96, P520, DOI 10.1021/j100181a007
   Iwanaga K, 2010, INT J PHARMACEUT, V388, P123, DOI 10.1016/j.ijpharm.2009.12.045
   Iwaura R, 2002, CHEM MATER, V14, P3047, DOI 10.1021/cm020263n
   Jadhav SR, 2010, ANGEW CHEM INT EDIT, V49, P7695, DOI 10.1002/anie.201002095
   JAMES TD, 1995, TETRAHEDRON, V51, P555, DOI 10.1016/0040-4020(94)00915-H
   Jang WD, 2003, MACROMOLECULES, V36, P8461, DOI 10.1021/ma034221b
   Jiyang L., 2013, BEILSTEIN J ORG CHEM, V9, P908
   JOKIC M, 1995, J CHEM SOC CHEM COMM, P1723, DOI 10.1039/c39950001723
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Jung JH, 2001, LANGMUIR, V17, P7229, DOI 10.1021/la0109516
   Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6
   Kempe S, 2012, J CONTROL RELEASE, V161, P668, DOI 10.1016/j.jconrel.2012.04.016
   Kim JK, 2009, MOL PHARMACEUT, V6, P978, DOI 10.1021/mp900009n
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kiyonaka S, 2002, J AM CHEM SOC, V124, P10954, DOI 10.1021/ja027277e
   Kiyonaka S, 2003, CHEM-EUR J, V9, P976, DOI 10.1002/chem.200390120
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kobayashi H, 2002, ORG LETT, V4, P1423, DOI 10.1021/ol025519+
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Latxague L, 2012, CR CHIM, V15, P29, DOI 10.1016/j.crci.2011.08.010
   Lebel O, 2006, CHEM MATER, V18, P3616, DOI 10.1021/cm060056d
   Li XF, 2010, APPL MICROBIOL BIOT, V88, P57, DOI 10.1007/s00253-010-2705-1
   Li XY, 2012, J MATER CHEM, V22, P21838, DOI 10.1039/c2jm35329f
   Li XM, 2011, J AM CHEM SOC, V133, P17513, DOI 10.1021/ja208456k
   Liebmann T, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-88
   LIN Y, 1989, J AM CHEM SOC, V111, P5542, DOI 10.1021/ja00197a005
   LIN YC, 1987, MACROMOLECULES, V20, P414, DOI 10.1021/ma00168a031
   Liu XY, 2005, TOP CURR CHEM, V256, P1, DOI 10.1007/b107170
   Liu XY, 2002, ANGEW CHEM INT EDIT, V41, P3641, DOI 10.1002/1521-3773(20021004)41:19<3641::AID-ANIE3641>3.0.CO;2-2
   Liu XY, 2001, APPL PHYS LETT, V79, P3518, DOI 10.1063/1.1415609
   Liu XY, 2002, J AM CHEM SOC, V124, P15055, DOI 10.1021/ja0206137
   Liu XY, 2002, ADV MATER, V14, P421, DOI 10.1002/1521-4095(20020318)14:6<421::AID-ADMA421>3.0.CO;2-7
   Lloyd DJ, 1926, COLLOID CHEM, V1, P767
   Lu LD, 1996, CHEM COMMUN, P2029, DOI 10.1039/cc9960002029
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   Maitra U, 2001, TETRAHEDRON-ASYMMETR, V12, P477, DOI 10.1016/S0957-4166(01)00073-8
   Malik S, 2007, TETRAHEDRON, V63, P7326, DOI 10.1016/j.tet.2007.05.027
   MARTINBORRET O, 1979, B SOC CHIM FR II-CH, P401
   Matteucci M, 2004, J PEPT SCI, V10, P318, DOI 10.1002/psc.544
   Menger FM, 2002, J AM CHEM SOC, V124, P1140, DOI 10.1021/ja011754w
   Menger FM, 2002, J AM CHEM SOC, V124, P12408, DOI 10.1021/ja021025w
   Menger FM, 2000, J AM CHEM SOC, V122, P11679, DOI 10.1021/ja0016811
   MENGER FM, 1978, J ORG CHEM, V43, P3413, DOI 10.1021/jo00411a041
   Milanesi L, 2011, CHEM-EUR J, V17, P9753, DOI 10.1002/chem.201100640
   Moreau L, 2004, J AM CHEM SOC, V126, P7533, DOI 10.1021/ja039597j
   Motulsky A, 2005, BIOMATERIALS, V26, P6242, DOI 10.1016/j.biomaterials.2005.04.004
   Mukai M, 2012, SOFT MATTER, V8, P11979, DOI 10.1039/c2sm26991k
   MUKKAMALA R, 1995, J CHEM SOC CHEM COMM, P375, DOI 10.1039/c39950000375
   Mukkamala R, 1996, LANGMUIR, V12, P1474, DOI 10.1021/la950666k
   MURATA K, 1994, J AM CHEM SOC, V116, P6664, DOI 10.1021/ja00094a023
   Murdan Sudaxshina, 2005, Expert Opin Drug Deliv, V2, P489, DOI 10.1517/17425247.2.3.489
   Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031
   Naskar J, 2009, J PHYS CHEM B, V113, P11787, DOI 10.1021/jp904251j
   NEWKOME GR, 1990, J AM CHEM SOC, V112, P8458, DOI 10.1021/ja00179a034
   Orbach R, 2012, LANGMUIR, V28, P2015, DOI 10.1021/la204426q
   Pal A, 2013, CHEM PHYS LETT, V556, P245, DOI 10.1016/j.cplett.2012.10.089
   Pal A, 2007, TETRAHEDRON, V63, P7334, DOI 10.1016/j.tet.2007.05.028
   Panda JJ, 2008, BIOMACROMOLECULES, V9, P2244, DOI 10.1021/bm800404z
   Park SM, 2003, CHEM COMMUN, P2912, DOI 10.1039/b311249g
   Patil SP, 2012, CHEM COMMUN, V48, P8901, DOI 10.1039/c2cc34466a
   Peng JX, 2009, J COLLOID INTERF SCI, V336, P780, DOI 10.1016/j.jcis.2009.04.055
   Penzes T, 2005, INT J PHARM, V298, P47, DOI 10.1016/j.ijpharm.2005.03.013
   Pham QN, 2008, NEW J CHEM, V32, P1131, DOI 10.1039/b714375c
   Pili B, 2010, BBA-BIOMEMBRANES, V1798, P1522, DOI 10.1016/j.bbamem.2010.04.011
   Plourde F, 2005, J CONTROL RELEASE, V108, P433, DOI 10.1016/j.conrel.2005.08.016
   Raeburn J, 2013, CHEM SOC REV, V42, P5143, DOI 10.1039/c3cs60030k
   Raeburn J, 2012, SOFT MATTER, V8, P1168, DOI 10.1039/c1sm06929b
   Rautio J, 2008, NAT REV DRUG DISCOV, V7, P255, DOI 10.1038/nrd2468
   Rogers MA, 2011, FOOD RES INT, V44, P1447, DOI 10.1016/j.foodres.2011.03.014
   Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r
   Rudra JS, 2010, BIOMATERIALS, V31, P8475, DOI 10.1016/j.biomaterials.2010.07.068
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   Ryan DM, 2010, SOFT MATTER, V6, P475, DOI 10.1039/b916738b
   Ryan DM, 2011, LANGMUIR, V27, P4029, DOI 10.1021/la1048375
   Sangeetha NM, 2005, CHEM SOC REV, V34, P821, DOI 10.1039/b417081b
   SASISEKHARAN V, 1975, J MOL BIOL, V92, P171, DOI 10.1016/0022-2836(75)90221-1
   Schoonbeek FS, 2000, CHEM-EUR J, V6, P2633, DOI 10.1002/1521-3765(20000717)6:14<2633::AID-CHEM2633>3.0.CO;2-L
   Shankar BV, 2007, J PHYS CHEM B, V111, P9294, DOI 10.1021/jp073275a
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simeone L, 2011, CHEM-EUR J, V17, P13854, DOI 10.1002/chem.201101827
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Smith DK, 2006, CHEM COMMUN, P34, DOI 10.1039/b507416a
   Smith DK, 2005, PROG POLYM SCI, V30, P220, DOI 10.1016/j.progpolymsci.2005.01.006
   Soukasene S, 2011, ACS NANO, V5, P9113, DOI 10.1021/nn203343z
   Steed JW, 2011, CHEM COMMUN, V47, P1379, DOI 10.1039/c0cc03293j
   Storrie H, 2007, BIOMATERIALS, V28, P4608, DOI 10.1016/j.biomaterials.2007.06.026
   Sutton S, 2009, LANGMUIR, V25, P10285, DOI 10.1021/la9011058
   Suzuki M, 2003, HELV CHIM ACTA, V86, P2228, DOI 10.1002/hlca.200390179
   Suzuki M, 2003, CHEM-EUR J, V9, P348, DOI 10.1002/chem.200390030
   Suzuki M, 2007, TETRAHEDRON, V63, P7302, DOI 10.1016/j.tet.2007.02.065
   Suzuki M, 2009, CHEM SOC REV, V38, P967, DOI 10.1039/b816192e
   TACHIBANA T, 1981, B CHEM SOC JPN, V54, P73, DOI 10.1246/bcsj.54.73
   TACHIBANA T, 1980, B CHEM SOC JPN, V53, P1714, DOI 10.1246/bcsj.53.1714
   Tachibana T., 1968, J COLLOID INTERF SCI, V38, P173
   Tang C, 2011, LANGMUIR, V27, P14438, DOI 10.1021/la202113j
   Tang C, 2009, LANGMUIR, V25, P9447, DOI 10.1021/la900653q
   TATA M, 1994, J AM CHEM SOC, V116, P9464, DOI 10.1021/ja00100a008
   TERECH P, 1991, COLLOID POLYM SCI, V269, P490, DOI 10.1007/BF00655887
   Terech P, 2002, ADV MATER, V14, P495, DOI 10.1002/1521-4095(20020404)14:7<495::AID-ADMA495>3.0.CO;2-9
   Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282
   Terech P, 2006, RHEOL ACTA, V45, P435, DOI 10.1007/s00397-005-0067-x
   Tomasini C, 2013, CHEM SOC REV, V42, P156, DOI 10.1039/c2cs35284b
   Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4
   UZU Y, 1975, J COLLOID INTERF SCI, V51, P346, DOI 10.1016/0021-9797(75)90125-3
   van Bommel KJC, 2005, ORG BIOMOL CHEM, V3, P2917, DOI 10.1039/b507157g
   van Bommel KJC, 2004, ANGEW CHEM INT EDIT, V43, P1663, DOI 10.1002/anie.200352396
   van Esch J, 1999, CHEM-EUR J, V5, P937
   van Esch JH, 2000, ANGEW CHEM INT EDIT, V39, P2263
   Vegners R, 1995, J Pept Sci, V1, P371, DOI 10.1002/psc.310010604
   Vemula P. K., 2013, CURR OPIN BIOTECH, DOI [10.1016/j.copbio.2013.02.006, DOI 10.1016/J.C0PBI0.2013.02.006]
   Vemula PK, 2009, BIOMATERIALS, V30, P383, DOI 10.1016/j.biomaterials.2008.09.045
   Vintiloiu A, 2008, J CONTROL RELEASE, V125, P179, DOI 10.1016/j.jconrel.2007.09.014
   Wang GJ, 2003, CHEM COMMUN, P310, DOI 10.1039/b205733f
   Wang GJ, 2009, LANGMUIR, V25, P8696, DOI 10.1021/la804337g
   Wang GJ, 2011, BEILSTEIN J ORG CHEM, V7, P234, DOI 10.3762/bjoc.7.31
   Wang HM, 2012, NANOSCALE, V4, P5259, DOI 10.1039/c2nr31149f
   Wang HM, 2012, BIOMATERIALS, V33, P5848, DOI 10.1016/j.biomaterials.2012.04.047
   Wang HM, 2012, SOFT MATTER, V8, P2344, DOI 10.1039/c2sm06923g
   Wang HM, 2011, CHEM COMMUN, V47, P4439, DOI 10.1039/c1cc10506j
   Wang WJ, 2011, CARBOHYD RES, V346, P1013, DOI 10.1016/j.carres.2011.03.031
   Xing BG, 2002, J AM CHEM SOC, V124, P14846, DOI 10.1021/ja028539f
   Yan N, 2010, LANGMUIR, V26, P5909, DOI 10.1021/la903853u
   Yang CH, 2012, J PHYS CHEM B, V116, P633, DOI 10.1021/jp209441r
   Yang ZM, 2007, J MATER CHEM, V17, P850, DOI 10.1039/b611255b
   Yang ZM, 2006, CHEM COMMUN, P738, DOI 10.1039/b516133a
   Yoshikawa I, 2007, TETRAHEDRON, V63, P7474, DOI 10.1016/j.tet.2007.02.010
   Yoza K, 1999, CHEM-EUR J, V5, P2722, DOI 10.1002/(SICI)1521-3765(19990903)5:9<2722::AID-CHEM2722>3.0.CO;2-N
   Yun YJ, 2003, CHEM COMMUN, P254, DOI 10.1039/b210822d
   Zhang S, 2008, ADV CANCER RES, V99, P335, DOI 10.1016/S0065-230X(07)99005-3
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zhang Y, 2004, J AM CHEM SOC, V126, P15028, DOI 10.1021/ja044401g
   Zhang ZK, 2013, SOFT MATTER, V9, P1015, DOI 10.1039/c2sm27264d
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
   Ziane S, 2012, EUR CELLS MATER, V23, P147, DOI 10.22203/eCM.v023a11
NR 203
TC 156
Z9 159
U1 27
U2 297
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2014
VL 10
IS 2
BP 237
EP 256
DI 10.1039/c3sm52244j
PG 20
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 264AM
UT WOS:000327849300001
PM 24651822
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Stasiak, J
   Nair, S
   Moggridge, GD
AF Stasiak, Joanna
   Nair, Sukumaran
   Moggridge, Geoff D.
TI Mechanical strength of sutured block copolymers films for load bearing
   medical applications
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Biomedical Engineering and Biotechnology
   (iCBEB)
CY OCT 11-13, 2013
CL Wuhan, PEOPLES R CHINA
DE biomaterials; heart valves; sutures; mechanical behavior
ID PROSTHETIC HEART-VALVES; OSTRICH PERICARDIUM; CALF PERICARDIUM;
   AORTIC-VALVE; FOLLOW-UP; BEHAVIOR; BIOMATERIAL; BIOPROSTHESIS;
   CONSTRUCTION; REPLACEMENT
AB The mechanical behavior of three styrenic thermoplastic block copolymer elastomers with applied surgical sutures was studied by uniaxial tensile testing. The materials exhibited oriented cylindrical microstructure. Distinct macroscopic deformation mechanisms have been observed upon stretching of samples with vertical and horizontal orientation. Deformation progressed along the axis of the suture in samples with parallel orientation (P), while it in case of normal orientation (N) the whole sample responded to the applied force. Also the analysis of the stress-strain curves showed a significant difference between samples P and N. Greater stress at break was observed for samples P, while samples N showed the capability to tolerate higher strain. The influence of morphology on the tear-out shape has been also observed. The thread made a vertical tear out in samples P while for samples N ripping off the bottom was observed.
C1 [Stasiak, Joanna; Moggridge, Geoff D.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.
   [Nair, Sukumaran] Papworth Hosp NHS, Cambridge BC23 3RE, England.
RP Stasiak, J (reprint author), Univ Cambridge, Dept Chem Engn & Biotechnol, Pembroke St, Cambridge CB2 3RA, England.
EM js744@cam.ac.uk
RI Stasiak, Joanna/C-6612-2015
OI Stasiak, Joanna/0000-0002-8132-8694
FU British Heart Foundation [NH/11/4/29059]
CR Bernacca GM, 2002, J BIOMED MATER RES, V61, P138, DOI 10.1002/jbm.10149
   Bernacca GM, 2002, BIOMATERIALS, V23, P45, DOI 10.1016/S0142-9612(01)00077-1
   Bernet FH, 2007, J HEART VALVE DIS, V16, P151
   Chen YF, 2003, J CARDIOVASC SURG, V44, P691
   Claiborne TE, 2011, ASAIO J, V57, P26, DOI 10.1097/MAT.0b013e3181fcbd86
   Eichinger WB, 2008, ANN THORAC SURG, V86, P1204, DOI 10.1016/j.athoracsur.2008.05.058
   El Fray M, 2006, BIOMACROMOLECULES, V7, P844, DOI 10.1021/bm050971c
   Emery RW, 2003, ANN THORAC SURG, V75, P1815, DOI 10.1016/S0003-4975(03)00016-X
   Gallocher SL, 2006, J BIOMED MATER RES B, V79B, P325, DOI 10.1002/jbm.b.30546
   Garcia Paez J.M., 1994, BIOMATERIALS, V15, P172
   Ghanbari H, 2009, TRENDS BIOTECHNOL, V27, P359, DOI 10.1016/j.tibtech.2009.03.002
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2
   Kidane AG, 2009, ACTA BIOMATER, V5, P2409, DOI 10.1016/j.actbio.2009.02.025
   Paez JMG, 2003, J MATER SCI-MATER M, V14, P411, DOI 10.1023/A:1023258700845
   Paez JMG, 2003, BIOMATERIALS, V24, P1671, DOI 10.1016/S0142-9612(02)00536-7
   Paez JMG, 2002, J BIOMED MATER RES, V62, P73, DOI 10.1002/jbm.10266
   Paez JMG, 2001, J BIOMATER APPL, V16, P68, DOI 10.1106/3JXM-UTPN-PXTG-72DT
   Paez JMG, 2001, BIOMATERIALS, V22, P2731
   Paez JMG, 1996, BIOMATERIALS, V17, P1677, DOI 10.1016/0142-9612(96)87647-2
   Rahmani B, 2012, J BIOMECH, V45, P1205, DOI 10.1016/j.jbiomech.2012.01.046
   Stasiak J, 2011, SOFT MATTER, V7, P11475, DOI 10.1039/c1sm06503c
   Stasiak J, 2010, FUNCT MATER LETT, V3, P249, DOI 10.1142/S1793604710001342
   Stasiak J, 2009, MACROMOLECULES, V42, P5256, DOI 10.1021/ma8026639
   Yang JM, 2010, MAT SCI ENG C-MATER, V30, P1151, DOI 10.1016/j.msec.2010.06.014
NR 25
TC 9
Z9 9
U1 1
U2 13
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 1
BP 563
EP 569
DI 10.3233/BME-130843
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256LU
UT WOS:000327312600066
PM 24211940
DA 2018-10-20
ER

PT J
AU Zhu, DY
   Jin, LQ
   Wang, XM
   Xu, L
   Liu, TQ
AF Zhu, Deyi
   Jin, Liqiang
   Wang, Xuemei
   Xu, Li
   Liu, Tianqi
TI Combined anticalcification treatment of bovine pericardium with
   decellularization and hyaluronic acid derivative
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Biomedical Engineering and Biotechnology
   (iCBEB)
CY OCT 11-13, 2013
CL Wuhan, PEOPLES R CHINA
DE Glutaraldehyde fixed bovine pericardium; anticalcification;
   decellularization; hyaluronic acid derivative
ID BIOPROSTHETIC HEART-VALVES; CARDIOVASCULAR CALCIFICATION; MITIGATES
   CALCIFICATION; STABILIZATION; PROTEOGLYCAN; BIOMATERIAL; PERIODATE
AB The objective of this work was to evaluate the effect of decellularization and hyaluronic acid derivative on the improvement of anticalcification of glutaraldehyde fixed bovine pericardium (GFBP) using a rat subcutaneous implantation model A cell extraction process was employed to remove the cells and cellular components from bovine pericardium ( BP), leaving a framework of largely insoluble collagen. Then acellular BP was cross-linked by glutaraldehyde solution and treated with hyaluronic acid derivative (HA-ADH) which was obtained by coupling adipic dihydrazide (ADH) on-COOH of hyaluronic acid ( HA). The results of in vivo calcification tests showed that the calcium content was decreased dramatically by decellularization alone (from 28.07 +/- 18.87 to 2.44 +/- 0.55 mu g Ca/mg dry tissue after 8 weeks' implantation), and even less concentration was shown by the combination of HA derivative treatment and decellularization (GFaBP-HA group) (0.25 +/- 0.08 mu g Ca/mg dry tissue after 8 weeks' implantation). In addition, GFaBP-HA group not only presented a lower degree of calcification, but also showed lower ratios of Ca/P molar, which corresponded to amorphous calcium phosphates. The obtained results indicated that GFaBP-HA was a potential candidate for the manufacture of anticalcification bioprostheses.
C1 [Zhu, Deyi; Jin, Liqiang] Qilu Univ Technol, Sch Chem & Pharmaceut Engn, Jinan 250353, Peoples R China.
   [Wang, Xuemei; Xu, Li; Liu, Tianqi] Shandong Univ, Qianfoshan Hosp, Dept Cardiac Surg, Jinan 250014, Peoples R China.
RP Liu, TQ (reprint author), Shandong Univ, Qianfoshan Hosp, Dept Cardiac Surg, Jinan 250014, Peoples R China.
EM tianqiliu84@gmail.com
CR Arenaz B, 2004, BIOMATERIALS, V25, P3359, DOI 10.1016/j.biomaterials.2003.09.105
   Carpentier SM, 1998, ANN THORAC SURG, V66, pS264, DOI 10.1016/S0003-4975(98)01101-1
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Demer LL, 1997, CIRCULATION, V95, P297
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hahn SK, 2005, BIOTECHNOL BIOPROC E, V10, P218, DOI 10.1007/BF02932016
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   HUNTER GK, 1991, CLIN ORTHOP RELAT R, P256
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Lee WK, 2000, BIOMATERIALS, V21, P2323, DOI 10.1016/S0142-9612(00)00159-9
   LEVY RJ, 1991, BIOMATERIALS, V12, P707, DOI 10.1016/0142-9612(91)90017-5
   Lovekamp J, 2001, J BIOMED MATER RES, V56, P478, DOI 10.1002/1097-4636(20010915)56:4<478::AID-JBM1119>3.0.CO;2-C
   Maizato MJS, 2003, ARTIF ORGANS, V27, P692, DOI 10.1046/j.1525-1594.2003.07275.x
   Mikroulis D, 2002, J MATER SCI-MATER M, V13, P885, DOI 10.1023/A:1016556514203
   New SEP, 2011, CIRC J, V75, P1305, DOI 10.1253/circj.CJ-11-0395
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   O'Brien M F, 1999, Semin Thorac Cardiovasc Surg, V11, P194
   Ohri R, 2004, J BIOMED MATER RES A, V70A, P328, DOI 10.1002/jbm.a.30088
   Oswal D, 2007, J HEART VALVE DIS, V16, P165
   Simionescu DT, 2004, EXPERT OPIN BIOL TH, V4, P1971, DOI 10.1517/14712598.4.12.1971
   Valente M, 1998, J HEART VALVE DIS, V7, P283
   VALENTE M, 1985, AM J PATHOL, V119, P12
   Vasudev SC, 2001, J BIOMATER APPL, V16, P109, DOI 10.1106/XXFC-JAUW-3HAX-UY6T
   Vasudev SC, 1997, ARTIF ORGANS, V21, P1007
   Wilson G J, 1990, ASAIO Trans, V36, pM340
NR 26
TC 2
Z9 2
U1 2
U2 21
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 1
BP 741
EP 749
DI 10.3233/BME-130862
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256LU
UT WOS:000327312600085
PM 24211959
DA 2018-10-20
ER

PT J
AU Pan, CJ
   Hou, YH
   Zhang, BB
   Zhang, LC
AF Pan, Chang-Jiang
   Hou, Yan-Hua
   Zhang, Bin-Bin
   Zhang, Lin-Cai
TI Fabrication of anticoagulation layer on titanium surface by sequential
   immobilization of poly (ethylene glycol) and albumin
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Biomedical Engineering and Biotechnology
   (iCBEB)
CY OCT 11-13, 2013
CL Wuhan, PEOPLES R CHINA
DE Titanium; surface modification; anticoagulation; PEG; albumin
ID PROTEIN ADSORPTION; HEMOCOMPATIBILITY; ACTIVATION; ENDOTHELIALIZATION;
   BIOMATERIAL; THROMBOSIS; PLATELETS; CHITOSAN; HEPARIN
AB This paper presents a simple method to sequentially immobilize poly (ethylene glycol) (PEG) and albumin on titanium surface to enhance the blood compatibility. Attenuated total reflectance Fourier transform infrared spectroscopy (ATRFTIR) analysis indicated that PEG and albumin were successfully immobilized on the titanium surface. Water contact angle results showed a better hydrophilic surface after the immobilization. The immobilized PEG or albumin can not only obviously prevent platelet adhesion and activation but also prolong activated partial thromboplastin time (APTT), leading to the improved anticoagulation. Moreover, immobilization of albumin on PEG-modified surface can further improve the anticoagulation. The approach in the present study provides an effective and efficient method to improve the anticoagulation of blood-contact biomedical devices such as coronary stents.
C1 [Pan, Chang-Jiang; Hou, Yan-Hua; Zhang, Bin-Bin; Zhang, Lin-Cai] Huaiyin Inst Technol, Jiangsu Prov Key Lab Intervent Med Devices, Huaian 223003, Peoples R China.
RP Pan, CJ (reprint author), 1 Meicheng Rd, Huaian 223003, Peoples R China.
EM swjtupcj@163.com
CR Alibeik S, 2010, COLLOID SURFACE B, V81, P389, DOI 10.1016/j.colsurfb.2010.07.024
   Finley MJ, 2012, BIOMATERIALS, V33, P5803, DOI 10.1016/j.biomaterials.2012.04.051
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Li QL, 2009, J BIOMED MATER RES A, V89A, P575, DOI 10.1002/jbm.a.31999
   Li QL, 2009, J BIOACT COMPAT POL, V24, P129, DOI 10.1177/0883911508101553
   Liu SH, 2013, J BIOMED MATER RES A, V101, P1144, DOI 10.1002/jbm.a.34392
   Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861
   Ren ZC, 2013, J APPL POLYM SCI, V127, P308, DOI 10.1002/app.37885
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Yamazoe H, 2010, MAT SCI ENG C-MATER, V30, P812, DOI 10.1016/j.msec.2010.03.015
   Ye SH, 2010, COLLOID SURFACE B, V79, P357, DOI 10.1016/j.colsurfb.2010.04.018
   Zhang C, 2013, COLLOID SURFACE B, V102, P45, DOI 10.1016/j.colsurfb.2012.08.007
NR 16
TC 2
Z9 3
U1 1
U2 14
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 1
BP 781
EP 787
DI 10.3233/BME-130868
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256LU
UT WOS:000327312600090
PM 24211964
DA 2018-10-20
ER

PT J
AU Chalal, S
   Hussain, FSJ
   Yusoff, MBM
AF Chalal, Sugandha
   Hussain, Fathima Shahitha Jahir
   Yusoff, Mashitah Binti Mohd
TI Biomimetic growth of bone-like apatite via simulated body fluid on
   hydroxyethyl cellulose/polyvinyl alcohol electrospun nanofibers
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Biomedical Engineering and Biotechnology
   (iCBEB)
CY OCT 11-13, 2013
CL Wuhan, PEOPLES R CHINA
DE Hydroxyethyl cellulose; electrospinning; bone-like apatite; simulated
   body fluid; bone tissue engineering.
ID COMPOSITE SCAFFOLDS; TISSUE; HYDROXYAPATITE; FIBERS; WATER
AB In this study, randomly oriented hydroxyethyl cellulose/polyvinyl alcohol (HEC/PVA) nanofibers were fabricated by electrospinning. The blend solutions of HEC/PVA with different weight ratio of HEC to PVA were prepared using water as solvent to fabricate nanofibers. These nanofibrous scaffolds were coated with bone-like apatite by immersing into 10x simulated body fluid (SBF) for different time periods. The morphology and structure of the nanofibers were characterized by SEM, FTIR and DSC. FESEM-EDS and FTIR analysis were used to confirm the deposition of apatite on the surface of nanofibers. The results of this study suggest that this apatite coated nanofibrous scaffolds could be a suitable biomaterial for bone tissue engineering.
C1 [Chalal, Sugandha; Hussain, Fathima Shahitha Jahir; Yusoff, Mashitah Binti Mohd] Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan 26300, Pahang, Malaysia.
RP Chalal, S (reprint author), Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan 26300, Pahang, Malaysia.
EM fathimashahitha@gmail.com; mlt.mony@gmail.com
RI Yusoff, Mashitah/A-3622-2011
OI Yusoff, Mashitah/0000-0003-4118-5307
CR Asran AS, 2010, POLYMER, V51, P868, DOI 10.1016/j.polymer.2009.12.046
   Beskardes IG, 2009, J BIOACT COMPAT POL, V24, P507, DOI 10.1177/0883911509349311
   Chen M., 2007, TISSUE ENG, V13, P79
   Coates J., 2000, INTERPRETATION INFRA, P10815
   Costa H. S., 2012, J NANOMATERIALS
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P643, DOI 10.1002/jbm.a.30866
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Mallapragada SK, 1996, J POLYM SCI POL PHYS, V34, P1339, DOI 10.1002/(SICI)1099-0488(199605)34:7<1339::AID-POLB15>3.0.CO;2-B
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mavis B, 2009, ACTA BIOMATER, V5, P3098, DOI 10.1016/j.actbio.2009.04.037
   MORRILL T. C., 1994, IDENTIFICACAO ESPECT
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Song JH, 2008, J MATER SCI-MATER M, V19, P95, DOI 10.1007/s10856-007-3169-4
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Tas AC, 2004, J MATER RES, V19, P2742, DOI 10.1557/JMR.2004.0349
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Xu HHK, 2001, J BIOMED MATER RES, V57, P457, DOI 10.1002/1097-4636(20011205)57:3<457::AID-JBM1189>3.0.CO;2-X
   Yang GL, 2009, ORAL SURG ORAL MED O, V107, P782, DOI 10.1016/j.tripleo.2008.12.023
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
NR 28
TC 6
Z9 7
U1 1
U2 46
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 1
BP 799
EP 806
DI 10.3233/BME-130871
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256LU
UT WOS:000327312600092
PM 24211966
DA 2018-10-20
ER

PT J
AU Yang, YL
   Chang, CH
   Huang, CC
   Kao, WMW
   Liu, WC
   Liu, HW
AF Yang, Yueh-Lung
   Chang, Ching-Hsien
   Huang, Ching-Cheng
   Kao, Wenny Mei-Wen
   Liu, Wei-Chung
   Liu, Hsia-Wei
TI Osteogenic activity of nanonized pearl powder/poly
   (lactide-co-glycolide) composite scaffolds for bone tissue engineering
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Biomedical Engineering and Biotechnology
   (iCBEB)
CY OCT 11-13, 2013
CL Wuhan, PEOPLES R CHINA
DE nanonized pearl powder; poly (D; L-lactide-co-glycolide); osteoblast;
   bio-mineralization; bone tissue engineering
ID ALKALINE-PHOSPHATASE ACTIVITY; WATER-SOLUBLE MATRIX; PINCTADA-MAXIMA;
   NACRE; OSTEOBLASTS; MINERALIZATION; FIBROBLASTS; CELLS
AB Numerous materials have been proposed for bone tissue engineering. In this study, a newly designed hybrid composite scaffold composed of poly (D, L-lactide-co-glycolide) and a naturally bioceramic hybrid material, nanonized pearl powder, were prepared and the biological activities and physical properties of the scaffold for bone tissue engineering were evaluated. It is a composite consisting calcium carbonate crystal in an aragonite structure, embedded in an organic matrix. Peral contains one or more signal molecules capable of stimulating bone formation. The nanonized pearl powder is considered as a promising osteoinductive biomaterial. This biomaterial is biocompatible and shows osteogenic activity. In this study, the designed biohybrid of nanonized pearl powder/ poly (lactide-co-glycolide) (NPP/PLGA) biocomposite scaffolds would employ biodegradable material as MC3T3-E1 cells seeded scaffolds. Therefore, the biocomposite scaffolds would be used to culture with MC3T3-E1 cells under spinner bioreactor in vitro. Furthermore, it also detailed how these tissues were characterized, qualitatively and quantitatively, with scanning electron microscopy and biochemical testing. The identity and the mode of action of these molecules on the osteoblast differentiation were analyzed. This study indicates that the efficiency of nanonized pearl powders in bone cell differentiation are certainly different from that of proteins. Further sudy will look forward to manufacturing the promising new generation bone substitute, three dimensional biocomposite scaffolds to replace the implant and autogeneous bone graft, which combines basic research and clinical application.
C1 [Yang, Yueh-Lung] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Keelung, Taiwan.
   [Chang, Ching-Hsien] En Chu Kong Hosp, Dep Chinese Med, New Taipei City, Taiwan.
   [Huang, Ching-Cheng] Ming Chuan Univ, Dept Biomed Engn, Tao Yuan, Taiwan.
   [Huang, Ching-Cheng; Liu, Wei-Chung] Met Ind Res & Dev Ctr, Reg R&D Serv Dep, Taipei, Taiwan.
   [Kao, Wenny Mei-Wen] Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan.
   [Liu, Hsia-Wei] Fu Jen Catholic Univ, Dept Life Sci, New Taipei City 24205, Taiwan.
RP Liu, HW (reprint author), Fu Jen Catholic Univ, Dept Life Sci, 510 Jhongiheng Rd, New Taipei City 24205, Taiwan.
EM 079336@mail.fju.edu.tw
CR Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Asvanund P, 2011, IMPLANT DENT, V20, P32, DOI 10.1097/ID.0b013e3182061be1
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Flausse A, 2013, J BIOMEDICAL MAT R A
   Liu HW, 2007, TISSUE ENG, V13, P1113, DOI 10.1089/ten.2006.0209
   Liu HW, 2006, BONE, V39, P825, DOI 10.1016/j.bone.2006.04.027
   Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217
   Moutahir-Belqasmi F, 2001, J MATER SCI-MATER M, V12, P1, DOI 10.1023/A:1026759431595
   Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0
   Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553
NR 10
TC 7
Z9 9
U1 1
U2 45
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 1
BP 979
EP 985
DI 10.3233/BME-130893
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256LU
UT WOS:000327312600113
PM 24211987
DA 2018-10-20
ER

PT J
AU Chiu, KH
   Liu, WS
AF Chiu, Kuo-Hsun
   Liu, Wen-Sheng
TI Dietary administration of the extract of Rhodobacter sphaeroides
   WL-APD911 enhances the growth performance and innate immune responses of
   seawater red tilapia (Oreochromis mossambicus x Oreochromis niloticus)
SO AQUACULTURE
LA English
DT Article
DE Rhodobacter sphaeroidesWL-APD911; Carotenoid; Growth performance; Red
   tilapia; Lycogen (TM)
ID ORANGE-SPOTTED GROUPER; EPINEPHELUS-COIOIDES; DISEASE RESISTANCE;
   VIBRIO-ALGINOLYTICUS; SHRIMP AQUACULTURE; CYPRINUS-CARPIO; SODIUM
   ALGINATE; FISH; CAROTENOIDS; PROBIOTICS
AB A commercial carotenoid product from the extract of probiotic Rhodobacter sphaeroides mutant strain WL-APD911 (Lycogen (TM)) contains neurosporene, xi-carotene, spheroidenone and methoxyneurosporene rather than lycopene. In the present study, Lycogen (TM) was used to improve the growth performance of seawater red tilapia (Oreochromis mossambicus x Oreochromis niloticus) for 7 weeks. The results showed that dietary supplementation with 1.0% Lycogen (TM) in seawater tilapia did not cause changes in body length but significantly increased muscle weight, weight gain, the specific growth rate (SGR) and the feed conversion ratio (FCR). Because there were no intergroup differences in the proximate composition of the fish muscle, the increased body weight of Lycogen (TM)-supplemented tilapia might have resulted from muscle growth instead of changes in muscle composition. An analysis of the expression levels of growth-associated genes, i.e., growth hormone receptor 1 (GHR1) and insulin growth factor-1 (IGF-1), showed that an alternative splicing form of GHR1 accumulated to a significant extent in the muscle of tilapia fed with a Lycogen (TM)-supplemented diet. In addition, innate humoral responses, reflected by lysozyme activity and alternative complement activity (ACH(50)), also significantly increased in the sera of Lycogen (TM)-treated tilapia. The present study suggests a potential application of the biomaterial Lycogen (TM) in the aquaculture field: to enhance tilapia growth performance via immune regulation. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Chiu, Kuo-Hsun; Liu, Wen-Sheng] Natl Kaohsiung Marine Univ, Dept & Grad Inst Aquaculture, Kaohsiung 811, Taiwan.
   [Liu, Wen-Sheng] Asia Pacific Biotech Dev Inc, Kaohsiung, Taiwan.
RP Chiu, KH (reprint author), Natl Kaohsiung Marine Univ, Dept & Grad Inst Aquaculture, 142 Hai Chuan Rd, Kaohsiung 811, Taiwan.
EM kuohsun@mail.nkmu.edu.tw; ws5339@apd-biotech.com.tw
FU Office of Research and Development Affairs, National Kaohsiung Marine
   University [101AB007]; Ministry of Education [102B-07-024]
FX This work was supported by Grants 101AB007 from the Office of Research
   and Development Affairs, National Kaohsiung Marine University, and
   102B-07-024 for Development of Industry-Academy Cooperation from the
   Ministry of Education. We also thank the three anonymous reviewers for
   providing helpful comments on the draft manuscript.
CR ALBRECHT M, 1995, FEBS LETT, V372, P199, DOI 10.1016/0014-5793(95)00978-I
   Albrecht M, 1997, J BACTERIOL, V179, P7462, DOI 10.1128/jb.179.23.7462-7467.1997
   Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013
   *AOAC, 1984, OFF METH AN
   Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009
   BENDICH A, 1989, FASEB J, V3, P1927
   BENDICH A, 1989, J NUTR, V119, P112
   BJORNSON AB, 1990, REV INFECT DIS, V12, pS161
   Butler MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038043
   CANFIELD LM, 1992, P SOC EXP BIOL MED, V200, P260
   Cheng AC, 2007, FISH SHELLFISH IMMUN, V22, P197, DOI 10.1016/j.fsi.2006.04.009
   Cheng AC, 2009, FISH SHELLFISH IMMUN, V26, P768, DOI 10.1016/j.fsi.2009.03.011
   CHEW BP, 1993, J DAIRY SCI, V76, P2804, DOI 10.3168/jds.S0022-0302(93)77619-5
   Chiu CH, 2010, FISH SHELLFISH IMMUN, V29, P1053, DOI 10.1016/j.fsi.2010.08.019
   Das S, 2008, APPL MICROBIOL BIOT, V81, P419, DOI 10.1007/s00253-008-1731-8
   Ebihara K, 1996, MOL CELL BIOL, V16, P3393
   Farzanfar A, 2006, FEMS IMMUNOL MED MIC, V48, P149, DOI 10.1111/j.1574-695X.2006.00116.x
   Harikrishnan R, 2011, FISH SHELLFISH IMMUN, V30, P128, DOI 10.1016/j.fsi.2010.09.013
   Horak P, 2006, J EXP BIOL, V209, P4329, DOI 10.1242/jeb.02502
   KEUSCH GT, 1991, REV INFECT DIS, V13, pS486
   Kraiczy P, 2002, INT J MED MICROBIOL, V291, P141, DOI 10.1016/S1438-4221(02)80027-3
   Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522
   Lin SM, 2012, FISH SHELLFISH IMMUN, V32, P909, DOI 10.1016/j.fsi.2012.02.019
   Liu CH, 2012, FISH SHELLFISH IMMUN, V33, P699, DOI 10.1016/j.fsi.2012.06.012
   Liu WS, 2012, MOLECULES, V17, P13622, DOI 10.3390/molecules171113622
   Mambrini M, 1999, J ANIM SCI, V77, P2990
   Martinez R, 2012, J ENDOCRINOL, V214, P409, DOI 10.1530/JOE-11-0373
   Mayilyan KR, 2012, PROTEIN CELL, V3, P487, DOI 10.1007/s13238-012-2924-6
   Moharram S G, 2007, Pak J Biol Sci, V10, P3742
   Munoz-Atienza E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-15
   Nakao M, 1998, IMMUNOL REV, V166, P27, DOI 10.1111/j.1600-065X.1998.tb01250.x
   Nandeesha MC, 2001, BIORESOURCE TECHNOL, V80, P117, DOI 10.1016/S0960-8524(01)00085-2
   Ninawe AS, 2009, CRIT REV MICROBIOL, V35, P43, DOI 10.1080/10408410802667202
   Panicker SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038449
   Pantel J, 2000, J BIOL CHEM, V275, P18664, DOI 10.1074/jbc.M001615200
   Perez-Rodriguez L, 2008, J EXP BIOL, V211, P2155, DOI 10.1242/jeb.017178
   Pratheepa V, 2010, PHARM BIOL, V48, P1224, DOI 10.3109/13880201003713598
   Ravi AV, 2007, LETT APPL MICROBIOL, V45, P219, DOI 10.1111/j.1472-765X.2007.02180.x
   Rodriguez A, 2004, FISH SHELLFISH IMMUN, V16, P241, DOI 10.1016/S1050-4648(03)00082-2
   Sahu Maloy Kumar, 2008, Indian J Microbiol, V48, P299, DOI 10.1007/s12088-008-0024-3
   Schwaeble WJ, 1999, IMMUNOL TODAY, V20, P17, DOI 10.1016/S0167-5699(98)01376-0
   SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427
   Sitja-Bobadilla A, 2008, PARASITE, V15, P420, DOI 10.1051/parasite/2008153420
   Soleimani N, 2012, FISH SHELLFISH IMMUN, V32, P316, DOI 10.1016/j.fsi.2011.11.023
   Son VM, 2009, FISH SHELLFISH IMMUN, V26, P691, DOI 10.1016/j.fsi.2009.02.018
   Tukmechi A, 2011, FISH SHELLFISH IMMUN, V30, P923, DOI 10.1016/j.fsi.2011.01.016
   Vine NG, 2004, FEMS MICROBIOL LETT, V231, P145, DOI 10.1016/S0378-1097(03)00954-6
   VIRELLA G, 1991, CLIN IMMUNOL IMMUNOP, V61, P161, DOI 10.1016/S0090-1229(05)80021-2
   Watts M, 2001, AUST VET J, V79, P570, DOI 10.1111/j.1751-0813.2001.tb10753.x
   Weisburger JH, 1999, FOOD CHEM TOXICOL, V37, P943, DOI 10.1016/S0278-6915(99)00086-1
   Wu WT, 2011, ADV MATER RES-SWITZ, V287-290, P2028, DOI 10.4028/www.scientific.net/AMR.287-290.2028
   Yeh SP, 2008, FISH SHELLFISH IMMUN, V25, P19, DOI 10.1016/j.fsi.2007.11.011
   Yeliseev AA, 1997, FEBS LETT, V403, P10, DOI 10.1016/S0014-5793(97)00006-9
NR 53
TC 7
Z9 10
U1 1
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0044-8486
EI 1873-5622
J9 AQUACULTURE
JI Aquaculture
PD JAN 1
PY 2014
VL 418
BP 32
EP 38
DI 10.1016/j.aquaculture.2013.10.007
PG 7
WC Fisheries; Marine & Freshwater Biology
SC Fisheries; Marine & Freshwater Biology
GA 252BC
UT WOS:000326978300005
DA 2018-10-20
ER

PT J
AU Rai, RK
   Barbhuyan, T
   Singh, C
   Mittal, M
   Khan, MP
   Sinha, N
   Chattopadhyay, N
AF Rai, Ratan Kumar
   Barbhuyan, Tarun
   Singh, Chandan
   Mittal, Monika
   Khan, Mohd Parvez
   Sinha, Neeraj
   Chattopadhyay, Naibedya
TI Total Water, Phosphorus Relaxation and Inter-Atomic Organic to Inorganic
   Interface Are New Determinants of Trabecular Bone Integrity
SO PLOS ONE
LA English
DT Article
ID SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; MECHANICAL-PROPERTIES;
   COMPUTED-TOMOGRAPHY; CANCELLOUS BONE; SPECTROSCOPY; LACTATION;
   DEHYDRATION; COLLAGEN; MICE
AB Bone is the living composite biomaterial having unique structural property. Presently, there is a considerable gap in our understanding of bone structure and composition in the native state, particularly with respect to the trabecular bone, which is metabolically more active than cortical bones, and is readily lost in post-menopausal osteoporosis. We used solid-state nuclear magnetic resonance (NMR) to compare trabecular bone structure and composition in the native state between normal, bone loss and bone restoration conditions in rat. Trabecular osteopenia was induced by lactation as well as prolonged estrogen deficiency (bilateral ovariectomy, Ovx). Ovx rats with established osteopenia were administered with PTH (parathyroid hormone, trabecular restoration group), and restoration was allowed to become comparable to sham Ovx (control) group using bone mineral density (BMD) and mu CT determinants. We used a technique combining H-1 NMR spectroscopy with P-31 and C-13 to measure various NMR parameters described below. Our results revealed that trabecular bones had diminished total water content, inorganic phosphorus NMR relaxation time (T-1) and space between the collagen and inorganic phosphorus in the osteopenic groups compared to control, and these changes were significantly reversed in the bone restoration group. Remarkably, bound water was decreased in both osteopenic and bone restoration groups compared to control. Total water and T-1 correlated strongly with trabecular bone density, volume, thickness, connectivity, spacing and resistance to compression. Bound water did not correlate with any of the microarchitectural and compression parameters. We conclude that total water, T-1 and atomic space between the crystal and organic surface are altered in the trabecular bones of osteopenic rats, and PTH reverses these parameters. Furthermore, from these data, it appears that total water and T-1 could serve as trabecular surrogates of micro-architecture and compression strength.
C1 [Rai, Ratan Kumar; Singh, Chandan; Sinha, Neeraj] Ctr Biomed Res, Lucknow, Uttar Pradesh, India.
   [Barbhuyan, Tarun; Mittal, Monika; Khan, Mohd Parvez; Chattopadhyay, Naibedya] Cent Drug Res Inst, Div Endocrinol, CSIR, Lucknow, Uttar Pradesh, India.
   [Barbhuyan, Tarun; Mittal, Monika; Khan, Mohd Parvez; Chattopadhyay, Naibedya] Cent Drug Res Inst, CSIR, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, Lucknow 226001, Uttar Pradesh, India.
RP Sinha, N (reprint author), Ctr Biomed Res, SGPGIMS Campus, Lucknow, Uttar Pradesh, India.
EM neeraj.sinha@cbmr.res.in; n_chattopadhyay@cdri.res.in
RI Rai, Ratan/N-6344-2018
OI Rai, Ratan/0000-0001-6015-5539; Chattopadhyay,
   Naibedya/0000-0003-2473-0246
FU Council of Scientific and Industrial Research, Government of India
   [BSC0201]; University Grants Commission, Government of India; Indian
   Council of Medical Research, Government of India; Department of
   Biotechnology, Government of India [BT/PR12700/BRB/10/719/2009]
FX This study was supported by the Council of Scientific and Industrial
   Research (BSC0201, ASTHI), Government of India. Fellowship grants from
   the Council of Scientific and Industrial Research (RKR, TB, CS),
   University Grants Commission (MM), Indian Council of Medical Research
   (MPK), Department of Biotechnology (BT/PR12700/BRB/10/719/2009),
   Government of India. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ardeshirpour L, 2007, ENDOCRINOLOGY, V148, P3875, DOI 10.1210/en.2006-1467
   BAUD CA, 1978, CLIN ORTHOP RELAT R, P270
   BELANGER LF, 1969, CALC TISS RES, V4, P1, DOI 10.1007/BF02279101
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Cho GY, 2003, SCIENCE, V300, P1123, DOI 10.1126/science.1078470
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   Compston J, 2011, J OSTEOPOROSIS, V2011, P4
   Fernandez-Seara MA, 2004, J BONE MINER RES, V19, P289, DOI 10.1359/JBMR.0301227
   GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1
   Iida-Klein A, 2007, BONE, V40, P391, DOI 10.1016/j.bone.2006.09.010
   Jerome CP, 2001, BONE, V28, P150, DOI 10.1016/S8756-3282(00)00430-0
   Kaflak A, 2007, SOLID STATE NUCL MAG, V31, P174, DOI 10.1016/j.ssnmr.2007.04.005
   Kalkwarf HJ, 1999, J MAMMARY GLAND BIOL, V4, P319, DOI 10.1023/A:1018780425600
   Khan K, 2013, OSTEOPOROSIS INT, V24, P1455, DOI 10.1007/s00198-012-2121-8
   Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832
   Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3
   MEIER DE, 1984, ANN INTERN MED, V101, P605, DOI 10.7326/0003-4819-101-5-605
   Mroue KH, 2012, J PHYS CHEM B, V116, P11656, DOI 10.1021/jp307935g
   Nikel O, 2012, J PHYS CHEM C, V116, P6320, DOI 10.1021/jp2125312
   Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559
   Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567
   Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087
   Rai RK, 2011, J PHYS CHEM C, V115, P14219, DOI 10.1021/jp2025768
   Recker RR, 2009, BONE, V44, P113, DOI 10.1016/j.bone.2008.09.019
   Reichert D, 2004, MAGN RESON CHEM, V42, P276, DOI 10.1002/mrc.1334
   ROBINSON RA, 1975, CLIN ORTHOP RELAT R, P263
   SAITO H, 1992, J BIOCHEM-TOKYO, V111, P376, DOI 10.1093/oxfordjournals.jbchem.a123765
   Sharan K, 2011, J BONE MINER RES, V26, P2096, DOI 10.1002/jbmr.434
   Sharan K, 2010, MENOPAUSE, V17, P393, DOI [10.1097/gme.0b013e3181d2ce7f, 10.1097/gme.0b013e3181bfae38]
   Siddiqui JA, 2011, MENOPAUSE, V18, P198, DOI 10.1097/gme.0b013e3181e84e67
   Singh C, 2013, SOLID STATE NUCL MAG, V54, P18, DOI 10.1016/j.ssnmr.2013.05.003
   Srivastava K, 2013, EVID-BASED COMPL ALT, V2013, P12
   Takata Shinjiro, 2004, J Med Invest, V51, P133, DOI 10.2152/jmi.51.133
   Trivedi R, 2009, MOL CELL ENDOCRINOL, V302, P86, DOI 10.1016/j.mce.2009.01.011
   Tyagi AM, 2012, MENOPAUSE, V19, P856, DOI 10.1097/gme.0b013e31824f9306
   Vinogradov E, 1999, CHEM PHYS LETT, V314, P443, DOI 10.1016/S0009-2614(99)01174-4
   Wehrli FW, 2005, ANN BIOMED ENG, V33, P79, DOI 10.1007/s10439-005-8965-8
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wilson EE, 2006, BIOPHYS J, V90, P3722, DOI 10.1529/biophysj.105.070243
   Wilson EE, 2005, J BONE MINER RES, V20, P625, DOI 10.1359/JBMR.041217
   Xu JD, 2011, J PHYS CHEM B, V115, P9948, DOI 10.1021/jp205663z
   Zhang G, 2005, CLIN BIOMECH, V20, P729, DOI 10.1016/j.clinbiomech.2005.03.016
   Zhang QB, 2009, RADIAT RES, V172, P607, DOI 10.1667/RR1715.1
   Zhu PZ, 2009, J AM CHEM SOC, V131, P17064, DOI 10.1021/ja9081028
NR 46
TC 13
Z9 13
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 30
PY 2013
VL 8
IS 12
AR e83478
DI 10.1371/journal.pone.0083478
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 282SX
UT WOS:000329194700043
PM 24386209
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Van Koughnett, JAM
   Wexner, SD
AF Van Koughnett, Julie Ann M.
   Wexner, Steven D.
TI Current management of fecal incontinence: Choosing amongst treatment
   options to optimize outcomes
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Fecal incontinence; Treatment; Sacral nerve stimulation;
   Sphincteroplasty; Artificial bowel Sphincter; Biofeedback
ID SACRAL NERVE-STIMULATION; ANTEGRADE CONTINENCE ENEMA; QUALITY-OF-LIFE;
   ARTIFICIAL BOWEL SPHINCTER; LONG-TERM OUTCOMES; INJECTABLE SILICONE
   BIOMATERIAL; RADIOFREQUENCY ENERGY DELIVERY; RANDOMIZED
   CONTROLLED-TRIAL; STABILIZED HYALURONIC-ACID; PELVIC FLOOR DYSFUNCTION
AB The severity of fecal incontinence widely varies and can have dramatic devastating impacts on a person's life. Fecal incontinence is common, though it is often under-reported by patients. In addition to standard treatment options, new treatments have been developed during the past decade to attempt to effectively treat fecal incontinence with minimal morbidity. Non-operative treatments include dietary modifications, medications, and biofeedback therapy. Currently used surgical treatments include repair (sphincteroplasty), stimulation (sacral nerve stimulation or posterior tibial nerve stimulation), replacement (artificial bowel sphincter or muscle transposition) and diversion (stoma formation). Newer augmentation treatments such as radiofrequency energy delivery and injectable materials, are minimally invasive tools that may be good options before proceeding to surgery in some patients with mild fecal incontinence. In general, more invasive surgical treatments are now reserved for moderate to severe fecal incontinence. Functional and quality of life related outcomes, as well as potential complications of the treatment must be considered and the treatment of fecal incontinence must be individualized to the patient. General indications, techniques, and outcomes profiles for the various treatments of fecal incontinence are discussed in detail. Choosing the most effective treatment for the individual patient is essential to achieve optimal outcomes in the treatment of fecal incontinence. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.
C1 [Van Koughnett, Julie Ann M.; Wexner, Steven D.] Cleveland Clin Florida, Dept Colorectal Surg, Weston, FL 33331 USA.
RP Wexner, SD (reprint author), Cleveland Clin Florida, Dept Colorectal Surg, 2950 Cleveland Clin Blvd, Weston, FL 33331 USA.
EM wexners@ccf.org
FU Incontinence Devices, Inc; Mediri Therapeutics, Inc.; Medtronic Inc.;
   Renew Medical; Salix Pharmaceuticals
FX Supported by Dr. Wexner is a consultant and receives consulting fees in
   the field of fecal incontinence from: Incontinence Devices, Inc; Mediri
   Therapeutics, Inc.; Medtronic Inc.; Renew Medical; Salix Pharmaceuticals
CR Abbas MA, 2012, DIS COLON RECTUM, V55, P605, DOI 10.1097/DCR.0b013e3182415406
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Altomare DF, 2001, BRIT J SURG, V88, P1481, DOI 10.1046/j.0007-1323.2001.01895.x
   Altomare DF, 2010, WORLD J GASTROENTERO, V16, P5267, DOI 10.3748/wjg.v16.i42.5267
   Bani-Hani AH, 2008, J UROLOGY, V180, P1757, DOI 10.1016/j.juro.2008.04.074
   Bani-Hani AH, 2008, J UROLOGY, V180, P1106, DOI 10.1016/j.juro.2068.05.062
   Barisic GI, 2006, INT J COLORECTAL DIS, V21, P52, DOI 10.1007/s00384-004-0737-7
   Bartlett L, 2011, DIS COLON RECTUM, V54, P846, DOI 10.1007/DCR.0b013e3182148fef
   Bharucha AE, 2012, AM J GASTROENTEROL, V107, P902, DOI 10.1038/ajg.2012.45
   Bharucha AE, 2010, GASTROENTEROLOGY, V139, P1559, DOI 10.1053/j.gastro.2010.07.056
   Bliss DZ, 2001, NURS RES, V50, P203, DOI 10.1097/00006199-200107000-00004
   Boselli AS, 2010, WORLD J SURG, V34, P815, DOI 10.1007/s00268-010-0392-9
   Boyle DJ, 2009, DIS COLON RECTUM, V52, P1234, DOI 10.1007/DCR.0b013e31819f7400
   Bresler L, 2002, ANN CHIR, V127, P520, DOI 10.1016/S0003-3944(02)00828-3
   Briel JW, 1998, DIS COLON RECTUM, V41, P209, DOI 10.1007/BF02238250
   Brill Scott A, 2005, Clin Colon Rectal Surg, V18, P38, DOI 10.1055/s-2005-864079
   Brouwer R, 2010, DIS COLON RECTUM, V53, P273, DOI 10.1007/DCR.0b013e3181ceeb22
   Brown HW, 2012, INT J CLIN PRACT, V66, P1101, DOI 10.1111/ijcp.12018
   Brown HW, 2012, INT J CLIN PRACT, V66, P1109, DOI 10.1111/ijcp.12017
   Brown HW, 2013, FEMALE PELVIC MED RE, V19, P66, DOI 10.1097/SPV.0b013e31828016d3
   Brown SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001757.pub3
   Byrne CM, 2007, DIS COLON RECTUM, V50, P417, DOI 10.1007/s10350-006-0846-1
   Cera Susan M, 2005, Clin Colon Rectal Surg, V18, P46, DOI 10.1055/s-2005-864081
   Colquhoun P, 2006, WORLD J SURG, V30, P1925, DOI 10.1007/s00268-006-0531-5
   da Silva GM, 2004, DIS COLON RECTUM, V47, P204, DOI 10.1007/s10350-003-0039-0
   Damon H, 2013, INT J COLORECTAL DIS, V28, P227, DOI 10.1007/s00384-012-1558-8
   Danielson J, 2013, TECH COLOPROCTOL, V17, P389, DOI 10.1007/s10151-012-0949-8
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   Dehli T, 2013, SCAND J GASTROENTERO, V48, P302, DOI 10.3109/00365521.2012.758770
   Devesa JM, 1997, DIS COLON RECTUM, V40, P883, DOI 10.1007/BF02051193
   Devesa JM, 2002, DIS COLON RECTUM, V45, P1154, DOI 10.1007/s10350-004-6382-y
   Devroede G, 2012, FEMALE PELVIC MED RE, V18, P103, DOI 10.1097/SPV.0b013e3182486e60
   Dodi G, 2010, GASTROENT RES PRACT, DOI 10.1155/2010/467136
   Duelund-Jakobsen J, 2012, COLORECTAL DIS, V14, P753, DOI 10.1111/j.1463-1318.2011.02800.x
   Duelund-Jakobsen J, 2013, ANN SURG, V257, P219, DOI 10.1097/SLA.0b013e318269d493
   Eccersley AJP, 1999, BRIT J SURG, V86, P647
   Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1097/01.DCR.0000098927.47914.D0
   El-Gazzaz G, 2012, DIS COLON RECTUM, V55, P256, DOI 10.1097/DCR.0b013e31823deb85
   Ellison JS, 2013, J UROLOGY, V190, P1529, DOI 10.1016/j.juro.2013.01.092
   Felt-Bersma RJ, 2007, EUR J GASTROEN HEPAT, V19, P575, DOI 10.1097/MEG.0b013e32811ec010
   Fernandez-Fraga X, 2003, DIS COLON RECTUM, V46, P1218, DOI 10.1097/01.DCR.0000084337.15575.26
   Gallas S, 2011, COLORECTAL DIS, V13, P689, DOI 10.1111/j.1463-1318.2010.02260.x
   Gallas S, 2009, INT J COLORECTAL DIS, V24, P969, DOI 10.1007/s00384-009-0693-3
   George AT, 2012, DIS COLON RECTUM, V55, P302, DOI 10.1097/DCR.0b013e3182401ecd
   Gerharz EW, 1997, J AM COLL SURGEONS, V185, P544, DOI 10.1016/S1072-7515(97)00125-7
   Glasgow SC, 2012, DIS COLON RECTUM, V55, P482, DOI 10.1097/DCR.0b013e3182468c22
   Goetz Laura H, 2005, Clin Colon Rectal Surg, V18, P22, DOI 10.1055/s-2005-864072
   Gourcerol G, 2011, COLORECTAL DIS, V13, pE203, DOI 10.1111/j.1463-1318.2011.02623.x
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Gregorcyk Sharon G, 2005, Clin Colon Rectal Surg, V18, P32, DOI 10.1055/s-2005-864078
   Griffin KM, 2011, BRIT J SURG, V98, P1160, DOI 10.1002/bjs.7536
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   HALLGREN T, 1994, DIGEST DIS SCI, V39, P2612, DOI 10.1007/BF02087698
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Hassan MZM, 2010, WORLD J SURG, V34, P1641, DOI 10.1007/s00268-010-0489-1
   Hayden Dana M, 2011, Clin Colon Rectal Surg, V24, P64, DOI 10.1055/s-0031-1272825
   Herndon CDA, 2004, J UROLOGY, V172, P1689, DOI 10.1097/01.ju.0000138528.55602.20
   Heymen S, 2009, DIS COLON RECTUM, V52, P1730, DOI 10.1007/DCR.0b013e3181b55455
   Hoekstra LT, 2011, J PEDIATR SURG, V46, P1603, DOI 10.1016/j.jpedsurg.2011.04.050
   Hollingshead JRF, 2011, COLORECTAL DIS, V13, P1030, DOI 10.1111/j.1463-1318.2010.02383.x
   Hull T, 2013, DIS COLON RECTUM, V56, P234, DOI 10.1097/DCR.0b013e318276b24c
   Hull Tracy, 2007, Clin Colon Rectal Surg, V20, P118, DOI 10.1055/s-2007-977490
   Iachetta R. P., 2012, J INTERV GASTROENTER, V2, p[189, 17]
   Indinnimeo M, 2010, DIS COLON RECTUM, V53, P1661, DOI 10.1007/DCR.0b013e3181f46309
   Jadav AM, 2013, COLORECTAL DIS, V15, P848, DOI 10.1111/codi.12181
   Jodorkovsky D, 2013, J CLIN GASTROENTEROL, V47, P252, DOI 10.1097/MCG.0b013e318266f43a
   Johnson E, 2010, ACTA OBSTET GYN SCAN, V89, P1466, DOI 10.3109/00016349.2010.519019
   Kang HW, 2012, J NEUROGASTROENTEROL, V18, P86, DOI 10.5056/jnm.2012.18.1.86
   Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020
   Karpman E, 2002, J ENDOUROL, V16, P325, DOI 10.1089/089277902760261310
   KECK JO, 1994, DIS COLON RECTUM, V37, P1271, DOI 10.1007/BF02257795
   KELVIN FM, 1994, OBSTET GYNECOL, V83, P307
   Kim DW, 2009, AM J SURG, V197, P14, DOI 10.1016/j.amjsurg.2007.11.023
   KUMAR D, 1995, BRIT J SURG, V82, P1645, DOI 10.1002/bjs.1800821219
   La Torre F, 2013, COLORECTAL DIS, V15, P569, DOI 10.1111/codi.12155
   Lamberts MP, 2013, SURG ENDOSC, V27, P709, DOI 10.1007/s00464-012-2516-9
   Lefebure B, 2008, INT J COLORECTAL DIS, V23, P993, DOI 10.1007/s00384-008-0514-0
   Lefevre JH, 2006, BRIT J SURG, V93, P1265, DOI 10.1002/bjs.5383
   Lehto K, 2013, INT J COLORECTAL DIS, V28, P653, DOI 10.1007/s00384-013-1663-3
   Lehur PA, 2002, DIS COLON RECTUM, V45, P508, DOI 10.1007/s10350-004-6230-0
   Lehur PA, 2000, DIS COLON RECTUM, V43, P1100, DOI 10.1007/BF02236557
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   Leroi AM, 2011, ANN SURG, V253, P720, DOI 10.1097/SLA.0b013e318210f1f4
   Lim JT, 2011, DIS COLON RECTUM, V54, P969, DOI 10.1097/DCR.0b013e31821e57c2
   Madoff RD, 1999, GASTROENTEROLOGY, V116, P549, DOI 10.1016/S0016-5085(99)70176-9
   Maeda Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub3
   Maeda Y, 2011, DIS COLON RECTUM, V54, P1443, DOI 10.1097/DCR.0b013e318227f65d
   Maglinte DDT, 1999, AM J ROENTGENOL, V172, P439, DOI 10.2214/ajr.172.2.9930799
   Maglinte DDT, 2013, ABDOM IMAGING, V38, P952, DOI 10.1007/s00261-012-9870-x
   MALONE PS, 1990, LANCET, V336, P1217, DOI 10.1016/0140-6736(90)92834-5
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   Markland AD, 2011, INT UROGYNECOL J, V22, P1151, DOI 10.1007/s00192-011-1444-x
   Maslekar S, 2007, J AM COLL SURGEONS, V204, P40, DOI 10.1016/j.jamcollsurg.2006.10.008
   Matsuoka H, 2000, DIS COLON RECTUM, V43, P1561, DOI 10.1007/BF02236739
   Mattix KD, 2007, PEDIATR SURG INT, V23, P1175, DOI 10.1007/s00383-007-2026-3
   Matzel KE, 2001, DIS COLON RECTUM, V44, P1427, DOI 10.1007/BF02234593
   Melenhorst J, 2008, INT J COLORECTAL DIS, V23, P107, DOI 10.1007/s00384-007-0357-0
   Mellgren A, 2011, DIS COLON RECTUM, V54, P1065, DOI 10.1097/DCR.0b013e31822155e9
   Mevik K, 2009, SCAND J SURG, V98, P234, DOI 10.1177/145749690909800408
   Michot F, 2003, ANN SURG, V237, P52, DOI 10.1097/00000658-200301000-00008
   Mundy L, 2004, BRIT J SURG, V91, P665, DOI 10.1002/bjs.4587
   Naimy N, 2007, DIS COLON RECTUM, V50, P2040, DOI 10.1007/s10350-007-9075-5
   Nanigian DK, 2008, J UROLOGY, V179, P299, DOI 10.1016/j.juro.2007.08.161
   Nelson RL, 2004, GASTROENTEROLOGY, V126, pS3, DOI 10.1053/j.gastro.2003.10.010
   Norderval S, 2013, TECH COLOPROCTOL, V17, P511, DOI 10.1007/s10151-013-0999-6
   Norton C, 2005, DIS COLON RECTUM, V48, P1062, DOI 10.1007/s10350-004-0868-5
   Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1053/S0016-5085(03)01368-4
   Norton C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002111.pub3
   O'Brien PE, 2004, DIS COLON RECTUM, V47, P1852, DOI 10.1007/s10350-004-0717-6
   Oberwalder M, 2006, Tech Coloproctol, V10, P94, DOI 10.1007/s10151-006-0259-0
   Ok JH, 2011, J PEDIATR UROL, V7, P389, DOI 10.1016/j.jpurol.2011.02.012
   Oliveira L, 1996, BRIT J SURG, V83, P502, DOI 10.1002/bjs.1800830421
   Oliveira LCC, 2009, SURG INNOV, V16, P155, DOI 10.1177/1553350609338374
   Omar M.I., 2013, COCHRANE DATE BASE S, P11, DOI DOI 10.1002/14651858.CD002116.PUB2]
   Oom DMJ, 2010, DIS COLON RECTUM, V53, P150, DOI 10.1007/DCR.0b013e3181bb059f
   Oom DMJ, 2009, DIS COLON RECTUM, V52, P1681, DOI 10.1007/DCR.0b013e3181b13862
   ORROM WJ, 1991, DIS COLON RECTUM, V34, P305, DOI 10.1007/BF02050589
   Ortiz H, 2003, INT J COLORECTAL DIS, V18, P349, DOI 10.1007/s00384-002-0472-x
   Otto SD, 2010, J GASTROINTEST SURG, V14, P636, DOI 10.1007/s11605-009-1122-1
   Ozturk R, 2004, ALIMENT PHARM THERAP, V20, P667, DOI 10.1111/j.1365-2036.2004.02125.x
   Parisien Christine J, 2005, Clin Colon Rectal Surg, V18, P42, DOI 10.1055/s-2005-864080
   Parker SC, 2003, DIS COLON RECTUM, V46, P722, DOI 10.1097/01.DCR.0000070530.79998.86
   Patton V, 2013, BRIT J SURG, V100, P959, DOI 10.1002/bjs.9114
   Poirier M, 2007, DIS COLON RECTUM, V50, P22, DOI 10.1007/s10350-006-0732-x
   Ratto C, 2012, COLORECTAL DIS, V14, pE297, DOI 10.1111/j.1463-1318.2012.03003.x
   Ratto C, 2010, DIS COLON RECTUM, V53, P264, DOI 10.1007/DCR.0b013e3181c7642c
   Rongen MJGM, 2003, DIS COLON RECTUM, V46, P716, DOI 10.1097/01.DCR.0000070035.45378.BD
   ROSEN HR, 2002, COLORECTAL DIS, V4, P266, DOI DOI 10.1046/J.1463-1318.2002.00331.X]
   Carmona MDR, 2009, COLORECTAL DIS, V11, P831, DOI 10.1111/j.1463-1318.2008.01652.x
   Ruiz D, 2010, DIS COLON RECTUM, V53, P1041, DOI 10.1007/DCR.0b013e3181defff8
   Schwandner O, 2011, SURG INNOV, V18, P130, DOI 10.1177/1553350610392243
   Schwandner T, 2010, DIS COLON RECTUM, V53, P1007, DOI 10.1007/DCR.0b013e3181db7738
   Soerensen MM, 2008, DIS COLON RECTUM, V51, P312, DOI 10.1007/s10350-007-9084-4
   Solomon MJ, 2003, DIS COLON RECTUM, V46, P703, DOI 10.1097/01.DCR.0000070034.58255.06
   Soylet Y, 2006, EUR J PEDIATR SURG, V16, P251, DOI 10.1055/s-2006-924337
   Tackett LD, 2002, J UROLOGY, V167, P683, DOI 10.1016/S0022-5347(01)69125-0
   Takahashi-Monroy T, 2008, DIS COLON RECTUM, V51, P355, DOI 10.1007/s10350-007-9169-0
   Tan EK, 2008, COLORECTAL DIS, V10, P653, DOI 10.1111/j.1463-1318.2008.01507.x
   Tan EK, 2008, COLORECTAL DIS, V10, P577, DOI 10.1111/j.1463-1318.2007.01418.x
   Tan E, 2011, INT J COLORECTAL DIS, V26, P275, DOI 10.1007/s00384-010-1119-y
   Teichman JMH, 1998, J UROLOGY, V160, P1278, DOI 10.1016/S0022-5347(01)62515-1
   Teichman JMH, 2003, UROLOGY, V61, P502, DOI 10.1016/S0090-4295(02)02282-3
   Terra MP, 2008, INT J COLORECTAL DIS, V23, P503, DOI 10.1007/s00384-008-0438-8
   Terra MP, 2006, DIS COLON RECTUM, V49, P1149, DOI 10.1007/s10350-006-0569-3
   Thornton M J, 2004, Colorectal Dis, V6, P470, DOI 10.1111/j.1463-1318.2004.00714.x
   Tiryaki S, 2010, EUR J PEDIATR SURG, V20, P405, DOI 10.1055/s-0030-1265156
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Townsend MK, 2013, AM J GASTROENTEROL, V108, P113, DOI 10.1038/ajg.2012.364
   Vallet C, 2010, COLORECTAL DIS, V12, P247, DOI 10.1111/j.1463-1318.2009.01899.x
   Van Savage JG, 2000, J UROLOGY, V164, P1084, DOI 10.1016/S0022-5347(05)67257-6
   Watson NFS, 2012, COLORECTAL DIS, V14, P29, DOI 10.1111/codi.12047
   Wexner SD, 2002, DIS COLON RECTUM, V45, P809, DOI 10.1097/01.DCR.0000017604.54619.64
   Wexner SD, 2010, J GASTROINTEST SURG, V14, P1081, DOI 10.1007/s11605-010-1177-z
   Wexner SD, 2010, ANN SURG, V251, P441, DOI 10.1097/SLA.0b013e3181cf8ed0
   Wexner SD, 2009, DIS COLON RECTUM, V52, P1550, DOI 10.1007/DCR.0b013e3181af62f8
   Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054
   Wong MTC, 2011, ANN SURG, V254, P951, DOI 10.1097/SLA.0b013e31823ac2bc
   Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3
   Yerkes EB, 2003, J UROLOGY, V169, P320, DOI 10.1097/01.ju.0000041721.26576.92
   Zutshi M, 2009, DIS COLON RECTUM, V52, P1089, DOI 10.1007/DCR.0b013e3181a0a79c
NR 161
TC 25
Z9 27
U1 0
U2 7
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD DEC 28
PY 2013
VL 19
IS 48
BP 9216
EP 9230
DI 10.3748/wjg.v19.i48.9216
PG 15
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 281VS
UT WOS:000329129700009
PM 24409050
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Alexander, A
   Ajazuddin
   Khan, J
   Saraf, S
   Saraf, S
AF Alexander, Amit
   Ajazuddin
   Khan, Junaid
   Saraf, Swarnlata
   Saraf, Shailendra
TI Poly(ethylene glycol)-poly(lactic-co-glycolic acid) based
   thermosensitive injectable hydrogels for biomedical applications
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE Hydrogel; In Situ; Parenteral; Thermoresponsive; Thermoreversible;
   Polyethylene glycol
ID BIODEGRADABLE TRIBLOCK COPOLYMER; EXTENDED-RELEASE NALTREXONE;
   DRUG-DELIVERY SYSTEMS; TRI-BLOCK COPOLYMERS; PLURONIC F-127 GELS; BEE
   VENOM PEPTIDE; IN-SITU GEL; AQUEOUS-SOLUTIONS; SUSTAINED-RELEASE;
   LIGHT-SCATTERING
AB Stimuli triggered polymers provide a variety of applications related with the biomedical fields. Among various stimuli triggered mechanisms, thermoresponsive mechanisms have been extensively investigated, as they are relatively more convenient and effective stimuli for biomedical applications. In a contemporary approach for achieving the sustained action of proteins, peptides and bioactives, injectable depots and implants have always remained the thrust areas of research. In the same series, Poloxamer based thermogelling copolymers have their own limitations regarding biodegradability. Thus, there is a need to have an alternative biomaterial for the formulation of injectable hydrogel, which must remain biocompatible along with safety and efficacy. In the same context, poly(ethylene glycol) (PEG) based copolymers play a crucial role as a biomedical material for biomedical applications, because of their biocompatibility, biodegradability, thermosensitivity and easy controlled characters. This review stresses on the physicochemical property, stability and composition prospects of smart PEG/poly(lactic-co-glycolic acid) (PLGA) based thermoresponsive injectable hydrogels, recently utilized for biomedical applications. The manuscript also highlights the synthesis scheme and stability characteristics of these copolymers, which will surely help the researchers working in the same area. We have also emphasized the applied use of these smart copolymers along with their formulation problems, which could help in understanding the possible modifications related with these, to overcome their inherent associated limitations. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Alexander, Amit; Khan, Junaid; Saraf, Swarnlata; Saraf, Shailendra] Pt Ravishankar Shukla Univ, Univ Inst Pharm, Raipur 492010, CG, India.
   [Ajazuddin] Rungta Coll Pharmaceut Sci & Res, Bhilai 490023, CG, India.
RP Saraf, S (reprint author), Pt Ravishankar Shukla Univ, Univ Inst Pharm, Raipur 492010, CG, India.
EM itsmeamitalex@gmail.com; write2ajaz@gmail.com; junaid1010@gmail.com;
   swarnlata_saraf@rediffmail.com; drshailendrasaraf@gmail.com
OI Alexander, Amit/0000-0003-0391-7650; Saraf,
   Shailendra/0000-0002-8384-9370
FU Department of Science and Technology, New Delhi (SERC Division), India
   [SR/FST/LSI-434/2010]; UGC-SAP, New Delhi, India [3-54/2011]; Maulana
   Azad National Fellowship (MANF) UGC, New Delhi, India
FX The authors acknowledge the Department of Science and Technology (No.
   SR/FST/LSI-434/2010), New Delhi (SERC Division), India and UGC-SAP F.
   No. 3-54/2011 (SAP II) dated March 2011, New Delhi, India for providing
   financial assistance under DST-FIST scheme as well as the Maulana Azad
   National Fellowship (MANF) UGC, New Delhi, India for providing financial
   assistance.
CR Ajazuddin, 2012, EXPERT OPIN DRUG DEL, V9, P1573
   Ajazuddin A., 2013, DRUG DEV IND PHARM, V39, P1053
   Alexander A, 2012, J CONTROL RELEASE, V164, P26, DOI 10.1016/j.jconrel.2012.09.017
   ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037
   [Anonymous], 1996, TREAT REV, P10
   AOSHIMA S, 1992, J POLYM SCI POL CHEM, V30, P2407, DOI 10.1002/pola.1992.080301115
   ATTWOOD D, 1985, INT J PHARM, V26, P25, DOI 10.1016/0378-5173(85)90197-8
   Badi N, 2009, J CONTROL RELEASE, V140, P224, DOI 10.1016/j.jconrel.2009.04.012
   Barichello JM, 1999, INT J PHARM, V184, P189, DOI 10.1016/S0378-5173(99)00119-2
   Baroli B, 2010, NATO SCI PEACE SEC A, P347, DOI 10.1007/978-90-481-8790-4_17
   Behra A, 2012, INT J PHARMACOL, V8, P283, DOI 10.3923/ijp.2012.283.305
   Bentley MVLB, 1999, INT J PHARM, V193, P49, DOI 10.1016/S0378-5173(99)00313-0
   Bromberg L, 1998, J PHYS CHEM B, V102, P1956, DOI 10.1021/jp9803687
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   BROWN W, 1991, J PHYS CHEM-US, V95, P1850, DOI 10.1021/j100157a064
   Burgess DJ, 2012, ADV DEL SCI TECHNOL, P1, DOI 10.1007/978-1-4614-0554-2_1
   Burman P, 2010, GROWTH HORM IGF RES, V20, P438, DOI 10.1016/j.ghir.2010.10.004
   Campochiaro PA, 2013, OPHTHALMOLOGY, V120, P583, DOI 10.1016/j.ophtha.2012.09.014
   Caraballo I, 1999, INT J PHARM, V181, P23, DOI 10.1016/S0378-5173(98)00415-3
   Cazares-Delgadill J, 2011, EUR J PHARM BIOPHARM, V78, P278, DOI 10.1016/j.ejpb.2011.01.006
   Chamradova I, 2012, CHEM PAP, V66, P977, DOI 10.2478/s11696-012-0210-y
   Chan A, 2013, ADV DRUG DELIVER REV, V65, P497, DOI 10.1016/j.addr.2012.07.007
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   Chen SB, 2005, INT J PHARM, V295, P183, DOI 10.1016/j.ijpharm.2005.02.023
   Chen S, 2008, INT J PHARM, V352, P58, DOI 10.1016/j.ijpharm.2007.10.016
   Choi S, 2003, PHARM RES, V20, P2008, DOI 10.1023/B:PHAM.0000008050.99985.5c
   Darney P, 2009, FERTIL STERIL, V91, P1646, DOI 10.1016/j.fertnstert.2008.02.140
   Dreicer R, 2011, UROLOGY, V78, pS494, DOI 10.1016/j.urology.2011.06.058
   Edsman K, 1998, EUR J PHARM SCI, V6, P105, DOI 10.1016/S0928-0987(97)00075-4
   ENG J, 1992, J BIOL CHEM, V267, P7402
   FEIL H, 1993, MACROMOLECULES, V26, P2496, DOI 10.1021/ma00062a016
   Finigan MW, 2011, J SUBST ABUSE TREAT, V41, P288, DOI 10.1016/j.jsat.2011.04.003
   Food and Drug Administration, 1995, J INT ASS PHYS AIDS, V1, P37
   Friedlander TW, 2012, UROL ONCOL-SEMIN ORI, V30, P408, DOI 10.1016/j.urolonc.2010.06.014
   Gajendiran M, 2013, COLLOID SURFACE B, V104, P107, DOI 10.1016/j.colsurfb.2012.12.008
   Gao YA, 2010, DRUG DEV IND PHARM, V36, P1131, DOI 10.3109/03639041003680826
   Gao Y, 2011, J DRUG TARGET, V19, P516, DOI 10.3109/1061186X.2010.519031
   GECKELER K, 1980, POLYM BULL, V3, P347
   Ghahremankhani AA, 2007, POLYM BULL, V59, P637, DOI 10.1007/s00289-007-0807-4
   Ghandehari H, 2008, ADV DRUG DELIVER REV, V60, P956, DOI 10.1016/j.addr.2008.04.001
   Ghandehari H, 2010, ADV DRUG DELIVER REV, V62, P1403, DOI 10.1016/j.addr.2010.07.007
   Giri TK, 2013, SAUDI PHARM J, V21, P125, DOI 10.1016/j.jsps.2012.05.009
   Gong CY, 2009, ACTA BIOMATER, V5, P3358, DOI 10.1016/j.actbio.2009.05.025
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Gustafson JA, 2010, ADV DRUG DELIVER REV, V62, P1509, DOI 10.1016/j.addr.2010.04.006
   Hammell DC, 2004, J CONTROL RELEASE, V97, P283, DOI 10.1016/j.jconrel.2004.03.020
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Heijckmann CA, 2001, NETH J MED, V59, P286, DOI 10.1016/S0300-2977(01)00171-1
   Hennink WE, 2012, ADV DRUG DELIVER REV, V64, P223, DOI 10.1016/j.addr.2012.09.009
   Herrlich S, 2012, ADV DRUG DELIVER REV, V64, P1617, DOI 10.1016/j.addr.2012.02.003
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   HORNE RA, 1971, J COLLOID INTERF SCI, V35, P77
   HUATAN H, 1995, BIOMATERIALS, V16, P1297, DOI 10.1016/0142-9612(95)91044-Y
   Iyer SS, 2007, INT J PHARM, V340, P104, DOI 10.1016/j.ijpharm.2007.03.032
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2012, ADV DRUG DELIVER REV, V64, P154, DOI 10.1016/j.addr.2012.09.012
   JOHNSTON TP, 1993, BIOCHEM PHARMACOL, V46, P1037, DOI 10.1016/0006-2952(93)90668-M
   Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9
   Jorgensen EB, 1997, MACROMOLECULES, V30, P2355, DOI 10.1021/ma9616322
   Kempe S, 2012, J CONTROL RELEASE, V161, P668, DOI 10.1016/j.jconrel.2012.04.016
   Khan J, 2013, J CONTROL RELEASE, V168, P50, DOI 10.1016/j.jconrel.2013.02.025
   Khodaverdi E, 2012, POLYM BULL, V69, P429, DOI 10.1007/s00289-012-0747-5
   Kim SJ, 2003, SENSOR ACTUAT B-CHEM, V88, P286, DOI 10.1016/S0925-4005(02)00371-4
   Kim YJ, 2001, PHARMACEUT RES, V18, P548, DOI 10.1023/A:1011074915438
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Kwon G. S., 2003, CRIT REV THER DRUG C, V20
   Kwon YM, 2003, MACROMOL SYMP, V201, P179, DOI 10.1002/masy.200351121
   Lapham S, 2009, J SUBST ABUSE TREAT, V36, P1, DOI 10.1016/j.jsat.2008.07.001
   Lee DS, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P123, DOI 10.1007/978-1-4419-5919-5_7
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Liu HY, 1999, POLYMER, V40, P6985, DOI 10.1016/S0032-3861(98)00858-1
   Liu ZS, 2000, ADV MATER, V12, P288, DOI 10.1002/(SICI)1521-4095(200002)12:4<288::AID-ADMA288>3.0.CO;2-1
   Lukyanov AN, 2004, J BIOMAT SCI-POLYM E, V15, P621, DOI 10.1163/156856204323046889
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   McGregor C, 2002, DRUG ALCOHOL DEPEN, V68, P5, DOI 10.1016/S0376-8716(02)00077-7
   Merki-Feld GS, 2011, FERTIL STERIL, V95, P23, DOI 10.1016/j.fertnstert.2010.05.018
   Mikheeva LM, 1997, MACROMOLECULES, V30, P2693, DOI 10.1021/ma9615112
   Mitchell Helen, 2004, Eur J Oncol Nurs, V8 Suppl 2, pS95, DOI 10.1016/j.ejon.2004.09.004
   MIYAZAKI S, 1992, CHEM PHARM BULL, V40, P2224
   Nehra V., 2000, GASTROENTEROLOGY, V118
   Nicholson BP, 2012, AM J OPHTHALMOL, V154, P969, DOI 10.1016/j.ajo.2012.06.004
   Oh KT, 2009, INT J PHARMACEUT, V375, P163, DOI 10.1016/j.ijpharm.2009.04.005
   Okada H, 1997, ADV DRUG DELIVER REV, V28, P43, DOI 10.1016/S0169-409X(97)00050-1
   Overstreet DJ, 2012, J POLYM SCI POL PHYS, V50, P881, DOI 10.1002/polb.23081
   Paavola A, 1998, J CONTROL RELEASE, V52, P169, DOI 10.1016/S0168-3659(97)00206-X
   Paavola A, 1998, PHARMACEUT RES, V15, P482, DOI 10.1023/A:1011992702604
   Peppas N. A., 2013, BIOMATERIALS SCI, P166
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P203, DOI 10.1016/0168-3659(91)90044-E
   Porte R.J.L., 1997, HYDROPHILIC POLYM CO, P186
   Preston KL, 1999, DRUG ALCOHOL DEPEN, V54, P127, DOI 10.1016/S0376-8716(98)00152-5
   Qiao MX, 2007, INT J PHARM, V345, P116, DOI 10.1016/j.ijpharm.2007.05.056
   Qiao MX, 2006, PHARMAZIE, V61, P199
   Qiao MX, 2005, INT J PHARM, V294, P103, DOI 10.1016/j.ijpharm.2005.01.017
   Qiu Y, 2012, ADV DRUG DELIVER REV, V64, P49, DOI 10.1016/j.addr.2012.09.024
   Quiroz JA, 2010, BIOL PSYCHIAT, V68, P156, DOI 10.1016/j.biopsych.2010.01.015
   RASSING J, 1982, INT J PHARM, V13, P47, DOI 10.1016/0378-5173(82)90141-7
   Roberson DW, 2013, J ASSOC NURSE AIDS C, V24, pS135, DOI 10.1016/j.jana.2012.08.010
   ROSKOS KV, 1995, BIOMATERIALS, V16, P313, DOI 10.1016/0142-9612(95)93259-G
   Roy R, 2013, CAN J OPHTHALMOL, V48, pE15, DOI 10.1016/j.jcjo.2012.03.033
   Sadekar S, 2012, ADV DRUG DELIVER REV, V64, P571, DOI 10.1016/j.addr.2011.09.010
   Sadzuka Y, 2006, INT J PHARM, V312, P83, DOI 10.1016/j.ijpharm.2005.12.043
   Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943
   Sandvig K, 2000, INT J MED MICROBIOL, V290, P415
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   SCHMOLKA IR, 1972, J BIOMED MATER RES, V6, P571, DOI 10.1002/jbm.820060609
   Seow WY, 2007, BIOMATERIALS, V28, P1730, DOI 10.1016/j.biomaterials.2006.11.039
   series W.T.R., 2000, WTR SER
   SHIVELY ML, 1995, J CONTROL RELEASE, V33, P237, DOI 10.1016/0168-3659(94)00097-E
   Silverman L., 2012, J PEDIAT NURS, V27, pe9
   Smith K, 2008, CLIN THER, V30, P2051, DOI 10.1016/j.clinthera.2008.11.008
   Soga O, 2004, BIOMACROMOLECULES, V5, P818, DOI 10.1021/bm049955q
   Song SC, 1999, MACROMOLECULES, V32, P2188, DOI 10.1021/ma981190p
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Suwa K, 1997, J POLYM SCI POL CHEM, V35, P1763
   Tang Y, 2011, STUD MECHANOBIOL TIS, V8, P457, DOI 10.1007/8415_2011_65
   TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113
   Thiagarajan G., EUROPEAN J PHARM BIO
   Thornton P., 2012, J PEDIAT NURS, V27, pe8
   Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0
   Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011
   Torchilin VP, 2007, PHARM RES, V24, P2333, DOI 10.1007/s11095-007-9463-5
   Torchilin VP, 2006, ADV DRUG DELIVER REV, V58, P1532, DOI 10.1016/j.addr.2006.09.009
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Torchilin VP, 2002, ADV DRUG DELIVER REV, V54, P235, DOI 10.1016/S0169-409X(02)00019-4
   Ur-Rehman T, 2011, INT J PHARMACEUT, V409, P19, DOI 10.1016/j.ijpharm.2011.02.017
   Veyries ML, 1999, INT J PHARM, V192, P183, DOI 10.1016/S0378-5173(99)00307-5
   Vyas SP, 2006, DRUG DEV IND PHARM, V32, P699, DOI 10.1080/03639040500528954
   Wang YY, 2010, POLYM DEGRAD STABIL, V95, P207, DOI 10.1016/j.polymdegradstab.2009.11.023
   Wei XW, 2009, INT J PHARMACEUT, V381, P1, DOI 10.1016/j.ijpharm.2009.07.033
   Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/S1522851702000236
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wout Z., 1992, J PARENTER SCI TECHN, V46, P192
   Wright JC, 2012, ADV DEL SCI TECHNOL, P153, DOI 10.1007/978-1-4614-0554-2_9
   Xue YN, 2009, POLYMER, V50, P3706, DOI 10.1016/j.polymer.2009.05.033
   Ye ML, 2010, J CONTROL RELEASE, V146, P241, DOI 10.1016/j.jconrel.2010.05.011
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2010, COLLOID POLYM SCI, V288, P1151, DOI 10.1007/s00396-010-2246-2
   Zalewska-Kaszubska J, 2006, PHARMACOL BIOCHEM BE, V85, P155, DOI 10.1016/j.pbb.2006.07.028
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang Y, 2005, J PHARM SCI-US, V94, P1676, DOI 10.1002/jps.20310
   Zhang Y, 2005, J CONTROL RELEASE, V105, P260, DOI 10.1016/j.jconrel.2005.04.001
   Zhang ZP, 2012, ADV DRUG DELIVER REV, V64, P1129, DOI 10.1016/j.addr.2012.04.008
   Zhi-kui C., 2008, J CLIN REHABIL TISSU, V12, P9792
   Zhu L, 2013, INTEGR BIOL-UK, V5, P96, DOI 10.1039/c2ib20135f
NR 156
TC 68
Z9 74
U1 17
U2 312
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD DEC 28
PY 2013
VL 172
IS 3
BP 715
EP 729
DI 10.1016/j.jconrel.2013.10.006
PG 15
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 272WH
UT WOS:000328492800014
PM 24144918
DA 2018-10-20
ER

PT J
AU Liu, YT
   Kung, KC
   Lee, TM
   Lui, TS
AF Liu, Yen-Ting
   Kung, Kuan-Chen
   Lee, Tzer-Min
   Lui, Truan-Sheng
TI Enhancing biological properties of porous coatings through the
   incorporation of manganese
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Manganese; Micro-arc oxidation (MAO); Porous; Osteoblastic cell;
   Biological properties
ID CALCIUM-PHOSPHATE COATINGS; MICRO-ARC OXIDATION; BIOMEDICAL
   APPLICATIONS; HYDROXYAPATITE COATINGS; TITANIUM; BIOACTIVITY; BONE;
   ALLOYS; MICROSTRUCTURES; ELECTROLYTES
AB Titanium (Ti) and titanium alloys are bio-inert materials ideally suited to the fabrication of dental and orthopedic implants. A number of surface modifications have been proposed to enhance the bioactivity of the titanium surface. Micro-arc oxidation (MAO) has proven to be a simple, controllable, and cost-effective process for the fabrication of porous oxide coatings. In a previous study, a porous 3D structure comprising calcium and phosphate improved the biocompatibility of titanium. Nonetheless, the biological behavior of coatings, such as differentiation, is important for successful osseointegration. Because manganese has been shown to have advantageous effects on osteoblastic cell differentiation and bone metabolism, this study investigated whether manganese-containing MAO coatings could improve the biological performances of titanium implants. EDX, ICP-OES, and XPS analysis demonstrated that manganese was successfully incorporated within the MAO coatings. TF-XRD results showed that the phases of the coatings were anatase, rutile, and titanium. SEM results demonstrated that the addition of manganese produced coatings with continuous uniformity while preserving the topography. Additionally, manganese-containing coatings induced higher bone-related gene expression than that afforded by standard MAO coatings in a culture of osteoblastic cells. This indicates that manganese could improve cell-mediated mineralization. Our findings suggest that incorporating manganese within MAO coatings leads to the formation of a porous 3D topography which is capable of improving osteoblastic cell differentiation. Thus, the proposed Mn-MAO coating shows considerable promise as a biomaterial for implants with enhanced biological properties. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Liu, Yen-Ting; Kung, Kuan-Chen; Lui, Truan-Sheng] Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 701, Taiwan.
   [Lee, Tzer-Min] Natl Cheng Kung Univ, Inst Oral Med, Tainan 701, Taiwan.
   [Lee, Tzer-Min] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan.
RP Lee, TM (reprint author), Natl Cheng Kung Univ, Inst Oral Med, 1 Univ Rd, Tainan 701, Taiwan.
EM tmlee@mail.ncku.edu.tw
RI Lee, Tzer-Min/G-3713-2011
FU National Science Council of Taiwan [101-2221-E-006-061-MY3]
FX The work was financially supported by the National Science Council of
   Taiwan under Grant 101-2221-E-006-061-MY3.
CR Aaseth J, 2012, J TRACE ELEM MED BIO, V26, P149, DOI 10.1016/j.jtemb.2012.03.017
   Bae YJ, 2008, BIOL TRACE ELEM RES, V124, P28, DOI 10.1007/s12011-008-8119-6
   Bellof G, 2007, J ANIM PHYSIOL AN N, V91, P100, DOI 10.1111/j.1439-0396.2006.00648.x
   Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057
   Bracci B, 2009, J INORG BIOCHEM, V103, P1666, DOI 10.1016/j.jinorgbio.2009.09.009
   Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975
   Chesnick IE, 2011, BONE, V48, P1194, DOI 10.1016/j.bone.2011.02.014
   Chien CS, 2011, SURF COAT TECH, V205, P3141, DOI 10.1016/j.surfcoat.2010.11.028
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Han Y, 2008, ACTA BIOMATER, V4, P1518, DOI 10.1016/j.actbio.2008.03.005
   Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031
   Hu HJ, 2010, SURF COAT TECH, V204, P3265, DOI 10.1016/j.surfcoat.2010.03.028
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   Kung KC, 2012, J ALLOY COMPD, V515, P68, DOI 10.1016/j.jallcom.2011.11.050
   Kung KC, 2010, SURF COAT TECH, V205, P1714, DOI 10.1016/j.surfcoat.2010.05.018
   Kung KC, 2010, J ALLOY COMPD, V508, P384, DOI 10.1016/j.jallcom.2010.08.057
   Li GD, 2011, J MATER SCI-MATER M, V22, P2197, DOI 10.1007/s10856-011-4417-1
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lohmann CH, 2002, BIOMATERIALS, V23, P1855, DOI 10.1016/S0142-9612(01)00312-X
   Mu M, 2012, APPL SURF SCI, V258, P8570, DOI 10.1016/j.apsusc.2012.05.051
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   Paluszkiewicz C, 2010, J MOL STRUCT, V976, P301, DOI 10.1016/j.molstruc.2010.04.001
   Schreckenbach JP, 1999, J MATER SCI-MATER M, V10, P453, DOI 10.1023/A:1008988706980
   Sima F, 2007, APPL SURF SCI, V254, P1155, DOI 10.1016/j.apsuse.2007.08.053
   Song HJ, 2009, J MATER PROCESS TECH, V209, P864, DOI 10.1016/j.jmatprotec.2008.02.055
   Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676
   Sul YT, 2006, CLIN ORAL IMPLAN RES, V17, P521, DOI 10.1111/j.1600-0501.2005.01230.X
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Wang J, 2009, ACTA BIOMATER, V5, P1798, DOI 10.1016/j.actbio.2009.01.005
   Wei DQ, 2007, APPL SURF SCI, V253, P5045, DOI 10.1016/j.apsusc.2006.11.012
   Yang CY, 2007, J BIOMED MATER RES B, V82B, P450, DOI 10.1002/jbm.b.30750
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Zhang FM, 2010, J BIOMED MATER RES B, V94B, P406, DOI 10.1002/jbm.b.31668
NR 34
TC 9
Z9 9
U1 5
U2 144
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD DEC 25
PY 2013
VL 581
BP 459
EP 467
DI 10.1016/j.jallcom.2013.07.106
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 223QS
UT WOS:000324823000076
DA 2018-10-20
ER

PT J
AU Kim, YJ
   Wu, W
   Chun, SE
   Whitacre, JF
   Bettinger, CJ
AF Kim, Young Jo
   Wu, Wei
   Chun, Sang-Eun
   Whitacre, Jay F.
   Bettinger, Christopher J.
TI Biologically derived melanin electrodes in aqueous sodium-ion energy
   storage devices
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; organic electronics; biopolymer; battery
ID HIGH-PERFORMANCE; BATTERY APPLICATIONS; ANODE MATERIALS; LOW-COST;
   EUMELANIN; POLYMERS; BINDING; FILMS; SUPERCAPACITORS; SPECTROSCOPY
AB Biodegradable electronics represents an attractive and emerging paradigm in medical devices by harnessing simultaneous advantages afforded by electronically active systems and obviating issues with chronic implants. Integrating practical energy sources that are compatible with the envisioned operation of transient devices is an unmet challenge for biodegradable electronics. Although high-performance energy storage systems offer a feasible solution, toxic materials and electrolytes present regulatory hurdles for use in temporary medical devices. Aqueous sodium-ion charge storage devices combined with biocompatible electrodes are ideal components to power next-generation biodegradable electronics. Here, we report the use of biologically derived organic electrodes composed of melanin pigments for use in energy storage devices. Melanins of natural (derived from Sepia officinalis) and synthetic origin are evaluated as anode materials in aqueous sodium-ion storage devices. Na+-loaded melanin anodes exhibit specific capacities of 30.4 +/- 1.6 mAhg(-1). Full cells composed of natural melanin anodes and lambda-MnO2 cathodes exhibit an initial potential of 1.03 +/- 0.06 V with a maximum specific capacity of 16.1 +/- 0.8 mAhg(-1). Natural melanin anodes exhibit higher specific capacities compared with synthetic melanins due to a combination of beneficial chemical, electrical, and physical properties exhibited by the former. Taken together, these results suggest that melanin pigments may serve as a naturally occurring biologically derived charge storage material to power certain types of medical devices.
C1 [Kim, Young Jo; Wu, Wei; Whitacre, Jay F.; Bettinger, Christopher J.] Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA.
   [Chun, Sang-Eun] Univ Oregon, Dept Chem, Eugene, OR 97403 USA.
   [Whitacre, Jay F.] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.
   [Bettinger, Christopher J.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
RP Whitacre, JF (reprint author), Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA.
EM whitacre@cmu.edu; cbetting@andrew.cmu.edu
RI Bettinger, Christopher/A-3895-2009
FU American Chemical Society [PRF51980DN17]; Carnegie Mellon University
   (CMU) School of Engineering; CMU Center for Technology Transfer and
   Enterprise Creation; Pennsylvania Department of Community and Economic
   Development; Innovation Works (Pittsburgh, PA); Shurl and Kay Curci
   Foundation; Department of Energy [DE-OE0000226]; National Science
   Foundation [CHE-0130903, CHE-1039870]
FX The authors thank Vince Bojan of the Materials Characterization Lab at
   Pennsylvania State University for assistance in acquiring XPS data. The
   authors are grateful to Kyu Hun Kim and Youngseok Oh for valuable
   discussions. The authors acknowledge the financial support provided by
   the following organizations: American Chemical Society (PRF51980DN17);
   the Carnegie Mellon University (CMU) School of Engineering; the CMU
   Center for Technology Transfer and Enterprise Creation; the Pennsylvania
   Department of Community and Economic Development; Innovation Works
   (Pittsburgh, PA); the Shurl and Kay Curci Foundation; and the Department
   of Energy (DE-OE0000226). The authors also thank the CMU
   Thermomechanical Characterization Facility. NMR instrumentation at CMU
   was partially supported by National Science Foundation (CHE-0130903 and
   CHE-1039870).
CR Ajayi FF, 2012, BIORESOURCE TECHNOL, V116, P86, DOI 10.1016/j.biortech.2012.04.019
   Armand M, 2009, NAT MATER, V8, P120, DOI [10.1038/NMAT2372, 10.1038/nmat2372]
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   Belitsky JM, 2012, BIOORG MED CHEM LETT, V22, P5503, DOI 10.1016/j.bmcl.2012.07.027
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Bettinger CJ, 2009, BIOMATERIALS, V30, P3050, DOI 10.1016/j.biomaterials.2009.02.018
   Capozzi V, 2005, J MOL STRUCT, V744, P717, DOI 10.1016/j.molstruc.2004.11.074
   Centeno SA, 2008, J MOL STRUCT, V873, P149, DOI 10.1016/j.molstruc.2007.03.026
   Chen CT, 2013, ACS NANO, V7, P1524, DOI 10.1021/nn305305d
   Chen H, 2008, CHEMSUSCHEM, V1, P348, DOI 10.1002/cssc.200700161
   Chen HY, 2009, J AM CHEM SOC, V131, P8984, DOI 10.1021/ja9024897
   Chen Z, 2012, ACS NANO, V6, P4319, DOI 10.1021/nn300920e
   Cheng FY, 2011, ADV MATER, V23, P1695, DOI 10.1002/adma.201003587
   Chun SE, 2011, J ELECTROCHEM SOC, V158, pA83, DOI 10.1149/1.3518416
   Collins J, 2013, CARBON, V57, P174, DOI 10.1016/j.carbon.2013.01.061
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2
   Gaikwad AM, 2012, ADV MATER, V24, P5071, DOI 10.1002/adma.201201329
   Gaikwad AM, 2011, ADV MATER, V23, P3251, DOI 10.1002/adma.201100894
   Glowacki ED, 2013, J MATER CHEM B, V1, P3742, DOI 10.1039/c3tb20193g
   Holten-Andersen N, 2011, P NATL ACAD SCI USA, V108, P2651, DOI 10.1073/pnas.1015862108
   Hong L, 2004, PHOTOCHEM PHOTOBIOL, V80, P477, DOI 10.1562/0031-8655(2004)080<0477:BOMITM>2.0.CO;2
   Hong L, 2007, J PHYS CHEM B, V111, P7938, DOI 10.1021/jp071439h
   Hong L, 2006, PHOTOCHEM PHOTOBIOL, V82, P1265, DOI 10.1562/2006-02-23-RA-809
   Hu B, 2010, ADV MATER, V22, P813, DOI 10.1002/adma.200902812
   Hu LB, 2010, NANO LETT, V10, P708, DOI 10.1021/nl903949m
   Hwang SW, 2013, ADV FUNCT MATER, V23, P4087, DOI 10.1002/adfm.201300127
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Irimia-Vladu M., 2012, ADV MATER, V24, P321
   Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4017
   Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031
   Janoschka T, 2012, ADV MATER, V24, P6397, DOI 10.1002/adma.201203119
   Kaxiras E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218102
   Kerzenmacher S, 2008, J POWER SOURCES, V182, P66, DOI 10.1016/j.jpowsour.2008.03.049
   Kettlgruber G, 2013, J MATER CHEM A, V1, P5505, DOI 10.1039/c3ta00019b
   Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157
   Kim IG, 2011, ELECTROCHIM ACTA, V56, P2954, DOI 10.1016/j.electacta.2010.12.095
   Kim J, 2006, MACROMOLECULES, V39, P4202, DOI 10.1021/ma060261e
   Kim YJ, 2013, J MATER CHEM B, V1, P3781, DOI 10.1039/c3tb20183j
   Lang XY, 2011, NAT NANOTECHNOL, V6, P232, DOI 10.1038/nnano.2011.13
   Lee KT, 2011, CHEM MATER, V23, P3593, DOI 10.1021/cm200450y
   Li Z, 2013, ADV ENERGY MATER, V3, P290, DOI 10.1002/aenm.201200598
   Li Z, 2013, ENERG ENVIRON SCI, V6, P871, DOI 10.1039/c2ee23599d
   Lindgren J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1819
   Mai LQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01718
   Marsh H, 2006, ACTIVATED CARBON, P1
   Meng S, 2008, BIOPHYS J, V94, P2095, DOI 10.1529/biophysj.107.121087
   Meredith P, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/3/034501
   Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x
   Milczarek G, 2012, SCIENCE, V335, P1468, DOI 10.1126/science.1215159
   Moreau P, 2010, CHEM MATER, V22, P4126, DOI 10.1021/cm101377h
   Mostert AB, 2012, P NATL ACAD SCI USA, V109, P8943, DOI 10.1073/pnas.1119948109
   Muskovich M, 2012, ADV HEALTHC MATER, V1, P248, DOI 10.1002/adhm.201200071
   Najder-Kozdrowska L, 2009, APPL MAGN RESON, V36, P81, DOI 10.1007/s00723-009-0001-y
   Nethravathi C, 2011, NANOSCALE, V3, P569, DOI 10.1039/c0nr00664e
   Palomares V, 2012, ENERG ENVIRON SCI, V5, P5884, DOI 10.1039/c2ee02781j
   Park Y, 2012, ADV MATER, V24, P3562, DOI 10.1002/adma.201201205
   Popa M, 2010, MICROPOR MESOPOR MAT, V132, P80, DOI 10.1016/j.micromeso.2009.12.024
   Povlich LK, 2010, MACROMOLECULES, V43, P3770, DOI 10.1021/ma9023558
   Reddy ALM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00960
   Renault S, 2011, CHEM COMMUN, V47, P2414, DOI 10.1039/c0cc04440g
   Robertson T., 2010, US Patent, Patent No. [2010/0185055 A1, 20100185055]
   RUDGE A, 1994, J POWER SOURCES, V47, P89, DOI 10.1016/0378-7753(94)80053-7
   Sakaushi K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2481
   Sangaletti L, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.174203
   Siegel A. C., 2009, ADV FUNCT MATER, V20, P28
   Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Slater M. D., 2012, ADV FUNCT MATER, V23, P947
   Southcott M, 2013, PHYS CHEM CHEM PHYS, V15, P6278, DOI 10.1039/c3cp50929j
   Suga T, 2011, ADV MATER, V23, P751, DOI 10.1002/adma.201003525
   Suzuki S, 2011, CARBON, V49, P2264, DOI 10.1016/j.carbon.2011.01.059
   Wakamatsu K, 2012, PIGM CELL MELANOMA R, V25, P434, DOI 10.1111/j.1755-148X.2012.01011.x
   Wang CY, 2007, J POWER SOURCES, V163, P1105, DOI 10.1016/j.jpowsour.2006.08.021
   Wang CY, 2011, ADV MATER, V23, P3580, DOI 10.1002/adma.201101067
   Wang HG, 2013, CHEMSUSCHEM, V6, P56, DOI 10.1002/cssc.201200680
   Wang L, 2013, RSC ADV, V3, P1307, DOI 10.1039/c2ra22375a
   Watt AAR, 2009, SOFT MATTER, V5, P3754, DOI 10.1039/b902507c
   Wei D, 2012, CHEM COMMUN, V48, P1239, DOI 10.1039/c2cc16859f
   Wei X, 2008, FRONT ENERGY POWER E, V2, P1, DOI DOI 10.1007/S11708-008-0016-3
   Wessells CD, 2011, NANO LETT, V11, P5421, DOI 10.1021/nl203193q
   Whitacre JF, 2012, J POWER SOURCES, V213, P255, DOI 10.1016/j.jpowsour.2012.04.018
   Whitacre JF, 2010, ELECTROCHEM COMMUN, V12, P463, DOI 10.1016/j.elecom.2010.01.020
   Wu W, 2013, J ELECTROCHEM SOC, V160, pA497, DOI 10.1149/2.054303jes
   Yang C, 2009, IND ENG CHEM RES, V48, P9498, DOI 10.1021/ie900189j
   Yang LC, 2012, J MATER CHEM, V22, P13148, DOI 10.1039/c2jm31364b
   Zhang K, 2010, CHEM MATER, V22, P1392, DOI 10.1021/cm902876u
NR 87
TC 91
Z9 91
U1 13
U2 164
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 24
PY 2013
VL 110
IS 52
BP 20912
EP 20917
DI 10.1073/pnas.1314345110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 277ZW
UT WOS:000328858800029
PM 24324163
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Lozito, TP
   Alexander, PG
   Lin, H
   Gottardi, R
   Cheng, AWM
   Tuan, RS
AF Lozito, Thomas P.
   Alexander, Peter G.
   Lin, Hang
   Gottardi, Riccardo
   Cheng, Anthony Wai-Ming
   Tuan, Rocky S.
TI Three-dimensional osteochondral microtissue to model pathogenesis of
   osteoarthritis
SO STEM CELL RESEARCH & THERAPY
LA English
DT Review
DE osteoarthritis; microtissue; osteochondral tissue engineering;
   mesenchyme stem cells
ID ARTICULAR-CARTILAGE; SUBCHONDRAL BONE; ENDOTHELIAL-CELLS; YOUNG-ADULTS;
   STEM-CELLS; SCAFFOLDS; DIFFERENTIATION; REGENERATION; DISEASE
AB Osteoarthritis (OA), the most prevalent form of arthritis, affects up to 15% of the adult population and is principally characterized by degeneration of the articular cartilage component of the joint, often with accompanying subchondral bone lesions. Understanding the mechanisms underlying the pathogenesis of OA is important for the rational development of disease-modifying OA drugs. While most studies on OA have focused on the investigation of either the cartilage or the bone component of the articular joint, the osteochondral complex represents a more physiologically relevant target because the disease ultimately is a disorder of osteochondral integrity and function. In our current investigation, we are constructing an in vitro three-dimensional microsystem that models the structure and biology of the osteochondral complex of the articular joint. Osteogenic and chondrogenic tissue components are produced using adult human mesenchymal stem cells derived from bone marrow and adipose seeded within biomaterial scaffolds photostereolithographically fabricated with defined internal architecture. A three-dimensional-printed, perfusion-ready container platform with dimensions to fit into a 96-well culture plate format is designed to house and maintain the osteochondral microsystem that has the following features: an anatomic cartilage/bone biphasic structure with a functional interface; all tissue components derived from a single adult mesenchymal stem cell source to eliminate possible age/tissue-type incompatibility; individual compartments to constitute separate microenvironment for the synovial and osseous components; accessible individual compartments that may be controlled and regulated via the introduction of bioactive agents or candidate effector cells, and tissue/medium sampling and compositional assays; and compatibility with the application of mechanical load and perturbation. The consequences of mechanical injury, exposure to inflammatory cytokines, and compromised bone quality on degenerative changes in the cartilage component are examined in the osteochondral microsystem as a first step towards its eventual application as an improved and high-throughput in vitro model for prediction of efficacy, safety, bioavailability, and toxicology outcomes for candidate disease-modifying OA drugs.
C1 [Lozito, Thomas P.; Alexander, Peter G.; Lin, Hang; Gottardi, Riccardo; Cheng, Anthony Wai-Ming; Tuan, Rocky S.] Ctr Cellular & Mol Engn, Dept Orthopaed Surg, Pittsburgh, PA 15219 USA.
   [Gottardi, Riccardo] Ri MED Fdn, I-90133 Palermo, Italy.
RP Tuan, RS (reprint author), Ctr Cellular & Mol Engn, Dept Orthopaed Surg, 450 Technol Dr,Room 221, Pittsburgh, PA 15219 USA.
EM rst13@pitt.edu
OI Lin, Hang/0000-0002-0781-6630; Gottardi, Riccardo/0000-0001-8040-5531
FU Commonwealth of Pennsylvania Department of Health; National Institutes
   of Health [1U18 TR000532-01, U18TR000532]; Ri.MED Foundation
FX This work was supported by grants from the Commonwealth of Pennsylvania
   Department of Health, the National Institutes of Health (1U18
   TR000532-01), and the Ri.MED Foundation. The publication costs for this
   article were funded by National Institutes of Health grant U18TR000532.
CR Amin AK, 2009, J BONE JOINT SURG BR, V91B, P691, DOI 10.1302/0301-620X.91B5.21544
   Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P2384, DOI 10.1097/00006534-200206000-00033
   Buckland-Wright Christopher, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS10
   Burr David B, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS20
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021
   COLLINOSDOBY P, 1994, J CELL BIOCHEM, V55, P304, DOI 10.1002/jcb.240550306
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Elder SH, 2001, ANN BIOMED ENG, V29, P476, DOI 10.1114/1.1376696
   Fukui N, 2001, Curr Rheumatol Rep, V3, P496, DOI 10.1007/s11926-001-0064-8
   Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x
   Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719
   Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007
   Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198
   Hillig WB, 2008, J MATER SCI-MATER M, V19, P11, DOI 10.1007/s10856-007-0154-x
   Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08
   Hunter DJ, 2006, BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639
   Imhof H, 1997, SKELETAL RADIOL, V26, P398, DOI 10.1007/s002560050254
   Imhof H, 2000, INVEST RADIOL, V35, P581, DOI 10.1097/00004424-200010000-00004
   Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje
   Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388
   Krasnokutsky S, 2008, OSTEOARTHR CARTILAGE, V16, pS1, DOI 10.1016/j.joca.2008.06.025
   Kraus KH, 2006, VET SURG, V35, P232, DOI 10.1111/j.1532-950X.2006.00142.x
   Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797
   Laborie LB, 2011, RADIOLOGY, V260, P494, DOI 10.1148/radiol.11102354
   Lin H, 2013, BIOMATERIALS, V34, P331, DOI 10.1016/j.biomaterials.2012.09.048
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5
   Mueller MB, 2011, PM&R, V3, pS3, DOI 10.1016/j.pmrj.2011.05.009
   Muraoka T, 2007, ARTHRITIS RHEUM, V56, P3366, DOI 10.1002/art.22921
   Pan J, 2009, J ORTHOP RES, V27, P1347, DOI 10.1002/jor.20883
   Roos EM, 2005, CURR OPIN RHEUMATOL, V17, P195, DOI 10.1097/01.bor.0000151406.64393.00
   Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P1633, DOI 10.1007/s11999-008-0242-3
   Sugano N, 1998, J BONE JOINT SURG BR, V80B, P711, DOI 10.1302/0301-620X.80B4.8319
   van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
NR 37
TC 25
Z9 26
U1 3
U2 53
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD DEC 20
PY 2013
VL 4
SU 1
AR S6
DI 10.1186/scrt367
PG 6
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 286DG
UT WOS:000329444700007
PM 24564995
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wu, C
   Qiu, H
   Hu, XY
   Ruan, YM
   Tian, Y
   Chu, Y
   Xu, XL
   Xu, L
   Tang, Y
   Gao, RL
AF Wu Chao
   Qiu Hong
   Hu Xiao-ying
   Ruan Ying-mao
   Tian Yi
   Chu Yan
   Xu Xin-lin
   Xu Liang
   Tang Yue
   Gao Run-lin
TI Short-term safety and efficacy of the biodegradable iron stent in
   mini-swine coronary arteries
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
ID ELUTING VASCULAR SCAFFOLD; IMAGING OUTCOMES; IMPLANTATION; STENOSIS;
   2ND-GENERATION; SYSTEM; ABSORB; TRIAL
AB Background To overcome the drawbacks of permanent stents, biodegradable stents have been studied in recent years. The bioabsorbable polymer vascular scaffold (BVS) was the first bioabsorbable stent to undergo clinical trials, demonstrating safety and feasibility in the ABSORB studies. Iron can potentially serve as the biomaterial for biodegradable stents. This study aimed to assess the short-term safety and efficacy of a biodegradable iron stent in mini-swine coronary arteries.
   Methods Eight iron stents and eight cobalt chromium alloy (VISION) control stents were randomly implanted into the LAD and RCA of eight healthy mini-swine, respectively. Two stents of the same metal base were implanted into one animal. At 28 days the animals were sacrificed after coronary angiography, and histopathological examinations were performed.
   Results Histonnorphometric measurements showed that mean neointimal thickness ((0.46 +/- 0.17) mm vs. (0.45 +/- 0.18) mm, P=0.878), neointimal area ((2.55 +/- 0.91) mm(2) vs. (3.04 +/- 1.15) mm(2), P=0.360) and percentage of area stenosis ((44.50 +/- 11.40)% vs. (46.00 +/- 17.95)%, P=0.845) were not significantly different between the iron stents and VISION stents. There was no inflammation, thrombosis or necrosis in either group. The scanning electron microscopy (SEM) intimal injury scores (0.75 +/- 1.04 vs. 0.88 +/- 0.99, P=0.809) and number of proliferating cell nuclear antigen (PCNA) positive staining cells were not significantly different between the two groups. The percentage of neointimal coverage by SEM examination was numerically higher in iron stents than in VISION stents ((84.38 +/- 14.50)% vs. (65.00 +/- 22.04)%, P=0.057), but the difference was not statistically significant. Iron staining in the tissue surrounding the iron stents at 28 days was positive and the vascular wall adjacent to the iron stent had a brownish tinge, consistent with iron degradation. No abnormal histopathological changes were detected in coronary arteries or major organs.
   Conclusions The biodegradable iron stent has good biocompatibility and short-term safety and efficacy in the mini-swine coronary artery. Corrosion of iron stents is observed at four weeks and no signs of organ toxicity related to iron degradation were noted.
C1 [Wu Chao] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fu Wai Hosp, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China.
   [Qiu Hong; Hu Xiao-ying; Xu Liang; Gao Run-lin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fu Wai Hosp, Dept Cardiol, Beijing 100037, Peoples R China.
   [Ruan Ying-mao; Chu Yan; Xu Xin-lin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fu Wai Hosp, Dept Pathol, Beijing 100037, Peoples R China.
   [Tian Yi; Tang Yue] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fu Wai Hosp, Ctr Expt Anim, Beijing 100037, Peoples R China.
   [Qiu Hong] Peking Union Med Coll, Beijing 100037, Peoples R China.
RP Qiu, H (reprint author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fu Wai Hosp, Dept Cardiol, Beijing 100037, Peoples R China.
EM qiuhong6780@sina.com
FU National 863 Program of China [2011AA030103]
FX This work was supported by a grant from the National 863 Program of
   China (No. 2011AA030103).
CR Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607
   Auerbach M, 1998, AM J KIDNEY DIS, V31, P81, DOI 10.1053/ajkd.1998.v31.pm9428456
   Colombo A, 2000, CIRCULATION, V102, P371
   Drynda A, 2010, J MATER SCI-MATER M, V21, P1655, DOI 10.1007/s10856-010-4014-8
   Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9
   Gyongyosi M, 2000, J AM COLL CARDIOL, V35, P1580, DOI 10.1016/S0735-1097(00)00570-2
   Hermosilla D, 2009, CHEM ENG J, V155, P637, DOI 10.1016/j.cej.2009.08.020
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Mueller PP, 2006, BIOMATERIALS, V27, P2193, DOI 10.1016/j.biomaterials.2005.10.042
   Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8
   Ormiston JA, 2007, CATHETER CARDIO INTE, V69, P128, DOI 10.1002/ccd.20895
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4
   Serruys PW, 2011, J AM COLL CARDIOL, V58, P1578, DOI 10.1016/j.jacc.2011.05.050
   Serruys PW, 2010, CIRCULATION, V122, P2301, DOI 10.1161/CIRCULATIONAHA.110.970772
   Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1
   Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Wentzel JJ, 2000, J BIOMECH, V33, P1287, DOI 10.1016/S0021-9290(00)00066-X
NR 21
TC 21
Z9 22
U1 0
U2 28
PU CHINESE MEDICAL ASSOC
PI BEIJING
PA 42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD DEC 20
PY 2013
VL 126
IS 24
BP 4752
EP 4757
DI 10.3760/cma.j.issn.0366-6999.20131120
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 281FA
UT WOS:000329084200029
PM 24342324
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Wang, HY
   Wei, RH
   Zhao, SZ
AF Wang, Hai-Yan
   Wei, Rui-Hua
   Zhao, Shao-Zhen
TI Evaluation of corneal cell growth on tissue engineering materials as
   artificial cornea scaffolds
SO INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
LA English
DT Review
DE artificial cornea; keratoprosthesis; tissue-engineered scaffold; corneal
   cells collagen; fibrin; amniotic membrane; biomaterial
ID IMMOBILIZED POLY(VINYL ALCOHOL); AMNIOTIC MEMBRANE; OCULAR SURFACE; SILK
   FIBROIN; AUTOLOGOUS TRANSPLANTATION; EXTRACELLULAR-MATRIX; STEM-CELLS;
   IN-VITRO; COLLAGEN; EPITHELIUM
AB The keratoprosthesis (KPro; artificial cornea) is a special refractive device to replace human cornea by using heterogeneous forming materials for the implantation into the damaged eyes in order to obtain a certain vision. The main problems of artificial cornea are the biocompatibility and stability of the tissue particularly in penetrating keratoplasty. The current studies of tissue-engineered scaffold materials through comprising composites of natural and synthetic biopolymers together have developed a new way to artificial cornea. Although a wide agreement that the long-term stability of these devices would be greatly improved by the presence of cornea cells, modification of keratoprosthesis to support cornea cells remains elusive. Most of the studies on corneal substrate materials and surface modification of composites have tried to improve the growth and biocompatibility of cornea cells which can not only reduce the stimulus of heterogeneous materials, but also more importantly continuous and stable cornea cells can prevent the destruction of collagenase. The necrosis of stroma and spontaneous extrusion of the device, allow for maintenance of a precorneal tear layer, and play the role of ensuring a good optical surface and resisting bacterial infection. As a result, improvement in corneal cells has been the main aim of several recent investigations; some effort has focused on biomaterial for its well biological properties such as promoting the growth of cornea cells. The purpose of this review is to summary the growth status of the corneal cells after the implantation of several artificial corneas.
C1 [Wang, Hai-Yan] Shijiazhuang 1 Hosp, Dept Ophthalmol, Shijiazhuang 050000, Hebei Province, Peoples R China.
   [Wang, Hai-Yan; Wei, Rui-Hua; Zhao, Shao-Zhen] Tianjin Med Univ, Hosp Eye, Dept Ophthalmol, Tianjin 300070, Hebei Province, Peoples R China.
RP Wang, HY (reprint author), Shijiazhuang 1 Hosp, Dept Ophthalmol, Shijiazhuang 050011, Hebei Province, Peoples R China.
EM wanghaiyan19840901@126.com
FU National Natural Science Foundation of China [50973082]
FX National Natural Science Foundation of China (No.50973082)
CR Ahn JI, 2007, ARTIF ORGANS, V31, P711, DOI 10.1111/j.1525-1594.2007.00441.x
   Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Ambrose WM, 2009, J BIOMED MATER RES B, V90B, P818, DOI 10.1002/jbm.b.31351
   Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.11.010305.104258
   Baharvand H, 2007, MOL VIS, V13, P1711
   Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904
   Chajra H, 2008, BIO-MED MATER ENG, V18, pS33
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen JS, 2005, ARTIF ORGANS, V29, P104, DOI 10.1111/j.1525-1594.2005.29021.x
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022
   Fagerholm P, 2009, CTS-CLIN TRANSL SCI, V2, P162, DOI 10.1111/j.1752-8062.2008.00083.x
   Foster A, 2003, TROP DOCT, V33, P193, DOI 10.1177/004947550303300401
   Gonzalez-Andrades M, 2009, J TISSUE ENG REGEN M, V3, P442, DOI 10.1002/term.178
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Higa K, 2008, CORNEA, V27, pS41, DOI 10.1097/ICO.0b013e31817f358e
   Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   McLaughlin CR, 2010, BIOMATERIALS, V31, P2770, DOI 10.1016/j.biomaterials.2009.12.031
   Miyashita H, 2006, J BIOMED MATER RES B, V76B, P56, DOI 10.1002/jbm.b.30332
   Mollers S, 2009, TISSUE ENG PT A, V15, P461, DOI 10.1089/ten.tea.2007.0107
   Myung D, 2008, BIOTECHNOL PROGR, V24, P735, DOI 10.1021/bp070476n
   NAKAYASU K, 1986, OPHTHALMIC RES, V18, P1, DOI 10.1159/000265406
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   PISKIN E, 1995, J BIOMAT SCI-POLYM E, V6, P775, DOI 10.1163/156856295X00175
   Marquez SP, 2009, ACTA BIOMATER, V5, P1839, DOI 10.1016/j.actbio.2009.02.011
   Princz MA, 2009, BIOMATERIALS AND REGENERATIVE MEDICINE IN OPHTHALMOLOGY, P134
   Rahman I, 2009, EYE, V23, P1954, DOI 10.1038/eye.2008.410
   Scott EM, 2004, ARTERIOSCL THROM VAS, V24, P1558, DOI 10.1161/01.ATV.0000136649.83297.bf
   Shimmura S, 2003, CORNEA, V22, pS81, DOI 10.1097/00003226-200310001-00012
   Talbot M, 2006, MOL VIS, V12, P65
   THACHARODI D, 1995, INT J PHARM, V120, P115, DOI 10.1016/0378-5173(94)00423-3
   Uchino Y, 2007, J BIOMED MATER RES B, V81B, P201, DOI 10.1002/jbm.b.30654
   Vrana NE, 2008, INVEST OPHTH VIS SCI, V49, P5325, DOI 10.1167/iovs.07-1599
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   Wu Z, 2009, BIOMATERIALS, V30, P3513, DOI 10.1016/j.biomaterials.2009.03.003
   Xu YG, 2008, MOL VIS, V14, P2180
   Zhou Y, 2011, CORNEA, V30, P73, DOI 10.1097/ICO.0b013e3181dc8184
   Zhu YX, 2009, J MATER SCI-MATER M, V20, P799, DOI 10.1007/s10856-008-3636-6
NR 46
TC 13
Z9 16
U1 1
U2 74
PU IJO PRESS
PI XI AN
PA NO 269 YOUYI EAST RD, XI AN, 710054, PEOPLES R CHINA
SN 2222-3959
EI 2227-4898
J9 INT J OPHTHALMOL-CHI
JI Int. J. Ophthalmol.
PD DEC 18
PY 2013
VL 6
IS 6
BP 873
EP 878
DI 10.3980/j.issn.2222-3959.2013.06.23
PG 6
WC Ophthalmology
SC Ophthalmology
GA 276CS
UT WOS:000328726300023
PM 24392340
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Liao, IC
   Moutos, FT
   Estes, BT
   Zhao, XH
   Guilak, F
AF Liao, I-Chien
   Moutos, Franklin T.
   Estes, Bradley T.
   Zhao, Xuanhe
   Guilak, Farshid
TI Composite Three-Dimensional Woven Scaffolds with Interpenetrating
   Network Hydrogels to Create Functional Synthetic Articular Cartilage
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE osteoarthritis; tissue engineering; hydrogels; synthetic cartilage; 3D
   weaving; scaffolds
ID MESENCHYMAL STEM-CELLS; INTERSTITIAL FLUID PRESSURIZATION; HIGH
   MECHANICAL STRENGTH; POLY(EPSILON-CAPROLACTONE) SCAFFOLDS; CHONDROGENIC
   DIFFERENTIATION; AGAROSE; COMPRESSION; FRICTION; ALGINATE; LUBRICATION
AB The development of synthetic biomaterials that possess mechanical properties mimicking those of native tissues remains an important challenge to the field of materials. In particular, articular cartilage is a complex nonlinear, viscoelastic, and anisotropic material that exhibits a very low coefficient of friction, allowing it to withstand millions of cycles of joint loading over decades of wear. Here, a three-dimensionally woven fiber scaffold that is infiltrated with an interpenetrating network hydrogel can build a functional biomaterial that provides the load-bearing and tribological properties of native cartilage. An interpenetrating dual-network tough-gel consisting of alginate and polyacrylamide was infused into a porous three-dimensionally woven poly(E-caprolactone) fiber scaffold, providing a versatile fiber-reinforced composite structure as a potential acellular or cell-based replacement for cartilage repair.
C1 [Liao, I-Chien; Moutos, Franklin T.; Estes, Bradley T.; Guilak, Farshid] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27710 USA.
   [Zhao, Xuanhe; Guilak, Farshid] Duke Univ, Dept Mech Engn & Mat Sci, Med Ctr, Durham, NC 27708 USA.
RP Liao, IC (reprint author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27710 USA.
EM xz69@duke.edu; guilak@duke.edu
RI Zhao, Xuanhe/B-1532-2008
OI Zhao, Xuanhe/0000-0001-5387-6186; Guilak, Farshid/0000-0001-7380-0330
FU National Institutes of Health [AG15768, AR50245, AR48182, AR48852];
   Arthritis Foundation; Collaborative Research Center, AO Foundation,
   Davos, Switzerland; NSF [CMMI-1253495, CMMI-1200515, DMR-1121107]
FX This work was supported in part by National Institutes of Health grants
   AG15768, AR50245, AR48182, AR48852, the Arthritis Foundation, the
   Collaborative Research Center, AO Foundation, Davos, Switzerland and the
   NSF (CMMI-1253495, CMMI-1200515, and DMR-1121107). The authors thank Dr.
   Jeffrey Coles, Dr. Stefan Zauscher, Hiral Tailor, and Julia Weidner for
   their intellectual and experimental contributions.
CR Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Awad HA, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P267
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Azuma C, 2007, J BIOMED MATER RES A, V81A, P373, DOI 10.1002/jbm.a.31043
   Bachrach NM, 1998, J BIOMECH, V31, P445, DOI 10.1016/S0021-9290(98)00035-9
   Bian L, 2008, J BIOMECH, V41, P1153, DOI 10.1016/jbiomech.2008.01.026
   Bodugoz-Senturk H, 2009, BIOMATERIALS, V30, P589, DOI 10.1016/j.biomaterials.2008.10.010
   BROWN TD, 1983, J BIOMECH, V16, P373, DOI 10.1016/0021-9290(83)90071-4
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Freeman ME, 2000, WEAR, V241, P129, DOI 10.1016/S0043-1648(00)00387-2
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Gong JP, 2001, J AM CHEM SOC, V123, P5582, DOI 10.1021/ja003794q
   Guilak F, 2000, PRINCIPLES AND PRACTICE OF ORTHOPAEDIC SPORTS MEDICINE, P53
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Huang AH, 2009, TISSUE ENG PT A, V15, P3461, DOI [10.1089/ten.tea.2009.0198, 10.1089/ten.TEA.2009.0198]
   Huang CY, 2001, J BIOMECH ENG-T ASME, V123, P410, DOI 10.1115/1.1392316
   Hwang CM, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014105
   Ingavle GC, 2012, J MATER SCI-MATER M, V23, P157, DOI 10.1007/s10856-011-4499-9
   Kinnunen J, 2011, BIOMED OPT EXPRESS, V2, P1394, DOI 10.1364/BOE.2.001394
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Kurokawa T, 2010, ACTA BIOMATER, V6, P1353, DOI 10.1016/j.actbio.2009.10.046
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   LEE RC, 1981, J BIOMECH ENG-T ASME, V103, P280, DOI 10.1115/1.3138294
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Myung D, 2008, POLYM ADVAN TECHNOL, V19, P647, DOI 10.1002/pat.1134
   Na YH, 2004, MACROMOLECULES, V37, P5370, DOI 10.1021/ma049506i
   Oka M, 1997, J BONE JOINT SURG BR, V79B, P1003, DOI 10.1302/0301-620X.79B6.7606
   Omidian H, 2006, MACROMOL BIOSCI, V6, P703, DOI 10.1002/mabi.200600062
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   PRAEMER A, 1999, MUSCULOSKELETAL COND
   Riley SL, 2001, J MATER SCI-MATER M, V12, P983, DOI 10.1023/A:1012817317296
   Soltz MA, 2000, ANN BIOMED ENG, V28, P150, DOI 10.1114/1.239
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092
   Wang HQ, 1997, J BIOMECH, V30, P771, DOI 10.1016/S0021-9290(97)00031-6
   Yasuda K, 2005, BIOMATERIALS, V26, P4468, DOI 10.1016/j.biomaterials.2004.11.021
   Yasuda K, 2009, MACROMOL BIOSCI, V9, P307, DOI 10.1002/mabi.200800223
NR 50
TC 79
Z9 79
U1 23
U2 222
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD DEC 17
PY 2013
VL 23
IS 47
BP 5833
EP 5839
DI 10.1002/adfm.201300483
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 272JQ
UT WOS:000328457000001
PM 24578679
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Oosterbeek, RN
   Seal, CK
   Seitz, JM
   Hyland, MM
AF Oosterbeek, Reece N.
   Seal, Christopher K.
   Seitz, Jan-Marten
   Hyland, Margaret M.
TI Polymer-bioceramic composite coatings on magnesium for biomaterial
   applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Biodegradable implant; Composite coating; Magnesium implant
ID IN-VIVO CORROSION; HANKS SOLUTION; BONE RESPONSE; ALLOYS;
   HYDROXYAPATITE; SPECTROSCOPY; BEHAVIOR; PROGRESS; SURFACE; VITRO
AB Magnesium's combination of low weight, biodegradability, and favourable mechanical properties make it an ideal material for a biodegradable orthopaedic implant. However, current magnesium-based materials degrade too quickly to be used. In this work, bioceramic-polymer composite coatings were applied to magnesium in an attempt to improve their corrosion resistance.
   The coatings were characterised and subjected to mechanical tests and qualitative corrosion tests. All of the coatings provided some resistance to corrosion, however, due to gas evolution (a by-product of magnesium corrosion), the coatings blister and crack, allowing corrosion to increase.
   The adhesion strength of the coating was seen to correlate with the time until cracking failure (during the corrosion test), which indicates that adhesion strength must be increased in order to provide corrosion protection for a suitable time period.
   The bioceramic-polymer composite coatings had a lower adhesion strength compared to the polymer only coating, due to poor bonding between the bioceramic layer and the magnesium substrate. This decreased adhesion strength leads to cracking failure occurring earlier during the corrosion test, indicating worse performance.
   In order to improve mechanical and corrosion properties of this method, work needs to be done on strengthening the bonding between the bioceramic layer and the magnesium substrate. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Oosterbeek, Reece N.; Hyland, Margaret M.] Univ Auckland, Dept Chem Mat Engn, Auckland 1, New Zealand.
   [Seal, Christopher K.] Univ Auckland, Light Met Res Ctr, Auckland 1, New Zealand.
   [Seitz, Jan-Marten] Univ Hannover, Inst Werkstoffkunde Mat Sci, D-30823 Garbsen, Germany.
RP Oosterbeek, RN (reprint author), Univ Auckland, Dept Chem Mat Engn, Private Bag 92019, Auckland 1, New Zealand.
EM reece.oosterbeek@auckland.ac.nz
OI Oosterbeek, Reece/0000-0002-2412-4505; Seal,
   Christopher/0000-0002-4850-1395; Hyland, Margaret/0000-0002-4505-1077
CR ASTM, 2011, F104409 ASTM
   ASTM, 2008, D517902 ASTM
   BARR TL, 1990, ZEOLITES, V10, P760, DOI 10.1016/0144-2449(90)90058-Y
   Briggs D., 1990, PRACTICAL SURFACE AN, V1
   Chen Y., 2011, BIOMED MAT, V6
   CHRISTIE AB, 1983, APPL SURF SCI, V15, P224, DOI 10.1016/0378-5963(83)90018-1
   CONMED Corporation, 2012, FIX IMPL PROD CAT
   Cui F, 2008, FRONT MAT SCI CHINA, V2, P143
   Hiromoto S, 2011, SURF COAT TECH, V205, P4711, DOI 10.1016/j.surfcoat.2011.04.036
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Hu RG, 2012, PROG ORG COAT, V73, P129, DOI 10.1016/j.porgcoat.2011.10.011
   Huang Jing-jing, 2007, Chinese Journal of Nonferrous Metals, V17, P1465
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   LANDIS WJ, 1984, J VAC SCI TECHNOL A, V2, P1108, DOI 10.1116/1.572680
   Li JN, 2010, J MATER SCI, V45, P6038, DOI 10.1007/s10853-010-4688-9
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   LIM AS, 1990, APPL PHYS A-MATER, V51, P411, DOI 10.1007/BF00348382
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Merolli A, 2003, J MATER SCI-MATER M, V14, P327, DOI 10.1023/A:1022979831639
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Murphey S., 2011, THESIS
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   NatureWorks, 2005, NATUREWORKS PLA POLY
   Perry RH, 1984, PERRYS CHEM ENG HDB
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tomozawa M, 2011, ACTA MATER, V59, P355, DOI 10.1016/j.actamat.2010.09.041
   WAGNER CD, 1980, ANAL CHEM, V52, P1445, DOI 10.1021/ac50059a017
   Wei M, 1999, J MATER SCI-MATER M, V10, P401, DOI 10.1023/A:1008923029945
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009
   Yang J.X., 2009, IEEE T PLASMA SCI, V37
   Yang TI, 2012, J APPL POLYM SCI, V124, P2333, DOI 10.1002/app.35277
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang XP, 2007, J MATER SCI, V42, P8523, DOI 10.1007/s10853-007-1738-z
NR 38
TC 11
Z9 12
U1 1
U2 32
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC 15
PY 2013
VL 236
BP 420
EP 428
DI 10.1016/j.surfcoat.2013.10.029
PG 9
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 292EF
UT WOS:000329884300059
DA 2018-10-20
ER

PT J
AU Sethuraman, V
   Makornkaewkeyoon, K
   Khalf, A
   Madihally, SV
AF Sethuraman, Vijayalakshmi
   Makornkaewkeyoon, Kornkarn
   Khalf, Abdurizzagh
   Madihally, Sundararajan V.
TI Influence of Scaffold Forming Techniques on Stress Relaxation Behavior
   of Polycaprolactone Scaffolds
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE electrospinning; salt leaching; polycaprolactone; stress relaxation;
   cyclical tests
ID IN-VITRO; VISCOELASTIC PROPERTIES; ELECTROSPRAYED FIBERS; COMPOSITE
   SCAFFOLDS; TISSUE REGENERATION; SOFT-TISSUE; PORE-SIZE; CHITOSAN;
   MATRICES; PCL
AB This study evaluated the effect of scaffold processing methods on viscoelastic properties of polycaprolactone (PCL), a frequently explored biomaterial in tissue engineering. 80 kDa and 45 kDa PCL scaffolds were synthesized using salt leaching and electrospinning techniques. Also, films were formed by air drying. Scanning electron microscopy analysis confirmed that salt leached scaffolds had open pore architecture and electrospun scaffolds had randomly distributed uniform fibers. Using the tensile test results in phosphate buffered saline (pH=7.4) and 37 degrees C, ramp-hold tests were performed for five stages by setting the strain rate to be 1%s(-1) for 2 s followed by 58 s of hold. Also, tests were performed at various strain rates and total strain. Salt leached scaffolds of same MW showed less relaxation in each stage relative to electrospun scaffolds. 45 kDa salt leached scaffolds relaxed more than 80 kDa scaffolds. Stress accumulated in each stage was more in films than in scaffolds. However, relaxation function appeared similar between films and electrospun fibers. Strain rate and amount of applied strain had significant effect on relaxation characteristics; 0.6%s(-1) strain rate had higher accumulated stress than 1%s(-1) and 3%s(-1). Increased amount of loading had significant effect in the first stage with repetitive relaxation characteristics in subsequent stages. SEM analysis of tested samples showed no change in the microstructure with the exception of a few locations where pores oriented in the direction of the pull. In summary, viscoelastic characteristics vary based on the type of scaffold processing used, despite use of the same polymer. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 130: 4237-4244, 2013
C1 [Sethuraman, Vijayalakshmi; Makornkaewkeyoon, Kornkarn; Khalf, Abdurizzagh; Madihally, Sundararajan V.] Oklahoma State Univ, Sch Chem Engn, Stillwater, OK 74078 USA.
RP Madihally, SV (reprint author), Oklahoma State Univ, Sch Chem Engn, Stillwater, OK 74078 USA.
EM sundar.madihally@okstate.edu
RI Madihally, Sundararajan/D-9285-2012
OI Madihally, Sundararajan/0000-0001-7498-5760
FU Oklahoma Center for Advancement of Science and Technology [HR12-023];
   Edward Joullian Endowment
FX Authors thank Mr. Jagdeep T Podichetty for help on preparing scaffolds
   using the salt leaching technique. Financial support was provided by the
   Oklahoma Center for Advancement of Science and Technology (HR12-023),
   and the Edward Joullian Endowment.
CR Abramowitch SD, 2004, ANN BIOMED ENG, V32, P329, DOI 10.1023/B:ABME.0000017539.85245.6a
   Aoki Y, 2001, J APPL POLYM SCI, V82, P2037, DOI 10.1002/app.2049
   Barbanti SH, 2008, MATER RES-IBERO-AM J, V11, P75, DOI 10.1590/S1516-14392008000100014
   Craiem D., 2008, PHYS MED BIOL, P53
   Duling R., 2008, J BIOMECH ENG, P130
   Eberli D, 2009, METHODS, V47, P109, DOI 10.1016/j.ymeth.2008.10.014
   Ergun A, 2012, TISSUE ENG PT A, V18, P2426, DOI [10.1089/ten.tea.2011.0625, 10.1089/ten.TEA.2011.0625]
   Erisken C, 2011, TISSUE ENG PT A, V17, P1239, DOI [10.1089/ten.tea.2009.0693, 10.1089/ten.TEA.2009.0693]
   Erisken C, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001884
   Estelles JM, 2008, J MATER SCI-MATER M, V19, P189, DOI 10.1007/s10856-006-0101-2
   FUNG YCB, 1967, AM J PHYSIOL, V213, P1532
   Funk JR, 2000, J BIOMECH ENG-T ASME, V122, P15, DOI 10.1115/1.429623
   Gercek I, 2008, J BIOMED MATER RES A, V86A, P1012, DOI 10.1002/jbm.a.31723
   Haslach HW, 2005, BIOMECH MODEL MECHAN, V3, P172, DOI 10.1007/s10237-004-0055-6
   Heo SJ, 2009, J BIOMED MATER RES A, V89A, P108, DOI 10.1002/jbm.a.31726
   Ho KLV, 2004, J UROLOGY, V171, P268, DOI 10.1097/01.ju.0000098680.60020.32
   Hong JK, 2011, TISSUE ENG PART B-RE, V17, P125, DOI [10.1089/ten.teb.2010.0552, 10.1089/ten.TEB.2010.0552]
   Hong JK, 2013, J APPL POLYM SCI, V128, P1583, DOI 10.1002/app.38326
   Hong JK, 2010, ACTA BIOMATER, V6, P4734, DOI 10.1016/j.actbio.2010.07.003
   Hou QP, 2003, BIOMATERIALS, V24, P1937, DOI 10.1016/S0142-9612(02)00562-8
   Kwak SY, 2003, MACROMOL MATER ENG, V288, P503, DOI 10.1002/mame.200390047
   Little U, 2009, POLYM DEGRAD STABIL, V94, P213, DOI 10.1016/j.polymdegradstab.2008.11.001
   Mirani RD, 2009, BIOMATERIALS, V30, P703, DOI 10.1016/j.biomaterials.2008.10.023
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Ozkan S, 2009, BIOMATERIALS, V30, P4336, DOI 10.1016/j.biomaterials.2009.04.050
   Pok SW, 2010, ACTA BIOMATER, V6, P1061, DOI 10.1016/j.actbio.2009.08.002
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Ratakonda S, 2012, ACTA BIOMATER, V8, P1566, DOI 10.1016/j.actbio.2011.12.013
   Sarasam AR, 2008, J MATER SCI-MATER M, V19, P1083, DOI 10.1007/s10856-007-3072-z
   Sarasam AR, 2007, MACROMOL BIOSCI, V7, P1160, DOI 10.1002/mabi.200700001
   Shazly TM, 2008, BIOMATERIALS, V29, P4584, DOI 10.1016/j.biomatetials.2008.08.032
   Wang CCB, 2001, J BIOMECH, V34, P75, DOI 10.1016/S0021-9290(00)00137-8
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
NR 34
TC 9
Z9 9
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 15
PY 2013
VL 130
IS 6
BP 4237
EP 4244
DI 10.1002/app.39599
PG 8
WC Polymer Science
SC Polymer Science
GA 282EO
UT WOS:000329153300048
DA 2018-10-20
ER

PT J
AU Myung, SW
   Ko, YM
   Kim, BH
AF Myung, Sung Woon
   Ko, Yeong Mu
   Kim, Byung Hoon
TI Effect of plasma surface functionalization on preosteoblast cells
   spreading and adhesion on a biomimetic hydroxyapatite layer formed on a
   titanium surface
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Plasma polymerization; Preosteoblast cells; Simulated body fluid;
   Hydroxyapatite; Cell spreading
ID SELF-ASSEMBLED MONOLAYERS; SIMULATED BODY-FLUID; IN-VITRO; APATITE
   FORMATION; THIN-FILMS; STEM-CELLS; ATTACHMENT; BEHAVIOR
AB This study examined the plasma surface modification of biomimetic hydroxyapatite (HAp) formed on a titanium (Ti) surface as well as its influence on the behavior of preosteoblast cells. Ti substrates pre-treated with a plasma-polymerized thin film rich in carboxyl groups were subjected to a biomimetic process in a simulated body fluid solution to synthesize the HAp. The HAp layer grown on Ti substrate was then coated with two types of plasma polymerized acrylic acid and allyl amine thin film. The different types of Ti substrates were characterized by attenuated total reflection Fourier transform infrared spectroscopy, energy dispersive spectroscopy and X-ray diffraction. HAp with a Ca/P ratio from 1.25 to 1.38 was obtained on the Ti substrate and hydrophilic carboxyl (-COOH) and amine (-NH2) functional groups were introduced to its surface. Scanning electron microscopy was used to observe the surface of the HAp coatings and the morphology of MC3T3-E1 cells. These results showed that the COOH-modified HAp surfaces promoted the cell spreading synergistically by changing the surface morphology and chemical state. -NH2 modified HAp had the lowest cell spreading and proliferation compared to HAp and -COOH-modified HAp. These results correspond to fluorescein analysis, which showed many more cell spreading of COOH/HAp/Ti surface compared to HAp and NH2 modified HAp. A MTT assay was used to evaluatecell proliferation. The results showed that the proliferation of MC3T3-E1 cells increased in the order of COOH/HAp/Ti > HAp/Ti > NH2/Ti > Ti, corresponding to the effect of cell spreading for 6 days. The change in morphology and the chemical surface properties of the biomaterial via plasma polymerization can affect the behavior of MC3T3-E1 cells. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Myung, Sung Woon; Ko, Yeong Mu; Kim, Byung Hoon] Chosun Univ, MRC Ctr, Sch Dent, Dept Dent Mat, Kwangju, South Korea.
RP Kim, BH (reprint author), Chosun Univ, MRC Ctr, Sch Dent, Dept Dent Mat, 309 Pilmun Daero, Kwangju, South Korea.
EM kim5055@chosun.ac.kr
FU National Research Foundation of Korea (NRF); Ministry of Science, ICT &
   Future Planning [R13-2008-010-00000-0]
FX This study was supported by the National Research Foundation of Korea
   (NRF) funded by the Ministry of Science, ICT & Future Planning (No.
   R13-2008-010-00000-0).
CR Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   BRUNETTE DM, 2005, INT C SER, V1284, P229
   de Andrade MC, 2002, J EUR CERAM SOC, V22, P505
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Jafari R, 2006, REACT FUNCT POLYM, V66, P1757, DOI 10.1016/j.reactfunctpolym.2006.08.006
   Jung H, 2008, COLLOID SURFACE A, V313, P562, DOI 10.1016/j.colsurfa.2007.05.070
   Jung SC, 2012, THIN SOLID FILMS, V521, P150, DOI 10.1016/j.tsf.2011.12.089
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Ko YM, 2012, THIN SOLID FILMS, V521, P128, DOI 10.1016/j.tsf.2012.02.036
   Lebourg M, 2010, COMPOS SCI TECHNOL, V70, P1796, DOI 10.1016/j.compscitech.2010.07.017
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lin DY, 2011, COLLOID SURFACE B, V82, P637, DOI 10.1016/j.colsurfb.2010.09.025
   Liu XJ, 2013, APPL SURF SCI, V270, P473, DOI 10.1016/j.apsusc.2013.01.063
   Mangindaan D, 2011, SURF COAT TECH, V206, P1299, DOI 10.1016/j.surfcoat.2011.08.046
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   Okaka S., 2010, ACTA BIOMATER, V6, P591
   Pennisi CP, 2011, COLLOID SURFACE B, V85, P189, DOI 10.1016/j.colsurfb.2011.02.028
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Rezaei A, 2013, MAT SCI ENG C-MATER, V33, P390, DOI 10.1016/j.msec.2012.09.004
   Ricciardi S, 2012, SURF COAT TECH, V207, P389, DOI 10.1016/j.surfcoat.2012.07.026
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Sanborn SL, 2002, BIOMATERIALS, V23, P1, DOI 10.1016/S0142-9612(01)00066-7
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Seo H.S., 2010, APPL SURF SCI, V257, P593
   Sjostrom T, 2011, APPL SURF SCI, V257, P4552, DOI 10.1016/j.apsusc.2010.11.064
   Taguchi T, 2001, BIOMATERIALS, V22, P53, DOI 10.1016/S0142-9612(00)00162-9
   Topala I, 2009, NUCL INSTRUM METH B, V267, P442, DOI 10.1016/j.nimb.2008.10.029
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   Yang ZL, 2009, PLASMA PROCESS POLYM, V6, P498, DOI 10.1002/ppap.200800195
   Zhang EL, 2009, SURF COAT TECH, V203, P1075, DOI 10.1016/j.surfcoat.2008.09.038
NR 33
TC 13
Z9 13
U1 1
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 15
PY 2013
VL 287
BP 62
EP 68
DI 10.1016/j.apsusc.2013.09.064
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 254RI
UT WOS:000327184100009
DA 2018-10-20
ER

PT J
AU Zhang, X
   Ferraris, S
   Prenesti, E
   Verne, E
AF Zhang, Xin
   Ferraris, Sara
   Prenesti, Enrico
   Verne, Enrica
TI Surface functionalization of bioactive glasses with natural molecules of
   biological significance, PartI: Gallic acid as model molecule
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Surface functionalization; Bioactive glasses; Gallic acid
ID CERAMICS; ANTIOXIDANT; TITANIUM; CHEMISTRY; CELLS; BONE; NANOPARTICLES;
   DERIVATIVES; APOPTOSIS; DELIVERY
AB Gallic acid (3,4,5-trihydroxybenzoic acid, GA) and its derivatives are a group of biomolecules (polyphenols) obtained from plants. They have effects which are potentially beneficial to heath, for example they are antioxidant, anticarcinogenic and antibacterial, as recently investigated in many fields such as medicine, food and plant sciences. The main drawbacks of these molecules are both low stability and bioavailability. In this research work the opportunity to graft GA to bioactive glasses is investigated, in order to deliver the undamaged biological molecule into the body, using the biomaterial surfaces as a localized carrier. GA was considered for functionalization since it is a good model molecule for polyphenols and presents several interesting biological activities, like antibacterial, antioxidant and anticarcinogenic properties. Two different silica based bioactive glasses (SCNA and CEL2), with different reactivity, were employed as substrates. UV photometry combined with the Folin&Ciocalteu reagent was adopted to test the concentration of GA in uptake solution after functionalization. This test verified how much GA consumption occurred with surface modification and it was also used on solid samples to test the presence of GA on functionalized glasses. XPS and SEM-EDS techniques were employed to characterize the modification of material surface properties and functional group composition before and after functionalization. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Zhang, Xin; Ferraris, Sara; Verne, Enrica] Politecn Torino, Appl Sci & Technol Dept, I-10129 Turin, Italy.
   [Prenesti, Enrico] Univ Turin, Dept Chem, I-10125 Turin, Italy.
RP Ferraris, S (reprint author), Politecn Torino, Appl Sci & Technol Dept, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
EM sara.ferraris@polito.it
OI Verne, Enrica/0000-0002-8649-4739
FU CSC project (China Scholarship Council)
FX The CSC project (China Scholarship Council) is kindly acknowledged for
   funding PhD activities of one of the authors (X. Zhang).
CR Agarwal C, 2006, MOL CANCER THER, V5, P3294, DOI 10.1158/1535-7163.MCT-06-0483
   Bhola R, 2011, J MATER SCI-MATER M, V22, P1147, DOI 10.1007/s10856-011-4305-8
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Cho YS, 2011, CARBOHYD POLYM, V83, P1617, DOI 10.1016/j.carbpol.2010.10.019
   Ferraris S, 2011, MATER CHEM PHYS, V130, P1307, DOI 10.1016/j.matchemphys.2011.09.019
   Ferraz MP, 1999, J BIOMED MATER RES, V45, P376, DOI 10.1002/(SICI)1097-4636(19990615)45:4<376::AID-JBM13>3.0.CO;2-S
   Ghotbi M.Y., J PHYS CHEM SOLIDS
   Gil-Longo J., 2010, J NUTR BIOCH, V21
   He L, 2012, ANN MICROBIOL, V62, P319, DOI 10.1007/s13213-011-0265-y
   Hench L. L., 1993, BIOACTIVE GLASSES IN, P41
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   Kong X., 2010, APPL CLAY SCI, V49
   Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Li D, 2011, PROCESS BIOCHEM, V46, P2210, DOI 10.1016/j.procbio.2011.08.011
   Locatelli C, 2008, BIOORGAN MED CHEM, V16, P3791, DOI 10.1016/j.bmc.2008.01.049
   Lu ZB, 2006, NEUROCHEM INT, V48, P263, DOI 10.1016/j.neuint.2005.10.010
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Ming DS, 2005, PHYTOTHER RES, V19, P740, DOI 10.1002/ptr.1597
   Moreno-Alvarez SA, 2010, J NANOPART RES, V12, P2741, DOI 10.1007/s11051-010-0060-x
   Morra M, 2003, INT J ORAL MAX IMPL, V18, P40
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Mowlder J. F., 1995, HDB XRAY PHOTOELECTR
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Naumkin A.V., 2013, 20 NIST
   Owen R.W., 2003, J FOOD CHEM TOXICOL, V41, P17
   Park W, 2008, TOXICOL IN VITRO, V22, P159, DOI 10.1016/j.tiv.2007.08.010
   Pasanphan W, 2010, CARBOHYD RES, V345, P132, DOI 10.1016/j.carres.2009.09.038
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Qiao GY, 2012, DENT MATER J, V31, P564, DOI 10.4012/dmj.2011-159
   Singh J, 2004, INDIAN J AGR SCI, V74, P3
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Textor M, 2001, ENG MAT SER, P171
   Verne E, 2009, J BIOMED MATER RES A, V90A, P981, DOI 10.1002/jbm.a.32153
   Verne E, 2009, J MATER SCI-MATER M, V20, P75, DOI 10.1007/s10856-008-3537-8
   Verne E, 2010, ACTA BIOMATER, V6, P229, DOI 10.1016/j.actbio.2009.06.025
   Vitale-Brovarone C, 2008, J MATER SCI-MATER M, V19, P471, DOI 10.1007/s10856-006-0111-0
   X-Ray Photoelectron Spectroscopy Reference pages, 2013, C1S CARB
   Yang ZL, 2012, PLASMA PROCESS POLYM, V9, P718, DOI 10.1002/ppap.201100199
   Yen GC, 2002, FOOD CHEM, V79, P307, DOI 10.1016/S0308-8146(02)00145-0
   Yu SH, 2011, CARBOHYD POLYM, V84, P794, DOI 10.1016/j.carbpol.2010.04.035
   Zeitler TR, 2006, J CRYST GROWTH, V294, P96, DOI 10.1016/j.jcrysgro.2006.05.029
NR 43
TC 12
Z9 12
U1 1
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 15
PY 2013
VL 287
BP 329
EP 340
DI 10.1016/j.apsusc.2013.09.151
PG 12
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 254RI
UT WOS:000327184100046
DA 2018-10-20
ER

PT J
AU Zhang, X
   Ferraris, S
   Prenesti, E
   Verne, E
AF Zhang, Xin
   Ferraris, Sara
   Prenesti, Enrico
   Verne, Enrica
TI Surface functionalization of bioactive glasses with natural molecules of
   biological significance, part II: Grafting of polyphenols extracted from
   grape skin
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Surface functionalization; Bioactive glasses; Polyphenols; Extraction
ID IN-VITRO; MEDICAL APPLICATIONS; ASSISTED EXTRACTION; PHENOLIC-COMPOUNDS;
   TITANIUM; RESVERATROL; CERAMICS; PRODUCTS; COATINGS; BEHAVIOR
AB Polyphenols, as one of the most important family of phytochemicals protective substances from grape fruit, possess various biological activities and health-promoting benefits, for example: inhibition of some degenerative diseases, cardiovascular diseases and certain types of cancers, reduction of plasma oxidative stress and slowing aging. The combination of polyphenols and biomaterials may have good potential to reach good bioavailability and controlled release, as well as to give biological signaling properties to the biomaterial surfaces. In this research, conventional solvent extraction was developed for obtaining polyphenols from dry grape skins. The Folin&Ciocalteu method was used to determine the amount of total polyphenols in the extracts. Surface functionalization of two bioactive glasses (SCNA and CEL2) was performed by grafting the extracted polyphenols on their surfaces. The effectiveness of the functionalization was tested by UV spectroscopy, which analyzes the amount of polyphenols in the uptake solution (before and after functionalization) and on solid samples, and XPS, which analyzes the presence of phenols on the material surface. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Zhang, Xin; Ferraris, Sara; Verne, Enrica] Politecn Torino, Appl Sci & Technol Dept, I-10129 Turin, Italy.
   [Prenesti, Enrico] Univ Turin, Dept Chem, I-10125 Turin, Italy.
RP Ferraris, S (reprint author), Politecn Torino, Appl Sci & Technol Dept, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
EM sara.ferraris@polito.it
OI Verne, Enrica/0000-0002-8649-4739
FU CSC project (China Scholarship Council)
FX The CSC project (China Scholarship Council) is kindly acknowledged for
   funding PhD activities of one of the authors (X. Zhang).
CR Bhola R, 2011, J MATER SCI-MATER M, V22, P1147, DOI 10.1007/s10856-011-4305-8
   Casas L, 2010, J FOOD ENG, V96, P304, DOI 10.1016/j.jfoodeng.2009.08.002
   Cho YJ, 2006, J FOOD ENG, V77, P725, DOI 10.1016/j.jfoodeng.2005.06.076
   Falchi M, 2006, J AGR FOOD CHEM, V54, P6613, DOI 10.1021/jf061048k
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Ferraris S, 2011, MATER CHEM PHYS, V130, P1307, DOI 10.1016/j.matchemphys.2011.09.019
   Ferraris S, 2013, APPL SURF SCI, V271, P412, DOI 10.1016/j.apsusc.2013.02.002
   Ferraz MP, 1999, J BIOMED MATER RES, V45, P376, DOI 10.1002/(SICI)1097-4636(19990615)45:4<376::AID-JBM13>3.0.CO;2-S
   He L, 2012, ANN MICROBIOL, V62, P319, DOI 10.1007/s13213-011-0265-y
   Hernandez-Jimenez A, 2009, J AGR FOOD CHEM, V57, P10798, DOI 10.1021/jf903465p
   Hildebrand HF, 2006, SURF COAT TECH, V200, P6318, DOI 10.1016/j.surfcoat.2005.11.086
   Hong N, 2001, NAT PROD LETT, V15, P197, DOI 10.1080/10575630108041280
   Hudson T.S., 2007, CANCER RES, P67
   Lee S.H., 2007, ADV DRUG DELIVERY RE, V59
   Li Y, 2011, ACTA BIOMATER, V7, P751, DOI 10.1016/j.actbio.2010.09.008
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Morra M., 2003, INT J ORAL MAXILLOFA, V18
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Mowlder J. F., 1995, HDB XRAY PHOTOELECTR
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Naumkin A.V., 2013, 20 NIST
   Pastrana-Bonilla E., 2003, J AGR FOOD CHEM, V51, P4503
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Qiao GY, 2012, DENT MATER J, V31, P564, DOI 10.4012/dmj.2011-159
   Shahidi F., 2003, PHENOLICS FOOD NUTRA
   Shrikhande AJ, 2000, FOOD RES INT, V33, P469, DOI 10.1016/S0963-9969(00)00071-5
   Singleton V.L., AM J ENOL VITIC, P16
   Textor M, 2001, ENG MAT SER, P171
   Thomas P.S., 2012, J APPL POLYM SCI, P124
   Vatai T, 2009, J FOOD ENG, V90, P246, DOI 10.1016/j.jfoodeng.2008.06.028
   Verne E, 1998, J EUR CERAM SOC, V18, P363, DOI 10.1016/S0955-2219(97)00134-9
   Verne E, 2009, J BIOMED MATER RES A, V90A, P981, DOI 10.1002/jbm.a.32153
   Verne E, 2009, J MATER SCI-MATER M, V20, P75, DOI 10.1007/s10856-008-3537-8
   Verne E, 2010, ACTA BIOMATER, V6, P229, DOI 10.1016/j.actbio.2009.06.025
   Vislocky LM, 2010, NUTR REV, V68, P656, DOI 10.1111/j.1753-4887.2010.00335.x
   Wada M, 2007, FOOD CHEM, V101, P980, DOI 10.1016/j.foodchem.2006.02.050
   Wang H, 2008, BIOTECHNOL LETT, V30, P2079, DOI 10.1007/s10529-008-9815-1
   Xia E.Q., 2012, INT J MOL SCI, V11, P622
   Yang ZL, 2012, PLASMA PROCESS POLYM, V9, P718, DOI 10.1002/ppap.201100199
   Zhang X, 2013, APPL SURF SCI, V287, P329, DOI 10.1016/j.apsusc.2013.09.151
NR 40
TC 13
Z9 13
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 15
PY 2013
VL 287
BP 341
EP 348
DI 10.1016/j.apsusc.2013.09.152
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 254RI
UT WOS:000327184100047
DA 2018-10-20
ER

PT J
AU Pietsch, M
   Wodtke, R
   Pietzsch, J
   Loser, R
AF Pietsch, Markus
   Wodtke, Robert
   Pietzsch, Jens
   Loeser, Reik
TI Tissue transglutaminase: An emerging target for therapy and imaging
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Tissue transglutaminase (TGase 2); Cancer; Biomaterial-tissue interface;
   Activity assays; Inhibitors; Imaging probes
ID PIG LIVER TRANSGLUTAMINASE; COAGULATION-FACTOR-XIII; NF-KAPPA-B;
   SENSITIVE FLUOROMETRIC ASSAY; INDEPENDENT CELL-ADHESION; BETA-AMINOETHYL
   KETONES; GLUTEN PEPTIDE ANALOGS; CROSS-LINKING ACTIVITY;
   HEPARIN-BINDING-SITE; CELIAC-DISEASE
AB Tissue transglutaminase (transglutaminase 2) is a multifunctional enzyme with many interesting properties resulting in versatile roles in both physiology and pathophysiology. Herein, the particular involvement of the enzyme in human diseases will be outlined with special emphasis on its role in cancer and in tissue interactions with biomaterials. Despite recent progress in unraveling the different cellular functions of transglutaminase 2, several questions remain. Transglutaminase 2 features in both confirmed and some still ambiguous roles within pathological conditions, raising interest in developing inhibitors and imaging probes which target this enzyme. One important prerequisite for identifying and characterizing such molecular tools are reliable assay methods to measure the enzymatic activity. This digest Letter will provide clarification about the various assay methods described to date, accompanied by a discussion of recent progress in the development of inhibitors and imaging probes targeting transglutaminase 2. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
C1 [Pietsch, Markus] Univ Hosp Cologne, Inst Pharmacol, D-50931 Cologne, Germany.
   [Wodtke, Robert; Pietzsch, Jens; Loeser, Reik] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, D-01328 Dresden, Germany.
   [Wodtke, Robert; Pietzsch, Jens; Loeser, Reik] Tech Univ Dresden, Dept Chem & Food Chem, D-01062 Dresden, Germany.
RP Loser, R (reprint author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Bautzner Landstr 400, D-01328 Dresden, Germany.
EM r.loeser@hzdr.de
RI Loser, Reik/I-9469-2016; Pietzsch, Jens/O-5070-2017
OI Loser, Reik/0000-0003-1531-7601; Pietzsch, Jens/0000-0002-1610-1493
FU Fonds der Chemischen Industrie
FX We thank Dr. Megan Garvey for critical reading of the manuscript and the
   anonymous reviewers for helpful comments and suggestions. The academic
   guidance of R. W. by Professor Dieter Greif, University of Applied
   Sciences Zittau/Gorlitz, is cordially appreciated. This work is part of
   a research initiative within the Helmholtz-Portfoliothema 'Technologie
   und Medizin-Multimodale Bildgebung zur Aufklarung des In-vivo-Verhaltens
   von polymeren Biomaterialien'. Partial financial support by the Fonds
   der Chemischen Industrie is gratefully acknowledged.
CR Ai LB, 2012, J BIOL CHEM, V287, P18330, DOI 10.1074/jbc.M112.339317
   Al-Nedawi K, 2009, CELL CYCLE, V13, P2014
   Alea MP, 2009, ANAL BIOCHEM, V389, P150, DOI 10.1016/j.ab.2009.03.029
   Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108
   Badarau E, 2013, AMINO ACIDS, V44, P119, DOI 10.1007/s00726-011-1188-4
   Badarau E, 2013, EUR J MED CHEM, V66, P526, DOI 10.1016/j.ejmech.2013.05.018
   Baek KJ, 1996, BIOCHEM J, V315, P739
   Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x
   BENINATI S, 1993, INT J CANCER, V53, P792, DOI 10.1002/ijc.2910530515
   Beninati S., 2012, AMINO ACIDS, V44, P25
   Brown KD, 2013, BREAST CANCER RES TR, V137, P329, DOI 10.1007/s10549-012-2351-7
   Budillon A, 2013, AMINO ACIDS, V44, P63, DOI 10.1007/s00726-011-1167-9
   Caccamo D, 2010, EXPERT OPIN THER TAR, V14, P989, DOI 10.1517/14728222.2010.510134
   Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158
   Caron NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044159
   Case A, 2005, ANAL BIOCHEM, V338, P237, DOI 10.1016/j.ab.2004.09.047
   Case A, 2003, BIOCHEMISTRY-US, V42, P9466, DOI 10.1021/bi030084z
   Castonguay R, 2002, BIOORGAN MED CHEM, V10, P4185, DOI 10.1016/S0968-0896(02)00165-7
   Chabot N, 2010, CHEM BIOL, V17, P1143, DOI 10.1016/j.chembiol.2010.06.019
   Chau DYS, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045011
   Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007
   CHUNG SI, 1970, J BIOL CHEM, V245, P6424
   CHURCH FC, 1983, J DAIRY SCI, V66, P1219, DOI 10.3168/jds.S0022-0302(83)81926-2
   Clare DA, 2007, J AGR FOOD CHEM, V55, P432, DOI 10.1021/jf062309t
   Clare DA, 2010, J FOOD SCI, V75, pC369, DOI 10.1111/j.1750-3841.2010.01605.x
   Cleary DB, 2006, BBA-PROTEINS PROTEOM, V1764, P1207, DOI 10.1016/j.bbapap.2006.05.003
   Clouthier CM, 2012, ANGEW CHEM INT EDIT, V51, P12464, DOI 10.1002/anie.201205575
   Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y
   Cooper AJL, 1997, J NEUROCHEM, V69, P431
   CURTIS CG, 1973, BIOCHEM BIOPH RES CO, V52, P51, DOI 10.1016/0006-291X(73)90952-2
   CURTIS CG, 1974, BIOCHEMISTRY-US, V13, P3257, DOI 10.1021/bi00713a012
   Dafik L, 2011, CHEM BIOL, V18, P58, DOI 10.1016/j.chembiol.2010.11.004
   Datta S, 2006, BIOCHEMISTRY-US, V45, P13163, DOI 10.1021/bi0606795
   Day N, 1999, ANAL BIOCHEM, V274, P141, DOI 10.1006/abio.1999.4255
   De Colli M, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/055005
   de Macedo P, 2000, ANAL BIOCHEM, V285, P16, DOI 10.1006/abio.2000.4713
   Di Sabatino A, 2012, AUTOIMMUN REV, V11, P746, DOI 10.1016/j.autrev.2012.01.007
   Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797
   Duval E, 2005, BIOORG MED CHEM LETT, V15, P1885, DOI 10.1016/j.bmcl.2005.02.005
   FINK ML, 1992, ANAL BIOCHEM, V201, P270
   Flanagan J, 2003, NAHRUNG, V47, P207, DOI 10.1002/food.200390047
   Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200
   Fok JY, 2006, MOL CANCER THER, V5, P1493, DOI 10.1158/1535-7163.MCT-06-0083
   FOLK JE, 1965, J BIOL CHEM, V240, P2951
   FOLK JE, 1971, J BIOL CHEM, V246, P6683
   FOLK JE, 1966, BIOCHIM BIOPHYS ACTA, V122, P244, DOI 10.1016/0926-6593(66)90066-X
   Fraij BM, 2011, J CELL BIOCHEM, V112, P3469, DOI 10.1002/jcb.23278
   Furutani Y, 2001, J HISTOCHEM CYTOCHEM, V49, P247, DOI 10.1177/002215540104900212
   Gentile P, 2011, ADV BIOCHEM ENG BIOT, V125, P181, DOI 10.1007/10_2010_85
   Gharst G, 2007, J FOOD SCI, V72, pC369, DOI 10.1111/j.1750-3841.2007.00442.x
   Gillet SMFG, 2005, ANAL BIOCHEM, V347, P221, DOI 10.1016/j.ab.2005.09.035
   Gillet SMFG, 2004, PROTEIN EXPRES PURIF, V33, P256, DOI 10.1016/j.pep.2003.10.003
   Gnaccarini C, 2012, ORG BIOMOL CHEM, V10, P5258, DOI 10.1039/c2ob25752a
   Gnaccarini C, 2009, BIOORGAN MED CHEM, V17, P6354, DOI 10.1016/j.bmc.2009.07.031
   GORMAN JJ, 1980, J BIOL CHEM, V255, P419
   Gravel C, 2007, CAN J CHEM, V85, P164, DOI 10.1139/V07-011
   GRIFFIN M, 1984, MOL CELL BIOCHEM, V58, P37, DOI 10.1007/BF00240603
   Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234
   Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006
   GROSS M, 1975, J BIOL CHEM, V250, P7693
   GROSS M, 1975, J BIOL CHEM, V250, P4648
   Grosso H, 2012, PHARMACOL THERAPEUT, V133, P392, DOI 10.1016/j.pharmthera.2011.12.003
   GROSSOWICZ N, 1950, J BIOL CHEM, V187, P111
   Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012
   Hakimzadeh N, 2010, BIOMATERIALS, V31, P9256, DOI 10.1016/j.biomaterials.2010.08.060
   Halim D, 2007, BIOORG MED CHEM LETT, V17, P305, DOI 10.1016/j.bmcl.2006.10.061
   Hardes K, 2013, ANAL BIOCHEM, V442, P223, DOI 10.1016/j.ab.2013.07.043
   Hardes K, 2012, ANAL BIOCHEM, V428, P73, DOI 10.1016/j.ab.2012.05.023
   Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084
   Hausch F, 2003, CHEM BIOL, V10, P225, DOI 10.1016/S1074-5521(03)00045-0
   Heath DJ, 2001, J BONE MINER RES, V16, P1477, DOI 10.1359/jbmr.2001.16.8.1477
   Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324
   Hitomi K, 2009, ANAL BIOCHEM, V394, P281, DOI 10.1016/j.ab.2009.07.039
   Iismaa SE, 2003, P NATL ACAD SCI USA, V100, P12636, DOI 10.1073/pnas.1635052100
   Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008
   Isobe T, 1999, EUR J CELL BIOL, V78, P876, DOI 10.1016/S0171-9335(99)80089-2
   Jeitner TM, 2009, J NEUROCHEM, V109, P160, DOI 10.1111/j.1471-4159.2009.05843.x
   Jeitner TM, 2001, ANAL BIOCHEM, V292, P198, DOI 10.1006/abio.2001.5040
   Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y
   Jeon JH, 2004, ANAL BIOCHEM, V333, P399, DOI 10.1016/j.ab.2004.01.014
   JEON WM, 1989, ANAL BIOCHEM, V182, P170, DOI 10.1016/0003-2697(89)90737-9
   Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490
   Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X
   Jones LJ, 1997, ANAL BIOCHEM, V251, P144, DOI 10.1006/abio.1997.2259
   Jones RA, 2006, CELL DEATH DIFFER, V13, P1442, DOI 10.1038/sj.cdd.4401816
   Jones RA, 2013, AMINO ACIDS, V44, P89, DOI 10.1007/s00726-011-1214-6
   Kamiya N, 2003, BIOCONJUGATE CHEM, V14, P351, DOI 10.1021/bc025610y
   Kappel A, 2010, CLIN CHEM LAB MED, V48, P1739, DOI 10.1515/CCLM.2010.339
   Karagiannis S. N., 2013, PLOS ONE, V8
   Karpati L, 2000, CLIN CHEM, V46, P1946
   Keillor JW, 2008, CAN J CHEM, V86, P271, DOI 10.1139/V08-024
   Keillor Jeffrey W, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P415
   Kenniston JA, 2013, ANAL BIOCHEM, V436, P13, DOI 10.1016/j.ab.2013.01.016
   Kiraly R, 2011, FEBS J, V278, P4717, DOI 10.1111/j.1742-4658.2011.08345.x
   Kiraly R, 2009, FEBS J, V276, P7083, DOI 10.1111/j.1742-4658.2009.07420.x
   Klebe G., 2012, TRANSGLUTAMINASE 2 C, DOI [10.2210/pdb3s3p/pdb, DOI 10.2210/PDB3S3P/PDB]
   Klock C, 2012, SEMIN IMMUNOPATHOL, V34, P513, DOI 10.1007/s00281-012-0305-0
   Klock C, 2012, PROTEIN SCI, V21, P1781, DOI 10.1002/pro.2162
   Klock C, 2011, BIOORG MED CHEM LETT, V21, P2692, DOI 10.1016/j.bmcl.2010.12.037
   Knop K., 2004, ANN REPORT 2003, P36
   Kotsakis P, 2007, AMINO ACIDS, V33, P373, DOI 10.1007/s00726-007-0516-1
   Kotsakis P, 2011, AMINO ACIDS, V41, P909, DOI 10.1007/s00726-010-0790-1
   Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390
   Kumar S, 2013, AMINO ACIDS, V44, P81, DOI 10.1007/s00726-011-1139-0
   Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049321
   Kusch M, 2006, BLOOD COAGUL FIBRIN, V17, P575, DOI 10.1097/01.mbc.0000245305.02763.2c
   Kwon MH, 2011, ANAL CHEM, V83, P8718, DOI 10.1021/ac202178g
   Kwon MH, 2009, MOL CELLS, V27, P337, DOI 10.1007/s10059-009-0043-x
   Lai TS, 2010, PROTEIN SCI, V19, P229, DOI 10.1002/pro.301
   Lai TS, 2008, CHEM BIOL, V15, P969, DOI 10.1016/j.chembiol.2008.07.015
   Lai TS, 2013, FRONT BIOSCI-LANDMRK, V18, P504, DOI 10.2741/4117
   Lai TS, 1998, J BIOL CHEM, V273, P1776, DOI 10.1074/jbc.273.3.1776
   Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t
   Lajemi M, 1997, HISTOCHEM J, V29, P593, DOI 10.1023/A:1026484227851
   Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322
   Leblanc A, 2001, BIOCHEMISTRY-US, V40, P8335, DOI 10.1021/bi0024097
   Lee J. H., 2013, BIOTECHNOL BIOENG
   Lentini A, 2011, PROTEIN J, V30, P109, DOI 10.1007/s10930-011-9311-7
   LEVITZKI A, 1980, P NATL ACAD SCI-BIOL, V77, P2706, DOI 10.1073/pnas.77.5.2706
   Lewis KB, 1997, BIOCHEMISTRY-US, V36, P995, DOI 10.1021/bi961636z
   Li Bo, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P247
   Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107
   Lilley GR, 1997, J BIOCHEM BIOPH METH, V34, P31, DOI 10.1016/S0165-022X(96)01200-6
   Lin CY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-87
   Lindemann I., 2012, TRANSGLUTAMINASE 2 C, V3S3S, DOI [10.2210/pdb3s3s/pdb, DOI 10.2210/PDB3S3S/PDB]
   LIPMANN F, 1945, J BIOL CHEM, V159, P21
   Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899
   LORAND L, 1972, ANAL BIOCHEM, V50, P623, DOI 10.1016/0003-2697(72)90074-7
   LORAND L, 1979, BIOCHEMISTRY-US, V18, P1756, DOI 10.1021/bi00576a019
   LORAND L, 1971, ANAL BIOCHEM, V44, P221, DOI 10.1016/0003-2697(71)90363-0
   Lorand L, 1998, EXP EYE RES, V66, P531, DOI 10.1006/exer.1997.0463
   LORAND L, 1981, P NATL ACAD SCI-BIOL, V78, P1356, DOI 10.1073/pnas.78.3.1356
   Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014
   Lortat-Jacob H, 2012, J BIOL CHEM, V287, P18005, DOI 10.1074/jbc.M111.337089
   Malhotra V, 2013, EMBO J, V32, P1660, DOI 10.1038/emboj.2013.104
   Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457
   Marrano C, 2001, BIOORGAN MED CHEM, V9, P3231, DOI 10.1016/S0968-0896(01)00228-0
   Marrano C, 2001, BIOORGAN MED CHEM, V9, P1923, DOI 10.1016/S0968-0896(01)00101-8
   Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093
   Mastroberardino PG, 2006, BBA-BIOENERGETICS, V1757, P1357, DOI 10.1016/j.bbabio.2006.07.007
   Mehta K, 2005, PROG EXP TUMOR RES, V38, P1
   Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107
   Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029
   MIRAGLIA CC, 1985, ANAL BIOCHEM, V144, P165, DOI 10.1016/0003-2697(85)90099-5
   Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200
   Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200
   Mishra S, 2006, BIOCHEM BIOPH RES CO, V347, P1166, DOI 10.1016/j.bbre.2006.07.041
   Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713
   MUSZBEK L, 1985, CLIN CHEM, V31, P35
   Nadalutti C, 2011, CELL PROLIFERAT, V44, P49, DOI 10.1111/j.1365-2184.2010.00716.x
   Nakano Y, 2010, J CELL PHYSIOL, V223, P260, DOI 10.1002/jcp.22034
   NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253
   Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402
   Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X
   Oertel K., 2008, PCT Int. Appl., Patent No. [WO 2008055488 A1 20080515, 2008055488]
   Oertel K., 2006, <IT>PCT Int. Appl.</IT>, Patent No. [WO 2006018164 A2 20060223, 2006018164]
   Oertel K, 2007, ANAL BIOCHEM, V367, P152, DOI 10.1016/j.ab.2007.05.011
   Ozaki S, 2011, BIOORG MED CHEM LETT, V21, P377, DOI 10.1016/j.bmcl.2010.10.136
   Ozaki S, 2010, BIOORG MED CHEM LETT, V20, P1141, DOI 10.1016/j.bmcl.2009.12.011
   Parameswaran KN, 1997, J BIOL CHEM, V272, P10311
   Pardin C, 2008, CHEM BIOL DRUG DES, V72, P189, DOI 10.1111/j.1747-0285.2008.00696.x
   Pardin C, 2008, J ORG CHEM, V73, P5766, DOI 10.1021/jo8004843
   Pardin C, 2006, BIOORGAN MED CHEM, V14, P8379, DOI 10.1016/j.bmc.2006.09.011
   Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z
   Park JY, 2009, ANAL BIOCHEM, V394, P217, DOI 10.1016/j.ab.2009.07.040
   Park MK, 2013, EUR J CANCER, V49, P1692, DOI 10.1016/j.ejca.2012.11.036
   Park SS, 2006, J BIOL CHEM, V281, P34965, DOI 10.1074/jbc.M604150200
   Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x
   Pasternack R, 1997, ANAL BIOCHEM, V249, P54, DOI 10.1006/abio.1997.2139
   Pavlyukov MS, 2012, BIOCHEM BIOPH RES CO, V421, P773, DOI 10.1016/j.bbrc.2012.04.082
   Piacentini M, 2005, PROG EXP TUMOR RES, V38, P58
   Pietzsch J., 2004, ANN REPORT 2003, P37
   Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   PLIURA DH, 1992, J ENZYM INHIB, V6, P181, DOI 10.3109/14756369209020168
   Prime ME, 2012, ACS MED CHEM LETT, V3, P731, DOI 10.1021/ml3001352
   Prime ME, 2012, J MED CHEM, V55, P1021, DOI 10.1021/jm201310y
   Reno F, 2012, J MATER SCI-MATER M, V23, P565, DOI 10.1007/s10856-011-4519-9
   Salmeron-Sanchez M, 2011, BIOMATERIALS, V32, P2099, DOI 10.1016/j.biomaterials.2010.11.057
   Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948
   Schaertl S, 2010, J BIOMOL SCREEN, V15, P478, DOI 10.1177/1087057110366035
   Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257
   Shridas P, 2001, FEBS LETT, V499, P245, DOI 10.1016/S0014-5793(01)02565-0
   Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861
   Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003
   Siegel M, 2007, BIOORGAN MED CHEM, V15, P6253, DOI 10.1016/j.bmc.2007.06.020
   SLAUGHTER TF, 1992, ANAL BIOCHEM, V205, P166, DOI 10.1016/0003-2697(92)90594-W
   Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803
   Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53
   SONG YQC, 1994, ANAL BIOCHEM, V223, P88, DOI 10.1006/abio.1994.1551
   Song YY, 2013, NEURON, V78, P109, DOI 10.1016/j.neuron.2013.01.036
   Spurlin TA, 2009, BIOMATERIALS, V30, P5486, DOI 10.1016/j.biomaterials.2009.07.014
   Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162
   STENBERG P, 1975, BIOCHEM J, V147, P155
   Tabolacci C, 2012, AMINO ACIDS, V42, P975, DOI 10.1007/s00726-011-1011-2
   Takeuchi Y, 1998, Z NATURFORSCH C, V53, P352
   Tanaka T, 2004, BIOCONJUGATE CHEM, V15, P491, DOI 10.1021/bc034209o
   Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200
   Trigwell SM, 2004, ANAL BIOCHEM, V330, P164, DOI 10.1016/j.ab.2004.03.068
   van den Hoff J., 2004, NUKLEARMEDIZIN, V43, pA78
   Van der Wildt B, 2013, J LABELLED COMPD RAD, V56, pS342
   van Geel R, 2012, AMINO ACIDS, V43, P1251, DOI 10.1007/s00726-011-1198-2
   Verderio E, 2001, J BIOMED MATER RES, V54, P294, DOI 10.1002/1097-4636(200102)54:2<294::AID-JBM17>3.0.CO;2-Q
   Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200
   Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387
   Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529
   Vezza R, 1999, J BIOL CHEM, V274, P12774, DOI 10.1074/jbc.274.18.12774
   Wang Y, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-277
   Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819
   Wang Z, 2012, AMINO ACIDS, V42, P939, DOI 10.1007/s00726-011-1008-x
   Wilhelm B, 1996, J CHROMATOGR B, V684, P163, DOI 10.1016/0378-4347(95)00562-5
   Wityak J, 2012, ACS MED CHEM LETT, V3, P1024, DOI [10.1021/mI300241m, 10.1021/ml300241m]
   Wodtke R., 2013, NUKLEARMEDIZIN, V52, pA71
   Wu LQ, 2011, INT J ARTIF ORGANS, V34, P215, DOI 10.5301/IJAO.2011.6406
   Wu YW, 2006, J BIOMOL SCREEN, V11, P836, DOI 10.1177/1087057106291585
   Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103
   Yakubov B, 2013, NEOPLASIA, V15, P609, DOI 10.1593/neo.121878
   YAMADA K, 1977, THROMB RES, V11, P557, DOI 10.1016/0049-3848(77)90015-9
   Yang LQ, 2012, FUTURE ONCOL, V8, P431, DOI [10.2217/fon.12.27, 10.2217/FON.12.27]
   Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414
   Zhang JW, 2013, CELL REP, V3, P2008, DOI 10.1016/j.celrep.2013.05.021
   Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288
NR 222
TC 18
Z9 18
U1 0
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD DEC 15
PY 2013
VL 23
IS 24
BP 6528
EP 6543
DI 10.1016/j.bmcl.2013.09.060
PG 16
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA 263DU
UT WOS:000327787700002
PM 24432384
OA Other Gold
DA 2018-10-20
ER

PT J
AU Ibrahim, NS
   Krishnamurithy, G
   Raghavendran, HRB
   Puvaneswary, S
   Min, NW
   Kamarul, T
AF Ibrahim, Nurul Syuhada
   Krishnamurithy, Genasan
   Raghavendran, Hanumantha Rao Balaji
   Puvaneswary, Subramaniam
   Ng Wuey Min
   Kamarul, Tunku
TI Novel HA-PVA/NOCC bilayered scaffold for osteochondral
   tissue-engineering applications - Fabrication, characterization, in
   vitro and in vivo biocompatibility study
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Porous materials; Hydroxyapatite; Hydrogel;
   Biocompatibility; Osteochondral
AB This study aimed to examine the bilayered scaffold containing hydroxyapatite (HA) and N, O-carboxymethylated chitosan (PVA/NOCC) seeded with mesenchymal stem cells in vitro to determine its potential use as a scaffold in tissue engineering. SEM analysis revealed that pores in this scaffold were interconnected with parallel grooves and ridges. EDS indicated that the level of calcium was relatively higher in HA. FTIR confirmed the presence of functional groups corresponding to alkyl halide, alkyne, hydroxyl group, and alkane groups, while XRD results revealed that the phase content of HA and hydrogel comprised organic substance. Significantly higher, levels of differentiation markers, namely, alkaline phosphatase and glycosaminoglycans, were detected in the scaffold cultures. Furthermore, histology and blood profile demonstrated biocompatibility of this bilayered scaffold in a rat model. In conclusion, our results demonstrate that bilayered scaffold may be a promising construct for osteochondral defects. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Ibrahim, Nurul Syuhada; Krishnamurithy, Genasan; Raghavendran, Hanumantha Rao Balaji; Puvaneswary, Subramaniam; Ng Wuey Min; Kamarul, Tunku] Univ Malaya, TEG, Dept Orthopaed Surg, NOCERAL,Fac Med, Kuala Lumpur 50603, Malaysia.
RP Kamarul, T (reprint author), Univ Malaya, TEG, Dept Orthopaed Surg, NOCERAL,Fac Med, Kuala Lumpur 50603, Malaysia.
EM tkzrea@um.edu.my
RI balaji raghavendran, hanumantha rao/B-8507-2012; Tunku Zainol Abidin,
   Tunku Kamarul Zaman/B-9633-2011; Ng, Wuey Min/J-3196-2016
OI Tunku Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313; Ng, Wuey
   Min/0000-0002-3542-8993
FU HIRG-MOHE; University of Malaya;  [RG144/09 HTM]
FX Authors are thankful to HIRG-MOHE, University of Malaya and RG144/09 HTM
   for the financial support.
CR Abbas A, 2008, EUROPEAN CELLS MAT, V16, P1
   Krishnamurithy G, 2014, CERAM INT, V40, P771, DOI 10.1016/j.ceramint.2013.06.067
   Lee SY, 2009, ACTA BIOMATER, V5, P1919, DOI 10.1016/j.actbio.2009.02.014
   Nerem RM, 2006, TISSUE ENG, V12, P1143, DOI 10.1089/ten.2006.12.1143
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
NR 9
TC 11
Z9 11
U1 2
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD DEC 15
PY 2013
VL 113
BP 25
EP 29
DI 10.1016/j.matlet.2013.09.026
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 263JQ
UT WOS:000327805300007
DA 2018-10-20
ER

PT J
AU Lin, QY
   Wang, QH
   Duan, YX
   Wei, XP
   Wu, GR
   Luo, YH
   Xie, QL
AF Lin, Qingyu
   Wang, Qihui
   Duan, Yixiang
   Wei, Xiaoping
   Wu, Guirong
   Luo, Yanghe
   Xie, Qinglin
TI Removal of Cu(II), Cr(III), and Cr(VI) from Aqueous Solution using a
   Novel Agricultural Waste Adsorbent
SO SEPARATION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE adsorption; chufa corm peels; equilibrium; heavy metal; kinetics
ID AGAVE-LECHUGUILLA BIOMASS; HEAVY-METAL IONS; SELECTIVE ADSORPTION;
   HEXAVALENT CHROMIUM; CONTAMINATED WATER; ACTIVATED ALUMINA; COPPER(II)
   IONS; DRINKING-WATER; BIOSORPTION; EQUILIBRIUM
AB A novel adsorbent, chufa corm peels (CCP), is used for removing Cu(II), Cr(III), and Cr(VI) from aqueous solutions. The adsorption ability and characteristics of the CCP are thoroughly investigated. The adsorption capability for three heavy metal ions is in the order of Cu(II)>Cr(III)>Cr(VI). The morphology and elemental distribution on the biomass of CCP were evaluated by scanning electron microscopy (SEM) and energy dispersive spectrometry (EDS). Fourier-transform infrared spectroscopy (FTIR) analysis revealed that oxygen-containing functional groups, especially carboxylic and hydroxyl groups were responsible for chemical coordination between ionizable functional groups and metal ions. The adsorption features were evaluated based on the batch biosorption experiment. The results showed that the adsorption well meets the Freundlich adsorption isotherm models and pseudo-second-order kinetics model. In summary, this work demonstrated that CCP is an attractive, efficient, and low-cost adsorbent biomaterial that can be used for the removal of heavy metals from environmental contaminations.
C1 [Lin, Qingyu; Wang, Qihui; Duan, Yixiang] Sichuan Univ, Analyt & Testing Ctr, Res Ctr Analyt Instrumentat, Chengdu 610064, Peoples R China.
   [Lin, Qingyu; Wu, Guirong; Luo, Yanghe; Xie, Qinglin] Hezhou Univ, Coll Chem & Biol Engn, Hezhou, Peoples R China.
   [Wei, Xiaoping] Guilin Univ Technol, Coll Chem & Bioengn, Guilin, Peoples R China.
   [Wu, Guirong] Guangxi Key Lab Environm Engn Protect & Assessmen, Guilin, Peoples R China.
RP Duan, YX (reprint author), Sichuan Univ, Analyt & Testing Ctr, Res Ctr Analyt Instrumentat, 29 Wangjiang Rd, Chengdu 610064, Peoples R China.
EM yduan@scu.edu.cn
FU Guangxi Natural Science Foundation of China [GuiKeZi 0832274];
   Educational Office Guangxi [201010LX536]; Guangxi Key Laboratory of
   Environmental Engineering, Protection, and Assessment [GuiJiaoKe
   0704K002]
FX The authors gratefully acknowledge the financial support received from
   the Guangxi Natural Science Foundation of China (GuiKeZi 0832274), the
   Research Funds of the Educational Office Guangxi (201010LX536), and the
   Research Funds of the Guangxi Key Laboratory of Environmental
   Engineering, Protection, and Assessment (GuiJiaoKe 0704K002).
CR Acar FN, 2004, BIORESOURCE TECHNOL, V94, P13, DOI [10.1016/j.biortech.2003.10.032, 10.1016/j.biotech.2003.10.032]
   Akar ST, 2012, CHEM ENG J, V185, P82, DOI 10.1016/j.cej.2012.01.032
   Alimohamadi M, 2005, MINER ENG, V18, P1325, DOI 10.1016/j.mineng.2005.08.007
   Anwar J, 2010, BIORESOURCE TECHNOL, V101, P1752, DOI 10.1016/j.biortech.2009.10.021
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Bhatti HN, 2007, PROCESS BIOCHEM, V42, P547, DOI 10.1016/j.procbio.2006.11.009
   Campos V, 2005, ENVIRON GEOL, V47, P926, DOI 10.1007/s00254-005-1222-5
   CHEN SL, 1945, NATURE, V156, P234, DOI 10.1038/156234b0
   Dawood S, 2012, WATER RES, V46, P1933, DOI 10.1016/j.watres.2012.01.009
   Esposito A, 2001, HYDROMETALLURGY, V60, P129, DOI 10.1016/S0304-386X(00)00195-X
   Feng NC, 2011, J HAZARD MATER, V185, P49, DOI 10.1016/j.jhazmat.2010.08.114
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gardea-Torresday JL, 2000, J HAZARD MATER, V80, P175, DOI 10.1016/S0304-3894(00)00301-0
   Gialamouidis D, 2010, J HAZARD MATER, V182, P672, DOI 10.1016/j.jhazmat.2010.06.084
   Goel J., J HAZARD MAT, V125, P211
   GROFF G. WEIDMAN, 1950, PROC FLORIDA STATE HORT SOC, V63, P262
   Gu HB, 2012, RSC ADV, V2, P11007, DOI 10.1039/c2ra21991c
   Gupta VK, 2008, J HAZARD MATER, V152, P407, DOI 10.1016/j.jhazmat.2007.07.028
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P332, DOI 10.1205/095758298529696
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Iqbal M, 2009, J HAZARD MATER, V164, P161, DOI 10.1016/j.jhazmat.2008.07.141
   Izqulerdo M, 2012, CLEAN-SOIL AIR WATER, V40, P428, DOI 10.1002/clen.201100303
   Johar N, 2012, IND CROP PROD, V37, P93, DOI 10.1016/j.indcrop.2011.12.016
   Kalidhasan S, 2012, J COLLOID INTERF SCI, V372, P88, DOI 10.1016/j.jcis.2012.01.013
   Kusvuran E, 2012, CLEAN-SOIL AIR WATER, V40, P1273, DOI 10.1002/clen.201100443
   KUYUCAK N, 1988, BIOTECHNOL LETT, V10, P137, DOI 10.1007/BF01024641
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Li JP, 2009, J COLLOID INTERF SCI, V333, P71, DOI 10.1016/j.jcis.2009.02.021
   Li SX, 2012, ADV MATER RES-SWITZ, V433-440, P793, DOI 10.4028/www.scientific.net/AMR.433-440.793
   Lin LL, 2010, BIORESOURCE TECHNOL, V101, P8217, DOI 10.1016/j.biortech.2010.05.084
   Liu Xin, 2006, Food Science, China, V27, P251
   Macek T, 2011, MICROBIAL BIOSORPTIO, P7, DOI [10.1007/978-94-007-0443-5_2, DOI 10.1007/978-94-007-0443-5_2]
   Malik DJ, 2002, WATER RES, V36, P1527, DOI 10.1016/S0043-1354(01)00348-7
   Mor S, 2007, BIORESOURCE TECHNOL, V98, P954, DOI 10.1016/j.biortech.2006.03.018
   MURAGALELLI MJ, 1991, P NATL ACAD SCI USA, V88, P5557, DOI 10.1073/pnas.88.13.5557
   Ngah WSW, 2008, BIOCHEM ENG J, V39, P521, DOI 10.1016/j.bej.2007.11.006
   Omorogie MO, 2012, BIORESOURCE TECHNOL, V118, P576, DOI 10.1016/j.biortech.2012.04.053
   Parr AJ, 1996, J SCI FOOD AGR, V71, P501, DOI 10.1002/(SICI)1097-0010(199608)71:4<501::AID-JSFA608>3.0.CO;2-L
   Persson P, 2005, GEOCHIM COSMOCHIM AC, V69, P541, DOI 10.1016/j.gca.2004.07.009
   Piron E, 1997, LANGMUIR, V13, P1653, DOI 10.1021/la960765d
   Romero-Gonzalez J, 2006, BIORESOURCE TECHNOL, V97, P178, DOI 10.1016/j.biortech.2005.01.037
   Romero-Gonzalez J, 2005, J CHEM THERMODYN, V37, P343, DOI 10.1016/j.jct.2004.09.013
   Rosenwinkel KH, 2005, ENVIRONMENTAL BIOTECHNOLOGY: CONCEPTS AND APPLICATIONS, P49
   Sag Y., 2001, BIOTECHNOL BIOPROC E, V6, P376, DOI DOI 10.1007/BF02932318
   Sawalha MF, 2006, J COLLOID INTERF SCI, V300, P100, DOI 10.1016/j.jcis.2006.03.029
   Schiewer S, 2008, J HAZARD MATER, V157, P8, DOI 10.1016/j.jhazmat.2007.12.076
   SenthilKumar P, 2011, DESALINATION, V266, P63, DOI 10.1016/j.desal.2010.08.003
   SPERLING M, 1992, ANAL CHEM, V64, P3101, DOI 10.1021/ac00048a007
   Tan GQ, 2010, J HAZARD MATER, V174, P740, DOI 10.1016/j.jhazmat.2009.09.114
   Vieira R. H. S. F., 2000, INT MICROBIOL, V3, P17
   Villaescusa I, 2004, WATER RES, V38, P992, DOI 10.1016/j.watres.2003.10.040
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Wang SG, 2007, SEP PURIF TECHNOL, V58, P17, DOI 10.1016/j.seppur.2007.07.006
   Webi T. W., 1974, AICHE J, V20, P228, DOI DOI 10.1002/AIC.690200204
   Wuana R. A., 2011, ISRN ECOL, DOI [DOI 10.5402/2011/402647, 10.5402/2011/402647]
   Zein R, 2010, J HAZARD MATER, V181, P52, DOI 10.1016/j.jhazmat.2010.04.076
   Zhang WJ, 2012, ADV MATER RES-SWITZ, V550-553, P2338, DOI 10.4028/www.scientific.net/AMR.550-553.2338
NR 58
TC 7
Z9 7
U1 5
U2 82
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0149-6395
EI 1520-5754
J9 SEP SCI TECHNOL
JI Sep. Sci. Technol.
PD DEC 12
PY 2013
VL 48
IS 18
BP 2843
EP 2851
DI 10.1080/01496395.2013.808216
PG 9
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 248DP
UT WOS:000326674200014
DA 2018-10-20
ER

PT J
AU de Moraes, MA
   Beppu, MM
AF de Moraes, Mariana Agostini
   Beppu, Marisa Masumi
TI Biocomposite membranes of sodium alginate and silk fibroin fibers for
   biomedical applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biocompatibility; biopolymers and renewable polymers; composites;
   properties and characterization
ID MECHANICAL-PROPERTIES; SUCCINATE) BIOCOMPOSITES; THERMAL-PROPERTIES;
   WOUND DRESSINGS; BOMBYX-MORI; WATER; BIOMATERIALS; FILMS
AB Biocomposite membranes from biodegradable and biocompatible natural polymers were prepared from sodium alginate solution reinforced with silk fibroin fibers in several fiber content by casting and solvent evaporation. The properties of these biocomposites were investigated by scanning electron microscopy, swelling test, water vapor transmission, mechanical and thermal analyses, and cytotoxicity test. A biocomposite with uniform fiber dispersion and good fiber-matrix interaction was obtained through the incorporation of fibroin fibers in the alginate membrane, even though the fibers were used without any surface treatment to enhance the interfacial adhesion. The incorporation of fibroin fibers improved the tensile strength and also provided a new property to the alginate, that is, the resistance to tear. Moreover, the use of silk fibroin fibers in polymeric composites can result in a material with adequate characteristics for application in the biomaterial field, especially as wound dressings, because of its nontoxic effect to cells, flexibility, and resistance to tear. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 130: 3451-3457, 2013
C1 [de Moraes, Mariana Agostini; Beppu, Marisa Masumi] Univ Estadual Campinas, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
RP Beppu, MM (reprint author), Univ Estadual Campinas, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
EM beppu@feq.unicamp.br
RI Agostini de Moraes, Mariana/C-4595-2013; BEPPU, MARISA/E-1057-2012
OI Agostini de Moraes, Mariana/0000-0002-2586-6834; 
FU CNPq
FX The authors thank Andrea Rodas and Olga Higa, from the Biotechnology
   Center of the Energy and Nuclear Research Institute (IPEN/USP) for
   performing the cytotoxicity tests and to CNPq for the financial support.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bogoeva-Gaceva G, 2007, POLYM COMPOSITE, V28, P98, DOI 10.1002/pc.20270
   Cheung HY, 2008, COMPOS PART B-ENG, V39, P1026, DOI 10.1016/j.compositesb.2007.11.009
   Dong ZF, 2006, J MEMBRANE SCI, V280, P37, DOI 10.1016/j.memsci.2006.01.002
   Fowler PA, 2006, J SCI FOOD AGR, V86, P1781, DOI 10.1002/jsfa.2558
   Freddi G, 1999, INT J BIOL MACROMOL, V24, P251, DOI 10.1016/S0141-8130(98)00087-7
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Han SO, 2006, J APPL POLYM SCI, V100, P4972, DOI 10.1002/app.23300
   Kalyani S, 2008, DESALINATION, V229, P68, DOI 10.1016/j.desal.2007.07.027
   Ki CS, 2009, MACROMOL RES, V17, P935, DOI 10.1007/BF03218639
   Lee SM, 2005, COMPOS SCI TECHNOL, V65, P647, DOI 10.1016/j.compscitech.2004.09.023
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Li W, 2008, J APPL POLYM SCI, V110, P134, DOI 10.1002/app.28514
   Liu Y., 2012, BIOFABRICATION, V4, P1
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Moura LIF, 2013, ACTA BIOMATER, V9, P7093, DOI 10.1016/j.actbio.2013.03.033
   Olivas GI, 2008, LWT-FOOD SCI TECHNOL, V41, P359, DOI 10.1016/j.lwt.2007.02.015
   Plaza GR, 2008, J APPL POLYM SCI, V109, P1793, DOI 10.1002/app.28288
   Qin YM, 2008, POLYM INT, V57, P171, DOI 10.1002/pi.2296
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P302, DOI 10.1016/j.actbio.2011.10.009
   Siddaramaiah, 2008, J APPL POLYM SCI, V109, P4075, DOI 10.1002/app.28625
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
NR 26
TC 10
Z9 10
U1 6
U2 195
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 5
PY 2013
VL 130
IS 5
BP 3451
EP 3457
DI 10.1002/app.39598
PG 7
WC Polymer Science
SC Polymer Science
GA 213YU
UT WOS:000324097400049
DA 2018-10-20
ER

PT J
AU Forstater, JH
   Kleinhammes, A
   Wu, Y
AF Forstater, Jacob H.
   Kleinhammes, Alfred
   Wu, Yue
TI Self-Assembly of Protein-Based Biornaterials Initiated by Titania
   Nanotubes
SO LANGMUIR
LA English
DT Article
ID RIBONUCLEASE-A; SILICA NANOPARTICLES; DELAMINATED ANATASE; 001 FACETS;
   ENZYMES; ADSORPTION; STABILITY; SURFACES; NANOSTRUCTURES; FIBRILLATION
AB Protein-based biomaterials are a promising strategy for creating robust highly selective biocatalysts. The assembled biomaterials must sufficiently retain the near-native structure of proteins and provide molecular access to catalytically active sites. These requirements often exclude the use of conventional assembly techniques, which rely on covalent cross-linking of proteins or entrapment within a scaffold. Here we demonstrate that titania nanotubes can initiate and template the self-assembly of enzymes, such as ribonuclease A, while maintaining their catalytic activity. Initially, the enzymes form multilayer thick ellipsoidal aggregates centered on the nanotube surface; subsequently, these nanosized entities assemble into a micrometer-sized enzyme material that has enhanced enzymatic activity and contains as little as 0.1 wt % TiO2 nanotubes. This phenomenon is uniquely associated with the active anatase (001)-like surface of titania nanotubes and does not occur on other anatase nanomaterials, which contain significantly fewer undercoordinated Ti surface sites. These findings present a nanotechnology-enabled mechanism of biomaterial growth and open a new route for creating stable protein-based biomaterials and biocatalysts without the need for chemical modification.
C1 [Forstater, Jacob H.; Kleinhammes, Alfred; Wu, Yue] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA.
RP Wu, Y (reprint author), Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA.
EM yuewu@physics.unc.edu
OI Forstater, Jacob/0000-0003-0268-1009
FU NSF [DMR-0906547]
FX This work was supported in part by NSF DMR-0906547. We thank the
   DeSimone group (UNC) for use of equipment in their lab, M. Woody for
   assistance with work leading up to this project, and C. Hadsell for
   providing the titania nanotiles. We are grateful to P. Sen and G. Pielak
   for their helpful feedback and fruitful discussions. SEM and TEM imaging
   was performed in the Chapel Hill Area Nanofabrication Laboratory
   (CHANL); we thank A. Kumbhar and W. Ambrose for performing the TEM
   imaging.
CR Asuri P, 2007, LANGMUIR, V23, P12318, DOI 10.1021/la702091c
   Banta S, 2010, ANNU REV BIOMED ENG, V12, P167, DOI 10.1146/annurev-bioeng-070909-105334
   BELFORT G, 1991, P NATL ACAD SCI USA, V88, P9146, DOI 10.1073/pnas.88.20.9146
   Berne B. J., 1976, DYNAMIC LIGHT SCATTE, P14
   Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117
   Cabaleiro-Lago C, 2010, ACS CHEM NEUROSCI, V1, P279, DOI 10.1021/cn900027u
   Cao L., 2006, CARRIER BOUND IMMOBI, P1, DOI DOI 10.1002/3527607668
   Chen Q, 2009, CHEM PHYS LETT, V482, P134, DOI 10.1016/j.cplett.2009.10.003
   Corma A, 2002, ADV MATER, V14, P71, DOI 10.1002/1521-4095(20020104)14:1<71::AID-ADMA71>3.0.CO;2-W
   Dullien F. A. L., 1992, POROUS MEDIA FLUID T, P6
   GELBART WM, 1984, J PHYS CHEM-US, V88, P861, DOI 10.1021/j150649a008
   Han XG, 2009, J AM CHEM SOC, V131, P3152, DOI 10.1021/ja8092373
   Holmberg M, 2009, LANGMUIR, V25, P2081, DOI 10.1021/la8031978
   Hu X, 2012, MATER TODAY, V15, P208, DOI 10.1016/S1369-7021(12)70091-3
   Huang Z, 2011, ADV FUNCT MATER, V21, P2633, DOI 10.1002/adfm.201100067
   HUTCHENS TW, 1991, J INORG BIOCHEM, V42, P105, DOI 10.1016/0162-0134(91)80037-I
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P503, DOI 10.1016/B978-0-12-375182-9.10019-3
   Jia HF, 2003, BIOTECHNOL BIOENG, V84, P406, DOI 10.1002/bit.10781
   Kim J, 2006, CHEM ENG SCI, V61, P1017, DOI 10.1016/j.ces.2005.05.067
   Klink TA, 2000, EUR J BIOCHEM, V267, P566, DOI 10.1046/j.1432-1327.2000.01037.x
   Lai Y.-C., 2012, TRENDS CELL BIOL, P1
   Li GS, 2005, J AM CHEM SOC, V127, P8659, DOI 10.1021/ja050517g
   Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104
   Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725
   Mogilevsky G, 2008, CHEM PHYS LETT, V460, P517, DOI 10.1016/j.cplett.2008.06.063
   Mogilevsky G, 2008, J PHYS CHEM C, V112, P3239, DOI 10.1021/jp076899p
   Ninham B. W., 2010, MOL FORCES SELF ASSE, P251
   NORDE W, 2005, FUNDAM INTERFACE COL, V5, P1
   Payne GF, 2013, SOFT MATTER, V9, P6019, DOI 10.1039/c3sm50527h
   Pedersen C, 2013, SMALL, V9, P3320, DOI 10.1002/smll.201300149
   Peng LL, 2009, NANO LETT, V9, P1932, DOI 10.1021/nl9001052
   Puddu V, 2012, ACS NANO, V6, P6356, DOI 10.1021/nn301866q
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h
   Safran S., 2003, STAT THERMODYNAMICS, P237
   Salgado EN, 2008, J AM CHEM SOC, V130, P6082, DOI 10.1021/ja8012177
   Salgado EN, 2010, ACCOUNTS CHEM RES, V43, P661, DOI 10.1021/ar900273t
   Salgado EN, 2010, P NATL ACAD SCI USA, V107, P1827, DOI 10.1073/pnas.0906852107
   Selcuk S, 2013, J PHYS CHEM C, V117, P6358, DOI 10.1021/jp402100v
   Shang W, 2007, NANO LETT, V7, P1991, DOI 10.1021/nl070777r
   Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082
   Sun CH, 2010, J MATER CHEM, V20, P10319, DOI 10.1039/c0jm01491e
   Thomas CS, 2011, ACS NANO, V5, P5697, DOI 10.1021/nn2013673
   Torres-Salas P, 2011, ADV MATER, V23, P5275, DOI 10.1002/adma.201101821
   Turci F, 2010, LANGMUIR, V26, P8336, DOI 10.1021/la904758j
   Vertegel AA, 2004, LANGMUIR, V20, P6800, DOI 10.1021/la0497200
   Vittadini A, 1998, PHYS REV LETT, V81, P2954, DOI 10.1103/PhysRevLett.81.2954
   Wagner GW, 2008, J PHYS CHEM C, V112, P11901, DOI 10.1021/jp803003k
   Zhang Y., 2011, SMALL, V8, P154
   Zhou ZY, 2011, CHEM SOC REV, V40, P4167, DOI 10.1039/c0cs00176g
NR 50
TC 9
Z9 9
U1 5
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 3
PY 2013
VL 29
IS 48
BP 15013
EP 15021
DI 10.1021/la403414t
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 266CJ
UT WOS:000327999600033
PM 24200123
DA 2018-10-20
ER

PT J
AU Guo, LT
   Tian, JL
   Wu, J
   Li, BE
   Xu, C
   Zhu, YB
   Qiang, YH
AF Guo, Litong
   Tian, Junlong
   Wu, Jing
   Li, Baoe
   Xu, Cheng
   Zhu, Yabo
   Qiang, Yinghuai
TI Effect of Anodization on Titanium-Porcelain Bonding
SO MATERIALS AND MANUFACTURING PROCESSES
LA English
DT Article
DE Anodization; Biomaterial; Bonding; Corrosion; Titanium
ID SURFACE MODIFICATIONS; PURE TITANIUM; IN-VITRO; CORROSION; STRENGTH;
   BIOCOMPATIBILITY; FABRICATION; NANOTUBES; TI
AB The effects of anodization processes on titanium-porcelain bonding were investigated. The morphologies and phase structures were evaluated by field-emission scanning electron microscopy (F-SEM) and X-ray diffraction (XRD). The bonding strength was investigated by three-point flexure test. The corrosion resistance of titanium in artificial saliva was investigated. The SEM results showed that a titanium oxide film with submicron stripes and nano-pores could be prepared by anodization and HF acid pretreatment. This titanium oxide film increased chemical bonding and mechanical interlocking between titanium and porcelain. The anodization process also enhanced the corrosion resistance of the titanium, which led to the increase of corrosion durability of the Ti-porcelain bonding strength.
C1 [Guo, Litong; Tian, Junlong; Wu, Jing; Xu, Cheng; Zhu, Yabo; Qiang, Yinghuai] China Univ Min & Technol, Xuzhou 221116, Peoples R China.
   [Li, Baoe] Chinese Acad Sci, Key Lab Inorgan Coating Mat, Shanghai, Peoples R China.
RP Guo, LT (reprint author), China Univ Min & Technol, Sch Mat Sci & Engn, Xuzhou 221116, Peoples R China.
EM guolitong810104@163.com
OI xu, cheng/0000-0001-8075-2867
FU National Natural Science Foundation of China [81100789, 51201056];
   Fundamental Research Funds for the Central Universities [2012QNA04]; Key
   Laboratory of Inorganic Coating Materials, Chinese Academy of Sciences
   [KLICM-2012-02]; Zhejiang Provincial Administration of Traditional
   Chinese Medicine [2008YA023]; Department of Education of Zhejiang
   Province [ZC200803873]
FX This research was supported by the National Natural Science Foundation
   of China (No. 81100789 and 51201056), the Fundamental Research Funds for
   the Central Universities (No. 2012QNA04), Key Laboratory of Inorganic
   Coating Materials, Chinese Academy of Sciences (No. KLICM-2012-02),
   Zhejiang Provincial Administration of Traditional Chinese Medicine
   (2008YA023), and Department of Education of Zhejiang Province
   (ZC200803873).
CR [Anonymous], 1999, 9693 ISO
   Cai Z, 2001, BIOMATERIALS, V22, P979, DOI 10.1016/S0142-9612(00)00263-5
   Elsaka SE, 2010, DENT MATER, V26, P793, DOI 10.1016/j.dental.2010.04.004
   Fan XP, 2012, J BIOMED MATER RES A, V100A, P3422, DOI 10.1002/jbm.a.34268
   Guo L T, 2008, MATER LETT, V62, P2204
   Guo LT, 2012, MATER MANUF PROCESS, V27, P1189, DOI 10.1080/10426914.2012.663124
   Guo LT, 2012, MAT SCI ENG C-MATER, V32, P1531, DOI 10.1016/j.msec.2012.04.038
   Guo LT, 2010, MATER MANUF PROCESS, V25, P710, DOI 10.1080/15394450902996577
   Guo LT, 2010, MATER MANUF PROCESS, V25, P696, DOI 10.1080/10426914.2010.489594
   Guo LT, 2009, MATER LETT, V63, P2486, DOI 10.1016/j.matlet.2009.08.040
   Lai YK, 2009, ELECTROCHIM ACTA, V54, P6536, DOI 10.1016/j.electacta.2009.06.029
   Minagar S, 2012, ACTA BIOMATER, V8, P2875, DOI 10.1016/j.actbio.2012.04.005
   Mohsen Q, 2011, MATER CORROS, V62, P310, DOI 10.1002/maco.200905534
   Wang SS, 2010, SURF COAT TECH, V205, P1886, DOI 10.1016/j.surfcoat.2010.08.066
   Wang Y, 2011, J ALLOY COMPD, V509, pL157, DOI 10.1016/j.jallcom.2011.01.096
   Yu WQ, 2011, COLLOID SURFACE B, V84, P400, DOI 10.1016/j.colsurfb.2011.01.033
   Yun KD, 2010, MAT SCI ENG C-MATER, V30, P27, DOI 10.1016/j.msec.2009.08.004
   Zhang H, 2007, SURF COAT TECH, V201, P5637, DOI 10.1016/j.surfcoat.2006.07.023
NR 18
TC 2
Z9 2
U1 0
U2 17
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1042-6914
EI 1532-2475
J9 MATER MANUF PROCESS
JI Mater. Manuf. Process.
PD DEC 2
PY 2013
VL 28
IS 12
BP 1305
EP 1309
DI 10.1080/10426914.2013.832303
PG 5
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 269LH
UT WOS:000328242300005
DA 2018-10-20
ER

PT J
AU Bencherif, SA
   Braschler, TM
   Renaud, P
AF Bencherif, Sidi A.
   Braschler, Thomas M.
   Renaud, Philippe
TI Advances in the design of macroporous polymer scaffolds for potential
   applications in dentistry
SO JOURNAL OF PERIODONTAL AND IMPLANT SCIENCE
LA English
DT Review
DE Hydrogels; Polymers; Tissue engineering
ID TISSUE-ENGINEERING SCAFFOLDS; POLY(ETHYLENE GLYCOL) DIMETHACRYLATE; VIVO
   CELL INFILTRATION; SMOOTH-MUSCLE-CELLS; CO-PGA HYDROGELS; IN-VITRO;
   NANOFIBROUS SCAFFOLDS; POLY(D,L-LACTIDE) SCAFFOLD; ELECTROSPINNING
   TECHNIQUE; MECHANICAL-PROPERTIES
AB A paradigm shift is taking place in medicine and dentistry from using synthetic implants and tissue grafts to a tissue engineering approach that uses degradable porous three-dimensional (3D) material hydrogels integrated with cells and bioactive factors to regenerate tissues such as dental bone and other oral tissues. Hydrogels have been established as a biomaterial of choice for many years, as they offer diverse properties that make them ideal in regenerative medicine, including dental applications. Being highly biocompatible and similar to native extracellular matrix, hydrogels have emerged as ideal candidates in the design of 3D scaffolds for tissue regeneration and drug delivery applications. However, precise control over hydrogel properties, such as porosity, pore size, and pore interconnectivity, remains a challenge. Traditional techniques for creating conventional crosslinked polymers have demonstrated limited success in the formation of hydrogels with large pore size, thus limiting cellular infiltration, tissue ingrowth, vascularization, and matrix mineralization (in the case of bone) of tissue-engineered constructs. Emerging technologies have demonstrated the ability to control microarchitectural features in hydrogels such as the creation of large pore size, porosity, and pore interconnectivity, thus allowing the creation of engineered hydrogel scaffolds with a structure and function closely mimicking native tissues. In this review, we explore the various technologies available for the preparation of macroporous scaffolds and their potential applications.
C1 [Bencherif, Sidi A.; Braschler, Thomas M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Bencherif, Sidi A.] Harvard Univ, Wyss Inst Biolog Inspired Engn, Boston, MA 02115 USA.
   [Braschler, Thomas M.; Renaud, Philippe] Ecole Polytech Fed Lausanne, STI LMIS4, Lab Microsyst, Lausanne, Switzerland.
RP Bencherif, SA (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM sidi@seas.harvard.edu
RI Renaud, P/A-6994-2011; Braschler, Thomas/C-5208-2015
OI Renaud, P/0000-0001-5199-1252; Braschler, Thomas/0000-0003-1811-1713
CR Andreu N, 2012, SMALL, V8, P2495, DOI 10.1002/smll.201200138
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Barbetta A, 2009, BIOMACROMOLECULES, V10, P2328, DOI 10.1021/bm900517q
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bartolo PJ, 2011, STEREOLITHOGRAPHY: MATERIALS, PROCESSES AND APPLICATIONS, P1
   Battistella E, 2011, J APPL BIOMATER BIOM, V9, P223, DOI 10.5301/JABB.2011.8867
   Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Bencherif SA, 2011, M S-MED SCI, V27, P19, DOI 10.1051/medsci/201127119
   Bencherif SA, 2009, BIOMATERIALS, V30, P5270, DOI 10.1016/j.biomaterials.2009.06.011
   Bencherif SA, 2009, BIOMACROMOLECULES, V10, P2499, DOI 10.1021/bm9004639
   Bencherif SA, 2009, ACTA BIOMATER, V5, P1872, DOI 10.1016/j.actbio.2009.02.030
   Bencherif SA, 2009, BIOMACROMOLECULES, V10, P1795, DOI 10.1021/bm900213u
   Bencherif SA, 2009, J BIOMED MATER RES A, V90A, P142, DOI 10.1002/jbm.a.32069
   Brown AN, 2000, TISSUE ENG, V6, P297, DOI 10.1089/107632700418029
   Brown TD, 2011, ADV MATER, V23, P5651, DOI 10.1002/adma.201103482
   Capes JS, 2005, J MATER SCI-MATER M, V16, P1069, DOI 10.1007/s10856-005-4708-5
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   Cho HY, 2010, BIOMACROMOLECULES, V11, P2199, DOI 10.1021/bm1006272
   Dainiak MB, 2007, ADV BIOCHEM ENG BIOT, V106, P101, DOI 10.1007/10_2006_044
   Davis HE, 2008, TOPICS MULTIFUNCTION, P1
   Dehghani F, 2011, CURR OPIN BIOTECH, V22, P661, DOI 10.1016/j.copbio.2011.04.005
   Draghi L, 2005, J MATER SCI-MATER M, V16, P1093, DOI 10.1007/s10856-005-4711-x
   Ekaputra AK, 2011, BIOMATERIALS, V32, P8108, DOI 10.1016/j.biomaterials.2011.07.022
   Gavrilas C, 2009, United States patent, Patent No. [WO/2009/029087, 2009029087]
   Henderson TMA, 2013, J MATER CHEM B, V1, P2682, DOI 10.1039/c3tb20280a
   Hockaday LA, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035005
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Huang GY, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/012001
   Huang X, 2007, TISSUE ENG, V13, P2645, DOI 10.1089/ten.2007.0084
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hwang YS, 2010, TISSUE ENG PT A, V16, P3033, DOI [10.1089/ten.tea.2010.0045, 10.1089/ten.TEA.2010.0045]
   Jayasinghe SN, 2007, NANOMEDICINE-UK, V2, P555, DOI 10.2217/17435889.2.4.555
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Jhaveri SJ, 2009, CHEM MATER, V21, P2003, DOI 10.1021/cm803174e
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kennedy S, 2013, ADV HEALTHC MAT 0912
   Keskar V, 2009, TISSUE ENG PT A, V15, P1695, DOI 10.1089/ten.tea.2008.0238
   Kim K, 2010, J DENT RES, V89, P842, DOI 10.1177/0022034510370803
   Lee M, 2012, METHODS MOL BIOL, V868, P257, DOI 10.1007/978-1-61779-764-4_15
   Lee W, 2010, BIOTECHNOL BIOENG, V105, P1178, DOI 10.1002/bit.22613
   Lee YH, 2005, BIOMATERIALS, V26, P3165, DOI 10.1016/j.biomaterials.2004.08.018
   Leong MF, 2010, J BIOMED MATER RES A, V94A, P1141, DOI 10.1002/jbm.a.32795
   Leong MF, 2009, J BIOMED MATER RES A, V91A, P231, DOI 10.1002/jbm.a.32208
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li LH, 2012, BIOMATERIALS, V33, P3428, DOI 10.1016/j.biomaterials.2012.01.038
   Lin-Gibson S, 2005, MACROMOL SYMP, V227, P243, DOI 10.1002/masy.200550924
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   Lo CW, 2010, POLYM ENG SCI, V50, P232, DOI 10.1002/pen.21531
   Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025
   Lozinsky VI, 2001, BIOSEPARATION, V10, P163, DOI 10.1023/A:1016386902611
   Lytle J. C., 2006, ANN REV NANO RES, V1, P1
   Marga F, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/022001
   Mishra R, 2013, TISSUE ENG A
   Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09
   Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747
   Nguyen AK, 2013, REGEN MED, V8, P725, DOI 10.2217/rme.13.60
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   Pandit Nymphea, 2011, J Indian Soc Periodontol, V15, P328, DOI 10.4103/0972-124X.92564
   Park S, 2009, J MATER SCI-MATER M, V20, P229, DOI 10.1007/s10856-008-3573-4
   Parrag IC, 2012, BIOTECHNOL BIOENG, V109, P813, DOI 10.1002/bit.23353
   Pataky K, 2012, ADV MATER, V24, P391, DOI 10.1002/adma.201102800
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Plieva FM, 2007, J SEP SCI, V30, P1657, DOI 10.1002/jssc.200700127
   Plieva FM, 2005, SOFT MATTER, V1, P303, DOI 10.1039/b510010k
   Prado SS, 2011, MAT SCI ENG C-MATER, V31, P1767, DOI 10.1016/j.msec.2011.08.008
   Qu TJ, 2013, J MATER CHEM B, V1, P4764, DOI 10.1039/c3tb21002b
   Sequeira SJ, 2012, BIOMATERIALS, V33, P3175, DOI 10.1016/j.biomaterials.2012.01.010
   Shabani I, 2012, BIOCHEM BIOPH RES CO, V423, P50, DOI 10.1016/j.bbrc.2012.05.069
   Siegwart DJ, 2008, J BIOMED MATER RES A, V87A, P345, DOI 10.1002/jbm.a.31708
   Siegwart DJ, 2009, BIOMACROMOLECULES, V10, P2300, DOI 10.1021/bm9004904
   Silva DS, 2007, ENG MED BIOL WORKSH, P71
   Singh D, 2011, J BIOMAT SCI-POLYM E, V22, P1733, DOI 10.1163/092050610X522486
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Stampfl J, 2008, PROC MONOGR ENG WATE, P283
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Sultana N, 2008, J EXP NANOSCI, V3, P121, DOI 10.1080/17458080701867429
   Sultana N, 2008, J MATER SCI-MATER M, V19, P2555, DOI 10.1007/s10856-007-3214-3
   Sun LT, 2010, ACTA BIOMATER, V6, P4708, DOI 10.1016/j.actbio.2010.06.029
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Takei Takayuki, 2006, Biotechnology Journal, V1, P1014, DOI 10.1002/biot.200600055
   Thomson RC, 1997, PRINCIPLES TISSUE EN, P263
   Townsend-Nicholson A, 2006, BIOMACROMOLECULES, V7, P3364, DOI 10.1021/bm060649h
   Tran RT, 2011, BIOTECHNOL APPL BIOC, V58, P335, DOI 10.1002/bab.44
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Vasilev MP, 1972, FIBRE CHEM+, V4, P48
   Wang Y, 2013, INT J NANOMED, V8, P4015, DOI 10.2147/IJN.S52605
   Wei GB, 2009, BIOMATERIALS, V30, P6426, DOI 10.1016/j.biomaterials.2009.08.012
   Xu F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019344
   Xue Shi-hua, 2013, Beijing Da Xue Xue Bao Yi Xue Ban, V45, P105
   Yoon JA, 2011, CHEM-ASIAN J, V6, P128, DOI 10.1002/asia.201000514
   Zhang K, 2005, BIOMACROMOLECULES, V6, P1615, DOI 10.1021/bm0500648
   Zhang K, 2005, BIOMATERIALS, V26, P4532, DOI 10.1016/j.biomaterials.2004.11.030
   Zhang K, 2003, J BIOMED MATER RES A, V66A, P860, DOI 10.1002/jbm.a.10093
   Zhong SP, 2012, TISSUE ENG PART B-RE, V18, P77, DOI 10.1089/ten.teb.2011.0390
NR 100
TC 18
Z9 18
U1 1
U2 76
PU KOREAN ACAD PERIODONTOLOGY
PI SEOUL
PA OFFICIAL B-D 2212, 163 SINMUNRO 1-GA, JONGNO-GU, SEOUL, 110-990, SOUTH
   KOREA
SN 2093-2278
EI 2093-2286
J9 J PERIODONTAL IMPLAN
JI J. Periodontal Implant Sci.
PD DEC
PY 2013
VL 43
IS 6
BP 251
EP 261
DI 10.5051/jpis.2013.43.6.251
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AP8QP
UT WOS:000342344200002
PM 24455437
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Barroso, SD
   Jales, TS
   Correa-Faria, P
   Alcantara, CEP
   Botelho, AM
   Tavano, KTA
AF Barroso, S. D.
   Jales, T. S.
   Correa-Faria, P.
   Alcantara, C. E. P.
   Botelho, A. M.
   Tavano, K. T. A.
TI Esthetic and Functional Recovery of Extensively Decayed Posterior Teeth
   Through Conservative Treatment
SO JOURNAL OF CLINICAL PEDIATRIC DENTISTRY
LA English
DT Article
DE dental pulp capping; permanent dental restoration; recovery of function
ID DEEP CARIOUS LESIONS; CORONAL RECONSTRUCTION; PERMANENT TEETH; REMOVAL
AB The case exemplifies the combination of two important principles in dentistry: 1) the maintenance of pulp vitality by the partial excavation of the contaminated dentin followed by the application of a biomaterial; and 2) esthetic and functional recovery based on biological restoration. Tooth vitality was confirmed two months after pulp treatment and restoration was accomplished with a fragment of a tooth extracted from another individual. This method is easy to perform and offers esthetic, functional, emotional and social benefits to the patient.
C1 [Barroso, S. D.; Jales, T. S.; Correa-Faria, P.; Alcantara, C. E. P.; Botelho, A. M.; Tavano, K. T. A.] Fed Univ Vales Jequitinhonha & Mucuri, Diamantina, Brazil.
RP Correa-Faria, P (reprint author), Rua da Gloria 187, BR-39100000 Diamantina, Brazil.
EM Patriciafarialaria09@gmail.com
RI Correa de Faria, Patricia/N-9428-2013
OI Correa de Faria, Patricia/0000-0002-0528-1425
CR Tavano KTA, 2009, DENT TRAUMATOL, V25, P535, DOI 10.1111/j.1600-9657.2009.00766.x
   Moura LFAD, 2013, DENT TRAUMATOL, V29, P161, DOI 10.1111/j.1600-9657.2011.01064.x
   Correa-Faria P, 2010, J ESTHET RESTOR DENT, V22, P168, DOI 10.1111/j.1708-8240.2010.00331.x
   Modena KCD, 2009, J APPL ORAL SCI, V17, P544, DOI 10.1590/S1678-77572009000600002
   Dalpian DM, 2012, J CLIN PEDIATR DENT, V36, P363, DOI 10.17796/jcpd.36.4.n404t58110t18082
   Gruythuysen R, 2010, J ENDODONT, V36, P1490, DOI 10.1016/j.joen.2010.06.006
   Gupta A, 2011, J Conserv Dent, V14, P113, DOI 10.4103/0972-0707.82603
   Imparato J. C. P., 2003, BANKS HUMAN TEETH
   Lo Giudice Giuseppe, 2012, J Conserv Dent, V15, P80, DOI 10.4103/0972-0707.92613
   Alcantara CEP, 2011, EUR J PROSTHODONT RE, V19, P155, DOI 10.1922/EJPRD_1001Alcantara05
   de Alcantara CEP, 2010, DENT TRAUMATOL, V26, P355, DOI 10.1111/j.1600-9657.2010.00902.x
   Pramila R, 2012, J Conserv Dent, V15, P97, DOI 10.4103/0972-0707.94571
   Thompson V, 2008, J AM DENT ASSOC, V139, P705, DOI 10.14219/jada.archive.2008.0252
   Trope M, 2010, J ESTHET RESTOR DENT, V22, P178, DOI 10.1111/j.1708-8240.2010.00332.x
   Witherspoon DE, 2008, PEDIATR DENT, V30, P220
NR 15
TC 0
Z9 0
U1 0
U2 2
PU JOURNAL PEDODONTICS INC
PI BIRMINGHAM
PA 5724 HIGHWAY 280 EAST, BIRMINGHAM, AL 35242 USA
SN 1053-4628
EI 1557-5268
J9 J CLIN PEDIATR DENT
JI J. Clin. Pediatr. Dent.
PD WIN
PY 2013
VL 38
IS 2
BP 113
EP 115
DI 10.17796/jcpd.38.2.106178744570k7h6
PG 3
WC Dentistry, Oral Surgery & Medicine; Pediatrics
SC Dentistry, Oral Surgery & Medicine; Pediatrics
GA AG0GE
UT WOS:000335093100004
PM 24683772
DA 2018-10-20
ER

PT J
AU Momoh, MA
   Brown, SA
   Muogbo, CC
AF Momoh, M. A.
   Brown, S. A.
   Muogbo, C. C.
TI Formulation and Evaluation of Cat Fish Slim Mucin Ointment for Wound
   Healing
SO TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Article
DE Fish mucin; Ointment; Wound; biomaterial
ID ARABIAN GULF CATFISH; SKIN
AB Purpose: To evaluate the effect of fish mucin ointment on wound healing in a rat model.
   Methods: Fish mucin was formulated into an ointment using soft paraffin ointment base. Its wound-healing activity and toxicity were evaluated using an incision and excision wound model in rats. A range of concentrations (2.5 - 10 % w/w) of mucin in the ointment was tested to determine the concentration that will give optimum wound healing activity The ointment base (i.e., without mucin) was used as control while 2 % nitrofurazone served as positive control.
   Results: Wound healing activity increased with increase in mucin concentration up to a maximum of 5 %. Negative control produced wound healing of 41.2 +/- 0.0 % on the 19th day with the mean hydroxyproline content and tensile strength being 682.07 +/- 0.11 mu g/g and 874.11 +/- 0.39 g/cm(2), respectively. Mucin ointment (5 %) exhibited 100 % wound healing properties on day 12. Significant increase (p > 0.05) in skin tensile strength (1311.02 +/- 0.16 g/cm(2)) and hydroxyproline (1163.11 +/- 0.16 mu g/g) was found for mucin ointment as against 1151.21 +/- 0.41 g/cm2 and 875.12 +/- 0.84 mu g/g, respectively, for positive control. At the concentrations tested, no toxicity was recorded for mucin ointment.
   Conclusion: This study demonstrates that the fish mucin ointment promotes wound-healing.
C1 [Momoh, M. A.; Muogbo, C. C.] Univ Nigeria, Fac Pharmaceut Sci, Dept Pharmaceut, Drug Delivery Unit, Nsukka, Nigeria.
   [Brown, S. A.] Univ Port Harcourt, Fac Pharmaceut Sci, Port Harcourt, Nigeria.
RP Momoh, MA (reprint author), Univ Nigeria, Fac Pharmaceut Sci, Dept Pharmaceut, Drug Delivery Unit, Nsukka, Nigeria.
EM jointmomoh@yahoo.com
CR Adikwu MU, 2007, SCI RES ESSAYS, V2, P195
   Adikwu MU, 2006, TROP J PHARM RES, V5, P581
   AlBow HA, 1997, GEN PHARMACOL, V28, P737, DOI 10.1016/S0306-3623(96)00307-2
   ALHASSAN JM, 1990, INT J TISSUE REACT, V12, P121
   Bradshow CM, 1971, SOC EXPT BIOL MED P, V136, P1122
   Cortfield A, 2002, GUT
   Gruen RL, 1996, AUST NZ J SURG, V66, P171, DOI 10.1111/j.1445-2197.1996.tb01150.x
   Huang XJ, 2009, CELL MOL NEUROBIOL, V29, P1211, DOI 10.1007/s10571-009-9417-z
   Momoh M. A., 2012, Journal of Pharmacy Research, V5, P2061
   Momoh MA, 2008, J PHARM RES, V7, P5
   Momoh MA, 2008, DHAKA U J PHARM SCI, V7, P7
   Momoh MA, 2012, J PHARM RES, V5, P2052
   MORTAZAVI SA, 1993, INT J PHARM, V94, P195, DOI 10.1016/0378-5173(93)90024-A
   Nwokoro EA, 2004, J INNOV LIFE SCI, V7, P6
   Pinky SS, 1988, ANAT HISTOL EMBRYOL, V37, P101
   PRUDDEN JF, 1965, J AMER MED ASSOC, V192, P352, DOI 10.1001/jama.1965.03080180010002
   Saha K, 1997, J ETHNOPHARMACOL, V56, P139, DOI 10.1016/S0378-8741(97)01522-5
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
NR 18
TC 1
Z9 1
U1 0
U2 3
PU PHARMACOTHERAPY GROUP
PI BENIN CITY
PA UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA
SN 1596-5996
J9 TROP J PHARM RES
JI Trop. J. Pharm. Res.
PD DEC
PY 2013
VL 12
IS 6
BP 885
EP 890
DI 10.4314/tjpr.v12i6.4
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AB8XE
UT WOS:000332072500004
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Vindigni, V
   Tonello, C
   Lancerotto, L
   Abatangelo, G
   Cortivo, R
   Zavan, B
   Bassetto, F
AF Vindigni, Vincenzo
   Tonello, Carolin
   Lancerotto, Luca
   Abatangelo, Giovanni
   Cortivo, Roberta
   Zavan, Barbara
   Bassetto, Franco
TI Preliminary Report of In Vitro Reconstruction of a Vascularized
   Tendonlike Structure A Novel Application for Adipose-Derived Stem Cells
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
DE adipose-derived stem cells; tendon; adipose tissue; hyaluronic acid;
   endothelial cells; tissue engineering; extracellular matrix; type I
   collagen
ID BONE-MARROW; FIBROBLAST RESPONSES; POLYMERIC SCAFFOLDS; STROMAL CELLS;
   TISSUE; LIGAMENT; DIFFERENTIATION; THERAPIES; TENOCYTES; FIBERS
AB Introduction: A greater supply of tendinous tissue can be obtained through tissue engineering technology with increasing application of adult stem cells. It is well known that adipose-derived stem cells (ADSCs), found in abundance in adipose tissue, have the same differentiating capacity as mesenchymal stem cells yet have the advantage of being easily isolated. In the present study, we combined the great facility of ADSCs to differentiate with the application of an external mechanical stimulus to successfully create an in vitro reconstructed tendonlike structure with a microcapillary network.
   Materials and Methods: Hyalonect meshes (Fidia Advanced Biopolymers, Abano Terme, Padova, Italy) were used as scaffold. Human ADSCs were seeded onto the biomaterials, and the cell/scaffold constructs were cultured under mechanical stress for up to 15 days. Human tenocytes were used in the same conditions as control. Performance was assessed by histology, immunochemistry, ultrastructure, and biomolecular analysis.
   Results: Adipose-derived stem cells seeded onto Hyalonect adhered and differentiated along the entire surface of the biomaterial and began to infiltrate within its structure. Subsequently, endothelial cells migrated, forming a capillary in the new extracellular matrix.
   Conclusions: This technique allowed for the creation of a vascularized tendon equivalent that could easily be detached from the bioreactor, thus facilitating its implant at the lesion site. These results highlight the biologic performance of biodegradable hyaluronic acid-based (HYAFF-11) scaffolds, which were shown to be suitable for deposition of the autologous extracellular matrix critical for ADSCs differentiation.
C1 [Vindigni, Vincenzo; Lancerotto, Luca; Bassetto, Franco] Univ Padua, Plast & Reconstruct Surg Unit, I-35100 Padua, Italy.
   [Tonello, Carolin; Abatangelo, Giovanni; Cortivo, Roberta; Zavan, Barbara] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
RP Vindigni, V (reprint author), Univ Padua, Clin Plast & Reconstruct Surg, Via Giustiniani 2, I-35100 Padua, Italy.
EM vincenzo.vindigni@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105
   BANES AJ, 1988, J ORTHOP RES, V6, P83, DOI 10.1002/jor.1100060111
   Barkhausen T, 2003, EXP TOXICOL PATHOL, V55, P153, DOI 10.1078/0940-2993-00302
   Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x
   Buchanan CI, 2002, COMP BIOCHEM PHYS A, V133, P1101, DOI 10.1016/S1095-6433(02)00139-3
   Butler D, 1999, CLIN ORTHOP RELAT R, V367, P324
   Butler D.L., 2007, J ORTHOP RES, V26, P1
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Doroski DM, 2007, BIOMATERIALS, V28, P187, DOI 10.1016/j.biomaterials.2006.08.040
   Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/036354650427689
   HUANG D, 1993, ANN BIOMED ENG, V21, P289, DOI 10.1007/BF02368184
   Jevon M, 2008, CELL PROLIFERAT, V41, P146, DOI 10.1111/j.1365-2184.2008.00488.x
   Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200
   Kryger GS, 2007, J HAND SURG-AM, V32A, P597, DOI 10.1016/j.jhsa.2007.02.018
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   Meliga E, 2007, CELL TRANSPLANT, V16, P963, DOI 10.3727/096368907783338190
   Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77
   Ogawa Rei, 2006, Curr Stem Cell Res Ther, V1, P13, DOI 10.2174/157488806775269043
   Qin TW, 2005, BIOMATERIALS, V26, P6635, DOI 10.1016/j.biomaterials.2005.04.023
   Rodeo SA, 2004, J BONE JOINT SURG AM, V86A, P2085, DOI 10.2106/00004623-200409000-00034
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Tonello C, 2005, FASEB J, V19, P1546, DOI 10.1096/fj.05-3804fje
   Wang JHC, 2004, J BIOMECH, V37, P573, DOI 10.1016/j.jbiomech.2003.09.011
   Woo SLY, 2006, J BIOMECH, V39, P1, DOI 10.1016/j.jbiomech.2004.10.025
   Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005
   Zavan B, 2007, EUR J HISTOCHEM, V51, P1
   Zavan B, 2005, BIOMATERIALS, V26, P7038, DOI 10.1016/j.biomaterials.2005.04.067
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 30
TC 8
Z9 8
U1 1
U2 14
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
EI 1536-3708
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD DEC
PY 2013
VL 71
IS 6
BP 664
EP 670
DI 10.1097/SAP.0b013e3182583e99
PG 7
WC Surgery
SC Surgery
GA 300IY
UT WOS:000330458800011
PM 23429220
DA 2018-10-20
ER

PT J
AU Li, X
   Fan, DD
   Deng, JJ
   Hui, JF
   Ma, XX
   Zhu, CH
   Xue, WJ
AF Li, Xian
   Fan, Dai-Di
   Deng, Jian-Jun
   Hui, Jun-Feng
   Ma, Xiao-Xuan
   Zhu, Chen-Hui
   Xue, Wen-Jiao
TI Synthesis and Characterization of Chitosan Human Like
   Collagen/beta-Sodium Glycerophosphate-Carbodiimide Hydrogel
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE Biodegradable; Chitosan; Human-like Collagen; Carbodiimide; beta-Sodium
   glycerophosphate
ID NERVE REGENERATION; GROWTH-FACTOR; TISSUE; SCAFFOLD; DEGRADATION
AB Injectable in situ forming biodegradable chitosan-human like collagen (CS-HLC) based hydrogels has proved to be a potential candidate as an injectable biomaterial for tissue engineering. With crosslinking agent of carbodiimide, the properties of the novel chitosan-human-like collagen/beta-sodium glycerophosphate-carbodiimide hydrogel were also examined. The gelation time, structure, equilibrium swelling and degradation in vitro and in vivo were dependent upon crosslinking and structure of composite hydrogels. The chitosan-human-like collagen/beta-sodium glycerophosphate-carbodiimide hydrogel showed a desirable gelling time, swelling ratio, a smooth surface, regular porous networks and biodegradable. Therefore, the chitosan-human-like collagen/beta-sodium glycerophosphate-carbodiimide hydrogels are excellent candidates for use in biomedical fields, such as in soft tissue defect filling and drug delivery.
C1 [Li, Xian; Fan, Dai-Di; Deng, Jian-Jun; Hui, Jun-Feng; Ma, Xiao-Xuan; Zhu, Chen-Hui] NW Univ Xian, Dept Chem Engn, Shaanxi Key Lab Degradable Biomed Mat, Xian 710069, Shaanxi Provinc, Peoples R China.
   [Xue, Wen-Jiao] Shaanxi Prov Inst Microbiol, Xian 710043, Peoples R China.
RP Fan, DD (reprint author), NW Univ Xian, Dept Chem Engn, Shaanxi Key Lab Degradable Biomed Mat, Taibai North Rd 229, Xian 710069, Shaanxi Provinc, Peoples R China.
EM fandaidi@nwu.edu.cn
RI Fan, daidi/J-1128-2017
OI xue, wenjiao/0000-0002-8867-1575
FU National Natural Science Foundation of China [21176200, 21276210,
   21106112, 21206135, 31000019, 21106111]; China Postdoctoral Science
   Foundation [20110490171]; China Postdoctoral Science Special Foundation
   [2012T50755]; Scientific Research Program of Shaanxi Provincial
   Department of Education, China [2013JK0696, 12JK0449, 12JS099, 12JS100,
   12JS101, 2012JC23, 11JS102]; Shaanxi Provincial Scientific Technology
   Research and Development Program [2012KJXX-28, 2013KJXX-28, 2012JM2014,
   2011JE003, 2011JQ4026, 2010JQ2012]; NWU Graduate Innovation and
   Creativity Funds [YZZ12037]; Shaanxi Key Subject Program, China
FX This study was financially supported by the National Natural Science
   Foundation of China (21176200, 21276210, 21106112, 21206135, 31000019
   and 21106111), China Postdoctoral Science Foundation (20110490171),
   China Postdoctoral Science Special Foundation (2012T50755), the
   Scientific Research Program of Shaanxi Provincial Department of
   Education, China (2013JK0696, 12JK0449, 12JS099, 12JS100, 12JS101,
   2012JC23 and 11JS102); Shaanxi Provincial Scientific Technology Research
   and Development Program (2012KJXX-28, 2013KJXX-28, 2012JM2014,
   2011JE003, 2011JQ4026 and 2010JQ2012) and the NWU Graduate Innovation
   and Creativity Funds (YZZ12037) and the Shaanxi Key Subject Program,
   China.
CR Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fan D. D., 2002, CHINESE J CHEM ENG, V10, P752
   Ganji F, 2007, J SOL-GEL SCI TECHN, V42, P47, DOI 10.1007/s10971-006-9007-1
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Hua XF, 2006, CHINESE J CHEM ENG, V14, P242, DOI 10.1016/S1004-9541(06)60065-7
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Li X, 2014, SOFT MATER, V12, P1, DOI 10.1080/1539445X.2011.584269
   Li X, 2012, SOFT MATTER, V8, P3781, DOI 10.1039/c2sm06994f
   Lu GY, 2007, EUR POLYM J, V43, P3807, DOI 10.1016/j.eurpolymj.2007.06.016
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   SANTOS PM, 1991, OTOLARYNG HEAD NECK, V105, P12, DOI 10.1177/019459989110500103
   Tan HP, 2007, J MATER SCI-MATER M, V18, P1961, DOI 10.1007/s10856-007-3095-5
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Wang Y, 2006, MAT SCI ENG C-BIO S, V26, P635, DOI 10.1016/j.msec.2005.07.019
   Yu Y.Y., 2011, ASIAN J CHEM, V23, P1548
   Zhai Y, 2005, CURR APPL PHYS, V5, P429, DOI 10.1016/j.cap.2005.01.004
   Zhu CH, 2009, J BIOMED MATER RES A, V89A, P829, DOI 10.1002/jbm.a.32256
NR 20
TC 2
Z9 2
U1 0
U2 13
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
EI 0975-427X
J9 ASIAN J CHEM
JI Asian J. Chem.
PD DEC
PY 2013
VL 25
IS 17
BP 9613
EP 9616
PN A
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 297EQ
UT WOS:000330238700042
DA 2018-10-20
ER

PT J
AU Zhang, ZJ
   Jia, HL
   Sun, JY
   Ling, MZ
   Wang, YM
   Tong, J
AF Zhang, Zhijun
   Jia, Honlei
   Sun, Jiyu
   Ling, Mingze
   Wang, Yueming
   Tong, Jin
TI THE DIFFERENTIAL CONSTITUTIVE EQUATION AND MODEL OF ABALONE NACRE BY
   NANOINDENTER
SO JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Nanoindentation; viscoelastic properties; nacre; biomaterial
ID MECHANICAL-PROPERTIES; HIERARCHICAL STRUCTURE; VISCOELASTIC BEHAVIOR;
   BIOLOGICAL-MATERIALS; INDENTATION; SHELLS; TIME; LIGAMENTS
AB Nacre has a complex hierarchical microarchitecture that spans over multiple length scales from nanoscale to macroscale. Its structures are optimized leading to extraordinary mechanical performance and energy absorption. Nacre's special characteristics of the self-assembly method have attracted the interest of material scientists to develop laminated composite materials, molecular scale self-assembly and biomineralization. Nanoindentation testing can determine a material's anisotropic properties through a single indentation. In the present study, nanoindentation stress-strain curves were used to characterize the complete mechanical behavior of nacre of abalone shell. A differential constitutive equation was developed with time-dependent spring constants k and viscosities eta. Furthermore, to describe the complex viscoelastic behavior of abalone nacre, a descriptive representation of the linear viscoelasticity law for the multilayer matrix was formulated. A qualitative model for the relationship between nacre structure and mechanical properties of nacre may help develop bionic composite materials for micro-aircraft, bionic tribology, bionic medical apparatus and bionic organs (tissue engineering).
C1 [Zhang, Zhijun] Jilin Univ, Inst Mech Sci & Engn, Changchun 130022, Peoples R China.
   [Jia, Honlei; Sun, Jiyu; Ling, Mingze; Wang, Yueming; Tong, Jin] Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun 130022, Peoples R China.
RP Jia, HL (reprint author), Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun 130022, Peoples R China.
EM zhijunzhang@jlu.edu.cn; jiahl@vip.163.com; sjy@jlu.edu.cn
FU National Natural Science Foundation of China [31172144]; Project of the
   National Twelfth-Five Year Research Program of China [2011BAD20B09-15];
   Science & Technology Development Projects of Jilin Province
   [201303040ZY]; Basic Operation Foundation of Jilin University
   [201200007]; Open Foundation of Key Laboratory of Bionics Engineering,
   Jilin University, Ministry of Education [K201205A]; "Project 985" of
   Jilin University
FX This work was supported by National Natural Science Foundation of China
   (No. 31172144), by the Project of the National Twelfth-Five Year
   Research Program of China (No. 2011BAD20B09-15), by the Science &
   Technology Development Projects of Jilin Province (No. 201303040ZY), by
   the Basic Operation Foundation of Jilin University (No. 201200007), Open
   Foundation of Key Laboratory of Bionics Engineering, Jilin University,
   Ministry of Education (No. K201205A) and by "Project 985" of Jilin
   University.
CR Ahearne M, 2007, ANN BIOMED ENG, V35, P1608, DOI 10.1007/s10439-007-9323-9
   Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007
   BARTHELAT F, 2011, J MATER RES, V9999, P181
   Bergstrom JS, 2000, MECH MATER, V32, P627, DOI 10.1016/S0167-6636(00)00028-4
   Cartwright JHE, 2009, P NATL ACAD SCI USA, V106, P10499, DOI 10.1073/pnas.0900867106
   Dubey DK, 2010, ANN BIOMED ENG, V38, P2040, DOI 10.1007/s10439-010-9988-3
   Ehlers W, 2001, J BIOMECH ENG-T ASME, V123, P418, DOI 10.1115/1.1388292
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Funk JR, 2000, J BIOMECH ENG-T ASME, V122, P15, DOI 10.1115/1.429623
   Gorb S, 2000, J COMP PHYSIOL A, V186, P821, DOI 10.1007/s003590000135
   Holzapfel GA, 2002, EUR J MECH A-SOLID, V21, P441, DOI 10.1016/S0997-7538(01)01206-2
   Garcia JJ, 2006, J BIOMECH, V39, P2991, DOI 10.1016/j.jbiomech.2005.10.017
   Jeffrey E., 2006, ANN BIOMED ENG, V34, P1164
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Lopes-Lima M, 2010, J SHELLFISH RES, V29, P969, DOI 10.2983/035.029.0431
   Martinez E, 2003, APPL PHYS A-MATER, V77, P419, DOI 10.1007/s00339-002-1669-0
   Menig R, 2001, MAT SCI ENG A-STRUCT, V297, P203, DOI 10.1016/S0921-5093(00)01228-4
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Mohanty B, 2006, J MATER RES, V21, P2045, DOI 10.1557/JMR.2006.0247
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Sun JY, 2012, RSC ADV, V2, P7617, DOI 10.1039/c2ra20218b
   Sverdlik A, 2002, J BIOMECH ENG-T ASME, V124, P78, DOI 10.1115/1.1427699
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   Vena P, 2006, J BIOMECH ENG-T ASME, V128, P449, DOI 10.1115/1.2187046
   Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340
   Wu XY, 2006, BIOMATERIALS, V27, P5315, DOI 10.1016/j.biomaterials.2006.06.003
   Yourdkhani M, 2011, J BIONIC ENG, V8, P357, DOI 10.1016/S1672-6529(11)60041-3
   Zaremba CM, 1996, CHEM MATER, V8, P679, DOI 10.1021/cm9503285
NR 28
TC 0
Z9 0
U1 2
U2 24
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-5194
EI 1793-6810
J9 J MECH MED BIOL
JI J. Mech. Med. Biol.
PD DEC
PY 2013
VL 13
IS 6
SI SI
AR UNSP 1340011
DI 10.1142/S0219519413400113
PG 12
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 302YF
UT WOS:000330640400002
DA 2018-10-20
ER

PT J
AU Hutten, M
   Ehrhart, F
   Zimmermann, H
AF Huetten, M.
   Ehrhart, F.
   Zimmermann, H.
TI UHV-Alginate as Matrix for Neurotrophic Factor Producing Cells-A Novel
   Biomaterial for Cochlear Implant Optimization to Preserve Inner Ear
   Neurons From Degeneration (vol 34, pg 1127, 2013)
SO OTOLOGY & NEUROTOLOGY
LA English
DT Correction
CR Hutten M, 2013, OTOL NEUROTOL, V34, P1127, DOI 10.1097/MAO.0b013e3182804949
NR 1
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1531-7129
EI 1537-4505
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD DEC
PY 2013
VL 34
IS 9
BP 1751
EP 1751
PG 1
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 301HY
UT WOS:000330524600040
DA 2018-10-20
ER

PT J
AU Karygianni, L
   Jahnig, A
   Schienle, S
   Bernsmann, F
   Adolfsson, E
   Kohal, RJ
   Chevalier, J
   Hellwig, E
   Al-Ahmad, A
AF Karygianni, Lamprini
   Jaehnig, Andrea
   Schienle, Stefanie
   Bernsmann, Falk
   Adolfsson, Erik
   Kohal, Ralf J.
   Chevalier, Jerome
   Hellwig, Elmar
   Al-Ahmad, Ali
TI Initial Bacterial Adhesion on Different Yttria-Stabilized Tetragonal
   Zirconia Implant Surfaces in Vitro
SO MATERIALS
LA English
DT Article
DE antimicrobial surface; initial bacteria adhesion; live/dead staining;
   yttria-stabilized zirconia; zirconia ceramics
ID BIOFILM FORMATION; DENTAL PLAQUE; COLONIZATION; CERAMICS; VIVO;
   BIOMATERIAL; COMPOSITES; COATINGS; DISEASES; STRAINS
AB Bacterial adhesion to implant biomaterials constitutes a virulence factor leading to biofilm formation, infection and treatment failure. The aim of this study was to examine the initial bacterial adhesion on different implant materials in vitro. Four implant biomaterials were incubated with Enterococcus faecalis, Staphylococcus aureus and Candida albicans for 2 h: 3 mol % yttria-stabilized tetragonal zirconia polycrystal surface (B1a), B1a with zirconium oxide (ZrO2) coating (B2a), B1a with zirconia-based composite coating (B1b) and B1a with zirconia-based composite and ZrO2 coatings (B2b). Bovine enamel slabs (BES) served as control. The adherent microorganisms were quantified and visualized using scanning electron microscopy (SEM); DAPI and live/dead staining. The lowest bacterial count of E. faecalis was detected on BES and the highest on B1a. The fewest vital C. albicans strains (42.22%) were detected on B2a surfaces, while most E. faecalis and S. aureus strains (approximately 80%) were vital overall. Compared to BES; coated and uncoated zirconia substrata exhibited no anti-adhesive properties. Further improvement of the material surface characteristics is essential.
C1 [Karygianni, Lamprini; Jaehnig, Andrea; Schienle, Stefanie; Hellwig, Elmar; Al-Ahmad, Ali] Univ Freiburg, Div Restorat Dent & Periodontol, Dept Dent Med Oral & Maxillofacial Surg, Med Ctr, D-79106 Freiburg, Germany.
   [Bernsmann, Falk] NTTF Coatings GmbH, D-53619 Rheinbreitbach, Germany.
   [Adolfsson, Erik] Swerea IVF, Ceram Mat, SE-43122 Molndal, Sweden.
   [Kohal, Ralf J.] Univ Freiburg, Div Prosthodont, Dept Dent Med Oral & Maxillofacial Surg, Med Ctr, D-79106 Freiburg, Germany.
   [Chevalier, Jerome] Univ Lyon, INSA Lyon, MATEIS, CNRS,UMR 5510, F-69621 Villeurbanne, France.
RP Al-Ahmad, A (reprint author), Univ Freiburg, Div Restorat Dent & Periodontol, Dept Dent Med Oral & Maxillofacial Surg, Med Ctr, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM lamprini.karygianni@uniklinik-freiburg.de; andrea.saw@web.de;
   stefanieschienle@web.de; falk.bernsmann@nttf-coatings.de;
   Erik.Adolfsson@swerea.se; ralf.kohal@uniklinik-freiburg.de;
   jeromechevalier@me.com; elmar.hellwig@uniklinik-freiburg.de;
   ali.al-ahmad@uniklinik-freiburg.de
OI Kohal, Ralf/0000-0001-7095-4190
FU European Commission [FP7-280741-LONGLIFE]
FX The authors express their gratitude to Anja Stork, Bettina Spitzmuller
   and Simon Schulz for their excellent technical help. This study was
   supported by the European Commission (FP7-280741-LONGLIFE Collaborative
   project). The authors deny any conflicts of interest related to this
   study.
CR Al-Ahmad A, 2013, ARCH ORAL BIOL, V58, P1139, DOI 10.1016/j.archoralbio.2013.04.011
   Al-Ahmad A, 2010, J BIOMED MATER RES B, V95B, P101, DOI 10.1002/jbm.b.31688
   Al-Ahmad A, 2009, J MED MICROBIOL, V58, P1359, DOI 10.1099/jmm.0.011213-0
   Andreiotelli M, 2009, CLIN IMPLANT DENT R, V11, P158, DOI 10.1111/j.1708-8208.2008.00105.x
   Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7
   Bumgardner JD, 2011, INT J ORAL MAX IMPL, V26, P553
   Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2004, BIOMATERIALS, V25, P5539, DOI 10.1016/j.biomaterials.2004.01.002
   Chevalier J, 2009, BIOMATERIALS, V30, P5279, DOI 10.1016/j.biomaterials.2009.06.022
   Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015
   do Nascimento C, 2014, CLIN ORAL IMPLAN RES, V25, P337, DOI 10.1111/clr.12093
   Eliaz N, 2009, ACTA BIOMATER, V5, P3178, DOI 10.1016/j.actbio.2009.04.005
   Furst MM, 2007, CLIN ORAL IMPLAN RES, V18, P501, DOI 10.1111/j.1600-0501.2007.01381.x
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3
   Karygianni L, 2012, APPL ENVIRON MICROB, V78, P8703, DOI 10.1128/AEM.02416-12
   Katsikogianni M, 2006, J MATER SCI-MATER M, V17, P679, DOI 10.1007/s10856-006-9678-8
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Madianos PN, 2005, J CLIN PERIODONTOL, V32, P57, DOI 10.1111/j.1600-051X.2005.00821.x
   Marchi J, 2013, DENT MATER, V29, P954, DOI 10.1016/j.dental.2013.07.002
   Marsh PD, 2004, CARIES RES, V38, P204, DOI 10.1159/000077756
   Marsh PD, 2005, J CLIN PERIODONTOL, V32, P7, DOI 10.1111/j.1600-051X.2005.00790.x
   Nganga S, 2013, J MATER SCI-MATER M, V24, P2775, DOI 10.1007/s10856-013-5022-2
   Okada A, 2008, DENT MATER J, V27, P565, DOI 10.4012/dmj.27.565
   Pardun K, 2015, CLIN IMPLANT DENT R, V17, P186, DOI 10.1111/cid.12071
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P290, DOI 10.1111/j.1600.051X.2006.00906.x
   Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2
   Sanon C, 2013, DENT MATER, V29, P389, DOI 10.1016/j.dental.2013.01.007
   Schaudinn C, 2009, J AM DENT ASSOC, V140, P978, DOI 10.14219/jada.archive.2009.0307
   Schmidlin PR, 2013, J APPL ORAL SCI, V21, P48, DOI 10.1590/1678-7757201302312
   Schwartz T, 2003, J APPL MICROBIOL, V95, P591, DOI 10.1046/j.1365-2672.2003.02019.x
   Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x
   Tawakoli PN, 2013, CLIN ORAL INVEST, V17, P841, DOI 10.1007/s00784-012-0792-3
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Treccani L, 2013, ACTA BIOMATER, V9, P7115, DOI 10.1016/j.actbio.2013.03.036
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   van Merode AEJ, 2008, COLLOID SURFACE B, V64, P302, DOI 10.1016/j.colsurfb.2008.02.004
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   Yeo IS, 2012, INT J ARTIF ORGANS, V35, P762, DOI 10.5301/ijao.5000154
NR 48
TC 9
Z9 9
U1 1
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD DEC
PY 2013
VL 6
IS 12
BP 5659
EP 5674
DI 10.3390/ma6125659
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA 298AZ
UT WOS:000330297600015
PM 28788415
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wan, ACA
   Tai, BCU
AF Wan, Andrew C. A.
   Tai, Benjamin C. U.
TI CHITIN - A promising biomaterial for tissue engineering and stem cell
   technologies
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE Chitin; Stem cell; Tissue engineering; Scaffolds
ID INTERFACIAL POLYELECTROLYTE COMPLEXATION; BIOMIMETIC NANOFIBROUS
   SCAFFOLDS; PARTIALLY DEACETYLATED CHITIN; N-ACETYLATED CHITOSANS;
   BETA-CHITIN; ALPHA-CHITIN; IN-VITRO; MOLECULAR-WEIGHT; GENE DELIVERY;
   PATHOGEN RECOGNITION
AB Chitin, after cellulose, is the second most abundant natural polymer. With a 200-year history of scientific research, chitin is beginning to see fruitful application in the fields of stein cell and tissue engineering. To date, however, research in chitin as a biomaterial appears to lag far behind that of its close relative, chitosan, due to the perceived difficulty in processing chitin. This review presents methods to improve the processability of chitin, and goes on further to discuss the unique physicochemical and biological characteristics of chitin that favor it as a biomaterial for regenerative medicine applications. Examples of the latter are presented, with special attention on the qualities of chitin that make it inherently suitable as scaffolds and matrices for tissue engineering, stem cell propagation and differentiation. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Wan, Andrew C. A.; Tai, Benjamin C. U.] Inst Bioengn & Nanotechnol, The Nanos 138669, Singapore.
RP Wan, ACA (reprint author), Inst Bioengn & Nanotechnol, 31 Biopolis Way,04-01, The Nanos 138669, Singapore.
EM awan@ibn.a-star.edu.sg; btai@ibn.a-star.edu.sg
RI Wan, Andrew/B-8525-2014
FU Institute of Bioengineering and Nanotechnology (Biomedical Research
   Council, Agency for Science, Technology and Research, Singapore)
FX This work is funded by the Institute of Bioengineering and
   Nanotechnology (Biomedical Research Council, Agency for Science,
   Technology and Research, Singapore).
CR Abe M, 2004, TISSUE ENG, V10, P585, DOI 10.1089/107632704323061942
   AIBA S, 1992, INT J BIOL MACROMOL, V14, P225, DOI 10.1016/S0141-8130(05)80032-7
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Alemdaroglu C, 2006, BURNS, V32, P319, DOI 10.1016/j.burns.2005.10.015
   ATKINS E, 1985, J BIOSCIENCE, V8, P375, DOI 10.1007/BF02703990
   Austin P. R, 1975, US patent, Patent No. [3879377, 3,879,377]
   AUSTIN PR, 1981, SCIENCE, V212, P749, DOI 10.1126/science.7221561
   AUSTIN PR, 1988, METHOD ENZYMOL, V161, P403
   Austin PR, 1975, US patent, Patent No. [3892731, 3,892,731]
   BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511
   BLACKWEL.J, 1969, BIOPOLYMERS, V7, P281, DOI 10.1002/bip.1969.360070302
   BUCK KW, 1971, BIOCHEM J, V125, P461, DOI 10.1042/bj1250461
   Campos M, 2006, MACROMOL SYMP, V245, P515, DOI 10.1002/masy.200651373
   Capozza RC, 1976, US Patent, Patent No. [3989535, 3,989,535]
   Carvalho V, 2008, MOL BIOTECHNOL, V40, P269, DOI 10.1007/s12033-008-9089-9
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Cho YW, 2000, BIOMACROMOLECULES, V1, P609, DOI 10.1021/bm000036j
   Cui ZR, 2001, J CONTROL RELEASE, V75, P409, DOI 10.1016/S0168-3659(01)00407-2
   Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P141, DOI 10.1016/j.ijbiomac.2010.05.009
   Ercelen S, 2006, COLLOID SURFACE B, V51, P140, DOI 10.1016/j.colsurfb.2006.06.008
   Fang N, 2001, BIOMACROMOLECULES, V2, P1161, DOI 10.1021/bm015548s
   Funakoshi T, 2006, J SHOULDER ELB SURG, V15, P112, DOI 10.1016/j.jse.2005.05.012
   Ge ZG, 2004, BIOMATERIALS, V25, P1049, DOI 10.1016/S0142-9612(03)00612-4
   Germershaus O, 2008, J CONTROL RELEASE, V125, P145, DOI 10.1016/j.jconrel.2007.10.013
   Guan SP, 2009, PROTEIN PEPTIDE LETT, V16, P490, DOI 10.2174/092986609788167842
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   HEPBURN HR, 1975, COMP BIOCHEM PHYSIOL, V50, P551, DOI 10.1016/0300-9629(75)90313-8
   HIRANO S, 1988, METHOD ENZYMOL, V161, P408
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001
   Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20179
   Jayakumar R, 2011, INT J BIOL MACROMOL, V49, P274, DOI 10.1016/j.ijbiomac.2011.04.020
   Jayakumar R, 2010, CARBOHYD POLYM, V79, P1, DOI 10.1016/j.carbpol.2009.08.026
   KAIFU K, 1982, J BIOMED MATER RES, V16, P757, DOI 10.1002/jbm.820160602
   Katas H, 2006, J CONTROL RELEASE, V115, P216, DOI 10.1016/j.jconrel.2006.07.021
   Kawai T, 2010, ARTIF ORGANS, V34, P55, DOI 10.1111/j.1525-1594.2009.00786.x
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   KNORR D, 1991, FOOD TECHNOL-CHICAGO, V45, P114
   Kristiansen A, 1999, CARBOHYD POLYM, V38, P23, DOI 10.1016/S0144-8617(98)00106-4
   Kubota N, 2000, CARBOHYD RES, V324, P268, DOI 10.1016/S0008-6215(99)00263-3
   Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1
   Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272
   Kumar PTS, 2011, INT J BIOL MACROMOL, V49, P20, DOI 10.1016/j.ijbiomac.2011.03.006
   Kumirska J, 2010, MAR DRUGS, V8, P1567, DOI 10.3390/md8051567
   Kuo YC, 2006, BIOTECHNOL BIOENG, V95, P132, DOI 10.1002/bit.21007
   Kuo YC, 2012, COLLOID SURFACE B, V93, P85, DOI 10.1016/j.colsurfb.2011.12.011
   Kuo YC, 2011, COLLOID SURFACE B, V82, P616, DOI 10.1016/j.colsurfb.2010.10.031
   Kuo YC, 2010, BIOMACROMOLECULES, V11, P731, DOI 10.1021/bm901312x
   Kuo YC, 2009, BIOTECHNOL PROGR, V25, P1459, DOI 10.1002/btpr.232
   Kurita K, 2005, BIOMACROMOLECULES, V6, P1414, DOI 10.1021/bm049295p
   Kurita K, 2003, BIOMACROMOLECULES, V4, P1264, DOI 10.1021/bm034074p
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CG, 2009, YONSEI MED J, V50, P22, DOI 10.3349/ymj.2009.50.1.22
   Leong MF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3353
   Li J, 1999, BIOPOLYMERS, V723, P88
   Li L, 2004, J PEDIATR ORTHOPED, V24, P205, DOI 10.1097/01241398-200403000-00014
   Liao IC, 2005, J CONTROL RELEASE, V104, P347, DOI 10.1016/j.jconrel.2005.02.013
   Lieder R, 2012, INT J BIOL MACROMOL, V51, P675, DOI 10.1016/j.ijbiomac.2012.07.005
   Lim SH, 2006, MOL THER, V13, P1163, DOI 10.1016/j.ymthe.2005.12.016
   Lim TC, 2013, BIOMATERIALS, V34, P7064, DOI 10.1016/j.biomaterials.2013.05.068
   Lu HF, 2012, BIOMATERIALS, V33, P9179, DOI 10.1016/j.biomaterials.2012.09.006
   Lu HF, 2012, BIOMATERIALS, V33, P2419, DOI 10.1016/j.biomaterials.2011.11.077
   Maeda Y, 2008, INT J BIOL MACROMOL, V42, P463, DOI 10.1016/j.ijbiomac.2008.03.002
   Mason C, 2009, REGEN MED, V4, P153, DOI 10.2217/17460751.4.2.153
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Minagawa T, 2007, CARBOHYD POLYM, V67, P640, DOI 10.1016/j.carbpol.2006.07.007
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   NISHI N, 1986, INT J BIOL MACROMOL, V8, P311, DOI 10.1016/0141-8130(86)90046-2
   Nishimura K, 1984, Vaccine, V2, P93, DOI 10.1016/S0264-410X(98)90039-1
   Nishino T, 1999, J POLYM SCI POL PHYS, V37, P1191, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1191::AID-POLB13>3.0.CO;2-H
   Noh HK, 2006, BIOMATERIALS, V27, P3934, DOI 10.1016/j.biomaterials.2006.03.016
   Notin L, 2006, ACTA BIOMATER, V2, P387, DOI 10.1016/j.actbio.2006.03.003
   Ogawa Y, 2011, CARBOHYD POLYM, V83, P1213, DOI 10.1016/j.carbpol.2010.09.025
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   OKAMOTO Y, 1993, J VET MED SCI, V55, P739, DOI 10.1292/jvms.55.739
   Okamoto Y, 1997, CARBOHYD POLYM, V33, P33, DOI 10.1016/S0144-8617(97)00040-4
   Paoletti MG, 2007, ANN NUTR METAB, V51, P244, DOI 10.1159/000104144
   Park IK, 2001, J APPL POLYM SCI, V80, P2624, DOI 10.1002/app.1374
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Park KE, 2006, BIOMACROMOLECULES, V7, P635, DOI 10.1021/bm0509265
   Peng L, 2009, J BIOMED MATER RES A, V90A, P564, DOI 10.1002/jbm.a.32117
   Peng Q, 2010, J BIOMED MATER RES A, V93A, P920, DOI 10.1002/jbm.a.32408
   Qin CQ, 2002, INT J BIOL MACROMOL, V31, P111, DOI 10.1016/S0141-8130(02)00064-8
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   RUDALL K. M., 1963, ADVAN INSECT PHYSIOL, V1, P257, DOI 10.1016/S0065-2806(08)60177-0
   RUDALL KM, 1973, BIOL REV, V48, P597, DOI 10.1111/j.1469-185X.1973.tb01570.x
   Safronova E E, 1991, Biomed Sci, V2, P162
   SAIKI I, 1990, CANCER RES, V50, P3631
   Saito Y, 1997, MACROMOLECULES, V30, P3867, DOI 10.1021/ma961787+
   SANNAN T, 1976, MAKROMOL CHEM, V177, P3589
   Sashiwa H, 2000, BIOMACROMOLECULES, V1, P303, DOI 10.1021/bm005536r
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Sato M, 2000, J Orthop Sci, V5, P256, DOI 10.1007/s007760050161
   Shikhman AR, 2009, OSTEOARTHR CARTILAGE, V17, P1022, DOI 10.1016/j.joca.2009.03.004
   Shikhman AR, 2001, J IMMUNOL, V166, P5155, DOI 10.4049/jimmunol.166.8.5155
   Silva SS, 2011, ACTA BIOMATER, V7, P1166, DOI 10.1016/j.actbio.2010.09.041
   Su CH, 1999, BIOMATERIALS, V20, P61, DOI 10.1016/S0142-9612(98)00139-2
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki D, 2008, J MATER SCI-MATER M, V19, P1307, DOI 10.1007/s10856-007-3245-9
   Suzuki S, 2005, BIOMACROMOLECULES, V6, P3238, DOI 10.1021/bm050486h
   Sylvester KG, 2004, ARCH SURG-CHICAGO, V139, P93, DOI 10.1001/archsurg.139.1.93
   Tahara K, 2008, INT J PHARM, V354, P210, DOI 10.1016/j.ijpharm.2007.11.002
   Tai BCU, 2010, BIOMATERIALS, V31, P5927, DOI 10.1016/j.biomaterials.2010.04.003
   Tai BCU, 2010, BIOMATERIALS, V31, P48, DOI 10.1016/j.biomaterials.2009.09.022
   Takegawa A, 2010, CARBOHYD POLYM, V79, P85, DOI 10.1016/j.carbpol.2009.07.030
   Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514
   TOKURA S, 1994, J MACROMOL SCI PURE, VA31, P1701, DOI 10.1080/10601329408545878
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tong YJ, 2011, CARBOHYD RES, V346, P495, DOI 10.1016/j.carres.2010.12.013
   TRUJILLO R, 1968, CARBOHYD RES, V7, P483, DOI 10.1016/S0008-6215(00)82969-9
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   Wan ACA, 2006, ADV MATER, V18, P641, DOI 10.1002/adma.200502096
   Wan ACA, 2004, J BIOMED MATER RES A, V71A, P586, DOI 10.1002/jbm.a.30158
   Wan ACA, 1998, J BIOMED MATER RES, V41, P541, DOI 10.1002/(SICI)1097-4636(19980915)41:4<541::AID-JBM5>3.0.CO;2-C
   Wan ACA, 1998, BIOMATERIALS, V19, P1309
   Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X
   Wan ACA, 1997, J BIOMED MATER RES, V38, P235, DOI 10.1002/(SICI)1097-4636(199723)38:3<235::AID-JBM8>3.0.CO;2-Q
   Wan ACA, 2012, ADV HEALTHC MATER, V1, P101, DOI 10.1002/adhm.201100020
   Wang J, 2008, INT J BIOL MACROMOL, V42, P450, DOI 10.1016/j.ijbiomac.2008.02.007
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497
   Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998
   Yim EKF, 2007, TISSUE ENG, V13, P423, DOI 10.1089/ten.2006.0113
   Yim EKF, 2006, BIOMATERIALS, V27, P6111, DOI 10.1016/j.biomaterials.2006.07.037
   Yoo CR, 2008, INT J BIOL MACROMOL, V42, P324, DOI 10.1016/j.ijbiomac.2007.12.004
   Yusof NLBM, 2003, J BIOMED MATER RES A, V66A, P224, DOI 10.1002/jbm.a.10545
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
   Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962
   Zhang YF, 2009, J CONTROL RELEASE, V136, P172, DOI 10.1016/j.jconrel.2009.02.016
   Zhong C, 2010, SOFT MATTER, V6, P5298, DOI 10.1039/c0sm00450b
NR 134
TC 37
Z9 39
U1 2
U2 80
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
EI 1873-1899
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD DEC
PY 2013
VL 31
IS 8
BP 1776
EP 1785
DI 10.1016/j.biotechadv.2013.09.007
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 281DW
UT WOS:000329081200048
PM 24080076
DA 2018-10-20
ER

PT J
AU Garbelotto, LGD
   Volpato, CAM
   da Rocha, M
   Maranghello, CA
   Calasans, A
   Ozcan, M
AF D'Altoe Garbelotto, Luis Gustavo
   Maziero Volpato, Claudia Angela
   da Rocha, Marcelo
   Maranghello, Carlos Augusto
   Calasans, Alberto
   Oezcan, Mutlu
TI Laboratory and Clinical Considerations on Prosthetic Zirconia
   Infrastructures for Implants
SO IMPLANT DENTISTRY
LA English
DT Article
DE ceramics; zirconia; zirconia blocks; vitrification of zirconia
ID SHEAR BOND STRENGTH; CERAMICS; SURFACE; TRANSFORMATION; BIOMATERIAL;
   FUTURE
AB Zirconia is a ceramic material that is used for constructing prosthetic infrastructures and implant abutments using CAD/CAM techniques. Although good initial mechanical properties are obtained with zirconia that is partially stabilized by yttrium, it may age in a moist environment, compromising such properties and, consequently, the longevity of the restorative work. To optimize the longevity of this material, it is essential that the clinician and laboratory technician understand its mechanical properties and limitations and take specific precautions needed to maintain its mechanical properties and ensure long-term performance especially in implant prosthetics. This article presents a clinical case where these precautions were taken, emphasizing the key surface treatments advocated for zirconia.
C1 [D'Altoe Garbelotto, Luis Gustavo; Maziero Volpato, Claudia Angela] Univ Fed Santa Catarina, Dept Dent, BR-88015130 Florianopolis, SC, Brazil.
   [da Rocha, Marcelo] Inga Fac, Criciuma, Brazil.
   [Maranghello, Carlos Augusto] Dent Lab, Porto Alegre, RS, Brazil.
   [Calasans, Alberto] Dent Lab, Sao Paulo, Brazil.
   [Oezcan, Mutlu] Univ Zurich, Ctr Dent & Oral Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Dent Mat Unit, Zurich, Switzerland.
RP Garbelotto, LGD (reprint author), Univ Fed Santa Catarina, Dept Dent, Rua Esteves Jr 366,Sala 407, BR-88015130 Florianopolis, SC, Brazil.
EM luisgarbelotto@me.com
CR Aboushelib MN, 2010, J PROSTHODONT, V19, P340, DOI 10.1111/j.1532-849X.2010.00575.x
   Aboushelib MN, 2009, INT J PROSTHODONT, V22, P616
   Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1
   Andreiotelli M, 2009, CLIN IMPLANT DENT R, V11, P158, DOI 10.1111/j.1708-8208.2008.00105.x
   CALES B, 1994, J BIOMED MATER RES, V28, P619, DOI 10.1002/jbm.820280512
   Casucci A, 2009, J DENT, V37, P891, DOI 10.1016/j.jdent.2009.06.013
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Denry IL, 2010, J BIOMED MATER RES B, V93B, P236, DOI 10.1002/jbm.b.31580
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Guo X, 1999, J PHYS CHEM SOLIDS, V60, P539, DOI 10.1016/S0022-3697(98)00301-1
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Kim HJ, 2011, J PROSTHET DENT, V105, P315, DOI 10.1016/S0022-3913(11)60060-7
   Koutayas SO, 2009, INT J ESTHET DENT, V4, P348
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Mosharraf R, 2011, J ADV PROSTHODONT, V3, P221, DOI 10.4047/jap.2011.3.4.221
   Nakamura K, 2010, INT J PROSTHODONT, V23, P299
   Ntala P, 2010, J DENT, V38, P773, DOI 10.1016/j.jdent.2010.06.008
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rashad MM, 2008, J MATER PROCESS TECH, V195, P178, DOI 10.1016/j.jmatprotec.2007.04.135
   Truninger TC, 2012, CLIN ORAL IMPLAN RES, V23, P12, DOI 10.1111/j.1600-0501.2010.02141.x
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   Zhang Y, 2012, J DENT RES, V91, P311, DOI 10.1177/0022034511434356
NR 25
TC 2
Z9 2
U1 1
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1056-6163
EI 1538-2982
J9 IMPLANT DENT
JI Implant Dent.
PD DEC
PY 2013
VL 22
IS 6
BP 578
EP 583
DI 10.1097/ID.0000000000000009
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 292SV
UT WOS:000329923600005
PM 24177281
DA 2018-10-20
ER

PT J
AU Mastrangelo, F
   Quaresima, R
   Grilli, A
   Tettamanti, L
   Vinci, R
   Sammartino, G
   Tete, S
   Gherlone, E
AF Mastrangelo, Filiberto
   Quaresima, Raimondo
   Grilli, Alfredo
   Tettamanti, Lucia
   Vinci, Raffaele
   Sammartino, Gilberto
   Tete, Stefano
   Gherlone, Enrico
TI A Comparison of Bovine Bone and Hydroxyapatite Scaffolds During Initial
   Bone Regeneration: An In Vitro Evaluation
SO IMPLANT DENTISTRY
LA English
DT Article
DE Bio-Oss; ENGIpore; bone; regeneration; osteogenesis; mesenchymal stem
   cells
ID MESENCHYMAL STEM-CELLS; CALVARIAL BONE; GROWTH-FACTORS; RECONSTRUCTION;
   GRAFTS; EXPRESSION; IMPLANTS; BEHAVIOR; SURFACE; ASSAY
AB Objectives:To evaluate the different behavior of 3-dimensional biomaterial scaffoldsBovine Bone (BB; Bio-Oss) and Hydroxyapatite (HA; ENGIpore)during initial bone healing and development.Materials and Methods:Human dental papilla stem cells (hDPaSCs) were selected with FACsorter cytofluorimetric analysis, cultured with osteogenic medium, and analyzed with Alizarin red stained after differentiation. The obtained osteoblast-like cells (OCs) were cultured with BB and HA. alkaline phosphatase (ALP), OC, MEPE, and runt-related transcription factor 2 (RUNX2) expression markers were investigated performing Western blot and reverse transcription-polymerase chain reaction (RT-PCR) analysis. After 40 days, samples were analyzed by light and electron microscopy.Results:All the samples showed high in vitro biocompatibility and qualitative differences of OCs adhesion. RT-PCR and Western blot data exhibited similar marker rate, but ALP, OC, MEPE, and RUNX2expression, during initial healing and bone regeneration phase, was higher and faster in human dental papilla onto BB than in HA scaffolds. In biomaterials growth, RUNX2 seems to play an important role as a key regulator in human OCs from dental papilla bone development.Conclusion:Different surface BB scaffold characteristics seem to play a critical role in OCs differentiation showing different time of bone regeneration morphological characteristics as well as higher and faster levels of all observed markers.
C1 [Mastrangelo, Filiberto; Grilli, Alfredo; Tete, Stefano] Univ G dAnnunzio, Dept Oral Med Sci & Biotechnol, Chieti, Italy.
   [Quaresima, Raimondo] Univ Aquila, Dept Civil Engn Architecture & Environm, I-67100 Laquila, Italy.
   [Grilli, Alfredo] Leonardo da Vinci Telemat Univ, Chieti, Italy.
   [Tettamanti, Lucia] Insubria Univ Varese, Dept Oral Sci, Varese, Italy.
   [Vinci, Raffaele; Gherlone, Enrico] Univ Vita & Salute Milano, Dept Oral Sci, Milan, Italy.
   [Sammartino, Gilberto] Univ Naples Federico II, Dept Surg Sci, Naples, Italy.
RP Mastrangelo, F (reprint author), Univ G DAnnunzio, Dept Oral Sci, Via Vestini 31, I-66013 Chieti, CH, Italy.
EM filibertomastrangelo@hotmail.com
RI Gherlone, Enrico/M-7376-2016
OI grilli, alfredo/0000-0002-5746-5007; QUARESIMA,
   RAIMONDO/0000-0002-7517-2769; MASTRANGELO, Filiberto/0000-0002-3746-5675
CR Aravamudhan A, 2013, CURR PHARM DESIGN, V19, P3420, DOI 10.2174/1381612811319190008
   Boeck-Neto RJ, 2002, J PERIODONTOL, V73, P26
   Boeckel DG, 2012, J ORAL IMPLANTOL, V38, P538, DOI 10.1563/AAID-JOI-D-11-00197
   Despang F., 2013, J TISSUE ENG REGEN M
   Gierloff M, 2012, J CRANIOFAC SURG, V23, P161, DOI 10.1097/SCS.0b013e3182413edc
   Gonzalez M, 2013, J BIOMED MATER RES A, V101, P819, DOI 10.1002/jbm.a.34388
   Gonzalez-Garcia Raul, 2005, Med Oral Patol Oral Cir Bucal, V10, P343
   Hising P, 2001, INT J ORAL MAX IMPL, V16, P90
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   Iizuka T, 2004, CLIN ORAL IMPLAN RES, V15, P607, DOI 10.1111/j.1600-0501.2004.01043.x
   Jafarian M, 2008, ORAL SURG ORAL MED O, V105, pE14, DOI 10.1016/j.tripleo.2008.01.010
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Li XM, 2013, J BIOMED MAT RES A, DOI 10. 1002/jbm. a. 34539
   Liao X, 2012, PLOS ONE, V7
   Liu H, 2006, METHOD ENZYMOL, V419, P99, DOI 10.1016/S0076-6879(06)19005-9
   Lundgren S, 1996, Int J Oral Maxillofac Implants, V11, P760
   Manfrini M, 2013, J CELL PHYSIOL, V228, P1229, DOI 10.1002/jcp.24276
   Mangano Carlo, 2006, J Oral Implantol, V32, P122, DOI 10.1563/796.1
   Mastrangelo F, 2008, J HEALTH SCI, V54, P154, DOI 10.1248/jhs.54.154
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   Nadeem D, 2013, MAT SCI ENG C-MATER, V33, P2669, DOI 10.1016/j.msec.2013.02.021
   Neman J, 2012, ADV EXP MED BIOL, V760, P174
   Orsini G, 2003, INT J ORAL MAX IMPL, V18, P594
   Otsuka F, 2012, DENT MATER J, V31, P309, DOI 10.4012/dmj.2011-039
   Pappalardo S, 2008, J BIOL REG HOMEOS AG, V22, P175
   Riccio M, 2010, Eur J Histochem, V54, pe46
   Rogers GF, 2012, J CRANIOFAC SURG, V23, P323, DOI 10.1097/SCS.0b013e318241dcba
   Somanathan Rakesh V, 2006, Acta Medica (Hradec Kralove), V49, P87
   Springer ING, 2005, BONE, V37, P570, DOI 10.1016/j.bone.2005.04.037
   Sun XQ, 2013, BIOMATERIALS, V34, P4971, DOI 10.1016/j.biomaterials.2013.03.015
   Tete S, 2008, INT J IMMUNOPATH PH, V21, P309, DOI 10.1177/039463200802100207
   Tete S, 2009, INT J IMMUNOPATH PH, V22, P1105, DOI 10.1177/039463200902200427
   Tete S, 2010, IMPLANT DENT, V19, P520, DOI 10.1097/ID.0b013e3182002eac
   Tete S, 2010, J CRANIOFAC SURG, V21, P1147, DOI 10.1097/SCS.0b013e3181e484a7
   Trubiani O, 2010, EUR CELLS MATER, V20, P72
   Turhani D, 2005, INT J ORAL MAX SURG, V34, P543, DOI 10.1016/j.ijom.2004.10.023
   Wang CJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/579141
   Wood R M, 1988, Int J Oral Maxillofac Implants, V3, P209
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
   ZORZANO LAA, 2007, MED ORAL PATOL ORAL, V12, pE532
NR 40
TC 2
Z9 3
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1056-6163
EI 1538-2982
J9 IMPLANT DENT
JI Implant Dent.
PD DEC
PY 2013
VL 22
IS 6
BP 613
EP 622
DI 10.1097/ID.0b013e3182a69858
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 292SV
UT WOS:000329923600011
PM 24185465
DA 2018-10-20
ER

PT J
AU Cui, Y
   Yuan, WQ
AF Cui, Yan
   Yuan, Wenqiao
TI Thermodynamic modeling of algal cell-solid substrate interactions
SO APPLIED ENERGY
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Applied Energy (ICAE)
CY JUL 01-04, 2012
CL Suzhou, PEOPLES R CHINA
DE Biofuel; Microalgae; Cell attachment; Thermodynamic model; Surface
   energy
ID SURFACE FREE-ENERGY; BACTERIAL ADHESION; BIOMATERIAL SURFACES;
   MECHANISMS; POLYMERS
AB The process of microalgal cell attachment to solid-carrier surfaces was simulated through a thermodynamic model. The modeling results showed that, for most microbes, when the polar surface energy of the cell is smaller than that of water, cellular attachment would be more favorable on materials with higher dispersive surface energy but lower polar surface energy. If the polar surface energy of the cell is greater than that of water, more cell attachment would be expected on materials that are higher in both dispersive and polar surface energies. Modeling results qualitatively matched experimental data in the attachment of a freshwater alga, Scenedesmus dimorphus, and a marine alga, Nannochloropsis oculata, on five materials (nylon, stainless steel, polycarbonate, polypropylene, and glass). The model was also validated by published literature data on a wider variety of microbes and materials, indicating that the model developed can be applicable in designing, selecting, and matching algal strains and solid carrier materials to enhance cell attachment. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Cui, Yan; Yuan, Wenqiao] N Carolina State Univ, Dept Biol & Agr Engn, Raleigh, NC 27695 USA.
RP Yuan, WQ (reprint author), N Carolina State Univ, Dept Biol & Agr Engn, Raleigh, NC 27695 USA.
EM wyuan2@ncsu.edu
CR ABSOLOM DR, 1985, J COLLOID INTERF SCI, V104, P51, DOI 10.1016/0021-9797(85)90008-6
   Absolom DR, 1994, ASAIO J, V25, P152
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anderson C, 2003, J MAR DESIGN OPERA B, V4, P11
   BAIER RE, 1968, SCIENCE, V162, P1360, DOI 10.1126/science.162.3860.1360
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BAIER RE, 1986, J ADHESION, V20, P171, DOI 10.1080/00218468608071235
   Baier RE, 1992, BIOFOULING, V6, P165, DOI 10.1080/08927019209386220
   Baier RE, 2006, J MATER SCI-MATER M, V17, P1057, DOI 10.1007/s10856-006-0444-8
   BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6
   BENAMOTZ A, 1985, J PHYCOL, V21, P72
   Bennett SM, 2010, BIOFOULING, V26, P235, DOI 10.1080/08927010903469676
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
   Cao J, 2009, J MANUF SCI E-T ASME, V131
   Chang YY, 2013, APPL ENERG, V102, P427, DOI 10.1016/j.apenergy.2012.07.024
   Chisti Y, 2011, APPL ENERG, V88, P3277, DOI 10.1016/j.apenergy.2011.04.038
   Cui Y, 2010, P ASME 2010 INT MAN
   Demirbas A, 2011, APPL ENERG, V88, P3541, DOI 10.1016/j.apenergy.2010.12.050
   Demirbas MF, 2011, APPL ENERG, V88, P3473, DOI 10.1016/j.apenergy.2011.01.059
   Derjaguin B, 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L
   Fletcher M, 1994, J COLLOID INTERF SCI, V140, P5
   GOOD RJ, 1960, J PHYS CHEM-US, V64, P561, DOI 10.1021/j100834a012
   Goupil DW, 1973, P 9 MAR TECHN SOC C
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Harun R, 2011, APPL ENERG, V88, P3464, DOI 10.1016/j.apenergy.2010.10.048
   Helena M., 2011, APPL ENERG, V88, P3402
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Ikada Y., 1984, POLYM BIOMATERIALS, P135
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Li Y, 2010, COLLOID SURFACE B, V75, P550, DOI 10.1016/j.colsurfb.2009.09.026
   Ludwicka A, 1984, POLYM BIOMATERIALS
   Magin CM, 2010, MATER TODAY, V13, P36, DOI 10.1016/S1369-7021(10)70058-4
   Mariette U, 1985, FEMS MICROBIOL LETT, V30, P103
   Markou G, 2011, APPL ENERG, V88, P3389, DOI 10.1016/j.apenergy.2010.12.042
   Massingill M, 2008, MICR BIOM SUMM SEATT
   Neumann A W, 1979, Cell Biophys, V1, P79
   NEUMANN AW, 1973, J MACROMOL SCI PHYS, VB  7, P525, DOI 10.1080/00222347308207882
   NEUMANN AW, 1980, J BIOMED MATER RES, V14, P499, DOI 10.1002/jbm.820140416
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   PRATTTERPSTRA IH, 1988, CURR MICROBIOL, V16, P311, DOI 10.1007/BF01568537
   PRATTTERPSTRA IH, 1989, J COLLOID INTERF SCI, V129, P568, DOI 10.1016/0021-9797(89)90471-2
   Rawat I, 2011, APPL ENERG, V88, P3411, DOI 10.1016/j.apenergy.2010.11.025
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Singh A, 2011, APPL ENERG, V88, P3548, DOI 10.1016/j.apenergy.2010.12.012
   Van Oss GJ, 1986, J COLLOID INTERF SCI, V95, P23
   Van Oss GJ, 1987, SEP SCI TECHNOL, V22, P1
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANPELT AWJ, 1985, APPL ENVIRON MICROB, V49, P1270
   VERWEY EJW, 1948, THEORY STABILITY LYO
   Vijayanand K., 2005, TRENDS BIOMATER ARTI, V18, P73
   WU S, 1973, J ADHESION, V5, P39, DOI 10.1080/00218467308078437
   Yang ZM, 2011, APPL ENERG, V88, P3468, DOI 10.1016/j.apenergy.2010.09.009
NR 57
TC 13
Z9 13
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0306-2619
EI 1872-9118
J9 APPL ENERG
JI Appl. Energy
PD DEC
PY 2013
VL 112
SI SI
BP 485
EP 492
DI 10.1016/j.apenergy.2013.03.036
PG 8
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA 285FA
UT WOS:000329377800050
DA 2018-10-20
ER

PT J
AU Li, Y
   Yu, SM
AF Li, Yang
   Yu, S. Michael
TI Targeting and mimicking collagens via triple helical peptide assembly
SO CURRENT OPINION IN CHEMICAL BIOLOGY
LA English
DT Review
ID HIGHER-ORDER STRUCTURES; HUMANIZED ANTIBODY D93; PEG-BASED HYDROGELS;
   MIMETIC PEPTIDES; CONFORMATIONAL STABILITY; IN-VIVO; TUMOR-GROWTH;
   BINDING; SCAFFOLDS; ANGIOGENESIS
AB As the major structural component of the extracellular matrix, collagen plays a crucial role in tissue development and regeneration. Since structural and metabolic abnormalities of collagen are associated with numerous debilitating diseases and pathologic conditions, the ability to target collagens of diseased tissues could lead to new diagnostics and therapeutics. Collagen is also a natural biomaterial widely used in drug delivery and tissue engineering, and construction of synthetic collagen-like materials is gaining interests in the biomaterials community. The unique triple helical structure of collagen has been explored for targeting collagen strands, and for engineering collagen-like functional assemblies and conjugates. This review focuses on the forefront of research activities in the use of the collagen mimetic peptide for both targeting and mimicking collagens via its triple helix mediated strand hybridization and higher order assembly.
C1 [Li, Yang; Yu, S. Michael] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [Yu, S. Michael] Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD 21218 USA.
RP Yu, SM (reprint author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
EM michael.yu@utah.edu
FU National Institute of Health [R01-AR060484]; US Department of Defense
   [W81XWH-12-1-0555]
FX Part of the work presented in this article was supported by National
   Institute of Health (R01-AR060484) and US Department of Defense
   (W81XWH-12-1-0555).
CR Akers WJ, 2012, BIOCONJUGATE CHEM, V23, P656, DOI 10.1021/bc300027y
   Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008
   Breurken M, 2011, CHEM COMMUN, V47, P7998, DOI 10.1039/c1cc11964h
   Breurken M, 2010, CHEMBIOCHEM, V11, P1665, DOI 10.1002/cbic.201000223
   Caravan P, 2007, ANGEW CHEM INT EDIT, V46, P8171, DOI 10.1002/anie.200700700
   Chan TR, 2011, ADV FUNCT MATER, V21, P4252, DOI 10.1002/adfm.201101163
   Chattopadhyay S, 2012, ORG BIOMOL CHEM, V10, P5892, DOI 10.1039/c2ob25190f
   Chen JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019097
   Cuesta AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005381
   Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818
   Erdmann RS, 2012, J AM CHEM SOC, V134, P17117, DOI 10.1021/ja3066418
   Erdmann RS, 2012, ORG BIOMOL CHEM, V10, P1982, DOI 10.1039/c2ob06720j
   Erdmann RS, 2011, ANGEW CHEM INT EDIT, V50, P6835, DOI 10.1002/anie.201008118
   Erdmann RS, 2010, J AM CHEM SOC, V132, P13957, DOI 10.1021/ja103392t
   Fan CY, 2008, FASEB J, V22, P3795, DOI 10.1096/fj.08-111484
   Freimark B, 2007, MOL IMMUNOL, V44, P3741, DOI 10.1016/j.molimm.2007.03.027
   Hsu W, 2012, LANGMUIR, V28, P3194, DOI 10.1021/la204351w
   Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200
   Kojima C, 2011, SOFT MATTER, V7, P8991, DOI 10.1039/c1sm06157g
   Kojima C, 2009, J AM CHEM SOC, V131, P6052, DOI 10.1021/ja809639c
   Krishna OD, 2012, SOFT MATTER, V8, P3832, DOI 10.1039/c2sm07025a
   Krishna OD, 2011, BIOMATERIALS, V32, P6412, DOI 10.1016/j.biomaterials.2011.05.034
   Lee HJ, 2008, TISSUE ENG PT A, V14, P1843, DOI 10.1089/ten.tea.2007.0204
   Li Y, 2013, BIOCONJUGATE CHEM, V24, P9, DOI 10.1021/bc3005842
   Li Y, 2012, P NATL ACAD SCI USA, V109, P14767, DOI 10.1073/pnas.1209721109
   Lobo VJSA, 2006, INT J CANCER, V119, P455, DOI 10.1002/ijc.21851
   Luo JN, 2011, ACS NANO, V5, P7739, DOI 10.1021/nn202822f
   Matsusaki M, 2011, ADV MATER, V23, P2957, DOI 10.1002/adma.201101284
   Megens RTA, 2007, MOL IMAGING, V6, P247, DOI 10.2310/7290.2007.00021
   Mo X, 2006, ANGEW CHEM INT EDIT, V45, P2267, DOI 10.1002/anie.200504529
   Mueller J, 2009, MOL CANCER RES, V7, P1078, DOI 10.1158/1541-7786.MCR-08-0538
   Muzard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005585
   Nanda M, 2012, J ORG CHEM, V77, P4131, DOI 10.1021/jo300070p
   Okada T, 2013, BIOCONJUGATE CHEM, V24, P841, DOI 10.1021/bc3006013
   Paderi JE, 2008, BIOMACROMOLECULES, V9, P2562, DOI 10.1021/bm8006852
   Perez CMR, 2011, MACROMOL BIOSCI, V11, P1426, DOI 10.1002/mabi.201100230
   Pernasetti F, 2006, INT J ONCOL, V29, P1371
   Pires MM, 2012, LANGMUIR, V28, P1993, DOI 10.1021/la203848r
   Pires MM, 2011, J AM CHEM SOC, V133, P14469, DOI 10.1021/ja2042645
   Pires MM, 2011, BIOMACROMOLECULES, V12, P2429, DOI 10.1021/bm2004934
   Pires MM, 2009, ANGEW CHEM INT EDIT, V48, P7813, DOI 10.1002/anie.200902375
   Pires MM, 2009, J AM CHEM SOC, V131, P2706, DOI 10.1021/ja8088845
   Przybyla DE, 2013, J AM CHEM SOC, V135, P3418, DOI 10.1021/ja307651e
   Przybyla DE, 2010, J AM CHEM SOC, V132, P7866, DOI 10.1021/ja103148t
   Ravikumar M, 2012, BIOCONJUGATE CHEM, V23, P1266, DOI 10.1021/bc300086d
   Reulen SWA, 2009, J AM CHEM SOC, V131, P7304, DOI 10.1021/ja807723p
   Rothenfluh DA, 2008, NAT MATER, V7, P248, DOI 10.1038/nmat2116
   Stahl PJ, 2012, SOFT MATTER, V8, P10409, DOI 10.1039/c2sm25903f
   Stahl PJ, 2012, ANAL BIOCHEM, V424, P137, DOI 10.1016/j.ab.2012.02.032
   Stahl PJ, 2010, BIOMACROMOLECULES, V11, P2336, DOI 10.1021/bm100465q
   Stuart K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022139
   Suehiro T, 2011, BIOPOLYMERS, V95, P270, DOI 10.1002/bip.21576
   Wang AY, 2008, BIOMACROMOLECULES, V9, P2929, DOI 10.1021/bm800727z
   Wang AY, 2008, BIOMACROMOLECULES, V9, P1755, DOI 10.1021/bm701378k
   Wang AY, 2005, J AM CHEM SOC, V127, P4130, DOI 10.1021/ja0431915
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Xu JS, 2000, HYBRIDOMA, V19, P375, DOI 10.1089/02724570050198893
   Yamazaki CM, 2013, ANGEW CHEM INT EDIT, V52, P5497, DOI 10.1002/anie.201301266
   Yu SM, 2011, SOFT MATTER, V7, P7927, DOI 10.1039/c1sm05329a
   Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888
NR 60
TC 48
Z9 49
U1 3
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1367-5931
EI 1879-0402
J9 CURR OPIN CHEM BIOL
JI Curr. Opin. Chem. Biol.
PD DEC
PY 2013
VL 17
IS 6
BP 968
EP 975
DI 10.1016/j.cbpa.2013.10.018
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 288GX
UT WOS:000329601100015
PM 24210894
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Sanada, JT
   Pereira, JR
   Assaoka, AMF
   Zingra, ACD
   de Oliveira, PCG
   do Valle, AL
AF Sanada, Jefferson Tomio
   Pereira, Jefferson Ricardo
   Ferreira Assaoka, Aliana Mayumi
   de Godoi Zingra, Ana Cristina
   Garcia de Oliveira, Pedro Cesar
   do Valle, Accacio Lins
TI Tensile Resistance of Mineralized and Demineralized Rat Bones in
   Different Regions (Calvarial and Femur)
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE bone; biomaterial; tensile strength
ID MORPHOGENETIC PROTEIN-4; DEFECTS; REGENERATION; AUGMENTATION; MEMBRANES;
   STRENGTH; CARRIER; SYSTEM; TISSUE; SIZE
AB The aim of this study was to evaluate the tensile resistance of mineralized and demineralized bones. Twelve mice were used. Specimens were collected and divided into groups 1 and 2, mineralized and demineralized calvarial bone, and groups 3 and 4, mineralized and demineralized femoral bone. There was not a statistically significant difference (analysis of variance) between the regions; however, when comparing the demineralized and mineralized groups, a statistically significant difference (Student test) for the mineralized group was noticed.
C1 [Sanada, Jefferson Tomio; Ferreira Assaoka, Aliana Mayumi; de Godoi Zingra, Ana Cristina; Garcia de Oliveira, Pedro Cesar; do Valle, Accacio Lins] Univ Sao Paulo, Bauru Dent Sch, Sao Paulo, Brazil.
   [Pereira, Jefferson Ricardo] Univ Southern Santa Catarina UNISUL, Sch Dent, Florianopolis, SC, Brazil.
RP Pereira, JR (reprint author), Univ Southern Santa Catarina UNISUL, Sch Dent, Florianopolis, SC, Brazil.
EM jeffripe@rocketmail.com
RI Oliveira, Pedro Cesar/F-1093-2013; Valle, Accacio/F-7790-2012
OI Pereira, Jefferson/0000-0001-5663-3710; Zingra, Ana/0000-0002-8714-0801
FU CNPq
FX The authors thank CNPq for financial support.
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Ahn SH, 2003, J PERIODONTOL, V74, P787, DOI 10.1902/jop.2003.74.6.787
   AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0
   Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4
   Beck JD, 1997, BONE, V21, P281, DOI 10.1016/S8756-3282(97)00122-1
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Carvalho R M, 2001, J Adhes Dent, V3, P309
   Carvalho RM, 1996, ARCH ORAL BIOL, V41, P379, DOI 10.1016/0003-9969(95)00130-1
   Francis PO, 2003, J PERIODONTOL, V74, P1023, DOI 10.1902/jop.2003.74.7.1023
   GLOWACKI J, 1981, CALCIFIED TISSUE INT, V33, P71, DOI 10.1007/BF02409414
   Han DK, 2005, J PERIODONTOL, V76, P2216, DOI 10.1902/jop.2005.76.12.2216
   Hong SJ, 2006, BIOMATERIALS, V27, P3810, DOI 10.1016/j.biomaterials.2006.02.045
   Hyun SJ, 2005, J PERIODONTOL, V76, P1667, DOI 10.1902/jop.2005.76.10.1667
   Jahangiri L, 1998, J PROSTHET DENT, V80, P224, DOI 10.1016/S0022-3913(98)70116-7
   Jung UW, 2006, J PERIODONTOL, V77, P765, DOI 10.1902/jop.2006.050268
   Lee YM, 2003, J PERIODONTOL, V74, P865, DOI 10.1902/jop.2003.74.6.865
   Mardas N, 2002, J CRANIOFAC SURG, V13, P453, DOI 10.1097/00001665-200205000-00017
   Matzenbacher SA, 2003, J PERIODONTOL, V74, P1641, DOI 10.1902/jop.2003.74.11.1641
   Mendonca JS, 2003, DENT MATER, V19, P308, DOI 10.1016/S0109-5641(02)00059-3
   Pang EK, 2005, J PERIODONTOL, V76, P1526, DOI 10.1902/jop.2005.76.9.1526
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   SANO H, 1994, DENT MATER, V10, P236, DOI 10.1016/0109-5641(94)90067-1
   Simpson H E, 1969, Br Dent J, V126, P550
   Tamimi FM, 2006, J CLIN PERIODONTOL, V33, P922, DOI 10.1111/j.1600-051X.2006.01004.x
   Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8
   TURNER CH, 1994, J BONE MINER RES, V9, P87
   TURNER CH, 1995, BONE, V17, P85, DOI 10.1016/8756-3282(95)00148-7
   Verna C, 2002, J CLIN PERIODONTOL, V29, P865, DOI 10.1034/j.1600-051X.2002.290912.x
NR 28
TC 0
Z9 0
U1 0
U2 4
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD DEC
PY 2013
VL 39
IS 6
BP 643
EP 647
DI 10.1563/AAID-JOI-D-10-00091
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 287SL
UT WOS:000329562400003
PM 21241181
DA 2018-10-20
ER

PT J
AU Huang, YC
   Chu, HW
AF Huang, Yi-Cheng
   Chu, Hao-Wen
TI USING HYDROXYAPATITE FROM FISH SCALES TO PREPARE
   CHITOSAN/GELATIN/HYDROXYAPATITE MEMBRANE: EXPLORING POTENTIAL FOR BONE
   TISSUE ENGINEERING
SO JOURNAL OF MARINE SCIENCE AND TECHNOLOGY-TAIWAN
LA English
DT Article
DE hydroxyapatite; fish scale; chitosan; gelatin; bone tissue engineering
ID NATURAL HYDROXYAPATITE; CELL-ADHESION; BOVINE BONES; PORE-SIZE; IN-SITU;
   CHITOSAN; SCAFFOLDS; GELATIN; DIFFERENTIATION; EXTRACTION
AB Concerns have recently been raised about the treatment and use of hydroxyapatite, an important component of fish scale. The goal of this investigation is to evaluate the feasibility of using hydroxyapatite extracted from fish scale (FHAP) for bone tissue engineering. FHAP or sintered FHAP (sFHAP) was added to chitosan/gelatin (CS/GEL) mixture to prepare membrane. The effect of FHAP and sFHAP on the physical and chemical properties of the membrane and their affinities towards MG63 cells were studied. Accordingly, the prepared CS/GEL/FHAP membrane was characterized by FTIR (ATR-FTIR) and SEM. Following sintering at 800 degrees C for 4 h, the CS/GEL/sFHAP membrane had a rougher surface than the CS/GEL/FHAP membrane. Hydroxyapatite from Sigma (SHAP) was used as a standard and the biological response of MG63 cells on the CS/GEL/sFHAP membrane was determined to exceed that of hydroxyapatite, with higher proliferation and differentiation, as verified by MTT assay and alkaline phosphate assay. Briefly, the biocompatible CS/GEL/FHAP membrane may potentially be useful as a biomaterial for engineering bone tissue.
C1 [Huang, Yi-Cheng; Chu, Hao-Wen] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan.
RP Huang, YC (reprint author), Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan.
EM ychuang@mail.ntou.edu.tw
FU National Science Council of the Republic of China, Taiwan [NSC
   101-2221-E-019-026]
FX The authors would like to thank the National Science Council of the
   Republic of China, Taiwan for financially supporting (NSC
   101-2221-E-019-026). The authors would like to thank Fisheries Research
   Institute for helping extraction of hydroxyapatite.
CR Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Barakat NAM, 2008, MAT SCI ENG C-BIO S, V28, P1381, DOI 10.1016/j.msec.2008.03.003
   Coelho T. M., 2006, J APPL PHYS, V100
   Cui WU, 2007, J BIOMED MATER RES A, V82A, P831, DOI 10.1002/jbm.a.31187
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Ferraro V, 2010, FOOD RES INT, V43, P2221, DOI 10.1016/j.foodres.2010.07.034
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Ho YC, 2009, INT J PHARMACEUT, V376, P69, DOI 10.1016/j.ijpharm.2009.04.048
   Huang YC, 2011, CERAM INT, V37, P1825, DOI 10.1016/j.ceramint.2011.01.018
   Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Miyajima K, 1990, Nihon Kyosei Shika Gakkai Zasshi, V49, P226
   Muyonga JH, 2004, FOOD CHEM, V86, P325, DOI 10.1016/j.foodchem.2003.09.038
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   Nagahama H, 2009, CARBOHYD POLYM, V76, P255, DOI 10.1016/j.carbpol.2008.10.015
   Nair MB, 2009, ACTA BIOMATER, V5, P1742, DOI 10.1016/j.actbio.2009.01.009
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Ozawa M, 2002, J AM CERAM SOC, V85, P1315, DOI 10.1111/j.1151-2916.2002.tb00268.x
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Rustad T., 2003, ELECT J ENV AGR FOOD, V2, P458
   Sang S., 2002, J CRYST GROWTH, V237-239, P55
   Sanosh KP, 2009, MATER LETT, V63, P2100, DOI 10.1016/j.matlet.2009.06.062
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   Xu JL, 2004, MAT SCI ENG A-STRUCT, V374, P101, DOI 10.1016/j.msea.2003.12.040
NR 32
TC 4
Z9 4
U1 1
U2 19
PU NATL TAIWAN OCEAN UNIV
PI KEELUNG
PA NO 2 PEI-NING RD, KEELUNG, 202, TAIWAN
SN 1023-2796
J9 J MAR SCI TECH-TAIW
JI J. Mar. Sci. Technol.-Taiwan
PD DEC
PY 2013
VL 21
IS 6
BP 716
EP 722
DI 10.6119/JMST-013-0320-1
PG 7
WC Engineering, Multidisciplinary; Oceanography
SC Engineering; Oceanography
GA 285SK
UT WOS:000329415100014
DA 2018-10-20
ER

PT J
AU Fang, J
   Mehlich, A
   Koga, N
   Huang, JQ
   Koga, R
   Gao, XY
   Hu, CG
   Jin, C
   Rief, M
   Kast, J
   Baker, D
   Li, HB
AF Fang, Jie
   Mehlich, Alexander
   Koga, Nobuyasu
   Huang, Jiqing
   Koga, Rie
   Gao, Xiaoye
   Hu, Chunguang
   Jin, Chi
   Rief, Matthias
   Kast, Juergen
   Baker, David
   Li, Hongbin
TI Forced protein unfolding leads to highly elastic and tough protein
   hydrogels
SO NATURE COMMUNICATIONS
LA English
DT Article
ID EXTRACELLULAR-MATRIX; IMMUNOGLOBULIN DOMAINS; MECHANICAL-PROPERTIES;
   TISSUE SEALANT; SINGLE PROTEIN; CROSS-LINKING; BIOMATERIALS; TITIN;
   FIBRONECTIN; CELLS
AB Protein-based hydrogels usually do not exhibit high stretchability or toughness, significantly limiting the scope of their potential biomedical applications. Here we report the engineering of a chemically cross-linked, highly elastic and tough protein hydrogel using a mechanically extremely labile, de novo-designed protein that assumes the classical ferredoxin-like fold structure. Due to the low mechanical stability of the ferredoxin-like fold structure, swelling of hydrogels causes a significant fraction of the folded domains to unfold. Subsequent collapse and aggregation of unfolded ferredoxin-like domains leads to intertwining of physically and chemically cross-linked networks, entailing hydrogels with unusual physical and mechanical properties: a negative swelling ratio, high stretchability and toughness. These hydrogels can withstand an average strain of 450% before breaking and show massive energy dissipation. Upon relaxation, refolding of the ferredoxin-like domains enables the hydrogel to recover its massive hysteresis. This novel biomaterial may expand the scope of hydrogel applications in tissue engineering.
C1 [Fang, Jie; Huang, Jiqing; Gao, Xiaoye; Jin, Chi; Kast, Juergen; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada.
   [Mehlich, Alexander; Rief, Matthias] Tech Univ Munich, Phys Dept E22, D-85748 Garching, Germany.
   [Koga, Nobuyasu; Koga, Rie; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
   [Koga, Nobuyasu; Koga, Rie; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.
   [Hu, Chunguang; Li, Hongbin] Tianjin Univ, Sch Precis Instrument & Optoelect Engn, State Key Lab Precis Measurements Technol & Instr, Tianjin 30072, Peoples R China.
RP Li, HB (reprint author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.
EM Hongbin@chem.ubc.ca
RI Li, Hongbin/G-2949-2012; Hu, Chunguang/S-5084-2016
OI Li, Hongbin/0000-0001-7813-1332; Hu, Chunguang/0000-0001-6485-904X;
   Koga, Nobuyasu/0000-0001-8457-0809; Baker, David/0000-0001-7896-6217
FU Deutsche Forschungsgemeinschaft [SFB863]; Alexander von Humboldt
   fellowship; Canadian Institutes of Health Research; Canada Research
   Chair program; Canada Foundation for Innovation; Michael Smith
   Foundation for Health Research; Natural Science Engineering Research
   Council of Canada
FX We thank anonymous reviewers for their constructive suggestions and Dr.
   Zheng Yang for his technical assistance. This work is supported by
   Canadian Institutes of Health Research, Canada Research Chair program,
   Canada Foundation for Innovation, Michael Smith Foundation for Health
   Research and Natural Science Engineering Research Council of Canada. M.
   R. acknowledges funding through an SFB863 grant of Deutsche
   Forschungsgemeinschaft. H. L. is a Canada Research Chair and Michael
   Smith Foundation for Health Research Career Investigator. H. L.
   acknowledges the support of an Alexander von Humboldt fellowship.
CR Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bjork JW, 2011, BIOMATERIALS, V32, P2479, DOI 10.1016/j.biomaterials.2010.12.010
   Brockwell DJ, 2007, CURR NANOSCI, V3, P3, DOI 10.2174/157341307779940634
   Brown AEX, 2009, SCIENCE, V325, P741, DOI 10.1126/science.1172484
   Cao Y, 2008, NAT NANOTECHNOL, V3, P512, DOI 10.1038/nnano.2008.168
   Cao Y, 2007, NAT MATER, V6, P109, DOI 10.1038/nmat1825
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1
   Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702
   Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j
   Doi M., 1995, INTRO POLYM PHYS
   Elvin CM, 2010, BIOMATERIALS, V31, P8323, DOI 10.1016/j.biomaterials.2010.07.032
   Elvin CM, 2009, BIOMATERIALS, V30, P2059, DOI 10.1016/j.biomaterials.2008.12.059
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   Fang J, 2012, LANGMUIR, V28, P8260, DOI 10.1021/la301225w
   Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857
   Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106
   Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Krieger CC, 2011, P NATL ACAD SCI USA, V108, P8269, DOI 10.1073/pnas.1018887108
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lemmon CA, 2011, J BIOL CHEM, V286, P26375, DOI 10.1074/jbc.M111.240028
   Li H., 2011, PROTEIN NANOMECHANIC
   Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00398
   LI Y, 1992, ANNU REV MATER SCI, V22, P243
   LILLIE MA, 1994, CONNECT TISSUE RES, V31, P23, DOI 10.3109/03008209409005632
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lv SS, 2013, ACTA BIOMATER, V9, P6481, DOI 10.1016/j.actbio.2013.01.002
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4
   Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103
   Nagapudi K, 2005, MACROMOLECULES, V38, P345, DOI 10.1021/ma0491199
   Oberhauser AF, 1998, NATURE, V393, P181
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Qin GK, 2011, BIOMATERIALS, V32, P9231, DOI 10.1016/j.biomaterials.2011.06.010
   Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   SHIBAYAMA M, 1993, ADV POLYM SCI, V109, P1
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   von Hansen Y, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4753917
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
NR 52
TC 37
Z9 38
U1 7
U2 137
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD DEC
PY 2013
VL 4
AR 2974
DI 10.1038/ncomms3974
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 285MH
UT WOS:000329397600010
PM 24352111
OA DOAJ Gold, Green Accepted
DA 2018-10-20
ER

PT J
AU Mollon, B
   Kandel, R
   Chahal, J
   Theodoropoulos, J
AF Mollon, B.
   Kandel, R.
   Chahal, J.
   Theodoropoulos, J.
TI The clinical status of cartilage tissue regeneration in humans
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Review
DE Cartilage; Tissue engineering; Autologous chondrocyte implantation;
   Chondrocytes
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; MESENCHYMAL STEM-CELLS;
   FIBROBLAST-GROWTH-FACTOR; BONE MORPHOGENETIC PROTEIN-2; HUMAN ARTICULAR
   CHONDROCYTES; PASSAGED HUMAN CHONDROCYTES; IN-VITRO CHONDROGENESIS;
   TERM-FOLLOW-UP; STROMAL CELLS; OSTEOCHONDRAL ALLOGRAFTS
AB Purpose: To provide a comprehensive overview of the basic science and clinical evidence behind cartilage regeneration techniques as they relate to surgical management of chondral lesions in humans. Methods: A descriptive review of current literature.
   Results: Articular cartilage defects are common in orthopedic practice, with current treatments yielding acceptable short-term but inconsistent long-term results. Tissue engineering techniques are being employed with aims of repopulating a cartilage defect with hyaline cartilage containing living chondrocytes with hopes of improving clinical outcomes. Cartilage tissue engineering broadly involves the use of three components: cell source, biomaterial/membranes, and/or growth stimulators, either alone or in any combination. Tissue engineering principles are currently being applied to clinical medicine in the form of autologous chondrocyte implantation (ACI) or similar techniques. Despite refinements in technique, current literature fails to support a clinical benefit of ACI over older techniques such as microfracture except perhaps for larger (>4 cm) lesions. Modern ACI techniques may be associated with lower operative revision rates. The notion that Ad-like procedures produce hyaline-like cartilage in humans remains unsupported by high-quality clinical research.
   Conclusions: Many of the advancements in tissue engineering have yet to be applied in a clinical setting. While basic science has refined orthopedic management of chondral lesions, available evidence does not conclude the superiority of modern tissue engineering methods over other techniques in improving clinical symptoms or restoring native joint mechanics. It is hoped further research will optimize ease of cell harvest and growth, enhanced cartilage production, and improve cost-effectiveness of medical intervention. (C) 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
C1 [Mollon, B.] Univ Toronto, Dept Orthopaed Surg, Toronto, ON, Canada.
   [Kandel, R.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada.
   [Kandel, R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.
   [Chahal, J.] Univ Hlth Network, Arthrit Program, Toronto, ON, Canada.
   [Chahal, J.; Theodoropoulos, J.] Univ Toronto, Womens Coll Hosp, Orthopaed Sports Med Program, Toronto, ON, Canada.
   [Theodoropoulos, J.] Univ Toronto, Mt Sinai Hosp, Dept Orthopaed Surg, Toronto, ON M5G 1X5, Canada.
RP Theodoropoulos, J (reprint author), Univ Toronto Orthopaed Sports Med, 600 Univ Ave,Suite 476C, Toronto, ON M5G 1X5, Canada.
EM brent.mollon@mail.utoronto.ca; rkandel@mtsinai.on.ca; jchahal@utosm.com;
   jtheodoropoulos@mtsinai.on.ca
RI Kandel, Rita/E-2149-2017
OI Kandel, Rita/0000-0003-4047-3913; Theodoropoulos,
   John/0000-0003-3185-7800
FU Smith; Nephew
FX Authors BM, RK and JC have no financial disclosures or notable competing
   interests. Author JT serves as a consultant for Zimmer and for Smith and
   Nephew, has received speaker honorariums from ConMed Linvatec, and
   receives fellowship funding from Smith and Nephew.
CR Adams MA, 2009, MATRIX BIOL, V28, P384, DOI 10.1016/j.matbio.2009.06.004
   Ahmed N, 2010, J TISSUE ENG REGEN M, V4, P233, DOI 10.1002/term.235
   Ahmed N, 2009, TISSUE ENG PT A, V15, P665, DOI 10.1089/ten.tea.2008.0004
   Aicher WK, 2011, ADV DRUG DELIVER REV, V63, P342, DOI 10.1016/j.addr.2010.12.004
   ALBRECHT FH, 1983, FORTSCHR MED, V101, P1650
   Allan KS, 2007, TISSUE ENG, V13, P167, DOI 10.1089/ten.2006.0081
   Bai HY, 2010, J BIOMED MATER RES A, V94A, P539, DOI 10.1002/jbm.a.32732
   Battula VL, 2007, DIFFERENTIATION, V75, P279, DOI 10.1111/j.1432-0436.2006.00139.x
   Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740
   Bedi A, 2010, J BONE JOINT SURG AM, V92A, P994, DOI 10.2106/JBJS.I.00895
   Breinan HA, 2000, J ORTHOPAED RES, V18, P781, DOI 10.1002/jor.1100180516
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465
   Chaipinyo K, 2002, J ORTHOPAED RES, V20, P1070, DOI 10.1016/S0736-0266(02)00025-6
   Clar C, 2005, HLTH TECHNOL ASSESS, V9
   Cole BJ, 2011, AM J SPORT MED, V39, P1170, DOI 10.1177/0363546511399382
   Crawford DC, 2009, AM J SPORT MED, V37, P1334, DOI 10.1177/0363546509333011
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   Dell'Accio F, 2003, EXP CELL RES, V287, P16, DOI 10.1016/S0014-4827(03)00036-3
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dorotka R, 2005, OSTEOARTHR CARTILAGE, V13, P655, DOI 10.1016/j.joca.2005.04.001
   Drengk A, 2009, CELLS TISSUES ORGANS, V189, P317, DOI 10.1159/000151290
   El-Ayoubi R, 2011, J BIOMATER APPL, V25, P429, DOI 10.1177/0885328209355332
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Fan JB, 2010, ACTA BIOMATER, V6, P1178, DOI 10.1016/j.actbio.2009.08.042
   Farr J, 2012, J KNEE SURG, V25, P23, DOI 10.1055/s-0031-1299652
   Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3
   Francioli SE, 2007, TISSUE ENG, V13, P1227, DOI 10.1089/ten.2006.0342
   Franke O, 2007, ACTA BIOMATER, V3, P873, DOI 10.1016/j.actbio.2007.04.005
   Gaissmaier C, 2008, INJURY S96, V39
   Gille J, 2013, ARCH ORTHOP TRAUM SU, V133, P87, DOI 10.1007/s00402-012-1621-5
   Goldberg AJ, 2005, J BONE JOINT SURG BR, V87B, P128, DOI 10.1302/0301-620X.87B1.14154
   Gomoll AH, 2012, J KNEE SURG, V25, P9, DOI 10.1055/s-0031-1299654
   Gooch KJ, 2002, TISSUE ENG, V8, P591, DOI 10.1089/107632702760240517
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Gross AE, 2008, CLIN ORTHOP RELAT R, V466, P1863, DOI 10.1007/s11999-008-0282-8
   Haddo O, 2004, KNEE, V11, P51, DOI 10.1016/S0968-0160(03)00041-3
   Harris JD, 2011, OSTEOARTHR CARTILAGE, V19, P779, DOI 10.1016/j.joca.2011.02.010
   Harris JD, 2010, J BONE JOINT SURG AM, V92A, P2220, DOI 10.2106/JBJS.J.00049
   Heinegard D, 2009, INT J EXP PATHOL, V90, P575, DOI 10.1111/j.1365-2613.2009.00695.x
   Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062
   Hettrich CM, 2008, SPORTS MED ARTHROSC, V16, P230, DOI 10.1097/JSA.0b013e31818cdc98
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hwang NS, 2007, J CELL PHYSIOL, V212, P281, DOI 10.1002/jcp.21052
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   INOUE H, 1989, J CELL PHYSIOL, V138, P329, DOI 10.1002/jcp.1041380216
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   James AW, 2009, PLAST RECONSTR SURG, V123, P31, DOI 10.1097/PRS.0b013e3181904c19
   KATO Y, 1990, J BIOL CHEM, V265, P5903
   Kessler MW, 2008, SPORTS MED ARTHROSC, V16, P246, DOI 10.1097/JSA.0b013e31818d56b3
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105
   Koh JL, 2004, AM J SPORT MED, V32, P317, DOI 10.1177/0363546503261730
   Kuroda R, 2006, ARTHRITIS RHEUM, V54, P433, DOI 10.1002/art.21632
   Li X, 2012, J CELL BIOCHEM, V113, P2532, DOI 10.1002/jcb.24129
   Lin Sylvia S, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P4358
   Lu YL, 2006, J ORTHOP RES, V24, P1261, DOI 10.1002/jor.20135
   LUYTEN FP, 1994, EXP CELL RES, V210, P224, DOI 10.1006/excr.1994.1033
   Mandl EW, 2004, MATRIX BIOL, V23, P231, DOI 10.1016/j.matbio.2004.06.004
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   MCNICKLE AG, 2008, SPORTS MED ARTHROSC, V16, P196, DOI DOI 10.1097/JSA.0B013E31818CDB82
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mithoefer K, 2013, SPORTS MED ARTHROSC, V21, P31, DOI 10.1097/JSA.0b013e318266f0c3
   Mueller MB, 2013, INT ORTHOP, V37, P153, DOI 10.1007/s00264-012-1726-z
   Munirah S, 2008, J Orthop Surg (Hong Kong), V16, P220
   Nakajima M, 2008, J ORTHOP RES, V26, P10, DOI 10.1002/jor.20462
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761
   Safran MR, 2008, J AM ACAD ORTHOP SUR, V16, P306, DOI 10.5435/00124635-200806000-00002
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898
   Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546
   Shive MS, 2012, OPER TECH ORTHOPAEDI, V16, P271
   Siebert CH, 2003, ARTHROSCOPY, V19, P182, DOI 10.1053/jars.2003.50000
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326
   Toh WS, 2011, STEM CELL REV REP, V7, P544, DOI 10.1007/s12015-010-9222-6
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Toh WS, 2009, J CELL MOL MED, V13, P3570, DOI 10.1111/j.1582-4934.2009.00762.x
   Vanlauwe J, 2011, AM J SPORT MED, V39, P2566, DOI 10.1177/0363546511422220
   Vasiliadis HS, 2010, KNEE SURG SPORT TR A, V18, P1645, DOI 10.1007/s00167-010-1050-3
   Vavken P, 2010, OSTEOARTHR CARTILAGE, V18, P857, DOI 10.1016/j.joca.2010.03.005
   Wakitani S, 2004, CELL TRANSPLANT, V13, P331, DOI 10.3727/000000004783983891
   Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299
   Wei YY, 2012, EUR CELLS MATER, V23, P1
   Widuchowski W, 2008, ACTA CHIR ORTHOP TR, V75, P382
   Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001
   Williams GM, 2008, PEDIATR RES, V63, P527, DOI 10.1203/PDR.0b013e31816b4fe5
   Williams SK, 2003, J BONE JOINT SURG AM, V85A, P2111, DOI 10.2106/00004623-200311000-00008
   Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5
   Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3
   Zhang B, 2011, TISSUE ENG PART C-ME, V17, P1189, DOI 10.1089/ten.tec.2011.0011
NR 100
TC 64
Z9 65
U1 0
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
EI 1522-9653
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD DEC
PY 2013
VL 21
IS 12
BP 1824
EP 1833
DI 10.1016/j.joca.2013.08.024
PG 10
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 283SG
UT WOS:000329266700002
PM 24018339
OA Bronze
DA 2018-10-20
ER

PT J
AU Campos, JM
   Ribeiro, MR
   Ribeiro, MF
   Deffieux, A
   Peruch, F
AF Campos, Joao M.
   Rosario Ribeiro, M.
   Filipa Ribeiro, M.
   Deffieux, Alain
   Peruch, Frederic
TI Copolymerisation of epsilon-caprolactone and trimethylene carbonate
   Catalysed by methanesulfonic acid
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Copolymerisation; Ring-opening polymerisation; Biomaterial; Trimethylene
   carbonate; epsilon-Caprolactone
ID RING-OPENING POLYMERIZATION; CATIONIC-POLYMERIZATION; ACTIVATED MONOMER;
   REACTIVITY RATIOS; L,L-LACTIDE; MECHANISM; LACTIDE
AB The copolymerisation of epsilon-caprolactone (epsilon-CL) and trimethylene carbonate (TMC) catalysed by methanesulfonic acid was investigated. Preliminary copolymerisation tests using a monofunctional initiator confirm that the side bidirectional propagation previously detected in the homopolymerisation of TMC is also present in the copolymerisation. The comonomers in the a-CL/TMC system do not follow first order kinetics. The values of the reactivity ratios obtained by the Kellen-Tficlos method (r(epsilon-CL) = 2.90; r(TMC) = 0.62) suggest that random copolymerisation can be achieved, although the copolymer will be richer in epsilon-CL. Dihydroxyl-telechelic epsilon-CL/TMC random copolymers were prepared using a bifunctional initiator. H-1 and C-13 NMR, SEC and DSC measurements show that the poly(TMC-co-epsilon-CL) samples presented the expected microstructural characteristics, a unimodal molarmass distribution and a very narrow polydispersity. Based on these features a novel route for the preparation of block copolyesters with tuned properties, and highly regarded in the development of materials for biomedicine, may be foreseen. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Campos, Joao M.; Rosario Ribeiro, M.; Filipa Ribeiro, M.] Univ Tecn Lisboa, Inst Super Tecn, Dept Engn Quim, Inst Biotecnol & Bioengn, P-1049001 Lisbon, Portugal.
   [Deffieux, Alain; Peruch, Frederic] Univ Bordeaux, LCPO, UMR 5629, F-33600 Pessac, France.
   [Deffieux, Alain; Peruch, Frederic] CNRS, LCPO, UMR 5629, F-33600 Pessac, France.
RP Ribeiro, MR (reprint author), Univ Tecn Lisboa, Inst Super Tecn, Dept Engn Quim, Inst Biotecnol & Bioengn, Av Rovisco Pais 1, P-1049001 Lisbon, Portugal.
EM rosario@ist.utl.pt; peruch@enscbp.fr
RI PERUCH, Frederic/E-1765-2015; Ribeiro, Maria/E-6381-2013; Ribeiro, M
   Filipa/F-8581-2013
OI PERUCH, Frederic/0000-0003-1891-5877; Ribeiro,
   Maria/0000-0003-1704-1362; Ribeiro, M Filipa/0000-0001-9538-821X;
   Campos, Joao/0000-0002-1045-4095
FU Fundacao Para a Ciencia e a Tecnologia [SFRH/BPD/63275/2009]
FX The authors would like to thank Boehringer for the gift of TMC. JMC
   thanks the Fundacao Para a Ciencia e a Tecnologia for his post-doctoral
   research grant (SFRH/BPD/63275/2009).
CR Agarwal S, 2002, MACROMOLECULES, V35, P7713, DOI 10.1021/ma020584k
   Basko M, 2006, J POLYM SCI POL CHEM, V44, P7071, DOI 10.1002/pola.21712
   Basko M, 2007, J POLYM SCI POL CHEM, V45, P3090, DOI 10.1002/pola.22065
   Basko M, 2010, J POLYM SCI POL CHEM, V48, P2650, DOI 10.1002/pola.24048
   Basko M, 2008, J POLYM SCI POL CHEM, V46, P7919, DOI 10.1002/pola.23074
   BAUDUIN G, 1995, MACROMOLECULES, V28, P1750, DOI 10.1021/ma00110a004
   Bourissou D, 2005, MACROMOLECULES, V38, P9993, DOI 10.1021/ma051646k
   Campos JM, 2013, MACROMOL CHEM PHYS, V214, P85, DOI 10.1002/macp.201200433
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   Delcroix D, 2010, MACROMOLECULES, V43, P8828, DOI 10.1021/ma101461y
   Domb AJ, 2011, BIODEGRADABLE POLYM
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Feng J, 2012, PROG POLYM SCI, V37, P211, DOI 10.1016/j.progpolymsci.2011.07.008
   Gazeau-Bureau S, 2008, MACROMOLECULES, V41, P3782, DOI 10.1021/ma800626q
   Gnanou Y., 2008, ORGANIC PHYS CHEM PO
   KELEN T, 1974, REACT KINET CATAL L, V1, P487, DOI 10.1007/BF02074484
   Kubisa P, 1999, PROG POLYM SCI, V24, P1409, DOI 10.1016/S0079-6700(99)00028-3
   Ling J, 2004, MACROMOLECULES, V37, P758, DOI 10.1021/ma035352f
   Palard I, 2007, CHEM-EUR J, V13, P1511, DOI 10.1002/chem.200600843
   Pego AP, 2001, J BIOMAT SCI-POLYM E, V12, P35
   Schappacher M, 2001, BIOMATERIALS, V22, P2849, DOI 10.1016/S0142-9612(01)00029-1
   Sisson AL, 2011, HANDBOOK OF BIODEGRADABLE POLYMERS: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS, P1
   Sperling LH, 2006, INTRODUCTION TO PHYSICAL POLYMER SCIENCE, 4TH EDITION, P1
   Suriano F, 2011, POLYM CHEM-UK, V2, P528, DOI 10.1039/c0py00211a
   Susperregui N, 2010, J ORG CHEM, V75, P6581, DOI 10.1021/jo101346t
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Zhao B, 2007, J APPL POLYM SCI, V106, P1383, DOI 10.1002/app.26761
NR 27
TC 8
Z9 8
U1 1
U2 39
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD DEC
PY 2013
VL 49
IS 12
BP 4025
EP 4034
DI 10.1016/j.eurpolymj.2013.09.008
PG 10
WC Polymer Science
SC Polymer Science
GA 275GH
UT WOS:000328663800030
DA 2018-10-20
ER

PT J
AU Rosato, A
   Piarulli, M
   Schiavone, BPI
   Catalano, A
   Carocci, A
   Carrieri, A
   Carone, A
   Caggiano, G
   Franchini, C
   Corbo, F
   Montagna, MT
AF Rosato, Antonio
   Piarulli, Monica
   Schiavone, Brigida Pia Immacolata
   Catalano, Alessia
   Carocci, Alessia
   Carrieri, Antonio
   Carone, Addolorata
   Caggiano, Giuseppina
   Franchini, Carlo
   Corbo, Filomena
   Montagna, Maria Teresa
TI In vitro effectiveness of Anidulafungin against Candida sp biofilms
SO JOURNAL OF ANTIBIOTICS
LA English
DT Article
DE anidulafungin; antifungal agent; biofilm; Candida sp.; paradoxical
   effect; XTT
ID ALBICANS BIOFILMS; ANTIFUNGAL AGENTS; PLANKTONIC CELLS; DRUG-RESISTANCE;
   AMPHOTERICIN-B; ECHINOCANDINS; CASPOFUNGIN; SUSCEPTIBILITY; GROWTH;
   EFFICACY
AB This study furnishes deeper insights to previous works on anidulafungin, demonstrating the potent activity against Candida strains planktonic cells and biofilms. Candida sp., associated with many biomaterial-related infections, give rise to infective pathologies typically associated with biofilm formation. We recently determined the in vitro antifungal activities of echinocandin anidulafungin in association with some antifungal drugs against some Candida strains in their planktonic states. A total of 11 Candida strains biofilms were tested in this study: six Candida albicans, three C. parapsilosis and two C. tropicalis. All yeast isolates and ATCC strains were stored at -20 degrees C in glycerol stocks and were subcultured on antimicrobial agent-free Sabouraud dextrose agar plates. MIC endpoints were determined colorimetrically by using the indicator 2,3-bis(2-methoxy-4-nitro-5-sulphophenyl)- 5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) with menadione as electron-coupling agent. The activity of anidulafungin was assessed using in vitro microbiological model relevant for clinical practice. Anidulafungin showed a strong activity in vitro against both planktonic and biofilms cells, and our study confirms that high anidulafungin concentrations might establish paradoxical growth effect in C. albicans and C. tropicalis biofilms.
C1 [Rosato, Antonio; Catalano, Alessia; Carocci, Alessia; Carrieri, Antonio; Carone, Addolorata; Franchini, Carlo; Corbo, Filomena] Univ Bari Aldo Moro, Dipartimento Farm Sci Farm, Bari, Italy.
   [Piarulli, Monica; Schiavone, Brigida Pia Immacolata] Univ Bari Aldo Moro, Scuola Dottorato, Bari, Italy.
   [Piarulli, Monica; Schiavone, Brigida Pia Immacolata] Univ Bari Aldo Moro, Sez Igiene, Bari, Italy.
   [Caggiano, Giuseppina; Montagna, Maria Teresa] Univ Bari Aldo Moro, Dipartimento Sci Biomed & Oncol Umana, Sez Igiene, Bari, Italy.
RP Rosato, A (reprint author), Univ Bari, Dept Pharm, Via Orabona 4, I-70125 Bari, Italy.
EM arosato@farmchim.uniba.it
OI Carocci, Alessia/0000-0003-2248-9292; rosato,
   antonio/0000-0001-5462-4650; Franchini, Carlo/0000-0002-3725-750X;
   Caggiano, Giuseppina/0000-0003-3009-9147; Catalano,
   Alessia/0000-0002-7420-4706; Carrieri, Antonio/0000-0002-7725-6667;
   Corbo, Filomena/0000-0002-6951-1103; Montagna, Maria
   Teresa/0000-0002-2958-5458
FU Pfizer s.r.l. Italy
FX This study was supported by an unrestricted grant from Pfizer s.r.l.
   Italy.
CR Alem MAS, 2004, ANTIMICROB AGENTS CH, V48, P41, DOI 10.1128/AAC.48.1.41-47.2004
   Bachmann J. S. P., 2002, ANTIMICROB AGENTS CH, V46, P3591
   Chamilos G, 2007, ANTIMICROB AGENTS CH, V51, P2257, DOI 10.1128/AAC.00095-07
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Choi HW, 2007, ANTIMICROB AGENTS CH, V51, P1520, DOI 10.1128/AAC.01141-06
   Cocuaud C, 2005, J ANTIMICROB CHEMOTH, V56, P507, DOI 10.1093/jac/dki269
   COX GM, 1993, CURR OPIN INFECT DIS, V6, P422
   d'Enfert C, 2006, CURR DRUG TARGETS, V7, P465, DOI 10.2174/138945006776359458
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Ferreira JAG, 2009, ANTIMICROB AGENTS CH, V53, P4377, DOI 10.1128/AAC.00316-09
   Fleischhacker M, 2008, EUR J CLIN MICROBIOL, V27, P127, DOI 10.1007/s10096-007-0411-4
   Georgopapadakou NH, 2001, EXPERT OPIN INV DRUG, V10, P269, DOI 10.1517/13543784.10.2.269
   HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128
   Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450
   Jacobson MJ, 2008, ANTIMICROB AGENTS CH, V52, P2242, DOI 10.1128/AAC.00211-08
   Kim R, 2007, EXPERT OPIN PHARMACO, V8, P1479, DOI 10.1517/14656566.8.10.1479
   Koijc E. M., 2004, CLIN MICROBIOL REV, V17, P255
   Ku TSN, 2011, J MED MICROBIOL, V60, P1708, DOI 10.1099/jmm.0.032235-0
   Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002
   Kuhn DM, 2003, J CLIN MICROBIOL, V41, P506, DOI 10.1128/JCM.41.1.506-508.2003
   Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186
   LaFleur MD, 2006, ANTIMICROB AGENTS CH, V50, P3839, DOI 10.1128/AAC.00684-06
   Melo AS, 2007, ANTIMICROB AGENTS CH, V51, P3081, DOI 10.1128/AAC.00676-07
   Miceli MH, 2009, INT J ANTIMICROB AG, V34, P326, DOI 10.1016/j.ijantimicag.2009.04.011
   Mishra Nagendra Nath, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P201, DOI 10.1556/AMicr.54.2007.3.1
   Mukherjee PK, 2004, DRUG RESIST UPDATE, V7, P301, DOI 10.1016/j.drup.2004.09.002
   Ramage G, 2001, Am Clin Lab, V20, P42
   Rosato A, 2012, MED CHEM, V8, P690, DOI 10.2174/157340612801216184
   Simitsopoulou M, 2013, ANTIMICROB AGENTS CH, V57, P2562, DOI 10.1128/AAC.02541-12
   Stevens DA, 2006, ANTIMICROB AGENTS CH, V50, P3160, DOI 10.1128/AAC.00563-06
   Wiederhold NR, 2007, CURR OPIN INFECT DIS, V20, P574, DOI 10.1097/QCO.0b013e3282f1be7f
NR 31
TC 6
Z9 6
U1 0
U2 5
PU JAPAN ANTIBIOTICS RESEARCH ASSOC
PI TOKYO
PA 2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN
SN 0021-8820
J9 J ANTIBIOT
JI J. Antibiot.
PD DEC
PY 2013
VL 66
IS 12
BP 701
EP 704
DI 10.1038/ja.2013.83
PG 4
WC Biotechnology & Applied Microbiology; Immunology; Microbiology;
   Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Immunology; Microbiology;
   Pharmacology & Pharmacy
GA 278KP
UT WOS:000328889500002
PM 24022607
DA 2018-10-20
ER

PT J
AU Schniepp, HC
   Koebley, SR
   Vollrath, F
AF Schniepp, Hannes C.
   Koebley, Sean R.
   Vollrath, Fritz
TI Brown Recluse Spider's Nanometer Scale Ribbons of Stiff Extensible Silk
SO ADVANCED MATERIALS
LA English
DT Article
DE silk; polymer thin films; protein fibers; fiber spinning
ID ATOMIC-FORCE MICROSCOPY; DRAGLINE SILK; ADHESION MEASUREMENTS; SPRING
   CONSTANT; CANTILEVERS; FIBERS; FILMS; WEBS; ORGANIZATION; BIOMATERIAL
C1 [Schniepp, Hannes C.; Koebley, Sean R.] Coll William & Mary, Dept Appl Sci, Williamsburg, VA 23187 USA.
   [Vollrath, Fritz] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
RP Schniepp, HC (reprint author), Coll William & Mary, Dept Appl Sci, POB 8795, Williamsburg, VA 23187 USA.
EM schniepp@wm.edu
RI Schniepp, Hannes/B-8368-2008; Koebley, Sean/B-1205-2013
OI Schniepp, Hannes/0000-0003-4645-9469; Koebley, Sean/0000-0003-1451-1453
FU AFOSR [FA9550-12-1-0294 06]; ERC [SP2-GA-2008-233409]; Jeffress Memorial
   Trust [J-1012]
FX The authors thank Rick Vetter for providing Loxosceles specimens,
   Matthew Wawersik for a Drosophila sample, David Porter for providing
   feedback on the manuscript, Michael Funk and NASA Langley's Advanced
   Materials & Processing Branch for their electron microscopy support.
   F.V. thanks the AFOSR (FA9550-12-1-0294 06) and ERC (SP2-GA-2008-233409)
   for generous funding. H.C.S. thanks the Jeffress Memorial Trust (J-1012)
   for financial support.
CR AGNARSSON I, 2010, PLOS ONE, V5
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Coddington J. A., 2001, BIOMACROMOLECULES, V3, P5
   Crosby AJ, 2005, LANGMUIR, V21, P11738, DOI 10.1021/la051721k
   DENNY M, 1976, J EXP BIOL, V65, P483
   Du N, 2011, ADV FUNCT MATER, V21, P772, DOI 10.1002/adfm.201001397
   Greving I, 2012, BIOMACROMOLECULES, V13, P676, DOI 10.1021/bm201509b
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Heim LO, 2004, LANGMUIR, V20, P2760, DOI 10.1021/la036128m
   Heim M, 2010, CHEM SOC REV, V39, P156, DOI 10.1039/b813273a
   Hutter JL, 2005, LANGMUIR, V21, P2630, DOI 10.1021/la047670t
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kerr RA, 2011, SCIENCE, V331, P1510, DOI 10.1126/science.331.6024.1510
   Kharlampieva E, 2010, ACS NANO, V4, P7053, DOI 10.1021/nn102456w
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Knight DP, 2002, PHILOS T ROY SOC B, V357, P219, DOI 10.1098/rstb.2001.1026
   Koski K. J., 2013, NAT MATER, V12, P1
   LI SFY, 1994, BIOPHYS J, V66, P1209, DOI 10.1016/S0006-3495(94)80903-8
   Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105
   O'Connell PA, 2005, SCIENCE, V307, P1760, DOI 10.1126/science.1105658
   Omenetto FG, 2012, NAT MATER, V11, P273, DOI 10.1038/nmat3291
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021
   Santos S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023821
   Shahsavan H, 2012, SOFT MATTER, V8, P8281, DOI 10.1039/c2sm25795e
   Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103
   Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493
   Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Tien LW, 2013, ADV FUNCT MATER, V23, P3185, DOI 10.1002/adfm.201203716
   Viney C, 1997, SUPRAMOL SCI, V4, P75, DOI 10.1016/S0968-5677(96)00059-4
   Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n
   Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4
   VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447
   Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023
   Vollrath F, 2011, SOFT MATTER, V7, P9595, DOI 10.1039/c1sm05812f
   WORK RW, 1982, J ARACHNOL, V10, P1
   WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003
NR 42
TC 10
Z9 10
U1 4
U2 48
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD DEC
PY 2013
VL 25
IS 48
BP 7028
EP 7032
DI 10.1002/adma.201302740
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 275VV
UT WOS:000328707300021
PM 24352987
DA 2018-10-20
ER

PT J
AU Tang, H
   Lu, A
   Li, L
   Zhou, WJ
   Xie, ZX
   Zhang, LN
AF Tang, Hu
   Lu, Ang
   Li, Li
   Zhou, Weijie
   Xie, Zhixiong
   Zhang, Lina
TI Highly antibacterial materials constructed from silver molybdate
   nanoparticles immobilized in chitin matrix
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Antibacterial; Chitin gel-membrane; Reaction chamber; Silver molybdate
   nanoparticles; Templates
ID NEURAL STEM; CHITOSAN; NANOWIRES; FILMS; BIOCOMPATIBILITY;
   DIFFERENTIATION; NANOCOMPOSITE; COMPOSITES; SYSTEM; CELLS
AB Chitin gel-membranes (CGM), which fabricated directly from chitin solution in NaOH/urea aqueous system at low temperature, were applied for in situ synthesis of Ag2Mo2O7 nanoparticles to obtain hybrid nanomaterials. The microporous structure of CGM at wet state was served as reaction chambers to synthesize the Ag2Mo2O7 nanoparticles. The structure and properties of the nanocomposite membranes were characterized with X-ray diffraction, thermal gravimetric analysis, scanning electron microscopy and Fourier transform infrared spectroscopy. The results indicated that the CGM film at dry state showed mesopore structure, and the Ag2Mo2O7 nanoparticles with average size of 10 nm dispersed uniformly along the wall and immobilized in the chitin matrix. There was a strong interaction between Ag2Mo2O7 and chitin, and the porous structure of the CGM matrix played an important role in the synthesis and immobilization of inorganic nanoparticles. Moreover, the Ag2Mo2O7/chitin membranes exhibited a significantly antibacterial activity even tested in the microbial broth. It could be explained that DNA lost its replication ability and the protein became inactivated due to the associating with the Ag+. The Ag2Mo2O7/chitin composite membrane would be an ideal candidate for the tissue engineering and wound dressing application. This work provided a novel and "green" pathway for the fabrication of the nanoparticle/ polymer hybrid materials, having great potentials in the biomaterial field. Crown Copyright (C) 2013 Published by Elsevier B.V. All rights reserved.
C1 [Tang, Hu; Lu, Ang; Li, Li; Zhou, Weijie; Zhang, Lina] Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
   [Li, Li; Xie, Zhixiong] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.
RP Xie, ZX (reprint author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.
EM zxxie@whu.edu.cn; lnzhang@public.wh.hb.cn
OI Lu, Ang/0000-0001-6457-8264
FU National Basic Research Program of China (973 Program) [2010CB732203];
   National Natural Science Foundation of China [20474048, 20874079]
FX This work was supported by National Basic Research Program of China (973
   Program, 2010CB732203), and the National Natural Science Foundation of
   China (20474048 and 20874079).
CR Chang CY, 2011, J MATER CHEM, V21, P3865, DOI 10.1039/c0jm03075a
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Cui XJ, 2004, CHEM-EUR J, V10, P218, DOI 10.1002/chem.200305429
   Darder M, 2007, ADV MATER, V19, P1309, DOI 10.1002/adma.200602328
   Dong J, 1997, MACROMOLECULES, V30, P286, DOI 10.1021/ma9607168
   Duan B, 2013, J MATER CHEM A, V1, P1867, DOI 10.1039/c2ta00068g
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Gregg S. J., 1982, ADSORPTION SURFACE A, P121
   Hashim M, 2011, PHYS STATUS SOLIDI A, V208, P1937, DOI 10.1002/pssa.201026648
   Hsu SH, 2010, BIOMATERIALS, V31, P6796, DOI 10.1016/j.biomaterials.2010.05.015
   Ifuku S, 2011, GREEN CHEM, V13, P1708, DOI 10.1039/c1gc15321h
   Ifuku S, 2011, GREEN CHEM, V13, P1499, DOI 10.1039/c0gc00860e
   Ifuku S, 2010, BIOMACROMOLECULES, V11, P1326, DOI 10.1021/bm100109a
   Ifuku S, 2009, BIOMACROMOLECULES, V10, P2714, DOI 10.1021/bm9006979
   Jeon HJ, 2003, BIOMATERIALS, V24, P4921, DOI 10.1016/S0142-9612(03)00415-0
   Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P
   Kim H, 2011, J BIOMED MATER RES A, V97A, P395, DOI 10.1002/jbm.a.33070
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Lenoir S, 2006, BIOMACROMOLECULES, V7, P2291, DOI 10.1021/bm050850c
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5
   Liu SL, 2009, CELLULOSE, V16, P189, DOI 10.1007/s10570-008-9268-7
   Liu SJ, 2005, BIOMATERIALS, V26, P4662, DOI 10.1016/j.biomaterials.2004.11.053
   Luo XG, 2009, J MATER CHEM, V19, P3538, DOI 10.1039/b900103d
   Marini M, 2007, BIOMACROMOLECULES, V8, P1246, DOI 10.1021/bm060721b
   Meynen V, 2009, MICROPOR MESOPOR MAT, V125, P170, DOI 10.1016/j.micromeso.2009.03.046
   Nagaraju G, 2008, B MATER SCI, V31, P367, DOI 10.1007/s12034-008-0057-6
   Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9
   Scanga VI, 2010, CAN J CHEM, V88, P277, DOI 10.1139/V09-171
   Shah MSAS, 2008, CHEM MATER, V20, P2455, DOI 10.1021/cm7033867
   Spinde K, 2011, CHEM MATER, V23, P2973, DOI 10.1021/cm200677d
   Tang H, 2012, J HAZARD MATER, V209, P218, DOI 10.1016/j.jhazmat.2012.01.010
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
NR 35
TC 34
Z9 35
U1 6
U2 114
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD DEC
PY 2013
VL 234
BP 124
EP 131
DI 10.1016/j.cej.2013.08.096
PG 8
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 274EI
UT WOS:000328588300016
DA 2018-10-20
ER

PT J
AU Xu, X
   Gao, BY
   Yue, QY
   Li, Q
   Wang, Y
AF Xu, Xing
   Gao, Baoyu
   Yue, Qinyan
   Li, Qian
   Wang, Yan
TI Nitrate adsorption by multiple biomaterial based resins: Application of
   pilot-scale and lab-scale products
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Nitrate; Wheat stalk; Cotton stalk; Resins; Pilot-scale
ID ANION-EXCHANGERS; AQUEOUS-SOLUTION; WASTE-WATER; REMOVAL; KINETICS;
   EQUILIBRIUM; GROUNDWATER; PHOSPHATE; ISOTHERM; MAXIMUM
AB Resins produced from pilot-scale tests and lab-scale tests were employed for the adsorption of nitrate from aqueous solutions. All these products were prepared by using virgin wheat stalk and cotton stalk as starting materials. Physicochemical properties of the products were determined after TG, BET surface area, SEM, FTIR and elemental analysis. It was illustrated that nitrate uptake by these products was based on electrostatic attraction. In the static adsorption tests, removal of nitrate by these resins was almost constant for a pH range of 4-10. The maximum adsorption capacities (q(max)) of these products for nitrate were in the range of 33.35-50.24 mg/g. Products prepared in lab conditions showed relatively higher nitrate uptake as compared with those of pilot-scale products. Desorption efficiencies of the acid elution (HCl) and salt elution (NaCl) in column were between 95% and 98%. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Xu, Xing; Gao, Baoyu; Yue, Qinyan; Li, Qian; Wang, Yan] Shandong Univ, Sch Environm Sci & Engn, Key Lab Water Pollut Control & Recycling Shandong, Jinan 250100, Peoples R China.
RP Gao, BY (reprint author), Shandong Univ, Sch Environm Sci & Engn, Key Lab Water Pollut Control & Recycling Shandong, Jinan 250100, Peoples R China.
EM bygao@sdu.edu.cn
RI SDU, Environ Res/P-4462-2015
FU National Natural Science Foundation of China [50878121, 51178252];
   Shandong Outstanding Young and Middle-aged Scientists Research Award
   Fund [BS2011HZ007]; Shanghai Tongji Gao Tingyao Environmental Science &
   Technology Development Foundation (STGEF); Scholarship Award for
   Excellent Doctoral Student; Ministry of Education
FX The research was supported by the National Natural Science Foundation of
   China (50878121), National Natural Science Foundation of China
   (51178252), Shandong Outstanding Young and Middle-aged Scientists
   Research Award Fund (BS2011HZ007). Shanghai Tongji Gao Tingyao
   Environmental Science & Technology Development Foundation (STGEF) and
   the Scholarship Award for Excellent Doctoral Student granted by Ministry
   of Education.
CR Ada K, 2009, J HAZARD MATER, V165, P637, DOI 10.1016/j.jhazmat.2008.10.036
   Akkaya R, 2013, DESALINATION, V321, P3, DOI [10.1016/j.desa1.2012.09.020, 10.1016/j.desal.2012.09.020]
   Azizian S, 2007, CHEMOSPHERE, V68, P2040, DOI 10.1016/j.chemosphere.2007.02.042
   Balci S, 2004, WATER RES, V38, P1129, DOI 10.1016/j.watres.2003.12.005
   Bohdziewicz J, 1999, DESALINATION, V121, P139, DOI 10.1016/S0011-9164(99)00015-6
   Chabani M, 2007, DESALINATION, V206, P560, DOI 10.1016/j.desal.2006.04.064
   Del Bubba M, 2003, WATER RES, V37, P3390, DOI 10.1016/S0043-1354(03)00231-8
   Demiral H, 2010, BIORESOURCE TECHNOL, V101, P1675, DOI 10.1016/j.biortech.2009.09.087
   El-Khaiary MI, 2007, J HAZARD MATER, V147, P28, DOI 10.1016/j.jhazmat.2006.12.058
   Kesore K, 1997, J MEMBRANE SCI, V127, P17, DOI 10.1016/S0376-7388(96)00282-7
   Lafforgue M, 1995, WATER SCI TECHNOL, V32, P117, DOI 10.1016/0273-1223(95)00688-5
   Lehman SG, 2008, WATER RES, V42, P969, DOI 10.1016/j.watres.2007.09.011
   MEGURO T, 1985, CARBON, V23, P137, DOI 10.1016/0008-6223(85)90003-X
   Milmile SN, 2011, DESALINATION, V276, P38, DOI 10.1016/j.desal.2011.03.015
   MohseniBandpi A, 1996, WATER SCI TECHNOL, V34, P323, DOI 10.1016/0273-1223(96)00522-7
   Namasivayam C, 2008, BIORESOURCE TECHNOL, V99, P2218, DOI 10.1016/j.biortech.2007.05-023
   Orlando US, 2002, BIORESOURCE TECHNOL, V83, P195, DOI 10.1016/S0960-8524(01)00220-6
   Orlando US, 2002, CHEMOSPHERE, V48, P1041, DOI 10.1016/S0045-6535(02)00147-9
   Osifo PO, 2009, J HAZARD MATER, V167, P1242, DOI 10.1016/j.jhazmat.2009.01.109
   Passe-Coutrin N, 2009, J COLLOID INTERF SCI, V332, P515, DOI 10.1016/j.jcis.2008.12.079
   Ribbe L, 2008, DESALINATION, V226, P13, DOI 10.1016/j.desal.2007.01.232
   Savant DV, 2006, BIORESOURCE TECHNOL, V97, P1092, DOI 10.1016/j.biortech.2004.12.013
   Song HO, 2012, DESALINATION, V296, P53, DOI 10.1016/j.desal.2012.04.003
   Sundaraganesan N, 2008, SPECTROCHIM ACTA A, V71, P898, DOI 10.1016/j.saa.2008.02.016
   Xing X, 2011, J HAZARD MATER, V186, P206, DOI 10.1016/j.jhazmat.2010.10.104
   Xu X, 2013, CHEM ENG J, V226, P1, DOI 10.1016/j.cej.2013.04.033
   Xu X, 2011, J HAZARD MATER, V192, P1690, DOI 10.1016/j.jhazmat.2011.07.009
   Xu X, 2011, CARBOHYD POLYM, V84, P1054, DOI 10.1016/j.carbpol.2010.12.069
   Xu X, 2010, BIORESOURCE TECHNOL, V101, P8558, DOI 10.1016/j.biortech.2010.06.060
   Yang GCC, 2005, WATER RES, V39, P884, DOI 10.1016/j.watres.2004.11.030
   Yue QY, 2007, SEP PURIF TECHNOL, V54, P279, DOI 10.1016/j.seppur.2006.10.024
NR 31
TC 20
Z9 20
U1 1
U2 20
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD DEC
PY 2013
VL 234
BP 397
EP 405
DI 10.1016/j.cej.2013.08.117
PG 9
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 274EI
UT WOS:000328588300047
DA 2018-10-20
ER

PT J
AU Akar, T
   Balk, YY
   Tuna, O
   Akar, ST
AF Akar, Tamer
   Balk, Yasemin Yetimoglu
   Tuna, Okan
   Akar, Sibel Tunali
TI Characterization and application of plant-based magnetic biomaterial for
   batch and fixed-bed mode sequestration of lead from synthetic and real
   effluents
SO ECOLOGICAL ENGINEERING
LA English
DT Article
DE Magnetic sorbent; Sorption; Lead; Characterization; Wastewater
ID AQUEOUS-SOLUTION; THUJA-ORIENTALIS; REMOVAL; ADSORPTION; BIOSORPTION;
   BIOMASS; EQUILIBRIUM; SORPTION; CARBON; DYE
AB In this study, biomass obtained from Thuja orientalis (T. orientalis) cones was converted to magnetic derivative (Mag-TOCP) and effectively used as a sorbent material for the removal of Pb2+ ions from contaminated solutions. IR, SEM, EDX and zeta potential analysis were employed to analyze the biomaterial modification and sorption mechanism. Batch mode operating conditions were investigated as functions of pH, contact time, Mag-TOCP dose and temperature. Modeling studies showed that equilibrium data were well predicted by the Langmuir isotherm with a monolayer sorption capacity of 1.92 x 10(-4) mol g(-1) and sorption kinetics was followed by the pseudo-second-order model. It was also observed that Pb2+ biosorption potential of Mag-TOCP did not significantly changed in competitive biosorption conditions. The results imply that the suggested biomaterial may find promising applications for the treatment of lead contaminated solutions. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Akar, Tamer; Tuna, Okan; Akar, Sibel Tunali] Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
   [Balk, Yasemin Yetimoglu] Eskisehir Osmangazi Univ, Grad Sch Nat & Appl Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
RP Akar, T (reprint author), Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
EM takar@ogu.edu.tr
CR Akar ST, 2013, CARBOHYD POLYM, V94, P400, DOI 10.1016/j.carbpol.2013.01.062
   Akar ST, 2009, CHEM ENG J, V148, P26, DOI 10.1016/j.cej.2008.07.027
   Akar T, 2011, J CHEM TECHNOL BIOT, V86, P1332, DOI 10.1002/jctb.2639
   CHISOLM JJ, 1971, SCI AM, V224, P15, DOI 10.1038/scientificamerican0271-15
   Dubinin M, 1947, CHEM ZENTR, V1, P875
   Freundlich H., 1906, ABSORPTION LOSUNGEN, P98
   Guerra DL, 2010, J COLLOID INTERF SCI, V346, P178, DOI 10.1016/j.jcis.2010.02.041
   Hammaini A, 2007, J ENVIRON MANAGE, V84, P419, DOI 10.1016/j.jenvman.2006.06.015
   HAMMOND PB, 1977, ANNU REV PHARMACOL, V17, P197, DOI 10.1146/annurev.pa.17.040177.001213
   Hasany SM, 1996, APPL RADIAT ISOTOPES, V47, P467, DOI 10.1016/0969-8043(95)00310-X
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   HOBSON JP, 1969, J PHYS CHEM-US, V73, P2720, DOI 10.1021/j100842a045
   Janos P, 2013, REACT FUNCT POLYM, V73, P46, DOI 10.1016/j.reactfunctpolym.2012.09.001
   Johnson FM, 1998, MUTAT RES-REV MUTAT, V410, P123, DOI 10.1016/S1383-5742(97)00032-X
   Konicki W, 2012, CHEM ENG J, V210, P87, DOI 10.1016/j.cej.2012.08.025
   Lagergren S, 1989, HANDLINGAR, V24, P1
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Li TT, 2013, CHEM ENG J, V214, P189, DOI 10.1016/j.cej.2012.10.055
   Malkoc E, 2006, J HAZARD MATER, V137, P899, DOI 10.1016/j.jhazmat.2006.03.004
   Mohan D, 2011, CHEM ENG J, V172, P1111, DOI 10.1016/j.cej.2011.06.054
   Pokhrel D, 2008, CHEM ENG J, V140, P165, DOI 10.1016/j.cej.2007.09.038
   Subbaiah MV, 2011, J TAIWAN INST CHEM E, V42, P965, DOI 10.1016/j.jtice.2011.04.007
   Volesky B., 1990, BIOSORPTION HEAVY ME, P3
NR 23
TC 4
Z9 4
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-8574
EI 1872-6992
J9 ECOL ENG
JI Ecol. Eng.
PD DEC
PY 2013
VL 61
BP 251
EP 257
DI 10.1016/j.ecoleng.2013.09.062
PN A
PG 7
WC Ecology; Engineering, Environmental; Environmental Sciences
SC Environmental Sciences & Ecology; Engineering
GA 272UO
UT WOS:000328487200031
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
TI XPS measurements of LDX 2101 duplex steel surface after
   magnetoelectropolishing
SO INTERNATIONAL JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
DE LDX 2101 steel; Magnetoelectropolishing MEP; Cr-X/Fe-X ratio; Cr6+
   content drop; Models
ID 316L STAINLESS-STEEL; RAY PHOTOELECTRON-SPECTROSCOPY; MAGNETIC-FIELD;
   TITANIUM BIOMATERIAL; PYRITE; IRON; CORROSION; SS; SULFUR; WATER
AB The work presents the X-ray photoelectron spectroscopy measurement results of LDX 2101 duplex steel surface after magnetoelectropolishing in comparison with the results obtained after a standard electropolishing in still electrolyte and in the electrolyte with moderate mixing. A considerable improvement of the steel surface was found to appear after the magnetoelectropolishing treatment concerning the general composition. The calculated ratio of chromium compounds to iron compounds Cr-X/FeX equals 2 after magnetoelectropolishing and only 0.5 after a standard electropolishing. On the other hand, the ionic Cr6+ content after magnetoelectropolishing was the lowest (2.77 at.%), and after a standard electropolishing it was the highest (30.3 at.%). Such results are expected to influence the corrosion behavior of the steel and increase the corrosion resistance greatly.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz] Koszalin Univ Technol, Div Surface Electrochem & Technol, PL-75620 Koszalin, Poland.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl
CR [Anonymous], 1990, METALS HDB, V1
   Barquist K.N., 2009, THESIS U IOWA
   Biesinger MC, 2004, SURF INTERFACE ANAL, V36, P1550, DOI 10.1002/sia.1983
   BRION D, 1980, APPL SURF SC, V5, P133, DOI 10.1016/0378-5963(80)90148-8
   Crist V., 2000, HDB MONOCHROMATIC XP
   Daulton TL, 2006, ULTRAMICROSCOPY, V106, P561, DOI 10.1016/j.ultramic.2006.02.005
   Descostes M, 2000, APPL SURF SCI, V165, P288, DOI 10.1016/S0169-4332(00)00443-8
   Eggleston CM, 1996, AM MINERAL, V81, P1036
   Fantauzzi M, 2010, ANAL BIOANAL CHEM, V396, P2889, DOI 10.1007/s00216-010-3576-0
   Grosvenor AP, 2004, SURF INTERFACE ANAL, V36, P1564, DOI 10.1002/sia.1984
   Hryniewicz T, 2008, CORROS SCI, V50, P2676, DOI 10.1016/j.corsci.2008.06.048
   Hryniewicz T, 2008, CORROSION, V64, P660, DOI 10.5006/1.3279927
   Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2008, SURF COAT TECH, V202, P1668, DOI 10.1016/j.surfcoat.2007.07.067
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T, 2010, MATER CHEM PHYS, V123, P47, DOI 10.1016/j.matchemphys.2010.03.060
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2012, SURF COAT TECH, V206, P4027, DOI 10.1016/j.surfcoat.2012.03.083
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Hryniewicz T, 2009, MATERIALS, V2, P129, DOI 10.3390/ma2010129
   Kish JR, 2003, CORROS SCI, V45, P1571, DOI 10.1016/S0010-938X(02)00232-9
   KONNO H, 1991, BUNSEKI KAGAKU, V40, P609
   Li XY, 2013, STEEL RES INT, V84, P155, DOI 10.1002/srin.201200131
   MILLS P, 1983, J PHYS D APPL PHYS, V16, P723, DOI 10.1088/0022-3727/16/5/005
   NESBITT HW, 1994, GEOCHIM COSMOCHIM AC, V58, P4667, DOI 10.1016/0016-7037(94)90199-6
   NILSSON JO, 1992, MATER SCI TECH SER, V8, P685, DOI 10.1179/mst.1992.8.8.685
   NILSSON JO, 1993, MATER SCI TECH SER, V9, P545, DOI 10.1179/mst.1993.9.7.545
   Pramatarova L, 2007, J MATER SCI-MATER M, V18, P435, DOI 10.1007/s10856-007-2002-4
   Rokicki R., 2008, MED DEVICE DIAGN IND, V30, P102
   Rokicki R., 2009, US Patent, Patent No. 7632390
   Rokosz K., 2010, CORROSION, V66, DOI 10.5006/1.3360910
   Rokosz K., 2012, MEASUREMENT AUTOMATI, V58, P460
   Rokosz K., 2010, T VSB MECH SER TU OS, V56, P301
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Selvaduray G., 2005, P MAT PROC MED DEV C
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   Stypula B., 2009, P 33 SCI C
   Tang S, 2006, SURF COAT TECH, V200, P5220, DOI 10.1016/j.surfcoat.2005.06.020
   Tauson VL, 2008, GEOCHEM INT+, V46, P565, DOI 10.1134/S0016702908060037
   Trigwell S., 2005, KSC2005182 NASA
   VOGT KW, 1995, THIN SOLID FILMS, V256, P106, DOI 10.1016/0040-6090(94)06308-7
   Wagner C.D., 2000, HDB XRAY PHOTOELECTR
   Wagner CD, 1979, HDB XRAY PHOTOELECTR
   Wang SG, 2007, J MAGN MAGN MATER, V310, P1935, DOI 10.1016/j.jmmm.2006.10.767
   Wang XY, 2001, CORROSION, V57, P540, DOI 10.5006/1.3290380
   Zhang XY, 2005, CHINESE SCI BULL, V50, P738, DOI 10.1360/04wb0110
NR 48
TC 14
Z9 14
U1 1
U2 26
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 1862-5282
EI 2195-8556
J9 INT J MATER RES
JI Int. J. Mater. Res.
PD DEC
PY 2013
VL 104
IS 12
BP 1223
EP 1232
DI 10.3139/146.110984
PG 10
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 278VZ
UT WOS:000328919300006
DA 2018-10-20
ER

PT J
AU Felgueiras, H
   Migonney, V
AF Felgueiras, H.
   Migonney, V.
TI Presence of sulfonate groups on Ti6A14V surfaces enhances osteoblastic
   attachment strength at the interface
SO IRBM
LA English
DT Article
ID CHEMICAL-CHARACTERIZATION; TITANIUM IMPLANTS; OXIDE-FILMS;
   DIFFERENTIATION; PROLIFERATION
AB The application of the titanium alloy Ti6A14V in the biomedical field is not new. It has been used for more than 50 years with excellent results. Nonetheless, the interactions developed at the interface biomaterial-cell still present some challenges during implantation. The use of bioactive polymers bearing anionic groups in combination with titanium-based materials has been shown to be an excellent solution. In this study, we demonstrated the impact of the poly(sodium styrene sulfonate) (or poly(NaSS)) chemical grafting on Ti6A14V surfaces by following the attachment strength of the osteoblastic cells MC3T3-E1, in their initial moments of interaction, and by afterward examine their differentiation. The grafting process was proved to be successful by measuring the poly(NaSS) concentration on the Ti6A14V using the toluidine blue colorimetric method. The cells morphology was observed without changes being detected between substrates. On the other hand, the presence of the sulfonate groups enhanced the strength of the cellular bond, enabling the MC3T3-E1 to resist to shear stress of 10 dyn/cm(2) of magnitude. The poly(NaSS) was found to enhance the osteoblastic cells differentiation by increasing the alkaline phosphatase concentration and, consequently, the cells metabolic activity. This in vitro study proved once again the poly(NaSS) to be suitable for biomedical applications. (C) 2013 Published by Elsevier Masson SAS.
C1 [Felgueiras, H.; Migonney, V.] Univ Paris 13, Inst Galilee, LBPS CSPBAT CNRS UMR 7244, Lab Biomat & Specialty Polymers, F-93430 Villetaneuse, France.
RP Migonney, V (reprint author), Univ Paris 13, Inst Galilee, LBPS CSPBAT CNRS UMR 7244, Lab Biomat & Specialty Polymers, F-93430 Villetaneuse, France.
EM veronique.migonney@univ-paris13.fr
RI Felgueiras, Helena/H-4323-2017
OI Felgueiras, Helena/0000-0002-4354-0256; MIGONNEY,
   VERONIQUE/0000-0002-1055-3720
CR Angwarawong T, 2011, DENT MATER J, V30, P158, DOI 10.4012/dmj.2010-097
   Aparicio C, 2002, J MATER SCI-MATER M, V13, P1105, DOI 10.1023/A:1021173500990
   Ciobanu M, 2006, BIOMACROMOLECULES, V7, P755, DOI 10.1021/bm050694+
   De Angelis E, 2009, J BIOMED MATER RES B, V88B, P280, DOI 10.1002/jbm.b.31179
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Feng B, 2002, J MATER SCI-MATER M, V13, P457, DOI 10.1023/A:1014737831371
   Gabbi C, 2005, ANN FM VET PARMA, V25, P307
   Helary G, 2010, J MATER SCI-MATER M, V21, P655, DOI 10.1007/s10856-009-3892-0
   Helary G, 2009, ACTA BIOMATER, V5, P124, DOI 10.1016/j.actbio.2008.07.037
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Mayingi J, 2008, IRBM, V29, P1, DOI 10.1016/j.rbmret.2007.10.001
   Michiardi A, 2010, ACTA BIOMATER, V6, P667, DOI 10.1016/j.actbio.2009.08.043
   Oughlis S., 2012, J BIOMED MATER RES A, V101A, P582
   Park GW, 2010, ACTA BIOMATER, V6, P2843
   Pavon-Djavid G, 2007, BIOMACROMOLECULES, V8, P3317, DOI 10.1021/bm070344i
   Viateau V, 2011, IRBM, V32, P118, DOI 10.1016/j.irbm.2011.01.007
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 18
TC 4
Z9 4
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1959-0318
EI 1876-0988
J9 IRBM
JI IRBM
PD DEC
PY 2013
VL 34
IS 6
BP 371
EP 375
DI 10.1016/j.irbm.2013.09.006
PG 5
WC Engineering, Biomedical
SC Engineering
GA 275HL
UT WOS:000328666800003
DA 2018-10-20
ER

PT J
AU Zhao, DP
   Chang, KK
   Ebel, T
   Qian, M
   Willumeit, R
   Yan, M
   Pyczak, F
AF Zhao, Dapeng
   Chang, Keke
   Ebel, Thomas
   Qian, Ma
   Willumeit, Regine
   Yan, Ming
   Pyczak, Florian
TI Microstructure and mechanical behavior of metal injection molded Ti-Nb
   binary alloys as biomedical material
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Metal injection molding; Ti-Nb alloy; Porosity; Titanium carbide;
   Tensile strength and elongation; Young's modulus
ID NONSTOICHIOMETRIC TITANIUM CARBIDE; PHASE; COMPOSITES; TRANSFORMATIONS;
   DIFFRACTION; COMPONENTS; POROSITY; DESIGN
AB The application of titanium (Ti) based biomedical materials which are widely used at present, such as commercially pure titanium (CP-Ti) and Ti-6Al-4V, are limited by the mismatch of Young's modulus between the implant and the bones, the high costs of products, and the difficulty of producing complex shapes of materials by conventional methods. Niobium (Nb) is a non-toxic element with strong p stabilizing effect in Ti alloys, which makes Ti-Nb based alloys attractive for implant application. Metal injection molding (MIM) is a cost-efficient near-net shape process. Thus, it attracts growing interest for the processing of Ti and Ti alloys as biomaterial. In this investigation, metal injection molding was applied to the fabrication of a series of Ti-Nb binary alloys with niobium content ranging from 10 wt% to 22 wt%, and CP-Ti for comparison. Specimens were characterized by melt extraction, optical microscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM), energy-dispersive spectroscopy (EDS), and transmission electron microscopy (TEM). Titanium carbide formation was observed in all the as-sintered Ti-Nb binary alloys but not in the as-sintered CP-Ti. Selected area electron diffraction (SAED) patterns revealed that the carbides are Ti2C. It was found that with increasing niobium content from 0% to 22%, the porosity increased from about 1.6% to 5.8%, and the carbide area fraction increased from 0% to about 1.8% in the as-sintered samples. The effects of niobium content, porosity and titanium carbides on mechanical properties have been discussed. The as-sintered Ti-Nb specimens exhibited an excellent combination of high tensile strength and low Young's modulus, but relatively low ductility. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Zhao, Dapeng; Ebel, Thomas; Willumeit, Regine; Pyczak, Florian] Helmholtz Zentrum Geesthacht, Inst Mat Res, D-21502 Geesthacht, Germany.
   [Chang, Keke] Rhein Westfal TH Aachen, D-52056 Aachen, Germany.
   [Qian, Ma; Yan, Ming] Univ Queensland, Sch Mech & Min Engn, ARC Ctr Excellence Design Light Met, Brisbane, Qld 4072, Australia.
RP Zhao, DP (reprint author), Helmholtz Zentrum Geesthacht, Inst Mat Res, Max Planck Str 1, D-21502 Geesthacht, Germany.
EM Da-Peng.Zhao@hzg.de
RI Zhao, Dapeng/I-5984-2018; Chang, Keke/A-3203-2017; Pyczak,
   Florian/I-4331-2013; Willumeit, Regine/I-8029-2013
OI Zhao, Dapeng/0000-0001-6777-7760; Chang, Keke/0000-0001-9118-7031;
   Pyczak, Florian/0000-0002-9686-6575; Willumeit,
   Regine/0000-0002-6004-6946
FU Helmholtz - CSC Fellowship Programme
FX This research was funded by Helmholtz - CSC Fellowship Programme. The
   authors are grateful to Uwe Lorenz, Wolfgang Limberg, Andreas
   Dobernowsky, Petra Fischer, Michael Oehring, Jonathan Paul, Martin Wolff
   and Juliano Soyama from Helmholtz-Zentrum Geesthacht.
CR Abdel-Hady M, 2006, SCRIPTA MATER, V55, P477, DOI 10.1016/j.scriptamat.2006.04.022
   Aksyonov DA, 2012, COMP MATER SCI, V65, P434, DOI 10.1016/j.commatsci.2012.08.014
   Banerjee R, 2005, MAT SCI ENG C-BIO S, V25, P282, DOI 10.1016/j.msec.2004.12.010
   Baril E, 2010, PIM INT, V4, P22
   Bertrand E, 2010, J MECH BEHAV BIOMED, V3, P559, DOI 10.1016/j.jmbbm.2010.06.007
   Bidaux J.-E., 2012, POWDER INJECTION MOU, V6, P72
   Bidaux J.-E., 2011, EUR CELLS MATER, V22, P32
   Biesiekierski A, 2012, ACTA BIOMATER, V8, P1661, DOI 10.1016/j.actbio.2012.01.018
   Bolzoni L, 2012, J MECH BEHAV BIOMED, V9, P91, DOI 10.1016/j.jmbbm.2012.01.015
   BOURCIER RJ, 1986, ACTA METALL MATER, V34, P2443, DOI 10.1016/0001-6160(86)90147-1
   Chen BY, 2012, MAT SCI ENG A-STRUCT, V541, P88, DOI 10.1016/j.msea.2012.02.007
   Chen ZQ, 2004, MATER SCI TECH-LOND, V20, P343, DOI 10.1179/026708304225012288
   CONRAD H, 1966, ACTA METALL MATER, V14, P1631, DOI 10.1016/0001-6160(66)90186-6
   Ebel T., 2008, PIM INT, V2, P21
   Ebel T, 2011, ADV POWDER METALLURG
   Eibler R, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/19/196226
   Eibler R, 2002, J PHYS-CONDENS MAT, V14, P4425, DOI 10.1088/0953-8984/14/17/315
   Em VT, 1996, PHYS STATUS SOLIDI B, V198, P571, DOI 10.1002/pssb.2221980202
   Ferri OM, 2010, MAT SCI ENG A-STRUCT, V527, P1800, DOI 10.1016/j.msea.2009.11.007
   Fores F.H., 2007, POWDER METALL MET C, V45, P303
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   German R.M., 2010, INT J POWDER METALL, V46, P11
   German R M, 2009, POWDER INJECTION MOU, V3, P21
   GERMAN R M, 1990, POWDER INJECTION MOL
   Gusev AI, 2000, USP FIZ NAUK+, V170, P3, DOI 10.3367/UFNr.0170.200001a.0003
   He G, 2006, MAT SCI ENG C-BIO S, V26, P14, DOI 10.1016/j.msec.2005.03.007
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   KONITZER DG, 1989, ACTA METALL MATER, V37, P397, DOI 10.1016/0001-6160(89)90224-1
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lee BJ, 2001, METALL MATER TRANS A, V32, P2423, DOI 10.1007/s11661-001-0033-x
   Lipatnikov VN, 1998, PHYS SOLID STATE+, V40, P1211, DOI 10.1134/1.1130523
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   NAKAJIMA H, 1991, ISIJ INT, V31, P757, DOI 10.2355/isijinternational.31.757
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Obasi GC, 2010, MAT SCI ENG A-STRUCT, V527, P3929, DOI 10.1016/j.msea.2010.02.070
   Ramarolahy A, 2012, J MECH BEHAV BIOMED, V9, P83, DOI 10.1016/j.jmbbm.2012.01.017
   Sago JA, 2012, INT J POWDER METALL, V48, P41
   Sekimoto W, 2012, MATER TRANS, V53, P1405, DOI 10.2320/matertrans.M2012127
   Sidambe AT, 2012, J MATER PROCESS TECH, V212, P1591, DOI 10.1016/j.jmatprotec.2012.03.001
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Tan KE, 1997, MODEL SIMUL MATER SC, V5, P187, DOI 10.1088/0965-0393/5/3/001
   Tane M, 2011, ACTA MATER, V59, P6975, DOI 10.1016/j.actamat.2011.07.050
   Tashmetov MY, 2002, PHYSICA B, V311, P318, DOI 10.1016/S0921-4526(01)01033-X
   Wang HW, 2012, MAT SCI ENG A-STRUCT, V545, P209, DOI 10.1016/j.msea.2012.03.037
   Wanjara P, 2000, ACTA MATER, V48, P1443, DOI 10.1016/S1359-6454(99)00453-X
   Wei QQ, 2011, MATER DESIGN, V32, P2934, DOI 10.1016/j.matdes.2010.11.049
   Whittaker D., 2011, POWDER INJECTION MOU, V5, P47
   Whittaker D., 2007, POWDER INJECTION MOU, V1, P27
NR 49
TC 48
Z9 51
U1 5
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD DEC
PY 2013
VL 28
SI SI
BP 171
EP 182
DI 10.1016/j.jmbbm.2013.08.013
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 269IH
UT WOS:000328234500015
PM 23994942
DA 2018-10-20
ER

PT J
AU Leng, Z
   Zhang, JH
   Yin, TT
   Zhang, L
   Guo, XY
   Peng, QM
   Zhang, ML
   Wu, RZ
AF Leng, Zhe
   Zhang, Jinghuai
   Yin, Tingting
   Zhang, Li
   Guo, Xuying
   Peng, Qiuming
   Zhang, Milin
   Wu, Ruizhi
TI Influence of biocorrosion on microstructure and mechanical properties of
   deformed Mg-Y-Er-Zn biomaterial containing 18R-LPSO phase
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Mg alloys; Biocorrosion; Mechanical properties; Long period stacking
   ordered phase
ID STACKING ORDERED STRUCTURE; IN-VIVO CORROSION; MAGNESIUM ALLOYS; ZR
   ALLOY; RARE-EARTH; BEHAVIOR; BONE; ALUMINUM; MEDIA; VITRO
AB The microstructure and mechanical properties of as-extruded Mg-8Y-1Er-2Zn (wt%) alloy containing long period stacking ordered (LPSO) phase are comparatively investigated before and after corrosion in a simulated body fluid (SBF) at 37 degrees C. The as-extruded alloy consists of a long strip-like 18R-LPSO phase and some fine lamellae grains formed by primary recrystallization during the extrusion process. The hydrogen evolution volume per day fluctuates between 0.21 and 0.32 ml/cm(2) in the immersion test for 240 h, and the corresponding corrosion rate is calculated as 0.568 mm/y. The corrosion product is determined as Mg(OH)2, whilst a Ca(H2PO4)(2) compound is also observed on the surface of the samples. The corrosion site preferentially occurs at the interface between LPSO phase and Mg matrix. Before immersing, the tensile yield strength (TYS), ultimate tensile strength (UTS) and elongation of the alloy are 275 MPa, 3.59 MPa, and 19%, respectively. More attractively, these mechanical properties can be maintained even after immersing in SBF for 240 h (TYS, UTS and elongation are 216 MPa, 286 MPa and 6.8%, respectively) because of the existence of high anti-corrosion LPSO phase. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Leng, Zhe; Zhang, Jinghuai; Yin, Tingting; Zhang, Li; Guo, Xuying; Zhang, Milin; Wu, Ruizhi] Harbin Engn Univ, Minist Educ, Key Lab Superlight Mat & Surface Technol, Harbin 150001, Peoples R China.
   [Peng, Qiuming] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.
RP Zhang, JH (reprint author), Harbin Engn Univ, Minist Educ, Key Lab Superlight Mat & Surface Technol, Harbin 150001, Peoples R China.
EM jinghuaizhang@gmail.com; pengqiuming@gmail.com
FU Natural Science Foundation of Heilongjiang Province of China
   [QC2012C114]; Postdoctoral Science-research Developmental Foundation of
   Heilongjiang Province [LBH-Q12129]; Peng's Overseas Returned Scientific
   Research Foundation of Hebei Province; Foundation of State Key
   Laboratory of Rare Earth Resources Utilization [RERU2013011]
FX This work was supported by Natural Science Foundation of Heilongjiang
   Province of China (QC2012C114), Postdoctoral Science-research
   Developmental Foundation of Heilongjiang Province (LBH-Q12129), Peng's
   Overseas Returned Scientific Research Foundation of Hebei Province and
   Foundation of State Key Laboratory of Rare Earth Resources Utilization
   (RERU2013011).
CR Alvarez-Lopez M, 2010, ACTA BIOMATER, V6, P1763, DOI 10.1016/j.actbio.2009.04.041
   Conceicao T. F., 2010, THIN SOLID FILMS, V518, P5209
   El-Rahman SSA, 2003, PHARM RES, V47, P189, DOI DOI 10.1016/S1043-6618(02)00336-5
   Ferreira PC, 2008, REV LAT-AM ENFERM, V16, P151, DOI 10.1590/S0104-11692008000100023
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Hagihara K, 2010, INTERMETALLICS, V18, P267, DOI 10.1016/j.intermet.2009.07.014
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Kannan MB, 2010, MATER LETT, V64, P739, DOI 10.1016/j.matlet.2010.01.022
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Leng Z, 2012, MAT SCI ENG A-STRUCT, V540, P38, DOI 10.1016/j.msea.2012.01.057
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2007, THIN SOLID FILMS, V516, P422, DOI 10.1016/j.tsf.2007.05.048
   Ma N, 2012, INT J ELECTROCHEM SC, V7, P8020
   Mogilevskaya O.Y., 1964, POROSHKOV METALL, V21, P105
   Nakamura Y, 1997, FUND APPL TOXICOL, V37, P106, DOI 10.1006/faat.1997.2322
   Peng QM, 2013, J MECH BEHAV BIOMED, V17, P176, DOI 10.1016/j.jmbbm.2012.08.017
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Shao XH, 2010, ACTA MATER, V58, P4760, DOI 10.1016/j.actamat.2010.05.012
   Shingde M, 2005, MED J AUSTRALIA, V183, P145
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xue-Nan Gu, 2010, Frontiers of Materials Science in China, V4, P111, DOI 10.1007/s11706-010-0024-1
   Yamasaki M, 2007, ACTA MATER, V55, P6798, DOI 10.1016/j.actamat.2007.08.033
   Yan TT, 2010, MAT SCI ENG C-MATER, V30, P740, DOI 10.1016/j.msec.2010.03.007
   Yang L, 2012, J MECH BEHAV BIOMED, V13, P36, DOI 10.1016/j.jmbbm.2012.04.007
   Zhang J, 2010, MATER DESIGN, V31, P4043, DOI 10.1016/j.matdes.2010.05.008
   Zhang J, 2010, SCRIPTA MATER, V63, P367, DOI 10.1016/j.scriptamat.2010.04.015
   Zhang JH, 2011, J ALLOY COMPD, V509, P7717, DOI 10.1016/j.jallcom.2011.04.089
   Zhang JH, 2009, J ALLOY COMPD, V471, P322, DOI 10.1016/j.jallcom.2008.03.089
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang XB, 2012, J MECH BEHAV BIOMED, V7, P77, DOI 10.1016/j.jmbbm.2011.05.026
   Zhao X, 2013, J MECH BEHAV BIOMED, V18, P181, DOI 10.1016/j.jmbbm.2012.11.016
   Zhu YM, 2010, ACTA MATER, V58, P2936, DOI 10.1016/j.actamat.2010.01.022
NR 35
TC 19
Z9 19
U1 2
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD DEC
PY 2013
VL 28
SI SI
BP 332
EP 339
DI 10.1016/j.jmbbm.2013.08.012
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 269IH
UT WOS:000328234500029
PM 24036280
DA 2018-10-20
ER

PT J
AU Tan, F
   Walshe, P
   Viani, L
   Al-Rubeai, M
AF Tan, Fei
   Walshe, Peter
   Viani, Laura
   Al-Rubeai, Mohamed
TI Surface biotechnology for refining cochlear implants
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
DE cochlear implant; biomaterial; surface modification; coating; drug
   delivery; complication
ID IN-VITRO BIOCOMPATIBILITY; SPIRAL GANGLION NEURITE; SCHWANN-CELL GROWTH;
   CONDUCTING POLYMERS; NEURAL INTERFACES; DRUG-DELIVERY; HYDROGEL
   COATINGS; ELECTROCHEMICAL PROPERTIES; HIPPOCAMPAL-NEURONS; COATED
   ELECTRODES
AB The advent of the cochlear implant is phenomenal because it is the first surgical prosthesis that is capable of restoring one of the senses. The subsequent rapid evolution of cochlear implants through increasing complexity and functionality has been synchronized with the recent advancements in biotechnology. Surface biotechnology has refined cochlear implants by directly influencing the implant tissue interface. Emerging surface biotechnology strategies are exemplified by nanofibrous polymeric materials, topographical surface modification, conducting polymer coatings, and neurotrophineluting implants. Although these novel developments have received individual attention in. the recent literature, the time has come to investigate their collective applications to cochlear implants to restore lost hearing.
C1 [Tan, Fei; Al-Rubeai, Mohamed] Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin 4, Ireland.
   [Tan, Fei; Al-Rubeai, Mohamed] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.
   [Tan, Fei] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland.
   [Tan, Fei; Walshe, Peter; Viani, Laura] Beaumont Hosp, Dept Otorhinolaryngol Head & Neck Surg, Dublin 9, Ireland.
RP Al-Rubeai, M (reprint author), Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin 4, Ireland.
EM m.al-rubeai@ucd.ie
FU Science Foundation Ireland [08/SRC/11411]
FX MA-R and FT are supported by Science Foundation Ireland (grant no.
   08/SRC/11411).
CR Abidian MR, 2010, SMALL, V6, P421, DOI 10.1002/smll.200901868
   Aliuos P, 2013, J BIOMED MATER RES A, V101, P981, DOI 10.1002/jbm.a.34401
   Asplund M, 2008, BIOINTERPHASES, V3, P83, DOI 10.1116/1.2998407
   Awaja F, 2010, PLASMA PROCESS POLYM, V7, P866, DOI 10.1002/ppap.201000018
   Azemi E, 2011, BIOMATERIALS, V32, P681, DOI 10.1016/j.biomaterials.2010.09.033
   Bax DV, 2012, ACTA BIOMATER, V8, P2538, DOI 10.1016/j.actbio.2012.03.023
   Bax DV, 2011, BIOMATERIALS, V32, P6710, DOI 10.1016/j.biomaterials.2011.05.060
   Bax DV, 2010, BIOMATERIALS, V31, P2526, DOI 10.1016/j.biomaterials.2009.12.009
   Boehm R, 2009, JOM-US, V61, P53, DOI 10.1007/s11837-009-0134-3
   Bohl A, 2012, J MATER SCI-MATER M, V23, P2151, DOI 10.1007/s10856-012-4698-z
   Brohede U, 2009, J MATER SCI-MATER M, V20, P1859, DOI 10.1007/s10856-009-3749-6
   Brohede U, 2009, APPL SURF SCI, V255, P7723, DOI 10.1016/j.apsusc.2009.04.149
   Carballo-Vila M, 2009, J BIOMED MATER RES A, V90A, P94, DOI 10.1002/jbm.a.32058
   Chikar JA, 2012, BIOMATERIALS, V33, P1982, DOI 10.1016/j.biomaterials.2011.11.052
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Clarke JC, 2011, HEARING RES, V278, P96, DOI 10.1016/j.heares.2011.05.004
   Claros Pedro, 2010, Cochlear Implants Int, V11 Suppl 1, P176, DOI 10.1179/146701010X12671177818623
   Cogan SF, 2009, J BIOMED MATER RES B, V89B, P353, DOI 10.1002/jbm.b.31223
   Collazos-Castro JE, 2010, BIOMATERIALS, V31, P9244, DOI 10.1016/j.biomaterials.2010.08.057
   Deng M, 2011, SENSOR ACTUAT B-CHEM, V158, P176, DOI 10.1016/j.snb.2011.05.062
   Dinh C, 2008, OTOL NEUROTOL, V29, P1012, DOI 10.1097/MAO.0b013e3181859a1f
   Evans AJ, 2009, J BIOMED MATER RES A, V91A, P241, DOI 10.1002/jbm.a.32228
   Fan JA, 2011, J BIOMED MATER RES B, V97B, P271, DOI 10.1002/jbm.b.31810
   Ganske G, 2011, THIN SOLID FILMS, V519, P3965, DOI 10.1016/j.tsf.2011.01.344
   Ghavi FF, 2010, J BIOMED MATER RES B, V94B, P388, DOI 10.1002/jbm.b.31666
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Green RA, 2012, BIOMATERIALS, V33, P5875, DOI 10.1016/j.biomaterials.2012.05.017
   Green RA, 2010, BIOMATERIALS, V31, P886, DOI 10.1016/j.biomaterials.2009.09.099
   Green RA, 2010, ACTA BIOMATER, V6, P63, DOI 10.1016/j.actbio.2009.06.030
   Green RA, 2009, BIOMATERIALS, V30, P3637, DOI 10.1016/j.biomaterials.2009.03.043
   Guevara N, 2010, ANN OTO RHINOL LARYN, V119, P501, DOI 10.1177/000348941011900801
   Hassler C, 2010, J BIOMED MATER RES B, V93B, P266, DOI 10.1002/jbm.b.31584
   He QR, 2009, J MATER SCI-MATER M, V20, P1457, DOI 10.1007/s10856-009-3702-8
   Hendricks JL, 2008, HEARING RES, V242, P117, DOI 10.1016/j.heares.2008.06.003
   Horie RT, 2010, LARYNGOSCOPE, V120, P377, DOI 10.1002/lary.20713
   Hronik-Tupaj M, 2013, J BIOMED MATER RES A, V101, P2559, DOI 10.1002/jbm.a.34565
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Jiang X, 2014, J TISSUE ENG REGEN M, V8, P377, DOI 10.1002/term.1531
   Kang K, 2011, BIOMATERIALS, V32, P6374, DOI 10.1016/j.biomaterials.2011.05.028
   Khodagholy D, 2011, ADV MATER, V23, pH268, DOI 10.1002/adma.201102378
   Kim DH, 2010, ACTA BIOMATER, V6, P57, DOI 10.1016/j.actbio.2009.07.034
   Kontorinis G, 2012, LARYNGOSCOPE, V122, P2057, DOI 10.1002/lary.23408
   Lawand NS, 2011, PROCEDIA ENGINEER, V25, DOI 10.1016/j.proeng.2011.12.249
   Li BE, 2008, J BIOMED MATER RES A, V87A, P84, DOI 10.1002/jbm.a.31776
   Li N, 2011, BIOMATERIALS, V32, P9374, DOI 10.1016/j.biomaterials.2011.08.065
   Lin SP, 2009, BIOMATERIALS, V30, P3110, DOI 10.1016/j.biomaterials.2009.03.017
   Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271
   Liu X, 2011, BIOMATERIALS, V32, P7309, DOI 10.1016/j.biomaterials.2011.06.047
   Liu XA, 2010, J BIOMED MATER RES A, V94A, P1004, DOI 10.1002/jbm.a.32675
   Lu Y, 2010, BIOMATERIALS, V31, P5169, DOI 10.1016/j.biomaterials.2010.03.022
   Lu Y, 2009, BIOMATERIALS, V30, P4143, DOI 10.1016/j.biomaterials.2009.04.030
   Luo XL, 2011, BIOMATERIALS, V32, P6316, DOI 10.1016/j.biomaterials.2011.05.020
   Luo XL, 2011, BIOMATERIALS, V32, P5551, DOI 10.1016/j.biomaterials.2011.04.051
   Matefi-Tempfli S, 2009, ADV MATER, V21, P4005, DOI 10.1002/adma.200900344
   Paasche G, 2011, J NEUROSCI RES, V89, P611, DOI 10.1002/jnr.22569
   Palmgren B, 2012, EXP NEUROL, V235, P599, DOI 10.1016/j.expneurol.2012.03.014
   Pararas EEL, 2012, ADV DRUG DELIVER REV, V64, P1650, DOI 10.1016/j.addr.2012.02.004
   Prasad BR, 2010, COLLOID SURFACE B, V78, P237, DOI 10.1016/j.colsurfb.2010.03.006
   Quigley AF, 2009, ADV MATER, V21, P4393, DOI 10.1002/adma.200901165
   Radeloff A, 2009, LARYNGOSCOPE, V119, P959, DOI 10.1002/lary.20206
   Rao L, 2012, ACTA BIOMATER, V8, P2233, DOI 10.1016/j.actbio.2012.03.001
   Reich U, 2008, J BIOMED MATER RES B, V87B, P146, DOI 10.1002/jbm.b.31084
   Reich U, 2012, J BIOMED MATER RES B, V100B, P940, DOI 10.1002/jbm.b.32656
   Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010
   Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015
   Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001
   Rodger DC, 2008, SENSOR ACTUAT B-CHEM, V132, P449, DOI 10.1016/j.snb.2007.10.069
   Roohpour N, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015007
   Roy S, 2010, INT J PHARMACEUT, V390, P214, DOI 10.1016/j.ijpharm.2010.02.003
   Rubehn B, 2010, BIOMATERIALS, V31, P3449, DOI 10.1016/j.biomaterials.2010.01.053
   Schlie-Wolter S, 2013, ACS APPL MATER INTER, V5, P1070, DOI 10.1021/am3028487
   Seidlits SK, 2009, ADV FUNCT MATER, V19, P3543, DOI 10.1002/adfm.200901115
   Stamatiou GA, 2011, ANN OTO RHINOL LARYN, V120, P428, DOI 10.1177/000348941112000702
   Stover T, 2009, Laryngorhinootologie, V88 Suppl 1, pS12, DOI 10.1055/s-0028-1119552
   Szmigiel D, 2008, PLASMA PROCESS POLYM, V5, P246, DOI 10.1002/ppap.200700130
   Tan F, 2012, ACTA BIOMATER, V8, P1627, DOI 10.1016/j.actbio.2011.12.014
   Tan F, 2012, BIOTECHNOL ADV, V30, P352, DOI 10.1016/j.biotechadv.2011.07.008
   Tan F, 2011, BIOTECHNOL BIOENG, V108, P454, DOI 10.1002/bit.22955
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Tarkan O, 2013, INT J PEDIATR OTORHI, V77, P473, DOI 10.1016/j.ijporl.2012.12.009
   Tewari R, 2010, MICROSYST TECHNOL, V16, P1601, DOI 10.1007/s00542-010-1084-y
   Thanawala SS, 2008, APPL SURF SCI, V254, P5164, DOI 10.1016/j.apsusc.2008.02.054
   Thompson BC, 2011, BIOMATERIALS, V32, P3822, DOI 10.1016/j.biomaterials.2011.01.053
   Thompson BC, 2010, J CONTROL RELEASE, V141, P161, DOI 10.1016/j.jconrel.2009.09.016
   Thompson BC, 2009, CARBON, V47, P1282, DOI 10.1016/j.carbon.2009.01.013
   Tien LW, 2013, ADV FUNCT MATER, V23, P3185, DOI 10.1002/adfm.201203716
   Tuft BW, 2013, BIOMATERIALS, V34, P42, DOI 10.1016/j.biomaterials.2012.09.053
   Volkenstein S, 2012, EUR ARCH OTO-RHINO-L, V269, P1111, DOI 10.1007/s00405-011-1775-8
   Ware T, 2012, ADV FUNCT MATER, V22, P3470, DOI 10.1002/adfm.201200200
   Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007
   Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005
   Wu TH, 2013, J BIOMED MATER RES A, V101, P1165, DOI 10.1002/jbm.a.34413
   Yue ZL, 2013, ELECTROCHEM COMMUN, V27, P54, DOI 10.1016/j.elecom.2012.11.007
   Yue ZL, 2011, BIOMATERIALS, V32, P4714, DOI 10.1016/j.biomaterials.2011.03.032
   Zhou HH, 2013, J ELECTROANAL CHEM, V688, P69, DOI 10.1016/j.jelechem.2012.09.009
   Zhou HH, 2012, SENSOR ACTUAT B-CHEM, V161, P198, DOI 10.1016/j.snb.2011.10.019
NR 96
TC 6
Z9 6
U1 0
U2 21
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD DEC
PY 2013
VL 31
IS 12
BP 678
EP 687
DI 10.1016/j.tibtech.2013.09.001
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 275HY
UT WOS:000328668100003
PM 24404581
DA 2018-10-20
ER

PT J
AU Cantu, DA
   Kao, WJ
AF Cantu, David Antonio
   Kao, W. John
TI Combinatorial Biomatrix/Cell-Based Therapies for Restoration of Host
   Tissue Architecture and Function
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE biomaterials; cell-based therapy; cell presentation; extracellular
   matrix; foreign body response
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   ALGINATE-POLYLYSINE MICROCAPSULES; POLY(ETHYLENE GLYCOL) HYDROGELS;
   HUMAN SKIN EQUIVALENT; DIABETIC FOOT ULCERS; MARROW STROMAL CELLS;
   DRUG-DELIVERY; BONE-MARROW; IN-VITRO
AB This Progress Report reviews recent advances in the utility of extracellular matrix (ECM)-mimic biomaterials in presenting and delivering therapeutic cells to promote tissue healing. This overview gives a brief introduction of different cell types being used in regenerative medicine and tissue engineering while addressing critical issues that must be overcome before cell-based approaches can be routinely employed in the clinic. A selection of five commonly used cell-associated, biomaterial platforms (collagen, hyaluronic acid, fibrin, alginate, and poly(ethylene glycol)) are reviewed for treatment of a number of acute injury or diseases with emphasis on animal models and clinical trials. This article concludes with current challenges and future perspectives regarding foreign body host response to biomaterials and immunological reactions to allogeneic or xenogeneic cells, vascularization and angiogenesis, matching mechanical strength and anisotropy of native tissues, as well as other non-technical issues regarding the clinical translation of biomatrix/cell-based therapies.
C1 [Cantu, David Antonio; Kao, W. John] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA.
   [Cantu, David Antonio; Kao, W. John] Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI 53705 USA.
   [Kao, W. John] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53705 USA.
   [Kao, W. John] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.
EM WJKao@pharmacy.wisc.edu
FU University of Wisconsin-Madison School of Pharmacy; NIH [EB6613]
FX This research was supported inpart by the University of
   Wisconsin-Madison School of Pharmacy and the NIH grant EB6613.
CR Acosta FL, 2011, TISSUE ENG PT A, V17, P3045, DOI 10.1089/ten.tea.2011.0229
   Aimetti AA, 2009, BIOMACROMOLECULES, V10, P1484, DOI 10.1021/bm9000926
   Alberts B, 2002, MOL BIOL CELL
   Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Aper T, 2007, EUR J VASC ENDOVASC, V33, P33, DOI 10.1016/j.ejvs.2006.08.008
   Archer R, 2005, NAT BIOTECHNOL, V23, P1353, DOI 10.1038/ndt1105-1353
   Arifin DR, 2012, BIOMATERIALS, V33, P4681, DOI 10.1016/j.biomaterials.2012.03.008
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Bateman J. F., 1996, EXTRACELLULAR MATRIX
   Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Branski LK, 2009, BURNS, V35, P171, DOI 10.1016/j.burns.2008.03.009
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brown DL, 2006, CELL TRANSPLANT, V15, P319, DOI 10.3727/000000006783981909
   Cai YZ, 2010, J BIOMED MATER RES A, V95A, P49, DOI 10.1002/jbm.a.32816
   Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417
   Cantu D., 2012, STEM CELL T MED, V10, P740
   Centanni J. M., 2011, ANN SURG, V253, P1
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   CHARRIERE G, 1989, J AM ACAD DERMATOL, V21, P1203, DOI 10.1016/S0190-9622(89)70330-3
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P291
   Chung AS, 2009, J BIOMED MATER RES A, V91A, P742, DOI 10.1002/jbm.a.32259
   Chung HJ, 2008, TISSUE ENG PT A, V14, P607, DOI 10.1089/tea.2007.0263
   Chung HJ, 2009, NANO TODAY, V4, P429, DOI 10.1016/j.nantod.2009.08.008
   Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162
   Crawford DC, 2009, AM J SPORT MED, V37, P1334, DOI 10.1177/0363546509333011
   Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009
   DARQUY S, 1994, ARTIF ORGANS, V18, P898, DOI 10.1111/j.1525-1594.1994.tb03341.x
   Doillon CJ, 1997, J BIOMED MATER RES, V37, P212
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Dufrane D, 2006, TRANSPLANTATION, V81, P1345, DOI 10.1097/01.tp.0000208610.75997.20
   Eaglstein WH, 1999, DERMATOL SURG, V25, P195, DOI 10.1046/j.1524-4725.1999.08186.x
   Ekser B, 2012, LANCET, V379, P672, DOI 10.1016/S0140-6736(11)61091-X
   Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712
   Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253
   Fodor William L, 2003, Reprod Biol Endocrinol, V1, P102, DOI 10.1186/1477-7827-1-102
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freed L. E., 2006, TISSUE ENG, V12, P3286
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fu Y, 2012, BIOMATERIALS, V33, P48, DOI 10.1016/j.biomaterials.2011.09.031
   Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487
   Gaston J, 2013, BIOMATTER, V3
   Geoge T. M., 2006, J CONTROL RELEASE, V114, P1
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gomez-Guillen M. C., 2001, FOOD HYDROCOLLOID, V25, P1813
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033
   Grim S. A., 2011, NATURE, V90, P333
   Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742
   Halban PA, 2010, J CLIN ENDOCR METAB, V95, P1034, DOI 10.1210/jc.2009-1819
   Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086
   Hamdi H, 2009, ANN THORAC SURG, V87, P1196, DOI 10.1016/j.athoracsur.2008.12.074
   Helary C, 2011, J TISSUE ENG REGEN M, V5, P248, DOI 10.1002/term.326
   Henricks PAJ, 1998, EUR J PHARMACOL, V344, P1, DOI 10.1016/S0014-2999(98)00036-3
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Hunkeler D, 1997, TRENDS POLYM SCI, V5, P286
   Hyun I, 2010, J CLIN INVEST, V120, P71, DOI 10.1172/JCI40435
   Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244
   Jaehyup K. i. m., 2009, EXP HEMATOL, V37, P1445
   Johnson BQ, 2010, LARYNGOSCOPE, V120, P537, DOI 10.1002/lary.20782
   Jonston A. P. R., 2006, CURR OPIN COLLOID IN, V11, P203
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Kelm JM, 2006, TISSUE ENG, V12, P2151, DOI 10.1089/ten.2006.12.2151
   Kelm JM, 2010, ADV DRUG DELIVER REV, V62, P753, DOI 10.1016/j.addr.2010.02.003
   Kelm JM, 2010, J BIOTECHNOL, V148, P46, DOI 10.1016/j.jbiotec.2010.03.002
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553
   Kleinbeck K, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0012-8
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7
   Lareu RR, 2007, FEBS LETT, V581, P2709, DOI 10.1016/j.febslet.2007.05.020
   Lauer-Fields JL, 2002, BIOL CHEM, V383, P1095, DOI 10.1515/BC.2002.118
   LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee K. W., 2003, JAMA INTERN MED, V163, P2368
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   MASSIA SP, 1992, CYTOTECHNOLOGY, V10, P189, DOI 10.1007/BF00146670
   Menasche P, 2009, MOL THER, V17, P758, DOI 10.1038/mt.2009.40
   Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010
   Messenger MP, 2011, ADV MATER, V23, pH10, DOI 10.1002/adma.201100254
   Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301
   Murua A, 2007, BIOMACROMOLECULES, V8, P3302, DOI 10.1021/bm070194b
   Necas J, 2008, VET MED-CZECH, V53, P397
   Nehrer S, 2008, CLIN ORTHOP RELAT R, V466, P1849, DOI 10.1007/s11999-008-0322-4
   Nehrer S, 2006, EUR J RADIOL, V57, P3, DOI 10.1016/j.ejrad.2005.08.005
   Nehrer S, 2009, AM J SPORT MED, V37, p81S, DOI 10.1177/0363546509350704
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Nussler A, 2006, J HEPATOL, V45, P144, DOI 10.1016/j.jhep.2006.04.002
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Perez-Castillejos R, 2010, MATER TODAY, V13, P32, DOI 10.1016/S1369-7021(10)70015-8
   Perin Emerson C, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS110, DOI 10.1038/ncpcardio0447
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jeb.21386
   Prockop D. J., 2011, MOL THER, V20, P14
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   PUEYO ME, 1993, J BIOMAT SCI-POLYM E, V5, P197
   Qasim W, 2009, GENE THER, V16, P1285, DOI 10.1038/gt.2009.127
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rayment EA, 2010, STEM CELLS, V28, P996, DOI 10.1002/stem.416
   Ren G., 2011, STEM CELL TRANSL MED, V1, P51
   Rest M. V. D., 1991, FASEB J, V5, P2814
   Robertson JA, 2001, NAT REV GENET, V2, P74, DOI 10.1038/35047594
   Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009
   ROSSMURPHY SB, 1992, POLYMER, V33, P2622, DOI 10.1016/0032-3861(92)91146-S
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Rutanen J, 2004, CIRCULATION, V109, P1029, DOI 10.1161/01.CIR.0000115519.03688.A2
   Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3
   Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Schmidt JJ, 2008, J BIOMED MATER RES A, V87A, P1113, DOI 10.1002/jbm.a.32287
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Schoenfelder M, 2003, BIOL REPROD, V69, P269, DOI 10.1095/biolreprod.102.011577
   Schurr MJ, 2009, J TRAUMA, V66, P866, DOI 10.1097/TA.0b013e31819849d6
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Selmi TAS, 2007, TECH KNEE SURG, V6, P253, DOI [10.1097/BTK.0b013e318148b797aB, DOI 10.1097/BTK.0B013E318148B797AB]
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Sullivan MJ, 2008, NAT REV CANCER, V8, P554, DOI 10.1038/nrc2418
   Sun N, 2010, CELL CYCLE, V9, P880, DOI 10.4161/cc.9.5.10827
   Tam SK, 2009, J BIOMED MATER RES A, V89A, P609, DOI 10.1002/jbm.a.32002
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Veves A, 2001, DIABETES CARE, V24, P290, DOI 10.2337/diacare.24.2.290
   Vos Pd, 2006, IMMUNOL ENDOCRINOL M, V6, P139
   Waldeck H, 2012, BIOMATERIALS, V33, P29, DOI 10.1016/j.biomaterials.2011.09.044
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Weigand C., 2009, J BIOMED MATER RES B, V90, P710
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001
   Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6
   Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580
   Xu KD, 2012, ACTA BIOMATER, V8, P2504, DOI 10.1016/j.actbio.2012.03.049
   Yamada K., 2005, TRANSPLANT REV, V19, P164
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Zaulyanov L, 2007, CLIN INTERV AGING, V2, P93, DOI 10.2147/ciia.2007.2.1.93
   Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-67
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zhu JM, 2009, BIOCONJUGATE CHEM, V20, P333, DOI 10.1021/bc800441v
   Ziche M, 2004, CURR DRUG TARGETS, V5, P485, DOI 10.2174/1389450043345371
   Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2
NR 177
TC 9
Z9 9
U1 0
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD DEC
PY 2013
VL 2
IS 12
BP 1544
EP 1563
DI 10.1002/adhm.201300063
PG 20
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 270UI
UT WOS:000328344000001
PM 23828863
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Galindo-Moreno, P
   Hernandez-Cortes, P
   Mesa, F
   Carranza, N
   Juodzbalys, G
   Aguilar, M
   O'Valle, F
AF Galindo-Moreno, Pablo
   Hernandez-Cortes, Pedro
   Mesa, Francisco
   Carranza, Nelson
   Juodzbalys, Gintaras
   Aguilar, Mariano
   O'Valle, Francisco
TI Slow Resorption of Anorganic Bovine Bone by Osteoclasts in Maxillary
   Sinus Augmentation
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE anorganic bovine bone; bone remodeling; cathepsin K;
   immunohistochemistry; intrasinus graft; osteoclasts; osteocyte;
   resorption; TRAP
ID AUTOGENOUS BONE; FLOOR ELEVATION; BIO-OSS; SUBSTITUTE BIOMATERIALS;
   HISTOLOGIC EVALUATION; BIO-OSS(R); HYDROXYAPATITE; GRAFT; DOG;
   OSTEOGENESIS
AB Purpose: Different biomaterials have been suggested for guided bone regeneration (GBR). These might show the ideal properties to let a new bone formation in the grafted area. Among these ideal features, it is essential their controlled resorption in order to be replaced for new vital bone. Bovine bone has been used widely as a good biomaterial for GBR, however there is still an interesting controversy about its resorbable capacity. In this sense, the objective of this study was to examine the behavior of anorganic bovine bone (ABB) in long-term maxillary sinus graft healing and study its relationship with morphological and morphometrical variables. Materials and Methods: Seventeen maxillary sinus augmentation procedures were performed in patients. Bone cores were obtained from implant receptor sites at 6 months, 3 years, and 7 years of implant placement for histological, morphometric, and immunohistochemical (tartrate resistant acid phosphatase [TRAP]/cathepsin K/CD68) studies. Results: The percentages of bone, ABB particles, connective tissue, osteocytes, and osteoblasts in maxillary sinus grafts were similar at 6 months, 3 years, and 7 years. A progressive and significant decrease was detected in osteoclasts (p=.05, Kruskal-Wallis test), TRAP and cathepsin K expression (p=.014 and p=.021, respectively), and osteoid lines (p=.038). Conclusion: According to these data, a decrease in osteoclasts over time may, partially, explain the ABB persistence observed in core biopsies. Further studies with more cases and different graft maturation times are required to elucidate the resorption rates and cell events underlying these phenomena.
C1 [Galindo-Moreno, Pablo] Univ Granada, Sch Dent, Oral Surg & Implant Dent Dept, Granada, Spain.
   [Hernandez-Cortes, Pedro] San Cecilio Clin Hosp, Traumatol & Orthoped Surg Dept, Granada, Spain.
   [Hernandez-Cortes, Pedro] Univ Granada, Granada, Spain.
   [Mesa, Francisco] Univ Granada, Sch Dent, Dept Periodontol, Granada, Spain.
   [Carranza, Nelson] Univ Buenos Aires, Sch Dent, Dept Periodontol, Buenos Aires, DF, Argentina.
   [Juodzbalys, Gintaras] Lithuanian Univ Hlth Sci, Dept Maxillofacial Surg, Kaunas, Lithuania.
   [Aguilar, Mariano; O'Valle, Francisco] Univ Granada, Sch Med, Dept Pathol, Granada, Spain.
   [Aguilar, Mariano; O'Valle, Francisco] Univ Granada, IBIMER, Granada, Spain.
RP Galindo-Moreno, P (reprint author), C Recogidas 39 5 Izq, Granada 18005, Spain.
EM pgalindo@ugr.es
RI Galindo-Moreno, Pablo/F-5567-2015; Mesa, Francisco/L-9712-2018
OI Galindo-Moreno, Pablo/0000-0002-6614-6470; Mesa,
   Francisco/0000-0002-8293-2527
FU Junta de Andalucia, Spain [CTS-138, CTS-583]
FX This investigation was supported in part by Research Groups #CTS-138 and
   #CTS-583 (Junta de Andalucia, Spain).
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165
   Carmagnola D, 2002, J CLIN PERIODONTOL, V29, P377, DOI 10.1034/j.1600-051X.2002.290501.x
   Chaikof EL, 2002, ANN NY ACAD SCI, V961, P96, DOI 10.1111/j.1749-6632.2002.tb03057.x
   Chellaiah MA, 2003, CALCIFIED TISSUE INT, V72, P197, DOI 10.1007/s00223-002-1025-6
   COBB CM, 1990, J ORAL MAXIL SURG, V48, P268, DOI 10.1016/0278-2391(90)90392-F
   Duong LT, 1999, J BONE MINER METAB, V17, P1, DOI 10.1007/s007740050055
   Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019
   Galindo-Moreno P, 2007, CLIN ORAL IMPLAN RES, V18, P376, DOI 10.1111/j.1600-0501.2007.01337.x
   Galindo-Moreno P, 2011, CLIN ORAL IMPLAN RES, V22, P857, DOI 10.1111/j.1600-0501.2010.02073.x
   Galindo-Moreno P, 2010, CLIN ORAL IMPLAN RES, V21, P122, DOI 10.1111/j.1600-0501.2009.01814.x
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Hallman M, 2008, PERIODONTOL 2000, V47, P172, DOI 10.1111/j.1600-0757.2008.00251.x
   Joldersma M, 2001, AM J PHYSIOL-ENDOC M, V280, pE436
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Katayama Y, 1998, J CELL PHYSIOL, V176, P179, DOI 10.1002/(SICI)1097-4652(199807)176:1<179::AID-JCP19>3.0.CO;2-2
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   McAllister BS, 1999, INT J ORAL MAX IMPL, V14, P361
   Merkx MAW, 2000, CLIN ORAL IMPLAN RES, V11, P422, DOI 10.1034/j.1600-0501.2000.011005422.x
   PEETZ M, 1997, OSSEOUS RECONSTRUCTI, P87
   Perrotti V, 2009, CLIN ORAL IMPLAN RES, V20, P17, DOI 10.1111/j.1600-0501.2008.01608.x
   Perrotti V, 2009, J BIOMED MATER RES A, V90A, P238, DOI 10.1002/jbm.a.32079
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Radomsky ML, 1998, CLIN ORTHOP RELAT R, pS283
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schuklenk U, 2000, BIOETHICS, V14, P158, DOI 10.1111/1467-8519.00187
   Simion M, 2007, CLIN ORAL IMPLAN RES, V18, P620, DOI 10.1111/j.1600-0501.2007.01389.x
   Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   Wang HL, 2008, INT J PERIODONT REST, V28, P383
   Watzek G, 2006, SINUS BONE GRAFT, P13
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 44
TC 27
Z9 27
U1 1
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD DEC
PY 2013
VL 15
IS 6
BP 858
EP 866
DI 10.1111/j.1708-8208.2012.00445.x
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 260NU
UT WOS:000327602400009
PM 22376122
DA 2018-10-20
ER

PT J
AU Ghanaati, S
   Barbeck, M
   Willershausen, I
   Thimm, B
   Stuebinger, S
   Korzinskas, T
   Obreja, K
   Landes, C
   Kirkpatrick, CJ
   Sader, RA
AF Ghanaati, Shahram
   Barbeck, Mike
   Willershausen, Ines
   Thimm, Benjamin
   Stuebinger, Stefan
   Korzinskas, Tadas
   Obreja, Karina
   Landes, Constantin
   Kirkpatrick, Charles J.
   Sader, Robert A.
TI Nanocrystalline Hydroxyapatite Bone Substitute Leads to Sufficient Bone
   Tissue Formation Already after 3 Months: Histological and
   Histomorphometrical Analysis 3 and 6 Months following Human Sinus Cavity
   Augmentation
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE NanoBone; nanocrystalline hydroxyapatite; sinus floor augmentation
ID IN-VIVO; BIO-OSS; TRICALCIUM PHOSPHATE; ELEVATION PROCEDURE; FLOOR
   AUGMENTATION; AUTOGENOUS BONE; DENTAL IMPLANTS; REGENERATION; PERIOD
AB Purpose: In this study the de novo bone formation capacity of a nanocrystalline hydroxyapatite bone substitute was assessed 3 and 6 months after its insertion into the human sinus cavity. Materials and Methods: Sinus cavity augmentation was performed in a total of 14 patients (n=7 implantation after 3 months; n=7 implantation after 6 months) with severely atrophic maxillary bone. The specimens obtained after 3 and 6 months were analyzed histologically and histomorphometrically with special focus on bone metabolism within the residual bone and the augmented region. Results: This study revealed that bone tissue formation started from the bone-biomaterial-interface and was directed into the most cranial parts of the augmented region. There was no statistically significant difference in new bone formation after 3 and 6 months (24.8910.22% vs 31.29 +/- 2.29%), respectively. Conclusions: Within the limits of the present study and according to previously published data, implant insertion in regions augmented with this bone substitute material could be considered already after 3 months. Further clinical studies with bone substitute materials are necessary to validate these findings.
C1 [Ghanaati, Shahram; Korzinskas, Tadas; Obreja, Karina; Landes, Constantin; Sader, Robert A.] Goethe Univ Frankfurt, Med Ctr, Dept Oral Craniomaxillofacial & Facial Plast Surg, D-60054 Frankfurt, Germany.
   [Ghanaati, Shahram; Barbeck, Mike; Kirkpatrick, Charles J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, REPAIR Lab, Inst Pathol, Mainz, Germany.
   [Willershausen, Ines] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Dent Mat Sci & Technol, Mainz, Germany.
   [Thimm, Benjamin] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.
   [Stuebinger, Stefan] Ctr Appl Biotechnol & Mol Med, Zurich, Switzerland.
RP Ghanaati, S (reprint author), Goethe Univ Frankfurt, Clin Maxillofacial & Plast Surg, D-60054 Frankfurt, Germany.
EM Ghanaati@uni-mainz.de
OI Barbeck, Mike/0000-0002-3001-1347
CR AlGhamdi Ali Saad, 2010, J Int Acad Periodontol, V12, P39
   Barrere F, 2006, INT J NANOMED, V1, P317
   Bienengraeber V., 2006, Folia Morphologica, V65, P84
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Branemark R, 1997, BIOMATERIALS, V18, P969, DOI 10.1016/S0142-9612(97)00018-5
   Canullo L, 2011, ANN ANAT
   Canullo Luigi, 2009, Clin Implant Dent Relat Res, V11 Suppl 1, pe7, DOI 10.1111/j.1708-8208.2008.00141.x
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Froum SJ, 2006, INT J PERIODONT REST, V26, P543
   Garetto L P, 1995, Implant Dent, V4, P235, DOI 10.1097/00008505-199500440-00002
   Gerber T, 2003, J SOL-GEL SCI TECHN, V26, P1173, DOI 10.1023/A:1020743732259
   Gerber T, 2000, J SOL-GEL SCI TECHN, V19, P441, DOI 10.1023/A:1008799513932
   Ghanaati S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015010
   Ghanaati S, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035005
   Ghanaati SM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/025004
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Haas R, 2002, CLIN ORAL IMPLAN RES, V13, P396, DOI 10.1034/j.1600-0501.2002.130408.x
   Hallman M, 2002, J ORAL MAXIL SURG, V60, P277, DOI 10.1053/joms.2002.30576
   Hising P, 2001, INT J ORAL MAX IMPL, V16, P90
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P513
   Kang YM, 2009, ACTA BIOMATER, V5, P462, DOI 10.1016/j.actbio.2008.07.004
   Kessler P, 2005, BRIT J ORAL MAX SURG, V43, P51, DOI 10.1016/j.bjoms.2004.08.026
   Krennmair G, 2010, INT J ORAL MAX IMPL, V25, P357
   Lazzara R J, 1996, Curr Opin Periodontol, V3, P178
   Nelson K, 2008, INT J ORAL MAX IMPL, V23, P726
   Pareek A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035418
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   ROBERTS WE, 1984, AM J ORTHOD DENTOFAC, V86, P95, DOI 10.1016/0002-9416(84)90301-4
   Semper W, 2007, Z ZAHNARZTL IMPL, V23, P176
   Stubinger S, 2009, EUR SURG RES, V42, P143, DOI 10.1159/000197215
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   Tarnow DP, 2000, INT J PERIODONT REST, V20, P117
   Tatum Jr OH, 1977, ANN M AL IMPL STUD G
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   Trisi P, 2003, INT J PERIODONT REST, V23, P69
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
NR 39
TC 22
Z9 22
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD DEC
PY 2013
VL 15
IS 6
BP 883
EP 892
DI 10.1111/j.1708-8208.2011.00433.x
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 260NU
UT WOS:000327602400012
PM 22251462
DA 2018-10-20
ER

PT J
AU Pan, WM
   Li, D
   Wei, YY
   Hu, YY
   Zhou, L
AF Pan Weimin
   Li Dan
   Wei Yiyong
   Hu Yunyu
   Zhou Li
TI Tendon-to-bone healing using an injectable calcium phosphate cement
   combined with bone xenograft/BMP composite
SO BIOMATERIALS
LA English
DT Article
DE Calcium phosphate cement; Recombined xenograft bone; Anterior cruciate
   ligament reconstruction; Tendon-to-bone healing
ID ANTERIOR CRUCIATE LIGAMENT; MORPHOGENETIC PROTEIN-2;
   CLINICAL-APPLICATIONS; RABBIT MODEL; RECONSTRUCTION; TUNNEL; GROWTH;
   CELLS; GRAFT; AUGMENTATION
AB Injectable calcium phosphate cement (ICPC) has been applied to enhance the tendon-to-bone healing. However, its slow degradation delays the osteointegration of grafted tendon in bone tunnels. We therefore constructed a synthetic biomaterial of ICPC combined with recombined bone xenograft granules (RBX). In this study, the first stage study demonstrated that the ICPCB contained 3 mg BMPs (ICPCB-3) obtained a porous structure. More importantly, the values of ICPCB-3 were highest in cell proliferation, alkaline phosphatase (ALP) activity, expression of osteogenic genes, and newly ectopic bone-forming area (P < 0.05). Then, ICPCB-3 was used in an anterior cruciate ligament (ACL) reconstruction model. Ninety skeletal mature rabbits underwent bilateral ACL reconstructions and were assigned to 3 groups: control group, ICPC alone group, and ICPCB-3 group. Animals were sacrificed at 6, 12 and 24 weeks. The results showed compared with ICPC, ICPCB-3 composite markedly accelerated tendon-to-bone healing. In addition, little remnants were observed in ICPCB-3 group. Moreover, the maximum loads to failure of ICPCB-3 group was significantly higher than ICPC group at 24 weeks (P < 0.01). We conclude that the ICPCB composite, with a porous structure and better osteointegration effect, has direct clinical instruction to arthroscopic techniques of the ACL reconstruction. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Pan Weimin; Zhou Li] Xian Phys Educ Univ, Dept Human Movement Studies, Xian 710068, Shaanxi Prov, Peoples R China.
   [Li Dan; Hu Yunyu] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed & Traumatol, Xian 710032, Shaanxi Prov, Peoples R China.
   [Wei Yiyong] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai 200025, Peoples R China.
RP Pan, WM (reprint author), Xian Phys Educ Univ, Dept Human Movement Studies, Xian 710068, Shaanxi Prov, Peoples R China.
EM panweimin@163.com
FU Chinese General Administration of Sport of Science and Technology
   [10B019]
FX This study was supported by Chinese General Administration of Sport of
   Science and Technology (No. 10B019).
CR BERESFORD JN, 1992, J CELL SCI, V102, P341
   Bi L, 2012, XENOTRANSPLANTATION, V19, P122, DOI 10.1111/j.1399-3089.2012.00694.x
   Bigerelle M, 2002, BIOMOL ENG, V19, P79, DOI 10.1016/S1389-0344(02)00048-5
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Chang Chih-Hsiang, 2012, Biomed J, V35, P473, DOI 10.4103/2319-4170.104412
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   Dong Y, 2012, INT J MOL SCI, V13, P13605, DOI 10.3390/ijms131013605
   Edwards RB, 2004, J BONE JOINT SURG AM, V86A, P1425, DOI 10.2106/00004623-200407000-00010
   Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P82, DOI 10.2106/00004623-200300003-00014
   Fei ZQ, 2008, J MATER SCI-MATER M, V19, P1109, DOI 10.1007/s10856-007-3050-5
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   Gordon MD, 2004, ORTHOPAEDIC KNOWLEDG, P169
   Gulotta LV, 2008, AM J SPORT MED, V36, P1290, DOI 10.1177/0363546508314396
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Hashimoto Y, 2007, J ORTHOP RES, V25, P1415, DOI 10.1002/jor.20447
   Hays PL, 2008, J BONE JOINT SURG AM, V90A, P565, DOI 10.2106/JBJS.F.00531
   Hu Y Y, 1993, Zhonghua Wai Ke Za Zhi, V31, P709
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawamura S, 2005, J ORTHOP RES, V23, P1425, DOI 10.1016/j.orthres.2005.01.014
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Ma CB, 2007, AM J SPORT MED, V35, P597, DOI 10.1177/0363546506296312
   Mihelic R, 2004, AM J SPORT MED, V32, P1619, DOI 10.1177/0363546504263703
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nawata K, 2002, J ORTHOPAED RES, V20, P1339, DOI 10.1016/S0736-0266(02)00048-7
   Pan WM, 2011, J ORTHOP RES, V29, P1015, DOI 10.1002/jor.21351
   Pan WM, 2009, INT ORTHOP, V33, P1761, DOI 10.1007/s00264-008-0715-8
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Rodeo SA, 1999, AM J SPORT MED, V27, P476, DOI 10.1177/03635465990270041201
   RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009
   Sanzana ES, 2008, ACTA BIOMATER, V4, P1924, DOI 10.1016/j.actbio.2008.04.023
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman H, 2003, J BONE JOINT SURG AM, V85A, P96, DOI 10.2106/00004623-200300003-00016
   Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Singhal MC, 2005, ORTHOPEDICS, V28, P920
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Tien YC, 2004, J BONE JOINT SURG BR, V86B, P1072, DOI 10.1302/0301-620X.86B7.14578
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   Walsh WR, 2007, ARTHROSCOPY, V23, P197, DOI 10.1016/j.arthro.2006.09.003
   Wang CJ, 2005, J ORTHOP RES, V23, P274, DOI 10.1016/j.orthres.2004.07.004
   Wen CY, 2009, J BIOMED MATER RES B, V89B, P466, DOI 10.1002/jbm.b.31236
   Winkler MM, 1998, J PROSTHET DENT, V79, P532, DOI 10.1016/S0022-3913(98)70174-X
   Yao WT, 2008, J MATER SCI-MATER M, V19, P2485, DOI 10.1007/s10856-008-3383-8
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 47
TC 12
Z9 15
U1 7
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2013
VL 34
IS 38
BP 9926
EP 9936
DI 10.1016/j.biomaterials.2013.09.018
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 267JT
UT WOS:000328094600019
PM 24075477
DA 2018-10-20
ER

PT J
AU Ansari, S
   Moshaverinia, A
   Pi, SH
   Han, A
   Abdelhamid, AI
   Zadeh, HH
AF Ansari, Sahar
   Moshaverinia, Alireza
   Pi, Sung Hee
   Han, Alexander
   Abdelhamid, Alaa I.
   Zadeh, Homayoun H.
TI Functionalization of scaffolds with chimeric anti-BMP-2 monoclonal
   antibodies for osseous regeneration
SO BIOMATERIALS
LA English
DT Article
DE Tissue engineering; Monoclonal antibody; Scaffold; Growth factor; Bone
   morphogenetic protein
ID MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEIN-2; OSTEOGENIC
   DIFFERENTIATION; TGF-BETA/BMP; IN-VITRO; RHBMP-2; MICROSPHERES
AB Recent studies have demonstrated the ability of murine anti-BMP-2 monoclonal antibodies (mAb) immobilized on an absorbable collagen sponge (ACS) to mediate de novo bone formation, a process termed antibody-mediated osseous regeneration (AMOR). The objectives of this study were to assess the efficacy of a newly generated chimeric anti-BMP-2 mAb in mediating AMOR, as well as to evaluate the suitability of different biomaterials as scaffolds to participate in AMOR. Chimeric anti-BMP-2 mAb was immobilized on 4 biomaterials, namely, titanium microbeads (Ti), alginate hydrogel, macroporous biphasic calcium phosphate (MBCP) and ACS, followed by surgical implantation into rat critical-size calvarial defects. Animals were sacrificed after 8 weeks and the degree of bone fill was assessed using micro-CT and histomorphometry. Results demonstrated local persistence of chimeric anti-BMP-2 mAb up to 8 weeks, as well as significant de nova bone regeneration in sites implanted with chimeric anti-BMP-2 antibody immobilized on each of the 4 scaffolds. Ti and MBCP showed the highest volume of bone regeneration, presumably due to their resistance to compression. Alginate and ACS also mediated de novo bone formation, though significant volumetric shrinkage was noted. In vitro assays demonstrated cross-reactivity of chimeric anti-BMP-2 mAb with BMP-4 and BMP-7. Immune complex of anti-BMP-2 mAb with BMP-2 induced osteogenic differentiation of C2C12 cells in vitro, involving expression of RUNX2 and phosphorylation of Smad1. The present data demonstrated the ability of chimeric anti-BMP-2 mAb to functionalize different biomaterial with varying characteristics to mediate osteogenesis. Published by Elsevier Ltd.
C1 [Ansari, Sahar; Moshaverinia, Alireza; Han, Alexander; Zadeh, Homayoun H.] Univ So Calif, Ostrow Sch Dent, Los Angeles, CA 90089 USA.
   [Pi, Sung Hee] Wonkwang Univ, Dept Periodont, Iksan, South Korea.
   [Abdelhamid, Alaa I.] Qassim Univ, Coll Dent, TEBRU, DRC, Qasim, Saudi Arabia.
RP Zadeh, HH (reprint author), Univ So Calif, Herman Ostrow Sch Dent, Lab Immunoregulat & Tissue Engn, 925 West 34th St, Los Angeles, CA 90089 USA.
EM zadeh@usc.edu
OI Abdelhamid, Alaa/0000-0002-0755-7122; Pi, Sung-Hee/0000-0002-1916-6321;
   Zadeh, Homayoun/0000-0002-7770-9363
FU NIDCR [T90DE021982]; USC Office of Postdoctoral Affairs
FX Authors SA and AM were supported by a NIDCR postdoctoral training grant
   (T90DE021982). Also, an author (AM) was supported by Provost's
   Postdoctoral Scholar Research Grant by the USC Office of Postdoctoral
   Affairs. The authors declare no potential conflicts of interest with
   respect to the authorship and/or publication of this article.
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Betz VM, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2724
   Brunette D. M., 2001, TITANIUM MED, P171
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019
   Chin M, 2005, J CRANIOFAC SURG, V16, P778, DOI 10.1097/01.scs.0000166802.49021.01
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Freire MO, 2013, TISSUE ENG PT A, V19, P1165, DOI [10.1089/ten.TEA.2012.0282, 10.1089/ten.tea.2012.0282]
   Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302
   Ishikawa H, 2007, ACTA ORTHOP, V78, P285, DOI 10.1080/17453670710013816
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Khan SN, 2004, EXPERT OPIN BIOL TH, V4, P741
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Lin NH, 2008, AUST DENT J, V53, P108, DOI 10.1111/j.1834-7819.2008.00019.x
   Liu DD, 2013, J CELL BIOCHEM, V114, P1105, DOI 10.1002/jcb.24451
   Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359
   MEFFERT RM, 1992, J PERIODONTOL, V63, P859, DOI 10.1902/jop.1992.63.11.859
   Monaco E, 2011, THERIOGENOLOGY, V75, P1381, DOI 10.1016/j.theriogenology.2010.11.020
   Moshaverinia A, 2013, BIOMATERIALS, V34, P6572, DOI 10.1016/j.biomaterials.2013.05.048
   Moshaverinia A, 2012, J MATER SCI-MATER M, V23, P3041, DOI 10.1007/s10856-012-4759-3
   Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   PARFITT AM, 1984, CALCIFIED TISSUE INT, V36, pS37, DOI 10.1007/BF02406132
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   SCHROFF RW, 1985, CANCER RES, V45, P879
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   Valamehr B, 2008, P NATL ACAD SCI USA, V105, P14459, DOI 10.1073/pnas.0807235105
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269
   Wikesjo UME, 2005, CLIN IMPLANT DENT R, V7, P112, DOI 10.1111/j.1708-8208.2005.tb00054.x
NR 33
TC 22
Z9 23
U1 0
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2013
VL 34
IS 38
BP 10191
EP 10198
DI 10.1016/j.biomaterials.2013.08.069
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 267JT
UT WOS:000328094600044
PM 24055525
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Modo, M
   Ambrosio, F
   Friedlander, RM
   Badylak, SF
   Wechsler, LR
AF Modo, Michel
   Ambrosio, Fabrisia
   Friedlander, Robert M.
   Badylak, Stephen F.
   Wechsler, Lawrence R.
TI Bioengineering solutions for neural repair and recovery in stroke
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE biomaterial; brain-computer interface; physical therapy; rehabilitation;
   robot-assisted; stroke; tissue engineering
ID NEUROPROTECTIVE GENE-THERAPY; CENTRAL-NERVOUS-SYSTEM; EPI-CORTICAL
   DELIVERY; STEM-CELLS; HUNTINGTONS-DISEASE; CEREBRAL-ISCHEMIA; XENOGENEIC
   CELLS; INJURED BRAIN; GROWTH-FACTOR; TRANSPLANTATION
AB Purpose of review This review discusses emerging bioengineering opportunities for the treatment of stroke and their potential to build on current rehabilitation protocols.
   Recent findings Bioengineering is a vast field that ranges from biomaterials to brain-computer interfaces. Biomaterials find application in the delivery of pharmacotherapies, as well as the emerging field of tissue engineering. For the treatment of stroke, these approaches have to be seen in the context of physical therapy in order to maximize functional outcomes. There is also an emergence of rehabilitation that engages engineering solutions, such as robot-assisted training, as well as brain-computer interfaces that can potentially assist in the case of paralysis.
   Summary Stroke remains the main cause of adult disability with rehabilitation therapy being the focus for chronic impairments. Bioengineering is offering new opportunities to both support and synergize with currently available treatment options, and also promises to potentially dramatically improve available approaches.
   Video abstract available See the Video Supplementary Digital Content 1 (http://links.lww.com/CONR/A21).
C1 [Modo, Michel; Ambrosio, Fabrisia; Badylak, Stephen F.; Wechsler, Lawrence R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15203 USA.
   [Modo, Michel] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15203 USA.
   [Modo, Michel; Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15203 USA.
   [Ambrosio, Fabrisia] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15203 USA.
   [Friedlander, Robert M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15203 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15203 USA.
   [Wechsler, Lawrence R.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15203 USA.
RP Modo, M (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 3025 East Carson St, Pittsburgh, PA 15203 USA.
EM modomm@upmc.edu
RI Friedlander, Robert/A-2845-2016
OI Friedlander, Robert/0000-0003-4423-9219; Badylak,
   Stephen/0000-0003-3555-0689; Modo, Michel/0000-0003-4436-735X
FU Commonwealth of Pennsylvania's Department of Health SAP [4100061];
   Medical Research Council of the UK [G0900188]
FX The authors would like to acknowledge the continuing support of the
   McGowan Institute for Regenerative Medicine, as well as the
   translational effort of the University of Pittsburgh and the University
   of Pittsburgh Medical Center (UPMC) to develop novel strategies to
   repair the damaged brain. M.M. is supported by Commonwealth of
   Pennsylvania's Department of Health (SAP# 4100061) and the Medical
   Research Council of the UK (G0900188).
CR AEBISCHER P, 1991, EXP NEUROL, V111, P269, DOI 10.1016/0014-4886(91)90093-R
   Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   AEBISCHER P, 1994, TRANSPLANTATION, V58, P1275, DOI 10.1097/00007890-199412150-00025
   [Anonymous], 2006, WHO NEUR DIS PUBL HL
   Bachoud-Levi AC, 2000, HUM GENE THER, V11, P1723, DOI 10.1089/10430340050111377
   Bertram JP, 2010, PHARM RES-DORD, V27, P82, DOI 10.1007/s11095-009-0009-x
   Bible E, 2012, BIOMATERIALS, V33, P7435, DOI 10.1016/j.biomaterials.2012.06.085
   Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033
   Bible E, 2009, NAT PROTOC, V4, P1440, DOI 10.1038/nprot.2009.156
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409
   Bjugstad KB, 2010, J BIOMED MATER RES A, V95A, P79, DOI 10.1002/jbm.a.32809
   Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968
   Caicco MJ, 2013, J CONTROL RELEASE, V166, P197, DOI 10.1016/j.jconrel.2013.01.002
   Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644
   Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592
   Carrera I, 2011, MED BIOL ENG COMPUT, V49, P1201, DOI 10.1007/s11517-011-0805-4
   Cheeran B, 2009, NEUROREHAB NEURAL RE, V23, P97, DOI 10.1177/1545968308326636
   Chu HH, 2011, P NATL ACAD SCI USA, V108, P13444, DOI 10.1073/pnas.1110121108
   Cicerone KD, 2012, ARCH PHYS MED REHAB, V93, P188, DOI 10.1016/j.apmr.2011.12.003
   Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9
   Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032
   Crum WR, 2013, J NEUROSCI METH, V218, P170, DOI 10.1016/j.jneumeth.2013.05.009
   Dobkin BH, 2004, ANN NY ACAD SCI, V1038, P148, DOI 10.1196/annals.1315.024
   Dobrossy M, 2010, NEUROREHAB NEURAL RE, V24, P692, DOI 10.1177/1545968310363586
   El-Akabawy G, 2011, STEM CELLS DEV, V20, P1873, DOI 10.1089/scd.2010.0282
   Emerich DF, 2011, CURR STEM CELL RES T, V6, P171
   Franco CL, 2011, ACTA BIOMATER, V7, P3267, DOI 10.1016/j.actbio.2011.06.011
   Frisoli A, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-36
   Granziera C, 2012, NEUROLOGY, V79, P39, DOI 10.1212/WNL.0b013e31825f25e7
   Hachinski V, 2010, STROKE, V41, P1084, DOI 10.1161/STROKEAHA.110.586156
   Harbeck-Seu A, 2011, CURR OPIN ANESTHESIO, V24, P144, DOI 10.1097/ACO.0b013e328344587f
   Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219
   Jin YC, 2011, BIOMATERIALS, V32, P899, DOI 10.1016/j.biomaterials.2010.09.054
   Jones TA, 2009, STROKE, V40, pS136, DOI 10.1161/STROKEAHA.108.533653
   Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002
   Kim ID, 2010, J CONTROL RELEASE, V142, P422, DOI 10.1016/j.jconrel.2009.11.011
   Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745
   Krebs HI, 2011, IEEE ENG MED BIO, P6709, DOI 10.1109/IEMBS.2011.6091654
   Lampe KJ, 2010, TISSUE ENG PT A, V16, P1857, DOI 10.1089/ten.TEA.2009.0509
   Lampe KJ, 2011, J BIOMED MATER RES A, V96A, P595, DOI 10.1002/jbm.a.33011
   Lo Albert C, 2012, Am J Phys Med Rehabil, V91, pS204, DOI 10.1097/PHM.0b013e31826bcfa3
   Loureiro RCV, 2011, MED BIOL ENG COMPUT, V49, P1103, DOI 10.1007/s11517-011-0797-0
   MacIntosh BJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00060
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Moshayedi P, 2013, BIOMATTER, V3, P3267
   Noorian AR, 2011, J NEUROSURG SCI, V55, P127
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Qutachi O, 2013, J CONTROL RELEASE, V168, P18, DOI 10.1016/j.jconrel.2013.02.029
   Ren YP, 2013, IEEE T NEUR SYS REH, V21, P490, DOI 10.1109/TNSRE.2012.2225073
   Santos E, 2013, J CONTROL RELEASE, V170, P1, DOI 10.1016/j.jconrel.2013.04.015
   Schurr A, 2004, CURR DRUG TARGETS, V5, P603, DOI 10.2174/1389450043345209
   Scott SH, 2011, J REHABIL RES DEV, V48, P335, DOI 10.1682/JRRD.2010.04.0057
   Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024
   Stinear C, 2013, STROKE, V44, P2039, DOI 10.1161/STROKEAHA.113.000968
   Sullivan JE, 2013, PHYS THER, V93, P1383, DOI 10.2522/ptj.20120492
   Tretriluxana J, 2013, TOP STROKE REHABIL, V20, P151, DOI 10.1310/tsr2002-151
   Wang YF, 2012, BIOMATERIALS, V33, P2681, DOI 10.1016/j.biomaterials.2011.12.031
   Whishaw IQ, 2008, BEHAV BRAIN RES, V192, P124, DOI 10.1016/j.bbr.2007.12.026
   Yu HW, 2010, ANAT REC, V293, P911, DOI 10.1002/ar.20941
   Zhang M, 2012, IEEE ENG MED BIO, P6111, DOI 10.1109/EMBC.2012.6347388
NR 65
TC 13
Z9 13
U1 0
U2 35
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD DEC
PY 2013
VL 26
IS 6
BP 626
EP 631
DI 10.1097/WCO.0000000000000031
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 259VL
UT WOS:000327554300005
PM 24136127
DA 2018-10-20
ER

PT J
AU Davis, NF
   Coakley, DN
   Callanan, A
   Flood, HD
   McGloughlin, TM
AF Davis, Niall F.
   Coakley, Daniel N.
   Callanan, Anthony
   Flood, Hugh D.
   McGloughlin, Tim M.
TI Evaluation of xenogenic extracellular matrices as adjuvant scaffolds for
   the treatment of stress urinary incontinence
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Article
DE Stress urinary incontinence; Tissue engineering; Polypropylene; Urinary
   bladder matrix; Small intestinal submucosal; Regenerative medicine
ID SMALL-INTESTINAL SUBMUCOSA; POLYPROPYLENE MESH; BIOMECHANICAL
   PROPERTIES; SURGERY; MODEL; TAPE
AB Introduction and hypothesis Tissue-engineered biomaterials have shown recent promise as adjuvant scaffolds for treating stress urinary incontinence (SUI). The objective of the present study was to compare their mechanical and regenerative properties with synthetic biomaterials in this urogynaecological setting. Methods The biomechanical properties of polypropylene ;(Serasis (R); n= 12), four-ply urinary bladder matrix (UBM; n= 12) and four-ply small intestinal submucosa (SIS; n= 12) were determined with uni-axial tensile testing protocols and compared with stress-strain curves. Subsequently, human dermal fibroblasts (2.5x104cells/cm(2)) were cultured onto each biomaterial under conventional laboratory growth conditions for 12 consecutive days. Attachment, viability, and proliferative activity of fibroblasts were evaluated and compared using quantitative viability indicators and scanning electron microscopy. Results There were no significant differences in the biomechanical properties of each biomaterial assessed. Incremental stiffness at 0-10 % strain measured 5.73 +/- 0.36 MPa for polypropylene compared with 8.23x0.92MPa and 6.81 +/- 0.83 MPa for SIS and UBM respectively (p> 0.05). Viability and proliferative activity of fibroblasts differed significantly on all three biomaterials with the luminal and abluminal surfaces of the UBM demonstrating significantly greater rates of fibroblast proliferation compared with polypropylene and SIS (p< 0.01). Conclusion This is the first comparative study on porcine UBM, porcine SIS, and synthetic polypropylene as adjuvant scaffolds for the treatment of SUI. Our results demonstrate that porcine UBMmay provide an attractive alternative owing to its superior remodelling potential.
C1 [Davis, Niall F.; Flood, Hugh D.] Univ Limerick, Teaching Hosp, Dept Urol, Limerick, Ireland.
   [Coakley, Daniel N.; Callanan, Anthony; McGloughlin, Tim M.] Univ Limerick, Ctr Appl Biomed Engn Res, Castletroy, Limerick, Ireland.
RP Davis, NF (reprint author), Univ Limerick, Teaching Hosp, Dept Urol, Limerick, Ireland.
EM nialldavis2001@yahoo.com
RI McGloughlin, Tim/D-3639-2009; McGloughlin, Tim/G-9526-2015; maiza,
   marisa/L-6168-2013
OI McGloughlin, Tim/0000-0002-6632-2075; McGloughlin,
   Tim/0000-0002-6632-2075; McGloughlin, Tim/0000-0003-3519-8988; Coakley,
   Daniel/0000-0003-1262-2782
CR Afonso JS, 2008, INT UROGYNECOL J, V19, P375, DOI 10.1007/s00192-007-0446-1
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Boennelycke M, 2012, INT UROGYNECOL J, V24, P741
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Buckley BS, 2010, UROLOGY, V76, P265, DOI 10.1016/j.urology.2009.11.078
   Callanan A, 2012, MED ENG PHYS, V34, P1368, DOI 10.1016/j.medengphy.2012.06.022
   Cannon TW, 2005, BJU INT, V96, P664, DOI 10.1111/j.1464-410X.2005.05702.x
   Davis NF, 2012, J UROLOGY, V188, P1828, DOI 10.1016/j.juro.2012.07.040
   Davis NF, 2010, J UROLOGY, V184, P2246, DOI 10.1016/j.juro.2010.07.038
   Davis N. F., 2011, UROLOGY, V77, pe1001
   Dora CD, 2004, J UROLOGY, V171, P1970, DOI 10.1097/01.ju.0000121377.61788.ad
   IOSIF CS, 1987, ARCH GYNECOL OBSTET, V240, P131
   John TT, 2008, UROLOGY, V72, P1036, DOI 10.1016/j.urology.2008.07.043
   Krause H, 2008, INT UROGYNECOL J, V19, P1677, DOI 10.1007/s00192-008-0711-y
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 2004, J UROLOGY, V172, P1710, DOI 10.1097/01.ju.0000139952.64753.27
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Latthe PM, 2007, BJOG-INT J OBSTET GY, V114, P522, DOI 10.1111/j.1471-0528.2007.01268.x
   Ostergard DR, 2011, INT UROGYNECOL J, V22, P771, DOI 10.1007/s00192-011-1399-y
   Patel H, 2012, INT UROGYNECOL J, V23, P669, DOI 10.1007/s00192-012-1718-y
   Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378
NR 23
TC 0
Z9 0
U1 0
U2 10
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD DEC
PY 2013
VL 24
IS 12
BP 2105
EP 2110
DI 10.1007/s00192-013-2147-2
PG 6
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA 267XS
UT WOS:000328132300018
PM 23812578
DA 2018-10-20
ER

PT J
AU Sano, H
   Ichioka, S
   Minamimura, A
   Tanaka, R
   Ikebuchi, K
   Suzuki, M
AF Sano, Hitomi
   Ichioka, Shigeru
   Minamimura, Ai
   Tanaka, Ryuhei
   Ikebuchi, Kenji
   Suzuki, Miho
TI Preservation of the properties of elastic plasma protein plus platelet
   film for wound dressing
SO JOURNAL OF PLASTIC SURGERY AND HAND SURGERY
LA English
DT Article
DE Biological dressing; biomaterial; chronic wound; platelet-rich plasma;
   wound healing
ID VITRO FUNCTIONAL-ACTIVITY; 4 DEGREES-C; GROWTH-FACTORS; RICH PLASMA;
   STORAGE; ULCERS; GEL; RECOVERY
AB Experimental results have previously been reported for a new biological dressing consisting of concentrated plasma proteins and platelet-rich plasma (PRP), which is named Platelet-Protein film (PPF). Based on the results of this experimental study, a clinical trial was begun to examine the usefulness of PPF. Although fresh autologous PPF is being used in the clinical trial, it is considered that the use of a preserved material prepared in advance would enable more convenient application. To verify the usefulness of preserved PPF, this preliminary study was conducted to examine the effects of fresh PPF, preserved PPF or blood clot, as control, applied to excisional skin defects in healing-impaired mice. The wound area and vascular density were analysed on day 9 after wound creation. Significant decrease of the wound size was observed in the preserved PPF and fresh PPF groups (4.2 (3.7), 2.2 (0.53)%) in comparison with that in the control group (38.5 (18.6)%, p < 0.05). Furthermore, a significant increase of the vascular density was also observed in the preserved PPF and fresh PPF groups (0.055 (0.021), 0.050 (0.019) mm(2)/mm(2)) as compared with that in the control group (0.016 (0.010) mm(2), p < 0.01). There was no significant difference in the effect on the wound size or vascular density between the preserved PPF and fresh PPF groups. The results showed that the properties of PPFs could be maintained for at least 1 week under appropriate storage conditions. The possibility of preservation of PPF for future use could be of practical advantage in actual clinical situations.
C1 [Sano, Hitomi; Ichioka, Shigeru; Minamimura, Ai] Saitama Med Univ, Dept Plast & Reconstruct Surg, Saitama, Japan.
   [Tanaka, Ryuhei] Saitama Med Univ, Int Med Ctr, Dept Pediat Oncol, Saitama, Japan.
   [Ikebuchi, Kenji; Suzuki, Miho] Saitama Med Univ Hosp, Dept Transfus & Cell Therapy, Saitama, Japan.
RP Sano, H (reprint author), Saitama Med Univ, Dept Plast & Reconstruct Surg, 38 Morohongo, Moroyama, Saitama 3500495, Japan.
EM sasasa116sasasa@hotmail.com
CR Anitua E, 2008, J BIOMED MATER RES B, V84B, P415, DOI 10.1002/jbm.b.30886
   Carter CA, 2003, EXP MOL PATHOL, V74, P244, DOI 10.1016/S0014-4800(03)00017-0
   Connor J, 1996, TRANSFUSION, V36, P691, DOI 10.1046/j.1537-2995.1996.36896374372.x
   Crovetti G, 2004, TRANSFUS APHER SCI, V30, P145, DOI 10.1016/j.transci.2004.01.004
   Currie LM, 1997, TRANSFUSION, V37, P18, DOI 10.1046/j.1537-2995.1997.37197176946.x
   Dumont LJ, 2002, TRANSFUSION, V42, P847, DOI 10.1046/j.1537-2995.2002.00147.x
   Featherstone C, 1997, LANCET, V349, P334, DOI 10.1016/S0140-6736(05)62837-1
   Ganio C, 1993, J Foot Ankle Surg, V32, P263
   Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012
   Holme S, 1997, TRANSFUSION, V37, P5, DOI 10.1046/j.1537-2995.1997.37197176944.x
   Knighton D R, 1988, Prog Clin Biol Res, V266, P319
   KRUPSKI WC, 1991, J VASC SURG, V14, P526, DOI 10.1016/0741-5214(91)90247-R
   Marx R E, 2001, Implant Dent, V10, P225
   Mehta S, 2008, J ORTHOP TRAUMA, V22, P433, DOI 10.1097/BOT.0b013e31817e793f
   O'Connell SM, 2008, WOUND REPAIR REGEN, V16, P749, DOI 10.1111/j.1524-475X.2008.00426.x
   Saldalamacchia G, 2004, NUTR METAB CARDIOVAS, V14, P395, DOI 10.1016/S0939-4753(04)80029-2
   Spicer PP, 2010, J CONTROL RELEASE, V148, P49, DOI 10.1016/j.jconrel.2010.06.025
   STURK A, 1982, TRANSFUSION, V22, P115, DOI 10.1046/j.1537-2995.1982.22282177116.x
   Tanaka R, 2007, VOX SANG, V93, P49, DOI 10.1111/j.1423-0410.2007.00913.x
   Thorn JJ, 2004, INT J ORAL MAX SURG, V33, P95, DOI 10.1054/ijom.2003.0461
   TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245
   Vostal JG, 1997, TRANSFUS MED REV, V11, P286, DOI 10.1053/tmrv.1997.0110286
   WINOKUR R, 1995, BLOOD, V85, P1796
   Yazawa M, 2003, CELL TRANSPLANT, V12, P509, DOI 10.3727/000000003108747073
NR 24
TC 0
Z9 0
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2000-656X
EI 2000-6764
J9 J PLAST SURG HAND SU
JI J. Plast. Surg. Hand Surg.
PD DEC
PY 2013
VL 47
IS 6
BP 458
EP 461
DI 10.3109/2000656X.2013.779582
PG 4
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 267IY
UT WOS:000328091900008
PM 23848423
DA 2018-10-20
ER

PT J
AU Sano, H
   Ichioka, S
   Minamimura, A
   Tanaka, R
   Ikebuchi, K
   Suzuki, M
AF Sano, Hitomi
   Ichioka, Shigeru
   Minamimura, Ai
   Tanaka, Ryuhei
   Ikebuchi, Kenji
   Suzuki, Miho
TI Treatment of chronic ulcer with elastic plasma protein and platelet film
   for wound dressing
SO JOURNAL OF PLASTIC SURGERY AND HAND SURGERY
LA English
DT Article
DE Biological dressing; biomaterial; chronic wound; platelet-rich plasma;
   wound healing
ID RICH PLASMA; MATRIX
AB Experimental results have previously been reported for a new biological dressing consisting of concentrated plasma proteins and platelet-rich plasma (PRP), which is named Platelet-Protein film (PPF). This study reports clinical experience using PPF produced from the patients' own blood by the original technique. Ten patients with chronic wounds underwent PPF treatment and evaluated the transcutaneous oxygen tension (TcPO2) and vascular density. Eight of the 10 patients received a split-thickness skin graft on induced granulation tissue and have remained free from complications for more than 12 months since treatment. The TcPO2 values significantly increased at 4 days after treatment (before 38.4 (14.1) mmHg, after 55 (19.9) mmHg, p < 0.01). The vascular density at the ulcer base increased at 14 days after treatment in all the cases. The results showed that PPF has the potential to enhance chronic wound healing.
C1 [Sano, Hitomi; Ichioka, Shigeru; Minamimura, Ai] Saitama Med Univ, Dept Plast & Reconstruct Surg, Saitama, Japan.
   [Tanaka, Ryuhei] Saitama Med Univ, Int Med Ctr, Dept Pediat Oncol, Saitama, Japan.
   [Ikebuchi, Kenji; Suzuki, Miho] Saitama Med Univ Hosp, Dept Transfus & Cell Therapy, Saitama, Japan.
RP Sano, H (reprint author), Saitama Med Sch, Dept Plast & Reconstruct Surg, 38 Morohongo, Moroyama, Saitama 3500495, Japan.
EM sasasa116sasasa@hotmail.com
CR Carter CA, 2003, EXP MOL PATHOL, V74, P244, DOI 10.1016/S0014-4800(03)00017-0
   COOPER DM, 1994, ANN SURG, V219, P688, DOI 10.1097/00000658-199406000-00012
   Fennis JPM, 2002, INT J ORAL MAX SURG, V31, P281, DOI 10.1054/ijom.2002.0151
   Ganio C, 1993, J Foot Ankle Surg, V32, P263
   Haynesworth SE, 2002, T 48 ANN M ORTH RES
   Ichioka S, 2009, WOUND REPAIR REGEN, V17, P492, DOI 10.1111/j.1524-475X.2009.00508.x
   KNIGHTON DR, 1990, SURG GYNECOL OBSTET, V170, P56
   Liu YW, 2002, WOUND REPAIR REGEN, V10, P336, DOI 10.1046/j.1524-475X.2002.10510.x
   O'Connell SM, 2008, WOUND REPAIR REGEN, V16, P749, DOI 10.1111/j.1524-475X.2008.00426.x
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Standelmann WK, 1998, AM J SURG, V176, p26S
   Tanaka R, 2007, VOX SANG, V93, P49, DOI 10.1111/j.1423-0410.2007.00913.x
   Thorn JJ, 2004, INT J ORAL MAX SURG, V33, P95, DOI 10.1054/ijom.2003.0461
   Yazawa M, 2003, CELL TRANSPLANT, V12, P509, DOI 10.3727/000000003108747073
NR 14
TC 3
Z9 4
U1 0
U2 2
PU INFORMA HEALTHCARE
PI NEW YORK
PA 52 VANDERBILT AVE, NEW YORK, NY 10017 USA
SN 2000-656X
EI 2000-6764
J9 J PLAST SURG HAND SU
JI J. Plast. Surg. Hand Surg.
PD DEC
PY 2013
VL 47
IS 6
BP 462
EP 466
DI 10.3109/2000656X.2013.783485
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 267IY
UT WOS:000328091900009
PM 23586320
DA 2018-10-20
ER

PT J
AU Rabin, Y
   Taylor, MJ
   Feig, JSG
   Baicu, S
   Chen, Z
AF Rabin, Yoed
   Taylor, Michael J.
   Feig, Justin S. G.
   Baicu, Simona
   Chen, Zhen
TI A new cryomacroscope device (Type III) for visualization of physical
   events in cryopreservation with applications to vitrification and
   synthetic ice modulators
SO CRYOBIOLOGY
LA English
DT Article
DE Cryomacroscopy; Synthetic ice modulators; Vitrification;
   Crystallization; Thermal stress; DP6
ID CAROTID-ARTERY SEGMENTS; FUNCTIONAL RECOVERY; THERMAL-STRESSES;
   CRYOPROTECTANTS; TEMPERATURE; BODY
AB The objective of the current study is to develop a new cryomacroscope prototype for the study of vitrification in large-size specimens. The unique contribution in the current study is in developing a cryomacroscope setup as an add-on device to a commercial controlled-rate cooler and in demonstration of physical events in ciyoprotective cocktails containing synthetic ice modulators (SIM)-compounds which hinder ice crystal growth. Cryopreservation by vitrification is a highly complex application, where the likelihood of crystallization, fracture formation, degradation of the biomaterial quality, and other physical events are dependent not only upon the instantaneous cryogenic conditions, but more significantly upon the evolution of conditions along the cryogenic protocol. Nevertheless, cryopreservation success is most frequently assessed by evaluating the cryopreserved product at its end states either at the cryogenic storage temperature or room temperature. The cryomacroscope is the only available device for visualization of large-size specimens along the thermal protocol, in an effort to correlate the quality of the cryopreserved product with physical events. Compared with earlier cryomacroscope prototypes, the new Cryomacroscope-III evaluated here benefits from a higher resolution color camera, improved illumination, digital recording capabilities, and high repeatability in tested thermal conditions via a commercial controlled-rate cooler. A specialized software package was developed in the current study, having two modes of operation: (a) experimentation mode to control the operation of the camera, record camera frames sequentially, log thermal data from sensors, and save case-specific information; and (b) post-processing mode to generate a compact file integrating images, elapsed time, and thermal data for each experiment. The benefits of the Cryomacroscope-III are demonstrated using various tested mixtures of SIMs with the cryoprotective cocktail DP6, which were found effective in preventing ice growth, even at significantly subcritical cooling rates with reference to the pure DP6. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Rabin, Yoed; Taylor, Michael J.; Feig, Justin S. G.] Carnegie Mellon Univ, Biothermal Technol Lab, Pittsburgh, PA 15213 USA.
   [Taylor, Michael J.; Baicu, Simona; Chen, Zhen] Cell & Tissues Syst Inc, N Charleston, SC USA.
RP Rabin, Y (reprint author), Carnegie Mellon Univ, Biothermal Technol Lab, Pittsburgh, PA 15213 USA.
EM rabin@cmu.edu
FU National Institute of Biomedical Imaging and Bioengineering (NIBIB)
   [R21EB009370]; National Center for Research Resources (NCRR)
   [R21RR026210]; National Institute of General Medical Sciences (NIGMS)
   [R21GM103407]
FX This project has been supported by Award Number R21EB009370 from the
   National Institute of Biomedical Imaging and Bioengineering (NIBIB),
   Award Number R21RR026210 from the National Center for Research Resources
   (NCRR), and Award Number R21GM103407 from the National Institute of
   General Medical Sciences (NIGMS). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health.
CR Baicu S, 2008, CRYOBIOLOGY, V57, P1, DOI 10.1016/j.cryobiol.2008.03.002
   Baicu S, 2006, CELL PRESERV TECHNOL, V4, P236, DOI 10.1089/cpt.2006.9994
   Brockbank K.G.M., 2007, ADV BIOPRESERVATION, P157
   Campbell L.H., 1999, CRYOBIOLOGY, V39, P362
   CHAN KS, 1969, J BIOMECH, V2, P299, DOI 10.1016/0021-9290(69)90086-4
   Diller K R, 1970, Cryobiology, V7, P191
   Eisenberg D.P., 2013, CRYOBIOLOGY
   Eisenberg DP, 2012, CRYOBIOLOGY, V65, P117, DOI 10.1016/j.cryobiol.2012.04.011
   FAHY GM, 1987, CRYOBIOLOGY, V24, P196, DOI 10.1016/0011-2240(87)90023-X
   Fahy GM, 1987, BIOPHYSICS ORGAN CRY, P265
   Fahy GM, 1995, CELL BIOL TRAUMA
   Feig J.S.G., 2012, 38 ANN NE BIOENG C P
   Fletcher N. H, 1970, CHEM PHYS ICE
   Grout BWW, 1991, CLIN APPL CRYOBIOLOG, P81
   Jimenez-Rios J.L., 2006, CRYOBIOLOGY, V52, P284
   LUYET B, 1957, Biodynamica, V7, P337
   NARAYANASWAMY OS, 1971, J AM CERAM SOC, V54, P491, DOI 10.1111/j.1151-2916.1971.tb12186.x
   Pegg DE, 2006, CRYOBIOLOGY, V52, P360, DOI 10.1016/j.cryobiol.2006.01.004
   Plitz J, 2004, CELL PRESERV TECHNOL, V2, P215, DOI DOI 10.1089/CPT.2004.2.215
   Rabin Y, 1998, J APPL MECH-T ASME, V65, P328, DOI 10.1115/1.2789058
   Rabin Y, 2000, INT J SOLIDS STRUCT, V37, P2363, DOI 10.1016/S0020-7683(98)00345-X
   Rabin Y, 2006, ADV BIOPRESERVATION, P359, DOI 10.1201/9781420004229.ch13
   Rabin Y, 2006, CRYOBIOLOGY, V53, P75, DOI 10.1016/j.cryobiol.2006.03.013
   Rabin Yoed, 2005, Cell Preserv Technol, V3, P169, DOI 10.1089/cpt.2005.3.169
   RAPATZ G, 1957, Biodynamica, V7, P347
   References T., 2010, OPEN BIOTECHNOLOGY J, V4, P26
   Rios JLJ, 2007, ANN BIOMED ENG, V35, P2077, DOI 10.1007/s10439-007-9372-0
   Scholtze H., 1991, GLASS NATURE STRUCTU
   Sevanto S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00107
   Steif PS, 2007, CELL PRESERV TECHNOL, V5, P104, DOI 10.1089/cpt.2007.9994
   Steif Paul S, 2005, Cell Preserv Technol, V3, P184, DOI 10.1089/cpt.2005.3.184
   Taylor MJ, 2001, TRANSPLANT P, V33, P677, DOI 10.1016/S0041-1345(00)02198-9
   Taylor MJ, 2004, LIFE IN THE FROZEN STATE, P603, DOI 10.1201/9780203647073.ch22
   Taylor MJ, 2007, ADV BIOPRESERVATION, P15
   TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670
   Trad FS, 1999, HUM REPROD, V14, P1569, DOI 10.1093/humrep/14.6.1569
   WEINER JH, 1963, J MECH PHYS SOLIDS, V11, P145, DOI 10.1016/0022-5096(63)90049-8
NR 37
TC 9
Z9 9
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
EI 1090-2392
J9 CRYOBIOLOGY
JI Cryobiology
PD DEC
PY 2013
VL 67
IS 3
BP 264
EP 273
DI 10.1016/j.cryobiol.2013.08.005
PG 10
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 261UQ
UT WOS:000327690500003
PM 23993920
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Yao, L
   Daly, W
   Newland, B
   Yao, S
   Wang, W
   Chen, BKK
   Madigan, N
   Windebank, A
   Pandit, A
AF Yao, L.
   Daly, W.
   Newland, B.
   Yao, S.
   Wang, W.
   Chen, B. K. K.
   Madigan, N.
   Windebank, A.
   Pandit, A.
TI Improved axonal regeneration of transected spinal cord mediated by
   multichannel collagen conduits functionalized with neurotrophin-3 gene
SO GENE THERAPY
LA English
DT Article
DE non-viral gene delivery; neural conduits; 2-(Dimethylamino)ethyl
   methacrylate; spinal cord injury
ID PERIPHERAL-NERVE REGENERATION; NEURAL STEM-CELLS; CORTICOSPINAL TRACT;
   SCHWANN-CELLS; ADULT-RATS; TRANSGENE EXPRESSION; POLYMER SCAFFOLDS; KNOT
   POLYMER; IN-VIVO; RECOVERY
AB Functionalized biomaterial scaffolds targeted at improving axonal regeneration by enhancing guided axonal growth provide a promising approach for the repair of spinal cord injury. Collagen neural conduits provide structural guidance for neural tissue regeneration, and in this study it is shown that these conduits can also act as a reservoir for sustained gene delivery. Either a G-luciferase marker gene or a neurotrophin-3-encoding gene, complexed to a non-viral, cyclized, PEGylated transfection vector, was loaded within a multichannel collagen conduit. The complexed genes were then released in a controlled fashion using a dual release system both in vitro and in vivo. For evaluation of their biological performance, the loaded conduits were implanted into the completely transected rat thoracic spinal cord (T8-T10). Aligned axon regeneration through the channels of conduits was observed one month post-surgery. The conduits delivering neurotrophin-3 polyplexes resulted in significantly increased neurotrophin-3 levels in the surrounding tissue and a statistically higher number of regenerated axons versus the control conduits (P<0.05). This study suggests that collagen neural conduits delivering a highly effective non-viral therapeutic gene may hold promise for repair of the injured spinal cord.
C1 [Yao, L.; Daly, W.; Newland, B.; Wang, W.; Pandit, A.] Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland.
   [Yao, L.] Wichita State Univ, Dept Biol Sci, Wichita, KS 67208 USA.
   [Yao, S.] Univ Liverpool, Sect Cellular Pathol & Mol Genet, Dept Mol & Clin Canc Med, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.
   [Chen, B. K. K.; Madigan, N.; Windebank, A.] Mayo Clin, Dept Neurobiol, Rochester, MN USA.
RP Pandit, A (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008; Yao, Li/J-1372-2016
OI Pandit, Abhay/0000-0002-6292-4933; Wang, Wenxin/0000-0002-5053-0611;
   Newland, Ben/0000-0002-5214-2604
FU Science Foundation Ireland Research Frontiers Program [08/RFP/ENM1218]
FX We thank the Science Foundation Ireland Research Frontiers Program
   (Grant no.: 08/RFP/ENM1218) for providing financial support to this
   project.
CR Afshari FT, 2010, GLIA, V58, P857, DOI 10.1002/glia.20970
   Camborieux L, 2000, J NEUROIMMUNOL, V107, P29, DOI 10.1016/S0165-5728(00)00246-0
   Chattopadhyay S, 2009, GLIA, V57, P1316, DOI 10.1002/glia.20851
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Chen BKK, 2011, BIOMATERIALS, V32, P8077, DOI 10.1016/j.biomaterials.2011.07.029
   Chen X, 2006, MICROSURG, V26, P111, DOI 10.1002/micr.20184
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Daly WT, 2012, BIOMATERIALS, V33, P6660, DOI 10.1016/j.biomaterials.2012.06.002
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Donnelly EM, 2010, J GENE MED, V12, P863, DOI 10.1002/jgm.1509
   FERNANDEZ E, 1993, NEUROSURGERY, V33, P889
   Hari A, 2004, INT J DEV NEUROSCI, V22, P113, DOI 10.1016/j.ijdevneu.2003.12.002
   Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405
   Holladay C, 2010, NANOSCALE, V2, P2718, DOI 10.1039/c0nr00456a
   Huang WC, 2010, NEUROSCI LETT, V472, P79, DOI 10.1016/j.neulet.2010.01.012
   Itoh S, 1999, J MATER SCI-MATER M, V10, P129, DOI 10.1023/A:1008977221827
   Jefferson SC, 2011, J NEUROSCI, V31, P5710, DOI 10.1523/JNEUROSCI.4459-10.2011
   Krych AJ, 2009, ACTA BIOMATER, V5, P2551, DOI 10.1016/j.actbio.2009.03.021
   KUHLENGEL KR, 1990, J COMP NEUROL, V293, P74, DOI 10.1002/cne.902930107
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Lee JY, 2012, J BONE JOINT SURG AM, V94A, P2084, DOI 10.2106/JBJS.K.00658
   Li GN, 2008, TISSUE ENG PT B-REV, V14, P33, DOI 10.1089/teb.2007.0181
   Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000
   LI Y, 1994, J NEUROSCI, V14, P4050
   Longo Frank M., 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P29
   Lu KW, 2002, J NEUROTRAUM, V19, P1081, DOI 10.1089/089771502760341983
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3
   Newland B, 2013, ACS CHEM NEUROSCI, V4, P540, DOI 10.1021/cn4000023
   Newland B, 2012, BIOMATERIALS, V34, P2130
   Newland B, 2013, BIOMATER SCI-UK, V1, P556, DOI 10.1039/c3bm60030k
   Newland B, 2012, J AM CHEM SOC, V134, P4782, DOI 10.1021/ja2105575
   Newland B, 2010, CHEM COMMUN, V46, P4698, DOI 10.1039/c0cc00439a
   Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Peleshok J, 2006, BIOCHEM SOC T, V34, P612, DOI 10.1042/BST0340612
   Ramer MS, 2002, MOL CELL NEUROSCI, V19, P239, DOI 10.1006/mcne.2001.1067
   Saeed AO, 2012, CHEM COMMUN, V48, P585, DOI 10.1039/c1cc16538k
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002
   Shi L, 2003, GENE THER, V10, P1179, DOI 10.1038/sj.gt.3301970
   Sterne GD, 1997, EUR J NEUROSCI, V9, P1388, DOI 10.1111/j.1460-9568.1997.tb01493.x
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Takahashi K, 1999, J COMP NEUROL, V404, P159, DOI 10.1002/(SICI)1096-9861(19990208)404:2<159::AID-CNE2>3.0.CO;2-E
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Wang JM, 2011, BIOMATERIALS, V32, P7454, DOI 10.1016/j.biomaterials.2011.06.036
   XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056
   Yang JX, 2009, J CLIN INVEST, V119, P3678, DOI 10.1172/JCI37914
   Yao L, 2010, TISSUE ENG PART C-ME, V16, P1585, DOI 10.1089/ten.TEC.2010.0152
   Yao L, 2010, BIOMATERIALS, V31, P5789, DOI 10.1016/j.biomaterials.2010.03.081
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Yoshil S, 2009, J TISSUE ENG REGEN M, V3, P19, DOI 10.1002/term.130
   Zheng Y, 2011, J AM CHEM SOC, V133, P13130, DOI 10.1021/ja2039425
NR 61
TC 24
Z9 24
U1 3
U2 45
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0969-7128
EI 1476-5462
J9 GENE THER
JI Gene Ther.
PD DEC
PY 2013
VL 20
IS 12
BP 1149
EP 1157
DI 10.1038/gt.2013.42
PG 9
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Research & Experimental Medicine
GA 265CB
UT WOS:000327926200006
PM 23883961
OA Bronze
DA 2018-10-20
ER

PT J
AU Fatehi, F
AF Fatehi, Farida
TI Natural Scaffold Materials Used in Regenerative Endodontic: A Review
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Review
DE Pulp Regeneration; Scaffold; Natural Polymers
ID PULP STEM-CELLS; TISSUE ENGINEERING APPLICATIONS; CHITOSAN-BASED
   BIOMATERIALS; DENTIN MATRIX PROTEIN-1; ALGINATE HYDROGELS; COLLAGEN;
   REPAIR; REVASCULARIZATION; RESPONSES; GELATIN
AB Modern medical therapy believes restoration of full healing or recovery of complete organ function. The goal of inspired field of regenerative endodontic is to create an alternative to commonly used treatment modalities which achieved higher success rate of 97% in last one decade. Beside very small volume (similar to 10-100 mu l) regeneration of entire pulp is difficult task due to anatomical arrangement of pulp chamber, minimal collateral blood supply, and impaired ability of the immune system to combat infections. Scaffold is the key component of engineering dental pulp tissue which help to transplant stem cells or help to recruit endogenous stem cells. Continued advances in material science helps to design scaffold material using natural or synthetic polymers, extracellular matrix, self-assembling systems, hydrogels, or bioceramics with tailored properties which support the feasibility of pulp tissue engineering. In last two decades researchers relied on natural polymers, such as collagen, polyester, chitosan, or hydroxyapatite for pulp tissue engineering. Each biomaterial has its own pros and cons when they are used for tissue engineering of a complex tissue like pulp. This paper aims to review the natural scaffolds and the major scaffolding approaches used in regenerative dentistry to date as important guidelines for selecting scaffolds.
C1 [Fatehi, Farida] NYU, Coll Dent, New York, NY 10010 USA.
   [Fatehi, Farida] NYU, Coll Nursing, New York, NY 10010 USA.
RP Fatehi, F (reprint author), NYU, Coll Dent, New York, NY 10010 USA.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Alexander D., 2006, MACROMOLECULAR BIOSC, V6, P623
   Alsanea R, 2011, J ENDODONT, V37, P1092, DOI 10.1016/j.joen.2011.05.019
   Anna H., METHODS MOL BIOL, V171
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Avery P. F. S. J. K., 2001, ORAL DEV HISTOLOGY, P31
   Bae WJ, 2012, DENT MATER, V28, P1271, DOI 10.1016/j.dental.2012.09.011
   Banchs F, 2004, J ENDODONT, V30, P196, DOI 10.1097/00004770-200404000-00003
   Chen HQ, 2007, J BIOACT COMPAT POL, V22, P475, DOI 10.1177/0883911507081329
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Dobie K, 2002, CONNECT TISSUE RES, V43, P387, DOI 10.1080/03008200290000574
   Eric L., 2008, J AM DENT ASSOC, V139, P457
   Galler KM, 2011, REGEN MED, V6, P191, DOI 10.2217/RME.11.3
   Haghgoo R. N. J. N., 2007, J DENT, V4, P154
   Harris P., 1990, ELSEVIER APPL FOOD S, P476
   Huang GTJ, 2009, REGEN MED, V4, P697, DOI 10.2217/RME.09.45
   Huang GTJ, 2012, FRONT BIOSCI ELITE E, V3, P788
   Inuyama Y, 2010, J BIOMED MATER RES B, V92B, P120, DOI 10.1002/jbm.b.31497
   Jancar J, 2007, PHYSIOL RES, V56, pS17
   Keswani D., 2013, INT ENDOD J, P1
   Kim NR, 2009, ORAL SURG ORAL MED O, V108, pE94, DOI 10.1016/j.tripleo.2009.07.031
   Kokol S., COLLAGEN VERSUS GELA
   Kumabe M. S., 2006, OKAJIMAS FOLIA ANAT, V82, P147
   Kuo TF, 2008, J BIOMED MATER RES A, V86A, P1062, DOI 10.1002/jbm.a.31.746
   Liu X, 2011, ADV POLYM SCI, V244, P81, DOI 10.1007/12_2011_118
   Matsunaga T, 2006, J BIOMED MATER RES A, V76A, P711, DOI 10.1002/jbm.a.30588
   MEYER MW, 1993, INT ENDOD J, V26, P6
   NYGAARD-OSTBY B, 1971, Scandinavian Journal of Dental Research, V79, P333
   Ogilvie A. L., 1965, ATLAS PULP PERIAPICA
   OLGART LM, 1985, J DENT RES, V64, P572, DOI 10.1177/002203458506400412
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Salehrabi R, 2004, J ENDODONT, V30, P846, DOI 10.1097/01.don.0000145031.04236.ca
   Salem R. S. A. K., 2002, J BIOMEDICAL MAT R A, V61, P212
   Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002
   Shivashankar Vasundara Yayathi, 2012, J Conserv Dent, V15, P395, DOI 10.4103/0972-0707.101926
   Srisuwan T, 2012, TISSUE CELL, V44, P111, DOI 10.1016/j.tice.2011.12.003
   Srisuwan T, 2013, DENT TRAUMATOL, V29, P84, DOI 10.1111/j.1600-9657.2012.01136.x
   Stamov DR, 2012, SOFT MATTER, V8, P10200, DOI 10.1039/c2sm26134k
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   Suzuki T, 2011, J DENT RES, V90, P1013, DOI 10.1177/0022034511408426
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Yamauchi N, 2011, J ENDODONT, V37, P390, DOI 10.1016/j.joen.2010.11.010
   Yu C, 2007, AUST DENT J, V52, pS4, DOI 10.1111/j.1834-7819.2007.tb00525.x
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
NR 46
TC 8
Z9 8
U1 5
U2 90
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD DEC
PY 2013
VL 3
IS 6
BP 597
EP 604
DI 10.1166/jbt.2013.1131
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 266EA
UT WOS:000328005000001
DA 2018-10-20
ER

PT J
AU Nagiah, N
   Ramanathan, G
   Shobana, L
   Singaravelu, S
   Uma, TS
   Natarajan, TS
AF Nagiah, Naveen
   Ramanathan, Giriprasath
   Shobana, Liji
   Singaravelu, Sivakumar
   Uma, Tiruchirapalli Sivagnanam
   Natarajan, Tirupattur Srinivasan
TI Preparation and Characterization of Electrospun Poly(3-Hydroxybutyric
   acid)-Poly(N-vinylpyrrolidone) and
   Poly(caprolactone)-Poly(N-vinylpyrrolidone) Fibers as Potential
   Scaffolds for Skin Regeneration
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Electrospinning; Thin Film; Biomaterial; Bioengineering
ID TISSUE ENGINEERING SCAFFOLDS; IN-VIVO DEGRADATION; DRUG-RELEASE;
   NANOFIBERS; POLYMER
AB Tissue engineered scaffold mimics the structure and function of native extracellular matrix proteins. Electrospinning is a simple and versatile method to produce ultrathin extracellular matrix mimicking fibers for tissue engineering. Blended fibers of poly(3-hydroxybutyric acid)-Poly(N-vinylpyrrolidone) and Poly(caprolactone)-Poly(N-vinylpyrrolidone) were electrospun using 1,1,1,3,3,3 hexafluoro-2-propanaol as solvent. The resultant fibers were tested and analyzed using scanning electron microscopy, differential scanning calorimetry, thermogravimetric analysis, X-ray diffraction, Attenuated total refelection Fourier transformed infrared spectroscopy. The fibrous scaffolds were found to exhibit good tensile strength and proved the stability of fibers for tissue engineering applications. The fibrous scaffold supported the growth and rapid proliferation of human dermal fibroblasts and keratinocytes with normal morphology thus proving its reliability in using it as a potential scaffold for skin regeneration.
C1 [Nagiah, Naveen; Ramanathan, Giriprasath; Shobana, Liji; Singaravelu, Sivakumar; Uma, Tiruchirapalli Sivagnanam] Cent Leather Res Inst, Bioprod Lab, Madras 600025, Tamil Nadu, India.
   [Natarajan, Tirupattur Srinivasan] Indian Inst Technol, Dept Phys, Conducting Polymers Lab, Madras 600036, Tamil Nadu, India.
RP Uma, TS (reprint author), Cent Leather Res Inst, Bioprod Lab, Madras 600025, Tamil Nadu, India.
RI Ramanathan, Giriprasath/E-2019-2017; singaravelu, sivakumar/I-6528-2016;
   Tirichurapalli Sivagnanam, uma/E-1325-2017
OI Ramanathan, Giriprasath/0000-0002-2541-6577; singaravelu,
   sivakumar/0000-0002-1043-0165; Tirichurapalli Sivagnanam,
   uma/0000-0002-1401-2569
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Castillo-Ortega MM, 2012, MATER LETT, V76, P250, DOI 10.1016/j.matlet.2012.02.093
   Elzubair A, 2006, J DENT, V34, P784, DOI 10.1016/j.jdent.2006.03.002
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Kansiz M, 2000, APPL ENVIRON MICROB, V66, P3415, DOI 10.1128/AEM.66.8.3415-3420.2000
   Kim GM, 2007, J APPL POLYM SCI, V103, P1860, DOI 10.1002/app.25348
   Koo B., 2003, POLYMER, V44, P681
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Min BM, 2004, POLYMER, V45, P7137, DOI 10.1016/j.polymer.2004.08.048
   Nagiah N, 2012, ADV ENG MATER, V14, pB138, DOI 10.1002/adem.201180041
   Naveen N, 2010, ADV ENG MATER, V12, pB380, DOI 10.1002/adem.200980067
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Piras AM, 2008, J BIOACT COMPAT POL, V23, P423, DOI 10.1177/0883911508093357
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Sascha M., 2007, J CONTROL RELEASE, V127, P180
   Sascha M., 2008, J CONTROL RELEASE, V127, P180
   Scarber RE, 2013, J BIOMATER TISS ENG, V3, P440, DOI 10.1166/jbt.2013.1101
   Sell S, 2007, POLYM INT, V56, P1349, DOI 10.1002/pi.2344
   Smith R., 2005, BIODEGRADABLE POLYM
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   van der Veen VC, 2011, WOUND REPAIR REGEN, V19, pS59, DOI 10.1111/j.1524-475X.2011.00713.x
   Wang W, 2012, J APPL POLYM SCI, V124, P1919, DOI 10.1002/app.34617
   Zhang YZ, 2006, NANOTECHNOLOGY, V17, P901, DOI 10.1088/0957-4484/17/3/047
NR 26
TC 11
Z9 11
U1 0
U2 21
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD DEC
PY 2013
VL 3
IS 6
BP 624
EP 629
DI 10.1166/jbt.2013.1130
PG 6
WC Cell & Tissue Engineering
SC Cell Biology
GA 266EA
UT WOS:000328005000003
DA 2018-10-20
ER

PT J
AU Olyveira, GM
   Costa, LMM
   Basmaji, P
AF Olyveira, Gabriel Molina
   Manzine Costa, Ligia Maria
   Basmaji, Pierre
TI High Dispersivity Bacterial Cellulose/Carbon Nanotube Nanocomposite for
   Sensor Applications
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Bacterial Cellulose (Nanoskin); Carbon Nanotubes; Biocomposites; Sensor
   Applications
ID WALLED CARBON NANOTUBES; THERMAL-DEGRADATION
AB Bacterial cellulose (BC) has established to be a remarkably versatile biomaterial and can be used in wide variety of applied scientific endeavors, especially for medical devices. In fact, biomedical devices recently have gained a significant amount of attention because of increased interesting tissue-engineered products for both wound care and the regeneration of damaged or diseased organs. The architecture of BC materials can be engineered over length scales ranging from nano to macro by controlling the biofabrication process, besides, surface modifications bring a vital role in in vivo performance of biomaterials. In this work, bacterial cellulose fermentation was modified with carbon nanotubes for sensor applications and diseases diagnostic. SEM images showed that polymer modified-carbon nanotube (PVOH-carbon nanotube) produced well dispersed system and without agglomeration. Influences of carbon nanotube in bacterial cellulose were analyzed by FTIR. TGA showed higher thermal properties of developed bionanocomposites.
C1 [Olyveira, Gabriel Molina] UNESP Araraquara, Dept Phys Chem, BR-14800900 Araraquara, SP, Brazil.
   [Manzine Costa, Ligia Maria] Dept Nanosci & Adv Mat UFABC, BR-09291170 Santo Andre, SP, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13560042 Sao Carlos, SP, Brazil.
RP Olyveira, GM (reprint author), UNESP Araraquara, Dept Phys Chem, BR-14800900 Araraquara, SP, Brazil.
RI Manzine Costa, Ligia Maria/N-1780-2015
OI Manzine Costa, Ligia Maria/0000-0001-6483-7633
CR Alvarez VA, 2004, POLYM DEGRAD STABIL, V84, P13, DOI 10.1016/j.polvmdegradstab.2003.09.003
   Basmaji P., 2011, J NANOTECH ENG MED, V2
   Basmaji P., 2011, P NAN 2011 BIOS INST
   Chen P, 2010, MACROMOL RES, V18, P309, DOI 10.1007/s13233-010-0404-5
   Cherian B. M., 2013, ADV NATURAL POLYM AD, V18, P337, DOI [10.1007/978-3-642-20940-6_10, DOI 10.1007/978-3-642-20940-6_10]
   Cherian BM, 2012, RSC GREEN CHEM SER, P255, DOI 10.1039/9781849735315-00255
   Costa L. M. M., 2011, J BIONANOSCIENCE, V5, P167
   Costa L. M. M., 2012, J BIOMATERIALS NANOB, V2, P92
   Gois P. B. P., 2012, INT REV BIOPHYSICAL, V3, P48
   Jung R, 2008, J POLYM SCI POL PHYS, V46, P1235, DOI 10.1002/polb.21457
   Kim Y, 2009, J APPL POLYM SCI, V114, P2864, DOI 10.1002/app.30829
   Manfredi B.L., 2006, POLYM DEGRAD STABIL, V91, P255
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P48, DOI 10.1166/jbt.2012.1031
   Nature Neuroscience E, 2013, J NANOSCI NANOTECHNO, V16, P1
   Olyveira G. M., 2011, J BIOMATER NANOBIOTE, V02, P239
   Olyveira G. M., 2011, J NANOTECHNOLOGY ENG, V2
   Olyveira G. M., 2013, J BIOMATER TISS ENG, V3, P1
   Olyveira G. M., 2013, J BIOMEDICAL NANOTEC, V9, P1
   Ouajai S, 2005, POLYM DEGRAD STABIL, V89, P327, DOI 10.1016/j.polymdegradstab.2005.01.016
   Tanaka T, 2010, J APPL PHYS, V107, DOI 10.1063/1.3319675
   Yan ZY, 2008, CARBOHYD RES, V343, P73, DOI 10.1016/j.carres.2007.10.024
   Yoon SH, 2006, BIOMACROMOLECULES, V7, P1280, DOI 10.1021/bm050597g
   Yun S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3224200
   Zhbanko R. G., 1966, INFRARED SPECTRA CEL, P325
NR 25
TC 7
Z9 7
U1 3
U2 46
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD DEC
PY 2013
VL 3
IS 6
BP 665
EP 668
DI 10.1166/jbt.2013.1127
PG 4
WC Cell & Tissue Engineering
SC Cell Biology
GA 266EA
UT WOS:000328005000009
DA 2018-10-20
ER

PT J
AU Rao, W
   Celiz, AD
   Scurr, DJ
   Alexander, MR
   Barrett, DA
AF Rao, Wei
   Celiz, Adam D.
   Scurr, David J.
   Alexander, Morgan R.
   Barrett, David A.
TI Ambient DESI and LESA-MS Analysis of Proteins Adsorbed to a Biomaterial
   Surface Using In-Situ Surface Tryptic Digestion
SO JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
LA English
DT Article
DE LESA-MS; DESI-MS; Ambient MS; Protein arrays; In-situ digestion; MS
   imaging; MCR analysis
ID IONIZATION-MASS-SPECTROMETRY; DESORPTION ELECTROSPRAY-IONIZATION;
   TISSUE-SECTIONS; MULTIVARIATE-ANALYSIS; STEM-CELLS; IDENTIFICATION;
   CHIP; PEPTIDES; PLATFORM; CULTURE
AB The detection and identification of proteins adsorbed onto biomaterial surfaces under ambient conditions has significant experimental advantages but has proven to be difficult to achieve with conventional measuring technologies. In this study, we present an adaptation of desorption electrospray ionization (DESI) and liquid extraction surface analysis (LESA) mass spectrometry (MS) coupled with in-situ surface tryptic digestion to identify protein species from a biomaterial surface. Cytochrome c, myoglobin, and BSA in a combination of single and mixture spots were printed in an array format onto Permanox slides, followed by in-situ surface digestion and detection via MS. Automated tandem MS performed on surface peptides was able to identify the proteins via MASCOT. Limits of detection were determined for DESI-MS and a comparison of DESI and LESA-MS peptide spectra characteristics and sensitivity was made. DESI-MS images of the arrays were produced and analyzed with imaging multivariate analysis to automatically separate peptide peaks for each of the proteins within a mixture into distinct components. This is the first time that DESI and LESA-MS have been used for the in-situ detection of surface digested proteins on biomaterial surfaces and presents a promising proof of concept for the use of ambient MS in the rapid and automated analysis of surface proteins.
C1 [Rao, Wei; Barrett, David A.] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England.
   [Celiz, Adam D.; Scurr, David J.; Alexander, Morgan R.] Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
RP Barrett, DA (reprint author), Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England.
EM david.barrett@nottingham.ac.uk
RI Scurr, David/E-8441-2012; Alexander, Morgan/C-2506-2009; Celiz,
   Adam/G-6841-2013; Barrett, David/C-9922-2011
OI Scurr, David/0000-0003-0859-3886; Alexander, Morgan/0000-0001-5182-493X;
   Celiz, Adam/0000-0003-4568-7734; Barrett, David/0000-0001-6900-9474
FU UK Engineering and Physical Sciences Research Council (EPSRC)
   [EP/H045384/1]; Engineering and Physical Sciences Research Council
   [EP/H045384/1]
FX The authors acknowledge support from the UK Engineering and Physical
   Sciences Research Council (EPSRC) grant number EP/H045384/1.
CR Adler B, 2012, ANAL CHEM, V84, P8663, DOI 10.1021/ac3017983
   Brown SHJ, 2013, ANALYST, V138, P1316, DOI 10.1039/c2an36189b
   Casadonte R, 2011, NAT PROTOC, V6, P1695, DOI 10.1038/nprot.2011.388
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Deininger SO, 2008, J PROTEOME RES, V7, P5230, DOI 10.1021/pr8005777
   Djidja MC, 2009, PROTEOMICS, V9, P2750, DOI 10.1002/pmic.200800624
   Douglass KA, 2013, J MASS SPECTROM, V48, P553, DOI 10.1002/jms.3206
   Edwards RL, 2011, ANAL CHEM, V83, P2265, DOI 10.1021/ac1030804
   Eikel D, 2011, RAPID COMMUN MASS SP, V25, P2345, DOI 10.1002/rcm.5107
   Emory JF, 2010, EUR J MASS SPECTROM, V16, P21, DOI 10.1255/ejms.1041
   Gao L., 2011, J PHYS CHEM-US, V114, P5331
   Gerbig S, 2012, ANAL BIOANAL CHEM, V403, P2315, DOI 10.1007/s00216-012-5841-x
   Groseclose MR, 2007, J MASS SPECTROM, V42, P254, DOI 10.1002/jms.1177
   Ha NY, 2011, LANGMUIR, V27, P10098, DOI 10.1021/la201812a
   Heaton K, 2009, J ARCHAEOL SCI, V36, P2145, DOI 10.1016/j.jas.2009.05.016
   Ho M, 2006, BIOMATERIALS, V27, P4333, DOI 10.1016/j.biomaterials.2006.03.037
   Ifa DR, 2010, ANALYST, V135, P669, DOI 10.1039/b925257f
   Jackson AU, 2009, ANALYST, V134, P867, DOI 10.1039/b823511b
   Kaur-Atwal G, 2007, RAPID COMMUN MASS SP, V21, P1131, DOI 10.1002/rcm.2941
   Kertesz V, 2010, J MASS SPECTROM, V45, P252, DOI 10.1002/jms.1709
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   Liu LY, 2008, J BIOMAT SCI-POLYM E, V19, P821, DOI 10.1163/156856208784522083
   Marshall P, 2010, ANAL CHEM, V82, P7787, DOI 10.1021/ac1017524
   Martinez-Osorio H, 2009, MOL VIS, V15, P2185
   McCombie G, 2005, ANAL CHEM, V77, P6118, DOI 10.1021/ac051081q
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Muramoto S, 2011, J PHYS CHEM C, V115, P24247, DOI 10.1021/jp208035x
   Parson WB, 2012, J MASS SPECTROM, V47, P1420, DOI 10.1002/jms.3068
   Pasilis SP, 2008, ANAL BIOANAL CHEM, V391, P317, DOI 10.1007/s00216-008-1874-6
   Quanico J, 2013, J PROTEOMICS, V79, P200, DOI 10.1016/j.jprot.2012.11.025
   Rao W, 2012, ANALYST, V137, P3946, DOI 10.1039/c2an35430f
   Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108
   Schober Y, 2012, RAPID COMMUN MASS SP, V26, P1141, DOI 10.1002/rcm.6192
   Shin YS, 2007, ANAL CHEM, V79, P3514, DOI 10.1021/ac062451t
   Soparawalla S, 2010, ANALYST, V135, P1953, DOI 10.1039/c0an00189a
   Stauber J, 2010, J AM SOC MASS SPECTR, V21, P338, DOI 10.1016/j.jasms.2009.09.016
   Stein MJ, 2012, ANAL CHEM, V84, P1572, DOI 10.1021/ac2028134
   Su Y, 2013, LAB CHIP, V13, P1876, DOI 10.1039/c3lc00063j
   Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404
   Takats Z., 2008, CSH PROTOC, V2008
   Van Berkel GJ, 2013, RAPID COMMUN MASS SP, V27, P1329, DOI 10.1002/rcm.6580
   Van Berkel GJ, 2006, RAPID COMMUN MASS SP, V20, P1144, DOI 10.1002/rcm.2438
   Vickerman JC, 2011, ANALYST, V136, P2199, DOI 10.1039/c1an00008j
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Walcher W, 2003, J PROTEOME RES, V2, P534, DOI 10.1021/pr034034s
   Wu CP, 2009, ANAL CHEM, V81, P7618, DOI 10.1021/ac901003u
   Yao ZP, 2012, MASS SPECTROM REV, V31, P437, DOI 10.1002/mas.20346
NR 47
TC 27
Z9 27
U1 0
U2 58
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1044-0305
EI 1879-1123
J9 J AM SOC MASS SPECTR
JI J. Am. Soc. Mass Spectrom.
PD DEC
PY 2013
VL 24
IS 12
BP 1927
EP 1936
DI 10.1007/s13361-013-0737-3
PG 10
WC Biochemical Research Methods; Chemistry, Analytical; Chemistry,
   Physical; Spectroscopy
SC Biochemistry & Molecular Biology; Chemistry; Spectroscopy
GA 258LF
UT WOS:000327460100014
PM 24048891
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Kan, QH
   Rajan, R
   Fu, J
   Kang, GZ
   Yan, WY
AF Kan, Qianhua
   Rajan, Ramesh
   Fu, Jing
   Kang, Guozheng
   Yan, Wenyi
TI Elastic modulus of rat whiskers-A key biomaterial in the rat whisker
   sensory system
SO MATERIALS RESEARCH BULLETIN
LA English
DT Article
DE Organic compounds; Elastic properties; Mechanical properties
ID RADIAL DISTANCE DETERMINATION; MECHANICAL-PROPERTIES; VIBRISSAL SYSTEM;
   BONE LAMELLAE; NANOINDENTATION; HARDNESS; ENAMEL; LOAD
AB Nanoindentation tests were carried out to measure the elastic modulus of rat whisker, which is used as a high-acuity sensor for exploring the world and discriminating object distance, size and surface texture. The measured load-depth curves show that the biomaterial of rat whisker exhibits obvious visco-elastic characteristic, such as load relaxation and displacement creeping. The measured indentation modulus of rat whiskers decreases with indentation depth at the same location. The mean value of the measured indentation moduli of 24 major whiskers varies from 0.33 GPa to 4.92 GPa. The elastic modulus is independent of the freshness of the whisker sample. It is also found that the length and diameter of whiskers have no direct relationship to the indentation modulus at the base. Based on the measured elastic modulus, the bending stiffness at the base of a whisker is predicted in the range of 0.58-134.79 mN mm(2) and the rotational stiffness at the middle of a whisker is within 0.06-10.93 mN mm/rad. These results can be used to study the mechanical behavior of the rat whisker sensor system. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Kan, Qianhua; Kang, Guozheng] Southwest Jiaotong Univ, Sch Mech & Engn, Chengdu 610031, Peoples R China.
   [Rajan, Ramesh] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.
   [Fu, Jing; Yan, Wenyi] Monash Univ, Dept Mech & Aerosp Engn, Clayton, Vic 3800, Australia.
RP Yan, WY (reprint author), Monash Univ, Dept Mech & Aerosp Engn, Clayton, Vic 3800, Australia.
EM wenyi.yan@monash.edu
RI Yan, Wenyi/H-3899-2011; kan, qianhua/J-7356-2012; kang,
   guozheng/G-3335-2015
OI Yan, Wenyi/0000-0001-9006-6270; kan, qianhua/0000-0002-5190-7804; Fu,
   Jing/0000-0002-7752-5417; Rajan, Ramesh/0000-0001-9862-0520
FU National Natural Science Foundation of China [11025210, 11202171];
   Fundamental Research Funds for the Central Universities [SWJTU12CX044];
   Australian Government's Endeavor Awards program under the scheme of
   Endeavor Research Fellowships
FX This work was supported by National Natural Science Foundation of China
   (11025210 and 11202171) and the Fundamental Research Funds for the
   Central Universities (SWJTU12CX044). The experimental tests were carried
   out during QHK's academic visit to Monash University with the financial
   support from the Australian Government's Endeavor Awards program under
   the scheme of Endeavor Research Fellowships.
CR Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006
   Bushby A.J., 2004, J MATER RES, V19, P24
   Cao YF, 2005, J MATER RES, V20, P2004, DOI 10.1557/JMR.2005.0256
   Carl K., 2011, SENS J IEEE, V99, P1
   Donnelly E, 2006, J BIOMED MATER RES A, V77A, P426, DOI 10.1002/jbm.a.30633
   Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9
   Gershon AL, 2010, MAT SCI ENG C-MATER, V30, P235, DOI 10.1016/j.msec.2009.10.004
   Gibson CT, 2001, TEXT RES J, V71, P573, DOI 10.1177/004051750107100702
   Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3
   Hartmann MJ, 2003, J NEUROSCI, V23, P6510
   He LH, 2007, BIOMATERIALS, V28, P4512, DOI 10.1016/j.biomaterials.2007.06.020
   Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X
   Herzog E.K., 2005, MAT RES SOC
   Hipp J, 2006, J NEUROPHYSIOL, V95, P1792, DOI 10.1152/jn.01104.2005
   Ishimoto T, 2011, J MATER SCI-MATER M, V22, P969, DOI 10.1007/s10856-011-4266-y
   Jadhav SP, 2010, CURR OPIN NEUROBIOL, V20, P313, DOI 10.1016/j.conb.2010.02.014
   Kania M, 2009, ACTA BIOENG BIOMECH, V11, P53
   Nayar VT, 2011, MAT SCI ENG C-MATER, V31, P796, DOI 10.1016/j.msec.2011.02.001
   Neimark MA, 2003, J NEUROSCI, V23, P6499
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Quist BW, 2011, J BIOMECH, V44, P2775, DOI 10.1016/j.jbiomech.2011.08.027
   Sehadri I.P., 2008, ACTA MAT, V56, P774
   Solomon JH, 2006, NATURE, V443, P525, DOI 10.1038/443525a
   Solomon JH, 2011, PHILOS T R SOC B, V366, P3049, DOI 10.1098/rstb.2011.0166
   Song F, 2007, MAT SCI ENG A-STRUCT, V457, P254, DOI 10.1016/j.msea.2007.01.136
   Staudacher EM, 2005, ADV INSECT PHYSIOL, V32, P49, DOI 10.1016/S0065-2806(05)32002-9
   Tsui TY, 1999, J MATER RES, V14, P292, DOI 10.1557/JMR.1999.0042
   VanLandingham MR, 2001, MACROMOL SYMP, V167, P15, DOI 10.1002/1521-3900(200103)167:1<15::AID-MASY15>3.0.CO;2-T
   Voges D., 2010, SENSORS, V4718, P1
   Wu ZH, 2011, J BIOMECH, V44, P1066, DOI 10.1016/j.jbiomech.2011.01.039
   Ziskind D, 2011, J STRUCT BIOL, V174, P23, DOI 10.1016/j.jsb.2010.09.010
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 32
TC 5
Z9 5
U1 0
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-5408
EI 1873-4227
J9 MATER RES BULL
JI Mater. Res. Bull.
PD DEC
PY 2013
VL 48
IS 12
SI SI
BP 5026
EP 5032
DI 10.1016/j.materresbull.2013.04.070
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 259XN
UT WOS:000327559700013
DA 2018-10-20
ER

PT J
AU Kuzmenko, V
   Samfors, S
   Hagg, D
   Gatenholm, P
AF Kuzmenko, Volodymyr
   Samfors, Sanna
   Hagg, Daniel
   Gatenholm, Paul
TI Universal method for protein bioconjugation with nanocellulose scaffolds
   for increased cell adhesion
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Nanocellulose; Protein bioconjugation; Cell adhesion; Cell morphology
ID POLYSACCHARIDE CONJUGATE VACCINES; BACTERIAL CELLULOSE;
   1-CYANO-4-DIMETHYLAMINOPYRIDINIUM TETRAFLUOROBORATE; SOLUBLE
   POLYSACCHARIDES; IMMUNOLOGICAL REAGENTS; MECHANICAL-PROPERTIES;
   EXTRACELLULAR-MATRIX; ACETOBACTER-XYLINUM; POTENTIAL SCAFFOLD;
   ACTIVATION
AB Bacterial nanocellulose (BNC) is an emerging biomaterial since it is biocompatible, integrates well with host tissue and can be biosynthesized in desired architecture. However, being a hydrogel, it exhibits low affinity for cell attachment, which is crucial for the cellular fate process. To increase cell attachment, the surface of BNC scaffolds was modified with two proteins, fibronectin and collagen type I, using an effective bioconjugation method applying 1-cyano-4-dimethylaminopyridinium (CDAP) tetrafluoroborate as the intermediate catalytic agent. The effect of CDAP treatment on cell adhesion to the BNC surface is shown for human umbilical vein endothelial cells and the mouse mesenchymal stem cell line C3H10T1/2. In both cases, the surface modification increased the number of cells attached to the surfaces. In addition, the morphology of the cells indicated more healthy and viable cells. CDAP activation of bacterial nanocellulose is shown to be a convenient method to conjugate extracellular proteins to the scaffold surfaces. CDAP treatment can be performed in a short period of time in an aqueous environment under heterogeneous and mild conditions preserving the nanofibrillar network of cellulose. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Kuzmenko, Volodymyr] Chalmers, Dept Microtechnol & Nanosci, SE-41296 Gothenburg, Sweden.
   [Kuzmenko, Volodymyr; Gatenholm, Paul] Chalmers, Wallenberg Wood Sci Ctr, SE-41296 Gothenburg, Sweden.
   [Samfors, Sanna; Hagg, Daniel; Gatenholm, Paul] Chalmers, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
RP Gatenholm, P (reprint author), Chalmers, Dept Chem & Biol Engn, Kemivagen 4, SE-41296 Gothenburg, Sweden.
EM kuzmenko@chalmers.se; samfors@student.chalmers.se;
   daniel.hagg@chalmers.se; paul.gatenholm@chalmers.se
OI Kuzmenko, Volodymyr/0000-0002-9510-2477
FU Knut and Alice Wallenberg Foundation
FX The Wallenberg Wood Science Center funded by Knut and Alice Wallenberg
   Foundation is greatly acknowledged for their financial support. We also
   thank Dr. Ergang Wang, Anders Martensson, Anne Wendel, and Johan
   Sundberg for their experimental assistance, as well as Janet Vesterlund
   for proofreading the English version of the manuscript.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Andrade FK, 2010, J BIOMED MATER RES A, V92A, P9, DOI 10.1002/jbm.a.32284
   Andrade FK, 2010, ACTA BIOMATER, V6, P4034, DOI 10.1016/j.actbio.2010.04.023
   Auer S, 2010, J NEUROSCI METH, V186, P72, DOI 10.1016/j.jneumeth.2009.11.002
   AXEN R, 1967, NATURE, V214, P1302, DOI 10.1038/2141302a0
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   BARKER SA, 1971, CARBOHYD RES, V17, P471, DOI 10.1016/S0008-6215(00)82559-8
   Beamson G., 1992, HIGH RESOLUTION XPS
   BEHRENS MM, 1967, ARCH BIOCHEM BIOPHYS, V119, P411, DOI 10.1016/0003-9861(67)90472-9
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   Dudash LA, 2012, J BIOMED MATER RES A, V100A, P2204, DOI 10.1002/jbm.a.34119
   Fink H, 2011, J TISSUE ENG REGEN M, V5, P454, DOI 10.1002/term.334
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Galtayries A, 2006, SURF INTERFACE ANAL, V38, P186, DOI 10.1002/sia.2295
   Gatenholm P, 2010, MRS BULL, V35, P208, DOI 10.1557/mrs2010.653
   Gelin K, 2007, POLYMER, V48, P7623, DOI 10.1016/j.polymer.2007.10.039
   Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4
   Haller R., 1932, U. S. Patent, Patent No. 1886480
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Jeschke B, 2002, BIOMATERIALS, V23, P3455, DOI 10.1016/S0142-9612(02)00052-2
   Khidoyatov A.A., 1969, POLYM SCI USSR, V11, P2123
   Kim J, 2012, TISSUE ENG PART C-ME, V18, P913, DOI [10.1089/ten.tec.2011.0731, 10.1089/ten.TEC.2011.0731]
   Kim UJ, 2000, CELLULOSE, V7, P287, DOI 10.1023/A:1009252124465
   KLEINMAN HK, 1987, ANAL BIOCHEM, V166, P1, DOI 10.1016/0003-2697(87)90538-0
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D., 1998, COMPREHENSIVE CELLUL, V1, DOI DOI 10.1002/3527601929
   KOHN J, 1984, APPL BIOCHEM BIOTECH, V9, P285, DOI 10.1007/BF02798493
   KOHN J, 1983, FEBS LETT, V154, P209, DOI 10.1016/0014-5793(83)80905-3
   LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J
   Lees A, 1996, VACCINE, V14, P190, DOI 10.1016/0264-410X(95)00195-7
   Li HM, 2011, POLYM CHEM-UK, V2, P323, DOI 10.1039/c0py00178c
   Lopez-Perez PM, 2010, J MATER CHEM, V20, P483, DOI 10.1039/b911854c
   Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   Mckelvey J. B., 1959, TEXT RES J, V29, P918, DOI DOI 10.1177/004051755902901111
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   Orelma H, 2012, BIOMACROMOLECULES, V13, P2802, DOI 10.1021/bm300781k
   Paul R, 1960, J AM CHEM SOC, V82, P4596, DOI 10.1021/ja01502a038
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Prichard HL, 2007, BIOMATERIALS, V28, P936, DOI 10.1016/j.biomaterials.2006.09.012
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   Shafer DE, 2000, VACCINE, V18, P1273, DOI 10.1016/S0264-410X(99)00370-9
   SHARON N, 1969, SCI AM, V220, P92, DOI 10.1038/scientificamerican0569-92
   Stollner D, 2002, ANAL BIOCHEM, V304, P157, DOI 10.1006/abio.2001.5603
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Vanea E, 2011, APPL SURF SCI, V257, P2346, DOI 10.1016/j.apsusc.2010.09.101
   Verma SK, 2012, TETRAHEDRON LETT, V53, P2373, DOI 10.1016/j.tetlet.2012.01.125
   WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
NR 53
TC 17
Z9 17
U1 2
U2 86
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2013
VL 33
IS 8
BP 4599
EP 4607
DI 10.1016/j.msec.2013.07.031
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 261TG
UT WOS:000327686900017
PM 24094166
DA 2018-10-20
ER

PT J
AU Berti, FV
   Rambo, CR
   Dias, PF
   Porto, LM
AF Berti, Fernanda V.
   Rambo, Carlos R.
   Dias, Paulo F.
   Porto, Luismar M.
TI Nanofiber density determines endothelial cell behavior on hydrogel
   matrix
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bacterial cellulose tissue engineering construct (BCTEC); Scaffold
   microarchitecture; HUVEC; Secondary necrosis
ID SMOOTH-MUSCLE-CELLS; BACTERIAL CELLULOSE; IN-VITRO; ADHESION; DEATH;
   NANOTOPOGRAPHY; PROLIFERATION; MORPHOLOGY; SCAFFOLDS; NECROSIS
AB When cultured under static conditions, bacterial cellulose pellicles, by the nature of the polymer synthesis that involves molecular oxygen, are characterized by two distinct surface sides. The upper surface is denser in fibers (entangled) than the lower surface that shows greater surface porosity. Human umbilical vein endothelial cells (HUVECs) were used to exploit how the microarchitecture (i.e., surface porosity, fiber network structure, surface topology, and fiber density) of bacterial cellulose pellicle surfaces influence cell-biomaterial interaction and therefore cell behavior. Adhesion, cell ingrowth, proliferation, viability and cell death mechanisms were evaluated on the two pellicle surface sides. Cell behavior, including secondary necrosis, is influenced only by the microarchitecture of the surface, since the biomaterial is extremely pure (constituted of cellulose and water only). Cell-cellulose fiber interaction is the determinant signal in the cell-biomaterial responses, isolated from other frequently present interferences such as protein and other chemical traces usually present in cell culture matrices. Our results suggest that microarchitecture of hydrogel materials might determine the performance of biomedical products, such as bacterial cellulose tissue engineering constructs (BCTECs). (C) 2013 Elsevier B.V. All rights reserved.
C1 [Berti, Fernanda V.; Porto, Luismar M.] Univ Fed Santa Catarina, Dept Chem & Food Engn, BR-88040900 Florianopolis, SC, Brazil.
   [Rambo, Carlos R.] Univ Fed Santa Catarina, Dept Elect Engn, BR-88040900 Florianopolis, SC, Brazil.
   [Dias, Paulo F.] Univ Fed Santa Catarina, Dept Cell Biol Embryol & Genet, BR-88040900 Florianopolis, SC, Brazil.
RP Berti, FV (reprint author), Univ Fed Santa Catarina, Dept Chem & Food Engn, BR-88040900 Florianopolis, SC, Brazil.
EM fernanda@intelab.ufsc.br
RI Berti, Fernanda/O-8760-2016; Rambo, Carlos/D-3878-2014
OI Berti, Fernanda/0000-0003-2185-3822; 
FU Brazilian National Council for Scientific and Technological Development
   (CNPq); CAPES, Brazil
FX The authors thank the Brazilian National Council for Scientific and
   Technological Development (CNPq) and CAPES, Brazil, for the financial
   support. The authors also thank central analytical laboratory units at
   UFSC: LCME, LAMATE, LAMEB and FLUORBEG. Laboratory support by Dr. Renata
   Aparecida Nedel Pertile, Dr. Beatriz Veleirinho, Dr. Daliana Muller,
   Jose da Silva Jr., and Natalia Piccoli is greatly appreciated.
CR Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   Andrade FK, 2010, ACTA BIOMATER, V6, P4034, DOI 10.1016/j.actbio.2010.04.023
   Andukuri A, 2010, NANOMED-NANOTECHNOL, V6, P289, DOI 10.1016/j.nano.2009.09.004
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445
   Berghe TV, 2010, CELL DEATH DIFFER, V17, P922, DOI DOI 10.1038/CDD.2009.184
   BORZANI W, 1995, BIOTECHNOL LETT, V17, P1271, DOI 10.1007/BF00128400
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   Cao Y, 2004, J BIOMED MATER RES A, V71A, P81, DOI 10.1002/jbm.a.30126
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105
   Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001
   Indolfi L, 2012, BIOMATERIALS, V33, P7019, DOI 10.1016/j.biomaterials.2012.06.052
   Jeong SI, 2010, MOL CELL TOXICOL, V6, P373, DOI 10.1007/s13273-010-0049-7
   Khetani SR, 2006, CURR OPIN BIOTECH, V17, P524, DOI 10.1016/j.copbio.2006.08.009
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D, 2006, ADV POLYM SCI, V205, P49, DOI 10.1007/12_097
   Lawrence BD, 2012, ACTA BIOMATER, V8, P3732, DOI 10.1016/j.actbio.2012.06.009
   Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Lutolf MP, 2009, NAT MATER, V8, P451, DOI 10.1038/nmat2458
   Methe H, 2008, SEMIN IMMUNOL, V20, P117, DOI 10.1016/j.smim.2007.12.005
   Norman JJ, 2008, TISSUE ENG PT A, V14, P379, DOI 10.1089/tea.2007.0077
   Pertile RAN, 2012, J BIOMAT SCI-POLYM E, V23, P1339, DOI 10.1163/092050611X581516
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Prasad CK, 2008, ACTA BIOMATER, V4, P182, DOI 10.1016/j.actbio.2007.05.012
   Rambo CR, 2008, MAT SCI ENG C-BIO S, V28, P549, DOI 10.1016/j.msec.2007.11.011
   Rani VVD, 2012, ACTA BIOMATER, V8, P1976, DOI 10.1016/j.actbio.2012.01.021
   Recouvreux DOS, 2011, MAT SCI ENG C-MATER, V31, P151, DOI 10.1016/j.msec.2010.08.004
   Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046
   STUPACK DG, 2002, SCI STKE, V119, pPE7
   Tajima S, 2008, J BIOMED MATER RES A, V84A, P828, DOI 10.1002/jbm.a.31539
   Tsai SH, 2007, BIOCHEM BIOPH RES CO, V357, P984, DOI 10.1016/j.bbrc.2007.04.047
   Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021
   Wyllie A H, 1980, Int Rev Cytol, V68, P251
   Xia Y, 2011, J MATER SCI-MATER M, V22, P389, DOI 10.1007/s10856-010-4211-5
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 39
TC 13
Z9 13
U1 3
U2 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2013
VL 33
IS 8
BP 4684
EP 4691
DI 10.1016/j.msec.2013.07.029
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 261TG
UT WOS:000327686900027
PM 24094176
DA 2018-10-20
ER

PT J
AU Zhuang, Y
   Wu, XQ
   Cao, ZJ
   Zhao, XX
   Zhou, MH
   Gao, P
AF Zhuang, Yuan
   Wu, Xiaoqian
   Cao, Zhangjun
   Zhao, Xiaoxiang
   Zhou, Meihua
   Gao, Pin
TI Preparation and characterization of sponge film made from feathers
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Feather; Waste treatment; Sponge film; Reduction reaction; Biomaterial
ID AQUEOUS-SOLUTIONS; CHICKEN FEATHERS; IONIC LIQUID; HEN FEATHERS;
   ADSORPTION; REMOVAL; KERATIN; CR(VI); WASTE; EQUILIBRIUM
AB Feather wastes generated from poultry farms will pose a problem for disposal, but they are sustainable resources of keratin. Reduction is one of the commonly used methods to obtain soluble keratin from feather. However, the residues generated during feather reduction reaction were rarely investigated. In this study, the residues were transformed into a porous and flexible sponge film by freeze-drying without pretreatment or addition of cross-linking agents. Glycerol was used to alter the physical and chemical characteristics of the sponge film. The film was characterized with a fiber strong stretch instrument, a Fourier transform infrared spectrophotometer, scanning electron microscopy, an elemental analyzer, a differential scanning calorimeter and an automatic air permeability apparatus. Tensile strength and melting point of the sponge film with the optimum glycerol content were 6.2 MPa and 170 degrees C respectively. Due to air permeability of 368 mm/s, the film can potentially be used in medicine, biology, textile, environmental technology, and so on. It is ecologically friendly and will produce additional benefits from the renewable materials. The film was utilized as adsorbents to remove Cr(VI) from aqueous solutions and as a filtering material for air pollution. Its maximum Cr(VI) uptake capacity was about 148.8 mg/g and the removal rate of PM10 was 983%. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Zhuang, Yuan; Wu, Xiaoqian; Zhao, Xiaoxiang; Zhou, Meihua; Gao, Pin] Donghua Univ, Coll Environm Sci & Engn, Shanghai 201620, Peoples R China.
   [Cao, Zhangjun] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
RP Zhao, XX (reprint author), 2999 North Renmin Rd, Shanghai 201620, Peoples R China.
EM gaopin@mail.dhu.edu.cn
FU Ph.D. Programs Foundation of Ministry of Education of China
   [20090075110007]; National Natural Science Foundation of China
   [31000989, 51208086]; Shanghai Pujiang Program [13PJ1400100]
FX This work was partially sponsored by the Ph.D. Programs Foundation of
   Ministry of Education of China (20090075110007), the National Natural
   Science Foundation of China (31000989, 51208086) and the Shanghai
   Pujiang Program (13PJ1400100).
CR Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Aluigi A, 2011, EUR POLYM J, V47, P1756, DOI 10.1016/j.eurpolymj.2011.06.009
   Baral SS, 2008, CHEM ENG J, V139, P245, DOI 10.1016/j.cej.2007.07.090
   Chen SH, 2010, J COLLOID INTERF SCI, V349, P256, DOI 10.1016/j.jcis.2010.05.057
   DOSHI J, 2001, NONWOVENS WORLD, V10, P64
   ECKERT JM, 1991, ANAL CHIM ACTA, V255, P31, DOI 10.1016/0003-2670(91)85083-5
   Gupta VK, 2006, J COLLOID INTERF SCI, V304, P52, DOI 10.1016/j.jcis.2006.08.032
   Jeong JH, 2010, PROCESS BIOCHEM, V45, P1738, DOI 10.1016/j.procbio.2010.07.020
   Justin R.B., 2007, POLYM DEGRAD STABIL, V92, P859
   Kobya M, 2004, BIORESOURCE TECHNOL, V91, P317, DOI 10.1016/j.biortech.2003.07.001
   Lim LT, 1999, J FOOD SCI, V64, P616, DOI 10.1111/j.1365-2621.1999.tb15096.x
   Martelli SM, 2006, J POLYM ENVIRON, V14, P215, DOI 10.1007/s10924-006-0017-4
   Mittal A, 2006, J HAZARD MATER, V133, P196, DOI 10.1016/j.jhazmat.2005.10.017
   Oliveira DQL, 2008, J HAZARD MATER, V151, P280, DOI 10.1016/j.jhazmat.2007.11.001
   Parkinson G, 1998, CHEM ENG, V105, P21
   Peter M.M.S., 2001, J COLLOID INTERF SCI, V240, P30
   Reddy N, 2011, MAT SCI ENG C-MATER, V31, P1706, DOI 10.1016/j.msec.2011.07.022
   Saucedo-Rivalcoba V., 2010, APPL PHYS A, V104, P219
   Schrooyen PMM, 2000, J AGR FOOD CHEM, V48, P4326, DOI 10.1021/jf9913155
   Sun P, 2009, J HAZARD MATER, V170, P786, DOI 10.1016/j.jhazmat.2009.05.034
   Tsaia P.P., 2002, J ELECTROSTAT, V54, P411
   Wang X., 2011, POLYM MAT SCI ENG, V8, P137
   Wang YX, 2012, PROCESS BIOCHEM, V47, P896, DOI 10.1016/j.procbio.2012.02.013
   Wen Y, 2011, CHEM ENG J, V175, P110, DOI 10.1016/j.cej.2011.09.066
   Wojciechowskaa E., 1999, J MOL STRUCT, V511-512, P307
   Zhang YW, 2012, CARBOHYD POLYM, V88, P931, DOI 10.1016/j.carbpol.2012.01.040
NR 26
TC 6
Z9 6
U1 0
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2013
VL 33
IS 8
BP 4732
EP 4738
DI 10.1016/j.msec.2013.07.032
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 261TG
UT WOS:000327686900032
PM 24094181
DA 2018-10-20
ER

PT J
AU Yavari, SA
   Wauthle, R
   van der Stok, J
   Riemslag, AC
   Janssen, M
   Mulier, M
   Kruth, JP
   Schrooten, J
   Weinans, H
   Zadpoor, AA
AF Yavari, S. Amin
   Wauthle, R.
   van der Stok, J.
   Riemslag, A. C.
   Janssen, M.
   Mulier, M.
   Kruth, J. P.
   Schrooten, J.
   Weinans, H.
   Zadpoor, A. A.
TI Fatigue behavior of porous biomaterials manufactured using selective
   laser melting
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Titanium foam; Fatigue; Porous materials; Selective laser melting;
   Additive manufacturing
ID COATED TI-6AL-4V ALLOY; TOTAL HIP-ARTHROPLASTY; TAILOR-MADE BLANKS;
   MECHANICAL-PROPERTIES; COMPRESSION FATIGUE; METAL PLASTICITY;
   BONE-RESORPTION; TITANIUM-ALLOYS; IMPLANTS; STRESS
AB Porous titanium alloys are considered promising bone-mimicking biomaterials. Additive manufacturing techniques such as selective laser melting allow for manufacturing of porous titanium structures with a precise design of micro-architecture. The mechanical properties of selective laser melted porous titanium alloys with different designs of micro-architecture have been already studied and are shown to be in the range of mechanical properties of bone. However, the fatigue behavior of this biomaterial is not yet well understood. We studied the fatigue behavior of porous structures made of Ti6Al4V ELI powder using selective laser melting. Four different porous structures were manufactured with porosities between 68 and 84% and the fatigue S-N curves of these four porous structures were determined. The three-stage mechanism of fatigue failure of these porous structures is described and studied in detail. It was found that the absolute S-N curves of these four porous structures are very different. In general, given the same absolute stress level, the fatigue life is much shorter for more porous structures. However, the normalized fatigue S-N curves of these four structures were found to be very similar. A power law was fitted to all data points of the normalized S-N curves. It is shown that the measured data points conform to the fitted power law very well, R-2 = 0.94. This power law may therefore help in estimating the fatigue life of porous structures for which no fatigue test data is available. It is also observed that the normalized endurance limit of all tested porous structures (<0.2) is lower than that of corresponding solid material (c.a. 0.4). (C) 2013 Elsevier B.V. All rights reserved.
C1 [Yavari, S. Amin; Riemslag, A. C.; Janssen, M.; Weinans, H.; Zadpoor, A. A.] Delft Univ Technol TU Delft, Fac Mech Maritime & Mat Engn, NL-2628 CD Delft, Netherlands.
   [Yavari, S. Amin] FT Innovat BV, NL-5831 PW Boxmeer, Netherlands.
   [Wauthle, R.; Kruth, J. P.] Katholieke Univ Leuven, Dept Mech Engn, Div Prod Engn Machine Design & Automat PMA, B-3001 Louvain, Belgium.
   [Wauthle, R.] LayerWise NV, B-3001 Heverlee, Belgium.
   [van der Stok, J.; Weinans, H.] Erasmus Univ, Med Ctr, Dept Orthopaed, Orthopaed Res Lab, Rotterdam, Netherlands.
   [Mulier, M.] Katholieke Univ Leuven, Dept Dev & Regenerat, Div Biomech Implants & Tissue Engn, B-3212 Pellenberg, Belgium.
   [Schrooten, J.] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
   [Weinans, H.] UMC Utrecht, Dept Orthoped, NL-3584 CX Utrecht, Netherlands.
   [Weinans, H.] UMC Utrecht, Dept Rheumatol, NL-3584 CX Utrecht, Netherlands.
RP Yavari, SA (reprint author), Delft Univ Technol TU Delft, Fac Mech Maritime & Mat Engn, Mekelweg 2, NL-2628 CD Delft, Netherlands.
EM s.aminyavari@tudelft.nl
RI Amin Yavari, Saber/E-5360-2017; Amin Yavari, Saber/G-9486-2013; Zadpoor,
   Amir A/A-8510-2008
OI Amin Yavari, Saber/0000-0003-1677-5751; Amin Yavari,
   Saber/0000-0003-1677-5751; Zadpoor, Amir Abbas/0000-0003-3234-2112
FU BioMedical Materials Institute [P2.04 BONE-IP]; Dutch Ministry of
   Economic Affairs
FX This research forms part of the Project P2.04 BONE-IP of the research
   program of the BioMedical Materials Institute, co-funded by the Dutch
   Ministry of Economic Affairs.
CR Arciniegas M, 2007, J EUR CERAM SOC, V27, P3391, DOI 10.1016/j.jeurceramsoc.2007.02.184
   Bai YL, 2008, INT J PLASTICITY, V24, P1071, DOI 10.1016/j.ijplas.2007.09.004
   Bansiddhi A, 2008, ACTA BIOMATER, V4, P773, DOI 10.1016/j.actbio.2008.02.009
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Bernard S, 2011, MAT SCI ENG C-MATER, V31, P815, DOI 10.1016/j.msec.2010.12.007
   BOBYN JD, 1990, CLIN ORTHOP RELAT R, P196
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   COOK SD, 1988, J BIOMED MATER RES, V22, P287, DOI 10.1002/jbm.820220404
   COOK SD, 1984, J BIOMED MATER RES, V18, P497, DOI 10.1002/jbm.820180504
   CURREY JD, 1990, J MATER SCI-MATER M, V1, P14, DOI 10.1007/BF00705348
   Engh CA, 2003, CLIN ORTHOP RELAT R, P157, DOI 10.1097/01.blo.0000096825.67494.e3
   Heinl P, 2008, ADV ENG MATER, V10, P882, DOI 10.1002/adem.200800137
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   Hrabe NW, 2011, J BIOMED MATER RES B, V99B, P313, DOI 10.1002/jbm.b.31901
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Joshi MG, 2000, J BIOMECH, V33, P1655, DOI 10.1016/S0021-9290(00)00110-X
   Kashef S, 2011, MAT SCI ENG A-STRUCT, V528, P1602, DOI 10.1016/j.msea.2010.11.024
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Kwok PJ, 2008, ADV ENG MATER, V10, P820, DOI 10.1002/adem.200800072
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010
   Niu WJ, 2009, MAT SCI ENG A-STRUCT, V506, P148, DOI 10.1016/j.msea.2008.11.022
   Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006
   Pyka G, 2012, ADV ENG MATER, V14, P363, DOI 10.1002/adem.201100344
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rudinger K., 1985, TITANIUM 84 SCI TECH, V4, P2123
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Ryan G, 2009, J BIOMED MATER RES B, V90B, P894, DOI 10.1002/jbm.b.31361
   Sugimura Y, 1999, MAT SCI ENG A-STRUCT, V269, P38, DOI 10.1016/S0921-5093(99)00147-1
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Thijs L, 2010, ACTA MATER, V58, P3303, DOI 10.1016/j.actamat.2010.02.004
   Van Bael S, 2012, ACTA BIOMATER, V8, P2824, DOI 10.1016/j.actbio.2012.04.001
   Van Bael S, 2011, MAT SCI ENG A-STRUCT, V528, P7423, DOI 10.1016/j.msea.2011.06.045
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Vendra L, 2009, MAT SCI ENG A-STRUCT, V517, P146, DOI 10.1016/j.msea.2009.03.075
   Weinberg K, 2006, COMPUT MECH, V37, P142, DOI 10.1007/s00466-005-0685-2
   YUE S, 1984, J BIOMED MATER RES, V18, P1043, DOI 10.1002/jbm.820180908
   Zadpoor AA, 2008, J MATER PROCESS TECH, V200, P288, DOI 10.1016/j.jmatprotec.2007,09.049
   Zadpoor AA, 2010, METALL MATER TRANS A, V41A, P3365, DOI 10.1007/s11661-010-0403-3
   Zadpoor AA, 2010, MATER DESIGN, V31, P4611, DOI 10.1016/j.matdes.2010.05.041
   Zadpoor AA, 2009, INT J PLASTICITY, V25, P2269, DOI 10.1016/j.ijplas.2009.02.005
   Zadpoor AA, 2009, INT J ADHES ADHES, V29, P558, DOI 10.1016/j.ijadhadh.2009.01.003
NR 45
TC 105
Z9 105
U1 7
U2 149
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2013
VL 33
IS 8
BP 4849
EP 4858
DI 10.1016/j.msec.2013.08.006
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA 261TG
UT WOS:000327686900047
PM 24094196
DA 2018-10-20
ER

PT J
AU Teong, B
   Chang, SJ
   Chuang, CW
   Kuo, SM
   Manousakas, I
AF Teong, Benjamin
   Chang, Shwu Jen
   Chuang, Chin Wen
   Kuo, Shyh Ming
   Manousakas, Ioannis
TI The production of volvox spheres and their potential application in
   multi-drugs encapsulation and release
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Volvox sphere; Microsphere; Alginate; Drug delivery system; High-voltage
   electrostatic field
ID CHITOSAN MICROSPHERES; ALBUMIN MICROSPHERES; DELIVERY; SYSTEM; CELL;
   ALGINATE
AB Volvox sphere is a bio-mimicking concept of an innovative biomaterial structure of a sphere that contains smaller microspheres which then encapsulate chemicals, drugs and/or cells. The volvox spheres were produced via a high-voltage electrostatic field system, using alginate as the primary material. Encapsulated materials tested in this study include staining dyes, nuclear fast red and trypan blue, and model drugs, bovine serum albumin (BSA) and cytochrome c (CytC). The external morphology of the volvox spheres was observed via electron microscopy whereas the internal structure of the volvox spheres was observed via an optical microscope with the aid of the staining dyes, since alginate is colorless and transparent. The diameter of the microspheres was about 200 to 300 mu m, whereas the diameter of the volvox spheres was about 1500 mu m. Volvox spheres were durable, retaining about 95% of their mass after 4 weeks. Factors affecting entrapment efficiency, such as temperature and concentration of the bivalent cross-linker, were compared followed by a 7-day in vitro release study. The encapsulation efficiency of CytC within the microspheres was higher at cold (similar to 4 degrees C) and warm (similar to 50 degrees C) temperatures whereas temperature has no obvious effect on the BSA encapsulation. High crosslinking concentration (25% w/v) of calcium chloride has resulted higher entrapment efficiency for BSA but not for CytC. Furthermore, volvox spheres showed a different release pattern of BSA and CytC when compared to microspheres encapsulating BSA and CytC Despite the fact that the mechanisms behind remain unclear and further investigation is required, this study demonstrates the potential of the volvox spheres for drug delivery. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Teong, Benjamin; Chang, Shwu Jen; Kuo, Shyh Ming; Manousakas, Ioannis] I Shou Univ, Coll Med, Dept Biomed Engn, Kaohsiung 82445, Taiwan.
   [Chuang, Chin Wen] I Shou Univ, Dept Elect Engn, Kaohsiung 84001, Taiwan.
RP Kuo, SM (reprint author), I Shou Univ, Coll Med, Dept Biomed Engn, 8 Yida Rd, Kaohsiung 82445, Taiwan.
EM smkuo@isu.edu.tw; i.manousakas@ieee.org
FU National Science Council of the Republic of China (Taiwan)
   [NSC101-2221-E-214-007-MY3-1_001_001]
FX We would like to thank the National Science Council of the Republic of
   China (Taiwan) for financial support of this research under contract
   number NSC101-2221-E-214-007-MY3-1_001_001.
CR Cetin M., 2007, FABAD J PHARM SCI, V32, P103
   Chen RH, 2011, POLYM INT, V60, P897, DOI 10.1002/pi.3055
   Chung TS, 1997, J MEMBRANE SCI, V126, P19, DOI 10.1016/S0376-7388(96)00269-4
   Groth S. F. De St., 1963, BIOCHIM BIOPHYS ACTA, V71, P377
   GUPTA PK, 1990, INT J PHARM, V59, P57, DOI 10.1016/0378-5173(90)90064-B
   Haque A, 2011, BIOMATERIALS, V32, P2032, DOI 10.1016/j.biomaterials.2010.11.045
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   Jain RA, 2000, J MICROENCAPSUL, V17, P343
   Kuo SM, 2012, MICRO NANO LETT, V7, P1011, DOI 10.1049/mnl.2012.0397
   Kuo SM, 2004, J APPL POLYM SCI, V94, P2150, DOI 10.1002/app.21131
   Lee JH, 2012, J DRUG DELIV, V2012
   Leong W, 2013, ACTA BIOMATER, V9, P6459, DOI 10.1016/j.actbio.2012.10.047
   Li HY, 2011, BIOMATERIALS, V32, P5994, DOI 10.1016/j.biomaterials.2011.05.009
   Mi FL, 1999, J APPL POLYM SCI, V71, P747, DOI 10.1002/(SICI)1097-4628(19990131)71:5<747::AID-APP9>3.3.CO;2-Y
   Modi S., 2005, EJC SUPPL, P3
   REISNER AH, 1975, ANAL BIOCHEM, V64, P509, DOI 10.1016/0003-2697(75)90461-3
   Rilling P, 1997, J MEMBRANE SCI, V129, P283, DOI 10.1016/S0376-7388(97)00042-2
   Sanli O, 2007, EUR J PHARM BIOPHARM, V65, P204, DOI 10.1016/j.ejpb.2006.08.004
   Schmitt R, 2003, NATURE, V424, P499, DOI 10.1038/424499a
   WIDDER KJ, 1983, EUR J CANCER CLIN ON, V19, P141, DOI 10.1016/0277-5379(83)90409-1
   Xu PH, 2010, INT J BIOL MACROMOL, V47, P654, DOI 10.1016/j.ijbiomac.2010.08.012
   Yang YY, 2000, CHEM ENG SCI, V55, P2223, DOI 10.1016/S0009-2509(99)00503-5
   Zhang QC, 2012, MAT SCI ENG C-MATER, V32, P2589, DOI 10.1016/j.msec.2012.07.045
NR 23
TC 4
Z9 4
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2013
VL 33
IS 8
BP 4859
EP 4866
DI 10.1016/j.msec.2013.08.005
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 261TG
UT WOS:000327686900048
PM 24094197
DA 2018-10-20
ER

PT J
AU Lianhua, Y
   Yunchao, H
   Geng, X
   Youquang, Z
   Guangqiang, Z
   Yujie, L
AF Lianhua, Ye
   Yunchao, Huang
   Geng, Xu
   Youquang, Zhou
   Guangqiang, Zhao
   Yujie, Lei
TI Effect of Brominated Furanones on the Formation of Biofilm by
   Escherichia coli on Polyvinyl Chloride Materials
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Brominated furanone; Polyvinyl chloride; Bacterial biofilm; Escherichia
   coli
ID STAPHYLOCOCCUS-AUREUS; IMPLANT INFECTION; QUORUM; VIRULENCE; SYSTEM;
   SIGNAL
AB To study the influence of brominated furanones on the biofilm (BF) formation by Escherichia coli (E. coli) on polyvinyl chloride (PVC) material, and to provide new ways of surface modification of materials to clinically prevent biomaterial centered infection. Three brominated furanones, dissolved in ethanol, furanone-1(3,4-dibromo-5-hydroxyl-furanone), furanone-2(4-bromo-5-(4-methoxypheny)-3-(methylamino)-furanone), and furanone-3(3,4-dibromo-5,5-dimethoxypheny-2(5H)-furanone) with representative chemical structure, were coated on the surfaces of separate PVC materials (1 x 1 cm), respectively. The surface-modified PVC materials were incubated with E. coli and for controls, 75 % ethanol-treated PVC materials were used. This treatment played as control group. The cultivation incubations were for 6, 12, 18, and 24 h. The thickness of bacterial BF and bacterial community quantity unit area on the PVC materials was determined by confocal laser scanning microscopy (CLSM), and the surface structure of bacterial BF formation was examined by scanning electron microscopy (SEM). The results of CLSM indicated the thickness of bacterial BF and bacterial community quantity unit area on PVC materials treated with furanone-3 were significantly lower than that of control at all time points (P < 0.05), whereas, the differences between furanone-1 and furanone-2 groups and control group were not significantly different (P > 0.05). The results of SEM indicated that after 6 h incubation, the quantity of bacterial attachment to the surface of PVC material treated with furanone-3 was lower than the control group. By 18 h incubation there was completely formed BF structure on the surface of control PVC material. However, there was no significant BF formation on the surface of PVC material treated with furanone-3. The impact of different brominated furanones on SA biofilm formation on the surface of PVC materials are different, furanone-3 can inhibit E. coli biofilm formation on the surface of PVC material.
C1 [Lianhua, Ye; Yunchao, Huang; Guangqiang, Zhao; Yujie, Lei] Kunming Med Univ, Yunnan Prov Tumor Hosp, Affiliated Hosp 3, Yunnan Inst Oncol,Lung Canc Res Ctr,Cardiothorac, Kunming 650118, Yunnan, Peoples R China.
   [Geng, Xu] Shangdong Heze Hosp, Cardiothorac Surg Sect, Heze 274031, Shangdong, Peoples R China.
   [Youquang, Zhou] Kunming Med Univ, Affiliated Hosp 3, Clin Bacteriol Lab, Kunming 650118, Yunnan, Peoples R China.
RP Lianhua, Y (reprint author), Kunming Med Univ, Yunnan Prov Tumor Hosp, Affiliated Hosp 3, Yunnan Inst Oncol,Lung Canc Res Ctr,Cardiothorac, Kunming 650118, Yunnan, Peoples R China.
EM Lhye1204@yahoo.com.cn; huangych2001@yahoo.com.cn
FU Chinese National Natural Science Foundation [30872555, 81000672,
   81260228]; Yunnan Province Innovation Key Project [2007C009Z]; Yunnan
   Natural Science Foundation [2008ZC139M, 2009CD184]; Yunnan Provincia
   High-level personnel training fund [2012HB032, D-201222]
FX This study is sponsored by Chinese National Natural Science Foundation
   (30872555, 81000672, 81260228); Yunnan Province Innovation Key Project
   (2007C009Z); Yunnan Natural Science Foundation (2008ZC139M, 2009CD184);
   Yunnan Provincia High-level personnel training fund (No. 2012HB032,
   D-201222).
CR Arciola CR, 2010, INT J ARTIF ORGANS, V33, P565
   Benedetti P, 2008, J MED MICROBIOL, V57, P904, DOI 10.1099/jmm.0.2008/000356-0
   Boyen F, 2009, VET MICROBIOL, V135, P187, DOI 10.1016/j.vetmic.2008.12.025
   Chen GZ, 2011, MOL CELL, V42, P199, DOI 10.1016/j.molcel.2011.04.003
   Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a
   Faggion CM, 2010, CLIN ORAL IMPLAN RES, V21, P137, DOI 10.1111/j.1600-0501.2009.01753.x
   Han Y, 2008, BIOORG MED CHEM LETT, V18, P1006, DOI 10.1016/j.bmcl.2007.12.032
   John AK, 2011, ANTIMICROB AGENTS CH, V55, P3510, DOI 10.1128/AAC.00172-11
   Kavanaugh JS, 2007, MOL MICROBIOL, V65, P780, DOI 10.1111/j.1365-2958.2007.05830.x
   Lianhua Y., 2009, CHINESE J MICROBIOLO, V7, P75
   Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165
   Quave CL, 2011, PLANTA MED, V77, P188, DOI 10.1055/s-0030-1250145
   Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005
   Teasdale ME, 2011, MAR BIOTECHNOL, V13, P722, DOI 10.1007/s10126-010-9334-7
   Yang S, 2006, P NATL ACAD SCI USA, V103, P2386, DOI 10.1073/pnas.0502890102
   Zhao GQ, 2011, CELL BIOCHEM BIOPHYS, V61, P371, DOI 10.1007/s12013-011-9220-6
   Zhao LP, 2010, INFECT IMMUN, V78, P3506, DOI 10.1128/IAI.00131-10
NR 17
TC 1
Z9 1
U1 0
U2 9
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PD DEC
PY 2013
VL 67
IS 3
BP 893
EP 897
DI 10.1007/s12013-013-9578-8
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 258JL
UT WOS:000327455400008
PM 23549735
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Yujie, L
   Geng, X
   Huang, YC
   Li, Y
   Yang, KY
   Ye, LH
   Chen, XB
   Zhao, GQ
   Yin, C
AF Yujie, Lei
   Geng, Xu
   Huang, Yun-chao
   Li, Yang
   Yang, Kaiyun
   Ye, Lianhua
   Chen, Xiaobo
   Zhao, Guangqiang
   Yin, Chen
TI The Effect of Brominated Furanones on The Formation of Staphylococcus
   aureus Biofilm on PVC
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Brominated furanone; PVC; Bacterial biofilm; Staphylococcus aureus
ID QUORUM; COMMUNICATION; INFECTION; BACTERIA
AB To study the influence of brominated furanones on the formation of Staphylococcus aureus (SA) biofilm on PVC thus providing new avenues of research on the surface modification of materials and clinical treatment of biomaterial-centered infection. Three brominated furanones (furanone-1, furanone-2, and furanone-3) were coated on the surface of PVC material. Both the modified PVC materials and SA were co-cultivated together. To assess the thickness of bacterial biofilm and bacterium colony unit area on PVC materials, confocal laser scanning microscopy and scanning electron microscopy (SEM) were used to observe the surface structure of SA biofilm formation. All treatments were compared with the control group which was not coated with furanones. PVC materials coated with furanone-1 had an increase in bacterial biofilm as well as SA colony area when compared with control. However, there was no significant difference between treating with furanone-1 and furanone-3 (P > 0.05). The impact of different brominated furanones on SA biofilm formation on the surface of PVC materials is different, furanone-1 can promote the SA biofilm formation on the surface of PVC material.
C1 [Yujie, Lei; Geng, Xu; Huang, Yun-chao; Yang, Kaiyun; Ye, Lianhua; Chen, Xiaobo; Zhao, Guangqiang; Yin, Chen] Kunming Med Univ, Yunnan Prov Canc Hosp, Lung Canc Res Ctr,Yunnan Inst Oncol, Cardiothorac Surg Sect, Kunming 650118, Yunnan, Peoples R China.
   [Geng, Xu] Shangdong Heze Hosp, Cardiothorac Surg Sect, Heze 274031, Shangdong, Peoples R China.
   [Li, Yang] Kunming Med Coll, Affiliated Hosp 3, Clin Bacteriol Lab, Kunming 650118, Yunnan, Peoples R China.
RP Huang, YC (reprint author), Kunming Med Univ, Yunnan Prov Canc Hosp, Lung Canc Res Ctr,Yunnan Inst Oncol, Cardiothorac Surg Sect, 519 Kun Zhou Rd, Kunming 650118, Yunnan, Peoples R China.
EM 583271025@qq.com
FU Chinese National Natural Science Foundation [81260228/H1820, 30872555];
   Yunnan Natural Science Foundation [2011FB205, 2011WS0063, 2009ZC116M,
   2011C146]
FX This study is sponsored by Chinese National Natural Science Foundation
   (Nos. 81260228/H1820); Yunnan Natural Science Foundation (Nos.
   2011FB205; 2011WS0063), and Chinese National Natural Science Foundation
   (30872555); Yunnan Natural Science Foundation (2009ZC116M, 2011C146).
CR Benedetti P, 2008, J MED MICROBIOL, V57, P904, DOI 10.1099/jmm.0.2008/000356-0
   Boyen F, 2009, VET MICROBIOL, V135, P187, DOI 10.1016/j.vetmic.2008.12.025
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   FUQUA WC, 1994, J BACTERIOL, V176, P269
   Gondela E, 2010, EUR J MED CHEM, V45, P3993, DOI 10.1016/j.ejmech.2010.05.055
   Gospodarek E, 2009, POL J MICROBIOL, V58, P191
   Li L, 2010, MOL ORAL MICROBIOL, V25, P384, DOI 10.1111/j.2041-1014.2010.00586.x
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Pei DH, 2004, CURR OPIN CHEM BIOL, V8, P492, DOI 10.1016/j.cbpa.2004.08.003
   Plummer P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015876
   Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36
   Wang WZ, 2008, ACTA BIOCH BIOPH SIN, V40, P1023, DOI 10.1111/j.1745-7270.2008.00490.x
   Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x
   Xu Geng H. Y., 2008, BIOMEDICAL ENG CLIN, V12, P81
   Yang S, 2006, P NATL ACAD SCI USA, V103, P2386, DOI 10.1073/pnas.0502890102
   Ye Lianhua H. Y., 2009, CHINESE J MICROBIOLO, V7, P75
   Ye Lianhua H. Y., 2007, BIOMEDICAL ENG CLIN, V2007, P251
NR 17
TC 7
Z9 8
U1 2
U2 17
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PD DEC
PY 2013
VL 67
IS 3
BP 1501
EP 1505
DI 10.1007/s12013-013-9652-2
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 258JL
UT WOS:000327455400078
PM 23979982
DA 2018-10-20
ER

PT J
AU Li, MH
   Zhang, ZY
AF Li, MengHui
   Zhang, ZhenYu
TI Laparoscopically assisted biomaterial graft for reconstruction in
   congenital atresia of vagina and cervix
SO FERTILITY AND STERILITY
LA English
DT Article
DE Cervical atresia; vagina agenesis; biomaterial graft; uterovaginal
   anastomosis; laparoscopy
ID KUSTER-HAUSER SYNDROME; UTERINE CERVIX; UTEROVAGINAL ANASTOMOSIS;
   SURGERY; APLASIA
AB Objective: To report successful treatment by laparoscopically assisted biomaterial graft for reconstruction in patients with congenital atresia of the uterine cervix and vagina.
   Design: Technique and instrumentations.
   Setting: University-based tertiary care hospital.
   Patient(s): An 18-year-old woman with vaginal agenesis and cervical dysgenesis and a 13-year-old woman with vaginal agenesis and cervical agenesis, both patients with a functional uterus.
   Intervention(s): Creation of a neovagina by vaginal procedure and laparoscopically assisted biomaterial graft for uterovaginal anastomosis was performed in all patients.
   Main Outcome Measure(s): All surgical findings were carefully reviewed to determine the anatomic characteristics of the malformed cervix. Subsequent follow-up was done by referring physicians.
   Result(s): Uterovaginal continuity was established successfully in both patients, and all of the women were menstruating normally. Granulomatous polyps occurred in one patient, and this condition was successfully managed. At 6-month follow-up, mean vaginal length was 12 cm and >= 80% of neovaginal epithelium was iodine positive in both patients. Unimpeded menstrual flow continued after 4 years of follow-up in one patient and 5 years of follow-up in the other patient.
   Conclusion(s): A combined laparoscopic and vaginal procedure with biomaterial graft could be an effective alternative in selected women with atresia of cervix and vagina. (Fertil Steril (R) 2013; 100: 1784-7. (C) 2013 by American Society for Reproductive Medicine.)
C1 [Li, MengHui; Zhang, ZhenYu] Capital Univ Med Sci, Beijing ChaoYang Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China.
RP Zhang, ZY (reprint author), 8 Baijiazhuang Rd, Beijing 100020, Peoples R China.
EM cyzyzhang@126.com
CR Chakravarty B, 2000, AM J OBSTET GYNECOL, V183, P421, DOI 10.1067/mob.2000.105740
   Creighton SM, 2006, FERTIL STERIL, V85
   Darai E, 2009, J MINIM INVAS GYN, V16, P92, DOI 10.1016/j.jmig.2008.09.617
   Fedele L, 2008, FERTIL STERIL, V89, P212, DOI 10.1016/j.fertnstert.2007.01.168
   Kriplani A, 2012, J MINIM INVAS GYN, V19, P477, DOI 10.1016/j.jmig.2012.03.017
   Lai TH, 2001, HUM REPROD, V16, P268, DOI 10.1093/humrep/16.2.268
   Lee CL, 1999, HUM REPROD, V14, P928, DOI 10.1093/humrep/14.4.928
   Mhaskar R, 2005, INT J GYNECOL OBSTET, V90, P123, DOI 10.1016/i.ijgo.2005.04.015
   NIVER DH, 1980, FERTIL STERIL, V33, P25
   Raudrant D, 2008, FERTIL STERIL, V90, P2416, DOI 10.1016/j.fertnstert.2007.10.031
   Rock JA, 2010, FERTIL STERIL, V94, P1858, DOI 10.1016/j.fertnstert.2009.10.024
   Selvaggi G, 2003, FERTIL STERIL, V80, P607, DOI 10.1016/S0015-0282(03)00977-4
   Xu C, 2009, FERTIL STERIL, V91
   Yang YP, 2012, J PEDIATR ADOL GYNEC, V25, P295, DOI 10.1016/j.jpag.2012.03.002
   Zhu L, 2013, J SEX MED, V10, P1652, DOI 10.1111/jsm.12143
NR 15
TC 8
Z9 11
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD DEC
PY 2013
VL 100
IS 6
BP 1784
EP 1787
DI 10.1016/j.fertnstert.2013.08.046
PG 4
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 259NG
UT WOS:000327533000054
PM 24083872
DA 2018-10-20
ER

PT J
AU Vazquez, E
   Villaverde, A
AF Vazquez, Esther
   Villaverde, Antonio
TI Microbial biofabrication for nanomedicine: biomaterials, nanoparticles
   and beyond
SO NANOMEDICINE
LA English
DT Editorial Material
DE biomaterial; genetic design; metabolic circuit; microbial factory;
   nanoparticle; upstream engineering
ID BACTERIAL INCLUSION-BODIES; PROTEIN-ONLY NANOPARTICLES; INDUSTRIAL
   BIOTECHNOLOGY; METALLIC NANOPARTICLES; FACTORIES
C1 [Vazquez, Esther; Villaverde, Antonio] Univ Autonoma Barcelona, Inst Biotecnol Biomed, E-08193 Barcelona, Spain.
   [Vazquez, Esther; Villaverde, Antonio] Univ Autonoma Barcelona, Dept Gen Microbiol, E-08193 Barcelona, Spain.
   [Vazquez, Esther; Villaverde, Antonio] CIBER Bioingn Biomat & Nanomed, Barcelona 08193, Spain.
RP Villaverde, A (reprint author), Univ Autonoma Barcelona, Inst Biotecnol Biomed, E-08193 Barcelona, Spain.
EM antoni.villaverde@uab.cat
OI Vazquez, Esther/0000-0003-1052-0424; Villaverde,
   Antonio/0000-0002-2615-4521
CR Bajaj M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-64
   Chen GQ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-111
   Clardy J, 2009, CURR BIOL, V19, pR437, DOI 10.1016/j.cub.2009.04.001
   Ferrer-Miralles N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-17
   Ferrer-Miralles Neus, 2013, CRIT REV BIOTECHNOL
   Garc ia-Fruitos E, 2012, TRENDS BIOTECHNOL, V30, P65
   Lee SY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-156
   Corchero JL, 2013, BIOTECHNOL ADV, V31, P140, DOI 10.1016/j.biotechadv.2012.09.001
   Mironov V, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022001
   Mironov V, 2011, CURR OPIN BIOTECH, V22, P667, DOI 10.1016/j.copbio.2011.02.006
   Park TJ, 2010, ANGEW CHEM INT EDIT, V49, P7019, DOI 10.1002/anie.201001524
   Quester K, 2013, MICRON, V54-55, P1, DOI 10.1016/j.micron.2013.07.003
   Rodriguez-Carmona E, 2010, TRENDS MICROBIOL, V18, P423, DOI 10.1016/j.tim.2010.06.007
   Sharma N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-86
   Talafova K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-16
   Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002
   Unzueta U, 2012, BIOMATERIALS, V33, P8714, DOI 10.1016/j.biomaterials.2012.08.033
   Unzueta U, 2012, INT J NANOMED, V7, P4533, DOI 10.2147/IJN.S34450
   Villaverde A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-76
   Villaverde A, 2012, NANOMEDICINE-UK, V7, P1277, DOI 10.2217/NNM.12.100
NR 20
TC 15
Z9 15
U1 3
U2 15
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PD DEC
PY 2013
VL 8
IS 12
BP 1895
EP 1898
DI 10.2217/nnm.13.164
PG 4
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 257JM
UT WOS:000327379600001
PM 24279484
OA Bronze
DA 2018-10-20
ER

PT J
AU Grainger, DW
   van der Mei, HC
   Jutte, PC
   van den Dungen, JJAM
   Schultz, MJ
   van der Laan, BFAM
   Zaat, SAJ
   Busscher, HJ
AF Grainger, David W.
   van der Mei, Henny C.
   Jutte, Paul C.
   van den Dungen, Jan J. A. M.
   Schultz, Marcus J.
   van der Laan, Bernard F. A. M.
   Zaat, Sebastian A. J.
   Busscher, Henk J.
TI Critical factors in the translation of improved antimicrobial strategies
   for medical implants and devices
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial-associated infection; Clinical translation; Hospital
   hygiene; Clinical trials; Stakeholders; Implant infection
ID IN-VIVO EFFICACY; HEART-VALVE; INFECTION; RISK
AB Biomaterials-associated infection incidence represents an increasing clinical challenge as more people gain access to medical device technologies worldwide and microbial resistance to current approaches mounts. Few reported antimicrobial approaches to implanted biomaterials ever get commercialized for physician use and patient benefit. This is not for lack of ideas since many thousands of claims to new approaches to antimicrobial efficacy are reported. Lack of translation of reported ideas into medical products approved for use, results from conflicting goals and purposes between the various participants involved in conception, validation, development, commercialization, safety and regulatory oversight, insurance reimbursement, and legal aspects of medical device innovation. The scientific causes, problems and impressive costs of the limiting clinical options for combating biomaterials-associated infection are well recognized. Demands for improved antimicrobial technologies constantly appear. Yet, the actual human, ethical and social costs and consequences of their occurrence are less articulated. Here, we describe several clinical cases of biomaterials-associated infections to illustrate the often-missing human elements of these infections. We identify the current societal forces at play in translating antimicrobial research concepts into clinical implant use and their often-orthogonal constituencies, missions and policies. We assert that in the current complex environment between researchers, funding agencies, physicians, patients, providers, producers, payers, regulatory agencies and litigators, opportunities for translatable successes are minimized under the various risks assumed in the translation process. This argues for an alternative approach to more effectively introduce new biomaterials and device technologies that can address the clinical issues by providing patients and medical practitioners new options for desperate clinical conditions ineffectively addressed by biomedical innovation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Grainger, David W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [Grainger, David W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Jutte, Paul C.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed Surg, NL-9713 GZ Groningen, Netherlands.
   [van den Dungen, Jan J. A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9713 GZ Groningen, Netherlands.
   [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands.
   [van der Laan, Bernard F. A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, NL-9713 GZ Groningen, Netherlands.
   [Zaat, Sebastian A. J.] Univ Amsterdam, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands.
RP Grainger, DW (reprint author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
EM david.grainger@utah.edu
RI van der Laan, Bernard/H-2420-2011
OI van der Laan, Bernard/0000-0002-5016-2871
FU NANTICO project of the BioMedical Materials program; Dutch Ministry of
   Economic Affairs, Agriculture and Innovation; George C. and Dolores Dore
   Eccles Foundation (USA)
FX HJB, SAJZ, MJS and HCvdM acknowledge support from the NANTICO project of
   the BioMedical Materials program, co-funded by the Dutch Ministry of
   Economic Affairs, Agriculture and Innovation. DWG is grateful for
   support from the George C. and Dolores Dore Eccles Foundation (USA).
CR Brooks B., 2012, BIOMATERIALS ASS INF, P307
   Brown J, 2009, CLIN INFECT DIS, V49, P743, DOI 10.1086/604719
   Busscher HJ, 2012, SCI TRANSL MED, V4, prv10
   Dairouche RO, 2004, NEW ENGL J MED, V350, P1422
   Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842
   Darouiche RO, 1998, J HEART VALVE DIS, V7, P639
   Darouiche RO, 2012, BIOMATERIALS ASS INF, P485
   Englberger L, 2005, EUR J CARDIO-THORAC, V28, P838, DOI 10.1016/j.ejcts.2005.09.014
   Grunkemeier GL, 2006, EUR J CARDIO-THORAC, V30, P20, DOI 10.1016/j.ejcts.2006.04.012
   Grunkemeier GL, 2004, EUR J CARDIO-THORAC, V25, P371, DOI 10.1016/j.ejcts.2003.12.014
   Illingworth BL, 1998, J HEART VALVE DIS, V7, P524
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Knobben BAS, 2006, CLIN ORTHOP RELAT R, P236, DOI 10.1097/01.blo.0000229339.11351.ea
   Ratner B.D., 2012, BIOMATERIALS SCI INT, pxli
   Ratner B. D., 2012, BIOMATERIALS SCI, pxxv
   Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184
   Schmidmaier G, 2012, BIOMATERIALS ASS INF, P435
   Uckay I, 2013, J HOSP INFECT, V84, P5, DOI 10.1016/j.jhin.2012.12.014
   Zimmerli W, 2012, BIOMATERIALS ASS INF, P3
NR 19
TC 35
Z9 37
U1 3
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2013
VL 34
IS 37
BP 9237
EP 9243
DI 10.1016/j.biomaterials.2013.08.043
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 251AW
UT WOS:000326901200001
PM 24034505
DA 2018-10-20
ER

PT J
AU Hoffman, AS
AF Hoffman, Allan S.
TI Biomaterials in the nano-era
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE biomaterials; nano-era
ID SELF-ASSEMBLED MONOLAYERS; DRUG-DELIVERY SYSTEMS; QUANTUM DOTS; POLYMER
   BRUSHES; NANOPARTICLES; CELLS; GOLD; FRAGMENTATION; COPOLYMERS;
   BIOMARKERS
AB This article is a brief summary of my plenary talk at the World Biomaterials Congress in Chengdu, Sichuan, China, June 1-5, 2012. It highlights the trend to design and develop biomaterial implants and devices that are more compact and more efficient, as they "shrink" from the macro- to the micro- and down to the nano-scale.
C1 [Hoffman, Allan S.] Univ Washington, Dept Bioengn, Seattle, WA 98104 USA.
   [Hoffman, Allan S.] Kyungpook Natl Univ, Sch Med, Taegu 427724, South Korea.
RP Hoffman, AS (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98104 USA.
EM hoffman@u.washington.edu
CR Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147
   Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Golden AL, 2010, BIOCONJUGATE CHEM, V21, P1820, DOI 10.1021/bc100169y
   Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228
   He XF, 2011, MOL PHARMACEUT, V8, P430, DOI 10.1021/mp100266g
   Hoffman AS, 2007, PROG POLYM SCI, V32, P922, DOI 10.1016/j.progpolymsci.2007.05.005
   Hoffman AS, 2008, J CONTROL RELEASE, V132, P153, DOI 10.1016/j.jconrel.2008.08.012
   Hoste K, 2000, J CONTROL RELEASE, V64, P53, DOI 10.1016/S0168-3659(99)00142-X
   Hu SH, 2010, J AM CHEM SOC, V132, P7234, DOI 10.1021/ja102489q
   Humes HD, 2006, KIDNEY INT, V69, P1115, DOI 10.1038/sj.ki.5000204
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jin YD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1042
   Jin YD, 2009, J AM CHEM SOC, V131, P17774, DOI 10.1021/ja9076765
   Jin YD, 2009, NAT NANOTECHNOL, V4, P571, DOI [10.1038/nnano.2009.193, 10.1038/NNANO.2009.193]
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim JH, 2012, J CONTROL RELEASE, V157, P493, DOI 10.1016/j.jconrel.2011.09.070
   Koo H, 2011, ACCOUNTS CHEM RES, V44, P1018, DOI 10.1021/ar2000138
   Koo H, 2011, NANO TODAY, V6, P204, DOI 10.1016/j.nantod.2011.02.007
   Lai JJ, 2009, LAB CHIP, V9, P1997, DOI 10.1039/b817754f
   Lee DE, 2012, CHEM SOC REV, V41, P2656, DOI 10.1039/c2cs15261d
   Luo K, 2011, MACROMOLECULES, V44, P2481, DOI 10.1021/ma102574e
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Malugin A, 2007, J CONTROL RELEASE, V124, P6, DOI 10.1016/j.jconrel.2007.08.016
   Man M, 2005, IDRUGS, V8, P739
   Manocha B, 2008, CRIT REV BIOTECHNOL, V28, P83, DOI [10.1080/07388550802107483, 10.1080/07388550802107483 ]
   Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989
   Martinez AW, 2008, P NATL ACAD SCI USA, V105, P19606, DOI 10.1073/pnas.0810903105
   Mizutani A, 2008, BIOMATERIALS, V29, P2073, DOI 10.1016/j.biomaterials.2009.01.004
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   Mrksich M, 1997, ACS SYM SER, V680, P361
   Nash MA, 2010, BIOCONJUGATE CHEM, V21, P2197, DOI 10.1021/bc100180q
   Nash MA, 2010, NANO LETT, V10, P85, DOI [10.1021/nl902865v, 10.1021/nl902865V]
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Probst CE, 2011, J AM CHEM SOC, V133, P17126, DOI 10.1021/ja2072324
   Shimoboji T, 2002, P NATL ACAD SCI USA, V99, P16592, DOI 10.1073/pnas.262427799
   Stayton P, 2008, MULTIFUNCTIONAL PHAR
   Stayton PS, 2005, P IEEE, V93, P726, DOI 10.1109/JPROC.2005.844619
   Takahashi H, 2012, BIOMACROMOLECULES, V13, P253, DOI 10.1021/bm201545u
   Tamura A, 2012, ACTA BIOMATER, V8, P3904, DOI 10.1016/j.actbio.2012.07.006
   Wang K, 2010, J CONTROL RELEASE, V148, P283, DOI 10.1016/j.jconrel.2010.09.010
   Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2
   Yang J, 2008, J AM CHEM SOC, V130, P5286, DOI 10.1021/ja710934v
   Yezhelyev MV, 2008, J AM CHEM SOC, V130, P9006, DOI 10.1021/ja800086u
   Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g
   Zrazhevskiy P, 2009, NANO TODAY, V4, P414, DOI 10.1016/j.nantod.2009.07.004
NR 46
TC 1
Z9 1
U1 0
U2 19
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
EI 1861-9541
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD DEC
PY 2013
VL 58
IS 35
BP 4337
EP 4341
DI 10.1007/s11434-013-6090-x
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 251PW
UT WOS:000326943300001
OA Bronze
DA 2018-10-20
ER

PT J
AU Warren, PD
   Sycks, DG
   McGrath, DV
   Vande Geest, JP
AF Warren, P. Daniel
   Sycks, Dalton G.
   McGrath, Dominic V.
   Vande Geest, Jonathan P.
TI Modeling the microstructurally dependent mechanical properties of
   poly(ester-urethane-urea)s
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polycaprolactone; polyester-urethane-urea; statistic; modeling;
   biomaterial
ID PHOSPHATE BUFFER SOLUTION; ENZYMATIC DEGRADATION; EPSILON-CAPROLACTONE;
   IN-VIVO; STATISTICAL-MECHANICS; MOLECULAR-WEIGHT; AMINO-ACIDS; POLYMERS;
   POLY(EPSILON-CAPROLACTONE); POLYURETHANE
AB Poly(ester-urethane-urea) (PEUU) is one of many synthetic biodegradable elastomers under scrutiny for biomedical and soft tissue applications. The goal of this study was to investigate the effect of the experimental parameters on mechanical properties of PEUUs following exposure to different degrading environments, similar to that of the human body, using linear regression, producing one predictive model. The model utilizes two independent variables of poly(caprolactone) (PCL) type and copolymer crystallinity to predict the dependent variable of maximum tangential modulus (MTM). Results indicate that comparisons between PCLs at different degradation states are statistically different (p < 0.0003), while the difference between experimental and predicted average MTM is statistically negligible (p < 0.02). The linear correlation between experimental and predicted MTM values is R-2 = 0.75. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3382-3387, 2013.
C1 [Warren, P. Daniel; Vande Geest, Jonathan P.] Univ Arizona, Grad Interdisciplinary Program Biomed Engn, Tucson, AZ 85721 USA.
   [Sycks, Dalton G.] Univ Arizona, Dept Mat Sci, Tucson, AZ 85721 USA.
   [McGrath, Dominic V.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.
   [Vande Geest, Jonathan P.] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA.
   [Vande Geest, Jonathan P.] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.
   [Vande Geest, Jonathan P.] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA.
RP Vande Geest, JP (reprint author), Univ Arizona, Grad Interdisciplinary Program Biomed Engn, Tucson, AZ 85721 USA.
EM jpv1@email.arizona.edu
RI Vande Geest, Jonathan/L-8136-2016
OI Vande Geest, Jonathan/0000-0003-2444-1751; McGrath,
   Dominic/0000-0001-9605-2224
FU Science Foundation of Arizona; NSF CAREER [0644570]
FX We would like to acknowledge the crucial aid of Dr. Mark Borgstrom on
   the statistic-based modeling portion of this project, synthesis help
   provided by Luis Oquendo, Aura Collazo, and Brian Korth of Dr. Dominic
   McGrath's group as well as SEC aid provided by Lawrence Hill of Dr.
   Jeffery Pyun's group, all from the University of Arizona. The Science
   Foundation of Arizona provided funding to PDW and as well as a NSF
   CAREER award to JPVG (0644570).
CR Altan M, 2010, MATER DESIGN, V31, P599, DOI 10.1016/j.matdes.2009.06.049
   AMIN MB, 1995, J APPL POLYM SCI, V56, P279, DOI 10.1002/app.1995.070560219
   Binder K, 1997, REP PROG PHYS, V60, P487, DOI 10.1088/0034-4885/60/5/001
   Brown H, 1999, APPL MIXED MODELS ME
   BROWN RP, 1995, POLYM TEST, V14, P403, DOI 10.1016/0142-9418(95)00006-E
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Buryachenko VA, 2005, COMPOS SCI TECHNOL, V65, P2435, DOI 10.1016/j.compscitech.2005.08.005
   Chen DR, 2000, POLYM DEGRAD STABIL, V67, P455, DOI 10.1016/S0141-3910(99)00145-7
   Cometa S, 2010, POLYM DEGRAD STABIL, V95, P2013, DOI 10.1016/j.polymdegradstab.2010.07.007
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   DAVIDOVICH YA, 1977, B ACAD SCI USSR CH+, V26, P1554, DOI 10.1007/BF00928562
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Gan ZH, 1999, POLYMER, V40, P2859, DOI 10.1016/S0032-3861(98)00549-7
   Gan ZH, 1997, POLYM DEGRAD STABIL, V56, P209, DOI 10.1016/S0141-3910(96)00208-X
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gmachowski L, 2007, POLYMER, V48, P4316, DOI 10.1016/j.polymer.2007.05.042
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   HALPINHEALY T, 1995, PHYS REP, V254, P215, DOI 10.1016/0370-1573(94)00087-J
   HAMID SH, 1991, J APPL POLYM SCI, V43, P651, DOI 10.1002/app.1991.070430404
   He F, 2005, POLYMER, V46, P12682, DOI 10.1016/j.polymer.2005.10.121
   HUANG SJ, 1979, J APPL POLYM SCI, V23, P429, DOI 10.1002/app.1979.070230212
   KATSARAVA RD, 1985, MAKROMOL CHEM, V186, P939
   Krol P, 2005, J APPL POLYM SCI, V97, P1855, DOI 10.1002/app.21160
   Ma ZW, 2011, BIOMACROMOLECULES, V12, P3265, DOI 10.1021/bm2007218
   Madkour TM, 2001, CHEM PHYS, V274, P187, DOI 10.1016/S0301-0104(01)00507-9
   Marcos-Fernandez A, 2006, POLYMER, V47, P785, DOI 10.1016/j.polymer.2005.12.007
   MOCHIZUKI M, 1995, J APPL POLYM SCI, V55, P289, DOI 10.1002/app.1995.070550212
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Pretsch T, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/1/015006
   Reddy SK, 2005, POLYMER, V46, P4212, DOI 10.1016/j.polymer.2005.02.050
   SHI FY, 1991, ACS SYM SER, V469, P141
   STOREY RF, 1993, POLYM COMPOSITE, V14, P17, DOI 10.1002/pc.750140104
   STOREY RF, 1994, J POLYM SCI POL CHEM, V32, P2345, DOI 10.1002/pola.1994.080321216
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   SZYCHER M, 1983, J ELASTOM PLAST, V15, P81, DOI 10.1177/009524438301500205
   SZYCHER M, 1983, IND ENG CHEM PROD RD, V22, P588, DOI 10.1021/i300012a014
   Tanyildizi H, 2009, MATER DESIGN, V30, P3252, DOI 10.1016/j.matdes.2008.11.032
   Tzoumanekas C, 2006, CURR OPIN SOLID ST M, V10, P61, DOI 10.1016/j.cossms.2006.11.003
   Van Krevelen D.W., 1990, PROPERTIES POLYM
   Wei XW, 2009, INT J PHARMACEUT, V381, P1, DOI 10.1016/j.ijpharm.2009.07.033
   WU MP, 1994, J BIOMED MATER RES, V28, P387, DOI 10.1002/jbm.820280314
   Wunderlich B, 2005, THERMAL ANAL POLYM M
   Zilberman M, 2006, ANNU REV BIOMED ENG, V8, P153, DOI 10.1146/annurev.bioeng.8.013106.151418
NR 46
TC 1
Z9 1
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2013
VL 101
IS 12
BP 3382
EP 3387
DI 10.1002/jbm.a.34641
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 240TR
UT WOS:000326121000003
PM 23554009
DA 2018-10-20
ER

PT J
AU Pedron, S
   Harley, BAC
AF Pedron, S.
   Harley, B. A. C.
TI Impact of the biophysical features of a 3D gelatin microenvironment on
   glioblastoma malignancy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE glioblastoma; gelatin; tumor microenvironment; biophysical properties;
   malignancy
ID PHOTO-CROSS-LINKING; I COLLAGEN GELS; EXTRACELLULAR-MATRIX;
   CELL-MIGRATION; GLIOMA INVASION; TENSIONAL HOMEOSTASIS; LAYERED
   SCAFFOLDS; CANCER-CELLS; TUMOR-CELLS; HYDROGELS
AB Three-dimensional tissue engineered constructs provide a platform to examine how the local extracellular matrix (ECM) contributes to the malignancy of cancers such as human glioblastoma multiforme. Improved resolution of how local matrix biophysical features impact glioma proliferation, genomic and signal transduction paths, as well as phenotypic malignancy markers would complement recent improvements in our understanding of molecular mechanisms associated with enhanced malignancy. Here, we report the use of a gelatin methacrylate (GelMA) platform to create libraries of three-dimensional biomaterials to identify combinations of biophysical features that promote malignant phenotypes of human U87MG glioma cells. We noted key biophysical properties, namely matrix density, crosslinking density, and biodegradability, that significantly impact glioma cell morphology, proliferation, and motility. Gene expression profiles and secreted markers of increased malignancy, notably VEGF, MMP-2, MMP-9, HIF-1, and the ECM protein fibronectin, were also significantly impacted by the local biophysical environment as well as matrix-induced deficits in diffusion-mediated oxygen and nutrient biotransport. Overall, this biomaterial system provides a flexible platform to explore the role biophysical factors play in the etiology, growth, and subsequent invasive spreading of gliomas. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3404-3415, 2013.
C1 [Pedron, S.; Harley, B. A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
   [Harley, B. A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
EM bharley@illinois.edu
RI Pedron, Sara/E-6404-2015
CR Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   Baker EL, 2010, J BIOMECH, V43, P38, DOI 10.1016/j.jbiomech.2009.09.007
   Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054
   Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Bernsen HJJA, 2000, J NEUROSURG, V93, P449, DOI 10.3171/jns.2000.93.3.0449
   Bichsel CA, 2012, LAB CHIP, V12, P2313, DOI [10.1039/c2lc40130d, 10.1039/c21c40130d]
   Boykin C, 2011, BRIT J CANCER, V104, P781, DOI 10.1038/bjc.2011.10
   Braeckmans K, 2003, BIOPHYS J, V85, P2240, DOI 10.1016/S0006-3495(03)74649-9
   Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3
   Brinkman WT, 2003, BIOMACROMOLECULES, V4, P890, DOI 10.1021/bm0257412
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Carey SP, 2012, BIOMATERIALS, V33, P4157, DOI 10.1016/j.biomaterials.2012.02.029
   Carey SP, 2011, CRIT REV ONCOL HEMAT, V83, P170
   Censi R, 2009, J CONTROL RELEASE, V140, P230, DOI 10.1016/j.jconrel.2009.06.003
   David L, 2004, MATRIX BIOL, V23, P183, DOI 10.1016/j.matbio.2004.05.005
   Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711
   DeVolder R, 2012, WIRES SYST BIOL MED, V4, P351, DOI 10.1002/wsbm.1174
   Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040
   Du R, 2008, NEURO-ONCOLOGY, V10, P254, DOI 10.1215/15228517-2008-001
   Duffy GP, 2011, EUR CELLS MATER, V21, P15, DOI 10.22203/eCM.v021a02
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Fujiwara S, 2007, INT J ONCOL, V30, P793
   Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707
   Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Hayes A. W., 1994, PRINCIPLES METHODS T, P1231
   Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187
   Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]
   Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016
   Ito TK, 2007, ONCOGENE, V26, P7194, DOI 10.1038/sj.onc.1210535
   Kievit FM, 2010, BIOMATERIALS, V31, P5903, DOI 10.1016/j.biomaterials.2010.03.062
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372
   Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5
   Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Okada H, 2009, CRIT REV IMMUNOL, V29, P1
   Pandey V, 2010, ENDOCRINOLOGY, V151, P909, DOI 10.1210/en.2009-0979
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pathak A, 2012, P NATL ACAD SCI USA, V109, P10334, DOI 10.1073/pnas.1118073109
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465
   Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299
   Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677
   Raghavan S, 2010, J CELL SCI, V123, P2877, DOI 10.1242/jcs.055079
   Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Sen S, 2012, J R SOC INTERFACE, V9, P1311, DOI 10.1098/rsif.2011.0567
   Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Wiranowska M, 2011, GLIOMAEXPLORING ITS
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yang LQ, 2012, EXP CELL RES, V318, P2417, DOI 10.1016/j.yexcr.2012.07.017
   Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   Zaman MH, 2007, ANN BIOMED ENG, V35, P91, DOI 10.1007/s10439-006-9205-6
   Zhou JA, 2011, ACTA BIOMATER, V7, P3999, DOI 10.1016/j.actbio.2011.06.040
NR 69
TC 30
Z9 30
U1 2
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2013
VL 101
IS 12
BP 3404
EP 3415
DI 10.1002/jbm.a.34637
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 240TR
UT WOS:000326121000006
PM 23559545
DA 2018-10-20
ER

PT J
AU Garber, L
   Chen, C
   Kilchrist, KV
   Bounds, C
   Pojman, JA
   Hayes, D
AF Garber, Leah
   Chen, Cong
   Kilchrist, Kameron V.
   Bounds, Christopher
   Pojman, John A.
   Hayes, Daniel
TI Thiol-acrylate nanocomposite foams for critical size bone defect repair:
   A novel biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE adipose tissue; stem cells; bone regeneration; PETA; scaffold
ID TISSUE ENGINEERING SCAFFOLDS; HUMAN ADIPOSE-TISSUE; STEM-CELLS;
   IN-VITRO; OSTEOGENIC DIFFERENTIATION; PEG HYDROGELS; COMPOSITE;
   BEHAVIOR; PROLIFERATION; PHOTOPOLYMERS
AB Bone tissue engineering approaches using polymer/ceramic composites show promise as effective biocompatible, absorbable, and osteoinductive materials. A novel class of in situ polymerizing thiol-acrylate based copolymers synthesized via an amine-catalyzed Michael addition was studied for its potential to be used in bone defect repair. Both pentaerythritol triacrylate-co-trimethylolpropane tris(3-mercaptopropionate) (PETA-co-TMPTMP) and PETA-co-TMPTMP with hydroxyapatite (HA) composites were fabricated in solid cast and foamed forms. These materials were characterized chemically and mechanically followed by an in vitro evaluation of the biocompatibility and chemical stability in conjunction with human adipose-derived mesenchymal pluripotent stem cells (hASC). The solid PETA-co-TMPTMP with and without HA exhibited compressive strength in the range of 7-20 MPa, while the cytotoxicity and biocompatibility results demonstrate higher metabolic activity of hASC on PETA-co-TMPTMP than on a polycaprolactone control. Scanning electron microscope imaging of hASC show expected spindle shaped morphology when adhered to copolymer. Micro-CT analysis indicates open cell interconnected pores. Foamed PETA-co-TMPTMP HA composite shows promise as an alternative to FDA-approved biopolymers for bone tissue engineering applications. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3531-3541, 2013.
C1 [Garber, Leah; Bounds, Christopher; Pojman, John A.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA.
   [Chen, Cong; Kilchrist, Kameron V.; Hayes, Daniel] Louisiana State Univ, Dept Biol & Agr Engn, Baton Rouge, LA 70803 USA.
   [Chen, Cong; Kilchrist, Kameron V.; Hayes, Daniel] Louisiana State Univ, Ctr Agr, Baton Rouge, LA 70803 USA.
RP Hayes, D (reprint author), Louisiana State Univ, Dept Biol & Agr Engn, Baton Rouge, LA 70803 USA.
EM danielhayes@lsu.edu
RI Chen, Cong/G-3137-2017
OI Kilchrist, Kameron/0000-0002-2391-9488; Hayes,
   Daniel/0000-0001-9499-4111
FU National Science Foundation [CBET-1254281]; ARI [0963482]
FX The authors thank Dr. Jeffery Gimble of the Pennington Biomedical
   Research Center for providing this project with human adipose derived
   stem cells and Dr. Vinod Dasa of the Louisiana State University Health
   Science Center, Department of Orthopedics for his insight into clinical
   practice of critical sized defect repair. This research was supported by
   the National Science Foundation grants CBET-1254281 and ARI Proposal
   0963482.
CR Ahn HH, 2009, TISSUE ENG PT A, V15, P1821, DOI 10.1089/ten.tea.2008.0386
   Bounds CO, 2011, J POLYM SCI A, V50, P409
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Gaalen S, 2008, TISSUE ENG, P559
   Gimble JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt19
   Hong ZK, 2008, ACTA BIOMATER, V4, P1297, DOI 10.1016/j.actbio.2008.03.007
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hwang S, 2012, J MECH SCI TECHNOL, V26, P1999, DOI 10.1007/s12206-012-0502-8
   Jeon BJ, 2012, MACROMOL RES, V20, P715, DOI 10.1007/s13233-012-0103-5
   Kumar D, 2010, ACTA BIOMATER, V6, P1549, DOI 10.1016/j.actbio.2009.11.008
   Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884
   Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002
   Liu L, 2012, J BIOMED MATER RES B, V100B, P956, DOI 10.1002/jbm.b.32658
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Muller AM, 2010, EUR CELLS MATER, V19, P127
   Nuttelman CR, 2006, BIOMATERIALS, V27, P1377, DOI 10.1016/j.biomaterials.2005.08.014
   Ohba S, 2012, ACTA BIOMATER, V8, P2778, DOI 10.1016/j.actbio.2012.04.015
   Pallua N., 2010, TISSUE ENG LAB CLIN
   Papadimitropoulos A, 2011, EUR CELLS MATER, V21, P445, DOI 10.22203/eCM.v021a33
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Ravichandran R, 2012, MAT SCI ENG C-MATER, V32, P1443, DOI 10.1016/j.msec.2012.04.024
   Reynaud E, 2001, POLYMER, V42, P8759, DOI 10.1016/S0032-3861(01)00446-3
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Rydholm AE, 2008, J BIOMED MATER RES A, V86A, P23, DOI 10.1002/jbm.a.31526
   Rydholm AE, 2006, BIOMACROMOLECULES, V7, P2827, DOI 10.1021/bm0603793
   Salinas CN, 2008, MACROMOLECULES, V41, P6019, DOI 10.1021/ma800621h
   Scherberich A, 2007, STEM CELLS, V25, P1823, DOI 10.1634/stemcells.2007-0124
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Wu F, 2012, COMPOS PART B-ENG, V43, P2192, DOI 10.1016/j.compositesb.2012.02.040
   Zanetti A. S, 2012, J TISSUE ENG REGENER
NR 33
TC 15
Z9 15
U1 1
U2 46
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2013
VL 101
IS 12
BP 3531
EP 3541
DI 10.1002/jbm.a.34651
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 240TR
UT WOS:000326121000019
PM 23629851
DA 2018-10-20
ER

PT J
AU Love, RJ
   Jones, KS
AF Love, Ryan J.
   Jones, Kim S.
TI Transient inhibition of connective tissue infiltration and collagen
   deposition into porous poly(lactic-co-glycolic acid) discs
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; drug delivery; connective tissue; fibrosis; prolyl
   hydroxylase
ID HYPOXIA-INDUCIBLE FACTOR; HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR;
   PROLYL HYDROXYLATION; BIOMATERIAL SURFACES; CANCER CELLS;
   FACTOR-1-ALPHA; ANGIOGENESIS; EXPRESSION; MIGRATION
AB Connective tissue rapidly proliferates on and around biomaterials implanted in vivo, which impairs the function of the engineered tissues, biosensors, and devices. Glucocorticoids can be utilized to suppress tissue ingrowth, but can only be used for a limited time because they nonselectively arrest cell proliferation in the local environment. The present study examined use of a prolyl-4-hydroxylase inhibitor, 1,4-dihydrophenonthrolin-4-one-3-carboxylic acid (1,4-DPCA), to suppress connective tissue ingrowth in porous PLGA discs implanted in the peritoneal cavity for 28 days. The prolyl-4-hydroxylase inhibitor was found to be effective at inhibiting collagen deposition within and on the outer surface of the disc, and also limited connective tissue ingrowth, but not to the extent of glucocorticoid inhibition. Finally, it was discovered that 1,4-DPCA suppressed Scavenger Receptor A expression on a macrophage-like cell culture, which may account for the drug's ability to limit connective tissue ingrowth in vivo. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3599-3606, 2013.
C1 [Love, Ryan J.; Jones, Kim S.] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.
   [Jones, Kim S.] McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RP Jones, KS (reprint author), McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.
EM kjones@mcmaster.ca
RI Love, Ryan/I-8597-2012
OI Love, Ryan/0000-0003-1759-2957
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
FX This work was supported by the Natural Sciences and Engineering Research
   Council of Canada (NSERC).
CR Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200
   Banerji B, 2005, CHEM COMMUN, P5438, DOI 10.1039/b510707e
   Beamer CA, 2005, AM J PHYSIOL-LUNG C, V289, pL186, DOI 10.1152/ajplung.00474.2004
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   Bhardwaj Upkar, 2007, J Diabetes Sci Technol, V1, P8
   BREEMHAAR W, 1984, BIOMATERIALS, V5, P269, DOI 10.1016/0142-9612(84)90071-1
   Cao Y, 2006, J BIOMAT SCI-POLYM E, V17, P369, DOI 10.1163/156856206776374142
   Cao Y, 2004, BIOPOLYMER METHODS T, V238, P87
   Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7
   Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003
   Corley KM, 2005, J CELL BIOCHEM, V96, P971, DOI 10.1002/jcb.20559
   Franklin TJ, 2001, BIOCHEM J, V353, P333, DOI 10.1042/bj3530333
   FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0
   Fujiwara S, 2007, INT J ONCOL, V30, P793
   Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991
   Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200
   Iyer R, 1996, TOXICOL APPL PHARM, V141, P84, DOI 10.1006/taap.1996.0263
   Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   Leelarasamee N, 1986, J Microencapsul, V3, P171, DOI 10.3109/02652048609031571
   Love Ryan J., 2009, Critical Reviews in Biomedical Engineering, V37, P259
   Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197
   Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104
   Orr GA, 2011, NANOTOXICOLOGY, V5, P296, DOI 10.3109/17435390.2010.513836
   Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497
   Rakshit DS, 2006, J ORTHOP RES, V24, P2036, DOI 10.1002/jor.20275
   Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   Siegel SJ, 2006, EUR J PHARM BIOPHARM, V64, P287, DOI 10.1016/j.wjpb.2006.06.009
   Zagzag D, 2000, CANCER, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W
   Zhong H, 2000, CANCER RES, V60, P1541
NR 33
TC 0
Z9 0
U1 2
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2013
VL 101
IS 12
BP 3599
EP 3606
DI 10.1002/jbm.a.34648
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 240TR
UT WOS:000326121000026
PM 23766241
DA 2018-10-20
ER

PT J
AU Vankar, PS
   Sarswat, R
   Dwivedi, AK
   Sahu, RS
AF Vankar, Padma S.
   Sarswat, Rishabh
   Dwivedi, Ashish K.
   Sahu, Rama Shanker
TI An assessment and characterization for biosorption efficiency of natural
   dye waste
SO JOURNAL OF CLEANER PRODUCTION
LA English
DT Article
DE Women SHG; Waste material reuse; Biosorption; Chromium (VI); Trapa
   natans
ID HEXAVALENT CHROMIUM; ACTIVATED CARBON; ECKLONIA BIOMASS; REMOVAL; LEAD;
   KINETICS; BINDING; IONS; PULP; PH
AB The local natural dyeing house run by a women's self-help group was generating a huge amount of dye extracted pulp. We thought of using this pulp for an alternative use other than just composting it. This biomaterial was found to be excellent heavy metal adsorbents and was demonstrated to be very effective in remediation of groundwater and surface water of chrome metals in contaminated sites of tannery operations. In this article, sorption efficacy studies were carried out on selected biomaterials known for their potential usage as natural dyes. Canna indica flower, Portulaca olecera flower and stem, Hibiscus rosa sinensis flower and Trapa natans fruit skin (exocarp) were used for sorption studies. These plant parts, after the extraction of natural dye, were dried and evaluated for biosorption of heavy metal from effluent. Batch tests indicated that hexavalent chromium sorption capacity (qe) followed the sequence qe(Trapa) >qe(Hibiscus) >qe(Portulaca) >q(e)(Canna). Due to high sorptive capacity, Trapa fruit skin (exocarp) was selected. The optimization studies were carried out by taking the Trapa exocarp in powdered form, and of particular mesh size. Sorption kinetic data have shown first order reversible kinetic model for all the sorbents, however the biosorption of chromium by T natans biomass occurred in two stages. In the first stage, 95% sorption was reported for Chromium (VI) in 15 min followed by a slower second stage. It reached equilibrium in 1 h at which 90-98% of the Chromium (VI) was biosorbed by 7: natans. Experimentally reported equilibrium data fitted well with both the Langmuir and Freundlich Isotherms. The FT-IR, XRD and XPS analysis showed that the main mechanism of Chromium (VI) biosorption onto Trapa dried powder was through the binding of Chromium ions with amide group of the biomass. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Vankar, Padma S.; Sarswat, Rishabh; Dwivedi, Ashish K.; Sahu, Rama Shanker] Indian Inst Technol, FEAT, Kanpur 208016, Uttar Pradesh, India.
RP Vankar, PS (reprint author), Indian Inst Technol, FEAT, Kanpur 208016, Uttar Pradesh, India.
EM psv@iitk.ac.in
FU Ministry of Environment and Forest (MOEF), New Delhi
FX The authors thank Ministry of Environment and Forest (MOEF), New Delhi,
   for their financial support.
CR Ahalya N., 2005, ELECT J BIOTECHNOLOG, V8
   GardeaTorresdey JL, 1996, J HAZARD MATER, V48, P181, DOI 10.1016/0304-3894(95)00155-7
   HUANG CP, 1977, WATER RES, V11, P673, DOI 10.1016/0043-1354(77)90106-3
   Lee MY, 1998, SEPAR SCI TECHNOL, V33, P1043, DOI 10.1080/01496399808545007
   LUJAN JR, 1994, SOLVENT EXTR ION EXC, V12, P803, DOI 10.1080/07366299408918239
   Mahvi A. H., 2005, American Journal of Applied Sciences, V2, P372
   Melo JS, 2004, BIORESOURCE TECHNOL, V92, P151, DOI 10.1016/j.biortech.2003.08.015
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2008, J COLLOID INTERF SCI, V317, P54, DOI 10.1016/j.jcis.2007.09.049
   Park D, 2007, CHEMOSPHERE, V66, P939, DOI 10.1016/j.chemosphere.2006.05.068
   Park D, 2006, J MICROBIOL BIOTECHN, V16, P1720
   Reed BE, 1996, WATER ENVIRON RES, V68, P877, DOI 10.2175/106143096X127875
   Sarin V, 2006, BIORESOURCE TECHNOL, V97, P15, DOI 10.1016/j.biortech.2005.02.010
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V47, P257, DOI 10.1016/0960-8524(94)90189-9
   Singhal V, 2003, J SCI IND RES INDIA, V62, P319
   TAN WT, 1993, ENVIRON TECHNOL, V14, P277, DOI 10.1080/09593339309385290
   Vankar P.S., 2011, ENV PROGR SUSTAINABL
   Vankar PS, 2010, ENVIRON PROG SUSTAIN, V29, P421, DOI 10.1002/ep.10423
   Verma VK, 2005, J SCI IND RES INDIA, V64, P778
NR 19
TC 15
Z9 15
U1 0
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-6526
EI 1879-1786
J9 J CLEAN PROD
JI J. Clean Prod.
PD DEC 1
PY 2013
VL 60
SI SI
BP 65
EP 70
DI 10.1016/j.jclepro.2011.09.021
PG 6
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA 251SO
UT WOS:000326951200008
DA 2018-10-20
ER

PT J
AU Donanzam, BA
   Campos, TPR
   Dalmazio, I
   Valente, ES
AF Donanzam, B. A.
   Campos, T. P. R.
   Dalmazio, I.
   Valente, E. S.
TI Synthesis and characterization of calcium phosphate loaded with Ho-166
   and Sm-153: a novel biomaterial for treatment of spine metastases
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TRICALCIUM PHOSPHATE; BONE; HYDROXYAPATITE; VERTEBROPLASTY; BEHAVIOR;
   CEMENT; SUBSTITUTION; RADIOTHERAPY; KYPHOPLASTY; PARTICLES
AB Spine metastases are a common and painful complication of cancer. A novel concept of treatment combines the in situ vertebroplasty with radiotherapy employing radioactive bone cement into the human vertebrae. Thus, investigations concerning possible bioactive and radioactive cements become a relevant theme. In this work, we have synthesized calcium phosphate bioceramics incorporated with Ho and Sm nuclides using sol-gel technique. Characterizations were performed using X-ray diffractometry, infrared spectroscopy, scanning electron microscopy, instrumental neutron activation analysis, and gamma spectroscopy. Results showed bioceramics composed by multiphasic calcium phosphates along with holmium and samarium phosphates, with 8.9 and 13.7 % of Sm and Ho in weight, respectively. After neutron activation, the Ho-166 and Sm-153 beta-emitters were identified and quantified on the bioceramics with activities estimated at 32.5 and 14.5 MBq/mg of Sm-153 and Ho-166 bioceramic powder, respectively. These radioactive calcium phosphate bioceramics can compose suitable radioactive cements to radiovertebroplasty.
C1 [Donanzam, B. A.; Campos, T. P. R.] Univ Fed Minas Gerais UFMG, Dept Engn Nucl, BR-31270901 Belo Horizonte, MG, Brazil.
   [Dalmazio, I.] Ctr Desenvolvimento Tecnol Nucl CDTN, Serv Reator & Tecn Analit, BR-31270901 Belo Horizonte, MG, Brazil.
   [Valente, E. S.] Ctr Desenvolvimento Tecnol Nucl CDTN, Unidade Pesquisa & Prod Radiofarm, BR-31270901 Belo Horizonte, MG, Brazil.
RP Dalmazio, I (reprint author), Ctr Desenvolvimento Tecnol Nucl CDTN, Serv Reator & Tecn Analit, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM id@cdtn.br
RI Campos, Tarcisio/D-1183-2017
FU Conselho Nacional de Desenvolvimento Cientifico (CNPq) e Tecnologico
FX The authors would like to thank Conselho Nacional de Desenvolvimento
   Cientifico (CNPq) e Tecnologico for grant support, Centro de
   Desenvolvimento da Tecnologia Nuclear (CDTN/CNEN), Departamento de
   Quimica da Universidade Federal de Minas Gerais (DQ-UFMG) and Centro de
   Microscopia da UFMG, for experimental support.
CR Ashamalla H, 2009, INT J RADIAT ONCOL, V75, P836, DOI 10.1016/j.ijrobp.2008.11.060
   Bilsky M H, 1999, Oncologist, V4, P459
   CAMPOS TPR, 2006, Patent No. 06057217
   Cardoso ER, 2009, J NEUROSURG-SPINE, V10, P336, DOI 10.3171/2008.11.SPINE0856
   Chen JD, 2011, MATER LETT, V65, P1923, DOI 10.1016/j.matlet.2011.03.076
   Chow LC, 2009, DENT MATER J, V28, P1
   Das T, 2009, CANCER BIOTHER RADIO, V24, P7, DOI 10.1089/cbr.2008.0545
   Destainville A, 2003, MATER CHEM PHYS, V80, P269, DOI 10.1016/S0254-0584(02)00466-2
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   El Kady AA, 2009, CERAM INT, V35, P2933, DOI 10.1016/j.ceramint.2009.03.042
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   Gerszten PC, 2005, J NEUROSURG-SPINE, V3, P296, DOI 10.3171/spi.2005.3.4.0296
   Haley ML, 2011, J NEUROSURG-SPINE, V14, P537, DOI 10.3171/2010.12.SPINE10233
   Heini PF, 2001, EUR SPINE J, V10, pS205, DOI 10.1007/s005860100308
   Helissey C, 2011, DISCOV MED, V11, P505
   Herath HMTU, 2010, J BIOMED MATER RES A, V94A, P130, DOI 10.1002/jbm.a.32667
   Hernandez L, 2009, J MATER SCI-MATER M, V20, P89, DOI 10.1007/s10856-008-3542-y
   HEZEL A, 1968, SPECTROCHIM ACTA A-M, VA 24, P131, DOI 10.1016/0584-8539(68)80019-4
   Hirsch AE, 2008, RADIOTHER ONCOL, V87, P119, DOI 10.1016/j.radonc.2008.01.010
   ICRP, 1979, ANN ICRP, V2, DOI 10.1016/0146-6453(79)90122-2
   Jasper LE, 2002, J MATER SCI-MATER M, V13, P1, DOI 10.1023/A:1013673830184
   Jillavenkatesa A, 1998, SPECTROSC LETT, V31, P1619, DOI 10.1080/00387019808007439
   Kaneko TS, 2010, PHYS MED BIOL, V55, P2451, DOI 10.1088/0031-9155/55/9/002
   KITSUGI T, 1995, BIOMATERIALS, V16, P1101, DOI 10.1016/0142-9612(95)98907-V
   Komath M, 2003, B MATER SCI, V26, P415, DOI 10.1007/BF02711186
   Kuo Jeffrey V, 2002, Med Dosim, V27, P137, DOI 10.1016/S0958-3947(02)00096-1
   Layrolle P, 1998, J AM CERAM SOC, V81, P1421
   Lee JH, 2003, KEY ENG MAT, V240-2, P399, DOI 10.4028/www.scientific.net/KEM.240-242.399
   Lieberman IH, 2005, SPINE J SUPPL 6, V5, P305
   Liu CS, 2003, BIOMATERIALS, V24, P2995, DOI 10.1016/S0142-9612(03)00125-X
   Loher S, 2005, CHEM MATER, V17, P36, DOI 10.1021/cm048776c
   Lu J, 2011, EUR J RADIOL, V78, P296, DOI 10.1016/j.ejrad.2010.09.002
   MACEDO RD, 2005, INT NUCL ATL C INAC, P1
   Menezes MABC, 2006, J RADIOANAL NUCL CH, V270, P111, DOI 10.1007/s10967-006-0316-1
   Neves M, 2011, APPL RADIAT ISOTOPES, V69, P80, DOI 10.1016/j.apradiso.2010.09.015
   Parry S J, 2003, HDB NEUTRON ACTIVATI
   Pena J, 2003, J EUR CERAM SOC, V23, P1687, DOI 10.1016/S0955-2219(02)00369-2
   Silveira Márcia Flávia, 2007, Matéria (Rio J.), V12, P186, DOI 10.1590/S1517-70762007000100024
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   Sz-Cluan L., 2002, BIOMATERIALS, V23, P4541
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Unni PR, 2002, NUCL MED BIOL, V29, P199, DOI 10.1016/S0969-8051(01)00303-1
   Vidaud C, 2012, CHEM RES TOXICOL, V25, P1161, DOI 10.1021/tx300064m
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   WONG DA, 1990, SPINE, V15, P1, DOI 10.1097/00007632-199001000-00001
NR 46
TC 4
Z9 4
U1 1
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2013
VL 24
IS 12
BP 2873
EP 2880
DI 10.1007/s10856-013-5024-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 253ZC
UT WOS:000327128300019
PM 23912793
DA 2018-10-20
ER

PT J
AU Kroustalli, A
   Zisimopoulou, AE
   Koch, S
   Rongen, L
   Deligianni, D
   Diamantouros, S
   Athanassiou, G
   Kokozidou, M
   Mavrilas, D
   Jockenhoevel, S
AF Kroustalli, A.
   Zisimopoulou, A. E.
   Koch, S.
   Rongen, L.
   Deligianni, D.
   Diamantouros, S.
   Athanassiou, G.
   Kokozidou, M.
   Mavrilas, D.
   Jockenhoevel, S.
TI Carbon nanotubes reinforced chitosan films: mechanical properties and
   cell response of a novel biomaterial for cardiovascular tissue
   engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HUMAN ENDOTHELIAL-CELLS; POLYMER COMPOSITES; SCAFFOLDS;
   BIOCOMPATIBILITY; FIBROBLASTS; FABRICATION; FIBERS; GROWTH
AB Carbon nanotubes have been proposed as fillers to reinforce polymeric biomaterials for the strengthening of their structural integrity to achieve better biomechanical properties. In this study, a new polymeric composite material was introduced by incorporating various low concentrations of multiwalled carbon nanotubes (MWCNTs) into chitosan (CS), aiming at achieving a novel composite biomaterial with superior mechanical and biological properties compared to neat CS, in order to be used in cardiovascular tissue engineering applications. Both mechanical and biological characteristics in contact with the two relevant cell types (endothelial cells and vascular myofibroblasts) were studied. Regarding the mechanical behavior of MWCNT reinforced CS (MWCNT/CS), 5 and 10 % concentrations of MWCNTs enhanced the mechanical behavior of CS, with that of 5 % exhibiting a superior mechanical strength compared to 10 % concentration and neat CS. Regarding biological properties, MWCNT/CS best supported proliferation of endothelial and myofibroblast cells, MWCNTs and MWCNT/CS caused no apoptosis and were not toxic of the examined cell types. Conclusively, the new material could be suitable for tissue engineering (TE) and particularly for cardiovascular TE applications.
C1 [Kroustalli, A.; Zisimopoulou, A. E.; Deligianni, D.; Athanassiou, G.; Mavrilas, D.] Univ Patras, Dept Mech Engn & Aeronaut, Lab Biomech & Biomed Engn, Patras, Greece.
   [Koch, S.; Rongen, L.; Diamantouros, S.; Jockenhoevel, S.] Rhein Westfal TH Aachen, AME Helmholtz Inst Biomed Engn, Dept Tissue Engn & Text Implants, Aachen, Germany.
   [Kokozidou, M.] Univ Hosp RWTH Aachen, Dept Vasc Surg, European Vasc Ctr Aachen Maastricht, Aachen, Germany.
RP Deligianni, D (reprint author), Univ Patras, Dept Mech Engn & Aeronaut, Lab Biomech & Biomed Engn, Patras, Greece.
EM deligian@mech.upatras.gr
OI Mavrilas, Dimosthenis/0000-0002-2503-5053; Jockenhoevel,
   Stefan/0000-0003-0584-9444; Athanassiou, George/0000-0003-3582-0204
FU Greek-German bilateral cooperation program IKY DAAD (IKYDA)
FX This work was partly supported with a Greek-German bilateral cooperation
   program IKY & DAAD (IKYDA 2010).
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Albanna MZ, 2012, J MECH BEHAV BIOMED, V5, P171, DOI 10.1016/j.jmbbm.2011.08.021
   Byrne MT, 2010, ADV MATER, V22, P1672, DOI 10.1002/adma.200901545
   Carson L, 2009, MATER LETT, V63, P617, DOI 10.1016/j.matlet.2008.11.060
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Fan HL, 2010, BIOMACROMOLECULES, V11, P2345, DOI 10.1021/bm100470q
   Fang N, 2005, MACROMOL BIOSCI, V5, P1022, DOI 10.1002/mabi.200500123
   Hirano S, 2010, TOXICOL APPL PHARM, V249, P8, DOI 10.1016/j.taap.2010.08.019
   Huang YC, 2011, J BIOMED MATER RES A, V99A, P86, DOI 10.1002/jbm.a.33164
   Khan U, 2007, COMPOS SCI TECHNOL, V67, P3158, DOI 10.1016/j.compscitech.2007.04.015
   Kim HS, 2008, ADV COMPOS MATER, V17, P157, DOI 10.1163/156855108X314788
   Liao HH, 2011, COLLOID SURFACE B, V84, P528, DOI 10.1016/j.colsurfb.2011.02.010
   Pagoulatou E, 2012, J MATER SCI-MATER M, V23, P1387, DOI 10.1007/s10856-012-4620-8
   Reddy ARN, 2010, TOXICOLOGY, V272, P11, DOI 10.1016/j.tox.2010.03.017
   Sahithi K, 2010, INT J BIOL MACROMOL, V46, P281, DOI 10.1016/j.ijbiomac.2010.01.006
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   Spinks GM, 2006, SENSOR ACTUAT B-CHEM, V115, P678, DOI 10.1016/j.snb.2005.10.047
   Tschoeke B, 2009, TISSUE ENG PT A, V15, P1909, DOI 10.1089/ten.tea.2008.0499
   Tsukahara T, 2011, MOL CELL BIOCHEM, V352, P57, DOI 10.1007/s11010-011-0739-z
   Tutak W, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/25/255101
   Upadhyayula VKK, 2010, BIOTECHNOL ADV, V28, P802, DOI 10.1016/j.biotechadv.2010.06.006
   van Vlimmeren MAA, 2010, J APPL PHYSIOL, V109, P1483, DOI 10.1152/japplphysiol.00571.2010
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Yildirim ED, 2008, J BIOMED MATER RES B, V87B, P406, DOI 10.1002/jbm.b.31118
   Zhao B, 2008, MATER LETT, V62, P4380, DOI 10.1016/j.matlet.2008.07.037
   Zhao QC, 2010, J NANOSCI NANOTECHNO, V10, P7126, DOI 10.1166/jnn.2010.2834
   Zund G, 1998, EUR J CARDIO-THORAC, V13, P160, DOI 10.1016/S1010-7940(97)00309-6
NR 31
TC 14
Z9 14
U1 1
U2 48
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2013
VL 24
IS 12
BP 2889
EP 2896
DI 10.1007/s10856-013-5029-8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 253ZC
UT WOS:000327128300021
PM 23979364
DA 2018-10-20
ER

PT J
AU Anderson-Schmidt, H
   Adler, L
   Aly, C
   Anghelescu, IG
   Bauer, M
   Baumgartner, J
   Becker, J
   Bianco, R
   Becker, T
   Bitter, C
   Bonsch, D
   Buckow, K
   Budde, M
   Buhrig, M
   Deckert, J
   Demiroglu, SY
   Dietrich, D
   Dumpelmann, M
   Engelhardt, U
   Fallgatter, AJ
   Feldhaus, D
   Figge, C
   Folkerts, H
   Franz, M
   Gade, K
   Gaebel, W
   Grabe, HJ
   Gruber, O
   Gullatz, V
   Gusky, L
   Heilbronner, U
   Helbing, K
   Hegerl, U
   Heinz, A
   Hensch, T
   Hiemke, C
   Jager, M
   Jahn-Brodmann, A
   Juckel, G
   Kandulski, F
   Kaschka, WP
   Kircher, T
   Koller, M
   Konrad, C
   Kornhuber, J
   Krause, M
   Krug, A
   Lee, M
   Leweke, M
   Lieb, K
   Mammes, M
   Meyer-Lindenberg, A
   Muhlbacher, M
   Muller, MJ
   Nieratschker, V
   Nierste, B
   Ohle, J
   Pfennig, A
   Pieper, M
   Quade, M
   Reich-Erkelenz, D
   Reif, A
   Reitt, M
   Reininghaus, B
   Reininghaus, EZ
   Riemenschneider, M
   Rienhoff, O
   Roser, P
   Rujescu, D
   Schennach, R
   Scherk, H
   Schmauss, M
   Schneider, F
   Schosser, A
   Schott, BH
   Schwab, SG
   Schwanke, J
   Skrowny, D
   Spitzer, C
   Stierl, S
   Stockel, J
   Stubner, S
   Thiel, A
   Volz, HP
   von Hagen, M
   Walter, H
   Witt, SH
   Wobrock, T
   Zielasek, J
   Zimmermann, J
   Zitzelsberger, A
   Maier, W
   Falkai, PG
   Rietschel, M
   Schulze, TG
AF Anderson-Schmidt, Heike
   Adler, Lothar
   Aly, Chadiga
   Anghelescu, Ion-George
   Bauer, Michael
   Baumgaertner, Jessica
   Becker, Joachim
   Bianco, Roswitha
   Becker, Thomas
   Bitter, Cosima
   Boensch, Dominikus
   Buckow, Karoline
   Budde, Monika
   Buehrig, Martin
   Deckert, Juergen
   Demiroglu, Sara Y.
   Dietrich, Detlef
   Duempelmann, Michael
   Engelhardt, Uta
   Fallgatter, Andreas J.
   Feldhaus, Daniel
   Figge, Christian
   Folkerts, Here
   Franz, Michael
   Gade, Katrin
   Gaebel, Wolfgang
   Grabe, Hans-Joergen
   Gruber, Oliver
   Gullatz, Verena
   Gusky, Linda
   Heilbronner, Urs
   Helbing, Krister
   Hegerl, Ulrich
   Heinz, Andreas
   Hensch, Tilman
   Hiemke, Christoph
   Jaeger, Markus
   Jahn-Brodmann, Anke
   Juckel, Georg
   Kandulski, Franz
   Kaschka, Wolfgang P.
   Kircher, Tilo
   Koller, Manfred
   Konrad, Carsten
   Kornhuber, Johannes
   Krause, Marina
   Krug, Axel
   Lee, Mahsa
   Leweke, Markus
   Lieb, Klaus
   Mammes, Mechthild
   Meyer-Lindenberg, Andreas
   Muehlbacher, Moritz
   Mueller, Matthias J.
   Nieratschker, Vanessa
   Nierste, Barbara
   Ohle, Jacqueline
   Pfennig, Andrea
   Pieper, Marlenna
   Quade, Matthias
   Reich-Erkelenz, Daniela
   Reif, Andreas
   Reitt, Markus
   Reininghaus, Bernd
   Reininghaus, Eva Z.
   Riemenschneider, Matthias
   Rienhoff, Otto
   Roser, Patrik
   Rujescu, Dan
   Schennach, Rebecca
   Scherk, Harald
   Schmauss, Max
   Schneider, Frank
   Schosser, Alexandra
   Schott, Bjoern H.
   Schwab, Sybille G.
   Schwanke, Jens
   Skrowny, Daniela
   Spitzer, Carsten
   Stierl, Sebastian
   Stoeckel, Judith
   Stuebner, Susanne
   Thiel, Andreas
   Volz, Hans-Peter
   von Hagen, Martin
   Walter, Henrik
   Witt, Stephanie H.
   Wobrock, Thomas
   Zielasek, Juergen
   Zimmermann, Joerg
   Zitzelsberger, Antje
   Maier, Wolfgang
   Falkai, Peter G.
   Rietschel, Marcella
   Schulze, Thomas G.
TI The "DGPPN-Cohort": a national collaboration initiative by the German
   Association for Psychiatry and Psychotherapy (DGPPN) for establishing a
   large-scale cohort of psychiatric patients
SO EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
LA English
DT Article
DE Schizophrenia; Bipolar disorder; Major depression; Anxiety disorders;
   Biobank
ID SCHIZOPHRENIA; PSYCHOSES; GENES; GWAS
AB The German Association for Psychiatry and Psychotherapy (DGPPN) has committed itself to establish a prospective national cohort of patients with major psychiatric disorders, the so-called DGPPN-Cohort. This project will enable the scientific exploitation of high-quality data and biomaterial from psychiatric patients for research. It will be set up using harmonised data sets and procedures for sample generation and guided by transparent rules for data access and data sharing regarding the central research database. While the main focus lies on biological research, it will be open to all kinds of scientific investigations, including epidemiological, clinical or health-service research.
C1 [Anderson-Schmidt, Heike; Aly, Chadiga; Bianco, Roswitha; Bitter, Cosima; Budde, Monika; Engelhardt, Uta; Feldhaus, Daniel; Gade, Katrin; Gruber, Oliver; Gullatz, Verena; Heilbronner, Urs; Jahn-Brodmann, Anke; Krause, Marina; Nierste, Barbara; Reich-Erkelenz, Daniela; Reitt, Markus; Stoeckel, Judith; Falkai, Peter G.; Schulze, Thomas G.] Univ Med Ctr Gottingen, Sect Psychiat Genet, Dept Psychiat & Psychotherapy, D-37075 Gottingen, Germany.
   [Adler, Lothar] Oecumen Hainich Clin GmbH, Dept Neurol Child & Adolescent Psychiat, Muhlhausen, Germany.
   [Aly, Chadiga; Dietrich, Detlef; Reif, Andreas] Ameos Psychiat & Psychotherapeut Hosp Hildesheim, Hildesheim, Germany.
   [Anghelescu, Ion-George; Zielasek, Juergen] Private Mental Hosp Dr Med Kurt Fontheim, Liebenburg, Germany.
   [Bauer, Michael; Pfennig, Andrea] Univ Hosp Carl Gustav Carus Dresden, Dept Psychiat & Psychotherapy, Dresden, Germany.
   [Baumgaertner, Jessica; Schmauss, Max; Stuebner, Susanne] Hosp Psychiat Psychotherapy & Psychosomat, Augsburg, Germany.
   [Becker, Joachim] Vitos Clin Psychiat & Psychotherapy, Herborn, Germany.
   [Becker, Joachim; Jaeger, Markus] Univ Ulm, Dept Psychiat 2, Bkh Gunzburg, Germany.
   [Bitter, Cosima; Feldhaus, Daniel; Krause, Marina; Scherk, Harald] Ameos Hosp, Osnabruck, Germany.
   [Boensch, Dominikus] Mental State Hosp, Lohr, Germany.
   [Buckow, Karoline; Demiroglu, Sara Y.; Gusky, Linda; Helbing, Krister; Lee, Mahsa; Quade, Matthias; Rienhoff, Otto; Schwanke, Jens; Skrowny, Daniela] Univ Med Ctr Gottingen, Dept Med Informat, D-37075 Gottingen, Germany.
   [Buehrig, Martin] Psychiat Treatment Ctr North Bremen, Bremen, Germany.
   [Deckert, Juergen; Reif, Andreas] Univ Hosp Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany.
   [Duempelmann, Michael; Spitzer, Carsten] Asklepios Specialist Hosp Tiefenbrunn, Tiefenbronn, Germany.
   [Fallgatter, Andreas J.; Nieratschker, Vanessa] Univ Tubingen, Dept Psychiat, Tubingen, Germany.
   [Figge, Christian; Mammes, Mechthild; Ohle, Jacqueline] Karl Jaspers Hosp, Bad Zwischenahn, Germany.
   [Folkerts, Here; Zitzelsberger, Antje] Reinhard Nieter Hosp, Dept Psychiat & Psychotherapy, Wilhelmshaven, Germany.
   [Franz, Michael] Vitos Clin Kurhessen Psychiat & Psychotherapy, Bad Emstal, Germany.
   [Gaebel, Wolfgang; Zielasek, Juergen] Univ Dusseldorf, Dept Psychiat & Psychotherapy, Dusseldorf, Germany.
   [Grabe, Hans-Joergen] Univ Hosp Greifswald, Dept Psychiat & Psychotherapy, Greifswald, Germany.
   [Hegerl, Ulrich; Hensch, Tilman] Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany.
   [Heinz, Andreas; Schott, Bjoern H.; Walter, Henrik] Charite, Dept Neurol Neurosurg & Psychiat, Berlin, Germany.
RP Schulze, TG (reprint author), Univ Med Ctr Gottingen, Sect Psychiat Genet, Dept Psychiat & Psychotherapy, Von Siebold Str 5, D-37075 Gottingen, Germany.
EM thomas.schulze@med.uni-goettingen.de
RI Leweke, F. Markus/D-5435-2009; Reich-Erkelenz, Daniela/D-9736-2018;
   Schott, Bjorn/U-5626-2017; Becker, Thomas/O-9769-2014; Walter,
   Henrik/O-2612-2013; Kornhuber, Johannes/B-9613-2014; Muller,
   Matthias/A-2613-2015
OI Leweke, F. Markus/0000-0002-8163-195X; Reich-Erkelenz,
   Daniela/0000-0001-7818-539X; Schott, Bjorn/0000-0002-8237-4481; Becker,
   Thomas/0000-0001-8179-1219; Kornhuber, Johannes/0000-0002-8096-3987;
   Muller, Matthias/0000-0002-7577-2748; Heilbronner,
   Urs/0000-0001-7135-762X; Reininghaus, Eva/0000-0001-5964-4087; Hensch,
   Tilman/0000-0003-2696-6017; Meyer-Lindenberg,
   Andreas/0000-0001-5619-1123; Kircher, Tilo/0000-0002-2514-2625; Hegerl,
   Ulrich/0000-0002-3039-7470; Muehlbacher, Moritz/0000-0002-3398-3889
FU Deutsche Forschungsgemeinschaft (DFG) [SCHU 1603/5-1]
FX This work is supported by the Deutsche Forschungsgemeinschaft (DFG) via
   the Clinical Research Group 241 "Genotype-phenotype relationships and
   neurobiology of the longitudinal course of psychosis"
   (http://www.kfo241.de; grant number SCHU 1603/5-1).
CR Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410
   Bondy Brigitta, 2003, Dialogues Clin Neurosci, V5, P129
   David AS, 2008, SCHIZOPHRENIA BULL, V34, P1035, DOI 10.1093/schbul/sbn028
   Johnstone Eve C, 2003, World Psychiatry, V2, P45
   Kim H, 2011, J MED SYST, V35, P647, DOI 10.1007/s10916-009-9402-6
   Lee KW, 2012, NEUROSCI BIOBEHAV R, V36, P556, DOI 10.1016/j.neubiorev.2011.09.001
   Lonnqvist JE, 2009, J ABNORM PSYCHOL, V118, P418, DOI 10.1037/a0015127
   Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71
   Manrique-Garcia E, 2012, PSYCHOL MED, V42, P1321, DOI 10.1017/S0033291711002078
   Nielbuhr DW, 2008, AM J PSYCHIAT, V165, P99
   Stefanis NC, 2007, BIOL PSYCHIAT, V62, P784, DOI 10.1016/j.biopsych.2006.11.015
   Sullivan PF, 2010, NEURON, V68, P182, DOI 10.1016/j.neuron.2010.10.003
   Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9
   Williams HJ, 2009, BRIT MED BULL, V91, P61, DOI 10.1093/bmb/ldp017
   Wray NR, 2010, SCHIZOPHRENIA BULL, V36, P14, DOI 10.1093/schbul/sbp137
NR 15
TC 16
Z9 16
U1 0
U2 18
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0940-1334
EI 1433-8491
J9 EUR ARCH PSY CLIN N
JI Eur. Arch. Psych. Clin. Neurosci.
PD DEC
PY 2013
VL 263
IS 8
BP 695
EP 701
DI 10.1007/s00406-013-0401-8
PG 7
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 249TI
UT WOS:000326799500009
PM 23545941
DA 2018-10-20
ER

PT J
AU Silva, D
   Arancibia, R
   Tapia, C
   Acuna-Rougier, C
   Diaz-Dosque, M
   Caceres, M
   Martinez, J
   Smith, PC
AF Silva, D.
   Arancibia, R.
   Tapia, C.
   Acuna-Rougier, C.
   Diaz-Dosque, M.
   Caceres, M.
   Martinez, J.
   Smith, P. C.
TI Chitosan and platelet-derived growth factor synergistically stimulate
   cell proliferation in gingival fibroblasts
SO JOURNAL OF PERIODONTAL RESEARCH
LA English
DT Article
DE cell proliferation; chitosan; fibroblast; gingival
ID AKT SIGNALING PATHWAYS; IN-VITRO; EXTRACELLULAR-MATRIX; SKIN
   FIBROBLASTS; BREAST-CANCER; ERK; ACTIVATION; KINASE; ROLES;
   PHOSPHORYLATION
AB Background and ObjectiveChitosan is a naturally derived polymer that may be applied in periodontal therapy for tissue-reconstruction purposes. Previous studies have shown that chitosan may stimulate tissue healing. However, reports exploring the cellular responses stimulated by chitosan are lacking. In the present study we analyzed whether chitosan may promote cell proliferation in primary cultures of human gingival fibroblasts.
   Material and MethodsChitosan particles were generated, and their size, zeta potential and morphology were characterized using transmission and scanning electron microscopy and zetasizer analysis. The biocompatibility of chitosan particles was analyzed using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) cell-viability assay and by detecting the release of lactate dehydrogenase into the cell-culture medium. The total number of cells was estimated by staining with crystal violet followed by measurement of the absorbance at 560nm on a microplate reader. Cell proliferation was studied by detecting proliferating cell nuclear antigen protein levels, immunofluorescence for Ki67 and incorporation of 5-bromo-2-deoxyuridine.
   ResultsThe sizes of the chitosan particles generated were in the micrometer and nanometer ranges. Cell viability was increased in the presence of chitosan. Moreover, the combination of chitosan and platelet-derived growth factor (PDGF-BB) potently stimulated cell viability, cell proliferation and activation of the ERK1/2 pathway involved in cell proliferation.
   ConclusionsThe present study shows that chitosan is well tolerated by gingival fibroblasts and is able to stimulate cell proliferation through the ERK1/2 signaling pathway. A synergistic response between chitosan and growth factors (such as PDGF-BB) may stimulate cell proliferation in gingival fibroblasts exposed to this biomaterial.
C1 [Silva, D.; Arancibia, R.; Caceres, M.; Smith, P. C.] Pontificia Univ Catolica Chile, Dent Acad Unit, Fac Med, Santiago 8330024, Chile.
   [Tapia, C.; Acuna-Rougier, C.] Univ Chile, Fac Odontol, Santiago, Chile.
   [Diaz-Dosque, M.] Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile.
   [Martinez, J.] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile.
RP Smith, PC (reprint author), Pontificia Univ Catolica Chile, Sch Dent, Fac Med, Marcoleta 391, Santiago 8330024, Chile.
EM psmith@med.puc.cl
RI Smith, Patricio/I-5897-2014; tapia, cristian/J-3615-2014
OI Smith, Patricio/0000-0001-7314-621X; tapia, cristian/0000-0003-0151-6829
FU Chilean Fund for Science and Development FONDEF [DO8I1141]; Government
   of Chile; Colgate Palmolive; Pontificia Universidad Catolica de Chile;
   Universidad de Chile
FX The present study was funded by a grant from the Chilean Fund for
   Science and Development FONDEF, grant number DO8I1141. This fund
   involves resources from the Government of Chile, Colgate Palmolive,
   Pontificia Universidad Catolica de Chile and Universidad de Chile.
CR Akman AC, 2010, J BIOMED MATER RES A, V92A, P953, DOI 10.1002/jbm.a.32428
   Akncbay H, 2007, J BIOMED MATER RES B, V80, P290
   Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   Beresford MJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1618
   Bernkop-Schnurch A, 2012, EUR J PHARM BIOPHARM, V81, P463, DOI 10.1016/j.ejpb.2012.04.007
   Bindar D., 2010, ROMANIAN J BIOPHYS, V20, P23
   Caceres M, 2005, EXP CELL RES, V309, P229, DOI 10.1016/j.yexcr.2005.05.020
   Choi BK, 2001, INT J ANTIMICROB AG, V18, P553, DOI 10.1016/S0924-8579(01)00434-4
   Chrissouli S, 2010, WOUND REPAIR REGEN, V18, P643, DOI 10.1111/j.1524-475X.2010.00626.x
   DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686
   Eckes B, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-4
   Faucheux N, 2002, BIOMATERIALS, V23, P2295, DOI 10.1016/S0142-9612(01)00363-5
   Francesko A, 2011, ADV BIOCHEM ENG BIOT, V125, P1, DOI [10.1007/10_2010_93, 10.10007/10_2010_93]
   GERDES J, 1991, AM J PATHOL, V138, P867
   Guo F, 2011, PLOS ONE, V6
   Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x
   He B, 2011, EUR J PHARMACOL, V667, P195, DOI 10.1016/j.ejphar.2011.06.001
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Ikinci G, 2002, INT J PHARM, V235, P121, DOI 10.1016/S0378-5173(01)00974-7
   IRWIN CR, 1994, J PERIODONTAL RES, V29, P309, DOI 10.1111/j.1600-0765.1994.tb01227.x
   Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83
   Larjava H, 2011, J CAN DENT ASSOC, V77
   Lee J.-K., 1998, ENV ENG RES, V3, P97
   LEONARDI E, 1992, J CLIN PATHOL, V45, P416, DOI 10.1136/jcp.45.5.416
   Lopez-Leon T, 2005, J COLLOID INTERF SCI, V283, P344, DOI 10.1016/j.jcis.2004.08.186
   Majima T, 2007, P I MECH ENG H, V221, P537, DOI 10.1243/09544119JEIM203
   Marichal N, 2009, J NEUROSCI, V29, P10010, DOI 10.1523/JNEUROSCI.6183-08.2009
   Matsuda N, 2003, BIOMATERIALS, V24, P4771, DOI 10.1016/S0142-9612(03)00375-2
   Mattioli-Belmonte M, 1997, CARBOHYDR EUR, V19, P30
   McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001
   Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633
   Morelli T, 2011, J DENT RES, V90, P456, DOI 10.1177/0022034510389334
   Nagasawa Hiromichi, 2012, Front Biosci (Elite Ed), V4, P711
   PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403
   Pratsinis H, 2012, J ORTHOP RES, V30, P958, DOI 10.1002/jor.22017
   Ramseier CA, 2012, PERIODONTOL 2000, V59, P185, DOI 10.1111/j.1600-0757.2011.00432.x
   Sarasam AR, 2008, J MATER SCI-MATER M, V19, P1083, DOI 10.1007/s10856-007-3072-z
   Shen EC, 2008, J PERIODONTAL RES, V43, P642, DOI 10.1111/j.1600-0765.2007.01045.x
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224
   Xu C, 2012, J BIOMED MATER RES B, V100B, P1435, DOI 10.1002/jbm.b.32662
   Xu JH, 1996, J CELL BIOL, V132, P239, DOI 10.1083/jcb.132.1.239
   Yan Y X, 2012, PLOS ONE, V7
   Zhou WJ, 2011, J MATER SCI-MATER M, V22, P1221, DOI 10.1007/s10856-011-4304-9
NR 44
TC 7
Z9 8
U1 0
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3484
EI 1600-0765
J9 J PERIODONTAL RES
JI J. Periodont. Res.
PD DEC
PY 2013
VL 48
IS 6
BP 677
EP 686
DI 10.1111/jre.12053
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 248XF
UT WOS:000326738400001
PM 23452122
DA 2018-10-20
ER

PT J
AU Brooks, AE
   Brooks, BD
   Davidoff, SN
   Hogrebe, PC
   Fisher, MA
   Grainger, DW
AF Brooks, Amanda E.
   Brooks, Benjamin D.
   Davidoff, Sherry N.
   Hogrebe, Paul C.
   Fisher, Mark A.
   Grainger, David W.
TI Polymer-controlled release of tobramycin from bone graft void filler
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Article
DE Allograft bone; Tobramycin; Controlled release; Polycaprolactone;
   Implant infection
AB Despite clinical, material, and pharmaceutical advances, infection remains a major obstacle in total joint revision surgery. Successful solutions must extend beyond bulk biomaterial and device modifications, integrating locally delivered pharmaceuticals and physiological cues at the implant site, or within large bone defects with prominent avascular spaces. One approach involves coating clinically familiar allograft bone with an antibiotic-releasing rate-controlling polymer membrane for use as a matrix for local drug release in bone. The kinetics of drug release from this system can be tailored via alterations in the substrate or the polymeric coating. Drug-loaded polycaprolactone coating releases bioactive tobramycin from both cadaveric-sourced cancellous allograft fragments and synthetic hybrid coralline ceramic bone graft fragments with similar kinetics over a clinically relevant 6-week timeframe. However, micron-sized allograft particulate provides extended bioactive tobramycin release. Addition of porogen polyethylene glycol to the polymer coating formulation changes tobramycin release kinetics without significant impact on released antibiotic bioactivity. Incorporation of oil-microencapsulated tobramycin into the polymer coating did not significantly modify tobramycin release kinetics. In addition to releasing inhibitory concentrations of tobramycin, antibiotic-loaded allograft bone provides recognized beneficial osteoconductive potential, attractive for decreasing orthopedic surgical infections with improved filling of dead space and new bone formation.
C1 [Brooks, Amanda E.; Brooks, Benjamin D.; Grainger, David W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [Fisher, Mark A.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.
   [Davidoff, Sherry N.; Hogrebe, Paul C.; Grainger, David W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Brooks, AE (reprint author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
EM amanda.brooks@utah.edu
FU University of Utah [51003471]
FX The authors gratefully acknowledge support from an internal University
   of Utah technology commercialization grant (#51003471). Additionally, we
   thank Dr. B. Evans for gifts of allograft bone and synthetic corraline
   HAP material for all experiments. This article does not contain any
   studies with human or animal subjects.
CR [Anonymous], 2007, ORTHOPEDIC BIOMATERI
   Antoci V, 2007, CLIN ORTHOP RELAT R, P200, DOI 10.1097/BLO.0b013e31811ff866
   Beaman FD, 2006, RADIOGRAPHICS, V26, P373, DOI 10.1148/rg.262055039
   BEGG EJ, 1995, BRIT J CLIN PHARMACO, V39, P597
   Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P2
   Bordes C, 2010, INT J PHARMACEUT, V383, P236, DOI 10.1016/j.ijpharm.2009.09.023
   Borkhuu B, 2008, SPINE, V33, P2300, DOI 10.1097/BRS.0b013e31818786ff
   Bostrom Mathias P G, 2005, HSS J, V1, P9, DOI 10.1007/s11420-005-0111-5
   Bramfeldt H, 2008, POLYM DEGRAD STABIL, V93, P877, DOI 10.1016/j.polymdegradstab.2008.01.023
   BRANDL M, 1992, DRUG DEV IND PHARM, V18, P1423, DOI 10.3109/03639049209040849
   Buttaro MA, 2005, J BONE JOINT SURG BR, V87B, P1684, DOI 10.1302/0301-620X.87B12.16781
   Buttaro MA, 2003, ACTA ORTHOP SCAND, V74, P505, DOI 10.1080/00016470310017884
   Buttaro M, 2007, CLIN ORTHOP RELAT R, P74, DOI 10.1097/BLO.0b013e318073c290
   Chang HI, 2006, J CONTROL RELEASE, V110, P414, DOI 10.1016/j.jconrel.2005.10.028
   Chen CE, 2005, ARCH ORTHOP TRAUM SU, V125, P369, DOI 10.1007/s00402-005-0794-6
   Chuang W, 2005, J POLYM RES, V12
   Chuang WT, 2006, MACROMOL RES, V14, P45, DOI 10.1007/BF03219067
   Ciampolini J, 2000, POSTGRAD MED J, V76, P479, DOI 10.1136/pmj.76.898.479
   Communication OotADf, 2006, CDC URG HOSP HEALTHC
   Conterno LO, 2009, COCHRANE DB SYST REV, V3
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   Costerton J, 1984, REV INFECT DIS S3, V6, P608
   Darley ESR, 2004, J ANTIMICROB CHEMOTH, V53, P928, DOI 10.1093/jac/dkh191
   Davidoff Sherry N, 2011, Biomed Sci Instrum, V47, P46
   Davidoff Sherry N, 2010, Biomed Sci Instrum, V46, P184
   Day RE, 2005, J BONE JOINT SURG BR, V87B, P1568, DOI 10.1302/0301-620X.87B11.16384
   Diefenbeck M, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2006.04.015
   Dunnett C, 2006, STAT PHARM IND, P421
   Finley J M, 2001, J West Soc Periodontol Periodontal Abstr, V49, P5
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gogia Jaspaul S, 2009, Semin Plast Surg, V23, P100, DOI 10.1055/s-0029-1214162
   Harris RJ, 1998, J PERIODONTOL, V69, P536, DOI 10.1902/jop.1998.69.5.536
   Huang JC, 2006, J APPL POLYM SCI, V100, P2002, DOI 10.1002/app.22340
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jiranek WA, 2006, J BONE JOINT SURG AM, V88A, P2487, DOI 10.2106/JBJS.E.01126
   Kanellakopoulou K, 2008, J CHEMOTHERAPY, V20, P645, DOI 10.1179/joc.2008.20.5.645
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Ketonis C, 2010, TISSUE ENG PT A, V16, P2041, DOI [10.1089/ten.tea.2009.0610, 10.1089/ten.TEA.2009.0610]
   Ketonis C, 2011, ANTIMICROB AGENTS CH, V55, P487, DOI 10.1128/AAC.00741-10
   Ketonis C, 2011, BONE, V48, P631, DOI 10.1016/j.bone.2010.10.171
   Ketonis C, 2010, CLIN ORTHOP RELAT R, V468, P2113, DOI 10.1007/s11999-010-1322-8
   Koort JK, 2005, ANTIMICROB AGENTS CH, V49, P1502, DOI 10.1128/AAC.49.4.1502-1508.2005
   Koort JK, 2008, ACTA ORTHOP, V79, P295, DOI 10.1080/17453670710015111
   Koort JK, 2006, J BIOMED MATER RES A, V78A, P532, DOI 10.1002/jbm.a.30766
   Lam CXF, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034108
   Landersdorfer CB, 2009, CLIN PHARMACOKINET, V48, P89, DOI 10.2165/0003088-200948020-00002
   LEVIN PD, 1975, J BONE JOINT SURG BR, V57, P234
   LEVISON ME, 1972, ANTIMICROB AGENTS CH, V1, P381, DOI 10.1128/AAC.1.5.381
   LINDSEY RW, 1993, CLIN ORTHOP RELAT R, P303
   Liu JB, 2004, J PHARM SCI-US, V93, P132, DOI 10.1002/jps.10533
   Liu KL, 2011, MOL PHARMACEUT, V8, P2173, DOI 10.1021/mp200513b
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   Malinin Theodore I, 2007, Open Orthop J, V1, P19, DOI 10.2174/1874325000701010019
   Mathijssen NMC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-96
   McKee MD, 2002, J ORTHOP TRAUMA, V16, P622, DOI 10.1097/01.BOT.0000031145.58425.82
   McLaren AC, 2004, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000143554.56897.26
   MICLAU T, 1993, J ORTHOPAED RES, V11, P627, DOI 10.1002/jor.1100110503
   MOUSSET B, 1995, INT ORTHOP, V19, P157
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Orthovita, 2000, PACK VIT SYNTH CANC
   Parikh S N, 2002, J Postgrad Med, V48, P142
   Patzakis MJ, 2005, J AM ACAD ORTHOP SUR, V13, P417, DOI 10.5435/00124635-200510000-00006
   PETRI WH, 1993, J ORAL MAXIL SURG, V51, P982, DOI 10.1016/S0278-2391(10)80039-4
   Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050
   Rhyu KH, 2003, INT ORTHOP, V27, P53, DOI 10.1007/s00264-002-0384-y
   Sevy Justin O, 2010, Biomed Sci Instrum, V46, P136
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Wan Y, 2006, BIOMACROMOLECULES, V7, P1362, DOI 10.1021/bm0600825
   Wei XW, 2009, INT J PHARMACEUT, V381, P1, DOI 10.1016/j.ijpharm.2009.07.033
   WHITESIDE LA, 1994, CLIN ORTHOP RELAT R, P169
   Winkler H, 2008, J BONE JOINT SURG BR, V90B, P1580, DOI 10.1302/0301-620X.90B12.20742
   Winkler H, 2000, J ANTIMICROB CHEMOTH, V46, P423, DOI 10.1093/jac/46.3.423
   Winkler Heinz, 2006, Cell and Tissue Banking, V7, P319, DOI 10.1007/s10561-006-9010-3
   Witso E, 2005, ACTA ORTHOP, V76, P481, DOI 10.1080/17453670510041457
   Witso E, 2004, ACTA ORTHOP SCAND, V75, P339, DOI 10.1080/00016470410001295
   Witso E, 2002, ACTA ORTHOP SCAND, V73, P199, DOI 10.1080/000164702753671812
   Witso E, 1999, ACTA ORTHOP SCAND, V70, P298, DOI 10.3109/17453679908997812
   Witso E, 2000, ACTA ORTHOP SCAND, V71, P80, DOI 10.1080/00016470052943955
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   WU PL, 1982, J PHARM SCI, V71, P1285, DOI 10.1002/jps.2600711125
NR 83
TC 7
Z9 7
U1 3
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD DEC
PY 2013
VL 3
IS 6
BP 518
EP 530
DI 10.1007/s13346-013-0155-x
PG 13
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA V39QF
UT WOS:000209424800003
PM 25786372
DA 2018-10-20
ER

PT J
AU Ahmad, B
   Stoyanov, S
   Pelan, E
   Stride, E
   Edirisinghe, M
AF Ahmad, Bilal
   Stoyanov, Simeon
   Pelan, Eddie
   Stride, Eleanor
   Edirisinghe, Mohan
TI Electrospinning of ethyl cellulose fibres with glass and steel needle
   configurations
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article
DE Electrospinning; Glass needle; Steel needle; Fibre aspect ratio; Ethyl
   cellulose
AB A novel device to produce ethyl cellulose fibres, an important biomaterial in modern food processing, using a glass needle in a modified electrospinning setup has been investigated. The effect of applied voltage on the fibre aspect ratio was analysed during electrospinning with a metallic (stainless steel) needle and then compared with that obtained with a glass-steel needle combination. A distinct difference in fibre diameter was observed between the two needle setups for the same processing conditions. A detailed quantitative study of the fibre length and diameter with respect to applied voltage was also carried out in order to determine any relationship between the needle material and the resulting electrospun fibres. There was an increase in fibre diameter in the case of steel-steel needle electrospinning with increasing applied voltage while a decrease in fibre diameter was observed with glass-steel needle electrospinning for the same voltage. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Ahmad, Bilal; Stride, Eleanor; Edirisinghe, Mohan] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Stoyanov, Simeon; Pelan, Eddie] Unilever Res, NL-3130 AC Vlaardingen, Netherlands.
   [Stride, Eleanor] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford OX3 7DQ, England.
RP Edirisinghe, M (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
EM m.edirisinghe@ucl.ac.uk
OI Stride, Eleanor/0000-0003-3371-5929; Stoyanov,
   Simeon/0000-0002-0610-3110
FU Unilever; EPSRC (doctoral research program of Bilal Ahmad); Engineering
   and Physical Sciences Research Council [EP/I021795/1]
FX The authors would like to thank Unilever and the EPSRC (doctoral
   research program of Bilal Ahmad) for providing the funding for this work
   via an industrial case studentship. The authors would also like to thank
   the Archaeology Department at UCL for the use of their scanning electron
   microscopes in this study and the Engineering Instrument Loan Pool for
   lending us the Phantom V7.1 high speed camera, especially Mr. Adrian
   Walker for his generous help.
CR Ahmad B, 2012, FOOD BIOPROCESS TECH, V5, P2848, DOI 10.1007/s11947-011-0650-3
   Ahmad B, 2012, CARBOHYD POLYM, V89, P222, DOI 10.1016/j.carbpol.2012.02.074
   Angammana CJ, 2011, IEEE T IND APPL, V47, P1028, DOI 10.1109/TIA.2010.2103392
   Chang ST, 2012, FOOD HYDROCOLLOID, V27, P137, DOI 10.1016/j.foodhyd.2011.08.004
   Cuculo J, 2000, STRUCTURE FORMATION, P296
   Dosunmu OO, 2006, NANOTECHNOLOGY, V17, P1123, DOI 10.1088/0957-4484/17/4/046
   Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Jaworek A., 1992, T I FLUID FLOW MACH, V94, P155
   Jimenez M, 2004, EUR FOOD RES TECHNOL, V219, P588, DOI 10.1007/s00217-004-0992-4
   Kim CW, 2006, POLYMER, V47, P5097, DOI 10.1016/j.polymer.2006.05.033
   Kim SJ, 2005, J APPL POLYM SCI, V96, P1388, DOI 10.1002/app.21567
   Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0
   Lee JS, 2004, J APPL POLYM SCI, V93, P1638, DOI 10.1002/app.20602
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S
   Lopez-Rubio A, 2006, TRENDS FOOD SCI TECH, V17, P567, DOI 10.1016/j.tifs.2006.04.012
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Niu H., 2012, J ENG FIBRE FABRIC, V7, P7
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Si T, 2012, ACTA MECH SINICA-PRC, V28, P644, DOI 10.1007/s10409-012-0101-z
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   TANG KQ, 1995, J COLLOID INTERF SCI, V175, P326, DOI 10.1006/jcis.1995.1464
   Yan ZY, 2008, CARBOHYD RES, V343, P73, DOI 10.1016/j.carres.2007.10.024
   Yarin AL, 2011, POLYM ADVAN TECHNOL, V22, P310, DOI 10.1002/pat.1781
   Ying Y., 2006, 8 INT C PROP APPL DI
   Yu JH, 2004, ADV MATER, V16, P1562, DOI 10.1002/adma.200306644
   Zhang JF, 2009, MACROMOLECULES, V42, P5278, DOI 10.1021/ma900657y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 31
TC 3
Z9 3
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD DEC
PY 2013
VL 54
IS 2
BP 1761
EP 1772
DI 10.1016/j.foodres.2013.09.021
PG 12
WC Food Science & Technology
SC Food Science & Technology
GA V38PE
UT WOS:000209354500001
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yu, Y
   Zhang, H
   Sun, H
   Xing, DD
   Yao, FL
AF Yu, Yang
   Zhang, Hong
   Sun, Hong
   Xing, Dandan
   Yao, Fanglian
TI Nano-hydroxyapatite formation via co-precipitation with
   chitosan-g-poly(N-isopropylacrylamide) in coil and globule states for
   tissue engineering application
SO FRONTIERS OF CHEMICAL SCIENCE AND ENGINEERING
LA English
DT Article
DE chitosan; poly(N-isopropylacrylamide); hydroxyapatite; coil; globule;
   bone tissue engineering
AB With the excellent biocompatibility and osteo-conductivity, nano-hydroxyapatite (nHA) has shown significant prospect in the biomedical applications. Controlling the size, crystallinity and surface properties of nHA crystals is a critical challenge in the design of HA based biomaterials. With the graft copolymer of chitosan and poly(N-isopropylacrylamide) in coil and globule states as a template respectively, a novel composite from chitosan-g-poly(N-isopropylacrylamide) and nano-hydroxyapatite (CS-g-PNIPAM/nHA) was prepared via co-precipitation. Zeta potential analysis, thermogravimetric analysis and X-ray diffraction were used to identify the formation mechanism of the CS-g-PNIPAM/nHA composite and its morphology was observed by transmission electron microscopy. The results suggested that the physical aggregation states of the template polymer could induce or control the size, crystallinity and morphology of HA crystals in the CS-g-PNIPAM/nHA composite. The CS-g-PNIPAM/nHA composite was then introduced to chitosan-gelatin (CS-Gel) polyelectronic complex and the cytocompatibility of the resulting CSGel/composite hybrid film was evaluated. This hybrid film was proved to be favorable for the proliferation of MC 3T3-E1 cells. Therefore, the CS-g-PNIPAM/nHA composite is a potential biomaterial in bone tissue engineering.
C1 [Yu, Yang; Xing, Dandan; Yao, Fanglian] Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.
   [Zhang, Hong] Waseda Univ ASMeW, Consolidated Res Inst Adv Sci & Med Care, Shinjuku Ku, Tokyo 1620041, Japan.
   [Sun, Hong] Hebei United Univ, Basic Med Coll, Tangshan 063000, Peoples R China.
RP Zhang, H (reprint author), Waseda Univ ASMeW, Consolidated Res Inst Adv Sci & Med Care, Shinjuku Ku, Tokyo 1620041, Japan.
EM hzhang@aoni.waseda.jp; yaofanglian@tju.edu.cn
FU National Natural Science Foundation of China [51073119, 31271016,
   81101448, 31100674]; Ministry of Science and Technology of China
   [2013DFG52040]
FX This work is supported by National Natural Science Foundation of China
   (Grant Nos. 51073119, 31271016, 81101448 and 31100674) and Ministry of
   Science and Technology of China (2013DFG52040). We appreciate Dr. Yan
   Wen (School of Science, Tianjin University of Commerce) greatly for many
   helpful discussion and suggestions.
CR Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2003, BIOMATERIALS, V24, P3087, DOI 10.1016/S0142-9612(03)00150-9
   Chen C, 2013, CARBOHYD POLYM, V92, P621, DOI 10.1016/j.carbpol.2012.09.014
   Chen JD, 2010, COLLOID SURFACE B, V81, P640, DOI 10.1016/j.colsurfb.2010.08.017
   Dai YF, 2012, APPL SURF SCI, V258, P2850, DOI 10.1016/j.apsusc.2011.10.147
   Davidenko N, 2010, ACTA BIOMATER, V6, P466, DOI 10.1016/j.actbio.2009.07.029
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   He D, 2008, APPL SURF SCI, V255, P361, DOI 10.1016/j.apsusc.2008.06.151
   Ho KM, 2010, COLLOID POLYM SCI, V288, P1503, DOI 10.1007/s00396-010-2276-9
   Jiang J, 2012, INT J BIOL MACROMOL, V50, P586, DOI 10.1016/j.ijbiomac.2012.01.033
   Jin HH, 2012, INT J BIOL MACROMOL, V51, P1079, DOI 10.1016/j.ijbiomac.2012.08.027
   Kailasanathan C, 2012, CERAM INT, V38, P3569, DOI 10.1016/j.ceramint.2011.12.073
   Kandori K, 2009, COLLOID SURFACE B, V73, P140, DOI 10.1016/j.colsurfb.2009.05.011
   Kim BS, 2013, J BIOMED MATER RES A, V101, P1550, DOI 10.1002/jbm.a.34456
   Lai JT, 2002, MACROMOLECULES, V35, P6754, DOI 10.1021/ma020362m
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Li D, 2012, LANGMUIR, V28, P16338, DOI 10.1021/la303237u
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Li JJ, 2011, CARBOHYD POLYM, V85, P885, DOI 10.1016/j.carbpol.2011.04.015
   Li JJ, 2010, MAT SCI ENG C-MATER, V30, P795, DOI 10.1016/j.msec.2010.03.011
   Li JJ, 2009, MAT SCI ENG C-BIO S, V29, P1207, DOI 10.1016/j.msec.2008.09.038
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Liou SC, 2003, BIOMATERIALS, V24, P3981, DOI 10.1016/S0142-9612(03)00303-X
   Liu HF, 2007, J BIOMATER APPL, V21, P413, DOI 10.1177/0885328206065241
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Poursamar SA, 2011, COLLOID SURFACE B, V84, P310, DOI 10.1016/j.colsurfb.2011.01.015
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Sena LA, 2009, J MATER SCI-MATER M, V20, P2395, DOI 10.1007/s10856-009-3813-2
   Shen XY, 2011, J MATER SCI-MATER M, V22, P299, DOI 10.1007/s10856-010-4199-x
   Spanos N, 2002, BIOMATERIALS, V23, P947, DOI 10.1016/S0142-9612(01)00207-1
   Thanigaiarul K, 2013, CERAM INT, V39, P3027, DOI 10.1016/j.ceramint.2012.09.081
   Thompson CJ, 2008, COLLOID POLYM SCI, V286, P1511, DOI 10.1007/s00396-008-1925-8
   Tien WB, 2012, MAT SCI ENG C-MATER, V32, P2096, DOI 10.1016/j.msec.2012.05.046
   Victor SP, 2011, COLLOID SURFACE B, V85, P221, DOI 10.1016/j.colsurfb.2011.02.032
   Wilson OC, 2008, MAT SCI ENG C-BIO S, V28, P434, DOI 10.1016/j.msec.2007.04.005
   Xiao XF, 2009, MAT SCI ENG C-BIO S, V29, P785, DOI 10.1016/j.msec.2008.07.015
   Yang LR, 2010, IND ENG CHEM RES, V49, P8518, DOI 10.1021/ie100587e
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 38
TC 8
Z9 9
U1 5
U2 34
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 2095-0179
EI 2095-0187
J9 FRONT CHEM SCI ENG
JI Front. Chem. Sci. Eng.
PD DEC
PY 2013
VL 7
IS 4
BP 388
EP 400
DI 10.1007/s11705-013-1355-0
PG 13
WC Engineering, Chemical
SC Engineering
GA V39BH
UT WOS:000209386000002
DA 2018-10-20
ER

PT J
AU Tallawi, M
   Rai, R
   R-Gleixner, M
   Roerick, O
   Weyand, M
   Roether, JA
   Schubert, DW
   Kozlowska, A
   El Fray, M
   Merle, B
   Goken, M
   Aifantis, K
   Boccaccini, AR
AF Tallawi, M.
   Rai, R.
   R-Gleixner, M.
   Roerick, O.
   Weyand, M.
   Roether, J. A.
   Schubert, D. W.
   Kozlowska, A.
   El Fray, M.
   Merle, B.
   Goeken, M.
   Aifantis, K.
   Boccaccini, A. R.
TI Poly(glycerol sebacate)\Poly(butylene succinate-dilinoleate) Blends as
   Candidate Materials for Cardiac Tissue Engineering
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 533rd WE-Heraeus Seminar on Advanced Functional Polymers for Medicine
CY MAY 27-29, 2013
CL Bad Honnef, GERMANY
SP Wilhelm & Heraeus Fdn
DE cardiac tissue engineering; mechanobiology; myoblasts; poly (butylene
   succinate-dilinoleate); substrate stiffness
ID MYOCARDIAL-INFARCTION; MECHANICAL-PROPERTIES; BIOMATERIALS; ELASTOMER;
   FAILURE; HEART; ACIDS
AB Poly (glycerol sebacate) (PGS) and poly (butylene succinate-dilinoleate) (PBS-DLA) are biodegradable polymers with potential application in cardiac tissue engineering. In the present study novel blends comprising PGS prepolymer and PBS-DLA were prepared with varying compositions (70/30, 60/40, 50/50, 40/60, 30/70 and 0/100 in weight percentage). The physical, chemical, and mechanical properties of the PGS/PBS-DLA blends were measured and compared. By adding PBS-DLA to PGS the need for curing PGS prepolymer was eliminated, as the blended films are chemically stable. With increasing amount of PBS-DLA the hydrophobicity of the blend system increased reaching values close to that of neat PBS-DLA films. Furthermore, addition of PBS-DLA significantly affected the mechanical properties of the blends, i.e. the elastic modulus of the blends was enhanced with increasing PBS-DLA addition from 1.2 MPa to 54 MPa. At the same time, PBS-DLA addition led to decreased degradation rate of the films. Furthermore the PBS-DLA counteracted the acidity of the free carboxylic groups on the free end chains of the PGS prepolymer. In vitro cytocompatibility studies indicated high biocompatibility. Taken together the results confirm that the novel PGS/PBS-DLA matrices exhibit promising characteristics as a biomaterial for application in cardiac regeneration approaches.
C1 [Tallawi, M.; Rai, R.; Boccaccini, A. R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
   [R-Gleixner, M.; Roerick, O.; Weyand, M.] Univ Erlangen Nurnberg, Dept Cardiac Surg, D-91054 Erlangen, Germany.
   [Roether, J. A.; Schubert, D. W.] Univ Erlangen Nurnberg, Inst Polymer Mat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
   [Kozlowska, A.; El Fray, M.] West Pomeranian Univ Technol, Inst Polymer, Div Biomat & Microbiol Technol, Szczecin, Poland.
   [Merle, B.; Goeken, M.] Univ Erlangen Nurnberg, Inst Gen Mat Properties, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
   [Aifantis, K.] Aristotle Univ Thessaloniki, Lab Mech & Mat, Sch Engn, Thessaloniki 54124, Greece.
RP Boccaccini, AR (reprint author), Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
EM aldo.boccaccini@ww.uni-erlangen.de
RI El Fray, Miroslawa/J-4128-2016
OI El Fray, Miroslawa/0000-0002-2474-3517; MERLE,
   Benoit/0000-0002-9562-1429
CR Banerjee I., 2006, ANN NY ACAD SCI, V76, P1080
   Boccaccini A. R., 2011, MYOCARDIAL TISSUE EN
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Curtis MW, 2009, J CARDIOVASC NURS, V24, P87, DOI 10.1097/01.JCN.0000343562.06614.49
   El Fray M, 2003, POLYMER, V44, P4635, DOI 10.1016/S0032-3861(03)00417-8
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Forte G, 2008, STEM CELLS, V26, P2093, DOI 10.1634/stemcells.2008-0061
   Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]
   Frangogiannis NG, 2004, CIRCULATION, V110, P1341, DOI 10.1161/01.CIR.0000141560.18364.63
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Kitsis RN, 2008, HEART FAIL REV, V13, P107, DOI 10.1007/s10741-008-9080-3
   Leal-Egana A., 2013, ADV MAT IN PRESS
   Liu GY, 1996, J BIOL CHEM, V271, P25338, DOI 10.1074/jbc.271.41.25338
   MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V664, P349, DOI 10.1016/0005-2760(81)90057-6
   Moura RM, 2011, ARTIF ORGANS, V35, P471, DOI 10.1111/j.1525-1594.2011.01257.x
   NICOLAIS L, 1977, INT J POLYM MATER, V5, P317, DOI 10.1080/00914037708075215
   Peschel G., 2007, J BIOMED MATER RES, P1073
   QUAINI F, 1994, CIRC RES, V75, P1050, DOI 10.1161/01.RES.75.6.1050
   Rai R, 2012, PROG POLYM SCI, V37, P1051, DOI 10.1016/j.progpolymsci.2012.02.001
   Randriamahefa S, 2003, BIOMACROMOLECULES, V4, P1092, DOI 10.1021/bm034104o
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rudnik E., 2010, COMPOSTABLE POLYM MA, P28
   Sanchez RJ, 2003, EUR POLYM J, V39, P1385, DOI 10.1016/S0014-3057(03)00019-3
   TAMADA J, 1992, J BIOMAT SCI-POLYM E, V3, P315, DOI 10.1163/156856292X00402
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Zdebiak P, 2008, FIBRES TEXT EAST EUR, V16, P77
NR 31
TC 6
Z9 6
U1 1
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD DEC
PY 2013
VL 334
IS 1
BP 57
EP 67
DI 10.1002/masy.201300114
PG 11
WC Polymer Science
SC Polymer Science
GA AG5DA
UT WOS:000335438200008
DA 2018-10-20
ER

PT J
AU German, SJ
   Behbahani, M
   Miettinen, S
   Grijpma, DW
   Haimi, SP
AF German, Salvador Jimenez
   Behbahani, Mehdi
   Miettinen, Susanna
   Grijpma, Dirk W.
   Haimi, Suvi P.
TI Proliferation and Differentiation of Adipose Stem Cells Towards Smooth
   Muscle Cells on Poly(trimethylene carbonate) Membranes
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 533rd WE-Heraeus Seminar on Advanced Functional Polymers for Medicine
CY MAY 27-29, 2013
CL Bad Honnef, GERMANY
SP Wilhelm & Heraeus Fdn
DE adipose stem cell differentiation; poly (trimethylene carbonate); smooth
   muscle cells; tissue engineering
ID TISSUE ENGINEERING APPLICATIONS; GROWTH-FACTOR-BETA; IN-VITRO; NETWORKS;
   EXPRESSION; SCAFFOLDS; STIFFNESS; CALPONIN; POLYMERS; ARTERIES
AB Multipotent human adipose stem cells (hASCs) are an abundant and potential source of cells for vascular tissue engineering when combined with a suitable biomaterial scaffold. Poly(trimethylene carbonate) (PTMC) has been shown to be a useful biodegradable material for tissue engineered vascular grafts due to its flexibility, excellent biocompatibility and enzymatic degradation by surface erosion in vivo. The purpose of the current study was to evaluate the proliferation and differentiation of hASCs towards smooth muscle cells (SMCs) on gamma-crosslinked and photo-crosslinked PTMC membranes.
   PTMC macromers were functionalized with methacrylate end groups and crosslinked by UV initiated radical polymerization. High molecular weight linear PTMC was crosslinked by gamma irradiation. Cell viability, cell numbers and SMC differentiation of hASCs were evaluated on the differently crosslinked PTMC films at 7 and 14 days (d). On the photo-crosslinked membranes, homogenous monolayers of hASC were detected by live/dead assay. Consistently, cells on the photo-crosslinked membranes had significantly higher cell numbers compared to cells on the gamma-crosslinked membranes after 14 d of culture. SMC specific genes were expressed on both membranes at 14 d. Photo-crosslinked membranes showed higher expression of SMC specific proteins at 14 d compared to gamma-crosslinked membranes.
   These results suggest that especially the photo-crosslinked PTMC membranes are suitable for vascular tissue engineering applications when combined with hASCs.
C1 [German, Salvador Jimenez; Grijpma, Dirk W.; Haimi, Suvi P.] Univ Twente, Dept Biomat Sci & Technol, NL-7500 AE Enschede, Netherlands.
   [German, Salvador Jimenez; Behbahani, Mehdi] Aachen Univ Appl Sci, Inst Bioengn, Biomat Lab, Julich, Germany.
   [Miettinen, Susanna; Haimi, Suvi P.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.
   [Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Groningen, Netherlands.
RP Haimi, SP (reprint author), Univ Twente, Dept Biomat Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands.
OI Haimi, Suvi/0000-0001-8467-0252
CR Bat E, 2010, BIOMATERIALS, V31, P8696, DOI 10.1016/j.biomaterials.2010.07.102
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   Casadei A, 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/462543
   Christen T, 1999, CIRC RES, V85, P99
   Dargaville BL, 2013, ACTA BIOMATER, V9, P6885, DOI 10.1016/j.actbio.2013.02.009
   Dargaville BL, 2011, BIOMACROMOLECULES, V12, P3856, DOI 10.1021/bm201291e
   Diban N, 2013, ACTA BIOMATER, V9, P6450, DOI 10.1016/j.actbio.2013.01.005
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   FRID MG, 1992, DEV BIOL, V153, P185, DOI 10.1016/0012-1606(92)90104-O
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Harris L. J., 2011, THE JOURNAL OF SURGI, V168, P306
   Hou QP, 2009, ACTA BIOMATER, V5, P1543, DOI 10.1016/j.actbio.2008.12.012
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim Y. M., 2008, THE INTERNATIONAL JO, V40, P2482
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319
   Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341
   Li XM, 2014, J BIOMED MATER RES A, V102, P1092, DOI 10.1002/jbm.a.34774
   Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7
   Liu JY, 2010, TISSUE ENG PT A, V16, P2553, DOI [10.1089/ten.tea.2009.0833, 10.1089/ten.TEA.2009.0833]
   Liu J, 2012, BIOMATERIALS, V33, P5036, DOI 10.1016/j.biomaterials.2012.03.050
   Madsen CS, 1998, CIRC RES, V82, P908
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747
   Olson E. N., 1996, JOURNAL OF BIOLOGICA, V271, P7095
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Pego AP, 2003, POLYMER, V44, P6495, DOI 10.1016/S0032-3861(03)00668-2
   Poot AA, 2012, NED TIJDSCHR KLIN CH, V37, P44
   Portalska KJ, 2013, TISSUE ENG PT A, V19, P2318, DOI [10.1089/ten.tea.2012.0646, 10.1089/ten.TEA.2012.0646]
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Ratner B. D., 2013, BIOMATERIALS SCIENCE
   Regan CP, 2000, CIRC RES, V87, P363
   Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963
   Ruiter M. C., 1990, ANATOMY AND EMBRYOLO, V181, P341
   Saad GR, 2002, J APPL POLYM SCI, V83, P703, DOI 10.1002/app.2265
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Schuller-Ravoo S, 2012, ACTA BIOMATER, V8, P3576, DOI 10.1016/j.actbio.2012.06.004
   Schuller-Ravoo S, 2011, MACROMOL BIOSCI, V11, P1662, DOI 10.1002/mabi.201100203
   Shi N, 2012, J BIOL CHEM, V287, P6860, DOI 10.1074/jbc.M111.306209
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Song Y, 2011, TISSUE ENG PT A, V17, P381, DOI 10.1089/ten.TEA.2009.0805
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Thomas LV, 2013, BIORESEARCH OPEN ACC, V2, P227, DOI 10.1089/biores.2013.0003
   Uchida T, 2008, J BIOTECHNOL, V133, P213, DOI 10.1016/j.jbiotec.2007.08.017
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086
   Wang J, 2013, ACTA BIOMATER, V9, P8678, DOI 10.1016/j.actbio.2013.02.041
   Wang T, 2013, ACS APPL MATER INTER, V5, P3757, DOI 10.1021/am400369c
   WINDER SJ, 1990, J BIOL CHEM, V265, P10148
   Zhang M, 2012, J MATER SCI-MATER M, V23, P2639, DOI 10.1007/s10856-012-4721-4
   Zhang Z, 2006, BIOMATERIALS, V27, P1741, DOI 10.1016/j.biomaterials.2005.09.017
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 57
TC 1
Z9 1
U1 2
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD DEC
PY 2013
VL 334
IS 1
BP 133
EP 142
DI 10.1002/masy.201300100
PG 10
WC Polymer Science
SC Polymer Science
GA AG5DA
UT WOS:000335438200017
DA 2018-10-20
ER

PT J
AU Serpooshan, V
   Zhao, MM
   Metzler, SA
   Wei, K
   Shah, PB
   Wang, A
   Mahmoudi, M
   Malkovskiy, AV
   Rajadas, J
   Butte, MJ
   Bernstein, D
   Ruiz-Lozano, P
AF Serpooshan, Vahid
   Zhao, Mingming
   Metzler, Scott A.
   Wei, Ke
   Shah, Parisha B.
   Wang, Andrew
   Mahmoudi, Morteza
   Malkovskiy, Andrey V.
   Rajadas, Jayakumar
   Butte, Manish J.
   Bernstein, Daniel
   Ruiz-Lozano, Pilar
TI The effect of bioengineered acellular collagen patch on cardiac
   remodeling and ventricular function post myocardial infarction
SO BIOMATERIALS
LA English
DT Article
DE Cardiac tissue engineering; Scaffold; Collagen; Heart; Cardiomyocyte;
   Angiogenesis
ID MESENCHYMAL STEM-CELLS; MULTIPLE UNCONFINED COMPRESSION; HYDRAULIC
   PERMEABILITY; EXTRACELLULAR-MATRIX; PLASTIC COMPRESSION; HEART; MUSCLE;
   REGENERATION; SCAFFOLDS; REPAIR
AB Regeneration of the damaged myocardium is one of the most challenging fronts in the field of tissue engineering due to the limited capacity of adult heart tissue to heal and to the mechanical and structural constraints of the cardiac tissue. In this study we demonstrate that an engineered acellular scaffold comprising type I collagen, endowed with specific physiomechanical properties, improves cardiac function when used as a cardiac patch following myocardial infarction. Patches were grafted onto the infarcted myocardium in adult murine hearts immediately after ligation of left anterior descending artery and the physiological outcomes were monitored by echocardiography, and by hemodynamic and histological analyses four weeks post infarction. In comparison to infarcted hearts with no treatment, hearts bearing patches preserved contractility and significantly protected the cardiac tissue from injury at the anatomical and functional levels. This improvement was accompanied by attenuated left ventricular remodeling, diminished fibrosis, and formation of a network of interconnected blood vessels within the infarct. Histological and immunostaining confirmed integration of the patch with native cardiac cells including fibroblasts, smooth muscle cells, epicardial cells, and immature cardiomyocytes. In summary, an acellular biomaterial with specific biomechanical properties promotes the endogenous capacity of the infarcted myocardium to attenuate remodeling and improve heart function following myocardial infarction. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Serpooshan, Vahid; Zhao, Mingming; Metzler, Scott A.; Shah, Parisha B.; Wang, Andrew; Mahmoudi, Morteza; Butte, Manish J.; Bernstein, Daniel; Ruiz-Lozano, Pilar] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.
   [Wei, Ke; Ruiz-Lozano, Pilar] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.
   [Malkovskiy, Andrey V.; Rajadas, Jayakumar] Stanford Univ, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA.
RP Ruiz-Lozano, P (reprint author), Stanford Univ, Stanford Cardiovasc Inst, 300 Pasteur Dr, Stanford, CA 94305 USA.
EM prlozano@stanford.edu
RI Mahmoudi, Morteza/L-5332-2017
OI Mahmoudi, Morteza/0000-0002-2575-9684; Butte, Manish/0000-0002-4490-5595
FU NIH [HL65484, HL086879]; Stanford BioX Interdisciplinary Initiatives
   Program; NSF NSEC [PHY-0830228]; NIG [HL061535];  [K08 AI079268]
FX This work was supported by NIH grants HL65484 and HL086879 (to PRL). KW
   was a SBMRI California Institute for Regenerative Medicine postdoctoral
   fellow (TG2-01162). VS is an Oak Foundation postdoctoral fellow at
   Stanford. MJB was supported by K08 AI079268 and MJB and AW by the
   Stanford BioX Interdisciplinary Initiatives Program and NSF NSEC Grant
   No. PHY-0830228. DB was supported by NIG grant HL061535.
CR Abou Neel EA, 2006, SOFT MATTER, V2, P986, DOI 10.1039/b609784g
   Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a
   Arshi A, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/2/025003
   Bitar M, 2007, J MATER SCI-MATER M, V18, P237, DOI 10.1007/s10856-006-0685-1
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Curtis MW, 2009, J CARDIOVASC NURS, V24, P87, DOI 10.1097/01.JCN.0000343562.06614.49
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Francis DP, 2013, INT J CARDIOL, DOI DOI 10.1016/J.IICARD.2013.04.152
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Gaballa MA, 2006, J HEART LUNG TRANSPL, V25, P946, DOI 10.1016/j.healun.2006.04.008
   Gho JMIH, 2013, J CARD FAIL, V19, P494, DOI 10.1016/j.cardfail.2013.05.006
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li ZQ, 2012, ACTA BIOMATER, V8, P3586, DOI 10.1016/j.actbio.2012.06.024
   Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175
   Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Pedraza CE, 2010, TISSUE ENG PT A, V16, P781, DOI [10.1089/ten.tea.2009.0351, 10.1089/ten.TEA.2009.0351]
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Serpooshan V, 2013, ACTA BIOMATER, V9, P4673, DOI 10.1016/j.actbio.2012.08.031
   Serpooshan V, 2011, SOFT MATTER, V7, P2918, DOI 10.1039/c0sm00691b
   Serpooshan V, 2011, J BIOMED MATER RES A, V96A, P609, DOI 10.1002/jbm.a.33008
   Serpooshan V, 2010, ACTA BIOMATER, V6, P3978, DOI 10.1016/j.actbio.2010.04.028
   Steinhauser ML, 2011, EMBO MOL MED, V3, P701, DOI 10.1002/emmm.201100175
   Takahashi H, 2009, ANN THORAC SURG, V88, P1269, DOI 10.1016/j.athoracsur.2009.04.087
   Takehara Naofumi, 2013, Ann Vasc Dis, V6, P137, DOI 10.3400/avd.ra.13.00019
   Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52
   Tucker OP, 2002, J THORAC CARDIOV SUR, V124, P1165, DOI 10.1067/mtc.2002.125818
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Walsh RG, 2005, HEART FAIL REV, V10, P101, DOI 10.1007/s10741-005-4637-x
   Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009
NR 44
TC 58
Z9 59
U1 6
U2 101
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2013
VL 34
IS 36
BP 9048
EP 9055
DI 10.1016/j.biomaterials.2013.08.017
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 244YQ
UT WOS:000326426500006
PM 23992980
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, H
   Shahbazi, MA
   Makila, EM
   da Silva, TH
   Reis, RL
   Salonen, JJ
   Hirvonen, JT
   Santos, HA
AF Zhang, Hongbo
   Shahbazi, Mohammad-Ali
   Makila, Ermei M.
   da Silva, Tiago H.
   Reis, Rui L.
   Salonen, Jarno J.
   Hirvonen, Jouni T.
   Santos, Helder A.
TI Diatom silica microparticles for sustained release and permeation
   enhancement following oral delivery of prednisone and mesalamine
SO BIOMATERIALS
LA English
DT Article
DE Diatom; Cytotoxicity; Drug delivery; Prednisone; Mesalamine; Porous
   silica
ID INFLAMMATORY-BOWEL-DISEASE; SURFACE-CHEMISTRY; MESALAZINE FORMULATIONS;
   SBA-15 MICROPARTICLES; MESOPOROUS SILICON; INSULIN DELIVERY;
   DRUG-DELIVERY; NANOPARTICLES; TOXICITY; CELLS
AB Diatoms are porous silica-based materials obtained from single cell photosynthetic algae. Despite low cost, easy purification process, environmentally safe properties, and rapidly increasing potentials for medical applications, the cytotoxicity of diatoms and the effect on drug permeation of oral formulations have not been studied so far. Herein, we have evaluated the potential of diatom silica microparticles (DSMs) for the delivery of mesalamine and prednisone, which are two commonly prescribed drugs for gastrointestinal (GI) diseases. Transmission electron microscopy analysis of the morphological surface changes of Caco-2/HT-29 monolayers and the cell viability data in colon cancer cells (Caco-2, HT-29 and HCT-116) showed very low toxicity of diatoms at concentrations up to 1000 mu g/mL. The mesalamine and prednisone release under simulated GI conditions indicated prolonged release of both drugs from the diatoms. Furthermore, drug permeation across Caco-2/HT-29 co-culture monolayers demonstrated that diatoms are capable to enhance the drug permeability. Overall, this study evaluated DSMs' cytotoxicity in colon cancer cells and the effect of DSMs on drug permeability across Caco-2/HT-29 monolayers. Our results demonstrate that DSMs can be considered as a non-cytotoxic biomaterial with high potential to improve the mesalamine and prednisone bioavailability by sustaining the drug release and enhancing drug permeability. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Zhang, Hongbo; Shahbazi, Mohammad-Ali; Makila, Ermei M.; Hirvonen, Jouni T.; Santos, Helder A.] Univ Helsinki, Div Pharmaceut Technol, Fac Pharm, FI-00014 Helsinki, Finland.
   [Makila, Ermei M.; Salonen, Jarno J.] Univ Turku, Lab Ind Phys, Dept Phys & Astron, FI-20014 Turku, Finland.
   [da Silva, Tiago H.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [da Silva, Tiago H.; Reis, Rui L.] ICVS 3Bs PT Govt Associate Lab, Braga, Guimaraes, Portugal.
RP Santos, HA (reprint author), Univ Helsinki, Div Pharmaceut Technol, Fac Pharm, FI-00014 Helsinki, Finland.
EM helder.santos@helsinki.fi
RI Santos, Helder/B-5253-2009; Group, 3Bs/E-4374-2012; Reis, Rui
   L./A-8938-2008; shahbazi, Mohammad-Ali/M-5838-2013
OI Santos, Helder/0000-0001-7850-6309; Group, 3Bs/0000-0002-5195-3456;
   Reis, Rui L./0000-0002-4295-6129; shahbazi,
   Mohammad-Ali/0000-0002-4860-3017; Makila, Ermei/0000-0002-8300-6533;
   Silva, Tiago Henriques da/0000-0001-8520-603X
FU Academy of Finland [252215, 256394]; University of Helsinki; European
   Research Council under the European Union [310892]; ERDF through the
   Atlantic Area Transnational Cooperation Programme [2011-1/164 MARMED];
   Portuguese Foundation for Science and Technology [SFRH/BPD/34704/2007]
FX Financial support from the Academy of Finland (decision numbers 252215
   and 256394), the University of Helsinki, the European Research Council
   under the European Union's Seventh Framework Programme (FP/2007-2013)
   grant no. 310892 and the ERDF through the Atlantic Area Transnational
   Cooperation Programme Project 2011-1/164 MARMED are gratefully
   acknowledged. T.H. Silva acknowledges the Portuguese Foundation for
   Science and Technology for a post-doc grant (SFRH/BPD/34704/2007). We
   thank Prof. Lauri A. Aaltonen (Genome-Scale Biology Program & Department
   of Medical Genetics, University of Helsinki, Finland) for generously
   providing the HCT-116 cells and Prof. Bruno Sarmento (INEB - Instituto
   de Engenharia Biomedica, Porto) for kindly providing the HT-29 cells.
   Pei Ting Mah (University of Otago, New Zeeland) is acknowledged for
   technical support with the XRPD instrument.
CR Actis Giovanni C., 2008, Inflammation & Allergy Drug Targets, V7, P1, DOI 10.2174/187152808784165180
   Quinteros DA, 2010, DRUG DELIV, V17, P208, DOI 10.3109/10717541003667806
   [Anonymous], 2013, NANOTOXICOLOGY, V7, P274
   Aw MS, 2013, J BIOMATER APPL, V28, P163, DOI 10.1177/0885328212441846
   Banan A, 2005, J PHARMACOL EXP THER, V313, P962, DOI 10.1124/jpet.104.083428
   Bariana M, 2013, INT J PHARMACEUT, V443, P230, DOI 10.1016/j.ijpharm.2012.12.012
   Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8
   Bimbo LM, 2012, CURR DRUG METAB, V13, P1068
   Bimbo LM, 2011, BIOMATERIALS, V32, P2625, DOI 10.1016/j.biomaterials.2010.12.011
   Bimbo LM, 2010, ACS NANO, V4, P3023, DOI 10.1021/nn901657w
   Bradbury J., 2004, PLOS BIOL, V2, P12
   BYE E, 1984, BRIT J IND MED, V41, P228
   Canton I, 2012, CHEM SOC REV, V41, P2718, DOI 10.1039/c2cs15309b
   Carter JD, 2012, CLIN RHEUMATOL, V31, P1605, DOI 10.1007/s10067-012-2059-4
   Chen MC, 2013, ADV DRUG DELIVER REV, V65, P865, DOI 10.1016/j.addr.2012.10.010
   Chen XM, 2010, J PHARMACOL TOX MET, V61, P334, DOI 10.1016/j.vascn.2010.02.004
   Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o
   Cho EC, 2010, SMALL, V6, P517, DOI 10.1002/smll.200901622
   Cho EC, 2009, NANO LETT, V9, P1080, DOI 10.1021/nl803487r
   Clement L, 2013, SCI TOTAL ENVIRON, V450, P120, DOI 10.1016/j.scitotenv.2013.01.042
   Collnot EM, 2012, J CONTROL RELEASE, V161, P235, DOI 10.1016/j.jconrel.2012.01.028
   Di Caprio G., 2012, J BIOPHOTONICS, DOI DOI 10.1002/JBI0.201200198
   Fonte P, 2012, METHOD ENZYMOL, V508, P295, DOI 10.1016/B978-0-12-391860-4.00015-X
   Fu CH, 2013, BIOMATERIALS, V34, P2565, DOI 10.1016/j.biomaterials.2012.12.043
   Gill Pooria, 2010, J Biomol Tech, V21, P167
   Gilson MR, 1999, J AM ACAD DERMATOL, V41, P476
   Ginski MJ, 1999, INT J PHARM, V177, P117, DOI 10.1016/S0378-5173(98)00330-5
   Goldberg M, 2003, NAT REV DRUG DISCOV, V2, P289, DOI 10.1038/nrd1067
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Gordon R, 2009, TRENDS BIOTECHNOL, V27, P116, DOI 10.1016/j.tibtech.2008.11.003
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Guo X, 2003, AM J PHYSIOL-CELL PH, V285, P9
   Heikkila T, 2010, EUR J PHARM BIOPHARM, V74, P483, DOI 10.1016/j.ejpb.2009.12.006
   Karagozian Raffi, 2007, Ther Clin Risk Manag, V3, P893
   Kichenadasse G, 2013, NEW ENGL J MED, V368, P1457, DOI 10.1056/NEJMc1301594
   Kinnari P, 2011, INT J PHARMACEUT, V414, P148, DOI 10.1016/j.ijpharm.2011.05.021
   Limnell T, 2011, EUR J PHARM SCI, V44, P125
   Limnell T, 2011, INT J PHARMACEUT, V416, P242, DOI 10.1016/j.ijpharm.2011.06.050
   Limnell T, 2011, J PHARM SCI-US, V100, P3294, DOI 10.1002/jps.22577
   Liu DF, 2013, J CONTROL RELEASE, V170, P268, DOI 10.1016/j.jconrel.2013.05.036
   Liu DF, 2013, ADV FUNCT MATER, V23, P1893, DOI 10.1002/adfm.201202491
   Losic D, 2006, J NANOSCI NANOTECHNO, V6, P982, DOI 10.1166/jnn.2006.174
   Losic D, 2010, CHEM COMMUN, V46, P6323, DOI 10.1039/c0cc01305f
   Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778
   Love SA, 2012, ANNU REV ANAL CHEM, V5, P181, DOI 10.1146/annurev-anchem-062011-143134
   Mahler GJ, 2009, J NUTR BIOCHEM, V20, P494, DOI 10.1016/j.jnutbio.2008.05.006
   McClements DJ, 2010, FOOD FUNCT, V1, P32, DOI 10.1039/c0fo00111b
   Mladenovska K, 2007, INT J PHARM, V345, P59, DOI 10.1016/j.ijpharm.2007.05.059
   Mura C, 2012, COLLOID SURFACE B, V94, P199, DOI 10.1016/j.colsurfb.2012.01.030
   Qiu Y, 2010, BIOMATERIALS, V31, P7606, DOI 10.1016/j.biomaterials.2010.06.051
   Rosenholm JM, 2011, CURR DRUG TARGETS, V12, P1166
   Rost M, 2003, J PHARMACEUT BIOMED, V31, P1129, DOI 10.1016/S0731-7085(02)00732-X
   Sandborn WJ, 2003, ALIMENT PHARM THER, V17, P29, DOI 10.1046/j.0269-2813.2003.01408.x
   Santos HA, 2010, ACTA BIOMATER, V6, P2721, DOI 10.1016/j.actbio.2009.12.043
   Shahbazi MA, 2013, BIOMATERIALS, V34, P7776, DOI 10.1016/j.biomaterials.2013.06.052
   Shahbazi Mohammad-Ali, 2012, Biomatter, V2, P296, DOI 10.4161/biom.22347
   Shahbazi MA, 2013, CURR DRUG METAB, V14, P28, DOI 10.2174/138920013804545133
   Silva TH, 2012, INT MATER REV, V57, P276, DOI 10.1179/1743280412Y.0000000002
   Sonaje K, 2012, MOL PHARMACEUT, V9, P1271, DOI 10.1021/mp200572t
   Sonaje K, 2010, ADV FUNCT MATER, V20, P3695, DOI 10.1002/adfm.201001014
   STOLK LML, 1990, PHARM WEEKBLAD, V12, P200, DOI 10.1007/BF01980047
   Su FY, 2012, BIOMATERIALS, V33, P2801, DOI 10.1016/j.biomaterials.2011.12.038
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Vishwas M, 2011, SPECTROCHIM ACTA A, V78, P695, DOI 10.1016/j.saa.2010.11.051
   Vogt M, 2007, J PHARM SCI-US, V96, P1480, DOI 10.1002/jps.20817
   Woitiski CB, 2011, INT J PHARMACEUT, V412, P123, DOI 10.1016/j.ijpharm.2011.04.003
   Yeh TH, 2011, BIOMATERIALS, V32, P6164, DOI 10.1016/j.biomaterials.2011.03.056
   Zhou SY, 1999, DRUG METAB DISPOS, V27, P479
   Zimmerman RP, 2011, TOXICOLOGY, V280, P71, DOI 10.1016/j.tox.2010.11.009
NR 70
TC 43
Z9 44
U1 3
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2013
VL 34
IS 36
BP 9210
EP 9219
DI 10.1016/j.biomaterials.2013.08.035
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 244YQ
UT WOS:000326426500024
PM 24008036
DA 2018-10-20
ER

PT J
AU Xie, HX
   Wang, JY
   Li, CS
   Gu, ZP
   Chen, QM
   Li, LJ
AF Xie, Huixu
   Wang, Jianyun
   Li, Chuansong
   Gu, Zhipeng
   Chen, Qianming
   Li, Longjiang
TI Application of strontium doped calcium polyphosphate bioceramic as
   scaffolds for bone tissue engineering
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Strontium-doped calcium polyphosphate; Scaffolds; Angiogenesis; Bone
   tissue engineering
ID IN-VITRO DEGRADATION; SUBSTITUTE APPLICATIONS; CERAMICS;
   CRYSTALLIZATION; POLYMERIZATION; ANGIOGENESIS; CELLS
AB The critical success factors for bone tissue engineering in clinical applications are scaffolds. Ion doping is one of the most important methods to modify the properties of bioceramics for better angiogenesis abilities, biomechanical properties, and biocompatibility. This paper presents a novel ion doping method applied in calcium polyphosphate (CPP)-based bioceramic scaffolds substituted by strontium ions to form (SCPP) scaffolds for bone tissue regeneration. The microstructure and crystallization of the scaffolds were detected by scanning electron microscopy (SEM) and X-ray diffraction (XRD). Degradation tests were assessed to evaluate the mechanical and chemical stabilities of SCPP in vitro. The cell biocompatibility was measured with respect to the cytotoxicity of the extractions of scaffolds. Bone implantation was performed to evaluate the biodegradability and osteoconductivity of the scaffolds, and the bone formation examined by using X-ray radiography. The results indicated that the obtained SCPP scaffolds had a single CPP phase. The SCPP scaffolds yielded a better degradation property than the pure CPP scaffold. The MTT assay and in vivo results reveal that the SCPP scaffolds exhibited a better cell biocompatibility and tissue biocompatibility than CPP and hydroxyapatite (HA) scaffolds. The in vivo immunohistochemistry staining for VEGF also showed that SCPP had a potential to promote the formation of angiogenesis and the regeneration of bone. SCPP scaffold could serve as a potential biomaterial with stimulating angiogenesis in bone tissue engineering and bone repair. (C) 2013 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Xie, Huixu; Chen, Qianming; Li, Longjiang] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610061, Peoples R China.
   [Wang, Jianyun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Human Tissue & Organs Degenerat, Shenzhen 518000, Peoples R China.
   [Li, Chuansong] Sichuan Peoples Hosp, Med Sci Acad, Chengdu 610031, Peoples R China.
   [Gu, Zhipeng] Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
RP Li, LJ (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610061, Peoples R China.
EM muzili63@163.com
RI Gu, Zhi peng/E-5108-2013
OI Gu, Zhi peng/0000-0003-4533-6539
FU National Natural Science Foundation of China [81172578]
FX This work was supported by the National Natural Science Foundation of
   China (81172578).
CR Chen YW, 2008, J MATER SCI-MATER M, V19, P2655, DOI 10.1007/s10856-007-3350-9
   Chen Y.W., 2008, APPL SURF SCI, V255, P335
   Dias AG, 2003, J NON-CRYST SOLIDS, V330, P81, DOI 10.1016/j.jnoncrysol.2003.08.056
   Ding YL, 2008, J MATER SCI-MATER M, V19, P1291, DOI 10.1007/s10856-007-3235-y
   FISKE CH, 1925, J BIOL CHEM, V66, P37
   Gomez F, 1997, J NON-CRYST SOLIDS, V222, P415, DOI 10.1016/S0022-3093(97)90144-7
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Heckmann L, 2007, J BIOMED MATER RES B, V81B, P82, DOI 10.1002/jbm.b.30640
   OHTSUKI C, 1991, J BIOMED MATER RES, V25, P1363, DOI 10.1002/jbm.820251105
   Park EK, 2004, BIOMATERIALS, V25, P3403, DOI 10.1016/j.biomaterials.2003.10.031
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Qiu K, 2006, J MATER SCI, V41, P2429, DOI 10.1007/s10853-006-5182-2
   Qiu K, 2005, KEY ENG MAT, V288-289, P553, DOI 10.4028/www.scientific.net/KEM.288-289.553
   Sayegh T.Y., 2002, J BIOMED MATER RES, V61, P482
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   Wang QB, 2009, MATER RES-IBERO-AM J, V12, P495, DOI 10.1590/S1516-14392009000400020
   WURST JC, 1972, J AM CERAM SOC, V55, P109, DOI 10.1111/j.1151-2916.1972.tb11224.x
   Yang S.M., 2004, KEY ENG MATER, V218, P657
   Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031
NR 21
TC 15
Z9 15
U1 1
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD DEC
PY 2013
VL 39
IS 8
BP 8945
EP 8954
DI 10.1016/j.ceramint.2013.04.091
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA 236YJ
UT WOS:000325835100051
DA 2018-10-20
ER

PT J
AU Yalinca, Z
   Yilmaz, E
   Taneri, B
   Bullici, F
   Tuzmen, S
AF Yalinca, Z.
   Yilmaz, E.
   Taneri, B.
   Bullici, F.
   Tuzmen, S.
TI Blood contact properties of ascorbyl chitosan
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE blood-biomaterial interaction; chitosan; ascorbic acid (Vitamin C);
   blood compatibility; hypocholesterolemic effect; anticoagulant; iron
   removal; chelation
ID IN-VITRO; FAMILIAL HYPERCHOLESTEROLEMIA; CHOLESTEROL; CHITIN;
   CHOLESTYRAMINE; RATS; MECHANISM; COAGULATION; SAFETY
AB Ascorbyl chitosan was synthesized by heating chitosan with ascorbic acid in isopropanol. The products were characterized by FTIR and C-13 NMR spectroscopies, SEM, and elemental analysis. Blood contact properties of ascorbyl chitosans were evaluated. The ascorbyl chitosans demonstrated to have increased lipid-lowering activity in comparison to chitosan alone upon contact with human blood serum in in vitro conditions. Furthermore, the total cholesterol/HDL ratio was improved towards the desirable ideal values after three hours contact with ascorbyl chitosan samples. The lipid-lowering activity increased with ascorbyl substitution. The inherent nonspecific adsorption capability of chitosan due to its chelating power with several different functional groups was exhibited by ascorbyl chitosans as well. This behavior was exemplified in a simultaneous decrease in the total iron values of the volunteers together with lower lipid levels. Furthermore, ascorbyl chitosans were observed to have less hemocompatibility but increased anticoagulant activity when compared to chitosan alone. Additional in vivo studies are necessary to support these results and to investigate further the advantages and disadvantages of these materials to prove their safety prior to clinical applications.
C1 [Yalinca, Z.; Yilmaz, E.] Eastern Mediterranean Univ, Dept Chem, Famagusta, Turkey.
   [Yalinca, Z.; Taneri, B.; Tuzmen, S.] Eastern Mediterranean Univ, Dept Biol Sci, Famagusta, Turkey.
   [Bullici, F.] Med Lab, Biolab, Famagusta, Turkey.
RP Yalinca, Z (reprint author), Eastern Mediterranean Univ, Dept Chem, North Cyprus via Mersin 10, Famagusta, Turkey.
EM zulal.yalinca@emu.edu.tr
CR Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   Bondiolotti G, 2011, FOOD CHEM, V124, P978, DOI 10.1016/j.foodchem.2010.07.039
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Dutkiewicz J, 1990, J BIOACT COMPAT POL, V5, P293, DOI 10.1177/088391159000500305
   Fana L, 2012, INT J BIOL MACROMOL, V50, P31
   Furda I, 1998, United States patent, Patent No. [US 573653, 573653]
   Furda N, 1980, US Patent, Patent No. 4223023
   GYLLING H, 1991, METABOLISM, V40, P35, DOI 10.1016/0026-0495(91)90189-4
   GYLLING H, 1989, EUR J CLIN PHARMACOL, V37, P111, DOI 10.1007/BF00558216
   HEMILA H, 1992, CRIT REV FOOD SCI, V32, P33, DOI 10.1080/10408399209527579
   Ishihara M., 2012, CHITOSAN BASED SYSTE, P93
   Janvikul W, 2006, J APPL POLYM SCI, V102, P445, DOI 10.1002/app.24192
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   JENNINGS CD, 1988, P SOC EXP BIOL MED, V189, P13
   KANAUCHI O, 1995, BIOSCI BIOTECH BIOCH, V59, P786, DOI 10.1271/bbb.59.786
   KLOKKEVOLD PR, 1991, J ORAL MAXIL SURG, V49, P858, DOI 10.1016/0278-2391(91)90017-G
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5
   MABUCHI H, 1983, NEW ENGL J MED, V308, P609, DOI 10.1056/NEJM198303173081101
   MAEZAKI Y, 1993, BIOSCI BIOTECH BIOCH, V57, P1439, DOI 10.1271/bbb.57.1439
   MALETTE WG, 1983, ANN THORAC SURG, V36, P55, DOI 10.1016/S0003-4975(10)60649-2
   Muzzarelli RA., 2000, CHITOSAN PER OS DIET, P3
   MUZZARELLI RAA, 1987, CARBOHYD POLYM, V7, P87, DOI 10.1016/0144-8617(87)90051-8
   MUZZARELLI RAA, 1997, APPL CHITIN CHITOSAN, P115
   Muzzarelli RAA, 2006, CARBOHYD POLYM, V66, P363, DOI 10.1016/j.carbpol.2006.03.021
   Okamoto Y, 2003, CARBOHYD POLYM, V53, P337, DOI 10.1016/S0144-8617(03)00076-6
   SUGANO M, 1978, NUTR REP INT, V18, P531
   Tapola NS, 2008, J AM COLL NUTR, V27, P22, DOI 10.1080/07315724.2008.10719671
   Tokura S., 1988, Goods, Japan Kokai Tokkyo Koho, JP, V89, P167, Patent No. [6389167, JP6389167]
   Trautwein EA, 1997, NUTR RES, V17, P1053, DOI 10.1016/S0271-5317(97)00069-9
   Wang QZ, 2008, J MATER SCI-MATER M, V19, P1371, DOI 10.1007/s10856-007-3243-y
   Xiaolin T, 2009, J APPL POLYM SCI, V114, P2986
   Xu GF, 2007, ASIA PAC J CLIN NUTR, V16, P313
   Yalinca Z, 2012, J APPL POLYM SCI, V125, P1493, DOI 10.1002/app.34911
NR 35
TC 1
Z9 1
U1 1
U2 22
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD DEC 1
PY 2013
VL 24
IS 17
BP 1969
EP 1987
DI 10.1080/09205063.2013.816929
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 231XE
UT WOS:000325450900004
PM 23862665
DA 2018-10-20
ER

PT J
AU Mallakpour, S
   Sabzalian, MR
AF Mallakpour, Shadpour
   Sabzalian, Mohammad R.
TI In vitro degradation assessment of optically active
   poly(urethane-imide)s based on alpha-amino acids
SO POLYMER BULLETIN
LA English
DT Article
DE Biodegradability; Poly(urethane-imide)s; In vitro toxicity; Optically
   active polymer
ID TYROSINE-DERIVED POLYCARBONATES; BISPHENOL-A; BIODEGRADABLE POLYESTERS;
   BIOMATERIAL APPLICATIONS; POLYURETHANES; POLYMERS; DIISOCYANATE;
   EXPOSURE
AB The aim of this work is to obtain optically and biologically active poly(urethane-imide)s (PUIs) using N,N'-(pyromellitoyl)-bis-l-tyrosine dimethyl ester (5) as a chiral and biologically active diphenolic monomer. Step-growth polymerization of diol 5 with various aliphatic and aromatic diisocyanates was carried out by gradual heating technique. The resulting PUIs were characterized with FT-IR, and two of them by H-1-NMR spectroscopy and elemental analysis. Thermogravimetric analysis and differential scanning calorimetry were used to determine the thermal properties of the two representative PUIs. The morphology of polymer was studied by X-ray diffraction analysis. Furthermore, in vitro toxicity and biodegradability behaviors of the obtained PUIs were studied in culture media and soil burial degradation which reveals that the synthesized polymers are biologically active and biodegradable in natural environment.
C1 [Mallakpour, Shadpour] Isfahan Univ Technol, Dept Chem, Organ Polymer Chem Res Lab, Esfahan 8415683111, Iran.
   [Mallakpour, Shadpour] Isfahan Univ Technol, Nanotechnol & Adv Mat Inst, Esfahan 8415683111, Iran.
   [Sabzalian, Mohammad R.] Isfahan Univ Technol, Coll Agr, Dept Agron & Plant Breeding, Esfahan 8415683111, Iran.
RP Mallakpour, S (reprint author), Isfahan Univ Technol, Nanotechnol & Adv Mat Inst, Esfahan 8415683111, Iran.
EM mallakpour84@alumni.ufl.edu
FU Research Affairs Division, Isfahan University of Technology (IUT);
   National Elite Foundation (NEF); Center of Excellence in Sensors and
   Green Research (IUT)
FX We wish to express our gratitude to the Research Affairs Division,
   Isfahan University of Technology (IUT), for partial financial support.
   Further financial support from National Elite Foundation (NEF) and
   Center of Excellence in Sensors and Green Research (IUT) is gratefully
   acknowledged.
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Bastioli C, 2005, HDB BIODEGRADABLE PO
   Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   CAUDE M, 1991, J CHROMATOGR, V550, P357, DOI 10.1016/S0021-9673(01)88550-2
   Chen MY, 2002, ENVIRON TOXICOL, V17, P80, DOI 10.1002/tox.10035
   Crain DA, 2007, REPROD TOXICOL, V24, P225, DOI 10.1016/j.reprotox.2007.05.008
   Ditto AJ, 2009, INT J PHARM, V368, P199, DOI 10.1016/j.ijpharm.2008.10.019
   Ensafi AA, 2010, ANAL LETT, V43, P2848, DOI 10.1080/00032711003763640
   Eversloh TL, 2007, APPL MICROBIOL BIOT, V77, P751
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Kang JH, 2006, TOXICOLOGY, V226, P79, DOI 10.1016/j.tox.2006.06.009
   Mallakpour S, 2005, EUR POLYM J, V41, P2945, DOI 10.1016/j.eurpolymj.2005.05.037
   Mallakpour S, 2004, POLYM INT, V53, P184, DOI 10.1002/pi.1416
   Mallakpour S, 2008, J APPL POLYM SCI, V109, P3603, DOI 10.1002/app.28263
   Mallakpour S, 2011, AMINO ACIDS, V40, P611, DOI 10.1007/s00726-010-0686-0
   Mallakpour S, 2011, J POLYM RES, V18, P373, DOI 10.1007/s10965-010-9427-z
   Mallakpour S, 2010, J POLYM ENVIRON, V18, P685, DOI 10.1007/s10924-010-0234-8
   Mallakpour S, 2010, COLLOID POLYM SCI, V288, P703, DOI 10.1007/s00396-010-2202-1
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mythili CV, 2004, B MATER SCI, V27, P235, DOI 10.1007/BF02708512
   Nakagawa Y, 2000, ARCH TOXICOL, V74, P99, DOI 10.1007/s002040050659
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Sen Gupta A, 2005, POLYMER, V46, P2133, DOI 10.1016/j.polymer.2005.01.023
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Shah PN, 2009, COLLOID POLYM SCI, V287, P1195, DOI 10.1007/s00396-009-2082-4
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2371, DOI 10.1016/S0142-9612(00)00104-6
   Tsai WT, 2006, J ENVIRON SCI HEAL C, V24, P225, DOI 10.1080/10590500600936482
   Xia H, 2008, J APPL POLYM SCI, V110, P2168, DOI 10.1002/app.28755
NR 31
TC 3
Z9 3
U1 0
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
EI 1436-2449
J9 POLYM BULL
JI Polym. Bull.
PD DEC
PY 2013
VL 70
IS 12
BP 3425
EP 3441
DI 10.1007/s00289-013-1031-z
PG 17
WC Polymer Science
SC Polymer Science
GA 236DM
UT WOS:000325774400013
DA 2018-10-20
ER

PT J
AU Gaur, PK
   Purohit, S
   Mishra, S
AF Gaur, Praveen Kumar
   Purohit, Suresh
   Mishra, Shikha
TI Development of aceclofenac nanovesicular system using biomaterial for
   transdermal delivery: physical characterization, ex vivo, in vivo, and
   anti-inflammatory studies
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE transdermal; biomaterial; in vivo; in vitro; permeation
ID DRUG-DELIVERY; THERMOTROPIC PROPERTIES; SKIN PENETRATION; VITRO
   EVALUATION; LIPOSOMES; DICLOFENAC; GEL; GANGLIOSIDE; FORMULATION;
   PERMEATION
AB Context: Aceclofenac is an important NSAID; however, it causes GI disturbances whereas employing transdermal route would require permeation enhancer for systemic application, thereby causing skin damage. Ceramide 2 is a natural lipid having an important role in the maintenance of skin. Objective: Aceclofenac-loaded nanovesicles of ceramide-2, cholesterol, palmitic acid, and cholesteryl sulfate were formulated and analyzed for physical and biological properties. Materials and method: Film hydration method was used to prepare the vesicles and physical parameters, in vitro drug release and stability were evaluated. Then, they were formulated into gel and evaluated against a commercial formulation (CF) and gel-containing plain drug (CPG) for ex vivo, in vivo drug permeation, and anti-inflammatory activity. Results: The developed formulations showed best physical profile and ACV-1 gave 92.89% drug release in in vitro studies. Ex vivo studies showed drug permeation between 15.32-31.12g/cm(2), whereas CPG and CF released 0.47 and 2.81g/cm(2), respectively. ACVG-1 and CF showed C-max of 8.1 and 1.2g/ml at 8 and 4h, respectively. ACVG-1 showed 11.6 times AUC than CF. ACVG-1 inhibited edema by 44% in first hour itself. Discussion: Ceramide 2 and palmitic acid played an important role in the formulation and promotes the drug permeation through stratum corneum and dermis. Ceramide content of the formulation also contributes towards stability and skin protection. Conclusion: The composition of the vesicle formulation performs an important role in physical properties and drug permeation, thereby producing an optimum formulation.
C1 [Gaur, Praveen Kumar] ITS Paramed Pharm Coll, Dept Pharmaceut, Ghaziabad 201206, UP, India.
   [Gaur, Praveen Kumar] Jodhpur Natl Univ, Dept Pharmaceut, Jodhpur 342001, Rajasthan, India.
   [Purohit, Suresh] IMS BHU, Dept Pharmacol, Varanasi, Uttar Pradesh, India.
   [Mishra, Shikha] Jamia Hamdard, Dept Pharmacognosy & Phytochem, New Delhi 110062, India.
RP Gaur, PK (reprint author), ITS Paramed Pharm Coll, Dept Pharmaceut, Ghaziabad 201206, UP, India.
EM praveengaur@its.edu.in
OI Gaur, Praveen/0000-0002-4221-1485
CR AGUIAR AJ, 1969, J PHARM SCI, V58, P210, DOI 10.1002/jps.2600580215
   Akhter S, 2008, CURR NANOSCI, V4, P381, DOI 10.2174/157341308786306071
   ALVAREZLARENA A, 1992, J CRYST SPECTROSC, V22, P323
   Babu RJ, 2005, PERCUTANEOUS PENETRA, V2, P137
   Batheja Priya, 2006, Expert Opin Drug Deliv, V3, P127
   Brogden RN, 1996, DRUGS, V52, P113, DOI 10.2165/00003495-199652010-00008
   Denet AR, 2004, ADV DRUG DELIVER REV, V56, P659, DOI 10.1016/j.addr.2003.10.027
   Dragicevic-Curic N, 2008, J CONTROL RELEASE, V127, P59, DOI 10.1016/j.jconrel.2007.12.013
   Dugard PH, 1976, ADV MODERN TOXICOLOG
   DURRHEIM H, 1980, J PHARM SCI, V69, P781, DOI 10.1002/jps.2600690709
   El-Kamel Amal H, 2008, Curr Drug Deliv, V5, P20, DOI 10.2174/156720108783331014
   El-Leithy ES, 2010, AAPS PHARMSCITECH, V11, P1695, DOI 10.1208/s12249-010-9544-3
   Ferraretto A, 1997, BIOCHEMISTRY-US, V36, P9232, DOI 10.1021/bi970428j
   Fresta M, 1996, J DRUG TARGET, V4, P95, DOI 10.3109/10611869609046267
   Furuishi T, 2008, BIOL PHARM BULL, V31, P1439, DOI 10.1248/bpb.31.1439
   Gaur P. K., 2013, PHARM DEV T IN PRESS
   Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011
   Haigh JM, 1998, INT J PHARM, V170, P151, DOI 10.1016/S0378-5173(98)00064-7
   HIGUCHI T, 1960, J SOC COSMET CHEM, V11, P85
   HMsS Office, 1998, BUD US GOV FISC YEAR, P33
   Honeywell-Nguyen P Loan, 2005, Drug Discov Today Technol, V2, P67, DOI 10.1016/j.ddtec.2005.05.003
   Insel P. A., 1992, ANALGESIC ANTIPYRETI
   Ishida T, 2002, INT J PHARM, V232, P59, DOI 10.1016/S0378-5173(01)00896-1
   Jaehwi L, 2005, ARCH PHARM RES, V28, P1097
   Jukanti R, 2011, J PHARM SCI-US, V100, P3208, DOI 10.1002/jps.22542
   Kitagawa S, 1995, INT J PHARM, V126, P49, DOI 10.1016/0378-5173(95)04075-7
   Kobayashi N, 1999, CHEM PHARM BULL, V47, P199
   Lee JW, 2011, J CONTROL RELEASE, V154, P58, DOI 10.1016/j.jconrel.2011.05.003
   Legrand E, 2004, EXPERT OPIN PHARMACO, V5, P1347, DOI 10.1517/14656566.5.6.1347
   Liu CH, 2011, COLLOID SURFACE B, V82, P63, DOI 10.1016/j.colsurfb.2010.08.018
   Manconi M, 2011, EUR J PHARM BIOPHARM, V78, P27, DOI 10.1016/j.ejpb.2010.12.010
   Manosroi A, 2008, INT J PHARM, V360, P156, DOI 10.1016/j.ijpharm.2008.04.033
   MartelPelletier J, 1997, CLIN DRUG INVEST, V14, P226, DOI 10.2165/00044011-199714030-00011
   Mishra D, 2007, J PHARM SCI, V96, P147
   Moore David J., 1999, International Journal of Cosmetic Science, V21, P353, DOI 10.1046/j.1467-2494.1999.211916.x
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Pasero G, 1995, CURR MED RES OPIN, V13, P305, DOI 10.1185/03007999509110491
   Patel NA, 2009, PHARM DEV TECHNOL, V14, P80, DOI 10.1080/10837450802409438
   Paudel KS, 2010, THER DELIV, V1, P109, DOI 10.4155/TDE.10.16
   PHILLIPS CA, 1995, J PHARM SCI, V84, P1427, DOI 10.1002/jps.2600841208
   Seyda A. A., 2010, FABAD J PHARM SCI, V35, P105
   Shavi GV, 2009, DRUG DEV IND PHARM, V35, P252, DOI [10.1080/03639040802277680, 10.1080/03639040802277680 ]
   Sinico C, 2005, J CONTROL RELEASE, V103, P123, DOI 10.1016/j.conrel.2004.11.020
   TERZAGHI A, 1993, BIOCHEMISTRY-US, V32, P9722, DOI 10.1021/bi00088a026
   Touitou E, 2000, J CONTROL RELEASE, V65, P403, DOI 10.1016/S0168-3659(99)00222-9
   Vasiljevic D, 2006, INT J PHARM, V309, P171, DOI 10.1016/j.ijpharm.2005.11.034
   Walters K. A., 2002, STRUCTURE FUNCTION S
   Wartewig S, 2007, SKIN PHARMACOL PHYS, V20, P220, DOI 10.1159/00010442
   YARDLEY HJ, 1981, PHARMACOL THERAPEUT, V13, P357, DOI 10.1016/0163-7258(81)90006-1
   Zellmer S, 1998, CHEM PHYS LIPIDS, V94, P97, DOI 10.1016/S0009-3084(98)00046-2
NR 50
TC 3
Z9 3
U1 1
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD DEC 1
PY 2013
VL 24
IS 18
BP 2126
EP 2141
DI 10.1080/09205063.2013.828579
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 231XA
UT WOS:000325450500008
PM 23944964
DA 2018-10-20
ER

PT J
AU Lai, JY
   Lue, SJ
   Cheng, HY
   Ma, DHK
AF Lai, Jui-Yang
   Lue, Shingjiang Jessie
   Cheng, Hsiao-Yun
   Ma, David Hui-Kang
TI Effect of Matrix Nanostructure on the Functionality of Carbodiimide
   Cross-Linked Amniotic Membranes as Limbal Epithelial Cell Scaffolds
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Carbodiimide Cross-Linked Amniotic Membrane; Matrix Nanostructure;
   Scaffold Functionality; Biophysical Cue; Limbal Epithelial Cell
   Cultivation
ID EMBRYONIC STEM-CELLS; IN-VITRO; MECHANICAL-PROPERTIES; GELATIN
   MEMBRANES; HYALURONIC-ACID; COLLAGEN; LINKING; TRANSPLANTATION; SURFACE;
   BIOMATERIALS
AB Carbodiimide cross-linked amniotic membrane (AM) can potentially serve as an artificial corneal epithelial stem cell niche in ocular surface wound healing. For the first time, this study was performed to investigate the relationship between nanostructure and functionality of carbodiimide cross-linked AM tissues as limbal epithelial cell (LEC) scaffold biomaterials. The triple-helical molecular conformation of AM collagen was checked after chemical treatment for varying cross-linking durations (1-4 h). Our data indicated that the unraveling of the helical structure into a more random globular state is accompanied by an increase in the cross-linking index of AM samples. The cross-linker-mediated alterations in tissue ultrastructure and substrate nanotopography of these proteinaceous matrices were confirmed by transmission electron and atomic force microscopy studies. With increasing treatment time, the chemically cross-linked AM possessed larger nanofiber diameter and exhibited rougher texture. Marked increases in the water content, light transmittance, and resistance to enzymatic degradation were found, probably due to collagen fibril aggregation in biological tissues. All the test AM materials were not toxic to the human corneal epithelial cell cultures and retained anti-inflammatory activity, indicating the tolerability and safety of carbodiimide (i.e., a zero-length cross-linker). In addition, the enhanced LEC growth and increased p63 and ABCG2 gene expressions were significantly noted on the AM samples with greater cross-linking degree. In summary, the findings reported in this paper suggest that a specific limbal epithelial stem cell-biomaterial interaction may occur in response to biophysical cue such as nanostructure of carbodiimide cross-linked AM matrix.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang; Cheng, Hsiao-Yun] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 33302, Taiwan.
   [Lue, Shingjiang Jessie] Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 33302, Taiwan.
   [Ma, David Hui-Kang] Chang Gung Mem Hosp, Dept Ophthalmol, Limbal Stem Cell Lab, Tao Yuan 33305, Taiwan.
   [Ma, David Hui-Kang] Chang Gung Univ, Dept Chinese Med, Tao Yuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw; davidhkma@yahoo.com
RI Lue, Jessie/B-4802-2011
OI Lue, Jessie/0000-0003-1950-8093; Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China
   [NSC100-2628-E-182-004-MY3]; Chang Gung Memorial Hospital [CMRPD2A0111]
FX This work was supported by grant NSC100-2628-E-182-004-MY3 from the
   National Science Council of Republic of China and grant CMRPD2A0111 from
   Chang Gung Memorial Hospital.
CR Altrock E, 2012, BIOMATERIALS, V33, P3107, DOI 10.1016/j.biomaterials.2012.01.002
   Bratt-Leal AM, 2011, BIOMATERIALS, V32, P48, DOI 10.1016/j.biomaterials.2010.08.113
   Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067
   Cooper LJ, 2005, CORNEA, V24, P722, DOI 10.1097/01.ico.0000154237.49112.29
   De Paiva CS, 2005, STEM CELLS, V23, P63, DOI 10.1634/stemcells.2004-0093
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   FREUND DE, 1995, INVEST OPHTH VIS SCI, V36, P1508
   Fujisato T, 1999, J BIOMAT SCI-POLYM E, V10, P1171, DOI 10.1163/156856299X00829
   Gagner JE, 2012, BIOMATERIALS, V33, P8503, DOI 10.1016/j.biomaterials.2012.07.009
   Gauthaman K, 2009, J CELL MOL MED, V13, P3475, DOI 10.1111/j.1582-4934.2009.00699.x
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   He H, 2008, INVEST OPHTH VIS SCI, V49, P4468, DOI 10.1167/iovs.08-1781
   HOEKZEMA R, 1992, INVEST OPHTH VIS SCI, V33, P532
   Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315
   Hsia HC, 2011, PLAST RECONSTR SURG, V127, P2312, DOI 10.1097/PRS.0b013e3182139fa4
   Hwang YJ, 2012, ACS APPL MATER INTER, V4, P261, DOI 10.1021/am2013147
   Jiang XL, 2012, J BIOMED NANOTECHNOL, V8, P791, DOI 10.1166/jbn.2012.1432
   KANG AH, 1970, P NATL ACAD SCI USA, V67, P1307, DOI 10.1073/pnas.67.3.1307
   KATZ EP, 1973, J MOL BIOL, V73, P351, DOI 10.1016/0022-2836(73)90347-1
   Kim DH, 2007, BIOMATERIALS, V28, P4231, DOI 10.1016/j.bioinaterials.2007.06.014
   Kitagawa K, 2011, JPN J OPHTHALMOL, V55, P16, DOI 10.1007/s10384-010-0903-0
   Krishnan R, 2012, J MATER SCI-MATER M, V23, P1511, DOI 10.1007/s10856-012-4630-6
   Kuhn K, 1978, Suppl Thromb Haemost, V63, P123
   Kumar TR, 2003, J BIOMAT SCI-POLYM E, V14, P689, DOI 10.1163/156856203322274941
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39
   Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008
   Li YP, 2012, BIOMACROMOLECULES, V13, P49, DOI 10.1021/bm201070g
   Lim LS, 2010, ARCH OPHTHALMOL-CHIC, V128, P1303, DOI 10.1001/archophthalmol.2010.222
   Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Ma DHK, 2009, OCUL SURF, V7, P128
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Mi FL, 2006, J AGR FOOD CHEM, V54, P3290, DOI 10.1021/jf0529868
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Ordonez P, 2012, STEM CELLS, V30, P100, DOI 10.1002/stem.794
   Penha FM, 2010, OPHTHAL RES, V44, P82, DOI 10.1159/000312817
   Saraswathy G., 2004, TRENDS BIOMATER ARTI, V17, P31
   Sharma S, 2011, MOL VIS, V17, P2898
   Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5
   Slansky H H, 1970, Surv Ophthalmol, V14, P402
   SPIRA M, 1994, J BIOMED MATER RES, V28, P91, DOI 10.1002/jbm.820280112
   Spoerl E, 2004, OPHTHAL RES, V36, P71, DOI 10.1159/000076884
   Stepp MA, 2005, OCUL SURF, V3, P15, DOI 10.1016/S1542-0124(12)70119-2
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tulinski M, 2012, J NANOSCI NANOTECHNO, V12, P8779, DOI 10.1166/jnn.2012.6832
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   Wang JX, 2012, J BIOMED MATER RES A, V100A, P632, DOI 10.1002/jbm.a.33291
   Williams SJ, 2009, BIOPOLYMERS, V91, P676, DOI 10.1002/bip.21196
   Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145
   Xu YH, 2010, J BIOMED NANOTECHNOL, V6, P260, DOI 10.1166/jbn.2010.1126
   Yoshita T, 2004, AM J OPHTHALMOL, V138, P486, DOI 10.1016/j.ajo.2004.03.021
   Yunoki S, 2008, BIOMACROMOLECULES, V9, P879, DOI 10.1021/bm7012058
   Zeng S, 2011, J BIOMED NANOTECHNOL, V7, P549, DOI 10.1166/jbn.2011.1316
NR 72
TC 23
Z9 24
U1 0
U2 25
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD DEC
PY 2013
VL 9
IS 12
BP 2048
EP 2062
DI 10.1166/jbn.2013.1734
PG 15
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 225VI
UT WOS:000324992000010
PM 24266260
DA 2018-10-20
ER

PT J
AU Jaiswal, AK
   Dhumal, RV
   Ghosh, S
   Chaudhari, P
   Nemani, H
   Soni, VP
   Vanage, GR
   Bellare, JR
AF Jaiswal, Amit K.
   Dhumal, Rohit V.
   Ghosh, Sandipto
   Chaudhari, Pradip
   Nemani, Harishankar
   Soni, Vivek P.
   Vanage, Geeta R.
   Bellare, Jayesh R.
TI Bone Healing Evaluation of Nanofibrous Composite Scaffolds in Rat
   Calvarial Defects: A Comparative Study
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Scaffold; Electrospinning; In Vivo Implantation; Biomaterial; Micro-CT
ID TISSUE-ENGINEERING SCAFFOLDS; MESENCHYMAL STEM-CELLS; CRITICAL-SIZE
   DEFECT; BIODEGRADABLE COLLOIDAL GELS; BETA-TRICALCIUM PHOSPHATE;
   ALTERNATE SOAKING PROCESS; IN-VIVO; HYDROXYAPATITE CERAMICS; POLYMERIC
   NANOFIBERS; REGENERATION
AB We studied the in vivo performance of scaffolds consisting of nanofibrous poly(L-lactic acid) (P) and blend of poly(L-lactic acid/gelatin) (PG) prepared by electrospinning and further composited them with hydroxyapatite (HA) via alternate soaking method, to get poly(L-lactic acid)/hydroxyapatite (PH) and poly(L-lactic acid)/gelatin/hydroxyapatite (PGH) scaffolds respectively. The purpose of this study was to assess and compare bone regeneration potential of electrospun P, PG and electrospun-alternate soaked PH and PGH scaffolds using rat as an animal model by creating two 5 mm circular defects in calvaria. The respective scaffolds were implanted into the defects as one side implantation and both side implantation. Defects left empty served as a negative control for one side implantation and as sham control for both side implantations. The outcomes of the scaffold implantation were determined after 6 and 10 weeks by digital radiography, micro-CT, dual-energy X-ray absorptiometry (DEXA) and histological analysis. PGH scaffold regenerated maximum amount of new bone with high bone mineral density (BMD) into the defects and complete closure occurred in just 6 weeks while other scaffolds failed to close the defects completely. PGH group exhibited highest BMD value after 10 weeks. Histological findings showed abundant osteoblasts and initiation of matrix mineralization in HA containing scaffolds. Masson's trichrome staining showed collagen deposition in all scaffold groups except sham control group. Biochemical and haematological parameters were well with in normal range, indicating no infection due to scaffold implantation. These results prove PGH scaffold as a potential biomaterial for bone regenerative medicine.
C1 [Jaiswal, Amit K.; Soni, Vivek P.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
   [Bellare, Jayesh R.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India.
   [Dhumal, Rohit V.; Vanage, Geeta R.] Natl Inst Res Reprod Hlth, Natl Ctr Preclin Reprod & Genet Toxicol, Bombay 400012, Maharashtra, India.
   [Ghosh, Sandipto; Chaudhari, Pradip] Adv Ctr Treatment Res & Educ Canc, Small Anim Imaging Facil, Navi Mumbai 410210, Maharashtra, India.
   [Nemani, Harishankar] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India.
RP Vanage, GR (reprint author), Natl Inst Res Reprod Hlth, Natl Ctr Preclin Reprod & Genet Toxicol, Bombay 400012, Maharashtra, India.
EM vanageg@nirrh.res.in; jb@iitb.ac.in
CR Alpaslan G, 1997, J ORAL MAXIL SURG, V55, P56, DOI 10.1016/S0278-2391(97)90447-X
   Arafat MT, 2011, ACTA BIOMATER, V7, P809, DOI 10.1016/j.actbio.2010.09.010
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3
   Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]
   Develioglu H, 2006, J BIOMED MATER RES A, V77A, P627, DOI 10.1002/jbm.a.30692
   Feng Y. F., 2012, PLOS ONE, V7
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Ge YJ, 2011, J BIOMAT SCI-POLYM E, V22, P2417, DOI 10.1163/092050610X540477
   Jaiswal A. K., 2013, DRUG DELIV TRANSL RE
   Jaiswal AK, 2013, APPL SURF SCI, V268, P477, DOI 10.1016/j.apsusc.2012.12.152
   Jaiswal AK, 2012, J BIOACT COMPAT POL, V27, P356, DOI 10.1177/0883911512447211
   Jose M. V., 2009, ACTA BIOMATER, V5, P305
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P643, DOI 10.1002/jbm.a.30866
   Kim SS, 2007, J BIOMED MATER RES A, V80A, P206, DOI 10.1002/jbm.a.30836
   Lee JB, 2013, J BIOMED NANOTECHNOL, V9, P424, DOI 10.1166/jbn.2013.1514
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Luvizuto ER, 2011, BIOMATERIALS, V32, P3855, DOI 10.1016/j.biomaterials.2011.01.076
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mao En-liang, 2010, Journal of Wuhan University of Technology, V32, P15, DOI 10.3963/j.issn.1671-4431.2010.12.004
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Rahman C.V., 2012, J TISSUE ENG REGEN M
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sin D, 2010, MAT SCI ENG C-MATER, V30, P78, DOI 10.1016/j.msec.2009.09.002
   Sohn J.-Y., 2010, J PERIODONTAL IMPLAN, V40, P180
   Taguchi T, 1998, CHEM LETT, P711, DOI 10.1246/cl.1998.711
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Wang Q, 2010, BIOMATERIALS, V31, P4980, DOI 10.1016/j.biomaterials.2010.02.052
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Woo KM, 2009, TISSUE ENG PT A, V15, P2155, DOI 10.1089/ten.tea.2008.0433
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Zhao J, 2012, TISSUE ENG PT A, V18, P185, DOI [10.1089/ten.tea.2011.0297, 10.1089/ten.TEA.2011.0297]
   Zhao X, 2011, J BIOMED NANOTECHNOL, V7, P823, DOI 10.1166/jbn.2011.1342
   Zong C, 2010, EUR CELLS MATER, V20, P109
   Zou B, 2012, ACTA BIOMATER, V8, P1576, DOI 10.1016/j.actbio.2012.01.003
NR 45
TC 13
Z9 13
U1 0
U2 46
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD DEC
PY 2013
VL 9
IS 12
BP 2073
EP 2085
DI 10.1166/jbn.2013.1736
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 225VI
UT WOS:000324992000012
PM 24266262
DA 2018-10-20
ER

PT J
AU Bahraminasab, M
   Sahari, BB
   Edwards, KL
   Farahmand, F
   Hong, TS
   Naghibi, H
AF Bahraminasab, Marjan
   Sahari, B. B.
   Edwards, K. L.
   Farahmand, Farzam
   Hong, Tang Sai
   Naghibi, Hamid
TI Material tailoring of the femoral component in a total knee replacement
   to reduce the problem of aseptic loosening
SO MATERIALS & DESIGN
LA English
DT Article
DE Materials selection; Functionally graded materials; Knee implant design;
   Finite element analysis
ID FUNCTIONALLY GRADED MATERIALS; FINITE-ELEMENT ANALYSIS; DESIGN
   OPTIMIZATION; MATERIAL SELECTION; JOINT REPLACEMENT; HIP-ARTHROPLASTY;
   DENTAL IMPLANT; WEAR BEHAVIOR; BONE-DENSITY; FOLLOW-UP
AB Aseptic loosening of femoral components is a significant problem affecting the life of current total knee replacements. To help reduce the problem of aseptic loosening, a new metal-ceramic poros functionally graded biomaterial (FGBM) has been designed to replace the existing metal alloy material normally used. In order to investigate the effect of using a FGBM on distal femur stresses compared to using standard material in a femoral component, a three-dimensional finite element model of the knee prosthesis has been developed. The results of the modeling and subsequent analysis indicate that by using the new FGBM compared to the existing material in a femoral component, higher levels of stress can be realized in the adjacent bone area of the femur and as a consequence reduce harmful atrophy effects. Also, by a judicious choice of material combinations and variation of porosity in the FGBM, the surface properties can be tailored to improve wear resistance at the articular interface and bone anchorage at the femoral end, as well as varying the stiffness in the core of the femoral component. Therefore, the use of the new FGBM improves the performance of knee prostheses by addressing concurrently the three current leading causes of failure; stress-shielding of the bone by the implant, wear of the articular surfaces, and the development of soft tissue at the bone/prosthesis interface as a result of relative implant motion. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Bahraminasab, Marjan; Sahari, B. B.; Hong, Tang Sai] Univ Putra Malaysia, Dept Mech & Mfg Engn, Serdang 43400, Malaysia.
   [Sahari, B. B.] Univ Putra Malaysia, ITMA, Inst Adv Technol, Serdang 43400, Malaysia.
   [Edwards, K. L.] Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England.
   [Farahmand, Farzam; Naghibi, Hamid] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran.
   [Farahmand, Farzam] Univ Tehran Med Sci, RCSTIM, Tehran, Iran.
RP Bahraminasab, M (reprint author), Univ Putra Malaysia, Dept Mech & Mfg Engn, Serdang 43400, Malaysia.
EM m.bahraminasab@yahoo.com
RI Farahmand, Farzam/B-3921-2011; Baharaminasab, Marjan/F-3230-2011;
   Naghibi Beidokhti, Hamid/E-5201-2016
OI Farahmand, Farzam/0000-0001-8900-7003; Baharaminasab,
   Marjan/0000-0003-3012-9799; Naghibi Beidokhti,
   Hamid/0000-0003-0555-3942; Edwards, Kevin/0000-0001-7619-9114; Sahari,
   Barkawi Bin/0000-0001-7138-6375
FU University Putra Malaysia
FX The first author would like to thank University Putra Malaysia for
   funding this work.
CR Au AG, 2007, J BIOMECH, V40, P1410, DOI 10.1016/j.jbiomech.2006.05.020
   Bahraminasab M., 2011, TRENDS BIOMATER ARTI, V25, P95
   Bahraminasab M, 2013, MATER DESIGN, V44, P155, DOI 10.1016/j.matdes.2012.07.066
   Bahraminasab M, 2012, MATER DESIGN, V42, P459, DOI 10.1016/j.matdes.2012.05.046
   Bahraminasab M, 2011, MATER DESIGN, V32, P4471, DOI 10.1016/j.matdes.2011.03.046
   BARTEL DL, 1986, J BONE JOINT SURG AM, V68A, P1041, DOI 10.2106/00004623-198668070-00010
   Bayat M, 2007, THIN WALL STRUCT, V45, P677, DOI 10.1016/j.tws.2007.05.005
   Bayat M, 2008, INT J COMPUT METH EN, V9, P121, DOI 10.1080/15502280701815416
   Bougherara H, 2010, P I MECH ENG H, V224, P1209, DOI 10.1243/09544119JEIM691
   Brechet AY, 2012, SCRIPTA MATER, DOI DOI 10.1016/J.SCRIPTAMAT.2012.07.038(0)
   Cho HJ, 2004, MATER CHEM PHYS, V88, P9, DOI 10.1016/j.matchemphys.2003.10.021
   Edwards KL, 2007, MATER DESIGN, V28, P1288, DOI 10.1016/j.matdes.2005.12.009
   Enab TA, 2011, COMP MATER SCI, V53, P94
   Enab TA, 2013, MATER DESIGN, V44, P454, DOI 10.1016/j.matdes.2012.08.017
   Geetha M., 2008, PROG MATER SCI, V54, P397, DOI DOI 10.1016/1
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Godest AC, 2002, J BIOMECH, V35, P267, DOI 10.1016/S0021-9290(01)00179-8
   GOLDBERG VM, 1988, CLIN ORTHOP RELAT R, P86
   Halloran JP, 2005, J BIOMECH, V38, P323, DOI 10.1016/j.jbiomech.2004.02.046
   Hedia HS, 2004, BIO-MED MATER ENG, V14, P133
   Hedia HS, 2004, INT J MECH MATER DES, V1, P329, DOI DOI 10.1007/S10999-005-3307-4
   Hernandez-Vaquero D, 2008, INT ORTHOP, V32, P47, DOI 10.1007/s00264-006-0280-y
   Hunter G, 2005, J ASTM INT, V2, P409
   Ishida T, 2011, ARTIF ORGANS, V35, P404, DOI 10.1111/j.1525-1594.2010.01117.x
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Liau Jiann-Jong, 2002, Clinical Biomechanics, V17, P698, DOI 10.1016/S0268-0033(02)00102-X
   Liau JJ, 2002, CLIN BIOMECH, V17, P140, DOI 10.1016/S0268-0033(01)00109-7
   Lin D, 2009, COMPOS PART B-ENG, V40, P668, DOI 10.1016/j.compositesb.2009.04.015
   Moro T, 2010, OSTEOARTHR CARTILAGE, V18, P1174, DOI 10.1016/j.joca.2010.05.019
   Murty AN, 2003, J ARTHROPLASTY, V18, P844, DOI 10.1054/S0883-5403(03)00324-3
   Nemat-Alla M, 2003, INT J SOLIDS STRUCT, V40, P7339, DOI 10.1016/j.ijsolstr.2003.08.017
   Oonishi H, 2006, BIOCERAMICS AND ALTERNATIVE BEARINGS IN JOINT ARTHROPLASTY, P101, DOI 10.1007/978-3-7985-1635-9_17
   Petersen MM, 1996, ACTA ORTHOP SCAND, V67, P339, DOI 10.3109/17453679609002327
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Rahaman MN, 2008, J MATER SCI-MATER M, V19, P2325, DOI 10.1007/s10856-007-3328-7
   Silva ECN, 2006, J MATER SCI, V41, P6991, DOI 10.1007/s10853-006-0232-3
   Spinelli M, 2010, ARTIF ORGANS, V34, pE177, DOI 10.1111/j.1525-1594.2009.00972.x
   STONE MH, 1989, J BONE JOINT SURG BR, V71, P217
   Thelen S, 2004, J BIOMED MATER RES A, V69A, P601, DOI 10.1002/jbm.a.20100
   van Loon CJM, 2001, ARCH ORTHOP TRAUM SU, V121, P282, DOI 10.1007/s004020000232
   Wagner P, 2011, EUR J CANCER, V47, P1061, DOI 10.1016/j.ejca.2010.11.023
   Wang AG, 2008, J ARTHROPLASTY, V23, P559, DOI 10.1016/j.arth.2007.05.007
   Yan WY, 2011, MATER DESIGN, V32, P1776, DOI 10.1016/j.matdes.2010.12.042
   Zhang Y, 2010, GRADED GLASS ZIRCONI
NR 44
TC 13
Z9 13
U1 0
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
J9 MATER DESIGN
JI Mater. Des.
PD DEC
PY 2013
VL 52
BP 441
EP 451
DI 10.1016/j.matdes.2013.05.066
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 210KR
UT WOS:000323832200051
DA 2018-10-20
ER

PT J
AU Ning, LM
   Miao, P
   Gao, T
   Wang, HY
   Li, GX
AF Ning, Limin
   Miao, Peng
   Gao, Tao
   Wang, Haiyan
   Li, Genxi
TI Preparation and assembly of collagen-DNA complex on an electrode surface
   and its application to protein analysis
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE Collagen-DNA complex; Protein analysis; Biomaterial; Biosensor;
   Molecular assembly
ID SMALL INTERFERING RNA; IV COLLAGEN; PHYSICOCHEMICAL CHARACTERISTICS;
   IN-VIVO; DELIVERY; ATELOCOLLAGEN; CHITOSAN; PEPTIDES; RELEASE; MATRIX
AB In this work, we have prepared collagen-DNA complex on the surface of an electrode through electrostatic interaction and hydrogen bonding between collagen triple helix and DNA double helix. The prepared tubular material is then deposited on the electrode surface to form a film. Due to the excellent biocompatibility of collagen and DNA, the prepared biomaterial can provide a new platform for protein analysis. On the one hand, since collagen in the complex is the substrate of matrix metalloproteinases-2 (MMP-2), a new kind of electrochemical biosensor for the detection of MMP-2 can be developed. On the other, the collagen-DNA complex can be used to entrap proteins onto the electrode surface with the activity of the target proteins being well maintained, thus further analysis can be conducted on the target proteins. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Ning, Limin; Miao, Peng; Gao, Tao; Wang, Haiyan; Li, Genxi] Nanjing Univ, Dept Biochem, Nanjing 210093, Jiangsu, Peoples R China.
   [Ning, Limin; Miao, Peng; Gao, Tao; Wang, Haiyan; Li, Genxi] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.
   [Li, Genxi] Shanghai Univ, Sch Life Sci, Lab Biosensing Technol, Shanghai 200444, Peoples R China.
RP Li, GX (reprint author), Nanjing Univ, Dept Biochem, Nanjing 210093, Jiangsu, Peoples R China.
EM genxili@nju.edu.cn
RI Li, Genxi/H-1952-2013; Miao, Peng/J-4249-2013
OI Li, Genxi/0000-0001-9663-9914; Miao, Peng/0000-0003-3993-4778
FU National Science Fund for Distinguished Young Scholars [20925520];
   National Natural Science Foundation of China [21235003]; Shanghai
   Science and Technology Committee [09DZ2271800]
FX This work is supported by the National Science Fund for Distinguished
   Young Scholars (Grant No. 20925520), the National Natural Science
   Foundation of China (Grant No. 21235003), and Shanghai Science and
   Technology Committee (Grant No. 09DZ2271800).
CR Cao Y, 2012, ANAL CHEM, V84, P4314, DOI 10.1021/ac203401h
   Dey SK, 2007, LANGMUIR, V23, P6475, DOI 10.1021/la070175n
   HUDSON BG, 1993, J BIOL CHEM, V268, P26033
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Kraatz HB, 2004, J PHYS CHEM B, V108, P20164, DOI 10.1021/jp047900c
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   Miao P, 2009, BIOSENS BIOELECTRON, V24, P3347, DOI 10.1016/j.bios.2009.04.041
   Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093
   Mu P, 2009, INT J CANCER, V125, P2978, DOI 10.1002/ijc.24382
   MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277
   Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d
   Prontera C, 1999, INT J CANCER, V81, P761, DOI 10.1002/(SICI)1097-0215(19990531)81:5<761::AID-IJC16>3.0.CO;2-1
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Svintradze DV, 2008, BIOMACROMOLECULES, V9, P21, DOI 10.1021/bm7008813
   Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215
   Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   Tenboll A, 2010, LANGMUIR, V26, P12165, DOI 10.1021/la1018136
   Vargova Viola, 2012, EXS, V103, P1, DOI 10.1007/978-3-0348-0364-9_1
   Wang AY, 2005, J AM CHEM SOC, V127, P4130, DOI 10.1021/ja0431915
   Yamamoto D, 2010, CLIN CHIM ACTA, V411, P762, DOI 10.1016/j.cca.2010.02.059
   Yemini M, 2006, ELECTROANAL, V18, P2049, DOI 10.1002/elan.200603597
   Zeng ZS, 1999, CARCINOGENESIS, V20, P749, DOI 10.1093/carcin/20.5.749
NR 26
TC 5
Z9 5
U1 2
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD NOV 30
PY 2013
VL 111
BP 499
EP 503
DI 10.1016/j.electacta.2013.08.008
PG 5
WC Electrochemistry
SC Electrochemistry
GA 287GX
UT WOS:000329531100065
DA 2018-10-20
ER

PT J
AU Lee, JH
   Kwon, JS
   Kim, YH
   Choi, EH
   Kim, KM
   Kim, KN
AF Lee, Jung-Hwan
   Kwon, Jae-Sung
   Kim, Yong-Hee
   Choi, Eun-Ha
   Kim, Kwang-Mahn
   Kim, Kyoung-Nam
TI The effects of enhancing the surface energy of a polystyrene plate by
   air atmospheric pressure plasma jet on early attachment of fibroblast
   under moving incubation
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Microelectronics and Plasma Technology
   (ICMAP)
CY JUL 04-07, 2012
CL Jeju, SOUTH KOREA
SP Korean Vacuum Soc, Natl Fus Res Inst, Plasma Technol Res Ctr, Jeju Natl Univ, Res Inst Basic Sci, KRISS UNM, Global Res Lab Quantum Detector Technol, Korean Federat Sci & Technol Soc, Sungkyunkwan Univ, Nano Convergence Core Technol Human Interface, Cheorwon Plasma Res Inst, Sungkyunkwan Univ, Chem & Biol Detect Res Ctr, Chonbuk Natl Univ, High Energy Plasma Res Ctr, Ctr Adv Res Fus Reactor Engn, Korea Vacuum Tech Ltd, Edwards Korea Ltd, SEMES Co Ltd, Adv Vacuum & Clean Equipment Optimizer, Adapt Plasma Technol Corp
DE Air non-thermal atmospheric pressure plasma jet; Surface energy; Moving
   incubation; Mouse fibroblast; Polystyrene plate; Hydrocarbon; Vinculin
ID IN-VITRO; NONTHERMAL PLASMA; CELL BEHAVIOR; TITANIUM; OSTEOBLAST;
   ADHESION; WETTABILITY; SUBSTRATE; POLYMERS; ALBUMIN
AB Enhancing the biomaterial surface energy has received wide attention as a possible option for improving cell adhesion. Non-thermal atmospheric pressure plasma jets (APPJ) have been introduced to medical fields as one of the on-site treatment methods to enhance surface energy before implantation. The aim of this study is to evaluate the effect of enhancing the surface energy of a polystyrene plate by air APPJ on the early attachment of fibroblasts under moving incubation. In addition, the range of plasma jet effect was measured for easy on-site application. After 2 min of air APPJ treatment, mouse fibroblasts (L929) were separately seeded through the prepared holes on the treated polystyrene plate as well as as-received polystyrene plate. Cells were allowed to attach for 30 min or 4 h under 70 revolutions per minute. The surface characteristic results confirmed the increase of surface energy six times after air APPJ treatment with the Owens-Wendt method. Minimal change of surface temperature and amine functional group without roughness changes were detected. In the case of a short attachment time (30 min), the attached L929 were only found on air APPJ-treated center surface. In 4 h attachment time, cells were attached with vinculin focal adhesion and elongated actin filament on the both the right and left side surfaces from the center area which was treated by the plasma jet flame. In light of this study, air APPJ could be useful for early-rapid attachment of mouse fibroblasts on polystyrene plates under moving incubation. Future studies can examine its on-site use with biomaterials. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Lee, Jung-Hwan; Kwon, Jae-Sung; Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120752, South Korea.
   [Lee, Jung-Hwan; Kwon, Jae-Sung; Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Res Ctr Orofacial Hard Tissue Regenerat, Seoul 120752, South Korea.
   [Kim, Yong-Hee; Choi, Eun-Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul 139701, South Korea.
RP Kim, KN (reprint author), Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120752, South Korea.
EM kimkn@yuhs.ac
RI Kwon, Jae-Sung/M-5430-2018
OI Kwon, Jae-Sung/0000-0001-9803-7730; Lee, Jung-Hwan/0000-0001-8678-5459
CR Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Araya M, 2007, THIN SOLID FILMS, V515, P4301, DOI 10.1016/j.tsf.2006.02.066
   ARGUMEDO A, 1978, J RHEOL, V22, P449, DOI 10.1122/1.549484
   Burger AJ, 1999, INT J CARDIOL, V71, P41, DOI 10.1016/S0167-5273(99)00110-2
   Carre A, 2010, J ADHES SCI TECHNOL, V24, P815, DOI 10.1163/016942409X12598231567862
   Caterina M., 2008, J NANOBIOTECHNOL, V6, P3
   Chen M, 2009, APPL SURF SCI, V255, P7257, DOI 10.1016/j.apsusc.2009.03.079
   Chou N.J., 1989, U.S. Patent, Patent No. 5019210
   Corrales T, 2012, BIOMACROMOLECULES, V13, P4247, DOI 10.1021/bm301537g
   Dadsetan M, 2001, J BIOMED MATER RES, V57, P183, DOI 10.1002/1097-4636(200111)57:2<183::AID-JBM1157>3.0.CO;2-M
   David R.B., 2009, PROTEIN ADSORPTION B
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x
   Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381
   Han I, 2011, J APPL PHYS, V109, DOI 10.1063/1.3599885
   Hirotsu T, 2007, THIN SOLID FILMS, V515, P4125, DOI 10.1016/j.tsf.2006.02.084
   Hong YC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3272089
   ISO, 2009, BIOL EV MED DEV 5, P10993
   Iwasa F, 2010, BIOMATERIALS, V31, P2717, DOI 10.1016/j.biomaterials.2009.12.024
   Karakecili AG, 2007, J BIOSCI BIOENG, V104, P69, DOI 10.1263/jbb.104.69
   Keiser K, 2000, J ENDODONT, V26, P288, DOI 10.1097/00004770-200005000-00010
   Koban I, 2011, PLASMA PROCESS POLYM, V8, P975, DOI 10.1002/ppap.201100030
   Lai HC, 2010, J BIOMED MATER RES A, V93A, P289, DOI 10.1002/jbm.a.32542
   Nayar S, 2006, COLLOID SURFACE B, V48, P183, DOI 10.1016/j.colsurfb.2005.09.006
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park GY, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/043001
   Paynter RW, 1998, SURF INTERFACE ANAL, V26, P674, DOI 10.1002/(SICI)1096-9918(199808)26:9<674::AID-SIA414>3.0.CO;2-5
   Powers JM, 2006, CRAIGS RESTORATIVE D
   Rieger J, 1996, J THERM ANAL, V46, P965, DOI 10.1007/BF01983614
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Seo YS, 2011, THIN SOLID FILMS, V519, P7071, DOI 10.1016/j.tsf.2010.11.057
   Uhm HS, 2011, THIN SOLID FILMS, V519, P6974, DOI 10.1016/j.tsf.2011.01.208
   Veleirinho B, 2013, MAT SCI ENG C-MATER, V33, P37, DOI 10.1016/j.msec.2012.07.047
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Werthen M, 2001, BIOMATERIALS, V22, P827, DOI 10.1016/S0142-9612(00)00246-5
   Yokota T, 2007, SURF COAT TECH, V201, P8048, DOI 10.1016/j.surfcoat.2006.03.051
   Zhao Y, 2006, POLYM TEST, V25, P327, DOI 10.1016/j.polymertesting.2005.12.007
   Zhu BS, 2004, J BIOMED MATER RES B, V70B, P43, DOI 10.1002/jbm.b.30011
NR 40
TC 16
Z9 18
U1 3
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD NOV 29
PY 2013
VL 547
BP 99
EP 105
DI 10.1016/j.tsf.2013.04.105
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 239OV
UT WOS:000326036100022
DA 2018-10-20
ER

PT J
AU Liu, W
   Su, Y
   Fang, J
   Wu, CC
   Mo, XM
AF Liu, Wei
   Su, Yan
   Fang, Jun
   Wu, Chunchen
   Mo, Xiumei
TI Effect of topological structure of electrospun substrates on cell
   proliferation and morphology
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Meeting Abstract
DE Cell-biomaterial interactions; poly(lactide-co-glycolide);
   Electrospinning; Nanofibers
ID SCAFFOLD
C1 [Liu, Wei; Su, Yan; Fang, Jun; Mo, Xiumei] Donghua Univ, Coll Mat Sci & Engn, Shanghai 201620, Peoples R China.
   [Liu, Wei; Su, Yan; Fang, Jun; Wu, Chunchen; Mo, Xiumei] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Biomat & Tissue Engn Lab, Shanghai 201620, Peoples R China.
EM www85108@163.com; xxm@dhu.edu.cn
RI mo, xiumei/C-9340-2013
CR Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 2
TC 0
Z9 0
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD NOV 28
PY 2013
VL 172
IS 1
BP E141
EP E141
DI 10.1016/j.jconrel.2013.08.228
PG 1
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AI6DX
UT WOS:000336961900242
DA 2018-10-20
ER

PT J
AU Wagner, DE
   Lawrence, J
   Bhaduri, SB
AF Wagner, Darcy E.
   Lawrence, Joseph
   Bhaduri, Sarit B.
TI Microwave-assisted solution combustion synthesis of high aspect ratio
   calcium phosphate nanoparticles
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
DE microwave heating; combustion synthesis; nanoscale
ID INORGANIC HOLLOW NANOPARTICLES; MOLTEN-SALT SYNTHESIS; HYDROXYAPATITE
   WHISKERS; HYDROTHERMAL SYNTHESIS; NONVIRAL VECTORS; GENE DELIVERY;
   MORPHOLOGY; NANORODS; NANOTUBES; NANOMEDICINE
AB Calcium phosphates (CaPs) are major chemical constituents of mammalian bone. Their osteoconductivity in vitro and in vivo has encouraged their use in biomaterial applications such as implant materials and drug delivery. High aspect ratio nanoparticles are attractive for many biomedical applications; however, precise control of the phase and morphology is challenging. The impact of fuel-to-oxidant ratio, pH, and cation chemistry on morphology and phase was studied for CaP-based compositions by microwave-assisted solution combustion synthesis (MASCS) in a urea-nitrate (fuel-oxidant) system. An initial calcium to phosphate ratio of 1.5 was used. Highly crystalline hydroxyapatite (HA) and biphasic CaP nanoparticle compositions were produced as confirmed by x-ray diffraction, scanning electron microscopy, and transmission electron microscopy. MASCS was capable of synthesizing high aspect ratio (approximate to 5 to 20) single and biphasic CaP nanoparticles with diameters ranging from 250 to 500 nm and lengths between 2 and 10 m.
C1 [Wagner, Darcy E.] Univ Toledo, Dept Biomed Engn, Coll Engn, Toledo, OH 43606 USA.
   [Wagner, Darcy E.] Univ Toledo, Dept Biomed Engn, Coll Med, Toledo, OH 43606 USA.
   [Lawrence, Joseph] Univ Toledo, Dept Bioengn, Coll Engn, Toledo, OH 43606 USA.
   [Bhaduri, Sarit B.] Univ Toledo, Dept Mech Ind & Mfg Engn, Coll Engn, Toledo, OH 43606 USA.
   [Bhaduri, Sarit B.] Univ Toledo, Div Dent, Coll Med, Toledo, OH 43614 USA.
RP Wagner, DE (reprint author), Univ Vermont, Vermont Lung Ctr, Dept Pulm & Crit Care, Coll Med, Burlington, VT 05405 USA.
EM darcy.wagner@rockets.utoledo.edu
RI Wagner, Darcy/R-4718-2017
OI Wagner, Darcy/0000-0003-3794-1309
FU NSF CMMI [0753479]
FX This work was funded by NSF CMMI 0753479.
CR Burgos-Montes O, 2006, J AM CERAM SOC, V89, P484, DOI 10.1111/j.1551-2916.2005.00771.x
   Cao JM, 2005, J MATER SCI, V40, P6311, DOI 10.1007/s10853-005-4221-8
   Chowdhury EH, 2004, GENE, V341, P77, DOI 10.1016/j.gene.2004.07.015
   Coelho JM, 2010, J MATER SCI-MATER M, V21, P2543, DOI 10.1007/s10856-010-4122-5
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Garcia-Tunon E, 2012, J MATER SCI-MATER M, V23, P2471, DOI 10.1007/s10856-012-4717-0
   JAIN SR, 1981, COMBUST FLAME, V40, P71, DOI 10.1016/0010-2180(81)90111-5
   Jalota S, 2004, J MATER RES, V19, P1876, DOI 10.1557/JMR.2004.0230
   Liu JB, 2004, CHEM PHYS LETT, V396, P429, DOI 10.1016/j.cplett.2004.08.094
   Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9
   Maitra A, 2005, EXPERT REV MOL DIAGN, V5, P893, DOI 10.1586/14737159.5.6.893
   Mao Y, 2007, SMALL, V3, P1122, DOI 10.1002/smll.200700048
   Neira IS, 2008, J MATER SCI, V43, P2171, DOI 10.1007/s10853-007-2032-9
   Neira IS, 2009, CRYST GROWTH DES, V9, P466, DOI 10.1021/cg800738a
   Park YM, 2008, MATER CHEM PHYS, V109, P440, DOI 10.1016/j.matchemphys.2007.12.013
   Rabinow BE, 2004, NAT REV DRUG DISCOV, V3, P785, DOI 10.1038/nrd1494
   Roeder RK, 2006, J AM CERAM SOC, V89, P2096, DOI 10.1111/j.1551-2916.2006.01067.x
   Roy I, 2003, INT J PHARM, V250, P25, DOI 10.1016/S0378-5173(02)00452-0
   Sokolova V, 2008, ANGEW CHEM INT EDIT, V47, P1382, DOI 10.1002/anie.200703039
   Son SJ, 2007, DRUG DISCOV TODAY, V12, P657, DOI 10.1016/j.drudis.2007.06.012
   Son SJ, 2007, DRUG DISCOV TODAY, V12, P650, DOI 10.1016/j.drudis.2007.06.002
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Tas AC, 2001, J AM CERAM SOC, V84, P295
   Varma HK, 1998, CERAM INT, V24, P467, DOI 10.1016/S0272-8842(97)00038-2
   Viswanath B, 2008, ACTA BIOMATER, V4, P1448, DOI 10.1016/j.actbio.2008.02.031
   Vollmer N, 2012, INT J SELF-PROPAG HI, V21, P189, DOI 10.3103/S1061386212040073
   Wagner DE, 2012, TISSUE ENG PART B-RE, V18, P1, DOI [10.1089/ten.TEB.2011.0081, 10.1089/ten.teb.2011.0081]
   Wang AL, 2007, MAT SCI ENG C-BIO S, V27, P865, DOI 10.1016/j.msec.2006.10.001
   Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971
   Zhang HQ, 2011, ACTA BIOMATER, V7, P2960, DOI 10.1016/j.actbio.2011.03.020
   Zhou H, 2012, J MATER SCI-MATER M, V23, P2831, DOI 10.1007/s10856-012-4743-y
NR 31
TC 4
Z9 4
U1 1
U2 27
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0884-2914
EI 2044-5326
J9 J MATER RES
JI J. Mater. Res.
PD NOV 28
PY 2013
VL 28
IS 22
BP 3119
EP 3129
DI 10.1557/jmr.2013.314
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 273PE
UT WOS:000328546900007
DA 2018-10-20
ER

PT J
AU McNeill, B
   Vulesevic, B
   Ruel, M
   Suuronen, EJ
AF McNeill, Brian
   Vulesevic, Branka
   Ruel, Marc
   Suuronen, Erik J.
TI Functional Enhancement of Circulating Angiogenic Cells Cultured on a
   Collagen Biomaterial Using the Cysteine-rich Angiogenic Inducer 61
   (CYR-61) Protein
SO CIRCULATION
LA English
DT Meeting Abstract
CT Scientific Sessions and Resuscitation Science Symposium of the
   American-Heart-Association
CY NOV 16-17, 2013
CL Dallas, TX
SP Amer Heart Assoc
DE Endothelial progenitor cell; Cell signaling; Proteins; Vascular;
   Stem/progenitor cells
C1 [McNeill, Brian; Vulesevic, Branka; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD NOV 26
PY 2013
VL 128
IS 22
SU S
MA 13786
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA AC0CR
UT WOS:000332162903298
DA 2018-10-20
ER

PT J
AU Roche, ET
   Hastings, CL
   Lewin, SA
   Shvartsman, D
   Brudno, Y
   Vasilyev, NV
   O'Brien, FJ
   Walsh, C
   Duffy, GP
   Mooney, DJ
AF Roche, Ellen T.
   Hastings, Conn L.
   Lewin, Sarah A.
   Shvartsman, Dmitry
   Brudno, Yevgeny
   Vasilyev, Nikolav V.
   O'Brien, Fergal J.
   Walsh, ConorJ
   Duffy, Garry P.
   Mooney, David J.
TI Biomaterial Delivery Vehicles Improve Acute Retention of Cells in the
   Infarcted Heart
SO CIRCULATION
LA English
DT Meeting Abstract
CT Scientific Sessions and Resuscitation Science Symposium of the
   American-Heart-Association
CY NOV 16-17, 2013
CL Dallas, TX
SP Amer Heart Assoc
DE Myocardial infarction; Cells
C1 [Roche, Ellen T.; Walsh, ConorJ; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Wyss Inst, Cambridge, MA 02138 USA.
   [Hastings, Conn L.; O'Brien, Fergal J.; Duffy, Garry P.] Royal Coll Surgeons Ireland, Dublin 2, Ireland.
   [Lewin, Sarah A.; Shvartsman, Dmitry; Brudno, Yevgeny] Wyss Inst, Cambridge, MA USA.
   [Vasilyev, Nikolav V.] Boston Childrens Hosp, Boston, MA USA.
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005
NR 0
TC 0
Z9 0
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD NOV 26
PY 2013
VL 128
IS 22
SU S
MA 18338
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA AC0CR
UT WOS:000332162907326
DA 2018-10-20
ER

PT J
AU Toeg, HD
   Abessi, O
   Al-Atassi, T
   de Kerchove, L
   El-Houry, G
   Labrosse, M
   Boodhwani, M
AF Toeg, Hadi D.
   Abessi, Ovais
   Al-Atassi, Talal
   de Kerchove, Laurent
   El-Houry, Gebrine
   Labrosse, Michel
   Boodhwani, Munir
TI Finding the Ideal Biomaterial for Aortic Valve Repair
SO CIRCULATION
LA English
DT Meeting Abstract
CT Scientific Sessions and Resuscitation Science Symposium of the
   American-Heart-Association
CY NOV 16-17, 2013
CL Dallas, TX
SP Amer Heart Assoc
C1 [Toeg, Hadi D.; Al-Atassi, Talal; Boodhwani, Munir] Univ Ottawa, Inst Heart, Ottawa, ON, Canada.
   [Abessi, Ovais; Labrosse, Michel] Univ Ottawa, Ottawa, ON, Canada.
   [de Kerchove, Laurent; El-Houry, Gebrine] Clin Univ St Luc, Dept Cardiovasc & Thorac Surg, B-1200 Brussels, Belgium.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD NOV 26
PY 2013
VL 128
IS 22
SU S
MA 18226
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA AC0CR
UT WOS:000332162907269
DA 2018-10-20
ER

PT J
AU McLoughlin, SY
   Kastantin, M
   Schwartz, DK
   Kaar, JL
AF McLoughlin, Sean Yu
   Kastantin, Mark
   Schwartz, Daniel K.
   Kaar, Joel L.
TI Single-molecule resolution of protein structure and interfacial dynamics
   on biomaterial surfaces
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE protein adhesion; single-molecule fluorescence; total internal
   reflection fluorescence microscopy
ID RESONANCE ENERGY-TRANSFER; INDUCED CONFORMATIONAL-CHANGES; AMYLOID
   BETA-PEPTIDE; FIBRINOGEN ADSORPTION; HYDROPHOBIC SURFACES; COMPETITIVE
   BEHAVIOR; RELAXATION KINETICS; PLATELET-ADHESION; SOLID-SURFACES; DNA
   HAIRPIN
AB A method was developed to monitor dynamic changes in protein structure and interfacial behavior on surfaces by single-molecule Forster resonance energy transfer. This method entails the incorporation of unnatural amino acids to site-specifically label proteins with single-molecule Forster resonance energy transfer probes for high-throughput dynamic fluorescence tracking microscopy on surfaces. Structural changes in the enzyme organophosphorus hydrolase (OPH) were monitored upon adsorption to fused silica (FS) surfaces in the presence of BSA on a molecule-by-molecule basis. Analysis of >30,000 individual trajectories enabled the observation of heterogeneities in the kinetics of surface-induced OPH unfolding with unprecedented resolution. In particular, two distinct pathways were observed: a majority population (similar to 85%) unfolded with a characteristic time scale of 0.10 s, and the remainder unfolded more slowly with a time scale of 0.7 s. Importantly, even after unfolding, OPH readily desorbed from FS surfaces, challenging the common notion that surface-induced unfolding leads to irreversible protein binding. This suggests that protein fouling of surfaces is a highly dynamic process because of subtle differences in the adsorption/desorption rates of folded and unfolded species. Moreover, such observations imply that surfaces may act as a source of unfolded (i.e., aggregation-prone) protein back into solution. Continuing study of other proteins and surfaces will examine whether these conclusions are general or specific to OPH in contact with FS. Ultimately, this method, which is widely applicable to virtually any protein, provides the framework to develop surfaces and surface modifications with improved biocompatibility.
C1 [McLoughlin, Sean Yu; Kastantin, Mark; Schwartz, Daniel K.; Kaar, Joel L.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
RP Kaar, JL (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
EM joel.kaar@colorado.edu
RI Kastantin, Mark/C-7519-2011
OI Kastantin, Mark/0000-0003-1766-8747
FU US Army Research Office Young Investigator Award [W911NF-12-1-0115];
   National Institutes of Health [1R21EB015532-01]
FX The authors are grateful to Ryan Mehl for technical help with pDule2
   pCNF RS. This work was supported by a US Army Research Office Young
   Investigator Award (W911NF-12-1-0115; to J.L.K.) and the National
   Institutes of Health (1R21EB015532-01).
CR Brandes N, 2006, J COLLOID INTERF SCI, V299, P56, DOI 10.1016/j.jcis.2006.01.065
   Brustad EM, 2008, J AM CHEM SOC, V130, P17664, DOI 10.1021/ja807430h
   Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716
   Di Risio S, 2010, COLLOID SURFACE B, V79, P397, DOI 10.1016/j.colsurfb.2010.05.004
   Di Risio S, 2009, J COLLOID INTERF SCI, V338, P410, DOI 10.1016/j.jcis.2009.07.005
   Fears KP, 2009, LANGMUIR, V25, P13926, DOI 10.1021/la900799m
   Felsovalyi F, 2012, PROTEIN SCI, V21, P1113, DOI 10.1002/pro.2099
   Felsovalyi F, 2011, LANGMUIR, V27, P11873, DOI 10.1021/la202585r
   Ganesan A, 2009, CHEMPHYSCHEM, V10, P1492, DOI 10.1002/cphc.200800759
   Giacomelli CE, 2005, MACROMOL BIOSCI, V5, P401, DOI 10.1002/mabi.200400189
   Giacomelli CE, 2003, BIOMACROMOLECULES, V4, P1719, DOI 10.1021/bm034151g
   Grimsley JK, 1997, BIOCHEMISTRY-US, V36, P14366, DOI 10.1021/bi971596e
   Hammill JT, 2007, NAT PROTOC, V2, P2601, DOI 10.1038/nprot.2007.379
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Karlsson M, 2005, J BIOL CHEM, V280, P25558, DOI 10.1074/jbc.M503665200
   Kastantin M, 2013, SMALL, V9, P933, DOI 10.1002/smll.201202335
   Kastantin M, 2013, CHEMPHYSCHEM, V14, P374, DOI 10.1002/cphc.201200838
   Kastantin M, 2012, LANGMUIR, V28, P12443, DOI 10.1021/la3017134
   Kastantin M, 2012, ADV FUNCT MATER, V22, P2617, DOI 10.1002/adfm.201102836
   Kastantin M, 2011, ACS NANO, V5, P9861, DOI 10.1021/nn2035389
   Kastantin M, 2011, J AM CHEM SOC, V133, P4975, DOI 10.1021/ja110663u
   Kim J, 2013, ANAL CHEM, V85, P1468, DOI 10.1021/ac303089v
   Kim SY, 2010, J MOL BIOL, V401, P553, DOI 10.1016/j.jmb.2010.06.050
   Li JJ, 2012, PHARM RES-DORDR, V29, P1689, DOI 10.1007/s11095-012-0696-6
   Maste MCL, 1997, J COLLOID INTERF SCI, V196, P224, DOI 10.1006/jcis.1997.5205
   Milles S, 2012, J AM CHEM SOC, V134, P5187, DOI 10.1021/ja210587q
   Mulchandani A, 2001, BIOSENS BIOELECTRON, V16, P225, DOI 10.1016/S0956-5663(01)00126-9
   Norde W, 2008, COLLOID SURFACE B, V61, P1, DOI 10.1016/j.colsurfb.2007.09.029
   Pan H, 2012, LANGMUIR, V28, P12779, DOI 10.1021/la302258k
   Peeler JC, 2012, METHODS MOL BIOL, V794, P125, DOI 10.1007/978-1-61779-331-8_8
   Schultz KC, 2006, J AM CHEM SOC, V128, P13984, DOI 10.1021/ja0636690
   Seo MH, 2011, ANAL CHEM, V83, P8849, DOI 10.1021/ac202096t
   Singh BK, 2006, FEMS MICROBIOL REV, V30, P428, DOI 10.1111/j.1574-6976.2006.00018.x
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Vertegel AA, 2004, LANGMUIR, V20, P6800, DOI 10.1021/la0497200
   Walder R, 2012, ANALYST, V137, P2987, DOI 10.1039/c2an16219a
   Wallace MI, 2001, P NATL ACAD SCI USA, V98, P5584, DOI 10.1073/pnas.101523498
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Yano YF, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/50/503101
   Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e
   Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030
NR 45
TC 24
Z9 24
U1 0
U2 66
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 26
PY 2013
VL 110
IS 48
BP 19396
EP 19401
DI 10.1073/pnas.1311761110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 257NB
UT WOS:000327390400065
PM 24235137
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Kusurkar, TS
   Tandon, I
   Sethy, NK
   Bhargava, K
   Sarkar, S
   Singh, SK
   Das, M
AF Kusurkar, Tejas S.
   Tandon, Ishita
   Sethy, Niroj Kumar
   Bhargava, Kalpana
   Sarkar, Sabyasachi
   Singh, Sushil Kumar
   Das, Mainak
TI Fluorescent silk cocoon creating fluorescent diatom using a "Water
   glass-fluorophore ferry"
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BOMBYX-MORI; RHODAMINE DYES; FLAVONOIDS; IDENTIFICATION; QUERCETIN;
   SILICA; ROLES; SHELL
AB Fluorophores are ubiquitous in nature. Naturally occurring fluorophores are exceptionally stable and have high quantum yield. Several natural systems have acquired fluorescent signature due to the presence of these fluorophores. Systematic attempt to harvest these fluorophores from natural systems could reap rich commercial benefit to bio-imaging industry. Silk cocoon biomaterial is one such example of natural system, which has acquired a fluorescent signature. The objective of this study is to develop simple, rapid, commercially viable technique to isolate silk cocoon membrane fluorophores and exploring the possibility of using them as fluorescent dye in bio-imaging. Here, we report an innovative water glass (Na2SiO3) based strategy to isolate the silk cocoon fluorophores. Isolated fluorophore is majorly quercetin derivatives and exhibited remarkable photo-and heat stability. Fluorescence and mass spectrometric analysis confirmed presence of a quercetin derivative. We further used this fluorophore to successfully label the silicate shell of diatom species Nitzschia palea.
C1 [Kusurkar, Tejas S.; Das, Mainak] Indian Inst Technol, Dept Biol Sci & Bioengn, Bioelect Green Energy Physiol & Sensor Grp, Kanpur 208016, Uttar Pradesh, India.
   [Tandon, Ishita] Banasthali Vidyapith, Dept Biosci & Biotechnol, Tonk 304022, Rajasthan, India.
   [Sethy, Niroj Kumar; Bhargava, Kalpana] Def Res Dev Org, Def Inst Physiol & Allied Sci, Peptide & Prote Div, Delhi 110054, India.
   [Sarkar, Sabyasachi] Bengal Engn & Sci Univ, Dept Chem, Howrah 711103, W Bengal, India.
   [Singh, Sushil Kumar] Def Res Dev Org, Solid State Phys Lab, Funct Mat Grp, Delhi 110054, India.
   [Das, Mainak] Indian Inst Technol, Design Program, Kanpur 208016, Uttar Pradesh, India.
RP Kusurkar, TS (reprint author), Indian Inst Technol, Dept Biol Sci & Bioengn, Bioelect Green Energy Physiol & Sensor Grp, Kanpur 208016, Uttar Pradesh, India.
EM tejask@iitk.ac.in; mainakd@iitk.ac.in
OI Sethy, Niroj/0000-0003-0675-1481; Sarkar, Sabyasachi/0000-0002-8954-4375
FU IITK [IITK/BSBE/20100206]; IIT K PhD fellowship program
FX The work was supported by IITK start-up grant (IITK/BSBE/20100206)
   (2010-2011) of MD. TSK is funded by IIT K PhD fellowship program. This
   work is part of TSK's doctoral thesis. Authors specially thank to Prof.
   P Sinha, Prof. A K Thakur and their PhD scholars for facilitating
   confocal microscopy and fluorescence spectroscopy work respectively. We
   thank Ms. Shraddha Singh and Prof. D S Katti for the SEM facility of
   BSBE, which was used for imaging the silicate shell of Diatom. We are
   exceptionally thankful to Mr. P Kagkachalam of Chemistry, IIT K for
   helping us with the MS facility. We specially thank Prof. K. Murugesh
   Babu of Department of Textile Technology, Bapuji Institute of
   Engineering & Technology, Davangere, PIN 77004, India for helping us to
   understand the current status of silk industry. A special thanks to
   'Directorate of Rural Industries, Sericulture Sector, Government of
   Chhattishgarh, Chhattishgarh, India' for providing all the necessary
   information regarding the rural economics of silk cottage industry.
CR Annenkov VV, 2010, ANAL BIOCHEM, V407, P44, DOI 10.1016/j.ab.2010.07.032
   Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x
   Daimon T, 2010, P NATL ACAD SCI USA, V107, P11471, DOI 10.1073/pnas.1000479107
   Danks HV, 2004, EUR J ENTOMOL, V101, P433, DOI 10.14411/eje.2004.062
   Descles J, 2008, NEW PHYTOL, V177, P822, DOI 10.1111/j.1469-8137.2007.02303.x
   Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1
   FUJIMOTO N, 1972, Journal of Sericultural Science of Japan, V41, P383
   FUJIMOTO N, 1972, J SERIC SCI JPN, V32, P338
   Harborne J.B., 1988, Progress in Clinical and Biological Research, V280, P17
   HARIZUKA MASAKI, 1953, BULL SERICUL EXPT STA [JAPAN], V14, P141
   HAYASHIYA K, 1959, J SERIC SCI JPN, V28, P27
   Hirayama C., 2009, Sanshi Konchuu Biotec (Journal of Insect Biotechnology and Sericology), V78, P57
   Horrocks NPC, 2013, COMP BIOCHEM PHYS A, V164, P645, DOI 10.1016/j.cbpa.2013.01.023
   Ito T., 1978, SILKWORM IMPORTANT L
   Kaur J, 2013, BIOMACROMOLECULES, V14, P3660, DOI 10.1021/bm401023h
   Kucki M, 2012, J R SOC INTERFACE, V9, P727, DOI 10.1098/rsif.2011.0424
   Kurioka A, 2002, BIOSCI BIOTECH BIOCH, V66, P1396, DOI 10.1271/bbb.66.1396
   NESTMANN ER, 1979, CANCER RES, V39, P4412
   Oku M, 1934, NIPPON NOGEIKAGUKU K, V10, P1029
   Oku M, 1934, NIPPON NOGEIKAGAKU K, V10, P1014
   Packard A. S., 1903, TXB ENTOMOLOGY
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Richardson AS, 1923, IND ENG CHEM, V15, P241, DOI 10.1021/ie50159a007
   Roy M., 2013, BIO-TECHNOL, V3, DOI [10.1007/s13205-013-0128-2, DOI 10.1007/S13205-013-0128-2]
   Roy M., 2012, BIOINTERPHASES, V7, P1
   Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104
   Sen K, 2004, J APPL POLYM SCI, V92, P1080, DOI 10.1002/app.13609
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2
   Shukla S R, 1992, AM DYEST REP, V81, P22
   Tamura Y, 2002, PHYTOCHEMISTRY, V59, P275, DOI 10.1016/S0031-9422(01)00477-0
   Trouvelot L, 1867, AM NAT, V1, P30
   Vail J. G., 1952, SOLUBLE SILICATES TH, V1
   WELDES HH, 1969, IND ENG CHEM, V61, P29, DOI 10.1021/ie50712a008
   Xiaohua Y., 1997, BOMBYX MORI ACTA SER, V3
   Xiaolong H., 2012, BOMBYX MORI MOL BIOL, V39, P1395
   Yu Z, 2000, ACTA SERICOLOGICA SI, V26, P123
   Yu Z, 1997, ACTA SERICOLOGICA SI, V23, P64
   Zhang J, 2013, MATER DESIGN, V49, P842, DOI 10.1016/j.matdes.2013.02.006
   Zhang YQ, 2010, SCI CHINA LIFE SCI, V53, P1330, DOI 10.1007/s11427-010-4084-3
NR 40
TC 7
Z9 7
U1 0
U2 22
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 21
PY 2013
VL 3
AR 3290
DI 10.1038/srep03290
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259IT
UT WOS:000327521300011
PM 24256845
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bassi, G
   Menard, C
   Guilloton, F
   Pacelli, L
   Carusone, R
   Di Trapani, M
   Zanoncello, J
   Bifari, F
   Sensebe, L
   Deschaseaux, F
   Baroth, S
   Schrezenmeier, H
   Rojewski, M
   Layrolle, P
   Giordano, R
   Lorenza, L
   Lavazza, C
   Bourin, P
   Tarte, K
   Krampera, M
AF Bassi, Giulio
   Menard, Cedric
   Guilloton, Fabian
   Pacelli, Luciano
   Carusone, Roberta
   Di Trapani, Mariano
   Zanoncello, Jasmina
   Bifari, Francesco
   Sensebe, Luc
   Deschaseaux, Fredric
   Baroth, Serge
   Schrezenmeier, Hubert
   Rojewski, Markus
   Layrolle, Pierre
   Giordano, Rosaria
   Lorenza, Lazzari
   Lavazza, Cristiana
   Bourin, Philippe
   Tarte, Karin
   Krampera, Mauro
TI Effects Of a Novel Ceramic Biomaterial On Immune Modulatory Properties
   and Differentiation Potential Of Mesenchymal Stromal Cells
SO BLOOD
LA English
DT Meeting Abstract
CT 55th Annual Meeting of the American-Society-of-Hematology
CY DEC 07-10, 2013
CL New Orleans, LA
SP Amer Soc Hematol
RI Di Trapani, Mariano/J-9877-2016; Lavazza, Cristiana/D-5661-2013
OI Di Trapani, Mariano/0000-0002-3077-8038; Lavazza,
   Cristiana/0000-0002-1167-6167
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD NOV 15
PY 2013
VL 122
IS 21
MA 4858
PG 2
WC Hematology
SC Hematology
GA AA9AB
UT WOS:000331385008270
DA 2018-10-20
ER

PT J
AU Kansal, I
   Tulyaganov, DU
   Pascual, MJ
   Gremillard, L
   Malchere, A
   Ferreira, JMF
AF Kansal, Ishu
   Tulyaganov, Dilshat U.
   Pascual, Maria J.
   Gremillard, Laurent
   Malchere, Annie
   Ferreira, Jose M. F.
TI Sintering behaviour of diopside (CaO center dot MgO center dot
   2SiO(2))-fluorapatite (9CaO center dot 3P(2)O(5)center dot CaF2)
   bioactive glass
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE Glass; Viscous flow sintering; Thermal analysis; Biomaterial
ID PHASE
AB The sintering behaviour of an alkali-free bioactive glass with its chemical composition corresponding to 80 wt.% diopside (CaMgSi2O6)-20 wt.% fluorapatite [Ca-5(PO4)(3)F] has been reported in this article. Glass powders with different particle size distributions and mean particle sizes varying between 14 mu m and 220 mu m were used. The influence of particle size variation on sintering ability of glass powders was studied by using an array of complementary advanced characterization techniques including in situ high temperature scanning electron microscopy (HT-SEM), differential thermal analysis (DTA), hot stage microscopy (HSM), X-ray diffraction (XRD) and scanning electron microscopy (SEM). The obtained results have been discussed with their implications on the development of glass-ceramic scaffolds for bone tissue engineering. Glass-ceramics consisting of dense glassy matrix with embedded diopside and fluorapatite crystals were obtained after sintering the glass powder compacts at 850 degrees C for 1 h. (C), 2013 Elsevier B.V. All rights reserved.
C1 [Kansal, Ishu; Ferreira, Jose M. F.] Univ Aveiro, CICECO, Dept Mat & Ceram Engn, P-3810193 Aveiro, Portugal.
   [Tulyaganov, Dilshat U.] Turin Polytech Univ Tashkent, Tashkent 100095, Uzbekistan.
   [Pascual, Maria J.] CSIC, Inst Ceram & Vidrio, Madrid 28049, Spain.
   [Gremillard, Laurent; Malchere, Annie] Univ Lyon, INSA Lyon, MATEIS UMR CNRS 5510, F-69621 Villeurbanne, France.
RP Ferreira, JMF (reprint author), Univ Aveiro, CICECO, Dept Mat & Ceram Engn, P-3810193 Aveiro, Portugal.
EM jmf@ua.pt
OI Gremillard, Laurent/0000-0001-7258-6483; Ferreira,
   Jose/0000-0002-7520-2809
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/70917/2010]
FX Ishu Kansal is indebted to the Portuguese Foundation for Science and
   Technology (FCT) for the PhD grant Reference SFRH/BD/70917/2010. Authors
   are thankful to CICECO, University of Aveiro for the facilities.
CR Clupper DC, 2004, J EUR CERAM SOC, V24, P2929, DOI 10.1016/S0955-2219(03)00363-7
   Frenkel JJ, 1945, J PHYS USSR, V9, P385
   Goel A, 2007, J EUR CERAM SOC, V27, P2325, DOI 10.1016/j.jeurceramsoc.2006.07.016
   Hench LL, 2003, GLASS TECHNOL, V44, P1
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Kang S.-J. L., 2005, SINTERING DENSIFICAT
   Kansal I, 2011, J MATER CHEM, V21, P16247, DOI 10.1039/c1jm11876e
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   MacKenzie J.K., 1949, Proceedings of the Physical Society. Section B, V62, P833, DOI 10.1088/0370-1301/62/12/310
   Plavushkin N., 1959, GLAS CERAM, V16, P15
   Prado MO, 2001, J NON-CRYST SOLIDS, V279, P169
   Tulyaganov DU, 2000, J AM CERAM SOC, V83, P3141, DOI 10.1111/j.1151-2916.2000.tb01695.x
NR 13
TC 2
Z9 2
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
EI 1873-4812
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD NOV 15
PY 2013
VL 380
BP 17
EP 24
DI 10.1016/j.jnoncrysol.2013.08.022
PG 8
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 295AI
UT WOS:000330088600004
DA 2018-10-20
ER

PT J
AU Gilbert, HTJ
   Hoyland, JA
   Richardson, SM
AF Gilbert, Hamish T. J.
   Hoyland, Judith A.
   Richardson, Stephen M.
TI Stem Cell Regeneration of Degenerated Intervertebral Discs: Current
   Status (Update)
SO CURRENT PAIN AND HEADACHE REPORTS
LA English
DT Review
DE Stem cell regeneration; Degenerated intervertebral discs; Adult
   mesenchymal stem cells; Low back pain; Cell-based therapy
ID LOW-BACK-PAIN; ANULUS FIBROSUS CELLS; INVESTIGATIONAL DEVICE EXEMPTION;
   MESENCHYMAL PROGENITOR CELLS; NUCLEUS PULPOSUS; IN-VITRO; GROWTH-FACTOR;
   NERVE GROWTH; CHITOSAN-GLYCEROPHOSPHATE; CHEMICAL MICROENVIRONMENT
AB Low back pain, strongly associated with intervertebral disc (IVD) degeneration, affects a large proportion of the population and has major social and economic costs. Current treatments remain inadequate, targeting the symptoms without addressing the underlying cause. As such, efforts are being directed towards development of therapies aimed at alleviating pain through the restoration of IVD function. The potential of cell-based therapies for the treatment of IVD degeneration are being actively explored, with an emphasis on cell/biomaterial tissue engineering. Adult mesenchymal stem cells, capable of differentiating down the discogenic lineage, have shown promise as a suitable cell source for IVD tissue engineering. However, a number of factors, (discussed in this review), remain to be addressed, including development of a differentiation protocol to produce the correct cell phenotype, identification of suitable biomaterials for cell delivery/implantation, and ensuring cell survival and correct function upon implantation into the degenerate IVD.
C1 [Gilbert, Hamish T. J.; Hoyland, Judith A.; Richardson, Stephen M.] Univ Manchester, Fac Med & Human Sci, Ctr Tissue Injury & Repair, Inst Inflammat & Repair, Manchester M13 9PT, Lancs, England.
RP Richardson, SM (reprint author), Univ Manchester, Fac Med & Human Sci, Ctr Tissue Injury & Repair, Inst Inflammat & Repair, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM S.Richardson@manchester.ac.uk
RI Hoyland, Judith/P-5168-2014; Richardson, Stephen/A-4124-2009
OI Hoyland, Judith/0000-0003-4876-5208; Richardson,
   Stephen/0000-0002-7637-4135; Gilbert, Hamish T J/0000-0003-2571-765X
FU Arthritis Research UK [19884]
CR Adams MA, 1996, J BONE JOINT SURG BR, V78B, P965, DOI 10.1302/0301-620X78B6.1287
   Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c
   Ali R, 2008, BIOTECH HISTOCHEM, V83, P239, DOI 10.1080/10520290802539186
   Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001
   BATTIE MC, 1991, SPINE, V16, P1015, DOI 10.1097/00007632-199109000-00001
   Brisby H, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0179
   BRODIN H, 1955, Acta Orthop Scand, V24, P177
   Calderon L, 2010, EUR CELLS MATER, V20, P134
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Chan CCM, 2008, J NEUROSCI RES, V86, P581, DOI 10.1002/jnr.21522
   Cheng YH, 2013, CARBOHYD POLYM, V92, P1512, DOI 10.1016/j.carbpol.2012.10.074
   Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f
   Chiou M, 2006, BIOCHEM BIOPH RES CO, V343, P644, DOI 10.1016/j.bbrc.2006.02.171
   Chun HJ, 2012, WORLD NEUROSURG, V78, P364, DOI 10.1016/j.wneu.2011.12.084
   Coric D, 2013, J NEUROSURG-SPINE, V18, P85, DOI 10.3171/2012.10.SPINE12512
   DIAMANT B, 1968, EXPERIENTIA, V24, P1195, DOI 10.1007/BF02146615
   Fei QM, 2006, ACTA BIOCH BIOPH SIN, V38, P773, DOI 10.1111/j.1745-7270.2006.00230.x
   Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038
   Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1
   Frith JE, 2013, BIOMATERIALS, V34, P9430, DOI 10.1016/j.biomaterials.2013.08.072
   Gawri R, 2011, SPINE, V36, P1835, DOI 10.1097/BRS.0b013e3181f81314
   Ghiselli G, 2004, J BONE JOINT SURG AM, V86A, P1497, DOI 10.2106/00004623-200407000-00020
   Gilbert HTJ, 2010, ARTHRITIS RHEUM-US, V62, P3385, DOI 10.1002/art.27643
   Gopal D, 2012, ADV EXP MED BIOL, V760, P114
   Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Guyer RD, 2009, SPINE J, V9, P374, DOI 10.1016/j.spinee.2008.08.007
   Harkness EF, 2005, RHEUMATOLOGY, V44, P890, DOI 10.1093/rheumatology/keh599
   Henriksson HB, 2009, SPINE, V34, P2278, DOI 10.1097/BRS.0b013e3181a95ad2
   Henriksson HB, 2009, SPINE, V34, P141, DOI 10.1097/BRS.0b013e31818f8c20
   Henriksson HB, 2013, CELLS TISSUES ORGANS, V197, P1, DOI 10.1159/000341153
   Hershkovich O, 2013, AM J EPIDEMIOL, V178, P603, DOI 10.1093/aje/kwt019
   Hohaus C, 2008, EUR SPINE J, V17, pS492, DOI 10.1007/s00586-008-0750-6
   Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347
   Hughes SPF, 2012, J BONE JOINT SURG BR, V94B, P1298, DOI 10.1302/0301-620X.94B10.28986
   Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002
   Imai Y, 2007, SPINE, V32, P1197, DOI 10.1097/BRS.0b013e3180574d26
   Johnson WEB, 2005, SPINE, V30, P1139, DOI 10.1097/01.brs.0000162624.95262.73
   Johnson WEB, 2002, ARTHRITIS RHEUM-US, V46, P2658, DOI 10.1002/art.10585
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Korecki CL, 2007, EUR SPINE J, V16, P1029, DOI 10.1007/s00586-007-0327-9
   Kostuik John P, 2004, Spine J, V4, p289S, DOI 10.1016/j.spinee.2004.07.021
   Larson JW, 2006, J BONE JOINT SURG AM, V88A, P83, DOI 10.2106/JBJS.F.00043
   Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652
   Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198
   Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732
   Lewis G, 2011, J BIOMED MATER RES B, V98B, P171, DOI 10.1002/jbm.b.31835
   Liang CZ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-49
   Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213
   Ludwinski FE, 2013, REGEN MED, V8, P75, DOI [10.2217/RME.12.108, 10.2217/rme.12.108]
   Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6
   Masuda K, 2008, EUR SPINE J, V17, pS441, DOI 10.1007/s00586-008-0749-z
   Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041
   Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002
   Minogue BM, 2010, ARTHRITIS RHEUM-US, V62, P3695, DOI 10.1002/art.27710
   Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929
   Moon SH, 2008, SPINE, V33, P1850, DOI 10.1097/BRS.0b013e31817e1cd7
   Mwale F, 2004, Eur Cell Mater, V8, P58
   Mwale F., 2004, EUR CELLS MATER, V8, P4
   Orozco L, 2011, TRANSPLANTATION, V92, P822, DOI 10.1097/TP.0b013e3182298a15
   Osada R, 1996, J ORTHOP RES, V14, P690, DOI 10.1002/jor.1100140503
   PAPAGEORGIOU AC, 1995, SPINE, V20, P1889, DOI 10.1097/00007632-199509000-00009
   Peroglio M, 2013, SPINE J, V13, P1627, DOI 10.1016/j.spinee.2013.05.029
   Podichetty VK, 2007, CELL MOL BIOL, V53, P4, DOI 10.1170/T814
   Purmessur D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2487
   Richardson SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047735
   Richardson SM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2793
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6
   Roberts S, 1996, SPINE, V21, P415, DOI 10.1097/00007632-199602150-00003
   Rodriguez AG, 2012, J ORTHOP RES, V30, P280, DOI 10.1002/jor.21513
   Roelofs PDDM, 2008, SPINE, V33, P1766, DOI 10.1097/BRS.0b013e31817e69d3
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226
   Samartzis D, 2011, J BONE JOINT SURG AM, V93A, P662, DOI 10.2106/JBJS.I.01568
   Sasso RC, 2008, SPINE, V33, P123, DOI 10.1097/BRS.0b013e31816043af
   Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91
   Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403
   SOUTHWICK WO, 1957, J BONE JOINT SURG AM, V39, P631, DOI 10.2106/00004623-195739030-00017
   Staal JB, 2009, SPINE, V34, P49, DOI 10.1097/BRS.0b013e3181909558
   Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443
   Stoyanov JV, 2011, EUR CELLS MATER, V21, P533, DOI 10.22203/eCM.v021a40
   Strassburg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033739
   Strassburg S, 2010, REGEN MED, V5, P701, DOI 10.2217/RME.10.59
   Sun Z, 2013, J ORTHOP RES, V31, P1804, DOI 10.1002/jor.22439
   Takatalo J, 2011, SPINE, V36, P2180, DOI 10.1097/BRS.0b013e3182077122
   Tao FH, 2008, J HUAZHONG U SCI-MED, V28, P156, DOI 10.1007/s11596-008-0210-x
   THOMPSON JP, 1991, SPINE, V16, P253, DOI 10.1097/00007632-199103000-00001
   Tolofari SK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2898
   TROUT JJ, 1982, ANAT REC, V204, P307, DOI 10.1002/ar.1092040403
   Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629
   URBAN JPG, 1985, BIORHEOLOGY, V22, P145
   URBAN JPG, 1981, CONNECT TISSUE RES, V9, P1, DOI 10.3109/03008208109160234
   Vaccaro AR, 2003, EUR SPINE J, V12, P495, DOI 10.1007/s00586-003-0561-8
   Vadala G, 2012, J TISSUE ENG REGEN M, V6, P348, DOI 10.1002/term.433
   Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003
   Walsh AJL, 2004, SPINE, V29, P156, DOI 10.1097/01.BRS.0000107231.67854.9F
   Wuertz K, 2008, SPINE, V33, P1843, DOI 10.1097/BRS.0b013e31817b8f53
   Yoshikawa T, 2010, SPINE, V35, pE475, DOI 10.1097/BRS.0b013e3181cd2cf4
   Zhang Y, 2008, SPINE, V33, P831, DOI 10.1097/BRS.0b013e31816b1f38
   Zhang Y, 2007, SPINE, V32, P2515, DOI 10.1097/BRS.0b013e318158cc09
   Zigler J, 2007, SPINE, V32, P1155, DOI 10.1097/BRS.0b013e318054e377
   Zigler JE, 2012, J NEUROSURG-SPINE, V17, P504, DOI 10.3171/2012.9.SPINE11717
NR 104
TC 18
Z9 19
U1 1
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1531-3433
EI 1534-3081
J9 CURR PAIN HEADACHE R
JI Curr. Pain Headache Rep.
PD NOV 15
PY 2013
VL 17
IS 12
AR 377
DI 10.1007/s11916-013-0377-0
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA 258IT
UT WOS:000327453500001
PM 24234817
DA 2018-10-20
ER

PT J
AU Pena-Serna, C
   Lopes, JF
AF Pena-Serna, Carolina
   Lopes-Filho, Jose Francisco
TI Influence of ethanol and glycerol concentration over functional and
   structural properties of zein-oleic acid films
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterial; Thin film; Optical microscopy; Electron microscopy;
   Diffusion; Surface properties
ID PHYSICAL-PROPERTIES; BARRIER PROPERTIES; PROTEIN ISOLATE; WATER;
   PLASTICIZERS; GELATIN
AB This study was performed in order to determine the effect of the addition of different concentrations of glycerol and ethanol over functional and structural properties of zein-oleic acid films. Films were prepared from zein and oleic acid formulations, containing: 0, 10, 20 and 30% (w/w) of glycerol as plasticizer and 75, 80, 85, 90 and 95% (v/v) of ethanol as zein solvent. Water vapor permeability (WVP) at 4 and 24 degrees C, opacity, water solubility and structural behavior of the film were assessed. The film water barrier properties, WVP and water solubility, were increased when higher ethanol concentration and lower glycerol concentration were used. Furthermore, WVP at 4 degrees C was lower than WVP at 24 degrees C due to the crystalline solid state of oleic acid at lower temperatures. Likewise, opacity, homogeneity and structure of the composite film were improved as ethanol increased and glycerol lowered. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Pena-Serna, Carolina] Univ Antioquia, Agr Sci Fac, Medellin, Colombia.
   [Pena-Serna, Carolina; Lopes-Filho, Jose Francisco] Univ Estadual Paulista, Food Engn & Technol Dept, Sao Jose Do Rio Preto, Brazil.
RP Pena-Serna, C (reprint author), Univ Antioquia, Agr Sci Fac, Medellin, Colombia.
EM cpenaser@gmail.com
OI Pena Serna, Carolina/0000-0002-8008-005X
FU FAPESP [2011/08107-3]
FX This study was supported by a grant (process no 2011/08107-3) from
   FAPESP.
CR Barbosa de Almeida C., 2010, Food Technology and Biotechnology, V48, P19
   Cao N, 2007, FOOD HYDROCOLLOID, V21, P1153, DOI 10.1016/j.foodhyd.2006.09.001
   Cerqueira M.A., P 6 INT S FOOD AGR P
   Ghanbarzadeh B, 2006, IRAN POLYM J, V15, P779
   Kim S, 2004, IND CROP PROD, V20, P291, DOI 10.1016/j.indcrop.2003.10.013
   Kokoszka S, 2010, INT DAIRY J, V20, P53, DOI 10.1016/j.idairyj.2009.07.008
   Krochta JM, 2002, PROTEIN-BASED FILMS AND COATINGS, P1
   Kyoungju K., 2007, J MICROBIOL BIOTECHN, V17, P520
   Lai HM, 1998, CEREAL CHEM, V75, P194, DOI 10.1094/CCHEM.1998.75.2.194
   Lawton JW, 2004, CEREAL CHEM, V81, P1, DOI 10.1094/CCHEM.2004.81.1.1
   Padua GW, 2002, PROTEIN-BASED FILMS AND COATINGS, P43
   Perez-Mateos M, 2009, FOOD HYDROCOLLOID, V23, P53, DOI 10.1016/j.foodhyd.2007.11.011
   Ryu SY, 2002, LEBENSM-WISS TECHNOL, V35, P680, DOI 10.1006/fstl.2002.0929
   Tihminlioglu F, 2010, J FOOD ENG, V96, P342, DOI 10.1016/j.jfoodeng.2009.08.018
   Wang Y, 2005, MACROMOL BIOSCI, V5, P1200, DOI 10.1002/mabi.200500140
   Wang Y, 2006, CEREAL CHEM, V83, P331, DOI 10.1094/CC-83-0331
NR 16
TC 14
Z9 14
U1 0
U2 29
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD NOV 15
PY 2013
VL 142
IS 2-3
BP 580
EP 585
DI 10.1016/j.matchemphys.2013.07.056
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 249HE
UT WOS:000326767500018
DA 2018-10-20
ER

PT J
AU Nam, K
   Yamamoto, K
   Kasahara, K
   Kimura, T
   Funamoto, S
   Shimizu, S
   Higami, T
   Masuzawa, T
   Kishida, A
AF Nam, Kwangwoo
   Yamamoto, Kenji
   Kasahara, Kosuke
   Kimura, Tsuyoshi
   Funamoto, Seiicihi
   Shimizu, Shigeru
   Higami, Tetsuya
   Masuzawa, Toru
   Kishida, Akio
TI Fundamental study on the development of a surgical device for
   polymer-tissue adhesion using vibration damping of polymeric materials
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE thermal properties; biomedical applications; films
AB To develop a surgical handheld device that can be used to promote polymer-tissue or tissue-tissue adhesion, we designed a polymeric clamp material (PCM) that self-heats as a result of vibration. By using the PCM, heat can be applied to the target biomaterial and the tissue simultaneously. The optimal temperature is high enough to promote adhesion but low enough to retain the native tissue's integrity. Furthermore, the PCM should not adhere to the target polymer or the native tissue. We found that the temperatures of fluorinated polymers, such as poly(tetrafluoroethylene) (PTFE) and perfluoroalkoxy (PFA), increased within 60 s to 150 degrees C and maintained a stable temperature thereafter. The heat that was transferred to the saucer attached to the potential PCM was slightly above 100 degrees C, a temperature that promotes adhesion but does not damage the native tissue. No deformation or melting was observed during the experiment, indicating that PTFE or PFA possess desirable PCM characteristics for use as a surgical heating device. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 130: 2532-2537, 2013
C1 [Nam, Kwangwoo; Kimura, Tsuyoshi; Kishida, Akio] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Nam, Kwangwoo; Kimura, Tsuyoshi; Kishida, Akio] JST CREST, Chiyoda Ku, Tokyo 1020075, Japan.
   [Yamamoto, Kenji; Kasahara, Kosuke; Shimizu, Shigeru] Nihon Univ, Coll Sci & Technol, Chiyoda Ku, Tokyo 1018308, Japan.
   [Funamoto, Seiicihi; Higami, Tetsuya] Sapporo Med Univ, Dept Thorac & Cardiac Surg, Chuo Ku, Sapporo, Hokkaido 0608543, Japan.
   [Masuzawa, Toru] Ibaraki Univ, Fac Engn, Hitachi, Ibaraki 3068511, Japan.
RP Nam, K (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM kishida.mbme@tmd.ac.jp
FU Core Research for Evolutional Science and Technology (CREST) of the
   Japan Science and Technology Agency (JST)
FX This work was supported by a grant-in-aid from the Core Research for
   Evolutional Science and Technology (CREST) of the Japan Science and
   Technology Agency (JST).
CR Hartmann B., 1990, SOUND VIBRATION DAMP, V424, P23
   Huscher CGS, 2003, SURG ENDOSC, V17, P442, DOI 10.1007/s00464-002-9068-3
   Jarzynski J., 2011, PROPERTIES BEHAV POL, P1
   Karnaukhov VG, 2008, J ENG MATH, V61, P399, DOI 10.1007/s10665-008-9217-3
   Karnaukhov VG, 2000, INT APPL MECH+, V36, P174, DOI 10.1007/BF02681993
   Katoh A, 2010, MED ENG PHYS, V32, P304, DOI 10.1016/j.medengphy.2009.12.005
   Lakes RS, 2002, J COMPOS MATER, V36, P287, DOI 10.1106/002199802023538
   Liang KM, 1998, ULTRASONICS, V36, P979, DOI 10.1016/S0041-624X(98)00033-X
   LOKE WK, 1995, BIOMATERIALS, V16, P251, DOI 10.1016/0142-9612(95)92125-P
   Nonhof CJ, 1996, POLYM ENG SCI, V36, P1177, DOI 10.1002/pen.10511
   OLABISI O, 1979, POLYM POLYM MISCIBIL, P119
   SPERLING LH, 1990, SOUND VIBRATION DAMP, V424, P5
   Tang J, 1997, LASER SURG MED, V21, P438, DOI 10.1002/(SICI)1096-9101(1997)21:5<438::AID-LSM5>3.3.CO;2-E
   van Krevelen D. W., 1990, PROPERTIES POLYM, P439
   Yamamoto K., 1986, POLYM DATE HDB BASIC, P511
   Yamamoto K, 2011, SURG ENDOSC, V25, P1270, DOI 10.1007/s00464-010-1357-7
NR 16
TC 1
Z9 1
U1 0
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 15
PY 2013
VL 130
IS 4
BP 2532
EP 2537
DI 10.1002/app.39464
PG 6
WC Polymer Science
SC Polymer Science
GA 202VX
UT WOS:000323249700036
DA 2018-10-20
ER

PT J
AU Zhang, N
   Qu, JP
   Tan, B
   Lu, X
   Huang, JT
   Zhang, GZ
   Zhao, YQ
   Jin, G
AF Zhang, Ning
   Qu, Jinping
   Tan, Bin
   Lu, Xiang
   Huang, Jintao
   Zhang, Guizhen
   Zhao, Yongqing
   Jin, Gang
TI Non-isothermal crystallization kinetics and morphology of mica particles
   filled biodegradable poly(butylene succinate)
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE crystallization; composites; kinetics
ID HOFFMAN-LAURITZEN PARAMETERS; MULTIPLE MELTING BEHAVIOR; POLY(ARYL ETHER
   KETONE); MECHANICAL-PROPERTIES; ISOCONVERSIONAL APPROACH; SILICATE
   NANOCOMPOSITES; POLYESTER BLENDS; COMPOSITES;
   POLY(ETHYLENE-TEREPHTHALATE); BIOMATERIAL
AB Biodegradable poly(butylene succinate) (PBS)/mica composites were prepared by melt blending. The non-isothermal crystallization kinetics, spherulitic morphology, and crystalline structure were investigated by DSC, POM, and WAXD, respectively. The concepts of 'crystallization rate coefficient'' and 'crystallization rate parameter'' were employed. The non-isothermal crystallization behavior was successfully analyzed by Avrami and Liu methods while the Ozawa method failed to describe it. The WAXD and POM results showed that the addition of mica did not alter the crystalline structure, but increased the number of nuclei and reduced the size of the spherulites. In addition, the activation energy was also obtained from Hoffman-Lauritzen theory. These results showed that the addition of mica into PBS matrix played a dual role: they acted as nucleation agents to promote the process of nucleation, while acted as physical impediments to retard the growth of crystal. The former was dominating as the crystallization rates of mica/PBS composites were accelerated. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 130: 2544-2556, 2013
C1 [Zhang, Ning; Qu, Jinping; Tan, Bin; Lu, Xiang; Huang, Jintao; Zhang, Guizhen; Zhao, Yongqing; Jin, Gang] S China Univ Technol, Natl Engn Res Ctr Novel Equipment Polymer Proc, Guangzhou 510640, Guangdong, Peoples R China.
   [Zhang, Ning; Qu, Jinping; Tan, Bin; Lu, Xiang; Huang, Jintao; Zhang, Guizhen; Zhao, Yongqing; Jin, Gang] S China Univ Technol, Key Lab Polymer Proc Engn, Minist Educ, Guangzhou 510640, Guangdong, Peoples R China.
RP Qu, JP (reprint author), S China Univ Technol, Natl Engn Res Ctr Novel Equipment Polymer Proc, Guangzhou 510640, Guangdong, Peoples R China.
EM pmrdd@scut.edu.cn; pmrdd@scut.edu.cn
OI TAN, BIN/0000-0002-4248-9460
FU National Nature Science Foundation of China [10872071, 50973035,
   50903033]; Fundamental Research Funds for the Central Universities
   [2011ZM0063]; National Key Technology R&D Program of China
   [2009BAI84B05, 2009BAI84B06]; Program for Changjiang Scholars and
   Innovative Research Team in University [IRT0827]; National Natural
   Science Foundation of China-Guangdong Joint Foundation Project
   [U1201242]
FX We thank the National Nature Science Foundation of China (Grant
   10872071, 50973035 and 50903033), the Fundamental Research Funds for the
   Central Universities (NO.2011ZM0063), the National Key Technology R&D
   Program of China (Grant 2009BAI84B05 and 2009BAI84B06), the Program for
   Changjiang Scholars and Innovative Research Team in University
   (IRT0827), and the National Natural Science Foundation of
   China-Guangdong Joint Foundation Project (U1201242) for their fund.
CR Achilias DS, 2005, MACROMOL CHEM PHYSIC, V206, P1511, DOI 10.1002/macp.200500175
   Avella M, 2000, POLYMER, V41, P3875, DOI 10.1016/S0032-3861(99)00663-1
   Avrami M., 1940, Journal of Chemical Physics, V8, P212, DOI 10.1063/1.1750631
   Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   Bian J., 2009, J APPL POLYM SCI, V116, P902
   Bin T., 2011, THERMOCHIM ACTA, V525, P141, DOI DOI 10.1016/J.TCA.2011.08.003
   BUSIGIN C, 1984, POLYM ENG SCI, V24, P169, DOI 10.1002/pen.760240303
   Chen GX, 2005, J POLYM SCI POL PHYS, V43, P817, DOI 10.1002/polb.20347
   Dean K, 2007, J APPL POLYM SCI, V103, P802, DOI 10.1002/app.25149
   DEWITTE P, 1996, J POLYM SCI B, V34, P2553
   Dipak B., 1999, POLYM DEGRAD STABIL, V65, P47
   Farzaneh S., 2011, INT J POLYM SCI, V2011, P1
   Fujimaki T, 1998, POLYM DEGRAD STABIL, V59, P209, DOI 10.1016/S0141-3910(97)00220-6
   Gan DJ, 2001, EUR POLYM J, V37, P1359, DOI 10.1016/S0014-3057(01)00010-6
   Ghannam L, 2004, POLYMER, V45, P7035, DOI 10.1016/j.polymer.2004.08.002
   Han SI, 2005, ADV FUNCT MATER, V15, P367, DOI 10.1002/adfm.200400079
   Hiromi U., 2000, FEMS MICROBIOL LETT, V189, P25
   Hwang SY, 2010, POLYM DEGRAD STABIL, V95, P1313, DOI 10.1016/j.polymdegradstab.2010.02.010
   JEZIORNY A, 1978, POLYMER, V19, P1142, DOI 10.1016/0032-3861(78)90060-5
   John J, 2002, J POLYM SCI POL CHEM, V40, P2003, DOI 10.1002/pola.10297
   Kong Y, 2003, POLYMER, V44, P623, DOI 10.1016/S0032-3861(02)00814-5
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   Liu LF, 2009, COMPOS PART A-APPL S, V40, P669, DOI 10.1016/j.compositesa.2009.03.002
   Liu TX, 1998, J APPL POLYM SCI, V67, P815, DOI 10.1002/(SICI)1097-4628(19980131)67:5<815::AID-APP6>3.3.CO;2-X
   Liu XQ, 2006, J APPL POLYM SCI, V102, P2493, DOI 10.1002/app.24625
   Maged A. O., 2001, POLYMER, V42, P6545
   Malcom F., 1982, POLYM COMPOSITE, V3, P218
   Ohkita T, 2005, J APPL POLYM SCI, V97, P1107, DOI 10.1002/app.21741
   Okamoto K, 2003, J POLYM SCI POL PHYS, V41, P3160, DOI 10.1002/polb.10708
   OZAWA T, 1971, POLYMER, V12, P150, DOI 10.1016/0032-3861(71)90041-3
   Park JW, 2002, POLYM INT, V51, P239, DOI 10.1002/pi.848
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Ray SS, 2003, MACROMOL RAPID COMM, V24, P815, DOI 10.1002/marc.200300008
   Ray SS, 2007, POLYM DEGRAD STABIL, V92, P802, DOI 10.1016/j.polymdegradstab.2007.02.002
   Ray SS, 2006, MACROMOL CHEM PHYSIC, V207, P1207, DOI 10.1002/macp.200600163
   Ren MQ, 2005, J POLYM SCI POL PHYS, V43, P3231, DOI 10.1002/polb.20539
   Rhee SH, 2004, BIOMACROMOLECULES, V5, P1575, DOI 10.1021/bm049885n
   Sinha Ray S, 2002, J NANOSCI NANOTECHNO, V2, P1, DOI [10.1166/jnn.2002.086, DOI 10.1166/JNN.2002.086]
   Soccio M, 2009, EUR POLYM J, V45, P171, DOI 10.1016/j.eurpolymj.2008.10.018
   Song JB, 2004, POLYM INT, V53, P1773, DOI 10.1002/pi.1579
   Song L, 2009, POLYM DEGRAD STABIL, V94, P632, DOI 10.1016/j.polymdegradstab.2009.01.009
   Tomar N, 2010, J APPL POLYM SCI, V117, P672, DOI 10.1002/app.30171
   Utama MIB, 2011, NANO LETT, V11, P3051, DOI 10.1021/nl1034495
   Vroman I, 2009, MATERIALS, V2, P307, DOI 10.3390/ma2020307
   Vyazovkin S, 2004, MACROMOL RAPID COMM, V25, P733, DOI 10.1002/marc.200300295
   Vyazovkin S, 2003, J PHYS CHEM B, V107, P882, DOI 10.1021/jp026592k
   Vyazovkin S., 2002, MACROMOL RAPID COMM, V80, P177
   Wu M, 2008, MATER CHEM PHYS, V109, P547, DOI 10.1016/j.matchemphys.2008.01.002
   Yang Z, 2010, J APPL POLYM SCI, V116, P2658, DOI 10.1002/app.31787
   Yasuniwa M, 2002, J POLYM SCI POL PHYS, V40, P2411, DOI 10.1002/polb.10298
   Yeun JH, 2006, J APPL POLYM SCI, V101, P591, DOI 10.1002/app.23372
   Yoo ES, 1999, J POLYM SCI POL PHYS, V37, P1357, DOI 10.1002/(SICI)1099-0488(19990701)37:13<1357::AID-POLB2>3.0.CO;2-Q
   YOSHITO I, 2000, MACROMOL RAPID COMM, V21, P117
NR 53
TC 3
Z9 5
U1 5
U2 92
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 15
PY 2013
VL 130
IS 4
BP 2544
EP 2556
DI 10.1002/app.39469
PG 13
WC Polymer Science
SC Polymer Science
GA 202VX
UT WOS:000323249700038
DA 2018-10-20
ER

PT J
AU Eldesoqi, K
   Seebach, C
   Ngoc, CN
   Meier, S
   Nau, C
   Schaible, A
   Marzi, I
   Henrich, D
AF Eldesoqi, Karam
   Seebach, Caroline
   Ngoc, Christina Nguyen
   Meier, Simon
   Nau, Christoph
   Schaible, Alexander
   Marzi, Ingo
   Henrich, Dirk
TI High Calcium Bioglass Enhances Differentiation and Survival of
   Endothelial Progenitor Cells, Inducing Early Vascularization in Critical
   Size Bone Defects
SO PLOS ONE
LA English
DT Article
ID ANGIOGENIC GROWTH-FACTORS; HUMAN PERIPHERAL-BLOOD; IN-VITRO CULTURE;
   BIOACTIVE GLASS; COMPOSITE SCAFFOLDS; POLY(LACTIC ACID); STROMAL CELLS;
   PHOSPHATE; PROMOTES; NANOPARTICLES
AB Early vascularization is a prerequisite for successful bone healing and endothelial progenitor cells (EPC), seeded on appropriate biomaterials, can improve vascularization. The type of biomaterial influences EPC function with bioglass evoking a vascularizing response. In this study the influence of a composite biomaterial based on polylactic acid (PLA) and either 20 or 40% bioglass, BG20 and BG40, respectively, on the differentiation and survival of EPCs in vitro was investigated. Subsequently, the effect of the composite material on early vascularization in a rat calvarial critical size defect model with or without EPCs was evaluated. Human EPCs were cultured with beta-TCP, PLA, BG20 or BG40, and seeding efficacy, cell viability, cell morphology and apoptosis were analysed in vitro. BG40 released the most calcium, and improved endothelial differentiation and vitality best. This effect was mimicked by adding an equivalent amount of calcium to the medium and was diminished in the presence of the calcium chelator, EGTA. To analyze the effect of BG40 and EPCs in vivo, a 6-mm diameter critical size calvarial defect was created in rats (n = 12). Controls (n = 6) received BG40 and the treatment group (n = 6) received BG40 seeded with 5610 5 rat EPCs. Vascularization after 1 week was significantly improved when EPCs were seeded onto BG40, compared to implanting BG40 alone. This indicates that Ca2+ release improves EPC differentiation and is useful for enhanced early vascularization in critical size bone defects.
C1 [Eldesoqi, Karam; Seebach, Caroline; Ngoc, Christina Nguyen; Meier, Simon; Nau, Christoph; Schaible, Alexander; Marzi, Ingo; Henrich, Dirk] Hosp Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany.
RP Seebach, C (reprint author), Hosp Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany.
EM caroline.seebach@kgu.de
OI Eldesoqi, Karam/0000-0001-5565-2565
FU DAAD [A109234]
FX This work was supported by DAAD (grant # A109234),
   https://www.daad.de/de/index.html. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aguirre A, 2012, EUR CELLS MATER, V24, P90, DOI 10.22203/eCM.v024a07
   Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472
   Arkudas A, 2007, TISSUE ENG, V13, P1549, DOI 10.1089/ten.2006.0387
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Brodie JC, 2005, J BIOMED MATER RES A, V73A, P409, DOI 10.1002/jbm.a.30279
   Crosby JR, 2000, CIRC RES, V87, P728, DOI 10.1161/01.RES.87.9.728
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334
   Dorozhkin SV, 2012, PROG BIOMATER, V1
   Doyle B, 2006, ENDOTHELIUM-J ENDOTH, V13, P403, DOI 10.1080/10623320601061656
   Fan X, 2010, POLYM-PLAST TECHNOL, V49, P309, DOI 10.1080/03602550903284255
   Fernandez PB, 2001, EUR J CELL BIOL, V80, P99
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Gehling UM, 2000, BLOOD, V95, P3106
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   He ZQ, 2009, POLYM-PLAST TECHNOL, V48, P1020, DOI 10.1080/03602550903092534
   Henrich D, 2004, SHOCK, V21, P13, DOI 10.1097/01.shk.0000101669.49265.50
   Henrich D, 2009, TISSUE ENG PART C-ME, V15, P551, DOI [10.1089/ten.tec.2008.0385, 10.1089/ten.TEC.2008.0385]
   Henrich D, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/364591
   Hong ZK, 2008, ACTA BIOMATER, V4, P1297, DOI 10.1016/j.actbio.2008.03.007
   Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542
   Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9
   Jones JR, 2010, P I MECH ENG H, V224, P1373, DOI 10.1243/09544119JEIM836
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P783
   Kim HW, 2008, J BIOMED MATER RES A, V85A, P651, DOI 10.1002/jbm.a.31339
   Leu A, 2008, PHARM RES, V25, P1222, DOI 10.1007/s11095-007-9508-9
   Leu A, 2009, TISSUE ENG PT A, V15, P877, DOI 10.1089/ten.tea.2008.0018
   Li X, 2008, J BIOMED MATER RES A, V84A, P84, DOI 10.1002/jbm.a.31371
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Liu AX, 2008, ACTA BIOMATER, V4, P1005, DOI 10.1016/j.actbio.2008.02.013
   Lu HH, 2005, BIOMATERIALS, V26, P6323, DOI 10.1016/j.biomaterials.2005.04.005
   Niemela T, 2008, ACTA BIOMATER, V4, P156, DOI 10.1016/j.actbio.2007.06.007
   Oki A, 2006, MATER LETT, V60, P1
   Peichev M, 2000, BLOOD, V95, P952
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Rasal RM, 2010, PROG POLYM SCI, V33, P338
   Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sander AL, 2011, J SURG RES, V165, P165, DOI 10.1016/j.jss.2009.07.003
   Schultheiss J, 2011, EUR J TRAUMA EMERG S, V37, P635, DOI 10.1007/s00068-011-0119-0
   Seebach C, 2012, CELL TRANSPLANT, V21, P1667, DOI 10.3727/096368912X638937
   Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI [10.1089/ten.tea.2009.0715, 10.1089/ten.TEA.2009.0715]
   Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816
   Vila OF, 2013, J BIOMED MATER RES A, V101, P932, DOI 10.1002/jbm.a.34391
   Xu CX, 2011, BIOMATERIALS, V32, P1051, DOI 10.1016/j.biomaterials.2010.09.068
   Zhang SJ, 2007, STEM CELLS DEV, V16, P683, DOI 10.1089/scd.2006.0062
   Zhang SJ, 2006, CELL RES, V16, P577, DOI 10.1038/sj.cr.7310075
   Zink D, 2003, METHODS, V29, P42, DOI 10.1016/S1046-2023(02)00289-X
NR 49
TC 16
Z9 16
U1 0
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 14
PY 2013
VL 8
IS 11
AR e79058
DI 10.1371/journal.pone.0079058
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 254DJ
UT WOS:000327143800024
PM 24244419
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Pascual, G
   Sotomayor, S
   Rodriguez, M
   Bayon, Y
   Bellon, JM
AF Pascual, Gemma
   Sotomayor, Sandra
   Rodriguez, Marta
   Bayon, Yves
   Bellon, Juan M.
TI Behaviour of a New Composite Mesh for the Repair of Full-Thickness
   Abdominal Wall Defects in a Rabbit Model
SO PLOS ONE
LA English
DT Article
ID INCISIONAL HERNIA MODEL; POLYPROPYLENE MESH; ADHESION FORMATION;
   PROSTHETIC MESH; TISSUE-RESPONSE; IN-VITRO; PREVENTION; REGENERATION;
   SEPRAMESH; MIGRATION
AB Introduction: Composite biomaterials designed for the repair of abdominal wall defects are composed of a mesh component and a laminar barrier in contact with the visceral peritoneum. This study assesses the behaviour of a new composite mesh by comparing it with two latest-generation composites currently used in clinical practice.
   Methods: Defects (7x5cm) created in the anterior abdominal wall of New Zealand White rabbits were repaired using a polypropylene mesh and the composites: Physiomesh (TM); Ventralight (TM) and a new composite mesh with a three-dimensional macroporous polyester structure and an oxidized collagen/chitosan barrier. Animals were sacrificed on days 14 and 90 postimplant. Specimens were processed to determine host tissue incorporation, gene/protein expression of neo-collagens (RT-PCR/immunofluorescence), macrophage response (RAM-11-immunolabelling) and biomechanical resistance. On postoperative days 7/14, each animal was examined laparoscopically to quantify adhesions between the visceral peritoneum and implant.
   Results: The new composite mesh showed the lowest incidence of seroma in the short term. At each time point, the mesh surface covered with adhesions was greater in controls than composites. By day 14, the implants were fully infiltrated by a loose connective tissue that became denser over time. At 90 days, the peritoneal mesh surface was lined with a stable mesothelium. The new composite mesh induced more rapid tissue maturation than Physiomesh (TM), giving rise to a neoformed tissue containing more type I collagen. In Ventralight (TM) the macrophage reaction was intense and significantly greater than the other composites at both follow-up times. Tensile strengths were similar for each biomaterial.
   Conclusions: All composites showed optimal peritoneal behaviour, inducing good peritoneal regeneration and scarce postoperative adhesion formation. A greater foreign body reaction was observed for Ventralight (TM). All composites induced good collagen deposition accompanied by optimal tensile strength. The three-dimensional macroporous structure of the new composite mesh may promote rapid tissue regeneration within the mesh.
C1 [Pascual, Gemma; Sotomayor, Sandra; Rodriguez, Marta; Bellon, Juan M.] Alcala Univ, Fac Med, Dept Surg & Med Specialties, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.
   [Bayon, Yves] Covidien Sofradim Prod, Trevoux, France.
RP Bellon, JM (reprint author), Alcala Univ, Fac Med, Dept Surg & Med Specialties, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.
EM juanm.bellon@uah.es
OI BELLON, JUAN M./0000-0002-6071-5011; PASCUAL, GEMMA/0000-0002-1623-4384
FU company COVIDIEN
FX The authors have a financial research grant with the company COVIDIEN.
   The funders had no role in study design, data collection and analysis
   and decision to publish.
CR AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   Anurov MV, 2012, HERNIA, V16, P199, DOI 10.1007/s10029-011-0877-y
   Balique J G, 2005, Hernia, V9, P68, DOI 10.1007/s10029-004-0300-z
   Baptista ML, 2000, J AM COLL SURGEONS, V190, P271, DOI 10.1016/S1072-7515(99)00277-X
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   Bellon JM, 2003, J MATER SCI-MATER M, V14, P359, DOI 10.1023/A:1022936016618
   Bellon JM, 2001, WORLD J SURG, V25, P147, DOI 10.1007/s002680020069
   Bellon JM, 1996, BIOMATERIALS, V17, P1369, DOI 10.1016/0142-9612(96)87276-0
   Bendavid R, 1997, HERNIA, V1, P5
   Binnebosel M, 2007, SURGERY, V142, P365, DOI 10.1016/j.surg.2007.04.024
   Breuing K, 2010, SURGERY, V148, P544, DOI 10.1016/j.surg.2010.01.008
   Chelala E, 2010, HERNIA, V14, P123, DOI 10.1007/s10029-010-0637-4
   Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122
   Deeken CR, 2012, HERNIA, V16, P69, DOI 10.1007/s10029-011-0854-5
   Deeken CR, 2012, SURG ENDOSC, V26, P566, DOI 10.1007/s00464-011-1899-3
   Diener MK, 2010, ANN SURG, V251, P843, DOI 10.1097/SLA.0b013e3181d973e4
   Dinsmore RC, 1999, AM SURGEON, V65, P383
   Felemovicius I, 2004, J AM COLL SURGEONS, V198, P543, DOI 10.1016/j.jamcollsurg.2003.12.004
   Gray SH, 2008, SURG CLIN N AM, V88, P17, DOI 10.1016/j.suc.2007.11.007
   Greenawalt KE, 2000, J SURG RES, V94, P92, DOI 10.1006/jsre.2000.6020
   Hernandez B, 2011, J MECH BEHAV BIOMED, V4, P392, DOI 10.1016/j.jmbbm.2010.11.012
   Hernandez-Gascon B, 2012, J MECH BEHAV BIOMED, V5, P257, DOI 10.1016/j.jmbbm.2011.09.005
   Hoer J, 2002, CHIRURG, V73, P881, DOI 10.1007/s00104-002-0539-9
   Judge TW, 2007, J AM COLL SURGEONS, V204, P276, DOI 10.1016/j.jamcollsurg.2006.11.003
   Junge K, 2005, Hernia, V9, P212, DOI 10.1007/s10029-004-0315-5
   Kilkenny C, 2010, PLOS BIOL, V29, DOI DOI 10.1371/JOURNAL.PBIO.1000412
   Konerding MA, 2012, MED ENG PHYS, V34, P806, DOI 10.1016/j.medengphy.2011.09.022
   Konerding MA, 2011, MED ENG PHYS, V33, P789, DOI 10.1016/j.medengphy.2011.01.010
   Lambrecht J, 2011, HERNIA, V15, P473, DOI 10.1007/s10029-011-0817-x
   Matthews BD, 2005, J SURG RES, V123, P227, DOI 10.1016/j.jss.2004.08.012
   Matthews BD, 2002, AM SURGEON, V68, P936
   Moreno-Egea A, 2010, SURG ENDOSC, V24, P359, DOI 10.1007/s00464-009-0573-5
   Moussi A, 2012, HERNIA, V16, P215, DOI 10.1007/s10029-010-0734-4
   Ott V, 2005, Hernia, V9, P103, DOI 10.1007/s10029-004-0271-0
   Pierce RA, 2009, SURG INNOV, V16, P46, DOI 10.1177/1553350608330479
   Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613
   Savioz D, 1997, EUR J SURG, V163, P631
   SCHEIN M, 1995, J AM COLL SURGEONS, V180, P745
   Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446
   Schug-Pass C, 2009, SURG ENDOSC, V23, P487, DOI 10.1007/s00464-008-0085-8
   Sugerman HJ, 1996, AM J SURG, V171, P80, DOI 10.1016/S0002-9610(99)80078-6
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   Walker AP, 1993, J SURG RES, V55, P27
   Yang F, 2013, AM J SURG, V205, P15, DOI 10.1016/j.amjsurg.2012.04.007
NR 44
TC 16
Z9 16
U1 4
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 13
PY 2013
VL 8
IS 11
AR e80647
DI 10.1371/journal.pone.0080647
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255QK
UT WOS:000327254700195
PM 24236192
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Iizuka, T
   Sezutsu, H
   Tatematsu, K
   Kobayashi, I
   Yonemura, N
   Uchino, K
   Nakajima, K
   Kojima, K
   Takabayashi, C
   Machii, H
   Yamada, K
   Kurihara, H
   Asakura, T
   Nakazawa, Y
   Miyawaki, A
   Karasawa, S
   Kobayashi, H
   Yamaguchi, J
   Kuwabara, N
   Nakamura, T
   Yoshii, K
   Tamura, T
AF Iizuka, Tetsuya
   Sezutsu, Hideki
   Tatematsu, Ken-ichiro
   Kobayashi, Isao
   Yonemura, Naoyuki
   Uchino, Keiro
   Nakajima, Kenichi
   Kojima, Katsura
   Takabayashi, Chiyuki
   Machii, Hiroaki
   Yamada, Katsushige
   Kurihara, Hiroyuki
   Asakura, Tetsuo
   Nakazawa, Yasumoto
   Miyawaki, Atsushi
   Karasawa, Satoshi
   Kobayashi, Hatsumi
   Yamaguchi, Junji
   Kuwabara, Nobuo
   Nakamura, Takashi
   Yoshii, Kei
   Tamura, Toshiki
TI Colored Fluorescent Silk Made by Transgenic Silkworms
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE transgenic silkworms; fluorescent silk; recombinant; bombyx
ID BOMBYX-MORI; FIBROIN; CHAIN; GENE; TRANSFORMATION; PROTEINS; MARKERS;
   MUTANT; GLAND
AB Silk is a protein fiber used to weave fabrics and as a biomaterial in medical applications. Recently, genetically modified silks have been produced from transgenic silkworms. In the present study, transgenic silkworms for the mass production of three colors of fluorescent silks, (green, red, and orange) are generated using a vector originating from the fibroin H chain gene and a classical breeding method. The suitability of the recombinant silks for making fabrics is investigated by harvesting large amounts of the cocoons, obtained from rearing over 20 thousand silkworms. The application of low temperature and a weakly alkaline solution for cooking and reeling enables the production of silk fiber without loss of color. The maximum strain tolerated and Young's modulus of the fluorescent silks are similar to those of ordinary silk, although the maximum stress value of the recombinant silk is slightly lower than that of the control. Fabrics with fluorescent color are demonstrated using the recombinant silk, with the color persisting for over two years. The results indicate that large amounts of genetically modified silk can be made by transgenic silkworms, and the silk is applicable as functional silk fiber for making fabrics and for use in medical applications.
C1 [Iizuka, Tetsuya; Sezutsu, Hideki; Tatematsu, Ken-ichiro; Kobayashi, Isao; Yonemura, Naoyuki; Uchino, Keiro; Nakajima, Kenichi; Kojima, Katsura; Takabayashi, Chiyuki; Machii, Hiroaki; Tamura, Toshiki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan.
   [Yamada, Katsushige; Kurihara, Hiroyuki] Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Kanagawa 2488555, Japan.
   [Asakura, Tetsuo; Nakazawa, Yasumoto] Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan.
   [Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan.
   [Karasawa, Satoshi] Amalgaam Ltd, Tokyo 1730004, Japan.
   [Kobayashi, Hatsumi; Yamaguchi, Junji; Kuwabara, Nobuo] Gunma Sericultural Technol Ctr, Maebashi, Gumma 3710852, Japan.
   [Nakamura, Takashi] Gunma Ind Technol Ctr, Maebashi, Gumma 3792147, Japan.
   [Yoshii, Kei] Text Res Inst Gunma, Kiryu, Gumma 3760011, Japan.
RP Iizuka, T (reprint author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan.
EM ttamura@affrc.go.jp
RI Miyawaki, Atsushi/K-3569-2014; Nakazawa, Yasumoto/B-9981-2013; Asakura,
   Tetsuo/B-9970-2013
OI Miyawaki, Atsushi/0000-0002-2329-3235; 
FU Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan
FX The authors thank Kaoru Nakamura, Yuji Inami, Toshihiko Misawa, and Koji
   Hashimoto for maintaining the silkworms. This work was partly supported
   by the grant from the Ministry of Agriculture, Forestry, and Fisheries
   (MAFF) of Japan. The suits and dresses were made with the help of
   Milanorib (Kiryu, Japan). The wedding dress was designed by Yumi Katsura
   and made with the help of Yumi Katsura International Co., (Tokyo,
   Japan).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009
   Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028
   Horn C, 2002, INSECT BIOCHEM MOLEC, V32, P1221, DOI 10.1016/S0965-1748(02)00085-1
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Julien E, 2005, COMPREHENSIVE MOL IN, P369
   Kludkiewicz B, 2009, INSECT BIOCHEM MOLEC, V39, P938, DOI 10.1016/j.ibmb.2009.11.005
   Kojima K, 2007, BIOSCI BIOTECH BIOCH, V71, P2943, DOI 10.1271/bbb.70353
   MORI K, 1995, J MOL BIOL, V251, P217, DOI 10.1006/jmbi.1995.0429
   Nakazawa Y., 2010, J BIOMATER SCI POLYM
   OKAMOTO H, 1982, J BIOL CHEM, V257, P5192
   Royer C, 2005, TRANSGENIC RES, V14, P463, DOI 10.1007/s11248-005-4351-4
   SUZUKI Y, 1974, J MOL BIOL, V88, P393, DOI 10.1016/0022-2836(74)90490-2
   Takasu Y, 2007, INSECT BIOCHEM MOLEC, V37, P1234, DOI 10.1016/j.ibmb.2007.07.009
   Tamura T, 2000, NAT BIOTECHNOL, V18, P81
   Tansil NC, 2012, ADV MATER, V24, P1388, DOI 10.1002/adma.201104118
   Tansil NC, 2011, BIOMATERIALS, V32, P9576, DOI 10.1016/j.biomaterials.2011.08.081
   Tansil NC, 2011, ADV MATER, V23, P1463, DOI 10.1002/adma.201003860
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Tatemastu K., 2012, J BIOTECHNOL BIOMATE, DOI 10.4172/2155-952X.S9-004
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Tomita M, 2011, BIOTECHNOL LETT, V33, P645, DOI 10.1007/s10529-010-0498-z
   Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 25
TC 29
Z9 32
U1 5
U2 51
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD NOV 13
PY 2013
VL 23
IS 42
BP 5232
EP 5239
DI 10.1002/adfm.201300365
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 258TF
UT WOS:000327480900002
DA 2018-10-20
ER

PT J
AU Wang, L
   Yang, XF
   Chen, HM
   Gong, T
   Li, WB
   Yang, G
   Zhou, SB
AF Wang, Lin
   Yang, Xifeng
   Chen, Hongmei
   Gong, Tao
   Li, Wenbing
   Yang, Guang
   Zhou, Shaobing
TI Design of Triple-Shape Memory Polyurethane with Photo-crosslinking of
   Cinnamon Groups
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE triple shape memory; polyurethane; photo crosslink; cinnamate group
ID BLOCK-COPOLYMERS; BIOMEDICAL APPLICATIONS; POLYMERS;
   POLY(EPSILON-CAPROLACTONE); COMPOSITES; SEGMENTS; DEGRADATION;
   ELASTOMER; GLYCOL); SYSTEM
AB A triple-shape memory polyurethane (TSMPU) with poly(e-caprolactone) -diols (PCL-diols) as the soft segments and diphenyl methane diisocyanate (MDI), N,N-bis (2-hydroxyethyl) cinnamamide (BHECA) as the hard segments was synthesized via simple photo-crosslinking of cinnamon groups irradiated under lambda > 280 nm ultraviolet (UV) light. Fourier transform infrared spectroscopy (FT-IR), proton nuclear magnetic resonance (H-1-NMR) and ultraviolet-visible absorption spectrum (UV vis) confirmed the chemical structure of the material. Differential scanning calorimetry (DSC) and dynamic mechanical analysis (DMA) results demonstrated that the photo-crosslinked polymer possessed two transition temperatures, one is due to the melting point of the soft segment PCL-diols, and the other is due to the glass transition temperature. All these contributed to the cross-linked structure of the hard segments and resulted in an excellent triple-shape memory effect. Alamar blue assay showed that the material has good non-cytotoxicity and can be potentially used in biomaterial devices.
C1 [Wang, Lin; Yang, Xifeng; Chen, Hongmei; Gong, Tao; Li, Wenbing; Yang, Guang; Zhou, Shaobing] Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
RP Zhou, SB (reprint author), Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
EM shaobingzhou@hotmail.com
RI zhou, shaobing/B-3148-2010; Chen, Hongmei/L-1798-2015
OI Chen, Hongmei/0000-0002-4674-3278
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [30970723, 51173150,
   51373138]; Research Fund for the Doctoral Program of Higher Education of
   China [20120184110029]; Fundamental Research Funds for The Central
   Universities [SWJTU11ZT10]
FX This work was partially supported by National Basic Research Program of
   China (973 Program, 2012CB933600), National Natural Science Foundation
   of China (30970723, 51173150, 51373138), Research Fund for the Doctoral
   Program of Higher Education of China (20120184110029), and Fundamental
   Research Funds for The Central Universities (SWJTU11ZT10).
CR Ahmad M, 2011, MACROMOL CHEM PHYS, V212, P592, DOI 10.1002/macp.201000540
   Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0
   Behl M, 2010, ADV MATER, V22, P3388, DOI 10.1002/adma.200904447
   Behl M, 2009, SOFT MATTER, V5, P676, DOI 10.1039/b810583a
   Bellin I, 2006, P NATL ACAD SCI USA, V103, P18043, DOI 10.1073/pnas.0608586103
   Cuevas JM, 2012, SOFT MATTER, V8, P4928, DOI 10.1039/c2sm07481h
   Du HY, 2010, SOFT MATTER, V6, P3370, DOI 10.1039/b922220k
   Fan MM, 2009, MACROMOL RAPID COMM, V30, P897, DOI 10.1002/marc.200800712
   Garle A, 2012, ACS APPL MATER INTER, V4, P645, DOI 10.1021/am2011542
   Guignot C, 2001, NUCL INSTRUM METH B, V185, P100, DOI 10.1016/S0168-583X(01)00850-3
   Guo WS, 2012, ACS APPL MATER INTER, V4, P4006, DOI 10.1021/am300828u
   Hoskins JN, 2009, MACROMOLECULES, V42, P6406, DOI 10.1021/ma9011076
   Jin CL, 2011, DES MONOMERS POLYM, V14, P47, DOI 10.1163/138577210X541196
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   Kloss J, 2002, J POLYM SCI POL CHEM, V40, P4117, DOI 10.1002/pola.10499
   Lee BS, 2001, MACROMOLECULES, V34, P6431, DOI 10.1021/ma001842l
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Lendlein A, 2009, ADV SCI TECH, V54, P96
   Li J., 2010, MACROMOLECULES, V44, P175
   Luo XF, 2010, ADV FUNCT MATER, V20, P2649, DOI 10.1002/adfm.201000052
   Mayer G, 2006, ANGEW CHEM INT EDIT, V45, P4900, DOI 10.1002/anie.200600387
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Narasimhan B, 2004, EUR J MED CHEM, V39, P827, DOI 10.1016/j.ejmech.2004.06.013
   Ping P, 2005, BIOMACROMOLECULES, V6, P587, DOI 10.1021/bm049477j
   Ping P, 2007, J POLYM SCI POL PHYS, V45, P557, DOI 10.1002/polb.20974
   Ratna D, 2008, J MATER SCI, V43, P254, DOI 10.1007/s10853-007-2176-7
   Saralegi A, 2013, POLYM INT, V62, P106, DOI 10.1002/pi.4330
   Shao SJ, 2011, BIOMATERIALS, V32, P2821, DOI 10.1016/j.biomaterials.2011.01.051
   Shao Y, 2012, MACROMOLECULES, V45, P1924, DOI 10.1021/ma202506b
   Small I. V. W., 2010, J MATER CHEM, V20, P3356
   Sun L, 2010, SOFT MATTER, V6, P4403, DOI 10.1039/c0sm00236d
   Wang WS, 2006, J POLYM SCI POL CHEM, V44, P5505, DOI 10.1002/pola.21643
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wu L., 2010, BIOMACROMOLECULES, V12, P235
   Xiao Y, 2010, ACS APPL MATER INTER, V2, P3506, DOI 10.1021/am100692n
   Xie T, 2010, NATURE, V464, P267, DOI 10.1038/nature08863
   Xue LA, 2010, BIOMATERIALS, V31, P8132, DOI 10.1016/j.biomaterials.2010.07.043
   Xue L, 2009, MACROMOLECULES, V42, P964, DOI 10.1021/ma802437f
   Yakacki CM, 2010, ADV POLYM SCI, V226, P147, DOI 10.1007/12_2009_23
   Zhang QL, 2012, J MATER CHEM, V22, P24776, DOI 10.1039/c2jm35619h
   Zhao J, 2013, ACS APPL MATER INTER, V5, P5550, DOI 10.1021/am400769j
   Zheng XT, 2006, BIOMATERIALS, V27, P4288, DOI 10.1016/j.biomaterials.2006.03.043
   Zhou SB, 2003, BIOMATERIALS, V24, P3563, DOI 10.1016/S0142-9612(03)00207-2
   Zotzmann J, 2010, ADV FUNCT MATER, V20, P3583, DOI 10.1002/adfm.201000478
NR 45
TC 34
Z9 34
U1 12
U2 91
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD NOV 13
PY 2013
VL 5
IS 21
BP 10520
EP 10528
DI 10.1021/am402091m
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 253QD
UT WOS:000327103500018
PM 24080202
DA 2018-10-20
ER

PT J
AU Cheng, N
   Wang, YQ
   Zhang, YF
   Shi, B
AF Cheng, Ning
   Wang, Yuanqin
   Zhang, Yufeng
   Shi, Bin
TI The Osteogenic Potential of Mesoporous Bioglasses/Silk and
   Non-Mesoporous Bioglasses/Silk Scaffolds in Ovariectomized Rats: In
   vitro and In vivo Evaluation
SO PLOS ONE
LA English
DT Article
ID BIOACTIVE GLASSES; CALVARIAL DEFECT; DRUG-DELIVERY; BONE; SILK;
   DIFFERENTIATION; BIOMATERIALS; CALCIUM; BIOCOMPATIBILITY; OSTEOPOROSIS
AB Silk-based scaffolds have been introduced to bone tissue regeneration for years, however, their local therapeutic efficency in bone metabolic disease condition has been seldom reported. According to our previous report, mesoporous bioactive glass (MBG)/silk scaffolds exhibits superior in vitro bioactivity and in vivo osteogenic properties compared to non-mesoporous bioactive glass (BG)/silk scaffolds, but no information could be found about their efficiency in osteoporotic (OVX) environment. This study investigated a biomaterial-based approach for improving MSCs behavior in vitro, and accelerating OVX defect healing by using 3D BG/silk and MBG/silk scaffolds, and pure silk scaffolds as control. The results of SEM, CCK-8 assay and quantitative ALP activity showed that MBG/silk scaffolds can improve attachment, proliferation and osteogenic differentiation of both O-MSCs and sham control. In vivo therapeutic efficiency was evaluated by mu CT analysis, hematoxylin and eosin staining, safranin O staining and tartrate-resistant acid phosphatase, indicating accelerated bone formation with compatible scaffold degradation and reduced osteoclastic response of defect healing in OVX rats after 2 and 4 weeks treatment, with a rank order of MBG/silk > BG/silk > silk group. Immunohistochemical markers of COL I, OPN, BSP and OCN also revealed that MBG/silk scaffolds can better induce accelerated collagen and non-collagen matrix production. The findings of this study suggest that MBG/silk scaffolds provide a better environment for cell attachment, proliferation and differentiation, and act as potential substitute for treating local osteoporotic defects.
C1 [Shi, Bin] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China.
   Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China.
RP Shi, B (reprint author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China.
EM shibin_dentist@126.com
FU National Natural Science Foundation of China [30700948, 81170992];
   Fundamental Research Fund for the Central Universities [2012304274818]
FX Funding for this study was provided by research grants from the National
   Natural Science Foundation of China (30700948) to Yufeng Zhang and
   (81170992) to Bin Shi, and the Fundamental Research Fund for the Central
   Universities (2012304274818) to Ning Cheng. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alcaide M, 2010, ACTA BIOMATER, V6, P892, DOI 10.1016/j.actbio.2009.09.008
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043
   Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284
   Egermann M, 2005, OSTEOPOROSIS INT, V16, pS129, DOI 10.1007/s00198-005-1859-7
   Fan J, 2003, ANGEW CHEM INT EDIT, V42, P3146, DOI 10.1002/anie.200351027
   Fernandes JC, 2008, MOL THER, V16, P1243, DOI 10.1038/mt.2008.99
   He YX, 2011, BONE, V48, P1388, DOI 10.1016/j.bone.2011.03.720
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hench Larry L., 2009, J EUR CERAM SOC, V29, P1257, DOI DOI 10.1016/J.JEURCERAMS0C.2008.08.002
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1971, J BIOMED MATER RES, V5, P117, DOI DOI 10.1002/JBM.820050611
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kaunitz JD, 2008, J CELL BIOCHEM, V105, P655, DOI 10.1002/jcb.21885
   KUNDU J, 2012, ACTA BIOMATER
   Lopez-Noriega A, 2010, CHEM-EUR J, V16, P10879, DOI 10.1002/chem.201000137
   Low KL, 2010, J BIOMED MATER RES B, V94B, P273, DOI 10.1002/jbm.b.31619
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082
   Meghji S, 2001, AM J PHYSIOL-ENDOC M, V280, pE112
   Monfoulet L, 2010, CALCIFIED TISSUE INT, V86, P72, DOI 10.1007/s00223-009-9314-y
   *NIH CONS DEV PAN, 2001, SOUTH MED J, V94, P569, DOI DOI 10.1097/00007611-200106000-00005
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Seib FP, 2012, BIOMATERIALS, V33, P1017, DOI 10.1016/j.biomaterials.2011.10.063
   Turner A. Simon, 2001, European Cells & Materials, V1, P66
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Wittrant Y, 2009, BIOCHEM BIOPH RES CO, V381, P259, DOI 10.1016/j.bbrc.2009.02.034
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Wu CT, 2008, ACTA BIOMATER, V4, P343, DOI 10.1016/j.actbio.2007.08.010
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu CT, 2011, ACTA BIOMATER, V7, P2229, DOI 10.1016/j.actbio.2010.12.019
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Zhang YF, 2012, BIOMATERIALS, V33, P6698, DOI 10.1016/j.biomaterials.2012.06.021
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
NR 49
TC 15
Z9 15
U1 3
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 12
PY 2013
VL 8
IS 11
AR UNSP e81014
DI 10.1371/journal.pone.0081014
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255PK
UT WOS:000327252100176
PM 24265840
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Weidner, C
   Wowro, SJ
   Rousseau, M
   Freiwald, A
   Kodelja, V
   Abdel-Aziz, H
   Kelber, O
   Sauer, S
AF Weidner, Christopher
   Wowro, Sylvia J.
   Rousseau, Morten
   Freiwald, Anja
   Kodelja, Vitam
   Abdel-Aziz, Heba
   Kelber, Olaf
   Sauer, Sascha
TI Antidiabetic Effects of Chamomile Flowers Extract in Obese Mice through
   Transcriptional Stimulation of Nutrient Sensors of the Peroxisome
   Proliferator-Activated Receptor (PPAR) Family
SO PLOS ONE
LA English
DT Article
ID INDUCED DIABETIC-RATS; NATURAL-PRODUCTS; STW-5 IBEROGAST(R); GAMMA;
   INFLAMMATION; MECHANISMS; COMPONENTS; DISCOVERY; POTENT; L.
AB Given the significant increases in the incidence of metabolic diseases, efficient strategies for preventing and treating of these common disorders are urgently needed. This includes the development of phytopharmaceutical products or functional foods to prevent or cure metabolic diseases. Plant extracts from edible biomaterial provide a potential resource of structurally diverse molecules that can synergistically interfere with complex disorders. In this study we describe the safe application of ethanolic chamomile (Matricaria recutita) flowers extract (CFE) for the treatment and prevention of type 2 diabetes and associated disorders. We show in vitro that this extract activates in particular nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) and its isotypes. In a cellular context, in human primary adipocytes CFE administration (300 mu g/ml) led to specific expression of target genes of PPAR gamma, whereas in human hepatocytes CFE-induced we detected expression changes of genes that were regulated by PPAR alpha. In vivo treatment of insulin-resistant high-fat diet (HFD)-fed C57BL/6 mice with CFE (200 mg/kg/d) for 6 weeks considerably reduced insulin resistance, glucose intolerance, plasma triacylglycerol, non-esterified fatty acids (NEFA) and LDL/VLDL cholesterol. Co-feeding of lean C57BL/6 mice a HFD with 200 mg/kg/d CFE for 20 weeks showed effective prevention of fatty liver formation and hepatic inflammation, indicating additionally hepatoprotective effects of the extract. Moreover, CFE treatment did not reveal side effects, which have otherwise been associated with strong synthetic PPAR-targeting molecules, such as weight gain, liver disorders, hemodilution or bone cell turnover. Taken together, modulation of PPARs and other factors by chamomile flowers extract has the potential to prevent or treat type 2 diabetes and related disorders.
C1 [Weidner, Christopher; Wowro, Sylvia J.; Rousseau, Morten; Freiwald, Anja; Kodelja, Vitam; Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, D-14195 Berlin, Germany.
   [Weidner, Christopher] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany.
   [Abdel-Aziz, Heba; Kelber, Olaf] Steigerwald Arzneimittelwerk GmbH, Dept Sci, Darmstadt, Germany.
RP Sauer, S (reprint author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany.
EM sauer@molgen.mpg.de
OI Abdel-Aziz, Heba/0000-0002-4808-5926; Wowro, Sylvia/0000-0003-1728-9210
FU German Ministry for Education and Research (BMBF) [0315082]; European
   Union [262055]; Max Planck Society
FX The authors' work is supported by the German Ministry for Education and
   Research (BMBF, grant number 0315082), the European Union
   (FP7/2007-2013, under grant agreement number no 262055 (ESGI)), and the
   Max Planck Society. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 2010, NAT REV DRUG DISCOV, V9, P828, DOI [10.1038/nrd3317, DOI 10.1038/NRD3317]
   Argmann CA, 2005, EUR J CLIN INVEST, V35, P80, DOI [10.1111/j.1365-2362.2005.01456.x, DOI 10.1111/J.1365-2362.2005.01456.X]
   Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018
   Cemek M, 2008, J NAT MED-TOKYO, V62, P284, DOI 10.1007/s11418-008-0228-1
   Cho N, 2008, CURR TOP MED CHEM, V8, P1483, DOI 10.2174/156802608786413474
   Christensen KB, 2010, PHYTOTHER RES, V24, pS129, DOI 10.1002/ptr.3005
   Chuang CC, 2011, ANNU REV NUTR, V31, P155, DOI 10.1146/annurev-nutr-072610-145149
   Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082
   Doshi LS, 2010, EXPERT OPIN INV DRUG, V19, P489, DOI 10.1517/13543781003640169
   Eddouks M, 2005, DIABETES RES CLIN PR, V67, P189, DOI 10.1016/j.diabres.2004.07.015
   Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025
   Ganesan A, 2004, CURR OPIN BIOTECH, V15, P584, DOI 10.1016/j.copbio.2004.09.002
   Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551
   Gupta A. K., 2006, American Journal of Pharmacology and Toxicology, V1, P17
   Harbourne N, 2009, FOOD CHEM, V115, P15, DOI 10.1016/j.foodchem.2008.11.044
   Heikkinen S, 2007, CURR PROTOC MOL BIOL, V23
   Heinle H, 2006, PHYTOMEDICINE, V13, P75, DOI 10.1016/j.phymed.2006.03.013
   Hohenester B, 2004, NEUROGASTROENT MOTIL, V16, P765, DOI 10.1111/j.1365-2982.2004.00548.x
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kato A, 2008, J AGR FOOD CHEM, V56, P8206, DOI 10.1021/jf8014365
   Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239
   Kroll U, 2006, PHYTOMEDICINE, V13, P12, DOI 10.1016/j.phymed.2006.03.016
   Lalloyer F, 2010, ARTERIOSCL THROM VAS, V30, P894, DOI 10.1161/ATVBAHA.108.179689
   Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026
   Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243
   Liang YC, 2001, FEBS LETT, V496, P12, DOI 10.1016/S0014-5793(01)02393-6
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   McCarty MF, 2005, MED HYPOTHESES, V64, P151, DOI 10.1016/j.mehy.2004.03.036
   Medjakovic S, 2010, NUTRIENTS, V2, P241, DOI 10.3390/nu2030241
   Meierhofer D, 2013, MOL CELL PROTEOMICS, V12, P1965, DOI 10.1074/mcp.M112.025031
   Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5
   Moreno M, 2010, PPAR RES, V2010
   Mueller M, 2008, J AGR FOOD CHEM, V56, P11621, DOI 10.1021/jf802298w
   Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047
   Portincasa P, 2006, CURR MED CHEM, V13, P2889, DOI 10.2174/092986706778521878
   Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379
   Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216
   Rosen CJ, 2010, NEW ENGL J MED, V363, P803, DOI 10.1056/NEJMp1008233
   Singh Ompal, 2011, Pharmacogn Rev, V5, P82, DOI 10.4103/0973-7847.79103
   Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75
   SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83
   Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507
   Wegener T, 2006, PHYTOMEDICINE, V13, P20, DOI 10.1016/j.phymed.2006.07.001
   Weidner C, 2013, DIABETOLOGIA
   Weidner C, 2012, P NATL ACAD SCI USA, V109, P7257, DOI 10.1073/pnas.1116971109
   Wilkinson AS, 2008, J AGR FOOD CHEM, V56, P3037, DOI 10.1021/jf800046n
   World Health Organization, 2003, OB OV FACT SHEET
   Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050
NR 50
TC 17
Z9 18
U1 1
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 12
PY 2013
VL 8
IS 11
AR UNSP e80335
DI 10.1371/journal.pone.0080335
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255PK
UT WOS:000327252100145
PM 24265809
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Shahidan, NN
   Liu, RX
   Thaiboonrod, S
   Alexander, C
   Shakesheff, KM
   Saunders, BR
AF Shahidan, Nur Nabilah
   Liu, Ruixue
   Thaiboonrod, Sineenat
   Alexander, Cameron
   Shakesheff, Kevin M.
   Saunders, Brian R.
TI Hollow Colloidosomes Prepared Using Accelerated Solvent Evaporation
SO LANGMUIR
LA English
DT Article
ID POLYMER SHELL MICROCAPSULES; COLLOIDAL PARTICLES; EMULSION DROPLETS;
   GRAFT-COPOLYMERS; SPHERES; BIREFRINGENCE; FABRICATION; CAPSULES;
   GELATION; SYSTEM
AB We demonstrate a new, scalable, simple, and generally applicable two-step method to prepare hollow colloidosomes. First, a high volume fraction oil-in-water emulsion was prepared. The oil phase consisted of CH2Cl2 containing a hydrophobic structural polymer, such as polycaprolactone (PCL) or polystyrene (PS), which was fed into the water phase. The water phase contained poly(vinylalcohol), poly(N-isopropylacrylamide), or a range of cationic graft copolymer surfactants. The emulsion was rotary evaporated to rapidly remove CH2Cl2. This caused precipitation of PCL or PS particles which became kinetically trapped at the periphery of the droplets and formed the shell of the hollow colloidosomes. Interestingly, the PCL colloidosomes were birefringent. The colloidosome yield increased and the polydispersity decreased when the preparation scale was increased. One example colloidosome system consisted of hollow PCL colloidosomes stabilized by PVA. This system should have potential biomaterial applications due to the known biocompatibility of PCL and PVA.
C1 [Shahidan, Nur Nabilah; Liu, Ruixue; Thaiboonrod, Sineenat; Saunders, Brian R.] Univ Manchester, Sch Mat, Biomat Res Grp, Manchester M13 9PL, Lancs, England.
   [Shahidan, Nur Nabilah] Univ Malaysia Kelantan, Fac Earth Sci, Kota Baharu, Malaysia.
   [Liu, Ruixue] Zhengzhou Univ Light Ind, Zhengzhou 450002, Peoples R China.
   [Alexander, Cameron; Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
RP Saunders, BR (reprint author), Univ Manchester, Sch Mat, Biomat Res Grp, Grosvenor St, Manchester M13 9PL, Lancs, England.
EM brian.saunders@manchester.ac.uk
RI Shakesheff, Kevin/O-6371-2018; Alexander, Cameron/N-7729-2014
OI Shakesheff, Kevin/0000-0003-3236-2439; Alexander,
   Cameron/0000-0001-8337-1875; Saunders, Brian/0000-0003-1410-2967
FU Malaysian Ministry of Higher Education; Universiti Malaysia Kelantan;
   EPSRC Centre for Innovative Manufacturing in Regenerative Medicine;
   European Research Council under the European Community [227845]; EPSRC
   [EP/H005625/1, EP/H028277/1]; Engineering and Physical Sciences Research
   Council [EP/H005625/1, EP/H028277/1]
FX We would like to thank the Malaysian Ministry of Higher Education and
   Universiti Malaysia Kelantan for funding. This work was in part funded
   by the EPSRC Centre for Innovative Manufacturing in Regenerative
   Medicine. Research leading to these results received funding from the
   European Research Council under the European Community's Seventh
   Framework Programme (FP7/2007-2013)/ERC grant agreement 227845 and also
   the EPSRC (grants EP/H005625/1 and EP/H028277/1). We would like to thank
   the referees for their helpful comments regarding this manuscript.
CR Bird R, 2011, CHEM COMMUN, V47, P1443, DOI 10.1039/c0cc04657d
   Bon SAF, 2007, SOFT MATTER, V3, P194, DOI 10.1039/b612066k
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Cayre OJ, 2004, J MATER CHEM, V14, P3351, DOI 10.1039/b411359d
   Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868
   Dowding PJ, 2004, LANGMUIR, V20, P11374, DOI 10.1021/la048561h
   Floudas G, 2000, MACROMOLECULES, V33, P6466, DOI 10.1021/ma000243b
   Horecha M, 2009, MACROMOLECULES, V42, P5811, DOI 10.1021/ma9008934
   Jiang S, 2008, LANGMUIR, V24, P2438, DOI 10.1021/la703274a
   Katz JS, 2012, SOFT MATTER, V8, P10853, DOI 10.1039/c2sm26275d
   Keen PHR, 2012, LANGMUIR, V28, P16007, DOI 10.1021/la303043n
   Kim YB, 2004, MACROMOL RAPID COMM, V25, P1643, DOI 10.1002/marc.200400203
   Krishnanand K, 2013, POLYM INT, V62, P49, DOI 10.1002/pi.4304
   Li W, 2013, COLLOID SURFACE A, V421, P173, DOI 10.1016/j.colsurfa.2012.12.058
   Lim GT, 2011, BIOMACROMOLECULES, V12, P1795, DOI 10.1021/bm200157b
   Liu R, 2008, LANGMUIR, V24, P7099, DOI 10.1021/la8002756
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Loxley A, 1998, J COLLOID INTERF SCI, V208, P49, DOI 10.1006/jcis.1998.5698
   Maglio G, 2011, BIOMACROMOLECULES, V12, P4221, DOI 10.1021/bm201036r
   McClements DJ, 2012, CURR OPIN COLLOID IN, V17, P235, DOI 10.1016/j.cocis.2012.06.002
   Minami H, 2008, LANGMUIR, V24, P9254, DOI 10.1021/la800188j
   Park CH, 2009, J APPL POLYM SCI, V114, P430, DOI 10.1002/app.30498
   Richardson RM, 2000, MACROMOLECULES, V33, P6269, DOI 10.1021/ma000095p
   Shahidan NN, 2013, J COLLOID INTERF SCI, V396, P187, DOI 10.1016/j.jcis.2013.01.025
   Shahidan NN, 2011, LANGMUIR, V27, P13868, DOI 10.1021/la203206s
   Thompson KL, 2012, LANGMUIR, V28, P16501, DOI 10.1021/la3025765
   Velev OD, 1996, LANGMUIR, V12, P2374, DOI 10.1021/la9506786
   Yow HN, 2006, SOFT MATTER, V2, P940, DOI 10.1039/b606965g
NR 28
TC 5
Z9 6
U1 2
U2 76
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 12
PY 2013
VL 29
IS 45
BP 13676
EP 13685
DI 10.1021/la402788a
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 252WW
UT WOS:000327044600004
PM 24111615
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Gunnewiek, MK
   Benetti, EM
   Di Luca, A
   van Blitterswijk, CA
   Moroni, L
   Vancso, GJ
AF Gunnewiek, Michel Klein
   Benetti, Edmondo M.
   Di Luca, Andrea
   van Blitterswijk, Clemens A.
   Moroni, Lorenzo
   Vancso, G. Julius
TI Thin Polymer Brush Decouples Biomaterial's Micro-/Nanotopology and Stem
   Cell Adhesion
SO LANGMUIR
LA English
DT Article
ID TRANSFER RADICAL POLYMERIZATION; OSTEOGENIC-DIFFERENTIATION;
   EXTRACELLULAR-MATRIX; BIOLOGICAL APPLICATIONS; POLYCAPROLACTONE FILMS;
   SURFACE-ROUGHNESS; ENDOTHELIAL-CELLS; RGD; SUBSTRATE; STIFFNESS
AB Surface morphology and chemistry of polymers used as biomaterials, such as tissue engineering scaffolds, have a strong influence on the adhesion and behavior of human mesenchymal stem cells. Here we studied semicrystalline poly(epsilon-caprolactone) (PCL) substrate scaffolds, which exhibited a variation of surface morphologies and roughness originating from different spherulitic superstructures. Substrates were obtained by varying the parameters of the thermal processing, that is, crystallization conditions. The cells attached to these polymer substrates adopted different morphologies responding to variations in spherulite density and size. In order to decouple substrate topology effects on the cells, sub-100 nm bioadhesive polymer brush coatings of oligo(ethylene glycol) methacrylates were grafted from PCL and functionalized with fibronectin. On surfaces featuring different surface textures, dense and sub-100 nm thick brush coatings determined the response of cells, irrespective to the underlying topology. Thus, polymer brushes decouple substrate micro-/nanoscale surface topology and the adhesion of stem cells.
C1 [Gunnewiek, Michel Klein; Vancso, G. Julius] Univ Twente, Inst Nanotechnol, MESA, Dept Mat Sci & Technol Polymers, NL-7500 AE Enschede, Netherlands.
   [Benetti, Edmondo M.] ETH, Dept Mat, Lab Surface Sci & Technol, CH-8093 Zurich, Switzerland.
   [Di Luca, Andrea; van Blitterswijk, Clemens A.; Moroni, Lorenzo] Univ Twente, Inst Biomed Technol & Tech Med, MIRA, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
RP Moroni, L (reprint author), Univ Twente, Inst Biomed Technol & Tech Med, MIRA, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
EM l.moroni@utwente.nl; g.j.vancso@utwente.nl
RI Moroni, Lorenzo/D-2826-2014; Klein Gunnewiek, Michel/O-1602-2014;
   Benetti, Edmondo Maria/N-5969-2015
OI Moroni, Lorenzo/0000-0003-1298-6025; Klein Gunnewiek,
   Michel/0000-0003-4680-439X; Benetti, Edmondo Maria/0000-0002-5657-5714;
   van Blitterswijk, Clemens/0000-0003-2371-4615
FU MESA+ Institute for Nanotechnology of the University of Twente;
   Technology foundation STW [11135]
FX This work was financially supported by the MESA+ Institute for
   Nanotechnology of the University of Twente and by the Technology
   foundation STW (STW, 11135). The authors thank Dr. M. A. Hempenius for
   the many useful discussions.
CR Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Ayres N, 2010, POLYM CHEM-UK, V1, P769, DOI 10.1039/b9py00246d
   Balloni S, 2009, INT J ORAL MAX IMPL, V24, P627
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Brown AA, 2005, EUR POLYM J, V41, P1757, DOI 10.1016/j.eurpolymj.2005.02.026
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Cooperstein MA, 2010, LANGMUIR, V26, P7695, DOI 10.1021/la902587p
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dolatshahi-Pirouz A, 2011, COLLOID SURFACE B, V84, P18, DOI 10.1016/j.colsurfb.2010.12.004
   Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gunnewiek MK, 2012, ISR J CHEM, V52, P339, DOI 10.1002/ijch.201100118
   Guvendiren M, 2010, BIOMATERIALS, V31, P6511, DOI 10.1016/j.biomaterials.2010.05.037
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu ZB, 2010, SOFT MATTER, V6, P2115, DOI 10.1039/b921150k
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Konradi R, 2012, MACROMOL RAPID COMM, V33, P1663, DOI 10.1002/marc.201200422
   Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053
   Le DM, 2011, ADV MATER, V23, P3278, DOI 10.1002/adma.201100821
   Lendlein A, 2005, J POLYM SCI POL CHEM, V43, P1369, DOI 10.1002/pola.20598
   Liu QS, 2012, BIOMACROMOLECULES, V13, P1086, DOI 10.1021/bm201814p
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Nam K, 2010, CHEM LETT, V39, P1164, DOI 10.1246/cl.2010.1164
   Nandakumar A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015006
   Navarro M, 2008, LANGMUIR, V24, P10996, DOI 10.1021/la800999y
   Ping P, 2005, BIOMACROMOLECULES, V6, P587, DOI 10.1021/bm049477j
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Raynor JE, 2007, ADV MATER, V19, P1724, DOI 10.1002/adma.200602129
   Samaroo HD, 2008, INT J NANOMED, V3, P75
   Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278
   Song W, 2011, LANGMUIR, V27, P6155, DOI 10.1021/la200487w
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tugulu S, 2007, BIOMATERIALS, V28, P2536, DOI 10.1016/j.biomaterials.2007.02.006
   Tugulu S, 2009, MACROMOL SYMP, V279, P103, DOI 10.1002/masy.200950516
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   van Delft FCMJ, 2008, MICROELECTRON ENG, V85, P1362, DOI 10.1016/j.mee.2008.01.028
   Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Wieringa P., 2012, NANOTECHNOLOGY, V23
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xu FJ, 2011, COLLOID SURFACE B, V85, P40, DOI 10.1016/j.colsurfb.2010.09.027
   Xu FJ, 2010, BIOMATERIALS, V31, P3139, DOI 10.1016/j.biomaterials.2010.01.032
   Xu FJ, 2009, BIOMACROMOLECULES, V10, P1665, DOI 10.1021/bm900307c
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yu BY, 2012, J BIOMAT SCI-POLYM E, V23, P1, DOI 10.1163/092050610X541386
NR 60
TC 13
Z9 13
U1 2
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 12
PY 2013
VL 29
IS 45
BP 13843
EP 13852
DI 10.1021/la403360r
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 252WW
UT WOS:000327044600021
PM 24117174
DA 2018-10-20
ER

PT J
AU Hutin, M
   Burakowska-Meise, E
   Appel, WPJ
   Dankers, PYW
   Meijer, EW
AF Hutin, Marie
   Burakowska-Meise, Ewelina
   Appel, Wilco P. J.
   Dankers, Patricia Y. W.
   Meijer, E. W.
TI From Molecular Structure to Macromolecular Organization: Keys to Design
   Supramolecular Biomaterials
SO MACROMOLECULES
LA English
DT Article
ID HYDROGEN-BONDING INTERACTIONS; PHYSICAL-ORGANIC-CHEMISTRY; ATOMIC-FORCE
   MICROSCOPY; HUMAN TUBULAR CELLS; THERMOPLASTIC ELASTOMERS; POLYMER
   CRYSTALLIZATION; BIOARTIFICIAL KIDNEY; THERMAL-STABILITY; MELTING
   BEHAVIOR; BONDED POLYMERS
AB In the past decade, significant progress has been made in the field of biomaterials, for potential applications in tissue engineering or drug delivery. We have recently developed a new class of thermoplastic elastomers, based on ureidopyrimidinone (UPy) quadruple hydrogen bonding motifs. These supramolecular polymers form nanofiber-like aggregates initially via the dimerization of the UPy units followed by lateral urea-hydrogen bonding. Combined kinetic and thermodynamic studies unravel the pathway complexity in the formation of these polymorphic nanofibers and the subtlety of the polymer's design, while these morphologies are so critically important when these materials are used in combination with cells. We also show that the cell behavior directly depends on the length and shape of the nanofibers, illustrating the key importance of macromolecular and supramolecular organization of biomaterials. This study leads to new design rules that determine what factors are decisive for a polymer to be a good candidate as biomaterial.
C1 [Meijer, E. W.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands.
   Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands.
RP Meijer, EW (reprint author), Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands.
EM e.w.meijer@tue.nl
RI Meijer, E.W./K-7632-2013
OI Meijer, E.W./0000-0003-4126-7492
FU Council for Chemical Sciences of The Netherlands Organization for
   Scientific Support (CW-NWO); BioMedical Materials institute [P1.01
   iValve]; Dutch Ministry of Economic Affairs, Agriculture and Innovation;
   Nederlandse Hartstichting
FX The authors thank the financial support from the Council for Chemical
   Sciences of The Netherlands Organization for Scientific Support
   (CW-NWO). This research forms part of the Project P1.01 iValve of the
   research program of the BioMedical Materials institute, cofunded by the
   Dutch Ministry of Economic Affairs, Agriculture and Innovation. The
   financial contribution of the Nederlandse Hartstichting is gratefully
   acknowledged.
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Appel WPJ, 2011, MACROMOL BIOSCI, V11, P1706, DOI 10.1002/mabi.201100225
   Appel WPJ, 2011, MACROMOLECULES, V44, P6776, DOI 10.1021/ma201303s
   Armstrong G, 2005, J MATER SCI, V40, P547, DOI 10.1007/s10853-005-6288-7
   Armstrong G, 2002, POLYM INT, V51, P1219, DOI 10.1002/pi.949
   BAS C, 1994, J APPL POLYM SCI, V53, P1745, DOI 10.1002/app.1994.070531305
   BASSETT DC, 1994, POLYMER, V35, P1855, DOI 10.1016/0032-3861(94)90974-1
   Beijer FH, 1998, J AM CHEM SOC, V120, P6761, DOI 10.1021/ja974112a
   Botterhuis NE, 2008, CHEM COMMUN, P3915, DOI 10.1039/b804457k
   Botterhuis NE, 2010, MACROMOLECULES, V43, P745, DOI 10.1021/ma902585w
   Bouteiller L, 2007, ADV POLYM SCI, V207, P79, DOI 10.1007/12_2006_110
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Castro REN, 2003, J MATER SCI, V38, P699, DOI 10.1023/A:1021888310159
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047
   Dankers PYW, 2011, J CONTROL RELEASE, V152, P177, DOI 10.1016/j.jconrel.2011.01.034
   Dankers PYW, 2011, BIOMATERIALS, V32, P723, DOI 10.1016/j.biomaterials.2010.09.020
   Dankers PYW, 2010, MACROMOL BIOSCI, V10, P1345, DOI 10.1002/mabi.201000146
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   de Greef TFA, 2008, J AM CHEM SOC, V130, P13755, DOI 10.1021/ja8046409
   de Moel K, 2001, CHEM MATER, V13, P4580, DOI 10.1021/cm0110932
   Fleischer S, 2013, CURR OPIN BIOTECH, V24, P664, DOI 10.1016/j.copbio.2012.10.016
   FLORY PJ, 1976, J AM CHEM SOC, V98, P5733, DOI 10.1021/ja00435a001
   Folmer BJB, 2001, J AM CHEM SOC, V123, P2093, DOI 10.1021/ja005754s
   Hartgerink JD, 2001, CURR OPIN SOLID ST M, V5, P355, DOI 10.1016/S1359-0286(01)00019-5
   Hauser G, 1998, MACROMOLECULES, V31, P6250, DOI 10.1021/ma980453c
   Hugel T, 2001, MACROMOL RAPID COMM, V22, P989, DOI 10.1002/1521-3927(20010901)22:13<989::AID-MARC989>3.0.CO;2-D
   Humes HD, 1999, NAT BIOTECHNOL, V17, P451, DOI 10.1038/8626
   Ikkala O, 2004, CHEM COMMUN, P2131, DOI 10.1039/b403983a
   IP TK, 1989, ARTIF ORGANS, V13, P58, DOI 10.1111/j.1525-1594.1989.tb02833.x
   JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547
   Kautz H, 2006, MACROMOLECULES, V39, P4265, DOI 10.1021/ma060706z
   Kieltyka RE, 2013, J AM CHEM SOC, V135, P11159, DOI 10.1021/ja403745w
   Korevaar PA, 2012, NATURE, V481, P492, DOI 10.1038/nature10720
   Leclere P, 2006, MAT SCI ENG R, V55, P1, DOI 10.1016/j.mser.2006.12.001
   Ligthart GBWL, 2005, J AM CHEM SOC, V127, P810, DOI 10.1021/ja043555t
   LONG Y, 1995, PROG POLYM SCI, V20, P651, DOI 10.1016/0079-6700(95)00002-W
   Magonov SN, 1997, ANNU REV MATER SCI, V27, P175, DOI 10.1146/annurev.matsci.27.1.175
   Mandelkern L, 2004, BIOPHYS CHEM, V112, P109, DOI 10.1016/j.bpc.2004.07.010
   Moore JS, 1999, CURR OPIN COLLOID IN, V4, P108, DOI 10.1016/S1359-0294(99)00018-7
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   Nap R, 2004, MACROMOLECULES, V37, P4296, DOI 10.1021/ma0356663
   Ni M, 2011, BIOMATERIALS, V32, P1465, DOI 10.1016/j.biomaterials.2010.10.061
   Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3
   Pan N, 1996, SCI ENG COMPOS MATER, V5, P63
   PAUKKERI R, 1993, POLYMER, V34, P4083, DOI 10.1016/0032-3861(93)90670-6
   Pillai O, 2001, CURR OPIN CHEM BIOL, V5, P447, DOI 10.1016/S1367-5931(00)00227-1
   Rudick JG, 2008, ACCOUNTS CHEM RES, V41, P1641, DOI 10.1021/ar800086w
   Sasaki T, 2003, POLYM ENG SCI, V43, P629, DOI 10.1002/pen.10051
   Schnell I, 2002, PHYS CHEM CHEM PHYS, V4, P3750, DOI 10.1039/b203333j
   Serpe MJ, 2007, LANGMUIR, V23, P1626, DOI 10.1021/la0621416
   Sheets K, 2013, ACTA BIOMATER, V9, P7169, DOI 10.1016/j.actbio.2013.03.042
   Sheiko SS, 2000, ADV POLYM SCI, V151, P61
   Sherrington DC, 2001, CHEM SOC REV, V30, P83, DOI 10.1039/b008033k
   Sheth JP, 2005, MACROMOLECULES, V38, P10074, DOI 10.1021/ma051063a
   Shoji M, 2002, MACROMOLECULES, V35, P7460, DOI 10.1021/ma02077e
   SIESLER HW, 1988, MIKROCHIM ACTA, V1, P323
   Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Sivakova S, 2005, J AM CHEM SOC, V127, P18202, DOI 10.1021/ja055245w
   Sontjens SHM, 2000, J AM CHEM SOC, V122, P7487, DOI 10.1021/ja000435m
   South CR, 2007, ACCOUNTS CHEM RES, V40, P63, DOI 10.1021/ar0500160
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Strobl G, 2006, PROG POLYM SCI, V31, P398, DOI 10.1016/j.progpolymsci.2006.01.001
   Strobl G, 2009, REV MOD PHYS, V81, P1287, DOI 10.1103/RevModPhys.81.1287
   Supaphol P, 2001, J APPL POLYM SCI, V82, P1083, DOI 10.1002/app.1943
   ten Brinke G, 2007, ADV POLYM SCI, V207, P113, DOI 10.1007/12_2006_111
   Threlfall T, 2003, ORG PROCESS RES DEV, V7, P1017, DOI 10.1021/op030026l
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   TSUJI H, 1992, MACROMOLECULES, V25, P5719, DOI 10.1021/ma00047a024
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Vandermeulen GWM, 2004, MACROMOL BIOSCI, V4, P383, DOI 10.1002/mabi.200300079
   WHITESIDES GM, 1995, ACCOUNTS CHEM RES, V28, P37, DOI 10.1021/ar00049a006
   Wietor JL, 2011, MACROMOLECULES, V44, P1211, DOI 10.1021/ma1026065
   Williamson MR, 2004, BIOMATERIALS, V25, P459, DOI 10.1016/S0142-9612(03)00536-2
   Wisse E, 2006, MACROMOLECULES, V39, P7425, DOI 10.1021/ma060986i
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Zerbi G, 1964, J POLYM SCI C, V7, P141
NR 79
TC 17
Z9 17
U1 3
U2 98
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD NOV 12
PY 2013
VL 46
IS 21
BP 8528
EP 8537
DI 10.1021/ma401552e
PG 10
WC Polymer Science
SC Polymer Science
GA 252WT
UT WOS:000327044300016
DA 2018-10-20
ER

PT J
AU Raja, WK
   MacCorkle, S
   Diwan, IM
   Abdurrob, A
   Lu, J
   Omenetto, FG
   Kaplan, DL
AF Raja, Waseem K.
   MacCorkle, Scott
   Diwan, Izzuddin M.
   Abdurrob, Abdurrahman
   Lu, Jessica
   Omenetto, Fiorenzo G.
   Kaplan, David L.
TI Transdermal Delivery Devices: Fabrication, Mechanics and Drug Release
   from Silk
SO SMALL
LA English
DT Article
DE silk; micromachining; transdermal drug delivery; microparticles;
   microneedles
ID BIODEGRADABLE POLYMER MICRONEEDLES; DISSOLVING MICRONEEDLES;
   PERCUTANEOUS-ABSORPTION; SUSTAINED-RELEASE; PROTEIN SCAFFOLDS; INSULIN;
   ARRAY; SKIN; NANOPARTICLES; VACCINATION
AB Microneedles are a relatively simple, minimally invasive and painless approach to deliver drugs across the skin. However, there remain limitations with this approach because of the materials most commonly utilized for such systems. Silk protein, with tunable and biocompatibility properties, is a useful biomaterial to overcome the current limitations with microneedles. Silk devices preserve drug activity, offer superior mechanical properties and biocompatibility, can be tuned for biodegradability, and can be processed under aqueous, benign conditions. In the present work, the fabrication of dense microneedle arrays from silk with different drug release kinetics is reported. The mechanical properties of the microneedle patches are tuned by post-fabrication treatments or by loading the needles with silk microparticles, to increase capacity and mechanical strength. Drug release is further enhanced by the encapsulation of the drugs in the silk matrix and coating with a thin dissolvable drug layer. The microneedles are used on human cadaver skin and drugs are delivered successfully. The various attributes demonstrated suggest that silk-based microneedle devices can provide significant benefit as a platform material for transdermal drug delivery.
C1 [Raja, Waseem K.; MacCorkle, Scott; Diwan, Izzuddin M.; Abdurrob, Abdurrahman; Lu, Jessica; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Ctr Sci & Technol, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Ctr Sci & Technol, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [EB002520]; AFOSR; NSF
FX We thank the NIH (EB002520), the AFOSR and the NSF for support of this
   work.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Badran MM, 2009, EUR J PHARM SCI, V36, P511, DOI 10.1016/j.ejps.2008.12.008
   Brown MB, 2006, DRUG DELIV, V13, P175, DOI 10.1080/10717540500455975
   Chen YT, 2010, J MAR SCI TECH-TAIW, V18, P243
   Chu LY, 2010, J PHARM SCI-US, V99, P4228, DOI 10.1002/jps.22140
   Cormier M, 2004, J CONTROL RELEASE, V97, P503, DOI 10.1016/j.jconrel.2004.04.003
   Coulman SA, 2009, INT J PHARM, V366, P190, DOI 10.1016/j.ijpharm.2008.08.040
   Cronin-Golomb M, 2012, J POLYM SCI POL PHYS, V50, P257, DOI 10.1002/polb.23003
   Davis SP, 2005, IEEE T BIO-MED ENG, V52, P909, DOI 10.1109/TBME.2005.845240
   Donnelly RF, 2011, PHARM RES-DORDR, V28, P41, DOI 10.1007/s11095-010-0169-8
   Donnelly RF, 2009, DRUG DEV IND PHARM, V35, P1242, DOI 10.1080/03639040902882280
   Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739
   Fukushima K, 2011, PHARM RES-DORDR, V28, P7, DOI 10.1007/s11095-010-0097-7
   Gil ES, 2011, J BIOMED MATER RES A, V99A, P16, DOI 10.1002/jbm.a.33158
   Gill HS, 2010, GENE THER, V17, P811, DOI 10.1038/gt.2010.22
   Gill HS, 2007, PHARM RES, V24, P1369, DOI 10.1007/s11095-007-9286-4
   Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017
   Gittard SD, 2010, EXPERT OPIN DRUG DEL, V7, P513, DOI 10.1517/17425241003628171
   Han M, 2007, J MICROMECH MICROENG, V17, P1184, DOI 10.1088/0960-1317/17/6/012
   Henry S, 1999, J PHARM SCI, V88, P948
   Hines DJ, 2011, BIOMACROMOLECULES, V12, P804, DOI 10.1021/bm101421r
   Hronik-Tupaj M., 2013, J BIOMED MAT RES A, DOI 10.1002/jbm.a.34565
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Ito Y, 2007, J DRUG TARGET, V15, P323, DOI 10.1080/10611860701349794
   Ito Y, 2006, EUR J PHARM SCI, V29, P82, DOI 10.1016/j.ejps.2006.05.011
   Ji J, 2006, J PHYS CONF SER, V34, P1127, DOI 10.1088/1742-6596/34/1/186
   Kim M, 2012, BIOMATERIALS, V33, P668, DOI 10.1016/j.biomaterials.2011.09.074
   Kochhar JS, 2013, DRUG DEV IND PHARM, V39, P299, DOI 10.3109/03639045.2012.679361
   Kojic N, 2012, SOFT MATTER, V8, P6897, DOI 10.1039/c2sm25783a
   Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Martin CJ, 2012, J CONTROL RELEASE, V158, P93, DOI 10.1016/j.jconrel.2011.10.024
   Matriano JA, 2002, PHARMACEUT RES, V19, P63, DOI 10.1023/A:1013607400040
   McAllister DV, 2003, P NATL ACAD SCI USA, V100, P13755, DOI 10.1073/pnas.2331316100
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Miyano T, 2005, BIOMED MICRODEVICES, V7, P185, DOI 10.1007/s10544-005-3024-7
   Park JH, 2006, PHARM RES, V23, P1008, DOI 10.1007/s11095-006-0028-9
   Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002
   Park JH, 2007, IEEE T BIO-MED ENG, V54, P903, DOI 10.1109/TBME.2006.889173
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Raja WK, 2010, INTEGR BIOL-UK, V2, P696, DOI 10.1039/c0ib00044b
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Raphael AP, 2010, SMALL, V6, P1785, DOI 10.1002/smll.201000326
   Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sachdeva Vishal, 2011, Recent Pat Drug Deliv Formul, V5, P95
   Sullivan SP, 2008, ADV MATER, V20, P933, DOI 10.1002/adma.200701205
   Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182
   Tsioris K, 2012, ADV FUNCT MATER, V22, P330, DOI 10.1002/adfm.201102012
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wei-Ze L, 2010, INT J PHARMACEUT, V389, P122, DOI 10.1016/j.ijpharm.2010.01.024
   Wilke N, 2005, MICROELECTRON J, V36, P650, DOI 10.1016/j.mejo.2005.04.044
NR 55
TC 25
Z9 26
U1 6
U2 103
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1613-6810
EI 1613-6829
J9 SMALL
JI Small
PD NOV 11
PY 2013
VL 9
IS 21
BP 3704
EP 3713
DI 10.1002/smll.201202075
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 268CY
UT WOS:000328147200018
PM 23653252
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yang, P
   Huang, X
   Shen, J
   Wang, CS
   Dang, XQ
   Mankin, H
   Duan, ZF
   Wang, KZ
AF Yang, Pei
   Huang, Xin
   Shen, Jacson
   Wang, Chunsheng
   Dang, Xiaoqian
   Mankin, Henry
   Duan, Zhenfeng
   Wang, Kunzheng
TI Development of a new pre-vascularized tissue-engineered construct using
   pre-differentiated rADSCs, arteriovenous vascular bundle and porous
   nano-hydroxyapatide-polyamide 66 scaffold
SO BMC MUSCULOSKELETAL DISORDERS
LA English
DT Article
DE Adipose-derived stem cells; Tissue engineering; Angiogenesis; Scaffolds;
   Prefabrication
ID HUMAN ADIPOSE-TISSUE; ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS;
   IN-VIVO; BONE-GRAFTS; PHOSPHATE CERAMICS; INTERNAL STRUCTURE; SKIN
   FLAPS; ANGIOGENESIS; PREFABRICATION
AB Background: Development of a pre-vascularized tissue-engineered construct with intrinsic vascular system for cell growth and tissue formation still faces many difficulties due to the complexity of the vascular network of natural bone tissue. The present study was to design and form a new vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nHA-PA 66 scaffold.
   Methods: rADSCs were pre-differentiated to endothelial cells (rADSCs-Endo) and then incorporated in nHA-PA 66 scaffolds in vitro. Subsequently, in vivo experiments were carried out according to the following groups: Group A (rADSCs-Endo/nHA-PA 66 scaffold with arteriovenous vascular bundle), Group B (rADSCs/nHA-PA 66 scaffold with arteriovenous vascular bundle); Group C (nHA-PA66 scaffold with arteriovenous vascular bundle), Group D (nHA-PA 66 scaffold only). The vessel density and vessel diameter were measured based on histological and immunohistochemical evaluation, furthermore, the VEGF-C, FGF-2 and BMP-2 protein expressions were also evaluated by western blot analysis.
   Results: The results of in vivo experiments showed that the vessel density and vessel diameter in group A were significantly higher than the other three groups. Between Group B and C, no statistical difference was observed at each time point. In accordance with the results, there were dramatically higher expressions of VEGF-C and FGF-2 protein in Group A than that of Group B, C and D at 2 or 4 weeks. Statistical differences were not observed in VEGF-C and FGF-2 expression between Group B and C. BMP-2 was not expressed in any group at each time point.
   Conclusions: Compared with muscular wrapping method, arteriovenous vascular bundle implantation could promote vascularization of the scaffold; and the angiogenesis of the scaffold was significantly accelerated when pre-differentiated rADSCs (endothelial differentiation) were added. These positive results implicate the combination of pre-differentiated rADSCs (endothelial differentiation) and arteriovenous vascular bundle may achieve rapidly angiogenesis of biomaterial scaffold.
C1 [Yang, Pei; Wang, Chunsheng; Dang, Xiaoqian; Wang, Kunzheng] Xi An Jiao Tong Univ, Dept Orthopaed, Affiliated Hosp 2, Coll Med, Xian 710004, Shaanxi, Peoples R China.
   [Huang, Xin] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Affiliated Hosp 1, Dept Cardiol,Med Coll,Ion Channel Dis Lab,Educ Mi, Xian 710061, Shaanxi, Peoples R China.
   [Shen, Jacson] Wellesley Coll, Dept Biol Chem, Wellesley, MA 02481 USA.
   [Mankin, Henry; Duan, Zhenfeng] Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA.
   [Mankin, Henry; Duan, Zhenfeng] Harvard Univ, Sch Med, Boston, MA USA.
   [Mankin, Henry; Duan, Zhenfeng] Massachusetts Gen Hosp, Sarcoma Biol Lab, Ctr Sarcoma & Connect Tissue Oncol, Boston, MA 02114 USA.
RP Wang, KZ (reprint author), Xi An Jiao Tong Univ, Dept Orthopaed, Affiliated Hosp 2, Coll Med, 157 Xiwu Rd, Xian 710004, Shaanxi, Peoples R China.
EM kunzhengwang@126.com
FU National Natural Science Foundation of China [81000809]; Natural Science
   Foundation of Shaanxi Province [2010JQ4009]
FX The study was supported by the National Natural Science Foundation of
   China (No. 81000809) and Natural Science Foundation of Shaanxi Province
   (2010JQ4009). We thank Prof. Zongchang He of the Foreign Language
   Department Xi'an Jiaotong University for the help in preparing the
   manuscript.
CR An SP, 2005, J TISSUE ENG RECONST, V1, P323
   Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Beris AE, 2011, MICROSURG, V31, P205, DOI 10.1002/micr.20841
   Bleiziffer O, 2011, J CELL MOL MED, V15, P2452, DOI 10.1111/j.1582-4934.2010.01247.x
   Borges J, 2003, TISSUE ENG, V9, P1263, DOI 10.1089/10763270360728170
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Cai L, 2011, BIOMATERIALS, V32, P8497, DOI 10.1016/j.biomaterials.2011.07.087
   Chen ACY, 2006, J TRAUMA, V61, P1192, DOI 10.1097/01.ta.0000234723.78487.52
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   De Oliveira JF, 2003, ARTIF ORGANS, V27, P406
   de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   DiMuzio P, 2007, J VASC SURG, V45, p99A, DOI 10.1016/j.jvs.2007.02.046
   Dong ZW, 2012, OR SURG OR MED OR PA, V114, pS153, DOI 10.1016/j.oooo.2011.09.028
   Fan WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045621
   Fang TL, 2013, ARCH ORTHOP TRAUM SU, V133, P1, DOI 10.1007/s00402-012-1627-z
   Fernandes AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062994
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   Han D, 2013, ARTIF ORGANS, DOI [10.1111/aor.12124, DOI 10.1111/A0R.12124]
   Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088
   Jabbarzadeh E, 2012, J BIOMED MATER RES B, V100B, P2187, DOI 10.1002/jbm.b.32787
   Kampmann A, 2013, MICROVASC RES, V90, P71, DOI 10.1016/j.mvr.2013.07.006
   Kaushiva A, 2007, ACTA BIOMATER, V3, P631, DOI 10.1016/j.actbio.2007.03.003
   Kokemueller H, 2010, INT J ORAL MAX SURG, V39, P379, DOI 10.1016/j.ijom.2010.01.010
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lee M, 2008, J BIOMED MATER RES A, V87A, P1010, DOI 10.1002/jbm.a.31816
   Lombardo E, 2009, TISSUE ENG PT A, V15, P1579, DOI 10.1089/ten.tea.2008.0340
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Matsuda K, 2013, TISSUE ENG PT A, V19, P1327, DOI [10.1089/ten.tea.2012.0391, 10.1089/ten.TEA.2012.0391]
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0
   Montero RB, 2012, ACTA BIOMATER, V8, P1778, DOI 10.1016/j.actbio.2011.12.008
   MORRISON WA, 1990, BRIT J PLAST SURG, V43, P645, DOI 10.1016/0007-1226(90)90184-2
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Rabie ABM, 1997, CONNECT TISSUE RES, V36, P337, DOI 10.3109/03008209709160232
   Rath SN, 2012, J BIOMATER APPL, V27, P277, DOI 10.1177/0885328211402243
   Rath SN, 2011, J MATER SCI-MATER M, V22, P1279, DOI 10.1007/s10856-011-4300-0
   Ren LL, 2008, MED HYPOTHESES, V71, P737, DOI 10.1016/j.mehy.2008.06.032
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685
   Sahar DE, 2012, J CRANIOFAC SURG, V23, P913, DOI 10.1097/SCS.0b013e31824e5cd8
   Scherberich A, 2007, STEM CELLS, V25, P1823, DOI 10.1634/stemcells.2007-0124
   Schroeder JW, 2007, OTOLARYNG HEAD NECK, V137, P465, DOI 10.1016/j.otohns.2007.04.027
   SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172/JCI116450
   Soucacos PN, 2006, INJURY, V37, pS41, DOI 10.1016/j.injury.2006.02.040
   Tanaka Y, 2003, PLAST RECONSTR SURG, V112, P1636, DOI 10.1097/01.PRS.0000086140.49022.AB
   Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   Wang Xiang, 2012, Zhonghua Kou Qiang Yi Xue Za Zhi, V47, P544, DOI 10.3760/cma.j.issn.1002-0098.2012.09.009
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Wosnitza M, 2007, DIFFERENTIATION, V75, P12, DOI 10.1111/j.1432-0436.2006.00110.x
   Xu YF, 2008, BRAIN RES, V1239, P49, DOI 10.1016/j.brainres.2008.08.088
   Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609
   Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047
   Zhang X, 2007, COMPOS PART A-APPL S, V38, P843, DOI 10.1016/j.compositesa.2006.08.002
   Zhu W, 2012, EXPT STUDIES PRP NHA, P16
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 59
TC 12
Z9 12
U1 3
U2 25
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2474
J9 BMC MUSCULOSKEL DIS
JI BMC Musculoskelet. Disord.
PD NOV 8
PY 2013
VL 14
AR 318
DI 10.1186/1471-2474-14-318
PG 14
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 266WJ
UT WOS:000328054300001
PM 24209783
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Shah, N
   Ul-Islam, M
   Khattak, WA
   Park, JK
AF Shah, Nasrullah
   Ul-Islam, Mazhar
   Khattak, Waleed Ahmad
   Park, Joong Kon
TI Overview of bacterial cellulose composites: A multipurpose advanced
   material
SO CARBOHYDRATE POLYMERS
LA English
DT Review
DE Bacterial cellulose composites; Synthetic approaches; Classification;
   Applications
ID GLUCONACETOBACTER-XYLINUS STRAIN; BATCH CULTIVATION STRATEGY;
   ROTATING-DISK BIOREACTOR; IN-SITU; BIOMEDICAL APPLICATIONS; MICROBIAL
   CELLULOSE; NANOCOMPOSITE FILMS; RACEMIC PROPRANOLOL; AGRICULTURAL WASTE;
   IMPRINTED POLYMER
AB Bacterial cellulose (BC) has received substantial interest owing to its unique structural features and impressive physico-mechanical properties. BC has a variety of applications in biomedical fields, including use as biomaterial for artificial skin, artificial blood vessels, vascular grafts, scaffolds for tissue engineering, and wound dressing. However, pristine BC lacks certain properties, which limits its applications in various fields; therefore, synthesis of BC composites has been conducted to address these limitations. A variety of BC composite synthetic strategies have been developed based on the nature and relevant applications of the combined materials. BC composites are primarily synthesized through in situ addition of reinforcement materials to BC synthetic media or the ex situ penetration of such materials into BC microfibrils. Polymer blending and solution mixing are less frequently used synthetic approaches. BC composites have been synthesized using numerous materials ranging from organic polymers to inorganic nanoparticles. In medical fields, these composites are used for tissue regeneration, healing of deep wounds, enzyme immobilization, and synthesis of medical devices that could replace cardiovascular and other connective tissues. Various electrical products, including biosensors, biocatalysts, E-papers, display devices, electrical instruments, and optoelectronic devices, are prepared from BC composites with conductive materials. In this review, we compiled various synthetic approaches for BC composite synthesis, classes of BC composites, and applications of BC composites. This study will increase interest in BC composites and the development of new ideas in this field. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Shah, Nasrullah; Ul-Islam, Mazhar; Khattak, Waleed Ahmad; Park, Joong Kon] Kyungpook Natl Univ, Dept Chem Engn, Taegu 702701, South Korea.
   [Shah, Nasrullah] Abdul Wali Khan Univ, Dept Chem, Mardan, Pakistan.
RP Park, JK (reprint author), Kyungpook Natl Univ, Dept Chem Engn, Taegu 702701, South Korea.
EM parkjk@knu.ac.kr
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science and Technology [NRF-2010-0012672]
FX This work was supported by Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education, Science and Technology (NRF-2010-0012672).
CR Ai H, 2012, FOOD CHEM, V132, P493, DOI 10.1016/j.foodchem.2011.11.033
   Ashori A, 2012, CARBOHYD POLYM, V90, P413, DOI 10.1016/j.carbpol.2012.05.060
   Bae S, 2004, BIOTECHNOL PROGR, V20, P1366, DOI 10.1021/bp0498490
   Bae S, 2004, J BIOSCI BIOENG, V97, P33
   Basta AH, 2009, J APPL MICROBIOL, V107, P2098, DOI 10.1111/j.1365-2672.2009.04467.x
   Berry V, 2005, J AM CHEM SOC, V127, P17600, DOI 10.1021/ja056428l
   Bloor D, 2005, J PHYS D APPL PHYS, V38, P2851, DOI 10.1088/0022-3727/38/16/018
   Bodhibukkana C, 2006, J CONTROL RELEASE, V113, P43, DOI 10.1016/j.jconrel.2006.03.007
   BORZANI W, 1995, BIOTECHNOL LETT, V17, P1271, DOI 10.1007/BF00128400
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   CANNON RE, 1991, CRIT REV MICROBIOL, V17, P435, DOI 10.3109/10408419109115207
   Castro C, 2012, CARBOHYD POLYM, V89, P1033, DOI 10.1016/j.carbpol.2012.03.045
   Cavka A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-25
   Chen HH, 2011, CELLULOSE, V18, P1573, DOI 10.1007/s10570-011-9594-z
   Chen Y, 2011, POLYMER, V52, P481, DOI 10.1016/j.polymer.2010.11.034
   Cheng KC, 2011, BIOMACROMOLECULES, V12, P730, DOI 10.1021/bm101363t
   Cheng Kuan-Chen, 2009, J Biol Eng, V3, P12, DOI 10.1186/1754-1611-3-12
   Choi YJ, 2004, J CHEM TECHNOL BIOT, V79, P79, DOI 10.1002/jctb.942
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Dahman Y, 2009, J NANOSCI NANOTECHNO, V9, P5105, DOI 10.1166/jnn.2009.1466
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   Emami-Razavi SH, 2006, ACTA MED IRAN, V44, P235
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Evans BR, 2003, BIOSENS BIOELECTRON, V18, P917, DOI 10.1016/S0956-5663(02)00212-9
   Feng YY, 2012, CARBOHYD POLYM, V87, P644, DOI 10.1016/j.carbpol.2011.08.039
   Finkenstadt VL, 2005, APPL MICROBIOL BIOT, V67, P735, DOI 10.1007/s00253-005-1931-4
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Gao FG, 2004, MATER TODAY, V7, P50, DOI 10.1016/S1369-7021(04)00509-7
   Gao QY, 2011, CARBOHYD POLYM, V83, P1253, DOI 10.1016/j.carbpol.2010.09.029
   Giannelis EP, 1999, ADV POLYM SCI, V138, P107
   Gutierrez J, 2012, J COLLOID INTERF SCI, V377, P88, DOI 10.1016/j.jcis.2012.03.075
   Ha JH, 2008, KOREAN J CHEM ENG, V25, P812, DOI 10.1007/s11814-008-0134-y
   Ha JH, 2011, PROCESS BIOCHEM, V46, P1717, DOI 10.1016/j.procbio.2011.05.024
   Haydel SE, 2008, J ANTIMICROB CHEMOTH, V61, P353, DOI 10.1093/jac/dkm468
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Hong F, 2012, BIORESOURCE TECHNOL, V104, P503, DOI 10.1016/j.biortech.2011.11.028
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Horii F, 1997, MACROMOL SYMP, V120, P197, DOI 10.1002/masy.19971200120
   Hornung M, 2006, ENG LIFE SCI, V6, P546, DOI 10.1002/elsc.200620163
   Hu WL, 2011, J PHYS CHEM B, V115, P8453, DOI 10.1021/jp204422v
   Hungund B. S., 2010, J MICROBIAL BIOCH TE, V2, P127, DOI DOI 10.4172/1948-5948.1000037
   Ifuku S, 2007, BIOMACROMOLECULES, V8, P1973, DOI 10.1021/bm070113b
   Islam Md. S., 2011, INT J BASIC APPL SCI, V11, P59
   Jantarat C, 2008, INT J PHARM, V349, P212, DOI 10.1016/j.ijpharm.2007.07.030
   Jeon JH, 2010, SENSOR ACTUAT B-CHEM, V146, P307, DOI 10.1016/j.snb.2010.02.046
   Katepetch C, 2011, CARBOHYD POLYM, V86, P162, DOI 10.1016/j.carbpol.2011.04.024
   Keshk S, 2006, APPL MICROBIOL BIOT, V72, P291, DOI 10.1007/s00253-005-0265-6
   Kim J, 2002, SMART MATER STRUCT, V11, P355, DOI 10.1088/0964-1726/11/3/305
   Kim J, 2010, J NANOTECHNOL ENG ME, V1, DOI DOI 10.1115/1.4000062
   Kim J, 2011, J POLYM RES, V18, P739, DOI 10.1007/s10965-010-9470-9
   Kim SY, 2006, APPL BIOCHEM BIOTECH, V131, P705, DOI 10.1385/ABAB:131:1:705
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kojima Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1585, DOI 10.1271/bbb.61.1585
   Kongruang S, 2008, APPL BIOCHEM BIOTECH, V148, P245, DOI 10.1007/s12010-007-8119-6
   Kurosumi A, 2009, CARBOHYD POLYM, V76, P333, DOI 10.1016/j.carbpol.2008.11.009
   Kuure-Kinsey M, 2005, P AMER CONTR CONF, P3259, DOI 10.1109/ACC.2005.1470474
   Laszkiewicz B, 1998, J APPL POLYM SCI, V67, P1871
   Lee BH, 2012, CURR APPL PHYS, V12, P75, DOI 10.1016/j.cap.2011.04.045
   Legnani C, 2008, THIN SOLID FILMS, V517, P1016, DOI 10.1016/j.tsf.2008.06.011
   Leszczynska A, 2007, THERMOCHIM ACTA, V453, P75, DOI 10.1016/j.tca.2006.11.002
   Li SM, 2010, CARBOHYD POLYM, V80, P270, DOI 10.1016/j.carbpol.2009.11.024
   Lin WC, 2013, CARBOHYD POLYM, V94, P603, DOI 10.1016/j.carbpol.2013.01.076
   Lindman B, 2010, J MOL LIQ, V156, P76, DOI 10.1016/j.molliq.2010.04.016
   Liu H, 2010, CARBOHYD POLYM, V83, P1591
   Lu XK, 2011, CARBOHYD POLYM, V86, P239, DOI 10.1016/j.carbpol.2011.04.042
   Luo HL, 2008, MATER CHEM PHYS, V110, P193, DOI 10.1016/j.matchemphys.2008.01.040
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Maria LCS, 2010, POLIMEROS, V20, P72, DOI 10.1590/S0104-14282010005000001
   Meftahi A, 2010, CELLULOSE, V17, P199, DOI 10.1007/s10570-009-9377-y
   Meng N, 2009, APPL CLAY SCI, V42, P667, DOI 10.1016/j.clay.2008.06.016
   Mikkelsen D, 2009, J APPL MICROBIOL, V107, P576, DOI 10.1111/j.1365-2672.2009.04226.x
   Million LE, 2008, J BIOMED MATER RES B, V86B, P444, DOI 10.1002/jbm.b.31040
   Moosavi-Nasab M, 2011, IRAN J BIOTECHNOL, V9, P94
   Mormino R, 2003, APPL MICROBIOL BIOT, V62, P503, DOI 10.1007/s00253-003-1377-5
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   Nogi M, 2005, APPL PHYS LETT, V87, DOI DOI 10.HTTP://DX.D0I.0RG/10.1063/1.2146056
   Okahisa Y, 2009, COMPOS SCI TECHNOL, V69, P1958, DOI 10.1016/j.compscitech.2009.04.017
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Park JK, 2003, BIOTECHNOL LETT, V25, P2055, DOI 10.1023/B:BILE.0000007065.63682.18
   Pinto RJB, 2007, J COLLOID INTERF SCI, V312, P506, DOI 10.1016/j.jcis.2007.03.043
   Qian L., 2004, J TEXT APPAREL TECHN, V4, P1
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Ruka DR, 2013, CARBOHYD POLYM, V92, P1717, DOI 10.1016/j.carbpol.2012.11.007
   Saibuatong OA, 2010, CARBOHYD POLYM, V79, P455, DOI 10.1016/j.carbpol.2009.08.039
   Serafica G, 2002, APPL MICROBIOL BIOT, V58, P756, DOI 10.1007/s00253-002-0978-8
   Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6
   Shah N, 2010, BIOTECHNOL BIOPROC E, V15, P110, DOI [10.1007/s12257-009-3064-6, 10.1007/S12257-009-3064-6]
   Shezad O, 2010, CARBOHYD POLYM, V82, P173, DOI 10.1016/j.carbpol.2010.04.052
   Shezad O, 2009, KOREAN J CHEM ENG, V26, P1689, DOI 10.1007/s11814-009-0232-5
   Shi ZJ, 2012, RSC ADV, V2, P1040, DOI 10.1039/c1ra00719j
   Small AC, 2009, J COLLOID INTERF SCI, V331, P122, DOI 10.1016/j.jcis.2008.11.038
   Sourty E, 1998, CELLULOSE, V5, P5, DOI 10.1023/A:1009207027869
   Sun DP, 2010, NANOSCALE, V2, P287, DOI 10.1039/b9nr00158a
   Sureshkumar M, 2010, J MATER CHEM, V20, P6948, DOI 10.1039/c0jm00565g
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tang WH, 2010, WORLD J MICROB BIOT, V26, P125, DOI 10.1007/s11274-009-0151-y
   Ul-Islam M, 2013, CELLULOSE, V20, P589, DOI 10.1007/s10570-012-9849-3
   Ul-Islam M, 2012, CARBOHYD POLYM, V89, P1189, DOI 10.1016/j.carbpol.2012.03.093
   Ul-Islam M, 2012, CARBOHYD POLYM, V88, P596, DOI 10.1016/j.carbpol.2012.01.006
   Ul-Islam M, 2011, KOREAN J CHEM ENG, V28, P1736, DOI 10.1007/s11814-011-0042-4
   Vandamme E. J., 1998, BIOPOLYMERS, P37
   Vitta S, 2012, CURR SCI INDIA, V102, P1398
   Nguyen VT, 2008, CURR MICROBIOL, V57, P449, DOI 10.1007/s00284-008-9228-3
   Wan WK, 2006, ACS SYM SER, V938, P221
   Yan ZY, 2008, CARBOHYD POLYM, V74, P659, DOI 10.1016/j.carbpol.2008.04.028
   Yang G, 2012, CARBOHYD POLYM, V87, P2482, DOI 10.1016/j.carbpol.2011.11.017
   Yang JZ, 2009, ELECTROCHIM ACTA, V54, P6300, DOI 10.1016/j.electacta.2009.05.073
   Yano S, 2008, CELLULOSE, V15, P111, DOI 10.1007/s10570-007-9152-x
   Yoon SH, 2006, BIOMACROMOLECULES, V7, P1280, DOI 10.1021/bm050597g
   Yoshino T, 1996, J FERMENT BIOENG, V81, P32, DOI 10.1016/0922-338X(96)83116-3
   Zhang S, 2011, J ENG FIBER FABR, V6, P69
   Zhang TJ, 2010, ADV FUNCT MATER, V20, P1152, DOI 10.1002/adfm.200902104
NR 114
TC 174
Z9 186
U1 48
U2 696
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD NOV 6
PY 2013
VL 98
IS 2
BP 1585
EP 1598
DI 10.1016/j.carbpol.2013.08.018
PG 14
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 243JV
UT WOS:000326313600045
PM 24053844
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Zhang, H
   Wang, JK
   Wang, R
   Dong, YC
AF Zhang, Hao
   Wang, Jian-kun
   Wang, Rui
   Dong, Yong-chun
TI Microwave irradiated synthesis of grafted cationic starch: Synthesis,
   characterization, application, and biodegradation
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE grafting; irradiation; properties and characterization; applications;
   biodegradable
ID STARCH-G-POLY(ACRYLIC ACID); FILM PROPERTIES; CORN STARCH; COPOLYMERS;
   EFFICIENCY; ADHESION
AB A biodegradable copolymer was synthesized by grafting copolymerization of acrylamide, -hydroxyethyl methacrylate, and n-butyl acrylate onto corn cationic starch (CS) by microwave irradiation. The grafted cationic starch (GCS) was characterized by Fourier-transform infrared spectroscopy, scanning electron microscopy, and X-ray diffraction. The optimum conditions on graft copolymerization with respect to reaction temperature, exposure time, and initiator concentration were investigated. Physicochemical properties of GCS, such as swelling power, solubility, intrinsic viscosity, and apparent viscosity, were studied, and its application performances as textile sizing agent were tested. Results showed that compared with CS, physicochemical properties of GCS were significantly improved, including decreased crystallinity, weakened granular, increased hydration capacity, and rheological property. Polyester/cotton blended yarns sized with GCS obtained more reinforced mechanical properties than samples sized with CS and exhibited higher tensile strength and abrasion resistance than polyvinyl alcohol (PVA) sized yarns. The mechanisms that the starch physicochemical properties affected on the sizing performances were discussed as well. Biodegradation analysis on these sizing agents showed that BOD5/CODcr of GCS was 0.263, which outclasses that of PVA (BOD5/CODcr=0.009). This novel biomaterial could be expected to have promising applications especially in textile industry and be an ideal substitute for PVA. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 130: 1645-1652, 2013
C1 [Zhang, Hao; Wang, Jian-kun; Wang, Rui; Dong, Yong-chun] Tianjin Polytech Univ, Sch Text, Tianjin, Peoples R China.
   [Zhang, Hao; Wang, Jian-kun; Wang, Rui] Tianjin Polytech Univ, Minist Educ, Key Lab Adv Text Composites, Tianjin, Peoples R China.
RP Wang, JK (reprint author), Tianjin Polytech Univ, Sch Text, Tianjin, Peoples R China.
EM jiankunwang2010@163.com
FU National Natural Science Foundation of China [20773093]; Tianjin Natural
   Science Foundation [08JCYBJC11400]
FX This work was sponsored by the National Natural Science Foundation of
   China (contract grant number 20773093) and the Tianjin Natural Science
   Foundation (contract grant number 08JCYBJC11400).
CR Athawale VD, 2000, CARBOHYD POLYM, V41, P407, DOI 10.1016/S0144-8617(99)00101-0
   Ben D. P., 2009, TEXT AUX, V26, P39
   Celik M, 2006, J POLYM RES, V13, P427, DOI 10.1007/s10965-006-9063-9
   Fares MM, 2010, J THERM ANAL CALORIM, V99, P659, DOI 10.1007/s10973-009-0213-2
   Han DW, 2011, J APPL POLYM SCI, V121, P1481, DOI 10.1002/app.33672
   Han F, 2012, INT J BIOL MACROMOL, V50, P1026, DOI 10.1016/j.ijbiomac.2012.02.030
   Hebeish A, 2005, STARCH-STARKE, V57, P616, DOI 10.1002/star.200400388
   Hebeish A, 2008, STARCH-STARKE, V60, P97, DOI 10.1002/star.200700627
   Lanthong P, 2006, CARBOHYD POLYM, V66, P229, DOI 10.1016/j.carbpol.2006.03.006
   Li ML, 2011, STARCH-STARKE, V63, P683, DOI 10.1002/star.201100002
   LINDEMANN MK, 1989, TEXT CHEM COLOR, V21, P21
   Lv XH, 2013, CARBOHYD POLYM, V92, P388, DOI 10.1016/j.carbpol.2012.10.002
   Malton S, 1998, APPITA J, V51, P292
   Meshram MW, 2009, CARBOHYD POLYM, V75, P71, DOI 10.1016/j.carbpol.2008.06.012
   Mostafa KM, 2010, J POLYM RES, V17, P789, DOI 10.1007/s10965-009-9370-z
   [宁芯 NING Xin], 2009, [华中农业大学学报, Journal of Huazhong Agricultural University], V28, P369
   Pal S, 2005, CARBOHYD POLYM, V59, P417, DOI 10.1016/j.carbpol.2004.06.047
   Singh AV, 2011, STARCH-STARKE, V63, P523, DOI 10.1002/star.201100012
   Singh V, 2006, STARCH-STARKE, V58, P536, DOI 10.1002/star.200600520
   Singh V, 2010, INT J BIOL MACROMOL, V47, P348, DOI 10.1016/j.ijbiomac.2010.05.023
   Wang J. K., 2010, J MATER RES, V24, P348
   Zhang B., 2005, THESIS DONGHUA U
   Zhang B, 2008, POLYM COMPOSITE, V29, P506, DOI 10.1002/pc.20430
   Zhu Z. F., 2001, CHEM WORLD, V1, P24
   Zhu ZF, 2007, FIBRES TEXT EAST EUR, V15, P82
   Zhu ZF, 2012, STARCH-STARKE, V64, P704, DOI 10.1002/star.201100203
   Zhu ZF, 2009, J APPL POLYM SCI, V112, P2822, DOI 10.1002/app.29621
NR 27
TC 4
Z9 7
U1 5
U2 64
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 5
PY 2013
VL 130
IS 3
BP 1645
EP 1652
DI 10.1002/app.39310
PG 8
WC Polymer Science
SC Polymer Science
GA 197SR
UT WOS:000322871700026
DA 2018-10-20
ER

PT J
AU Jong, L
AF Jong, Lei
TI Natural rubber protein as interfacial enhancement for bio-based
   nano-fillers
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE rubber; mechanical properties; biomaterial; viscoelasticity
ID NONLINEAR VISCOELASTIC BEHAVIOR; STYRENE-BUTADIENE RUBBER;
   MECHANICAL-PROPERTIES; MOLECULAR-WEIGHT; REINFORCEMENT; COMPOSITES;
   ELASTOMER; NANOCOMPOSITES; NANOCRYSTALS; STARCH
AB Natural rubber was enhanced with soy protein nano-aggregates and carbon black using a hybrid process. The rubber composites reinforced with an optimum amount of soy protein or soy protein/carbon black showed useful tensile properties. The stress-strain behaviors were analyzed with a micro-mechanical model that describes the stress-strain measurements well. The model analysis provides insight into filler network characteristics and entanglement modulus. The composites were also analyzed with both linear and nonlinear viscoelastic properties. Temperature and frequency dependent modulus as well as the model analysis of stress softening effect describe the ability of soy protein to constraint polymer chains in the highly filled composites. For the composites reinforced with soy protein, the good tensile properties are attributed to good filler-polymer adhesion through the compatibilization effect of natural rubber protein. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 130: 2188-2197, 2013
C1 USDA ARS, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL 61604 USA.
RP Jong, L (reprint author), USDA ARS, Natl Ctr Agr Utilizat Res, USDA, 1815 N Univ St, Peoria, IL 61604 USA.
EM lei.jong@ars.usda.gov
CR Angellier H, 2005, MACROMOLECULES, V38, P3783, DOI 10.1021/ma050054z
   Archer B.L., 1963, CHEM PHYS RUBBER LIK
   BADLEY RA, 1975, BIOCHIM BIOPHYS ACTA, V412, P214, DOI 10.1016/0005-2795(75)90036-7
   Bateman L, 1963, CHEM PHYS RUBBER LIK
   Cao XD, 2007, BIOMACROMOLECULES, V8, P899, DOI 10.1021/bm0610368
   Favier F., 1995, MACROMOLECULES, V28, P6365
   FETTERS LJ, 1994, MACROMOLECULES, V27, P4639, DOI 10.1021/ma00095a001
   Gauthier C, 2004, POLYMER, V45, P2761, DOI 10.1016/j.polymer.2003.12.081
   Gregg C. E., 1973, RUBBER CHEM TECHNOL, V46, P47
   Greve H-H, 2000, ULLMANNS ENCY IND CH
   Guth E, 1938, PHYS REV, V53, P322
   Heinrich G, 2002, CURR OPIN SOLID ST M, V6, P195, DOI 10.1016/S1359-0286(02)00030-X
   Jong L, 2005, POLYM INT, V54, P1572, DOI 10.1002/pi.1886
   Jong L, 2005, J APPL POLYM SCI, V98, P353, DOI 10.1002/app.22094
   Jouault N, 2009, MACROMOLECULES, V42, P2031, DOI 10.1021/ma801908u
   Kluppel M, 2000, MACROMOL THEOR SIMUL, V9, P742
   KLUPPEL M, 1995, RUBBER CHEM TECHNOL, V68, P623
   Kraus G., 1984, J APPL POLYM SCI, V39, P75
   Kurup VP, 1996, INT ARCH ALLERGY IMM, V109, P58, DOI 10.1159/000237232
   Leblanc JL, 2002, PROG POLYM SCI, V27, P627, DOI 10.1016/S0079-6700(01)00040-5
   Litvinov VM, 1999, MACROMOLECULES, V32, P8476, DOI 10.1021/ma9910080
   LU FJ, 1987, RUBBER CHEM TECHNOL, V60, P647, DOI 10.5254/1.3536148
   Lyon F, 1985, ENCY POLYM SCI ENG
   Maier PG, 1996, KAUT GUMMI KUNSTST, V49, P18
   Mark J. E., 1988, RUBBER ELASTICITY MO
   Meera AP, 2009, J PHYS CHEM C, V113, P17997, DOI 10.1021/jp9020118
   Merabia S, 2008, MACROMOLECULES, V41, P8252, DOI 10.1021/ma8014728
   Posch A, 1997, J ALLERGY CLIN IMMUN, V99, P385, DOI 10.1016/S0091-6749(97)70057-5
   Qi GY, 2011, J AGR FOOD CHEM, V59, P9958, DOI 10.1021/jf201077b
   Qi Q, 2006, POLYMER, V47, P3896, DOI 10.1016/j.polymer.2006.03.095
   Roberts AD, 1963, NATURAL RUBBER SCI T
   Stockelhuber KW, 2011, MACROMOLECULES, V44, P4366, DOI 10.1021/ma1026077
   Sun J, 2007, J POLYM SCI POL PHYS, V45, P2594, DOI 10.1002/polb.21263
   Takeshi K., 2007, BIMACROMOLECULES, V8, P693
   Tanaka Y, 2001, RUBBER CHEM TECHNOL, V74, P355, DOI 10.5254/1.3547643
   Trabelsi P.A., 2002, MACROMOLECULES, V35, P10054
   Trabelsi P. A., 2003, J MACROMOLECULES, V36, P7624
   Trabelsi P.A., 2003, MACROMOLECULES, V36, P9093
   Van der Hoff B. M. E., 1967, J MACROMOL SCI CHEM, V1, P747, DOI 10.1080/10601326708054008
   Vieweg S, 1998, J NON-CRYST SOLIDS, V235, P470, DOI 10.1016/S0022-3093(98)00658-9
   Vilgis T.A., 2009, REINFORCEMENT POLYM
   Wang MJ, 1998, RUBBER CHEM TECHNOL, V71, P520, DOI 10.5254/1.3538492
   WILLIAMS ML, 1955, J AM CHEM SOC, V77, P3701, DOI 10.1021/ja01619a008
   Zhang AQ, 2006, J APPL POLYM SCI, V101, P1763, DOI 10.1002/app.23516
NR 44
TC 8
Z9 8
U1 1
U2 48
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 5
PY 2013
VL 130
IS 3
BP 2188
EP 2197
DI 10.1002/app.39277
PG 10
WC Polymer Science
SC Polymer Science
GA 197SR
UT WOS:000322871700090
DA 2018-10-20
ER

PT J
AU Jeon, WB
AF Jeon, Won Bae
TI Application of elastin-mimetic recombinant proteins in chemotherapeutics
   delivery, cellular engineering, and regenerative medicine
SO BIOENGINEERED
LA English
DT Article
DE elastin-like proteins; extracellular matrix; surface-coatings;
   hydrogels; drug and gene delivery; regenerative medicine
ID CROSS-LINKING; POLYPEPTIDE GELS; TISSUE-REPAIR; STEM-CELLS; IN-VITRO;
   GROWTH; DIFFERENTIATION; BIOPOLYMERS; BEHAVIORS; HYDROGELS
AB With the remarkable increase in the fields of biomedical engineering and regenerative medicine, biomaterial design has become an indispensable approach for developing the biocompatible carriers for drug or gene cargo and extracellular matrix (ECM) for cell survival, proliferation, and differentiation. Native ECM materials derived from animal tissues were believed to be the best choices for tissue engineering. However, possible pathogen contamination by cellular remnants from foreign animal tissues is an unavoidable issue that has limited the use of native ECM for human benefit. Some synthetic polymers have been used as alternative materials for manufacturing native ECM because of the biodegradability and ease of large-scale production of the polymers. However, the inherent polydispersity of the polymers causes batch-to-batch variation in polymer composition and possible cytotoxic interactions between chemical matrices and neighboring cells or tissues have not yet been fully resolved. Elastin-like proteins (ELPs) are genetically engineered biopolymers modeled after the naturally occurring tropoelastin and have emerged as promising materials for biomedical applications because they are biocompatible, non-immunogenic, and biodegradable, and their composition, mechanical stiffness, and even fate within the cell can be controlled at the gene level. This commentary highlights the recent progresses in the development of the ELP-based recombinant proteins that are being increasingly used for the delivery of chemotherapeutics and to provide a cell-friendly ECM environment.
C1 Daegu Gyeongbuk Inst Sci & Technol, Lab Biochem & Cellular Engn, Div NanoBio Technol, Taegu, South Korea.
RP Jeon, WB (reprint author), Daegu Gyeongbuk Inst Sci & Technol, Lab Biochem & Cellular Engn, Div NanoBio Technol, Taegu, South Korea.
EM wbjeon@dgist.ac.kr
FU Biodefense Program Fund from the Ministry of Education, Science and
   Technology of the Republic of Korea [13-NB-04]
FX This study was supported by the Biodefense Program Fund (Project No.
   13-NB-04) to WBJ from the Ministry of Education, Science and Technology
   of the Republic of Korea.
CR Bandiera A, 2011, ENZYME MICROB TECH, V49, P347, DOI 10.1016/j.enzmictec.2011.06.012
   Barbosa JS, 2009, NANOSCALE RES LETT, V4, P1247, DOI 10.1007/s11671-009-9388-5
   Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bidwell GL, 2007, INVEST NEW DRUG, V25, P313, DOI 10.1007/s10637-007-9053-8
   Bidwell GL, 2012, CANCER LETT, V319, P136, DOI 10.1016/j.canlet.2011.12.042
   Bozzini S, 2011, J MATER SCI-MATER M, V22, P2641, DOI 10.1007/s10856-011-4451-z
   Rodriguez-Cabello JC, 2011, ADV BIOCHEM ENG BIOT, V125, P145, DOI 10.1007/10_2010_94
   Chen THH, 2008, PHARM RES, V25, P683, DOI 10.1007/s11095-007-9382-5
   Chen Y, 2011, J CONTROL RELEASE, V155, P175, DOI 10.1016/j.jconrel.2011.07.040
   Chung C, 2012, SOFT MATTER, V8, P10141, DOI 10.1039/c2sm26082d
   Ciofani G, 2012, ACTA BIOMATER, V9, P5111
   Costa RR, 2011, SMALL, V7, P2640, DOI 10.1002/smll.201100875
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119
   Hrabchak C, 2010, ACTA BIOMATER, V6, P2108, DOI 10.1016/j.actbio.2009.12.034
   Janorkar AV, 2008, BIOMATERIALS, V29, P625, DOI 10.1016/j.biomaterials.2007.10.022
   Janorkar AV, 2011, BIOTECHNOL BIOENG, V108, P1171, DOI 10.1002/bit.23025
   Jeon WB, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-61
   Jeon WB, 2011, J BIOMED MATER RES A, V97A, P152, DOI 10.1002/jbm.a.33041
   Jung GS, 2013, BMB REPORTS IN PRESS
   Kolbe A, 2011, MACROMOL RAPID COMM, V32, P186, DOI 10.1002/marc.201000491
   Krishna UM, 2012, ACTA BIOMATER, V8, P988, DOI 10.1016/j.actbio.2011.11.024
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   Lee KM, 2013, ACTA BIOMATER, V9, P5600, DOI 10.1016/j.actbio.2012.10.036
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Liu WG, 2010, J CONTROL RELEASE, V144, P2, DOI 10.1016/j.jconrel.2010.01.032
   Liu Y, 2011, MED HYPOTHESES, V76, P239, DOI 10.1016/j.mehy.2010.10.007
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Minato A, 2012, BIOMATERIALS, V33, P515, DOI 10.1016/j.biomaterials.2011.09.070
   Nettles DL, 2008, TISSUE ENG PT A, V14, P1133, DOI [10.1089/ten.tea.2007.0245, 10.1089/tea.2007.0245]
   Nettles DL, 2010, ADV DRUG DELIVER REV, V62, P1479, DOI 10.1016/j.addr.2010.04.002
   Raphel J, 2012, J MATER CHEM, V22, P19429, DOI 10.1039/c2jm31768k
   Serrano V, 2007, BIOPHYS J, V93, P2429, DOI 10.1529/biophysj.106.100594
   Shamji MF, 2008, J CONTROL RELEASE, V129, P179, DOI 10.1016/j.jconrel.2008.04.021
   Simnick AJ, 2011, J CONTROL RELEASE, V155, P144, DOI 10.1016/j.jconrel.2011.06.044
   Srivastava GK, 2011, J BIOMED MATER RES A, V97A, P243, DOI 10.1002/jbm.a.33050
   Straley Karin S, 2009, Front Neuroeng, V2, P9, DOI 10.3389/neuro.16.009.2009
   Sun GY, 2011, J CONTROL RELEASE, V155, P218, DOI 10.1016/j.jconrel.2011.06.010
   Swierczewska M, 2008, ACTA BIOMATER, V4, P827, DOI 10.1016/j.actbio.2007.11.004
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Xu DH, 2012, BIOMACROMOLECULES, V13, P2315, DOI 10.1021/bm300760s
NR 42
TC 7
Z9 7
U1 1
U2 12
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 2165-5979
EI 2165-5987
J9 BIOENGINEERED
JI Bioengineered
PD NOV-DEC
PY 2013
VL 4
IS 6
BP 368
EP 373
DI 10.4161/bioe.24158
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AI5KN
UT WOS:000336905300011
PM 23475122
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Otagiri, D
   Yamada, Y
   Hozumi, K
   Katagiri, F
   Kikkawa, Y
   Nomizu, M
AF Otagiri, Dai
   Yamada, Yuji
   Hozumi, Kentaro
   Katagiri, Fumihiko
   Kikkawa, Yamato
   Nomizu, Motoyoshi
TI Cell Attachment and Spreading Activity of Mixed Laminin Peptide-Chitosan
   Membranes
SO BIOPOLYMERS
LA English
DT Article
DE laminin peptide; cell attachment; chitosan; syndecan; integrin
ID HEPARAN-SULFATE CHAINS; ALPHA-1 CHAIN; G-DOMAIN; SYNTHETIC PEPTIDES;
   GLOBULAR DOMAIN; BIOLOGICAL-ACTIVITIES; EXTRACELLULAR-MATRIX; BINDING
   SEQUENCES; NEURITE OUTGROWTH; BASEMENT-MEMBRANE
AB Laminins are a multifunctional molecule with numerous active sites that have been identified in short peptide sequences. Mixed peptide-conjugated chitosan membranes using laminin-derived active peptides have been previously demonstrated to be useful as a biomaterial for tissue engineering. In this study, two syndecan-binding peptides, AG73 (RKRLQVQLSIRT) and C16 (KAFDITYVRLKF), and three integrin-binding peptides, EF1zz (ATLQLQEGRLHFXFDLGKGR, X: Nle, binding to integrin alpha 2 beta 1), A99a (ALRGDN, binding to integrin alpha v beta 3), and A2G10 (SYWYRIEASRTG, binding to integrin alpha 6 beta 1), were mixed in various combinations, conjugated to chitosan membranes, and evaluated for their cell attachment and spreading activities. The cell attachment and spreading activity of EF1zz, A99a, and A2G10 were enhanced by AG73. In contrast, C16 enhanced only the cell attachment and spreading activity of A99a and did not influence the activity of EF1zz and A2G10. As well as previous study, the AG73-chitosan membrane bound to only syndecan. On the other hand, the C16-chitosan membrane interacted with both syndecan and beta 1 integrin. These data suggest that interaction of different receptors can cause synergistic effects. Therefore, AG73 is widely applicable as a synergistic agent for mixed peptide-matrices using several types of integrin-binding peptides. Additionally, the A2G10/AG73-chitosan membrane may be useful to investigate detailed biological functions of a6b1 integrin, which is a major laminin-binding receptor. Using a combination of tissueappropriate laminin-derived peptides, the mixed peptide-chitosan membranes may serve as functional biomaterials for tissue engineering. (C) 2013 Wiley Periodicals, Inc.
C1 [Otagiri, Dai; Yamada, Yuji; Hozumi, Kentaro; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Fac Pharm, Hachioji, Tokyo 1920392, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Fac Pharm, Hachioji, Tokyo 1920392, Japan.
EM nomizu@toyaku.ac.jp
RI Kikkawa, Yamato/D-1503-2010
FU Ministry of Education, Cultures, Sports, Science and Technology of Japan
   [22390017]
FX Contract grant sponsor: Ministry of Education, Cultures, Sports, Science
   and Technology of Japan; Contract grant number: 22390017
CR Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3
   BERNIER SM, 1995, MATRIX BIOL, V14, P447, DOI 10.1016/0945-053X(95)90002-0
   Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521
   Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4
   Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200
   Couchman JR, 2001, INT REV CYTOL, V207, P113
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200
   Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200
   Hozumi K, 2012, BIOMATERIALS, V33, P4241, DOI 10.1016/j.biomaterials.2012.02.055
   Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012
   Hozumi K, 2010, FEBS LETT, V584, P3381, DOI 10.1016/j.febslet.2010.06.032
   Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043
   Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k
   Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x
   Kuratomi Y, 2002, BRIT J CANCER, V86, P1169, DOI 10.1038/sj/bjc/6600187
   Kusano Y, 2000, EXP CELL RES, V256, P434, DOI 10.1006/excr.2000.4802
   Lopes CC, 2006, BRAZ J MED BIOL RES, V39, P157, DOI 10.1590/S0100-879X2006000200001
   McLean SM, 2005, BRIT J OPHTHALMOL, V89, P1506, DOI 10.1136/bjo.2005.071886
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Ponce ML, 2001, FASEB J, V15, P1389, DOI 10.1096/fj.00-0736com
   Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995
   Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304
   Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805
   SASAKI M, 1987, J BIOL CHEM, V262, P17111
   SASAKI M, 1988, J BIOL CHEM, V263, P16536
   Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Urushibata S, 2010, ARCH BIOCHEM BIOPHYS, V497, P43, DOI 10.1016/j.abb.2010.03.006
   Urushibata S, 2009, BIOCHEMISTRY-US, V48, P10522, DOI 10.1021/bi901421t
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005
   Weeks BS, 1998, EXP CELL RES, V243, P375, DOI 10.1006/excr.1998.4157
   Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002
   Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4
   Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001
   Yamada Y, 2012, BIOMATERIALS, V33, P4118, DOI 10.1016/j.biomaterials.2012.02.044
   Yamada Y, 2011, CHEM-EUR J, V17, P10500, DOI 10.1002/chem.201101064
   Yamada Y, 2011, BIOMATERIALS, V32, P4327, DOI 10.1016/j.biomaterials.2011.02.052
   Yamada Y, 2010, BIOPOLYMERS, V94, P711, DOI 10.1002/bip.21429
NR 56
TC 4
Z9 4
U1 4
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD NOV
PY 2013
VL 100
IS 6
SI SI
BP 751
EP 759
DI 10.1002/bip.22303
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI0HZ
UT WOS:000336528700022
PM 23893700
DA 2018-10-20
ER

PT J
AU Molino, PJ
   Zhang, BB
   Wallace, GG
   Hanks, TW
AF Molino, Paul J.
   Zhang, BinBin
   Wallace, Gordon G.
   Hanks, Timothy W.
TI Surface modification of polypyrrole/biopolymer composites for controlled
   protein and cellular adhesion
SO BIOFOULING
LA English
DT Article
DE electroactive polymer; polypyrrole; protein adsorption; fibronectin;
   cell adhesion; poly(ethylene glycol)
ID SELF-ASSEMBLED MONOLAYERS; MICHAEL ADDITION-REACTIONS; CONDUCTING
   POLYMERS; NEURAL INTERFACES; OXIDE SURFACES; ADSORPTION; THIOL;
   RESISTANCE; DENSITY; FILMS
AB The ability to control the interaction between proteins and cells with biomaterials is critical for the effective application of materials for a variety of biomedical applications. Herein, the surface modification of the biological dopant dextran sulphate-doped polypyrrole (PPy-DS) with poly(ethylene glycol) to generate a biomaterial interface that is highly resistant to protein and cellular adhesion is described. Thiolated poly(ethylene glycol) (PEG-thiol) was covalently bound to PPy-DS backbone via a thiol-ene reaction. The surface resistance to an extracellular matrix protein fibronectin increased with increasing molecular weight and concentration of PEG-thiol, and was further optimised via increasing the reaction temperature and the pH of the reactant aqueous solution. Optimised surface modification conditions substantially reduced interfacial protein adsorption, with the complete inhibition of adhesion and colonisation by primary mouse myoblasts. PEG-thiol-modified inherently conducting polymers are highly protein resistant multifunctional materials that are promising compounds for a range of biomedical and aquatic applications.
C1 [Molino, Paul J.; Zhang, BinBin; Wallace, Gordon G.; Hanks, Timothy W.] Univ Wollongong, ARC Ctr Excellence Electromat Sci, Intelligent Polymer Res Inst, AIIM Facil, Wollongong, NSW, Australia.
   [Hanks, Timothy W.] Furman Univ, Dept Chem, Greenville, SC 29613 USA.
RP Molino, PJ (reprint author), Univ Wollongong, ARC Ctr Excellence Electromat Sci, Intelligent Polymer Res Inst, AIIM Facil, Wollongong, NSW, Australia.
EM pmolino@uow.edu.au
RI Zhang, Binbin/A-3483-2015; Wallace, Gordon/H-1123-2011
OI Zhang, Binbin/0000-0002-2488-4221; Wallace, Gordon/0000-0002-0381-7273;
   Molino, Paul/0000-0002-8868-2733
FU Australian Research Council; National Health and Medical Research
   Council [573430]; UOW; Australian-American Fulbright Commission
FX The authors gratefully acknowledge the Australian Research Council and
   the National Health and Medical Research Council (Grant No. 573430). PJM
   acknowledges funding support through the Vice Chancellors Fellowship
   award (UOW). TWH thanks the Australian-American Fulbright Commission for
   a scholarship supporting this work. The authors also acknowledge the
   Australian National Nanofabrication Facility (ANFF) for access to
   equipment.
CR Abidian MR, 2009, ADV FUNCT MATER, V19, P573, DOI 10.1002/adfm.200801473
   Aizawa Y, 2012, PROG POLYM SCI, V37, P645, DOI 10.1016/j.progpolymsci.2011.11.004
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Bergman B, 2000, MACROMOLECULES, V33, P8035, DOI 10.1021/ma000659p
   Bixler GD, 2012, PHILOS T R SOC A, V370, P2381, DOI 10.1098/rsta.2011.0502
   Chan JW, 2010, MACROMOLECULES, V43, P6381, DOI 10.1021/ma101069c
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   FORSYTH M, 1995, POLYMER, V36, P725, DOI 10.1016/0032-3861(95)93101-Q
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Gelmi A, 2012, J PHYS CHEM B, V116, P13498, DOI 10.1021/jp302944n
   Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Hanks T, 2005, SYNTHETIC MET, V153, P177, DOI 10.1016/j.synthmet.2005.07.230
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   Heuberger M, 2004, LANGMUIR, V20, P9445, DOI 10.1021/la048324k
   Higgins MJ, 2012, CHEM MATER, V24, P828, DOI 10.1021/cm203138j
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hoyle CE, 2004, J POLYM SCI POL CHEM, V42, P5301, DOI 10.1002/pola.20366
   Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924
   Hsu CF, 2011, POLYM INT, V60, P69, DOI 10.1002/pi.2912
   Khan S, 2010, J BIOMED MATER RES A, V93A, P1209, DOI 10.1002/jbm.a.32698
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Li GZ, 2010, POLYM CHEM-UK, V1, P1196, DOI 10.1039/c0py00100g
   Lowe AB, 2010, POLYM CHEM-UK, V1, P17, DOI 10.1039/b9py00216b
   Luhmann T, 2009, MATERIALS, V2, P1058, DOI 10.3390/ma2031058
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001
   Meyers SR, 2012, CHEM REV, V112, P1615, DOI 10.1021/cr2000916
   Molino PJ, 2012, SYNTHETIC MET, V162, P1464, DOI 10.1016/j.synthmet.2012.06.013
   Molino PJ, 2012, LANGMUIR, V28, P8433, DOI 10.1021/la300692y
   Ngadi N, 2008, INT J CHEM BIOL ENG, V1, P125
   Palacio MLB, 2012, PHILOS T R SOC A, V370, P2321, DOI 10.1098/rsta.2011.0483
   Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y
   PATIL JS, 2010, DIG J NANOMATER BIOS, V5, P8
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ravichandran R, 2010, J R SOC INTERFACE, V7, pS559, DOI 10.1098/rsif.2010.0120.focus
   Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Svirskis D, 2010, J CONTROL RELEASE, V146, P6, DOI 10.1016/j.jconrel.2010.03.023
   Szleifer I, 1997, CURR OPIN SOLID ST M, V2, P337, DOI 10.1016/S1359-0286(97)80125-8
   TENNIELS B, 2008, MACROMOLECULES, V41, P9946
   Thomas CA, 2000, ADV MATER, V12, P222, DOI 10.1002/(SICI)1521-4095(200002)12:3<222::AID-ADMA222>3.0.CO;2-D
   VLADKOVA TG, 2010, INT J POLYM SCI, V33, P1
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
   Zhang NL, 2012, BIRTH DEFECTS RES C, V96, P63, DOI 10.1002/bdrc.21003
NR 48
TC 8
Z9 9
U1 4
U2 44
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
EI 1029-2454
J9 BIOFOULING
JI Biofouling
PD NOV 1
PY 2013
VL 29
IS 10
BP 1155
EP 1167
DI 10.1080/08927014.2013.830110
PG 13
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA AB8JU
UT WOS:000332037000001
PM 24063598
DA 2018-10-20
ER

PT J
AU Muric, B
   Pantelic, D
   Vasiljevic, D
   Zarkov, B
   Jelenkovic, B
   Pantovic, S
   Rosic, M
AF Muric, B.
   Pantelic, D.
   Vasiljevic, D.
   Zarkov, B.
   Jelenkovic, B.
   Pantovic, S.
   Rosic, M.
TI Sensitized gelatin as a versatile biomaterial with tailored mechanical
   and optical properties
SO PHYSICA SCRIPTA
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on the Physics of Optical Materials and
   Devices
CY SEP 02-06, 2012
CL Belgrade, SERBIA
ID HUMAN LENS CAPSULE; CROSS-LINKING; FILMS; MICROLENSES; TOTHEMA; LAYER
AB We have found that gelatin doped with tot'hema (medication used for curing anemia) and eosin becomes elastic, while retaining good optical properties. The mechanical properties of tot'hema-eosin-sensitized gelatin films (TESG) have been investigated for various concentrations of tot'hema (ranging from 5 to 30% v/v). TESG specimens were prepared according to the ASTM standards for elastic materials. Tensile strength, strain at break and Young's modulus were measured. The results show that the extensibility of TESG film increases with increasing tot'hema concentration, while the Young's modulus and stress at break exponentially decrease. Mechanical properties can be tailored to suit various biomedical applications such as blood vessels, human lens capsules and biosensors based on microlenses. Tunable (strain responsive) TESG microlenses were produced and a mechanical model of blood vessels was prepared.
C1 [Muric, B.; Pantelic, D.; Vasiljevic, D.; Zarkov, B.; Jelenkovic, B.] Univ Belgrade, Inst Phys, Zemun, Serbia.
   [Pantovic, S.; Rosic, M.] Univ Kragujevac, Fac Med, Inst Physiol, Kragujevac, Serbia.
RP Muric, B (reprint author), Univ Belgrade, Inst Phys, Pregrevica 118, Zemun, Serbia.
EM muric@ipb.ac.rs
FU Ministry of Education and Science of the Republic of Serbia [ON171038,
   III45016]
FX This paper was written as a part of research on projects ON171038 and
   III45016 supported by the Ministry of Education and Science of the
   Republic of Serbia.
CR [Anonymous], 5273 BS EN ISO
   Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339
   Bigi A, 2004, BIOMATERIALS, V25, P5675, DOI 10.1016/j.biomaterials.2004.01.033
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Bigi A, 1998, BIOMATERIALS, V19, P2335, DOI 10.1016/S0142-9612(98)00149-5
   Cao N, 2009, FOOD HYDROCOLLOID, V23, P729, DOI 10.1016/j.foodhyd.2008.07.017
   FISHER RF, 1969, J PHYSIOL-LONDON, V201, P1
   Hiss K, 2006, LAB ANIM-UK, V40, P80, DOI 10.1258/002367706775404372
   Khanafer K, 2009, BIOMED MICRODEVICES, V11, P503, DOI 10.1007/s10544-008-9256-6
   Kim JS, 2006, ANGEW CHEM INT EDIT, V45, P1446, DOI 10.1002/anie.200503102
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Krag S, 2003, PROG RETIN EYE RES, V22, P749, DOI 10.1016/S1350-9462(03)00063-6
   Muric B, 2008, OPT MATER, V30, P1217, DOI 10.1016/j.optmat.2007.05.051
   Muric B, 2009, APPL OPTICS, V48, P3854, DOI 10.1364/AO.48.003854
   Muric BD, 2007, APPL OPTICS, V46, P8527, DOI 10.1364/AO.46.008527
   Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030
   Salsa T, 1996, APPL SPECTROSC, V50, P1314, DOI 10.1366/0003702963904881
   Veis A, 1964, MACROMOLEUCLAR CHEM, P164
   Williams C, 2009, ACTA BIOMATER, V5, P993, DOI 10.1016/j.actbio.2008.11.028
NR 20
TC 1
Z9 1
U1 1
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0031-8949
EI 1402-4896
J9 PHYS SCRIPTA
JI Phys. Scr.
PD NOV
PY 2013
VL T157
AR 014018
DI 10.1088/0031-8949/2013/T157/014018
PG 4
WC Physics, Multidisciplinary
SC Physics
GA AC4QA
UT WOS:000332504600019
DA 2018-10-20
ER

PT J
AU Tavakol, S
   Khoshzaban, A
   Azami, M
   Kashani, IR
   Tavakol, H
   Yazdanifar, M
   Sorkhabadi, SMR
AF Tavakol, Shima
   Khoshzaban, Ahad
   Azami, Mahmoud
   Kashani, Iraj Ragerdi
   Tavakol, Hani
   Yazdanifar, Mahbube
   Sorkhabadi, Seyed Mahdi Rezayat
TI The Effect of Carrier Type on Bone Regeneration of Demineralized Bone
   Matrix In Vivo
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Demineralized bone matrix gel; bone; bone regeneration; carrier;
   albumin; carboxymethyl cellulose
ID FREEZE-DRIED BONE; MORPHOGENETIC PROTEIN; CALVARIAL DEFECTS; GRAFT
   SUBSTITUTES; OSTEOINDUCTIVITY; RECONSTRUCTION; REPAIR; MODEL;
   DIFFERENTIATION; IMPLANTATION
AB Demineralized bone matrix (DBM) is a bone substitute biomaterial used as an excellent grafting material. Some factors such as carrier type might affect the healing potential of this material. The background data discuss the present status of the field: Albumin as a main protein in blood and carboxymethyl cellulose (CMC) were applied frequently in the DBM gels. We investigated the bone-repairing properties of 2 DBMs with different carriers. Bone regeneration in 3 groups of rat calvaria treated with DBM from the Iranian Tissue Bank Research and Preparation Center, DBM from Hans Biomed Corporation, and an empty cavity was studied. Albumin and CMC as carriers were used. The results of bone regeneration in the samples after 1, 4, and 8 weeks of implantation were compared. The block of the histologic samples was stained with hematoxylin and eosin, and the percentage area of bone formation was calculated using the histomorphometry method. The results of in vivo tests showed a significantly stronger new regenerated bone occupation in the DBM with albumin carrier compared with the one with CMC 8 weeks after the implantation. The 2 types of DBM had a significant difference in bone regeneration. This difference is attributed to the type of carriers. Albumin could improve mineralization and bioactivity compared with CMC.
C1 [Tavakol, Shima; Sorkhabadi, Seyed Mahdi Rezayat] Univ Tehran Med Sci, Sch Adv Med Technol, Dept Med Nanotechnol, Tehran 1417755469, Iran.
   [Khoshzaban, Ahad] Univ Tehran Med Sci, Iranian Tissue Bank Res & Preparat Ctr, Tehran 1417755469, Iran.
   [Azami, Mahmoud] Univ Tehran Med Sci, Dept Tissue Engn, Sch Adv Med Technol, Tehran 1417755469, Iran.
   [Kashani, Iraj Ragerdi] Univ Tehran Med Sci, Dept Anat, Tehran 1417755469, Iran.
   [Tavakol, Hani] Islamic Azad Univ Naragh, Naragh, Iran.
   [Yazdanifar, Mahbube] Univ Tehran Med Sci, Dept Med Biotechnol, Sch Adv Med Technol, Tehran 1417755469, Iran.
   [Sorkhabadi, Seyed Mahdi Rezayat] Islamic Azad Univ IAUPS, Dept Toxicol & Pharmacol, Fac Pharm, Pharmaceut Sci Branch, Tehran, Iran.
   [Sorkhabadi, Seyed Mahdi Rezayat] Univ Tehran Med Sci, Sch Med, Dept Pharmacol, Tehran 1417755469, Iran.
RP Sorkhabadi, SMR (reprint author), Univ Tehran Med Sci, Sch Adv Med Technol, Dept Med Nanotechnol, Tehran 1417755469, Iran.
EM rezayat@sina.tums.ac.ir
OI tavakol, shima/0000-0002-8531-7650; Azami, Mahmoud/0000-0003-4209-0668
FU School of Advanced Medical Technologies, Tehran University of Medical
   Sciences
FX Supported by a grant from the School of Advanced Medical Technologies,
   Tehran University of Medical Sciences.
CR [Anonymous], 1889, Ann Surg, V10, P352
   Davis Joel, 2010, Biomed Sci Instrum, V46, P63
   Gallego L, 2010, TISSUE ENG PT A, V16, P1179, DOI [10.1089/ten.tea.2009.0517, 10.1089/ten.TEA.2009.0517]
   Garraway R, 1998, J PERIODONTOL, V69, P1325, DOI 10.1902/jop.1998.69.12.1325
   GUTERMAN IA, 1988, COLLAGEN REL RES, V8, P419
   HAHN GV, 1992, GENOMICS, V14, P759, DOI 10.1016/S0888-7543(05)80181-8
   Hansen Arne, 2001, Cell and Tissue Banking, V2, P69, DOI 10.1023/A:1014361206240
   Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132
   Jensen Jonas, 2010, Open Orthop J, V4, P181, DOI 10.2174/1874325001004010181
   Kinney RC, 2010, J ORTHOP TRAUMA, V24, pS52, DOI 10.1097/BOT.0b013e3181d07ffa
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Kumaran S Thanga, 2010, Indian J Dent Res, V21, P3, DOI 10.4103/0970-9290.62796
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   LEGEROS RZ, 1985, CALCIFIED TISSUE INT, V37, P194, DOI 10.1007/BF02554841
   Madhumathi K, 2009, INT J BIOL MACROMOL, V45, P289, DOI 10.1016/j.ijbiomac.2009.06.009
   MARDEN LJ, 1993, CALCIFIED TISSUE INT, V53, P262, DOI 10.1007/BF01320912
   McMillan J, 2007, BONE, V40, P111, DOI 10.1016/j.bone.2006.07.022
   Miyaji H, 2006, J PERIODONTAL RES, V41, P311, DOI 10.1111/j.1600-0765.2006.00878.x
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Oakes DA, 2003, CLIN ORTHOP RELAT R, P281, DOI 10.1097/01.blo.0000073347.50837.16
   OKAMOTO Y, 1991, CLIN ORTHOP RELAT R, P242
   ONO I, 1995, PLAST RECONSTR SURG, V95, P1265, DOI 10.1097/00006534-199506000-00019
   Paiva AO, 2007, J MATER SCI-MATER M, V18, P599, DOI 10.1007/s10856-007-2307-3
   Pan Y, 2010, AFR J MICROBIOL RES, V4, P865
   PARALKAR VM, 1992, J CELL BIOL, V119, P1721, DOI 10.1083/jcb.119.6.1721
   Pekkarinen T, 2005, SCAND J SURG, V94, P67, DOI 10.1177/145749690509400116
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   Rabie ABM, 1996, INT J ORAL MAX SURG, V25, P311, DOI 10.1016/S0901-5027(06)80064-0
   Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   Reynolds MA, 2007, J BIOMED MATER RES B, V83B, P451, DOI 10.1002/jbm.b.30815
   RIPAMONTI U, 1993, PLAST RECONSTR SURG, V91, P27, DOI 10.1097/00006534-199301000-00005
   Russell JL, 1999, ORTHOPEDICS, V22, P524
   Sallam MM, 2010, J APPL SCI RES, V6, P653
   SAMPATH TK, 1990, J BIOL CHEM, V265, P13198
   Schwartz Z, 1998, J PERIODONTOL, V69, P470, DOI 10.1902/jop.1998.69.4.470
   Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060
   Tou LQ, 2003, MOL CELL ENDOCRINOL, V205, P121, DOI 10.1016/S0303-7207(03)00151-5
   Urban RM, 2003, ORTHOPEDICS, V26, pS581
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   Wang J, 1999, CALCIFIED TISSUE INT, V65, P486, DOI 10.1007/s002239900737
   Wang J, 1998, BONE, V22, P621, DOI 10.1016/S8756-3282(98)00057-X
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
   Zhang M, 1997, J PERIODONTOL, V68, P1076, DOI 10.1902/jop.1997.68.11.1076
   Zhu MY, 2010, CARBOHYD POLYM, V80, P672, DOI 10.1016/j.carbpol.2009.11.038
   Ziran Bruce, 2005, Am J Orthop (Belle Mead NJ), V34, P329
   Ziran BH, 2007, J TRAUMA, V63, P1324, DOI 10.1097/01.ta.0000240452.64138.b0
NR 49
TC 5
Z9 5
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD NOV
PY 2013
VL 24
IS 6
BP 2135
EP 2140
DI 10.1097/SCS.0b013e3182a243d4
PG 6
WC Surgery
SC Surgery
GA 298WF
UT WOS:000330354500092
PM 24220423
DA 2018-10-20
ER

PT J
AU Thurmer, MB
   Diehl, CE
   Brum, FJB
   dos Santos, LA
AF Thuermer, Monica Beatriz
   Diehl, Carlos Eduardo
   Bento Brum, Fabio Jose
   dos Santos, Luis Alberto
TI Development of Dual-Setting Calcium Phosphate Cement Using Absorbable
   Polymer
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Bioceramic; Biomaterial; Hydrogel; Poly(N-vinyl-2-pyrrolidone);
   Poly(N-vinyl-2-pyrrolidone-co-acrylic acid); Bone substitute
ID ACRYLIC-ACID; HYDROGELS; MICROSPHERES; DELIVERY; COLLAGEN
AB Calcium phosphate cements used as bone substitutes generally have low mechanical strength compared with the bones of the human body. To solve these needs, we have incorporated hydrogels in the manufacture of samples made of alpha-tricalcium phosphate (a-TCP) cement, developing a system of dual-setting cement. This study aimed to produce composite materials by combining a-TCP powder and hydrogels. The composites were prepared using the synthesized powder and four different formulations of hydrogels, using either poly(N-vinyl-2-pyrrolidone) or poly(N-vinyl-2-pyrrolidone-co-acrylic acid), with either azobisisobutyronitrile or ammonium persulfate as initiator. The properties of all composites were evaluated through measuring compressive strength and apparent density and through X-ray diffraction and scanning electron microscopy. The composites showed compressive strengths of around 24 MPa. Soaking the samples in simulated body fluid formed a layer of hydroxyapatite-like crystals on the surface of some samples, showing the bioactivity of the newly developed cements and their potential use as biomaterial.
C1 [Thuermer, Monica Beatriz; Diehl, Carlos Eduardo; dos Santos, Luis Alberto] Univ Fed Rio Grande do Sul, Biomat Lab, Dept Mat, BR-91501970 Porto Alegre, RS, Brazil.
   [Bento Brum, Fabio Jose] Univ Fed Rio Grande do Sul, Polymers Lab, Dept Mat, BR-91501970 Porto Alegre, RS, Brazil.
RP Thurmer, MB (reprint author), Univ Fed Rio Grande do Sul, Biomat Lab, Dept Mat, Av Bento Goncalves 9500,Agron Bloco 4,Predio 74, BR-91501970 Porto Alegre, RS, Brazil.
EM monicathurmer@yahoo.com.br
RI Thurmer, Monica/I-9528-2016
OI Loureiro dos Santos, Luis Alberto/0000-0002-9099-9748
CR Ameye D, 2002, J CONTROL RELEASE, V79, P173, DOI 10.1016/S0168-3659(01)00539-9
   [Anonymous], 2010, C2000 ASTM
   ASTM, 2008, F45108 ASTM
   Barbu E, 2005, J BIOMED MATER RES A, V74A, P598, DOI 10.1002/jbm.a.30329
   Chun MK, 2004, J APPL POLYM SCI, V94, P2390, DOI 10.1002/app.21176
   Davidenko N, 2002, INT J POLYM MATER, V51, P577
   Devine DM, 2006, INT J PHARM, V326, P50, DOI 10.1016/j.ijpharm.2006.07.008
   Dittgen M, 1997, STP PHARMA SCI, V7, P403
   Driessens FCM, 1997, AN QUIM-INT, V93, pS38
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Ginebra MP, 1995, J MATER SCI-MATER M, V6, P857, DOI 10.1007/BF00134332
   GRUNINGER SE, 1984, J DENT RES, V63, P200
   HENCH L, 1993, INTRO BIOCERAMICS
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   ISO, 2012, 23317 ISO
   Kannan S, 2001, TRENDS BIOMATERIALS, V14, P30
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kost J, 1986, HYDROGELS MED PHARM, P95
   Lai YC, 1997, J POLYM SCI POL CHEM, V35, P1039, DOI 10.1002/(SICI)1099-0518(19970430)35:6<1039::AID-POLA7>3.0.CO;2-#
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   PITT CG, 1990, INT J PHARMACEUT, V59, P173, DOI 10.1016/0378-5173(90)90108-G
   Santos L.A., 1999, BONE, V25, p99S
   Santos L. A., 2003, ARTIF ORGANS, V27, P412
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
NR 25
TC 3
Z9 3
U1 2
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD NOV
PY 2013
VL 37
IS 11
BP 992
EP 997
DI 10.1111/aor.12236
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 294IO
UT WOS:000330039000011
PM 24236442
DA 2018-10-20
ER

PT J
AU Hynowska, A
   Blanquer, A
   Pellicer, E
   Fornell, J
   Surinach, S
   Baro, MD
   Gonzalez, S
   Ibanez, E
   Barrios, L
   Nogues, C
   Sort, J
AF Hynowska, Anna
   Blanquer, Andreu
   Pellicer, Eva
   Fornell, Jordina
   Surinach, Santiago
   Dolors Baro, Maria
   Gonzalez, Sergio
   Ibanez, Elena
   Barrios, Lleonard
   Nogues, Carme
   Sort, Jordi
TI Novel Ti-Zr-Hf-Fe Nanostructured Alloy for Biomedical Applications
SO MATERIALS
LA English
DT Article
DE Ti-based alloy; biomaterial; microstructure; mechanical behavior;
   corrosion performance
ID STRAIN GRADIENT PLASTICITY; MECHANICAL-PROPERTIES; METALLIC-GLASS;
   MICROSTRUCTURE; BEHAVIOR; MODULUS
AB The synthesis and characterization of Ti40Zr20Hf20Fe20 (atom %) alloy, in the form of rods (phi = 2 mm), prepared by arc-melting, and subsequent Cu mold suction casting, is presented. The microstructure, mechanical and corrosion properties, as well as in vitro biocompatibility of this alloy, are investigated. This material consists of a mixture of several nanocrystalline phases. It exhibits excellent mechanical behavior, dominated by high strength and relatively low Young's modulus, and also good corrosion resistance, as evidenced by the passive behavior in a wide potential window and the low corrosion current densities values. In terms of biocompatibility, this alloy is not cytotoxic and preosteoblast cells can easily adhere onto its surface and differentiate into osteoblasts.
C1 [Hynowska, Anna; Pellicer, Eva; Fornell, Jordina; Surinach, Santiago; Dolors Baro, Maria; Gonzalez, Sergio] Univ Autonoma Barcelona, Dept Fis, Fac Ciencies, E-08193 Bellaterra, Spain.
   [Blanquer, Andreu; Ibanez, Elena; Barrios, Lleonard; Nogues, Carme] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, E-08193 Bellaterra, Spain.
   [Sort, Jordi] Univ Autonoma Barcelona, ICREA, E-08193 Bellaterra, Spain.
   [Sort, Jordi] Univ Autonoma Barcelona, Dept Fis, E-08193 Bellaterra, Spain.
RP Hynowska, A (reprint author), Univ Autonoma Barcelona, Dept Fis, Fac Ciencies, E-08193 Bellaterra, Spain.
EM anna.hynowska@campus.uab.cat; andreublanquer@gmail.com;
   eva.pellicer@uab.cat; jordinafornell@gmail.com;
   santiago.surinyach@uab.cat; dolors.baro@uab.es; sergiogs10@yahoo.es;
   elena.ibanez@uab.cat; lleonard.barrios@uab.cat; carme.nogues@uab.cat;
   jordi.sort@uab.es
RI Ibanez, Elena/K-4320-2014; Pellicer, Eva/G-2917-2014; Baro, Maria
   Dolors/A-2096-2009; Sort, Jordi/F-6582-2014; Nogues, Carme/A-2339-2009;
   Barrios, Leonardo/L-3315-2014; Surinach, Santiago/A-1749-2009
OI Ibanez, Elena/0000-0002-0275-6958; Pellicer, Eva/0000-0002-8901-0998;
   Baro, Maria Dolors/0000-0002-8636-1063; Sort, Jordi/0000-0003-1213-3639;
   Nogues, Carme/0000-0002-6361-8559; Barrios,
   Leonardo/0000-0002-6151-8503; Surinach, Santiago/0000-0001-8125-0594;
   Blanquer, Andreu/0000-0002-3551-1885; Gonzalez Sanchez,
   Sergio/0000-0002-0211-7822
FU European Commission [FP7PEOPLE-2010-ITN-264635]; ICREA-Academia Award;
   ICREA
FX The authors wish to thank A. Gebert, S. Abdi, M. Calin, S. Donath, J.
   Eckert and Servei de Microsc~piao of the Universitat Autonoma de
   Barcelona for helpful discussions and for technical support. Funding by
   the European Commission within the framework of the FP7-ITN network
   BioTiNet (FP7PEOPLE-2010-ITN-264635). We also acknowledge the Catalan
   DGR (2009-SGR-1292 and 2009-SGR-282), the Spanish MICINN
   (MAT2011-27380-C02-01 and TEC2011-29140-C03-03). M. D. B. acknowledges
   partial financial support from an ICREA-Academia Award.
CR Bao YW, 2004, ACTA MATER, V52, P5397, DOI 10.1016/j.actamat.2004.08.002
   Chen N, 2005, J NON-CRYST SOLIDS, V351, P2547, DOI 10.1016/j.jnoncrysol.2005.06.041
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Fornell J, 2011, J MECH BEHAV BIOMED, V4, P1709, DOI 10.1016/j.jmbbm.2011.05.028
   Fornell J, 2009, INTERMETALLICS, V17, P1090, DOI 10.1016/j.intermet.2009.05.015
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gerberich WW, 2002, J APPL MECH-T ASME, V69, P433, DOI 10.1115/1.1469004
   Gleiter H, 2013, BEILSTEIN J NANOTECH, V4, P517, DOI 10.3762/bjnano.4.61
   HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303
   Han JH, 2009, J ALLOY COMPD, V483, P44, DOI 10.1016/j.jallcom.2008.07.162
   Hertzberg R. W., 1996, DEFORMATION FRACTURE
   Huang Y, 2004, INT J PLASTICITY, V20, P753, DOI 10.1016/j.ijplas.2003.08.002
   Hynowska A, 2012, MAT SCI ENG C-MATER, V32, P2418, DOI 10.1016/j.msec.2012.07.016
   Ibrahim KM, 2012, J MATER ENG PERFORM, V21, P114, DOI 10.1007/s11665-010-9799-6
   Joshi Vydehi Arun, 2006, TITANIUM ALLOYS ATLA
   Kim WG, 2009, T NONFERR METAL SOC, V19, P1005, DOI 10.1016/S1003-6326(08)60396-9
   Koch C., 2007, NANOSTRUCTURED MAT P
   Leyland A, 2000, WEAR, V246, P1, DOI 10.1016/S0043-1648(00)00488-9
   LI H, 1993, J MATER RES, V8, P1028, DOI 10.1557/JMR.1993.1028
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Ma F- Y, 2012, PITTING CORROSION
   Majumdar P, 2012, J MECH BEHAV BIOMED, V10, P1, DOI 10.1016/j.jmbbm.2012.02.014
   Manika E, 2006, ACTA MATER, V54, P2049, DOI 10.1016/j.actamat.2005.12.031
   McCafferty E, 2005, CORROS SCI, V47, P3202, DOI 10.1016/j.corsci.2005.05.046
   Mei J., 2009, THESIS J FOURIER U G
   Naga S., 2005, MAT SCI ENG C, V25, P357
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Nix WD, 1998, J MECH PHYS SOLIDS, V46, P411, DOI 10.1016/S0022-5096(97)00086-0
   Nouri A, 2010, ACTA BIOMATER, V6, P1630, DOI 10.1016/j.actbio.2009.10.005
   PETCH NJ, 1953, J IRON STEEL I, V174, P25
   PIRICH RG, 1986, METALL TRANS A, V17, P1149, DOI 10.1007/BF02665313
   Rosenbloom S.N., 2007, P NACE CORR C EXP NA
   SMITH W F, 2006, FDN MAT SCI ENG
   Sun BB, 2006, ACTA MATER, V54, P1349, DOI 10.1016/j.actamat.2005.11.011
   Sun FS, 2001, METALL MATER TRANS A, V32, P1573, DOI 10.1007/s11661-001-0136-4
   Suryanarayana C, 2000, HYPERFINE INTERACT, V130, P5, DOI 10.1023/A:1011026900989
   Wang B.L., 2010, BIOMED MATER, V5
   Wang WH, 2000, PHYS REV B, V62, P25, DOI 10.1103/PhysRevB.62.25
   Xu LJ, 2008, J ALLOY COMPD, V453, P320, DOI 10.1016/j.jallcom.2006.11.144
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2004, MATER TRANS, V45, P1549, DOI 10.2320/matertrans.45.1549
NR 41
TC 6
Z9 6
U1 8
U2 26
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD NOV
PY 2013
VL 6
IS 11
BP 4930
EP 4945
DI 10.3390/ma6114930
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA 298AN
UT WOS:000330296400003
PM 28788368
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hintermeyer, BH
   Tavani, EL
AF Hintermeyer, B. H.
   Tavani, E. L.
TI Adsorption, Biosorption and Bioaccumulation Used to Remove Chromium(III)
   from Tanning Wastewaters: A Critical Review
SO JOURNAL OF THE SOCIETY OF LEATHER TECHNOLOGISTS AND CHEMISTS
LA English
DT Review
ID TANNERY WASTE-WATER; ACTIVATED CARBON; SULFUR-DIOXIDE; EFFLUENT;
   CR(III); CHLORINATION; KAOLINITE; IONS
AB Processes of adsorption, biosorption and bioaccumulation were analyzed considering their ability to remove chromium(III). Already published studies that represent the actual state of knowledge were taken into account for this purpose. The review includes a detailed description of principal physicochemical properties of adsorbents, biosorbents and micro-organisms, pointing out those features that explain the mechanism by which the separation occurs. We noted an inadequate evaluation of the bearing species of the tanning agent with respect to treated solutions and that, not always the most adequate species was selected. In order to elucidate both aspects, the way in which the electrical charge and the size of studied complex ions affect the attraction force in adsorption/biosorption were examined. The consideration of such parameters proved that the electrical charge varies enormously from one substance to another and besides it prevails on the size. Accordingly, it was decided to focus attention only on treatments that were performed with tanning wastewater or with basic chromium(III) sulphate. Finally, the amounts of chromium(III) sequestered per gram of each adsorbent/biomaterial were compared. The largest uptake was 189.1mg/g, obtained with a Cr-resistant autochthonous fungus.
C1 [Hintermeyer, B. H.] Univ Nacl San Luis, Fac Ingn & Ciencias Econ Sociales, Villa Mercedes, San Luis, Argentina.
   [Tavani, E. L.] Ctr Tecnol Recursos Minerales & Ceram CETMIC, Comis Invest Cient Prov Buenos Aires, Manuel B Gonnet, Argentina.
RP Tavani, EL (reprint author), Ctr Tecnol Recursos Minerales & Ceram CETMIC, Comis Invest Cient Prov Buenos Aires, Camino Centenario & 506,CC 49 B1897ZCA, Manuel B Gonnet, Argentina.
EM etavani@netverk.com.ar
FU Comision de Investigaciones Cientificas de la Provincia de Buenos Aires;
   Facultad de Ingenieria y Ciencias Economico-Sociales de la Universidad
   Nacional de San Luis
FX Authors thank C. Salvador, (Universidad Nacional de Lanus) for the
   critical reading of the first manuscript. This work was financed by
   Comision de Investigaciones Cientificas de la Provincia de Buenos Aires
   and Facultad de Ingenieria y Ciencias Economico-Sociales de la
   Universidad Nacional de San Luis.
CR Al-Meshragi M., 2008, P WORLD C ENG COMP S, P54
   Aravindhan R, 2004, ENVIRON SCI TECHNOL, V38, P300, DOI 10.1021/es034427s
   Blackburn W.H., 1994, PRINCIPLES MINERALOG
   Bohn H.L., 1993, QUIMICA SUELO
   Brierley CL, 2009, ADV MAT RES, V71-73, P3, DOI 10.4028/www.scientific.net/AMR.71-73.3
   Cotton F. A., 1999, ADV INORGANIC CHEM
   Covarrubias C, 2006, MICROPOR MESOPOR MAT, V88, P220, DOI 10.1016/j.micromeso.2005.09.007
   Covarrubias C, 2005, J CHEM TECHNOL BIOT, V80, P899, DOI 10.1002/jctb.1259
   Demergasso C, 2009, ADV MAT RES, V71-73, P21, DOI 10.4028/www.scientific.net/AMR.71-73.21
   Duarte E., 2009, SCI TECHNICA, V42, P290
   Fahim NFE, 2006, J HAZARD MATER, V136, P303, DOI 10.1016/j.jhazmat.2005.12.014
   Guru M, 2008, J HAZARD MATER, V160, P318, DOI 10.1016/j.jhazmat.2008.03.002
   Guibal E, 2009, ADV MAT RES, V71-73, P519, DOI 10.4028/www.scientific.net/AMR.71-73.519
   Gutierrez Corona J. F., 2010, REV LATINOAM BIOTECN, V1, P47
   Heidemann E., 1993, P 22 IULTCS C PORT A, P235
   Hintermeyer BH, 2008, LAT AM APPL RES, V38, P63
   KOPPELMAN MH, 1980, CLAY CLAY MINER, V28, P119, DOI 10.1346/CCMN.1980.0280207
   Lalueza J, 2010, J AM LEATHER CHEM AS, V105, P214
   LeVan M. D., 2008, PERRYS CHEM ENG HDB
   Mala JGS, 2006, J GEN APPL MICROBIOL, V52, P179
   MARJONIEMI M, 1992, APPL SPECTROSC, V46, P1908, DOI 10.1366/0003702924123386
   Menendez CJ, 2007, MINER ENG, V20, P1278, DOI 10.1016/j.mineng.2007.07.004
   Menendez CJ, 1999, THERMOCHIM ACTA, V338, P103, DOI 10.1016/S0040-6031(99)00204-X
   Mohan D, 2006, J HAZARD MATER, V135, P280, DOI 10.1016/j.jhazmat.2005.11.075
   NIGHTINGALE ER, 1959, J PHYS CHEM-US, V63, P1381, DOI 10.1021/j150579a011
   Onyancha D, 2008, J HAZARD MATER, V158, P605, DOI 10.1016/j.jhazmat.2008.02.043
   Oweis I. S., 1998, GEOTECHNOLOGY WASTE
   Prigione V, 2009, BIORESOURCE TECHNOL, V100, P2770, DOI 10.1016/j.biortech.2009.01.002
   Sahmoune MN, 2009, INT J ENVIRON RES, V3, P229
   Sharma S, 2011, INT BIODETER BIODEGR, V65, P309, DOI 10.1016/j.ibiod.2010.12.003
   Srivastava S, 2006, BIORESOURCE TECHNOL, V97, P1167, DOI 10.1016/j.biortech.2005.05.012
   STUNZI H, 1983, INORG CHEM, V22, P2145
   Tahir SS, 2007, SEP PURIF TECHNOL, V53, P312, DOI 10.1016/j.seppur.2006.08.008
   Tavani EL, 1997, J SOC LEATH TECH CH, V81, P143
   THOMPSON M, 1981, INORG CHEM, V20, P2279, DOI 10.1021/ic50221a068
   Tobin JM, 1998, WATER RES, V32, P1407, DOI 10.1016/S0043-1354(97)00343-6
   van Niekerk J, 2009, ADV MAT RES, V71-73, P465, DOI 10.4028/www.scientific.net/AMR.71-73.465
   VOLZONE C, 1995, J SOC LEATH TECH CH, V79, P148
   Volzone C, 2008, J ENVIRON MANAGE, V88, P1640, DOI 10.1016/j.jenvman.2007.08.003
NR 39
TC 2
Z9 2
U1 3
U2 23
PU SOC LEATHER TECHNOL CHEMISTS
PI MOULTON
PA 8 COPPER LEAF CLOSE, MOULTON NN3 7HS, NORTHAMPTON, ENGLAND
SN 0144-0322
J9 J SOC LEATH TECH CH
JI J. Soc. Leather Technol. Chem.
PD NOV-DEC
PY 2013
VL 97
IS 6
BP 231
EP 237
PG 7
WC Materials Science, Textiles
SC Materials Science
GA 288DC
UT WOS:000329591200001
DA 2018-10-20
ER

PT J
AU Gong, SH
   Lee, H
   Pae, A
   Noh, K
   Shin, YM
   Lee, JH
   Woo, YH
AF Gong, Soon-Hyun
   Lee, Heesu
   Pae, Ahran
   Noh, Kwantae
   Shin, Yong-Moon
   Lee, Jung-Haeng
   Woo, Yi-Hyung
TI Gene expression of MC3T3-E1 osteoblastic cells on titanium and zirconia
   surface
SO JOURNAL OF ADVANCED PROSTHODONTICS
LA English
DT Article
DE Dental implants; Zirconia; Titanium; Osteoblast-like cells; cDNA
   microarray
ID IN-VITRO; EXTRACELLULAR-MATRIX; PURE TITANIUM; BONE; INTERFACE;
   IMPLANTS; ADHESION; BIOMATERIAL; DISKS; VIVO
AB PURPOSE. This study was performed to define attachment and growth behavior of osteoblast-like cells and evaluate the gene expression on zirconia compared to titanium. MATERIALS AND METHODS. MC3T3-E1 cells were cultured on (1) titanium and (2) zirconia discs. The tetrazolium-based colorimetric assay (MTT test) was used for examining the attachment of cells. Cellular morphology was examined by scanning electron microscopy (SEM) and alkaline phosphatase (ALP) activity was measured to evaluate the cell differentiation rate. Mann-Whitney test was used to assess the significance level of the differences between the experimental groups. cDNA microarray was used for comparing the 20215 gene expressions on titanium and zirconia. RESULTS. From the MTT assay, there was no significant difference between titanium and zirconia (P>.05). From the SEM image, after 4 hours of culture, cells on both discs were triangular or elongated in shape with formation of filopodia. After 24 hours of culture, cells on both discs were more flattened and well spread compared to 4 hours of culture. From the ALP activity assay, the optical density of El cells on titanium was slightly higher than that of El cells on zirconia but there was no significant difference (P>.05). Most of the genes related to cell adhesion showed similar expression level between titanium and zirconia. CONCLUSION. Zirconia showed comparable biological responses of osteoblast-like cells to titanium for a short time during cell culture period. Most of the genes related to cell adhesion and signal showed similar expression level between titanium and zirconia.
C1 [Gong, Soon-Hyun; Pae, Ahran; Noh, Kwantae; Shin, Yong-Moon; Lee, Jung-Haeng; Woo, Yi-Hyung] Kyung Hee Univ, Sch Dent, Dept Prosthodont, Seoul 130701, South Korea.
   [Lee, Heesu] Gangneung Wonju Natl Univ, Sch Dent, Dept Oral Anat, Kangnung, South Korea.
RP Woo, YH (reprint author), Kyung Hee Univ, Sch Dent, Dept Prosthodont, 1 Hoegi Dong, Seoul 130701, South Korea.
EM yhwoo@khu.ac.kr
OI Noh, Kwantae/0000-0003-3480-7737
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403
   BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Cortada M, 2000, J MATER SCI-MATER M, V11, P287, DOI 10.1023/A:1008905229522
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   Henry P J, 1996, Int J Oral Maxillofac Implants, V11, P450
   Jaakkola P, 2000, PROG NUCLEIC ACID RE, V63, P109
   Ko HC, 2007, DENT MATER, V23, P1349, DOI 10.1016/j.dental.2006.11.023
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pistone M, 1996, CELL BIOL INT, V20, P471, DOI 10.1006/cbir.1996.0062
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Roynesdal AK, 1998, INT J ORAL MAX IMPL, V13, P500
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Schliephake H, 1993, Int J Oral Maxillofac Implants, V8, P502
   VANSTEENBERGHE D, 1989, J PROSTHET DENT, V61, P217, DOI 10.1016/0022-3913(89)90378-8
   Viornery C, 2002, J BIOMED MATER RES, V62, P149, DOI 10.1002/jbm.10205
   WILLOTT E, 1992, AM J PHYSIOL, V262, pC1119
   Wongdee K, 2008, HISTOCHEM CELL BIOL, V130, P79, DOI 10.1007/s00418-008-0419-6
   Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X
   Yamauchi R, 2000, CONTACT DERMATITIS, V42, P52
NR 28
TC 5
Z9 5
U1 1
U2 11
PU KOREAN ACAD PROSTHODONTICS
PI SEOUL
PA #705 KOREA SCIENCE & TECHNOLOGY CENTER, 22 TAHRANNO 7 GIL, GANGNAMGU,
   SEOUL, 135-703, SOUTH KOREA
SN 2005-7806
EI 2005-7814
J9 J ADV PROSTHODONT
JI J. Adv. Prosthodont.
PD NOV
PY 2013
VL 5
IS 4
BP 416
EP 422
DI 10.4047/jap.2013.5.4.416
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 283UN
UT WOS:000329272600008
PM 24353879
OA Green Published
DA 2018-10-20
ER

PT J
AU Wang, LS
   Cheng, SX
   Zhuo, RX
AF Wang, Lian-Sheng
   Cheng, Si-Xue
   Zhuo, Ren-Xi
TI Synthesis and hydrolytic degradation of aliphatic polycarbonate based on
   dihydroxyacetone
SO POLYMER SCIENCE SERIES B
LA English
DT Article
ID RING-OPENING POLYMERIZATION; TRIMETHYLENE CARBONATE; CYCLIC CARBONATES;
   COPOLYMERS; ACID; BIOMATERIAL; POLYMERS; POLY(CARBONATE-ESTER)S;
   INTERMEDIATE; METABOLISM
AB The six-membered cyclic carbonate monomer, 2,2-dimethoxy-1,3-propanediol carbonate based on dihydroxyacetone with methanol ketal protected carbonyl group, was prepared by a two-step reaction including protection and ring-closing, starting from dihydroxyacetone. The ring-opening polymerization of 2,2-dimethoxy-1,3-propanediol carbonate was carried out in bulk at 110-140A degrees C initiated by stannous octanoate to give polycarbonate, poly(2,2-dimethoxypropane-1,3-diol carbonate). The effects of different reaction conditions including different catalyst, reaction temperature, molar ratio of monomer to initiator and polymerization time on the polymerization were investigated. Polycarbonate was obtained with the yield of 58.9-91.0%. The number average molecular weight of polycarbonate was in the range of 1.43 x 10(4) to 13.82 x 10(4) with polydispersity indexes from 1.31 to 1.91. The protecting ketal group was partly removed by hydrolysis using 50% trifluroacetic acid as a catalyst to give a functional polycarbonate containing 70% ketone carbonyl group, which improved the hydrophilicity of initial polycarbonate. The in vitro degradation tests were carried out in a phosphate buffer solution with pH 7.4 at 37A degrees C, which showed that the modified polycarbonate degraded completely after 5 days.
C1 [Wang, Lian-Sheng; Cheng, Si-Xue; Zhuo, Ren-Xi] Wuhan Univ, Coll Chem & Mol Sci, Key Lab Biomed Polymers, Minist Educ, Wuhan 430072, Hubei, Peoples R China.
   [Wang, Lian-Sheng] Hubei Engn Univ, Sch Chem & Mat Sci, Xiaogan 432000, Hubei, Peoples R China.
RP Wang, LS (reprint author), Wuhan Univ, Coll Chem & Mol Sci, Key Lab Biomed Polymers, Minist Educ, Wuhan 430072, Hubei, Peoples R China.
EM wangls20052005@aliyun.com
FU National Key Basic Research Program of China [G1999064703]; Natural
   Science Foundation of Hubei Province, China [2007ABA210]; Scientific
   Research Foundation of the Higher Education Institutions of Hubei
   Province, China [2004Z001]
FX The authors are thankful for the financial support provided by the
   National Key Basic Research Program of China (Grant no. G1999064703),
   the Natural Science Foundation of Hubei Province, China (Grant no.
   2007ABA210), the Scientific Research Foundation of the Higher Education
   Institutions of Hubei Province, China (Grant no. 2004Z001).
CR Al-Azemi TF, 2002, J POLYM SCI POL CHEM, V40, P1267, DOI 10.1002/pola.10212
   ALBERTSSON AC, 1995, J APPL POLYM SCI, V57, P87, DOI 10.1002/app.1995.070570109
   Diaz-Celorio E, 2012, THERMOCHIM ACTA, V528, P23, DOI 10.1016/j.tca.2011.11.006
   ESMANN V, 1968, ACTA CHEM SCAND, V22, P2281, DOI 10.3891/acta.chem.scand.22-2281
   Feng J, 2012, PROG POLYM SCI, V37, P211, DOI 10.1016/j.progpolymsci.2011.07.008
   Ferroni EL, 1999, J ORG CHEM, V64, P4943, DOI 10.1021/jo9823902
   He F, 2008, POLYMER, V49, P1185, DOI 10.1016/j.polymer.2008.01.025
   Henderson PW, 2010, J BIOMED MATER RES A, V93A, P776, DOI 10.1002/jbm.a.32586
   KATO N, 1986, APPL MICROBIOL BIOT, V23, P180
   Kricheldorf HR, 1996, J POLYM SCI POL CHEM, V34, P2399
   Kricheldorf HR, 2000, MACROMOL CHEM PHYSIC, V201, P2557, DOI 10.1002/1521-3935(20001101)201:17<2557::AID-MACP2557>3.3.CO;2-6
   Li ZM, 2012, J APPL POLYM SCI, V124, P3704, DOI 10.1002/app.35386
   Mc Neill J.C., 1989, POLYM DEGRAD STABIL, V24, P59
   Mei LL, 2008, J APPL POLYM SCI, V108, P93, DOI 10.1002/app.27562
   Mullen BD, 2003, J POLYM SCI POL CHEM, V41, P1978, DOI 10.1002/pola.10724
   Putnam D., 2008, US Patent, Patent No. [2008/0194786 A1, 0194786]
   Rokicki G, 2000, PROG POLYM SCI, V25, P259, DOI 10.1016/S0079-6700(00)00006-X
   Sanda F, 2001, MACROMOLECULES, V34, P1564, DOI 10.1021/ma0013307
   SOLER C, 1993, BIOCHEM J, V294, P865, DOI 10.1042/bj2940865
   Wang L. S., 2004, THESIS WUHAN U WUHAN
   Wang LS, 2005, CHINESE CHEM LETT, V16, P572
   Wang LS, 2004, MACROMOL RAPID COMM, V25, P959, DOI 10.1002/marc.200300319
   Wang XL, 2002, J POLYM SCI POL CHEM, V40, P70, DOI 10.1002/pola.10088
   Weiser JR, 2011, BIOMACROMOLECULES, V12, P977, DOI 10.1021/bm101342p
   YAMADA S, 1979, J FERMENT TECHNOL, V57, P215
   Zawaneh PN, 2006, BIOMACROMOLECULES, V7, P3245, DOI 10.1021/bm0605457
   Zawaneh PN, 2010, P NATL ACAD SCI USA, V107, P11014, DOI 10.1073/pnas.0811529107
   Zelikin AN, 2006, BIOMACROMOLECULES, V7, P3239, DOI 10.1021/bm060544e
   Zelikin AN, 2005, MACROMOLECULES, V38, P5532, DOI 10.1021/ma050049v
   Zhou Y, 2005, MACROMOL RAPID COMM, V26, P1309, DOI 10.1002/marc.200500222
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
NR 31
TC 7
Z9 7
U1 4
U2 36
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1560-0904
EI 1555-6123
J9 POLYM SCI SER B+
JI Polym. Sci. Ser. B
PD NOV
PY 2013
VL 55
IS 11-12
BP 604
EP 610
DI 10.1134/S1560090413080101
PG 7
WC Polymer Science
SC Polymer Science
GA 281NN
UT WOS:000329108400009
DA 2018-10-20
ER

PT J
AU Ki, SB
   Singh, D
   Kim, SC
   Son, TW
   Han, SS
AF Ki, Saet Byul
   Singh, Deepti
   Kim, Seong Cheol
   Son, Tae Won
   Han, Sung Soo
TI Effect of cross-linkers in fabrication of carrageenan-alginate matrices
   for tissue engineering application
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Article
DE alginate; carageenan; CaCl2; cell; cross-linker; EDC; NHS; GA; genipin;
   scaffold
ID DRUG-DELIVERY; SCAFFOLDS; CRYOGEL; RELEASE; LINKING; PROLIFERATION;
   BIOMATERIALS; TECHNOLOGY; CARTILAGE; MEDICINE
AB The three-dimensional (3D) scaffold serves as a structural substrate and as a niche for cell proliferation to ensure tissue regeneration. Ideal scaffolds should have porous structures with high pore interconnectivity to allow cell adherence, differentiation, and proliferation while ensuring suitable mechanical strength and biodegradability without inflicting any immune response. Cross-linker is one of the major factors that affect the mechanical and biological properties of scaffolds. In this study, different chemical cross-linker effects on scaffold architecture were examined. Porous 3D scaffolds based on carrageenan and alginate (CA) were successfully fabricated by a freeze-drying technique and using various cross-linkers like glutaraldehyde (GA), genipin, and ethyl (dimethylamino propyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS). The chemical cross-linker effects on the CA scaffold were characterized by scanning electron microscopy, differential scanning calorimetry, and thermogravimetry. A human fibroblast cell line (L929) was seeded into the fabricated scaffold, and cell proliferation was assessed by MTT and live/dead assay. Overall results suggested the potential cross-linkers for ideal CA biomaterial could be EDC/NHS among other agents tested as the scaffold CA(EN) was found to be porous, interconnected, and physically and mechanically stable. When compared to matrices with other cross-linkers, higher cell attachment, better cellular response, and higher metabolic activity could be observed in the scaffold synthesized using EDC/NHS as cross-linker. (C) 2013 International Union of Biochemistry and Molecular Biology, Inc. Volume 60, Number 6, Pages 589-595, 2013
C1 [Ki, Saet Byul; Singh, Deepti; Kim, Seong Cheol; Son, Tae Won; Han, Sung Soo] Yeungnam Univ, Dept Nano Med & Polymer Mat, Kyongsan 712749, South Korea.
   [Ki, Saet Byul; Singh, Deepti] Yeungnam Univ, Polymer Gel Res Cluster Ctr, Kyongsan 712749, South Korea.
RP Han, SS (reprint author), Yeungnam Univ, Coll Engn, 280 Daehak Ro, Kyongsan 712749, South Korea.
EM sshan@yu.ac.kr
FU Yeungnam University
FX This work was supported by a 2010 Yeungnam University research grant.
CR Autissier A, 2010, ACTA BIOMATER, V6, P3640, DOI 10.1016/j.actbio.2010.03.004
   Bernkop-Schnurch A, 2001, J CONTROL RELEASE, V71, P277, DOI 10.1016/S0168-3659(01)00227-9
   Bolgen N, 2008, TISSUE ENG PT A, V14, P1743, DOI 10.1089/ten.tea.2007.0277
   BUCKLEY CT, 2004, TOPICS BIOMECHANICAL, P147
   Campo VL, 2009, CARBOHYD POLYM, V77, P167, DOI 10.1016/j.carbpol.2009.01.020
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chapekar M, 2000, BIOMATER RES, V53, P617
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   GUALANDI C, 2011, SPRINGER THESES RECO, P1
   Hezaveh H., 2012, J TAIWAN INST CHEM E, V44, P182
   ISTINI SO, 1994, B MARINE SCI FISHERI, V14, P49
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jeon O., 2009, BIOMATERIALS, V14, P2724
   Kim S. S., 1995, BIOMATERIALS, V17, P813
   Ko HF, 2010, PHILOS T R SOC A, V368, P1981, DOI 10.1098/rsta.2010.0009
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Liu CZ, 2007, MATER SCI TECH-LOND, V23, P379, DOI 10.1179/174328407X177027
   Liu XX, 2003, POLYMER, V44, P407, DOI 10.1016/S0032-3861(02)00771-1
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mammarella EJ, 2003, CHEM ENG J, V94, P73, DOI 10.1016/S1385-8947(03)00080-9
   Muhamad II, 2011, CARBOHYD POLYM, V83, P1207, DOI 10.1016/j.carbpol.2010.09.021
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Pascalau V., 2012, J ALLOY COMPD, V536, P418
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Pillay V, 1999, J CONTROL RELEASE, V59, P229, DOI 10.1016/S0168-3659(98)00196-5
   Popa EG, 2011, BIOMACROMOLECULES, V12, P3952, DOI 10.1021/bm200965x
   Rehm BHA, 1997, APPL MICROBIOL BIOT, V48, P281, DOI 10.1007/s002530051051
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Singh D, 2013, J BIOMAT SCI-POLYM E, V24, P1343, DOI 10.1080/09205063.2012.759505
   Singh D, 2011, J BIOMAT SCI-POLYM E, V22, P1733, DOI 10.1163/092050610X522486
   Tang CH, 2006, FOOD RES INT, V39, P87, DOI 10.1016/j.foodres.2005.06.004
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Van Vlierberghe S, 2006, J CONTROL RELEASE, V116, pE95, DOI 10.1016/j.jconrel.2006.09.069
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Zhao YY, 2012, MAT SCI ENG C-MATER, V32, P2153, DOI 10.1016/j.msec.2012.05.024
NR 39
TC 3
Z9 4
U1 4
U2 48
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD NOV
PY 2013
VL 60
IS 6
BP 589
EP 595
DI 10.1002/bab.1123
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 275NP
UT WOS:000328684400006
PM 23668797
DA 2018-10-20
ER

PT J
AU Seris, E
   Borget, P
   Durand, M
   Daculsi, C
   Daculsi, G
AF Seris, E.
   Borget, P.
   Durand, M.
   Daculsi, C.
   Daculsi, G.
TI Bone regeneration at the expense of Bioceramic/Hydrogel composite:
   Clinical evidence
SO IRBM
LA English
DT Article
AB It is often necessary to restore bone structure following the loss of osseous substance. Therefore, the use of bone substitutes made of synthetic calcium phosphate (CaP) ceramics has become more widespread. Granular forms of these biomaterials have demonstrated osteogenic capacities within various sites. Recently, a combination of CaP microporous granules and hydrosoluble polymers was developed (In'Oss (TM)). This composite material is non-self-hardening, injectable, and moldable. The purpose of this non-interventional clinical study was to demonstrate the safety and efficacy of these bioceramic/hydrogel bone substitutes in bone regeneration following maxillofacial surgery. In'Oss (TM) biomaterial was injected into bone defects created by tooth removal in 78 patients. Notably, no infectious or foreign body reactions were reported during at least 17 months of follow up for the study. Regeneration of bone architecture was observed by histomorphometry. (C) 2013 Published by Elsevier Masson SAS.
C1 [Seris, E.; Durand, M.] Bordeaux Univ, CIC INSERM BioDiMI, Bordeaux, France.
   [Daculsi, G.] Univ Nantes, INSERM LIOAD U791, Nantes, France.
EM guy.daculsi@univ-nantes.fr
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
FU European Union's 7th Framework Programme (REBORNE)
   [FP7-HEALTH-2009-241879]; Biomatlante SA
FX This research was funded by the European Union's 7th Framework Programme
   (grant number FP7-HEALTH-2009-241879; REBORNE) and was supported by
   Biomatlante SA. The authors would like to thank Paul Pilet (SC3M),
   Sophie Sourice (Inserm LIOAD), Francoise Moreau, and Thomas Miramond
   (Biomatlante) for their help with this work.
CR Daculsi G, 2012, IRBM, V33, P253, DOI 10.1016/j.irbm.2012.06.001
   Daculsi G, 1999, BONE, V25, P59
   Dorozhkin S, 2012, CALCIUM ORTHOPHOSPHATES: APPLICATIONS IN NATURE, BIOLOGY, AND MEDICINE, P1, DOI 10.1201/b12312
   Niwa S, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P385
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
NR 6
TC 1
Z9 1
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1959-0318
EI 1876-0988
J9 IRBM
JI IRBM
PD NOV
PY 2013
VL 34
IS 4-5
SI SI
BP 342
EP 345
DI 10.1016/j.irbm.2013.07.003
PG 4
WC Engineering, Biomedical
SC Engineering
GA 272BQ
UT WOS:000328435700020
DA 2018-10-20
ER

PT J
AU McHugh, KJ
   Saint-Geniez, M
   Tao, SL
AF McHugh, Kevin J.
   Saint-Geniez, Magali
   Tao, Sarah L.
TI Topographical control of ocular cell types for tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE cell-material interactions; nanomaterials; nanophase; microstructure;
   ophthalmic; eye
ID RETINAL-PIGMENT EPITHELIUM; SYNTHETIC BIODEGRADABLE POLYMERS; SCANNING
   TUNNELING MICROSCOPE; EXTRACELLULAR-MATRIX; REGENERATIVE MEDICINE;
   CORNEAL FIBROBLASTS; SUBRETINAL SPACE; SOFT LITHOGRAPHY; PROGENITOR
   CELLS; STEM-CELLS
AB Visual impairment affects over 285 million people worldwide and has a major impact on an individual's quality of life. Tissue engineering has the potential to increase the quality of life for many of these patients by preventing vision loss or restoring vision using cell-based therapies. However, these strategies will require an understanding of the microenvironmental factors that influence cell behavior. The eye is a well-organized organ whose structural complexity is essential for proper function. Interactions between ocular cells and their highly ordered extracellular matrix are necessary for maintaining key tissue properties including corneal transparency and retinal lamination. Therefore, it is not surprising that culturing these cells in vitro on traditional flat substrates result in irregular morphology. Instead, topographically patterned biomaterials better mimic native extracellular matrix and have been shown to elicit in vivo-like morphology and gene expression which is essential for tissue engineering. Herein we review multiple methods for producing well-controlled topography and discuss optimal biomaterial scaffold design for cells of the cornea, retina, and lens. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 101B: 1571-1584, 2013.
C1 [McHugh, Kevin J.; Tao, Sarah L.] Charles Stark Draper Lab, Cambridge, MA USA.
   [McHugh, Kevin J.; Saint-Geniez, Magali] Schepens Eye Res Inst, Boston, MA USA.
   [McHugh, Kevin J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Saint-Geniez, Magali] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA.
RP Saint-Geniez, M (reprint author), Schepens Eye Res Inst, Boston, MA USA.
EM magali.saintgeniez@schepens.harvard.edu
OI SAINT-GENIEZ, MAGALI/0000-0001-9897-138X; McHugh,
   Kevin/0000-0001-6801-4431
FU NIBIB NIH HHS [T32 EB006359]; NIH HHS [DP2 OD006649]
CR Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012
   ABRAMS GA, 2002, BIOMIMETIC MAT DESIG, P91
   Aguilar CA, 2005, BIOMATERIALS, V26, P7642, DOI 10.1016/j.biomaterials.2005.04.053
   Ambekar R, 2011, J MECH BEHAV BIOMED, V4, P223, DOI 10.1016/j.jmbbm.2010.09.014
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Arnold CB, 2007, MRS BULL, V32, P23, DOI 10.1557/mrs2007.11
   Banks DP, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2386921
   BASSNETT S, 1994, J CELL SCI, V107, P799
   Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002
   BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003
   Boulton M, 2004, INT J BIOCHEM CELL B, V36, P643, DOI 10.1016/j.biocel.2003.10.013
   BRITLAND S, 1992, EXP CELL RES, V198, P124, DOI 10.1016/0014-4827(92)90157-4
   Cai HC, 1999, MOL VIS, V5, pU1
   CARNEGIE JA, 1993, BIOL REPROD, V48, P287, DOI 10.1095/biolreprod48.2.287
   Chen KS, 2002, J MICROELECTROMECH S, V11, P264, DOI 10.1109/JMEMS.2002.1007405
   Chen Y, 2001, ELECTROPHORESIS, V22, P187, DOI 10.1002/1522-2683(200101)22:2<187::AID-ELPS187>3.0.CO;2-0
   Chien FSS, 1999, APPL PHYS LETT, V75, P2429, DOI 10.1063/1.125037
   Chiquet M, 1996, BIOCHEM CELL BIOL, V74, P737, DOI 10.1139/o96-080
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Chou SY, 1997, J VAC SCI TECHNOL B, V15, P2897, DOI 10.1116/1.589752
   Christiansen AT, 2012, STEM CELLS INT, V2012
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218
   Cumpston BH, 1999, NATURE, V398, P51
   Curtis A, 2004, IEEE T NANOBIOSCI, V3, P293, DOI 10.1109/TNB.2004.837898
   Curtis ASG, 2006, NANOMEDICINE-UK, V1, P67, DOI 10.2217/17435889.1.1.67
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2002, BIOMATERIALS, V23, P927
   de Gans BJ, 2004, ADV MATER, V16, P203, DOI 10.1002/adma.200300385
   Delamarche E, 1997, ADV MATER, V9, P741, DOI 10.1002/adma.19970090914
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Derby B, 2010, ANNU REV MATER RES, V40, P395, DOI 10.1146/annurev-matsci-070909-104502
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0
   Evans MDM, 2003, J BIOMED MATER RES A, V64A, P357, DOI 10.1002/jbm.a.10341
   Fitz-Gerald JM, 2000, INTEGR FERROELECTR, V29, P13
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   FOSTER JS, 1988, NATURE, V331, P324, DOI 10.1038/331324a0
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Giordano GG, 1997, J BIOMED MATER RES, V34, P87, DOI 10.1002/(SICI)1097-4636(199701)34:1<87::AID-JBM12>3.0.CO;2-M
   Gittard Shaun Davis, 2013, Front Biosci (Elite Ed), V5, P602
   Gong J, 2008, EXP EYE RES, V86, P957, DOI 10.1016/j.exer.2008.03.014
   Gratson GM, 2004, NATURE, V428, P386, DOI 10.1038/428386a
   Hadlock T, 1999, TISSUE ENG, V5, P187, DOI 10.1089/ten.1999.5.187
   Hageman G. S., 2008, AGE RELATED MACULAR
   Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7
   Jackman RJ, 1999, LANGMUIR, V15, P2973, DOI 10.1021/la981591y
   Julien S, 2011, BIOMATERIALS, V32, P3890, DOI 10.1016/j.biomaterials.2011.02.016
   Kancharla VV, 2002, BIOMED MICRODEVICES, V4, P105, DOI 10.1023/A:1014679013888
   Karuri NW, 2008, SCANNING, V30, P405, DOI 10.1002/sca.20123
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Khraiche ML, 2011, IEEE ENG MED BIO, P2933, DOI 10.1109/IEMBS.2011.6090807
   Kim Deok-Ho, 2008, P185
   Knupp C, 2009, ADV PROTEIN CHEM STR, V78, P25, DOI [10.1016/S1876-1623(08)78002-7, 10.1016/S1876-1623(09)78002-7]
   KUSZAK J, 1980, AM J ANAT, V159, P395, DOI 10.1002/aja.1001590406
   Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016
   Lavik EB, 2005, BIOMATERIALS, V26, P3187, DOI 10.1016/j.biomaterials.2004.08.022
   Lazzaro DR, 2005, J AM COLL SURGEONS, V200, P96, DOI 10.1016/j.jamcollsurg.2004.09.038
   Lewis JA, 2004, MATER TODAY, V7, P32, DOI 10.1016/S1369-7021(04)00344-X
   LI L, 1991, EXP EYE RES, V52, P669, DOI 10.1016/0014-4835(91)90019-B
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Lim JM, 2004, INVEST OPHTH VIS SCI, V45, P4210, DOI 10.1167/iovs.03-1036
   Lu B, 2012, BIOMED MICRODEVICES, V14, P659, DOI 10.1007/s10544-012-9645-8
   Lu LC, 2001, BIOMATERIALS, V22, P3345, DOI 10.1016/S0142-9612(01)00172-7
   Lutty G, 1999, MOL VIS, V5, pU70
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   Magalit E, 2003, ARTIF ORGANS, V27, P983
   Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406
   Martinez G, 2010, INT J BIOCHEM CELL B, V42, P1945, DOI 10.1016/j.biocel.2010.09.012
   Marty F, 2005, MICROELECTRON J, V36, P673, DOI 10.1016/j.mejo.2005.04.039
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   McUsic AC, 2012, BIOMATERIALS, V33, P1396, DOI 10.1016/j.biomaterials.2011.10.083
   MERKER HJ, 1994, MICROSC RES TECHNIQ, V28, P95, DOI 10.1002/jemt.1070280203
   Montezuma SR, 2006, INVEST OPHTH VIS SCI, V47, P3514, DOI 10.1167/iovs.06-0106
   MURAY A, 1985, J VAC SCI TECHNOL B, V3, P367, DOI 10.1116/1.583265
   Nakamura K, 2001, BRIT J OPHTHALMOL, V85, P209, DOI 10.1136/bjo.85.2.209
   Neeley WL, 2008, BIOMATERIALS, V29, P418, DOI 10.1016/j.biomaterials.2007.10.007
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   NISHIDA T, 1988, INVEST OPHTH VIS SCI, V29, P1887
   Ogilvie JM, 1999, J NEUROSCI METH, V87, P57
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Ong JM, 2012, BRIT MED BULL, V102, P133, DOI 10.1093/bmb/lds013
   Ovsianikov A, 2012, METHODS MOL BIOL, V868, P311, DOI 10.1007/978-1-61779-764-4_19
   Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539
   PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P38, DOI 10.1016/S0002-9394(14)75576-X
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Provis Jan M, 2005, Clin Exp Optom, V88, P269
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Raghunathan VK, 2013, J BIOMED MATER RES A, V101, P1069, DOI 10.1002/jbm.a.34417
   Raimondi MT, 2012, J APPL BIOMATER FUNC, V10, P56, DOI 10.5301/JABFM.2012.9278
   Rajnicek AM, 2008, BIOMATERIALS, V29, P2082, DOI 10.1016/j.biomaterials.2008.01.015
   Redenti S, 2009, BIOMATERIALS, V30, P3405, DOI 10.1016/j.biomaterials.2009.02.046
   REID TW, 1994, PROG RETIN EYE RES, V13, P507, DOI 10.1016/1350-9462(94)90021-3
   Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844
   Resnikoff S, 2012, INDIAN J OPHTHALMOL, V60, P387, DOI 10.4103/0301-4738.100532
   Romano NH, 2011, BBA-GEN SUBJECTS, V1810, P339, DOI 10.1016/j.bbagen.2010.07.005
   ROSENBERG MD, 1962, P NATL ACAD SCI USA, V48, P1342, DOI 10.1073/pnas.48.8.1342
   ROSENBERG MD, 1963, SCIENCE, V139, P411, DOI 10.1126/science.139.3553.411
   Salaita K, 2006, ANGEW CHEM INT EDIT, V45, P7220, DOI 10.1002/anie.200603142
   Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2
   Sheedlo HJ, 2007, IN VITRO CELL DEV-AN, V43, P361, DOI 10.1007/s11626-007-9051-3
   Sheridan C, 2004, GRAEF ARCH CLIN EXP, V242, P68, DOI 10.1007/s00417-003-0800-z
   Silverman M S, 1989, Prog Clin Biol Res, V314, P687
   Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123
   Smith G, 1998, OPHTHAL PHYSL OPT, V18, P21, DOI 10.1046/j.1475-1313.1998.97000586.x
   Snyder M C, 1998, J Am Optom Assoc, V69, P180
   Sodha S, 2011, J BIOMAT SCI-POLYM E, V22, P443, DOI 10.1163/092050610X487738
   Steedman MR, 2010, BIOMED MICRODEVICES, V12, P363, DOI 10.1007/s10544-009-9392-7
   Stefansson E, 2011, PROG RETIN EYE RES, V30, P72, DOI 10.1016/j.preteyeres.2010.09.003
   STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004
   STROSCIO JA, 1991, SCIENCE, V254, P1319, DOI 10.1126/science.254.5036.1319
   Suh KY, 2002, ADV FUNCT MATER, V12, P405, DOI 10.1002/1616-3028(20020618)12:6/7<405::AID-ADFM405>3.0.CO;2-1
   Tao S, 2007, LAB CHIP, V7, P695, DOI 10.1039/b618583e
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8
   Tezel TH, 1997, GRAEF ARCH CLIN EXP, V235, P41, DOI 10.1007/BF01007836
   Thomson RC, 1996, BIOMATERIALS, V17, P321, DOI 10.1016/0142-9612(96)85570-0
   Tiaw KS, 2007, BIOMACROMOLECULES, V8, P807, DOI 10.1021/bm060832a
   Tocce EJ, 2010, BIOMATERIALS, V31, P4064, DOI 10.1016/j.biomaterials.2010.01.101
   Tomita M, 2005, STEM CELLS, V23, P1579, DOI 10.1634/stemcells.2005-0111
   Torgersen J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.105008
   Trinkaus-Randall VCJ, 1988, INVEST OPHTH VIS SCI, V29, P293
   Trivedi RH, 2002, EYE, V16, P217, DOI 10.1038/sj/eye/6700066
   Truscott RJW, 2010, PROG RETIN EYE RES, V29, P487, DOI 10.1016/j.preteyeres.2010.05.002
   Tseng AA, 2005, J NANOSCI NANOTECHNO, V5, P683, DOI 10.1166/jnn.2005.116
   TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4
   Van Vlierberghe S, 2010, BIOMACROMOLECULES, V11, P2731, DOI 10.1021/bm100783h
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   Walker J, 2009, EXP EYE RES, V88, P216, DOI 10.1016/j.exer.2008.06.020
   WATANABE K, 1987, INVEST OPHTH VIS SCI, V28, P205
   WATANABE K, 1988, INVEST OPHTH VIS SCI, V29, P572
   Wederell ED, 2006, SEMIN CELL DEV BIOL, V17, P759, DOI 10.1016/j.semcdb.2006.10.006
   Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616
   WORTHINGTON CR, 1984, Q REV BIOPHYS, V17, P423, DOI 10.1017/S003358350000487X
   Wride MA, 2000, APOPTOSIS, V5, P203, DOI 10.1023/A:1009653326511
   Xie YY, 2011, METHODS MOL BIOL, V671, P239, DOI 10.1007/978-1-59745-551-0_14
   Yang J, 2006, J CONTROL RELEASE, V116, P193, DOI 10.1016/j.jconrel.2006.06.022
   Yang Y, 2010, WIRES NANOMED NANOBI, V2, P478, DOI 10.1002/wnan.74
   Zhang Y, 2012, CENT EUR J ENG, V2, P325, DOI DOI 10.2478/S13531-012-0016-2
NR 150
TC 10
Z9 10
U1 1
U2 69
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2013
VL 101
IS 8
BP 1571
EP 1584
DI 10.1002/jbm.b.32968
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 272HF
UT WOS:000328450200026
PM 23744715
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Samal, SK
   Kaplan, DL
   Chiellini, E
AF Samal, Sangram K.
   Kaplan, David L.
   Chiellini, Emo
TI Ultrasound Sonication Effects on Silk Fibroin Protein
SO MACROMOLECULAR MATERIALS AND ENGINEERING
LA English
DT Article
DE biomaterial; electrophoresis; silk fibroin protein; sonication; tissue
   engineering
ID CONTROLLED DRUG-DELIVERY; BOMBYX-MORI; AQUEOUS-SOLUTIONS;
   MOLECULAR-WEIGHT; BIOMATERIALS; POLYMERS; GENERATION; CHEMISTRY;
   MECHANISM; HYDROGELS
AB The utilization of silk fibroin protein (SFP) in the field of biomaterials and tissue engineering plays an important role due to its promising mechanical, biological, and processing properties. In the present study, SFP solutions were exposed to ultrasound sonication to assess impact on molecular weight (Mw), sol-gel transition behavior, and physico-chemical properties. The Mw of SFP was significantly reduced with sonication, determined by sodium dodecyl sulfate polyacrylamide gels (SDS-PAGE) gel electrophoresis. Sol-gel transitions were observed as SFP assembled to form a reversible SFP gel network at different concentrations and sonication time with the formation of a -sheet-rich conformation in the gel state. The conformational changes and morphological properties were correlated over a range of SFP concentrations by circular dichroism (CD), UV spectroscopy, swelling and attenuated total reflectance fourier transformed infrared spectroscopy (ATR-FTIR).
C1 [Samal, Sangram K.; Chiellini, Emo] Univ Pisa, Dept Chem & Ind Chem, BioLab UdR INSTM, I-56122 Pisa, Italy.
   [Samal, Sangram K.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Samal, Sangram K.] Univ Ghent, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Samal, Sangram/H-5442-2013
FU Bimolecular Sciences School, University of Pisa, Italy; NIH [EB002520]
FX Authors would like to thank Xiaoqin Wang, Mamoni Dash, Carmen Preda, and
   Guokui Qin for their technical help. The authors would also like to
   thank Bimolecular Sciences School, University of Pisa, Italy, and the
   NIH (EB002520) for financial support.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asakura T, 2002, BIOCHEMISTRY-US, V41, P4415, DOI 10.1021/bi0119013
   Bang JH, 2010, ADV MATER, V22, P1039, DOI 10.1002/adma.200904093
   Cho HJ, 2012, POLYM DEGRAD STABIL, V97, P1060, DOI 10.1016/j.polymdegradstab.2012.03.007
   Cravotto G, 2012, CHEM SCI, V3, P295, DOI 10.1039/c1sc00740h
   Donna W, 2000, BIOPHYS J, V78, P2690
   DOULAH MS, 1978, J APPL POLYM SCI, V22, P1735, DOI 10.1002/app.1978.070220622
   Fan X., 2008, NUCLEIC ACIDS RES, V36, P125
   Fang XW, 1996, ULTRASON SONOCHEM, V3, P57, DOI 10.1016/1350-4177(95)00032-1
   Fedel M, 2012, J BIOACT COMPAT POL, V27, P295, DOI 10.1177/0883911512446060
   Gil ES, 2005, MACROMOL BIOSCI, V5, P702, DOI 10.1002/mabi.200500076
   GRINSTAFF MW, 1991, P NATL ACAD SCI USA, V88, P7708, DOI 10.1073/pnas.88.17.7708
   Hawkins CL, 2001, BBA-BIOENERGETICS, V1504, P196, DOI 10.1016/S0005-2728(00)00252-8
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Maity I, 2012, SOFT MATTER, V8, P5301, DOI 10.1039/c2sm25126d
   MAKINO K, 1983, J PHYS CHEM-US, V87, P1369, DOI 10.1021/j100231a020
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Motta A, 2009, J BIOMAT SCI-POLYM E, V20, P1875, DOI 10.1163/156856208X399936
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nguyen TQ, 1997, POLYMER, V38, P3783, DOI 10.1016/S0032-3861(96)00950-0
   Paulusse JMJ, 2006, J POLYM SCI POL CHEM, V44, P5445, DOI 10.1002/pola.21646
   PRICE GJ, 1993, ULTRASONICS, V31, P451, DOI 10.1016/0041-624X(93)90055-5
   RIESZ P, 1985, ENVIRON HEALTH PERSP, V64, P233, DOI 10.2307/3430013
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stathopulos PB, 2004, PROTEIN SCI, V13, P3017, DOI 10.1110/ps.04831804
   Suslick KS, 1999, ANNU REV MATER SCI, V29, P295, DOI 10.1146/annurev.matsci.29.1.295
   Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wei YS, 2003, BIOPOLYMERS, V72, P345, DOI 10.1002/bip.10436
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wong SS, 2012, FOOD HYDROCOLLOID, V26, P365, DOI 10.1016/j.foodhyd.2011.02.028
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Wu T, 2008, J AGR FOOD CHEM, V56, P5112, DOI 10.1021/jf073136q
   Yonemura N, 2009, J MOL EVOL, V68, P641, DOI 10.1007/s00239-009-9234-5
   Yu L, 2010, BIOMACROMOLECULES, V11, P2766, DOI 10.1021/bm1008316
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 49
TC 20
Z9 20
U1 10
U2 63
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-7492
EI 1439-2054
J9 MACROMOL MATER ENG
JI Macromol. Mater. Eng.
PD NOV
PY 2013
VL 298
IS 11
BP 1201
EP 1208
DI 10.1002/mame.201200377
PG 8
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA 268DU
UT WOS:000328149600008
DA 2018-10-20
ER

PT J
AU Zhan, KH
   Bai, L
   Xu, JM
AF Zhan, Kuihua
   Bai, Lun
   Xu, Jianmei
TI Role of vascular endothelial progenitor cells in construction of new
   vascular loop
SO MICROVASCULAR RESEARCH
LA English
DT Article
ID BONE-MARROW; POSTNATAL NEOVASCULARIZATION; TUMOR ANGIOGENESIS; HYPOXIA;
   VEGF; GROWTH; PATHWAY; VASCULOGENESIS; MORPHOGENESIS; MECHANISMS
AB Since bone marrow-derived endothelial progenitor cells (EPCs) have been detected in adult peripheral blood, the mode of vasculogenesis in the adult tissue has caught attention in field of vascularization research. To confirm the role of EPCs in construction of new vascular loop, we took the biomaterial scaffold implanted into adult rat as an experimental model to observe and examine the actions of the EPCs in neovascularization of the material by immunohistochemistry and transmission electron microscopy. Additionally, by establishing a chemotactic migration model for vascular endothelial cells (ECs) and EPCs, the migrations of ECs and EPCs were explored in simulations. The results of 20,000 simulations showed that the number of the vascular loops assisted by the EPCs was 2-5 times that of the vascular sprouts being naturally joined. Based on the results of experiments and simulations, we conclude that the EPCs are able to assist the angiogenic sprouts in joining under the condition of plenty of the EPCs being mobilized, which aggregate at sites close to sprout tips, forming a cell cord and differentiating to ECs in situ, and become vessel segments between neighboring sprouts. This suggests that there is a difference between the adult and embryo in the manner of vasculogenesis and that a small number of EPCs can play an important role to make the new blood vessels achieve rapid functionalization. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Zhan, Kuihua] Soochow Univ, Sch Mech & Elect Engn, Suzhou 215006, Peoples R China.
   [Zhan, Kuihua; Bai, Lun; Xu, Jianmei] Soochow Univ, Coll Text & Clothing Engn, Suzhou 215006, Peoples R China.
RP Zhan, KH (reprint author), Soochow Univ, Sch Mech & Elect Engn, 178 Ganjiang East Rd, Suzhou 215006, Peoples R China.
EM zhankuihua@suda.edu.cn; bailun@suda.edu.cn; xujianmei@suda.edu.cn
OI Zhan, Kuihua/0000-0003-3638-9743
FU National Key Basic Research and Developing Project of China: Basic
   Research of the Tissue Inducing Biomaterial Used in Medicine
   [2005CB623906]
FX We thank Mingzhong Li for assisting with the material preparation; Baoqi
   Zuo, Liang Xie and Xinhong Wang for assisting with the animal
   experiments. We also acknowledge the reviewers for their exhaustive and
   useful comments. This work was partially supported by the National Key
   Basic Research and Developing Project of China: Basic Research of the
   Tissue Inducing Biomaterial Used in Medicine (Project no. 2005CB623906).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042
   Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017
   ARMSTRONG PB, 1972, J CELL BIOL, V55, P542, DOI 10.1083/jcb.55.3.542
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964
   Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745
   Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025
   Brat DJ, 2003, ANN INTERN MED, V138, P659, DOI 10.7326/0003-4819-138-8-200304150-00014
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Crosby JR, 2000, CIRC RES, V87, P728, DOI 10.1161/01.RES.87.9.728
   De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423
   Distler JHW, 2003, Q J NUCL MED, V47, P149
   Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3
   Djonov VG, 2002, DEV DYNAM, V224, P391, DOI 10.1002/dvdy.10119
   Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010
   Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275
   Fong GH, 2008, ANGIOGENESIS, V11, P121, DOI 10.1007/s10456-008-9107-3
   Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224
   Gehling UM, 2008, MEMO-MAG EUR MED ONC, V1, P3, DOI 10.1007/s12254-008-0003-8
   Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Guan GP, 2010, BIO-MED MATER ENG, V20, P295, DOI 10.3233/BME-2010-0643
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571
   Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081
   Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7
   Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5
   Huang PP, 2004, THROMB HAEMOSTASIS, V91, P606
   Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4
   Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315
   Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596
   Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614
   Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104
   Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307
   Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102
   Peichev M, 2000, BLOOD, V95, P952
   Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007
   Ramjaun AR, 2009, INT J BIOCHEM CELL B, V41, P521, DOI 10.1016/j.biocel.2008.05.030
   Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327
   RISAU W, 1988, DEVELOPMENT, V102, P471
   Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   Werner N, 2007, BASIC RES CARDIOL, V102, P565, DOI 10.1007/s00395-007-0680-1
   Zhan K., 2010, ADV MAT RES, V175-176, P181
NR 50
TC 9
Z9 11
U1 1
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0026-2862
EI 1095-9319
J9 MICROVASC RES
JI Microvasc. Res.
PD NOV
PY 2013
VL 90
BP 1
EP 11
DI 10.1016/j.mvr.2013.06.010
PG 11
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 272BJ
UT WOS:000328435000001
PM 23851047
DA 2018-10-20
ER

PT J
AU Bergmann, M
   Ledernez, L
   Dame, G
   Lickert, S
   Widmer, F
   Gier, Y
   Urban, G
AF Bergmann, Michael
   Ledernez, Loic
   Dame, Gregory
   Lickert, Sebastian
   Widmer, Frank
   Gier, Yvonne
   Urban, Gerald
TI Nanofilms Produced by Magnetron Enhanced Plasma Polymerization from
   Methane and Oxygen for Coating of Rigid Contact Lenses
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE biocompatibility; coatings; contact lenses; protein adsorption;
   wettability
ID PROTEIN ADSORPTION; GLOW-DISCHARGE; BIOMATERIAL SURFACES; DEPOSITION;
   ETHER; SILICONE; FILMS; HYDROGELS; LYSOZYME
AB Although soft contact lenses are more widespread, rigid contact lenses have been around for decades and their materials have been greatly improved, especially in terms of oxygen permeability. Protein adsorption and wettability are, however, complex challenges still faced by both soft and rigid contact lenses (CLs). This study aims at improving these two major attributes by means of a low-pressure magnetron enhanced 15kHz plasma polymerization process. The wide parameter range of the process allowed the tailoring of the surface properties and delivered stable, reproducible plasma coatings. The XPS, FT-IR, WCA, and QCM surface analysis methods were used to study the nanofilms. A contact angle of down to 18 degrees and a protein (lysozyme) adsorption of only 0.2 mu gcm(-2) were achieved. Some correlations with the more commonly used PEO-like coatings helped to explain the measurement results.
C1 [Bergmann, Michael; Ledernez, Loic; Dame, Gregory; Lickert, Sebastian; Urban, Gerald] Univ Freiburg, Dept Microsyst Engn, D-79110 Freiburg, Germany.
   [Widmer, Frank; Gier, Yvonne] Hecht Contactlinsen GmbH, D-79280 Au, Germany.
RP Bergmann, M (reprint author), Univ Freiburg, Dept Microsyst Engn, Georges Kohler Allee 103, D-79110 Freiburg, Germany.
EM michael.bergmann@imtek.de
RI URBAN, Gerald/H-7893-2014
CR Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   Bleshoy H, 1994, ICLC, V21, P82
   BOHNERT JL, 1988, INVEST OPHTH VIS SCI, V29, P362
   Bontempo AR, 1997, CURR EYE RES, V16, P1258, DOI 10.1076/ceyr.16.12.1258.5033
   Brennan N. A., 2002, ICLC, V27, P76
   CASTILLO EJ, 1985, BIOMATERIALS, V6, P338, DOI 10.1016/0142-9612(85)90089-4
   CASTILLO EJ, 1986, BIOMATERIALS, V7, P89, DOI 10.1016/0142-9612(86)90062-1
   Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4
   Choukourov A., 2010, PLASMA PROCESS POLYM, V6, P445
   Choukourov A, 2012, PLASMA PROCESS POLYM, V9, P48, DOI 10.1002/ppap.201100122
   Donshik P C, 1999, Trans Am Ophthalmol Soc, V97, P205
   FAKES DW, 1987, SURF INTERFACE ANAL, V10, P416, DOI 10.1002/sia.740100807
   Fromme R., 2010, PLASMA OBERFLACHENTE
   GELLATLY KW, 1988, AM J OPTOM PHYS OPT, V65, P937
   Glasier MA, 2008, CURR EYE RES, V33, P1, DOI 10.1080/02713680701830278
   Gonzalez-Meijome JM, 2006, J BIOMED MATER RES B, V76B, P412, DOI 10.1002/jbm.b.30387
   Grobe G. L., 2006, [No title captured], Patent No. [US 7094458 B2, 7094458]
   HO CP, 1988, J BIOMED MATER RES, V22, P919, DOI 10.1002/jbm.820221007
   Janiak C, 2001, CHEM UNSERER ZEIT, V35, P348, DOI 10.1002/1521-3781(200112)35:6<348::AID-CIUZ348>3.0.CO;2-F
   Johnston EE, 2005, LANGMUIR, V21, P870, DOI 10.1021/la036274s
   Jones I., 2006, CONTACT LENS MONTHLY, V232, P28
   Jones L, 2000, OPTOMETRY VISION SCI, V77, P503, DOI 10.1097/00006324-200010000-00004
   Jones L, 2003, EYE CONTACT LENS, V29, P75
   Jones L., 2004, SILICONE HYDROGEL 1
   Jones L., 2007, LINSEN MAT, V6, P78
   Lam CNC, 2002, ADV COLLOID INTERFAC, V96, P169, DOI 10.1016/S0001-8686(01)00080-X
   Ledernez L, 2007, PLASMA CHEM PLASMA P, V27, P659, DOI 10.1007/s11090-007-9098-7
   Ledernez L., 2007, PLASMA PROCESS POLYM, V4, P794
   Ledernez L., 2011, INVESTIGATION MAGNET
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Lopez-Alemany A, 2002, J BIOMED MATER RES, V63, P319, DOI 10.1002/jbm.10186
   Morgan P., 2009, TEAR FILM PROTEINS S
   Morra M, 2001, WATER BIOMATERIALS S
   Sardella E, 2004, PLASMA PROCESS POLYM, V1, P63, DOI 10.1002/ppap.200400013
   Sardella E., 2001, PLASMAS POLYM, V1, P163
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   Shin H. S., 2009, J KOREAN PHYS SOC, V6, P2436
   Shinko Seiki, S SEIKIS VACUUM PLAS
   Szczotka-Flynn L., 2010, CONTACT LENS SPECTR, V9, P1
   TRIPATHI PC, 1992, INVEST OPHTH VIS SCI, V33, P121
   Van Beek M, 2008, BIOMATERIALS, V29, P780, DOI 10.1016/j.biomaterials.2007.10.039
   WEDLER FC, 1977, J BIOMED MATER RES, V11, P525, DOI 10.1002/jbm.820110408
   Weikart CM, 2000, LANGMUIR, V16, P5169, DOI 10.1021/la991152e
   Yan G., 1992, INVEST OPHTH VIS SCI, V34, P1804
   Yasuda H, 2006, MACROMOL BIOSCI, V6, P121, DOI 10.1002/mabi.200500153
   Yasuda H, 2005, PLASMA PROCESS POLYM, V2, P507, DOI 10.1002/ppap.200500002
   Yasuda H., 2005, LUMINOUS CHEM VAPOR
   Yasuda H., 1985, PLASMA POLYM
   Yu Z.-J., 2006, REV CORNEA CONTACT L, V6, P42
   Zhang Z, 2003, LANGMUIR, V19, P4765, DOI 10.1021/la026980d
   Zhang ZH, 2011, PLASMA PROCESS POLYM, V8, P923, DOI 10.1002/ppap.201000156
NR 51
TC 6
Z9 6
U1 1
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1612-8850
EI 1612-8869
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD NOV
PY 2013
VL 10
IS 11
BP 970
EP 977
DI 10.1002/ppap.201300028
PG 8
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 270LU
UT WOS:000328320700005
DA 2018-10-20
ER

PT J
AU Zeng, RC
   Sun, XX
   Song, YW
   Zhang, F
   Li, SQ
   Cui, HZ
   Han, EH
AF Zeng, Rong-chang
   Sun, Xin-xin
   Song, Ying-wei
   Zhang, Fen
   Li, Shuo-qi
   Cui, Hong-zhi
   Han, En-hou
TI Influence of solution temperature on corrosion resistance of Zn-Ca
   phosphate conversion coating on biomedical Mg-Li-Ca alloys
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE magnesium alloy; lithium; calcium; phosphate conversion coating;
   corrosion; biomaterial
ID AZ91D MAGNESIUM ALLOY; IN-VIVO CORROSION; ZINC PHOSPHATE; HANKS
   SOLUTION; MG-8LI ALLOY; AZ31; FILM; OXIDATION; BEHAVIOR; VITRO
AB The influence of phosphating bath at different temperatures on the formation and corrosion property of calcium-modified zinc phosphate conversion coating (Zn-Ca-P coating) on Mg-Li-Ca alloy was investigated. The morphologies, elemental distribution and chemical structures of the coatings were examined via SEM, EPMA, EDS, XRD and FT-IR. The corrosion resistance was assessed by hydrogen evolution, potentiodynamic polarization and EIS. The results show that the coating is composed of single element Zn and ZnO at below 45 degrees C; whereas the coatings are predominantly characterized by Zn-3(PO4)(2)center dot 4H(2)O and small amount of element zinc and ZnO at above 50 degrees C. Mg-Li-Ca alloy with Zn-Ca-P coatings prepared at 55 degrees C has the highest corrosion resistance. However, the hydrogen evolution rates of the coatings obtained at 40-50 degrees C is accelerated due to the galvanic corrosion between the imperfection of the single element Zn coating and the Mg substrate.
C1 [Zeng, Rong-chang; Sun, Xin-xin; Zhang, Fen; Li, Shuo-qi; Cui, Hong-zhi] Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.
   [Zeng, Rong-chang; Song, Ying-wei; Han, En-hou] Chinese Acad Sci, Inst Met Res, State Key Lab Corros & Protect, Shenyang 110016, Peoples R China.
RP Zeng, RC (reprint author), Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.
EM rczeng@foxmail.com
RI Zeng, Rong-Chang/H-4154-2011
OI Zeng, Rong-Chang/0000-0002-5945-3851
FU National Natural Science Foundation of China [51241001]; Natural Science
   Foundation of Shandong Province, China [ZR2011EMM004]; Open Foundation
   of State Key Laboratory for Corrosion and Protection, China
   [SKLCP21012KF03]; Taishan Scholarship Project of Shandong Province,
   China [TS20110828]
FX Foundation item: Project (51241001) supported by the National Natural
   Science Foundation of China; Project (ZR2011EMM004) supported by the
   Natural Science Foundation of Shandong Province, China; Project (
   SKLCP21012KF03) supported by the Open Foundation of State Key Laboratory
   for Corrosion and Protection, China; Project (TS20110828) supported by
   Taishan Scholarship Project of Shandong Province, China
CR Arrabal R, 2012, SURF COAT TECH, V206, P4692, DOI 10.1016/j.surfcoat.2012.05.091
   Barchiche CE, 2007, ELECTROCHIM ACTA, V53, P417, DOI 10.1016/j.electacta.2007.04.030
   Brunelli K, 2005, CORROS SCI, V47, P989, DOI 10.1016/j.corsci.2004.06.016
   Chen J, 2011, T NONFERR METAL SOC, V21, P936, DOI 10.1016/S1003-6326(11)60804-2
   Chen XB, 2012, CORROS SCI, V55, P226, DOI 10.1016/j.corsci.2011.10.022
   Gao JC, 2008, T NONFERR METAL SOC, V18, P588, DOI 10.1016/S1003-6326(08)60102-8
   Gao LL, 2009, J ALLOY COMPD, V485, P789, DOI 10.1016/j.jallcom.2009.06.089
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Herschke L, 2006, J MATER SCI-MATER M, V17, P81, DOI 10.1007/s10856-006-6332-4
   Jin He-xi, 2011, Chinese Journal of Nonferrous Metals, V21, P2049
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu Feng, 2008, Chinese Journal of Nonferrous Metals, V18, P1825
   Mark P. S., 2006, BIOMATERIALS, V27, P1728
   Moore KL, 2008, CORROS SCI, V50, P3221, DOI 10.1016/j.corsci.2008.08.012
   Niu LY, 2006, SURF COAT TECH, V200, P3021, DOI 10.1016/j.surfcoat.2004.10.119
   Shi P, 2009, J ALLOY COMPD, V469, P286, DOI 10.1016/j.jallcom.2008.01.102
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song YW, 2007, ELECTROCHIM ACTA, V53, P2009, DOI 10.1016/j.electacta.2007.08.062
   Song YW, 2009, SURF COAT TECH, V203, P1107, DOI 10.1016/j.surfcoat.2008.10.004
   Van Phuong N., 2013, METALS MAT INT, V19, P273
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009
   YANG Guang-yu, 2004, FOUNDRY TECHNOLOGY, V25, P19
   Yang LH, 2008, APPL SURF SCI, V255, P2338, DOI 10.1016/j.apsusc.2008.07.094
   Yang LH, 2009, J ALLOY COMPD, V471, P197, DOI 10.1016/j.jallcom.2008.03.041
   Yang XW, 2009, J ALLOY COMPD, V487, P64, DOI 10.1016/j.jallcom.2009.07.113
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zeng R, 2008, ADV ENG MAT, V10
   Zeng Rong-chang, 2010, Chinese Journal of Nonferrous Metals, V20, P1461
   Zeng RC, 2011, ACTA METALL SIN, V47, P1477, DOI 10.3724/SP.J.1037.2011.00325
   Zeng RC, 2011, SURF COAT TECH, V205, P3347, DOI 10.1016/j.surfcoat.2010.11.027
   Zhang CY, 2010, SURF COAT TECH, V204, P3636, DOI 10.1016/j.surfcoat.2010.04.038
   Zhang CH, 2008, MATER LETT, V62, P2177, DOI 10.1016/j.matlet.2007.11.044
   Zhang Rong-fa, 2006, Chinese Journal of Nonferrous Metals, V16, P1136
   Zhang XB, 2012, MATER LETT, V66, P209, DOI 10.1016/j.matlet.2011.08.079
NR 37
TC 24
Z9 30
U1 4
U2 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1003-6326
EI 2210-3384
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD NOV
PY 2013
VL 23
IS 11
BP 3293
EP 3299
DI 10.1016/S1003-6326(13)62866-6
PG 7
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 273WR
UT WOS:000328567500019
DA 2018-10-20
ER

PT J
AU Ko, IK
   Lee, SJ
   Atala, A
   Yoo, JJ
AF Ko, In Kap
   Lee, Sang Jin
   Atala, Anthony
   Yoo, James J.
TI In situ tissue regeneration through host stem cell recruitment
SO EXPERIMENTAL AND MOLECULAR MEDICINE
LA English
DT Review
DE bioactive molecules; biomaterials; in situ tissue regeneration; protein
   delivery system; stem cells; tissue engineering
ID BONE MORPHOGENETIC PROTEIN-2; COLLAGEN SPONGE SCAFFOLD; HUMAN
   HEMATOPOIETIC STEM; PROGENITOR CELLS; GROWTH-FACTOR;
   MYOCARDIAL-INFARCTION; MUSCLE REGENERATION; VASCULAR GRAFT; HOMING
   FACTOR; SUBSTANCE-P
AB The field of tissue engineering has made steady progress in translating various tissue applications. Although the classical tissue engineering strategy, which involves the use of culture-expanded cells and scaffolds to produce a tissue construct for implantation, has been validated, this approach involves extensive cell expansion steps, requiring a lot of time and laborious effort before implantation. To bypass this ex vivo process, a new approach has been introduced. In situ tissue regeneration utilizes the body's own regenerating capacity by mobilizing host endogenous stem cells or tissue-specific progenitor cells to the site of injury. This approach relies on development of a target-specific biomaterial scaffolding system that can effectively control the host microenvironment and mobilize host stem/progenitor cells to target tissues. An appropriate microenvironment provided by implanted scaffolds would facilitate recruitment of host cells that can be guided to regenerating structural and functional tissues.
C1 [Ko, In Kap; Lee, Sang Jin; Atala, Anthony; Yoo, James J.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Yoo, JJ (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM jyoo@wakehealth.edu
RI Yoo, James/L-4850-2017
OI Atala, Anthony/0000-0001-8186-2160; Lee, Sang Jin/0000-0002-3899-1909
FU Armed Forces Institute for Regenerative Medicine [W81XWH-08-2-0032]
FX We thank Dr John D Jackson for editorial assistance. This work was
   supported, in part, by the Armed Forces Institute for Regenerative
   Medicine (W81XWH-08-2-0032).
CR Abbushi A, 2008, SPINE, V33, P1527, DOI 10.1097/BRS.0b013e3181788760
   Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111
   Amadesi S, 2012, CIRCULATION, V125, P1774, DOI 10.1161/CIRCULATIONAHA.111.089763
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak Stephen F., 2005, Anatomical Record Part B:The New Anatomist, V287, P36, DOI 10.1002/ar.b.20081
   Barnes B, 2005, SPINE, V30, P1127, DOI 10.1097/01.brs.0000162623.48058.8c
   Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385
   Burkus JK, 2002, SPINE, V27, P2396, DOI 10.1097/01.BRS.0000030193.26290.DD
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008
   Capoccia BJ, 2006, BLOOD, V108, P2438, DOI 10.1182/blood-2006-04-013755
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V44, P146, DOI 10.1002/bit.260440121
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606
   Dahms SE, 1998, NEUROUROL URODYNAM, V17, P37
   De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15
   De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016
   Deasy BM, 2002, CURR OPIN MOL THER, V4, P382
   Elia R, 2010, BIOMATERIALS, V31, P4630, DOI 10.1016/j.biomaterials.2010.02.043
   Erggelet C, 2007, BIOMATERIALS, V28, P5570, DOI 10.1016/j.biomaterials.2007.09.005
   Erggelet C, 2009, J ORTHOP RES, V27, P1353, DOI 10.1002/jor.20879
   Freed L. E., 1994, NAT BIOTECHNOL, V12, P689
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2007, ANN THORAC SURG, V83, P648, DOI 10.1016/j.athoracsur.2006.06.085
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   GILDING DK, 1981, BIOCOMPATIBILITY CLI, P209
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Green EM, 2013, PHYSIOL REV, V93, P311, DOI 10.1152/physrev.00005.2012
   Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007
   Haidar ZS, 2010, BIOMATERIALS, V31, P2746, DOI 10.1016/j.biomaterials.2009.12.034
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Herberg S, 2008, J CLIN PERIODONTOL, V35, P976, DOI 10.1111/j.1600-051X.2008.01323.x
   Hong HS, 2009, NAT MED, V15, P425, DOI 10.1038/nm.1909
   Hong HS, 2011, ARCH PHARM RES, V34, P2003, DOI 10.1007/s12272-011-1221-x
   Hori Y, 2001, ASAIO J, V47, P206, DOI 10.1097/00002480-200105000-00008
   Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Iwai S, 2005, ANN THORAC SURG, V80, P1821, DOI 10.1016/j.athoracsur.2005.03.139
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   JARCHO M, 1977, J BIOENG, V1, P79
   Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400
   Jordan JE, 2012, J THORAC CARDIOV SUR, V143, P201, DOI 10.1016/j.jtcvs.2011.10.005
   Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107
   Kin S, 2007, ASAIO J, V53, P506, DOI 10.1097/MAT.0b013e3180d09d81
   Ko IK, 2012, FASEB J, V26, P158, DOI 10.1096/fj.11-182998
   Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017
   Kubo M, 2007, ACTA ORTHOP, V78, P845, DOI 10.1080/17453670710014653
   Kuwabara F, 2012, ANN THORAC SURG, V93, P156, DOI 10.1016/j.athoracsur.2011.07.055
   LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338
   Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Lee SJ, 2008, REJUV RES, V11, P747, DOI 10.1089/rej.2008.0691
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Lee SJ, 2008, BIOMATERIALS, V29, P1422, DOI 10.1016/j.biomaterials.2007.11.024
   Liang YY, 2011, BIOMATERIALS, V32, P2004, DOI 10.1016/j.biomaterials.2010.11.021
   Lim TC, 2013, FASEB J, V27, P1023, DOI 10.1096/fj.12-221515
   Louridas M, 2009, BIOCHEM BIOPH RES CO, V390, P867, DOI 10.1016/j.bbrc.2009.10.064
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mabilleau G, 2008, BIOMATERIALS, V29, P1593, DOI 10.1016/j.biomaterials.2007.12.01
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009
   Matsumura G, 2013, BIOMATERIALS, V34, P6422, DOI 10.1016/j.biomaterials.2013.05.037
   MCNIECE IK, 1995, J LEUKOCYTE BIOL, V58, P14
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Nakahara T, 2003, TISSUE ENG, V9, P153, DOI 10.1089/107632703762687636
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813
   Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa
   Piacquadio D, 1997, J AM ACAD DERMATOL, V36, P544, DOI 10.1016/S0190-9622(97)70241-X
   Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017
   Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Urita Y, 2007, PEDIATR SURG INT, V23, P21, DOI 10.1007/s00383-006-1799-0
   Vanden Berg-Foels WS, TISSUE ENG PART B-RE, DOI [10.1089/ten.teb.2013.0100, DOI 10.1089/TEN.TEB.2013.0100)]
   Woo BH, 2001, PHARMACEUT RES, V18, P1600, DOI 10.1023/A:1013090700443
   Woodruff MA, 2007, J MOL HISTOL, V38, P425, DOI 10.1007/s10735-007-9137-y
   Yamamoto M, 2006, TISSUE ENG, V12, P1305, DOI 10.1089/ten.2006.12.1305
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   Yokota T, 2008, J THORAC CARDIOV SUR, V136, P900, DOI 10.1016/j.jtcvs.2008.02.058
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013
   Zhang Y, 2003, WORLD J GASTROENTERO, V9, P201, DOI 10.3748/wjg.v9.i2.201
   Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047
   Zhou M, 2010, J BIOMED MATER RES A, V95A, P600, DOI 10.1002/jbm.a.32864
NR 115
TC 79
Z9 80
U1 2
U2 50
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1226-3613
EI 2092-6413
J9 EXP MOL MED
JI Exp. Mol. Med.
PD NOV
PY 2013
VL 45
AR e57
DI 10.1038/emm.2013.118
PG 11
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA 267UO
UT WOS:000328123900007
PM 24232256
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Zhang, Q
   Li, MZ
   Li, JQ
   Yan, SQ
   Xu, WL
AF Zhang, Qiang
   Li, Mingzhong
   Li, Jianqiang
   Yan, Shuqin
   Xu, Weilin
TI Mechanism of Silk Fibroin Scaffolds with Oriented Multichannels and Its
   Cytocompatibility
SO FIBERS AND POLYMERS
LA English
DT Article
DE Silk fibroin; Directional temperature field freezing; Oriented channels;
   In vitro
ID MESENCHYMAL STEM-CELLS; SPINAL-CORD-INJURY; GROWTH; REGENERATION; RAT;
   PROLIFERATION; FABRICATION
AB As a biomaterial, besides excellent biocompatibility and biodegradability, suitable macropores and pores structure should be provided to guide cell extension and migration. In present study, the silk fibroin (SF) scaffold with uniaxial channels was prepared by directional temperature field freezing technique. The average. pore diameter, pore density and porosity of the scaffold with oriented channels are similar to 128.7 mu m, similar to 158 mm(-2) and similar to 91.4 %, respectively. By controlling of the temperature gradient direction, the oriented multichannels of the scaffolds were formed in longitudinal easily. In process of the scaffolds fabrication, the directional growth of ice crystal could shear and draft to the silk fibroin molecule segments, which resulted in the new crystal nucleus formation in new zone and increase of beta-sheet components in the scaffolds. In vitro, L929 cells were seeded on the scaffolds with oriented channels to evaluate the effect on cell behavior. Cell viability, adhesion and morphology were determined by methyl thiazolyl tetrazolium, confocal microscope and scanning electron microscope. The results showed that the cells anchored on the oriented channels, spread along the direction of the channels and hold a higher viability on the scaffolds with oriented channels. These new oriented multichannel scaffold could guide the adhesion and proliferation of L929 cells, which hold a potential in tissue engineering.
C1 [Zhang, Qiang; Li, Jianqiang; Yan, Shuqin] Wuhan Text Univ, Coll Text Sci & Engn, Wuhan 430073, Peoples R China.
   [Li, Mingzhong] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Zhang, Qiang; Xu, Weilin] Wuhan Text Univ, Hubei Key Lab New Text Mat & Applicat, Wuhan 430073, Peoples R China.
RP Xu, WL (reprint author), Wuhan Text Univ, Hubei Key Lab New Text Mat & Applicat, Wuhan 430073, Peoples R China.
EM weilin_xu@hotmail.com
FU National Natural Science Foundation of China [30970714]; Wuhan Textile
   University [125010, 125018]
FX This work was supported by the National Natural Science Foundation of
   China (30970714) and Introduction funding of Wuhan Textile University
   (125010, 125018).
CR Benfenati V, 2012, ADV FUNCT MATER, V22, P1871, DOI 10.1002/adfm.201102310
   Chamberlain LJ, 2000, J NEUROSCI RES, V60, P666, DOI 10.1002/(SICI)1097-4547(20000601)60:5<666::AID-JNR12>3.0.CO;2-0
   Fu QA, 2010, J BIOMED MATER RES A, V95A, P235, DOI 10.1002/jbm.a.32827
   Fuhrmann T, 2010, BIOMATERIALS, V31, P7705, DOI 10.1016/j.biomaterials.2010.06.060
   Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Kasoju N., 2012, BIOMED MATER, V1, P5004
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Luan XY, 2006, BIOMED MATER, V1, P181, DOI 10.1088/1748-6041/1/4/001
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023
   Park SH, 2008, ACTA BIOMATER, V4, P1198, DOI 10.1016/j.actbio.2008.03.019
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Tejeda-Montes E, 2012, ACTA BIOMATER, V8, P998, DOI 10.1016/j.actbio.2011.09.005
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wang G, 2010, ACTA BIOMATER, V6, P3630, DOI 10.1016/j.actbio.2010.03.039
   Wittmer CR, 2011, ADV FUNCT MATER, V21, P4232, DOI 10.1002/adfm.201100755
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zhang Q, 2012, ACTA BIOMATER, V8, P2628, DOI 10.1016/j.actbio.2012.03.033
   Zhang Q, 2009, MATERIALS, V2, P2276, DOI 10.3390/ma2042276
   Zorlutuna P, 2010, J TISSUE ENG REGEN M, V4, P628, DOI 10.1002/term.278
NR 28
TC 1
Z9 1
U1 1
U2 26
PU KOREAN FIBER SOC
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CTR #501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1229-9197
EI 1875-0052
J9 FIBER POLYM
JI Fiber. Polym.
PD NOV
PY 2013
VL 14
IS 11
BP 1841
EP 1848
DI 10.1007/s12221-013-1841-5
PG 8
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA 261UD
UT WOS:000327689200008
DA 2018-10-20
ER

PT J
AU Zhou, ZH
   Cao, DF
   Huang, TL
   Liu, LL
   Liu, QQ
   Zhao, YM
   Ou, BL
   Zeng, WN
   Xu, GR
   Tang, AP
   Yang, ZM
AF Zhou, Z. H.
   Cao, D. F.
   Huang, T. L.
   Liu, L. L.
   Liu, Q. Q.
   Zhao, Y. M.
   Ou, B. L.
   Zeng, W. N.
   Xu, G. R.
   Tang, A. P.
   Yang, Z. M.
TI Fabrication and characterisation of gelatin-hyaluronic
   acid/nanobioactive glass hybrid scaffolds for tissue engineering
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE Gelatin; Hyaluronic acid; Nanobioactive glass; Hybrid scaffold
AB Nanobioactive glass (NBG) particles were synthesised via sol-gel method and characterised by transmission electron microscopy (TEM) and X-ray diffraction (XRD). The new composite biomaterial based on gelatin (Gel) conjugated with hyaluronic acid (HA) and NBG in the ternary SiO2-CaO-P2O5 system was prepared through freeze drying method. The composite scaffold was characterised by using Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and thermal analyses. Mechanical properties and swelling behaviour of this composite are compared with properties of Gel-HA/NBG composite of similar material without NBG. The TEM results indicated that the prepared NBG particle size was similar to 100 nm. The SEM studies showed that the NBG were homogenously distributed within the Gel/HA matrix and the composite scaffolds showed interconnected pores with a size varied from 50 to 200 mu m. The Gel-HA/NBG composite scaffold showed higher compressive strength and better stability than the Gel/HA scaffold. These results indicate that composite scaffolds developed using NBG disseminated Gel/HA matrix as potential scaffolds for tissue engineering applications.
C1 [Zhou, Z. H.] Hunan Univ Sci & Technol, Key Lab Theoret Chem & Mol Simulat, Minist Educ, Xiangtan, Peoples R China.
   [Zhou, Z. H.; Cao, D. F.; Liu, L. L.; Liu, Q. Q.; Zhao, Y. M.; Ou, B. L.; Zeng, W. N.; Xu, G. R.; Tang, A. P.; Yang, Z. M.] Hunan Univ Sci & Technol, Sch Chem & Chem Engn, Xiangtan, Peoples R China.
   [Huang, T. L.] Cent S Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China.
RP Zhou, ZH (reprint author), Hunan Univ Sci & Technol, Key Lab Theoret Chem & Mol Simulat, Minist Educ, Xiangtan, Peoples R China.
EM zhou7381@126.com
FU National Natural Science Fund of China [51273062]; Hunan Provincial
   Natural Science Foundation of China [12JJA003]; Scientific Research Fund
   of Hunan Provincial Education Department [11B045]; Aid program for
   Science and Technology Innovative Research Team in Higher Educational
   Institutions of Hunan Province
FX This work was financially supported by the National Natural Science Fund
   of China (grant no. 51273062), Hunan Provincial Natural Science
   Foundation of China (grant no. 12JJA003), the Scientific Research Fund
   of Hunan Provincial Education Department (grant no. 11B045) and the Aid
   program for Science and Technology Innovative Research Team in Higher
   Educational Institutions of Hunan Province.
CR Azami M, 2010, J POROUS MAT, V17, P313, DOI 10.1007/s10934-009-9294-3
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chang MC, 2003, BIOMATERIALS, V24, P3087, DOI 10.1016/S0142-9612(03)00150-9
   Chen MF, 2008, APPL SURF SCI, V254, P2730, DOI 10.1016/j.apsusc.2007.10.011
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
NR 6
TC 6
Z9 6
U1 1
U2 16
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
EI 1433-075X
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD NOV
PY 2013
VL 17
IS 7
BP 532
EP 536
DI 10.1179/1433075X13Y.0000000095
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 267CV
UT WOS:000328075200017
DA 2018-10-20
ER

PT J
AU Nizamoglu, S
   Gather, MC
   Yun, SH
AF Nizamoglu, Sedat
   Gather, Malte C.
   Yun, Seok Hyun
TI All-Biomaterial Laser Using Vitamin and Biopolymers
SO ADVANCED MATERIALS
LA English
DT Article
DE laser; biomaterial; biomolecule; vitamin; biopolymer; superhydrophobic
ID SINGLE; MICRODROPLETS; WATER; DNA; FLAVINS; PROTEIN; FIBERS; ACID
C1 [Nizamoglu, Sedat; Gather, Malte C.; Yun, Seok Hyun] Harvard Univ, Sch Med, Cambridge, MA 02139 USA.
   [Nizamoglu, Sedat; Gather, Malte C.; Yun, Seok Hyun] Massachusetts Gen Hosp, Wellman Ctr Photomed, Cambridge, MA 02139 USA.
   [Yun, Seok Hyun] Korea Adv Inst Sci & Technol, WCU Grad Sch Nanosci & Technol, Taejon 305701, South Korea.
   [Gather, Malte C.] Tech Univ Dresden, Inst Angew Photophys, D-01062 Dresden, Germany.
RP Yun, SH (reprint author), Harvard Univ, Sch Med, 65 Landsdowne St,UP 5, Cambridge, MA 02139 USA.
EM syun@hms.harvard.edu
RI Nizamoglu, Sedat/H-5845-2018
OI Nizamoglu, Sedat/0000-0003-0394-5790; Gather, Malte/0000-0002-4857-5562
FU Bullock-Wellman Fellowship; National Science Foundation [ECS-1101947];
   Center for Nanoscale Systems (CNS); NSF [ECS-0335765]
FX The authors thank Turgut Fettah Kosar for discussions on
   superhydrophobic surfaces and to Kyung-bok Lee for SEM images. Sedat
   Nizamoglu acknowledges financial support from the Bullock-Wellman
   Fellowship. This work was supported in part by a grant from the National
   Science Foundation (ECS-1101947) and by the Center for Nanoscale Systems
   (CNS), a member of the National Nanotechnology Infrastructure Network
   (NNIN), which is supported under NSF award no. ECS-0335765. CNS is part
   of Harvard University.
CR Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573
   Alves NM, 2009, J BIOMED MATER RES A, V91A, P480, DOI 10.1002/jbm.a.32210
   Callies M, 2005, SOFT MATTER, V1, P55, DOI 10.1039/b501657f
   Cannuccia E, 2011, CHEM PHYS, V389, P35, DOI 10.1016/j.chemphys.2011.07.020
   Capelli R, 2011, ORG ELECTRON, V12, P1146, DOI 10.1016/j.orgel.2011.04.005
   Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115
   Dupuis A, 2007, OPT LETT, V32, P109, DOI 10.1364/OL.32.000109
   Gather MC, 2011, OPT LETT, V36, P3299, DOI 10.1364/OL.36.003299
   Gather MC, 2011, NAT PHOTONICS, V5, P406, DOI [10.1038/nphoton.2011.99, 10.1038/NPHOTON.2011.99]
   Grote JG, 2005, MOL CRYST LIQ CRYST, V426, P3, DOI 10.1080/15421400590890615
   Grote JG, 2004, J PHYS CHEM B, V108, P8584, DOI 10.1021/jp038056d
   HEELIS PF, 1982, CHEM SOC REV, V11, P15, DOI 10.1039/cs9821100015
   Heo YJ, 2011, P NATL ACAD SCI USA, V108, P13399, DOI 10.1073/pnas.1104954108
   Holzer W, 2005, CHEM PHYS, V308, P69, DOI 10.1016/j.chemphys.2004.08.006
   Humar M, 2011, OPT EXPRESS, V19, P19836, DOI 10.1364/OE.19.019836
   Jenkins AL, 1999, ANAL CHEM, V71, P373, DOI 10.1021/ac980985r
   Jeong KH, 2006, SCIENCE, V312, P557, DOI 10.1126/science.1123053
   Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157
   Kim RH, 2012, SMALL, V8, P2812, DOI 10.1002/smll.201200943
   Kiraz A, 2007, OPT COMMUN, V276, P145, DOI 10.1016/j.optcom.2007.04.026
   LAM CC, 1992, J OPT SOC AM B, V9, P1585, DOI 10.1364/JOSAB.9.001585
   Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019
   LIN HB, 1992, J OPT SOC AM B, V9, P43, DOI 10.1364/JOSAB.9.000043
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Ostby EP, 2009, OPT LETT, V34, P1153, DOI 10.1364/OL.34.001153
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   QIAN SX, 1986, SCIENCE, V231, P486, DOI 10.1126/science.231.4737.486
   Schafer J, 2008, NANO LETT, V8, P1709, DOI 10.1021/nl080661a
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   Stalder AF, 2006, COLLOID SURFACE A, V286, P92, DOI 10.1016/j.colsurfa.2006.03.008
   Sun YZ, 2010, P NATL ACAD SCI USA, V107, P16039, DOI 10.1073/pnas.1003581107
   Toffanin S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4748120
   Tona M, 2000, J PHYS SOC JPN, V69, P3533, DOI 10.1143/JPSJ.69.3533
   Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221
NR 34
TC 50
Z9 50
U1 6
U2 89
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD NOV
PY 2013
VL 25
IS 41
BP 5943
EP 5947
DI 10.1002/adma201300818
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 261VO
UT WOS:000327692900016
PM 24425626
DA 2018-10-20
ER

PT J
AU Murray, P
   Prewitz, M
   Hopp, I
   Wells, N
   Zhang, HF
   Cooper, A
   Parry, KL
   Short, R
   Antoine, DJ
   Edgar, D
AF Murray, Patricia
   Prewitz, Marina
   Hopp, Isabel
   Wells, Nicola
   Zhang, Haifei
   Cooper, Andrew
   Parry, Kristina L.
   Short, Robert
   Antoine, Daniel J.
   Edgar, David
TI The self-renewal of mouse embryonic stem cells is regulated by
   cell-substratum adhesion and cell spreading
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Embryonic stem cells; Cell spreading; Biomaterials; E-cadherin; Rho
   kinase
ID E-CADHERIN; FATE DECISIONS; ROCK INHIBITOR; DIFFERENTIATION;
   PLURIPOTENCY; GROWTH; SHAPE; LIF; CYTOSKELETON; EXPRESSION
AB Mouse embryonic stem cells (mESCs) undergo self-renewal in the presence of the cytokine, leukaemia inhibitory factor (LIF). Following LIE withdrawal, mESCs differentiate, and this is accompanied by an increase in cell-substratum adhesion and cell spreading. The purpose of this study was to investigate the relationship between cell spreading and mESC differentiation. Using E14 and R1 mESC lines, we have restricted cell spreading in the absence of LIF by either culturing mESCs on chemically defined, weakly adhesive biomaterial substrates, or by manipulating the cytoskeleton. We demonstrate that by restricting the degree of spreading by either method, mESCs can be maintained in an undifferentiated and pluripotent state. Under these conditions, self-renewal occurs without the need for LIF and is independent of nuclear translocation of tyrosine-phosphorylated STAT3 or beta-catenin, which have previously been implicated in self-renewal. We also demonstrate that the effect of restricted cell spreading on mESC self-renewal is not mediated by increased intercellular adhesion, as evidenced by the observations that inhibition of mESC adhesion using a function blocking anti E-cadherin antibody or siRNA do not promote differentiation. These results show that mESC spreading and differentiation are regulated both by LIE and by cell-substratum adhesion, consistent with the hypothesis that cell spreading is the common intermediate step in the regulation of mESC differentiation by either LIP or cell-substratum adhesion. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
C1 [Murray, Patricia; Prewitz, Marina; Hopp, Isabel; Wells, Nicola; Antoine, Daniel J.; Edgar, David] Univ Liverpool, Inst Translat Med, Liverpool L69 3GE, Merseyside, England.
   [Zhang, Haifei; Cooper, Andrew] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.
   [Parry, Kristina L.; Short, Robert] Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England.
   [Short, Robert] Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia.
RP Murray, P (reprint author), Univ Liverpool, Inst Translat Med, Liverpool L69 3GE, Merseyside, England.
EM p.a.murray@liv.ac.uk
RI Zhang, Haifei/F-3868-2011; Prewitz, Marina/G-4482-2013
OI Zhang, Haifei/0000-0001-5142-5824; Murray, Patricia/0000-0003-1316-148X;
   Reinsch, Marina/0000-0003-1054-6456
FU Royal Society; EPSRC [EP/C511794/1]; Medical Research Council
   [G0300296]; FP7 'NephroTools' ITN [289754]; Engineering and Physical
   Sciences Research Council [EP/C511794/1]
FX We would like to acknowledge the Institutes of Translational Medicine
   and Integrative Biology, and the Department of Chemistry for
   infrastructural support in this project. This work was supported by
   grants from the Royal Society, EPSRC (EP/C511794/1), the Medical
   Research Council (G0300296) and the FP7 'NephroTools' ITN (289754).
CR Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200
   Aplin AE, 2001, J CELL BIOL, V155, P187, DOI 10.1083/jcb.200107116
   Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8
   Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693
   Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456
   Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726
   Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]
   Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI [10.1038/ncb, 10.1038/ncb2074]
   Costa P, 2012, INT J BIOCHEM CELL B, V44, P2233, DOI 10.1016/j.biocel.2012.09.003
   Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026
   Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109
   Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034
   France RM, 1998, J MATER CHEM, V8, P37, DOI 10.1039/a705098d
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011
   Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   Hunt GC, 2012, EXP CELL RES, V318, P1820, DOI 10.1016/j.yexcr.2012.06.009
   Kitajima H, 2010, BIOCHEM BIOPH RES CO, V396, P933, DOI 10.1016/j.bbrc.2010.05.026
   Larue L, 1996, DEVELOPMENT, V122, P3185
   Li L, 2004, DEVELOPMENT, V131, P5277, DOI 10.1242/dev.01415
   Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104
   Nichols J, 2001, DEVELOPMENT, V128, P2333
   Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218
   Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z
   Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88
   ROBERTSON M, 1993, DEV GENET, V14, P165, DOI 10.1002/dvg.1020140303
   Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979
   Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068
   Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151
   Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134
   Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200
   Uda Y, 2011, BIOCHEM BIOPH RES CO, V415, P396, DOI 10.1016/j.bbrc.2011.10.080
   Viswanathan S, 2003, BIOTECHNOL BIOENG, V84, P505, DOI 10.1002/bit.10799
   Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310
   Wells N, 2009, BIOMATERIALS, V30, P1066, DOI 10.1016/j.biomaterials.2008.10.027
   Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968
   Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487
NR 41
TC 13
Z9 13
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD NOV
PY 2013
VL 45
IS 11
BP 2698
EP 2705
DI 10.1016/j.biocel.2013.07.001
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 264XR
UT WOS:000327914800038
PM 23871934
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Wang, H
   Park, ES
   Oak, JJ
   Setyawan, AD
   Zhu, SL
   Wada, T
   Wang, XM
   Takeuchi, A
   Kato, H
AF Wang, H.
   Park, E. S.
   Oak, J. J.
   Setyawan, A. D.
   Zhu, S. L.
   Wada, T.
   Wang, X. M.
   Takeuchi, A.
   Kato, H.
TI Effect of cobalt microalloying on the glass forming ability of
   Ti-Cu-Pd-Zr metallic glass
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE Ti-based BMG; MD simulation; Mechanical properties; Corrosion resistance
ID SUPERCOOLED LIQUID REGION; AMORPHOUS-ALLOYS; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; BULK; CRYSTALLIZATION; TI-6AL-4V; NB
AB Microalloying Co to a Ti-Cu-Pd-Zr bulk glass former would affect its glass-forming ability (GFA) and this was investigated by the tilt copper mold-casting technique. The base alloy Ti40Zr10Cu36Pd14 has a critical glass-forming diameter of 5 mm and this was increased significantly to 10 mm for 1 at.% Co replaced with Ti as a Ti39Zr10Cu36 Pd14Co1 alloy. The reason for this microalloying induced drastic increase in GFA is discussed with molecular dynamics (MD) simulations. The calculated results reveal that the Co atoms effectively connect isolated atoms and isolated bonds in network formed in the base alloy. Therefore, a larger network is formed and efficiently delays any atomic rearrangement of the crystal structure, and as a matter of fact, enhances the GFA of the Co substituted BMG. This Ni-free Ti-based BMG exhibits good plasticity and a high fracture strength of about 1960 MPa with a low Young's modulus of 93 GPa. Additionally, it has better corrosion resistance compared with the base alloy in a simulated body fluid and is thus expected to find application as a biomaterial. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Wang, H.; Park, E. S.] Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Sendai, Miyagi 9808579, Japan.
   [Oak, J. J.; Setyawan, A. D.; Zhu, S. L.; Wada, T.; Wang, X. M.; Kato, H.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Takeuchi, A.] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Kato, H (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
EM hikato@imr.tohoku.ac.jp
RI Wang, Hao/F-8467-2013; Zhu, Shengli/D-5281-2009; Setyawan, Albertus
   D.H./C-8602-2011; Wang, Hao/D-9512-2014; Kato, Hidemi/B-2492-2015;
   Takeuchi, Akira/A-3619-2010; Wada, Takeshi/B-2431-2015
OI Wang, Hao/0000-0002-1708-8075; Zhu, Shengli/0000-0002-0190-2626;
   Setyawan, Albertus D.H./0000-0001-8720-6455; Wang,
   Hao/0000-0002-1708-8075; Takeuchi, Akira/0000-0002-7246-8644; 
CR Ambrose A. M., 1976, Journal of Food Science and Technology, India, V13, P181
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   Chen H.S., 1971, J NONCRYST SOLIDS, V29, P444
   CLARK AE, 1973, APPL PHYS LETT, V23, P642, DOI 10.1063/1.1654777
   CLARKE EGC, 1953, J BONE JOINT SURG BR, V35, P467
   Clary J.J., 1975, TOXICOL APPL PHARM, V33, P211
   COHEN MH, 1984, J NON-CRYST SOLIDS, V61-2, P749, DOI 10.1016/0022-3093(84)90634-3
   Colinet C, 1997, J ALLOY COMPD, V247, P15, DOI 10.1016/S0925-8388(96)02590-X
   Delogu F, 2003, J ALLOY COMPD, V352, P92, DOI 10.1016/S0925-8388(02)01109-X
   Fukunaga T, 1999, J PHYS CHEM SOLIDS, V60, P1479, DOI 10.1016/S0022-3697(99)00146-8
   Gu X, 2002, J NON-CRYST SOLIDS, V311, P77, DOI 10.1016/S0022-3093(02)01193-6
   Hu Z, 2012, MATER RES-IBERO-AM J, V15, P713, DOI 10.1590/S1516-14392012005000047
   Huang B, 2011, J APPL PHYS, V110, DOI 10.1063/1.3672449
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   INOUE A, 1980, SCRIPTA METALL MATER, V14, P119, DOI 10.1016/0036-9748(80)90137-4
   KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0
   Kundig AA, 2002, MATER TRANS, V43, P3206, DOI 10.2320/matertrans.43.3206
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lu ZP, 2002, ACTA MATER, V50, P3501, DOI 10.1016/S1359-6454(02)00166-0
   Park JM, 2004, MATER TRANS, V45, P595, DOI 10.2320/matertrans.45.595
   Qin FX, 2008, INTERMETALLICS, V16, P1026, DOI 10.1016/j.intermet.2008.05.004
   Qin FX, 2007, MATER TRANS, V48, P2390, DOI 10.2320/matertrans.MAW200704
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Starosvetsky D, 2001, J MATER SCI-MATER M, V12, P145, DOI 10.1023/A:1008922111376
   Takeuchi A, 2010, PROG NAT SCI-MATER, V20, P87, DOI 10.1016/S1002-0071(12)60012-4
   Tang MQ, 2010, J MATER SCI TECHNOL, V26, P481, DOI 10.1016/S1005-0302(10)60077-1
   TANNER LE, 1977, SCRIPTA METALL MATER, V11, P783, DOI 10.1016/0036-9748(77)90076-X
   TURNBULL D, 1969, CONTEMP PHYS, V10, P473, DOI 10.1080/00107516908204405
   Wang CS, 1998, J POWER SOURCES, V70, P222, DOI 10.1016/S0378-7753(97)02674-8
   Wang WH, 2007, PROG MATER SCI, V52, P540, DOI 10.1016/j.pmatsci.2006.07.003
   Xia MX, 2005, MAT SCI ENG A-STRUCT, V390, P372, DOI 10.1016/j.msea.2004.08.019
   Zallen R, 2004, PHYS AMORPHOUS SOLID
   Zhang B, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.092201
   Zhang T, 1999, MATER T JIM, V40, P301, DOI 10.2320/matertrans1989.40.301
   Zhang T, 1998, MATER T JIM, V39, P1001, DOI 10.2320/matertrans1989.39.1001
   Zhu SL, 2008, INTERMETALLICS, V16, P1031, DOI 10.1016/j.intermet.2008.05.006
   Zhu SL, 2007, MATER TRANS, V48, P2445, DOI 10.2320/matertrans.MRA2007086
   Zhu SL, 2007, MAT SCI ENG A-STRUCT, V459, P233, DOI 10.1016/j.msea.2007.01.044
   Zhu SL, 2007, MATER TRANS, V48, P163, DOI 10.2320/matertrans.48.163
NR 39
TC 7
Z9 7
U1 0
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
EI 1873-4812
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD NOV 1
PY 2013
VL 379
BP 155
EP 160
DI 10.1016/j.jnoncrysol.2013.08.001
PG 6
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 260DG
UT WOS:000327574600022
DA 2018-10-20
ER

PT J
AU Li, DY
   Xu, DH
   Li, P
   Wei, J
   Yang, K
   Zhao, CH
AF Li, Dongyuan
   Xu, Donghui
   Li, Peng
   Wei, Jun
   Yang, Kun
   Zhao, Conghai
TI Viscoelastic evaluation of fetal umbilical vein for reconstruction of
   middle cerebral artery
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE neural regeneration; neural plasticity; middle cerebral artery; fetal
   umbilical vein; stress relaxation properties; creep properties;
   viscoelasticity; transplantation; biomaterial; biomechanics;
   neuroregeneration
ID ORGAN-CULTURE; RECEPTORS; INJURY; CELLS
AB The transplantation of artificial blood vessels with <6 mm inner diameter as substitutes for human arterioles or veins has not achieved satisfactory results. Umbilical vein has been substituted for artery in vascular transplantation, but it remains unclear whether the stress relaxation and creep between these vessels are consistent. In this study, we used the fetal umbilical vein and middle cerebral artery from adult male cadavers to make specimens 15 mm in length, 0.196-0.268 mm in tunica media thickness, and 2.82-2.96 mm in outer diameter. The results demonstrated that the stress decrease at 7 200 seconds was similar between the middle cerebral artery and fetal umbilical vein specimens, regardless of initial stress of 18.7 kPa or 22.5 kPa. However, the strain increase at 7 200 seconds of fetal umbilical veins was larger than that of middle cerebral arteries. Moreover, the stress relaxation experiment showed that the stress decrease at 7 200 seconds of the fetal umbilical vein and middle cerebral artery specimens under 22.5 kPa initial stress was less than the decrease in these specimens under 18.7 kPa initial stress. These results indicate that the fetal umbilical vein has appropriate stress relaxation and creep properties for transplantation. These properties are advantageous for vascular reconstruction, indicating that the fetal umbilical vein can be transplanted to repair middle cerebral artery injury.
C1 [Li, Dongyuan; Xu, Donghui; Wei, Jun; Zhao, Conghai] Jilin Univ, China Japan Friendship Hosp, Dept Neurosurg, Changchun 130031, Jilin Province, Peoples R China.
   [Li, Peng] Jilin Univ, Dept Engn Mech, Nanling Branch, Changchun 130022, Jilin Province, Peoples R China.
   [Yang, Kun] AF Aviat Univ, Basic Dept, Changchun 130022, Jilin Province, Peoples R China.
RP Zhao, CH (reprint author), Jilin Univ, China Japan Friendship Hosp, Dept Neurosurg, Changchun 130031, Jilin Province, Peoples R China.
EM shm753@sina.com
CR Ahmad A, 2012, MOL CELL BIOCHEM, V367, P215, DOI 10.1007/s11010-012-1335-6
   Amisten S, 2007, EUR HEART J, V28, P13, DOI 10.1093/eurheartj/ehl410
   Chen E, 2004, FUJIAN YIKE DAXUE XU, V38, P455
   Clerin V, 2003, TISSUE ENG, V9, P461, DOI 10.1089/107632703322066642
   Davis NP, 2005, ANN BIOMED ENG, V33, P867, DOI 10.1007/s10439-005-3488-x
   Dong WM, 2010, ZHONGGUO SHENJING JI, V36, P597
   Feng YZ, 1983, BIOMECHANICS
   Guo J, 2002, JICHU YIXUE YU LINCH, V22, P478
   Han HC, 2003, ANN BIOMED ENG, V31, P403, DOI 10.1114/1.1561291
   Han HC, 2012, YIYONG SHENGWU LIXUE, V27, P7
   HAYASHI K, 1980, J BIOMECH, V13, P175, DOI 10.1016/0021-9290(80)90191-8
   Huang ZH, 2012, ZHONGGUO XIANDAI SHE, V12, P37
   Jeffree RL, 2009, J CLIN NEUROSCI, V16, P226, DOI 10.1016/j.jocn.2008.01.022
   Jiao H, 1996, SHENGWU YIXUE GONGCH, V13, P109
   Li WC, 2005, ZHONGGUO LINCHUANG K, V9, P270
   Li WC, 2004, JICHU YIXUE YU LINCH, V24, P637
   Lin YC, 2011, STROKE, V42, P2045, DOI 10.1161/STROKEAHA.110.603621
   Liu GY, 2011, NEURAL REGEN RES, V6, P2424, DOI 10.3969/j.issn.1673-5374.2011.31.005
   Monson KL, 2008, ANN BIOMED ENG, V36, P2028, DOI 10.1007/s10439-008-9578-9
   Ramon y Cajal CL, 2002, J MATERN-FETAL NEO M, V12, P104
   RUIZRAZURA A, 1994, J RECONSTR MICROSURG, V10, P367, DOI 10.1055/s-2007-1006605
   Schmidt D, 2006, TISSUE ENG, V12, P3223, DOI 10.1089/ten.2006.12.3223
   Seye CI, 2007, PURINERG SIGNAL, V3, P153, DOI 10.1007/s11302-006-9047-6
   Seye CI, 2004, J BIOL CHEM, V279, P35679, DOI 10.1074/jbc.M401799200
   Sikkel E, 2003, FETAL DIAGN THER, V18, P472, DOI 10.1159/000073146
   Song G, 2008, CHIN J GERITAR HEART, V10, P680
   Stokes L, 2007, J IMMUNOL, V179, P6016, DOI 10.4049/jimmunol.179.9.6016
   Sun WQ, 2001, YIYONG SHENGWU LIXUE, V16, P222
   Sun YM, 2011, ZHONGGUO LINCHUANG S, V16, P577
   Velcheva I, 2010, CLIN HEMORHEOL MICRO, V45, P233, DOI 10.3233/CH-2010-1306
   Wang GQ, 2007, SHENGWU YIXUE GONGCH, V26, P121
   Wang L, 2012, NEUROSCIENCE, V220, P100, DOI 10.1016/j.neuroscience.2012.06.010
   Yu B, 2010, ZHONGGUO ZUZHI GONGC, V14, P4444
   Zeng AM, 2012, ZHONGGUO WUZHEN XUE, P37
   Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104
NR 35
TC 2
Z9 2
U1 0
U2 3
PU SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES
PI SHENYANG
PA PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA
SN 1673-5374
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD NOV
PY 2013
VL 8
IS 32
BP 3055
EP 3062
DI 10.3969/j.issn.1673-5374.2013.32.009
PG 8
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA 260DH
UT WOS:000327574700010
PM 25206626
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Piao, CD
   Li, P
   Liu, GY
   Yang, K
AF Piao, Chengdong
   Li, Peng
   Liu, Guangyao
   Yang, Kun
TI Viscoelasticity of repaired sciatic nerve by poly(lactic-co-glycolic
   acid) tubes
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE neural regeneration; peripheral nerve injury; sciatic nerve injury
   model; nerve autograft; poly(lactic-co-glycolic acid); transplantation;
   repair; stress relaxation; creep; biomaterial; neuroregeneration
ID HUMAN AMNIOTIC MEMBRANE; MESENCHYMAL STEM-CELLS; NANOFIBROUS SCAFFOLD;
   PLGA NANOPARTICLES; STROMAL CELLS; RAT MODEL; REGENERATION;
   TRANSPLANTATION; INJURY; POLY(DL-LACTIDE-CO-GLYCOLIDE)
AB Medical-grade synthetic poly(lactic-co-glycolic acid) polymer can be used as a biomaterial for nerve repair because of its good biocompatibility, biodegradability and adjustable degradation rate. The stress relaxation and creep properties of peripheral nerve can be greatly improved by repair with poly(lactic-co-glycolic acid) tubes. Ten sciatic nerve specimens were harvested from fresh corpses within 24 hours of death, and were prepared into sciatic nerve injury models by creating a 10 mm defect in each specimen. Defects were repaired by anastomosis with nerve autografts and poly(lactic-co-glycolic acid) tubes. Stress relaxation and creep testing showed that at 7 200 seconds, the sciatic nerve anastomosed by poly(lactic-co-glycolic acid) tubes exhibited a greater decrease in stress and increase in strain than those anastomosed by nerve autografts. These findings suggest that poly(lactic-co-glycolic acid) exhibits good viscoelasticity to meet the biomechanical requirements for a biomaterial used to repair sciatic nerve injury.
C1 [Piao, Chengdong] Jilin Univ, Hosp 2, Dept Orthoped, Chuangchun 130028, Jilin Province, Peoples R China.
   [Li, Peng] Jilin Univ, Dept Engn Mech, Chuangchun 130022, Jilin Province, Peoples R China.
   [Liu, Guangyao] Jilin Univ, China Japan Union Hosp, Dept Orthoped, Chuangchun 130031, Jilin Province, Peoples R China.
   [Yang, Kun] Aviat Univ AF China, Base Dept, Chuangchun 130022, Jilin Province, Peoples R China.
RP Liu, GY (reprint author), Jilin Univ, China Japan Union Hosp, Dept Orthoped, Chuangchun 130031, Jilin Province, Peoples R China.
EM lgy@jlu.edu.cn
CR Aronin CEP, 2009, J BIOMED MATER RES A, V89A, P632, DOI 10.1002/jbm.a.32015
   Basarkar A, 2007, INT J PHARM, V343, P247, DOI 10.1016/j.ijpharm.2007.05.023
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Chen ZY, 2011, BRAIN RES, V1368, P71, DOI 10.1016/j.brainres.2010.10.028
   Cheng FC, 2010, J NEUROSURG, V112, P868, DOI 10.3171/2009.8.JNS09850
   Chung TW, 2008, BIOMATERIALS, V29, P228, DOI 10.1016/j.biomaterials.2007.09.027
   Dong WL, 2010, CELL BIOL INT, V34, P573, DOI 10.1042/CBI20090248
   Elgazzar RF, 2008, INT J ORAL MAX SURG, V37, P748, DOI 10.1016/j.ijom.2008.05.010
   Esmaeili F, 2008, INT J PHARM, V349, P249, DOI 10.1016/j.ijpharm.2007.07.038
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Henry FP, 2009, SURGERY, V145, P313, DOI 10.1016/j.surg.2008.11.005
   Hou SY, 2006, NEUROSCIENCE, V140, P101, DOI 10.1016/j.neuroscience.2006.01.066
   Hu J, 2009, BIOMATERIALS, V30, P5061, DOI 10.1016/j.biomaterials.2009.06.013
   Hu XX, 2008, BIOMATERIALS, V29, P3128, DOI 10.1016/j.biomaterials.2008.04.010
   Jung Y, 2008, BIOMATERIALS, V29, P4630, DOI 10.1016/j.biomaterials.2008.08.031
   Kadam SS, 2010, CYTOTHERAPY, V12, P982, DOI 10.3109/14653249.2010.509546
   Karcher DM, 2009, GROWTH HORM IGF RES, V19, P31, DOI 10.1016/j.ghir.2008.05.003
   Kong XY, 2008, BRAIN RES, V1205, P108, DOI 10.1016/j.brainres.2008.02.040
   Li XK, 2007, COLLOID SURFACE B, V57, P198, DOI 10.1016/j.colsurfb.2007.02.010
   Liao S, 2008, J MECH BEHAV BIOMED, V1, P252, DOI 10.1016/j.jmbbm.2008.01.007
   Liu GY, 2011, NEURAL REGEN RES, V6, P2424, DOI 10.3969/j.issn.1673-5374.2011.31.005
   Liu XF, 2008, DISAN JUNYI DAXUE XU, V30, P1462
   Ma HS, 2004, ZHONGGUO SHENGWU YIX, V23, P274
   Madurantakam PA, 2009, NANOMEDICINE-UK, V4, P193, DOI 10.2217/17435889.4.2.193
   Meng H, 2011, NEUROSCI LETT, V496, P48, DOI 10.1016/j.neulet.2011.03.090
   Murakami H, 2000, J CONTROL RELEASE, V67, P29, DOI 10.1016/S0168-3659(99)00288-6
   O'Neill AC, 2009, J SURG RES, V151, P33, DOI 10.1016/j.jss.2008.01.025
   Pan H, 2008, BIOMATERIALS, V29, P1583, DOI 10.1016/j.biomaterials.2007.12.005
   Prasad BR, 2010, COLLOID SURFACE B, V78, P237, DOI 10.1016/j.colsurfb.2010.03.006
   Shen H, 2007, BIOMATERIALS, V28, P4219, DOI 10.1016/j.biomaterials.2007.06.004
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Urita Y, 2008, PEDIATR SURG INT, V24, P1041, DOI 10.1007/s00383-008-2212-y
   Wolford Larry M, 2011, Atlas Oral Maxillofac Surg Clin North Am, V19, P91, DOI 10.1016/j.cxom.2010.11.008
   Yu WJ, 2011, SHENGWU YIXUE GONGCH, V28, P163
   Zhang HA, 2010, CAILIAO DAOBAO, V24, P46
   Zhang HL, 2011, HARBIN YIYAO, V31, P321
   Zhang PB, 2009, BIOMATERIALS, V30, P58, DOI 10.1016/j.biomaterials.2008.08.041
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
   Zhang YJ, 2004, ZHONGHUA SHENJING WA, V3, P141
   Zhao L, 2008, ZHONGGUO SHENGWU GON, V28, P22
NR 40
TC 2
Z9 3
U1 1
U2 15
PU SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES
PI SHENYANG
PA PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA
SN 1673-5374
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD NOV
PY 2013
VL 8
IS 33
BP 3131
EP 3138
DI 10.3969/j.issn.1673-5374.2013.33.007
PG 8
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA 260DK
UT WOS:000327575000008
PM 25206634
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Maia, FR
   Bidarra, SJ
   Granja, PL
   Barrias, CC
AF Raquel Maia, F.
   Bidarra, Silvia J.
   Granja, Pedro L.
   Barrias, Cristina C.
TI Functionalization of biomaterials with small osteoinductive moieties
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Biomaterials; Bone regeneration; Biofunctionalization; Small moieties;
   Osteogenesis
ID MESENCHYMAL STEM-CELLS; SELF-ASSEMBLED-MONOLAYERS; OSTEOGENIC GROWTH
   PEPTIDE; MARROW STROMAL CELLS; C-TERMINAL PENTAPEPTIDE; SYNTHETIC
   EXTRACELLULAR-MATRIX; DIFFERENT SURFACE CHEMISTRIES; BONE MORPHOGENETIC
   PROTEIN-2; DIFFERENTIATION IN-VITRO; COLLAGEN-BINDING PEPTIDE
AB Human mesenchymal stem cells (MSCs) are currently recognized as a powerful cell source for regenerative medicine, notably for their capacity to differentiate into multiple cell types. The combination of MSCs with biomaterials functionalized with instructive cues can be used as a strategy to direct specific lineage commitment, and can thus improve the therapeutic efficacy of these cells. In terms of biomaterial design, one common approach is the functionalization of materials with ligands capable of directly binding to cell receptors and trigger specific differentiation signaling pathways. Other strategies focus on the use of moieties that have an indirect effect, acting, for example, as sequesters of bioactive ligands present in the extracellular milieu that, in turn, will interact with cells. Compared with complex biomolecules, the use of simple compounds, such as chemical moieties and peptides, and other small molecules can be advantageous by leading to less expensive and easily tunable biomaterial formulations. This review describes different strategies that have been used to promote substrate-mediated guidance of osteogenic differentiation of immature osteoblasts, osteoprogenitors and MSCs, through chemically conjugated small moieties, both in two- and three-dimensional set-ups. In each case, the selected moiety, the coupling strategy and the main findings of the study were highlighted. The latest advances and future perspectives in the field are also discussed. (C) 2013 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Raquel Maia, F.; Bidarra, Silvia J.; Granja, Pedro L.; Barrias, Cristina C.] INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Raquel Maia, F.; Granja, Pedro L.] Univ Porto, FEUP Fac Engn, Dept Engn Met & Mat, P-4200465 Oporto, Portugal.
   [Granja, Pedro L.] Univ Porto, ICBAS, P-4050313 Oporto, Portugal.
RP Barrias, CC (reprint author), INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM ccbarrias@ineb.up.pt
RI Maia, Raquel/B-5297-2017; Granja, Pedro/B-1685-2008
OI Maia, Raquel/0000-0002-2271-515X; Granja, Pedro/0000-0003-2761-4929;
   Bidarra, Silvia/0000-0002-1515-9597; Barrias,
   Cristina/0000-0002-8178-6134
FU FEDER funds through the Programa Operacional Factores de Competitividade
   (COMPETE); Portuguese funds through Fundacao para a Ciencia e a
   Tecnologia (FCT) [Pest-C/SAU/LA0002/2011, PTDC/SAU-BEB/101235/2008,
   FCOMP-01-0124-FEDER-010915]; INL-International Iberian Nanotechnology
   Laboratory; FCT-POPH [SFRH/BPD/80571/2011]; FCT-POPH-FSE
FX This work was financed by FEDER funds through the Programa Operacional
   Factores de Competitividade (COMPETE) and by Portuguese funds through
   Fundacao para a Ciencia e a Tecnologia (FCT), in the framework of the
   projects Pest-C/SAU/LA0002/2011 and BIOMATRIX (PTDC/SAU-BEB/101235/2008
   and FCOMP-01-0124-FEDER-010915). F.R.M. acknowledges INL-International
   Iberian Nanotechnology Laboratory for her PhD scholarship. S.B. is the
   recipient of a post-doctoral fellowship from FCT-POPH
   (SFRH/BPD/80571/2011). C.B. has a research position funded by
   FCT-POPH-FSE (Ciencia 2008). The authors are grateful to Graciosa
   Teixeira (INEB) for providing the images of hMSC osteogenic
   differentiation in chitosan scaffolds (Fig. 3).
CR Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Acharya B, 2012, J BIOMED MATER RES B, V100B, P841, DOI 10.1002/jbm.b.32648
   Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601
   Alves H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026678
   Amin HD, 2012, TISSUE ENG PT A, V18, P1193, DOI [10.1089/ten.TEA.2011.0375, 10.1089/ten.tea.2011.0375]
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Arrighi I, 2009, BIOMATERIALS, V30, P1763, DOI 10.1016/j.biomaterials.2008.12.023
   BAB I, 1992, EMBO J, V11, P1867, DOI 10.1002/j.1460-2075.1992.tb05238.x
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031
   BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P183, DOI 10.1177/41.2.8419458
   Bidarra SJ, 2011, BIOMATERIALS, V32, P7897, DOI 10.1016/j.biomaterials.2011.07.013
   Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   Brey DM, 2011, BIOTECHNOL BIOENG, V108, P163, DOI 10.1002/bit.22925
   Chen S, 2008, ARCH ORAL BIOL, V53, P879, DOI 10.1016/j.archoralbio.2008.05.005
   CHEN Y, 1992, J BIOL CHEM, V267, P24871
   Chen ZX, 2007, REGUL PEPTIDES, V142, P16, DOI 10.1016/j.regpep.2007.01.003
   Choi YJ, 2013, J BIOMED MATER RES A, V101, P547, DOI 10.1002/jbm.a.34356
   Connelly JT, 2011, EUR CELLS MATER, V22, P168, DOI 10.22203/eCM.v022a13
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   DENHARDT DT, 1993, FASEB J, V7, P1475
   Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157
   Doorn J, 2012, TISSUE ENG PT A, V18, P558, DOI [10.1089/ten.tea.2011.0312, 10.1089/ten.TEA.2011.0312]
   Doorn J, 2012, TISSUE ENG PT A, V18, P1431, DOI [10.1089/ten.TEA.2011.0484, 10.1089/ten.tea.2011.0484]
   Drevelle O, 2013, BIOMATERIALS, V34, P1051, DOI 10.1016/j.biomaterials.2012.10.066
   Drevelle O, 2010, BIOMATERIALS, V31, P6468, DOI 10.1016/j.biomaterials.2010.05.010
   Edwards CJ, 2002, ARTHRITIS RES, V4, P151, DOI 10.1186/ar399
   Egusa H, 2009, BIOMATERIALS, V30, P4676, DOI 10.1016/j.biomaterials.2009.05.032
   Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Fazzi R, 2002, LEUKEMIA RES, V26, P19, DOI 10.1016/S0145-2126(01)00091-1
   Fernandes TG, 2010, BIOTECHNOL BIOENG, V106, P106, DOI 10.1002/bit.22661
   Firestone AJ, 2010, ACS CHEM BIOL, V5, P15, DOI 10.1021/cb900249y
   Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146
   Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060
   Fonseca KB, 2013, SOFT MATTER, V9, P3283, DOI 10.1039/c3sm27560d
   Fonseca KB, 2011, ACTA BIOMATER, V7, P1674, DOI 10.1016/j.actbio.2010.12.029
   Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801
   Gabarin N, 2001, J CELL BIOCHEM, V81, P594, DOI 10.1002/jcb.1083
   Gafni RI, 2012, J BONE MINER RES, V27, P1811, DOI 10.1002/jbmr.1627
   Gandavarapu NR, 2013, ACTA BIOMATER, V9, P4525, DOI 10.1016/j.actbio.2012.09.007
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Gilmore L, 2013, BIOTECHNOL BIOENG, V110, P296, DOI 10.1002/bit.24598
   Granja PL, 2006, REACT FUNCT POLYM, V66, P728, DOI 10.1016/j.reactfunctpolym.2005.10.027
   Granja PL, 2001, J MATER SCI, V36, P2163, DOI 10.1023/A:1017587815583
   Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Hayashibara T, 2004, J BONE MINER RES, V19, P455, DOI 10.1359/JBMR.0301263
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   He XZ, 2012, LANGMUIR, V28, P5387, DOI 10.1021/la205005h
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Huang JH, 2010, SOFT MATTER, V6, P3395, DOI 10.1039/b927168f
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Huang NF, 2010, ACTA BIOMATER, V6, P4614, DOI 10.1016/j.actbio.2010.06.033
   Hudalla GA, 2011, ADV MATER, V23, P5415, DOI 10.1002/adma.201103046
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   Hudalla GA, 2011, ADV FUNCT MATER, V21, P1754, DOI 10.1002/adfm.201002468
   Hudalla GA, 2009, LANGMUIR, V25, P5737, DOI 10.1021/la804077t
   Hui Z, 2007, J CELL BIOCHEM, V101, P1423, DOI 10.1002/jcb.21258
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Jabbari E., 2013, CURR PHARM DESIGN, V12, P45
   Jacob JJ, 2008, BURDEN MUSCULOSKELET
   Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200
   Jung RE, 2007, CLIN ORAL IMPLAN RES, V18, P319, DOI 10.1111/j.1600-0501.2007.01342.x
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim HK, 2012, BIOMATERIALS, V33, P7057, DOI 10.1016/j.biomaterials.2012.06.036
   Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314
   Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
   Knaus P, 2001, BIOL CHEM, V382, P1189, DOI 10.1515/BC.2001.149
   Koepsel JT, 2012, INTEGR BIOL-UK, V4, P1508, DOI 10.1039/c2ib20029e
   Kurkuri MD, 2009, BIOMACROMOLECULES, V10, P1163, DOI 10.1021/bm801417s
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Lai YX, 2010, BIOMATERIALS, V31, P4809, DOI 10.1016/j.biomaterials.2010.02.064
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee JS, 2009, ANGEW CHEM INT EDIT, V48, P6266, DOI 10.1002/anie.200901618
   Lee JY, 2007, BIOCHEM BIOPH RES CO, V357, P68, DOI 10.1016/j.bbrc.2007.03.106
   Lee JY, 2009, BIOMATERIALS, V30, P3532, DOI 10.1016/j.biomaterials.2009.03.018
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Lee MH, 2005, BIOMATERIALS, V26, P1721, DOI 10.1016/j.biomaterials.2004.05.026
   LI Guang-Zan, 2005, J FUNCT POLYM, V127, P33
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870
   Liu LY, 2005, J BIOMED MATER RES A, V74A, P23, DOI 10.1002/jbm.a.30221
   Liu P, 2010, NANOSCALE, V2, P122, DOI 10.1039/b9nr00124g
   Luo W, 2011, J COLLOID INTERF SCI, V360, P325, DOI 10.1016/j.jcis.2011.04.098
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359
   Ma SQ, 2008, J PLAST RECONSTR AES, V61, P1558, DOI 10.1016/j.bjps.2008.03.040
   Maciel J, 2012, ACTA BIOMATER, V8, P3669, DOI 10.1016/j.actbio.2012.06.010
   Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   Mata A, 2010, BIOMATERIALS, V31, P6004, DOI 10.1016/j.biomaterials.2010.04.013
   Mattii L, 2008, MED SCI MONITOR, V14, pBR103
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   MERRY K, 1993, J CELL SCI, V104, P1013
   Coelho NM, 2011, BIOTECHNOL BIOENG, V108, P3009, DOI 10.1002/bit.23265
   Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Moore NM, 2010, BIOMATERIALS, V31, P1604, DOI [10.1016/j.biomatetials.2009.11.011, 10.1016/j.biomaterials.2009.11.011]
   Mrksich M, 1998, CELL MOL LIFE SCI, V54, P653, DOI 10.1007/s000180050193
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Mrksich M, 2009, ACTA BIOMATER, V5, P832, DOI 10.1016/j.actbio.2009.01.016
   Munarin F, 2011, BIOMACROMOLECULES, V12, P568, DOI 10.1021/bm101110x
   Munarin F, 2012, SOFT MATTER, V8, P4731, DOI 10.1039/c2sm07260b
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Nuttelman CR, 2006, BIOMATERIALS, V27, P1377, DOI 10.1016/j.biomaterials.2005.08.014
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   onnelly JT, 2011, EUR CELLS MATER, V22, P76
   Pandita D, 2011, BIOMACROMOLECULES, V12, P472, DOI 10.1021/bm1012647
   Park KW, 2009, MOL CELL BIOL, V29, P3905, DOI 10.1128/MCB.00002-09
   Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Peters A, 2009, TISSUE ENG PART B-RE, V15, P225, DOI [10.1089/ten.teb.2009.0049, 10.1089/ten.TEB.2009.0049]
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pregizer S, 2008, J CELL BIOCHEM, V105, P965, DOI 10.1002/jcb.21900
   Prieto S, 2011, BIOMACROMOLECULES, V12, P1480, DOI 10.1021/bm200287c
   Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302
   Reinoso RF, 2002, METHOD FIND EXP CLIN, V24, P593
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Saito A, 2004, J BIOMED MATER RES A, V70A, P115, DOI 10.1002/jbm.a.30071
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X
   San Miguel SM, 2005, J BIOL CHEM, V280, P37495, DOI 10.1074/jbc.M503861200
   Santos JL, 2011, CURR GENE THER, V11, P46
   Santos JL, 2010, J CONTROL RELEASE, V144, P55, DOI 10.1016/j.jconrel.2010.01.034
   Santos JL, 2010, MOL PHARMACEUT, V7, P763, DOI 10.1021/mp9002877
   Santos JL, 2009, J CONTROL RELEASE, V134, P141, DOI 10.1016/j.jconrel.2008.11.007
   Sargeant TD, 2012, ACTA BIOMATER, V8, P2456, DOI 10.1016/j.actbio.2012.03.026
   Saska S, 2012, J MATER SCI-MATER M, V23, P2253, DOI 10.1007/s10856-012-4676-5
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Senta H, 2009, CYTOKINE GROWTH F R, V20, P213, DOI 10.1016/j.cytogfr.2009.05.006
   Shakibaei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035712
   Sharon JL, 2008, BIOMATERIALS, V29, P3137, DOI 10.1016/j.biomaterials.2008.04.019
   Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sousa DM, 2009, CURR DRUG TARGETS, V10, P9, DOI 10.2174/138945009787122888
   Sprowson AP, 2008, J ORTHOP RES, V26, P1256, DOI 10.1002/jor.20606
   STAATZ WD, 1990, J BIOL CHEM, V265, P4778
   Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143
   Stakleff KS, 2013, ACTA BIOMATER, V9, P5132, DOI 10.1016/j.actbio.2012.08.035
   Sun JG, 2008, BIOMACROMOLECULES, V9, P2569, DOI 10.1021/bm800477s
   Sun JG, 2009, CHINESE SCI BULL, V54, P3154, DOI 10.1007/s11434-009-0240-1
   SUTTIE JW, 1993, FASEB J, V7, P445
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Takahata M, 2012, CELL TISSUE RES, V347, P545, DOI 10.1007/s00441-011-1188-4
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Teixeira L, 2009, J CELL BIOCHEM, V107, P908, DOI 10.1002/jcb.22194
   Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460
   Tzeng SY, 2012, BIOMATERIALS, V33, P8142, DOI 10.1016/j.biomaterials.2012.07.036
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Vacharathit V, 2011, BIOMATERIALS, V32, P3721, DOI 10.1016/j.biomaterials.2010.12.048
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201
   Wang DX, 2013, INT J NANOMED, V8, P1855, DOI 10.2147/IJN.S43706
   Wang H, 2006, J BIOMED MATER RES A, V77A, P672, DOI 10.1002/jbm.a.30586
   Wang V, 2008, J MATER SCI-MATER M, V19, P2145, DOI 10.1007/s10856-007-3306-0
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Whang KM, 2005, J BIOMED MATER RES A, V74A, P247, DOI 10.1002/jbm.a.30370
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908
   Yan C, 2011, BIOMATERIALS, V32, P3931, DOI 10.1016/j.biomaterials.2011.01.078
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Yewle JN, 2013, BIOMATERIALS, V34, P3141, DOI 10.1016/j.biomaterials.2013.01.059
   Zhang JF, 2010, MOL CELL ENDOCRINOL, V314, P70, DOI 10.1016/j.mce.2009.08.012
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
   Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007
   Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042
NR 200
TC 38
Z9 38
U1 2
U2 80
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2013
VL 9
IS 11
BP 8773
EP 8789
DI 10.1016/j.actbio.2013.08.004
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 251BJ
UT WOS:000326902500001
PM 23933486
DA 2018-10-20
ER

PT J
AU Tao, W
   Zeng, XW
   Liu, T
   Wang, ZY
   Xiong, QQ
   Ouyang, CP
   Huang, LQ
   Mei, L
AF Tao, Wei
   Zeng, Xiaowei
   Liu, Ting
   Wang, Zhongyuan
   Xiong, Qingqing
   Ouyang, Chunping
   Huang, Laiqiang
   Mei, Lin
TI Docetaxel-loaded nanoparticles based on star-shaped mannitol-core
   PLGA-TPGS diblock copolymer for breast cancer therapy
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Star-shaped copolymer; Docetaxel; Nanoparticles; Drug delivery;
   Nanotechnology for cancer therapy
ID VITAMIN-E TPGS; ORAL DELIVERY; CONTROLLED-RELEASE; ANTICANCER DRUGS;
   WATER; FORMULATIONS; MICELLES; EFFICACY; SIZE; PCL
AB A star-shaped biodegradable polymer, mannitol-core poly(D,L-lactide-co-glycolide)-D-alpha-tocopheryl polyethylene glycol 1000 succinate (M-PLGA-TPGS), was synthesized in order to provide a novel nanoformulation for breast cancer chemotherapy. This novel copolymer was prepared by a core-first approach via three stages of chemical reaction, and was characterized by nuclear magnetic resonance, gel permeation chromatography and thermogravimetric analysis. The docetaxel-loaded M-PLGA-TPGS nanoparticles (NPs), prepared by a modified nanoprecipitation method, were observed to be near-spherical shape with narrow size distribution. Confocal laser scanning microscopy showed that the uptake level of M-PLGA-TPGS NPs was higher than that of PLGA NPs and PLGA-TPGS NPs in MCF-7 cells. A significantly higher level of cytotoxicity was achieved with docetaxel-loaded M-PLGA-TPGS NPs than with commercial Taxotere, docetaxel-loaded PLGA-TPGS and PLGA NPs. Examination of the drug loading and encapsulation efficiency proved that star-shaped M-PLGA-TPGS could carry higher levels of drug than linear polymer. The in vivo experiment showed docetaxel-loaded M-PLGA-TPGS NPs to have the highest anti-tumor efficacy. In conclusion, the star-like M-PLGA-TPGS copolymer shows potential as a promising drug-loaded biomaterial that can be applied in developing novel nanoformulations for breast cancer therapy. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Tao, Wei; Zeng, Xiaowei; Wang, Zhongyuan; Huang, Laiqiang; Mei, Lin] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Tao, Wei; Zeng, Xiaowei; Wang, Zhongyuan; Huang, Laiqiang; Mei, Lin] Tsinghua Univ, Ctr Biotech & Biomed, Shenzhen Key Lab Gene & Antibody Therapy, Shenzhen 518055, Peoples R China.
   [Tao, Wei; Zeng, Xiaowei; Wang, Zhongyuan; Huang, Laiqiang; Mei, Lin] Tsinghua Univ, Div Life & Hlth Sci, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China.
   [Liu, Ting] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.
   [Xiong, Qingqing] Peking Union Med Coll, Inst Biomed Engn, Tianjin 300192, Peoples R China.
   [Xiong, Qingqing] Chinese Acad Med Sci, Tianjin Key Lab Biomat Res, Tianjin 300192, Peoples R China.
   [Ouyang, Chunping] Kingfa Sci & Technol Co Ltd, Ctr Res & Dev, Guangzhou 510520, Guangdong, Peoples R China.
RP Mei, L (reprint author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
EM huanglq@sz.tsinghua.edu.cn; mei.lin@sz.tsinghua.edu.cn
RI Zeng, Xiaowei/A-6506-2015
OI Tao, Wei/0000-0002-4277-3728
FU National Natural Science Foundation of China [31270019, 51203085]; China
   Postdoctoral Science Foundation [2012M520242]; Natural Science
   Foundation of Guangdong Province [S2012040006820, S2012010010046];
   Shenzhen Municipal Sci-Tech Programs for Building Shenzhen and State Key
   Laboratories Science, Technology & Innovation Commission of Shenzhen
   Municipality [CXB201005260070A, CX8201104220043A]; Program for New
   Century Excellent Talents in University [NCET-11-0275]; 
   [JCYJ20120616213729920];  [KQC201105310021A];  [JCYJ20120614191936420]; 
   [JC201005270308A]
FX The authors are grateful for financial support from the National Natural
   Science Foundation of China (No. 31270019, No. 51203085), China
   Postdoctoral Science Foundation (No. 2012M520242), Natural Science
   Foundation of Guangdong Province (No. S2012040006820, No.
   S2012010010046), Shenzhen Municipal Sci-Tech Programs for Building
   Shenzhen and State Key Laboratories (No. CXB201005260070A,
   CX8201104220043A) Science, Technology & Innovation Commission of
   Shenzhen Municipality (No. JCYJ20120616213729920, No. KQC201105310021A,
   No. JCYJ20120614191936420, No. JC201005270308A) and Program for New
   Century Excellent Talents in University (NCET-11-0275).
CR Abdulla JMA, 2010, AAPS PHARMSCITECH, V11, P663, DOI 10.1208/s12249-010-9428-6
   Baimark Y, 2012, J APPL POLYM SCI, V124, P3871, DOI 10.1002/app.35473
   Claesson H, 2002, POLYMER, V43, P3511, DOI 10.1016/S0032-3861(02)00073-3
   Feng SS, 2009, BIOMATERIALS, V30, P3297, DOI 10.1016/j.biomaterials.2009.02.045
   Grzegorz L., 2009, PROG POLYM SCI, V34, P852
   Grzegorz L, 2009, POLYMER, V50, P77
   Huang LQ, 2011, INTEGR BIOL-UK, V3, P993, DOI 10.1039/c1ib00026h
   Jeffrey AH, 2012, SCIENCE, V337, P303
   Kelly RJ, 2011, CLIN CANCER RES, V17, P569, DOI 10.1158/1078-0432.CCR-10-1725
   Kong SD, 2013, ACTA BIOMATER, V9, P5447, DOI 10.1016/j.actbio.2012.11.006
   Lee SJ, 2006, J POLYM SCI POL CHEM, V44, P888, DOI 10.1002/pola.21193
   Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350
   Liu Q, 2012, INT J PHARMACEUT, V430, P350, DOI 10.1016/j.ijpharm.2012.04.008
   Ma YD, 2011, INT J NANOMED, V6, P2679, DOI 10.2147/IJN.S25251
   Ma YD, 2010, POLYMER, V51, P5952, DOI 10.1016/j.polymer.2010.10.029
   Ma YD, 2010, NANOSCALE RES LETT, V5, P1161, DOI 10.1007/s11671-010-9620-3
   Maglio G, 2004, MACROMOL RAPID COMM, V25, P1139, DOI 10.1002/marc.200400113
   Mei L, 2013, ADV DRUG DELIVER REV, V65, P880, DOI 10.1016/j.addr.2012.11.005
   Mei L, 2009, NANOSCALE RES LETT, V4, P1530, DOI 10.1007/s11671-009-9431-6
   Mu L, 2003, J CONTROL RELEASE, V86, P33, DOI 10.1016/S0168-3659(02)00320-6
   Muthu MS, 2012, BIOMATERIALS, V33, P3494, DOI 10.1016/j.biomaterials.2012.01.036
   Nabid MR, 2011, POLYMER, V52, P2799, DOI 10.1016/j.polymer.2011.04.054
   Cuong NV, 2012, J MATER CHEM, V22, P1006, DOI 10.1039/c1jm13588k
   Ouyang CP, 2012, POLYM BULL, V68, P27, DOI 10.1007/s00289-011-0516-x
   Park W, 2012, BIOMATERIALS, V33, P8848, DOI 10.1016/j.biomaterials.2012.08.042
   Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Robert AS, 2012, CA-CANCER J CLIN, V62, P129
   Schubert S, 2011, SOFT MATTER, V7, P1581, DOI 10.1039/c0sm00862a
   Song SH, 2009, APPL MICROBIOL BIOT, V84, P55, DOI 10.1007/s00253-009-2086-5
   Thamake SI, 2012, BIOMATERIALS, V33, P7164, DOI 10.1016/j.biomaterials.2012.06.026
   TRABER MG, 1994, AM J CLIN NUTR, V59, P1270
   Valencia PM, 2011, BIOMATERIALS, V32, P6226, DOI 10.1016/j.biomaterials.2011.04.078
   Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050
   Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021
   Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022
   Yan F, 2010, NANOMED-NANOTECHNOL, V6, P170, DOI 10.1016/j.nano.2009.05.004
   Zeng XW, 2013, BIOMATERIALS, V34, P6058, DOI 10.1016/j.biomaterials.2013.04.052
   Zhang CN, 2012, BIOMATERIALS, V33, P2187, DOI 10.1016/j.biomaterials.2011.11.045
   Zhang XJ, 2010, MACROMOLECULES, V43, P6671, DOI 10.1021/ma100653u
   Zhang YQ, 2010, ACTA BIOMATER, V6, P2045, DOI 10.1016/j.actbio.2009.11.035
   Zhang ZP, 2012, NANOMEDICINE-UK, V7, P1645, DOI [10.2217/NNM.12.117, 10.2217/nnm.12.117]
   Zhang ZP, 2012, BIOMATERIALS, V33, P4889, DOI 10.1016/j.biomaterials.2012.03.046
   Zhou SB, 2004, MACROMOL MATER ENG, V289, P576, DOI 10.1002/mamc.20030000283
   Zhu ZS, 2010, J CONTROL RELEASE, V142, P438, DOI 10.1016/j.jconrel.2009.11.002
NR 45
TC 74
Z9 75
U1 3
U2 90
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2013
VL 9
IS 11
BP 8910
EP 8920
DI 10.1016/j.actbio.2013.06.034
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 251BJ
UT WOS:000326902500014
PM 23816645
DA 2018-10-20
ER

PT J
AU Wu, JQ
   Lemarie, CA
   Barralet, J
   Blostein, MD
AF Wu, Jianqiu
   Lemarie, Catherine A.
   Barralet, Jake
   Blostein, Mark D.
TI Amphiphilic peptide-loaded nanofibrous calcium phosphate microspheres
   promote hemostasis in vivo
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Amphipathic peptide; Amphiphile nanofiber; Microsphere; Trauma;
   Hemorrhage
ID EXTREMITY ARTERIAL HEMORRHAGE; AMPHIPATHIC PEPTIDES; MEDIATED
   HEMOSTASIS; LIVER-INJURY; HEMOPHILIA-B; FACTOR IXA; MODEL; BLOOD; SWINE;
   AGENT
AB Most fatalities from trauma occur due to severe blood loss. There is a need for improved hemostatic biomaterials that can address this problem. The aim of this study was to determine the in vivo efficacy of nanofibrous microspheres (NFM) loaded with hemostatic peptides, specifically ideal amphipathic peptides (IAP) that have been demonstrated to possess both procoagulant and antifibrinolyic activities. We demonstrate that IAP can be coupled to NFM (IAP-NFM) to form matrices that exhibit substantial hemostatic activity. IAP-NFM matrices were compared to a commercial zeolitic hemostatic biomaterial (QuikClot) and have superior efficacy in reducing bleeding in vivo. In both a murine tail transection and a murine hepatic injury model, bleeding times were significantly reduced (P < 0.05) with the use of IAP-NFM as compared with equal masses of either QuikClot or NFM alone, or no treatment. Importantly, histological examination revealed no tissue injury when IAP-NFM or NFM were applied to hepatic lacerations. In contrast, QuikClot caused widespread hepatocyte degeneration and necrosis, with higher average injury zone thickness as determined by semiquantitative analysis. In summary, NFM was able to maintain the pro-coagulant properties of IAP in our preclinical model, caused no observable tissue damage at the site of application and had better performance than QuikClot controls. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wu, Jianqiu; Lemarie, Catherine A.; Blostein, Mark D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Med, Montreal, PQ H3T 1E2, Canada.
   [Barralet, Jake] McGill Univ, Fac Med, Div Surg, Montreal, PQ, Canada.
   [Barralet, Jake] McGill Univ, Fac Dent, Montreal, PQ, Canada.
RP Barralet, J (reprint author), McGill Univ, Fac Med, Div Surg, Montreal, PQ, Canada.
EM jake.barralet@mcgill.ca
OI Barralet, jake/0000-0003-3543-6042
FU Canadian Haemophilia Society; Canada Research Chairs; NSERC
FX The authors acknowledge the support of the Canadian Haemophilia Society
   (M.B.), Canada Research Chairs (J.B.) and an NSERC discovery award
   (J.B).
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Begbie ME, 2005, THROMB HAEMOSTASIS, V94, P1138, DOI 10.1160/TH04-03-0201
   Blostein MD, 2000, BIOCHEMISTRY-US, V39, P12000, DOI 10.1021/bi000655c
   Charbonneau S, 2010, BIOCHEM BIOPH RES CO, V391, P1197, DOI 10.1016/j.bbrc.2009.12.031
   Charbonneau S, 2012, J TRAUMA ACUTE CARE, V72, P136, DOI 10.1097/TA.0b013e31823183b4
   CORNUT I, 1994, FEBS LETT, V349, P29, DOI 10.1016/0014-5793(94)00621-0
   Galownia J, 2006, MICROPOR MESOPOR MAT, V92, P61, DOI 10.1016/j.mici-omeso.2005.12.020
   Ganopolsky JG, 2008, BIOCHEM J, V412, P545, DOI 10.1042/BJ20071448
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Greenwood R, 2004, PART PART SYST CHAR, V21, P415, DOI 10.1002/ppsc.200400949
   HEDNER U, 1992, HEMATOL ONCOL CLIN N, V6, P1035
   Humphreys MR, 2008, AM J SURG, V195, P99, DOI 10.1016/j.amjsurg.2007.03.006
   Karmouty-Quintana H, 2010, BIOMATERIALS, V31, P6050, DOI 10.1016/j.biomaterials.2010.04.025
   Kheirabadi BS, 2010, J TRAUMA, V68, P269, DOI 10.1097/TA.0b013e3181c97ef1
   Kheirabadi BS, 2009, J TRAUMA, V66, P316, DOI [10.1097/TA.0b013e31819634a1, 10.1097/TA.0b0l3e31819634a1]
   Kheirabadi BS, 2005, J TRAUMA, V59, P25, DOI 10.1097/01.TA.0000171458.72037.EE
   Kheirabadi BS, 2009, J TRAUMA, V66, P27
   Kung SH, 1998, BLOOD, V91, P784
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   LUNDBLAD RL, 1982, THROMB RES, V25, P319, DOI 10.1016/0049-3848(82)90232-8
   MANN KG, 1990, BLOOD, V76, P1
   Oberdorster G, 2010, J INTERN MED, V267, P89, DOI 10.1111/j.1365-2796.2009.02187.x
   Ostomel TA, 2007, LANGMUIR, V23, P11233, DOI 10.1021/la701281t
   Pusateri AE, 2006, J TRAUMA, V60, P674, DOI 10.1097/01.ta.0000196672.47783.fd
   Pusateri AE, 2004, J TRAUMA, V57, P555, DOI 10.1097/01.TA.0000136155.97758.CD
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   Shvedova AA, 2010, J INTERN MED, V267, P106, DOI 10.1111/j.1365-2796.2009.02188.x
   Thatte HS, 2004, J TRAUMA, V57, pS13, DOI 10.1097/01.TA.0000136743.12440.89
   Ward KR, 2007, J TRAUMA, V63, P276, DOI 10.1097/%A.0b013e3180eea8a5
   Ward KR, 2007, J TRAUMA, V63, P83
   Wright JK, 2004, J TRAUMA, V57, P224, DOI 10.1097/01.TA.0000105916.30158.06
NR 31
TC 8
Z9 10
U1 4
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2013
VL 9
IS 11
BP 9194
EP 9200
DI 10.1016/j.actbio.2013.06.023
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 251BJ
UT WOS:000326902500040
PM 23796406
DA 2018-10-20
ER

PT J
AU Haeri, M
   Gilbert, JL
AF Haeri, Morteza
   Gilbert, Jeremy L.
TI Study of cellular dynamics on polarized CoCrMo alloy using time-lapse
   live-cell imaging
SO ACTA BIOMATERIALIA
LA English
DT Article
DE CoCrMo; Time-lapse; Cathodic polarization; Cell dynamics
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; CORROSION BEHAVIOR; BOVINE
   SERUM; TITANIUM; METAL; APOPTOSIS; IMPLANTS; SURFACES; ADHESION;
   PROLIFERATION
AB The physico-chemical processes and phenomena occurring at the interface of metallic biomedical implants and the body dictate their successful integration in vivo. Changes in the surface potential and the associated redox reactions at metallic implants can significantly influence several aspects of biomaterial/cell interactions such as cell adhesion and survival in vitro. Accordingly, there is a voltage viability range (voltages which do not compromise cellular viability of the cells cultured on the polarized metal) for metallic implants. We report on cellular dynamics (size, polarity, movement) and temporal changes in the number and total area of focal adhesion complexes in transiently transfected MOT3-E1 pre-osteoblasts cultured on CoCrMo alloy surfaces polarized at the cathodic and anodic edges of its voltage viability range (-400 and +500 mV (Ag/AgCl), respectively). Nucleus dynamics (size, circularity, movement) and the release of reactive oxygen species (ROS) were also studied on the polarized metal at -1000, -400 and +500 mV (Ag/AgCl). Our results show that at -400 mV, where reduction reactions dominate, a gradual loss of adhesion occurs over 24 h while cells shrink in size during this time. At +500 mV, where oxidation reactions dominate (i.e. metal ions form, including Cr6+, cells become non-viable after 5 h without showing any significant changes in adhesion behavior right before cell death. Nucleus size of cells at -1000 mV decreased sharply within 15 min after polarization, which rendered the cells completely non-viable. No significant amount of ROS release by cells was detected on the polarized CoCrMo at any of these voltages. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Gilbert, Jeremy L.] Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.
   Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA.
RP Gilbert, JL (reprint author), Syracuse Univ, Dept Biomed & Chem Engn, 303C Bowne Hall, Syracuse, NY 13244 USA.
EM gilbert@syr.edu
CR Aizawa M, 1999, ELECTROCHEMISTRY, V67, P118
   Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118
   Contu F, 2005, CORROS SCI, V47, P1863, DOI 10.1016/j.corsci.2004.09.003
   Diomidis N, 2011, WEAR, V271, P1093, DOI 10.1016/j.wear.2011.05.010
   Ehrensberger MT, 2010, J BIOMED MATER RES A, V93A, P1500, DOI 10.1002/jbm.a.32622
   Fonseca C, 2001, CORROS SCI, V43, P547, DOI 10.1016/S0010-938X(00)00107-4
   Gettens RTT, 2008, J BIOMED MATER RES A, V85A, P176, DOI 10.1002/jbm.a.31530
   Gilbert JL, 1998, J BIOMED MATER RES, V42, P321, DOI 10.1002/(SICI)1097-4636(199811)42:2<321::AID-JBM18>3.0.CO;2-L
   Gilbert JL, 2011, COMPREHENSIVE BIOMAT, P21
   Gilbert JL, 2011, US Patent No, Patent No. [12/534443, 12534443]
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Ha SW, 2008, MEDIZINTECHNIK LIFE
   Haeri M, 2012, BIOMATERIALS, V33, P6295, DOI 10.1016/j.biomaterials.2012.05.054
   Haeri M, 2011, CORROS SCI, V53, P582, DOI 10.1016/j.corsci.2010.09.067
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Jacobs JJ, 2009, J AM ACAD ORTHOP SUR, V17, P69, DOI 10.5435/00124635-200902000-00003
   Kalbacova M, 2007, BIOMATERIALS, V28, P3263, DOI 10.1016/j.biomaterials.2007.02.026
   Keegan GM, 2008, CRIT REV TOXICOL, V38, P645, DOI [10.1080/10408440701845534, 10.1080/10408440701845534 ]
   KOJIMA J, 1991, J BIOTECHNOL, V18, P129, DOI 10.1016/0168-1656(91)90241-M
   Koyama S, 1997, NAT BIOTECHNOL, V15, P164, DOI 10.1038/nbt0297-164
   Kwon YM, 2010, J BONE JOINT SURG BR, V92B, P356, DOI 10.1302/0301-620X.92B3.23281
   Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056
   Mahendra G, 2009, ACTA ORTHOP, V80, P653, DOI 10.3109/17453670903473016
   Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150
   Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1
   Pohler O. E., 2000, INJURY S4, V1, P7
   Russo P, 2005, AM J RESP CELL MOL, V33, P589, DOI 10.1165/rcmb.2005-0213OC
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   Spangehl MJ, 1998, AAOS INSTR COURS LEC, V47, P285
   STANKOVICH MT, 1978, J ELECTROANAL CHEM, V86, P189, DOI 10.1016/S0022-0728(78)80366-0
   YAOITA M, 1988, BIOELECTROCH BIOENER, V20, P169, DOI 10.1016/S0302-4598(98)80014-7
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
   Zhou T, 1997, MATER RES SOC S P, V489, P211
NR 37
TC 9
Z9 9
U1 2
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2013
VL 9
IS 11
BP 9220
EP 9228
DI 10.1016/j.actbio.2013.06.040
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 251BJ
UT WOS:000326902500043
PM 23831720
DA 2018-10-20
ER

PT J
AU Pajarinen, J
   Kouri, VP
   Jamsen, E
   Li, TF
   Mandelin, J
   Konttinen, YT
AF Pajarinen, Jukka
   Kouri, Vesa-Petteri
   Jamsen, Eemeli
   Li, Tian-Fang
   Mandelin, Jami
   Konttinen, Yrjo T.
TI The response of macrophages to titanium particles is determined by
   macrophage polarization
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Joint replacement; Wear debris; Titanium; Foreign body response;
   Macrophage
ID COLONY-STIMULATING FACTOR; TOTAL HIP-REPLACEMENT; TOLL-LIKE RECEPTORS;
   KAPPA-B LIGAND; RHEUMATOID SYNOVIAL FIBROBLASTS; MONOCYTE/MACROPHAGES
   IN-VITRO; WEAR-DEBRIS PARTICLES; BONE DESTRUCTION; ONCOSTATIN-M;
   OSTEOCLAST DIFFERENTIATION
AB Aseptic loosening of total joint replacements is driven by the reaction of macrophages to foreign body particles released from the implant. It was hypothesized that the macrophages' response to these particles is dependent, in addition to particle characteristics and contaminating biomolecules, on the state of macrophage polarization as determined by the local cytokine microenvironment. To test this hypothesis we differentiated M1 and M2 macrophages from human peripheral blood monocytes and compared their responses to titanium particles using genome-wide microarray analysis and a multiplex cytokine assay. In comparison to non-activated MO macrophages, the overall chemotactic and inflammatory responses to titanium particles were greatly enhanced in M1 macrophages and effectively suppressed in M2 macrophages. In addition, the genome-wide approach revealed several novel, potentially osteolytic, particle-induced mediators, and signaling pathway analysis suggested the involvement of toll-like and nod-like receptor signaling in particle recognition. It is concluded that the magnitude of foreign body reaction caused by titanium particles is dependent on the state of macrophage polarization. Thus, by limiting the action of M1 polarizing factors, e.g. bacterial biofilm formation, in pen-implant tissues and promoting M2 macrophage polarization by biomaterial solutions or pharmacologically, it might be possible to restrict wear-particle-induced inflammation and osteolysis. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Pajarinen, Jukka; Jamsen, Eemeli; Konttinen, Yrjo T.] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland.
   [Pajarinen, Jukka; Kouri, Vesa-Petteri; Jamsen, Eemeli; Mandelin, Jami; Konttinen, Yrjo T.] Univ Helsinki, Dept Med, Inst Clin Med, Helsinki 00029, Finland.
   [Pajarinen, Jukka; Kouri, Vesa-Petteri; Jamsen, Eemeli; Mandelin, Jami; Konttinen, Yrjo T.] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland.
   [Li, Tian-Fang] Univ Rochester, Med Ctr, Dept Orthoped, Rochester, NY 14642 USA.
   [Konttinen, Yrjo T.] Invalid Fdn, ORTON Orthopaed Hosp, Helsinki 00281, Finland.
RP Konttinen, YT (reprint author), Univ Helsinki, Dept Med, Inst Clin Med, Haartmaninkatu 8,POB 20, Helsinki 00029, Finland.
EM yrjo.konttinen@helsinki.fi
RI Kouri, Vesa-Petteri/M-7436-2015; Mandelin, Jami/A-7943-2008
OI Kouri, Vesa-Petteri/0000-0001-6256-0642; Jamsen,
   Eemeli/0000-0002-0267-0070
FU National Doctoral Program of Musculoskeletal Disorders and Biomaterials;
   Finnish Research Foundation of Orthopaedics and Traumatology; Research
   Foundation of the University of Helsinki; HUS EVO; Paulo Foundation;
   Emil Aaltonen Foundation; Sigrid Juselius Foundation
FX This work was supported by the National Doctoral Program of
   Musculoskeletal Disorders and Biomaterials, the Finnish Research
   Foundation of Orthopaedics and Traumatology, the Research Foundation of
   the University of Helsinki, HUS EVO, the Paulo Foundation, the Emil
   Aaltonen Foundation and the Sigrid Juselius Foundation. The authors are
   grateful to Mika Hukkanen and Mikko Liljestrom for help with the live
   cell imaging, Emilia Kaivosoja for assistance with image analysis, Liisa
   Virkki for assistance with statistical analysis, Lilli Saarinen for help
   with the microarray data analysis and Eija Kaila for invaluable
   laboratory assistance.
CR Abe M, 2002, BLOOD, V100, P2195
   Bukata SV, 2004, J ORTHOPAED RES, V22, P6, DOI 10.1016/S0736-0266(03)00153-0
   Clarke MT, 2004, CLIN ORTHOP RELAT R, P132, DOI 10.1097/01.blo.0000136839.90734.b7
   Edwards JR, 2006, ARTHRITIS RHEUM, V54, P1451, DOI 10.1002/art.21821
   Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109
   Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035
   Goodman SB, 2010, BIOMATERIALS, V31, P5045, DOI 10.1016/j.biomaterials.2010.03.046
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Greenfield EM, 2010, J BIOL CHEM, V285, P32378, DOI 10.1074/jbc.M110.136895
   Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040
   Ha J, 2010, J IMMUNOL, V184, P4717, DOI 10.4049/jimmunol.0902444
   Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686
   Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147
   Hui W, 2005, ARTHRITIS RES THER, V7, pR57, DOI 10.1186/ar1460
   Ishida S, 2009, IMMUNOLOGY, V128, pe315, DOI 10.1111/j.1365-2567.2008.02965.x
   Konttinen YT, 1997, J RHEUMATOL, V24, P694
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Lahdeoja T, 2010, J ORTHOP RES, V28, P184, DOI 10.1002/jor.20979
   Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088
   Lean JM, 2001, BLOOD, V98, P2707, DOI 10.1182/blood.V98.9.2707
   Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7
   Lee HY, 2006, ARTHRITIS RHEUM-US, V54, P1747, DOI 10.1002/art.21873
   Lee SK, 2005, IMMUNOL REV, V208, P169, DOI 10.1111/j.0105-2896.2005.00339.x
   Lisignoli G, 2007, J CELL PHYSIOL, V210, P798, DOI 10.1002/jcp.20905
   Lohmann CH, 2002, J BONE JOINT SURG AM, V84A, P411, DOI 10.2106/00004623-200203000-00012
   Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0
   Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058
   Maitra R, 2009, MOL IMMUNOL, V47, P175, DOI 10.1016/j.molimm.2009.09.023
   Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438
   Mandelin J, 2005, J RHEUMATOL, V32, P713
   Mandelin J, 2003, J BONE JOINT SURG BR, V85B, P1196, DOI 10.1302/0301-620X.85B8.13311
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Marshall A, 2008, J AM ACAD ORTHOP SUR, V16, pS1, DOI 10.5435/00124635-200800001-00003
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Montaner LJ, 1999, J IMMUNOL, V162, P4606
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nakano K, 2004, ARTHRITIS RHEUM, V50, P2450, DOI 10.1002/art.20367
   Nalepka JL, 2006, CLIN ORTHOP RELAT R, P229, DOI 10.1097/01.blo.0000224050.94248.38
   Nelson CL, 2005, CLIN ORTHOP RELAT R, P25, DOI 10.1097/01.blo.0000175715.68624.3d
   Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353
   Pearl JI, 2011, BIOMATERIALS, V32, P5535, DOI 10.1016/j.biomaterials.2011.04.046
   Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503
   Pollice PF, 1998, J ORTHOP RES, V16, P697, DOI 10.1002/jor.1100160611
   Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Rao AJ, 2012, ACTA BIOMATER, V8, P2815, DOI 10.1016/j.actbio.2012.03.042
   Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55
   Shimoaka T, 2002, J BIOL CHEM, V277, P7493, DOI 10.1074/jbc.M108653200
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2005, IMMUNOL REV, V205, P60, DOI 10.1111/j.0105-2896.2005.00260.x
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
   Trindade MCD, 2001, BIOMATERIALS, V22, P2067, DOI 10.1016/S0142-9612(00)00376-8
   Trindade MCD, 1999, J ORTHOP RES, V17, P797, DOI 10.1002/jor.1100170602
   Trindade MCD, 1999, J BIOMED MATER RES, V47, P1
   Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200
   Valles G, 2013, ACTA BIOMATER, V9, P4916, DOI 10.1016/j.actbio.2012.08.027
   Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025
   Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568
   Yang J, 2008, EUR J IMMUNOL, V38, P1598, DOI 10.1002/eji.200737650
   Yang SY, 2004, GENE THER, V11, P483, DOI 10.1038/sj.gt.3302192
   Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910
NR 68
TC 39
Z9 42
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2013
VL 9
IS 11
BP 9229
EP 9240
DI 10.1016/j.actbio.2013.06.027
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 251BJ
UT WOS:000326902500044
PM 23827094
DA 2018-10-20
ER

PT J
AU Bidault, L
   Deneufchatel, M
   Vancaeyzeele, C
   Fichet, O
   Larreta-Garde, V
AF Bidault, Laurent
   Deneufchatel, Marie
   Vancaeyzeele, Cedric
   Fichet, Odile
   Larreta-Garde, Veronique
TI Self-Supported Fibrin-Polyvinyl Alcohol Interpenetrating Polymer
   Networks: An Easily Handled and Rehydratable Biomaterial
SO BIOMACROMOLECULES
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; POLY(VINYL ALCOHOL); CELL
   ENCAPSULATION; CONTROLLED-RELEASE; GROWTH-FACTORS; HYDROGELS; SCAFFOLDS;
   DELIVERY; CLOT; MEMBRANES
AB A fibrin hydrogel at physiological concentration (5 mg/mL) was associated with polyvinyl alcohol (PVA) inside an interpenetrating polymer networks (IPN) architecture. Previously, PVA has been modified with methacrylate functions in order to cross-link it by free-radical polymerization. The fibrin network was synthesized by the enzymatic hydrolysis of fibrinogen by thrombin. The resulting self-supported materials simultaneously exhibit the properties of the fibrin hydrogel and those of the synthetic polymer network. Their storage modulus is 50-fold higher than that of the fibrin hydrogel and they are completely rehydratable. These materials are noncytotoxic toward human fibroblast and the fibrin present on the surface of PVAm-based IPNs favors cell development.
C1 [Bidault, Laurent; Deneufchatel, Marie; Larreta-Garde, Veronique] Univ Cergy Pontoise, Inst Mat, Equipe Rech Relat Matrice Extracellulaire Cellule, F-95000 Cergy Pontoise, France.
   [Bidault, Laurent; Deneufchatel, Marie; Vancaeyzeele, Cedric; Fichet, Odile] Univ Cergy Pontoise, Inst Mat, LPPI, F-95000 Cergy Pontoise, France.
RP Fichet, O (reprint author), Univ Cergy Pontoise, Inst Mat, LPPI, F-95000 Cergy Pontoise, France.
EM odile.fichet@u-cergy.fr
OI vancaeyzeele, cedric/0000-0002-9748-1562
FU Direction Generale de l'Armenent (DGA) of France; Region Ile-de-France;
   Fondation de l'UCP
FX This work was sponsored by the Direction Generale de l'Armenent (DGA) of
   France. The authors thank more particularly Dr Bruno Mortaigne,
   responsible for "Materials and Chemistry" at DS MRIS. The authors would
   like to thank the Region Ile-de-France which has sponsored the SESAME
   project (Comicer project) that has allowed the acquisition of confocal
   laser scanning microscope with which were recorded the images reported
   in this work. The authors are also grateful to the "Fondation de l'UCP"
   for its financial support to Marie Deneufchatel.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Akpalo E, 2011, ACTA BIOMATER, V7, P2418, DOI 10.1016/j.actbio.2011.03.002
   Akpalo E, 2010, ACTA BIOMATER, V6, P396, DOI 10.1016/j.actbio.2009.08.001
   Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010
   Araujo AM, 1997, BIOTECHNOL TECH, V11, P67, DOI 10.1023/A:1018404103626
   Arnoozgar Z., 2012, ACTA BIOMATER, V8, P1849
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Barrett DA, 2001, ANAL CHEM, V73, P5232, DOI 10.1021/ac010368u
   Briganti E, 2010, J CONTROL RELEASE, V142, P14, DOI 10.1016/j.jconrel.2009.09.029
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   Burnouf T, 2013, BLOOD REV, V27, P77, DOI 10.1016/j.blre.2013.02.001
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   HICKEY AS, 1995, J MEMBRANE SCI, V107, P229, DOI 10.1016/0376-7388(95)00119-0
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Khetani S. R., 2006, CURR OPIN BIOTECH, V17, P1
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kobayashi H., 2006, Biomedical Applications of Nano Technologies, P17, DOI 10.4028/www.scientific.net/AST.53.9
   Kobayashi M, 2010, MATERIALS, V3, P2753, DOI 10.3390/ma3042753
   Kulkarni RV, 2010, INT J BIOL MACROMOL, V47, P520, DOI 10.1016/j.ijbiomac.2010.07.009
   Larreta-Garde V., 2010, Eur. Patent, Patent No. W02010058132
   Lee F, 2013, ACTA BIOMATER, V9, P5143, DOI 10.1016/j.actbio.2012.08.036
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Lisi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034284
   Losi P, 2010, BIOMATERIALS, V31, P5336, DOI 10.1016/j.biomaterials.2010.03.033
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Moolman FS, 2005, POLYMER, V46, P6192, DOI 10.1016/j.polymer.2005.03.121
   Moura LIF, 2013, ACTA BIOMATER, V9, P7093, DOI 10.1016/j.actbio.2013.03.033
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Patachia S, 2009, EXPRESS POLYM LETT, V3, P320, DOI 10.3144/expresspolymlett.2009.40
   PEPPAS NA, 1992, J CONTROL RELEASE, V18, P95, DOI 10.1016/0168-3659(92)90178-T
   Peppas NA, 1987, POLYMERS, V2
   Picard J, 2010, MACROMOL SYMP, V291-292, P337, DOI 10.1002/masy.201050540
   Qi M, 2004, BIOMATERIALS, V25, P5885, DOI 10.1016/j.biomaterials.2004.01.050
   Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Shah JV, 1997, RHEOL ACTA, V36, P262, DOI 10.1007/BF00366667
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Shikanov A, 2009, BIOMATERIALS, V30, P5476, DOI 10.1016/j.biomaterials.2009.06.054
   Siritienthong T, 2012, INT J PHARMACEUT, V439, P175, DOI 10.1016/j.ijpharm.2012.09.043
   Soldani G, 2010, BIOMATERIALS, V31, P2592, DOI 10.1016/j.biomaterials.2009.12.017
   Sperling LH, 1997, INTERFACIAL ASPECTS OF MULTICOMPONENT POLYMER MATERIALS, P1
   SPERLING LH, 1994, ADV CHEM SER, V239, P3
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   Suri S, 2009, ACTA BIOMATER, V5, P2385, DOI 10.1016/j.actbio.2009.05.004
   Thankam FG, 2013, COLLOID SURFACE B, V107, P137, DOI 10.1016/j.colsurfb.2013.01.069
   URUSHIZAKI F, 1990, INT J PHARM, V58, P135
   Vert M, 2007, PROG POLYM SCI, V32, P755, DOI 10.1016/j.progpolymsci.2007.05.006
   Vrana NE, 2012, J TISSUE ENG REGEN M, V6, P280, DOI 10.1002/term.431
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Xiao WQ, 2011, ACTA BIOMATER, V7, P2384, DOI 10.1016/j.actbio.2011.01.016
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
NR 57
TC 8
Z9 8
U1 3
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2013
VL 14
IS 11
BP 3870
EP 3879
DI 10.1021/bm400991k
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 251UJ
UT WOS:000326955900008
PM 24050436
DA 2018-10-20
ER

PT J
AU Lee, CM
   Cheong, SJ
   Kim, EM
   Lim, ST
   Jeong, YY
   Sohn, MH
   Jeong, HJ
AF Lee, Chang-Moon
   Cheong, Su-Jin
   Kim, Eun-Mi
   Lim, Seok Tae
   Jeong, Yong Yeon
   Sohn, Myung-Hee
   Jeong, Hwan-Jeong
TI Nonpolymeric Surface-Coated Iron Oxide Nanoparticles for In Vivo
   Molecular Imaging: Biodegradation, Biocompatibility, and Multiplatform
SO JOURNAL OF NUCLEAR MEDICINE
LA English
DT Article
DE iron oxide nanoparticle; tumor imaging; ATP; multiplatform; molecular
   imaging
ID HEPATOCYTE GROWTH-FACTOR; MAGNETIC NANOPARTICLES; BIOMEDICAL
   APPLICATIONS; C-MET; CELLS; TOXICITY; THERAPY; PROBE; FUNCTIONALIZATION;
   BIODISTRIBUTION
AB A new approach to the surface engineering of superparamagnetic iron oxide nanoparticles (SPIONs) may encourage their development for clinical use. In this study, we demonstrated that nonpolymeric surface modification of SPIONs has the potential to be an advanced biocompatible contrast agent for biomedical applications, including diagnostic imaging in vivo. Methods: Adenosine triphosphate (ATP), which is an innate biomaterial derived from the body, was coated onto the surface of SPIONs. An in vivo degradation study of ATP-coated SPIONs (ATP@SPIONs) was performed for 28 d. To diminish phagocytosis, ATP@SPIONs were surface-modified with gluconic acid. We next studied the ability of the SPIONs to serve as a specific targeted contrast agent after conjugation of cMet-binding peptide. The SPIONs were conjugated with Cy5.5 and labeled with 125I for multimodality imaging. In vivo and in vitro tumor-targeted binding studies were performed on U87MG cells or a U87MG tumor model using animal SPECT/CT, an optical imaging system, and a 1.5-T clinical MR scanner. Results: ATP@SPIONs showed rapid degradation in vivo and in vitro, compared with ferumoxides. ATP@SPIONs modified with gluconic acid reduced phagocytic uptake, showed improved biodistribution, and provided good targetability in vivo. The gluconic acid-conjugated ATP@SPIONs, when conjugated with cMet-binding peptide, were successfully visualized on the U87MG tumors implanted in mice via multimodality imaging. Conclusion: We suggest that ATP@ SPIONs can be used as a multiplatform to target a region of interest in molecular imaging. When we consider the biocompatibility of contrast agents in vivo, ATP@SPIONs are superior to polymeric surface-modified SPIONs.
C1 [Lee, Chang-Moon] Chonnam Natl Univ, Dept Biomed Engn, Yeosu, South Korea.
   [Cheong, Su-Jin; Kim, Eun-Mi; Lim, Seok Tae; Sohn, Myung-Hee; Jeong, Hwan-Jeong] Chonbuk Natl Univ, Mol Imaging & Therapeut Med Res Ctr, Dept Nucl Med, Biomed Res Inst,Inst Med Sci,Med Sch & Hosp, Jeonju 561712, Jeonbuk, South Korea.
   [Cheong, Su-Jin; Kim, Eun-Mi; Lim, Seok Tae; Sohn, Myung-Hee; Jeong, Hwan-Jeong] Chonbuk Natl Univ, Med Sch & Hosp, Cyclotron Res Ctr, Jeonju 561712, Jeonbuk, South Korea.
   [Jeong, Yong Yeon] Chonnam Natl Univ, Sch Med, Dept Radiol, Kwangju, South Korea.
RP Jeong, HJ (reprint author), Chonbuk Natl Univ, Med Sch & Hosp, Dept Nucl Med, 634-18 Geumam Dong, Jeonju 561712, Jeonbuk, South Korea.
EM jayjeong@jbnu.ac.kr
FU National R&D Program for Cancer Control, Ministry of Health, Welfare and
   Family Affairs, Republic of Korea [0620220]; National Research
   Foundation of Korea (NRF); Korean Government (MEST) [2011-0028581,
   2012M2A2A7035779, 2012M2A2A7014020]
FX The costs of publication of this article were defrayed in part by the
   payment of page charges. Therefore, and solely to indicate this fact,
   this article is hereby marked "advertisement" in accordance with 18 USC
   section 1734. The authors had final responsibility for the decision to
   submit for publication. This work was supported by a grant from the
   National R&D Program for Cancer Control, Ministry of Health, Welfare and
   Family Affairs, Republic of Korea (0620220). This work was also
   supported by National Research Foundation of Korea (NRF) grants funded
   by the Korean Government (MEST) (grants 2011-0028581, 2012M2A2A7035779,
   and 2012M2A2A7014020). No other potential conflict of interest relevant
   to this article was reported.
CR Bae JE, 2011, BIOMATERIALS, V32, P9401, DOI 10.1016/j.biomaterials.2011.08.075
   Briley-Saebo K, 2004, J MAGN RESON IMAGING, V20, P622, DOI 10.1002/jmri.20175
   Briley-Saebo K, 2004, CELL TISSUE RES, V316, P315, DOI 10.1007/s00441-004-0884-8
   Choi JS, 2008, ANGEW CHEM INT EDIT, V47, P6259, DOI 10.1002/anie.200801369
   Gupta AK, 2007, NANOMEDICINE-UK, V2, P23, DOI 10.2217/17435889.2.1.23
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Jiskoot W, 2009, PHARM RES-DORDR, V26, P1303, DOI 10.1007/s11095-009-9855-9
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Kim EM, 2009, BIOCONJUGATE CHEM, V20, P1299, DOI 10.1021/bc8005539
   Kim EM, 2009, NUCL MED BIOL, V36, P371, DOI 10.1016/j.nucmedbio.2009.01.005
   Kojima H, 2010, BIOCONJUGATE CHEM, V21, P1026, DOI 10.1021/bc900487p
   Lalatonne Y, 2008, CHEM COMMUN, P2553, DOI 10.1039/b801911h
   Lee CM, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/28/285102
   Lee CM, 2010, ACS APPL MATER INTER, V2, P756, DOI 10.1021/am900769x
   Lee CM, 2010, PHARM RES-DORDR, V27, P712, DOI 10.1007/s11095-010-0072-3
   Lee CM, 2009, MAGN RESON MED, V62, P1440, DOI 10.1002/mrm.22123
   Lee CM, 2009, MACROMOL RES, V17, P133, DOI 10.1007/BF03218667
   Lee CM, 2009, INT J PHARMACEUT, V371, P163, DOI 10.1016/j.ijpharm.2008.12.021
   Lee H, 2006, J AM CHEM SOC, V128, P7383, DOI 10.1021/ja061529k
   Lee H, 2007, J AM CHEM SOC, V129, P12739, DOI 10.1021/ja072210i
   Levy M, 2011, BIOMATERIALS, V32, P3988, DOI 10.1016/j.biomaterials.2011.02.031
   Li Z, 2008, SMALL, V4, P231, DOI 10.1002/smll.200700575
   Lin MM, 2010, NANOMEDICINE-UK, V5, P109, DOI 10.2217/NNM.09.96
   Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   Lunov O, 2010, BIOMATERIALS, V31, P9015, DOI 10.1016/j.biomaterials.2010.08.003
   Mahmoudi M, 2008, J PHYS CHEM B, V112, P14470, DOI 10.1021/jp803016n
   Makhluf SBD, 2008, SMALL, V4, P1453, DOI 10.1002/smll.200701308
   Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2, DOI 10.2174/1871520611009010002
   Moriyama T, 1999, INT J MOL MED, V3, P531
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   OKSENDAL AN, 1993, JMRI-J MAGN RESON IM, V3, P157, DOI 10.1002/jmri.1880030128
   Parr C, 2001, HISTOL HISTOPATHOL, V16, P251, DOI 10.14670/HH-16.251
   Pazik R, 2011, J PHYS CHEM C, V115, P9850, DOI 10.1021/jp2000656
   Pittet MJ, 2006, NAT PROTOC, V1, P73, DOI 10.1038/nprot.2006.11
   Shi ZL, 2009, ACS APPL MATER INTER, V1, P328, DOI 10.1021/am8000538
   Shubayev VI, 2009, ADV DRUG DELIVER REV, V61, P467, DOI 10.1016/j.addr.2009.03.007
   Thorek DLJ, 2008, BIOMATERIALS, V29, P3583, DOI 10.1016/j.biomaterials.2008.05.015
   Wang J, 2010, INT J NANOMED, V5, P861, DOI 10.2147/IJN.S13662
   Wilkinson K, 2012, NANOSCALE, V4, P7383, DOI 10.1039/c2nr32572a
NR 40
TC 12
Z9 12
U1 0
U2 34
PU SOC NUCLEAR MEDICINE INC
PI RESTON
PA 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA
SN 0161-5505
EI 1535-5667
J9 J NUCL MED
JI J. Nucl. Med.
PD NOV 1
PY 2013
VL 54
IS 11
BP 1974
EP 1980
DI 10.2967/jnumed.113.122267
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 250TF
UT WOS:000326876800024
PM 24050935
OA Bronze
DA 2018-10-20
ER

PT J
AU Protopapadaki, M
   Monaco, EA
   Kim, HI
   Davis, EL
AF Protopapadaki, Maria
   Monaco, Edward A., Jr.
   Kim, Hyeong-Il
   Davis, Elaine L.
TI COMPARISON OF FRACTURE RESISTANCE OF PRESSABLE METAL CERAMIC CUSTOM
   IMPLANT ABUTMENT WITH A COMMERCIALLY FABRICATED CAD/CAM ZIRCONIA IMPLANT
   ABUTMENT
SO JOURNAL OF PROSTHETIC DENTISTRY
LA English
DT Article
ID LOAD FATIGUE PERFORMANCE; LOW-TEMPERATURE DEGRADATION; SUPPORTED
   RESTORATIONS; DENTAL APPLICATIONS; STATIC FATIGUE; RELIABILITY;
   BIOMATERIAL; OUTCOMES; CROWNS; TOOTH
AB Statement of problem. The predictable nature of the hot pressing ceramic technique has several applications, but no study was identified that evaluated its application to the fabrication of custom implant abutments.
   Purpose. The purpose of this study was to compare the fracture resistance of an experimentally designed pressable metal ceramic custom implant abutment (PR) with that of a duplicate zirconia abutment (ZR).
   Materials and methods. Two groups of narrow platform (NP) (Nobel Replace) implant abutment specimens were fabricated (n=10). The experimental abutment (PR) had a metal substructure cast with ceramic alloy (Lodestar) and veneered with leucite pressable glass ceramic (InLine PoM). Each PR abutment was individually scanned and 10 duplicate CAD/CAM ZR abutments were fabricated for the control group. Ceramic crowns (n=20) with the average dimensions of a human lateral incisor were pressed with lithium disilicate glass ceramic (IPS e.max Press) and bonded on the abutments with a resin luting agent (Multilink Automix). The specimens were subjected to thermocycling, cyclic loading, and finally static loading to failure with a computer-controlled Universal Testing Machine. An independent t test (1 sided) determined whether the mean values of the fracture load differed significantly (alpha=.05) between the 2 groups.
   Results. No specimen failed during cyclic loading. Upon static loading, the mean (SD) load to failure was significantly higher for the PR group (525.89 [143.547] N) than for the ZR group (413.70 [35.515] N) for internal connection narrow platform bone-level implants (P=.025). Failure was initiated at the screw and internal connection level for both groups.
   Conclusions. It is possible to fabricate PR abutments that are stronger than ZR abutments for Nobel Biocare internal connection NP bone-level implants. The screw and the internal connection are the weak links for both groups.
C1 [Monaco, Edward A., Jr.; Kim, Hyeong-Il] SUNY Buffalo, Sch Dent Med, Dept Restorat Dent, Buffalo, NY 14260 USA.
   [Davis, Elaine L.] SUNY Buffalo, Sch Dent Med, Dept Oral Diagnost Sci, Buffalo, NY 14260 USA.
RP Protopapadaki, M (reprint author), 8 Artemidos St, Athens 16674, Greece.
EM protomaria@gmail.com
OI Davis, Elaine/0000-0002-3529-098X
CR CHARLES RJ, 1958, J APPL PHYS, V29, P1549, DOI 10.1063/1.1722991
   CHARLES RJ, 1958, J APPL PHYS, V29, P1554, DOI 10.1063/1.1722992
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Christensen GJ, 2007, J AM DENT ASSOC, V138, P662, DOI 10.14219/jada.archive.2007.0239
   Conrad HJ, 2007, J PROSTHET DENT, V98, P389, DOI 10.1016/S0022-3913(07)60124-3
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Diamond M., 1929, DENT ANATOMY, P280
   Gomes AL, 2011, MED ORAL PATOL ORAL, V16, P50
   Heydecke G, 2002, INT J PROSTHODONT, V15, P488
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Iqbal MK, 2007, INT J ORAL MAX IMPL, V22, P96
   Kawai Y, 2011, DENT MATER J, V30, P286, DOI 10.4012/dmj.2010-175
   Kelly JR, 1999, J PROSTHET DENT, V81, P652, DOI 10.1016/S0022-3913(99)70103-4
   KILIARIDIS S, 1993, ACTA ODONTOL SCAND, V51, P323, DOI 10.3109/00016359309040583
   Kim JH, 2012, J PROSTHET DENT, V108, P96, DOI 10.1016/S0022-3913(12)60114-0
   Kim S, 2009, J PROSTHET DENT, V101, P226, DOI 10.1016/S0022-3913(09)60043-3
   KOHAL R, 2000, PERIODONTOL, V2008, P224
   Kohorst P, 2012, ACTA BIOMATER, V8, P1213, DOI 10.1016/j.actbio.2011.11.016
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   KREJCI I, 1994, J DENT RES, V73, P1228, DOI 10.1177/00220345940730061501
   Leblebicioglu B, 2007, J AM DENT ASSOC, V138, P321, DOI 10.14219/jada.archive.2007.0164
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   Maeda Y, 2007, CLIN ORAL IMPLAN RES, V18, P581, DOI 10.1111/j.1600-0501.2007.01398.x
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Nakamura K, 2010, INT J PROSTHODONT, V23, P299
   Nguyen HQ, 2009, INT J ORAL MAX IMPL, V24, P636
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Powers JM, 2012, CRAIGS RESTORATIVE D, P52
   Priest G, 2005, J ORAL MAXIL SURG, V63, P22, DOI 10.1016/j.joms.2005.05.158
   Quek HC, 2008, INT J ORAL MAX IMPL, V23, P253
   Quek HC, 2006, INT J ORAL MAXILLOF, V21, P929
   Sakaguchi RL, 2012, CRAIGS RESTORATIVE D, P255
   Salinas TJ, 2007, INT J ORAL MAX IMPL, V22, P71
   Seetoh YL, 2011, INT J ORAL MAX IMPL, V26, P797
   Siamos Georgios, 2002, J Oral Implantol, V28, P67, DOI 10.1563/1548-1336(2002)028<0067:TRBIPA>2.3.CO;2
   Silva NRFA, 2011, CLIN IMPLANT DENT R, V13, P168, DOI 10.1111/j.1708-8208.2009.00187.x
   Stappert CFJ, 2005, J PROSTHET DENT, V94, P132, DOI 10.1016/j.prosdent.2005.05.023
   SWAB JJ, 1991, J MATER SCI, V26, P6706, DOI 10.1007/BF02402664
   Taggart WH, 1907, DENT COSMOS, V49, P117
   Tinschert J, 2000, J DENT, V28, P529, DOI 10.1016/S0300-5712(00)00030-0
   Torabinejad M, 2007, J PROSTHET DENT, V98, P285, DOI 10.1016/S0022-3913(07)60102-4
   Torabinejad Mahmoud, 2008, J Calif Dent Assoc, V36, P429
   Winkler Sheldon, 2003, J Oral Implantol, V29, P242, DOI 10.1563/1548-1336(2003)029<0242:ISMATS>2.3.CO;2
   Wiskott H W, 1995, Int J Prosthodont, V8, P105
   Zarone F, 2011, DENT MATER, V27, P83, DOI 10.1016/j.dental.2010.10.024
   Zitzmann NU, 2010, J PROSTHET DENT, V104, P80, DOI 10.1016/S0022-3913(10)60096-0
NR 49
TC 10
Z9 11
U1 0
U2 11
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3913
EI 1097-6841
J9 J PROSTHET DENT
JI J. Prosthet. Dent.
PD NOV
PY 2013
VL 110
IS 5
BP 389
EP 396
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 250LV
UT WOS:000326855200009
PM 24011801
DA 2018-10-20
ER

PT J
AU Sakagami, Y
   Horiguchi, K
   Narita, Y
   Sirithep, W
   Morita, K
   Nagase, Y
AF Sakagami, Yuhki
   Horiguchi, Kenji
   Narita, Yusuke
   Sirithep, Wariya
   Morita, Kohei
   Nagase, Yu
TI Syntheses of a novel diol monomer and polyurethane elastomers containing
   phospholipid moieties
SO POLYMER JOURNAL
LA English
DT Article
DE biomaterial; diol monomer; phosphorylcholine; polyurethane; protein
   adsorption
ID IMPROVED BLOOD COMPATIBILITY; SEGMENTED POLYURETHANE;
   SEMIINTERPENETRATING POLYMER; PLATELET-ADHESION; SOFT SEGMENTS;
   SIDE-CHAIN; BIOSTABILITY; POLYCARBONATE; COPOLYMERS; ADDITIVES
AB To introduce a phosphorylcholine (PC) moiety into segmented polyurethane, which has been widely used as an elastic material, the synthesis of a novel diol monomer containing a PC unit was performed. PC-containing polyurethanes were then prepared by polyaddition of the diol monomer and poly(carbonate diol) with 4,4'-diphenylmethane diisocyanate. The obtained polyurethanes were soluble in aprotic polar solvents, such as N,N-dimethylacetamide, N,N-dimethylformamide (DMF) and dimethyl sulfoxide, but were insoluble in water and alcohol. According to thermal analysis and the stress-strain measurements, the polyurethane films exhibited thermal stability up to 250 degrees C and elastic properties with high tensile strength. In addition, it was confirmed from the results of the protein adsorption experiments that the PC-containing polyurethane films efficiently reduced protein adsorption to the surface.
C1 [Sakagami, Yuhki; Horiguchi, Kenji; Narita, Yusuke; Sirithep, Wariya; Morita, Kohei; Nagase, Yu] Tokai Univ, Course Ind Chem, Grad Sch Engn, Hiratsuka, Kanagawa 2591292, Japan.
RP Nagase, Y (reprint author), Tokai Univ, Course Ind Chem, Grad Sch Engn, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.
EM yunagase@tokai-u.jp
FU Tokai University Support Association Union
FX We express our sincere gratitude to Professor Kazuhiko Ishihara and
   Professor Yasuhiko Iwasaki, who are from the School of Engineering,
   University of Tokyo and from the Faculty of Chemistry, Materials and
   Bioengineering, Kansai University, respectively, for their scientific
   and technical support. We also thank Professor Takashi Asaka from the
   Department of Applied Chemistry, Tokai University, for his help in
   conducting the stress strain measurements. This work was partially
   supported by a Grant-in-Aid for Research from the Tokai University
   Support Association Union.
CR Chung YC, 2012, FIBER POLYM, V13, P815, DOI 10.1007/s12221-012-0815-3
   Eceiza A, 2008, POLYM ENG SCI, V48, P297, DOI 10.1002/pen.20905
   EDMUNDSON RS, 1962, CHEM IND-LONDON, P1828
   Eisenbach CD, 1996, POLYM MAT ENCY, V9, P6957
   Flemming RG, 1999, J BIOMAT SCI-POLYM E, V10, P679, DOI 10.1163/156856299X00874
   Horiguchi K, 2008, T MAT RES SOC JPN, V33, P1261
   Ishihara K, 2000, POLYM ADVAN TECHNOL, V11, P626, DOI 10.1002/1099-1581(200008/12)11:8/12<626::AID-PAT13>3.0.CO;2-G
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   Ishihara K, 1996, J BIOMED MATER RES, V32, P401, DOI 10.1002/(SICI)1097-4636(199611)32:3<401::AID-JBM13>3.0.CO;2-J
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 2000, J BIOMED MATER RES, V52, P701, DOI 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.3.CO;2-Y
   Kang IK, 1997, BIOMATERIALS, V18, P1099, DOI 10.1016/S0142-9612(97)00035-5
   Khan M, 2005, BIOMATERIALS, V26, P633, DOI 10.1016/j.biomaterials.2004.02.064
   Khan M, 2005, BIOMATERIALS, V26, P621, DOI 10.1016/j.biomaterials.2004.02.065
   Kojio K, 2009, MACROMOLECULES, V42, P8322, DOI 10.1021/ma901317t
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lelah M. D., 1986, POLYURETHANES MED
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   Nagase Y, 2007, POLYM J, V39, P712, DOI 10.1295/polymj.PJ2006253
   Nagase Y, 2011, BIOMEDICAL ENGINEERING - FRONTIERS AND CHALLENGES, P217
   Nagase Y, 2008, POLYM J, V40, P1149, DOI 10.1295/polymj.PJ2008158
   Roh HW, 1999, J BIOMAT SCI-POLYM E, V10, P123, DOI 10.1163/156856299X00324
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Tanaka H, 2002, POLYM ENG SCI, V42, P1333, DOI 10.1002/pen.11035
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 31
TC 7
Z9 7
U1 4
U2 28
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0032-3896
EI 1349-0540
J9 POLYM J
JI Polym. J.
PD NOV
PY 2013
VL 45
IS 11
BP 1159
EP 1166
DI 10.1038/pj.2013.48
PG 8
WC Polymer Science
SC Polymer Science
GA 251EH
UT WOS:000326910100008
DA 2018-10-20
ER

PT J
AU Zhou, WR
   Zheng, YF
   Leeflang, MA
   Zhou, J
AF Zhou, W. R.
   Zheng, Y. F.
   Leeflang, M. A.
   Zhou, J.
TI Mechanical property, biocorrosion and in vitro biocompatibility
   evaluations of Mg-Li-(Al)-(RE) alloys for future cardiovascular stent
   application
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Mg-Li-based alloys; Biodegradable; Corrosion; Biocompatibility; In vitro
ID MG-LI ALLOYS; MAGNESIUM ALLOYS; RARE-EARTH; DEFORMATION-BEHAVIOR;
   DEGRADABLE STENTS; VIVO CORROSION; PURE MAGNESIUM; MICROSTRUCTURES;
   BIOMATERIAL
AB Mg-Li-based alloys were investigated for future cardiovascular stent application as they possess excellent ductility. However, Mg-Li binary alloys exhibited reduced mechanical strengths due to the presence of lithium. To improve the mechanical strengths of Mg-Li binary alloys, aluminum and rare earth (RE) elements were added to form Mg-Li-Al ternary and Mg-Li-Al-RE quarternary alloys. In the present study, six Mg-Li-(Al)-(RE) alloys were fabricated. Their microstructures, mechanical properties and biocorrosion behavior were evaluated by using optical microscopy, X-ray diffraction, scanning electronic microscopy, tensile tests, immersion tests and electrochemical measurements. Microstructure characterization indicated that grain sizes were moderately refined by the addition of rare earth elements. Tensile testing showed that enhanced mechanical strengths were obtained, while electrochemical and immersion tests showed reduced corrosion resistance caused by intermetallic compounds distributed throughout the magnesium matrix in the rare-earth-containing Mg-Li alloys. Cytotoxicity assays, hemolysis tests as well as platelet adhesion tests were performed to evaluate in vitro biocompatibilities of the Mg-Li-based alloys. The results of cytotoxicity assays clearly showed that the Mg-3.5Li-2AI-2RE, Mg-3.5Li-4Al-2RE and Mg-8.5Li-2Al-2RE alloys suppressed vascular smooth muscle cell proliferation after 5 day incubation, while the Mg-3.5Li, Mg-8.5Li and Mg-8.5Li-1Al alloys were proven to be tolerated. In the case of human umbilical vein endothelial cells, the Mg-Li-based alloys showed no significantly reduced cell viabilities except for the Mg-8.5Li-2Al-2RE alloy, with no obvious differences in cell viability between different culture periods. With the exception of Mg-8.5Li-2Al-2RE, all of the other Mg-Li(AI)-(RE) alloys exhibited acceptable hemolysis ratios, and no sign of thrombogenicity was found. These in vitro experimental results indicate the potential of Mg-Li-(Al)-(RE) alloys as biomaterials for future cardiovascular stent application and the worthiness of investigating their biodegradation behaviors in vivo. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhou, W. R.; Zheng, Y. F.] Peking Univ, Ctr Biomed Mat & Tissue Engn, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.
   [Zheng, Y. F.] Peking Univ, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Zheng, Y. F.] Peking Univ, Dept Mat Sci & Engn, Coll Engn, Beijing 100871, Peoples R China.
   [Leeflang, M. A.; Zhou, J.] Delft Univ Technol, Dept Biomech Engn, NL-2628 CD Delft, Netherlands.
RP Zheng, YF (reprint author), Peking Univ, Ctr Biomed Mat & Tissue Engn, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn; J.Zhou@tudelft.nl
RI Zhou, Jie/J-3019-2012; Zheng, Yufeng/A-4146-2010
OI Zhou, Jie/0000-0002-6484-9156; Zheng, Yufeng/0000-0002-7402-9979;
   Leeflang, Marius Alexander/0000-0003-1702-7413
FU National Basic Research Program of China (973 Program) [2012CB619102,
   2012CB619100]; National Science Fund for Distinguished Young Scholars
   [51225101]; National Natural Science Foundation of China [31170909];
   Research Fund for the Doctoral Program of Higher Education
   [20100001110011]; Natural Science Foundation of Heilongjiang Province
   [ZD201012]; Project for Supervisor of Excellent doctoral dissertation of
   Beijing [20121000101]
FX This work was supported by the National Basic Research Program of China
   (973 Program) (Grant Nos. 2012CB619102 and 2012CB619100), the National
   Science Fund for Distinguished Young Scholars (Grant No. 51225101), the
   National Natural Science Foundation of China (Grant No. 31170909), the
   Research Fund for the Doctoral Program of Higher Education (Grant No.
   20100001110011), the Natural Science Foundation of Heilongjiang Province
   (Grant No. ZD201012) and a Project for Supervisor of Excellent doctoral
   dissertation of Beijing (Grant No. 20121000101).
CR [Anonymous], 2004, G3172 ASTM
   ASTM, 1999, ANN BOOK ASTM STAND
   ASTM, 2004, ANN BOOK ASTM STAND
   ASTM (American Society for Testing and Materials), 2000, ANN BOOK ASTM STAND, V4.08
   Bach FW, 2003, MATER SCI FORUM, V419-4, P1037, DOI 10.4028/www.scientific.net/MSF.419-422.1037
   Birbilis N, 2009, CORROS SCI, V51, P683, DOI 10.1016/j.corsci.2008.12.012
   Bondarenko A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-32
   Chang TC, 2006, MATER LETT, V60, P3272, DOI 10.1016/j.matlet.2006.03.052
   Di Virgilio AL, 2011, J BIOMED MATER RES B, V99B, P111, DOI 10.1002/jbm.b.31877
   Drozd Z, 2004, J ALLOY COMPD, V378, P192, DOI 10.1016/j.jallcom.2004.01.040
   El-Rahman SSA, 2003, PHARM RES, V47, P189, DOI DOI 10.1016/S1043-6618(02)00336-5
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Hermawan H, 2007, ADV MATER RES-SWITZ, V15-17, P113, DOI 10.4028/www.scientific.net/AMR.15-17.113
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Kim WJ, 2009, MAT SCI ENG A-STRUCT, V516, P17, DOI 10.1016/j.msea.2009.03.089
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   [乐启炽 Le Qichi], 2003, [材料导报, Materials Review], V17, P1
   Leeflang MA, 2011, MATER SCI ENG B-ADV, V176, P1741, DOI 10.1016/j.mseb.2011.08.002
   Li JF, 2006, MAT SCI ENG A-STRUCT, V433, P233, DOI 10.1016/j.msea.2006.06.107
   Lin HC, 2005, MAGNES TECHNOL, V2005, P275
   Liu T, 2007, MAT SCI ENG A-STRUCT, V460, P499, DOI 10.1016/j.msea.2007.01.108
   Liu T, 2004, SCRIPTA MATER, V51, P1057, DOI 10.1016/j.scriptamat.2004.08.007
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Reifenrath J, 2010, MATERIALWISS WERKST, V41, P1054, DOI 10.1002/mawe.201000709
   Ren YB, 2005, ACTA METALL SIN, V41, P1228
   Rong-chang Z, 2007, T NONFERR METAL SOC, V17, ps166
   Sabir MI, 2012, INT J MOL SCI, V13
   Seitz JM, 2011, ADV ENG MATER, V13, P1146, DOI 10.1002/adem.201100074
   Seitz JM, 2011, ADV ENG MATER, V13, pB313, DOI 10.1002/adem.201080144
   Seitz JM, 2010, ADV ENG MATER, V12, P1099, DOI 10.1002/adem.201000191
   Shao YW, 2009, CORROS SCI, V51, P2906, DOI 10.1016/j.corsci.2009.08.012
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song YW, 2009, SURF COAT TECH, V203, P1107, DOI 10.1016/j.surfcoat.2008.10.004
   Trojanova Z, 2005, MAT SCI ENG A-STRUCT, V410, P148, DOI 10.1016/j.msea.2005.08.088
   Verma A, 2006, BIO-MED MATER ENG, V16, P381
   Wang T, 2008, MATER LETT, V62, P1846, DOI 10.1016/j.matlet.2007.10.017
   Wen ZH, 2009, J ALLOY COMPD, V488, P392, DOI 10.1016/j.jallcom.2009.08.147
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Witte F, 2006, P SOC PHOTO-OPT INS, V6318
   Witte F, 2008, J BIOMED MATER RES A, V86A, P1041, DOI 10.1002/jbm.a.31713
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wu RZ, 2009, MAT SCI ENG A-STRUCT, V516, P96, DOI 10.1016/j.msea.2009.04.025
   Xue-Nan Gu, 2010, Frontiers of Materials Science in China, V4, P111, DOI 10.1007/s11706-010-0024-1
   Zhang M, 2010, KOVOVE MATER, V48, P211, DOI 10.4149/km_2010_3_211
   Zhang M., 2007, T NONFERR METAL SOC, V17, P381
   Zhang Milin, 2010, MG LI SUPERLIGHT ALL
NR 57
TC 59
Z9 65
U1 7
U2 145
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2013
VL 9
IS 10
BP 8488
EP 8498
DI 10.1016/j.actbio.2013.01.032
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 249JI
UT WOS:000326773100004
PM 23385218
DA 2018-10-20
ER

PT J
AU Chou, DT
   Wells, D
   Hong, D
   Lee, B
   Kuhn, H
   Kumta, PN
AF Chou, Da-Tren
   Wells, Derrick
   Hong, Daeho
   Lee, Boeun
   Kuhn, Howard
   Kumta, Prashant N.
TI Novel processing of iron-manganese alloy-based biomaterials by inkjet
   3-D printing
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone replacement material; 3-D inkjet printing; Biodegradable metal;
   Iron-manganese; Porous scaffold
ID FE-MN ALLOYS; IN-VITRO; MECHANICAL-PROPERTIES; MEDICAL APPLICATIONS;
   CELL VIABILITY; STENTS; DESIGN; METAL; BONE; EMBRITTLEMENT
AB The present work provides an assessment of 3-D printed iron-manganese biodegradable scaffolds as a bone scaffold material. Iron-based alloys have been investigated due to their high strength and ability to slowly corrode. Current fabrications of Fe-based materials generate raw material which must be machined into their desired form. By using inkjet 3-D printing, a technique which generates complex, customizable parts from powders mechanically milled Fe-30Mn (wt.%) powder was directly processed into scaffolds. The 3-D printed parts maintained an open porosity of 36.3% and formed a mixed phase alloy of martensitic a and austenitic gamma phases. Electrochemical corrosion tests showed the 3-D printed Fe-Mn to desirably corrode significantly more rapidly than pure iron. The scaffolds exhibited similar tensile mechanical properties to natural bone, which may reduce the risk of stress shielding. Cell viability testing of MC3T3-E1 pre-osteoblast cells seeded directly onto the Fe-Mn scaffolds using the live/dead assay and with cells cultured in the presence of the scaffolds' degradation products demonstrated good in vitro cytocompatibility compared to tissue culture plastic. Cell infiltration into the open pores of the 3-D printed scaffolds was also observed. Based on this preliminary study, we believe that 3-D printed Fe-Mn alloy is a promising material for craniofacial biomaterial applications, and represents an opportunity for other biodegradable metals to be fabricated using this unique method. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Chou, Da-Tren; Hong, Daeho; Lee, Boeun; Kumta, Prashant N.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Wells, Derrick] Robert Morris Univ, Moon Township, PA 15108 USA.
   [Kuhn, Howard] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15213 USA.
   [Kuhn, Howard; Kumta, Prashant N.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15213 USA.
   [Kumta, Prashant N.] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15213 USA.
   [Kumta, Prashant N.] Univ Pittsburgh, Sch Dent Med, Pittsburgh, PA 15261 USA.
   [Kumta, Prashant N.] Univ Pittsburgh, Ctr Craniofacial Regenerat, Pittsburgh, PA 15261 USA.
   [Kumta, Prashant N.] Univ Pittsburgh, Ctr Complex Engn Multifunct Mat, Pittsburgh, PA 15261 USA.
   [Kumta, Prashant N.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15261 USA.
RP Kumta, PN (reprint author), Univ Pittsburgh, Dept Bioengn, Swanson Sch Engn, 848 Benedum Hall,3700 OHara St, Pittsburgh, PA 15261 USA.
EM pkumta@pitt.edu
OI Hong, Daeho/0000-0002-7711-9670
FU NSF-ERC [EEC-0812348]; Swanson School of Engineering, University of
   Pittsburgh; Edward R. Weidlein Chair Professorship; Center for Complex
   Engineered Multifunctional Materials; NSF-CBET [0933153]
FX The authors are grateful for the assistance from The ExOne Company, LLC
   for their 3-D printing technologies, OrthoKinetic Technologies, LLC for
   conducting mechanical testing, and Alternative Testing Laboratories,
   Inc. for conducting O and C analyses using LECO systems. The authors
   acknowledge the financial assistance of NSF-ERC Grant # EEC-0812348 in
   supporting this work. The authors also acknowledge the financial support
   of the Swanson School of Engineering, University of Pittsburgh, while
   P.N.K. acknowledges the Edward R. Weidlein Chair Professorship, the
   Center for Complex Engineered Multifunctional Materials, and NSF-CBET
   Grant # 0933153 for partial support of this research.
CR [Anonymous], 2010, ANN BOOK ASTM STAND
   ASTM, 2004, ANN BOOK ASTM STAND
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Cima M., 1990, CIRP ANN-MANUF TECHN, P201, DOI DOI 10.1016/S0007-8506(07)61035-X
   Curodeau A, 2000, J BIOMED MATER RES, V53, P525, DOI 10.1002/1097-4636(200009)53:5<525::AID-JBM12>3.0.CO;2-1
   GARTSTEIN E, 1979, ACTA METALL MATER, V27, P1053, DOI 10.1016/0001-6160(79)90193-7
   Grajcar A., 2010, ARCH MAT SCI ENG, V41, P77
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   Hermawan H, 2006, ADV MAT RES, V15-17, P107
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224
   Hollister S J, 2005, Orthod Craniofac Res, V8, P162, DOI 10.1111/j.1601-6343.2005.00329.x
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   International Organization for Standardization, 2007, ISO1099312 ANSIAAMI
   Irsen SH, 2006, MATERIALWISS WERKST, V37, P533, DOI 10.1002/mawe.200600033
   ISHIKAWA Y, 1968, J APPL PHYS, V39, P1318, DOI 10.1063/1.1656274
   Kannan MB, 2008, CORROS SCI, V50, P2879, DOI 10.1016/j.corsci.2008.07.024
   Liu B, 2011, MATER LETT, V65, P540, DOI 10.1016/j.matlet.2010.10.068
   Martinez J, 2005, MAT SCI ENG A-STRUCT, V408, P26, DOI 10.1016/j.msea.2005.06.019
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Moravej M, 2011, MATER SCI ENG B-ADV, V176, P1812, DOI 10.1016/j.mseb.2011.02.031
   Mueller PP, 2012, J BIOMED MATER RES A, V100A, P2881, DOI 10.1002/jbm.a.34223
   Murr LE, 2009, J MECH BEHAV BIOMED, V2, P20, DOI 10.1016/j.jmbbm.2008.05.004
   Nasim M, 2000, MAT SCI ENG A-STRUCT, V281, P56, DOI 10.1016/S0921-5093(99)00734-0
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   PRAEMER A, 1999, MUSCULOSKELETAL COND
   RABINKIN A, 1979, CALPHAD, V3, P77, DOI 10.1016/0364-5916(79)90008-7
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   REILLY DT, 1974, J BONE JOINT SURG AM, VA 56, P1001, DOI 10.2106/00004623-197456050-00012
   Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Sachs E, 2000, POLYM ENG SCI, V40, P1232, DOI 10.1002/pen.11251
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Staiger MP, 2010, MATER LETT, V64, P2572, DOI 10.1016/j.matlet.2010.08.049
   Sun W, 2005, COMPUT AIDED DESIGN, V37, P1097, DOI 10.1016/j.cad.2005.02.002
   VOLYNOVA TF, 1986, SOV POWDER METALL+, V25, P999, DOI 10.1007/BF00797111
   Wegener B, 2011, MATER SCI ENG B-ADV, V176, P1789, DOI 10.1016/j.mseb.2011.04.017
   Wiria FE, 2010, MATER DESIGN, V31, pS101, DOI 10.1016/j.matdes.2009.12.050
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yamaura SI, 2003, MATER TRANS, V44, P1494, DOI 10.2320/matertrans.44.1494
   Yoo J., 1993, P SOL FREEF FABR S A, P40
NR 49
TC 51
Z9 53
U1 5
U2 88
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2013
VL 9
IS 10
BP 8593
EP 8603
DI 10.1016/j.actbio.2013.04.016
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 249JI
UT WOS:000326773100013
PM 23624222
DA 2018-10-20
ER

PT J
AU Neffe, AT
   Wischke, C
   Racheva, M
   Lendlein, A
AF Neffe, Axel T.
   Wischke, Christian
   Racheva, Miroslava
   Lendlein, Andreas
TI Progress in biopolymer-based biomaterials and their application in
   controlled drug delivery
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biomaterial; biopolymer; drug delivery; nucleic acids; polysaccharides;
   proteins
ID COLLAGEN TRIPLE-HELIX; BETA-SHEET PEPTIDES; CROSS-LINKING; POLY(ETHYLENE
   GLYCOL); SILK BIOMATERIALS; CLICK CHEMISTRY; POLYMERIC BIOMATERIALS;
   RADICAL POLYMERIZATION; ALGINATE MICROSPHERES; FUNCTIONAL MATERIALS
AB Biopolymer-based materials are based on re-growing resources and are attractive for biomedical applications, as they can inherently combine degradability in vivo, can offer sites of adhesion for cells and proteins, often show good biocompatibility and may additionally be used to release embedded bioactive molecules. However, their selection and efficient use for specific applications require an understanding of molecular principles and relationships between the molecular and macroscopic level to establish distinct properties and functions. Here, synthetic routes are described, which allow tailoring properties and functions of biopolymer-based materials. The biological evaluation of such materials is discussed, with a special emphasis on their application in controlled release systems such as hydrogels and particulate carriers.
C1 [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Wischke, Christian/K-9651-2013; Lendlein, Andreas/K-9553-2013; Neffe,
   Axel/H-6997-2013
OI Wischke, Christian/0000-0001-5531-9033; Lendlein,
   Andreas/0000-0003-4126-4670; Neffe, Axel/0000-0002-5056-3990
CR Albertsson AC, 2010, BIOMACROMOLECULES, V11, P1406, DOI 10.1021/bm100253e
   Alemdaroglu FE, 2008, ADV MATER, V20, P899, DOI 10.1002/adma.200700866
   Alemdaroglu FE, 2009, NANO LETT, V9, P3658, DOI 10.1021/nl901899t
   Altimari I, 2012, J APPL POLYM SCI, V125, P3006, DOI 10.1002/app.36234
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   Anaya M, 2010, CHEM-EUR J, V16, P12852, DOI 10.1002/chem.201001816
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739
   Ayaz MS, 2011, CHEM COMMUN, V47, P2243, DOI 10.1039/c0cc04746e
   Balabushevich NG, 2012, POLYM SCI SER A+, V54, P540, DOI 10.1134/S0965545X12040098
   Banwell EF, 2009, NAT MATER, V8, P596, DOI [10.1038/nmat2479, 10.1038/NMAT2479]
   Baskin JM, 2010, ALDRICHIM ACTA, V43, P15
   Bellas E, 2012, MACROMOL BIOSCI, V12, P1627, DOI 10.1002/mabi.201200262
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Birk D. E., 1991, CELL BIOL EXTRACELLU
   Bohrn R, 2005, SYNLETT, P3087, DOI 10.1055/s-2005-921923
   Bowerman CJ, 2012, BIOPOLYMERS, V98, P169, DOI 10.1002/bip.22058
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Brodsky B, 2008, NATURE, V453, P998, DOI 10.1038/453998a
   Campolongo MJ, 2011, J MATER CHEM, V21, P6113, DOI 10.1039/c0jm03854g
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Rodriguez-Cabello JC, 2009, POLYMER, V50, P5159, DOI 10.1016/j.polymer.2009.08.032
   Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f
   Celebi B, 2012, MACROMOL BIOSCI, V12, P1546, DOI 10.1002/mabi.201200170
   Chen PY, 2012, PROG MATER SCI, V57, P1492, DOI 10.1016/j.pmatsci.2012.03.001
   Cobucci-Ponzano B, 2012, NAT PROD REP, V29, P697, DOI 10.1039/c2np20032e
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   De Geest BG, 2007, ADV FUNCT MATER, V17, P531, DOI 10.1002/adfm.200600198
   Deming TJ, 2006, ADV POLYM SCI, V202, P1, DOI 10.1007/12_080
   Elchinger PH, 2011, POLYMERS-BASEL, V3, P1607, DOI 10.3390/polym3041607
   Elvin CM, 2010, BIOMATERIALS, V31, P8323, DOI 10.1016/j.biomaterials.2010.07.032
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Epstein-Barash H, 2012, ACTA BIOMATER, V8, P1703, DOI 10.1016/j.actbio.2012.01.028
   Farrugia A, 2011, J CLIN PHARMACOL, V51, P292, DOI 10.1177/0091270010372107
   Feldkamp U, 2009, ANGEW CHEM INT EDIT, V48, P5996, DOI 10.1002/anie.200902285
   Fleet R, 2008, EUR POLYM J, V44, P2899, DOI 10.1016/j.eurpolymj.2008.06.042
   Garcia-Fuentes M, 2008, BIOMATERIALS, V29, P633, DOI 10.1016/j.biomaterials.2007.10.024
   Haidar ZS, 2008, BIOMATERIALS, V29, P1207, DOI 10.1016/j.biomaterials.2007.11.012
   Halperin A, 2007, LANGMUIR, V23, P10603, DOI 10.1021/la701007j
   Hara M, 2010, J BIOMAT SCI-POLYM E, V21, P877, DOI 10.1163/156856209X449452
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   Hey KB, 1990, APPL BIOCH, V12, P85
   Holme HK, 2008, CARBOHYD POLYM, V73, P656, DOI 10.1016/j.carbpol.2008.01.007
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Hu XH, 2011, ACTA BIOMATER, V7, P1618, DOI 10.1016/j.actbio.2010.12.005
   Hu XH, 2009, MACROMOL BIOSCI, V9, P1194, DOI 10.1002/mabi.200900275
   Huang KS, 2009, J CONTROL RELEASE, V137, P15, DOI 10.1016/j.jconrel.2009.02.019
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Iha RK, 2009, CHEM REV, V109, P5620, DOI 10.1021/cr900138t
   Ingle NP, 2011, TRENDS BIOTECHNOL, V29, P443, DOI 10.1016/j.tibtech.2011.04.012
   Isoda K, 2011, REACT FUNCT POLYM, V71, P367, DOI 10.1016/j.reactfunctpolym.2010.11.020
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jayakumar R, 2010, CARBOHYD POLYM, V79, P1, DOI 10.1016/j.carbpol.2009.08.026
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   Jung F, 2012, CLIN HEMORHEOL MICRO, V50, P55, DOI 10.3233/CH-2011-1443
   Kim JH, 2006, J CONTROL RELEASE, V111, P228, DOI 10.1016/j.jconrel.2005.12.013
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Kopecek J, 2009, ACTA BIOMATER, V5, P805, DOI 10.1016/j.actbio.2008.10.001
   Kotch FW, 2008, J AM CHEM SOC, V130, P2952, DOI 10.1021/ja800225k
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kricheldorf HR, 2006, ANGEW CHEM INT EDIT, V45, P5752, DOI 10.1002/anie.200600693
   Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333
   Kristiansen KA, 2009, CARBOHYD POLYM, V77, P725, DOI 10.1016/j.carbpol.2009.02.018
   Kuhbier JW, 2010, PLOS ONE, V5
   KUIVANIEMI H, 1991, FASEB J, V5, P2052
   Kwak M, 2011, CHEM SOC REV, V40, P5475
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee JB, 2009, NAT NANOTECHNOL, V4, P430, DOI [10.1038/nnano.2009.93, 10.1038/NNANO.2009.93]
   Lee OJ, 2012, J BIOMED MATER RES A, V100A, P2018, DOI 10.1002/jbm.a.33308
   Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162
   Lendlein A, 2011, EXPERT REV MED DEVIC, V8, P533, DOI [10.1586/erd.11.39, 10.1586/ERD.11.39]
   Lendlein A, 2011, INT J ARTIF ORGANS, V34, P71, DOI 10.5301/IJAO.2011.6422
   Li Y, 2011, SOFT MATTER, V7, P10377, DOI 10.1039/c1sm06072d
   Lim YB, 2008, J MATER CHEM, V18, P723, DOI 10.1039/b711188f
   Liu ZH, 2010, PROG POLYM SCI, V35, P1144, DOI 10.1016/j.progpolymsci.2010.04.007
   LODISH HB, 2000, MOL CELL BIOL
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Mai-ngam K, 2011, J BIOMAT SCI-POLYM E, V22, P2001, DOI 10.1163/092050610X530964
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   Mergy J, 2012, J POLYM SCI POL CHEM, V50, P4019, DOI 10.1002/pola.26201
   Mitra T, 2011, J THERM ANAL CALORIM, V105, P325, DOI 10.1007/s10973-011-1472-2
   Morch YA, 2007, BIOMACROMOLECULES, V8, P2809, DOI 10.1021/bm700502b
   Neffe AT, 2011, MACROMOL SYMP, V309-310, P229, DOI 10.1002/masy.201100049
   Neffe AT, 2011, ACTA BIOMATER, V7, P1693, DOI 10.1016/j.actbio.2010.11.025
   Neffe AT, 2010, MACROMOL RAPID COMM, V31, P1534, DOI 10.1002/marc.201000274
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Orive G, 2010, THER DELIV, V1, P387, DOI 10.4155/TDE.10.36
   Ostmark E, 2008, MACROMOLECULES, V41, P4405, DOI 10.1021/ma702681u
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Ovsianikov A, 2011, BIOMACROMOLECULES, V12, P851, DOI 10.1021/bm1015305
   Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104
   Park N, 2009, NAT MATER, V8, P432, DOI [10.1038/NMAT2419, 10.1038/nmat2419]
   Peng SM, 2012, MATER TODAY, V15, P190, DOI 10.1016/S1369-7021(12)70089-5
   Pierce BF, 2012, MACROMOL BIOSCI, V12, P484, DOI 10.1002/mabi.201100232
   Pierce BF, 2012, MACROMOL BIOSCI, V12, P312, DOI 10.1002/mabi.201100237
   Pierce BF, 2011, MATER RES SOC S P, V1403, P145
   Piluso S, 2011, INT J ARTIF ORGANS, V34, P192, DOI 10.5301/IJAO.2011.6394
   Pires MM, 2009, J AM CHEM SOC, V131, P2706, DOI 10.1021/ja8088845
   Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324
   Prabaharan M, 2006, MACROMOL BIOSCI, V6, P991, DOI 10.1002/mabi.200600164
   Qi W, 2009, BIOMATERIALS, V30, P2799, DOI 10.1016/j.biomaterials.2009.01.027
   Rabanel JM, 2004, J MICROENCAPSUL, V21, P413, DOI 10.1080/02652040410001729223
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Roch T, 2011, MACROMOL SYMP, V309-310, P182, DOI 10.1002/masy.201100048
   Rudra JS, 2010, BIOMATERIALS, V31, P8475, DOI 10.1016/j.biomaterials.2010.07.068
   Sanderson K, 2010, NATURE, V464, P158, DOI 10.1038/464158a
   Satoh H, 2010, ACS SYM SER, V1038, P145
   Schatz C, 2010, MACROMOL RAPID COMM, V31, P1664, DOI 10.1002/marc.201000267
   Schatz C, 2009, ANGEW CHEM INT EDIT, V48, P2572, DOI 10.1002/anie.200805895
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Schnitzler T, 2012, ACCOUNTS CHEM RES, V45, P1419, DOI 10.1021/ar200211a
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Sengupta S, 2010, BIOMACROMOLECULES, V11, P3592, DOI 10.1021/bm101054q
   Shoulders MD, 2008, BIOPOLYMERS, V89, P443, DOI 10.1002/bip.20864
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Shoulders MD, 2009, ADV EXP MED BIOL, V611, P251, DOI 10.1007/978-0-387-73657-0_115
   Shoulders MD, 2006, J AM CHEM SOC, V128, P8112, DOI 10.1021/ja061793d
   Silva SS, 2008, MACROMOL BIOSCI, V8, P766, DOI 10.1002/mabi.200700300
   Soontornworajit B, 2010, BIOMACROMOLECULES, V11, P2724, DOI [10.1021/bm1007741, 10.1021/bm100774t]
   Spuch C, 2010, BIOMATERIALS, V31, P5608, DOI 10.1016/j.biomaterials.2010.03.042
   Statz AR, 2009, BIOINTERPHASES, V4, pFA22, DOI 10.1116/1.3115103
   Tan HP, 2011, MACROMOL RAPID COMM, V32, P905, DOI 10.1002/marc.201100125
   Teixeira LSM, 2012, BIOMATERIALS, V33, P1281, DOI 10.1016/j.biomaterials.2011.10.067
   Torres-Giner S, 2009, ACS APPL MATER INTER, V1, P218, DOI 10.1021/am800063x
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Usha R, 2012, COLLOID SURFACE B, V90, P83, DOI 10.1016/j.colsurfb.2011.10.002
   Van TSR, 2007, EXPERT REV MED DEVIC, V4, P147
   Voepel J, 2011, J POLYM SCI POL CHEM, V49, P2366, DOI 10.1002/pola.24666
   Voepel J, 2011, BIOMACROMOLECULES, V12, P253, DOI 10.1021/bm101357k
   Voepel J, 2009, J POLYM SCI POL CHEM, V47, P3595, DOI 10.1002/pola.23444
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wathier M, 2010, J AM CHEM SOC, V132, P15887, DOI 10.1021/ja106488h
   Wendt H, 2011, PLOS ONE, V6
   Wischke C, 2006, J CONTROL RELEASE, V114, P359, DOI 10.1016/j.jconrel.2006.06.020
   Wischke C, 2009, INT J PHARMACEUT, V365, P61, DOI 10.1016/j.ijpharm.2008.08.039
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yamada S, 2013, DENT MATER J, V32, P88, DOI 10.4012/dmj.2012-220
   Yamazaki CM, 2010, BIOMATERIALS, V31, P1925, DOI 10.1016/j.biomaterials.2009.10.014
   Yamazaki CM, 2008, BIOPOLYMERS, V90, P816, DOI 10.1002/bip.21100
   Yang B, 2009, FEBS J, V276, P2125, DOI 10.1111/j.1742-4658.2009.06947.x
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Zaupa A, 2011, INT J ARTIF ORGANS, V34, P139, DOI 10.5301/IJAO.2010.6083
   Zaupa A, 2011, BIOMACROMOLECULES, V12, P75, DOI 10.1021/bm101029k
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang QQ, 1999, ARTIF CELL BLOOD SUB, V27, P245, DOI 10.3109/10731199909117697
   Zhang XM, 2012, J BIOMED MATER RES A, V100A, P2960, DOI 10.1002/jbm.a.34243
NR 155
TC 21
Z9 21
U1 2
U2 77
PU EXPERT REVIEWS
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD NOV
PY 2013
VL 10
IS 6
BP 813
EP 833
DI 10.1586/17434440.2013.839209
PG 21
WC Engineering, Biomedical
SC Engineering
GA 248WU
UT WOS:000326737300011
PM 24195462
DA 2018-10-20
ER

PT J
AU Harmouch, C
AF Harmouch, C.
TI AN INGENIOUS BIOMATERIAL FOR VASCULAR ENGINEERING: FUNCTIONALIZED
   CHITOSAN/HYALURONAN POLYELECTROLYTE MULTILAYERS
SO WOUND REPAIR AND REGENERATION
LA English
DT Meeting Abstract
C1 [Harmouch, C.] Univ Lorraine, Fac Med, CNRS, UMR 7365, Nancy, France.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1067-1927
EI 1524-475X
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD NOV
PY 2013
VL 21
IS 6
BP A67
EP A67
PG 1
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 243OU
UT WOS:000326327100053
DA 2018-10-20
ER

PT J
AU Dubuc, D
   Mazouffre, O
   Llorens, C
   Taris, T
   Poupot, M
   Fournie, JJ
   Begueret, JB
   Grenier, K
AF Dubuc, David
   Mazouffre, Olivier
   Llorens, Clement
   Taris, Thierry
   Poupot, Mary
   Fournie, Jean-Jacques
   Begueret, Jean-Baptiste
   Grenier, Katia
TI Microwave-based biosensor for on-chip biological cell analysis
SO ANALOG INTEGRATED CIRCUITS AND SIGNAL PROCESSING
LA English
DT Article
DE Biosensor; Microwave; Biology; Biological cells
ID DIELECTRIC-PROPERTIES; TISSUES
AB This paper presents an innovative biosensing technique, based on the interaction between biomaterial and microwave electromagnetic (EM) waves, which probes the bio-parameters of investigated biological samples. Thanks to the microtechnologies, this approach is able to sense biomaterials down to living cells size without invasivity. The broadband dielectric spectroscopy of living cells suspensions is therefore demonstrated, sketching a rich EM signature, "rich" in terms of biological information's such as cells' proliferation and cells' viability. Capacitive contrasts of 4 and 12 % between the cells suspension and their pure medium are measured at 20 and 40 GHz respectively, which demonstrate the ability of such a technique to detect (and quantify) living cells non-invasively. Moreover, we demonstrate a capacitive contrast of 5 % at 30 GHz between living and dead cells. Such a result is based on the ability of the microwaves to penetrate into the cells and sense their intracellular content, and then to carry viability information's of biomaterials out. Finally, we present the feasibility of on-chip microwave signals processing, which points out that integrated circuit for data processing can be integrated together with a nano-liter range microfluidic bio-sample manipulation and a microwave-based biosensor. Such a work consequently permits to envision promising Lab-on-Chip applications such as cells' drug screening for personalized medicine notably.
C1 [Dubuc, David; Grenier, Katia] CNRS, LAAS, F-31031 Toulouse, France.
   [Dubuc, David; Grenier, Katia] Univ Toulouse, LAAS, F-31031 Toulouse, France.
   [Mazouffre, Olivier; Llorens, Clement; Taris, Thierry; Begueret, Jean-Baptiste] Univ Bordeaux 1, IMS Lab, F-33405 Talence, France.
   [Poupot, Mary; Fournie, Jean-Jacques] CHU Purpan, INSERM, U563, BAT B, F-31024 Toulouse 3, France.
RP Dubuc, D (reprint author), CNRS, LAAS, 7 Ave Colonel Roche, F-31031 Toulouse, France.
EM dubuc@laas.fr
RI Fournie, jean-jacques/J-7805-2013; Poupot, Mary/F-8570-2013
OI Fournie, jean-jacques/0000-0001-6542-6908; 
CR Blad B., 1996, PHYSIOL MEAS, V17, pA15
   Denef N, 2004, 34TH EUROPEAN MICROWAVE CONFERENCE, VOLS 1-3, CONFERENCE PROCEEDINGS, P669
   Di Carlo D, 2006, ANAL CHEM, V78, P7918
   Dubuc D., 2012, BROADBAND MICROWAVE
   Facer GR, 2001, APPL PHYS LETT, V78, P996, DOI 10.1063/1.1347020
   Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001
   Grenier K., 2010, RESONANT BASED MICRO
   Grenier K, 2009, IEEE T MICROW THEORY, V57, P3246, DOI 10.1109/TMTT.2009.2034226
   Helmy AA, 2012, IEEE J SOLID-ST CIRC, V47, P2467, DOI 10.1109/JSSC.2012.2203458
   Lazebnik M, 2007, PHYS MED BIOL, V52, P6093, DOI 10.1088/0031-9155/52/20/002
   Miled M. A., 2010, LOW VOLTAGE DIELECTR
   Morgan H, 2007, J PHYS D APPL PHYS, V40, P61, DOI 10.1088/0022-3727/40/1/S10
   Wang H., 2010, IEEE INT MICR S MAY
NR 13
TC 6
Z9 6
U1 1
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-1030
EI 1573-1979
J9 ANALOG INTEGR CIRC S
JI Analog Integr. Circuits Process.
PD NOV
PY 2013
VL 77
IS 2
SI SI
BP 135
EP 142
DI 10.1007/s10470-013-0111-1
PG 8
WC Computer Science, Hardware & Architecture; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA 245HH
UT WOS:000326453400006
DA 2018-10-20
ER

PT J
AU Chou, J
   Hao, J
   Ben-Nissan, B
   Milthorpe, B
   Otsuka, M
AF Chou, Joshua
   Hao, Jia
   Ben-Nissan, Besim
   Milthorpe, Bruce
   Otsuka, Makoto
TI Coral Exoskeletons as a Precursor Material for the Development of a
   Calcium Phosphate Drug Delivery System for Bone Tissue Engineering
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE biomimetic; beta-tricalcium phosphate; osteoporosis; coral; drug
   delivery system
ID ZINC RELEASE; RATS
AB With the global rise in aging of populations, the occurrence of osteoporosis will continue to increase. Biomaterial and pharmaceutical scientists continue to develop innovative strategies and materials to address this disease. In this article, we describe a new perspective and approach into the use of coral exoskeletons as a precursor material to synthesize a calcium phosphate-based drug delivery system. Studies detailing the methodology of the conversion methods and the strategies and approach for the development of these novel drug delivery systems are described. Furthermore, in vivo studies in osteoporotic mice using a drug loaded and chemically modified version of the biomimetic delivery system showed significant cortical and cancellous bone increases. These studies support the notion and the rationale for future research and development of the use of coral exoskeletons as materials for drug delivery applications.
C1 [Chou, Joshua; Otsuka, Makoto] Musashino Univ, Fac Pharm, Pharmaceut Sci Res Inst, Tokyo 2028585, Japan.
   [Hao, Jia] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138510, Japan.
   [Chou, Joshua; Ben-Nissan, Besim; Milthorpe, Bruce] Univ Technol Sydney, Fac Sci, Sydney, NSW 200Z, Australia.
RP Chou, J (reprint author), Musashino Univ, Fac Pharm, Pharmaceut Sci Res Inst, 1-1-20 Shin Machi, Tokyo 2028585, Japan.
EM joshua@musashino-u.ac.jp
FU Japan Society for the Promotion of Science (JSPS); University of
   Technology Sydney
FX The authors acknowledge the support from the Japan Society for the
   Promotion of Science (JSPS) and the University of Technology Sydney.
CR Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Chou I, 2013, NANOMEDICIN IN PRESS
   Chou J, 2010, ADV ENG MATER, V13, P93
   Chou J, 2012, J TISSUE ENG REGEN M
   Chou J., 2013, J TISSUE ENG REGEN M
   Chou J., 2007, J AUST CERAM SOC, V43, P44
   Chou J IT, 2012, ADV HEALTHC MATER, V2, P678, DOI [10.1002/adhm.201200342, DOI 10.1002/ADHM.2012]
   Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054676
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   KISHI S, 1994, BIOCHEM PHARMACOL, V48, P1225, DOI 10.1016/0006-2952(94)90160-0
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   Otsuka M, 2004, J BIOMED MATER RES A, V69A, P552, DOI 10.1002/jbm.a.30040
   Otsuka M, 2003, BIO-MED MATER ENG, V13, P103
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
NR 14
TC 1
Z9 3
U1 0
U2 10
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD NOV
PY 2013
VL 36
IS 11
BP 1662
EP 1665
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 244AQ
UT WOS:000326359900003
PM 24189408
DA 2018-10-20
ER

PT J
AU Bartlett, RS
   Hoffman, HT
   Dailey, SH
   Bock, JM
   Klemuk, SA
   Askeland, RW
   Ahlrichs-Hanson, JS
   Heaford, AC
   Thibeault, SL
AF Bartlett, Rebecca S.
   Hoffman, Henry T.
   Dailey, Seth H.
   Bock, Jonathan M.
   Klemuk, Sarah A.
   Askeland, Ryan W.
   Ahlrichs-Hanson, Jan S.
   Heaford, Andrew C.
   Thibeault, Susan L.
TI Restructuring the Vocal Fold Lamina Propria with Endoscopic
   Microdissection
SO LARYNGOSCOPE
LA English
DT Article
DE Laryngoscopy; Reinke's space; sialendoscopy; vocal fold scarring;
   minithyrotomy
ID SYNTHETIC EXTRACELLULAR-MATRIX; REINKES SPACE; VISCOELASTIC PROPERTIES;
   MINITHYROTOMY; MICROENDOSCOPY; INJECTABLES
AB Objectives/HypothesisThe purposes of this preclinical study were to investigate histologic and rheologic outcomes of Microendoscopy of Reinke's space (MERS)-guided minithyrotomy and to assess its instrumentation.
   Study DesignHuman cadaveric and in vivo animal study.
   MethodsThree human cadaveric larynges were treated with MERS-guided placement of Radiesse VoiceGel and immediately evaluated histologically for biomaterial location. In the second part of this investigation, two scarred porcine larynges were treated with MERS-guided placement of HyStem-VF and rheologically evaluated 6 weeks later. Student t tests determined differences in viscoelastic properties of treated/untreated vocal folds. Sialendoscopes and microendoscopes were subjectively compared for their visualization capacity.
   ResultsMERS imaged the subepithelial area and vocal ligament, guiding both tissue dissection and biomaterial positioning. Sialendoscopes provided adequate visualization and feature incorporated working channels. Enhanced image clarity was created in a gas-filled rather than saline-filled environment, per rater judgment. Histological analysis revealed desirable biomaterial positioning with MERS. Per rheological analysis, viscoelastic properties of the MERS-treated porcine vocal folds compared to uninjured vocal folds 6 weeks following treatment did not statistically differ.
   ConclusionsMERS-guided laryngoplasty using sialendoscopes yielded satisfactory biomaterial positioning in the short-term and normalized rheologic tissue properties in the long-term, contributing to proof of concept for MERS in the treatment of scarring. Strengths of MERS include direct, real-time visualization of Reinke's space and an ability to manipulate surgical instruments parallel to the vocal fold edge while maintaining an intact epithelium. Future work will explore the clinical utility of MERS for addressing scarring, sulcus vocalis, and other intracordal processes.
   Level of EvidenceN/A Laryngoscope, 123:2780-2786, 2013
C1 [Bartlett, Rebecca S.; Dailey, Seth H.; Thibeault, Susan L.] Univ Wisconsin, Div Otolaryngol Head & Neck Surg, Madison, WI 53705 USA.
   [Bock, Jonathan M.] Med Coll Wisconsin, Dept Otolaryngol & Commun Sci, Milwaukee, WI 53226 USA.
   [Hoffman, Henry T.; Ahlrichs-Hanson, Jan S.; Heaford, Andrew C.] Univ Iowa Hosp & Clin, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA.
   [Klemuk, Sarah A.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA.
   [Askeland, Ryan W.] Univ Iowa Hosp & Clin, Dept Anat Pathol, Iowa City, IA 52242 USA.
RP Thibeault, SL (reprint author), Univ Wisconsin, Div Otolaryngol Head & Neck Surg, Madison, WI 53705 USA.
EM thibeault@surgery.wisc.edu
OI Bock, Jonathan/0000-0002-4367-7527; Hoffman, Henry/0000-0003-4486-855X
FU Department of Otolaryngology at the University of Iowa; NIDCD [R01
   DC004336]
FX This work was funded by the Department of Otolaryngology at the
   University of Iowa and NIDCD R01 DC004336 (Thibeault). We also extend
   our gratitude to Glen E. Leverson, PhD (University of
   Wisconsin-Madison), for his assistance with statistical analysis, and to
   Douglas Van Daele, MD (University of Iowa Hospital and Clinics), for
   assistance with technical development of the MERS procedure.
CR Bartlett RS, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024103
   Bock JM, 2007, LARYNGOSCOPE, V117, P2251, DOI 10.1097/MLG.0b013e3181462a16
   Caton T, 2007, LARYNGOSCOPE, V117, P516, DOI 10.1097/MLG.0b013e31802e9291
   Chan RW, 2003, ANN BIOMED ENG, V31, P482, DOI 10.1114/1.1561287
   Duflo S, 2006, TISSUE ENG, V12, P3201, DOI 10.1089/ten.2006.12.3201
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   Ford CN, 2008, ANN OTO RHINOL LARYN, V117, P515, DOI 10.1177/000348940811700708
   Gray SD, 1999, ANN OTO RHINOL LARYN, V108, P1
   Hirano S, 2009, J VOICE, V23, P399, DOI 10.1016/j.jvoice.2007.12.002
   Hoffman HT, 2008, ANN OTO RHINOL LARYN, V117, P510, DOI 10.1177/000348940811700707
   Institute of Laboratory Animal Resources (US), 1996, GUIDE CARE USE LAB A
   Johnson BQ, 2010, LARYNGOSCOPE, V120, P537, DOI 10.1002/lary.20782
   Klemuk SA, 2010, LARYNGOSCOPE, V120, P995, DOI 10.1002/lary.20877
   Kutty JK, 2009, TISSUE ENG PART B-RE, V15, P249, DOI 10.1089/ten.TEB.2008.0588
   Mallur PS, 2012, ANN OTO RHINOL LARYN, V121, P490, DOI 10.1177/000348941212100711
   Martins RHG, 2010, J VOICE, V24, P531, DOI 10.1016/j.jvoice.2009.01.002
   Paniello RC, 2008, ANN OTO RHINOL LARYN, V117, P437, DOI 10.1177/000348940811700606
   Remacle M., 1996, Acta Oto-Rhino-Laryngologica Belgica, V50, P253
   WEXLER DB, 1989, ANN OTO RHINOL LARYN, V98, P668, DOI 10.1177/000348948909800902
NR 19
TC 5
Z9 5
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0023-852X
EI 1531-4995
J9 LARYNGOSCOPE
JI Laryngoscope
PD NOV
PY 2013
VL 123
IS 11
BP 2780
EP 2786
DI 10.1002/lary.24146
PG 7
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA 242IA
UT WOS:000326231200045
PM 23959803
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ning, H
   Song, JL
   Hou, MQ
   Yang, DZ
   Fan, HL
   Han, BX
AF Ning Hui
   Song JinLiang
   Hou MinQiang
   Yang DeZhong
   Fan HongLei
   Han BuXing
TI Efficient dehydration of carbohydrates to 5-hydroxymethylfurfural in
   ionic liquids catalyzed by tin(IV) phosphonate and zirconium phosphonate
SO SCIENCE CHINA-CHEMISTRY
LA English
DT Article
DE fructose; inulin; sucrose; dehydration; 5-hydroxymethylfurfural;
   heterogeneous catalysts
ID ROOM-TEMPERATURE; SOLID ACID; CONVERSION; FRUCTOSE; BIOMASS; SYSTEM;
   PHOSPHATE; GLUCOSE; CARBON; WATER
AB In this work, we synthesized tin(IV) phosphonate (SnBPMA) and zirconium phosphonate (ZrBPMA) by the reaction of SnCl4 center dot 5H(2)O or ZrOCl2 center dot 8H(2)O with N,N-bis(phosphonomethyl)aminoacetic acid, which was synthesized from a biomaterial glycine through a Mannich-type reaction. The SnBPMA and ZrBPMA were very efficient heterogeneous catalysts for the dehydration of fructose to produce 5-hydroxymethylfurfural (HMF), and the SnBPMA had higher activity than the ZrBPMA. The effects of solvents, temperature, reaction time, and reactant/solvent weight ratio on the reaction catalyzed by SnBPMA were investigated. It was demonstrated that the yield of HMF could reach 86.5% with 1-ethyl-3-methylimidazolium bromide ([Emim] Br) as solvent, and the SnBPMA and SnBPMA/[Emim]Br catalytic system could be reused five times without considerable reduction in catalytic efficiency. Further study indicated that the SnBPMA and ZrBPMA in [Emim]Br were also effective for the dehydration of sucrose and inulin to produce HMF with satisfactory yields.
C1 [Ning Hui; Song JinLiang; Hou MinQiang; Yang DeZhong; Fan HongLei; Han BuXing] Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China.
RP Han, BX (reprint author), Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China.
EM hanbx@iccas.ac.cn
FU National Natural Science Foundation of China [21003133, 21173234]
FX This work was supported by the National Natural Science Foundation of
   China (21003133, 21173234).
CR Alonso DM, 2012, CHEM SOC REV, V41, P8075, DOI 10.1039/c2cs35188a
   Deng TY, 2010, SCI CHINA CHEM, V53, P1476, DOI 10.1007/s11426-010-4002-3
   Dutta A, 2012, CHEM COMMUN, V48, P6738, DOI 10.1039/c2cc32298f
   Fang DW, 2012, SCI CHINA CHEM, V55, P1677, DOI 10.1007/s11426-012-4646-2
   Gallezot P, 2012, CHEM SOC REV, V41, P1538, DOI 10.1039/c1cs15147a
   Hansen TS, 2011, GREEN CHEM, V13, P109, DOI 10.1039/c0gc00355g
   Hu SQ, 2009, GREEN CHEM, V11, P1746, DOI 10.1039/b914601f
   Iremonger SS, 2011, J AM CHEM SOC, V133, P20048, DOI 10.1021/ja207606u
   Jimenez-Morales I, 2012, APPL CATAL B-ENVIRON, V123, P316, DOI 10.1016/j.apcatb.2012.04.023
   Lai LK, 2010, CHEMSUSCHEM, V3, P1257, DOI 10.1002/cssc.201000201
   Long JX, 2012, SCI CHINA CHEM, V55, P1500, DOI 10.1007/s11426-012-4633-7
   Ma TY, 2010, NEW J CHEM, V34, P1209, DOI 10.1039/b9nj00775j
   Mao JG, 2002, J CHEM SOC DALTON, P4541, DOI 10.1039/b206343n
   Pramanik M, 2012, GREEN CHEM, V14, P2273, DOI 10.1039/c2gc35225g
   Qi XH, 2012, CHEMSUSCHEM, V5, P2215, DOI 10.1002/cssc.201200363
   Qi XH, 2012, BIORESOURCE TECHNOL, V109, P224, DOI 10.1016/j.biortech.2012.01.034
   Qu YS, 2012, BIORESOURCE TECHNOL, V121, P462, DOI 10.1016/j.biortech.2012.06.081
   Sidhpuria KB, 2011, GREEN CHEM, V13, P340, DOI 10.1039/c0gc00690d
   Song JL, 2003, EUR J INORG CHEM, P4218, DOI 10.1002/ejic.200300417
   Stahlberg T, 2011, CHEM-EUR J, V17, P1456, DOI 10.1002/chem.201002171
   Stark A, 2012, SCI CHINA CHEM, V55, P1663, DOI 10.1007/s11426-012-4685-8
   Tong XL, 2010, CARBOHYD RES, V345, P1698, DOI 10.1016/j.carres.2010.05.019
   Tong XL, 2010, CHEMSUSCHEM, V3, P350, DOI 10.1002/cssc.200900224
   Tuck CO, 2012, SCIENCE, V337, P695, DOI 10.1126/science.1218930
   Wang JJ, 2011, GREEN CHEM, V13, P2678, DOI 10.1039/c1gc15306d
   Yang Y, 2012, GREEN CHEM, V14, P509, DOI 10.1039/c1gc15972k
   Zhang YM, 2011, CHEMSUSCHEM, V4, P59, DOI 10.1002/cssc.201000284
   Zhang Y, 2012, CATAL SCI TECHNOL, V2, P2485, DOI 10.1039/c2cy20204b
   Zhang ZH, 2012, CARBOHYD POLYM, V88, P891, DOI 10.1016/j.carbpol.2012.01.032
   Zhang ZH, 2011, CHEMSUSCHEM, V4, P131, DOI 10.1002/cssc.201000279
   Zhao S, 2011, CHEM COMMUN, V47, P2176, DOI 10.1039/c0cc04444j
NR 31
TC 5
Z9 5
U1 4
U2 95
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7291
EI 1869-1870
J9 SCI CHINA CHEM
JI Sci. China-Chem.
PD NOV
PY 2013
VL 56
IS 11
BP 1578
EP 1585
DI 10.1007/s11426-013-4944-3
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 243OY
UT WOS:000326327500012
DA 2018-10-20
ER

PT J
AU Kakinoki, S
   Yui, N
   Yamaoka, T
AF Kakinoki, Sachiro
   Yui, Nobuhiko
   Yamaoka, Tetsuji
TI Platelet responses to dynamic biomaterial surfaces with different
   poly(ethylene glycol) and polyrotaxane molecular architectures
   constructed on gold substrates
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Platelet responses; dynamic surface; poly(ethylene glycol);
   polyrotaxane; loop; graft architectures
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; CELL-ADHESION;
   ACTIVATION; FIBRINOGEN; OXIDE); ALPHA; SOFT; STIFFNESS; CHAIN
AB Four different dynamic biomaterial surfaces with different molecular architectures were prepared using two hydrophilic polymers: poly(ethylene glycol) and polyrotaxanes containing -cyclodextrin. Either one or both terminals of the poly(ethylene glycol) or polyrotaxanes were immobilized onto a gold substrate via Au-S bonds, resulting in poly(ethylene glycol)-graft, polyrotaxanes-graft, poly(ethylene glycol)-loop, and polyrotaxanes-loop structures. Human platelet adhesion was suppressed more effectively on the graft surfaces than on the loop surfaces for both poly(ethylene glycol) and polyrotaxanes due to the high mobility of graft polymer chains with a free terminal. Moreover, the platelets adhered to the polyrotaxane surfaces much less than the poly(ethylene glycol) surfaces, possibly because of the mobile nature of the -cyclodextrin molecules that were threaded on the poly(ethylene glycol) chain. Actin filament assembly in adherent platelets was also greatly prevented on the poly(ethylene glycol)/polyrotaxanes-graft surfaces in comparison with the corresponding loop surfaces. A clear correlation between the numbers and areas of adherent platelets on these surfaces suggests that platelet adhesion and activation were dominated by the platelet GPIIb/IIIa-adsorbed fibrinogen interaction. These results indicate that both of the different modes of dynamic features, sliding/rotation of -cyclodextrin and polymer chain mobility, effectively suppressed platelet adhesion in spite of the similar hydrophilicity. This research affords a novel chemical strategy for designing hemocompatibile biomaterial surfaces.
C1 [Kakinoki, Sachiro; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Osaka, Japan.
   [Kakinoki, Sachiro; Yui, Nobuhiko; Yamaoka, Tetsuji] JST CREST, Tokyo, Japan.
   [Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
RP Yamaoka, T (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.
EM yamtet@ri.ncvc.go.jp
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103
   Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Inoue Y, 2012, COLLOID SURFACE B, V89, P223, DOI 10.1016/j.colsurfb.2011.09.020
   Jeyachandran YL, 2009, LANGMUIR, V25, P11614, DOI 10.1021/la901453a
   Ji J, 2003, LANGMUIR, V19, P2643, DOI 10.1021/la0259961
   Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462
   Levental Ilya, 2006, SOFT MATTER, V2, P1
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   NAGAOKA S, 1987, T AM SOC ART INT ORG, V33, P76
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Patton D, 2011, MACROMOL CHEM PHYS, V212, P485, DOI 10.1002/macp.201000524
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Salsmann A, 2005, J BIOL CHEM, V280, P33610, DOI 10.1074/jbc.M500146200
   Schwarz U, 2007, SOFT MATTER, V3, P263, DOI 10.1039/b606409d
   Seo JH, 2012, SOFT MATTER, V8, P5477, DOI 10.1039/c2sm25318f
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474
   Wang W, 1998, LANGMUIR, V14, P602, DOI 10.1021/la9710177
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+
   Yamashita A, 2006, NAT PROTOC, V1, P2861, DOI 10.1038/nprot.2006.438
   Yui N, 1998, BIOCONJUGATE CHEM, V9, P118, DOI 10.1021/bc970189c
   Yui N., 2010, ADV SCI TECHNOL, V76, P10
   Yui N, 2009, MACROMOL SYMP, V279, P158, DOI 10.1002/masy.200950524
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 47
TC 5
Z9 5
U1 5
U2 35
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD NOV
PY 2013
VL 28
IS 4
BP 544
EP 551
DI 10.1177/0885328212462260
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 241GN
UT WOS:000326154500005
PM 23048065
DA 2018-10-20
ER

PT J
AU Feldmann, EM
   Sundberg, JF
   Bobbili, B
   Schwarz, S
   Gatenholm, P
   Rotter, N
AF Feldmann, Eva-Maria
   Sundberg, J. F.
   Bobbili, B.
   Schwarz, S.
   Gatenholm, P.
   Rotter, N.
TI Description of a novel approach to engineer cartilage with porous
   bacterial nanocellulose for reconstruction of a human auricle
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Human primary nasal and auricular chondrocytes; bacterial nanocellulose
   scaffolds; auricular reconstruction
ID BIODEGRADABLE POLYMER SCAFFOLDS; POLYGLYCOLIC ACID; IN-VITRO;
   CHONDROCYTE REDIFFERENTIATION; CELLULOSE SCAFFOLDS; CELL-GROWTH; TISSUE;
   DIFFERENTIATION; ADHESION; PROLIFERATION
AB In this study, we investigated the effects of human primary chondrocytes, derived from routine septorhino- and otoplasties on a novel nondegradable biomaterial. This biomaterial, porous bacterial nanocellulose, is produced by Gluconacetobacter xylinus. Porosity is generated by paraffin beads embedded during the fermentation process. Human primary chondrocytes were able to adhere to bacterial nanocellulose and produce cartilaginous matrix proteins such as aggrecan (after 14 days) and collagen type II (after 21 days) in the presence of differentiation medium. Cells were located within the pores and in a dense cell layer covering the surface of the biomaterial. Cells were able to re-differentiate, as cell shape and extra cellular matrix gene expression showed a chondrogenic phenotype in three-dimensional bacterial nanocellulose culture. Collagen type I and versican expression decreased during three-dimensional culture. Variations in pore sizes of 150-300 mu m and 300-500 mu m did not influence cartilaginous extra cellular matrix synthesis. Varying seeding densities from 9.95x10(2) to 1.99x10(3)cells/mm(2) and 3.98x10(3)cells/mm(2) did not result in differences in quality of extra cellular matrix neo-synthesis. Our results demonstrated that both nasal and auricular chondrocytes are equally suitable to synthesize new extra cellular matrix on bacterial nanocellulose. Therefore, we propose both cell sources in combination with bacterial nanocellulose as promising candidates for the special needs of auricular reconstruction.
C1 [Feldmann, Eva-Maria; Schwarz, S.; Rotter, N.] Univ Ulm, Med Ctr, Dept Otorhinolaryngol, D-89075 Ulm, Germany.
   [Sundberg, J. F.; Bobbili, B.; Gatenholm, P.] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.
RP Feldmann, EM (reprint author), Univ Ulm, Med Ctr, Frauensteige 14A,Haus 18 Ulm, D-89075 Ulm, Germany.
EM eva-maria.feldmann@uniklinik-ulm.de
FU European Union; BMBF; Excellence Initiative of the DFG, International
   Graduate School in Molecular Medicine Ulm; EAREG consortium
   [13N11075-13N11076]
FX This study was supported by the European Union under the Euronanomed
   Programme and the BMBF and is part of the EAREG consortium (grant number
   13N11075-13N11076). E.-M. Feldmann received additional support by the
   Excellence Initiative of the DFG, International Graduate School in
   Molecular Medicine Ulm.
CR Andersson J, 2010, J BIOMED MATER RES A, V94A, P1124, DOI 10.1002/jbm.a.32784
   Andrade FK, 2010, ACTA BIOMATER, V6, P4034, DOI 10.1016/j.actbio.2010.04.023
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Bichara DA, 2012, TISSUE ENG PART B-RE, V18, P51, DOI [10.1089/ten.TEB.2011.0326, 10.1089/ten.teb.2011.0326]
   Bodin A, 2006, J BIOMAT SCI-POLYM E, V17, P435, DOI 10.1163/156856206776374106
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Ciorba A, 2006, INT J PEDIATR OTORHI, V70, P1507, DOI 10.1016/j.ijporl.2006.03.013
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Emans PJ, 2013, J TISSUE ENG REGEN M, V7, P751, DOI 10.1002/term.1477
   Fink H, 2011, J TISSUE ENG REGEN M, V5, P454, DOI 10.1002/term.334
   FREED LE, 1994, BIOTECHNOL BIOENG, V43, P605, DOI 10.1002/bit.260430710
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Haisch A, 2002, EUR ARCH OTO-RHINO-L, V259, P316, DOI 10.1007/s00405-002-0446-1
   Haisch A, 2010, ADV OTO-RHINO-LARYNG, V68, P108, DOI 10.1159/000314566
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Higgins SP, 2003, J BIOMED MATER RES A, V67A, P295, DOI 10.1002/jbm.a.10599
   Homicz MR, 2003, LARYNGOSCOPE, V113, P25, DOI 10.1097/00005537-200301000-00005
   Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   International Organization of Standardization, 2009, 109935 ISO
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g
   Li Zhe, 2012, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V29, P164
   Liu J, 2012, J BURN CARE RES, DOI [10.1097/BCR.0b013e.31825d5d8d, DOI 10.1097/BCR.0B013E.31825D5D8D]
   Liu L, 2012, J BIOMED MATER RES B, V100B, P956, DOI 10.1002/jbm.b.32658
   Lu LC, 2001, CLIN ORTHOP RELAT R, pS251
   Makeen K., 2003, EGYPT J PLAST RECONS, V27, P225
   Malm CJ, 2012, SCAND CARDIOVASC J, V46, P57, DOI 10.3109/14017431.2011.623788
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   NAGATA S, 1994, PLAST RECONSTR SURG, V93, P254, DOI 10.1097/00006534-199402000-00004
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   NEIDEL J, 1993, AGENTS ACTIONS, V39, P82, DOI 10.1007/BF01975718
   Nuernberger S, 2011, BIOMATERIALS, V32, P1032, DOI 10.1016/j.biomaterials.2010.08.100
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Ohara K, 1997, PLAST RECONSTR SURG, V99, P1030, DOI 10.1097/00006534-199704000-00017
   Park SU, 2014, INT WOUND J, V11, P35, DOI 10.1111/j.1742-481X.2012.01035.x
   Rampichova M, 2010, PHYSIOL RES, V59, P773
   Rettinger G, 1992, Eur Arch Otorhinolaryngol Suppl, V1, P127
   Rotter N, 2005, TISSUE ENG, V11, P192, DOI 10.1089/ten.2005.11.192
   Rotter N, 2007, J TISSUE ENG REGEN M, V1, P411, DOI 10.1002/term.52
   Schuh E, 2012, J BIOMED MATER RES A, V100A, P38, DOI 10.1002/jbm.a.33226
   STEIN GS, 1990, FASEB J, V4, P3111
   Stenhamre H, 2011, J TISSUE ENG REGEN M, V5, P578, DOI 10.1002/term.350
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110
NR 54
TC 9
Z9 9
U1 1
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD NOV
PY 2013
VL 28
IS 4
BP 626
EP 640
DI 10.1177/0885328212472547
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 241GN
UT WOS:000326154500012
PM 23413229
DA 2018-10-20
ER

PT J
AU Sivoli, L
   Perez, E
   Caraballo, D
   Rodriguez, JP
   Rodriguez, D
   Moret, J
   Sojo, F
   Arvelo, F
   Tapia, M
   Colina, M
   Alvarez-Barreto, JF
AF Sivoli, L.
   Perez, E.
   Caraballo, D.
   Rodriguez, J. P.
   Rodriguez, D.
   Moret, J.
   Sojo, F.
   Arvelo, F.
   Tapia, M.
   Colina, M.
   Alvarez-Barreto, J. F.
TI Cytocompatibility of a matrix of methylated cassava starch and chitosan
SO JOURNAL OF CELLULAR PLASTICS
LA English
DT Article
DE Cell density; cell growth; cross-linked foams; structural foams;
   visualization
ID MARROW STROMAL CELLS; IN-VITRO; MECHANICAL-PROPERTIES; FLOW PERFUSION;
   STEM-CELLS; SCAFFOLDS; FIBROBLAST; GROWTH; PROLIFERATION; HYDROGELS
AB Starches can be used to form edible or biodegradable films, and recently modified starches have been used to form self-supporting films by casting from aqueous solution. In this work, we aimed to propose a novel starch-based composite biomaterial matrix for use in biomedical applications, especially tissue engineering. The goal of the study was to evaluate the cytocompatibility of composite hydrogels of methylated starch and chitosan, using glutaraldehyde as the cross-linker. Commercial cassava starch with high purity (96.69%) was methylated with dimethyl sulfate in order to obtain a rigid material that could possibly render stronger mechanical properties to chitosan hydrogels. Therefore, methylated starch was mixed with a solution of chitosan and the cross-linking was induced by the addition of glutaraldehyde, allowing the formation of hydrogel films which were visualized under scanning electron microscopy. The method of fabrication was optimized based on the capacity of the cells to attach to the material and proliferate. After thorough washes with ethanol and saline solution, human fibroblasts were seeded on top of the gels and allowed to grow for 3 to 5 days. Cell viability was measured using an (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) MMT assay, and cell morphology was visualized by light microscopy. It was found that cells were viable at every time point, with their metabolic activity comparable to the controls (tissue culture plastic and chitosan alone), as well as clear cell-matrix interactions. Moreover, an increase in the metabolic activity over time indicated the capacity of the material to support cell proliferation. The proposed methylated starch-chitosan system is an excellent matrix that allows cell adhesion and could thereby be further assessed as a scaffold for tissue engineering.
C1 [Sivoli, L.] Cent Univ Venezuela, Dept Ciencias Biomed, Fac Ciencias Vet, Maracay, Estado Aragua, Venezuela.
   [Perez, E.; Caraballo, D.; Tapia, M.] Cent Univ Venezuela, Fac Ciencias, ICTA, Caracas, Venezuela.
   [Rodriguez, J. P.] Univ Nacl Expt Simon Rodriguez, Inst Estudios Cient & Tecnol IDECYT, Lab Microscopia Elect, Caracas, Venezuela.
   [Rodriguez, D.; Moret, J.; Sojo, F.; Arvelo, F.; Alvarez-Barreto, J. F.] Inst Estudios Avanzados IDEA, Lab Ingn Tejidos Humanos, Sartaneja, Hoyo de la Puer, Venezuela.
   [Colina, M.] La Univ Zulia, Lab Quim Ambiental, Maracaibo, Venezuela.
RP Alvarez-Barreto, JF (reprint author), Inst Estudios Avanzados, Carretera Nacl Hoyo Puerta,Valle Sartenejas,Apart, Caracas 1015A, Venezuela.
EM jalvarreto@gmail.com
OI Alvarez-Barreto, Jose/0000-0002-4019-4319
FU National Fund for Science, Technology and Innovation (Fondo Nacional de
   Ciencia, Tecnologia e Innovacion, FONACIT) of the Bolivarian Republic of
   Venezuela
FX This work was funded by the National Fund for Science, Technology and
   Innovation (Fondo Nacional de Ciencia, Tecnologia e Innovacion, FONACIT)
   of the Bolivarian Republic of Venezuela.
CR A. A. C. C, 2003, APPR METH AM ASS CER
   Alpar B, 1999, Clin Oral Investig, V3, P41, DOI 10.1007/s007840050077
   Alvarez-Barreto JF, 2007, TISSUE ENG, V13, P1205, DOI 10.1089/ten.2006.0330
   Arvelo Francisco, 2007, Invest. clín, V48, P367
   Butler MF, 2006, BIOMACROMOLECULES, V7, P2961, DOI 10.1021/bm060133y
   Cai DZ, 2007, CHINESE MED J-PEKING, V120, P197
   Chim H, 2003, J BIOMED MATER RES A, V65A, P327, DOI 10.1002/jbm.a.10478
   Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102
   Dhanikula Anand Babu, 2004, AAPS J, V6, pe27
   Dulgar-Tulloch AJ, 2009, J BIOMED MATER RES A, V90A, P586, DOI 10.1002/jbm.a.32116
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   GUTSCHE AT, 1994, BIOTECHNOL BIOENG, V43, P801, DOI 10.1002/bit.260430815
   Heinemann C, 2009, BIOMACROMOLECULES, V10, P1305, DOI 10.1021/bm900172m
   Huang JR, 2007, CARBOHYD POLYM, V67, P542, DOI 10.1016/j.carbpol.2006.06.027
   Janvikul W, 2007, J MATER SCI-MATER M, V18, P943, DOI 10.1007/s10856-006-0099-5
   LIGHT JM, 1990, CEREAL FOOD WORLD, V35, P1081
   Lin YL, 2008, SURG NEUROL, V70, P9, DOI 10.1016/j.surneu.2008.01.057
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Malafaya PB, 2005, J MATER SCI-MATER M, V16, P1077, DOI 10.1007/s10856-005-4709-4
   Mali S, 2005, CARBOHYD POLYM, V60, P283, DOI 10.1016/j.carbpol.2005.01.003
   Mali S, 2001, INT J FOOD SCI TECH, V36, P641, DOI 10.1046/j.1365-2621.2001.00503.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mukhtar-Fayyad D, 2011, ORAL SURG ORAL MED O, V112, pE137, DOI 10.1016/j.tripleo.2011.05.042
   Nakashima Teruo, 2006, Biocontrol Science, V11, P27
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Qi BW, 2010, J HUAZHONG U SCI-MED, V30, P89, DOI 10.1007/s11596-010-0116-2
   Qi LF, 2008, J BIOMED MATER RES A, V87A, P236, DOI 10.1002/jbm.a.31753
   ROGOLS S, 1986, CEREAL FOOD WORLD, V31, P869
   Sanchez A, 2007, REV IBEROAMERICANA P, V5, P347
   Sitohy MZ, 2001, STARCH-STARKE, V53, P27, DOI 10.1002/1521-379X(200101)53:1<27::AID-STAR27>3.0.CO;2-L
   Sivoli L, 2009, INTERCIENCIA, V34, P53
   Stanislawski L, 2000, J BIOMED MATER RES, V51, P469, DOI 10.1002/1097-4636(20000905)51:3<469::AID-JBM22>3.0.CO;2-B
   Theiszova Marica, 2005, Biomedical Papers (Olomouc), V149, P393
   van der Burgt YEM, 2000, STARCH-STARKE, V52, P40
   Wang JW, 2003, J BIOMAT SCI-POLYM E, V14, P119, DOI 10.1163/156856203321142579
   Whistler K, 1967, STARCH CHEM TECHNOLO
   Whistler RL, 1964, METHODS CARBOHIDRATE, VII
   Zhang KH, 2010, J BIOMED MATER RES A, V95A, P870, DOI 10.1002/jbm.a.32895
   Zheng ZH, 2009, J BIOMATER APPL, V24, P209, DOI 10.1177/0885328208095825
NR 41
TC 2
Z9 3
U1 2
U2 25
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0021-955X
EI 1530-7999
J9 J CELL PLAST
JI J. Cell. Plast.
PD NOV
PY 2013
VL 49
IS 6
BP 507
EP 520
DI 10.1177/0021955X13503843
PG 14
WC Chemistry, Applied; Polymer Science
SC Chemistry; Polymer Science
GA 242ZL
UT WOS:000326285500003
DA 2018-10-20
ER

PT J
AU Wolchok, JC
   Tresco, PA
AF Wolchok, Jeffrey C.
   Tresco, Patrick A.
TI Using Vocally Inspired Mechanical Conditioning to Enhance the Synthesis
   of a Cell-derived Biomaterial
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Mechanical conditioning; Bioreactor; Extracellular matrix; Vibration;
   Vocal fold
ID EXTRACELLULAR-MATRIX PRODUCTION; COLLAGEN SPONGE CONSTRUCTS; SCAFFOLD
   MATERIAL; GENE-EXPRESSION; CYCLIC STRAIN; FIBROBLASTS; BIOREACTOR; FOLD;
   STIMULATION; ALIGNMENT
AB The collection of cell-derived extracellular matrix (ECM) to form implantable biomaterials has therapeutic potential. However, a significant challenge to the creation of these biomaterials is the ability to produce an adequate quantity of ECM from cells in culture. Mechanical stimulation has long been viewed as a practical means to enhance cellular matrix production. In this study we explored the influence of vocally inspired mechanical stimulation, a unique combination of high frequency vibration and low frequency strain, on the production of ECM. Using a custom fabricated vocal bioreactor, tracheal fibroblast seeded sacrificial foams were treated for 3 weeks using either isolated cyclic strain, combined cyclic strain and vibration (dual mode), or static conditioning. When compared to static controls, ECM production was significantly increased for samples conditioned with either cyclic strain or dual mode stimulation. The quantity of ECM harvested from sacrificial foams increased from 25 +/- A 1 mg for statically conditioned control foams, to 34 +/- A 3 and 52 +/- A 10 mg for cyclic strain and dual mode conditioned samples respectively. Furthermore, mechanical conditioning significantly increased the elastic modulus of ECM biomaterials collected from sacrificial foams. Static control modulus increased from 40 +/- A 2 to 63 +/- A 7 kPa and 92 +/- A 7 kPa following isolated cyclic strain and dual mode conditioning, respectively. These results indicate that cyclic strain conditioning can be used to accelerate the production of ECM by human tracheal cells during growth in culture, and that the addition of high frequency vibration to the conditioning program further enhances ECM production.
C1 [Wolchok, Jeffrey C.] Univ Arkansas, Coll Engn, Dept Biomed Engn, Fayetteville, AR 72701 USA.
   [Tresco, Patrick A.] Univ Utah, Coll Engn, Keck Ctr Tissue Engn, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Wolchok, JC (reprint author), Univ Arkansas, Coll Engn, Dept Biomed Engn, 317 Engn Hall, Fayetteville, AR 72701 USA.
EM jwolchok@uark.edu
CR Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Cha JM, 2006, ARTIF ORGANS, V30, P250, DOI 10.1111/j.1525-1594.2006.00212.x
   Chen QH, 2003, J VASC SURG, V37, P660, DOI 10.1067/mva.2003.95
   Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   Eifler RL, 2006, J ORTHOP RES, V24, P375, DOI 10.1002/jor.20028
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   FITCH JL, 1970, ARCHIV OTOLARYNGOL, V92, P379
   Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091
   Gaston J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030965
   Gupta V, 2007, TISSUE ENG, V13, P41, DOI 10.1089/ten.2006.0091
   Jeong SI, 2005, BIOMATERIALS, V26, P1405, DOI 10.1016/j.biomaterials.2004.04.036
   Johns Michael M, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P456, DOI 10.1097/00020840-200312000-00009
   Juncosa-Melvin N, 2007, TISSUE ENG, V13, P1219, DOI 10.1089/ten.2006.0339
   Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5
   Kutty JK, 2010, J TISSUE ENG REGEN M, V4, P62, DOI 10.1002/term.219
   Lee AA, 1999, J MOL CELL CARDIOL, V31, P1833, DOI 10.1006/jmcc.1999.1017
   Perazzo PSL, 2009, J VOICE, V23, P95, DOI 10.1016/j.jvoice.2007.05.006
   Lu HX, 2011, BIOMATERIALS, V32, P2489, DOI 10.1016/j.biomaterials.2010.12.016
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Milstein CF, 2005, LARYNGOSCOPE, V115, P1691, DOI 10.1097/01.mlg.0000173163.07828.30
   Mulder MM, 1998, J BIOMAT SCI-POLYM E, V9, P731, DOI 10.1163/156856298X00118
   Ng CP, 2003, AM J PHYSIOL-HEART C, V284, pH1771, DOI 10.1152/ajpheart.01008.2002
   Nirmalanandhan VS, 2008, TISSUE ENG PT A, V14, P1883, DOI 10.1089/ten.tea.2007.0125
   Nirmalanandhan VS, 2008, J BIOMECH, V41, P822, DOI 10.1016/j.jbiomech.2007.11.009
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   Screen HRC, 2005, BIOCHEM BIOPH RES CO, V336, P424, DOI 10.1016/j.bbro.2005.08.102
   Song L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042569
   Syedain ZH, 2011, BIOMATERIALS, V32, P714, DOI 10.1016/j.biomaterials.2010.09.019
   Tian J, 2010, J APPL PHYSIOL, V108, P162, DOI 10.1152/japplphysiol.00730.2009
   Titze IR, 2005, J BIOMECH, V38, P2406, DOI 10.1016/j.jbiomech.2004.10.011
   Titze IR, 2004, J BIOMECH, V37, P1521, DOI 10.1016/j.jbiomech.2004.01.007
   Titze IR, 1997, J VOICE, V11, P267, DOI 10.1016/S0892-1997(97)80004-5
   Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026
   Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5
   Wolchok JC, 2010, BIOMATERIALS, V31, P9595, DOI 10.1016/j.biomaterials.2010.08.072
   Wolchok JC, 2009, BIOMATERIALS, V30, P327, DOI 10.1016/j.biomaterials.2008.08.035
NR 38
TC 5
Z9 5
U1 2
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD NOV
PY 2013
VL 41
IS 11
BP 2358
EP 2366
DI 10.1007/s10439-013-0845-z
PG 9
WC Engineering, Biomedical
SC Engineering
GA 236CZ
UT WOS:000325772900009
PM 23793412
DA 2018-10-20
ER

PT J
AU Kortsmit, J
   Davies, NH
   Miller, R
   Macadangdang, JR
   Zilla, P
   Franz, T
AF Kortsmit, Jeroen
   Davies, Neil H.
   Miller, Renee
   Macadangdang, Jesse R.
   Zilla, Peter
   Franz, Thomas
TI The effect of hydrogel injection on cardiac function and myocardial
   mechanics in a computational post-infarction model
SO COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE myocardial infarction; injection therapy; hydrogel; finite element model
ID FINITE-ELEMENT MODEL; LEFT-VENTRICULAR ANEURYSM; CANINE LEFT-VENTRICLE;
   INJECTABLE HYDROGEL; STRESS-ANALYSIS; HEART-FAILURE; WALL RUPTURE;
   INFARCTION; DYSFUNCTION; VOLUME
AB An emerging therapy to limit adverse heart remodelling following myocardial infarction (MI) is the injection of polymers into the infarcted left ventricle (LV). In the few numerical studies carried out in this field, the definition and distribution of the hydrogel in the infarcted myocardium were simplified. In this computational study, a more realistic biomaterial distribution was simulated after which the effect on cardiac function and mechanics was studied. A validated finite element heart model was used in which an antero-apical infarct was defined. Four infarct models were created representing different temporal phases in the progression of a MI. Hydrogel layers were simulated in the infarcted myocardium in each model. Biomechanical and functional improvement of the LV was found after hydrogel inclusion in the ischaemic models representing the early phases of MI. In contrast, only functional but no mechanical restitution was shown in the scar model due to hydrogel presence.
C1 [Kortsmit, Jeroen; Davies, Neil H.; Miller, Renee; Macadangdang, Jesse R.; Zilla, Peter; Franz, Thomas] Univ Cape Town, Chris Barnard Div Cardiothorac Surg, Cardiovasc Res Unit, ZA-7925 Cape Town, South Africa.
   [Macadangdang, Jesse R.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA.
   [Franz, Thomas] Univ Cape Town, Ctr Res Computat & Appl Mech, ZA-7925 Cape Town, South Africa.
   [Franz, Thomas] Ctr High Performance Comp, Cape Town, South Africa.
RP Kortsmit, J (reprint author), Univ Cape Town, Chris Barnard Div Cardiothorac Surg, Cardiovasc Res Unit, ZA-7925 Cape Town, South Africa.
EM jeroen.kortsmit@uct.ac.za; thomas.franz@uct.ac.za
RI Franz, T/C-3386-2009
OI Franz, T/0000-0002-1504-3842
FU Claude Leon Foundation; Whitaker fellowship; National Science
   Foundation, USA
FX Jeroen Kortsmit acknowledges the Claude Leon Foundation for financial
   support in form of a post-doctoral fellowship. Renee Miller received a
   Whitaker fellowship. The internship of Jesse R. Macadangdang was
   supported from the National Science Foundation, USA.
CR AHA, 2008, HEART DIS STROK STAT
   Baig MK, 1999, HEART LUNG, V28, P87, DOI 10.1053/hl.1999.v28.a97762
   Becker RC, 1996, J AM COLL CARDIOL, V27, P1321, DOI 10.1016/0735-1097(96)00008-3
   Birnbaum Y, 2003, CORONARY ARTERY DIS, V14, P463, DOI 10.1097/01.mca.0000085885.61165.f9
   BOGEN DK, 1980, CIRC RES, V47, P728, DOI 10.1161/01.RES.47.5.728
   Bovendeerd PHM, 1996, AM J PHYSIOL-HEART C, V270, pH398
   Dang ABC, 2005, ANN THORAC SURG, V79, P185, DOI 10.1016/j.athoracsur.2004.06.007
   Dang ABC, 2005, AM J PHYSIOL-HEART C, V288, pH1844, DOI 10.1152/ajpheart.00961.2003
   Dang ABC, 2004, J AM COLL CARDIOL, V43, p177A, DOI 10.1016/S0735-1097(04)90753-X
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Fomovsky GM, 2010, AM J PHYSIOL-HEART C, V298, pH221, DOI 10.1152/ajpheart.00495.2009
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   GUCCIONE JM, 1991, J BIOMECH ENG-T ASME, V113, P42, DOI 10.1115/1.2894084
   Guccione JM, 2003, ANN THORAC SURG, V76, P1171, DOI 10.1016/S0003-4975(03)00731-8
   GUCCIONE JM, 1995, J BIOMECH, V28, P1167, DOI 10.1016/0021-9290(94)00174-3
   GUCCIONE JM, 1993, J BIOMECH ENG-T ASME, V115, P72, DOI 10.1115/1.2895473
   Guccione JM, 2001, ANN THORAC SURG, V71, P654, DOI 10.1016/S0003-4975(00)02338-9
   GUPTA KB, 1994, CIRCULATION, V89, P2315, DOI 10.1161/01.CIR.89.5.2315
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Holmes JW, 1996, CARDIOVASC PATHOBIOL, V1, P15
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   KASS DA, 1990, CIRCULATION, V81, P447, DOI 10.1161/01.CIR.81.2.447
   Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50
   Kerckhoffs RCP, 2007, ANN BIOMED ENG, V35, P1, DOI 10.1007/s10439-006-9212-7
   Klodell CT, 2008, J THORAC CARDIOV SUR, V135, P188, DOI 10.1016/j.jtcvs.2007.09.034
   LAIRD JD, 1977, CIRC RES, V41, P715, DOI 10.1161/01.RES.41.5.715
   LOPEZSENDON J, 1992, J AM COLL CARDIOL, V19, P1145, DOI 10.1016/0735-1097(92)90315-E
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365
   OMENS JH, 1993, J BIOMECH, V26, P665, DOI 10.1016/0021-9290(93)90030-I
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   PFEFFER MA, 1987, CIRCULATION, V75, P93
   SCHUSTER EH, 1979, CIRCULATION, V60, P1532, DOI 10.1161/01.CIR.60.7.1532
   SMITH M, 1974, CHEST, V65, P368, DOI 10.1378/chest.65.4.368
   Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452
   Sun K, 2009, J BIOMECH ENG T ASME, V131
   SUNAGAWA K, 1983, CIRC RES, V52, P170, DOI 10.1161/01.RES.52.2.170
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   TISCHLER MD, 1993, J AM COLL CARDIOL, V22, P751, DOI 10.1016/0735-1097(93)90187-6
   Usyk TP, 2000, J ELASTICITY, V61, P143, DOI 10.1023/A:1010883920374
   Walker JC, 2005, AM J PHYSIOL-HEART C, V289, pH692, DOI 10.1152/ajpheart.01226.2004
   Walker JC, 2008, J THORAC CARDIOV SUR, V135, P1094, DOI 10.1016/j.jtcvs.2007.11.038
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wehrens XHT, 2004, INT J CARDIOL, V95, P285, DOI 10.1016/j.ijcard.2003.06.006
   Wenk JF, 2009, J BIOMECH ENG T ASME, V131
   Wenk JF, 2011, J BIOMECH ENG, V133
   Wenk JF, 2010, ANN THORAC SURG, V89, P1546, DOI 10.1016/j.athoracsur.2010.02.036
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
   WHITTAKER P, 1989, AM J PATHOL, V134, P879
   WHO, 2010, CARD DIS CVDS KEY FA, V2011, P317
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
NR 52
TC 8
Z9 8
U1 0
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1025-5842
EI 1476-8259
J9 COMPUT METHOD BIOMEC
JI Comput. Methods Biomech. Biomed. Eng.
PD NOV 1
PY 2013
VL 16
IS 11
BP 1185
EP 1195
DI 10.1080/10255842.2012.656611
PG 11
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical
SC Computer Science; Engineering
GA 240BX
UT WOS:000326070800007
PM 22439799
DA 2018-10-20
ER

PT J
AU Via, B
AF Via, Brian
TI Characterization and evaluation of wood strand composite load capacity
   with near infrared spectroscopy
SO MATERIALS AND STRUCTURES
LA English
DT Article
DE NIR; Non-destructive; Adhesive; Composite; Biomaterial
ID ORIENTED STRANDBOARD; NIR SPECTROSCOPY; MICROFIBRIL ANGLE; CONCENTRATED
   LOAD; PANEL PROPERTIES; UREA ADDITION; DENSITY; SPECTRA; PERFORMANCE;
   STIFFNESS
AB This study looked at the ability to use near infrared reflectance spectroscopy to non-destructively assess the load capacity and deflection of oriented strand construction board in the presence of phenol formaldehyde (PF) resin variation. The influence of PF resin on both mechanical properties was significant. Principal components regression was used to determine and rank statistically important principal components. For prediction of load capacity, the following associated wavelengths were important and in the following order: urea > lignin > cellulose > PF. Likewise, for prediction of deflection within the elastic region, the following associated wavelengths were important: urea > cellulose > lignin > PF. Models for prediction of load capacity (R (2) = 0.69) were stronger than those for deflection (R (2) = 0.59). It was determined that the predictive capability of the multivariate models were strong enough to characterize population parameters and for interpretation purposes but may not be precise enough for the accurate screening of individual panels.
C1 Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.
RP Via, B (reprint author), Auburn Univ, Sch Forestry & Wildlife Sci, 520 Devall Dr, Auburn, AL 36849 USA.
EM bkv0003@auburn.edu
OI Via, Brian/0000-0003-2676-7376
FU Hatch-Project [ALA-031-1-09020]; McIntire-Stennis Project [ALAZ00051]
FX This research was in alignment with five year goals set forth in
   Hatch-Project Number ALA-031-1-09020 and McIntire-Stennis Project Number
   ALAZ00051.
CR Andre N, 2008, WOOD SCI TECHNOL, V42, P521, DOI 10.1007/s00226-008-0204-7
   Chen Z, 2008, HOLZ ROH WERKST, V66, P207, DOI 10.1007/s00107-008-0229-5
   Chen Z, 2008, FOREST PROD J, V58, P59
   Collins M, 2010, MATER STRUCT, V43, P1203, DOI 10.1617/s11527-009-9575-y
   Dolezel-Horwath E, 2005, ANAL CHIM ACTA, V544, P47, DOI 10.1016/j.aca.2005.03.072
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Gaspar F, 2009, POLYM DEGRAD STABIL, V94, P1061, DOI 10.1016/j.polymdegradstab.2009.04.011
   GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9
   Hein PRG, 2010, J NEAR INFRARED SPEC, V18, P455, DOI [10.1255/jnirs.907, 10.1255/jnirs.905]
   Hein PRG, 2011, EUR J WOOD WOOD PROD, V69, P431, DOI 10.1007/s00107-010-0471-5
   Hein PRG, 2009, BIORESOURCES, V4, P1620
   Jiang B, 2007, INT J MOL SCI, V8, P541, DOI 10.3390/i8060541
   Kim MG, 1996, J WOOD CHEM TECHNOL, V16, P21, DOI 10.1080/02773819608545780
   Meder R, 2002, HOLZ ROH WERKST, V60, P159, DOI 10.1007/S00107-002-0296-y
   Meder R, 2010, J NEAR INFRARED SPEC, V18, pV, DOI 10.1255/jnirs.913
   Minopoulou E, 2003, INT J ADHES ADHES, V23, P473, DOI 10.1016/S0143-7496(03)00089-7
   Mitsui K, 2008, BIOMACROMOLECULES, V9, P286, DOI 10.1021/bm7008069
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Rials TG, 2002, WOOD FIBER SCI, V34, P398
   Schimleck LR, 2004, J NEAR INFRARED SPEC, V12, P55, DOI 10.1255/jnirs.407
   Schwanninger M, 2004, J NEAR INFRARED SPEC, V12, P397, DOI 10.1255/jnirs.449
   Sjoblom E, 2004, FOREST PROD J, V54, P71
   So CL, 2007, J APPL POLYM SCI, V105, P733, DOI 10.1002/app.26094
   So CL, 2004, FOREST PROD J, V54, P6
   Soukupova J, 2002, INT J REMOTE SENS, V23, P3039, DOI 10.1080/01431160110104683
   Taylor A, 2009, EUR J WOOD WOOD PROD, V67, P3, DOI 10.1007/s00107-008-0266-0
   Terdwongworakul A, 2005, J WOOD SCI, V51, P167, DOI 10.1007/s10086-004-0633-3
   Thomas WH, 2004, HOLZ ROH WERKST, V62, P44, DOI 10.1007/s00107-003-0438-x
   Thomas WH, 2003, MATER STRUCT, V36, P68, DOI 10.1007/BF02481573
   Tsuchikawa S, 2004, FOREST PROD J, V54, P71
   Via BK, 2009, COMPOS PART A-APPL S, V40, P60, DOI 10.1016/j.compositesa.2008.10.007
   Via BK, 2003, J NEAR INFRARED SPEC, V11, P365, DOI 10.1255/jnirs.388
   Via B, 2012, WOOD SCI TECHNOL, V46, P1073, DOI 10.1007/s00226-012-0467-x
   Via BK, 2007, IAWA J, V28, P189, DOI 10.1163/22941932-90001633
   Via BK, 2011, BIORESOURCES, V6, P807
   Via BK, 2010, J NEAR INFRARED SPEC, V18, P491, DOI 10.1255/jnirs.893
   WOLCOTT MP, 1990, WOOD FIBER SCI, V22, P345
   Workman (Jr) J., 2008, PRACTICAL GUIDE INTE, P1
   Zhang Y, 2005, FOREST PROD J, V55, P148
NR 39
TC 6
Z9 6
U1 0
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1359-5997
EI 1871-6873
J9 MATER STRUCT
JI Mater. Struct.
PD NOV
PY 2013
VL 46
IS 11
BP 1801
EP 1810
DI 10.1617/s11527-013-0018-4
PG 10
WC Construction & Building Technology; Engineering, Civil; Materials
   Science, Multidisciplinary
SC Construction & Building Technology; Engineering; Materials Science
GA 236DU
UT WOS:000325775200002
DA 2018-10-20
ER

PT J
AU Cilurzo, F
   Selmin, F
   Aluigi, A
   Bellosta, S
AF Cilurzo, F.
   Selmin, F.
   Aluigi, A.
   Bellosta, S.
TI Regenerated keratin proteins as potential biomaterial for drug delivery
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE keratin; spray-drying; cytotoxicity
ID ACID
AB This work aims to preliminarily evaluate the reliability of regenerated keratins (RKs) in the design of microparticulate drug delivery systems by studying their processability and cytotoxicity. RKs were extracted by sulfitolysis from wool waste. A 4.5%w/w RK solution was spray-dried, and microparticles were sterilized by steam vapor under pressure. Scanning electron microscope, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and Fourier transform infrared spectroscopy were used to characterize RKs and microparticles thereof. The in vitro cytotoxicity was determined by assessing the release of lactate dehydrogenase in the human monocytic cell line Tamm-Horsfall glycoprotein-1. RK-based microparticles with a narrow and unimodal particle size distribution (similar to 6 mu m) were obtained. They had a raisin-like structure with a smooth surface. Both microparticle morphology and RK molecular weight were well-preserved after sterilization. The curve fitting of the amide I bands showed that RK in the microparticles was prevalently present in the disordered/-helix secondary structures which made the protein soluble in water. To promote crystallization in the -sheet secondary structure and, therefore, water insolubility, RK-based microparticles were immersed in an aqueous solution of acetic acid at pH3.5 overnight. RK did not induce any appreciable cellular cytotoxicity at any of the concentrations (from 1 up to 1000 mu g sterile microparticles in 1ml cell culture medium) or time-points (24-72h) tested. These preliminary data suggest the feasibility of producing RK biocompatible microparticles using waste wool as starting material. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Cilurzo, F.; Selmin, F.] Univ Milan, Dept Pharmaceut Sci, I-20133 Milan, Italy.
   [Aluigi, A.] Consiglio Nazl Ric Inst Studio Macromol, I-13900 Biella, Italy.
   [Bellosta, S.] Univ Milan, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy.
RP Cilurzo, F (reprint author), Univ Milan, Dept Pharmaceut Sci, Via G Colombo 71, I-20133 Milan, Italy.
EM francesco.cilurzo@unimi.it
RI Cilurzo, Francesco/F-6663-2012; Bellosta, Stefano/B-4473-2010; Aluigi,
   Annalisa/I-3945-2014
OI Cilurzo, Francesco/0000-0003-3560-291X; Aluigi,
   Annalisa/0000-0001-8754-7161; Selmin, Francesca/0000-0002-3680-6124
CR Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Aluigi A, 2008, EUR POLYM J, V44, P2465, DOI 10.1016/j.eurpolymj.2008.06.004
   Cilurzo F, 2011, INT J PHARMACEUT, V414, P218, DOI 10.1016/j.ijpharm.2011.05.023
   DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9
   DOWLING LM, 1986, BIOCHEM J, V236, P705, DOI 10.1042/bj2360705
   GILLESPIE JM, 1974, COMP BIOCHEM PHYSIOL, V47, P339, DOI 10.1016/0305-0491(74)90063-7
   Ikkai F, 2002, BIOMACROMOLECULES, V3, P482, DOI 10.1021/bm010160i
   Rouse J. G., 2010, MATERIALS, V2, P999
   Savitzky A., 1964, ANAL CHEM, V36, P1628
   Selmin Francesca, 2012, Results Pharma Sci, V2, P72, DOI 10.1016/j.rinphs.2012.10.001
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   TANABE T, 2001, RRD PRO ENG 2, V1, P247
NR 12
TC 18
Z9 18
U1 0
U2 39
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD NOV
PY 2013
VL 24
IS 11
BP 1025
EP 1028
DI 10.1002/pat.3168
PG 4
WC Polymer Science
SC Polymer Science
GA 238XH
UT WOS:000325984600011
DA 2018-10-20
ER

PT J
AU Kamitani, T
   Masumoto, H
   Kotani, H
   Ikeda, T
   Hyon, SH
   Sakata, R
AF Kamitani, Tetsuya
   Masumoto, Hidetoshi
   Kotani, Hirokazu
   Ikeda, Tadashi
   Hyon, Suong-Hyu
   Sakata, Ryuzo
TI Prevention of retrosternal adhesion by novel biocompatible glue derived
   from food additives
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID CARDIAC-SURGERY; PERICARDIAL ADHESIONS; STAPHYLOCOCCUS-AUREUS;
   ATRIAL-FIBRILLATION; MEMBRANE; CLOSURE; GRAFT; ACID
AB Background: Postoperative retrosternal adhesion increases the risk of cardiac injury during cardiac reoperation. We created a novel biodegradable glue called "Lydex" that is derived from food additives. The purpose of this study is to evaluate this new biomaterial's biocompatibility and its preventive effect on retrosternal adhesion.
   Methods: We performed a median sternotomy and anterior pericardiectomy on Japanese white rabbits, and then closed the chest (control, group 1; n = 12), implanted an expanded polytetrafluoroethylene membrane (group 2; n = 12), or applied Lydex (group 3; n = 12) before closure. After 4 weeks, we evaluated macroscopic adhesion (each group; n = 6) and microscopic findings for fibrosis and macrophage infiltration (each group; n = 6).
   Results: In group 3, the retrosternal adhesion score was significantly lower than in group 1 (P = .0022). There was no significant difference between groups 2 and 3. The fibrotic area ratio was significantly lower in group 3 than in groups 1 and 2 (P < .001 vs group 1; P < .001 vs group 2). In group 3, the macrophage count was significantly lower than in group 2 (P < .001) and almost equal to that in group 1.
   Conclusions: Our findings indicate that Lydex reduces retrosternal adhesion and attenuates the progression of fibrosis with excellent biocompatibility. Lydex is a next-generation substance for safer cardiac reoperation, with excellent capability for preventing adhesion, biocompatible and biodegradable properties, and lower potential for viral infections related to human plasma or other animal-derived products.
C1 [Kamitani, Tetsuya; Masumoto, Hidetoshi; Ikeda, Tadashi; Sakata, Ryuzo] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Kyoto 6038507, Japan.
   [Kotani, Hirokazu] Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto 6038507, Japan.
   [Hyon, Suong-Hyu] Kyoto Inst Technol, Ctr Fiber & Text Sci, Kyoto 606, Japan.
RP Ikeda, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6038507, Japan.
EM ike@kuhp.kyoto-u.ac.jp
FU Ministry of Education, Culture, Sports, Science, and Technology, Japan
FX This work was supported by research grants from the Ministry of
   Education, Culture, Sports, Science, and Technology, Japan (to T.I.).
CR Araki M, 2007, J THORAC CARDIOV SUR, V134, P1241, DOI 10.1016/j.jtcvs.2007.07.020
   Bel A, 2012, INTERACT CARDIOV TH, V14, P469, DOI 10.1093/icvts/ivr159
   Boyd WD, 2010, HEART SURG FORUM, V13, pE311, DOI 10.1532/HSF98.20091184
   BUNTON RW, 1990, J THORAC CARDIOV SUR, V100, P99
   GOEAUBRISSONNIERE O, 1987, J VASC SURG, V5, P743, DOI 10.1016/0741-5214(87)90163-7
   Hendrikx M, 2001, HEART SURG FORUM, V4, P204
   HEYDORN WH, 1987, J THORAC CARDIOV SUR, V94, P291
   Hiraki J, 2003, REGUL TOXICOL PHARM, V37, P328, DOI 10.1016/S0273-2300(03)00029-1
   Kumar V, 2010, ROBBINS COTRAN PATHO, P43
   LAKS H, 1981, J THORAC CARDIOV SUR, V82, P88
   Lodge AJ, 2008, ANN THORAC SURG, V86, P614, DOI 10.1016/j.athoracsur.2008.04.103
   LOOP FD, 1984, ANN THORAC SURG, V37, P271, DOI 10.1016/S0003-4975(10)60727-8
   Masumoto H, 2012, GEN THORAC CARDIOVAS, V60, P744, DOI 10.1007/s11748-012-0139-7
   MATHISEN SR, 1986, J THORAC CARDIOV SUR, V92, P92
   Morishima M, 2010, INTERACT CARDIOV TH, V11, P52, DOI 10.1510/icvts.2010.232447
   Naito Y, 2008, J THORAC CARDIOV SUR, V135, P850, DOI 10.1016/j.jtcvs.2007.10.062
   Nakajima N, 2007, KEY ENG MATER, V342-343, P713, DOI 10.4028/www.scientific.net/KEM.342-343.713
   Napoleone C. P., 2009, INTERACT CARDIOV TH, V9, P978
   Okuyama N, 1999, ANN THORAC SURG, V68, P913, DOI 10.1016/S0003-4975(99)00556-1
   REVUELTA JM, 1985, J THORAC CARDIOV SUR, V89, P451
   Sakata R, 2011, GEN THORAC CARDIOVAS, V59, P636
   Takagi K, 2013, J SURG RES, V179, pE13, DOI 10.1016/j.jss.2012.01.056
   Takeda T, 2011, ANN THORAC SURG, V91, P734, DOI 10.1016/j.athoracsur.2010.10.022
   Yau TM, 2000, J THORAC CARDIOV SUR, V120, P156, DOI 10.1067/mtc.2000.106983
   Yoshioka I, 2007, ANN THORAC SURG, V84, P864, DOI 10.1016/j.athoracsur.2007.04.029
NR 25
TC 2
Z9 2
U1 0
U2 5
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
EI 1097-685X
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD NOV
PY 2013
VL 146
IS 5
BP 1232
EP 1238
DI 10.1016/j.jtcvs.2013.02.001
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 233XR
UT WOS:000325603300036
PM 23582278
OA Bronze
DA 2018-10-20
ER

PT J
AU Marcacci, M
   Zaffagnini, S
   Kon, E
   Muccioli, GMM
   Di Martino, A
   Di Matteo, B
   Bonanzinga, T
   Iacono, F
   Filardo, G
AF Marcacci, M.
   Zaffagnini, S.
   Kon, E.
   Muccioli, G. M. Marcheggiani
   Di Martino, A.
   Di Matteo, B.
   Bonanzinga, T.
   Iacono, F.
   Filardo, G.
TI Unicompartmental osteoarthritis: an integrated biomechanical and
   biological approach as alternative to metal resurfacing
SO KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
LA English
DT Article
DE Unicompartmental osteoarthritis; Meniscal scaffold; Osteochondral
   scaffold; Biological reconstruction; Osteotomy; Allograft
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; MENISCAL ALLOGRAFT TRANSPLANTATION;
   COMPOSITE MULTILAYERED BIOMATERIAL; 2-YEAR FOLLOW-UP; OSTEOCHONDRAL
   REGENERATION; SURGICAL-TREATMENT; CARTILAGE DEFECTS; CHONDRAL DEFECTS;
   CLINICAL-TRIAL; KNEE
AB Although traditionally not indicated for the treatment of osteoarthritis (OA), regenerative procedures are becoming a focus of increased interest due to their potential to provide pain relief and alter the progression of degenerative diseases. The purpose of this study was to assess whether a combined biomechanical and biological approach could offer good results in unicompartmental OA, thus delaying the need for unicompartmental arthroplasty in patients too young or refusing metal resurfacing.
   Forty-three patients (mean age = 40.1 +/- A 11 years, 33 men and 10 women, mean BMI = 25 +/- A 3) affected by unicompartmental OA (Kellegren-Lawrence score = 3) in stable joints were enrolled and treated consecutively. Fifteen patients were treated with osteotomy and osteochondral biomimetic scaffold implant (3 of them also with meniscal substitution), 11 with osteotomy and meniscal scaffold implant, 9 with osteotomy and meniscal allograft implant, and 8 with both cartilage and meniscal reconstruction, depending on the specific joint compartment main requirements. Clinical evaluation was performed at 3-year (2-4) median follow-up using the following scoring systems: IKDC subjective and objective, VAS for pain, and Tegner scores. Failures, adverse events, and complications were also reported.
   The IKDC subjective score improved from 47.3 to 79.6 at the final evaluation (p < 0.0005), VAS improved from 6.1 to 2.3 (p < 0.0005), and also sport activity level evaluated with the Tegner score showed a significant improvement, from 2 (1-5) to 4 (3-10; p < 0.0005), even if without achieving the pre-injury level (6, p = 0.001). A further subanalysis confirmed the positive outcome obtained in all the treatment subgroups and showed a higher clinical improvement in patients under the age of 40 years (IKDC subjective 84.4 +/- A 13.2 vs 76.5 +/- A 17.3; p = 0.03).
   This integrated biological and biomechanical approach produced a marked improvement at short-medium follow-up in patients affected by unicompartmental OA. Even though a good outcome was achieved at all ages, patients under the age of 40 years presented a greater clinical and subjective improvement. Longer follow-up studies are needed to show results over time and confirm this approach as an effective alternative to unicompartmental implants.
   Case series, Level IV.
C1 [Marcacci, M.; Zaffagnini, S.; Muccioli, G. M. Marcheggiani; Di Martino, A.; Di Matteo, B.; Bonanzinga, T.; Iacono, F.] Rizzoli Orthopaed Inst, Orthopaed Clin 2, I-40136 Bologna, Italy.
   [Marcacci, M.; Zaffagnini, S.; Muccioli, G. M. Marcheggiani; Di Martino, A.; Di Matteo, B.; Bonanzinga, T.; Iacono, F.] Rizzoli Orthopaed Inst, Biomech Lab, I-40136 Bologna, Italy.
   [Kon, E.; Filardo, G.] Rizzoli Orthopaed Inst, Nanobiotechnol Lab, I-40136 Bologna, Italy.
RP Marcacci, M (reprint author), Rizzoli Orthopaed Inst, Orthopaed Clin 2, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM m.marcacci@biomec.ior.it
OI Iacono, Francesco/0000-0001-6825-2851; Bonanzinga,
   Tommaso/0000-0003-2861-4699; Filardo, Giuseppe/0000-0002-8136-0977
CR Bauer S, 2012, KNEE, V19, P431, DOI 10.1016/j.knee.2011.06.005
   Bollars P, 2012, KNEE SURG SPORT TR A, V20, P1753, DOI 10.1007/s00167-011-1757-9
   Cavallo C, 2010, J BIOMED MATER RES A, V93A, P86, DOI 10.1002/jbm.a.32547
   Dettoni Federico, 2010, Iowa Orthop J, V30, P131
   Farr J, 2007, AM J SPORT MED, V35, P1459, DOI 10.1177/0363546507301257
   Filardo G, 2012, CARTILAGE, V3, P288, DOI 10.1177/1947603512436371
   Filardo G, 2012, KNEE SURG SPORT TR A, V20, P1704, DOI 10.1007/s00167-011-1732-5
   Garrett JC, 1993, SPORTS MED ARTHROSC, V2, P164
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P468, DOI 10.1007/s00167-011-1714-7
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Gomoll Andreas H, 2009, J Knee Surg, V22, P137
   Heijink A, 2012, KNEE SURG SPORT TR A, V20, P423, DOI 10.1007/s00167-011-1818-0
   Hollander AP, 2006, TISSUE ENG, V12, P1787, DOI 10.1089/ten.2006.12.1787
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2012, KNEE SURG SPORT TR A, V20, P399, DOI 10.1007/s00167-011-1858-5
   Kon E, 2012, KNEE SURG SPORT TR A, V20, P436, DOI 10.1007/s00167-011-1713-8
   Kon E, 2011, AM J SPORT MED, V39, P1668, DOI 10.1177/0363546511404675
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Koskinen E, 2007, ACTA ORTHOP, V78, P128, DOI 10.1080/17453670610013538
   Kreuz PC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2638
   Lotz M, 2012, OSTEOARTHR CARTILAGE, V20, P192, DOI 10.1016/j.joca.2011.11.015
   Luyten FP, 2012, KNEE SURG SPORT TR A, V20, P401, DOI 10.1007/s00167-011-1743-2
   Marcacci M, 2012, AM J SPORT MED, V40, P395, DOI 10.1177/0363546511424688
   Minas T, 2010, CLIN ORTHOP RELAT R, V468, P146
   Minas T, 2010, CLIN ORTHOP RELAT R, V468, P147, DOI 10.1007/s11999-009-0998-0
   Nehrer S, 2009, AM J SPORT MED, V37, p81S, DOI 10.1177/0363546509350704
   Niemeyer P, 2010, ARTHROSCOPY, V26, P1074, DOI 10.1016/j.arthro.2009.12.028
   Ossendorf C, 2011, SPORTS MED ARTHROSC, V21, P11
   Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180
   Paletta GA, 1997, AM J SPORT MED, V25, P692, DOI 10.1177/036354659702500519
   Pape D, 2010, KNEE SURG SPORT TR A, V18, P448, DOI 10.1007/s00167-010-1052-1
   Robertsson O, 2000, ACTA ORTHOP SCAND, V71, P262, DOI 10.1080/000164700317411852
   Rosenberger RE, 2008, AM J SPORT MED, V36, P2336, DOI 10.1177/0363546508322888
   Rue JPH, 2008, AM J SPORT MED, V36, P1770, DOI 10.1177/0363546508317122
   Ryu RKN, 2002, ARTHROSCOPY, V18, P989, DOI 10.1053/jars.2002.36104
   Saccomanni B, 2010, CLIN RHEUMATOL, V29, P339, DOI 10.1007/s10067-009-1354-1
   Shirazi R, 2009, J BIOMECH, V42, P2458, DOI 10.1016/j.jbiomech.2009.07.022
   Tallheden T, 2005, ARTHRITIS RES THER, V7, pR560, DOI 10.1186/ar1709
   Tohyama H, 2009, J ORTHOP SCI, V14, P579, DOI 10.1007/s00776-009-1384-1
   Verma Nikhil N, 2008, J Knee Surg, V21, P20
   Zaffagnini S, 2009, TECH KNEE SURG, V8, P251
   Zaffagnini S, 2007, KNEE SURG SPORT TR A, V15, P175, DOI 10.1007/s00167-006-0144-4
   Zaffagnini S, 2012, AM J SPORT MED, V40, P2281, DOI 10.1177/0363546512456835
   Zaffagnini S, 2011, KNEE SURG SPORT TR A, V19, P1740, DOI 10.1007/s00167-011-1538-5
   Zaffagnini S, 2011, AM J SPORT MED, V39, P977, DOI 10.1177/0363546510391179
NR 47
TC 18
Z9 18
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0942-2056
EI 1433-7347
J9 KNEE SURG SPORT TR A
JI Knee Surg. Sports Traumatol. Arthrosc.
PD NOV
PY 2013
VL 21
IS 11
BP 2509
EP 2517
DI 10.1007/s00167-013-2388-0
PG 9
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 236VN
UT WOS:000325827600015
PM 23370980
DA 2018-10-20
ER

PT J
AU Zhang, F
   Liu, YJ
   Liu, QH
   Li, Q
   Li, H
   Cai, XY
   Wang, YD
AF Zhang, F.
   Liu, Y. J.
   Liu, Q. H.
   Li, Q.
   Li, H.
   Cai, X. Y.
   Wang, Y. D.
TI Synthesis and characterisation of Ni(OH)(2) and NiO nanosheets and their
   removal properties of azo dyes from aqueous solution
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Ni(OH)(2); NiO; Nanosheets; Azo dyes; Removal performance
ID FERRITE COMPOSITE NANOPARTICLES; NICKEL-HYDROXIDE; PHOTOCATALYTIC SHELL;
   BIOMATERIAL SYSTEM; MAGNETIC CORE; ANTIMICROBIAL ACTIVITY; HOLLOW
   MICROSPHERES; ANIONIC DYES; CONGO RED; BETA-NI(OH)(2)
AB The degradation of various kinds of synthetic dyestuffs, such as dyestuff, textiles, leather, paper and plastics, stimulated a particular research interest in recent years. Nickel hydroxide and nickel oxide compounds stimulated a large interest in industrial and technical applications, for example as the active materials in electrochemical cycling and as a photocatalyst to remove organic dyes. In this paper, the mainly research is focused on the preparation process and removal properties of azo dye pollutants from aqueous solutions using Ni(OH)(2) nanosheets or NiO nanosheets. The proposed research investigates the Ni(OH)(2) nanosheets or NiO nanosheets that are important in understanding the structure, morphology and the photocatalytic performances. Ni(OH)(2) nanosheets were synthesised by a simple chemical precipitation method using nickel chloride as precursors and ammonia as precipitating agent. The obtained Ni(OH)(2) nanosheets can be successfully converted to NiO nanosheets via calcination under appropriate conditions. Analytical methods, such as X-ray diffraction spectra, scanning electron microscopy, transmission electron microscopy, high resolution transmission electron microscopy and Fourier transformed infrared spectra, were employed to characterise the morphology and microstructure of the final products. The results reveal that Ni(OH)(2) nanosheets were shape preserved transformed to NiO nanosheets at 250 degrees C for 24 h. The removal performances for azo dyes Congo red, methyl orange, methylene blue, rhodaming B using the as prepared and commercial samples from aqueous solutions were investigated respectively. The as synthesised Ni(OH)(2) nanosheets is found to have high efficiency for the removal of Congo red pollutant as a result of their unique structures, make them to be promising candidates for wastewater treatment.
C1 [Zhang, F.; Liu, Q. H.; Li, Q.; Li, H.; Cai, X. Y.; Wang, Y. D.] Yunnan Univ, Dept Mat Sci & Engn, Kunming 650091, Peoples R China.
   [Liu, Y. J.] Yunnan Univ, Adv Anal & Measurement Ctr, Kunming 650091, Peoples R China.
RP Wang, YD (reprint author), Yunnan Univ, Dept Mat Sci & Engn, Kunming 650091, Peoples R China.
EM ydwang@ynu.edu.cn
RI Wang, Yude/G-6188-2012
FU Department of Science and Technology of Yunnan Province via the Key
   Project for the Science and Technology [2011FA001]; Key Project of
   Chinese Ministry of Education [210206]; National Natural Science
   Foundation of China [50662006]
FX This work was supported by the Department of Science and Technology of
   Yunnan Province via the Key Project for the Science and Technology
   (grant no. 2011FA001), the Key Project of Chinese Ministry of Education
   (grant no. 210206), and National Natural Science Foundation of China
   (grant no. 50662006).
CR Cai F. S., 2004, ANGEW CHEM, V116, P4308
   Chen DL, 2005, CHEM PHYS LETT, V405, P159, DOI 10.1016/j.cplett.2005.01.121
   Chen H, 2009, ADSORPTION, V15, P381, DOI 10.1007/s10450-009-9155-z
   Chen YC, 2012, COLLOID SURFACE A, V395, P125, DOI 10.1016/j.colsurfa.2011.12.016
   Cheng B, 2011, J HAZARD MATER, V185, P889, DOI 10.1016/j.jhazmat.2010.09.104
   Chiou MS, 2004, DYES PIGMENTS, V60, P69, DOI 10.1016/S1043-7208(03)00140-2
   CHUNG KT, 1992, CRIT REV MICROBIOL, V18, P175, DOI 10.3109/10408419209114557
   Coudun C, 2005, J PHYS CHEM B, V109, P6069, DOI 10.1021/jp0466441
   Deng XY, 2004, MATER LETT, V58, P276, DOI 10.1016/S0167-577X(03)00469-5
   Freitas MBJG, 2001, J POWER SOURCES, V93, P163, DOI 10.1016/S0378-7753(00)00570-X
   Gong RM, 2005, DYES PIGMENTS, V64, P187, DOI 10.1016/j.dyepig.2004.05.05
   Gopi D, 2012, SPECTROCHIM ACTA A, V93, P131, DOI 10.1016/j.saa.2012.02.033
   Hariprakash B, 2005, J APPL ELECTROCHEM, V35, P27, DOI 10.1007/s10800-004-2052-y
   Hu JS, 2008, ADV MATER, V20, P2977, DOI 10.1002/adma.200800623
   Lei LX, 2008, ELECTROCHIM ACTA, V54, P671, DOI 10.1016/j.electacta.2008.07.004
   Li BJ, 2011, CHEM COMMUN, V47, P3159, DOI 10.1039/c0cc04507a
   Li BJ, 2010, CHEM COMMUN, V46, P6267, DOI 10.1039/c0cc00155d
   Li Q, 2012, MATER TECHNOL, V27, P104, DOI 10.1179/175355511X13240279339842
   Liu XH, 2005, NANOTECHNOLOGY, V16, P1400, DOI 10.1088/0957-4484/16/8/071
   Liu Y, 2012, COMPOS PART B-ENG, V43, P1346, DOI 10.1016/j.compositesb.2011.11.057
   Liu YF, 2011, J MATER CHEM, V21, P4743, DOI 10.1039/c0jm01921f
   Luo YY, 2007, J SOLID STATE CHEM, V180, P2149, DOI 10.1016/j.jssc.2007.05.025
   Matsui K, 2002, ADV MATER, V14, P1216, DOI 10.1002/1521-4095(20020903)14:17<1216::AID-ADMA1216>3.0.CO;2-A
   Mohamed R. M., 2012, J NANOTECHNOLOGY, V10, P1155
   Qi YJ, 2009, J MATER SCI-MATER EL, V20, P479, DOI 10.1007/s10854-008-9755-5
   Ran JR, 2011, GREEN CHEM, V13, P2708, DOI 10.1039/c1gc15465f
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sarkar S, 2010, INORG CHEM, V49, P8813, DOI 10.1021/ic1015065
   Shukla AK, 2001, J POWER SOURCES, V100, P125, DOI 10.1016/S0378-7753(01)00890-4
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Vimonses V, 2009, CHEM ENG J, V148, P354, DOI 10.1016/j.cej.2008.09.009
   Wang XY, 2003, J POWER SOURCES, V115, P153, DOI 10.1016/S0378-7753(02)00649-3
   Wang Y, 2005, CHEM COMMUN, P5231, DOI 10.1039/b508807k
   Wang Y. M., 2011, RSC ADV, V10, P1039
   Yu JG, 2008, CRYST GROWTH DES, V8, P930, DOI 10.1021/cg700794y
   Zhang F, 2012, MATER TECHNOL, V27, P196, DOI 10.1179/1753555712Y.0000000003
   Zhang PP, 2012, CHEM ENG J, V189, P188, DOI 10.1016/j.cej.2012.02.055
   Zhang WD, 2012, J ALLOY COMPD, V521, P39, DOI 10.1016/j.jallcom.2011.12.172
NR 42
TC 6
Z9 6
U1 3
U2 96
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD NOV
PY 2013
VL 28
IS 6
BP 310
EP 315
DI 10.1179/1753555712Y.0000000052
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 235YC
UT WOS:000325757900003
DA 2018-10-20
ER

PT J
AU Hamed, A
   Fitzgerald, AG
   Wang, LY
   Gueorguieva, M
   Malik, R
   Melzer, A
AF Hamed, A.
   Fitzgerald, A. G.
   Wang, L. Y.
   Gueorguieva, M.
   Malik, R.
   Melzer, A.
TI Characterisation of Mn0.7Zn0.3Fe2O4 nanoparticles prepared by two stage
   annealing
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Nanoparticles; Ferrite; Relaxivity; Two stage annealing; MRI
ID FERRITE COMPOSITE NANOPARTICLES; IRON-OXIDE NANOPARTICLES; BIOMATERIAL
   SYSTEM; SUPERPARAMAGNETIC NANOPARTICLES; FE3O4 NANOPARTICLES;
   DRUG-DELIVERY; SHELL; CORE; FUNCTIONALIZATION; PRECURSOR
AB Nanoparticles of the spinel ferrite Mn0.7Zn0.3Fe2O4, with potential for use as contrast agents for magnetic resonance imaging applications, have been prepared by a sol-gel method followed by a two stage annealing process. The second stage of the annealing process improved the quality of the nanoparticles but also led to intergrown aggregates. The nanoparticles were milled to reduce this aggregation. After hand milling, the average nanoparticle size was 20 nm and after 5 h ball milling, the average nanoparticle size was 10 nm. The principal objectives of this study were to assess the effects of the two stage annealing process and milling on average nanoparticle size, crystal quality and magnetic properties relating to potential use in magnetic resonance imaging. Preliminary cytotoxicity measurements enabled assessment of possible nanoparticle contamination during milling on potential medical and clinical applications. A special surfactant was modified to disperse the nanoparticles in water and render them hydrophilic and to reduce agglomeration.
C1 [Hamed, A.; Fitzgerald, A. G.] Univ Dundee, Sch Engn Phys & Math, Carnegie Lab Phys, Dundee DD1 4HN, Scotland.
   [Wang, L. Y.; Gueorguieva, M.; Malik, R.; Melzer, A.] Univ Dundee, Inst Med Sci & Technol, Dundee DD2 1FD, Scotland.
RP Fitzgerald, AG (reprint author), Univ Dundee, Sch Engn Phys & Math, Carnegie Lab Phys, Dundee DD1 4HN, Scotland.
EM a.g.fitzgerald@dundee.ac.uk
FU Administration Missions of Libyan High Education; European Community's
   Seventh Framework Programme [230674]
FX Special thanks go to the Administration Missions of Libyan High
   Education for financial support for this research project, and the
   authors wish to thank Dr Pascal Andre of the University of St Andrews
   for assistance with SQUID measurements. The research leading to these
   results has received funding from the European Community's Seventh
   Framework Programme (FP7/2007/2013) under grant agreement number 230674
   (Nanoporation project).
CR Ajmal M., 2008, THESIS QUAID I AZAM, P72
   Alubaidy MA, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-375
   Amara D, 2009, COLLOID SURFACE A, V339, P106, DOI 10.1016/j.colsurfa.2009.02.003
   Arulmurugan R, 2006, J MAGN MAGN MATER, V298, P83, DOI 10.1016/j.jmmm.2005.03.002
   Baek MJ, 2010, ACS APPL MATER INTER, V2, P2949, DOI 10.1021/am100641z
   Barcena C, 2008, CHEM COMMUN, P2224, DOI 10.1039/b801041b
   Barnett CM, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1170-4
   Biasotto G., 2011, PROCESS APPL CERAM, V5, P171
   Chen DH, 2001, MATER RES BULL, V36, P1369, DOI 10.1016/S0025-5408(01)00620-1
   Chen ZP, 2008, COLLOID SURFACE A, V316, P210, DOI 10.1016/j.colsurfa.2007.09.017
   Cheng FX, 1999, THIN SOLID FILMS, V339, P109, DOI 10.1016/S0040-6090(98)01159-6
   Chikazumi S., 1997, INT SERIES MONOGRAPH, V94, P206
   Ge YQ, 2009, COLLOID SURFACE B, V73, P294, DOI 10.1016/j.colsurfb.2009.05.031
   Gupta AK, 2004, IEEE T NANOBIOSCI, V3, P66, DOI 10.1109/TNB.2003.820277
   Hamed A. A., 2012, THESIS U DUNDEE DUND, P83
   Herranz F, 2008, CHEM-EUR J, V14, P9126, DOI 10.1002/chem.200800755
   Herrmann IK, 2009, CHEM MATER, V21, P3275, DOI 10.1021/cm900785u
   Hong RY, 2009, APPL SURF SCI, V255, P3485, DOI 10.1016/j.apsusc.2008.09.071
   Hou XY, 2011, J COLLOID INTERF SCI, V353, P524, DOI 10.1016/j.jcis.2010.09.050
   Kim DH, 2009, J MAGN MAGN MATER, V321, P3899, DOI 10.1016/j.jmmm.2009.07.057
   Kruis FE, 1998, J AEROSOL SCI, V29, P511, DOI 10.1016/S0021-8502(97)10032-5
   Latorre-Esteves M, 2009, J MAGN MAGN MATER, V321, P3061, DOI 10.1016/j.jmmm.2009.05.023
   Leem G, 2010, ACS APPL MATER INTER, V2, P2789, DOI 10.1021/am100457v
   Lu J, 2009, BIOMATERIALS, V30, P2919, DOI 10.1016/j.biomaterials.2009.02.001
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   SASS M, 1977, J MAGN RESON, V25, P263, DOI 10.1016/0022-2364(77)90021-X
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Thakur A, 2003, CERAM INT, V29, P505, DOI 10.1016/S0272-8842(02)00194-3
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Yedjou Clement G, 2006, Int J Environ Res Public Health, V3, P136, DOI 10.3390/ijerph2006030017
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
NR 34
TC 1
Z9 1
U1 1
U2 25
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD NOV
PY 2013
VL 28
IS 6
BP 339
EP 346
DI 10.1179/1753555713Y.0000000066
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 235YC
UT WOS:000325757900007
DA 2018-10-20
ER

PT J
AU Tourani, H
   Molazemhosseini, A
   Khavandi, A
   Mirdamadi, S
   Shokrgozar, MA
   Mehrjoo, M
AF Tourani, Hamid
   Molazemhosseini, Alireza
   Khavandi, Alireza
   Mirdamadi, Shamseddin
   Shokrgozar, Mohamad Ali
   Mehrjoo, Morteza
TI Effects of Fibers and Nanoparticles Reinforcements on the Mechanical and
   Biological Properties of Hybrid Composite Polyetheretherketone/Short
   Carbon Fiber/Nano-SiO2
SO POLYMER COMPOSITES
LA English
DT Article
ID NANO-INDENTATION; NANOINDENTATION; BEHAVIOR; NANOCOMPOSITES;
   PERFORMANCE; TECHNOLOGY; INTERFACES; MORPHOLOGY; POLYMERS; IMPLANTS
AB Polyetheretherketone (PEEK) composites reinforced with short carbon fibers (SCFs) (20 vol%) and nano-SiO2 (1, 1.5, and 2 wt%) particles were prepared by incorporating nanoparticles into PEEK/SCF composites using the internal mixer. In the development of biomaterial, both mechanical and biological characteristics must be considered. Thus, the effects of nanoparticles on the mechanical and biological properties of the PEEK/SCF composites were studied. To evaluate the mechanical properties of this biomaterial, nanoindentation method and tensile test were used. Results showed that by increasing the weight percentage of nano-SiO2, the elastic modulus, hardness, and tensile energies were increased. In vitro biological evaluations of the samples were done by performing cytotoxicity (3-[4,5-dimethylthiazol-2-yl]-2,5-iphenyltetrazolium bromide assay) and cell adhesion assays. Cell-material interaction with the surface of the composite was examined by scanning electron microscopy (SEM). In all of the tests, osteoblast cells were used. Results of biological tests showed that the samples are biocompatible and they have no toxicity. Also, Adhered cells presented a normal morphology by SEM and many of the cells were observed to be undergoing cell division. POLYM. COMPOS., 34:1960-1968, 2013. (c) 2013 Society of Plastics Engineers
C1 [Tourani, Hamid; Molazemhosseini, Alireza] Iran Univ Sci & Technol, Sch Mat Sci & Engn, Composite Lab, Tehran, Iran.
   [Khavandi, Alireza; Mirdamadi, Shamseddin] Iran Univ Sci & Technol, Sch Mat Sci & Engn, Tehran, Iran.
   [Shokrgozar, Mohamad Ali; Mehrjoo, Morteza] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran.
RP Khavandi, A (reprint author), Iran Univ Sci & Technol, Sch Mat Sci & Engn, Tehran, Iran.
EM khavandi@iust.ac.ir
RI shokrgozar, mohammad ali/L-4149-2017; Arumugam, Thirumagal/C-3408-2014;
   khavandi, alireza/S-6562-2018; Khavandi, Alireza/S-3732-2018
OI shokrgozar, mohammad ali/0000-0001-5123-4155; 
CR Akay M, 1996, J BIOMED MATER RES, V31, P167
   Aldousiri B, 2011, POLYM TEST, V30, P688, DOI 10.1016/j.polymertesting.2011.05.008
   Balik K., 1999, ACTA MONTANA, V113, P57
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   BLUNDELL DJ, 1983, POLYMER, V24, P953, DOI 10.1016/0032-3861(83)90144-1
   Brooks RA, 2004, BIOMATERIALS, V25, P3429, DOI 10.1016/j.biomaterials.2003.10.064
   CHUNGUI Z, 2005, POLYM DEGRAD STABIL, V87, P183
   Davis DC, 2010, COMPOS STRUCT, V92, P2653, DOI 10.1016/j.compstruct.2010.03.019
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   Fujihara K, 2003, BIOMATERIALS, V24, P2661, DOI 10.1016/S0142-9612(03)00065-6
   Gilbert EN, 2003, COMPOS PART A-APPL S, V34, P245, DOI 10.1016/S1359-835X(02)00141-0
   Godora A., 2007, ACTA BIOMATER, V3, P209
   Guo-ming L., 2011, COMPOS B, V13, P11
   Hodzic A, 2000, POLYMER, V41, P6895, DOI 10.1016/S0032-3861(99)00890-3
   Hodzic A, 2001, POLYMER, V42, P5701, DOI 10.1016/S0032-3861(01)00029-5
   Homaeigohar SSH, 2006, J BIOMED MATER RES A, V78A, P129, DOI 10.1002/jbm.a.30691
   Hussain M, 2000, COMPOS PART A-APPL S, V31, P173, DOI 10.1016/S1359-835X(99)00060-3
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Li XD, 2002, MATER CHARACT, V48, P11
   Liao QZ, 2010, MECH MATER, V42, P1043, DOI 10.1016/j.mechmat.2010.09.005
   Liujie X, 2007, J MATER PROCESS TECH, V189, P374
   MAGEE FP, 1988, CLIN ORTHOP RELAT R, P237
   Molazemhosseini A, 2013, WEAR, V303, P397, DOI 10.1016/j.wear.2013.03.019
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Polineni VK, 1998, AM SOC TEST MATER, V1346, P266, DOI 10.1520/STP12844S
   Poveda R, 2010, MATER LETT, V64, P2360, DOI 10.1016/j.matlet.2010.07.063
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Sanchez M, 2011, COMPOS PART B-ENG, V42, P638, DOI 10.1016/j.compositesb.2011.02.017
   Shen L, 2005, POLYMER, V46, P11969, DOI 10.1016/j.polymer.2005.10.006
   SKINNER HB, 1988, CLIN ORTHOP RELAT R, P224
   Timmerman JF, 2002, COMPOS SCI TECHNOL, V62, P1249, DOI 10.1016/S0266-3538(02)00063-5
   TONTHAT PT, 2000, J BIOMED MATER RES, V51, P460
   Tsantzalis S, 2007, COMPOS PART A-APPL S, V38, P1159, DOI 10.1016/j.compositesa.2006.04.016
NR 33
TC 5
Z9 5
U1 3
U2 48
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-8397
EI 1548-0569
J9 POLYM COMPOSITE
JI Polym. Compos.
PD NOV
PY 2013
VL 34
IS 11
BP 1961
EP 1969
DI 10.1002/pc.22603
PG 9
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 235JL
UT WOS:000325714300022
DA 2018-10-20
ER

PT J
AU Zamperone, A
   Pietronave, S
   Merlin, S
   Colangelo, D
   Ranaldo, G
   Medico, E
   Di Scipio, F
   Berta, GN
   Follenzi, A
   Prat, M
AF Zamperone, Andrea
   Pietronave, Stefano
   Merlin, Simone
   Colangelo, Donato
   Ranaldo, Gabriella
   Medico, Enzo
   Di Scipio, Federica
   Berta, Giovanni Nicolao
   Follenzi, Antonia
   Prat, Maria
TI Isolation and Characterization of a Spontaneously Immortalized
   Multipotent Mesenchymal Cell Line Derived from Mouse Subcutaneous
   Adipose Tissue
SO STEM CELLS AND DEVELOPMENT
LA English
DT Article
ID STEM-CELLS; BONE-MARROW; REGENERATIVE MEDICINE; STROMAL CELLS;
   SCAFFOLDS; DIFFERENTIATION; PROLIFERATION; TELOMERASE; IDENTIFICATION;
   EXPRESSION
AB The emerging field of tissue engineering and regenerative medicine is a multidisciplinary science that is based on the combination of a reliable source of stem cells, biomaterial scaffolds, and cytokine growth factors. Adult mesenchymal stem cells are considered important cells for applications in this field, and adipose tissue has revealed to be an excellent source of them. Indeed, adipose-derived stem cells (ASCs) can be easily isolated from the stromal vascular fraction (SVF) of adipose tissue. During the isolation and propagation of murine ASCs, we observed the appearance of a spontaneously immortalized cell clone, named m17.ASC. This clone has been propagated for more than 180 passages and stably expresses a variety of stemness markers, such as Sca-1, c-kit/CD117, CD44, CD106, islet-1, nestin, and nucleostemin. Furthermore, these cells can be induced to differentiate toward osteogenic, chondrogenic, adipogenic, and cardiogenic phenotypes. m17.ASC clone displays a normal karyotype and stable telomeres; it neither proliferates when plated in soft agar nor gives rise to tumors when injected subcutaneously in NOD/SCID- (null) mice. The analysis of gene expression highlighted transcriptional traits of SVF cells. m17.ASCs were genetically modified by lentiviral vectors carrying green fluorescent protein (GFP) as a marker transgene and efficiently engrafted in the liver, when injected in the spleen of NOD/SCID- (null) monocrotaline-treated mice. These results suggest that this non-tumorigenic spontaneously immortalized ASC line may represent a useful tool (cell model) for studying the differentiation mechanisms involved in tissue repair as well as a model for pharmacological/toxicological studies.
C1 [Zamperone, Andrea; Pietronave, Stefano; Merlin, Simone; Colangelo, Donato; Ranaldo, Gabriella; Follenzi, Antonia; Prat, Maria] Univ Piemonte Orientale, Dipartimento Sci Salute, I-28100 Novara, Italy.
   [Medico, Enzo] Inst Canc Res Candiolo, Candiolo, Italy.
   [Medico, Enzo] Univ Turin, Dipartimento Oncol, Turin, Italy.
   [Di Scipio, Federica; Berta, Giovanni Nicolao] Univ Turin, Dipartimento Sci Clin & Biol, Turin, Italy.
   [Follenzi, Antonia; Prat, Maria] Ctr Biotecnol Ric Med Appl BRMA, Novara, Italy.
RP Prat, M (reprint author), Univ Piemonte Orientale, Dipartimento Sci Salute, Via Solaroli 17, I-28100 Novara, Italy.
EM mprat@med.unipmn.it
RI Berta, Giovanni/D-4418-2018
OI Berta, Giovanni/0000-0002-3263-9349; Merlin, Simone/0000-0001-5209-3921;
   Follenzi, Antonia/0000-0001-9780-300X; Medico, Enzo/0000-0002-3917-2438;
   Colangelo, Donato/0000-0003-2277-3226
FU Cariplo Foundation [2008-2459]; Regione Piemonte (Ricerca sanitaria
   finalizzata grant) [2008-2981]; PRIN; Telethon [GGP09280]
FX The authors are grateful to Andrea Sprio for helpful discussion, to
   Daniela Cantarella for technical assistance with gene expressing
   profile, and to Roberto Serra for helping in editing this article. This
   work was supported by Cariplo Foundation (grant 2008-2459), Regione
   Piemonte (Ricerca sanitaria finalizzata grant 2008-2981) to M. P. and
   PRIN 2008, and Telethon GGP09280 to A.F.
CR Asakawa N, 2010, BIOMATERIALS, V31, P3903, DOI 10.1016/j.biomaterials.2010.01.105
   Boklan J, 2002, CANCER RES, V62, P2104
   Callicott RJ, 2006, COMPARATIVE MED, V56, P17
   Casalbore P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004434
   Chen BY, 2012, CURR DRUG TARGETS, V13, P561, DOI 10.2174/138945012799499749
   Choi JS, 2012, TISSUE ENG PT A, V18, P80, DOI 10.1089/ten.tea.2011.0103
   Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083
   Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748
   Forte G, 2011, STEM CELLS, V29, P2051, DOI 10.1002/stem.763
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gimble JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt19
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Helder MN, 2007, TISSUE ENG, V13, P1799, DOI 10.1089/ten.2006.0165
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37
   Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665
   Li HB, 2012, TISSUE ENG PT A, V18, P1760, DOI [10.1089/ten.tea.2011.0424, 10.1089/ten.TEA.2011.0424]
   Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7
   Liu TM, 2007, STEM CELLS, V25, P750, DOI 10.1634/stemcells.2006-0394
   Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]
   Merlin S, 2009, CANCER SCI, V100, P633, DOI 10.1111/j.1349-7006.2008.01079.x
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246
   Neofytou EA, 2011, J BIOMED MATER RES A, V98A, P383, DOI 10.1002/jbm.a.33113
   Ning HX, 2009, DIFFERENTIATION, V77, P172, DOI 10.1016/j.diff.2008.09.019
   Ogushi Y, 2012, J TISSUE ENG REGEN M, DOI 101002/term1480
   Pagliari S, 2011, ADV MATER, V23, P514, DOI 10.1002/adma.201003479
   Pazdro R, 2013, PLOS ONE, V8
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qin YR, 2009, CLONING STEM CELLS, V11, P445, DOI 10.1089/clo.2009.0006
   Roche R, 2007, EXPERT OPIN BIOL TH, V7, P791, DOI 10.1517/14712598.7.6.791
   Rodrigues AI, 2012, ACTA BIOMATER, V8, P3765, DOI 10.1016/j.actbio.2012.05.025
   Santo VE, 2012, J CONTROL RELEASE, V162, P19, DOI 10.1016/j.jconrel.2012.06.001
   Saulnier N, 2011, CYTOTHERAPY, V13, P329, DOI 10.3109/14653249.2010.515576
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Sekine H, 2012, CELL TISSUE RES, V347, P775, DOI 10.1007/s00441-011-1267-6
   Shi JG, 2012, J BIOMED MATER RES A, V100A, P2612, DOI 10.1002/jbm.a.34182
   Shi Z., 2012, J TISSUE ENG REGEN M
   Sprio AE, 2012, STEM CELLS DEV, DOI 101089/scd20120141
   Thi MM, 2010, AM J PHYSIOL-CELL PH, V299, P994
   Toyoda M, 2009, CELL BIOCHEM FUNCT, V27, P440, DOI 10.1002/cbf.1591
   von Figura G, 2009, J MOL MED-JMM, V87, P1165, DOI 10.1007/s00109-009-0509-5
   Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058
   Yamakawa K, 2003, J RHEUMATOL, V30, P1032
   Yamaoka E, 2011, INT J ONCOL, V39, P5, DOI 10.3892/ijo.2011.1029
   Yuan HF, 2012, J MOL MED, V90, P389, DOI 10.1007/s00109-011-0825-4
   Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589
   1972, J HERED, V63, P69
NR 55
TC 11
Z9 11
U1 1
U2 22
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1547-3287
EI 1557-8534
J9 STEM CELLS DEV
JI Stem Cells Dev.
PD NOV 1
PY 2013
VL 22
IS 21
BP 2873
EP 2884
DI 10.1089/scd.2012.0718
PG 12
WC Cell & Tissue Engineering; Hematology; Medicine, Research &
   Experimental; Transplantation
SC Cell Biology; Hematology; Research & Experimental Medicine;
   Transplantation
GA 234JN
UT WOS:000325639500006
PM 23777308
OA Green Published
DA 2018-10-20
ER

PT J
AU Villa, MM
   Wang, LP
   Huang, JP
   Rowe, DW
   Wei, M
AF Villa, Max M.
   Wang, Liping
   Huang, Jianping
   Rowe, David W.
   Wei, Mei
TI Visualizing Osteogenesis In Vivo Within a Cell-Scaffold Construct for
   Bone Tissue Engineering Using Two-Photon Microscopy
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID 2ND-HARMONIC GENERATION; PROGENITOR CELLS; REGENERATION; COLLAGEN; STEM;
   MARROW; TRAFFICKING; IDENTIFY; MATRIX; IMAGES
AB Tissue-engineering therapies have shown early success in the clinic, however, the cell-biomaterial interactions that result in successful outcomes are not yet well understood and are difficult to observe. Here we describe a method for visualizing bone formation within a tissue-engineered construct in vivo, at a single-cell resolution, and in situ in three dimensions using two-photon microscopy. First, two-photon microscopy and histological perspectives were spatially linked using fluorescent reporters for cells in the skeletal lineage. In the process, the tissue microenvironment that precedes a repair-focused study was described. The distribution and organization of type I collagen in the calvarial microenvironment was also described using its second harmonic signal. Second, this platform was used to observe in vivo, for the first time, host cells, donor cells, scaffold, and new bone formation within cell-seeded constructs in a bone defect. We examined constructs during bone repair 4 and 6 weeks after implantation. New bone formed on scaffolds, primarily by donor cells. Host cells formed a new periosteal layer that covered the implant. Scaffold resorption appeared to be site specific, where areas near the top were removed and deeper areas were completely embedded in new mineral. Visualizing the in vivo progression of the cell and scaffold microenvironment will contribute to our understanding of tissue-engineered regeneration and should lead to the development of more streamlined and therapeutically powerful approaches.
C1 [Villa, Max M.; Wei, Mei] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Wang, Liping; Huang, Jianping; Rowe, David W.] Univ Connecticut, Sch Dent Med, Ctr Regenerat Med & Skeletal Dev, Dept Reconstruct Sci,Hlth Ctr, Farmington, CT 06032 USA.
RP Wei, M (reprint author), Univ Connecticut, Dept Mat Sci & Engn, 97 North Eagleville Rd,Unit 3136, Storrs, CT 06269 USA.
EM meiwei@engr.uconn.edu
FU GAANN predoctoral fellowship from the Department of Education
   [P200A09315]; NIH [1R21AR059962-01A1]
FX The authors would like to thank Dr. Xi Jiang, Ms. Li Chen, Dr. Mark
   Kronenberg, Dr. Kamal Khanna, and Dr. Peter Maye for their technical
   expertise and helpful discussions. This work was supported by a GAANN
   predoctoral fellowship from the Department of Education (P200A09315) and
   the NIH (1R21AR059962-01A1).
CR Aaron Jean E, 2012, Front Endocrinol (Lausanne), V3, P98, DOI 10.3389/fendo.2012.00098
   Aghaloo T, 2010, J ORAL MAXIL SURG, V68, P300, DOI 10.1016/j.joms.2009.03.066
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Beckman M, 2003, SCIENCE, V300, P76, DOI 10.1126/science.300.5616.76
   Blitterswijk C. V., 2008, TISSUE ENG
   Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935
   Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013
   Celli S, 2011, NAT MED, V17, P744, DOI 10.1038/nm.2376
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hickman HD, 2009, CELL HOST MICROBE, V5, P13, DOI 10.1016/j.chom.2008.12.007
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89
   Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15
   Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2
   Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023
   Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291
   Li WJ, 2012, J CLIN INVEST, V122, P2499, DOI 10.1172/JCI62970
   Lo Celso C, 2011, NAT PROTOC, V6, P1, DOI 10.1038/nprot.2010.168
   Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Martini J, 2006, PROC SPIE, V6089, DOI 10.1117/12.641430
   Mostany R., 2008, J VIS EXP, V12
   Muschler GF, 2010, TISSUE ENG PART B-RE, V16, P123, DOI [10.1089/ten.teb.2009.0658, 10.1089/ten.TEB.2009.0658]
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445
   Prasad P. N., 1991, INTRO NONLINEAR OPTI
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmid B., 2010, SOFTWARE HIGH LEVEL
   Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043
   Seung HS, 2011, NATURE, V471, P170, DOI 10.1038/471170a
   Tang JY, 2012, P NATL ACAD SCI USA, V109, P8434, DOI 10.1073/pnas.1119590109
   Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107
   Vogel G, 2011, SCIENCE, V333, P1088, DOI 10.1126/science.333.6046.1088
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Xu XY, 2010, MOL THER, V18, P835, DOI 10.1038/mt.2010.3
   Yin DZ, 2009, MOL THER, V17, P1967, DOI 10.1038/mt.2009.151
   Yu XH, 2013, J TISSUE ENG REGEN M, V7, P974, DOI 10.1002/term.1490
   Yu XH, 2012, J MATER CHEM, V22, P9721, DOI 10.1039/c2jm30332a
   Zinselmeyer BH, 2009, METHOD ENZYMOL, V461, P349, DOI 10.1016/S0076-6879(09)05416-0
NR 48
TC 16
Z9 16
U1 0
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD NOV 1
PY 2013
VL 19
IS 11
BP 839
EP 849
DI 10.1089/ten.tec.2012.0490
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 234JJ
UT WOS:000325639100003
PM 23641794
OA Green Published
DA 2018-10-20
ER

PT J
AU Altmann, B
   Kohal, RJ
   Steinberg, T
   Tomakidi, P
   Bachle-Haas, M
   Wennerberg, A
   Att, W
AF Altmann, Brigitte
   Kohal, Ralf-Joachim
   Steinberg, Thorsten
   Tomakidi, Pascal
   Baechle-Haas, Maria
   Wennerberg, Ann
   Att, Wael
TI Distinct Cell Functions of Osteoblasts on UV-Functionalized Titanium-
   and Zirconia-Based Implant Materials Are Modulated by Surface Topography
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID BONE APPOSITION; ALVEOLAR BONE; DIFFERENTIATION; HYDROPHILICITY;
   ROUGHNESS; MG63; GLUCOCORTICOIDS; MINERALIZATION; INTEGRATION;
   BIOACTIVITY
AB Though recent studies report decisive positive effects on cells, elicited by ultraviolet (UV)-induced bioactivation of biomaterial implant surfaces, they frequently employ cells other than of human origin or cells not representing oral implant targets. Therefore, the present study aims at exploring distinct cell functions of primary human alveolar bone osteoblasts (PHABO) in response to bioactivated microstructured titanium and zirconia implant surfaces with matched controls. UV-treatment significantly reduced surface carbon, while concomitantly increasing wettability. In case of titanium or zirconia biomaterial source of equal roughness, bioactivation did not significantly improve cell functions, including initial cell attachment, morphogenesis, proliferation, and gene expression of osteogenic biomarkers osteocalcin, alkaline phosphatase and collagen type I. However, cell functions discriminated surface roughness by either comparing titanium and zirconia or interindividual zirconia surfaces. While rough surfaces primarily favored primary adhesion, proliferation appeared improved on smooth surfaces, and gene expression seemed to be stronger modulated on the smoothest biomaterial. Our results show for the first time that bioactivation appears to be not the main causative for the observed modulation of the distinct cell functions analyzed in PHABO, but add to the body of evidence that they were more governed by surface architecture rather than by bioactivation.
C1 [Altmann, Brigitte; Kohal, Ralf-Joachim; Baechle-Haas, Maria; Att, Wael] Univ Med Ctr Freiburg, Dent Sch & Hosp, Dept Prosthodont, D-79106 Freiburg, Germany.
   [Steinberg, Thorsten; Tomakidi, Pascal] Univ Med Ctr Freiburg, Dent Sch & Hosp, Dept Oral Biotechnol, D-79106 Freiburg, Germany.
   [Wennerberg, Ann] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.
RP Altmann, B (reprint author), Univ Med Ctr Freiburg, Dent Sch & Hosp, Dept Prosthodont, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM brigitte.altmann@uniklinik-freiburg.de
OI Kohal, Ralf/0000-0001-7095-4190
FU SIC implant system''SIC invent AG'' Basel, CH-Switzerland''
   [ZVK20090511a]
FX We thank Dr. Mifsud for performing contact angle measurements. TiUnite
   and ZircaPore disks were provided by Nobel Biocare and Metoxit,
   respectively. For her work, Brigitte Altmann was supported by a grant
   from SIC implant system''SIC invent AG'' Basel, CH-Switzerland''
   received by Ralf Kohal (ID# ZVK20090511a).
CR Aita H, 2009, ACTA BIOMATER, V5, P3247, DOI 10.1016/j.actbio.2009.04.022
   Altmann B, 2011, BIOMATERIALS, V32, P8947, DOI 10.1016/j.biomaterials.2011.08.023
   Att W, 2009, BIOMATERIALS, V30, P4268, DOI 10.1016/j.biomaterials.2009.04.048
   Att W, 2009, BIOMATERIALS, V30, P1273, DOI 10.1016/j.biomaterials.2008.11.024
   Brammer KS, 2011, ACTA BIOMATER, V7, P2697, DOI 10.1016/j.actbio.2011.02.039
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Eijken M, 2006, MOL CELL ENDOCRINOL, V248, P87, DOI 10.1016/j.mce.2005.11.034
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Glauser Roland, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P47, DOI 10.1111/j.1708-8208.2003.tb00015.x
   Hayashi M, 2012, ACTA BIOMATER, V8, P2411, DOI 10.1016/j.actbio.2012.03.010
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim MJ, 2006, J BIOMED MATER RES A, V79A, P1023, DOI 10.1002/jbm.a.31040
   Lazzara RJ, 1999, INT J PERIODONT REST, V19, P117
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   Marin C, 2008, J PERIODONTOL, V79, P1942, DOI [10.1902/jop.2008.080106, 10.1902/jop.2008.080106 ]
   Matsubara T, 2005, J BONE MINER RES, V20, P399, DOI 10.1359/JBMR.041117
   Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020
   Mustafa K, 2000, CLIN ORAL IMPLAN RES, V11, P116, DOI 10.1034/j.1600-0501.2000.011002116.x
   Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4
   Ostman Par-Olov, 2010, Clin Implant Dent Relat Res, V12 Suppl 1, pe47, DOI 10.1111/j.1708-8208.2009.00166.x
   Passeri G, 2010, CLIN ORAL IMPLAN RES, V21, P756, DOI 10.1111/j.1600-0501.2009.01906.x
   Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Rausch-fan XH, 2008, DENT MATER, V24, P102, DOI 10.1016/j.dental.2007.03.001
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x
   SAYAMA K, 1993, J PHYS CHEM-US, V97, P531, DOI 10.1021/j100105a001
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Smith E, 2000, J BIOL CHEM, V275, P19992, DOI 10.1074/jbc.M001758200
   Sodek J, 2000, PERIODONTOL 2000, V24, P99, DOI 10.1034/j.1600-0757.2000.2240106.x
   Torricelli P, 2003, ARTIF CELL BLOOD SUB, V31, P263, DOI 10.1081/BIO-120023157
   Vandrovcova M, 2012, J BIOMED MATER RES A, V100A, P1016, DOI 10.1002/jbm.a.34047
   Wang GC, 2011, COLLOID SURFACE B, V86, P267, DOI 10.1016/j.colsurfb.2011.04.006
   Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
   Zubkov T, 2005, J PHYS CHEM B, V109, P15454, DOI 10.1021/jp058101c
NR 43
TC 17
Z9 17
U1 2
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD NOV 1
PY 2013
VL 19
IS 11
BP 850
EP 863
DI 10.1089/ten.tec.2012.0695
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 234JJ
UT WOS:000325639100004
PM 23581275
DA 2018-10-20
ER

PT J
AU Shuman, JA
   Zurcher, JR
   Sapp, AA
   Burdick, JA
   Gorman, RC
   Gorman, JH
   Goldsmith, EC
   Spinale, FG
AF Shuman, James A.
   Zurcher, Jonathan R.
   Sapp, Ashley A.
   Burdick, Jason A.
   Gorman, Robert C.
   Gorman, Joseph H., III
   Goldsmith, Edie C.
   Spinale, Francis G.
TI Localized targeting of biomaterials following myocardial infarction: A
   foundation to build on
SO TRENDS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
ID FINITE-ELEMENT MODEL; LEFT-VENTRICULAR FUNCTION; CARDIAC-FUNCTION;
   IN-VIVO; MYOFIBROBLAST DIFFERENTIATION; POSTMYOCARDIAL INFARCTION;
   INJECTABLE HYDROGEL; FIBRIN SCAFFOLD; HEART-FAILURE; GENE-TRANSFER
AB Acute coronary syndromes can give rise to myocardial injury infarction (MI), which in turn promulgates a series of cellular and extracellular events that result in left ventricular (LV) dilation and dysfunction. Localized strategies focused upon interrupting this inexorable process include delivery of bioactive molecules and stem cell derivatives. These localized treatment strategies are often delivered in a biomaterial complex in order to facilitate elution of the bioactive molecules or stem cell engraftment. However, these biomaterials can impart significant and independent effects upon the MI remodeling process. In addition, significant changes in local cell and interstitial biology within the targeted MI region can occur following injection of certain biomaterials, which may hold important considerations when using these materials as matrices for adjuvant drug/cell therapies. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Shuman, James A.; Zurcher, Jonathan R.; Sapp, Ashley A.; Goldsmith, Edie C.; Spinale, Francis G.] Univ S Carolina, Sch Med, Cardiovasc Translat Res Ctr, Columbia, SC 29208 USA.
   [Spinale, Francis G.] WJB Dorn Veteran Affairs Med Ctr, Columbia, SC USA.
   [Burdick, Jason A.; Gorman, Robert C.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Gorman, Joseph H., III] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA.
RP Spinale, FG (reprint author), Univ S Carolina, Sch Med, Cardiovasc Translat Res Ctr, 6439 Gamers Ferry Rd, Columbia, SC 29208 USA.
EM cvctrc@uscmed.sc.edu
FU National Institute of Health [HL057952, HL089944, HL095608, HL111090];
   Veterans Affairs Health Administration
FX This work was supported by the National Institute of Health grants
   HL057952, HL089944, HL095608, HL111090, and a Merit Award from the
   Veterans Affairs Health Administration. The authors wish to acknowledge
   Craig P. Novack for his assistance during manuscript preparation.
CR Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Chachques JC, 2007, CELL TRANSPLANT, V16, P927, DOI 10.3727/096368907783338217
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dang ABC, 2005, AM J PHYSIOL-HEART C, V288, pH1844, DOI 10.1152/ajpheart.00961.2003
   Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077
   DARBY I, 1990, LAB INVEST, V63, P21
   Dixon JA, 2011, CIRCULATION, V124, pS35, DOI 10.1161/CIRCULATIONAHA.111.035774
   Dixon JA, 2011, ANNU REV PHYSIOL, V73, P47, DOI 10.1146/annurev-physiol-012110-142230
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Dvir T, 2011, NANO LETT, V11, P4411, DOI 10.1021/nl2025882
   Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011
   Frangogiannis NG, 2000, CARDIOVASC RES, V48, P89, DOI 10.1016/S0008-6363(00)00158-9
   Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007
   Frangogiannis NG, 2006, ANTIOXID REDOX SIGN, V8, P1907, DOI 10.1089/ars.2006.8.1907
   Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Giraud M.N., 2012, CARDIOLOGY RES PRACT
   Gorman RC, 2011, J CARDIOVASC TRANSL, V4, P73, DOI 10.1007/s12265-010-9244-0
   Guccione JM, 2001, ANN THORAC SURG, V71, P654, DOI 10.1016/S0003-4975(00)02338-9
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hatam N, 2011, EUR J CARDIO-THORAC, V39, P335, DOI 10.1016/j.ejcts.2010.06.016
   Holladay CA, 2012, BIOMATERIALS, V33, P1303, DOI 10.1016/j.biomaterials.2011.10.019
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Jain PK, 2008, ACCOUNTS CHEM RES, V41, P1578, DOI 10.1021/ar7002804
   Jaroszewski DE, 2009, ANN THORAC SURG, V88, P112, DOI 10.1016/j.athoracsur.2009.04.006
   Kang K, 2012, J AM COLL CARDIOL, V60, P2237, DOI 10.1016/j.jacc.2012.08.985
   Kim J, 2010, J BIOMED MATER RES A, V95A, P673, DOI 10.1002/jbm.a.32884
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee RJ, 2012, CELL TRANSPLANT, P28
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   LoneStar Heart Inc., 2011, RAND CONTR STUD EV A
   Macarthur Jr JW, 2013, J THORACIC CARDIOVAS, V145, P278
   Morita M, 2011, ANN THORAC SURG, V92, P617, DOI 10.1016/j.athoracsur.2011.04.051
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268
   Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Papiashvilli M, 2011, HEART LUNG CIRC, V20, P220, DOI 10.1016/j.hlc.2010.11.003
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   Poobalarahi F, 2006, AM J PHYSIOL-HEART C, V291, pH2924, DOI 10.1152/ajpheart.00153.2006
   Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Santiago JJ, 2010, DEV DYNAM, V239, P1573, DOI 10.1002/dvdy.22280
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Sisco PN, 2008, NANO LETT, V8, P3409, DOI 10.1021/nl802142h
   Solis J, 2010, CIRC-CARDIOVASC INTE, V3, P499, DOI 10.1161/CIRCINTERVENTIONS.109.850255
   Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809
   Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007
   Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Tous E, 2012, ACTA BIOMATER, V8, P3218, DOI 10.1016/j.actbio.2012.05.027
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Vale PR, 1999, J AM COLL CARDIOL, V34, P246, DOI 10.1016/S0735-1097(99)00143-6
   Vale PR, 2001, CIRCULATION, V103, P2138
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang J, 2003, AM J PHYSIOL-HEART C, V285, pH1871, DOI 10.1152/ajpheart.00387.2003
   Webber MJ, 2012, BIOMATERIALS, V33, P6823, DOI 10.1016/j.biomaterials.2012.06.003
   Weir RAP, 2006, AM J CARDIOL, V97, p13F, DOI 10.1016/j.amjcard.2006.03.005
   Wenk JF, 2011, ANN THORAC SURG, V92, P935, DOI 10.1016/j.athoracsur.2011.04.089
   Widgerow AD, 2011, WOUND REPAIR REGEN, V19, P117, DOI 10.1111/j.1524-475X.2010.00662.x
   Wilson CG, 2009, BIOMATERIALS, V30, P5639, DOI 10.1016/j.biomaterials.2009.07.011
   Wilson CG, 2009, J MATER CHEM, V19, P6332, DOI 10.1039/b902760b
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Yeh YC, 2010, BIOMATERIALS, V31, P6444, DOI 10.1016/j.biomaterials.2010.04.069
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
NR 77
TC 4
Z9 4
U1 0
U2 31
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1050-1738
J9 TRENDS CARDIOVAS MED
JI Trends Cardiovasc. Med.
PD NOV
PY 2013
VL 23
IS 8
BP 301
EP 311
DI 10.1016/j.tcm.2013.04.004
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 236YG
UT WOS:000325834800005
PM 23746937
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Degidi, M
   Daprile, G
   Nardi, D
   Piattelli, A
AF Degidi, Marco
   Daprile, Giuseppe
   Nardi, Diego
   Piattelli, Adriano
TI Buccal bone plate in immediately placed and restored implant with
   Bio-Oss (R) collagen graft: a 1-year follow-up study
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; extraction socket; immediate loading; immediate placement;
   ridge dimension
ID FRESH EXTRACTION SOCKETS; BEAM COMPUTED-TOMOGRAPHY; ANTERIOR MAXILLA;
   DOG; PRESERVATION; 6-MONTH; HARD
AB ObjectivesThe aim of this study was to radiographically assess the vertical and horizontal alterations of buccal alveolar bone after the insertion of a post-extractive implant using Bio-Oss((R)) Collagen graft.
   Material and methodsThe study was designed as a prospective study. Adult patients were eligible for the study if they needed one or more immediately inserted and immediately restored implant replacing teeth to be extracted within region 15-25. After the insertion, the buccal gap was carefully grafted using Bio-Oss((R)) Collagen and the implant immediately restored. Cone-Beam Computed Tomography (CBCT) was performed immediately after surgery and a series of measurements were made to determine the dimension of the buccal bone plate and the void between implant and extraction socket. A second CBCT was taken and the measurements repeated after 12months.
   ResultsAltogether, 69 patients were included in the study; a total of 69 implants were inserted. The study demonstrated that the extraction of a tooth and the immediate insertion of an implant together with an xenograft resulted in alterations of the vertical and horizontal dimension of the buccal bone plate (respectively, 25.6% and 29.3%). Nevertheless, the vertical and horizontal gap reduction was nearly complete (respectively, 99.3% and 99.1%) and the implant was normally in contact with buccal bone.
   ConclusionsImplant placement into extraction sockets can result in favorable radiological results even in the presence of evident alterations of the buccal bone wall.
C1 [Piattelli, Adriano] Univ G dAnnunzio, Dept Oral Pathol, Sch Dent, Chieti, Italy.
RP Piattelli, A (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
EM apiattelli@unich.it
OI Nardi, Diego/0000-0002-1590-3865
CR Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P1, DOI 10.1111/j.1600-0501.2010.01920.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Botticelli D, 2006, CLIN ORAL IMPLAN RES, V17, P351, DOI 10.1111/j.1600-0501.2006.01270.x
   Cosyn J, 2011, J CLIN PERIODONTOL, V38, P746, DOI 10.1111/j.1600-051X.2011.01748.x
   Covani U, 2004, J PERIODONTOL, V75, P982, DOI 10.1902/jop.2004.75.7.982
   Covani U, 2007, J PERIODONTOL, V78, P810, DOI 10.1902/jop.2007.060254
   Degidi M, 2008, CLIN ORAL IMPLAN RES, V19, P276, DOI 10.1111/j.1600-0501.2007.01449.x
   Degidi M, 2012, IMPLANT DENT, V21, P62, DOI 10.1097/ID.0b013e31823fce9f
   Degidi M, 2011, J PERIODONTOL, V82, P708, DOI 10.1902/jop.2010.100450
   Evian CI, 2004, INT J ORAL MAX IMPL, V19, P393
   Ferrus J, 2010, CLIN ORAL IMPLAN RES, V21, P22, DOI 10.1111/j.1600-0501.2009.01825.x
   Hsu K. M., 2010, CLIN IMPLANT DENT R, DOI 10.1111/j.1708-8208.2010.00316.x
   Januario AL, 2011, CLIN ORAL IMPLAN RES, V22, P1168, DOI 10.1111/j.1600-0501.2010.02086.x
   Miyamoto Y, 2011, INT J PERIODONT REST, V31, P215
   Novaes Jr A. B., 2011, J ORAL IMPLANTOLOGY, DOI 10.1563/AAID-JOI-D-10-00176
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Quirynen M, 2007, INT J ORAL MAX IMPL, V22, P203
   Sanz M, 2010, CLIN ORAL IMPLAN RES, V21, P13, DOI 10.1111/j.1600-0501.2009.01824.x
   SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968
NR 22
TC 16
Z9 16
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD NOV
PY 2013
VL 24
IS 11
BP 1201
EP 1205
DI 10.1111/j.1600-0501.2012.02561.x
PG 5
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 230RB
UT WOS:000325358800004
PM 22882574
DA 2018-10-20
ER

PT J
AU Huang, R
   Lu, SM
   Han, Y
AF Huang, Run
   Lu, Shemin
   Han, Yong
TI Role of grain size in the regulation of osteoblast response to
   Ti-25Nb-3Mo-3Zr-2Sn alloy
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Ti-25Nb-3Mo-3Zr-2Sn alloy; Surface mechanical attrition treatment;
   Hydrophilicity; Grain size; Osteoblast response
ID AUSTENITIC STAINLESS-STEEL; CELLULAR-RESPONSE; GENE-EXPRESSION;
   NANOPHASE CERAMICS; MODIFIED TITANIUM; BONE-FORMATION; SURFACE-LAYER;
   IN-VITRO; ADHESION; DIFFERENTIATION
AB Nano- and ultrafine-grained beta-Ti layers were fabricated on Ti-25Nb-3Mo-3Zr-2Sn alloy by surface mechanical attrition treatment (SMAT). After being ground and polished, the two layers exhibited the same chemical composition, similar surface roughness and topography features to the coarse-grained surface, however, higher hardness values were exhibited on the ultrafine- and nano-grained surfaces, especially on nano-grained surface compared to coarse-grained surface. Hydrophilicity test, evaluated by measuring water contact angles, showed that the nano-grained surface was much more hydrophilic than the ultrafine- and coarse-grained surfaces. The adsorption of total protein and anchoring proteins such as vitronectin and fibronectin on the different surfaces from DMEM medium containing 10% fetal bovine serum was also examined. Employing hFOB1.19 cells, the behaviors of osteoblasts on the three kinds of grain-scaled surfaces, including adhesion, proliferation and differentiation, were evaluated by examining the morphology, the number of adherent cells, actin cytoskeleton reorganization, vinculin signals, expressions of steogenesis-related genes, alkaline phosphatase activity, contents of intracellular specific proteins and collagen type I, extracellular collagen secretion as well as matrix mineralization. The significant enhancements of osteoblast adhesion, proliferation, maturation and mineralization are exhibited on the nano-grained surface, while little improvements are found on the ultrafine-grained surface compared to the conventional coarse-grained surface. The differences in the cellular response to the three kinds of grain-scaled surfaces are related to grain size and degree of hydrophilicity. The improved cell functions together with mechanical properties make SMAT-processed nanograined beta-Ti a promising biomaterial for surgical implants. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Huang, Run; Han, Yong] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
   [Lu, Shemin] Xi An Jiao Tong Univ, Coll Med, Dept Genet & Mol Biol, Xian 710061, Peoples R China.
RP Han, Y (reprint author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
EM yonghan@mail.xjtu.edu.cn
RI Lu, Shemin/M-3350-2018
OI Lu, Shemin/0000-0001-8250-850X
FU National Basic Research Program (973 Program) of China [2012CB619103];
   National Natural Science Foundation of China [51071120]
FX We appreciate the National Basic Research Program (973 Program) of China
   (Grant Number 2012CB619103), and National Natural Science Foundation of
   China (Grant Number 51071120) for financially supporting this work.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Balasundaram G, 2007, MACROMOL BIOSCI, V7, P635, DOI 10.1002/mabi.200600270
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Challa VSA, 2013, J BIOMED MATER RES A, V101, P2083, DOI 10.1002/jbm.a.34492
   Cheng Y T, 2005, APPL PHYS LETT, V86, DOI DOI 10.1063/1.1895487
   Faghihi S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/48/485703
   Faghihi S, 2007, BIOMATERIALS, V28, P3887, DOI 10.1016/j.biomaterials.2007.05.010
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu J, 2012, BIOMATERIALS, V33, P5036, DOI 10.1016/j.biomaterials.2012.03.050
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Lu K, 2004, MAT SCI ENG A-STRUCT, V375, P38, DOI 10.1016/j.msea.2003.10.261
   Martines E, 2005, NANO LETT, V5, P2097, DOI [10.1021/nl051435t, 10.1021/nt051435t]
   Misra RDK, 2013, ACTA BIOMATER, V9, P6245, DOI 10.1016/j.actbio.2012.12.003
   Misra RDK, 2013, J BIOMED MATER RES A, V101, P1, DOI 10.1002/jbm.a.34105
   Misra RDK, 2010, ACTA BIOMATER, V6, P3339, DOI 10.1016/j.actbio.2010.01.034
   Misra RDK, 2009, ACTA BIOMATER, V5, P1455, DOI 10.1016/j.actbio.2008.12.017
   Misra RDK, 2009, ADV MATER, V21, P1280, DOI 10.1002/adma.200802478
   Misra RDK, 2009, ADV ENG MATER, V11, pB235, DOI 10.1002/adem.200900164
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pei J, 2011, BIOMATERIALS, V32, P8968, DOI 10.1016/j.biomaterials.2011.08.034
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Sugita Y, 2011, BIOMATERIALS, V32, P8374, DOI 10.1016/j.biomaterials.2011.07.077
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Venkatsurya PKC, 2010, MAT SCI ENG C-MATER, V30, P1050, DOI 10.1016/j.msec.2010.05.008
   Viereck V, 2002, J CELL BIOCHEM, V86, P348, DOI 10.1002/jcb.10220
   Wang CY, 2004, BIOMATERIALS, V25, P2949, DOI 10.1016/j.biomaterials.2003.09.088
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2005, BIOMATERIALS, V26, P953, DOI 10.1016/j.biomaterials.0204.03.040
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wu X, 2002, ACTA MATER, V50, P2075, DOI 10.1016/S1359-6454(02)00051-4
   Yu ZT, 2006, MAT SCI ENG A-STRUCT, V438, P391, DOI 10.1016/j.msea.2005.12.079
   Zhao CL, 2011, J NANOPART RES, V13, P645, DOI 10.1007/s11051-010-0061-9
NR 42
TC 33
Z9 36
U1 2
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 1
PY 2013
VL 111
BP 232
EP 241
DI 10.1016/j.colsurfb.2013.06.007
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 224OM
UT WOS:000324897900029
PM 23831591
DA 2018-10-20
ER

PT J
AU Weber, T
   Bechthold, M
   Winkler, T
   Dauselt, J
   Terfort, A
AF Weber, Theresa
   Bechthold, Maren
   Winkler, Tobias
   Dauselt, John
   Terfort, Andreas
TI Direct grafting of anti-fouling polyglycerol layers to steel and other
   technically relevant materials
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Antifouling surface; Protein adsorption; Surface grafting; Hydrogel;
   Dendrimer
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; POLY(ETHYLENE GLYCOL)S;
   BIOMATERIAL SURFACES; DIETHYLENE GLYCOL; RESISTANCE; POLYMERIZATION;
   OXIDE; GOLD; AUTOXIDATION
AB Direct grafting of hyperbranched polyglycerol (PG) layers onto the oxide surfaces of steel, aluminum, and silicon has been achieved through surface-initiated polymerization of 2-hydroxymethyloxirane (glycidol). Optimization of the deposition conditions led to a protocol that employed N-methyl-2-pyrrolidone (NMP) as the solvent and temperatures of 100 and 140 degrees C, depending on the substrate material. In all cases, a linear growth of the PG layers could be attained, which allows for control of film thickness by altering the reaction time. At layer thicknesses >5 nm, the PG layers completely suppressed the adhesion of albumin, fibrinogen, and globulin. These layers were also at least 90% bio-repulsive for two bacteria strains, E. coli and Acinetobacter baylyi, with further improvement being observed when the PG film thickness was increased to 17 nm (up to 99.9% bio-repulsivity on silicon). (C) 2013 Elsevier B.V. All rights reserved.
C1 [Weber, Theresa; Bechthold, Maren; Dauselt, John; Terfort, Andreas] Goethe Univ Frankfurt, Inst Inorgan & Analyt Chem, D-60438 Frankfurt, Germany.
   [Winkler, Tobias] Univ Hamburg, Inst Inorgan & Analyt Chem, D-20146 Hamburg, Germany.
RP Terfort, A (reprint author), Goethe Univ Frankfurt, Inst Inorgan & Analyt Chem, Max von Laue Str 7, D-60438 Frankfurt, Germany.
EM aterfort@chemie.uni-frankfurt.de
RI Fachbereich14, Dekanat/C-8553-2015
FU German Science Foundation (DFG) [TE 247/9-2]
FX This work was supported by the German Science Foundation (DFG) within
   the project TE 247/9-2. We thank Prof. Dr. B. Averhoff for permitting us
   to work with the Acinetobacter strain and Dr. A. Schnurr for
   proof-reading this manuscript.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Boulares-Pender A, 2011, J APPL POLYM SCI, V121, P2543, DOI 10.1002/app.33971
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   CROUZET C, 1976, MAKROMOL CHEM, V177, P145
   Deng L, 1996, J AM CHEM SOC, V118, P5136, DOI 10.1021/ja960461d
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   Feng W, 2006, BIOINTERPHASES, V1, P50, DOI 10.1116/1.2187495
   Frey H., 2002, REV MOL BIOTECHNOL, V90, P257, DOI DOI 10.1016/S1389-0352(01)00063-0
   GERHARDT W, 1985, Z CHEM, V25, P143
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GORDIENOK NI, 1986, J APPL CHEM-USSR+, V59, P1441
   HAMBURGER R, 1975, PHARM ACTA HELV, V50, P10
   Hartmann M, 2010, CHEM COMMUN, V46, P330, DOI 10.1039/b922525k
   Jeyachandran YL, 2013, J PHYS CHEM C, V117, P5824, DOI 10.1021/jp4000285
   Jeyachandran YL, 2012, J PHYS CHEM C, V116, P9019, DOI 10.1021/jp300436n
   Kainthan RK, 2006, BIOMACROMOLECULES, V7, P703, DOI 10.1021/bm0504882
   Karakoti AS, 2011, ANGEW CHEM INT EDIT, V50, P1980, DOI 10.1002/anie.201002969
   Khan M, 2003, MACROMOLECULES, V36, P5088, DOI 10.1021/ma0340762
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Ma H, 2003, EUR CELLS MAT SESSIO, V6, P16
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   Metzke M, 2003, J AM CHEM SOC, V125, P7760, DOI 10.1021/ja0349507
   Obermeier B, 2011, ANGEW CHEM INT EDIT, V50, P7988, DOI 10.1002/anie.201100027
   Oh SK, 2005, LANGMUIR, V21, P10209, DOI 10.1021/la050524i
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   SANDLER SR, 1966, J POLYM SCI A1, V4, P1253, DOI 10.1002/pol.1966.150040523
   Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la0347531
   Siegers C, 2004, CHEM-EUR J, V10, P2831, DOI 10.1002/chem.200306073
   Smith EA, 2003, J AM CHEM SOC, V125, P6140, DOI 10.1021/ja034165u
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   Talarico T, 1998, BIOCHEM BIOPH RES CO, V250, P354, DOI 10.1006/bbrc.1998.9312
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Unsworth LD, 2008, LANGMUIR, V24, P1924, DOI 10.1021/la702310t
   VANDENBERG EJ, 1985, J POLYM SCI POL CHEM, V23, P915, DOI 10.1002/pol.1985.170230401
   Vladkova T.J, 2007, U CHEM TECH METALLUR, V42, P239
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang GJ, 2009, ADV FUNCT MATER, V19, P2768, DOI 10.1002/adfm.200900402
   Wang L, 2009, ADV FUNCT MATER, V19, P2615, DOI 10.1002/adfm.200801689
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   Weber T, 2012, LANGMUIR, V28, P15916, DOI 10.1021/la303541h
   Weinhart M, 2011, ADV ENG MATER, V13, pB501, DOI 10.1002/adem.201180012
   West SL, 2004, BIOMATERIALS, V25, P1195, DOI 10.1016/j.biomaterials.2003.08.010
   Wyszogrodzka M, 2009, BIOMACROMOLECULES, V10, P1043, DOI 10.1021/bm801093t
   Yeh PYJ, 2008, LANGMUIR, V24, P4907, DOI 10.1021/la702867t
   Zdyrko B, 2011, MACROMOL RAPID COMM, V32, P859, DOI 10.1002/marc.201100162
   Zhang Z, 2006, J PHYS CHEM B, V110, P10799, DOI 10.1021/jp057266i
   Zhang Z, 2009, LANGMUIR, V25, P13516, DOI 10.1021/la901957k
   Zhou L, 2010, LANGMUIR, V26, P11217, DOI 10.1021/la100556p
   Zill A, 2011, CHEM COMMUN, V47, P1279, DOI 10.1039/c0cc04096g
NR 53
TC 19
Z9 19
U1 1
U2 81
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 1
PY 2013
VL 111
BP 360
EP 366
DI 10.1016/j.colsurfb.2013.05.026
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 224OM
UT WOS:000324897900047
PM 23856542
DA 2018-10-20
ER

PT J
AU Leitao, AF
   Gupta, S
   Silva, JP
   Reviakine, I
   Gama, M
AF Leitao, Alexandre F.
   Gupta, Swati
   Silva, Joao Pedro
   Reviakine, Ilya
   Gama, Miguel
TI Hemocompatibility study of a bacterial cellulose/polyvinyl alcohol
   nanocomposite
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Bacterial cellulose; Biocompatibility; Biomaterials; Polyvinyl alcohol;
   Platelets; Hemocompatibility
ID PLATELET-ADHESION; BLOOD COMPATIBILITY; IN-VITRO; FACTOR-XII; CELLULOSE;
   ACTIVATION; SURFACES; COAGULATION; ADSORPTION; CONTACT
AB Bacterial cellulose (BC) has been suggested to be a suitable biomaterial for the development of cardiovascular grafts. The combination of BC with polyvinyl alcohol (PVA) results in nanocomposites with improved properties. Surprisingly, there are very few studies on the BC blood interaction. This is the focus of this paper. We present the first thorough assessment of the hemocompatibility of the BC/PVA nanocomposite. Whole blood clotting time, plasma recalcification, Factor XII activation, platelet adhesion and activation, hemolytic index and complement activation are all determined. The platelet activation profiles on BC and BC/PVA surfaces are comprehensively characterized. BC and BC/PVA outperformed ePTFE - used as a point of comparison thus evidencing their suitability for cardiovascular applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Leitao, Alexandre F.; Silva, Joao Pedro; Gama, Miguel] Univ Minho, Dept Biol Engn, IBB Inst Biotechnol & Bioengn, CEB Ctr Biol Engn, P-4710057 Braga, Portugal.
   [Gupta, Swati; Reviakine, Ilya] Ctr Cooperat Res Biomat CIC biomaGUNE, San Sebastian 20009, Gipuzkoa, Spain.
   [Gupta, Swati] Univ Basque Country, Dept Biochem & Mol Biol, Leioa 48940, Spain.
   [Reviakine, Ilya] Univ Basque Country, Bilbao Int Sch Engn, Bilbao 48013, Spain.
RP Gama, M (reprint author), Univ Minho, Dept Biol Engn, Campus Gualtar, P-4710057 Braga, Portugal.
EM afleitao@deb.uminho.pt; sgupta@cicbiomagune.es; jpsilva@deb.uminho.pt;
   ireviakine@cicbiomagune.es; fmgama@deb.uminho.pt
RI Gama, Miguel/I-3140-2015; Silva, Joao/E-8444-2012; Reviakine,
   Ilya/B-2631-2013; biomaGUNE, CIC/J-9136-2014
OI Gama, Miguel/0000-0002-5655-0015; Silva, Joao/0000-0002-5656-0897;
   Reviakine, Ilya/0000-0002-3448-5072; biomaGUNE, CIC/0000-0001-7690-0660;
   Leitao, Alexandre Felipe/0000-0002-5764-104X
FU FCT [PTDC/EBB-EBI/112170/2009, SFRH/BD/66094/2009]; COST-Short Term
   Mission [COST-STSM-TD1003-8978]; Department of Industry of the Basque
   Government program ETORTEK; Spanish Ministry of Science and Innovation
   [CTQ2009-11245]
FX Funding for this work was made possible by the FCT funding through the
   project PTDC/EBB-EBI/112170/2009, FCT PhD grant (SFRH/BD/66094/2009) and
   COST-Short Term Mission (COST-STSM-TD1003-8978). Additionally, funding
   from the Department of Industry of the Basque Government program ETORTEK
   and from the Spanish Ministry of Science and Innovation (basic research
   grant CTQ2009-11245 to IR) are also gratefully acknowledged.
CR Aldenhoff Yvette B. J., 2003, European Cells & Materials, V5, P61
   Alvarez OM, 2004, WOUNDS, V16, P224
   Andrade FK, 2010, J BIOMED MATER RES A, V92A, P9, DOI 10.1002/jbm.a.32284
   Andrade F.K, 2010, BACTERIAL CELLULOSE
   Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   Andrade FK, 2010, ACTA BIOMATER, V6, P4034, DOI 10.1016/j.actbio.2010.04.023
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2010, MATER SCI ENG, V31, P14
   Chen XY, 2007, ANAL BIOANAL CHEM, V388, P65, DOI 10.1007/s00216-006-0999-8
   Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230
   Chulpac J, 2009, BACAKOV PHYSL RES, V58, pS119
   Colman RW, 1997, BLOOD, V90, P3819
   EKDAHL KN, 1993, J COLLOID INTERF SCI, V158, P121, DOI 10.1006/jcis.1993.1236
   Fink H, 2011, ACTA BIOMATER, V6, P1130
   Fink H, 2011, J BIOMED MATER RES A, V97A, P52, DOI 10.1002/jbm.a.33031
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Gemmell CH, 2001, J BIOMAT SCI-POLYM E, V12, P933, DOI 10.1163/156856201753113114
   Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001
   GOODMAN SL, 1993, J BIOMED MATER RES, V27, P683, DOI 10.1002/jbm.820270516
   Gupta S, 2012, BIOINTERPHASES, V7, P24
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   He Q, 2011, BIOMATER APPL J, P29
   Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045
   Jennings LK, 2009, THROMB HAEMOSTASIS, V102, P248, DOI 10.1160/TH09-03-0192
   Jin G, 2011, CHEM RES CHINESE U, V27, P1078
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Leitao AF, 2013, MATERIALS, V6, P1956, DOI 10.3390/ma6051956
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Mori Y, 1997, J MATER SCI, V32, P491, DOI 10.1023/A:1018586307534
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100
   Nurdin N., 2003, European Cells & Materials, V5, P17
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Schopka S, 2010, MATERIALS, V3, P638, DOI 10.3390/ma3010638
   SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107
   SHATTIL SJ, 1987, BLOOD, V70, P307
   Smith BS, 2010, J BIOMED MATER RES A, V95A, P350, DOI 10.1002/jbm.a.32853
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Stewart L, 1985, STEWART DL
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   van der Zijpp Y. J., 2003, Archives of Physiology and Biochemistry, V111, P415, DOI 10.3109/13813450312331342274
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   Wang SW, 2009, J BIOMAT SCI-POLYM E, V20, P619, DOI 10.1163/156856209X426439
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 49
TC 31
Z9 31
U1 2
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 1
PY 2013
VL 111
BP 493
EP 502
DI 10.1016/j.colsurfb.2013.06.031
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 224OM
UT WOS:000324897900064
PM 23880088
DA 2018-10-20
ER

PT J
AU Amornsudthiwat, P
   Mongkolnavin, R
   Kanokpanont, S
   Panpranot, J
   Wong, CS
   Damrongsakkul, S
AF Amornsudthiwat, Phakdee
   Mongkolnavin, Rattachat
   Kanokpanont, Sorada
   Panpranot, Joongjai
   Wong, Chiow San
   Damrongsakkul, Siriporn
TI Improvement of early cell adhesion on Thai silk fibroin surface by low
   energy plasma
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Low energy plasma; Nitrogen glow discharge plasma; Thai silk fibroin;
   Early cell adhesion
ID RAY PHOTOELECTRON-SPECTROSCOPY; MESENCHYMAL STEM-CELLS; INDUCED ARGON
   PLASMA; PROTEIN ADSORPTION; IN-VITRO; GLOW-DISCHARGE; ARTICULAR
   CHONDROCYTES; INTEGRIN BINDING; FILM; BIOMATERIAL
AB Low energy plasma has been introduced to treat the surface of Thai silk fibroin which should be enhanced for cell adhesion due to its native hydrophobic surface. Plasma surface treatment could introduce desirable hydrophilic functionalities on the surface without using any chemicals. In this work, nitrogen glow discharge plasma was generated by a low energy AC50Hz power supply system. The plasma operating conditions were optimized to reach the highest nitrogen active species by using optical emission spectroscopy. X-ray photoelectron spectroscopy (XPS) revealed that amine, hydroxyl, ether, and carboxyl groups were induced on Thai silk fibroin surface after plasma treatment. The results on Fourier transform infrared attenuated total reflection (FTIR-ATR) spectroscopy confirmed that the plasma treated effects were only on the outermost layer since there was no change in the bulk chemistry. The surface topography was insignificantly changed from the detection with atomic force microscopy (AFM). The plasma-treated effects were the improved surface wettability and cell adhesion. After a 90-s treatment, the water contact angle was at 20 degrees, while the untreated surface was at 70 degrees. The early cell adhesion of L929 mouse fibroblast was accelerated. L929 cells only took 3 h to reach 100% cell adhesion on 90s N-2 plasma-treated surface, while there was less than 50% cell adhesion on the untreated Thai silk fibroin surface after 6 h of culture. The cell adhesion results were in agreement with the cytoskeleton development. L929 F-actin was more evident on 90s N-2 plasma-treated surface than others. It could be concluded that a lower energy AC50Hz plasma system enhanced early L929 mouse fibroblast adhesion on Thai silk fibroin surface without any significant change in surface topography and bulk chemistry. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Amornsudthiwat, Phakdee; Kanokpanont, Sorada; Panpranot, Joongjai; Damrongsakkul, Siriporn] Chulalongkorn Univ, Dept Chem Engn, Fac Engn, Bangkok 10330, Thailand.
   [Mongkolnavin, Rattachat] Chulalongkorn Univ, Fac Sci, Dept Phys, Bangkok 10330, Thailand.
   [Wong, Chiow San] Univ Malaya, Fac Sci, Dept Phys, Plasma Technol Res Ctr, Kuala Lumpur 50603, Malaysia.
   [Mongkolnavin, Rattachat; Damrongsakkul, Siriporn] Chulalongkorn Univ, Plasma Technol & Nucl Fus Res Unit, Bangkok 10330, Thailand.
RP Damrongsakkul, S (reprint author), Chulalongkorn Univ, Dept Chem Engn, Fac Engn, Phyathai Rd, Bangkok 10330, Thailand.
EM siriporn.d@chula.ac.th
RI Wong, C.S./C-1047-2010
OI Wong, C.S./0000-0002-7186-2578
FU Royal Golden Jubilee Ph.D. Program; Thailand Research Fund;
   Chulalongkorn University Centenary Academic Development Project the
   Research, Development, and Engineering (RD&E) fund through the National
   Science and Technology Development Agency (NSTDA), Thailand
   [P-11-00672]; University of Malaya [RP008A-13AFR]
FX The authors appreciate useful advice from Dr. Mirko Nitschke, Leibniz
   Institute of Polymer Research Dresden, and the utilization of cell
   culture facility through Asst. Prof. T. Bunaprasert, MD, at i-Tissue
   Laboratory, Faculty of Medicine, Chulalongkorn University. The financial
   supports from the Royal Golden Jubilee Ph.D. Program, Thailand Research
   Fund, Chulalongkorn University Centenary Academic Development Project
   the Research, Development, and Engineering (RD&E) fund through the
   National Science and Technology Development Agency (NSTDA), Thailand
   (Project No.P-11-00672) are acknowledged. CS.Wong is grateful to
   University of Malaya for support under grant RP008A-13AFR.
CR Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Baek HS, 2008, SURF COAT TECH, V202, P5794, DOI 10.1016/j.surfcoat.2008.06.154
   BARAK LS, 1980, P NATL ACAD SCI-BIOL, V77, P980, DOI 10.1073/pnas.77.2.980
   Browne MM, 2004, SURF SCI, V553, P155, DOI 10.1016/j.susc.2004.01.046
   Costa P, 2010, INT REV CEL MOL BIO, V283, P57, DOI 10.1016/S1937-6448(10)83002-3
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Garland A, 2012, PROG SURF SCI, V87, P1, DOI 10.1016/j.progsurf.2012.02.001
   Gogoi D, 2011, APPL SURF SCI, V258, P126, DOI 10.1016/j.apsusc.2011.08.018
   Gu JW, 2002, MAT SCI ENG C-BIO S, V20, P199, DOI 10.1016/S0928-4931(02)00033-4
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jedlicka SS, 2007, J PHYS CHEM B, V111, P11850, DOI 10.1021/jp0744230
   Jeong L, 2009, INT J BIOL MACROMOL, V44, P222, DOI 10.1016/j.ijbiomac.2008.12.008
   Jewett S, 2011, J PHYS CHEM C, V115, P14244, DOI 10.1021/jp203203x
   Jin SC, 2009, MACROMOL RES, V17, P703, DOI 10.1007/BF03218931
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Konig U, 2002, COLLOID SURFACE B, V25, P313, DOI 10.1016/S0927-7765(01)00333-2
   Kramida A., 2012, NIST ATOMIC SPECTRA
   Lee HU, 2008, APPL SURF SCI, V254, P5700, DOI 10.1016/j.apsusc.2008.03.049
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Meyer-Plath AA, 2003, VACUUM, V71, P391, DOI 10.1016/S0042-207X(02)00766-2
   Miyanaga S, 2010, THIN SOLID FILMS, V518, P3509, DOI 10.1016/j.tsf.2009.11.049
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mwale F, 2006, BIOMATERIALS, V27, P2258, DOI 10.1016/j.biomaterials.2005.11.006
   Pleul D., 2008, POLYM SURFACES INTER, P71
   Prasertsung I, 2012, J BIOMAT SCI-POLYM E, V23, P1485, DOI 10.1163/092050611X584900
   Prasertsung I, 2010, SURF COAT TECH, V205, pS133, DOI 10.1016/j.surfcoat.2010.06.063
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Rhodes NP, 2007, BIOMATERIALS, V28, P4561, DOI 10.1016/j.biomaterials.2007.07.008
   Speit G, 2008, MUTAT RES-GEN TOX EN, V649, P146, DOI 10.1016/j.mrgentox.2007.08.010
   Valdes TI, 2008, BIOMATERIALS, V29, P1356, DOI 10.1016/j.biomaterials.2007.11.035
   Vandencasteele N, 2010, J ELECTRON SPECTROSC, V178, P394, DOI 10.1016/j.elspec.2009.12.003
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Wan YQ, 2006, BIOMATERIALS, V27, P2699, DOI 10.1016/j.biomaterials.2005.12.007
   Wu YC, 2010, J BIOMAT SCI-POLYM E, V21, P563, DOI 10.1163/156856209X430227
   Zeiger E, 2005, MUTAT RES-REV MUTAT, V589, P136, DOI 10.1016/j.mrrev.2005.01.001
NR 44
TC 29
Z9 34
U1 0
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 1
PY 2013
VL 111
BP 579
EP 586
DI 10.1016/j.colsurfb.2013.07.009
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 224OM
UT WOS:000324897900076
PM 23893032
DA 2018-10-20
ER

PT J
AU Cervini-Silva, J
   Nieto-Camacho, A
   Palacios, E
   Montoya, JA
   Gomez-Vidales, V
   Ramirez-Apan, MT
AF Cervini-Silva, Javiera
   Nieto-Camacho, Antonio
   Palacios, Eduardo
   Ascencion Montoya, Jose
   Gomez-Vidales, Virginia
   Teresa Ramirez-Apan, Maria
TI Anti-inflammatory and anti-bacterial activity, and CYTOTOXICITY of
   halloysite surfaces
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Surface morphology; Time-dependent infiltration
ID DRUG-DELIVERY SYSTEM; CLAY NANOTUBES; NANOCOMPOSITES; RELEASE; AGENTS
AB Halloysite is a naturally-occurring nanomaterial occurring in the thousands of tons and that serves as biomaterial, with applications in the areas of biotechnology, pharmaceutical, and medical research. This study reports on the anti-inflammatory, cytotoxic, and anti-oxidant activity of halloysite Jarrahdale (collected at similar to 45 km SE of Perth, Western Australia; JA), Dragon Mine (provided by Natural Nano Inc., Rochester, New York; NA), and Kalgoorie Archean (collected at Siberia, similar to 85 km NW of Kalgoorlie, West Australia; PA). Prior to biological testing, halloysites were characterized by 27Al and 29Si Nuclear Magnetic Resonance Spectroscopy, the anti-inflammatory activity was determined by (a) the mouse ear edema method, using 12-o-tetradecanoylphorbol-13-acetate (TPA) as anti-inflammatory agent; and (b) the myeloperoxidase enzymatic activity method (MPO). Cell viability was determined using the MTT method. Sample characterization by NMR method showed similar symmetry and atomic environments, with no evidence of distortion(s) due to shiftings in atomic ordering or electron density. The anti-inflammatory activity followed the order: PA > JA > NA, and remained invariant with time. Prolonged anti-inflammatory activity related inversely to surface area and lumen space. The low extent of infiltration at shorter reaction times confirmed a limiting number of active surface sites. EPR intensity signals followed the order: JA > NA > PA. The poor stabilization of RO center dot species in PA suspensions was explained by tube alignment provoking occlusion, thus limiting transfer of H+ or e(-) from-and-to the surface, and decreases in acidity associated to Al-oct. Cell viability (%) varied from one surface to the other, PA(92.3 +/- 6.0), JA(84.9 +/- 7.8), and NA(78.0 +/- 5.6), but related directly to S-BET values. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Cervini-Silva, Javiera] Univ Autonoma Metropolitana, Dept Proc & Tecnol, Unidad Cuajimalpa, Mexico City 01120, DF, Mexico.
   [Cervini-Silva, Javiera] Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA USA.
   [Nieto-Camacho, Antonio; Gomez-Vidales, Virginia; Teresa Ramirez-Apan, Maria] Univ Nacl Autonoma Mexico, Inst Quim, Lab Pruebas Biol, Mexico City 04510, DF, Mexico.
   [Palacios, Eduardo; Ascencion Montoya, Jose] Inst Mexicano Petr, Direcc Invest & Posgrad, Mexico City, DF, Mexico.
RP Cervini-Silva, J (reprint author), Univ Autonoma Metropolitana, Dept Proc & Tecnol, Artificios 40,6C Piso, Mexico City 01120, DF, Mexico.
EM jcervini@correo.cua.uam.mx
FU Universidad Autonoma Metropolitana Unidad Cuajimalpa; Instituto Mexicano
   del Petroleo (Mexican Oil Institute)
FX This work would not possible without the kind generosity of John Keeling
   Geological Survey of South Australia, Jock Churchman (Soil and Land
   Systems, School of Earth and Environmental Sciences, The University of
   Adelaide, Australia) and Benny Theng (Landcare Research, Palmerston
   North 4442, New Zealand), who provided the halloysite samples, and
   Professor Rossman Giese (Department of Geology, Columbia University) for
   providing insightful discussions. The authors are most thankful to
   librarians Lic. Maria del Rocio Galindo Ortega and Ms. Maria Ines
   Escalante Vargas (UAM-Cuajimalpa) for technical assistance. This project
   was supported in part by Universidad Autonoma Metropolitana Unidad
   Cuajimalpa and Instituto Mexicano del Petroleo (Mexican Oil Institute).
CR Abdullayev E, 2010, J MATER CHEM, V20, P6681, DOI 10.1039/c0jm00810a
   BATES TF, 1959, AM MINERAL, V44, P78
   BATES TF, 1950, AM MINERAL, V35, P463
   CHURCHMAN GJ, 1989, CLAY MINER, V24, P579, DOI 10.1180/claymin.1989.024.4.02
   CHURCHMAN GJ, 1995, CLAY MINER, V30, P89, DOI 10.1180/claymin.1995.030.2.01
   Cornejo-Garrido H, 2012, APPL CLAY SCI, V57, P10, DOI 10.1016/j.clay.2011.12.001
   Deng SQ, 2008, POLYMER, V49, P5119, DOI 10.1016/j.polymer.2008.09.027
   DEYOUNG LM, 1989, AGENTS ACTIONS, V26, P335
   Du ML, 2008, POLYMER, V49, P4871, DOI 10.1016/j.polymer.2008.08.042
   Du ML, 2010, POLYM INT, V59, P574, DOI 10.1002/pi.2754
   Gates WP, 2002, CLAY CLAY MINER, V50, P223, DOI 10.1346/000986002760832829
   Guo BC, 2008, APPL SURF SCI, V255, P2715, DOI 10.1016/j.apsusc.2008.07.188
   Hendricks SB, 1938, AM MINERAL, V23, P295
   Hughes AD, 2010, LANGMUIR, V26, P12155, DOI 10.1021/la101179y
   Keeling J.L., 2011, P INT C MIN, P1
   Kelly HM, 2004, INT J PHARM, V274, P167, DOI 10.1016/j.ijpharm.2004.01.019
   Kibanova D, 2011, CHEMOSPHERE, V82, P418, DOI 10.1016/j.chemosphere.2010.09.069
   Kommireddy DS, 2006, BIOMATERIALS, V27, P4296, DOI 10.1016/j.biomaterials.2006.03.042
   Krainev A., 1996, J CHEM SOC PERK T, V2, P747, DOI [10.1039/P29960000747, DOI 10.1039/P29960000747]
   Levis SR, 2002, INT J PHARM, V243, P125, DOI 10.1016/S0378-5173(02)00274-0
   Liu MX, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455703
   Lvov YM, 2008, ACS NANO, V2, P814, DOI 10.1021/nn800259q
   Marney DCO, 2008, POLYM DEGRAD STABIL, V93, P1971, DOI 10.1016/j.polymdegradstab.2008.06.018
   MCCREA AF, 1990, GEODERMA, V47, P33, DOI 10.1016/0016-7061(90)90046-C
   Mei DD, 2011, SOL ENERG MAT SOL C, V95, P2772, DOI 10.1016/j.solmat.2011.05.024
   Mei DD, 2011, INT J ENERG RES, V35, P828, DOI 10.1002/er.1874
   Mosmann T.J., 1993, IMMUNOL METHODS, V65, P55
   Ning NY, 2007, POLYMER, V48, P7374, DOI 10.1016/j.polymer.2007.10.005
   Norrish K., 1995, CLAYS CONTROLLING EN, P275
   Oh Yah W., 2012, J AM CHEM SOC, V134, P1853
   Pasbakhsh P, 2013, APPL CLAY SCI, V74, P47, DOI 10.1016/j.clay.2012.06.014
   Price RR, 2001, J MICROENCAPSUL, V18, P713
   Shchukin DG, 2005, SMALL, V1, P510, DOI 10.1002/smll.200400120
   THENG BKG, 1982, CLAY CLAY MINER, V30, P143, DOI 10.1346/CCMN.1982.0300209
   Veerabadran NG, 2007, NANO, V2, P115, DOI 10.1142/S1793292007000441
   Vergaro V, 2010, BIOMACROMOLECULES, V11, P820, DOI 10.1021/bm9014446
   Viseras M.I., 2007, MICROPOR MESOPOR MAT, V108, P112
   Ye YP, 2007, POLYMER, V48, P6426, DOI 10.1016/j.polymer.2007.08.035
   Zhang X., 2008, CURR PROTOC IMMUNOL, V83, P1411
NR 39
TC 20
Z9 20
U1 2
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 1
PY 2013
VL 111
BP 651
EP 655
DI 10.1016/j.colsurfb.2013.06.056
PG 5
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 224OM
UT WOS:000324897900085
PM 23907053
DA 2018-10-20
ER

PT J
AU He, HY
   Wang, J
   Gao, Q
   Chang, MW
   Ren, ZH
   Zhang, XW
   Li, X
   Weng, WJ
   Han, GR
AF He, Haiyan
   Wang, Juan
   Gao, Qian
   Chang, Mingwei
   Ren, Zhaohui
   Zhang, Xiwen
   Li, Xiang
   Weng, Wenjian
   Han, Gaorong
TI Ag-silica composite nanotube with controlled wall structures for
   biomedical applications
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Ag-silica nanotube; Controlled wall-structure; Electrospinning;
   Antibacterial
ID SILVER NANOPARTICLES; DRUG-DELIVERY; ANTIBACTERIAL; NANOCOMPOSITE;
   IMMOBILIZATION; NANOFIBERS; CITRATE; SHELL; CORE
AB A range of Ag-silica composite nanotubes with tailored wall structures were successfully synthesized in situ by single-nozzle electrospinning. By increasing AgNO3 concentration, the wall structure of Ag-silica tubes changes from dense to porous, and eventually turns into a 'lace-like' structure. This is attributed to Ag ions doping into the Si-O-Si network of precursors, as illustrated in FTIR study. More importantly, Ag-silica composite nanotubes show robust antibacterial activity against both Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli microorganisms. Therefore, it is a breakthrough of the nanostructure biomaterial research for future medical applications that require strong antibacterial properties. (C) 2013 Elsevier B.V. All rights reserved.
C1 [He, Haiyan; Wang, Juan; Gao, Qian; Ren, Zhaohui; Zhang, Xiwen; Li, Xiang; Weng, Wenjian; Han, Gaorong] Zhejiang Univ, Dept Mat Sci & Engn, State Key Lab Silicon Mat, Hangzhou 310027, Zhejiang, Peoples R China.
   [Chang, Mingwei] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310027, Zhejiang, Peoples R China.
RP Li, X (reprint author), Zhejiang Univ, Dept Mat Sci & Engn, State Key Lab Silicon Mat, Hangzhou 310027, Zhejiang, Peoples R China.
EM xiang.li@zju.edu.cn
RI LI, Xiang/F-3717-2011
OI LI, Xiang/0000-0002-4675-5367; Chang, Ming-Wei/0000-0002-0137-8895
FU National Natural Science Foundation of China [51103128]; Research Fund
   for the Doctoral Program of Higher Education of China [20110101120014]
FX This work was funded by the National Natural Science Foundation of China
   (contract number 51103128), and Research Fund for the Doctoral Program
   of Higher Education of China (fund number 20110101120014).
CR Aguiar H, 2009, J NON-CRYST SOLIDS, V355, P475, DOI 10.1016/j.jnoncrysol.2009.01.010
   Akhavan O, 2009, CURR APPL PHYS, V9, P1381, DOI 10.1016/j.cap.2009.03.003
   Bian S.-W., 2009, CHEM COMMUN, V10, P1261
   Chen ZD, 2012, COLLOID SURFACE B, V95, P274, DOI 10.1016/j.colsurfb.2012.03.012
   Dai CL, 2009, BIOMATERIALS, V30, P5364, DOI 10.1016/j.biomaterials.2009.06.052
   Das MR, 2013, COLLOID SURFACE B, V105, P128, DOI 10.1016/j.colsurfb.2012.12.033
   De G, 1996, J NON-CRYST SOLIDS, V194, P225, DOI 10.1016/0022-3093(91)00511-F
   Ding SL, 2010, LANGMUIR, V26, P4572, DOI 10.1021/la904851r
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Egger S, 2009, APPL ENVIRON MICROB, V75, P2973, DOI 10.1128/AEM.01658-08
   Gu GX, 2011, J COLLOID INTERF SCI, V359, P327, DOI 10.1016/j.jcis.2011.04.002
   He HY, 2013, MATER LETT, V94, P100, DOI 10.1016/j.matlet.2012.12.032
   Jan JS, 2011, LANGMUIR, V27, P2834, DOI 10.1021/la103923c
   Jung JH, 2010, CHEM SOC REV, V39, P4286, DOI 10.1039/c002959a
   Kim YH, 2007, J PHYS CHEM C, V111, P3629, DOI 10.1021/jp068302w
   Lee CS, 2012, COLLOID SURFACE B, V91, P219, DOI 10.1016/j.colsurfb.2011.11.010
   Li D, 2004, NANO LETT, V4, P933, DOI 10.1021/nl049590f
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li XH, 2007, LANGMUIR, V23, P10920, DOI 10.1021/la701806f
   Liu YY, 2007, COLLOID SURFACE B, V58, P180, DOI 10.1016/j.colsurfb.2007.03.005
   Nischala K, 2011, COLLOID SURFACE B, V82, P203, DOI 10.1016/j.colsurfb.2010.08.039
   Primeau N, 1997, THIN SOLID FILMS, V310, P47, DOI 10.1016/S0040-6090(97)00340-4
   Sotiriou GA, 2012, LANGMUIR, V28, P15929, DOI 10.1021/la303370d
   Sotiriou GA, 2011, CHEM ENG J, V170, P547, DOI 10.1016/j.cej.2011.01.099
   Sousa CT, 2012, COLLOID SURFACE B, V94, P288, DOI 10.1016/j.colsurfb.2012.02.003
   Tejamaya M, 2012, ENVIRON SCI TECHNOL, V46, P7011, DOI 10.1021/es2038596
   Wang JX, 2006, MATER CHEM PHYS, V96, P90, DOI 10.1016/j.matchemphys.2005.06.045
   Wang JX, 2004, SCRIPTA MATER, V51, P1035, DOI 10.1016/j.scriptamat.2004.08.016
   Wang SJ, 2011, CHEM MATER, V23, P2466, DOI 10.1021/cm2003885
   Wang W, 2010, J MATER CHEM, V20, P9068, DOI 10.1039/c0jm02120b
   Yang H, 2012, J MATER CHEM, V22, P24132, DOI 10.1039/c2jm35621j
   Yang XF, 2011, J MATER CHEM, V21, P6122, DOI 10.1039/c0jm04516k
NR 32
TC 7
Z9 7
U1 1
U2 65
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 1
PY 2013
VL 111
BP 693
EP 698
DI 10.1016/j.colsurfb.2013.07.015
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 224OM
UT WOS:000324897900091
PM 23907057
DA 2018-10-20
ER

PT J
AU Kumar, A
   Ting, YP
AF Kumar, Amit
   Ting, Yen-Peng
TI Effect of sub-inhibitory antibacterial stress on bacterial surface
   properties and biofilm formation
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biofilm; Stress; Staphylococcus aureus; Pseudomonas aeruginosa; DLVO;
   AFM force spectroscopy
ID ATOMIC-FORCE MICROSCOPY; STAPHYLOCOCCUS-AUREUS; ADHESION; SPECTROSCOPY;
   BIOMATERIAL; EPIDERMIDIS; MECHANISMS
AB Sub-inhibitory concentrations of antibacterial compounds do not effectively interfere with bacterial growth and only impart stress on them. Bacteria may react to external stress by abandoning planktonic life and form biofilms as the latter life-form offers superior resistance. This study on the effect of norfloxacin on biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa found that biofilm formation is enhanced under sub-inhibitory stress. Studies have reported increase in biofilm formation under the influence of external stress. In addition, the physicochemical properties of bacteria (i.e. zeta potential and contact angle) in the presence of antibacterial compounds were determined and its effect on initial attachment of bacteria to surfaces was examined. Single cell AFM force spectroscopy measurements were carried out to model the detachment force once the transient attachment takes place. The results indicate that once bacteria breach the physiochemical free energy barrier and come in direct contact with a surface, specific molecular interactions occur and detachment demands more energy than physicochemical forces alone can explain, especially at relatively higher separation distances. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Kumar, Amit; Ting, Yen-Peng] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
RP Ting, YP (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, 4 Engn Dr 4, Singapore 117576, Singapore.
EM chetyp@nus.edu.sg
CR Agranovski V, 2003, J AEROSOL SCI, V34, P1711, DOI 10.1016/S0021-8502(03)00191-5
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c
   Bowen WR, 2002, BIOTECHNOL BIOENG, V79, P170, DOI 10.1002/bit.10321
   Brant JA, 2002, J MEMBRANE SCI, V203, P257, DOI 10.1016/S0376-7388(02)00014-5
   Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Funken H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046857
   Gotoh H, 2008, RES MICROBIOL, V159, P294, DOI 10.1016/j.resmic.2008.02.002
   Harimawan A, 2011, J COLLOID INTERF SCI, V364, P213, DOI 10.1016/j.jcis.2011.08.021
   Kang S, 2009, LANGMUIR, V25, P9656, DOI 10.1021/la902247w
   Kaplan JB, 2011, INT J ARTIF ORGANS, V34, P737, DOI 10.5301/ijao.5000027
   Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004
   Liu Y, 2005, BIOPHYS CHEM, V117, P39, DOI 10.1016/j.bpc.2005.04.015
   Mei L, 2009, LANGMUIR, V25, P6227, DOI 10.1021/la9000494
   O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x
   Oliveira R., 1997, UNDERSTANDING ADHESI
   Rodrigues DF, 2009, BIOFOULING, V25, P401, DOI 10.1080/08927010902833443
   Roostalu J., 2008, BMC MICROBIOL, V8, P1471
   Sala C., 2012, MED VET, V45, P141
   Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744
   Sheng XX, 2007, J COLLOID INTERF SCI, V310, P661, DOI 10.1016/j.jcis.2007.01.084
   van Loosdrecht M C, 1990, J Biomater Appl, V5, P91, DOI 10.1177/088532829000500202
   van Oss C. J., 2006, INTERFACIAL FORCES A
   VANDERMEI HC, 1987, J MICROBIOL METH, V6, P277, DOI 10.1016/0167-7012(87)90065-0
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   VANOSS CJ, 1993, COLLOID SURFACE A, V78, P1, DOI 10.1016/0927-7757(93)80308-2
NR 32
TC 17
Z9 18
U1 2
U2 51
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 1
PY 2013
VL 111
BP 747
EP 754
DI 10.1016/j.colsurfb.2013.07.011
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 224OM
UT WOS:000324897900099
PM 23934235
DA 2018-10-20
ER

PT J
AU Syamaladevi, RM
   Lu, XN
   Sablani, SS
   Insan, SK
   Adhikari, A
   Killinger, K
   Rasco, B
   Dhingra, A
   Bandyopadhyay, A
   Annapure, U
AF Syamaladevi, Roopesh M.
   Lu, Xiaonan
   Sablani, Shyam S.
   Insan, Sunil Kumar
   Adhikari, Achyut
   Killinger, Karen
   Rasco, Barbara
   Dhingra, Amit
   Bandyopadhyay, Amit
   Annapure, Uday
TI Inactivation of Escherichia coli Population on Fruit Surfaces Using
   Ultraviolet-C Light: Influence of Fruit Surface Characteristics
SO FOOD AND BIOPROCESS TECHNOLOGY
LA English
DT Article
DE Atomic force microscopy; FT-IR spectroscopy; Scanning electron
   microscopy; Surface disinfection; Surface morphology
ID TRANSFORM INFRARED-SPECTROSCOPY; STAINLESS-STEEL SURFACES;
   LISTERIA-MONOCYTOGENES; BIOMATERIAL SURFACES; SALMONELLA-ENTERICA;
   RAMAN-SPECTROSCOPY; PULSED-LIGHT; UV-LIGHT; WATER; IRRADIATION
AB Ultraviolet-C (UV-C 254 nm) light is a possible alternative for chemical disinfection of fresh fruits. However, studies on the influence of surface characteristics on the kinetics of UV-C inactivation of microorganisms on fruits are limited. In this study, UV-C inactivation of generic Escherichia coli (ATCC 23716), a nonpathogenic surrogate strain for E. coli O157:H7, was inoculated onto the skin surface intact pear, pear with surface wounds, and the skin surface of intact peach. Disc shaped (0.057 m diameter x 0.01 m height) fruit surface were exposed at room temperature to UV-C light ranging from 0 to 7.56 +/- 0.52 kJ/m2 and microbial inactivation kinetics was determined. Maximum reductions of 3.70 +/- 0.125 log CFU/g were achieved for E. coli on intact pear surfaces (P < 0.05), with lesser reduction on wounded pear (3.10 +/- 0.329 log CFU/g) and peach surfaces (2.91 +/- 0.284 log CFU/g) after 4 min UV-C exposure at 7.56 kJ/m2 UV. The Weibull scale factor (alpha) values of UV-C inactivation for E. coli on an intact pear surface was 0.001 +/- 0.0007 min (0.235 +/- 0.001 kJ/m2), wounded pear surface, 0.003 +/- 0.001 min (0.240 +/- 0.002 kJ/m2) and peach surface, 0.004 +/- 0.0004 (0.241 +/- 0.0008 kJ/m2). The time required for a 90 % reduction in E. coli cell numbers or the reliable life time (t R) calculated with the Weibull model for intact pear surfaces (0.019 +/- 0.009 min, 0.268 +/- 0.017 kJ/m2) was smaller than for wounded pear (0.062 +/- 0.013 min, 0.348 +/- 0.024 kJ/m2) and peach surfaces (0.074 +/- 0.012, 0.371 +/- 0.012 kJ/m(2)), suggesting that the wounds on pear surfaces and trichomes (100-1000 mu m) on peach surfaces helped to shield and protect microorganisms from UV-C radiation. There was likely a more uniform distribution of bacterial cells onto pear surfaces due to its smaller surface roughness, spreading coefficient, and hydrophobic nature compared to peach. Fourier transform infrared spectroscopy indicate that bacterial membrane damage (phospholipids, protein secondary structures, and polysaccharides) and changes to DNA/RNA in E. coli resulted from UV-C treatment. UV-C can reduce E. coli populations on fresh fruit surfaces, but the efficacy of UV treatment is dependent upon the morphological and surface properties of the fruit and surface integrity.
C1 [Syamaladevi, Roopesh M.; Sablani, Shyam S.; Insan, Sunil Kumar] Washington State Univ, Dept Biol Syst Engn, Pullman, WA 99164 USA.
   [Lu, Xiaonan; Adhikari, Achyut; Killinger, Karen; Rasco, Barbara] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA.
   [Dhingra, Amit] Washington State Univ, Dept Hort & Landscape Architecture, Pullman, WA 99164 USA.
   [Bandyopadhyay, Amit] Washington State Univ, Sch Mech & Mat Engn, Pullman, WA 99164 USA.
   [Annapure, Uday] Inst Chem Technol, Dept Food Engn & Technol, Bombay 400019, Maharashtra, India.
RP Sablani, SS (reprint author), Washington State Univ, Dept Biol Syst Engn, POB 646120, Pullman, WA 99164 USA.
EM ssablani@wsu.edu
RI Dhingra, Amit/E-7369-2010; Bandyopadhyay, Amit/A-7780-2012
OI Bandyopadhyay, Amit/0000-0003-0992-5387; Annapure,
   Uday/0000-0002-3420-5077
FU Pear Bureau Northwest
FX This research work was funded, in part, with a grant from Pear Bureau
   Northwest.
CR Al-Qadiri HM, 2008, J FOOD SCI, V73, pM54, DOI 10.1111/j.1750-3841.2007.00640.x
   Al-Qadiri HM, 2008, J AGR FOOD CHEM, V56, P8992, DOI 10.1021/jf801604p
   Allende A, 2003, FOOD RES INT, V36, P739, DOI 10.1016/S0963-9969(03)00054-1
   Araujo EA, 2010, FOOD BIOPROCESS TECH, V3, P321, DOI 10.1007/s11947-009-0290-z
   Bernard SA, 2011, ACTA BIOMATER, V7, P1902, DOI 10.1016/j.actbio.2011.01.004
   Beuchat LR, 1998, J FOOD PROTECT, V61, P1305, DOI 10.4315/0362-028X-61.10.1305
   Bialka KL, 2007, J FOOD SCI, V72, pM391, DOI 10.1111/j.1750-3841.2007.00517.x
   Bintsis T, 2000, J SCI FOOD AGR, V80, P637, DOI 10.1002/(SICI)1097-0010(20000501)80:6<637::AID-JSFA603>3.0.CO;2-1
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Burks GA, 2003, LANGMUIR, V19, P2366, DOI 10.1021/la026375a
   Choi WY, 2002, J FOOD SCI, V67, P2668, DOI 10.1111/j.1365-2621.2002.tb08796.x
   Chun H, 2009, MEAT SCI, V83, P599, DOI 10.1016/j.meatsci.2009.07.007
   Cia P, 2007, POSTHARVEST BIOL TEC, V43, P366, DOI 10.1016/j.postharvbio.2006.10.004
   Cunha LM, 1998, J FOOD ENG, V37, P175, DOI 10.1016/S0260-8774(98)00085-5
   Cutler Timothy D., 2011, Animal Health Research Reviews, V12, P15, DOI 10.1017/S1466252311000016
   Erkan M, 2001, ENVIRON EXP BOT, V45, P1, DOI 10.1016/S0098-8472(00)00073-3
   Fernandez V, 2011, PLANT PHYSIOL, V156, P2098, DOI 10.1104/pp.111.176305
   Geveke DJ, 2008, J FOOD ENG, V85, P215, DOI 10.1016/j.jfoodeng.2007.06.029
   Geveke DJ, 2008, FOOD BIOPROCESS TECH, V1, P201, DOI 10.1007/s11947-008-0070-1
   Gomez PL, 2010, J FOOD ENG, V98, P60, DOI 10.1016/j.jfoodeng.2009.12.008
   Gonzalez-Aguilar GA, 2001, INT J FOOD SCI TECH, V36, P767, DOI 10.1046/j.1365-2621.2001.00522.x
   Guerrero-Beltran JA, 2004, FOOD SCI TECHNOL INT, V10, P137, DOI 10.1177/1082013204044359
   Gurtler JB, 2010, INT J FOOD MICROBIOL, V139, P1, DOI 10.1016/j.ijfoodmicro.2010.02.023
   Hershko V, 1998, J FOOD SCI, V63, P317
   Jagger J., 1967, INTRO RES ULTRAVIOLE
   Jin T, 2008, J FOOD ENG, V84, P608, DOI 10.1016/j.jfoodeng.2007.06.026
   Kim C, 2012, J FOOD SCI, V77, pM206, DOI 10.1111/j.1750-3841.2011.02595.x
   Koutchma T, 2007, J ENVIRON ENG SCI, V6, P319, DOI 10.1139/S06-058
   Levy C, 2012, INT J FOOD MICROBIOL, V152, P168, DOI 10.1016/j.ijfoodmicro.2011.08.022
   Lin MS, 2004, J AGR FOOD CHEM, V52, P5769, DOI 10.1021/jf049354q
   Liu Q, 2012, J FOOD SCI, V77, pM86, DOI 10.1111/j.1750-3841.2011.02503.x
   Lu XN, 2011, APPL ENVIRON MICROB, V77, P5257, DOI 10.1128/AEM.02845-10
   Lu XN, 2011, ANAL CHEM, V83, P4137, DOI 10.1021/ac2001498
   Lu XN, 2011, FOOD BIOPROCESS TECH, V4, P919, DOI 10.1007/s11947-011-0516-8
   Lu XN, 2011, FOOD MICROBIOL, V28, P537, DOI 10.1016/j.fm.2010.11.002
   Lu XN, 2010, J AGR FOOD CHEM, V58, P4056, DOI 10.1021/jf9038502
   Machado LF, 2010, J FOOD ENG, V96, P520, DOI 10.1016/j.jfoodeng.2009.08.035
   Manzocco L, 2011, INNOV FOOD SCI EMERG, V12, P13, DOI 10.1016/j.ifset.2010.11.006
   McDonald KF, 2000, IEEE T PLASMA SCI, V28, P1581, DOI 10.1109/27.901237
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043
   Naumann D, 2001, APPL SPECTROSC REV, V36, P239, DOI 10.1081/ASR-100106157
   Novak J, 2008, FOOD SCI TECHNOL INT, V14, P437, DOI 10.1177/1082013208098815
   Odriozola-Serrano I, 2009, J FOOD SCI, V74, P184
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Otto C, 2011, FOOD ENG REV, V3, P171, DOI 10.1007/s12393-011-9038-4
   Ribeiro C, 2007, POSTHARVEST BIOL TEC, V44, P63, DOI 10.1016/j.postharvbio.2006.11.015
   Sapers GM, 2001, FOOD TECHNOL BIOTECH, V39, P305
   Schenk M, 2008, FOOD BIOPROCESS TECH, V1, P384, DOI 10.1007/s11947-007-0029-7
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Sommers CH, 2010, J FOOD SAFETY, V30, P470, DOI 10.1111/j.1745-4565.2010.00220.x
   van Boekel MAJS, 2002, INT J FOOD MICROBIOL, V74, P139, DOI 10.1016/S0168-1605(01)00742-5
   Velasquez P, 2011, FOOD BIOPHYS, V6, P349, DOI 10.1007/s11483-011-9209-0
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wong E, 1998, FOOD MICROBIOL, V15, P415, DOI 10.1006/fmic.1998.0185
   Woodling SE, 2005, J FOOD SCI, V70, pM345, DOI 10.1111/j.1365-2621.2005.tb11478.x
   Yang HS, 2005, LWT-FOOD SCI TECHNOL, V38, P571, DOI 10.1016/j.lwt.2004.09.007
   Yaun BR, 2003, J FOOD PROTECT, V66, P1071, DOI 10.4315/0362-028X-66.6.1071
   Yaun BR, 2004, INT J FOOD MICROBIOL, V90, P1, DOI 10.1016/S0168-1605(03)00158-2
   Yuk HG, 2009, FOOD CONTROL, V20, P847, DOI 10.1016/j.foodcont.2008.10.004
   Zisman W. A, 1964, ADV CHEM SER, P1
NR 61
TC 18
Z9 18
U1 3
U2 56
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1935-5130
J9 FOOD BIOPROCESS TECH
JI Food Bioprocess Technol.
PD NOV
PY 2013
VL 6
IS 11
BP 2959
EP 2973
DI 10.1007/s11947-012-0989-0
PG 15
WC Food Science & Technology
SC Food Science & Technology
GA 227JQ
UT WOS:000325109300002
DA 2018-10-20
ER

PT J
AU Araque-Monros, MC
   Gamboa-Martinez, TC
   Santos, LG
   Bernabe, SG
   Pradas, MM
   Estelles, JM
AF Araque-Monros, Maria C.
   Gamboa-Martinez, Tatiana C.
   Gil Santos, Luis
   Girones Bernabe, Sagrario
   Monleon Pradas, Manuel
   Mas Estelles, Jorge
TI New concept for a regenerative and resorbable prosthesis for tendon and
   ligament: Physicochemical and biological characterization of PLA-braided
   biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE prosthesis; tendon; ligament; resorbable; regenerative
ID ANTERIOR CRUCIATE LIGAMENT; MESENCHYMAL STEM-CELLS; MEDIAL COLLATERAL
   LIGAMENT; GROWTH-FACTOR; HYDROLYTIC DEGRADATION; ACHILLES-TENDON;
   MOLECULAR-WEIGHT; PATELLAR TENDON; GENE-TRANSFER; IN-VIVO
AB We present a concept for a new regenerative and resorbable prosthesis for tendon and ligament and characterize the physicomechanical and biological behavior of one of its components, a hollow braid made of poly-lactide acid (PLA) which is the load-bearing part of the prosthesis concept. The prosthesis consists of a braid, microparticles in its interior serving as cell carriers, and a surface non-adherent coating, all these parts being made of biodegradable materials. The PLA braid has a nonlinear convex stress-strain behavior with a Young modulus of 1370 +/- 90 MPa in the linear, stretched state, and after 12 months of hydrolytic degradation the modulus shows a reduction by a factor of four. Different disinfection methods were tested as to their efficiency in cleansing the braid and preparing it for cell culture. Fibroblasts of L929 line were grown on the PLA braid for 14 days, showing good adherence and proliferation. These studies validate the PLA braid for the intended purpose in the regenerative prosthesis concept. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3228-3237, 2013.
C1 [Araque-Monros, Maria C.; Gamboa-Martinez, Tatiana C.; Gil Santos, Luis; Monleon Pradas, Manuel; Mas Estelles, Jorge] Univ Politecn Valencia, Ctr Biomat & Ingn Tisular, Valencia 46022, Spain.
   [Araque-Monros, Maria C.; Monleon Pradas, Manuel] CIBER BBN, Valencia, Spain.
   [Gil Santos, Luis] CRRL, Valencia, Spain.
   [Gil Santos, Luis] Univ Catolica Valencia San Vicente Martir, Inst Univ Invest Enfermedades Musculoesquelet, Valencia, Spain.
   [Girones Bernabe, Sagrario] Asociac Invest Ind Text AITEX, Alicante, Spain.
RP Araque-Monros, MC (reprint author), Univ Politecn Valencia, Ctr Biomat & Ingn Tisular, Valencia 46022, Spain.
EM marmon@upvnet.upv.es
RI Mas-Estelles, Jorge/H-5331-2015
OI Mas-Estelles, Jorge/0000-0001-8446-6737; MONLEON PRADAS,
   MANUEL/0000-0001-6457-0414
FU AITEX (Valencia, Spain)
FX This work has been developed thanks to the financial support of AITEX
   (Valencia, Spain). JME thanks Drs. Isabel Pascual, Andres Pena, and
   their team from Hospital Clinico of Valencia for their fine work.
CR Altman Greg, 2002, FASEB Journal, V16, P270
   Araque Monros MC, Spain Patent, Patent No. [P201130913, 201130913]
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Chen J, 2008, EXP REV MED DEV, V6, P61
   CHU CC, 1981, J APPL POLYM SCI, V26, P1727, DOI 10.1002/app.1981.070260527
   Cooper JA, 2006, BIOMATERIALS, V27, P2747, DOI 10.1016/j.biomaterials.2005.12.013
   Costa MA, 2006, TISSUE ENG, V12, P1937, DOI 10.1089/ten.2006.12.1937
   Dahlgren LA, 2002, J ORTHOPAED RES, V20, P910, DOI 10.1016/S0736-0266(02)00009-8
   Daniel KL, 2007, J FOOT ANKLE SURG, V46, P451
   Deborah PL, 2003, BEST PRACT RES CLIN, V17, P529
   Deng D, 2009, BIOMATERIALS, V30, P6724, DOI 10.1016/j.biomaterials.2009.08.054
   Dominkus M, 2006, CLIN ORTHOP RELAT R, P328, DOI 10.1097/01.blo.0000229368.42738.b6
   Eijk FV, 2004, TISSUE ENG, V10, p[5, 6]
   Freeman JW, 2007, J BIOMECH, V40, P2029, DOI 10.1016/j.jbiomech.2006.09.025
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689
   HOOLEY CJ, 1980, J BIOMECH, V13, P521, DOI 10.1016/0021-9290(80)90345-0
   Huang DQ, 2006, J HAND SURG-AM, V31A, P693, DOI 10.1016/j.jhsa.2005.10.022
   Iannace S, 2001, POLYMER, V42, P3799, DOI 10.1016/S0032-3861(00)00744-8
   Jayankura M, 2003, J GENE MED, V5, P618, DOI 10.1002/jgm.389
   JOHNSON GA, 1994, J ORTHOPAED RES, V12, P796, DOI 10.1002/jor.1100120607
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P681, DOI 10.1089/ten.2006.12.681
   Kimura Y, 2008, TISSUE ENG PT C-METH, V14, P47, DOI 10.1089/tec.2007.0286
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Kuo Catherine K, 2010, Sports Med Arthrosc Rehabil Ther Technol, V2, P20, DOI 10.1186/1758-2555-2-20
   Kurtz CA, 1999, AM J SPORT MED, V27, P363, DOI 10.1177/03635465990270031701
   Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073
   Loo SCJ, 2006, ACTA BIOMATER, V2, P287, DOI 10.1016/j.actbio.2005.10.003
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Maganaris C. N., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P204
   Maganaris CN, 2000, J BIOMECH, V33, P1723, DOI 10.1016/S0021-9290(00)00130-5
   Maganaris CN, 2002, J BIOMECH, V35, P1639, DOI 10.1016/S0021-9290(02)00240-3
   Magnusson SP, 2001, J PHYSIOL-LONDON, V531, P277, DOI 10.1111/j.1469-7793.2001.0277j.x
   Miller MD, 2006, J ARTHROPLASTY, V21, P765, DOI 10.1016/j.arth.2005.07.021
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   Murray AW, 2004, KNEE, V11, P9, DOI 10.1016/S0968-0160(03)00076-0
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Quynh TM, 2007, EUR POLYM J, V43, P1779, DOI 10.1016/j.eurpolymj.2007.03.007
   Rees JS, 1997, BIOMATERIALS, V18, P995, DOI 10.1016/S0142-9612(97)00021-5
   Saha SK, 2006, POLYM DEGRAD STABIL, V91, P1665, DOI 10.1016/j.polymdegradstab.2005.12.009
   Seldes RM, 2006, ARTHROSCOPY, V22, P113, DOI 10.1016/j.arthro.2005.10.005
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Spindler KP, 2003, J ORTHOPAED RES, V21, P245, DOI 10.1016/S0736-0266(02)00145-6
   TSUJI H, 1995, POLYMER, V36, P2709, DOI 10.1016/0032-3861(95)93647-5
   Tsuji H, 2004, POLYM DEGRAD STABIL, V84, P515, DOI 10.1016/j.polymdegradstab.2004.01.010
   Vieira AC, 2009, J BIOMECH, V42, P2421, DOI 10.1016/j.jbiomech.2009.07.019
   Wei XL, 2008, CHINESE MED J-PEKING, V121, P1426
   Wren TAL, 2001, CLIN BIOMECH, V16, P245, DOI 10.1016/S0268-0033(00)00089-9
   Yuan XY, 2002, POLYM DEGRAD STABIL, V75, P45, DOI 10.1016/S0141-3910(01)00203-8
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 51
TC 1
Z9 1
U1 3
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2013
VL 101
IS 11
BP 3228
EP 3237
DI 10.1002/jbm.a.34633
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 224YN
UT WOS:000324929200018
PM 23554342
DA 2018-10-20
ER

PT J
AU Daghighi, S
   Sjollema, J
   van der Mei, HC
   Busscher, HJ
   Rochford, ETJ
AF Daghighi, Seyedmojtaba
   Sjollema, Jelmer
   van der Mei, Henny C.
   Busscher, Henk J.
   Rochford, Edward T. J.
TI Infection resistance of degradable versus non-degradable biomaterials:
   An assessment of the potential mechanisms
SO BIOMATERIALS
LA English
DT Article
DE Degradation; Foreign body response; Immune response; Infection
ID PROTECTS STAPHYLOCOCCUS-EPIDERMIDIS; VASCULAR CATHETER MATERIAL;
   ABDOMINAL-WALL DEFECTS; HERNIA REPAIR; IN-VITRO; INTESTINAL SUBMUCOSA;
   EXTRACELLULAR-MATRIX; BACTERIAL BIOFILMS; CLINICAL-EVIDENCE; DERMAL
   COLLAGEN
AB Extended life expectancy and medical development has led to an increased reliance on biomaterial implants and devices to support or restore human anatomy and function. However, the presence of an implanted biomaterial results in an increased susceptibility to infection. Due to the severity of the potential outcomes of biomaterial-associated infection, different strategies have been employed to reduce the infection risk. Interestingly, degradable biological materials demonstrate increased resistance to bacterial infection compared to non-degradable synthetic biomaterials. Current knowledge about the specific mechanisms of how degradable biological materials are afforded increased resistance to infection is limited. Therefore, in this paper a number of hypotheses to explain the decreased infection risk associated with the use of degradable versus non-degradable biomaterials are evaluated and discussed with reference to the present state of knowledge. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Daghighi, Seyedmojtaba; Sjollema, Jelmer; van der Mei, Henny C.; Busscher, Henk J.; Rochford, Edward T. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP Sjollema, J (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, WJ Kolff Inst, POB 196, NL-9700 AD Groningen, Netherlands.
EM j.sjollema@umcg.nl
FU Dutch Ministry of Economic Affairs
FX This research forms part of the Project P4.01 NANTICO of the research
   program of the BioMedical Materials Institute, co-funded by the Dutch
   Ministry of Economic Affairs.
CR Alpert B, 1996, J ORAL MAXIL SURG, V54, P618, DOI 10.1016/S0278-2391(96)90645-X
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Asarias JR, 2011, J INVEST SURG, V24, P87, DOI 10.3109/08941939.2010.548904
   Badylak SF, 2003, J BIOMED MATER RES B, V67B, P648, DOI 10.1002/jbm.b.10062
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   Breuing K, 2010, SURGERY, V148, P544, DOI 10.1016/j.surg.2010.01.008
   Brown Patricia, 2009, AORN J, V90, P513
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Busscher H.J., 2012, SCI TRANSL MED, V4
   Casey AL, 2008, LANCET INFECT DIS, V8, P763, DOI 10.1016/S1473-3099(08)70280-9
   CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9
   Daghighi S, 2012, ACTA BIOMATER, V8, P3991, DOI 10.1016/j.actbio.2012.07.017
   Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Di Vita G, 2006, AM J SURG, V191, P785, DOI 10.1016/j.amjsurg.2005.11.008
   Disa JJ, 1996, PLAST RECONSTR SURG, V97, P801, DOI 10.1097/00006534-199604000-00017
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Elieson M, 2012, TEX HEART I J, V39, P884
   Falagas ME, 2009, DRUGS, V69, P1351, DOI 10.2165/00003495-200969100-00005
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Gonda Elizabeth, 2007, J Invasive Cardiol, V19, pE307
   Gretzer C, 2003, BIOMATERIALS, V24, P2843, DOI 10.1016/S0142-9612(03)00097-8
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Harth KC, 2011, SURG ENDOSC, V25, P2224, DOI 10.1007/s00464-010-1534-8
   Hartmann K, 1997, BLOOD, V89, P2863
   Holtom PD, 2004, CLIN ORTHOP RELAT R, P18, DOI 10.1097/01.blo.0000143573.03645.b4
   Jehle K S, 2007, J Wound Care, V16, P36
   JENSEN ET, 1993, MICROB PATHOGENESIS, V15, P377, DOI 10.1006/mpat.1993.1087
   Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x
   Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992
   Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824
   Leid J.G., 2009, MICROBE MAGAZINE, V4, P66
   Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145
   Li BY, 2010, J ORTHOP RES, V28, P48, DOI 10.1002/jor.20939
   Marculescu CE, 2006, CLIN INFECT DIS, V42, P471, DOI 10.1086/499234
   Marosok R, 1996, J BIOMED MATER RES, V30, P245
   MELULENI GJ, 1995, J IMMUNOL, V155, P2029
   Menon NG, 2003, ANN PLAS SURG, V50, P523, DOI 10.1097/01.SAP.0000044252.76804.6B
   Milburn ML, 2008, SURG INFECT, V9, P433, DOI 10.1089/sur.2007.044
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Neut D, 2011, J ORTHOP RES, V29, P1654, DOI 10.1002/jor.21433
   Parker David M, 2006, Curr Surg, V63, P255, DOI 10.1016/j.cursur.2006.05.003
   Peppas G, 2010, AM SURGEON, V76, P1290
   Prabhakara R, 2011, INFECT IMMUN, V79, P5010, DOI 10.1128/IAI.05571-11
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Saettele T M, 2007, Hernia, V11, P279, DOI 10.1007/s10029-006-0186-z
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   SHERERTZ RJ, 1995, J BIOMED MATER RES, V29, P635, DOI 10.1002/jbm.820290511
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Taylor M, 1997, J BONE JOINT SURG BR, V79B, P181, DOI 10.1302/0301-620X.79B2.7461
   Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Trouw LA, 2011, IMMUNOL LETT, V138, P35, DOI 10.1016/j.imlet.2011.02.014
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   WARD PA, 1965, J EXP MED, V122, P327, DOI 10.1084/jem.122.2.327
   Wilson SK, 2012, J SEX MED, V9, P44, DOI 10.1111/j.1743-6109.2011.02428.x
   WONG L, 1991, PLAST RECONSTR SURG, V88, P395, DOI 10.1097/00006534-199109000-00003
   Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091
   Zheng F, 2007, NEUROUROL URODYNAM, V26, P280, DOI 10.1002/nau.20317
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 72
TC 33
Z9 34
U1 2
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2013
VL 34
IS 33
BP 8013
EP 8017
DI 10.1016/j.biomaterials.2013.07.044
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 222HB
UT WOS:000324720700001
PM 23915949
DA 2018-10-20
ER

PT J
AU Campoccia, D
   Montanaro, L
   Arciola, CR
AF Campoccia, Davide
   Montanaro, Lucio
   Arciola, Carla Renata
TI A review of the clinical implications of anti-infective biomaterials and
   infection-resistant surfaces
SO BIOMATERIALS
LA English
DT Review
DE Implant infections; Anti-infective biomaterials; Catheter-related
   infections; Orthopaedic prosthesis infections; Ocular prosthesis
   infections
ID IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS;
   INTRAUTERINE-CONTRACEPTIVE-DEVICE; STAPHYLOCOCCUS-AUREUS BACTEREMIA;
   VENTRICULAR ASSIST DEVICE; HIGH-WATER-CONTENT; PEG-PLGA GEL; IN-VITRO;
   ANTIBIOTIC-RESISTANCE; EXTERNAL FIXATION; CONTACT-LENSES
AB Infection is currently regarded as the most severe and devastating complication associated to the use of biomaterials. The important social, clinical and economic impacts of implant-related infections are promoting the efforts to obviate these severe diseases. In this context, the development of anti-infective biomaterials and of infection-resistant surfaces is being regarded as the main strategy to prevent the establishment of implant colonisation and biofilm formation by bacteria. In this review, the attention is focused on the biomaterial-associated infections, from which the need for anti-infective biomaterials originates. Biomaterial-associated infections differ markedly for epidemiology, aetiology and severity, depending mainly on the anatomic site, on the time of biomaterial application, and on the depth of the tissues harbouring the prosthesis. Here, the diversity and complexity of the different scenarios where medical devices are currently utilised are explored, providing an overview of the emblematic applicative fields and of the requirements for anti-infective biomaterials. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Campoccia, Davide; Montanaro, Lucio; Arciola, Carla Renata] Rizzoli Orthopaed Inst, Res Unit Implant Infect, I-40136 Bologna, Italy.
   [Montanaro, Lucio; Arciola, Carla Renata] Univ Bologna, Dept Expt Diagnost & Specialty Med, I-40126 Bologna, Italy.
RP Campoccia, D (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
FU 5 per mille
FX This work was supported by the "5 per mille" financial contribution for
   Health Research to the Rizzoli Orthopaedic Institute of Bologna, a quota
   assigned by the Scientific Director to the Research Unit on Implant
   Infections.
CR ALBREKTSSON T, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P365
   Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arciola CR, 2011, INT J ARTIF ORGANS, V34, P727, DOI 10.5301/IJAO.2011.8784
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   ARCIOLA CR, 1995, BIOMATERIALS, V16, P685, DOI 10.1016/0142-9612(95)99695-I
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   Attenello FJ, 2010, NEUROSURGERY, V66, P284, DOI 10.1227/01.NEU.0000363405.12584.4D
   Barraclough KA, 2009, EXPERT REV ANTI-INFE, V7, P1185, DOI [10.1586/eri.09.100, 10.1586/ERI.09.100]
   Berman SJ, 2004, CLIN INFECT DIS, V39, P1747, DOI 10.1086/424516
   Bibbo C, 2010, J FOOT ANKLE SURG, V49, P87, DOI 10.1053/j.jfas.2009.07.026
   Brabham WW, 2012, J CARDIOVASC ELECTR, V23, P382, DOI 10.1111/j.1540-8167.2011.02225.x
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2008, BIOMATERIALS, V29, P4108, DOI 10.1016/j.biomaterials.2008.07.006
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Carnpoccia D, 2009, J BIOMED MATER RES A, V88A, P664, DOI 10.1002/jbm.a.32090
   Cauda R, 2009, DRUGS, V69, P33, DOI 10.2165/11315520-000000000-00000
   Cavanagh HD, 2002, OPHTHALMOLOGY, V109, P1957, DOI 10.1016/S0161-6420(02)01278-2
   Chamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097
   Clark SL, 2004, AM J VET RES, V65, P752, DOI 10.2460/ajvr.2004.65.752
   CORRELL JT, 1947, SURG GYNECOL OBSTET, V85, P211
   Corware K, 2011, BIOMATERIALS, V32, P8029, DOI 10.1016/j.biomaterials.2011.07.021
   COURTBROWN CM, 1990, J BONE JOINT SURG BR, V72, P801
   Cugola L, 2000, ORTHOFIX EXTERNAL FIXATION IN TRAUMA AND ORTHOPAEDICS, P145
   Darouiche R, 2007, INT J ARTIF ORGANS, V30, P820
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   DeRose JJ, 1997, J AM COLL CARDIOL, V30, P1773, DOI 10.1016/S0735-1097(97)00396-3
   Ducharne G, 2013, ORTHOP TRAUMATOL-SUR, V99, P111, DOI 10.1016/j.otsr.2012.09.015
   Dutta D, 2012, MOL VIS, V18, P14
   Duvvuri S, 2005, J CONTROL RELEASE, V108, P282, DOI 10.1016/j.jconrel.2005.09.002
   Duvvuri S, 2007, J OCUL PHARMACOL TH, V23, P264, DOI 10.1089/jop.2006.132
   Erich Raspe Rudolf, 1785, BARON MTINCHHAUSENS
   FANG GD, 1993, ANN INTERN MED, V119, P560, DOI 10.7326/0003-4819-119-7_Part_1-199310010-00003
   FARLEY TMM, 1992, LANCET, V339, P785, DOI 10.1016/0140-6736(92)91904-M
   Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606
   Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598
   Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07
   Gandhi T, 2012, INFECT DIS CLIN N AM, V26, P57, DOI 10.1016/j.idc.2011.09.001
   GREEN SA, 1983, CLIN ORTHOP RELAT R, P109
   Guducu N, 2012, CLIN EXP OBSTET GYN, V39, P333
   GURALNICK WC, 1946, AM J ORTHOD ORAL SUR, V32, P792, DOI 10.1016/0096-6347(46)90041-5
   Hay SM, 1997, INJURY, V28, P437, DOI 10.1016/S0020-1383(97)00025-9
   Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482
   Jaber BL, 2005, KIDNEY INT, V67, P2508, DOI 10.1111/j.1523-1755.2005.00364.x
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   Jan EL, 2012, J CARDIOVASC ELECTR, V23, P375, DOI 10.1111/j.1540-8167.2011.02212.x
   Jonas L, 2002, ULTRASTRUCT PATHOL, V26, P323, DOI 10.1080/01913120290104601
   Jung RE, 2012, CLIN ORAL IMPLAN RES, V23, P2, DOI 10.1111/j.1600-0501.2012.02547.x
   Kaliterna V, 2011, J OBSTET GYNAECOL RE, V37, P1035, DOI 10.1111/j.1447-0756.2010.01480.x
   Karchmer AW, 2002, INFECT DIS CLIN N AM, V16, P477, DOI 10.1016/S0891-5520(01)00005-8
   Kleinberg TT, 2011, SURV OPHTHALMOL, V56, P300, DOI 10.1016/j.survophthal.2010.09.001
   Kofman KE, 2012, EUR J PLAST SURG, V35, P673, DOI 10.1007/s00238-011-0642-6
   Kumar PS, 2012, J CLIN PERIODONTOL, V39, P425, DOI 10.1111/j.1600-051X.2012.01856.x
   Lafrance JP, 2008, AM J KIDNEY DIS, V52, P982, DOI 10.1053/j.ajkd.2008.06.014
   Lavini F, 2000, ORTHOFIX EXTERNAL FIXATION IN TRAUMA AND ORTHOPAEDICS, P121
   Legeay G, 2006, INT J ARTIF ORGANS, V29, P453
   Letharby A, 2008, COCHRANE DB SYST REV, V4
   Lewis JS, 1909, ANN SURG, V50, P793, DOI 10.1097/00000658-190910000-00009
   Romero EL, 2010, ADV DRUG DELIVER REV, V62, P576, DOI 10.1016/j.addr.2009.11.025
   Timms Anna, 2012, Nurs Stand, V27, P50, DOI 10.7748/ns.27.1.50.s53
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Ly CN, 2006, CLIN EXP OPHTHALMOL, V34, P44, DOI 10.1111/j.1442-9071.2006.1143.x
   Machtei EE, 2012, J CLIN PERIODONTOL, V39, P1198, DOI 10.1111/jcpe.12006
   Matsuda K, 2012, IN J WOMENS HEALTH, V4, P527, DOI 10.2147/IJWH.S35573
   Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x
   Montanaro L, 2007, BIOMATERIALS, V28, P5155, DOI 10.1016/j.biomaterials.2007.08.003
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Morrison CS, 2009, BEST PRACT RES CL OB, V23, P263, DOI 10.1016/j.bpobgyn.2008.11.004
   Murdoch DR, 2001, CLIN INFECT DIS, V32, P647, DOI 10.1086/318704
   Nicolle LE, 2012, INFECT DIS CLIN N AM, V26, P13, DOI 10.1016/j.idc.2011.09.009
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   O'Brien D, 2011, ACTA NEUROCHIR, V153, P1347, DOI 10.1007/s00701-011-0990-9
   Ockerblad NF, 1939, SOUTH MED J, V32, P653
   Pacheco RJ, 2004, TRAUMA, V6, P143
   Paquette David W, 2008, J Dent Hyg, V82 Suppl 3, P10
   Parker SL, 2011, J NEUROSURG-PEDIATR, V8, P259, DOI 10.3171/2011.6.PEDS11257
   Pereda D, 2011, CARDIOL CLIN, V29, P515, DOI 10.1016/j.ccl.2011.08.004
   Pjetursson BE, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2012.02546.x
   Raad II, 2011, BIOMATERIALS, V32, P2689, DOI 10.1016/j.biomaterials.2010.12.015
   Ratner BD, 2007, POLYM INT, V56, P1183, DOI 10.1002/pi.2319
   Reichenbach J, 2009, CLIN INFECT DIS, V49, P1703, DOI 10.1086/647945
   Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115
   Romeo E, 2004, Minerva Stomatol, V53, P215
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Sampedro MF, 2009, DIAGN MICR INFEC DIS, V64, P138, DOI 10.1016/j.diagmicrobio.2009.01.024
   Sanchez-Brunete JA, 2005, J DRUG TARGET, V13, P225, DOI 10.1080/10611860500097107
   Shanmughapriya S, 2012, BIOFOULING, V28, P929, DOI 10.1080/08927014.2012.717616
   SILVERMAN LM, 1949, ORAL SURG ORAL MED O, V2, P260, DOI 10.1016/0030-4220(49)90391-6
   Sims J M, 1869, Br Med J, V1, P326
   Singodia D, 2011, J BIOMED NANOTECHNOL, V7, P123, DOI 10.1166/jbn.2011.1232
   Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Stapleton F, 2012, EYE, V26, P185, DOI 10.1038/eye.2011.288
   Stapleton F, 2008, OPHTHALMOLOGY, V115, P1655, DOI 10.1016/j.ophtha.2008.04.002
   Swenson CL, 2003, J BONE JOINT SURG AM, V85A, P323, DOI 10.2106/00004623-200302000-00021
   Szczotka-Flynn LB, 2010, EYE CONTACT LENS, V36, P116, DOI 10.1097/ICL.0b013e3181d20cae
   Tallury P, 2008, DENT MATER, V24, P274, DOI 10.1016/j.dental.2007.05.008
   ten Cate JM, 2006, ODONTOLOGY, V94, P1, DOI 10.1007/s10266-006-0063-3
   Thomsen Todd W, 2006, N Engl J Med, V354, pe22, DOI 10.1056/NEJMvcm054648
   Tillander J, 2010, CLIN ORTHOP RELAT R, V468, P2781, DOI 10.1007/s11999-010-1370-0
   Von Eiff C, 2006, INT J ARTIF ORGANS, V29, P360
   Willcox Mark D P, 2002, Clin Exp Optom, V85, P172
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wirostko WJ, 2009, OPHTHAL SURG LAS IM, V40, P201, DOI 10.3928/15428877-20090301-22
   Wu P, 2003, Eye Contact Lens, V29, pS63
   Zegans ME, 2002, DNA CELL BIOL, V21, P415, DOI 10.1089/10445490260099700
   Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x
NR 113
TC 121
Z9 123
U1 7
U2 170
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2013
VL 34
IS 33
BP 8018
EP 8029
DI 10.1016/j.biomaterials.2013.07.048
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 222HB
UT WOS:000324720700002
PM 23932292
DA 2018-10-20
ER

PT J
AU Ma, ZJ
   Ji, HJ
   Hu, XM
   Teng, Y
   Zhao, GY
   Mo, LJ
   Zhao, XL
   Chen, WB
   Qiu, JR
   Zhang, M
AF Ma, Zhijun
   Ji, Huijiao
   Hu, Xiaomeng
   Teng, Yu
   Zhao, Guiyun
   Mo, Lijuan
   Zhao, Xiaoli
   Chen, Weibo
   Qiu, Jianrong
   Zhang, Ming
TI Investigation of bioactivity and cell effects of nano-porous sol-gel
   derived bioactive glass film
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE bioactive glass film; Nano-porous; Sol-gel; Bone marrow derived
   mesenchymal stem cells; Cellular effect
ID IN-VITRO; INCREASED OSTEOBLAST; HEMOSTATIC ACTIVITY; SCAFFOLDS;
   DIFFERENTIATION; MINERALIZATION; BIOMATERIAL; IMPLANTS; COATINGS;
   ALUMINA
AB In orthopedic surgery, bioactive glass film coating is extensively studied to improve the synthetic performance of orthopedic implants. A lot of investigations have confirmed that nano-porous structure in bioactive glasses can remarkably improve their bioactivity. Nevertheless, researches on preparation of nano-porous bioactive glasses in the form of film coating and their cell response activities are scarce. Herein, we report the preparation of nano-porous bioactive glass film on commercial glass slide based on a sol-gel technique, together with the evaluation of its in vitro bioactivity through immersion in simulated body fluid and monitoring the precipitation of apatite-like layer. Cell responses of the samples, including attachment, proliferation and osteogenic differentiation, were also investigated using BMSCS (bone marrow derived mesenchymal stem cells) as a model. The results presented here provide some basic information on structural influence of bioactive glass film on the improvement of bioactivity and cellular effects. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Ma, Zhijun; Teng, Yu; Qiu, Jianrong] S China Univ Technol, State Key Lab Luminescent Mat & Devices, Guangzhou 510640, Guangdong, Peoples R China.
   [Ji, Huijiao; Zhao, Guiyun; Mo, Lijuan; Zhao, Xiaoli; Zhang, Ming] Zhejiang Univ, Coll Life Sci, Hangzhou 310028, Zhejiang, Peoples R China.
   [Hu, Xiaomeng; Chen, Weibo] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510640, Guangdong, Peoples R China.
RP Qiu, JR (reprint author), S China Univ Technol, State Key Lab Luminescent Mat & Devices, Guangzhou 510640, Guangdong, Peoples R China.
EM mokuu@zju.edu.cn; qjr@scut.edu.cn; zhangming201201@126.com
FU National Natural Science Foundation of China [51072054, 51072060,
   51132004, 51102096]; Fundamental Research Funds for the Central
   Universities [2012ZB0003]; Research Funds for Postal Doctoral Students
   in China [2012M511555]; Guangdong Natural Science Foundation
   [S2011030001349, 1045106410104887]; Guangdong Natural Science Foundation
   for Distinguished Young Schloars [S20120011380]; Fok Ying Tong Education
   Foundation [132004]; Chinese Program for New Century Excellent Talents
   in University [NCET-110158]; National Basic Research Program of China
   [2011CB808100]
FX This work was financially supported by the National Natural Science
   Foundation of China (Grants no. 51072054, 51072060, 51132004, 51102096),
   Fundamental Research Funds for the Central Universities (Grants no.
   2012ZB0003), Research Funds for Postal Doctoral Students in China (NO.
   2012M511555); Guangdong Natural Science Foundation (Grant no.
   S2011030001349, 1045106410104887), Guangdong Natural Science Foundation
   for Distinguished Young Schloars (Grant no. S20120011380), Fok Ying Tong
   Education Foundation (Grant No. 132004), Chinese Program for New Century
   Excellent Talents in University (Grant no. NCET-110158) and National
   Basic Research Program of China (2011CB808100).
CR Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Duran A, 2004, J MATER CHEM, V14, P2282, DOI 10.1039/b401370k
   GABBI C, 1995, BIOMATERIALS, V16, P515, DOI 10.1016/0142-9612(95)91123-G
   Gomez-Vega JM, 2001, J BIOMED MATER RES, V56, P382, DOI 10.1002/1097-4636(20010905)56:3<382::AID-JBM1107>3.0.CO;2-P
   Hamadouche M, 2000, J BIOMED MATER RES, V52, P422, DOI 10.1002/1097-4636(200011)52:2<422::AID-JBM24>3.3.CO;2-G
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Itala A, 2003, J BIOMED MATER RES A, V67A, P496, DOI 10.1002/jbm.a.10501
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Ostomel TA, 2006, J AM CHEM SOC, V128, P8384, DOI 10.1021/ja061717a
   Ostomel TA, 2006, SMALL, V2, P1261, DOI 10.1002/smll.200600177
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PEREIRA MM, 1994, J MATER SYNTH PROCES, V2, P189
   Ravikovitch PI, 2001, COLLOID SURFACE A, V187, P11, DOI 10.1016/S0927-7757(01)00614-8
   Ruiz-Hernandez E, 2007, CHEM MATER, V19, P3455, DOI 10.1021/cm0705789
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Vallet- Regi M., 2003, EUROPEAN J INORGANIC, V102, p[9, 2]
   Variola F, 2009, SMALL, V5, P996, DOI 10.1002/smll.200801186
   Webster TJ, 2005, BIOMATERIALS, V26, P953, DOI 10.1016/j.biomaterials.0204.03.040
   Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009
   Wu C, 2009, BIOMATERIALS, V30, P2199, DOI 10.1016/j.biomaterials.2009.01.029
   Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Zhang LJ, 2008, TISSUE ENG PT A, V14, P1353, DOI 10.1089/ten.tea.2006.0436
NR 31
TC 9
Z9 9
U1 1
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 1
PY 2013
VL 284
BP 738
EP 744
DI 10.1016/j.apsusc.2013.08.003
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 215YY
UT WOS:000324248600104
DA 2018-10-20
ER

PT J
AU Nunes, J
   Piedade, AP
AF Nunes, J.
   Piedade, A. P.
TI Nanoindentation of functionally graded hybrid polymer/metal thin films
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Functionally graded coating; Stents; Nanocomposite; Hybrid
   polymer/metal; Nanoindentation
ID COATED SURFACE HARDNESS; MECHANICAL-PROPERTIES; NANOCOMPOSITE COATINGS;
   INDENTATION TESTS; YOUNGS MODULUS; ELASTIC-MODULI; DEFORMATION; MODEL;
   STEEL; SUBSTRATE
AB Hybrid functionally graded coatings (2D-FGC) were deposited by magnetron co-sputtering from poly(tetrafluoroethylene) (PTFE) and AISI 316L stainless steel (316L) targets. The carbon and fluorine content varied from 7.3 to 23.7 at.% and from 0 to 57 at.%, respectively. The surface modification was developed to change the surface of 316L vascular stents in order to improve the biocompatibility of the outmost layer of the metallic biomaterial. In-depth XPS analysis revealed the presence of a graded chemical composition accompanied by the variation of the film structure. These results were complemented by those of transmission electron microscopy (TEM) analysis that highlighted the nanocomposite nature of the coatings.
   The nanomechanical characterization of 2D-FGC was performed by nanoindentation at several loads on the thin films deposited onto two different steel substrates: 316L and AISI M2. The study allowed establishing 0.7 mN as the load that characterized the coatings without substrate influence. Both hardness and Young modulus decrease with the increase of fluorine content due to the evolution in chemical composition, chemical bonds and structure. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Nunes, J.; Piedade, A. P.] Univ Coimbra, Dept Mech Engn, CEMUC, GNM, P-3030788 Coimbra, Portugal.
RP Piedade, AP (reprint author), Univ Coimbra, Dept Mech Engn, CEMUC, GNM, Rua Luis Reis Santos, P-3030788 Coimbra, Portugal.
EM ana.piedade@dem.uc.pt
RI Piedade, Ana/K-8637-2012
OI Piedade, Ana/0000-0002-1588-0640
FU FEDER through the program COMPETE (Programa Operacional Factores de
   Competitividade); FCT (Fundacao para a Ciencia e a Tecnologia)
   [PEst-C/EME/UI0285/2013, CENTRO-07-0224-FEDER-002001]; FCT, Portugal
   [SFRH/BD/47586/2008]
FX This research is sponsored by FEDER funds through the program COMPETE
   (Programa Operacional Factores de Competitividade) and by national funds
   through FCT (Fundacao para a Ciencia e a Tecnologia), under the projects
   PEst-C/EME/UI0285/2013 and CENTRO-07-0224-FEDER-002001. J. Nunes also
   acknowledges FCT, Portugal, for the financial support through grant
   SFRH/BD/47586/2008. The authors gratefully acknowledge Prof. J. V.
   Fernandes for the fruitful scientific discussions.
CR Antunes JM, 2007, INT J SOLIDS STRUCT, V44, P8313, DOI 10.1016/j.ijsolstr.2007.06.015
   Antunes JM, 2007, INT J SOLIDS STRUCT, V44, P2732, DOI 10.1016/j.ijsolstr.2006.08.017
   Bar-On B, 2012, J MECH BEHAV BIOMED, V12, P174, DOI 10.1016/j.jmbbm.2012.03.007
   Cai F, 2011, APPL SURF SCI, V258, P1819, DOI 10.1016/j.apsusc.2011.10.053
   Fernandes JV, 2000, SURF COAT TECH, V131, P457, DOI 10.1016/S0257-8972(00)00839-2
   Fernandes JV, 1998, THIN SOLID FILMS, V335, P153, DOI 10.1016/S0040-6090(98)00864-5
   Han CF, 2012, J MECH BEHAV BIOMED, V12, P1, DOI 10.1016/j.jmbbm.2012.03.009
   Hassanin H, 2010, MICROELECTRON ENG, V87, P1610, DOI 10.1016/j.mee.2009.10.044
   Ipaz L, 2012, APPL SURF SCI, V258, P3805, DOI 10.1016/j.apsusc.2011.12.033
   Jose F, 2011, MAT SCI ENG A-STRUCT, V528, P6438, DOI 10.1016/j.msea.2011.04.068
   Keykamp H., 2001, J ALLOY COMPD, V321, P138
   Korsunsky AM, 2006, MAT SCI ENG A-STRUCT, V423, P28, DOI 10.1016/j.msea.2005.09.126
   Lide D. R., 2004, HDB CHEM PHYS, P5
   Lin YC, 2009, MATER DESIGN, V30, P1643, DOI 10.1016/j.matdes.2008.07.028
   Liu CZ, 2002, SURF COAT TECH, V149, P143, DOI 10.1016/S0257-8972(01)01443-8
   Lopez LM, 2012, APPL SURF SCI, V258, P7306, DOI 10.1016/j.apsusc.2012.03.162
   Makishima A., 1973, Journal of Non-Crystalline Solids, V12, P35, DOI 10.1016/0022-3093(73)90053-7
   MATECKI M, 1994, MATER RES BULL, V29, P473, DOI 10.1016/0025-5408(94)90034-5
   Mishra SK, 2013, APPL SURF SCI, V266, P209, DOI 10.1016/j.apsusc.2012.11.149
   Nakayama KS, 2008, NANO LETT, V8, P516, DOI 10.1021/nl0727462
   Nunes J., 2008, MICROSC MICROANAL, V4, P35
   Oyen ML, 2009, J MECH BEHAV BIOMED, V2, P396, DOI 10.1016/j.jmbbm.2008.10.002
   Pathak S, 2012, J MECH BEHAV BIOMED, V13, P102, DOI 10.1016/j.jmbbm.2012.03.018
   Piedade AP, 2008, ACTA BIOMATER, V4, P1073, DOI 10.1016/j.actbio.2008.02.023
   Piedade A. P., 2008, J NANOSCI NANOTECHNO, V8, P1
   Raman KHT, 2012, APPL SURF SCI, V258, P8629, DOI 10.1016/j.apsusc.2012.05.064
   ROCHERULLE J, 1989, J NON-CRYST SOLIDS, V108, P187, DOI 10.1016/0022-3093(89)90582-6
   ROOS JR, 1990, THIN SOLID FILMS, V193, P547, DOI 10.1016/S0040-6090(05)80064-1
   Saada G, 2005, MAT SCI ENG A-STRUCT, V400, P146, DOI 10.1016/j.msea.2005.02.091
   Song BB, 2012, SURF INTERFACE ANAL, V44, P466, DOI 10.1002/sia.3828
   Tricoteaux A, 2010, MECH MATER, V42, P166, DOI 10.1016/j.mechmat.2009.11.016
   Vaughan TJ, 2012, J MECH BEHAV BIOMED, V12, P50, DOI 10.1016/j.jmbbm.2012.03.003
   Wittling M, 1995, THIN SOLID FILMS, V270, P283, DOI 10.1016/0040-6090(95)06839-2
   Zhang S, 2007, PLASMA PROCESS POLYM, V4, P219, DOI 10.1002/ppap.200600179
   Zhou Y, 2003, SCRIPTA MATER, V48, P825, DOI 10.1016/S1359-6462(02)00511-0
NR 35
TC 6
Z9 6
U1 1
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 1
PY 2013
VL 284
BP 792
EP 797
DI 10.1016/j.apsusc.2013.08.009
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 215YY
UT WOS:000324248600111
DA 2018-10-20
ER

PT J
AU Liu, ZJ
   Guo, ZY
   Si, Y
   Zhang, XM
   Shi, ZY
   Chen, F
   Fu, WG
AF Liu, Zhenjie
   Guo, Zhenying
   Si, Yi
   Zhang, Xiangman
   Shi, Zhenyu
   Chen, Feng
   Fu, Weiguo
TI The research and preparation of a bi-layer biodegradable external sheath
   with directional drug release profiles for vein graft
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Electrospun; Copolymer; Biomaterial; Vein graft
ID SAPHENOUS-VEIN; NEOINTIMAL HYPERPLASIA; INTIMAL HYPERPLASIA;
   EPSILON-CAPROLACTONE; ETHYLENE CARBONATE; BYPASS; STENTS; ANASTOMOSIS;
   POLYGLACTIN; REDUCTION
AB External sheath has been suggested for autologous vein grafts to inhibit neointimal hyperplasia and prevent anastomosis stricture. In this study, we prepared a bi-layer biodegradable paclitaxel-loaded sheaths with a synthetic copolymer poly(ethylene carbonate-epsilon-caprolactone) at room temperature. The bi-layer drug release profiles of the Paclitaxel-loaded (PTX-loaded) sheath significantly slow down the paclitaxel (PTX) release rates and result in a directional drug release way. Moreover, the nanofibrous layer of PTX-loaded poly(EC-CL) sheaths reduced the cytotoxicity and provided a better support for fibroblast adhesion and proliferation than the PTX-loaded layer of the sheaths. Thus, this study demonstrates that the bi-layer PTX-loaded poly(EC-CL) sheath with directional drug release profiles have a promising application for vein graft to against neointimal hyperplasia and anastomotic stricture. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Liu, Zhenjie] Zhejiang Univ, Dept Surg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.
   [Liu, Zhenjie; Zhang, Xiangman; Shi, Zhenyu; Fu, Weiguo] Fudan Univ, Inst Vasc Surg, Shanghai 200433, Peoples R China.
   [Liu, Zhenjie; Si, Yi] Univ Wisconsin Madison, Dept Surg, Madison, WI USA.
   [Guo, Zhenying] Zhejiang Canc Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China.
   [Chen, Feng] Zhejiang Univ Technol, Coll Chem Engn & Mat Sci, Hangzhou, Zhejiang, Peoples R China.
RP Liu, ZJ (reprint author), Zhejiang Univ, Dept Surg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.
EM lawson3001@gmail.com
FU Natural Science Foundation China [30772110, 30972943]; Natural Science
   Foundation of Zhejiang Province China [Q12H180012]
FX This study was funded by the Natural Science Foundation China (grant
   nos. 30772110, 30972943), Natural Science Foundation of Zhejiang
   Province China (grant no. Q12H180012).
CR Bharat A, 2012, J VASC SURG, V55, P274, DOI 10.1016/j.jvs.2011.07.090
   Chen F, 2008, J POLYM SCI POL CHEM, V46, P4050, DOI 10.1002/pola.22747
   Chew DKW, 2001, J VASC SURG, V33, P259, DOI 10.1067/mva.2001.112699
   Darrel A. L. Y., 2008, POLYMER, V49, P2387
   DOBRIN PB, 1989, SURGERY, V105, P393
   El-Kurdi MS, 2008, BIOMATERIALS, V29, P3213, DOI 10.1016/j.biomaterials.2008.04.009
   ELSANADIKI MN, 1990, ANN SURG, V212, P87, DOI 10.1097/00000658-199007000-00012
   HIRKO MK, 1993, J VASC SURG, V17, P877, DOI 10.1016/0741-5214(93)90037-M
   Hosono M, 2000, J THORAC CARDIOV SUR, V120, P319, DOI 10.1067/mtc.2000.106328
   Jeremy JY, 2007, BIOMATERIALS, V28, P895, DOI 10.1016/j.biomaterials.2006.10.023
   Jeremy JY, 2004, J THORAC CARDIOV SUR, V127, P1766, DOI 10.1016/j.tevs.2003.09.054
   Kawatsu S, 2007, ANN THORAC SURG, V84, P560, DOI 10.1016/j.athoracsur.2007.02.034
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Kohler TR, 2007, J VASC SURG, V45, P1029, DOI 10.1016/j.jvs.2007.01.057
   Konjevic G, 1997, J IMMUNOL METHODS, V200, P199, DOI 10.1016/S0022-1759(96)00194-9
   KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Li D., 2004, ADV MATER, V16, P1151
   Liu Y. W. H. F, 2007, J BIOMEDICAL MAT R B, V82B, P129
   Liu Zhen-Jie, 2009, Chinese Journal of Biomedical Engineering, V28, P456
   Mack MJ, 1998, ANN THORAC SURG, V66, P1055, DOI 10.1016/S0003-4975(98)00815-7
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   Mutsuga M, 2009, J THORAC CARDIOV SUR, V137, P703, DOI 10.1016/j.jtcvs.2008.11.017
   Olausson M, 2012, LANCET, V380, P230, DOI 10.1016/S0140-6736(12)60633-3
   PARSONNET V, 1963, ARCH SURG-CHICAGO, V87, P696
   Schachner T, 2007, EUR J CARDIO-THORAC, V32, P906, DOI 10.1016/j.ejcts.2007.09.015
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Vijayan V, 2004, J VASC SURG, V40, P1011, DOI 10.1016/j.jvs.2004.08.047
   Zhang XM, 2012, APPL SURF SCI, V258, P2301, DOI 10.1016/j.apsusc.2011.09.135
   Zhang XM, 2011, APPL SURF SCI, V258, P196, DOI 10.1016/j.apsusc.2011.08.030
NR 30
TC 3
Z9 3
U1 2
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 1
PY 2013
VL 284
BP 819
EP 825
DI 10.1016/j.apsusc.2013.08.015
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 215YY
UT WOS:000324248600115
DA 2018-10-20
ER

PT J
AU Thormann, U
   Ray, S
   Sommer, U
   ElKhassawna, T
   Rehling, T
   Hundgeburth, M
   Henss, A
   Rohnke, M
   Janek, J
   Lips, KS
   Heiss, C
   Schlewitz, G
   Szalay, G
   Schumacher, M
   Gelinsky, M
   Schnettler, R
   Alt, V
AF Thormann, Ulrich
   Ray, Seemun
   Sommer, Ursula
   ElKhassawna, Thaqif
   Rehling, Tanja
   Hundgeburth, Marvin
   Henss, Anja
   Rohnke, Marcus
   Janek, Juergen
   Lips, Katrin S.
   Heiss, Christian
   Schlewitz, Gudrun
   Szalay, Gabor
   Schumacher, Matthias
   Gelinsky, Michael
   Schnettler, Reinhard
   Alt, Volker
TI Bone formation induced by strontium modified calcium phosphate cement in
   critical-size metaphyseal fracture defects in ovariectomized rats
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Strontium; Calcium phosphate; Bone; Fracture
ID OSTEOBLAST RESPONSE; IMPLANTS; OSTEOPOROSIS; OSSEOINTEGRATION; RANELATE;
   MODEL
AB The first objective was to investigate new bone formation in a critical-size metaphyseal defect in the femur of ovariectomized rats filled with a strontium modified calcium phosphate cement (SrCPC) compared to calcium phosphate cement (CPC) and empty defects. Second, detection of strontium release from the materials as well as calcium and collagen mass distribution in the fracture defect should be targeted by time of flight secondary ion mass spectrometry (TOF-SIMS). 45 female Sprague Dawley rats were randomly assigned to three different treatment groups: (1) SrCPC (n = 15), (2) CPC (n = 15), and (3) empty defect (n = 15). Bilateral ovariectomy was performed and three months after multi-deficient diet, the left femur of all animals underwent a 4 mm wedge-shaped metaphyseal osteotomy that was internally fixed with a T-shaped plate. The defect was then either filled with SrCPC or CPC or was left empty. After 6 weeks, histomorphometric analysis showed a statistically significant increase in bone formation of SrCPC compared to CPC (p = 0.005) and the empty defect (p = 0.002) in the former fracture defect zone. Furthermore, there was a statistically significant higher bone formation at the tissue implant interface in the SrCPC group compared to the CPC group (p < 0.0001). These data were confirmed by immunohistochemistry revealing an increase in bone-morphogenic protein 2, osteocalcin and osteoprotegerin expression and a statistically significant higher gene expression of alkaline phosphatase, collagen10a1 and osteocalcin in the SrCPC group compared to CPC. TOF-SIMS analysis showed a high release of Sr from the SrCPC into the interface region in this area compared to CPC suggesting that improved bone formation is attributable to the released Sr from the SrCPC. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
C1 [Thormann, Ulrich; Ray, Seemun; Sommer, Ursula; ElKhassawna, Thaqif; Rehling, Tanja; Hundgeburth, Marvin; Lips, Katrin S.; Heiss, Christian; Schlewitz, Gudrun; Szalay, Gabor; Schnettler, Reinhard; Alt, Volker] Univ Giessen, Lab Expt Trauma Surg, D-35385 Giessen, Germany.
   [Thormann, Ulrich; Heiss, Christian; Schlewitz, Gudrun; Szalay, Gabor; Schnettler, Reinhard; Alt, Volker] Univ Hosp Giessen Marburg GmbH, Dept Trauma Surg, Giessen, Germany.
   [Henss, Anja; Rohnke, Marcus; Janek, Juergen] Univ Giessen, Inst Phys Chem, D-35385 Giessen, Germany.
   [Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Fac Med, Ctr Translat Bone Joint & Soft Tissue Res, D-01062 Dresden, Germany.
   [Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Univ Hosp, D-01062 Dresden, Germany.
RP Alt, V (reprint author), Univ Giessen, Dept Orthopaed Trauma Surg, Rudolf Buchheim Str 7, D-35385 Giessen, Germany.
EM volker.alt@chiru.med.uni-giessen.de
RI Schumacher, Matthias/I-1530-2013; Rohnke, Marcus/I-2815-2013; Janek,
   Juergen/A-9482-2012
OI Schumacher, Matthias/0000-0001-7207-7355; Gelinsky,
   Michael/0000-0001-9075-5121; Janek, Jurgen/0000-0002-9221-4756; El
   khassawna, Thaqif/0000-0002-1187-8578
FU Deutsche Forschungsgemeinschaft (DFG) [SFB-TRR 79]
FX This study was supported by the Deutsche Forschungsgemeinschaft (DFG)
   SFB-TRR 79.
CR Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002
   Andersen OZ, 2013, BIOMATERIALS, V34, P5883, DOI 10.1016/j.biomaterials.2013.04.031
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Driessens F. C. M, 1996, BIOCERAMICS, V9, P231
   Fletcher JS, 2013, ANAL CHEM, V85, P610, DOI 10.1021/ac303088m
   Fu DL, 2012, J ZHEJIANG UNIV-SC B, V13, P364, DOI 10.1631/jzus.B1100381
   Goldhahn J, 2008, BONE, V43, P343, DOI 10.1016/j.bone.2008.04.017
   Heiss C, 2012, MED SCI MONITOR, V18, pBR199, DOI 10.12659/MSM.882895
   Li YF, 2010, BIOMATERIALS, V31, P9006, DOI 10.1016/j.biomaterials.2010.07.112
   Low KL, 2010, J BIOMED MATER RES B, V94B, P273, DOI 10.1002/jbm.b.31619
   Marie PJ, 2007, BONE, V40, pS5, DOI 10.1016/j.bone.2007.02.003
   Park JW, 2013, J BIOMED MATER RES A, V101, P298, DOI 10.1002/jbm.a.34433
   Park JW, 2010, ACTA BIOMATER, V6, P2843, DOI 10.1016/j.actbio.2010.01.017
   Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P398, DOI 10.1111/j.1600-0501.2009.01863.x
   Peters A, 2009, TISSUE ENG PT A, V15, P2947, DOI [10.1089/ten.tea.2009.0058, 10.1089/ten.TEA.2009.0058]
   PFAFFL MW, 2002, NUCL ACIDS RES, V30
   Sanni OD, 2002, SURF INTERFACE ANAL, V33, P715, DOI 10.1002/sia.1438
   Schlewitz G, 2013, Z ORTHOP UNFALLCHIR, V151, P14, DOI 10.1055/s-0032-1327976
   Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014
   Vestermark MT, 2011, ACTA ORTHOP, V82, P614, DOI 10.3109/17453674.2011.618909
   Vickerman J. C., 2001, TOF SIMS SURFACE ANA
   Xin YC, 2009, ACS NANO, V3, P3228, DOI 10.1021/nn9007675
   Zhao LZ, 2013, BIOMATERIALS, V34, P19, DOI 10.1016/j.biomaterials.2012.09.041
NR 23
TC 75
Z9 76
U1 7
U2 151
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2013
VL 34
IS 34
BP 8589
EP 8598
DI 10.1016/j.biomaterials.2013.07.036
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 218RR
UT WOS:000324450600005
PM 23906515
OA Other Gold
DA 2018-10-20
ER

PT J
AU Daly, WT
   Knight, AM
   Wang, H
   de Boer, R
   Giusti, G
   Dadsetan, M
   Spinner, RJ
   Yaszemski, MJ
   Windebank, AJ
AF Daly, William T.
   Knight, Andrew M.
   Wang, Huan
   de Boer, Ralph
   Giusti, Guilherme
   Dadsetan, Mahrokh
   Spinner, Robert J.
   Yaszemski, Michael J.
   Windebank, Anthony J.
TI Comparison and characterization of multiple biomaterial conduits for
   peripheral nerve repair
SO BIOMATERIALS
LA English
DT Article
DE Polymer; Scaffolds; Nerve conduits; Functional outcomes; Tissue
   engineering
ID REGENERATION IN-VIVO; SCHWANN-CELLS; POLY(EPSILON-CAPROLACTONE
   FUMARATE); ALLOGRAFT TRANSPLANTATION; FUNCTIONAL RECOVERY; NEURITE
   GROWTH; SPINAL-CORD; LONG GAP; TUBES; GUIDANCE
AB Four biomaterial tubes, poly(lactic-co-glycolic acid) (PLGA), poly(caprolactone fumarate) (PCLF), a neutral oligo[(polyethylene glycol) fumarate] (OPF) hydrogel or a positively charged oligo[(polyethylene glycol) fumarate] (OPF+) hydrogel with a PCLF sleeve, have previously been shown to have benefits for nerve repair. However, no direct comparison to identify the optimal material have been made. Herein, these nerve tubes were implanted in a rat sciatic nerve model and nerve regeneration was quantified and compared by using accepted nerve assessment techniques. Using standard statistical methods, no significant differences of individual parameters were apparent between groups despite PCLF showing a tendency to perform better than the others. Using a mean-variance based ranking system of multiple independent parameters, statistical differences became apparent. It was clear that the PLCF tube supported significantly improved nerve regeneration and recovery compared to the other three biomaterial conduits. The ability to simultaneously compare a number of regenerative parameters and elucidate the best material from the combination of these individual parameters is of importance to the nerve regeneration area and has implications for the tissue engineering field. By using this method of comparison, a number of biomaterial constructs may be compared under similar conditions and the optimal construct elucidated using the minimal number of animals and materials. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Daly, William T.] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
   [Knight, Andrew M.; Windebank, Anthony J.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.
   [Wang, Huan; de Boer, Ralph; Spinner, Robert J.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.
   [Giusti, Guilherme; Dadsetan, Mahrokh; Yaszemski, Michael J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
RP Windebank, AJ (reprint author), Mayo Clin, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.
EM windebank.anthony@mayo.edu
RI Daly, William/O-1714-2013
FU Armed Forces Institute of Regenerative Medicine (AFIRM)
   [W81XWH-08-2-0034]
FX The authors would like to thank Prof. Abhay Pandit for his support and
   input during this study. The technical support of LouAnn Gross, Shuya
   Zhang and Jarred Nesbitt was also appreciated. The work was supported by
   a grant from the Armed Forces Institute of Regenerative Medicine (AFIRM)
   W81XWH-08-2-0034.
CR Abu-Rub MT, 2011, SOFT MATTER, V7, P2770, DOI 10.1039/c0sm01062f
   Ahmed MR, 2005, BRAIN RES, V1046, P55, DOI 10.1016/j.brainres.2005.03.022
   Alluin O, 2009, BIOMATERIALS, V30, P363, DOI 10.1016/j.biomaterials.2008.09.043
   Angius D, 2012, BIOMATERIALS, V33, P8034, DOI 10.1016/j.biomaterials.2012.07.056
   ANSSELIN A D, 1988, Microsurgery, V9, P103, DOI 10.1002/micr.1920090210
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   Belkas SJ, 2004, NEURAL RES, V26, P10
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   Chen BKK, 2011, BIOMATERIALS, V32, P8077, DOI 10.1016/j.biomaterials.2011.07.029
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Dadsetan M, 2007, BIOMACROMOLECULES, V8, P1702, DOI 10.1021/bm070052h
   Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Daly WT, 2012, BIOMATERIALS, V33, P6660, DOI 10.1016/j.biomaterials.2012.06.002
   de Boer R, 2012, J BIOMED MATER RES A, V100A, P2139, DOI 10.1002/jbm.a.34088
   de Boer R, 2011, MICROSURG, V31, P293, DOI 10.1002/micr.20869
   de Ruiter GC, 2008, NEUROSURGERY, V63, P144, DOI [10.1227/01.NEU.0000335081.47352.78, 10.1227/01.NEU.0000319521.28683.75]
   de Ruiter GC, 2008, J BIOMED MATER RES A, V84A, P643, DOI 10.1002/jbm.a.31298
   Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011
   di Summa PG, 2011, NEUROSCIENCE, V181, P278, DOI 10.1016/j.neuroscience.2011.02.052
   Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fan WM, 2008, MICROSURG, V28, P238, DOI 10.1002/micr.20488
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Haastert K, 2006, NEUROBIOL DIS, V21, P138, DOI 10.1016/j.nbd.2005.06.020
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Itoh S, 1999, J MATER SCI-MATER M, V10, P129, DOI 10.1023/A:1008977221827
   JENQ CB, 1986, EXP NEUROL, V91, P154, DOI 10.1016/0014-4886(86)90033-6
   Kaewkhaw R, 2011, GLIA, V59, P734, DOI 10.1002/glia.21145
   Kalbermatten DF, 2008, J HAND SURG-EUR VOL, V33E, P587, DOI 10.1177/1753193408090755
   Kalbermatten DF, 2008, J PLAST RECONSTR AES, V61, P669, DOI 10.1016/j.bjps.2007.12.015
   Karabekmez Furkan E, 2009, Hand (N Y), V4, P245, DOI 10.1007/s11552-009-9195-6
   Kim J, 2010, J BIOMED MATER RES A, V95A, P191, DOI 10.1002/jbm.a.32810
   Knight AM, 2007, J PERIPHER NERV SYST, V12, P45
   Koh HS, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046003
   Kokai LE, 2011, TISSUE ENG PT A, V17, P1263, DOI [10.1089/ten.tea.2010.0507, 10.1089/ten.TEA.2010.0507]
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   Mackinnon SE, 2001, PLAST RECONSTR SURG, V107, P1419, DOI 10.1097/00006534-200105000-00016
   McGrath AM, 2010, BRAIN RES BULL, V83, P207, DOI 10.1016/j.brainresbull.2010.07.001
   Midha Rajiv, 2006, Clin Neurosurg, V53, P185
   Mukhatyar V, 2009, ADV MATER, V21, P4670
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Ngo TTB, 2003, J NEUROSCI RES, V72, P227, DOI 10.1002/jnr.10570
   Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003
   OBRIEN PC, 1988, MAYO CLIN PROC, V63, P1140, DOI 10.1016/S0025-6196(12)65511-6
   Pabari A, 2010, J PLAST RECONSTR AES, V63, P1941, DOI 10.1016/j.bjps.2009.12.010
   Pettersson J, 2010, J PLAST RECONSTR AES, V63, P1893, DOI 10.1016/j.bjps.2009.11.024
   Rooney GE, 2011, TISSUE ENG PT A, V17, P1287, DOI [10.1089/ten.tea.2010.0396, 10.1089/ten.TEA.2010.0396]
   Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Shin RH, 2008, MICROSURG, V28, P452, DOI 10.1002/micr.20520
   Siemionow M, 2007, J RECONSTR MICROSURG, V23, P511, DOI 10.1055/s-2007-1022694
   Sun M, 2010, J BIOMED MATER RES A, V93A, P1470, DOI 10.1002/jbm.a.32681
   Varon S, 1986, PERIPHERAL NERVE REP, V1, P9
   Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013
   Wang SF, 2008, BIOMACROMOLECULES, V9, P1229, DOI 10.1021/bm7012313
   Wang SF, 2009, ACTA BIOMATER, V5, P1531, DOI 10.1016/j.actbio.2008.12.015
   Wang W, 2008, J BIOMED MATER RES A, V85A, P919, DOI 10.1002/jbm.a.31522
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   Yao L, 2010, J BIOMED MATER RES A, V92A, P484, DOI 10.1002/jbm.a.32359
   Yao L, 2009, ACTA BIOMATER, V5, P580, DOI 10.1016/j.actbio.2008.09.002
NR 66
TC 40
Z9 42
U1 4
U2 123
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2013
VL 34
IS 34
BP 8630
EP 8639
DI 10.1016/j.biomaterials.2013.07.086
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 218RR
UT WOS:000324450600009
PM 23937914
DA 2018-10-20
ER

PT J
AU Khoda, AKMB
   Koc, B
AF Khoda, A. K. M. Bashirul
   Koc, Bahattin
TI Functionally heterogeneous porous scaffold design for tissue engineering
SO COMPUTER-AIDED DESIGN
LA English
DT Article
DE Functionally gradient porous structures; Scaffold architecture;
   Deposition direction; Tissue engineering
ID COMPUTER-AIDED-DESIGN; MECHANICAL-PROPERTIES; STRUCTURE LIBRARY;
   TRABECULAR BONE; CORTICAL BONE; MICROSTRUCTURE; POROSITY; POLYMER
AB Porous scaffolds with interconnected and continuous pores have recently been considered as one of the most successful tissue engineering strategies. In the literature, it has been concluded that properly interconnected and continuous pores with their spatial distribution could contribute to perform diverse mechanical, biological and chemical functions of a scaffold. Thus, there has been a need for reproducible and fabricatable scaffold design with controllable and functional gradient porosity. Improvements in Additive Manufacturing (AM) processes for tissue engineering and their design methodologies have enabled the development of controlled and interconnected scaffold structures. However homogeneous scaffolds with uniform porosity do not capture the intricate spatial internal micro architecture of the replaced tissue and thus are not capable of capturing the design. In this work, a novel heterogeneous scaffold modeling is proposed for layered-based additive manufacturing processes. First, layers are generated along the optimum build direction considering the heterogeneous micro structure of tissue. Each layer is divided into functional regions based on the spatial homogeneity factor. An area weight based method is developed to generate the spatial porosity function that determines the deposition pattern for the desired gradient porosity. To design a multi-functional scaffold, an optimum deposition angle is determined at each layer by minimizing the heterogeneity along the deposition path. The proposed methodology is implemented and illustrative examples are also provided. The effective porosity is compared between the proposed design and the conventional uniform porous scaffold design. Sample designed structures have also been fabricated with a novel micro-nozzle biomaterial deposition system. The result has shown that the proposed methodology generates scaffolds with functionally gradient porosity. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Khoda, A. K. M. Bashirul] N Dakota State Univ, Ind & Mfg Engn Dept, Fargo, ND 58102 USA.
   [Koc, Bahattin] Sabanci Univ, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.
RP Koc, B (reprint author), Sabanci Univ, Fac Engn & Nat Sci, FENS G013, TR-34956 Istanbul, Turkey.
EM bahattinkoc@sabanciuniv.edu
RI Koc, Bahattin/D-7277-2012
OI Koc, Bahattin/0000-0001-9073-8516
FU Telemedicine and Advanced Technology Research Center (TATRC) at the US
   Army Medical Research and Material Command (USAMRMC) [W81XWH-05-1-0401];
   EU FP7 Marie Curie Grant [PCIG09-GA-2011-294088]
FX The research was partially supported by the Telemedicine and Advanced
   Technology Research Center (TATRC) at the US Army Medical Research and
   Material Command (USAMRMC) through award W81XWH-05-1-0401 and by EU FP7
   Marie Curie Grant #: PCIG09-GA-2011-294088 awarded to Dr. Koc.
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Cai S, 2009, VIRTUAL PHYS PROTOTY, V4, P149
   Chow HN, 2007, COMPUT AIDED DESIGN, V4, P321, DOI DOI 10.1080/16864360.2007.10738552.
   Chua CK, 2011, MRS BULL, V36, P1006, DOI 10.1557/mrs.2011.271
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P291
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P302
   DALSTRA M, 1995, J BIOMECH, V28, P715, DOI 10.1016/0021-9290(94)00125-N
   Fryazinov O, 2013, COMPUT AIDED DESIGN, V45, P26, DOI 10.1016/j.cad.2011.09.007
   Geffre CP, 2009, J BIOMED MATER RES A, V91A, P795, DOI 10.1002/jbm.a.32251
   Gomez C., 2007, UNIT CELL BASED MULT
   Hadjizadeh A., 2009, J BIOMED MATER RES A, V93A, P1140
   Holdstein Y, 2011, COMPUT METH APPL SCI, V20, P91, DOI 10.1007/978-94-007-1254-6_6
   Hosokawa A, 2010, IEEE T ULTRASON FERR, V57, P1320, DOI 10.1109/TUFFC.2010.1552
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307
   Khoda A., 2011, BIOFABRICATION, V3, P1
   Khoda AKMB, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002933
   Khoda AKMB, 2012, J MED DEVICES, V6, DOI 10.1115/1.4007009
   Kou XY, 2011, INT J COMPUT INTEG M, V25, P177
   Lal P, 2004, COMPUT AIDED DESIGN, V36, P487, DOI 10.1016/S0010-4485(03)00134-9
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Lin JC, 1998, OSTEOPOROSIS INT, V8, P16, DOI 10.1007/s001980050043
   Liu Y, 2009, 2009 Conference on Lasers & Electro-Optics Europe & 11th European Quantum Electronics Conference (CLEO/EQEC), DOI 10.1109/CLEOE-EQEC.2009.5196364
   Ng KW, 2005, J BIOMED MATER RES A, V75A, P425, DOI 10.1002/jbm.a.30454
   Novitskaya E, 2011, ACTA BIOMATER, V7, P3170, DOI 10.1016/j.actbio.2011.04.025
   Ozbolat IT, 2012, VIRTUAL PHYS PROTOTY, V7, P37, DOI 10.1080/17452759.2012.668700
   Pandithevan Ponnusamy, 2009, Virtual and Physical Prototyping, V4, P165, DOI 10.1080/17452750903055512
   Pasko A, 2011, GRAPH MODELS, V73, P165, DOI 10.1016/j.gmod.2011.03.001
   Pietruszczak S, 1999, J BIOMECH, V32, P1071, DOI 10.1016/S0021-9290(99)00096-2
   Podshivalov L, 2011, BONE, V48, P693, DOI 10.1016/j.bone.2010.12.022
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Risbud MV, 2002, J MATER SCI LETT, V21, P1191, DOI 10.1023/A:1016564201212
   Schroeder C, 2005, COMPUT AIDED DESIGN, V37, P339, DOI 10.1016/j.cad.2004.03.008
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Sudarmadji N, 2011, ACTA BIOMATER, V7, P530, DOI 10.1016/j.actbio.2010.09.024
   Verhulp E, 2008, BONE, V42, P30, DOI 10.1016/j.bone.2007.08.039
   Wagermaier W, 2007, J APPL CRYSTALLOGR, V40, P115, DOI 10.1107/S0021889806044888
   Wettergreen MA, 2005, COMPUT AIDED DESIGN, V37, P1141, DOI 10.1016/j.cad.2005.02.005
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yildirim ED, 2008, VIRTUAL PHYS PROTOTY, V3, P199, DOI 10.1080/17452750802547338
   Zioupos P, 2008, J BIOMECH, V41, P1961, DOI 10.1016/j.jbiomech.2008.03.025
NR 44
TC 13
Z9 14
U1 2
U2 87
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0010-4485
J9 COMPUT AIDED DESIGN
JI Comput.-Aided Des.
PD NOV
PY 2013
VL 45
IS 11
BP 1276
EP 1293
DI 10.1016/j.cad.2013.05.005
PG 18
WC Computer Science, Software Engineering
SC Computer Science
GA 212VN
UT WOS:000324011000003
DA 2018-10-20
ER

PT J
AU Niepel, MS
   Fuhrmann, B
   Leipner, HS
   Groth, T
AF Niepel, Marcus S.
   Fuhrmann, Bodo
   Leipner, Hartmut S.
   Groth, Thomas
TI Nanoscaled Surface Patterns Influence Adhesion and Growth of Human
   Dermal Fibroblasts
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; STEM-CELL DIFFERENTIATION; POLY(ETHYLENE
   GLYCOL); MESENCHYMAL STEM; FIBRONECTIN ADSORPTION; COLLOIDAL
   LITHOGRAPHY; INTEGRIN LIGANDS; ORGANIZATION; PROTEINS; MATRIX
AB In general, there is a need for passivation of nanopatterned biomaterial surfaces if cells are intended to interact only with a feature of interest. For this reason self-assembled monolayers (SAM), varying in chain length, are used; they are highly effective in preventing protein adsorption or cell adhesion. In addition, a simple and cost-effective technique to design nanopatterns of various sizes and distances, the so-called nanosphere lithography (NSL), is discussed, which allows the control of cell adhesion and growth depending on the feature dimensions. Combining both techniques results in highly selective nanostructured surfaces, showing that single proteins selectively adsorb on activated nanopatterns. Additionally, adhesion and growth of normal human dermal fibroblasts (NHDF) is strongly affected by the nanostructure dimensions, and it is proven that fibronectin (FN) matrix formation of these cells is influenced, too. Moreover, the FN fibrils are linked to the hexagonally close-packed nanopatterns. As a result, the system presented here can be applied in tissue engineering and implant design due to the fact that the nanopattern dimensions give rise to further modifications and allow the introduction of chemical heterogeneity to guide stem cell differentiation in the future.
C1 [Niepel, Marcus S.; Groth, Thomas] Univ Halle Wittenberg, Biomed Mat Grp, Inst Pharm, D-06099 Halle, Saale, Germany.
   [Fuhrmann, Bodo; Leipner, Hartmut S.] Univ Halle Wittenberg, Ctr Mat Sci, D-06099 Halle, Saale, Germany.
RP Groth, T (reprint author), Univ Halle Wittenberg, Biomed Mat Grp, Inst Pharm, D-06099 Halle, Saale, Germany.
EM thomas.groth@pharmazie.uni-halle.de
RI Niepel, Marcus/G-2340-2011
OI Niepel, Marcus/0000-0002-4479-1225; Leipner,
   Hartmut/0000-0002-5563-7792; Groth, Thomas/0000-0001-6647-9657
FU European Union [NMP4-SL-2009-229292]; German Research Society (DFG) [GR
   1290/10-1]
FX This work was supported, in part, by the European Union Seventh
   Framework Program (FP7/2007-2013) under Grant Agreement
   NMP4-SL-2009-229292 ("Find & Bind") as well as the German Research
   Society (DFG) through Grant GR 1290/10-1.
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Altankov G, 1997, J BIOMAT SCI-POLYM E, V8, P721, DOI 10.1163/156856297X00524
   Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   ATRE SV, 1995, LANGMUIR, V11, P3882, DOI 10.1021/la00010a045
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038
   Caporizzo MA, 2012, LANGMUIR, V28, P12216, DOI 10.1021/la302250x
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   del Campo A, 2008, CHEM REV, V108, P911, DOI 10.1021/cr050018y
   Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Fick J, 2004, LANGMUIR, V20, P3848, DOI 10.1021/la049526d
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gale GW, 2008, HANDBOOK OF SILICON WAFER CLEANING TECHNOLOGY, 2ND EDITION, P201, DOI 10.1016/B978-081551554-8.50007-0
   Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314
   Gonzalez-Garcia C, 2013, COLLOID SURFACE B, V111, P618, DOI 10.1016/j.colsurfb.2013.07.016
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Groll J, 2005, BIOMACROMOLECULES, V6, P956, DOI 10.1021/bm049350u
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Guduru D, 2011, INT J ARTIF ORGANS, V34, P963, DOI [10.5301/ijao.5000012, 10.5301/IJAO.5000012]
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   HULTEEN JC, 1995, J VAC SCI TECHNOL A, V13, P1553, DOI 10.1116/1.579726
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Ladoux B., 2012, REP PROG PHYS, V75
   Lanfer B, 2009, BIOMATERIALS, V30, P5950, DOI 10.1016/j.biomaterials.2009.07.039
   Ling XY, 2010, NANOSCALE, V2, P1455, DOI 10.1039/c0nr00007h
   Martines E, 2006, LANGMUIR, V22, P11230, DOI 10.1021/la061611t
   Coelho NM, 2010, EUR CELLS MATER, V19, P262, DOI 10.22203/eCM.v019a25
   Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83
   Papra A, 2001, LANGMUIR, V17, P4090, DOI 10.1021/la0016930
   Perez-Garnes M, 2011, INT J ARTIF ORGANS, V34, P54, DOI 10.5301/IJAO.2011.6316
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Salmeron-Sanchez M, 2011, BIOMATERIALS, V32, P2099, DOI 10.1016/j.biomaterials.2010.11.057
   Schulte VA, 2009, BIOMACROMOLECULES, V10, P2795, DOI 10.1021/bm900631s
   Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001
   Seo CH, 2011, BIOMATERIALS, V32, P9568, DOI 10.1016/j.biomaterials.2011.08.077
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Sottile J, 1998, J CELL SCI, V111, P2933
   Taylor ZR, 2009, LANGMUIR, V25, P10932, DOI 10.1021/la901512z
   Thom VH, 2000, LANGMUIR, V16, P2756, DOI 10.1021/la990303a
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   Werner C, 2006, ADV POLYM SCI, P63, DOI 10.1007/12_089
   Xia DY, 2011, ADV MATER, V23, P147, DOI 10.1002/adma.201001856
   Zhang G, 2009, CHEM-ASIAN J, V4, P236, DOI 10.1002/asia.200800298
   Zhu XY, 2001, LANGMUIR, V17, P7798, DOI 10.1021/la010672i
NR 59
TC 12
Z9 13
U1 2
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
EI 1520-5827
J9 LANGMUIR
JI Langmuir
PD OCT 29
PY 2013
VL 29
IS 43
BP 13278
EP 13290
DI 10.1021/la402705r
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 244ZU
UT WOS:000326429500020
PM 24090166
DA 2018-10-20
ER

PT J
AU Ben-Nissan, B
   Choi, AH
   Bendavid, A
AF Ben-Nissan, Besim
   Choi, Andy H.
   Bendavid, Avi
TI Mechanical properties of inorganic biomedical thin films and their
   corresponding testing methods
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Nanocoating; Thin films; Mechanical properties; Biomaterial; Deposition;
   Adhesion
ID PULSED-LASER DEPOSITION; CHEMICAL-VAPOR-DEPOSITION; SOL-GEL PRODUCTION;
   CARBON-FILMS; CALCIUM-PHOSPHATE; CATHODIC ARC; DLC FILMS; BIOACTIVE
   NANOCOATINGS; MEDICAL APPLICATIONS; ELASTIC-MODULUS
AB Coatings on implants are aimed to achieve some or all of the improvements in abrasion, corrosion resistance, metal ion release protection, increased bioactivity, biocompatibility, and ultimately an improved environment and structure for new bone attachment. Adhesion, mechanical properties and testing methods are used to determine the viability of coated implants or devices and their performance under simulated physiological environments. Perforation or delamination of the coatings can expose the substrate to accelerated wear or corrosion, and the released coating particles may act to accelerate third party wear resulting in a negative host response. An in-depth understanding of the adhesion of the implants and the susceptibility of the coating to cracking and delamination are critical important reliability issues. The aim of this review is to give a brief description on the various techniques used to produce micro and nanocoatings currently used or being investigated within the biomedical field. This is followed by an overview of some of the most widely used test methods for measuring mechanical properties and adhesion performance of coatings used in medical applications. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Ben-Nissan, Besim; Choi, Andy H.] Univ Technol Sydney, Fac Sci, Sch Chem & Forens Sci, Sydney, NSW 2007, Australia.
   [Bendavid, Avi] CSIRO Mat Sci & Engn, Lindfield, NSW 2070, Australia.
RP Choi, AH (reprint author), Univ Technol, Fac Sci, Sch Chem & Forens Sci, POB 123, Broadway, NSW 2007, Australia.
EM ahchoi@hotmail.com
RI Bendavid, Avi/G-4234-2013
OI Bendavid, Avi/0000-0002-2454-9714
CR AGRAWAL DC, 1989, ACTA METALL MATER, V37, P1265, DOI 10.1016/0001-6160(89)90120-X
   ANAST M, 1992, J MATER SCI LETT, V11, P1483, DOI 10.1007/BF00729266
   Annunziata M, 2011, J DENT, V39, P720, DOI 10.1016/j.jdent.2011.08.003
   Aoki H., 2010, J AUST CERAM SOC, V47, P61
   Ben-Nissan B, 2002, J CERAM SOC JPN, V110, P601, DOI 10.2109/jcersj.110.601
   Ben-Nissan B, 2006, NANOMEDICINE-UK, V1, P311, DOI 10.2217/17435889.1.3.311
   Bendavid A, 2006, SURF COAT TECH, V201, P4139, DOI 10.1016/j.surfcoat.2006.08.021
   Bendavid A, 2007, DIAM RELAT MATER, V16, P1616, DOI 10.1016/j.diamond.2007.02.006
   Bendavid A, 2010, DIAM RELAT MATER, V19, P1466, DOI 10.1016/j.diamond.2010.10.001
   Bendavid A, 2008, THIN SOLID FILMS, V517, P494, DOI 10.1016/j.tsf.2008.06.060
   Berndt C. C., 1990, Materials Forum, V14, P161
   Beuth JL, 1996, J MECH PHYS SOLIDS, V44, P1411, DOI 10.1016/0022-5096(96)00042-7
   BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   BOYER R, 1994, MAT PROPERTIES HDB T
   Bujak J, 2011, P I MECH ENG J-J ENG, V225, P875, DOI 10.1177/1350650111411380
   Cheng K, 2008, THIN SOLID FILMS, V516, P3251, DOI 10.1016/j.tsf.2007.11.115
   Cheng YH, 2010, SURF COAT TECH, V205, P146, DOI 10.1016/j.surfcoat.2010.06.023
   Choi AH, 2007, NANOMEDICINE-UK, V2, P51, DOI 10.2217/17435889.2.1.51
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Clarke I.C., 2004, BIOCERAMICS MAT APPL, P155
   Cordingley R., 2003, Journal of the Australasian Ceramic Society, V39, P20
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Dey A, 2009, J THERM SPRAY TECHN, V18, P578, DOI 10.1007/s11666-009-9386-2
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   FIELD JS, 1995, J MATER RES, V10, P101, DOI 10.1557/JMR.1995.0101
   FIELD JS, 1993, J MATER RES, V8, P297, DOI 10.1557/JMR.1993.0297
   Filiaggi MJ, 1996, J BIOMED MATER RES, V33, P239, DOI 10.1002/(SICI)1097-4636(199624)33:4<239::AID-JBM4>3.0.CO;2-Q
   Fischer-Cripps AC, 2002, INTRO NANOINDENTATIO
   Gan L, 1996, THIN SOLID FILMS, V290, P362, DOI 10.1016/S0040-6090(96)08972-9
   Girleanu M, 2011, THIN SOLID FILMS, V519, P6190, DOI 10.1016/j.tsf.2011.04.113
   Habijan T, 2012, MAT SCI ENG C-MATER, V32, P2523, DOI 10.1016/j.msec.2012.07.035
   Hahn BD, 2009, ACTA BIOMATER, V5, P3205, DOI 10.1016/j.actbio.2009.05.005
   Hauert R, 2012, DIAM RELAT MATER, V25, P34, DOI 10.1016/j.diamond.2012.02.001
   He LH, 2007, DENT MATER, V23, P814, DOI 10.1016/j.dental.2006.06.017
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Ignat M, 1996, KEY ENG MAT, V116-, P279, DOI 10.4028/www.scientific.net/KEM.116-117.279
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jouanny I, 2010, THIN SOLID FILMS, V518, P3212, DOI 10.1016/j.tsf.2009.09.046
   Kealley CS, 2008, J NANOSCI NANOTECHNO, V8, P3936, DOI 10.1166/jnn.2008.188
   Kim H, 2010, ACTA BIOMATER, V6, P3234, DOI 10.1016/j.actbio.2010.02.031
   Kocourek T, 2011, SURF COAT TECH, V205, pS67, DOI 10.1016/j.surfcoat.2011.01.038
   Kumar A, 2009, SURF COAT TECH, V204, P1132, DOI 10.1016/j.surfcoat.2009.06.002
   Latella BA, 2007, SURF COAT TECH, V201, P6325, DOI 10.1016/j.surfcoat.2006.11.037
   Latella BA, 2007, SCRIPTA MATER, V56, P493, DOI 10.1016/j.scriptamat.2006.11.021
   Latella BA, 2006, SURF COAT TECH, V200, P3605, DOI 10.1016/j.surfcoat.2004.09.008
   Ligot S, 2012, ACTA MATER, V60, P3435, DOI 10.1016/j.actamat.2012.02.024
   Mathur S, 2006, SURF COAT TECH, V201, P807, DOI 10.1016/j.surfcoat.2005.12.039
   Mencik J, 1997, J MATER RES, V12, P2475, DOI 10.1557/JMR.1997.0327
   MENCIK J, 1995, J MATER RES, V10, P1491, DOI 10.1557/JMR.1995.1491
   Mittal K. L., 1995, ADHESION MEASUREMENT
   Nelea V, 2004, THIN SOLID FILMS, V453, P208, DOI 10.1016/j.tsf.2003.11.119
   Nelea V, 2004, APPL SURF SCI, V228, P346, DOI 10.1016/j.apsusc.2004.01.029
   Ogwu AA, 2003, ACTA MATER, V51, P3455, DOI 10.1016/S1359-6454(03)00166-6
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Orsini G, 2007, J PERIODONTOL, V78, P209, DOI 10.1902/jop.2007.060297
   Ouchabane M, 2010, PHYS STATUS SOLIDI A, V207, P2311, DOI 10.1002/pssa.200925581
   Rajagopalan S., 2009, APPL PHYS LETT, V95
   Randeniya LK, 2010, DIAM RELAT MATER, V19, P329, DOI 10.1016/j.diamond.2010.01.003
   Randeniya LK, 2009, ACTA BIOMATER, V5, P1791, DOI 10.1016/j.actbio.2009.01.013
   Rau JV, 2009, ACS APPL MATER INTER, V1, P1813, DOI 10.1021/am900356e
   Roest R, 2004, KEY ENG MAT, V254-2, P455, DOI 10.4028/www.scientific.net/KEM.254-256.455
   Roest R, 2011, SURF COAT TECH, V205, P3520, DOI 10.1016/j.surfcoat.2010.12.030
   Saha R, 2002, ACTA MATER, V50, P23, DOI 10.1016/S1359-6454(01)00328-7
   Sahoo S., 2010, SURF COAT TECH, V204, P16
   Sebdani MM, 2011, J ALLOY COMPD, V509, P2273, DOI 10.1016/j.jallcom.2010.10.202
   Srinivasan S, 2012, APPL SURF SCI, V258, P8094, DOI 10.1016/j.apsusc.2012.04.178
   Struts VK, 2011, J SURF INVESTIG, V5, P497, DOI 10.1134/S1027451011050144
   SWAIN MV, 1994, THIN SOLID FILMS, V253, P204, DOI 10.1016/0040-6090(94)90321-2
   Tabbal M, 1999, SURF COAT TECH, V116, P452, DOI 10.1016/S0257-8972(99)00183-8
   Tsai PC, 2008, SURF COAT TECH, V202, P5350, DOI 10.1016/j.surfcoat.2008.06.073
   Pham VH, 2011, J MATER SCI-MATER M, V22, P2231, DOI 10.1007/s10856-011-4410-8
   Wang JS, 1998, THIN SOLID FILMS, V325, P163, DOI 10.1016/S0040-6090(98)00418-0
   Xu S, 1996, J APPL PHYS, V79, P7234, DOI 10.1063/1.361440
   Zhang S, 2012, THIN SOLID FILMS, V520, P2375, DOI 10.1016/j.tsf.2011.09.036
NR 76
TC 12
Z9 12
U1 1
U2 29
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD OCT 25
PY 2013
VL 233
BP 39
EP 48
DI 10.1016/j.surfcoat.2012.11.020
PG 10
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 277GX
UT WOS:000328808100005
DA 2018-10-20
ER

PT J
AU Qi, PK
   Maitz, MF
   Huang, N
AF Qi, Pengkai
   Maitz, Manfred F.
   Huang, Nan
TI Surface modification of cardiovascular materials and implants
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Cardiovascular material; Cardiovascular device; Surface modification;
   Blood compatibility; Endothelialization
ID ENDOTHELIAL PROGENITOR CELLS; DRUG-ELUTING STENTS; BLOOD COMPATIBILITY;
   VASCULAR GRAFTS; PROTEIN ADSORPTION; IN-VIVO; COVALENT IMMOBILIZATION;
   RE-ENDOTHELIALIZATION; STAINLESS-STEEL; GROWTH-FACTOR
AB Cardiovascular implants find wide clinical applications, making a great contribution to the treatment of cardiovascular diseases. Such devices, endovascular stents, artificial vascular grafts, prosthetic heart valves to name a few typical examples, have been the mainstay of cardiovascular surgery. However, failure cases of the implants still exist, which urge us to understand what has happened at the blood-contacting interface and how the tissues have responded during the post-implantation period. Aiming to eliminate these pathological events, various approaches of surface modification of the cardiovascular devices have been used in order to improve hemocompatibility and cytocompatibility. In this review, the blood-biomaterial interfacial events and the evolution of the surface modification strategies are discussed, together with the recent developments on the surface modification of cardiovascular materials like biomimetic extracellular matrix and accelerated endothelialization. These novel surface modification strategies open a new chapter on designing ideal blood-friendly implantable materials. (C) 2013 Published by Elsevier B.V.
C1 [Qi, Pengkai; Huang, Nan] Southwest Jiaotong Univ, Educ Minist, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
   [Maitz, Manfred F.] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat Dresden, D-01097 Dresden, Germany.
   [Qi, Pengkai; Maitz, Manfred F.; Huang, Nan] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
RP Huang, N (reprint author), Southwest Jiaotong Univ, Educ Minist, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM nhuang@263.net
RI Maitz, Manfred/E-6749-2010; Umlauf, Ursula/D-3356-2014
OI Maitz, Manfred/0000-0002-0671-048X; 
FU Key Basic Research Program [2011CB606204]; NSFC [81271701]
FX This paper is supported by Key Basic Research Program 2011CB606204 and
   NSFC 81271701.
CR Achneck HE, 2011, BIOMATERIALS, V32, P10, DOI 10.1016/j.biomaterials.2010.08.073
   AKASHI M, 1992, BIOCONJUGATE CHEM, V3, P363, DOI 10.1021/bc00017a002
   Ali N, 2006, THIN SOLID FILMS, V515, P59, DOI 10.1016/j.tsf.2005.12.023
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005
   Beamish JA, 2009, BIOMATERIALS, V30, P6286, DOI 10.1016/j.biomaterials.2009.08.004
   Bhattacharya V, 2000, BLOOD, V95, P581
   BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0
   Bu XF, 2010, J SURG RES, V164, P50, DOI 10.1016/j.jss.2009.03.018
   Capila I., 2002, ANGEW CHEM INT EDIT, V1, 3, p[41, 390], DOI DOI 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.C0;2-B
   Ceylan H, 2011, BIOMATERIALS, V32, P8797, DOI 10.1016/j.biomaterials.2011.08.018
   Chen H, 2011, J CONTROL RELEASE, V150, P229, DOI 10.1016/j.jconrel.2010.11.011
   Chen L, 2009, J AM CHEM SOC, V131, P10467, DOI 10.1021/ja9019935
   Chen XY, 2007, ANAL BIOANAL CHEM, V388, P65, DOI 10.1007/s00216-006-0999-8
   Chen ZY, 2011, CHEM J CHINESE U, V32, P100
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Daemen J, 2007, CIRCULATION, V116, P316, DOI 10.1161/CIRCULATIONAHA.107.621342
   DAHL J, 2002, AM J CARDIOL, V89, P801
   DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0
   Davie EW, 2003, J BIOL CHEM, V278, P50819, DOI 10.1074/jbc.X300009200
   de Mel A, 2012, INT J BIOMATER, DOI 10.1155/2012/707863
   de Mel A, 2011, CHEM REV, V111, P5742, DOI 10.1021/cr200008n
   de Mel Achala, 2008, Expert Rev Cardiovasc Ther, V6, P1259, DOI 10.1586/14779072.6.9.1259
   De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016
   DION I, 1993, BIOMATERIALS, V14, P169, DOI 10.1016/0142-9612(93)90019-X
   Edelman ER, 2001, CIRCULATION, V103, P429
   Fan HL, 2009, SMALL, V5, P2144, DOI 10.1002/smll.200900345
   Fedel M, 2009, J BIOMED MATER RES B, V90B, P338, DOI 10.1002/jbm.b.31291
   Fink H, 2011, J TISSUE ENG REGEN M, V5, P454, DOI 10.1002/term.334
   Finley MJ, 2012, BIOMATERIALS, V33, P5803, DOI 10.1016/j.biomaterials.2012.04.051
   Fischer M, 2012, BIOMATERIALS, V33, P7677, DOI 10.1016/j.biomaterials.2012.07.007
   Freitas SC, 2012, ACTA BIOMATER, V8, P4101, DOI 10.1016/j.actbio.2012.07.020
   Freitas SC, 2010, BIOMATERIALS, V31, P3772, DOI 10.1016/j.biomaterials.2010.01.097
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Garg S., 2010, J AM COLL CARDIOL, V56, P43
   GERLACH J, 1989, ARTIF ORGANS, V13, P144, DOI 10.1111/j.1525-1594.1989.tb02849.x
   Golas A, 2010, BIOMATERIALS, V31, P1068, DOI 10.1016/j.biomaterials.2009.10.039
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gouzy MF, 2004, BIOMATERIALS, V25, P3493, DOI 10.1016/j.biomaterials.2003.10.091
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5
   Hoffman Allan S., 1982, ADV CHEM, V199
   Hoffmann J, 2008, J BIOMED MATER RES A, V84A, P614, DOI 10.1002/jbm.a.31309
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   Huang N, 2006, NUCL INSTRUM METH B, V242, P18, DOI 10.1016/j.nimb.2005.08.080
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Inoue Teruo, 2011, JACC-CARDIOVASC INTE, V10, P1057
   ISHIKAWA Y, 1984, THROMB RES, V35, P193, DOI 10.1016/0049-3848(84)90214-7
   Jen MC, 2012, ADV FUNCT MATER, V22, P239, DOI 10.1002/adfm.201101707
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Kador KE, 2011, ACTA BIOMATER, V7, P2508, DOI 10.1016/j.actbio.2011.03.015
   Khorana AA, 2003, ARTERIOSCL THROM VAS, V23, P2110, DOI 10.1161/23
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kihara S, 2003, ARTIF ORGANS, V27, P188, DOI 10.1046/j.1525-1594.2003.t01-2-06993.x
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Klomp M, 2009, EXPERT REV MED DEVIC, V6, P365, DOI 10.1586/ERD.09.16
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Kukreja N, 2008, PHARMACOL RES, V57, P171, DOI 10.1016/.i.phrs.2008.01.012
   Lee H., 2008, ADV MATER, V20, P1
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee JM, 2012, BIOMATERIALS, V33, P8917, DOI 10.1016/j.biomaterials.2012.08.066
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee YB, 2012, BIOMATERIALS, V33, P8343, DOI 10.1016/j.biomaterials.2012.08.011
   Lefevre G, 1997, CLIN PHARMACOL THER, V62, P50, DOI 10.1016/S0009-9236(97)90151-X
   Lepor NE, 2007, REV CARDIOVASC MED, V8, pS9
   Lewis AL, 2001, J MATER SCI-MATER M, V12, P865, DOI 10.1023/A:1012803503667
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104
   Lin QK, 2010, BIOMATERIALS, V31, P4017, DOI 10.1016/j.biomaterials.2010.01.092
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Maitz M. F., 2012, J BIOMED MATER RES A, V100A, P2421
   Maitz MF, 2010, J BIOMED MATER RES A, V94A, P905, DOI 10.1002/jbm.a.32780
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3
   Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u
   Martin DM, 2011, MED ENG PHYS, V33, P148, DOI 10.1016/j.medengphy.2010.10.009
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Melchiorr Anthony J., TISSUE ENG PART B-RE, DOI DOI 10.I089/TEN.TEB.2012.0577
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Meyers SR, 2012, CHEM REV, V112, P1615, DOI 10.1021/cr2000916
   Murugesan S, 2008, CURR TOP MED CHEM, V8, P80
   Nan H., 1998, BIOMATERIALS, V19, P771
   Nazneen F, 2012, J BIOMED MATER RES B, V100B, P1989, DOI 10.1002/jbm.b.32772
   Nguyen Minh Luan, 2011, BIOMATERIALS, V32, P6487
   Nilsson PH, 2010, BIOMATERIALS, V31, P4484, DOI 10.1016/j.biomaterials.2010.02.036
   Noh H, 2006, BIOMATERIALS, V27, P5801, DOI 10.1016/j.biomaterials.2006.08.005
   Nurdin N., 2003, European Cells & Materials, V5, P17
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Robinson DE, 2008, ADV MATER, V20, P1166, DOI 10.1002/adma.200702586
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Rzany A., 2001, PROG BIOMED RES, P182
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   SAPIRSTEIN W, 1994, CIRCULATION, V89, P1900, DOI 10.1161/01.CIR.89.4.1900
   Sharif F, 2004, CARDIOVASC RES, V64, P208, DOI 10.1016/j.cardiores.2004.07.003
   Sharif F, 2008, MOL THER, V16, P1674, DOI 10.1038/mt.2008.165
   Shirota T, 2003, BIOMATERIALS, V24, P2295, DOI 10.1016/S0142-9612(03)00042-5
   Sim DS, 2009, TISSUE ENG REGEN MED, V6, P555
   Sin DC, 2009, EXPERT REV MED DEVIC, V6, P51, DOI 10.1586/17434440.6.1.51
   Smith Roger S., 2012, SCI TRANSL MED, V4, P132
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   Tanzi MC, 2005, EXPERT REV MED DEVIC, V2, P473, DOI 10.1586/17434440.2.4.473
   Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010
   Tsyganov I, 2005, SURF COAT TECH, V200, P1041, DOI 10.1016/j.surfcoat.2005.02.093
   Tu Qiufen, 2012, TISSUE ENG PART A, V19, P91
   Veleva AN, 2007, BIOTECHNOL BIOENG, V98, P306, DOI 10.1002/bit.21420
   Villalona GA, 2010, TISSUE ENG PART B-RE, V16, P341, DOI 10.1089/ten.TEB.2009.0527
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wang XW, 2007, WORLD J SURG, V31, P682, DOI 10.1007/s00268-006-0731-z
   Warkentin Theodore E., 2004, BEST PRACT RES CLIN, V17, P105
   Weng YJ, 2011, BIOMATERIALS, V32, P1253, DOI 10.1016/j.biomaterials.2010.10.039
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   Windecker S, 2005, CIRCULATION, V111, P2617, DOI 10.1161/CIRCULASTIONAHA.104.486647
   Wischke C, 2011, CLIN HEMORHEOL MICRO, V49, P347, DOI 10.3233/CH-2011-1485
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447
   Wu X, 2011, J BIOMED MATER RES A, V98A, P442, DOI 10.1002/jbm.a.33133
   Xia F, 2008, ADV MATER, V20, P2842, DOI 10.1002/adma.200800836
   Yang J, 2013, BIOMATERIALS, V34, P1635, DOI 10.1016/j.biomaterials.2012.11.006
   Yang ZL, 2012, ADV HEALTHC MATER, V1, P548, DOI 10.1002/adhm.201200073
   Yang ZL, 2012, BIOMATERIALS, V33, P7959, DOI 10.1016/j.biomaterials.2012.07.050
   Yang ZL, 2012, BIOMATERIALS, V33, P6615, DOI 10.1016/j.biomaterials.2012.06.055
   Yang ZL, 2010, BIOMATERIALS, V31, P2072, DOI 10.1016/j.biomaterials.2009.11.091
   Yazdani SK, 2012, J INTERV CARDIOL, V4, P169, DOI [10.2217/ica.11.99, DOI 10.2217/ICA.11.99]
   Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
   Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x
   You I, 2011, BIOCONJUGATE CHEM, V22, P1264, DOI 10.1021/bc2000534
   Yu J, 2012, BIOMATERIALS, V33, P8062, DOI 10.1016/j.biomaterials.2012.07.042
   Zeng W, 2010, BIOMATERIALS, V31, P1636, DOI 10.1016/j.biomaterials.2009.11.037
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhu JZ, 2012, BIOMATERIALS, V33, P8204, DOI 10.1016/j.biomaterials.2012.07.066
NR 144
TC 41
Z9 43
U1 7
U2 72
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD OCT 25
PY 2013
VL 233
BP 80
EP 90
DI 10.1016/j.surfcoat.2013.02.008
PG 11
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 277GX
UT WOS:000328808100010
DA 2018-10-20
ER

PT J
AU Flynn, CN
   Byrne, CP
   Meenan, BJ
AF Flynn, C. N.
   Byrne, C. P.
   Meenan, B. J.
TI Surface modification of cellulose via atmospheric pressure plasma
   processing in air and ammonia-nitrogen gas
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Cellulose; Atmospheric pressure plasma modification; Dielectric barrier
   discharge; Water contact angle; Surface analysis
ID DIELECTRIC BARRIER DISCHARGE; BACTERIAL CELLULOSE; ADHESION; POLYMERS;
   OXYGEN
AB Changes to the surface properties of cellulose induced by a dielectric barrier discharge (DBD) plasma operating at atmospheric pressure in both air and an ammonia/nitrogen gas mixture have been analysed using water contact angle, XPS and AFM. The water contact angle for cellulose processed in air decreased significantly after exposure to DBD. XPS indicated that changes in surface chemistry are not the main cause of this reduction in wettability. AFM studies clearly show that a significant increase in surface roughness results from the plasma treatment and that there is a correlation between the increased Ra/Rq values for higher applied power and processing cycle numbers and the associated changes observed in the water contact angles. When cellulose is plasma processed in a v/v 10%NH3/90%N-2 gas mixture the surface undergoes functionalisation with nitrogen groups as indicated by XPS analysis. Specifically, the formation of both amine (-NH2) and to a lesser extent amide (-CONH2) moieties is evident. The contact angle results for these samples indicate an initial decrease in wettability followed by relaxation to slightly higher values consistent with a degree of surface relaxation post-processing. The corresponding AFM data indicate that whereas the slight increase in surface roughness contributes to the change in hydrophilicity, unlike processing in air, it is not the only factor involved. In this case, it is the modified surface chemistry that has the greatest influence for cellulose processed under these conditions. Hence, despite its inherently high oxygen content, cellulose can be modified using atmospheric plasma in air and 10%NH3/90%N-2 to produce modified surface properties known to actively promote biological cell adhesion. This offers a route to enhance the role that this abundant biomaterial can play as a construct for tissue engineering and related applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Flynn, C. N.; Byrne, C. P.; Meenan, B. J.] Univ Ulster, Nanotechnol & Integrated Bioengn Ctr NIBEC, Sch Engn, Coleraine BT37 0QB, Londonderry, North Ireland.
RP Meenan, BJ (reprint author), Univ Ulster, Nanotechnol & Integrated Bioengn Ctr NIBEC, Shore Rd, Coleraine BT37 0QB, Londonderry, North Ireland.
EM bj.meenan@ulster.ac.uk
CR Bhat NV, 2000, J APPL POLYM SCI, V76, P258, DOI 10.1002/(SICI)1097-4628(20000411)76:2<258::AID-APP15>3.0.CO;2-U
   Briggs D., 1998, SURFACE ANAL POLYM X
   Cagniant D, 2002, J ANAL APPL PYROL, V65, P1, DOI 10.1016/S0165-2370(01)00172-3
   Calvimontes A, 2011, CELLULOSE, V18, P803, DOI 10.1007/s10570-011-9511-5
   Charpentier PA, 2006, APPL SURF SCI, V252, P6360, DOI 10.1016/j.apsusc.2005.09.064
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   D'Sa RA, 2009, LANGMUIR, V26, P1894
   D'Sa RA, 2010, ACTA BIOMATER, V6, P2609, DOI 10.1016/j.actbio.2010.01.015
   de Jesus Martinez-Gomez A., 2009, CELLULOSE, V16, P501
   Deslandes Y., 1998, PLASMAS POLYM, V3, P61
   Dowling DP, 2011, PLASMA PROCESS POLYM, V8, P718, DOI 10.1002/ppap.201000145
   Fu RKY, 2005, NUCL INSTRUM METH B, V237, P417, DOI 10.1016/j.nimb.2005.05.029
   Ishihara K, 1995, ARTIF ORGANS, V19, P1215, DOI 10.1111/j.1525-1594.1995.tb02288.x
   Junkar I, 2009, VACUUM, V84, P83, DOI 10.1016/j.vacuum.2009.04.011
   Kolarova K, 2013, CELLULOSE, V20, P953, DOI 10.1007/s10570-013-9863-0
   Little U, 2009, ACTA BIOMATER, V5, P2025, DOI 10.1016/j.actbio.2009.01.042
   Liu C, 2004, SURF COAT TECH, V185, P311
   Liu CZ, 2006, APPL SURF SCI, V252, P2297, DOI 10.1016/j.apsusc.2005.04.016
   Mahlberg R, 1999, LANGMUIR, V15, P2985, DOI 10.1021/la980139b
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Niu JH, 2011, SURF COAT TECH, V205, P3434, DOI 10.1016/j.surfcoat.2010.12.004
   Pertile R, 2012, BIOTECHNOL PROGR, V28, P526, DOI 10.1002/btpr.1501
   Pertile RAN, 2010, CARBOHYD POLYM, V82, P692, DOI 10.1016/j.carbpol.2010.05.037
   VANDERWIELEN LC, 2004, EUR POLYM J, V40, P477
   Yasuda H., 1981, Journal of Polymer Science, Polymer Physics Edition, V19, P1285, DOI 10.1002/pol.1981.180190901
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
NR 27
TC 18
Z9 18
U1 3
U2 37
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD OCT 25
PY 2013
VL 233
BP 108
EP 118
DI 10.1016/j.surfcoat.2013.04.007
PG 11
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 277GX
UT WOS:000328808100013
DA 2018-10-20
ER

PT J
AU Coad, BR
   Jasieniak, M
   Griesser, SS
   Griesser, HJ
AF Coad, Bryan R.
   Jasieniak, Marek
   Griesser, Stefani S.
   Griesser, Hans J.
TI Controlled covalent surface immobilisation of proteins and peptides
   using plasma methods
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Bio-interfaces; Plasma polymerisation; Coating; Aldehyde; Epoxide;
   Antibacterial coating
ID PHOTOELECTRON-SPECTROSCOPY DATA; ION-IMPLANTATION TREATMENT; POLYMER
   SURFACES; ACRYLIC-ACID; BIOMOLECULE IMMOBILIZATION; FUNCTIONAL SURFACES;
   ATTACHMENT; FILMS; TROPOELASTIN; BIOFUNCTIONALIZATION
AB Coated layers of biologically active molecules on synthetic biomaterials and biomedical devices can promote a variety of desirable biological reactions by the host body or the biological medium, such as cell and tissue attachment or deterring bacterial biofilm formation. Such coated layers should be immobilised covalently in order to avoid competitive displacement phenomena, and the use of surface-activating plasmas or plasma polymer interlayers with suitable chemical surface groups has proved to be very convenient means of grafting bioactive molecules onto solid materials surfaces. We review selected work on the covalent immobilisation of proteins and peptides onto solid biomaterial surfaces and describe efforts towards plasma methods that allow biomolecules to be covalently captured in a single step. After reviewing a number of approaches, we discuss in more detail the use of plasma polymer interlayers that possess aldehyde or epoxide surface groups; these groups react readily with amine groups on proteins and peptides without undesirable side reactions, and avoid other issues such as crosslinking. We also emphasise the importance of detailed surface analysis to verify that covalent grafting has indeed taken place, and to assess the surface density of grafted molecules. With suitably chosen peptides or proteins, such covalently grafted layers can support the surface attachment of delicate cells, or combat bacterial biofilm formation. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Coad, Bryan R.; Jasieniak, Marek; Griesser, Stefani S.; Griesser, Hans J.] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
RP Griesser, HJ (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
EM hans.griesser@unisa.edu.au
RI Griesser, Hans/E-5628-2011; Coad, Bryan/B-4505-2009
OI Griesser, Hans/0000-0003-1072-7863; Coad, Bryan/0000-0003-3297-3977
FU NHMRC [631931]; Cooperative Research Centres Scheme via the Wound
   Management Innovation CRC [2-03]
FX This work was supported partly by the NHMRC via project grant 631931
   (BRC) and by the Cooperative Research Centres Scheme via the Wound
   Management Innovation CRC, project 2-03 (MJ and SSG).
CR Abbas A, 2009, COLLOID SURFACE B, V73, P315, DOI 10.1016/j.colsurfb.2009.06.007
   Bax DV, 2011, BIOMATERIALS, V32, P6710, DOI 10.1016/j.biomaterials.2011.05.060
   Bax DV, 2011, BIOMATERIALS, V32, P5100, DOI 10.1016/j.biomaterials.2011.03.079
   Bilek Marcela M, 2010, Biophys Rev, V2, P55, DOI 10.1007/s12551-010-0028-1
   Bilek MMM, 2011, P NATL ACAD SCI USA, V108, P14405, DOI 10.1073/pnas.1103277108
   Blattler TM, 2006, LANGMUIR, V22, P5760, DOI 10.1021/la0602766
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Charbonneau C, 2012, MACROMOL BIOSCI, V12, P812, DOI 10.1002/mabi.201100447
   Chen GL, 2011, PLASMA PROCESS POLYM, V8, P701, DOI 10.1002/ppap.201100008
   Christo SN, 2012, AUST J CHEM, V65, P45, DOI 10.1071/CH11311
   Chrzanowski W, 2012, J MATER SCI-MATER M, V23, P2203, DOI 10.1007/s10856-012-4687-2
   Chu LQ, 2008, BIOSENS BIOELECTRON, V24, P118, DOI 10.1016/j.bios.2008.03.026
   Coad BR, 2012, ACS APPL MATER INTER, V4, P2455, DOI 10.1021/am300128n
   Coad BR, 2012, LANGMUIR, V28, P2710, DOI 10.1021/la204714p
   D'Sa RA, 2011, SOFT MATTER, V7, P608, DOI 10.1039/c0sm00936a
   Martinez-Gomez AD, 2010, POLYM BULL, V65, P293, DOI 10.1007/s00289-010-0258-1
   Deeken CR, 2011, J BIOMED MATER RES B, V97B, P334, DOI 10.1002/jbm.b.31819
   Diener KR, 2012, ACTA BIOMATER, V8, P99, DOI 10.1016/j.actbio.2011.09.001
   Duque L, 2010, BIOMACROMOLECULES, V11, P2818, DOI 10.1021/bm100910q
   Gan BK, 2008, J BIOMED MATER RES A, V85A, P605, DOI 10.1002/jbm.a.31612
   Gan BK, 2007, LANGMUIR, V23, P2741, DOI 10.1021/la062722v
   Garvey M, 2011, BIOPOLYMERS, V95, P376, DOI 10.1002/bip.21584
   GENGENBACH TR, 1994, J ADHES SCI TECHNOL, V8, P305, DOI 10.1163/156856194X00267
   Gengenbach TR, 1996, SURF INTERFACE ANAL, V24, P271, DOI 10.1002/(SICI)1096-9918(199604)24:4<271::AID-SIA116>3.3.CO;2-A
   Ghasemi M, 2011, J PHYS CHEM B, V115, P10228, DOI 10.1021/jp204097a
   Gong X, 2000, J POLYM SCI POL PHYS, V38, P2323, DOI 10.1002/1099-0488(20000901)38:17<2323::AID-POLB120>3.0.CO;2-6
   Gong X, 1997, PLASMAS POLYM, V2, P261
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Haddow DB, 2000, LANGMUIR, V16, P5654, DOI 10.1021/la991537x
   Harris LG, 2007, CHEM MATER, V19, P1546, DOI 10.1021/cm0624670
   Heyse P, 2008, PLASMA PROCESS POLYM, V5, P186, DOI 10.1002/ppap.200700061
   Heyse P, 2011, PLASMA PROCESS POLYM, V8, P965, DOI 10.1002/ppap.201000170
   Hirsh SL, 2011, J MATER CHEM, V21, P17832, DOI 10.1039/c1jm13376d
   Hirsh SL, 2010, LANGMUIR, V26, P14380, DOI 10.1021/la1019845
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Kondyurin A, 2011, J APPL POLYM SCI, V120, P2891, DOI 10.1002/app.33355
   Kurkuri MD, 2011, J MATER CHEM, V21, P8841, DOI 10.1039/c1jm10317b
   Leich MA, 1998, MACROMOLECULES, V31, P7618, DOI 10.1021/ma980332c
   MacDonald C, 2008, J R SOC INTERFACE, V5, P663, DOI 10.1098/rsif.2007.1352
   Mishra G, 2011, POLYMER, V52, P1882, DOI 10.1016/j.polymer.2011.03.004
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   North SH, 2010, ACS APPL MATER INTER, V2, P2884, DOI 10.1021/am100566e
   Nosworthy NJ, 2009, BIOMACROMOLECULES, V10, P2577, DOI 10.1021/bm900523m
   Nuhiji E, 2012, ACS APPL MATER INTER, V4, P2912, DOI 10.1021/am300087k
   Rosso M, 2010, LANGMUIR, V26, P866, DOI 10.1021/la9023103
   Russo L, 2011, MATER TODAY, V14, P164, DOI 10.1016/S1369-7021(11)70088-8
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Strola S, 2010, SURF INTERFACE ANAL, V42, P1311, DOI 10.1002/sia.3297
   Thierry B, 2008, LANGMUIR, V24, P10187, DOI 10.1021/la801140u
   Thierry B, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3480573
   Vasilev K, 2011, PLASMA PROCESS POLYM, V8, P1010, DOI 10.1002/ppap.201100097
   Vasilev K, 2009, CHEM COMMUN, P3600, DOI 10.1039/b904367e
   Vreuls C, 2010, J MATER CHEM, V20, P8092, DOI 10.1039/c0jm01419b
   VROMAN L, 1980, BLOOD, V55, P156
   Waterhouse A, 2012, BIOMATERIALS, V33, P7984, DOI 10.1016/j.biomaterials.2012.07.059
   Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062
   Wise SG, 2012, NANOMEDICINE-UK, V7, P1907, DOI [10.2217/NNM.12.161, 10.2217/nnm.12.161]
   Yang ZL, 2011, PLASMA PROCESS POLYM, V8, P850, DOI 10.1002/ppap.201000101
   Yin YB, 2010, PLASMA PROCESS POLYM, V7, P708, DOI 10.1002/ppap.200900171
   Yin YB, 2009, PLASMA PROCESS POLYM, V6, P658, DOI 10.1002/ppap.200900045
   Yin YB, 2009, SURF COAT TECH, V203, P1310, DOI 10.1016/j.surfcoat.2008.10.035
   Yin YB, 2009, PLASMA PROCESS POLYM, V6, P68, DOI 10.1002/ppap.200800108
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
NR 64
TC 38
Z9 38
U1 2
U2 70
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD OCT 25
PY 2013
VL 233
BP 169
EP 177
DI 10.1016/j.surfcoat.2013.05.019
PG 9
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 277GX
UT WOS:000328808100019
DA 2018-10-20
ER

PT J
AU Pennesi, C
   Totti, C
   Beolchini, F
AF Pennesi, Chiara
   Totti, Cecilia
   Beolchini, Francesca
TI Removal of Vanadium(III) and Molybdenum(V) from Wastewater Using
   Posidonia oceanica (Tracheophyta) Biomass
SO PLOS ONE
LA English
DT Article
ID SPENT REFINERY CATALYSTS; L. DELILE; METAL CONTAMINATION; BIOSORPTION;
   SEAGRASS; EQUILIBRIUM; RECOVERY; CHROMIUM; ALGAE; VALIDATION
AB The use of dried and re-hydrated biomass of the seagrass Posidonia oceanica was investigated as an alternative and -low-cost biomaterial for removal of vanadium(III) and molybdenum(V) from wastewaters. Initial characterisation of this biomaterial identified carboxylic groups on the cuticle as potentially responsible for cation sorption, and confirmed the toxic-metal bioaccumulation. The combined effects on biosorption performance of equilibrium pH and metal concentrations were investigated in an ideal single-metal system and in more real-life multicomponent systems. There were either with one metal (vanadium or molybdenum) and sodium nitrate, as representative of high ionic strength systems, or with the two metals (vanadium and molybdenum). For the single-metal solutions, the optimum was at pH 3, where a significant proportion of vanadium was removed (ca. 70%) while there was ca. 40% adsorption of molybdenum. The data obtained from the more real-life multicomponent systems showed that biosorption of one metal was improved both by the presence of the other metal and by high ionic strength, suggesting a synergistic effect on biosorption rather than competition. There data ware used for the development of a simple multi-metal equilibrium model based on the noncompetitive Langmuir approach, which was successfully fitted to experimental data and represents a useful support tool for the prediction of biosorption performance in such real-life systems. Overall, the results suggest that biomass of P. oceanica can be used as an efficient biosorbent for removal of vanadium(III) and molybdenum(V) from aqueous solutions. This process thus offers an eco-compatible solution for the reuse of the waste material of leaves that accumulate on the beach due to both human activities and to storms at sea.
C1 [Pennesi, Chiara; Totti, Cecilia; Beolchini, Francesca] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy.
RP Pennesi, C (reprint author), Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy.
EM c.pennesi@univpm.it
RI Totti, Cecilia Maria/A-9178-2016; Beolchini, Francesca/L-6205-2014
OI Totti, Cecilia Maria/0000-0002-1532-6009; Beolchini,
   Francesca/0000-0002-6211-6354; Pennesi, Chiara/0000-0002-5774-2190
FU Polytechnic University of the Marche
FX This study was funded by research funds of the Polytechnic University of
   the Marche. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allouche FN, 2011, CHEM ENG J, V168, P1174, DOI 10.1016/j.cej.2011.02.005
   Aydin M, 2012, J RADIOANAL NUCL CH, V293, P489, DOI 10.1007/s10967-012-1782-2
   Benavente J, 1998, COLLOID SURFACE A, V140, P333, DOI 10.1016/S0927-7757(97)00290-2
   Benedetto G, 2012, DOSSIER COSTE PROFIL
   Beolchini F, 2006, ENVIRON SCI TECHNOL, V40, P2746, DOI 10.1021/es052114m
   Beolchini F, 2005, HYDROMETALLURGY, V76, P73, DOI 10.1016/j.hydromet.2004.09.003
   Beolchini F, 2010, J HAZARD MATER, V178, P529, DOI 10.1016/j.jhazmat.2010.01.114
   Boudouresque C.F., 1982, CAHIERS PARC NATL PO, V4, P1
   Boudouresque C.F., 2006, PRESERVATION CONSERV
   Bulgariu D, 2012, BIORESOURCE TECHNOL, V103, P489, DOI 10.1016/j.biortech.2011.10.016
   Cengiz S, 2012, CHEM ENG J, V189, P32, DOI 10.1016/j.cej.2012.02.015
   Cozza R, 2006, AQUAT BOT, V85, P317, DOI 10.1016/j.aquabot.2006.06.010
   Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Demirak A, 2011, MICROCHEM J, V99, P97, DOI 10.1016/j.microc.2011.04.002
   Ferrat L, 2003, AQUAT TOXICOL, V65, P187, DOI 10.1016/S0166-445X(03)00133-4
   Ferrat L, 2003, COMP BIOCHEM PHYS C, V134, P147, DOI 10.1016/S1532-0456(02)00220-X
   FOUREST E, 1996, TOXICOL ENVIRON CHEM, V54, P1
   Fourqurean JW, 2007, MAR BIOL, V151, P219, DOI 10.1007/s00227-006-0473-3
   Francour P., 2006, MANAGEMENT GUIDE MAR
   Gacia E, 2007, ESTUAR COAST SHELF S, V72, P579, DOI 10.1016/j.ecss.2006.11.021
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   Gerke TL, 2010, SCI TOTAL ENVIRON, V408, P5845, DOI 10.1016/j.scitotenv.2010.08.036
   Giordani T, 2000, PLANT PHYSIOL, V123, P1571, DOI 10.1104/pp.123.4.1571
   Gonzalez-Correa JM, 2005, J EXP MAR BIOL ECOL, V320, P65, DOI 10.1016/j.jembe.2004.12.032
   Hoffman R. V, 2004, ORGANIC CHEM INTERME
   Izquierdo M, 2010, BIORESOURCE TECHNOL, V101, P510, DOI 10.1016/j.biortech.2009.08.018
   Izqulerdo M, 2012, CLEAN-SOIL AIR WATER, V40, P428, DOI 10.1002/clen.201100303
   Khiari R, 2010, BIORESOURCE TECHNOL, V101, P775, DOI 10.1016/j.biortech.2009.08.079
   Krika F, 2012, INT J ENVIRON RES, V6, P719
   Lafabrie C, 2008, MAR POLLUT BULL, V57, P155, DOI 10.1016/j.marpolbul.2007.10.007
   Lafabrie C, 2008, ENVIRON POLLUT, V151, P262, DOI 10.1016/j.envpol.2007.01.047
   Lafabrie C, 2007, CHEMOSPHERE, V68, P2033, DOI 10.1016/j.chemosphere.2007.02.039
   Lafabrie C, 2007, ENVIRON POLLUT, V148, P688, DOI 10.1016/j.envpol.2006.11.015
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Liber K, 2011, ECOTOX ENVIRON SAFE, V74, P1171, DOI 10.1016/j.ecoenv.2011.02.014
   Maserti BE, 2005, AQUAT TOXICOL, V75, P288, DOI 10.1016/j.aquatox.2005.08.008
   Med-GIG, 2007, WFD INT TECHN REP 3
   Michalowski T, 2005, TALANTA, V65, P1241, DOI 10.1016/j.talanta.2004.08.053
   Michalowski T, 2008, ANAL CHIM ACTA, V606, P172, DOI 10.1016/j.aca.2007.11.020
   Montazer-Rahmati MM, 2011, J HAZARD MATER, V185, P401, DOI 10.1016/j.jhazmat.2010.09.047
   Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015
   Ncibi MC, 2009, DESALINATION, V243, P109, DOI 10.1016/j.desal.2008.04.018
   Ncibi MC, 2007, J HAZARD MATER, V139, P280, DOI 10.1016/j.jhazmat.2006.06.029
   Pennesi C, 2012, WATER ENVIRON RES, V84, P1
   Pennesi C, 2012, J APPL PHYCOL, V24, P1495, DOI 10.1007/s10811-012-9808-2
   Piazzi L, 1999, AQUAT BOT, V63, P103, DOI 10.1016/S0304-3770(98)00115-6
   Puigdomenech I., 2009, PROGRAM MEDUSA MAKE
   Rocchetti L, 2013, WASTE MANAGE RES, V31, P568, DOI 10.1177/0734242X13476364
   Sari A, 2008, J HAZARD MATER, V160, P349, DOI 10.1016/j.jhazmat.2008.03.005
   Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036
   Shriver D. F., 1999, INORGANIC CHEM
   Stasko R, 2006, MATER CHARACT, V56, P340, DOI 10.1016/j.matchar.2005.09.012
   Tang ZH, 2008, MATER CHARACT, V59, P717, DOI 10.1016/j.matchar.2007.06.001
   Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X
   Volesky B, 1990, BIOSORPTION HEAVY ME, P7
   Wahab MA, 2011, J HAZARD MATER, V191, P333, DOI 10.1016/j.jhazmat.2011.04.085
   Whittaker G, 2000, BIOS INSTANT NOTES P
NR 58
TC 12
Z9 12
U1 1
U2 45
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 25
PY 2013
VL 8
IS 10
AR e76870
DI 10.1371/journal.pone.0076870
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 241GW
UT WOS:000326155400019
PM 24204692
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sebastiani, F
   Orecchini, A
   Paciaroni, A
   Jasnin, M
   Zaccai, G
   Moulin, M
   Haertlein, M
   De Francesco, A
   Petrillo, C
   Sacchetti, F
AF Sebastiani, F.
   Orecchini, A.
   Paciaroni, A.
   Jasnin, M.
   Zaccai, G.
   Moulin, M.
   Haertlein, M.
   De Francesco, A.
   Petrillo, C.
   Sacchetti, F.
TI Collective THz dynamics in living Escherichia coli cells
SO CHEMICAL PHYSICS
LA English
DT Article
DE In vivo biomolecular dynamics; Picosecond collective density
   fluctuations; Brillouin neutron scattering
ID BRILLOUIN NEUTRON SPECTROSCOPY; IN-VIVO; NMR-SPECTROSCOPY; HYDRATION
   WATER; LIQUID WATER; SCATTERING; PROTEINS; STABILITY; SOUND;
   SPECTROMETER
AB We have employed neutron Brillouin spectroscopy to study coherent collective density fluctuations in the biological macromolecular components of living Escherichia coli cells. To highlight the contribution of the macromolecular material alone, a suitably prepared mixture of light and heavy water was exploited to cancel the scattering length of intracellular water. The present results indicate that the cellular biomaterial sustains THz coherent density fluctuations, characterised by a propagating mode travelling at about 3600 m/s and by a localised mode at energies between 4 and 7 meV. A comparison with both hydration water and simpler biomolecules, such as proteins or DNA, brings further support to the idea that the dynamical coupling between biomolecular structures and biological water provides the delicate dynamical adaptation needed to achieve a full biological functionality. Finally, the behaviour of the damping factors of the observed collective modes strengthens the dynamical similarity of biological systems with glass-forming materials. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Sebastiani, F.; Orecchini, A.; Paciaroni, A.; Petrillo, C.; Sacchetti, F.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy.
   [Sebastiani, F.; Orecchini, A.; Paciaroni, A.; Petrillo, C.; Sacchetti, F.] Univ Perugia, Dipartimento Fis, CNR, Ist Officina Mat,Unita Perugia, I-06123 Perugia, Italy.
   [Orecchini, A.; Zaccai, G.] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France.
   [Jasnin, M.] Max Planck Inst Biochem, D-82152 Martinsried, Germany.
   [Moulin, M.; Haertlein, M.] Inst Max Von Laue Paul Langevin, Deuterat Lab, F-38042 Grenoble, France.
   [De Francesco, A.] Inst Max Von Laue Paul Langevin, Unita Grenoble, CNR, Ist Officina Mat, F-38042 Grenoble, France.
RP Orecchini, A (reprint author), Univ Perugia, Dipartimento Fis, Via Pascoli, I-06123 Perugia, Italy.
EM andrea.orecchini@pg.infn.it
RI Sebastiani, Federico/Q-5520-2018; paciaroni, alessandro/J-2447-2012
OI paciaroni, alessandro/0000-0002-3952-1634
CR Aisa D, 2005, NUCL INSTRUM METH A, V544, P620, DOI 10.1016/j.nima.2004.12.037
   BELLISSENTFUNEL MC, 1989, BIOPHYS J, V56, P713, DOI 10.1016/S0006-3495(89)82718-3
   Boekelheide N, 2011, P NATL ACAD SCI USA, V108, P16159, DOI 10.1073/pnas.1106397108
   BROOKS CL, 1988, ADV CHEM PHYS, V71, P1
   Chaplin M., 2006, MOL CELL BIOL, V7, P861
   Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102
   Cornicchi E, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3609101
   Cunsolo A, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2174007
   Cunsolo A, 2010, J PHYS CHEM B, V114, P16713, DOI 10.1021/jp1073768
   Ebbinghaus S, 2010, NAT METHODS, V7, P319, DOI [10.1038/NMETH.1435, 10.1038/nmeth.1435]
   Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a
   Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754
   Gabel F, 2002, Q REV BIOPHYS, V35, P327, DOI 10.1017/S0033583502003840
   Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591
   Hartschuh RD, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021907
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101
   Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839
   Jasnin M, 2008, BIOPHYS J, V95, P857, DOI 10.1529/biophysj.107.124420
   Jasnin M, 2008, EMBO REP, V9, P543, DOI 10.1038/embor.2008.50
   Johnson JL, 1997, CELL, V90, P201, DOI 10.1016/S0092-8674(00)80327-X
   Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408
   LEE SA, 1987, BIOPOLYMERS, V26, P1637, DOI 10.1002/bip.360261002
   Leu B.M., 1995, J CHEM PHYS, V132
   Liu D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.135501
   Madigan M., 2010, BROCK BIOL MICROORGA
   Matic A, 2001, PHYS REV LETT, V86, P3803, DOI 10.1103/PhysRevLett.86.3803
   Monaco G, 2009, P NATL ACAD SCI USA, V106, P3659, DOI 10.1073/pnas.0808965106
   Orecchini A, 2008, CONDENS MATTER PHYS, V11, P19
   Orecchini A, 2012, J PHYS CONF SER, V340, DOI 10.1088/1742-6596/340/1/012091
   Orecchini A, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/6/064105
   Orecchini A, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/3/034026
   Orecchini A, 2001, J PHYS CHEM B, V105, P12150, DOI 10.1021/jp0114889
   Orecchini A, 2009, J AM CHEM SOC, V131, P4664, DOI 10.1021/ja807957p
   Osborne MJ, 2001, BIOCHEMISTRY-US, V40, P9846, DOI 10.1021/bi010621k
   Paciaroni A, 2012, J PHYS CHEM B, V116, P3861, DOI 10.1021/jp211190q
   Persson E, 2008, P NATL ACAD SCI USA, V105, P6266, DOI 10.1073/pnas.0709585105
   PETRILLO C, 1990, ACTA CRYSTALLOGR A, V46, P440, DOI 10.1107/S0108767389013000
   Pontecorvo E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011501
   Qvist J, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3578472
   Ramakrischnaiah K., 1990, B ELECTROCHEM, V6, P366
   RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0
   Rossignol C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988470
   Russo D, 2012, SPECTROSC-INT J, V27, P293, DOI 10.1155/2012/671265
   Sacchetti F, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061203
   Sebastiani F., 2012, THESIS
   Serber Z, 2001, J AM CHEM SOC, V123, P2446, DOI 10.1021/ja0057528
   Sette F, 1996, PHYS REV LETT, V77, P83, DOI 10.1103/PhysRevLett.77.83
   Speziale S, 2003, BIOPHYS J, V85, P3202, DOI 10.1016/S0006-3495(03)74738-9
   Stadler AM, 2009, BIOPHYS J, V96, P5073, DOI 10.1016/j.bpj.2009.03.043
   Stadler AM, 2008, J AM CHEM SOC, V130, P16852, DOI 10.1021/ja807691j
   Tehei M, 2004, EMBO REP, V5, P66, DOI 10.1038/sj.embor.7400049
   Violini N, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.134204
   Yoshida K, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3484238
   Yu X, 2003, J CHEM PHYS, V119, P12673, DOI 10.1063/1.1626636
   Zaccai G, 2013, CURR PHYS CHEM, V3, P9
NR 56
TC 9
Z9 9
U1 2
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-0104
EI 1873-4421
J9 CHEM PHYS
JI Chem. Phys.
PD OCT 16
PY 2013
VL 424
BP 84
EP 88
DI 10.1016/j.chemphys.2013.06.020
PG 5
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 252DA
UT WOS:000326983700016
DA 2018-10-20
ER

PT J
AU Filion, D
   Buschmann, MD
AF Filion, Dominic
   Buschmann, Michael D.
TI Chitosan-glycerol-phosphate (GP) gels release freely diffusible GP and
   possess titratable fixed charge
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan; Glycerol phosphate; Diffusion; Gel; Ionization
ID ARTICULAR-CARTILAGE; DELIVERY; BONE
AB Chitosan-glycerol-phosphate (GP) solutions undergo a sol-gel transition upon heating. A model of heat-induced transfer of protons from chitosan to GP in solution has been proposed to explain this sol-gel transition. This model suggests that reduced inter-chain electrostatic repulsion by a decreased protonation of positively charged amino groups - via proton transfer to GP(2-) thereby reduced to GP(-) - would allow chitosan polymer chains to precipitate together and form a solid hydrogel structure. The hypothesis that GP has the single role of acting as a proton acceptor and not as a divalent electrostatic cross-linker of chitosan amine groups suggests that it should freely diffuse out of the gel after the gel formation. We found indeed that GP is free to diffuse and the experimental diffusion profile corresponds to a free diffusion model indicating that it plays no role in electrostatic cross-linking.
   Finally since chitosan amine groups in the gel are not bound to GP, we examined whether they are titratable in the gel. We show that chitosan in the hydrogel indeed possesses titratable amine groups with significant fixed charge up to +80 mM and follows the same ionization behavior as chitosan in solution. The results of these studies are significant in light of the current and future biomedical applications of this system, including its recent clinical approval as a biomaterial for cartilage repair. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Buschmann, Michael D.] Ecole Polytech, Dept Chem Engn, Inst Biomed Engn, Montreal, PQ H3C 3A7, Canada.
   [Filion, Dominic] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.
RP Buschmann, MD (reprint author), Ecole Polytech, Dept Chem Engn, Inst Biomed Engn, POB 6079,Stn Ctr Ville, Montreal, PQ H3C 3A7, Canada.
EM dominic.filion@ircm.qc.ca; micheal.buschmann@polymtl.ca
OI Buschmann, Michael/0000-0002-2242-6198
CR Bayarri S, 2001, FOOD HYDROCOLLOID, V15, P67, DOI 10.1016/S0268-005X(00)00052-7
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Donnan FG, 1911, Z ELKTROCHEM ANGEW P, V17, P572
   Dumont J, 1999, CONNECT TISSUE RES, V40, P259, DOI 10.3109/03008209909000704
   Filion D, 2007, BIOMACROMOLECULES, V8, P3224, DOI 10.1021/bm700520m
   Hoemann CD, 2007, J BIOMED MATER RES A, V83A, P521, DOI 10.1002/jbm.a.31365
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Hoppe-Seiler F., 1994, BER DTSCH CHEM GES, V27, P3329
   Krawetz RJ, 2012, TISSUE ENG PT A, V18, P1014, DOI [10.1089/ten.tea.2011.0174, 10.1089/ten.TEA.2011.0174]
   LAUFFER MA, 1961, BIOPHYS J, V1, P205, DOI 10.1016/S0006-3495(61)86884-7
   Lavertu M, 2008, BIOMACROMOLECULES, V9, P640, DOI 10.1021/bm700745d
   Liao N., 1994, LACHAT INSTRUMENTS
   MAROUDAS A, 1969, BIOCHIM BIOPHYS ACTA, V177, P492, DOI 10.1016/0304-4165(69)90311-0
   MAROUDAS A, 1968, BIOPHYS J, V8, P575, DOI 10.1016/S0006-3495(68)86509-9
   MAROUDAS A, 1972, Connective Tissue Research, V1, P69, DOI 10.3109/03008207209152058
   MUHR AH, 1982, POLYMER, V23, P1012, DOI 10.1016/0032-3861(82)90402-5
   Payet L., 2003, 38 C GROUP FRANC RHE
   Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3
   SHAVIT U, 1995, J CONTROL RELEASE, V37, P21, DOI 10.1016/0168-3659(95)00043-8
   TANAKA T, 1985, PHYS REV LETT, V55, P2455, DOI 10.1103/PhysRevLett.55.2455
NR 21
TC 6
Z9 6
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD OCT 15
PY 2013
VL 98
IS 1
BP 813
EP 819
DI 10.1016/j.carbpol.2013.06.055
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 236YO
UT WOS:000325835600107
PM 23987416
DA 2018-10-20
ER

PT J
AU Hahn, BD
   Park, DS
   Choi, JJ
   Ryu, J
   Yoon, WH
   Choi, JH
   Kim, JW
   Ahn, CW
   Kim, HE
   Yoon, BH
   Jung, IK
AF Hahn, Byung Dong
   Park, Dong-Soo
   Choi, Jong-Jin
   Ryu, Jungho
   Yoon, Woon-Ha
   Choi, Joon-Hwan
   Kim, Jong-Woo
   Ahn, Cheol-Woo
   Kim, Hyoun-Ee
   Yoon, Byung-Ho
   Jung, In-Kwon
TI Osteoconductive hydroxyapatite coated PEEK for spinal fusion surgery
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE PEEK; Hydroxyapatite; Aerosol deposition; Adhesion strength;
   Biocompatibility
ID AEROSOL DEPOSITION; INTERBODY FUSION; IN-VITRO; COATINGS;
   POLYETHERETHERKETONE; PERFORMANCE; TITANIUM; ADHESION; CELLS
AB Polyetheretherketone (PEEK) has attracted much interest as biomaterial for interbody fusion cages due to its similar stiffness to bone and good radio-transparency for post-op visualization. Hydroxyapatite (HA) coating stimulates bone growth to the medical implant. The objective of this work is to make an implant consisting of biocompatible PEEK with an osteoconductive HA surface for spinal or orthopedic applications. Highly dense and well-adhered HA coating was developed on medical-grade PEEK using aerosol deposition (AD) without thermal degradation of the PEEK. The HA coating had a dense microstructure with no cracks or pores, and showed good adhesion to PEEK at adhesion strengths above 14.3 MPa. The crystallinity of the HA coating was remarkably enhanced by hydrothermal annealing as post-deposition heat-treatment. In addition, in vitro and in vivo biocompatibility of PEEK, in terms of cell adhesion morphology, cell proliferation, differentiation, and bone-to-implant contact ratio, were remarkably enhanced by the HA coating through AD. (c) 2013 Elsevier B.V. All rights reserved.
C1 [Hahn, Byung Dong; Ryu, Jungho; Yoon, Woon-Ha; Choi, Joon-Hwan; Kim, Jong-Woo; Ahn, Cheol-Woo] Korea Inst Mat Sci, Funct Ceram Grp, Chang Won 641010, Gyeong Nam, South Korea.
   [Kim, Hyoun-Ee] Seoul Natl Univ, Sch Mat Sci & Engn, Seoul 151742, South Korea.
   [Yoon, Byung-Ho; Jung, In-Kwon] Gyeonggi R& DB Ctr, GENOSS, Suwon 443270, Gyeonggi Do, South Korea.
RP Hahn, BD (reprint author), Korea Inst Mat Sci, Funct Ceram Grp, 797 Changwon Daero, Chang Won 641010, Gyeong Nam, South Korea.
EM cera72@kims.re.kr
FU Internal Research Program of the Korea Institute of Materials Science
   (KIMS): "Development of Advanced Powder Materials Technology for New
   Growth Engine and Its Transfer to Industry"
FX This work was supported by the Internal Research Program of the Korea
   Institute of Materials Science (KIMS): "Development of Advanced Powder
   Materials Technology for New Growth Engine and Its Transfer to
   Industry."
CR Beauvais S, 2007, THERMAL SPRAY 2007 G, P371
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Capps S.G., 2007, SPINAL NEWS INT, V4
   Cheang P, 1996, BIOMATERIALS, V17, P1901, DOI 10.1016/0142-9612(95)00146-8
   Cho DY, 2002, NEUROSURGERY, V51, P1343, DOI 10.1227/01.NEU.0000035851.01555.22
   Cook S D, 1995, J Oral Implantol, V21, P176
   Diedrich O, 2001, J SPINAL DISORD, V14, P522, DOI 10.1097/00002517-200112000-00012
   ENKER P, 1994, CLIN ORTHOP RELAT R, P90
   HA SW, 1994, J MATER SCI-MATER M, V5, P481, DOI 10.1007/BF00058987
   Hahn BD, 2013, J BIOMATER APPL, V27, P587, DOI 10.1177/0885328211415723
   Hahn BD, 2011, THIN SOLID FILMS, V519, P8085, DOI 10.1016/j.tsf.2011.07.008
   Hahn BD, 2011, APPL SURF SCI, V257, P7792, DOI 10.1016/j.apsusc.2011.04.031
   Hahn BD, 2011, SURF COAT TECH, V205, P3112, DOI 10.1016/j.surfcoat.2010.11.029
   Hahn BD, 2010, THIN SOLID FILMS, V518, P2194, DOI 10.1016/j.tsf.2009.09.024
   Hahn BD, 2009, ACTA BIOMATER, V5, P3205, DOI 10.1016/j.actbio.2009.05.005
   Hahn BD, 2009, J AM CERAM SOC, V92, P683, DOI 10.1111/j.1551-2916.2008.02876.x
   Hu QH, 2007, J MATER CHEM, V17, P4690, DOI 10.1039/b710936a
   Katz JN, 1995, SPINE, V20, pS78, DOI 10.1097/00007632-199512151-00002
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P961, DOI 10.1002/jbm.820280815
   Lupoi R, 2010, SURF COAT TECH, V205, P2167, DOI 10.1016/j.surfcoat.2010.08.128
   Lynn AK, 2002, BIOMATERIALS, V23, P1947, DOI 10.1016/S0142-9612(01)00320-9
   Mittal K.L., 2001, ADHESION MEASUREMENT
   Noiset O, 2000, J BIOMAT SCI-POLYM E, V11, P767, DOI 10.1163/156856200744002
   Sam Z, 2006, SURF COAT TECH, V200, P6350, DOI 10.1016/j.surfcoat.2005.11.033
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   TERJESEN T, 1988, J ORTHOPAED RES, V6, P293, DOI 10.1002/jor.1100060218
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce
   Zreiqat H., 1996, Cells and Materials, V6, P45
NR 29
TC 48
Z9 49
U1 5
U2 77
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD OCT 15
PY 2013
VL 283
BP 6
EP 11
DI 10.1016/j.apsusc.2013.05.073
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 207LR
UT WOS:000323601700002
DA 2018-10-20
ER

PT J
AU Yu, ZL
   Zhou, JD
   Cao, F
   Wen, BB
   Zhu, X
   Wei, P
AF Yu, Zuolong
   Zhou, Jiadong
   Cao, Fei
   Wen, Binbin
   Zhu, Xuan
   Wei, Ping
TI Chemosynthesis and characterization of fully biomass-based copolymers of
   ethylene glycol, 2,5-furandicarboxylic acid, and succinic acid
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE 2; 5-furan dicarboxylic acid; poly(ethylene 2; 5-furan
   dicarboxylate-co-ethylene succinate); synthesis; characterization;
   thermal properties
ID POLY(ETHYLENE-TEREPHTHALATE); PET; HYDROLYSIS; WATER; DEPOLYMERIZATION;
   BIODEGRADATION; TEMPERATURE; POLYESTERS; MECHANISM; OXIDATION
AB Poly(ethylene 2,5-furandicarboxylate-co-ethylene succinate) (PEFS) copolymers of 2,5-furandicarboxylic acid (FDCA) and succinic acid with 11.98-91.32 mol % FDCA composition were synthesized via melt polycondensation in the presence of ethylene glycol using tetrabutyl titanate as a catalyst. PEFSs' molecular weight, thermal properties, and molar composition were determined by Fourier transform infrared spectroscopy, gel permeation chromatography, intrinsic viscosity, H-1 NMR, differential scanning calorimetry (DSC), thermogravimetric analysis (H-1 NMR analyses. DSC analysis revealed that PEFS copolymers' melting temperatures differed depending on EF units' percentage. TGA studies confirmed that all PEFS copolymers' thermal stability exceeded 300 degrees C. From WAXD analysis, it is observed that the PEFS copolymer crystal structure was similar to that of PES when EF unit was 11.98 mol % and to that of PEF when EF units were 74.35 and 91.32 mol %. These results benefit this novel biodegradable copolymer to be used as a potential biomaterial. (C) 2013Wiley Periodicals, Inc.
C1 [Yu, Zuolong; Zhou, Jiadong; Cao, Fei; Wen, Binbin; Zhu, Xuan; Wei, Ping] Nanjing Univ Technol, Biocatalysis Lab, Coll Biotechnol & Pharmaceut Engn, Nanjing 210009, Peoples R China.
RP Zhou, JD (reprint author), Nanjing Univ Technol, Biocatalysis Lab, Coll Biotechnol & Pharmaceut Engn, Nanjing 210009, Peoples R China.
EM wrzjd@njut.edu.cn; csaofeiw@njut.edu.cn
FU National Natural Science Foundation [21106063, 30900009]; Natural
   Science Foundation of Jiangsu Province [BK2010557]
FX The authors acknowledge the financial support from the Project of the
   National Natural Science Foundation (No. 21106063 and No. 30900009) and
   the Project of the Natural Science Foundation of Jiangsu Province (No.
   BK2010557).
CR ABE H, 1995, MACROMOLECULES, V28, P7630, DOI 10.1021/ma00127a007
   Adschiri T, 1997, KAGAKU KOGAKU RONBUN, V23, P505, DOI 10.1252/kakoronbunshu.23.505
   Ajji A, 2002, J MATER SCI, V37, P3893, DOI 10.1023/A:1019603421841
   ALLEN NS, 1994, POLYM DEGRAD STABIL, V43, P229, DOI 10.1016/0141-3910(94)90074-4
   Bahloul A., 2000, J SOC ALGERIENNE CHI, V10, P135
   Branciforti MC, 2006, J APPL POLYM SCI, V102, P2241, DOI 10.1002/app.24395
   Chen HB, 2011, IND ENG CHEM RES, V50, P2065, DOI 10.1021/ie101798n
   Cranston E, 2003, BIOMACROMOLECULES, V4, P995, DOI 10.1021/bm034089n
   Davis SE, 2012, GREEN CHEM, V14, P143, DOI 10.1039/c1gc16074e
   Davis SE, 2011, CATAL TODAY, V160, P55, DOI 10.1016/j.cattod.2010.06.004
   Desgranges P, 2001, J BIOMED MATER RES, V58, P1, DOI 10.1002/1097-4636(2001)58:1<1::AID-JBM10>3.0.CO;2-8
   Gandini A, 2009, J POLYM SCI POL CHEM, V47, P295, DOI 10.1002/pola.23130
   Genta M, 2005, IND ENG CHEM RES, V44, P3894, DOI 10.1021/ie0488187
   Gomes M, 2011, J POLYM SCI POL CHEM, V49, P3759, DOI 10.1002/pola.24812
   Gorbanev YY, 2009, CHEMSUSCHEM, V2, P672, DOI 10.1002/cssc.200900059
   Gruter GJM, 2012, COMB CHEM HIGH T SCR, V15, P180
   Gupta NK, 2011, GREEN CHEM, V13, P824, DOI 10.1039/c0gc00911c
   Heppe B. L., 2000, World Pat, Patent No. [2000 066499, 2000066499]
   Impallomeni G, 2002, BIOMACROMOLECULES, V3, P835, DOI 10.1021/bm025525t
   Inkinen S, 2011, BIOMACROMOLECULES, V12, P523, DOI 10.1021/bm101302t
   Kamber NE, 2010, J CHEM EDUC, V87, P519, DOI 10.1021/ed800152c
   Koopman F, 2010, BIORESOURCE TECHNOL, V101, P6291, DOI 10.1016/j.biortech.2010.03.050
   Lewkowski J, 2001, POL J CHEM, V75, P1943
   Li J, 2011, BIORESOURCE TECHNOL, V102, P6147, DOI 10.1016/j.biortech.2011.02.093
   Lopez-Fonseca R, 2009, CHEM ENG J, V146, P287, DOI 10.1016/j.cej.2008.09.039
   Luo SL, 2011, J POLYM RES, V18, P393, DOI 10.1007/s10965-010-9429-x
   Ma JP, 2012, J MATER CHEM, V22, P3457, DOI [10.1039/C2jM15457A, 10.1039/c2jm15457a]
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   Nie T, 2003, MACROMOLECULES, V36, P8825, DOI 10.1021/ma035131+
   NIELEK S, 1988, J PRAKT CHEM, V330, P825, DOI 10.1002/prac.19883300523
   Ohara M, 2010, APPL CATAL A-GEN, V383, P149, DOI 10.1016/j.apcata.2010.05.040
   Paszun D, 1997, IND ENG CHEM RES, V36, P1373, DOI 10.1021/ie960563c
   Ramires PA, 2000, J BIOMED MATER RES, V51, P535, DOI 10.1002/1097-4636(20000905)51:3<535::AID-JBM31>3.0.CO;2-P
   Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337
   Sato O, 2006, CATAL TODAY, V111, P297, DOI 10.1016/j.cattod.2005.10.040
   Scandola M, 1997, MACROMOLECULES, V30, P2568, DOI 10.1021/ma961431y
   Schmuck C, 2006, EUR J ORG CHEM, P4385, DOI 10.1002/ejoc.200600324
   Singh N K, 2009, ACS APPL MATER INTER, V2, P69
   Sipos L., 2010, W.O. Patent, Patent No. [2010/077133 A1, 2010077133]
   Taguchi Y, 2008, CHEM LETT, V37, P50, DOI 10.1246/cl.2008.50
   UEDA AS, 1971, POLYM J, V2, P387, DOI 10.1295/polymj.2.387
   Wang JK, 2008, J PHYS CHEM B, V112, P14829, DOI 10.1021/jp806179z
   YOSHIOKA T, 1994, J APPL POLYM SCI, V52, P1353, DOI 10.1002/app.1994.070520919
   Zhang ZG, 2008, BIORESOURCE TECHNOL, V99, P5873, DOI 10.1016/j.biortech.2007.10.027
   Zhao HB, 2007, SCIENCE, V316, P1597, DOI 10.1126/science.1141199
NR 45
TC 28
Z9 29
U1 3
U2 179
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 15
PY 2013
VL 130
IS 2
BP 1415
EP 1420
DI 10.1002/app.39344
PG 6
WC Polymer Science
SC Polymer Science
GA 189AD
UT WOS:000322238200083
DA 2018-10-20
ER

PT J
AU Nchimi-Nono, K
   Wegner, KD
   Linden, S
   Lecointre, A
   Ehret-Sabatier, L
   Shakir, S
   Hildebrandt, N
   Charbonniere, LJ
AF Nchimi-Nono, Katia
   Wegner, K. David
   Linden, Stina
   Lecointre, Alexandre
   Ehret-Sabatier, Laurence
   Shakir, Shakir
   Hildebrandt, Niko
   Charbonniere, Loic J.
TI Activated phosphonated trifunctional chelates for highly sensitive
   lanthanide-based FRET immunoassays applied to total prostate specific
   antigen detection
SO ORGANIC & BIOMOLECULAR CHEMISTRY
LA English
DT Article
ID MRI-CONTRAST AGENTS; RESONANCE ENERGY-TRANSFER; BIOLOGICAL EVALUATION;
   QUANTUM YIELDS; PENDANT ARMS; COMPLEXES; LUMINESCENCE; STREPTAVIDIN;
   FLUORESCENCE; BIOASSAYS
AB The first example of an activated phosphonated trifunctional chelate (TFC) is presented, which combines a non-macrocyclic coordination site for lanthanide coordination based on two aminobis-methylphosphonate coordinating arms, a central bispyrazolylpyridyl antenna and an N-hydroxysuccinimide ester in para position of the central pyridine as an activated function for the labeling of biomaterial. The synthesis of the TFC is presented together with photo-physical studies of the related Tb and Eu complexes. Excited state lifetime measurements in H2O and D2O confirmed an excellent shielding of the cation from water molecules with a hydration number of zero. The Tb complex provides a high photoluminescence (PL) quantum yield of 24% in aqueous solutions (0.01 M Tris-HCl, pH 7.4) and a very long luminescence lifetime of 2.6 ms. The activated ligand was conjugated to different biological compounds such as streptavidin, and a monoclonal antibody against total prostate specific antigen (TPSA). In combination with AlexaFluor647 (AF647) and crosslinked allophycocyanin (XL665) antibody (ABs) conjugates, homogeneous time-resolved Fluorescence Resonance Energy Transfer (FRET) immunoassays of TPSA were performed in serum samples. The Tb donor-dye acceptor FRET pairs provided large Forster distances of 5.3 nm (AF647) and 7.1 nm (XL665). A detailed time-resolved FRET analysis of Tb donor and dye acceptor PL decays revealed average donor-acceptor distances of 4.2 nm (AF647) and 6.3 nm (XL665) within the sandwich immunocomplex and FRET efficiencies of 0.79 and 0.68, respectively. Very low detection limits of 1.4 ng mL(-1) (43 pM) and 2.4 ng mL(-1) (74 pM) TPSA were determined using a KRYPTOR fluorescence immunoanalyzer. These results demonstrate the applicability of our novel Tb-bioconjugates for highly sensitive clinical diagnostics.
C1 [Nchimi-Nono, Katia; Lecointre, Alexandre; Shakir, Shakir] CNRS UdS, UMR 7178, Lab Ingn Mol Appl Anal, IPHC,ECPM, F-67087 Strasbourg, France.
   [Wegner, K. David; Linden, Stina; Hildebrandt, Niko] Univ Paris 11, Inst Elect Fondamentale, F-91405 Orsay, France.
   [Ehret-Sabatier, Laurence; Charbonniere, Loic J.] CNRS UdS, UMR 7178, Lab Spectrometrie Masse Bioorgan, IPHC,ECPM, F-67087 Strasbourg, France.
RP Charbonniere, LJ (reprint author), CNRS UdS, UMR 7178, Lab Spectrometrie Masse Bioorgan, IPHC,ECPM, 25 Rue Becquerel, F-67087 Strasbourg, France.
EM l.charbonn@unistra.fr
FU European Commission
FX This work was supported by the European Commission (the FP7 project
   NANOGNOSTICS). The authors gratefully acknowledge Cezanne/Thermo Fisher
   Scientific for providing TPSA antibodies.
CR Abada S, 2012, CHEM COMMUN, V48, P4085, DOI 10.1039/c2cc30757j
   Aime S, 2000, CHEM-EUR J, V6, P2609, DOI 10.1002/1521-3765(20000717)6:14<2609::AID-CHEM2609>3.0.CO;2-S
   Allen BJ, 2001, APPL RADIAT ISOTOPES, V54, P53, DOI 10.1016/S0969-8043(00)00164-0
   ALPHA B, 1987, ANGEW CHEM INT EDIT, V26, P266, DOI 10.1002/anie.198702661
   Bartolini ME, 2003, MAGN RESON IMAGING, V21, P541, DOI 10.1016/S0730-725X(03)00081-X
   Beeby A, 1999, J CHEM SOC PERK T 2, P493, DOI 10.1039/a808692c
   Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e
   Burai L, 1998, INORG CHEM, V37, P69, DOI 10.1021/ic970599c
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Catalona W. J., 1991, NEW ENGL J MED, V324, P1156
   CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3
   Charbonniere L. J, 2011, CURR INORG CHEM, V1, P2
   Charbonniere LJ, 2008, EUR J INORG CHEM, P3241, DOI 10.1002/ejic.200800332
   Christine C, 2012, ORG BIOMOL CHEM, V10, P9183, DOI 10.1039/c2ob26452h
   DEMAS JN, 1971, J PHYS CHEM-US, V75, P991
   Faulkner S, 2005, APPL SPECTROSC REV, V40, P1, DOI 10.1081/ASR-200038308
   Ferdani R, 2012, DALTON T, V41, P1938, DOI 10.1039/c1dt11743b
   Geissler D, 2013, J AM CHEM SOC, V135, P1102, DOI 10.1021/ja310317n
   Geissler D, 2010, ANGEW CHEM INT EDIT, V49, P1396, DOI 10.1002/anie.200906399
   Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v
   Guo YJ, 2012, BIOCONJUGATE CHEM, V23, P1470, DOI 10.1021/bc300092n
   Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070
   HORROCKS WD, 1981, ACCOUNTS CHEM RES, V14, P384, DOI 10.1021/ar00072a004
   Hovinen J, 2009, BIOCONJUGATE CHEM, V20, P404, DOI 10.1021/bc800370s
   Ishida H, 2010, COORDIN CHEM REV, V254, P2449, DOI 10.1016/j.ccr.2010.04.006
   Kadjane P, 2009, INORG CHEM, V48, P4601, DOI 10.1021/ic9001169
   Krause W, 1996, INVEST RADIOL, V31, P502, DOI 10.1097/00004424-199608000-00006
   Lecointre A., 2011, INORG CHEM, V50, P1689
   Lukes I, 2001, COORDIN CHEM REV, V216, P287, DOI 10.1016/S0010-8545(01)00336-8
   Mameri S, 2004, INORG CHEM, V43, P1819, DOI 10.1021/ic030295s
   MATHIS G, 1993, CLIN CHEM, V39, P1953
   Mato-Iglesias M, 2009, INORG CHEM, V48, P1507, DOI 10.1021/ic801816p
   Mishra A. K., 2005, CHEM LETT, P1098
   OLMSTED J, 1979, J PHYS CHEM-US, V83, P2581, DOI 10.1021/j100483a006
   Pandya S, 2006, DALTON T, P2757, DOI 10.1039/b514637b
   PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001
   Song B, 2008, ORG BIOMOL CHEM, V6, P4125, DOI 10.1039/b811427g
   Starck M, 2011, CHEM-EUR J, V17, P9164, DOI 10.1002/chem.201100390
   Stromqvist J, 2011, EUR PHYS J-SPEC TOP, V199, P181, DOI 10.1140/epjst/e2011-01513-1
   VALEUR B, 2002, MOL FLUORESCENCE, P161
   Wegner KD, 2013, ACS APPL MATER INTER, V5, P2881, DOI 10.1021/am3030728
   Xu JD, 2011, J AM CHEM SOC, V133, P19900, DOI 10.1021/ja2079898
   Yuan JL, 2006, TRAC-TREND ANAL CHEM, V25, P490, DOI 10.1016/j.trac.2005.11.013
NR 43
TC 7
Z9 7
U1 2
U2 51
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-0520
EI 1477-0539
J9 ORG BIOMOL CHEM
JI Org. Biomol. Chem.
PD OCT 14
PY 2013
VL 11
IS 38
BP 6493
EP 6501
DI 10.1039/c3ob40898a
PG 9
WC Chemistry, Organic
SC Chemistry
GA 228OA
UT WOS:000325194900008
PM 23851931
DA 2018-10-20
ER

PT J
AU Cado, G
   Aslam, R
   Seon, L
   Garnier, T
   Fabre, R
   Parat, A
   Chassepot, A
   Voegel, JC
   Senger, B
   Schneider, F
   Frere, Y
   Jierry, L
   Schaaf, P
   Kerdjoudj, H
   Metz-Boutigue, MH
   Boulmedais, F
AF Cado, G.
   Aslam, R.
   Seon, L.
   Garnier, T.
   Fabre, R.
   Parat, A.
   Chassepot, A.
   Voegel, J. -C.
   Senger, B.
   Schneider, F.
   Frere, Y.
   Jierry, L.
   Schaaf, P.
   Kerdjoudj, H.
   Metz-Boutigue, M. -H.
   Boulmedais, F.
TI Self-Defensive Biomaterial Coating Against Bacteria and Yeasts:
   Polysaccharide Multilayer Film with Embedded Antimicrobial Peptide
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE layer-by-layer; chitosan; hyaluronic acid; hyaluronan; fibroblasts;
   cateslytin
ID POLYELECTROLYTE MULTILAYERS; CANDIDA-ALBICANS; CHROMOGRANIN-A;
   STAPHYLOCOCCUS-AUREUS; IN-VITRO; ANTIBACTERIAL PEPTIDE; STAINLESS-STEEL;
   MEDICAL DEVICES; SURFACES; ANTIFUNGAL
AB Prevention of pathogen colonization of medical implants is a major medical and financial issue since infection by microorganisms constitutes one of the most serious complications after surgery or critical care. Immobilization of antimicrobial molecules on biomaterials surfaces is an efficient approach to prevent biofilm formation. Herein, the first self-defensive coating against both bacteria and yeasts is reported, where the release of the antimicrobial peptide is triggered by enzymatic degradation of the film due to the pathogens themselves. Biocompatible and biodegradable polysaccharide multilayer films based on functionalized hyaluronic acid by cateslytin (CTL), an endogenous host-defensive antimicrobial peptide, and chitosan (HA-CTL-C/CHI) are deposited on a planar surface with the aim of designing both antibacterial and antifungal coating. After 24 h of incubation, HA-CTL-C/CHI films fully inhibit the development of Gram-positive Staphylococcus aureus bacteria and Candida albicans yeasts, which are common and virulent pathogens agents encountered in care-associated diseases. Hyaluronidase, secreted by the pathogens, leads to the film degradation and the antimicrobial action of the peptide. Furthermore, the limited fibroblasts adhesion, without cytotoxicity, on HA-CTL-C/CHI films highlights a medically relevant application to prevent infections on catheters or tracheal tubes where fibrous tissue encapsulation is undesirable.
C1 [Cado, G.; Seon, L.; Garnier, T.; Parat, A.; Frere, Y.; Jierry, L.; Schaaf, P.; Boulmedais, F.] Inst Charles Sadron, CNRS, UPR 22, F-67034 Strasbourg 2, France.
   [Aslam, R.; Fabre, R.; Chassepot, A.; Voegel, J. -C.] INSERM, UMR 1121, F-67085 Strasbourg, France.
   [Aslam, R.; Fabre, R.; Chassepot, A.; Voegel, J. -C.; Senger, B.; Schaaf, P.; Metz-Boutigue, M. -H.] Univ Strasbourg, Fac Chinirg Dentaire, F-67000 Strasbourg, France.
   [Schneider, F.] Univ Strasbourg, Hop Hautepierre, Serv Reanimat Med, F-67000 Strasbourg, France.
   [Kerdjoudj, H.] Univ Reims, SFR CapSante, EA 4691, F-51100 Reims, France.
   [Jierry, L.] Univ Strasbourg, Ecole Europeenne Chim, F-67087 Strasbourg 2, France.
   [Jierry, L.; Schaaf, P.; Boulmedais, F.] IntCtr Frontier Res Chem, F-67083 Strasbourg, France.
   [Schaaf, P.] Inst Univ France, F-75005 Paris, France.
RP Boulmedais, F (reprint author), Inst Charles Sadron, CNRS, UPR 22, 23 Rue Loess, F-67034 Strasbourg 2, France.
EM fouzia.boulmedais@ics-cnrs.unistra.fr
RI SCHAAF, Pierre/J-2751-2016; Aslam, Rizwan/E-8238-2014; Boulmedais,
   Fouzia/B-4657-2011
OI SCHAAF, Pierre/0000-0001-7423-5492; Boulmedais,
   Fouzia/0000-0002-4934-9276; JIERRY, Loic/0000-0002-7541-1360
FU Centre National de la Recherche Scientifique; Region Alsace; Ministere
   de l'Enseignement Superieur et de la Recherche (France); Higher
   Education Commission (Pakistan); Faculty of Dentistry of the University
   of Strasbourg; icFRC foundation; Pole Materiaux et Nanosciences d'Alsace
   (PMNA) ("Jeunes Chercheurs du PMNA" grant); MICA Carnot (SELF-DECAMP)
FX G.C., R.A., and L.S. contributed equally to this work. Aurelie Garnier
   is acknowledged for technical support. Karim Benmlih, Mathias Lefort and
   Joseph Hemmerle are acknowledged for the automated sprayer development.
   Bernard Guerold is acknowledged for peptide synthesis. Geraldine Koenig
   is acknowledged for fruitful discussion. G.C. was supported by a "BDI"
   doctoral fellowship of the Centre National de la Recherche Scientifique
   and the Region Alsace. L.S. was supported by the grant from Ministere de
   l'Enseignement Superieur et de la Recherche (France) and R.A. by the
   grant from Higher Education Commission (Pakistan) and the Faculty of
   Dentistry of the University of Strasbourg. T.G. was supported by the
   icFRC foundation. We acknowledge the Pole Materiaux et Nanosciences
   d'Alsace (PMNA) ("Jeunes Chercheurs du PMNA 2009" grant), the MICA
   Carnot (SELF-DECAMP) and the Faculty of Dentistry of the University of
   Strasbourg for financial contribution. The contributions of the
   different authors are as follows: G.C. and L.S. performed the
   physico-chemical characterization of the Multilayer films, B.S. treated
   the SPR data, R.A. performed the antimicrobial assays, G.C., A.P. and
   T.G performed the synthesis of the polymers, R.F. performed the confocal
   images, A.C. and G.C. performed the biocompatibility tests, H.K.
   supervised the biocompatibility tests. L.J. supervised the synthesis of
   functionalized polymers, M-H.M.B. supervised the purification of
   antimicrobial peptide and the antimicrobial assays, F.B. initiated the
   project, F.B. and P.S. supervised the work, Y.F., J-C.V., L.J., F.S.,
   P.S., M-H.M.B. and F.B. participated actively in the discussions about
   the results, G.C., F.B., L.J., and P.S. wrote the paper.
CR Arys X, 1998, PROG ORG COAT, V34, P108, DOI 10.1016/S0300-9440(98)00007-1
   Aslam R, 2012, CURR MED CHEM, V19, P4115, DOI 10.2174/092986712802430063
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Botequim D, 2012, LANGMUIR, V28, P7646, DOI 10.1021/la300948n
   Bratskaya S, 2007, BIOMACROMOLECULES, V8, P2960, DOI 10.1021/bm700620j
   Briolat J, 2005, CELL MOL LIFE SCI, V62, P377, DOI 10.1007/s00018-004-4461-9
   Bruellhoff K, 2010, INT J ARTIF ORGANS, V33, P646
   BULET P, 1993, J BIOL CHEM, V268, P14893
   Cado G, 2012, LANGMUIR, V28, P8470, DOI 10.1021/la300563s
   CARLSON E, 1983, INFECT IMMUN, V42, P285
   Chuang HF, 2008, BIOMACROMOLECULES, V9, P1660, DOI 10.1021/bm800185h
   Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI
   Dai JH, 2002, NANO LETT, V2, P497, DOI 10.1021/nl0255471
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   Etienne O, 2005, BIOMATERIALS, V26, P6704, DOI 10.1016/j.biomaterials.2005.04.068
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fu JH, 2006, J BIOMED MATER RES A, V79A, P665, DOI 10.1002/jbm.a.30819
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459
   Guggenbichler J., 2011, GMS KRANKENHAUSHYG I, V6, P1, DOI DOI 10.3205/DGKH000175
   Guyomard A, 2008, ADV FUNCT MATER, V18, P758, DOI 10.1002/adfm.200700793
   Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09
   Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0
   Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9
   Hu FX, 2005, BIOTECHNOL BIOENG, V89, P474, DOI 10.1002/bit.20384
   Karlsson AJ, 2010, BIOMACROMOLECULES, V11, P2321, DOI 10.1021/bm100424s
   Katneni R, 2007, NAT CLIN PRACT NEPHR, V3, P256, DOI 10.1038/ncpneph0447
   Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001
   KRETSCHM.E, 1971, Z PHYS, V241, P313, DOI 10.1007/BF01395428
   Larkin EA, 2009, CURR MED CHEM, V16, P4003, DOI 10.2174/092986709789352321
   Lee D, 2005, CHEM MATER, V17, P1099, DOI 10.1021/cm048441v
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Lee DY, 2009, J INVEST DERMATOL, V129, pS7
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166
   Lugardon K, 2001, J BIOL CHEM, V276, P35875, DOI 10.1074/jbc.M104670200
   Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3
   Malcher M, 2008, LANGMUIR, V24, P10209, DOI 10.1021/la8014755
   Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5
   Nguyen PM, 2007, CHEM MATER, V19, P5524, DOI 10.1021/cm070981f
   Oosterhof JJH, 2006, APPL ENVIRON MICROB, V72, P3673, DOI 10.1128/AEM.72.5.3673-3677.2006
   PAGE B, 1993, INT J ONCOL, V3, P473
   Paniagua-Contreras G, 2012, ADV MICROBIOL, V2, P476, DOI 10.4236/aim.2012.24061
   Pavlukhina S, 2010, BIOMACROMOLECULES, V11, P3448, DOI 10.1021/bm100975w
   Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   Riva R, 2011, ADV POLYM SCI, V244, P19, DOI 10.1007/12_2011_137
   Serizawa T, 2002, MACROMOLECULES, V35, P8656, DOI 10.1021/ma012153s
   Shi Z, 2006, J BIOMED MATER RES A, V76A, P826, DOI 10.1002/jbm.a.30597
   Shimizu MT, 1996, MYCOSES, V39, P161, DOI 10.1111/j.1439-0507.1996.tb00120.x
   Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x
   Shooshtarizadeh P, 2010, REGUL PEPTIDES, V165, P102, DOI 10.1016/j.regpep.2009.11.014
   Shukla A, 2010, BIOMATERIALS, V31, P2348, DOI 10.1016/j.biomaterials.2009.11.082
   Verran J, 2005, INT J ARTIF ORGANS, V28, P1138
   Volpi N, 2009, CURR MED CHEM, V16, P1718, DOI 10.2174/092986709788186138
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003
   Voytik-Harbin SL, 1998, IN VITRO CELL DEV-AN, V34, P239
   Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29
   Zhang D, 2008, CLIN CHEM, V54, P1497, DOI 10.1373/clinchem.2007.102442
NR 60
TC 72
Z9 72
U1 13
U2 155
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD OCT 11
PY 2013
VL 23
IS 38
BP 4801
EP 4809
DI 10.1002/adfm.201300416
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 258SO
UT WOS:000327479200005
DA 2018-10-20
ER

PT J
AU Souza, RC
   Silva, ES
   Jorge, AM
   Cabrera, JM
   Balancin, O
AF Souza, R. C.
   Silva, E. S.
   Jorge, A. M., Jr.
   Cabrera, J. M.
   Balancin, O.
TI Dynamic recovery and dynamic recrystallization competition on a Nb- and
   N-bearing austenitic stainless steel biomaterial: Influence of strain
   rate and temperature
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Dynamic recovery; Dynamic recrystallization; Stainless steel;
   Biomaterial
ID MICROALLOYED STEEL; HOT-WORKING; C-MN; TORSION; DEFORMATION; INITIATION;
   BEHAVIOR; FERRITE; ALLOY
AB The objective of this study was to investigate the dynamic softening behavior of an austenitic stainless steel with high nitrogen (type ISO 5832-9) through hot torsion tests, in the temperature range of 900 1200 degrees C and in the strain rate range of 0.01-10 s(-1). The shape of flow stress curves indicated that the softening was promoted by dynamic recovery followed by dynamic recrystallization with high level of recovery. The microstructure evolution indicated that even though after large straining as that of the steady state stresses a combination of strained and recrystallized grains was observed. The delay of dynamic reaystallization, which is a consequence of the intermediate level of stacking fault energy of this steel, and the presence of large recrystallized grains, inside of necklace formed by small grains, were associated with extended recovery regions. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Souza, R. C.] Univ Fed Maranhao, Sao Luis, MA, Brazil.
   [Silva, E. S.; Jorge, A. M., Jr.; Balancin, O.] Univ Fed Sao Carlos, BR-13560 Sao Carlos, SP, Brazil.
   [Cabrera, J. M.] Univ Politecn Cataluna, Barcelona, Spain.
RP Jorge, AM (reprint author), Univ Fed Sao Carlos, BR-13560 Sao Carlos, SP, Brazil.
EM moreira@dema.ufscar.br
RI Jorge Junior, Alberto/B-2566-2012; Cabrera, Jose Maria/D-5212-2014
OI Jorge Junior, Alberto/0000-0002-8121-9834; Cabrera, Jose
   Maria/0000-0001-8417-1736
CR Abad R, 2001, ISIJ INT, V41, P1373, DOI 10.2355/isijinternational.41.1373
   Abdollah-Zadeh A, 2007, MAT SCI ENG A-STRUCT, V457, P219, DOI 10.1016/j.msea.2006.12.022
   [Anonymous], 1968, ISI PUBL, V108
   Avramovic-Cingara G, 2003, MATER SCI TECH-LOND, V19, P11, DOI 10.1179/026708303225008716
   Azevedo G, 2005, MAT SCI ENG A-STRUCT, V402, P98, DOI 10.1016/j.msea.2005.04.026
   Balancin O, 2000, METALL MATER TRANS A, V31, P1353, DOI 10.1007/s11661-000-0254-4
   Barnett MR, 2002, ACTA MATER, V50, P2285, DOI 10.1016/S1359-6454(02)00048-4
   Beladi H, 2007, METALL MATER TRANS A, V38A, P450, DOI 10.1007/s11661-006-9080-7
   CANOVA G, 1979, JOM-J MIN MET MAT S, V31, P73
   Doherty RD, 1997, MAT SCI ENG A-STRUCT, V238, P219, DOI 10.1016/S0921-5093(97)00424-3
   El Wahabi M, 2003, MAT SCI ENG A-STRUCT, V343, P116, DOI 10.1016/S0921-5093(02)00357-X
   Fernandez AI, 1999, SCRIPTA MATER, V40, P543, DOI 10.1016/S1359-6462(98)00452-7
   Fields D. S., 1957, P AM SOCIETY SOCIETY, V57, P1259
   Giordani EJ, 2006, SCRIPTA MATER, V55, P743, DOI 10.1016/j.scriptamat.2006.05.015
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   Hernandez CA, 1996, ACTA MATER, V44, P155, DOI 10.1016/1359-6454(95)00153-4
   Hodgson PD, 2004, ISIJ INT, V44, P1224, DOI 10.2355/isijinternational.44.1224
   Hurley PJ, 2002, METALL MATER TRANS A, V33, P2985, DOI 10.1007/s11661-002-0283-2
   Jafari M, 2009, MAT SCI ENG A-STRUCT, V501, P16, DOI 10.1016/j.msea.2008.09.073
   Jonas JJ, 2009, ACTA MATER, V57, P2748, DOI 10.1016/j.actamat.2009.02.033
   Jorge Jr A.M., 2003, J MATER PROCESS TECH, V142, P321
   Jorge Junior A. M., 2012, J MAT RES TECHNOL, V1, P141
   Jorge Junior Alberto Moreira, 2005, Mat. Res., V8, P309, DOI 10.1590/S1516-14392005000300015
   LAASRAOUI A, 1991, METALL TRANS A, V22, P1545, DOI 10.1007/BF02667368
   Mataya MC, 2003, METALL MATER TRANS A, V34A, P1683, DOI 10.1007/s11661-003-0313-8
   Mejia I., 2011, MAT SCI ENG A-STRUCT, V528, P4133
   Militzer M., 2000, METALL MATER TRANS A, V31A, P1246
   Najafizadeh A, 2006, ISIJ INT, V46, P1679, DOI 10.2355/isijinternational.46.1679
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Poliak EI, 2003, ISIJ INT, V43, P684, DOI 10.2355/isijinternational.43.684
   POLIAK EI, 1996, J ACTA MAT, V44, P127
   Rossard C., 1957, PUBLICATIONS I REC A
   ROUCOULES C, 1995, MATER SCI TECH SER, V11, P548, DOI 10.1179/mst.1995.11.6.548
   RYAN ND, 1993, J MATER PROCESS TECH, V36, P103, DOI 10.1016/0924-0136(93)90025-2
   SAKAI T, 1995, J MATER PROCESS TECH, V53, P349, DOI 10.1016/0924-0136(95)01992-N
   SCHRAMM RE, 1975, METALL TRANS A, V6, P1345, DOI 10.1007/BF02641927
   Semiatin S.L, ASM METALS HDB, V8, pOH154
   Silva ES, 2012, MAT SCI ENG A-STRUCT, V543, P69, DOI 10.1016/j.msea.2012.02.048
   Spigarelli S, 2010, MAT SCI ENG A-STRUCT, V527, P4218, DOI 10.1016/j.msea.2010.03.029
   Taylor AS, 2011, MAT SCI ENG A-STRUCT, V528, P3310, DOI 10.1016/j.msea.2010.12.093
NR 41
TC 24
Z9 25
U1 2
U2 32
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD OCT 10
PY 2013
VL 582
BP 96
EP 107
DI 10.1016/j.msea.2013.06.037
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 220EV
UT WOS:000324566100015
DA 2018-10-20
ER

PT J
AU Lopez, EO
   Mello, A
   Sendao, H
   Costa, LT
   Rossi, AL
   Ospina, RO
   Borghi, FF
   Silva, JG
   Rossi, AM
AF Lopez, Elvis O.
   Mello, Alexandre
   Sendao, Henrique
   Costa, Lilian T.
   Rossi, Andre L.
   Ospina, Rogelio O.
   Borghi, Fabricio F.
   Silva Filho, Jose G.
   Rossi, Alexandre M.
TI Growth of Crystalline Hydroxyapatite Thin Films at Room Temperature by
   Tuning the Energy of the RF-Magnetron Sputtering Plasma
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE hydroxyapatite; thin films; rf magnetron sputtering; plasma
   thermodynamics; biomaterial; bioengineering
ID CALCIUM-PHOSPHATE COATINGS; SURFACE CHARACTERIZATION;
   CHEMICAL-COMPOSITION; BOND STRENGTH; TITANIUM; DEPOSITION; COMPOSITE;
   ALLOY; XPS; TEM
AB Right angle radio frequency magnetron sputtering technique (RAMS) was redesigned to favor the production of high-quality hydroxyapatite (HA) thin coatings for biomedical applications. Stoichiometric HA films with controlled crystallinity, thickness varying from 254 to 540 nm, crystallite mean size of 73 nm, and RMS roughness of 1.7 +/- 0.9 nm, were obtained at room temperature by tuning the thermodynamic properties of the plasma sheath energy. The plasma energies were adjusted by using a suitable high magnetic field confinement of 143 mT (1430 G) and a substrate floating potential of 2 V at the substrate-to-magnetron distance of Z = 10 mm and by varying the sputtering geometry, substrate-to-magnetron distance from Z = 5 mm to Z = 18 mm, forwarded RF power and reactive gas pressure. Measurements that were taken with a Langmuir probe showed that the adjusted RAMS geometry generated a plasma with an adequate effective temperature of T-eff approximate to 11.8 eV and electron density of 2.0 x 10(15) m(-3) to nucleate nanoclusters and to Further crystallize the nanodomains of stoichiometric HA. The deposition mechanism in the RAMS geometry was described by the formation of building units of amorphous calcium phosphate clusters (ACP), the conversion into HA nanodomains and the crystallization of the grain domains with a preferential orientation along the HA [002] direction.
C1 [Lopez, Elvis O.; Mello, Alexandre; Sendao, Henrique; Costa, Lilian T.; Rossi, Andre L.; Ospina, Rogelio O.; Borghi, Fabricio F.; Silva Filho, Jose G.; Rossi, Alexandre M.] Urca, Brazilian Ctr Phys Res, Dept Appl Phys, BR-22290180 Rio De Janeiro, Brazil.
RP Rossi, AM (reprint author), Urca, Brazilian Ctr Phys Res, Dept Appl Phys, BR-22290180 Rio De Janeiro, Brazil.
EM rossi@cbpf.br
RI Mello de Paula Silva, Alexandre/L-5493-2016; Rossi, Andre/E-8149-2013
OI Mello de Paula Silva, Alexandre/0000-0002-7503-6601; Rossi,
   Andre/0000-0002-9920-4411
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) -
   Brazil; Brazilian Center for Physics Research (CBPF)
FX This project was supported by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) - Brazil and the Brazilian Center for
   Physics Research (CBPF); we thank the Brazilian Synchrotron Light
   Laboratory (LNLS) in Campinas - Sao Paulo for the use of XRD1 and XRD2
   beamlines; Dr. Suzana Bottega Peripolli of the National Institute of
   Metrology (INMETRO) - Rio de Janeiro and Dr. Joao Paulo Sinnecker of the
   Brazilian Center for Physics Research (CBPF) for sample preparation
   using FIB and the use of COMSOL Multiphysic software (license 2072699),
   respectively, and Prof. Rolf Andreas Eichler for his kind support.
CR Astala R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075427
   Bigi A, 2005, BIOMATERIALS, V26, P4085, DOI 10.1016/j.biomaterials.2004.10.034
   Boyd AR, 2006, SURF COAT TECH, V200, P6002, DOI [10.1016/j.surfcoat.2005.09.032, 10.1016/j.surfcoat.09.032]
   Carrado A, 2011, J COAT TECHNOL RES, V8, P749, DOI 10.1007/s11998-011-9355-9
   Chastain J., 1995, HDB XRAY PHOTOELECTR
   Chow LC, 2004, J RES NATL INST STAN, V109, P543, DOI 10.6028/jres.109.041
   Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017
   Cullity B. D., 1956, ELEMENTS XRAY DIFFRA, P309
   Demri B., 1995, J MATER PROCESS TECH, V55, P31
   Dong ZL, 2003, BIOMATERIALS, V24, P97, DOI 10.1016/S0142-9612(02)00267-3
   Dorozhkin SV, 2012, PROG BIOMATER, V1, DOI 10.1186/2194-0517-1-1
   dos Santos EA, 2010, MATER SCI ENG B-ADV, V169, P138, DOI 10.1016/j.mseb.2009.10.007
   ELLIES LG, 1992, BIOMATERIALS, V13, P313, DOI 10.1016/0142-9612(92)90055-S
   FULLERTON EE, 1992, PHYS REV B, V45, P9292, DOI 10.1103/PhysRevB.45.9292
   Guipont V, 2010, J BIOMED MATER RES A, V95A, P1096, DOI 10.1002/jbm.a.32907
   HOLLAND L, 1980, VACUUM, V30, P267, DOI 10.1016/S0042-207X(80)80038-8
   Hong ZD, 2007, THIN SOLID FILMS, V515, P6773, DOI 10.1016/j.tsf.2007.02.089
   HOSHI Y, 1977, JPN J APPL PHYS, V16, P1715, DOI 10.1143/JJAP.16.1715
   HOSTE S, 1979, J ELECTRON SPECTROSC, V17, P191, DOI 10.1016/0368-2048(79)85040-9
   HUGHES JM, 1989, AM MINERAL, V74, P870
   Iliescu M, 2004, SURF COAT TECH, V187, P131, DOI 10.1016/j.surfcoat.2004.01.022
   INOUE Y, 1981, B CHEM SOC JPN, V54, P1505, DOI 10.1246/bcsj.54.1505
   Jeong YH, 2011, THIN SOLID FILMS, V519, P7050, DOI 10.1016/j.tsf.2011.04.086
   Joanni Ednan, 2004, Mat. Res., V7, P431, DOI 10.1590/S1516-14392004000300010
   Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6
   Khor KA, 2000, MAT SCI ENG A-STRUCT, V281, P221, DOI 10.1016/S0921-5093(99)00717-0
   Kim WG, 2011, THIN SOLID FILMS, V519, P7045, DOI 10.1016/j.tsf.2011.04.090
   LANDIS WJ, 1984, J VAC SCI TECHNOL A, V2, P1108, DOI 10.1116/1.572680
   Li C, 2008, ANGEW CHEM INT EDIT, V47, P2388, DOI 10.1002/anie.200705403
   Li C, 2010, CHEM MATER, V22, P3206, DOI 10.1021/cm100363a
   Lieberman MA, 2005, PRINCIPLES OF PLASMA DISCHARGES AND MATERIALS PROCESSING, 2ND EDITION, P165
   Liu DX, 2011, SURF COAT TECH, V205, P3975, DOI 10.1016/j.surfcoat.2011.02.008
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   Macaskie LE, 2005, J BIOTECHNOL, V118, P187, DOI 10.1016/j.jbiotec.2005.03.006
   Melde BJ, 2002, CHEM MATER, V14, P3326, DOI 10.1021/cm020259b
   Mello A, 2007, BIOMED MATER, V2, P67, DOI 10.1088/1748-6041/2/2/003
   Milev A, 2003, MATER LETT, V57, P1960, DOI 10.1016/S0167-577X(02)01112-6
   Morgan H, 2000, BIOMATERIALS, V21, P617, DOI 10.1016/S0142-9612(99)00225-2
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Nelea V, 2003, SURF COAT TECH, V173, P315, DOI 10.1016/S0257-8972(03)00729-1
   Ostrikov K, 2005, REV MOD PHYS, V77, P489, DOI 10.1103/RevModPhys.77.489
   Ozeki K, 2010, J AUST CERAM SOC, V46, P59
   Padilla S, 2005, BIOMATERIALS, V26, P475, DOI 10.1016/j.biomaterials.2004.02.054
   Paul W, 2006, AM J BIOCH BIOTECHNO, V2, P41, DOI DOI 10.3844/AJBBSP.2006.41.48
   Popovic RS, 2000, SENSOR ACTUAT A-PHYS, V85, P9, DOI 10.1016/S0924-4247(00)00323-X
   Rabiei A, 2006, SURF COAT TECH, V200, P6111, DOI 10.1016/j.surfcoat.2005.09.027
   Shaginyan LR, 2006, J VAC SCI TECHNOL A, V24, P1083, DOI 10.1116/1.2210947
   Shi JZ, 2008, B MATER SCI, V31, P877, DOI 10.1007/s12034-008-0140-z
   SINGH RB, 1965, J PHYS CHEM-US, V69, P3461, DOI 10.1021/j100894a036
   Snyders R, 2008, PLASMA PROCESS POLYM, V5, P168, DOI 10.1002/ppap.200700112
   Stranak V, 2012, J APPL PHYS, V112, DOI 10.1063/1.4764102
   SUGDEN TM, 1966, T FARADAY SOC, V62, P566, DOI 10.1039/tf9666200566
   Surmenev RA, 2012, SURF COAT TECH, V206, P2035, DOI 10.1016/j.surfcoat.2011.11.002
   Surmenev RA, 2011, SURF COAT TECH, V205, P3600, DOI 10.1016/j.surfcoat.2010.12.039
   Terra J, 2002, PHILOS MAG A, V82, P2357, DOI 10.1080/01418610210131010
   Treboux G, 2000, J PHYS CHEM A, V104, P5111, DOI 10.1021/jp994399t
   Uchida M, 2004, ADV MATER, V16, P1071, DOI 10.1002/adma.200400152
   Ueda K, 2007, BIOMED MATER, V2, pS160, DOI 10.1088/1748-6041/2/3/S14
   van der Wal E, 2005, APPL SURF SCI, V246, P183, DOI 10.1016/j.apsusc.2004.11.006
   Venkateswarlu K, 2010, PHYSICA B, V405, P4256, DOI 10.1016/j.physb.2010.07.020
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
   Wang H, 2011, MATER LETT, V65, P2455, DOI 10.1016/j.matlet.2011.05.016
   Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574
   Wen CE, 2007, ACTA BIOMATER, V3, P403, DOI 10.1016/j.actbio.2006.10.004
   Xu SY, 2005, PLASMA PROCESS POLYM, V2, P373, DOI 10.1002/ppap.200400094
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Ying WB, 2001, APPL SURF SCI, V181, P1, DOI 10.1016/S0169-4332(01)00202-1
   Yogamalar R, 2009, SOLID STATE COMMUN, V149, P1919, DOI 10.1016/j.ssc.2009.07.043
   Zhang HM, 2006, SOLID STATE COMMUN, V139, P87, DOI 10.1016/j.ssc.2006.05.026
   Zhang K, 2005, J AM CERAM SOC, V88, P587, DOI 10.1111/j.1551-2916.2005.00143.x
NR 70
TC 22
Z9 22
U1 1
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
EI 1944-8252
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD OCT 9
PY 2013
VL 5
IS 19
BP 9435
EP 9445
DI 10.1021/am4020007
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 243ZJ
UT WOS:000326356600027
PM 24059686
DA 2018-10-20
ER

PT J
AU Corsaro, C
   Mallamace, D
   Lojewska, J
   Mallamace, F
   Pietronero, L
   Missori, M
AF Corsaro, Carmelo
   Mallamace, Domenico
   Lojewska, Joanna
   Mallamace, Francesco
   Pietronero, Luciano
   Missori, Mauro
TI Molecular degradation of ancient documents revealed by H-1 HR-MAS NMR
   spectroscopy
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CAPILLARY-ELECTROPHORESIS; CELLULOSE; PAPER; DISCOLORATION; SPECTROMETRY
AB For centuries mankind has stored its knowledge on paper, a remarkable biomaterial made of natural cellulose fibers. However, spontaneous cellulose degradation phenomena weaken and discolorate paper over time. The detailed knowledge of products arising from cellulose degradation is essential in understanding deterioration pathways and in improving durability of cultural heritage. In this study, for the first time, products of cellulose degradation were individually detected in solid paper samples by means of an extremely powerful proton HR-MAS NMR set-up, in combination to a wise use of both ancient and, as reference, artificially aged paper samples. Carboxylic acids, in addition to more complex dicarboxylic and hydroxy-carboxylic acids, were found in all samples studied. Since these products can catalyze further degradation, their knowledge is fundamental to improve conservation strategies of historical documents. Furthermore, the identification of compounds used in ancient production techniques, also suggests for artifacts dating, authentication and provenance.
C1 [Corsaro, Carmelo; Mallamace, Francesco] Univ Messina, Dipartimento Fis & Sci Terra, I-98166 Messina, Italy.
   [Corsaro, Carmelo; Mallamace, Francesco] Univ Messina, CNISM, I-98166 Messina, Italy.
   [Mallamace, Domenico] Univ Messina, Dipartimento Sci Ambiente Sicurezza Territorio Al, I-98166 Messina, Italy.
   [Lojewska, Joanna] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland.
   [Pietronero, Luciano] CNR, Ist Sistemi Complessi, I-00185 Rome, Italy.
   [Missori, Mauro] CNR, Ist Sistemi Complessi, I-00015 Rome, Italy.
RP Corsaro, C (reprint author), Univ Messina, Dipartimento Fis & Sci Terra, Viale F Stagno dAlcontres 31, I-98166 Messina, Italy.
EM ccorsaro@unime.it; mauro.missori@isc.cnr.it
RI Pietronero, Luciano/O-4473-2018; Mallamace, Domenico/F-7492-2018;
   Corsaro, Carmelo/B-7393-2011
OI Pietronero, Luciano/0000-0001-6424-8863; Mallamace,
   Domenico/0000-0002-7168-7263; Corsaro, Carmelo/0000-0002-1497-8750;
   Mallamace, Francesco/0000-0003-4098-174X
FU Fondazione Frisone (Catania, Italy); Istituto Centrale per il Restauro e
   la Conservazione del Patrimonio Archivistico e Librario (Roma, Italy);
   Centro Italiano di Studi e Ricerche di Storia e Tecnologia della Carta
   "Andrea F. Gasparinetti" Fabriano, Italy
FX The research in Messina is supported by the Fondazione Frisone (Catania,
   Italy). All authors thank the Istituto Centrale per il Restauro e la
   Conservazione del Patrimonio Archivistico e Librario (Roma, Italy) and
   the Centro Italiano di Studi e Ricerche di Storia e Tecnologia della
   Carta "Andrea F. Gasparinetti" Fabriano, Italy for their support. Dr.
   Pawel Wojcieszek is acknowledged for his close reading and correction of
   text in the English language.
CR Ahmed SSSJ, 2014, METABOLOMICS, V10, P52, DOI 10.1007/s11306-013-0551-8
   Ali M, 2001, POLYMER, V42, P2893, DOI 10.1016/S0032-3861(00)00691-1
   Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45
   Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814
   Bogolitsyna A, 2011, J CHROMATOGR A, V1218, P8561, DOI 10.1016/j.chroma.2011.09.063
   Capitani D, 2002, MACROMOLECULES, V35, P5536, DOI 10.1021/ma020174w
   Conte AM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.158301
   Corsaro C, 2011, PHYSICA A, V390, P2904, DOI 10.1016/j.physa.2011.03.038
   Cox Michael M., 2008, PRINCIPLES BIOCH
   De Spirito M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041801
   Dupont AL, 2012, TALANTA, V89, P301, DOI 10.1016/j.talanta.2011.12.032
   Federici C., 1996, SCI TECHNOL CULTURAL, V5, P37
   Hunter D., 1978, PAPERMAKING HIST TEC
   Kato KL, 1999, CELLULOSE, V6, P23, DOI 10.1023/A:1009292120151
   Klemm D., 1998, COMPREHENSIVE CELLUL, V1
   Kolar J, 1997, RESTAURATOR, V18, P163, DOI 10.1515/rest.1997.18.4.163
   Krassig HA, 1993, CELLULOSE STRUCTURE
   Lattuati-Derieux A, 2006, J CULT HERIT, V7, P123, DOI 10.1016/j.culher.2006.02.004
   Lojewski T, 2010, CARBOHYD POLYM, V82, P370, DOI 10.1016/j.carbpol.2010.04.087
   Lojewski T, 2010, APPL PHYS A-MATER, V100, P873, DOI 10.1007/s00339-010-5663-7
   Missori M, 2004, OPT COMMUN, V231, P99, DOI 10.1016/j.optcom.2003.12.034
   Missori M, 2006, OPT COMMUN, V263, P289, DOI 10.1016/j.optcom.2006.02.004
   Missori M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238001
   Moestue S, 2011, CURR TOP MED CHEM, V11, P2, DOI 10.2174/156802611793611869
   Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319
   Rosenau T, 2011, CELLULOSE, V18, P1623, DOI 10.1007/s10570-011-9585-0
   Souguir Z, 2008, BIOMACROMOLECULES, V9, P2546, DOI 10.1021/bm8006067
   Sterflinger K, 2012, ENVIRON MICROBIOL, V14, P559, DOI 10.1111/j.1462-2920.2011.02584.x
   Strlic M, 2007, SENSORS-BASEL, V7, P3136, DOI 10.3390/s7123136
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Szpak P, 2011, J ARCHAEOL SCI, V38, P3358, DOI 10.1016/j.jas.2011.07.022
   Topgaard D, 2001, LANGMUIR, V17, P2694, DOI 10.1021/la000982l
   Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957
   Winter W. T., 2010, POLYSACCHARIDE MAT P, P261
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Zervos S, 2010, BIOTECH AGR IND MED, P155
NR 36
TC 26
Z9 27
U1 1
U2 32
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 9
PY 2013
VL 3
AR 2896
DI 10.1038/srep02896
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 231EM
UT WOS:000325396800001
PM 24104201
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Geringer, J
   Demanget, N
   Pellier, J
AF Geringer, Jean
   Demanget, Nicolas
   Pellier, Julie
TI From acid etching treatments to tribocorrosive properties of dental
   implants: do some experimental results on surface treatments have an
   influence on the tribocorrosion behaviour of dental implants?
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Article
ID IN-VITRO; CORROSION BEHAVIOR; ARTIFICIAL SALIVA; BITE FORCE; TITANIUM;
   ALLOYS
AB Surface treatments of dental implants aim at promoting osseointegration, i.e. the anchorage of the metallic part. Titanium-, grade II-V, based material is used as a bulk material for dental implants. For promoting the anchorage of this metallic biomaterial in human jaw, some strategies have been applied for improving the surface state, i.e. roughness, topography and coatings. A case study, experimental study, is described with the method of acid etching on titanium grade 4, CpTi. The main goal is to find the right proportion in a mixture of two acids in order to obtain the best surface state. Finally, a pure theoretical prediction is quite impossible and some experimental investigations are necessary to improve the surface state. The described acid etching is compared with some other acid etching treatments and some coatings available on dental implants. Thus, the discussion is focused on the tribocorrosion behaviour of titanium-based materials. The purpose of the coating is that the lifetime under tribocorrosion is limited. Moreover, the surgery related to the implantation has a huge impact on the stability of dental implants. Thus, the performance of dental implants depends on factors related to surgery (implantation) that are difficult to predict from the biomaterial characteristics. From the tribocorrosion point of view, i.e. during the mastication step, the titanium material is submitted to some deleterious factors that cause the performance of dental implants to decrease.
C1 [Geringer, Jean; Demanget, Nicolas; Pellier, Julie] CNRS UMR5307, LGF, Ctr Biomed & Healthcare Engn EMSE, Biotribocorros Lab,STBio Dept, F-42023 St Etienne, France.
RP Geringer, J (reprint author), CNRS UMR5307, LGF, Ctr Biomed & Healthcare Engn EMSE, Biotribocorros Lab,STBio Dept, 158 Cours Fauriel, F-42023 St Etienne, France.
EM geringer@emse.fr
OI geringer, jean/0000-0002-4843-2844
CR Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   BOYER R, 1994, MAT PROPERTIES HDB T
   Calderon Patrícia dos Santos, 2006, J. Appl. Oral Sci., V14, P448, DOI 10.1590/S1678-77572006000600011
   Daculsi G, 1999, BONE, V25, p59S, DOI 10.1016/S8756-3282(99)00135-0
   DACULSI G, 2002, ITBM RBM, V23, P317
   Daculsi G, 2011, BIOMATERIALS, V32, P3166, DOI 10.1016/j.biomaterials.2011.01.033
   Dimah MK, 2012, WEAR, V294, P409, DOI 10.1016/j.wear.2012.04.014
   Fathi MH, 2003, DENT MATER, V19, P188, DOI 10.1016/S0109-5641(02)00029-5
   Fellah BH, 2009, ACTA BIOMATER, V5, P735, DOI 10.1016/j.actbio.2008.09.005
   Greenstein G, 2013, J AM DENT ASSOC, V144, P362, DOI 10.14219/jada.archive.2013.0129
   Grill V, 2000, Minerva Stomatol, V49, P77
   Grill V, 2000, J BIOMED MATER RES, V52, P479, DOI 10.1002/1097-4636(20001205)52:3<479::AID-JBM5>3.0.CO;2-X
   Regalo SCH, 2008, ARCH ORAL BIOL, V53, P282, DOI 10.1016/j.archoralbio.2007.10.003
   Her TH, 2011, COMPREHENSIVE NANOSCIENCE AND TECHNOLOGY, VOL 4: NANOFABRICATION AND DEVICES, P277
   Julien M, 2007, BIOMATERIALS, V28, P956, DOI 10.1016/j.biomaterials.2006.10.018
   Juodzbalys G, 2003, BALTIC DENT MAXILLOF, V5, P101
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Levin R P, TRENDS IMPLANT DENT
   Licausi MP, 2013, J MECH BEHAV BIOMED, V20, P137, DOI 10.1016/j.jmbbm.2013.01.019
   Lopez-Callejas R, 2013, SURF COAT TECH, V229, P22, DOI 10.1016/j.surfcoat.2012.08.033
   Mathew MT, 2012, J MECH BEHAV BIOMED, V8, P71, DOI 10.1016/j.jmbbm.2011.11.004
   Samukawa S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/25/253001
   Souza JCM, 2012, WEAR, V292, P82, DOI 10.1016/j.wear.2012.05.030
   Souza JCM, 2013, J DENT, V41, P528, DOI 10.1016/j.jdent.2013.03.008
   Stout K J, 1983, DEV METHODS CHARACTE
   van der Bilt A, 2008, EUR J ORAL SCI, V116, P217, DOI 10.1111/j.1600-0722.2008.00531.x
   WALTIMO A, 1995, ACTA ODONTOL SCAND, V53, P254, DOI 10.3109/00016359509005982
   Waltimo A, 1993, EUR J ORAL SCI, V1, P171
NR 28
TC 2
Z9 2
U1 0
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
EI 1361-6463
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD OCT 9
PY 2013
VL 46
IS 40
AR 404005
DI 10.1088/0022-3727/46/40/404005
PG 7
WC Physics, Applied
SC Physics
GA 224DC
UT WOS:000324861100007
DA 2018-10-20
ER

PT J
AU Moller, J
   Luhmann, T
   Chabria, M
   Hall, H
   Vogel, V
AF Moeller, Jens
   Luehmann, Tessa
   Chabria, Mamta
   Hall, Heike
   Vogel, Viola
TI Macrophages lift off surface-bound bacteria using a
   filopodium-lamellipodium hook-and-shovel mechanism
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ESCHERICHIA-COLI; CATCH-BOND; STRUCTURAL BASIS; FIMH ADHESIN; FORCE;
   CELLS; PHAGOCYTOSIS; TRAP; ARCHITECTURE; PATHOGENS
AB To clear pathogens from host tissues or biomaterial surfaces, phagocytes have to break the adhesive bacteria-substrate interactions. Here we analysed the mechanobiological process that enables macrophages to lift-off and phagocytose surface-bound Escherichia coli (E. coli). In this opsonin-independent process, macrophage filopodia hold on to the E. coli fimbriae long enough to induce a local protrusion of a lamellipodium. Specific contacts between the macrophage and E. coli are formed via the glycoprotein CD48 on filopodia and the adhesin FimH on type 1 fimbriae (hook). We show that bacterial detachment from surfaces occurrs after a lamellipodium has protruded underneath the bacterium (shovel), thereby breaking the multiple bacterium-surface interactions. After lift-off, the bacterium is engulfed by a phagocytic cup. Force activated catch bonds enable the long-term survival of the filopodium-fimbrium interactions while soluble mannose inhibitors and CD48 antibodies suppress the contact formation and thereby inhibit subsequent E. coli phagocytosis.
C1 [Moeller, Jens; Luehmann, Tessa; Chabria, Mamta; Hall, Heike; Vogel, Viola] ETH, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, CH-8093 Zurich, Switzerland.
RP Vogel, V (reprint author), ETH, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, CH-8093 Zurich, Switzerland.
EM viola.vogel@hest.ethz.ch
RI Moeller, Jens/F-5110-2011; Vogel, Viola/O-8025-2015; Luhmann,
   Tessa/E-1209-2015
OI Moeller, Jens/0000-0002-7226-0675; Vogel, Viola/0000-0003-2898-7671; 
FU ETH Zurich, Switzerland; Ciba Speciality Chemicals, Basel, Switzerland;
   BASF, Ludwigshafen, Germany [2-70627-05]; Commission of the European
   Communities/ERC Advanced Grant [231157]; Competence Center for Materials
   Science and Technology CCMX MatLife [0-21154-07]
FX We gratefully acknowledge financial support from ETH Zurich, Switzerland
   (VV), Ciba Speciality Chemicals, Basel, Switzerland and BASF,
   Ludwigshafen, Germany (VV, grant Nb. 2-70627-05), Commission of the
   European Communities/ERC Advanced Grant (VV, grant Nb. 231157) and the
   Competence Center for Materials Science and Technology CCMX MatLife (HH,
   grant Nb. 0-21154-07). We thank Dr. A. Bittermann for advice and help
   with SEM sample preparation, S. Luna for graphic design and Dr. I.
   Schoen for discussion of the manuscript. Warm memories and gratitude go
   to Dr. Heike Hall who passed away before the study was completed.
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Aderem A., J INFECT DIS S, V187
   Albuschies J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01658
   Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6
   Almolda B, 2011, FRONT BIOSCI-LANDMRK, V16, P1157, DOI 10.2741/3781
   Amer AO, 2005, AUTOPHAGY, V1, P53, DOI 10.4161/auto.1.1.1589
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Ashkar AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000233
   Baorto DM, 1997, NATURE, V389, P636
   BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x
   Cojoc D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001072
   Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265
   Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104
   Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298
   Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7
   Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829
   Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952
   Khan NA, 2007, CELL MICROBIOL, V9, P169, DOI 10.1111/j.1462-5822.2006.00779.x
   Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104
   Laishram J, 2009, DEV NEUROBIOL, V69, P731, DOI 10.1002/dneu.20733
   Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038
   Malaviya R, 1999, P NATL ACAD SCI USA, V96, P8110, DOI 10.1073/pnas.96.14.8110
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   May RC, 2001, J CELL SCI, V114, P1061
   Moller J, 2012, NANO LETT, V12, P2901, DOI 10.1021/nl3004896
   Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101
   Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200
   Pidhatika B, 2010, BIOMATERIALS, V31, P9462, DOI 10.1016/j.biomaterials.2010.08.033
   Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X
   Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159
   Prien JM, 2009, J AM SOC MASS SPECTR, V20, P539, DOI 10.1016/j.jasms.2008.11.012
   Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127
   Shin JS, 2001, FEMS MICROBIOL LETT, V197, P131, DOI 10.1016/S0378-1097(01)00108-2
   Smith M.L., 2007, PLOS BIOL, V5, pe268
   Sokurenko EV, 2008, CELL HOST MICROBE, V4, P314, DOI 10.1016/j.chom.2008.09.005
   Steketee MB, 2002, J NEUROSCI, V22, P8071
   Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x
   Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1
   Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804
   Vonna L, 2007, EUR BIOPHYS J BIOPHY, V36, P145, DOI 10.1007/s00249-006-0118-y
   Vonna L, 2003, J CELL SCI, V116, P785, DOI 10.1242/jcs.00230
   WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x
   Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200
   Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200
   Zakrisson J, 2013, BIOPHYS J, V104, P2137, DOI 10.1016/j.bpj.2013.03.059
NR 50
TC 26
Z9 26
U1 1
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 7
PY 2013
VL 3
AR 2884
DI 10.1038/srep02884
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 230OC
UT WOS:000325349900002
PM 24097079
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yao, X
   Peng, R
   Ding, JD
AF Yao, Xiang
   Peng, Rong
   Ding, Jiandong
TI Cell-Material Interactions Revealed Via Material Techniques of Surface
   Patterning
SO ADVANCED MATERIALS
LA English
DT Review
DE biomedical materials; cell-material interaction; regenerative medicine;
   surface patterning; cell shape; stem cell
ID MESENCHYMAL STEM-CELLS; SELF-ASSEMBLED MONOLAYERS; ELECTRON-BEAM
   LITHOGRAPHY; DIP-PEN NANOLITHOGRAPHY; POROUS
   POLY(D,L-LACTIDE-CO-GLYCOLIDE) SCAFFOLDS; AMPHIPHILIC BLOCK-COPOLYMERS;
   ENDOTHELIAL GROWTH-FACTOR; MONTE-CARLO-SIMULATION; IN-VITRO DEGRADATION;
   MODEL PROTEIN DRUGS
AB Cell-material interactions constitute a key fundamental topic in biomaterials study. Various cell cues and matrix cues as well as soluble factors regulate cell behaviors on materials. These factors are coupled with each other as usual, and thus it is very difficult to unambiguously elucidate the role of each regulator. The recently developed material techniques of surface patterning afford unique ways to reveal the underlying science. This paper reviews the pertinent material techniques to fabricate patterns of microscale and nanoscale resolutions, and corresponding cell studies. Some issues are emphasized, such as cell localization on patterned surfaces of chemical contrast, and effects of cell shape, cell size, cell-cell contact, and seeding density on differentiation of stem cells. Material cues to regulate cell adhesion, cell differentiation and other cell events are further summed up. Effects of some physical properties, such as surface topography and matrix stiffness, on cell behaviors are also discussed; nanoscaled features of substrate surfaces to regulate cell fate are summarized as well. The pertinent work sheds new insight into the cell-material interactions, and is stimulating for biomaterial design in regenerative medicine, tissue engineering, and high-throughput detection, diagnosis, and drug screening.
C1 [Yao, Xiang; Peng, Rong; Ding, Jiandong] Fudan Univ, State Key Lab Mol Engn Polymers, Adv Mat Lab, Dept Macromol Sci, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, State Key Lab Mol Engn Polymers, Adv Mat Lab, Dept Macromol Sci, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
RI yao, xiang/I-4257-2013
FU Chinese Ministry of Science and Technology [2009CB930000, 2011CB606203];
   NSF of China [21034002, 91127028, 51273046]; Science and Technology
   Developing Foundation of Shanghai
FX The authors are grateful for the financial supports from Chinese
   Ministry of Science and Technology (973 programs no. 2009CB930000 and
   no. 2011CB606203), NSF of China (grants no. 21034002, no. 91127028, and
   no. 51273046), and Science and Technology Developing Foundation of
   Shanghai.
CR Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   Baik KY, 2011, SMALL, V7, P741, DOI 10.1002/smll.201001930
   Baker M, 2011, NATURE, V471, P661, DOI 10.1038/471661a
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U
   BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.0.CO;2-M
   Bernard AB, 2012, TISSUE ENG PART C-ME, V18, P583, DOI [10.1089/ten.tec.2011.0504, 10.1089/ten.TEC.2011.0504]
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621
   Bhatia SN, 1999, FASEB J, V13, P1883
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012
   Borza CM, 2012, EXP CELL RES, V318, P1001, DOI 10.1016/j.yexcr.2012.02.033
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205
   CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chang GT, 2010, MACROMOL BIOSCI, V10, P1248, DOI 10.1002/mabi.201000117
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   CHANG THP, 1975, J VAC SCI TECHNOL, V12, P1271, DOI 10.1116/1.568515
   Chatterjee M, 2006, CANCER RES, V66, P1181, DOI 10.1158/0008-5472.CAN-04-2962
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058
   Choi CK, 2010, TRENDS CELL BIOL, V20, P705, DOI 10.1016/j.tcb.2010.09.007
   Choi YS, 2012, BIOMATERIALS, V33, P6943, DOI 10.1016/j.biomaterials.2012.06.057
   Chou SY, 1997, J VAC SCI TECHNOL B, V15, P2897, DOI 10.1116/1.589752
   CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851
   Ci TY, 2013, J CONTROL RELEASE, V169, P329, DOI 10.1016/j.jconrel.2012.12.004
   Ci TY, 2013, POLYM CHEM-UK, V4, P3245, DOI 10.1039/c3py00118k
   Costa P, 2010, INT REV CEL MOL BIO, V283, P57, DOI 10.1016/S1937-6448(10)83002-3
   Crocker PR, 1996, CURR OPIN STRUC BIOL, V6, P679, DOI 10.1016/S0959-440X(96)80036-4
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Culver JC, 2012, ADV MATER, V24, P2344, DOI 10.1002/adma.201200395
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Davidson PM, 2009, ADV MATER, V21, P3586, DOI 10.1002/adma.200900582
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   DEMUTH JE, 1986, J VAC SCI TECHNOL A, V4, P1320, DOI 10.1116/1.573601
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Diez M, 2011, ADV ENG MATER, V13, pB395, DOI 10.1002/adem.201080122
   Ding JD, 1998, MACROMOLECULES, V31, P176, DOI 10.1021/ma961558n
   Ding JD, 1998, LIQ CRYST, V25, P101, DOI 10.1080/026782998206542
   Ding YF, 2011, ADV MATER, V23, P421, DOI 10.1002/adma.201001757
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Duan SF, 2005, CHINESE SCI BULL, V50, P1093, DOI 10.1360/982004-459
   DYER PE, 1990, APPL PHYS LETT, V57, P765, DOI 10.1063/1.103414
   Efremov AN, 2013, BIOMATERIALS, V34, P1757, DOI 10.1016/j.biomaterials.2012.11.034
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Folch A, 1999, J BIOMECH ENG-T ASME, V121, P28, DOI 10.1115/1.2798038
   Forster S, 1998, ADV MATER, V10, P195, DOI 10.1002/(SICI)1521-4095(199802)10:3<195::AID-ADMA195>3.0.CO;2-V
   Fouchard J, 2011, CELL ADHES MIGR, V5, P16, DOI 10.4161/cam.5.1.13281
   FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173
   FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029
   GIBSON GA, 1993, J APPL PHYS, V73, P4516, DOI 10.1063/1.352794
   Glass R, 2003, ADV FUNCT MATER, V13, P569, DOI 10.1002/adfm.200304331
   GLENDINNING WB, 1964, IEEE T COMPON PARTS, VCP11, P19, DOI 10.1109/TCP.1964.1135021
   Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g
   GREEN AM, 1994, J BIOMED MATER RES, V28, P647, DOI 10.1002/jbm.820280515
   GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   Guvendiren M, 2013, ADV HEALTHC MATER, V2, P155, DOI 10.1002/adhm.201200105
   Hagiwara T., 2006, OPTICAL MICROLITHO 1, V6154, pU2510
   Harris TM, 2000, NAT BIOTECHNOL, V18, P384, DOI 10.1038/74435
   Harrison RG, 1912, ANAT REC, V6, P181, DOI 10.1002/ar.1090060404
   He Y, 2013, CHINESE SCI BULL, V58, P2404, DOI 10.1007/s11434-013-5798-y
   He Y, 2013, ACTA POLYM SIN, P755, DOI 10.3724/SP.J.1105.2013.12439
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoff JD, 2004, NANO LETT, V4, P853, DOI 10.1021/nl049758x
   Huang JH, 2010, SOFT MATTER, V6, P3395, DOI 10.1039/b927168f
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104
   Hunt JA, 2008, NAT MATER, V7, P617, DOI 10.1038/nmat2242
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Jang SY, 2005, ADV MATER, V17, P2177, DOI 10.1002/adma.200500577
   Ji SC, 2001, POLYM J, V33, P701
   Jing DY, 2007, MACROMOL BIOSCI, V7, P1290, DOI 10.1002/mabi.200700113
   Jing DY, 2006, MACROMOL BIOSCI, V6, P747, DOI 10.1002/mabi.200600079
   Kalinina S, 2008, BIOMATERIALS, V29, P3004, DOI 10.1016/j.biomaterials.2008.04.003
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002
   Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kidambi S, 2007, TISSUE ENG, V13, P2105, DOI 10.1089/ten.2006.0151
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   Kim E, 1997, ADV MATER, V9, P651
   Kim J, 2013, J MATER CHEM B, V1, P933, DOI 10.1039/c2tb00274d
   Kirschner CM, 2013, SMALL, V9, P578, DOI 10.1002/smll.201201841
   Kolind K, 2010, BIOMATERIALS, V31, P9182, DOI 10.1016/j.biomaterials.2010.08.048
   Krishnamoorthy S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71621-2
   Kruss S, 2012, LANGMUIR, V28, P1562, DOI 10.1021/la204395d
   Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9
   Lai YX, 2010, BIOMATERIALS, V31, P4809, DOI 10.1016/j.biomaterials.2010.02.064
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lele BS, 2000, J CONTROL RELEASE, V69, P237, DOI 10.1016/S0168-3659(00)00303-5
   LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534
   Li BJ, 2012, APPL SURF SCI, V263, P45, DOI 10.1016/j.apsusc.2012.08.092
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Li Y, 2007, ANGEW CHEM INT EDIT, V46, P1094, DOI 10.1002/anie.200603844
   Liu P, 2010, NANOSCALE, V2, P122, DOI 10.1039/b9nr00124g
   Liu P, 2010, LANGMUIR, V26, P492, DOI 10.1021/la9021504
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lohmueller T, 2008, ADV MATER, V20, P2297, DOI 10.1002/adma.200702635
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Lu WQ, 2006, MACROMOLECULES, V39, P7433, DOI 10.1021/ma061356j
   Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706
   Ma DW, 2010, SOFT MATTER, V6, P4920, DOI 10.1039/c0sm00344a
   Ma DW, 2009, SOFT MATTER, V5, P4635, DOI 10.1039/b917438a
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Merrin J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000663
   Mi L, 2012, BIOMATERIALS, V33, P8928, DOI 10.1016/j.biomaterials.2012.09.011
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Ming M, 2006, BIOPHYS J, V90, P3322, DOI 10.1529/biophysj.105.076547
   Ming M, 2006, FEBS LETT, V580, P6749, DOI 10.1016/j.febslet.2006.11.035
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   Mrksich M, 2011, NAT MATER, V10, P559, DOI 10.1038/nmat3086
   Muth CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054778
   Namgung S, 2011, ACS NANO, V5, P7383, DOI 10.1021/nn2023057
   NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981
   Neufeld G, 1999, FASEB J, V13, P9
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Ofir Y, 2010, ADV MATER, V22, P3608, DOI 10.1002/adma.200904396
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003
   Okamoto T, 2000, NAT BIOTECHNOL, V18, P438
   Olk S, 2009, CELL MOTIL CYTOSKEL, V66, P1000, DOI 10.1002/cm.20404
   Palama IE, 2012, INTEGR BIOL-UK, V4, P228, DOI 10.1039/c2ib00116k
   Pan Z, 2013, CHINESE J POLYM SCI, V31, P737, DOI 10.1007/s10118-013-1264-1
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401
   Park TH, 2003, BIOTECHNOL PROGR, V19, P243, DOI 10.1021/bp020143k
   PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Perl A, 2009, ADV MATER, V21, P2257, DOI 10.1002/adma.200801864
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   POBER JS, 1990, PHYSIOL REV, V70, P427
   Qu J, 2012, APPL SURF SCI, V261, P320, DOI 10.1016/j.apsusc.2012.08.008
   Qu ZH, 2013, J BIOMAT SCI-POLYM E, V24, P447, DOI 10.1080/09205063.2012.690285
   Qu ZH, 2012, CHINESE J CHEM, V30, P2292, DOI 10.1002/cjoc.201200841
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Rogers JA, 1997, APPL PHYS LETT, V70, P2658, DOI 10.1063/1.118988
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Ruiz R, 2008, SCIENCE, V321, P936, DOI 10.1126/science.1157626
   Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422
   Rykaczewski K, 2011, ADV MATER, V23, P659, DOI 10.1002/adma.201003833
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Salaita K, 2007, NAT NANOTECHNOL, V2, P145, DOI 10.1038/nnano.2007.39
   Salber J, 2007, SMALL, V3, P1023, DOI 10.1002/smll.200600596
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Schoenfisch MH, 1998, J AM CHEM SOC, V120, P4502, DOI 10.1021/ja974301t
   Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f
   Schwarz US, 2005, MED ENG PHYS, V27, P763, DOI 10.1016/j.medengphy.2005.04.007
   Shahal T, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0023-0
   Shi MM, 2001, CLIN CHEM, V47, P164
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh G, 2011, ADV MATER, V23, P1519, DOI 10.1002/adma.201004657
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Song W, 2011, J NANOMATER, DOI 10.1155/2011/265251
   Song W, 2011, LANGMUIR, V27, P6155, DOI 10.1021/la200487w
   Spatz JP, 2000, LANGMUIR, V16, P407, DOI 10.1021/1a990070n
   Spatz JP, 1996, ADV MATER, V8, P337, DOI 10.1002/adma.19960080411
   Spatz JP, 1999, ADV MATER, V11, P149, DOI 10.1002/(SICI)1521-4095(199902)11:2<149::AID-ADMA149>3.0.CO;2-W
   Spatz JP, 1996, MACROMOLECULES, V29, P3220, DOI 10.1021/ma951712q
   Spivey EC, 2012, BIOMATERIALS, V33, P4264, DOI 10.1016/j.biomaterials.2012.02.043
   Springham SV, 1997, NUCL INSTRUM METH B, V130, P155, DOI 10.1016/S0168-583X(97)00275-9
   Steinberg T, 2007, NANO LETT, V7, P287, DOI 10.1021/nl06227z
   Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614
   Sun JG, 2008, BIOMACROMOLECULES, V9, P2569, DOI 10.1021/bm800477s
   Sun JG, 2009, CHINESE SCI BULL, V54, P3154, DOI 10.1007/s11434-009-0240-1
   Sutherland J, 2005, J ANAT, V206, P581, DOI 10.1111/j.1469-7580.2005.00415.x
   Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3
   Takayama S, 2001, ADV MATER, V13, P570, DOI 10.1002/1521-4095(200104)13:8<570::AID-ADMA570>3.0.CO;2-B
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Teng X. L., 2010, APPL PHYS LETT, P97
   Terris BD, 1996, APPL PHYS LETT, V69, P4262, DOI 10.1063/1.116965
   Thebault P, 2012, ADV MATER, V24, P1952, DOI 10.1002/adma.201103532
   Theiler S, 2011, BIOTECHNOL BIOENG, V108, P694, DOI 10.1002/bit.22979
   Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126
   Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]
   Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Tsimbouri PM, 2013, BIOMATERIALS, V34, P2177, DOI 10.1016/j.biomaterials.2012.12.019
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Vericat C, 2010, CHEM SOC REV, V39, P1805, DOI 10.1039/b907301a
   Vieu C, 2000, APPL SURF SCI, V164, P111, DOI 10.1016/S0169-4332(00)00352-4
   Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang B, 2006, REACT FUNCT POLYM, V66, P509, DOI 10.1016/j.reactfunctpolym.2005.10.003
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Wang YZ, 2012, ACTA POLYM SIN, P698, DOI 10.3724/SP.J.1105.2012.12051
   Wang YZ, 2012, PHOTOCHEM PHOTOBIOL, V88, P922, DOI 10.1111/j.1751-1097.2012.01146.x
   Wang YZ, 2012, BIOSCI BIOTECH BIOCH, V76, P250, DOI 10.1271/bbb.110508
   Wang YZ, 2011, SCI CHINA CHEM, V54, P405, DOI 10.1007/s11426-010-4213-7
   Wang Z, 2009, CHINESE SCI BULL, V54, P2968, DOI 10.1007/s11434-009-0181-8
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   WEBB A, 1995, J CELL SCI, V108, P2747
   Wei L., 2007, APPL PHYS LETT, P90
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   WIEDENSOHLER A, 1992, APPL PHYS LETT, V61, P837, DOI 10.1063/1.107761
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   WOOD A, 1988, J CELL SCI, V90, P667
   Wu J, 2009, J PHYS CHEM B, V113, P4482, DOI 10.1021/jp804838h
   Wu LB, 2005, J BIOMED MATER RES A, V75A, P767, DOI 10.1002/jbm.a.30487
   Wu LB, 2006, J BIOMED MATER RES A, V76A, P264, DOI 10.1002/jbm.a.30544
   Wu LB, 2005, TISSUE ENG, V11, P1105, DOI 10.1089/ten.2005.11.1105
   Wu LB, 2006, BIOMATERIALS, V27, P185, DOI 10.1016/j.biomaterials.2005.05.105
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Wu SC, 2011, J BIOACT COMPAT POL, V26, P565, DOI 10.1177/0883911511423563
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   Yan C, 2011, BIOMATERIALS, V32, P3931, DOI 10.1016/j.biomaterials.2011.01.078
   Yang ZG, 2008, MACROMOL RAPID COMM, V29, P751, DOI 10.1002/marc.200700872
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2013, BIOMATER SCI-UK, V1, P411, DOI 10.1039/c2bm00159d
   Yu L, 2013, MACROMOL RES, V21, P207, DOI 10.1007/s13233-013-1021-x
   Yu L, 2011, BIOMACROMOLECULES, V12, P1290, DOI 10.1021/bm101572j
   Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q
   Yu L, 2010, COLLOID POLYM SCI, V288, P1151, DOI 10.1007/s00396-010-2246-2
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   Yu X, 2012, ADV MATER, V24, P6330, DOI 10.1002/adma.201202776
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
   Zamir E, 2000, NAT CELL BIOL, V2, P191
   Zhang H, 2008, MACROMOLECULES, V41, P6493, DOI 10.1021/ma7026484
   Zhang H, 2010, J BIOMAT SCI-POLYM E, V21, P253, DOI 10.1163/156856209X415747
   Zhang JC, 2005, POLYMER, V46, P4979, DOI 10.1016/j.polymer.20058.02.120
   Zhang ML, 2008, J PHYS CHEM C, V112, P4444, DOI 10.1021/jp077053o
   Zhang Y, 2005, J BIOMED MATER RES A, V75A, P342, DOI 10.1002/jbm.a.30437
   Zhang Y, 2005, J PHARM SCI-US, V94, P1676, DOI 10.1002/jps.20310
   Zhang Y, 2005, J CONTROL RELEASE, V105, P260, DOI 10.1016/j.jconrel.2005.04.001
   Zhang Z, 2012, J BIOMED MATER RES B, V100B, P1599, DOI 10.1002/jbm.b.32728
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
   Zhao XM, 1996, ADV MATER, V8, P837, DOI 10.1002/adma.19960081016
   Zhao YC, 2012, CHINESE J CHEM, V30, P491, DOI 10.1002/cjoc.201100252
   Zhao YC, 2012, CHINESE SCI BULL, V57, P234, DOI 10.1007/s11434-011-4904-2
   Zhao YC, 2011, BIOSCI BIOTECH BIOCH, V75, P1364, DOI 10.1271/bbb.110180
   Zhao YC, 2010, CHINESE SCI BULL, V55, P3825, DOI 10.1007/s11434-010-3217-1
   Zheng WF, 2013, ADV HEALTHC MATER, V2, P95, DOI 10.1002/adhm.201200104
   Zhu JX, 1999, MACROMOL THEOR SIMUL, V8, P409, DOI 10.1002/(SICI)1521-3919(19990901)8:5<409::AID-MATS409>3.0.CO;2-0
   Zhu JX, 1998, POLYMER, V39, P6455, DOI 10.1016/S0032-3861(97)10338-X
   Zhu W, 2006, J APPL POLYM SCI, V99, P2375, DOI 10.1002/app.22674
   Zhu W, 2005, EUR POLYM J, V41, P2161, DOI 10.1016/j.eurpolymj.2005.04.006
NR 310
TC 211
Z9 212
U1 34
U2 423
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD OCT 4
PY 2013
VL 25
IS 37
SI SI
BP 5257
EP 5286
DI 10.1002/adma.201301762
PG 30
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 262SA
UT WOS:000327756700007
PM 24038153
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Seras-Franzoso, J
   Peebo, K
   Corchero, JL
   Tsimbouri, PM
   Unzueta, U
   Rinas, U
   Dalby, MJ
   Vazquez, E
   Garcia-Fruitos, E
   Villaverde, A
AF Seras-Franzoso, Joaquin
   Peebo, Karl
   Luis Corchero, Jose
   Tsimbouri, Penelope M.
   Unzueta, Ugutz
   Rinas, Ursula
   Dalby, Matthew J.
   Vazquez, Esther
   Garcia-Fruitos, Elena
   Villaverde, Antonio
TI A nanostructured bacterial bioscaffold for the sustained bottom-up
   delivery of protein drugs
SO NANOMEDICINE
LA English
DT Article
DE biomaterial; building block; drug delivery; scaffold; tissue engineering
ID INCLUSION-BODY FORMATION; FIBROBLAST-GROWTH-FACTOR; ESCHERICHIA-COLI;
   CONFORMATIONAL QUALITY; CELL-PROLIFERATION; NERVE REGENERATION; BODIES;
   AGGREGATION; SCAFFOLDS; SOLUBILITY
AB Aims: Bacterial inclusion bodies (IBs) are protein-based, amyloidal nanomaterials that mechanically stimulate mammalian cell proliferation upon surface decoration. However, their biological performance as potentially functional scaffolds in mammalian cell culture still needs to be explored. Materials & methods: Using fluorescent proteins, we demonstrate significant membrane penetration of surface-attached IBs and a corresponding intracellular bioavailability of the protein material. Results: When IBs are formed by protein drugs, such as the intracellular acting human chaperone Hsp70 or the extracellular/intracellular acting human FGF-2, IB components intervene on top-growing cells, namely by rescuing them from chemically induced apoptosis or by stimulating cell division under serum starvation, respectively. Protein release from IBs seems to mechanistically mimic the sustained secretion of protein hormones from amyloid-like secretory granules in higher organisms. Conclusion: We propose bacterial IBs as biomimetic nanostructured scaffolds (bioscaffolds) suitable for tissue engineering that, while acting as adhesive materials, partially disintegrate for the slow release of their biologically active building blocks. The bottom-up delivery of protein drugs mediated by bioscaffolds offers a highly promising platform for emerging applications in regenerative medicine.
C1 [Seras-Franzoso, Joaquin; Peebo, Karl; Luis Corchero, Jose; Unzueta, Ugutz; Vazquez, Esther; Garcia-Fruitos, Elena; Villaverde, Antonio] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.
   [Seras-Franzoso, Joaquin; Luis Corchero, Jose; Unzueta, Ugutz; Vazquez, Esther; Garcia-Fruitos, Elena; Villaverde, Antonio] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain.
   [Seras-Franzoso, Joaquin; Luis Corchero, Jose; Unzueta, Ugutz; Vazquez, Esther; Garcia-Fruitos, Elena; Villaverde, Antonio] CIBER BBN, Barcelona 08193, Spain.
   [Peebo, Karl] Competence Ctr Food & Fermentat Technol, EE-12618 Tallinn, Estonia.
   [Tsimbouri, Penelope M.; Dalby, Matthew J.] Univ Glasgow, Ctr Cell Engn, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.
   [Rinas, Ursula] Leibniz Univ Hannover, Inst Tech Chem Life Sci, D-30167 Hannover, Germany.
   [Rinas, Ursula] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.
RP Villaverde, A (reprint author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.
EM antoni.villaverde@uab.cat
RI Unzueta, Ugutz/C-2521-2017; Corchero, Jose/G-8413-2016
OI Unzueta, Ugutz/0000-0001-5119-2266; Corchero, Jose/0000-0002-6109-144X;
   Garcia-Fruitos, Elena/0000-0001-7498-4864; Tsimbouri,
   Penelope/0000-0001-5124-7458; Dalby, Matthew/0000-0002-0528-3359;
   Vazquez, Esther/0000-0003-1052-0424; Villaverde,
   Antonio/0000-0002-2615-4521; Seras-Franzoso, Joaquin/0000-0002-7893-4773
FU Modalidad Infrastructuras Cientifico-Tecnologicas (MINECO)
   [BFU2010-17450]; Agencia de Gestio d'Ajuts Universitaris i de Recerca
   (AGAUR) [2009SGR-00108]; Centro de Investigacion Biomedica En Red de
   Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN, Spain); VI
   National RDi Plan; Instituto de Salud Carlos III; Programa Personal de
   Tecnico de Apoyo (Ministerio De Economia Y Competitividad); Universitat
   Autonoma de Barcelona
FX This study was funded by Modalidad Infrastructuras
   Cientifico-Tecnologicas (MINECO; BFU2010-17450), Agencia de Gestio
   d'Ajuts Universitaris i de Recerca (AGAUR; 2009SGR-00108) and Centro de
   Investigacion Biomedica En Red de Bioingenieria, Biomateriales y
   Nanomedicina (CIBER-BBN, Spain). CIBER-BBN is an initiative funded by
   the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010,
   Consolider Program, CIBER Actions and financed by the Instituto de Salud
   Carlos III with assistance from the European Regional Development Fund.
   E Garcia-Fruitos is supported by the Programa Personal de Tecnico de
   Apoyo (Ministerio De Economia Y Competitividad). J Seras-Franzoso is
   recipient of a PIF doctoral fellowship from Universitat Autonoma de
   Barcelona, K Peebo of an Erasmus placement scholarship and A Villaverde
   of an ICREA ACADEMIA award. A Villaverde, E Garcia-Fruitos and E Vazquez
   are coinventors of a patent (P200900045) on the use of inclusion bodies
   as reagents for mammalian cell culture. The authors have no other
   relevant affiliations or financial involvement with any organization or
   entity with a financial interest in or financial conflict with the
   subject matter or materials discussed in the manuscript apart from those
   disclosed.
CR AMALRIC F, 1991, ANN NY ACAD SCI, V638, P127, DOI 10.1111/j.1749-6632.1991.tb49023.x
   Ami D, 2005, FEBS LETT, V579, P3433, DOI 10.1016/j.febslet.2005.04.085
   Ami D, 2006, BBA-PROTEINS PROTEOM, V1764, P793, DOI 10.1016/j.bbapap.2005.12.005
   Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43
   Bailly K, 2000, FASEB J, V14, P333
   Bhang SH, 2009, BIOMATERIALS, V30, P126, DOI 10.1016/j.biomaterials.2008.09.021
   Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030
   Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133
   Cho Hyung Joon, 2008, Biotechnology Journal, V3, P631, DOI 10.1002/biot.200700258
   de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009
   Diederichs S, 2012, TISSUE ENG PT A, V18, P1140, DOI [10.1089/ten.TEA.2011.0426, 10.1089/ten.tea.2011.0426]
   Diez-Gil C, 2010, BIOMATERIALS, V31, P5805, DOI 10.1016/j.biomaterials.2010.04.008
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Doschak MR, 2009, MOL PHARMACEUT, V6, P634, DOI 10.1021/mp8002368
   Ferrer-Miralles N, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-101
   Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27
   Garcia-Fruitos E, 2007, J MOL BIOL, V374, P195, DOI 10.1016/j.jmb.2007.09.004
   Garcia-Fruitos E, 2007, APPL ENVIRON MICROB, V73, P289, DOI 10.1128/AEM.01952-06
   Garcia-Fruitos E, 2012, TRENDS BIOTECHNOL, V30, P65, DOI 10.1016/j.tibtech.2011.09.003
   Garcia-Fruitos E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-80
   Garcia-Fruitos E, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/20/205101
   Garcia-Fruitos E, 2010, KOREAN J CHEM ENG, V27, P385, DOI 10.1007/s11814-010-0161-3
   Garcia-Fruitos E, 2009, ADV MATER, V21, P4249, DOI 10.1002/adma.200900283
   Gonzalez-Montalban N, 2008, BIOTECHNOL BIOENG, V100, P797, DOI 10.1002/bit.21797
   Gonzalez-Montalban N, 2007, NAT BIOTECHNOL, V25, P718, DOI 10.1038/nbt0707-718
   He SH, 2012, ACTA BIOMATER, V8, P2659, DOI 10.1016/j.actbio.2012.03.044
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014
   Hoffmann F, 2004, ENZYME MICROB TECH, V34, P235, DOI 10.1016/j.enzmictec.2003.10.011
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Liovic M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-67
   Lisi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034284
   Corchero JL, 2013, BIOTECHNOL ADV, V31, P140, DOI 10.1016/j.biotechadv.2012.09.001
   Madduri S, 2010, BIOMATERIALS, V31, P8402, DOI 10.1016/j.biomaterials.2010.07.052
   Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017
   Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155
   Marcantonio NA, 2009, BIOMATERIALS, V30, P4629, DOI 10.1016/j.biomaterials.2009.05.061
   Martinez-Alonso M, 2007, FEMS MICROBIOL LETT, V273, P187, DOI 10.1111/j.1574-6968.2007.00788.x
   Martinez-Alonso M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-4
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Mitraki A, 2010, ADV PROTEIN CHEM STR, V79, P89, DOI 10.1016/S1876-1623(10)79003-9
   Molnar P, 2007, BIOTECHNOL PROGR, V23, P265, DOI 10.1021/bp060302q
   Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007
   OBERG K, 1994, BIOCHEMISTRY-US, V33, P2628, DOI 10.1021/bi00175a035
   Peternel S, 2011, INT J MOL SCI, V12, P8275, DOI 10.3390/ijms12118275
   Peternel S, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-66
   Peternel S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-34
   Platas G, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-79
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Rodriguez-Carmona E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-71
   Rodriguez-Carmona E, 2010, TRENDS MICROBIOL, V18, P423, DOI 10.1016/j.tim.2010.06.007
   Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659
   Seras-Franzoso J, 2012, NANOMEDICINE-UK, V7, P79, DOI [10.2217/nnm.11.83, 10.2217/NNM.11.83]
   Sokic S, 2012, ACTA BIOMATER, V8, P2213, DOI 10.1016/j.actbio.2012.03.017
   Upadhyay AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033951
   Vazquez E, 2012, ADV MATER, V24, P1742, DOI 10.1002/adma.201104330
   Vazquez E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-60
   Vazquez E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-101
   Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007
   Vera A, 2007, BIOTECHNOL BIOENG, V96, P1101, DOI 10.1002/bit.21218
   Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862
   Villaverde A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-76
   Villaverde A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-53
   Wu W, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-9
   Zhao X, 2011, J BIOMED NANOTECHNOL, V7, P823, DOI 10.1166/jbn.2011.1342
   Zhou BH, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-10
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
NR 67
TC 10
Z9 10
U1 3
U2 30
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PD OCT
PY 2013
VL 8
IS 10
BP 1587
EP 1599
DI 10.2217/NNM.12.188
PG 13
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 299DD
UT WOS:000330374400010
PM 23394133
DA 2018-10-20
ER

PT J
AU Schnieders, J
   Gbureck, U
   Germershaus, O
   Kratz, M
   Jones, DB
   Kissel, T
AF Schnieders, Julia
   Gbureck, Uwe
   Germershaus, Oliver
   Kratz, Marita
   Jones, David B.
   Kissel, Thomas
TI Ex Vivo Human Trabecular Bone Model for Biocompatibility Evaluation of
   Calcium Phosphate Composites Modified with Spray Dried Biodegradable
   Microspheres
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE bone cement; biocompatibility; composites; microspheres; drug delivery
ID OSTEOBLAST-LIKE CELLS; CONTROLLED-RELEASE; CULTURE-SYSTEM; TETRACYCLINE;
   CEMENT; OSTEOMYELITIS; BIOMATERIAL; BIOREACTOR; METABOLISM; EXPRESSION
AB Our aim was to study the suitability of the ex-vivo human trabecular bone bioreactor ZetOS to test the biocompatibility of calcium phosphate bone cement composites modified with spray dried, drug loaded microspheres. We hypothesized, that this bone bioreactor could be a promising alternative to in vivo assessment of biocompatibility in living human bone over a defined time period. Composites consisting of tetracycline loaded poly(lactic-co-glycolic acid) microspheres and calcium phosphate bone cement, were inserted into in vitro cultured human femora head trabecular bone and incubated over 30 days at 37 degrees C in the incubation system. Different biocompatibility parameters, such as lactate dehydrogenase activity, alkaline phosphatase release and the expression of relevant cytokines, IL-1, IL-6, and TNF-, were measured in the incubation medium. No significant differences in alkaline phosphatase, osteocalcin, and lactate dehydrogenase activity were measured compared to control samples. Tetracycline was released from the microspheres, delivered and incorporated into newly formed bone. In this study we demonstrated that ex vivo biocompatibility testing using human trabecular bone in a bioreactor is a potential alternative to animal experiments since bone metabolism is still maintained in a physiological environment ex vivo.
C1 [Schnieders, Julia; Kissel, Thomas] Univ Marburg, Dept Pharmaceut Technol & Biopharm, D-35032 Marburg, Germany.
   [Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
   [Germershaus, Oliver] Univ Wurzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany.
   [Kratz, Marita; Jones, David B.] Univ Marburg, Dept Expt Orthoped & Biomech, D-35032 Marburg, Germany.
RP Germershaus, O (reprint author), Univ Wurzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany.
EM o.germershaus@pharmazie.uni-wuerzburg.de
RI Gbureck, Uwe/G-1430-2012
OI Germershaus, Oliver/0000-0002-8440-2781
CR AKIRA S, 1990, FASEB J, V4, P2860
   Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Angeliewa A, 2004, J BONE MINER METAB, V22, P192, DOI 10.1007/s00774-003-0469-8
   Bailey LO, 2005, BIOMATERIALS, V26, P5296, DOI 10.1016/j.biomaterilas.2005.01.055
   Bittner B, 1999, J CONTROL RELEASE, V59, P23, DOI 10.1016/S0168-3659(98)00170-9
   Bittner B, 1998, J MICROENCAPSUL, V15, P495, DOI 10.3109/02652049809006876
   Brockmann E., 2004, THESIS PHILIPPS U MA
   Chow JWM, 1998, J BONE MINER RES, V13, P1760, DOI 10.1359/jbmr.1998.13.11.1760
   Dahners LE, 2002, J ORTHOP TRAUMA, V16, P345, DOI 10.1097/00005131-200205000-00009
   David V, 2008, TISSUE ENG PT A, V14, P117, DOI 10.1089/ten.a.2007.0051
   Davies CM, 2006, EUR CELLS MATER, V11, P57, DOI 10.22203/eCM.v011a07
   Debrunner A. M., 1994, ORTHOPADIE ORTHOPADI
   Delmas P. D., 1993, PHYSL PHARM BONE
   Di Toro R, 2004, EUR J PHARM SCI, V21, P161, DOI 10.1016/j.ejps.2003.10.001
   Dumas V, 2009, BIOMATERIALS, V30, P3279, DOI 10.1016/j.biomaterials.2009.02.048
   Endres S, 2009, J MUSCULOSKEL NEURON, V9, P173
   Esposito E, 1997, J MICROENCAPSUL, V14, P175, DOI 10.3109/02652049709015331
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Hermsen Derik, 2002, Clin Lab, V48, P131
   Jones D, 1995, BIOCHEM CELL BIOL, V73, P525, DOI 10.1139/o95-058
   Jones D. B., 2003, European Cells & Materials, V5, P48
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Lanyon L. E., 1993, PHYSL PHARM BONE
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Luginbuehl V, 2010, J BIOMED MATER RES B, V92B, P341, DOI 10.1002/jbm.b.31520
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   ONIGBINDE TA, 1990, CLIN CHEM, V36, P1819
   Oringer RJ, 2002, J PERIODONTOL, V73, P835, DOI 10.1902/jop.2002.73.8.835
   PRENTICE AI, 1967, J CLIN PATHOL, V20, P717, DOI 10.1136/jcp.20.5.717
   Ratier A, 2004, INT J PHARM, V274, P261, DOI 10.1016/j.ijpharm.2004.01.021
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   Richards RG, 2007, ALTEX-ALTERN TIEREXP, V24, P56
   Rubin C, 2002, J BONE MINER RES, V17, P349, DOI 10.1359/jbmr.2002.17.2.349
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Schnettler R, 2005, J CONTROL RELEASE, V106, P154, DOI 10.1016/j.jconrel.2005.04.011
   Schnieders J, 2006, BIOMATERIALS, V27, P4239, DOI 10.1016/j.biomaterials.2006.03.032
   STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420
   TIETZ NW, 1983, CLIN CHEM, V29, P751
   WESTGARD JO, 1972, CLIN CHEM, V18, P1334
   Yang R, 2003, Eur Cell Mater, V6, P57
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
NR 41
TC 5
Z9 5
U1 1
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD OCT
PY 2013
VL 2
IS 10
BP 1361
EP 1369
DI 10.1002/adhm.201200390
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 264RY
UT WOS:000327899400008
PM 23568426
DA 2018-10-20
ER

PT J
AU Cumpata, CN
   Raescu, M
   Defta, CL
   Constantinescu, FE
   Constantinescu, MV
AF Cumpata, C. N.
   Raescu, M.
   Defta, C. L.
   Constantinescu, F. E.
   Constantinescu, M. V.
TI STUDY ON BIOCOMPATIBILITY OF CHEMICALLY COATED TITANIUM WITH BIOLOGICAL
   HYDROXYAPATIT
SO DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES
LA English
DT Article
DE Biocompatibility; Titanium; Cell cultures; Biological hydroxyapatite
ID APATITE WOLLASTONITE; IN-VIVO; BONE; IMPLANTS; OSTEOCONDUCTION; INVITRO
AB The reconstruction of large bone defects after traumatisms or after extirpation of tumoral formations, benefits today of surgical methods which morphologically and functionally remake of the bone tissue, using transplants or implants based on calcium phosphate. A remarkable characteristic of the phosphatic ceramic which differentiates biologically inert implants, is represented by its capacity to interact directly with bone tissue. The main objective of the study has pursued obtaining a biomaterial made of titanium with higher mechanical, physical and chemical properties with direct applications in oral and maxillofacial surgery. The study tries to emphasize the bioactive potential of the biomaterial obtained by coating titanium with biological hydroxyapatite as consequence of this immersion in blood plasma similar solution.
C1 [Cumpata, C. N.] Titu Maiorescu Univ, Fac Med Dent, Dept Oral & Maxillofacial Surg, RO-031593 Bucharest, Romania.
   [Raescu, M.] Titu Maiorescu Univ, Fac Med Dent, Dept Prevent Dent & Oral Hlth, RO-031593 Bucharest, Romania.
   [Defta, C. L.] Carol Davila Univ Med & Pharm, Fac Med Dent, Dept Microbiol, RO-020021 Bucharest, Romania.
   [Constantinescu, F. E.] European Soc Neuromuscular Prosthodont, RO-20082 Bucharest, Romania.
   [Constantinescu, M. V.] Titu Maiorescu Univ, Fac Med Dent, Dept Oral Rehabil, RO-031593 Bucharest, Romania.
RP Raescu, M (reprint author), Titu Maiorescu Univ, Fac Med Dent, Dept Prevent Dent & Oral Hlth, 67A Gh Petrascu St,Sect 3, RO-031593 Bucharest, Romania.
EM mihaela.raescu@gmail.com
CR Badr NA, 2007, IMPLANT DENT, V16, P297, DOI 10.1097/ID.0b013e31805d7dc4
   Cook S D, 1987, Int J Oral Maxillofac Implants, V2, P15
   Gallagher J A, 1996, Methods Mol Med, V2, P233, DOI 10.1385/0-89603-335-X:233
   GALLAGHER JA, 1984, ADV EXP MED BIOL, V171, P279
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   IWASHITA Y, 1992, J APPL BIOMATER, V3, P259, DOI 10.1002/jab.770030404
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   JANSEN JA, 1993, J APPL BIOMATER, V4, P213, DOI 10.1002/jab.770040302
   JARCHO M, 1992, Dental Clinics of North America, V36, P19
   Kizuki T, 2010, ACTA BIOMATER, V6, P2836, DOI 10.1016/j.actbio.2010.01.007
   Manen van EH, 2012, ODONTOLOGY
   ONO K, 1990, BIOMATERIALS, V11, P265
   ONO K, 1990, J BIOMED MATER RES, V24, P11, DOI 10.1002/jbm.820240103
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Reigstad O, 2011, J BIOMED MATER RES B, V99B, P14, DOI 10.1002/jbm.b.31866
   Seydlova M, 2008, Prague Med Rep, V109, P142
   SKJODT H, 1985, J ENDOCRINOL, V105, P391, DOI 10.1677/joe.0.1050391
   van der Zande M, 2011, J TISSUE ENG REGEN M, V5, P476, DOI 10.1002/term.339
   Vidigal GM, 2009, IMPLANT DENT, V18, P353, DOI 10.1097/ID.0b013e3181ac9a3d
   Wang MB, 2008, J BIOMED MATER RES A, V85A, P418, DOI 10.1002/jbm.a.31585
   Wilson J, 1988, Phillip J Restaur Zahnmed, V5, P242
   Yan YG, 2006, J BIOMED MATER RES A, V77A, P815, DOI 10.1002/jbm.a.30674
   Zakaria SM, 2013, TISSUE ENG PART B-RE, P14
   Zechner W, 2003, CLIN ORAL IMPLAN RES, V14, P150, DOI 10.1034/j.1600-0501.2003.140203.x
NR 24
TC 1
Z9 1
U1 0
U2 8
PU INST MATERIALS PHYSICS
PI BUCHAREST
PA NATL INST R&D MATERIALS PHYSICS, ATOMISTILOR STR, 105 BIS, BUCHAREST,
   077125, ROMANIA
SN 1842-3582
J9 DIG J NANOMATER BIOS
JI Dig. J. Nanomater. Biostruct.
PD OCT-DEC
PY 2013
VL 8
IS 4
BP 1653
EP 1663
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 263ON
UT WOS:000327818000030
DA 2018-10-20
ER

PT J
AU Wells, LA
   Valic, MS
   Lisovsky, A
   Sefton, MV
AF Wells, Laura A.
   Valic, Michael S.
   Lisovsky, Alexandra
   Sefton, Michael V.
TI Angiogenic Biomaterials to Promote Tissue Vascularization and
   Integration
SO ISRAEL JOURNAL OF CHEMISTRY
LA English
DT Review
DE angiogenesis; biomaterials; polyanions; polymers
ID METHYL METHACRYLATE) BEADS; SONIC HEDGEHOG; IN-VIVO; PEPTIDE NANOFIBERS;
   HYDROGEL SCAFFOLDS; CLOSE PROXIMITY; CELL-MIGRATION; GROWTH; ACID; VEGF
AB Robert Langer's work with Judah Folkman brought angiogenesis into the spotlight and herein we focus on an offshoot of this work - biomaterial-driven therapeutic angiogenesis. Angiogenic biomaterials are expected to improve vascularization and integration in tissue engineering, wound healing and medical device applications. This review focuses on therapeutic methacrylic acid copolymers, highlighting some new approaches to use these materials. Such copolymers require no biological components (drugs or cells) to promote in vivo vascularization; they are therapeutic polymers.
C1 [Wells, Laura A.; Valic, Michael S.; Lisovsky, Alexandra; Sefton, Michael V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Sefton, Michael V.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
RP Wells, LA (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St,Suite 407, Toronto, ON M5S 3G9, Canada.
EM michael.sefton@utoronto.ca
FU Ontario Research Foundation; Natural Sciences and Engineering Research
   Council; Canadian Institutes of Health Research; CIHR Training Program
   in Regenerative Medicine
FX We acknowledge financial support from the Ontario Research Foundation
   and the Natural Sciences and Engineering Research Council. We
   acknowledge Dr. Harald Stover and Alison Stewart (M.Sc. student), from
   McMaster University, for guidance in material synthesis and development
   for the PVMA-MAL/PVMA-FFA hydrogel work. L. A. Wells acknowledges
   fellowship support from the Canadian Institutes of Health Research and
   the CIHR Training Program in Regenerative Medicine.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167
   Baiguera S, 2013, ANGIOGENESIS, V16, P1, DOI 10.1007/s10456-012-9307-8
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Burgess E, 1998, PLAST RECONSTR SURG, V102, P2395, DOI 10.1097/00006534-199812000-00019
   Butler MJ, 2007, J BIOMED MATER RES A, V82A, P265, DOI 10.1002/jbm.a.31314
   Cao Y, 2011, SCI TRANSL MED, V3
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Cencioni C, 2012, CARDIOVASC RES, V94, P400, DOI 10.1093/cvr/cvs132
   Cho H, 2012, ACTA BIOMATER, V8, P154, DOI 10.1016/j.actbio.2011.08.029
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Connors D, 2000, WOUND REPAIR REGEN, V8, P292, DOI 10.1046/j.1524-475X.2000.00292.x
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Eckhaus AA, 2008, PLAST RECONSTR SURG, V122, P1361, DOI 10.1097/PRS.0b013e3181882082
   Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002
   Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381
   Fitzpatrick L. E., SCAFFOLDS TISSUE ENG
   Fitzpatrick LE, 2012, BIOMATERIALS, V33, P5297, DOI 10.1016/j.biomaterials.2012.04.008
   Fitzpatrick LE, 2011, BIOMATERIALS, V32, P8957, DOI 10.1016/j.biomaterials.2011.08.021
   Fleckman P, 2012, J BIOMED MATER RES A, V100A, P1256, DOI 10.1002/jbm.a.34012
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Gardner CM, 2011, J BIOMAT SCI-POLYM E, V22, P2127, DOI 10.1163/092050610X535149
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596
   Koschwanez HE, 2008, J BIOMED MATER RES A, V87A, P792, DOI 10.1002/jbm.a.31824
   Koschwanez HE, 2007, BIOMATERIALS, V28, P3687, DOI 10.1016/j.biomaterials.2007.03.034
   Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057
   LANGER R, 1976, SCIENCE, V193, P70, DOI 10.1126/science.935859
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Luo JD, 2009, AM J PHYSIOL-ENDOC M, V297, pE525, DOI 10.1152/ajpendo.00308.2009
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mammadov R, 2011, BIOMACROMOLECULES, V12, P3508, DOI 10.1021/bm200957s
   Martin DC, 2010, J BIOMED MATER RES A, V93A, P484, DOI 10.1002/jbm.a.32528
   Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Oh HH, 2012, J BIOMAT SCI-POLYM E, V23, P2185, DOI 10.1163/092050611X611693
   Paradise RK, 2013, EXP CELL RES, V319, P487, DOI 10.1016/j.yexcr.2012.11.006
   Patel RJ, 2012, J BIOMED MATER RES A, V100A, P2054, DOI 10.1002/jbm.a.34101
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Renault MA, 2009, CIRC RES, V105, P818, DOI 10.1161/CIRCRESAHA.109.206706
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x
   Shoham Y, 2013, J WOUND CARE, V22, P144, DOI 10.12968/jowc.2013.22.3.144
   Sun GM, 2011, P NATL ACAD SCI USA, V108, P20976, DOI 10.1073/pnas.1115973108
   Sun G, 2011, BIOMATERIALS, V32, P95, DOI 10.1016/j.biomaterials.2010.08.091
   Tawil NJ, 1999, WOUND REPAIR REGEN, V7, P389, DOI 10.1046/j.1524-475X.1999.00389.x
   Wallez Y, 2006, TRENDS CARDIOVAS MED, V16, P55, DOI 10.1016/j.tcm.2005.11.008
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122
   West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799
   Wu LC, 1999, J SURG RES, V85, P43, DOI 10.1006/jsre.1999.5354
NR 66
TC 5
Z9 5
U1 3
U2 32
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0021-2148
EI 1869-5868
J9 ISR J CHEM
JI Isr. J. Chem.
PD OCT
PY 2013
VL 53
IS 9-10
SI SI
BP 637
EP 645
DI 10.1002/ijch.201300053
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 262MW
UT WOS:000327740500006
DA 2018-10-20
ER

PT J
AU Ruvinov, E
   Cohen, S
AF Ruvinov, Emil
   Cohen, Smadar
TI Engineering Biomaterials for Myocardial Regeneration and Repair
SO ISRAEL JOURNAL OF CHEMISTRY
LA English
DT Review
DE angiogenesis; gels; myocardial infarction; regeneration; tissue
   engineering
ID ENDOTHELIAL GROWTH-FACTOR; BIOENGINEERED CARDIAC GRAFTS; SHEET
   MANIPULATION TECHNIQUE; REDUCES INFARCT EXPANSION; POROUS ALGINATE
   SCAFFOLDS; LEFT-VENTRICULAR GEOMETRY; EXTRACELLULAR-MATRIX;
   HEART-FAILURE; FACTOR-I; CARDIOMYOCYTE PROLIFERATION
AB Augmentation of myocardial tissue regeneration processes in injured hearts represents a major challenge in cardiology as current therapeutic approaches do not regenerate the myocardial tissue. Herein, we describe three emerging biomaterial-based strategies to treat heart injuries, as stand-alone therapies or in combination with regeneration-inducing signals and/or cells. One strategy relies on the injection of acellular biomaterials, at an early stage after myocardial infarction (MI); these materials replace the damaged extracellular matrix, maintain left ventricular (LV) thickness, and prevent the negative LV remodeling and progression to heart failure. This strategy is currently being investigated in advanced clinical trials using a novel alginate-based biomaterial. The second strategy employs engineered biomaterials, spatially presenting multiple regeneration-inducing factors, to promote myocardial tissue regeneration in chronic infarcted hearts. The recent attempts to understand the natural capacity of the myocardium to heal and the factors involved in these processes are promising to advance this therapy. The third strategy applies biomaterials to promote cardiac tissue engineering and create a pre-vascularized cardiac patch to replace damaged or missing myocardial tissue. Collectively, this review emphasizes the increasing importance of biomaterials in cardiology, describes the engineering schemes used in their fabrication, and their implementation in various therapeutic strategies aimed at cardiac tissue regeneration and repair. It mainly highlights the contribution of our group in developing these strategies.
C1 [Ruvinov, Emil; Cohen, Smadar] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
   [Cohen, Smadar] Ben Gurion Univ Negev, Ctr Regenerat Med & Stem Cell RMSC Res, IL-84105 Beer Sheva, Israel.
   [Cohen, Smadar] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel.
RP Ruvinov, E (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
EM scohen@bgu.ac.il
FU European Union FWP7 (INELPY); Israel Science Foundation [52/99-1,
   793/04, 1368/08]; Israel Ministry of Science, Culture and Sport
FX The research has been supported by the European Union FWP7 (INELPY),
   three grants from the Israel Science Foundation (52/99-1,
   793/04&1368/08) and the Israel Ministry of Science, Culture and Sport.
   Prof. Cohen holds the Claire and Harold Oshry Professor Chair in
   Biotechnology.
CR Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006
   Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060
   BioLineRx Ltd, SAF FEAS INJ BL 1040
   Boersma E, 2003, LANCET, V361, P847, DOI 10.1016/S0140-6736(03)12712-2
   Bollini S., 2010, J MOL CELL CARDIOL, V50, P296
   Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chiu LLY, 2012, ANN NY ACAD SCI, V1269, P16, DOI 10.1111/j.1749-6632.2012.06718.x
   Chiu LLY, 2010, MACROMOL BIOSCI, V10, P1286, DOI 10.1002/mabi.201000202
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cohen S, 2004, SCI AM, V291, P44, DOI 10.1038/scientificamerican1104-44
   Conti E, 2004, CIRCULATION, V110, P2260, DOI 10.1161/01.CIR.0000144309.87183.FB
   Dahlmann J, 2013, BIOMATERIALS, V34, P940, DOI 10.1016/j.biomaterials.2012.10.008
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]
   Eschenhagen T, 1997, FASEB J, V11, P683
   Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Furuta A, 2006, CIRC RES, V98, P705, DOI 10.1161/01.RES.0000209515.59115.70
   Gao J, 2011, TISSUE ENG PT A, V17, P2739, DOI [10.1089/ten.tea.2011.0105, 10.1089/ten.TEA.2011.0105]
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Haraguchi Y., 2011, CARDIOL RES PRACT, V2011, DOI DOI 10.4061/2011/845170
   Hassink RJ, 2008, CARDIOVASC RES, V78, P18, DOI 10.1093/cvr/cvm101
   Hausenloy DJ, 2009, CARDIOVASC RES, V83, P179, DOI 10.1093/cvr/cvp062
   Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Ikaria Holdings Inc, IK 5001 PREV REM VEN
   Iraqi W, 2009, CIRCULATION, V119, P2471, DOI 10.1161/CIRCULATIONAHA.108.809194
   Iyer RK, 2012, TISSUE ENG PT A, V18, P1771, DOI [10.1089/ten.tea.2011.0468, 10.1089/ten.TEA.2011.0468]
   Iyer RK, 2009, J BIOMED MATER RES A, V89A, P616, DOI 10.1002/jbm.a.32014
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172
   Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024
   Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee HM, 2003, TISSUE ENG, V9, P1227, DOI 10.1089/10763270360728134
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2004, CIRCULATION, V110, P279
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Lesman A., 2009, TISSUE ENG PART A, V16, P115
   Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730
   Li RK, 1999, CIRCULATION, V100, P63
   Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Maidhof R, 2010, BIOTECHNOL PROGR, V26, P565, DOI 10.1002/btpr.337
   Maltais S, 2010, J CARDIOVASC TRANSL, V3, P652, DOI 10.1007/s12265-010-9198-2
   McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392
   Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570
   Nakamura T, 2005, AM J PHYSIOL-HEART C, V288, pH2131, DOI 10.1152/ajpheart.01239.2003
   Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226
   Novoyatleva T, 2010, CARDIOVASC RES, V85, P681, DOI 10.1093/cvr/cvp360
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Parmacek MS, 2009, NEW ENGL J MED, V361, P86, DOI 10.1056/NEJMcibr0903347
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Ruvinov E, 2011, J CARDIOVASC TRANSL, V4, P559, DOI 10.1007/s12265-011-9288-9
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Saik JE, 2011, ACTA BIOMATER, V7, P133, DOI 10.1016/j.actbio.2010.08.018
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397
   Segers VFM, 2007, DRUG DISCOV TODAY, V12, P561, DOI 10.1016/j.drudis.2007.05.003
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Seif-Naraghi S.B., 2013, SCI TRANSL MED, V5
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Sekine H, 2006, J HEART LUNG TRANSPL, V25, P324, DOI 10.1016/j.healun.2005.09.017
   Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659
   Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007
   Suleiman MS, 2007, PHARMACOL THERAPEUT, V114, P278, DOI 10.1016/j.pharmthera.2007.03.001
   Suzuki R, 2009, BIOCHEM BIOPH RES CO, V387, P353, DOI 10.1016/j.bbrc.2009.07.024
   Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052
   Tomita N, 2003, CIRCULATION, V107, P1411, DOI 10.1161/01.CIR.0000055331.41937.AA
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   Vandervelde S, 2005, J MOL CELL CARDIOL, V39, P363, DOI 10.1016/j.yjmcc.2005.05.012
   Wainwright JM, 2009, TISSUE ENG PART C-ME, V16, P525
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004
   Webster KA, 2007, TRENDS PHARMACOL SCI, V28, P492, DOI 10.1016/j.tips.2007.07.004
   Whelan RS, 2007, J CLIN INVEST, V117, P2751, DOI 10.1172/JCI33706
   WHO, ATLAS HEART DIS STRO
   Ye KY, 2011, J CARDIOVASC TRANSL, V4, P575, DOI 10.1007/s12265-011-9303-1
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026
   Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 121
TC 0
Z9 0
U1 1
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0021-2148
EI 1869-5868
J9 ISR J CHEM
JI Isr. J. Chem.
PD OCT
PY 2013
VL 53
IS 9-10
SI SI
BP 695
EP 709
DI 10.1002/ijch.201300050
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA 262MW
UT WOS:000327740500011
DA 2018-10-20
ER

PT J
AU Ghezzi, CE
   Rnjak-Kovacina, J
   Weiss, AS
   Kaplan, DL
AF Ghezzi, Chiara E.
   Rnjak-Kovacina, Jelena
   Weiss, Anthony S.
   Kaplan, David L.
TI Multifunctional Silk-Tropoelastin Biomaterial Systems
SO ISRAEL JOURNAL OF CHEMISTRY
LA English
DT Review
DE materials science; natural products; polymers; structureactivity
   relationships; tissue engineering
ID EXTRACELLULAR-MATRIX; MECHANICAL-PROPERTIES; ELASTIC FIBERS; PROTEIN;
   COLLAGEN; FIBROIN; POLYMER; STEM; SUBSTRATE; SPIDERS
AB New multifunctional, degradable, polymeric biomaterial systems would provide versatile platforms to address cell and tissue needs in both in vitro and in vivo environments. While protein-based composites or alloys are the building blocks of biological organisms, similar systems have not been largely exploited, to date, to generate ad hoc biomaterials able to control and direct biological functions by recapitulating their inherent structural and mechanical complexities. Therefore, we have recently proposed silktropoelastin material platforms that are able to conjugate a mechanically robust and durable protein, silk, to a highly flexible and biologically active protein, tropoelastin. This review focuses on the elucidation of the interactions between silk and tropoelastin to control the structure of the material its properties, and ultimately functions. In addition, an approach is provided for novel material designs to provide tools to control biological outcomes through surface roughness, elasticity, and net charge for neuronal and mesenchymal stem-cell-based tissue engineering.
C1 [Ghezzi, Chiara E.; Rnjak-Kovacina, Jelena; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
   [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
RP Ghezzi, CE (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM Tony.weiss@syndney.edu.au; david.kaplan@tufts.edu
RI Rnjak-Kovacina, Jelena/B-8928-2014
OI WEISS, ANTHONY/0000-0002-8106-4836
FU NIH [EB014283, AR005593, AR061988, P41 EB002520]; Australian Research
   Council; National Health & Medical Research Council
FX We thank funding agencies for support of these studies (NIH EB014283,
   AR005593, AR061988, P41 EB002520, Australian Research Council, National
   Health & Medical Research Council). A. S. W. is the Scientific Founder
   of Elastagen Pty Ltd.
CR Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   AUBIN M, 1983, J POLYM SCI POL PHYS, V21, P233, DOI 10.1002/pol.1983.180210205
   Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   COX BA, 1973, BIOCHIM BIOPHYS ACTA, V317, P209, DOI 10.1016/0005-2795(73)90215-8
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   Domke J, 2000, COLLOID SURFACE B, V19, P367, DOI 10.1016/S0927-7765(00)00145-4
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7
   Ghezzi CE, 2011, BIOTECHNOL J, V6, P1198, DOI 10.1002/biot.201100127
   GUIDRY C, 1987, J CELL BIOL, V104, P1097, DOI 10.1083/jcb.104.4.1097
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   HARDINGHAM TE, 1992, FASEB J, V6, P861
   Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x
   Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Hudson S. M., 1944, ACS S SERIES, V544
   Hudson S. M., 1995, POLYM ADVAN TECHNOL, V6, P717
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KAGAN HM, 1982, METHOD ENZYMOL, V82, P637
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mithieux SM, 2013, ADV DRUG DELIVER REV, V65, P421, DOI 10.1016/j.addr.2012.06.009
   Miwa Y, 2005, MACROMOLECULES, V38, P2355, DOI 10.1021/ma0480401
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Paul D. R., 1985, ADV CHEM SER, V211, P3
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Ramirez F, 2000, MATRIX BIOL, V19, P455, DOI 10.1016/S0945-053X(00)00098-6
   Reguera J, 2004, J AM CHEM SOC, V126, P13212, DOI 10.1021/ja047417f
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rodriguez-Cabello C. J., 2006, NANOMEDICINE, V1, P267
   ROSE JR, 1993, FASEB J, V7, pA1208
   SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Schneck D. J., 2006, OUTLINE CARDIOVASCUL
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Skopinska-Wisniewska J, 2009, APPL SURF SCI, V255, P8286, DOI 10.1016/j.apsusc.2009.05.127
   Taddese S, 2009, MATRIX BIOL, V28, P84, DOI 10.1016/j.matbio.2008.12.002
   THOMAS JT, 1994, ANN RHEUM DIS, V53, P488, DOI 10.1136/ard.53.8.488
   Tu YD, 2010, MICRON, V41, P268, DOI 10.1016/j.micron.2009.11.003
   UITTO VJ, 1991, CRIT REV ORAL BIOL M, V2, P323, DOI 10.1177/10454411910020030301
   VALENTINI RF, 1993, J BIOMAT SCI-POLYM E, V5, P13
   VANDERREST M, 1991, FASEB J, V5, P2814
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003
   Yu J, 2010, J ANAT, V216, P533, DOI 10.1111/j.1469-7580.2009.01207.x
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 70
TC 6
Z9 6
U1 1
U2 22
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0021-2148
EI 1869-5868
J9 ISR J CHEM
JI Isr. J. Chem.
PD OCT
PY 2013
VL 53
IS 9-10
SI SI
BP 777
EP 786
DI 10.1002/ijch.201300082
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 262MW
UT WOS:000327740500019
PM 26005219
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Dado-Rosenfeld, D
   Levenberg, S
AF Dado-Rosenfeld, Dekel
   Levenberg, Shulamit
TI Induction of Angiogenesis and Vasculogenesis in Cell-Embedded
   Biomaterials
SO ISRAEL JOURNAL OF CHEMISTRY
LA English
DT Review
DE angiogenesis; biomaterials; cell adhesion; growth factors;
   vasculogenesis
ID ENDOTHELIAL GROWTH-FACTOR; VESSEL MATURATION; VASCULAR NETWORKS;
   SHEAR-STRESS; RESPONSES; TISSUE; TUBULOGENESIS; ORGANIZATION;
   INTEGRATION; CONSTRUCTS
AB The central role of prevascularization of engineered tissue grafts in postimplantational survival and integration is becoming increasingly appreciated. An in-depth understanding of the regulating factors and intricacies of generation of three-dimensional vascular networks in vitro will facilitate effective fabrication of clinically relevant vascularized tissues. In this review we aim to examine the influence of different biomaterials on vasculogenesis and angiogenesis, with particular focus on the impact of various matrix properties, such as composition, stiffness and geometry, on the resulting vasculature. Additionally, the contribution of externally applied mechanical forces, mimicking blood flow patterns, to tissue vascularization efforts is reviewed. We present here pivotal studies focusing on the influence of mechanical forces, such as shear stress and stretching tension, on vascular network formation in biomaterial-based scaffolds. Comprehensive understanding of the key factors dictating the patterns and functionality of engineered vasculature will facilitate more efficient fabrication of viable tissue grafts, with a broad range of medical applications.
C1 [Dado-Rosenfeld, Dekel; Levenberg, Shulamit] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel.
RP Dado-Rosenfeld, D (reprint author), Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel.
EM shulamit@bm.technion.ac.il
FU ERC grant ENG-VASC; Israel Science Foundation; Ed Sattel scholarship
FX The authors would like to thank the ERC grant ENG-VASC, the Israel
   Science Foundation and the Ed Sattel scholarship for their support.
CR Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389
   Anderson DEJ, 2011, ANN BIOMED ENG, V39, P2329, DOI 10.1007/s10439-011-0352-z
   Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583
   Bae H., 2012, SCI TRANSL MED, V4
   Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110
   Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005
   Byfield FJ, 2009, J BIOMECH, V42, P1114, DOI 10.1016/j.jbiomech.2009.02.012
   Ceccarelli J, 2012, CELL MOL BIOENG, V5, P463, DOI 10.1007/s12195-012-0242-y
   Chancellor TJ, 2010, BIOPHYS J, V99, P115, DOI 10.1016/j.bpj.2010.04.011
   Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   d'Angelo I, 2013, ACTA BIOMATER, V9, P7389, DOI 10.1016/j.actbio.2013.03.013
   Dickinson LE, 2012, J BIOMED MATER RES A, V100A, P1457, DOI 10.1002/jbm.a.34059
   Haghighipour N, 2010, ARTIF ORGANS, V34, P481, DOI 10.1111/j.1525-1594.2010.01003.x
   Hatami J., 2013, EXP MECH, DOI 10.1007/s11340-013-9744-3
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Kaufman-Francis K., 2012, PLOS ONE, V7
   Khan OF, 2012, TISSUE ENG PT A, V18, P744, DOI [10.1089/ten.tea.2011.0058, 10.1089/ten.TEA.2011.0058]
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Krishnan R, 2011, AM J PHYSIOL-CELL PH, V300, pC146, DOI 10.1152/ajpcell.00195.2010
   Lai ES, 2012, REGEN MED, V7, P649, DOI [10.2217/RME.12.48, 10.2217/rme.12.48]
   Leslie-Barbick JE, 2011, TISSUE ENG PT A, V17, P221, DOI [10.1089/ten.tea.2010.0202, 10.1089/ten.TEA.2010.0202]
   Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003
   Lesman A, 2010, BIOTECHNOL BIOENG, V105, P645, DOI 10.1002/bit.22555
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Liu XM, 2013, AM J PHYSIOL-HEART C, V304, pH1634, DOI 10.1152/ajpheart.00872.2012
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Nseir N, 2013, TISSUE ENG PART C-ME, V19, P257, DOI [10.1089/ten.tec.2012.0118, 10.1089/ten.TEC.2012.0118]
   Obi S, 2012, AM J PHYSIOL-CELL PH, V303, P595
   Oh HH, 2012, J BIOACT COMPAT POL, V27, P97, DOI 10.1177/0883911511435590
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Raghavan S, 2010, TISSUE ENG PT A, V16, P2255, DOI 10.1089/ten.TEA.2009.0584
   Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1
   Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109
   Rotenberg MY, 2012, LAB CHIP, V12, P2696, DOI [10.1039/c2lc40144d, 10.1039/c21c40144d]
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Saunders RL, 2010, CELL MOL BIOENG, V3, P60, DOI 10.1007/s12195-010-0112-4
   Singh S, 2011, BIOMATERIALS, V32, P2059, DOI 10.1016/j.biomaterials.2010.11.038
   Wray LS, 2013, ADV FUNCT MATER, V23, P3404, DOI 10.1002/adfm.201202926
   Yung YC, 2009, P NATL ACAD SCI USA, V106, P15279, DOI 10.1073/pnas.0905891106
NR 41
TC 0
Z9 0
U1 1
U2 33
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0021-2148
EI 1869-5868
J9 ISR J CHEM
JI Isr. J. Chem.
PD OCT
PY 2013
VL 53
IS 9-10
SI SI
BP 815
EP 820
DI 10.1002/ijch.201300071
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 262MW
UT WOS:000327740500023
DA 2018-10-20
ER

PT J
AU Satoh, K
   Ohtsu, N
   Sato, S
   Wagatsuma, K
AF Satoh, Kozue
   Ohtsu, Naofumi
   Sato, Shigeo
   Wagatsuma, Kazuaki
TI Surface modification of Ti-6Al-4V alloy using an oxygen glow-discharge
   plasma to suppress the elution of toxic elements into physiological
   environment
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Metallic biomaterial; Ti-6Al-4V; Corrosion resistance; Glow discharge;
   Plasma; Oxidation
ID METALLIC BIOMATERIALS; OXIDE-FILMS; IN-VITRO; TITANIUM; SPECTROSCOPY;
   REPLACEMENT; BEHAVIOR; TI6AL4V; IONS
AB We present the application of a plasma-oxidation technique for modifying a the corrosion resistance of a Ti-6Al-4V bio-implant material in a physiological environment. The corrosion resistance of a plasma-oxidized Ti-6Al-4V alloy sample was evaluated by immersing the sample in a lactic acid solution and determining the amounts of eluted elements in the immersion-test solution. The amounts of toxic elements, aluminum and vanadium, eluted from the plasma-oxidized sample were compared with those from the thermally oxidized sample to demonstrate the corrosion resistance of the plasma-oxidized surface to be greatly improved. To elucidate the reasons for this improvement in corrosion resistance, the oxide layers formed on the Ti-6Al-4V alloy were characterized by X-ray photoelectron spectroscopy, which revealed that Al and V oxides were enriched at the outermost surface of the thermally oxidized sample, whereas they were less segregated at the outermost surface of the plasma-oxidized sample. Based on the atomic fractions of elements at the outermost surface of the oxide layers after the immersion test, it was deduced that the elution occurred mainly at the outermost surface of the oxide layer. Therefore, it can be deduced that the characteristic surface composition of the plasma-oxidized sample, with reduced fractions of toxic elements, played an important role in suppressing the elution of toxic elements. (C) 2013 Published by Elsevier B.V.
C1 [Satoh, Kozue; Sato, Shigeo; Wagatsuma, Kazuaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Ohtsu, Naofumi] Kitami Inst Technol, Instrumental Anal Ctr, Kitami, Hokkaido 0908507, Japan.
RP Satoh, K (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
EM kozue.satoh@imr.tohoku.ac.jp
RI Ohtsu, Naofumi/L-6021-2018; Wagatsuma, Kazuaki/B-3079-2012
OI Ohtsu, Naofumi/0000-0001-7935-3949; 
CR Akahori T, 1998, MAT SCI ENG A-STRUCT, V243, P237, DOI 10.1016/S0921-5093(97)00807-1
   Ashino T, 2008, MATER TRANS, V49, P1342, DOI 10.2320/matertrans.MRA2007325
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   Kumar S, 2010, MAT SCI ENG C-MATER, V30, P921, DOI 10.1016/j.msec.2010.03.024
   Kumar S, 2010, MATER CHEM PHYS, V119, P337, DOI 10.1016/j.matchemphys.2009.09.007
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Masahashi N, 2012, THIN SOLID FILMS, V520, P4956, DOI 10.1016/j.tsf.2012.03.026
   Masmoudi M, 2006, APPL SURF SCI, V253, P2237, DOI 10.1016/j.apsusc.2006.04.047
   Ng BD, 2005, BIOMATERIALS, V26, P1087, DOI 10.1016/j.biomaterials.2004.04.022
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   Ohtsu N, 2007, J MATER SCI-MATER M, V18, P429, DOI 10.1007/s10856-007-2001-5
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Perez-Jorge C, 2012, J BIOMED MATER RES A, V100A, P1696, DOI 10.1002/jbm.a.34118
   PROCTOR A, 1982, ANAL CHEM, V54, P13, DOI 10.1021/ac00238a008
   Rastkar AR, 2007, PLASMA PROCESS POLYM, V4, pS761, DOI 10.1002/ppap.200731813
   Seah MP, 2001, SURF INTERFACE ANAL, V31, P721, DOI 10.1002/sia.1076
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   Song HJ, 2009, J MATER PROCESS TECH, V209, P864, DOI 10.1016/j.jmatprotec.2008.02.055
   Steinemann S., 1980, EVALUATION BIOMATERI
   Taktak S, 2004, VACUUM, V75, P247, DOI 10.1016/j.vacuum.2004.03.004
   Zaffe D, 2004, BIOMATERIALS, V25, P3837, DOI 10.1016/j.biomaterials.2003.10.020
NR 22
TC 5
Z9 5
U1 1
U2 18
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD OCT
PY 2013
VL 232
BP 298
EP 302
DI 10.1016/j.surfcoat.2013.05.018
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 261UY
UT WOS:000327691300039
DA 2018-10-20
ER

PT J
AU Jebahi, S
   Oudadesse, H
   Elleuch, J
   Tounsi, S
   Keskes, H
   Pellen, P
   Rebai, T
   El Feki, A
   El Feki, H
AF Jebahi, Samira
   Oudadesse, Hassane
   Elleuch, Jiheun
   Tounsi, Slim
   Keskes, Hassib
   Pellen, Pascal
   Rebai, Tarek
   El Feki, Abdelfatteh
   El Feki, Hafed
TI The Potential Restorative Effects of Strontium-doped Bioactive Glass on
   Bone Microarchitecture after Estrogen-deficieny Induced Osteoporosis:
   Physico-chemical and Histomorphometric Analyses
SO JOURNAL OF THE KOREAN SOCIETY FOR APPLIED BIOLOGICAL CHEMISTRY
LA English
DT Article
DE bioactive glass; bone regeneration; ions release; osteoporosis;
   strontium effect
ID IN-VIVO; DIFFERENTIATION; PARTICLES; APATITE; CELLS; RATS; SIZE
AB Strontium (Sr) compounds have become increasingly popular in the field of osteoporosis treatment. However, the quality of new bone after implantation of strontium-containing bioceramics has yet to be investigated. In the present study, the newly formed bone tissue around strontium-doped bioactive glass (BG-Sr) implants was characterized. BG-Sr was implanted in the femoral condyl of ovariectomised rats (OVX). The resected bone was prepared for analysis using several physico-chemical and biological assays such as Fourier transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy, energy-dispersive X-ray, and histomorphometry. BG-Sr biomaterial favored calcium phosphate layer integration on the surface of the glass and offered better bioactivity. Moreover, the histomorphometric analysis demonstrated that BV/TV, N. Ob were significantly higher in BG-Sr treated rats groups than those of BG groups. However, Ob. S/BS, and OV/BV were significantly lower in BG-Sr treated rats groups than those of BG groups. The (Oc.S/ BS) was significantly decreased in BG-Sr groups, when compared with that of BG rat groups. On the other hand, the MS/BS had not significantly decreased in the BG-Sr treated rats groups when compared with that of BG groups, however; it was significantly higher when compared with control and OVX groups. These findings suggest that BG-Sr can be used as an inhibitory therapeutic potential of osteoporosis by delivering strontium to stimulate new bone remodeling.
C1 [Jebahi, Samira; Oudadesse, Hassane; Pellen, Pascal] Univ Rennes 1, UMR CNRS 6226, F-35042 Rennes, France.
   [Jebahi, Samira; El Feki, Abdelfatteh] Sfax Fac Sci, Anim Ecophysiol Lab, Dept Life Sci, Sfax, Tunisia.
   [El Feki, Hafed] Sfax Fac Sci, Sci Mat & Environement Lab, Sfax, Tunisia.
   [Keskes, Hassib; Rebai, Tarek] Sfax Fac Sci, Histol Orthopaed & Traumatol Lab, Sfax, Tunisia.
   [Elleuch, Jiheun; Tounsi, Slim] Ctr Biotechnol Sfax, Lab Biopesticides, Sfax, Tunisia.
RP Jebahi, S (reprint author), Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu,263 Av Gen Leclerc, F-35042 Rennes, France.
EM jebahisamira@yahoo.fr
CR Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Da Cruz ACC, 2008, J MATER SCI-MATER M, V19, P2809, DOI 10.1007/s10856-008-3407-4
   Caetano-Lopes J, 2007, ACTA REUMATOL PORT, V32, P103
   Danilchenko SN, 2002, CRYST RES TECHNOL, V37, P1234, DOI 10.1002/1521-4079(200211)37:11<1234::AID-CRAT1234>3.0.CO;2-X
   de Carmejane O, 2005, CALCIFIED TISSUE INT, V76, P207, DOI 10.1007/s00223-004-0168-z
   Furusawa T, 1998, INT J ORAL MAX IMPL, V13, P672
   Furusawa T, 1997, Implant Dent, V6, P93, DOI 10.1097/00008505-199700620-00003
   Gorustovich AA, 2007, J BIOMED MATER RES A, V81A, P443, DOI 10.1002/jbm.a.31071
   Gorustovich AA, 2010, J BIOMED MATER RES A, V92A, P232, DOI 10.1002/jbm.a.32355
   Granito R N, 2010, J BIOMED MATER RES B, V97, P139
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Isaac J, 2011, EUR CELLS MATER, V21, P130, DOI 10.22203/eCM.v021a11
   Jallot E, 2000, J PHYS D APPL PHYS, V33, P2775, DOI 10.1088/0022-3727/33/21/316
   Jebahi S, 2012, J APPL BIOMED, V10, P195, DOI 10.2478/v10136-012-0009-8
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lakhkar N, 2011, J BIOMATER APPL, V25, P877, DOI 10.1177/0885328210362125
   Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001
   Lochman P, 2011, J APPL BIOMED, V9, P143, DOI 10.2478/v10136-009-0033-5
   Lusvardi Q, 2008, J APPL BIOMED, V22, P505
   Nguyen MC, 2010, J KOREAN SOC APPL BI, V53, P22, DOI 10.3839/jksabc.2010.004
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   Oudadesse H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035006
   Pan HB, 2010, J R SOC INTERFACE, V7, P1025, DOI 10.1098/rsif.2009.0504
   Park YS, 2012, J KOREAN SOC APPL BI, V55, P457, DOI 10.1007/s13765-012-2001-0
   SCHENK RK, 1969, ACTA ANAT, V74, P44
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wiesmann HP, 2005, INT REV CYTOL, V242, P121
   Yang F, 2011, STEM CELLS, V29, P981, DOI 10.1002/stem.646
   Zhang X, 2010, BIOMATERIALS, V31, P5865, DOI 10.1016/j.biomaterials.2010.04.005
   Zhu LL, 2007, BIOCHEM BIOPH RES CO, V355, P307, DOI 10.1016/j.bbrc.2007.01.120
NR 31
TC 2
Z9 2
U1 0
U2 15
PU KOREAN SOC  APPLIED BIOLOGICAL CHEMISTRY
PI KANGNAM-GU
PA RM 803,  KOREA SCIENCE & TECHNOLOGY CENTER, 635-4 YEOGSAM-DONG,
   KANGNAM-GU, SEOUL 135-703, SOUTH KOREA
SN 1738-2203
J9 J KOREAN SOC APPL BI
JI J. Korean Soc. Appl. Biol. Chem.
PD OCT
PY 2013
VL 56
IS 5
BP 533
EP 540
DI 10.1007/s13765-013-3167-9
PG 8
WC Food Science & Technology
SC Food Science & Technology
GA 257EG
UT WOS:000327365800007
DA 2018-10-20
ER

PT J
AU Toeg, HD
   Abessi, O
   Al-Atassi, T
   de Kerchove, L
   El-Khoury, G
   Labrosse, M
   Boodhwani, M
AF Toeg, H. D.
   Abessi, O.
   Al-Atassi, T.
   de Kerchove, L.
   El-Khoury, G.
   Labrosse, M.
   Boodhwani, M.
TI FINDING THE IDEAL BIOMATERIAL FOR AORTIC VALVE CUSP REPAIR
SO CANADIAN JOURNAL OF CARDIOLOGY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0828-282X
EI 1916-7075
J9 CAN J CARDIOL
JI Can. J. Cardiol.
PD OCT
PY 2013
VL 29
IS 10
SU S
MA 715
BP S371
EP S371
DI 10.1016/j.cjca.2013.07.636
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 253BC
UT WOS:000327055601211
DA 2018-10-20
ER

PT J
AU Ma, JF
   Zou, J
   Cui, BY
   Yao, C
   Li, DL
AF Ma, Jianfeng
   Zou, Jing
   Cui, Bingying
   Yao, Chao
   Li, Dinglong
TI Adsorption of Orange II dye from aqueous solutions using phosphoric-acid
   modified clam shell powder
SO DESALINATION AND WATER TREATMENT
LA English
DT Article
DE Adsorption; Orange II; Clam shell; Wastewater treatment; Dye
ID LOW-COST ADSORBENTS; EQUILIBRIUM; KINETICS; REMOVAL; SURFACTANT; CARBON;
   WATER
AB In this study, the clam shell, a waste biomaterial, was modified with phosphoric acid to improve the adsorption amount of Orange II dye. The effects of initial concentration, contact time, and temperature on the adsorption were studied. The equilibrium adsorption data of Orange II on the phosphoric acid-modified clam shell powder (PCSP) were adequately represented by Langmuir isotherm with an adsorption capacity of 1,017.13mg/g, which is higher than that obtained using raw clam shell powder. Adsorption kinetics followed the pseudo-second-order rate expression. Thermodynamic parameters show that the process is exothermal, feasible, and spontaneous. The effect of temperature inferred that the type of adsorption in the study is a physical adsorption. Therefore, PCSP is an efficient and economical adsorbent for dye removal.
C1 [Ma, Jianfeng; Zou, Jing; Cui, Bingying; Yao, Chao; Li, Dinglong] Changzhou Univ, Sch Environm & Safety Engn, Changzhou 213164, Jiangsu, Peoples R China.
   [Ma, Jianfeng] Zhejiang Univ, State Key Lab Silicon Mat, Hangzhou 310027, Zhejiang, Peoples R China.
RP Ma, JF (reprint author), Changzhou Univ, Sch Environm & Safety Engn, Changzhou 213164, Jiangsu, Peoples R China.
EM jma@zju.edu.cn
FU National Natural Science Foundation of China [21007005, 20907038];
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions; Technology Innovation Team of Colleges and Universities
   [2011-24]
FX This study was supported by the Project of National Natural Science
   Foundation of China (Nos 21007005 and 20907038), a Project funded by the
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions, and Technology Innovation Team of Colleges and
   Universities Funded Project of Jiangsu Province (2011-24).
CR Abramian L, 2009, CHEM ENG J, V150, P403, DOI 10.1016/j.cej.2009.01.019
   Arai Y, 2001, J COLLOID INTERF SCI, V241, P317, DOI 10.1006/jcis.2001.7773
   Belhachemi M, 2012, DESALIN WATER TREAT, V37, P122, DOI 10.5004/dwt.2012.2608
   Chen XG, 2010, CHINESE CHEM LETT, V21, P122, DOI 10.1016/j.cclet.2009.08.003
   Chiang HsiuMei, 2009, Journal of Hazardous Materials, V161, P1384
   Chiang HL, 2007, DYES PIGMENTS, V75, P52, DOI 10.1016/j.dyepig.2006.05.017
   Chiou MS, 2004, DYES PIGMENTS, V60, P69, DOI 10.1016/S1043-7208(03)00140-2
   Chowdhury S, 2012, DESALIN WATER TREAT, V37, P331, DOI 10.5004/dwt.2012.3063
   Chowdhury S, 2010, CHEM ENG J, V164, P168, DOI 10.1016/j.cej.2010.08.050
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Demirbas A, 2009, J HAZARD MATER, V167, P1, DOI 10.1016/j.jhazmat.2008.12.114
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Geraud E, 2007, J PHYS CHEM SOLIDS, V68, P818, DOI 10.1016/j.jpcs.2007.02.053
   Gunay A, 2007, J HAZARD MATER, V146, P362, DOI 10.1016/j.jhazmat.2006.12.034
   Gupta VK, 2009, J ENVIRON MANAGE, V90, P2313, DOI 10.1016/j.jenvman.2008.11.017
   Haghseresht F, 1998, ENERG FUEL, V12, P1100, DOI 10.1021/ef9801165
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Ho YS, 2004, SCIENTOMETRICS, V59, P171
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Hu ZH, 2010, J HAZARD MATER, V173, P292, DOI 10.1016/j.jhazmat.2009.08.082
   Jin XY, 2008, J COLLOID INTERF SCI, V328, P243, DOI 10.1016/j.jcis.2008.08.066
   Kara M, 2003, WATER RES, V37, P224, DOI 10.1016/S0043-1354(02)00265-8
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Liu DL, 2011, DESALIN WATER TREAT, V27, P285, DOI 10.5004/dwt.2011.2031
   Narayanan R, 2006, SURF COAT TECH, V200, P4720, DOI 10.1016/j.surfcoat.2005.04.040
   Shih PY, 2004, MATER CHEM PHYS, V84, P151, DOI 10.1016/j.matchemphys.2003.11.016
   Silva JP, 2004, SEP PURIF TECHNOL, V40, P309, DOI 10.1016/j.seppur.2004.03.010
   Silverstein R. M. C., 1991, SPECTROPHOTOMETRIC I
   Tsai W. T., 2009, J ENV ENG MANAGE, V19, P165
   VARSHNEY KG, 1995, COLLOID SURFACE A, V104, P7, DOI 10.1016/0927-7757(95)03258-F
   Wang ZW, 2011, DESALIN WATER TREAT, V30, P195, DOI 10.5004/dwt.2011.1984
   Wu CH, 2007, J HAZARD MATER, V144, P93, DOI 10.1016/j.jhazmat.2006.09.083
   YOSHIDA H, 1993, CHEM ENG SCI, V48, P2267, DOI 10.1016/0009-2509(93)80242-I
   Zhu LZ, 2008, CHEM ENG J, V139, P503, DOI 10.1016/j.cej.2007.08.023
NR 34
TC 5
Z9 5
U1 0
U2 23
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1944-3994
EI 1944-3986
J9 DESALIN WATER TREAT
JI Desalin. Water Treat.
PD OCT 1
PY 2013
VL 51
IS 34-36
BP 6536
EP 6544
DI 10.1080/19443994.2013.770114
PG 9
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA 244FF
UT WOS:000326371800011
DA 2018-10-20
ER

PT J
AU Bojic, DV
   Randelovic, MS
   Zarubica, AR
   Mitrovic, JZ
   Radovic, MD
   Purenovic, MM
   Bojic, AL
AF Bojic, Danijela V.
   Randelovic, Marjan S.
   Zarubica, Aleksandra R.
   Mitrovic, Jelena Z.
   Radovic, Miljana D.
   Purenovic, Milovan M.
   Bojic, Aleksandar Lj.
TI Comparison of new biosorbents based on chemically modified Lagenaria
   vulgaris shell
SO DESALINATION AND WATER TREATMENT
LA English
DT Article
DE Biosorption; Lagenaria vulgaris; Chemical modification; Mehylene blue;
   Kinetics; Isotherms
ID METHYLENE-BLUE BIOSORPTION; AQUEOUS-SOLUTIONS; HEAVY-METALS; BASIC-DYES;
   ION-EXCHANGE; RICE HUSK; ADSORPTION; REMOVAL; WATER; MECHANISM
AB Sorption characteristics of three Lagenaria vulgaris-based biosorbents: raw biomass (rLVB), acid-base-activated biomass (aLVB) and sulfuric acid-treated biomass (ccLVB), were compared as a function of contact time, initial methylene blue concentration, and initial pH, in order to evaluate the effect of chemical modifications. The adsorption studies of raw and chemically modified L. vulgaris biomass were compared in batch mode. The Fourier transform Infrared spectroscopy (FTIR) results of biosorbents' characterization showed presence of different functional groups which can be responsible for sorption of MB from aqueous solutions. Moreover, FTIR analysis reveals that acid-base activation of raw biomaterial resulted in hydrolysis of esters providing more reactive sites (-COO-), while sulfuric acid-treatment method introduced new functional groups such as -SO3-. Surface functional groups containing oxygen, such as carboxylic, lactonic, and phenolic, are quantified using the Boehm's method. The kinetics of MB biosorption were found to follow a pseudo-second-order kinetics in all cases, while experimental equilibrium data were fitted to Freundlich, Langmuir, and Dubinin-Radushkevich isotherms by linear regression method. Langmuir model provides the best fitting. The MB biosorption capacity and uptake kinetics are greatly improved by chemical modification of the biomass. Effectiveness of examined biosorbents in MB removal from aqueous solutions can be put in the following order: rLVB<aLVB<ccLVB.
C1 [Bojic, Danijela V.; Randelovic, Marjan S.; Zarubica, Aleksandra R.; Mitrovic, Jelena Z.; Radovic, Miljana D.; Purenovic, Milovan M.; Bojic, Aleksandar Lj.] Univ Nis, Dept Chem, Fac Sci & Math, Nish 18000, Serbia.
RP Randelovic, MS (reprint author), Univ Nis, Dept Chem, Fac Sci & Math, 33 Visegradska St, Nish 18000, Serbia.
EM marjanra@pmf.ni.ac.rs
FU Serbian Ministry of Education and Science [TR34008]
FX The research was supported by the Serbian Ministry of Education and
   Science (Grant No. TR34008).
CR Aksu Z, 2010, CHEM ENG J, V158, P474, DOI 10.1016/j.cej.2010.01.029
   Barka N, 2011, J TAIWAN INST CHEM E, V42, P320, DOI 10.1016/j.jtice.2010.07.004
   Cengiz S, 2008, BIORESOURCE TECHNOL, V99, P2357, DOI 10.1016/j.biortech.2007.05.011
   Chergui A, 2007, DESALINATION, V206, P179, DOI 10.1016/j.desal.2006.03.566
   Cheung WH, 2007, BIORESOURCE TECHNOL, V98, P2897, DOI 10.1016/j.biortech.2006.09.045
   El-Geundi S. M., 1991, WATER RES, V25, P271
   Fernandez ME, 2012, BIORESOURCE TECHNOL, V106, P55, DOI 10.1016/j.biortech.2011.12.003
   Gnanasambandam R, 2000, FOOD CHEM, V68, P327, DOI 10.1016/S0308-8146(99)00191-0
   Guibaud G, 2003, CHEMOSPHERE, V52, P1701, DOI 10.1016/S0045-6535(03)00355-2
   Gupta VK, 2005, J COLLOID INTERF SCI, V288, P55, DOI 10.1016/j.jcis.2005.02.054
   Han RP, 2007, J HAZARD MATER, V141, P156, DOI 10.1016/j.jhazmat.2006.06.107
   Iqbal M, 2009, J HAZARD MATER, V164, P161, DOI 10.1016/j.jhazmat.2008.07.141
   Jadhao MM, 2009, DESALINATION, V247, P456, DOI 10.1016/j.desal.2008.07.020
   Krishnani KK, 2008, J HAZARD MATER, V153, P1222, DOI 10.1016/j.jhazmat.2007.09.113
   LOW KS, 1995, BIORESOURCE TECHNOL, V52, P79, DOI 10.1016/0960-8524(95)00007-2
   Mitic-Stojanovic DL, 2011, WATER SA, V37, P303
   Mohammadi SZ, 2010, DESALINATION, V262, P86, DOI 10.1016/j.desal.2010.05.048
   Momilovi M., 2011, DESALINATION, V276, P53, DOI DOI 10.1016/J.DESAL.2011.03.013
   Naiya TK, 2009, J COLLOID INTERF SCI, V333, P14, DOI 10.1016/j.jcis.2009.01.003
   Namasivayam C, 1998, BIORESOURCE TECHNOL, V64, P77, DOI 10.1016/S0960-8524(97)86722-3
   Ofomaja AE, 2010, CARBOHYD POLYM, V82, P1031, DOI 10.1016/j.carbpol.2010.05.024
   Panda GC, 2008, COLLOID SURFACE B, V62, P173, DOI 10.1016/j.colsurfb.2007.09.034
   Pavan FA, 2008, J HAZARD MATER, V150, P703, DOI 10.1016/j.jhazmat.2007.05.023
   Qiu H, 2009, J ZHEJIANG UNIV-SC A, V10, P716, DOI 10.1631/jzus.A0820524
   Rajic N, 2009, J HAZARD MATER, V172, P1450, DOI 10.1016/j.jhazmat.2009.08.011
   Randelovic M, 2012, J HAZARD MATER, V199, P367, DOI 10.1016/j.jhazmat.2011.11.025
   Randelovic M, 2011, DESALINATION, V279, P353, DOI 10.1016/j.desal.2011.06.036
   Sciban M, 2007, BIORESOURCE TECHNOL, V98, P402, DOI 10.1016/j.biortech.2005.12.014
   Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007
   Vijayaraghavan K, 2008, BIORESOURCE TECHNOL, V99, P2864, DOI 10.1016/j.biortech.2007.06.008
   Wang L, 2010, DESALINATION, V254, P68, DOI 10.1016/j.desal.2009.12.012
   Witek-Krowiak A, 2011, DESALINATION, V265, P126, DOI 10.1016/j.desal.2010.07.042
   Yao YJ, 2010, BIORESOURCE TECHNOL, V101, P3040, DOI 10.1016/j.biortech.2009.12.042
NR 33
TC 8
Z9 8
U1 0
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1944-3994
EI 1944-3986
J9 DESALIN WATER TREAT
JI Desalin. Water Treat.
PD OCT 1
PY 2013
VL 51
IS 34-36
BP 6871
EP 6881
DI 10.1080/19443994.2013.771287
PG 11
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA 244FF
UT WOS:000326371800045
DA 2018-10-20
ER

PT J
AU Meneghini, RM
   de Beaubien, BC
AF Meneghini, R. Michael
   de Beaubien, Brian C.
TI Early Failure of Cementless Porous Tantalum Monoblock Tibial Components
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE failure; cementless; uncemented; total knee replacement; total knee
   arthroplasty; tibia; tantalum
ID TOTAL KNEE ARTHROPLASTY; TERM FOLLOW-UP; TRABECULAR METAL; REPLACEMENT;
   OSTEOLYSIS; SURVIVORSHIP; BIOMATERIAL; PROSTHESES; FIXATION; REVISION
AB Patient selection for cementless knee arthroplasty (TKA) remains challenging. 106 consecutive TKAs performed with a cementless porous tantalum tibial component of PS-design were reviewed. Nine failures (8 male/1 female) occurred at a mean 18 months and demonstrated a characteristic failure mode of medial tibial collapse. The mean height of 72.5 inches in the failure group was greater than the 65.8 inches in the well-functioning group (P < 0.001). The mean weight of 260.4 lb in the failure group was greater than the 204.1 lb in the well-functioning group (P = 0.006). The high early failure rate occurred predominantly in tall, heavy, male patients and may be related to medial tibial overload resulting from increased flexibility of the implant in this patient type. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Meneghini, R. Michael] Indiana Univ Sch Med, Indiana Univ Hlth Phys, Indianapolis, IN 46202 USA.
   [de Beaubien, Brian C.] Michigan Hip & Knee Replacement, Saginaw, MI USA.
RP Meneghini, RM (reprint author), Indiana Univ Sch Med, Dept Orthopaed Surg, Indiana Univ Hlth Phys, 13100 136th St,Suite 2000, Fishers, IN 46037 USA.
OI Meneghini, Robert/0000-0001-9602-3925
CR Berger RA, 2001, CLIN ORTHOP RELAT R, P58
   Berger RA, 2001, CLIN ORTHOP RELAT R, P196
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Deshmane PP, 2012, AM AC ORTH SURG MARC
   DUCHEYNE P, 1978, J BONE JOINT SURG AM, V60, P384, DOI 10.2106/00004623-197860030-00021
   Dunbar MJ, 2009, J BONE JOINT SURG AM, V91A, P1578, DOI 10.2106/JBJS.H.00282
   ENGH GA, 1994, CLIN ORTHOP RELAT R, P33
   Faris PM, 2003, J BONE JOINT SURG AM, V85A, P489, DOI 10.2106/00004623-200303000-00014
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Font-Rodriguez DE, 1997, CLIN ORTHOP RELAT R, P79
   Frenkel SR, 2004, J BIOMED MATER RES B, V71B, P387, DOI 10.1002/jbm.b.30104
   Helm AT, 2008, J ARTHROPLASTY
   Kamath AF, 2011, J ARTHROPLASTY, V26, P1390, DOI 10.1016/j.arth.2011.06.030
   KIM YH, 1995, J BONE JOINT SURG BR, V77B, P236
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Long WJ, 2008, J ARTHROPLASTY
   Lonner JH, 2000, CLIN ORTHOP RELAT R, P85
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   MORAN CG, 1995, J BONE JOINT SURG BR, V77B, P667
   MORELAND JR, 1988, CLIN ORTHOP RELAT R, P49
   NAFEI A, 1992, J BONE JOINT SURG BR, V74, P243
   O'Keefe TJ, 2010, J ARTHROPLASTY, V25, P785, DOI 10.1016/j.arth.2009.05.029
   PETERS PC, 1992, J BONE JOINT SURG AM, V74A, P864, DOI 10.2106/00004623-199274060-00007
   RANAWAT CS, 1993, CLIN ORTHOP RELAT R, P94
   Rasquinha VJ, 2006, J BONE JOINT SURG AM, V88A, P1006, DOI 10.2106/JBJS.C.01104
   Ritter MA, 2001, CLIN ORTHOP RELAT R, P51
   Rodriguez JA, 2001, CLIN ORTHOP RELAT R, P10
   Stilling M, 2011, ACTA ORTHOP, V82, P177, DOI 10.3109/17453674.2011.566139
   Unger AS, 2011, J ARTHROPLASTY, V26, P855, DOI 10.1016/j.arth.2010.08.017
   Wilson DAJ, 2012, ACTA ORTHOP, V83, P36, DOI 10.3109/17453674.2011.645196
   Wilson DAJ, 2010, J ARTHROPLASTY, V25, P893, DOI 10.1016/j.arth.2009.06.015
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269
NR 35
TC 19
Z9 19
U1 0
U2 7
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD OCT
PY 2013
VL 28
IS 9
BP 1505
EP 1508
DI 10.1016/j.arth.2013.03.005
PG 4
WC Orthopedics
SC Orthopedics
GA 241WN
UT WOS:000326199500011
PM 23561931
DA 2018-10-20
ER

PT J
AU Schmitz, HCR
   Klauser, W
   Citak, M
   Al-Khateeb, H
   Gehrke, T
   Kendoff, D
AF Schmitz, Hans-Christian R.
   Klauser, Wolfgang
   Citak, Mustafa
   Al-Khateeb, Hesham
   Gehrke, Thorsten
   Kendoff, Daniel
TI Three-Year Follow Up Utilizing Tantal Cones in Revision Total Knee
   Arthroplasty
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE tantal cones; revision; total knee arthroplasty; short-term
ID KINEMATIC ROTATING HINGE; POROUS TANTALUM; BONE LOSS; JOINT REPLACEMENT;
   METAPHYSEAL CONES; HIP; RECONSTRUCTION; BIOMATERIAL; PROJECTIONS;
   PROSTHESIS
AB There still is no consensus on the treatment of choice in revision knee arthroplasty associated with severe femoral and/or tibial bone loss. A total of 44 patients underwent revision knee arthroplasty procedures using porous tantalum cones (TM cones) to reconstruct tibial and/or femoral bone defects. At latest follow up after 37 months (32-48), 38 patients remained in the study. Tibial and femoral bone loss was categorized according to the AORI-Classification. The average preoperative KSS improved from 34 (range, 6-90) to 63 points (range, 7-90 points). The VAS improved from 7.5 to 4.8. Two patients required a re-revision due to aseptic loosening. There was no correlation between the different types of knee prosthesis implanted. Our study shows favourable clinical and radiological outcomes using TM cones in managing significant bone loss in revision total knee surgery. (C) 2013 Published by Elsevier Inc.
C1 [Schmitz, Hans-Christian R.; Klauser, Wolfgang; Citak, Mustafa; Gehrke, Thorsten; Kendoff, Daniel] HELIOS ENDO Klin Hamburg, D-22767 Hamburg, Germany.
   [Al-Khateeb, Hesham] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England.
RP Schmitz, HCR (reprint author), HELIOS ENDO Klin Hamburg, Holstenstr 2, D-22767 Hamburg, Germany.
OI , HESHAM/0000-0002-3332-6387
CR Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Breer S, 2012, INT ORTHOP, V36, P2269, DOI 10.1007/s00264-012-1640-4
   Bush JL, 2006, CLIN ORTHOP RELAT R, P186, DOI 10.1097/01.blo.0000229360.04620.93
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Davies JH, 2011, J ARTHROPLASTY, V26, P1245, DOI 10.1016/j.arth.2011.02.022
   Dixon T, 2004, ANN RHEUM DIS, V63, P825, DOI 10.1136/ard.2003.012724
   Engh G A, 1999, Instr Course Lect, V48, P167
   Engh Gerard A, 2004, Instr Course Lect, V53, P243
   EWALD FC, 1989, CLIN ORTHOP RELAT R, P9
   Fernandez-Fairen M, 2012, SPINE, V37, P1734, DOI 10.1097/BRS.0b013e318255a184
   Haasper C, 2012, Z ORTHOP UNFALLCHIR, V150, P290, DOI 10.1055/s-0031-1298529
   INSALL JN, 1989, CLIN ORTHOP RELAT R, P13
   Jacofsky DJ, 2010, J BONE JOINT SURG AM, V92A, P1282
   Jensen CL, 2012, INT ORTHOP, V36, P1857, DOI 10.1007/s00264-012-1601-y
   Jones RE, 2001, J ARTHROPLASTY, V16, P279, DOI 10.1054/arth.2001.21498
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Lachiewicz PF, 2012, CLIN ORTHOP RELAT R, V470, P199, DOI 10.1007/s11999-011-1888-9
   Lonner JH, 2002, CLIN ORTHOP RELAT R, P145, DOI 10.1097/01.blo.0000036534.46246.4b
   Malizos KN, 2012, J BONE JOINT SURG BR, V94B, P173, DOI 10.1302/0301-620X.94B2.27287
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   MURRAY PB, 1994, CLIN ORTHOP RELAT R, P116
   Nakashima Y, 2013, MOD RHEUMATOL, V23, P112, DOI 10.1007/s10165-012-0618-9
   Panni AS, 2012, KNEE SURG S IN PRESS
   Pour AE, 2007, J BONE JOINT SURG AM, V89A, P1735, DOI 10.2106/JBJS.F00893
   Radnay CS, 2006, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000214437.57151.41
   Sagherian BH, 2012, FOOT ANKLE INT, V33, P179, DOI 10.3113/FAI.2012.0179
   Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005
   Schmitz HC, 2011, ORTHOPADE, V40, P624, DOI 10.1007/s00132-010-1732-z
   Sheth Neil P, 2009, Am J Orthop (Belle Mead NJ), V38, P526
   Springer BD, 2001, CLIN ORTHOP RELAT R, P283
   Springer BD, 2004, CLIN ORTHOP RELAT R, P181, DOI 10.1097/01.blo.0000126306.87452.59
   Toms AD, 2004, J BONE JOINT SURG AM, V86A, P2050, DOI 10.2106/00004623-200409000-00028
   TSAHAKIS PJ, 1994, CLIN ORTHOP RELAT R, P86
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
NR 35
TC 30
Z9 30
U1 0
U2 3
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD OCT
PY 2013
VL 28
IS 9
BP 1556
EP 1560
DI 10.1016/j.arth.2013.01.028
PG 5
WC Orthopedics
SC Orthopedics
GA 241WN
UT WOS:000326199500020
PM 23664075
DA 2018-10-20
ER

PT J
AU Shinozaki, Y
   Yanagi, T
   Yamaguchi, Y
   Kido, H
   Fukushima, T
AF Shinozaki, Yosuke
   Yanagi, Tsukasa
   Yamaguchi, Yuichiro
   Kido, Hirofumi
   Fukushima, Tadao
TI Osteogenic Evaluation of DNA/Protamine Complex Paste in Rat Cranial
   Defects
SO JOURNAL OF HARD TISSUE BIOLOGY
LA English
DT Article
DE DNA/protamine complex paste; Micro-computed tomography; Osteogenic
   evaluation; Rat cranial defect
ID DNA-CHITOSAN COMPLEXES; IN-VITRO; GENE-EXPRESSION; CRITICAL-SIZE;
   PHOSPHATE; PROTAMINE; POLYMER
AB A DNA/protamine complex powder, prepared from the reaction between DNA and protamine sulfate solutions, was mixed with water to make a paste. The ALP activity of MC 313 El cultured on a thin film of the complex paste was higher than that cultured on a plastic well. It was found that DNA/protamine complex induced new bone formation from the results of micro-computed tomography (mu-CT) images and conventional histological sections with hematoxylin and eosin staining in rat cranial defect tests. mu-CT image analyses showed that newly formed bone areas in defects for DNA/protamine complex were significantly higher than those for sham operation (controls) two and three months after surgery. Although the area of red-appearing osteoids reduced with increasing times after surgery, stimulated new bone formation areas were observed around newly formed bone in histological sections stained with Villanuva osteochrome bone stain. Therefore, DNA/protamine complex paste with a biodegradable property will be a useful injectable biomaterial for the repair of bone defects.
C1 [Shinozaki, Yosuke; Yanagi, Tsukasa; Yamaguchi, Yuichiro; Kido, Hirofumi] Fukuoka Dent Coll, Sect Oral Implantol, Dept Oral Rehabil, Fukuoka 8140193, Japan.
   [Fukushima, Tadao] Fukuoka Dent Coll, Ctr Regenerat Med, Fukuoka 8140193, Japan.
RP Fukushima, T (reprint author), Fukuoka Dent Coll, Ctr Regenerat Med, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.
EM tadaof@college.fdcnet.ac.jp
FU Japan Society for the Promotion of Science [23390455, 25670838,
   S1001059]
FX This study was supported in part by Grants-in-aid for Scientific
   Research (B) (23390455), by Challenging Exploratory Research (25670838),
   and by a Grant-in-aid for strategic study base formation support
   business (S1001059) from the Japan Society for the Promotion of Science.
CR Aurer A., 2005, ACTA STOMA T CROAT, V39, P107
   Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997
   Bosh C, 1998, J CRANIOFAC SURG, V9, P310
   Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3
   Cowan CM, 2007, TISSUE ENG, V13, P501, DOI 10.1089/ten.2006.0141
   Fukushima T, 2006, J BIOMED MATER RES B, V76B, P121, DOI 10.1002/jbm.b.30334
   Fukushima T, 2008, J ORAL TISSUE ENG, V6, P24
   Fukushima T, 2011, J MATER SCI-MATER M, V22, P2607, DOI 10.1007/s10856-011-4446-9
   Fukushima T, 2010, DENT MATER J, V29, P529, DOI 10.4012/dmj.2009-131
   Fukushima T, 2009, J BIOMED MATER RES B, V91B, P746, DOI 10.1002/jbm.b.31451
   Goldman A., 1996, NUCL ACIDS CHEM BIOL, P375
   Golub EE, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   Kamei S, 1997, J BIOMED MATER RES, V37, P384
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   McMichael A. J., 1992, OXFORD TXB PATHOLOGY, P198
   Messora MR, 2008, J PERIODONTAL RES, V43, P723, DOI 10.1111/j.1600-0765.2008.01084.x
   Mori N, 2013, J BIOMED MATER RES B, V101B, P743, DOI 10.1002/jbm.b.32877
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   QUARLES LD, 1989, J CLIN INVEST, V83, P1644, DOI 10.1172/JCI114063
   Tian XY, 2008, BONE, V42, P914, DOI 10.1016/j.bone.2007.12.228
   TRETINNIKOV ON, 1994, J BIOMED MATER RES, V28, P1365, DOI 10.1002/jbm.820281115
   van den Beucken JJJP, 2007, ACTA BIOMATER, V3, P587, DOI 10.1016/j.actbio.2006.12.007
   Werner MH, 1996, SCIENCE, V271, P778, DOI 10.1126/science.271.5250.778
   Wilson W. D., 1996, NUCL ACIDS CHEM BIOL, P329
   Zhou LM, 2013, GENE, V516, P228, DOI 10.1016/j.gene.2012.12.056
NR 25
TC 8
Z9 8
U1 0
U2 1
PU JOURNAL HARD TISSUE BIOLOGY
PI MINATO KU
PA NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO
   106-0031, JAPAN
SN 1341-7649
J9 J HARD TISSUE BIOL
JI J. Hard Tissue Biol.
PD OCT
PY 2013
VL 22
IS 4
BP 401
EP 408
PG 8
WC Engineering, Biomedical
SC Engineering
GA 244WN
UT WOS:000326421000002
OA Bronze
DA 2018-10-20
ER

PT J
AU Fernandes, EM
   Pires, RA
   Mano, JF
   Reis, RL
AF Fernandes, Emanuel M.
   Pires, Ricardo A.
   Mano, Joao F.
   Reis, Rui L.
TI Bionanocomposites from lignocellulosic resources: Properties,
   applications and future trends for their use in the biomedical field
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Nanocomposite; Cellulose; Scaffold; Tissue engineering; Lignocellulosic;
   Biomedical
ID OSTEOBLAST-LIKE CELLS; TISSUE ENGINEERING APPLICATIONS; CELLULOSE-BASED
   HYDROGELS; SEMIINTERPENETRATING POLYMER NETWORKS; PLASMA-INDUCED
   POLYMERIZATION; IN-VITRO BIOCOMPATIBILITY; STARCH-BASED BIOMATERIALS;
   DEGRADABLE BONE CEMENTS; BACTERIAL CELLULOSE; MECHANICAL-PROPERTIES
AB The selection, synthesis, modification and shaping of biomaterials are complex tasks within the biomedical field. Human and plant tissues, such as, wood, bone and cartilage are structured at the nanometer level and exhibit a hierarchical structure up to the macroscale. Their morphological similarities enable the exploitation of lignocellulosic materials in the development of nanostructured composites targeting tissue engineering and regeneration. In this review, lignocellulosic materials and their chemical constituents are highlighted as promising alternatives for the development of drug-delivery vehicles and for the engineering or regeneration of bone and cartilage. Special focus is given to the recent developments of lignocellulosic bionanocomposite supports that induce cell attachment and proliferation. Chemical modifications techniques as well as composite processing methodologies that enhance the biomaterial performance are reviewed. It is anticipated the increasing interest in nanocellulose, bacterial cellulose, hemicellulose and lignin from natural resources as added-value biomedical materials in the near future. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Fernandes, Emanuel M.; Pires, Ricardo A.; Mano, Joao F.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Guimaraes, Taipas, Portugal.
   [Fernandes, Emanuel M.; Pires, Ricardo A.; Mano, Joao F.; Reis, Rui L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
RP Reis, RL (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM rgreis@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Fernandes,
   Emanuel/A-4464-2013; Pires, Ricardo/A-1595-2009; Mano, Joao/A-4418-2009
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456;
   Fernandes, Emanuel/0000-0002-4296-2529; Pires,
   Ricardo/0000-0002-9197-0138; Mano, Joao/0000-0002-2342-3765
FU Portuguese Foundation for Science and Technology [SFRH/BPD/39333/2007,
   SFRH/BD/71561/2010]
FX The authors acknowledge the financial support to the Portuguese
   Foundation for Science and Technology for the Post-doc Grant to R.A.
   Pires (SFRH/BPD/39333/2007) and the PhD Grant to E.M. Fernandes
   (SFRH/BD/71561/2010).
CR ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615
   Ahmadi R, 2010, J TISSUE ENG REGEN M, V4, P309, DOI 10.1002/term.247
   Albertsson AC, 2010, BIOMACROMOLECULES, V11, P1406, DOI 10.1021/bm100253e
   Ali AEH, 2008, J MACROMOL SCI A, V45, P628, DOI 10.1080/10601320802168751
   Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65
   Alves NM, 2007, ACTA BIOMATER, V3, P69, DOI 10.1016/j.actbio.2006.07.004
   Alves NM, 2010, J MATER CHEM, V20, P2911, DOI 10.1039/b910960a
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Ambrosio L, 2011, WOODHEAD PUBL MATER, P25
   Ambrosio L, 2009, Forming superabsorbent polymer hydrogel in biomedical devices involves cross-linking aqueous solution of carboxymethylcellulose salt precursor with citric acid as cross-linking agent in presence of molecular spacer, washing and drying steps, Patent No. [WO2009022358-A1, 2009022358]
   [Anonymous], 2012, ASHLAND MATRIX FILM, P11
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2011, MAT SCI ENG C-MATER, V31, P14, DOI 10.1016/j.msec.2010.07.010
   Barbieri D, 2011, ACTA BIOMATER, V7, P2007, DOI 10.1016/j.actbio.2011.01.017
   Barbosa M.A., 2005, ITBM RBM, V26, P212, DOI DOI 10.1016/J.RBMRET.2005.04.006
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Batista EL, 1999, J PERIODONTOL, V70, P1000, DOI 10.1902/jop.1999.70.9.1000
   Beck-Candanedo S, 2005, BIOMACROMOLECULES, V6, P1048, DOI 10.1021/bm049300p
   Beniash E, 2011, WIRES NANOMED NANOBI, V3, P47, DOI 10.1002/wnan.105
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bledzki AK, 2005, COMPOS PART A-APPL S, V36, P789, DOI 10.1016/j.compositesa.2004.10.029
   Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5
   Bodin A, 2007, J TISSUE ENG REGEN M, V1, P406, DOI 10.1002/term.51
   Boesel LF, 2004, J BIOMED MATER RES B, V70B, P368, DOI 10.1002/jbm.b.30055
   Boesel LF, 2004, J MATER SCI-MATER M, V15, P73, DOI 10.1023/B:JMSM.0000010100.07715.eb
   Boesel LF, 2008, PROG POLYM SCI, V33, P180, DOI 10.1016/j.progpolymsci.2007.09.001
   Boesel LF, 2007, ACTA BIOMATER, V3, P175, DOI 10.1016/j.actbio.2006.09.010
   Bohic S, 2001, J MATER SCI-MATER M, V12, P201, DOI 10.1023/A:1008902829840
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4
   Bondeson D, 2007, COMPOS INTERFACE, V14, P617, DOI 10.1163/156855407782106519
   Bondeson D, 2007, COMPOS PART A-APPL S, V38, P2486, DOI 10.1016/j.compositesa.2007.08.001
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   Brown-Etris M, 2006, EVALUATION XCELL CEL
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Cai ZJ, 2011, J APPL POLYM SCI, V120, P2938, DOI 10.1002/app.33318
   Cao J, 2004, J POROUS MAT, V11, P163, DOI 10.1023/B:JOPO.0000038012.58705.c9
   Carrie S, 2007, WOUND CARE COLLABORA
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cazacu G, 2004, IND CROP PROD, V20, P261, DOI 10.1016/j.indcrop.2004.04.030
   Chang CY, 2011, CARBOHYD POLYM, V84, P40, DOI 10.1016/j.carbpol.2010.12.023
   Chen WS, 2011, CARBOHYD POLYM, V86, P453, DOI 10.1016/j.carbpol.2011.04.061
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Darder M, 2007, ADV MATER, V19, P1309, DOI 10.1002/adma.200602328
   de Arellano-Lopez AR, 2004, INT J APPL CERAM TEC, V1, P56
   de Carlos A, 2006, J MATER SCI-MATER M, V17, P523, DOI 10.1007/s10856-006-8935-1
   de Mesquita JP, 2010, BIOMACROMOLECULES, V11, P473, DOI 10.1021/bm9011985
   de Rodriguez NLG, 2006, CELLULOSE, V13, P261, DOI 10.1007/s10570-005-9039-7
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939
   Dugan JM, 2010, BIOMACROMOLECULES, V11, P2498, DOI 10.1021/bm100684k
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0
   Eichhorn SJ, 2001, CELLULOSE, V8, P197, DOI 10.1023/A:1013181804540
   Eichhorn SJ, 2011, SOFT MATTER, V7, P303, DOI 10.1039/c0sm00142b
   El-Saied H, 2004, POLYM-PLAST TECHNOL, V43, P797, DOI 10.1081/PPT-120038065
   Elvira C, 2005, BIODEGRADABLE SYSTEMS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE, P493
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Eyholzer C, 2011, BIOMACROMOLECULES, V12, P1419, DOI 10.1021/bm101131b
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Fang B, 2009, TISSUE ENG PT A, V15, P1091, DOI 10.1089/ten.tea.2008.0110
   Fatimi A, 2008, MACROMOL SYMP, V266, P12, DOI 10.1002/masy.200850603
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Feng QH, 2011, BIORESOURCES, V6, P4942
   Fernandes EM, 2011, ANTEC C P, V1, P611
   Fernandes EM, 2011, COMPOS STRUCT, V93, P3120, DOI 10.1016/j.compstruct.2011.06.020
   Fernandes EM, 2010, COMPOS SCI TECHNOL, V70, P2310, DOI 10.1016/j.compscitech.2010.09.010
   Filpponen I, 2012, BIOMACROMOLECULES, V13, P736, DOI 10.1021/bm201661k
   Fink H, 2011, J TISSUE ENG REGEN M, V5, P454, DOI 10.1002/term.334
   Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090
   Fleming K, 2000, J AM CHEM SOC, V122, P5224, DOI 10.1021/ja000764e
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   Fukuyama T, 2010, DENT MATER J, V29, P160, DOI 10.4012/dmj.2009-063
   Gabrielii I, 2000, CARBOHYD POLYM, V43, P367, DOI 10.1016/S0144-8617(00)00181-8
   Gandini A, 2006, PROG POLYM SCI, V31, P878, DOI 10.1016/j.progpolymsci.2006.07.004
   Garrote G, 1999, HOLZ ROH WERKST, V57, P191, DOI 10.1007/s001070050039
   Gatenholm P, 2010, MRS BULL, V35, P208, DOI 10.1557/mrs2010.653
   Gibson LJ, 2003, MRS BULL, V28, P270, DOI 10.1557/mrs2003.79
   Gizdavic-Nikolaidis M, 2004, SYNTHETIC MET, V140, P225, DOI 10.1016/S0379-6779(03)00372-2
   Goffin AL, 2011, BIOMACROMOLECULES, V12, P2456, DOI 10.1021/bm200581h
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gonzalez P, 2003, BIOMATERIALS, V24, P4827, DOI 10.1016/S0142-9612(03)00405-8
   Gonzalez P, 2009, J BIOMED MATER RES A, V88A, P807, DOI 10.1002/jbm.a.31951
   Gouma P, 2012, MAT SCI ENG C-MATER, V32, P607, DOI 10.1016/j.msec.2011.12.019
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Granja P L, 2005, Eur Cell Mater, V10, P31
   Granja PL, 2006, REACT FUNCT POLYM, V66, P728, DOI 10.1016/j.reactfunctpolym.2005.10.027
   Granja PL, 2001, J MATER SCI, V36, P2163, DOI 10.1023/A:1017587815583
   Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330
   Granja PL, 2001, J APPL POLYM SCI, V82, P3354, DOI 10.1002/app.2194
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   Gross KA, 2003, J BIOMED MATER RES A, V64A, P672, DOI 10.1002/jbm.a.10437
   Grunert M, 2002, J POLYM ENVIRON, V10, P27, DOI 10.1023/A:1021065905986
   Guillot F, 2003, A composition for wound dressings consists of a hydrogel of chitosan and is used alone or on a cellulose based adhesive support, Patent No. [WO2003068281-A1, 2003068281]
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hench L.L., 2002, FUTURE STRATEGIES TI, P3
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024
   HOLLISTER SJ, 2001, BONE MECH HDB
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Hutchens SA, 2009, AATCC REV, V9, P40
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jeon JH, 2008, PHARM DEV TECHNOL, V13, P505, DOI [10.1080/10837450802282488, 10.1080/10837450802282488 ]
   Jeon JH, 2008, J PERIODONTOL, V79, P1457, DOI [10.1902/jop.2008.080004, 10.1902/jop.2008.080004 ]
   Jeon JH, 2007, INT J PHARM, V340, P6, DOI 10.1016/j.ijpharm.2007.03.007
   Jiang LY, 2008, J MATER SCI-MATER M, V19, P981, DOI 10.1007/s10856-007-3208-1
   Jiang LY, 2009, J MATER SCI-MATER M, V20, P1645, DOI 10.1007/s10856-009-3720-6
   Jiang LY, 2009, MAT SCI ENG C-BIO S, V29, P193, DOI 10.1016/j.msec.2008.06.009
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   Kalambur S, 2005, J APPL POLYM SCI, V96, P1072, DOI 10.1002/app.21504
   Kalia S, 2011, INT J POLYM SCI, DOI 10.1155/2011/837875
   Kamel S, 2007, EXPRESS POLYM LETT, V1, P546, DOI 10.3144/expresspolymlett.2007.78
   Karaaslan AM, 2010, BIORESOURCES, V5, P1036
   Karaaslan MA, 2011, CARBOHYD POLYM, V86, P192, DOI 10.1016/j.carbpol.2011.04.030
   Keaveny T, 2003, STANDARD HDB BIOMEDI
   Keavney T., 1992, BONE, P285
   Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078
   Kickelbick G, 2003, PROG POLYM SCI, V28, P83, DOI 10.1016/S0079-6700(02)00019-9
   Kim EJ, 2009, J BIOMED MATER RES A, V90A, P1198, DOI 10.1002/jbm.a.32160
   Kingshott P, 2011, CURR OPIN CHEM BIOL, V15, P667, DOI 10.1016/j.cbpa.2011.07.012
   Kitamura M, 2004, J MATER SCI-MATER M, V15, P1153, DOI 10.1023/B:JMSM.0000046399.40310.47
   Kitamura M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002611
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D, 2006, ADV POLYM SCI, V205, P49, DOI 10.1007/12_097
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Klemm D, 2009, MACROMOL SYMP, V280, P60, DOI 10.1002/masy.200950608
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990
   Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622
   Krawczyk H, 2011, SEP PURIF TECHNOL, V79, P43, DOI 10.1016/j.seppur.2011.03.009
   KRIEGER J, 1990, CHEM ENG NEWS, V68, P35
   Kuang J, 2011, CARBOHYD POLYM, V83, P284, DOI 10.1016/j.carbpol.2010.07.052
   Kvien I, 2005, BIOMACROMOLECULES, V6, P3160, DOI 10.1021/bm050479t
   Landman KA, 2007, B MATH BIOL, V69, P2405, DOI 10.1007/s11538-007-9225-x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laranjeira MCM, 2009, QUIM NOVA, V32, P672, DOI 10.1590/S0100-40422009000300011
   Lazaro Martinez JL, 2007, CIR ESPAN, V82, P27
   Lee H, 2008, 19499A TW U VAN
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Lee J, 2012, MACROMOL RES, V20, P76, DOI 10.1007/s13233-012-0008-3
   Lelli M, 2010, ADV ENG MATER, V12, pB348, DOI 10.1002/adem.200980086
   Leonor IB, 2003, J MATER SCI-MATER M, V14, P435, DOI 10.1023/A:1023214918592
   Li B, 2009, BIOMATERIALS, V30, P3486, DOI 10.1016/j.biomaterials.2009.03.008
   Li SH, 1997, BIOMATERIALS, V18, P389, DOI 10.1016/S0142-9612(96)00122-6
   Li SH, 1996, J MATER SCI LETT, V15, P1882, DOI 10.1007/BF00264085
   Li XM, 2010, J BIOBASED MATER BIO, V4, P289, DOI 10.1166/jbmb.2010.1107
   Li XF, 2006, J EUR CERAM SOC, V26, P3657, DOI 10.1016/j.jeurceramsoc.2005.10.015
   Li Z, 2010, J SERB CHEM SOC, V75, P385, DOI 10.2298/JSC090410010Z
   Lopez-Perez PM, 2007, J MATER CHEM, V17, P4064, DOI 10.1039/b707326g
   Lopez-Perez PM, 2010, ACTA BIOMATER, V6, P3704, DOI 10.1016/j.actbio.2010.03.008
   Luo Y, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P359, DOI 10.1016/B978-012370615-7/50029-9
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mangalam AP, 2009, BIOMACROMOLECULES, V10, P497, DOI 10.1021/bm800925x
   Mano JF, 2005, BIODEGRADABLE SYSTEMS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE, P127
   Mano JF, 2002, J MATER SCI, V37, P257, DOI 10.1023/A:1013635809035
   Mansur HS, 2005, KEY ENG MAT, V284-286, P745, DOI 10.4028/www.scientific.net/KEM.284-286.745
   Marques AP, 2005, MAT SCI ENG C-BIO S, V25, P215, DOI 10.1016/j.msec.2005.01.013
   Marques AP, 2005, J MATER SCI-MATER M, V16, P833, DOI 10.1007/s10856-005-3580-7
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Mathew AP, 2005, J APPL POLYM SCI, V97, P2014, DOI 10.1002/app.21779
   Million LE, 2008, J BIOMED MATER RES B, V86B, P444, DOI 10.1002/jbm.b.31040
   Millon L, 2009, Producing nanocomposite hydrogel comprises forming solution containing solvent, hydrogel-forming material and cellulose, crosslinking the material to give nanocomposite hydrogel and applying tensile force, and thermal cycling the hydrogel, Patent No. [US 2009252800-Al, 2009252800]
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Millon LE, 2009, J BIOMED MATER RES B, V90B, P922, DOI 10.1002/jbm.b.31364
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Mohammadi H, 2011, P I MECH ENG H, V225, P718, DOI 10.1177/0954411911399826
   Mohanty AK, 2000, MACROMOL MATER ENG, V276, P1, DOI 10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   Nishida M, 2003, BIORESOURCE TECHNOL, V88, P81, DOI 10.1016/S0960-8524(02)00264-X
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Oksman K, 2006, COMPOS SCI TECHNOL, V66, P2776, DOI 10.1016/j.compscitech.2006.03.002
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Osorio-Madrao A, 2012, BIOMACROMOLECULES, V13, P850, DOI 10.1021/bm201764y
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Paul MA, 2003, POLYMER, V44, P443, DOI 10.1016/S0032-3861(02)00778-4
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Pertile RAN, 2010, CARBOHYD POLYM, V82, P692, DOI 10.1016/j.carbpol.2010.05.037
   Peschel D, 2012, ACTA BIOMATER, V8, P183, DOI 10.1016/j.actbio.2011.08.012
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Pinto PCRO, 2009, IND CROP PROD, V29, P126, DOI 10.1016/j.indcrop.2008.04.015
   Pires RA, 2011, NAT PROD COMMUN, V6, P1577
   Pourjavadi A, 2003, J APPL POLYM SCI, V90, P3115, DOI 10.1002/app.13054
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Rambo CR, 2005, ADV MATER, V17, P1088, DOI 10.1002/adma.200401049
   Rambo CR, 2004, MATER CHEM PHYS, V87, P345, DOI 10.1016/j.matchemphys.2004.05.031
   Raschip IE, 2007, HIGH PERFORM POLYM, V19, P603, DOI 10.1177/0954008307081202
   Raschip IE, 2011, HIGH PERFORM POLYM, V23, P219, DOI 10.1177/0954008311399112
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rodriguez K, 2011, ACS APPL MATER INTER, V3, P681, DOI 10.1021/am100972r
   Roos AA, 2008, BIOMACROMOLECULES, V9, P2104, DOI 10.1021/bm701399m
   Rubenstein DA, 2010, J BIOMAT SCI-POLYM E, V21, P1713, DOI 10.1163/092050609X12559317149363
   Sa-Lima H, 2011, J BIOMED MATER RES A, V98A, P596, DOI 10.1002/jbm.a.33140
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sain M, 2006, ACS SYM SER, V938, P2
   Samir MASA, 2004, MACROMOLECULES, V37, P1386, DOI 10.1021/ma030532a
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Samir MASFA, 2004, MACROMOLECULES, V37, P4839
   Sannino A, 2005, POLYMER, V46, P11206, DOI 10.1016/j.polymer.2005.10.048
   Sannino A, 2004, BIOMACROMOLECULES, V5, P92, DOI 10.1021/bm0341881
   Sannino A, 2003, J BIOMED MATER RES A, V67A, P1016, DOI 10.1002/jbm.a.10149
   Sannino A, 2009, MATERIALS, V2, P353, DOI 10.3390/ma2020353
   Sannino A, 2010, J APPL POLYM SCI, V115, P1438, DOI 10.1002/app.30956
   Santo VE, 2012, NANOMEDICINE-UK, V7, P1045, DOI [10.2217/NNM.12.78, 10.2217/nnm.12.78]
   Santos MI, 2009, J MATER CHEM, V19, P4091, DOI 10.1039/b819089e
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Saska S, 2011, INT J BIOMATER, DOI 10.1155/2011/175362
   Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315
   Schmitt M, 2002, BIOMATERIALS, V23, P2789, DOI 10.1016/S0142-9612(02)00015-7
   Schonfelder U, 2005, BIOMATERIALS, V26, P6664, DOI 10.1016/j.biomaterials.2005.04.030
   Seifert M, 2004, J POLYM SCI POL CHEM, V42, P463, DOI 10.1002/pola.10862
   Shankar S, 2012, APPL BIOCHEM BIOTECH, V166, P1082, DOI 10.1007/s12010-011-9496-4
   Shi ZJ, 2012, RSC ADV, V2, P1040, DOI 10.1039/c1ra00719j
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Silva SP, 2005, INT MATER REV, V50, P345, DOI 10.1179/174328005X41168
   Silva-Correia J, 2011, J TISSUE ENG REGEN M, V5, pE97, DOI 10.1002/term.363
   Simonpietri-C JJ, 2000, J PERIODONTOL, V71, P904, DOI 10.1902/jop.2000.71.6.904
   Singh S, 2007, J NANOSCI NANOTECHNO, V7, P2596, DOI 10.1166/jnn.2007.909
   Siqueira G, 2009, BIOMACROMOLECULES, V10, P425, DOI 10.1021/bm801193d
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Sprio S, 2011, J BIOTECHNOL, V156, P347, DOI 10.1016/j.jbiotec.2011.07.034
   Stokke DD, 2003, J VINYL ADDIT TECHN, V9, P96, DOI 10.1002/vnl.10069
   Struillou X, 2011, J MATER SCI-MATER M, V22, P1707, DOI 10.1007/s10856-011-4344-1
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sun BH, 2004, CARBON, V42, P177, DOI 10.1016/j.carbon.2003.09.008
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tahara N, 1997, BIOSCI BIOTECH BIOCH, V61, P1862, DOI 10.1271/bbb.61.1862
   Tampieri A, 2009, J MATER CHEM, V19, P4973, DOI 10.1039/b900333a
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Trojani C, 2005, BIOMATERIALS, V26, P5509, DOI 10.1016/j.biomaterials.2005.02.001
   Turczyn R, 2000, J BIOMAT SCI-POLYM E, V11, P217, DOI 10.1163/156856200743661
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057
   Vinatier C, 2009, BIOTECHNOL BIOENG, V102, P1259, DOI 10.1002/bit.22137
   Vroman I, 2009, MATERIALS, V2, P307, DOI 10.3390/ma2020307
   Wambua P, 2003, COMPOS SCI TECHNOL, V63, P1259, DOI 10.1016/S0266-3538(03)00096-4
   Wan WK, 2006, ACS SYM SER, V938, P221
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wang JH, 2010, MAT SCI ENG C-MATER, V30, P214, DOI 10.1016/j.msec.2009.10.006
   Wang YX, 2010, MACROMOL MATER ENG, V295, P137, DOI 10.1002/mame.200900212
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Wu HD, 2012, MAT SCI ENG C-MATER, V32, P207, DOI 10.1016/j.msec.2011.10.020
   Yang JY, 2011, CARBOHYD POLYM, V86, P1113, DOI 10.1016/j.carbpol.2011.05.043
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   Ye H, 2007, J MATER SCI-MATER M, V18, P641, DOI 10.1007/s10856-007-2314-4
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Yun HS, 2008, J BIOMED MATER RES B, V87B, P374, DOI 10.1002/jbm.b.31114
   Zakharov NA, 2005, INORG MATER+, V41, P509, DOI 10.1007/s10789-005-0159-0
   Zhang JM, 2010, ACTA POLYM SIN, P1376, DOI 10.3724/SP.J.1105.2010.10238
   Zhang K, 2002, J BIOMED MATER RES, V61, P551, DOI 10.1002/jbm.10227
   Zhang LM, 2005, J BIOACT COMPAT POL, V20, P297, DOI 10.1177/0883911505053882
   Zhang XL, 2010, POLYMER, V51, P4398, DOI 10.1016/j.polymer.2010.07.025
   Zhang Z, 2011, J POLYM SCI POL CHEM, V49, P2941, DOI 10.1002/pola.24730
   Zhu HX, 2009, ADV MAT RES, V79-82, P1371, DOI 10.4028/www.scientific.net/AMR.79-82.1371
   Zimmermann KA, 2011, MAT SCI ENG C-MATER, V31, P43, DOI 10.1016/j.msec.2009.10.007
NR 278
TC 76
Z9 77
U1 3
U2 225
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
EI 1873-1619
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD OCT-NOV
PY 2013
VL 38
IS 10-11
BP 1415
EP 1441
DI 10.1016/j.progpolymsci.2013.05.013
PG 27
WC Polymer Science
SC Polymer Science
GA 238ND
UT WOS:000325953700004
DA 2018-10-20
ER

PT J
AU Ji, Y
   Zhang, XD
   Wang, XC
   Che, ZC
   Yu, XM
   Yang, HZ
AF Ji, Y.
   Zhang, X. D.
   Wang, X. C.
   Che, Z. C.
   Yu, X. M.
   Yang, H. Z.
TI ZIRCONIA BIOCERAMICS AS ALL-CERAMICS CROWNS MATERIAL: A REVIEW
SO REVIEWS ON ADVANCED MATERIALS SCIENCE
LA English
DT Article
ID SOL-GEL METHOD; FIXED DENTAL PROSTHESES; STRENGTH; NANOCOMPOSITES;
   BIOMATERIAL; PORCELAIN; IMPLANTS; BEHAVIOR; POWDER
AB Zirconia (ZrO2), known as a kind of bioceramics widely applied in prosthodontics, is considered as a promising alternative to conventional bioceramics owing to its desirable mechanical strength, toughness, wear resistance, corrosion resistance, biocompatibility etc. However, the development of zirconia is hindered due to its instability in long-term clinical observations such as the cracking (chipping) of veneering porcelain and deterioration of mechanical properties of zirconia dental crowns under intraoral condition. The aim of this study is to review the development and actuality of ZrO2 in prosthodontics. In addition, stability problems in commercial zirconia crowns are discussed in detail and the potential solution has been proposed. Furthermore, the authors' ongoing works and perspective has also been put forward.
C1 [Ji, Y.; Zhang, X. D.; Wang, X. C.; Che, Z. C.] Shenyang Mil Area Command, Gen Hosp, Shenyang 110840, Peoples R China.
   [Yu, X. M.; Yang, H. Z.] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
   [Yang, H. Z.] China Med Univ, Coll Basic Med Sci, Dept Biophys, Shenyang 110001, Peoples R China.
RP Zhang, XD (reprint author), Shenyang Mil Area Command, Gen Hosp, Shenyang 110840, Peoples R China.
EM yxmbadboy@gmail.com; yanghuazhe@gmail.com
CR Attia A, 2011, DENT MATER, V27, P207, DOI 10.1016/j.dental.2010.10.004
   Baldassarri M, 2011, J DENT, V39, P489, DOI 10.1016/j.jdent.2011.04.006
   Benetti P, 2011, DENT MATER, V27, P948, DOI 10.1016/j.dental.2011.05.009
   Brakel R., 2011, CLIN ORAL IMPLAN RES, V22, P571
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Conrad HJ, 2007, J PROSTHET DENT, V98, P389, DOI 10.1016/S0022-3913(07)60124-3
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Derek W.J., 1985, DENT CLIN N AM, V29, P621
   Elshazly ES, 2011, J MATER SCI TECHNOL, V27, P332, DOI 10.1016/S1005-0302(11)60070-4
   Eric A., 1999, J DENT, V27, P275
   Eriksson M, 2006, MATER SCI TECH-LOND, V22, P611, DOI 10.1179/174328046X84076
   Fischer J, 2009, DENT MATER, V25, P419, DOI 10.1016/j.dental.2008.09.003
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Jin E.L., 2007, INT J STOMATOLOGY, V34, P62
   Kasuga H., KEY ENG MAT
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Kern M, 1998, DENT MATER, V14, P64, DOI 10.1016/S0109-5641(98)00011-6
   Kohal RJ, 2011, CLIN ORAL IMPLAN RES, V22, P808, DOI 10.1111/j.1600-0501.2010.02067.x
   Kohorst P, 2011, CLIN ORAL INVEST, V15, P527, DOI 10.1007/s00784-010-0415-9
   Kou W, 2011, J BIOMED MATER RES B, V96B, P376, DOI 10.1002/jbm.b.31782
   Li B, 2009, J POWER SOURCES, V193, P598, DOI 10.1016/j.jpowsour.2009.04.050
   Liang XJ, 2008, J UNIV SCI TECHNOL B, V15, P764, DOI 10.1016/S1005-8850(08)60284-4
   Mainjot AK, 2011, DENT MATER, V27, P906, DOI 10.1016/j.dental.2011.05.005
   Marchi J, 2010, INT J APPL CERAM TEC, V7, P139, DOI 10.1111/j.1744-7402.2009.02388.x
   Mitov G, 2011, DENT MATER, V27, P684, DOI 10.1016/j.dental.2011.03.010
   Mochales C, 2011, ACTA BIOMATER, V7, P2994, DOI 10.1016/j.actbio.2011.04.007
   Moon JE, 2011, DENT MATER, V27, P651, DOI 10.1016/j.dental.2011.03.005
   Otrop A., 2009, J DENT, V37, P731
   Ozkurt Z, 2011, J ORAL IMPLANTOL, V37, P367, DOI 10.1563/AAID-JOI-D-09-00079
   Piascik JR, 2011, DENT MATER, V27, pE99, DOI 10.1016/j.dental.2011.01.005
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   Rosenblum MA, 1997, J AM DENT ASSOC, V128, P297, DOI 10.14219/jada.archive.1997.0193
   Sailer I, 2009, INT J PROSTHODONT, V22, P553
   Sarkar D, 2007, J MATER SCI, V 42, P1847, DOI 10.1007/s10853-006-0737-9
   Shijo Y, 2009, DENT MATER J, V28, P352, DOI 10.4012/dmj.28.352
   Smith RL, 2011, DENT MATER, V27, P779, DOI 10.1016/j.dental.2011.03.018
   Stefanic G, 2009, J MOL STRUCT, V924, P225, DOI 10.1016/j.molstruc.2008.10.044
   Subarrao E. C., 1981, SCI TECHNOLOGY ZIRCO, P1
   Sun J, 2002, KEY ENG MAT, V224-2, P663, DOI 10.4028/www.scientific.net/KEM.224-226.663
   Swain MV, 2009, ACTA BIOMATER, V5, P1668, DOI 10.1016/j.actbio.2008.12.016
   Taavoni-Gilan A, 2009, J NON-CRYST SOLIDS, V355, P311, DOI 10.1016/j.jnoncrysol.2008.11.012
   Tholey MJ, 2009, DENT MATER, V25, P857, DOI 10.1016/j.dental.2009.01.006
   Thompson JY, 2011, DENT MATER, V27, P71, DOI 10.1016/j.dental.2010.10.022
   Vargas A.P., 2011, DENT MATER, V27, P581
   Vladimir V., 2001, CERAM INT, V27, P859
   Vladimir V.S., 2000, J AM CERAM SOC, V83, P729
   Xia B, 2000, J AM CERAM SOC, V83, P1077
   Xie ZP, 2004, CERAM INT, V30, P219, DOI 10.1016/S0272-8842(03)00092-0
   Yang HZ, 2011, MATER RES INNOV, V15, P391, DOI 10.1179/143307511X13189528030834
   Yang H.Z., 2008, THESIS NE U SHENYANG
   Yang HZ, 2007, MATER SCI FORUM, V546-549, P1993, DOI 10.4028/www.scientific.net/MSF.546-549.1993
   Yang HZ, 2012, ASIAN J CHEM, V24, P3510
   Yang HZ, 2012, APPL SURF SCI, V258, P4852, DOI 10.1016/j.apsusc.2012.01.055
   Yilmaz H, 2011, DENT MATER, V27, P786, DOI 10.1016/j.dental.2011.03.019
   Zhang G.L., 2006, BEIJING BIOMED ENG, V25, P109
   Zhang Y, 2010, CRYSTENGCOMM, V12, P3046, DOI 10.1039/b927276c
NR 56
TC 9
Z9 10
U1 2
U2 37
PU INST PROBLEMS MECHANICAL ENGINEERING-RUSSIAN ACAD SCIENCES
PI ST PTERSBURG
PA BOLSHOJ 61, VAS OSTROV, ST PTERSBURG, 199178, RUSSIA
SN 1606-5131
J9 REV ADV MATER SCI
JI Rev. Adv. Mater. Sci.
PD OCT
PY 2013
VL 34
IS 1
BP 72
EP 78
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 245SB
UT WOS:000326483000008
DA 2018-10-20
ER

PT J
AU Binazadeh, M
   Faghihnejad, A
   Unsworth, LD
   Zeng, HB
AF Binazadeh, Mojtaba
   Faghihnejad, Ali
   Unsworth, Larry D.
   Zeng, Hongbo
TI Understanding the Effect of Secondary Structure on Molecular
   Interactions of Poly-L-lysine with Different Substrates by SFA
SO BIOMACROMOLECULES
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; POLY(ETHYLENE GLYCOL);
   SURFACE FORCES; IONIC-STRENGTH; MICA SURFACES; ALPHA-HELIX;
   CONFORMATIONAL-CHANGES; POLY(L-GLUTAMIC ACID); ADSORBED FIBRINOGEN
AB Nonspecific adsorption of proteins on biomaterial surfaces challenges the widespread application of engineered materials, and understanding the impact of secondary structure of proteins and peptides on their adsorption process is of both fundamental and practical importance in bioengineering. In this work, poly-L-lysine (PLL)-based alpha-helices and beta-sheets were chosen as a model system to investigate the effect of secondary structure on peptide interactions with substrates of various surface chemistries. Circular dichroism (CD) was used to confirm the presence of both alpha-helix and beta-sheet structured PLL in aqueous solutions and upon adsorption to quartz, where these secondary structures seemed to be preserved. Atomic force microscopy (AFM) imaging showed different surface patterns for adsorbed alpha-helix and beta-sheet PLL. Interactions between PLL of different secondary structures and various substrates (i.e., PLL, Au, mica, and poly(ethylene glycol) (PEG)) were directly measured using a surface forces apparatus (SFA). It was found that beta-sheet PLL films showed higher adsorbed layer thicknesses in general. Adhesion energies of beta-sheet versus Au and beta-sheet versus beta-sheet were considerably higher than that of alpha-helix versus Au and alpha-helix versus alpha-helix systems, respectively. Au and beta-sheet PLL interactions seemed to be more dependent on the salt concentration than that of alpha-helix, while the presence of a grafted PEG layer greatly diminished any attraction with either PLL structure. The molecular interaction mechanism of peptide in different secondary structures is discussed in terms of Derjaguin-Landau-Verwey-Overbeek (DLVO) theory, Alexander-de Gennes (AdG) steric model and hydrogen bonding, which provides important insight into the fundamental understanding of the interaction mechanism between proteins and biomaterials.
C1 [Binazadeh, Mojtaba; Faghihnejad, Ali; Unsworth, Larry D.; Zeng, Hongbo] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada.
   [Unsworth, Larry D.] Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada.
RP Unsworth, LD (reprint author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada.
EM lunswort@ualberta.ca; hongbo.zeng@ualberta.ca
RI Zeng, Hongbo/C-8491-2011
OI Zeng, Hongbo/0000-0002-1432-5979; Unsworth, Larry/0000-0003-3162-3545
FU NSERC; Natural Sciences and Engineering Research Council of Canada
FX This work was supported by an NSERC Discovery Grant and a RTI Grant from
   the Natural Sciences and Engineering Research Council of Canada.
CR ABE T, 1995, J PHYS CHEM-US, V99, P1820, DOI 10.1021/j100007a003
   ABSOLOM DR, 1983, T AM SOC ART INT ORG, V29, P146
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   ANDREWS DW, 1982, ULTRAMICROSCOPY, V9, P337, DOI 10.1016/0304-3991(82)90094-8
   Ball V, 2004, COLLOID SURFACE B, V33, P129, DOI 10.1016/j.colsurfb.2003.09.006
   BARBOSA RV, 1995, J MACROMOL SCI PURE, VA32, P663, DOI 10.1080/10601329508018956
   Binazadeh M, 2013, ACTA BIOMATER, V9, P6403, DOI 10.1016/j.actbio.2013.01.018
   Binazadeh M, 2012, ACS SYM SER, V1120, P621
   Bostrom M, 2005, J PHYS CHEM B, V109, P24489, DOI 10.1021/jp0551869
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   CHIOU JS, 1992, BIOCHIM BIOPHYS ACTA, V1119, P211, DOI 10.1016/0167-4838(92)90394-S
   Chittchang M, 2002, J PHARM PHARMACOL, V54, P315, DOI 10.1211/0022357021778556
   CLAESSON PM, 1987, J COLLOID INTERF SCI, V117, P366, DOI 10.1016/0021-9797(87)90395-X
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Demirdoven N, 2004, J AM CHEM SOC, V126, P7981, DOI 10.1021/ja049811j
   Dormidontova EE, 2002, MACROMOLECULES, V35, P987, DOI 10.1021/ma010804e
   Dougherty GM, 2008, ELECTROPHORESIS, V29, P1131, DOI 10.1002/elps.200700448
   Du YJ, 2003, J APPL POLYM SCI, V90, P594, DOI 10.1002/app.12545
   ELGERSMA AV, 1992, COLLOID SURFACE, V65, P17, DOI 10.1016/0166-6622(92)80171-W
   Evans-Nguyen KM, 2006, LANGMUIR, V22, P5115, DOI 10.1021/la053070y
   Faghihnejad A., 2013, POLYM ADHESION FRICT, P1
   Giesbers M, 2002, J COLLOID INTERF SCI, V248, P88, DOI 10.1006/jcis.2001.8144
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Grigsby JJ, 2002, BIOPHYS CHEM, V99, P107, DOI 10.1016/S0301-4622(02)00138-2
   Hansen PL, 2003, BIOPHYS J, V84, P350, DOI 10.1016/S0006-3495(03)74855-3
   Hayashi S, 2002, LANGMUIR, V18, P3932, DOI 10.1021/la0114979
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   Hlady V., 1985, SURFACE INTERFACIAL, V2, P81
   HOFMEISTER F, 1888, ARCH EXP PATHOL PH, V24, P247, DOI DOI 10.1007/BF01918191
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   ISRAELAC.JN, 1973, J COLLOID INTERF SCI, V44, P259, DOI 10.1016/0021-9797(73)90218-X
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P223, DOI 10.1016/B978-0-12-375182-9.10012-0
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P253, DOI 10.1016/B978-0-12-375182-9.10013-2
   Jordan CE, 1997, ANAL CHEM, V69, P1449, DOI 10.1021/ac961012z
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   KLEIN J, 1984, NATURE, V308, P836, DOI 10.1038/308836a0
   KURIHARA K, 1995, COLLOID SURFACE A, V103, P265, DOI 10.1016/0927-7757(95)03295-O
   LECKBAND D, 1993, ENZYME MICROB TECH, V15, P450, DOI 10.1016/0141-0229(93)90077-F
   Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   LI YQ, 1993, LANGMUIR, V9, P637, DOI 10.1021/la00027a003
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   LUCKHAM PF, 1984, J CHEM SOC FARAD T 1, V80, P865, DOI 10.1039/f19848000865
   Meder F, 2012, ACTA BIOMATER, V8, P1221, DOI 10.1016/j.actbio.2011.09.014
   MELANDER WR, 1989, J CHROMATOGR, V469, P3, DOI 10.1016/S0021-9673(01)96437-4
   Miles AJ, 2005, PROTEIN SCI, V14, P368, DOI 10.1110/ps.041019905
   MYER YP, 1969, MACROMOLECULES, V2, P624, DOI 10.1021/ma60012a012
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   Parson W. W., 2009, MODERN OPTICAL SPECT, P307
   Putnam C., PROTEIN CALCULATOR V
   RAMSDEN JJ, 1994, J PHYS CHEM-US, V98, P5376, DOI 10.1021/j100071a031
   Schweiss R, 2004, J PHYS CHEM B, V108, P2910, DOI 10.1021/jp035724m
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   STAHLBERG J, 1992, ANAL CHEM, V64, P3118, DOI 10.1021/ac00048a009
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   Teraoka I., 2002, POLYM SOLUTIONS INTR, P69
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   Unsworth LD, 2005, J COLLOID INTERF SCI, V281, P112, DOI 10.1016/j.jcis.2004.08.022
   Valentini M, 2003, LANGMUIR, V19, P4852, DOI 10.1021/la026896y
   Van J.-N., 1988, 63 ANN TECHN C EXH S, P557
   Vladkova T.G., 2010, INT J POLYM SCI, V2010, P1, DOI DOI 10.1155/2010/296094
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
   Wolkers WF, 1998, BBA-GEN SUBJECTS, V1425, P127, DOI 10.1016/S0304-4165(98)00059-2
   Wong SY, 2012, BIOMACROMOLECULES, V13, P719, DOI 10.1021/bm201637e
   Yang H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001325
   Yang Q, 2010, LANGMUIR, V26, P5746, DOI 10.1021/la903895q
   Zeng H, 2008, LANGMUIR, V24, P1173, DOI 10.1021/la7017242
   Zhang L, 2012, J PHYS CHEM C, V116, P17554, DOI 10.1021/jp303561p
NR 77
TC 3
Z9 3
U1 1
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT
PY 2013
VL 14
IS 10
BP 3498
EP 3508
DI 10.1021/bm400837t
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 240UI
UT WOS:000326122800018
PM 24032485
DA 2018-10-20
ER

PT J
AU Marquardt, LM
   Sakiyama-Elbert, SE
AF Marquardt, Laura M.
   Sakiyama-Elbert, Shelly E.
TI Engineering peripheral nerve repair
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID SPINAL-CORD-INJURY; NEUROTROPHIC FACTOR; STEM-CELLS;
   ELECTRICAL-STIMULATION; COLLAGEN SCAFFOLDS; CONDUCTING POLYMER; NEURITE
   EXTENSION; FIBRIN MATRICES; REGENERATION; POLYPYRROLE
AB Current approaches for treating peripheral nerve injury have resulted in promising, yet insufficient functional recovery compared to the clinical standard of care, autologous nerve grafts. In order to design a construct that can match the regenerative potential of the autograft, all facets of nerve tissue must be incorporated in a combinatorial therapy. Engineered biomaterial scaffolds in the future will have to promote enhanced regeneration and appropriate reinnervation by targeting the highly sensitive response of regenerating nerves to their surrounding microenvironment.
C1 [Marquardt, Laura M.; Sakiyama-Elbert, Shelly E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   [Sakiyama-Elbert, Shelly E.] Washington Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, St Louis, MO 63110 USA.
RP Sakiyama-Elbert, SE (reprint author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
EM sakiyama@wustl.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851
FU NINDS NIH HHS [R01 NS051454, R01 NS051706]
CR Alrashdan MS, 2010, ACTA NEUROL BELG, V110, P168
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Bruder JM, 2007, J BIOMAT SCI-POLYM E, V18, P967, DOI 10.1163/156856207781494412
   Cao JN, 2013, BIOMATERIALS, V34, P1302, DOI 10.1016/j.biomaterials.2012.10.031
   Cao JI, 2011, BIOMATERIALS, V32, P3939, DOI 10.1016/j.biomaterials.2011.02.020
   Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.TEA.2011.0534, 10.1089/ten.tea.2011.0534]
   Daly WT, 2012, BIOMATERIALS, V33, P6660, DOI 10.1016/j.biomaterials.2012.06.002
   Davidenko N, 2012, ACTA BIOMATER, V8, P667, DOI 10.1016/j.actbio.2011.09.033
   Fan JA, 2011, J BIOMED MATER RES B, V97B, P271, DOI 10.1002/jbm.b.31810
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255
   Hsieh SC, 2011, J BIOMED MATER RES A, V99A, P576, DOI 10.1002/jbm.a.33157
   Huang JH, 2012, PLOS ONE, P7
   Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641
   Il Cho Y, 2010, ACTA BIOMATER, V6, P4725, DOI 10.1016/j.actbio.2010.06.019
   Jurga M, 2011, BIOMATERIALS, V32, P3423, DOI 10.1016/j.biomaterials.2011.01.049
   Kijenska E, 2012, J BIOMED MATER RES B, V100B, P1093, DOI 10.1002/jbm.b.32676
   Kim SY, 2011, ACS APPL MATER INTER, V3, P16, DOI 10.1021/am1008369
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   Lee BK, 2012, BIOMATERIALS, V33, P9027, DOI 10.1016/j.biomaterials.2012.09.008
   Lee JY, 2012, IEEE T NANOBIOSCI, V11, P15, DOI 10.1109/TNB.2011.2159621
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee JY, 2009, J R SOC INTERFACE, V6, P801, DOI 10.1098/rsif.2008.0403
   Marquardt L, 2011, J BIOMED MATER RES A, V98A, P1, DOI 10.1002/jbm.a.33044
   Moore AM, 2010, J HAND SURG-AM, V35A, P2008, DOI 10.1016/j.jhsa.2010.08.016
   Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3
   Moroder P, 2011, ACTA BIOMATER, V7, P944, DOI 10.1016/j.actbio.2010.10.013
   Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015
   Nagao RJ, 2011, NEUROL RES, V33, P600, DOI 10.1179/1743132810Y.0000000023
   Neal RA, 2012, J BIOMED MATER RES A, V100A, P406, DOI 10.1002/jbm.a.33204
   Oh SH, 2013, TISSUE ENG PART C-ME, V19, P233, DOI [10.1089/ten.tec.2012.0221, 10.1089/ten.TEC.2012.0221]
   Park SY, 2012, J TISSUE ENG REGEN M, DOI DOI 10.1002/TERM.1615.EPUB
   Pawar K, 2011, ACTA BIOMATER, V7, P2826, DOI 10.1016/j.actbio.2011.04.006
   Prabhakaran MP, 2011, J BIOSCI BIOENG, V112, P501, DOI 10.1016/j.jbiosc.2011.07.010
   Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007
   Richardson JA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046015
   Runge MB, 2010, BIOMATERIALS, V31, P5916, DOI 10.1016/j.biomaterials.2010.04.012
   Scott RA, 2011, ACTA BIOMATER, V7, P3841, DOI 10.1016/j.actbio.2011.06.054
   Shepard JA, 2011, BIOMATERIALS, V32, P5092, DOI 10.1016/j.biomaterials.2011.03.083
   Song HK, 2006, BIOMATERIALS, V27, P473, DOI 10.1016/j.biomaterials.2005.06.030
   Spivey EC, 2012, BIOMATERIALS, V33, P4264, DOI 10.1016/j.biomaterials.2012.02.043
   Suri S, 2011, BIOMED MICRODEVICES, V13, P983, DOI 10.1007/s10544-011-9568-9
   Swindle-Reilly KE, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046007
   Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x
   Wang GL, 2011, IN VITRO CELL DEV-AN, V47, P234, DOI 10.1007/s11626-010-9381-4
   Wang Y, 2012, CELL MOL NEUROBIOL, V32, P361, DOI 10.1007/s10571-011-9764-4
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   Wood MD, 2009, J BIOMED MATER RES A, V89A, P909, DOI 10.1002/jbm.a.32043
   Wood MD, 2009, J NEURAL ENG, P6
   Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xu HX, 2011, BIOMATERIALS, V32, P4506, DOI 10.1016/j.biomaterials.2011.02.023
   Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]
   Zhou W, 2012, J BIOMAT SCI-POLYM E, P1
   Zhu YQ, 2011, TISSUE ENG PART C-ME, V17, P705, DOI 10.1089/ten.tec.2010.0565
   Zustiak SP, 2010, ACTA BIOMATER, V6, P3404, DOI 10.1016/j.actbio.2010.03.040
NR 58
TC 35
Z9 36
U1 2
U2 52
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
EI 1879-0429
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD OCT
PY 2013
VL 24
IS 5
BP 887
EP 892
DI 10.1016/j.copbio.2013.05.006
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 241BP
UT WOS:000326141700010
PM 23790730
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Coronel, MM
   Stabler, CL
AF Coronel, Maria M.
   Stabler, Cherie L.
TI Engineering a local microenvironment for pancreatic islet replacement
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID BETA-CELL FUNCTION; NONHUMAN PRIMATE ISLETS; LONG-TERM SURVIVAL;
   EXTRACELLULAR-MATRIX; THERAPEUTIC VASCULARIZATION; INSULIN-SECRETION;
   OMENTAL POUCH; TRANSPLANTATION; ENGRAFTMENT; SCAFFOLD
AB Intraportal islet transplantation has emerged as a promising treatment for type 1 diabetes mellitus (T1DM). Nevertheless, long-term efficacy has been limited to a marginal number of patients. Outcomes have been restricted, in part, by challenges associated with the transplant site, poor vascularization, and disruption of the native islet architecture during the isolation process. Engineering a biomaterial platform that recapitulates critical components of the pancreatic environment can serve to address these hurdles. This review highlights the challenges and opportunities in engineering 3D niches for islets, specifically: the importance of site selection; the application of scaffold functionalization to present bioactive motifs; and the development of technologies for enhancing implant nutritional profiles. The potential of these novel approaches to improve islet engraftment and duration of function is discussed.
C1 [Coronel, Maria M.; Stabler, Cherie L.] Univ Miami, Coll Engn, Dept Biomed Engn, Coral Gables, FL 33146 USA.
   [Coronel, Maria M.; Stabler, Cherie L.] Univ Miami, Diabet Res Inst, Miller Sch Med, Miami, FL 33136 USA.
   [Stabler, Cherie L.] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA.
   [Stabler, Cherie L.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.
RP Stabler, CL (reprint author), Univ Miami, Coll Engn, Dept Biomed Engn, Coral Gables, FL 33146 USA.
EM cstabler@med.miami.edu
RI Stabler, Cherie/E-8227-2011
OI Coronel, Maria/0000-0001-9661-7221
FU Juvenile Diabetes Research Foundation [17-2012-361]; National Institutes
   of Health through the Type 1 Diabetes Pathfinder Award Program
   [1DP2-DK083096-01]; SBIR Phase I/II [R43 DK093145-01]; Diabetes Research
   Institute Foundation; Ruth L Kirschstein NRSA predoctoral fellowship
   [F31-DK-097956-01]
FX Funding support for our research currently comes from the Juvenile
   Diabetes Research Foundation (17-2012-361), the National Institutes of
   Health through the Type 1 Diabetes Pathfinder Award Program
   (1DP2-DK083096-01) and SBIR Phase I/II (R43 DK093145-01), and the
   Diabetes Research Institute Foundation. Maria M Coronel is funded by a
   Ruth L Kirschstein NRSA predoctoral fellowship (F31-DK-097956-01). We
   greatly thank Jessica D Weaver for her illustration used in Figure 1.
CR Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063
   Berman DM, 2009, AM J TRANSPLANT, V9, P91, DOI 10.1111/j.1600-6143.2008.02489.x
   Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136
   Borg DJ, 2011, CURR DIABETES REP, V11, P434, DOI 10.1007/s11892-011-0210-2
   Burke GW, 2011, CURR DIABETES REP, V11, P413, DOI 10.1007/s11892-011-0206-y
   Cantley J, 2010, DIABETES OBES METAB, V12, P159, DOI 10.1111/j.1463-1326.2010.01276.x
   Cheng K, 2010, J CLIN INVEST
   Chow LW, 2010, BIOMATERIALS, V31, P6154, DOI 10.1016/j.biomaterials.2010.04.002
   Christoffersson G, 2010, DIABETES, V59, P2569, DOI 10.2337/db10-0205
   Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057
   Daoud JT, 2011, BIOMATERIALS
   Davis NE, 2012, BIOMATERIALS
   Ding Y, 2009, DIABETES
   DIONNE KE, 1993, DIABETES, V42, P12, DOI 10.2337/diabetes.42.1.12
   Dubois S, 2010, J MOL ENDOCRINOL, V45, P99, DOI 10.1677/JME-10-0020
   Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434
   Gibly RF, 2011, BIOMATERIALS, V32, P9677, DOI 10.1016/j.biomaterials.2011.08.084
   Hefty TR, 2010, J SURG RES, V161, P134, DOI 10.1016/j.jss.2008.11.842
   Hussey AJ, 2009, TISSUE ENG PT A, V15, P3823, DOI [10.1089/ten.tea.2008.0682, 10.1089/ten.TEA.2008.0682]
   Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4
   Kakabadze Z, 2012, TRANSPLANTATION, V94, P319, DOI 10.1097/TP.0b013e31825e4a83
   Kenyon NS, 2011, AM J TRANSPLANT, V11, P117
   Kheradmand T, 2011, BIOMATERIALS, V32, P4517, DOI 10.1016/j.biomaterials.2011.03.009
   Kin T, 2008, ARTIF ORGANS, V32, P990, DOI 10.1111/j.1525-1594.2008.00688.x
   Komori J, 2012, NAT BIOTECHNOL, V30, P976, DOI 10.1038/nbt.2379
   Kontos S, 2013, P NATL ACAD SCI USA, V110, pE60, DOI 10.1073/pnas.1216353110
   Koulmanda M, 2012, P NATL ACAD SCI USA, V109, P15443, DOI 10.1073/pnas.1018366109
   LIFSON N, 1985, AM J PHYSIOL, V249, pE43
   Lim DJ, 2011, TISSUE ENG PT A, V17, P399, DOI [10.1089/ten.tea.2010.0151, 10.1089/ten.TEA.2010.0151]
   Lin CC, 2011, P NATL ACAD SCI USA, V108, P6380, DOI 10.1073/pnas.1014026108
   Ludwig B, 2010, HORM METAB RES, V42, P918, DOI 10.1055/s-0030-1267916
   Ludwig B, 2012, P NATL ACAD SCI USA, V109, P5022, DOI 10.1073/pnas.1201868109
   Martino M. M., 2011, SCI TRANSL MED, V3
   McCall M, 2012, AM J TRANSPLANT, V12, P322, DOI 10.1111/j.1600-6143.2011.03796.x
   Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391
   Moritz W, 2002, FASEB J, V16, P745, DOI 10.1096/fj.01-0403fje
   Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015
   Pedraza E, 2012, CELL TRANSP IN PRESS
   Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109
   Perez VL, 2011, DIABETOLOGIA, V54, P1121, DOI 10.1007/s00125-011-2091-y
   Phelps EA, 2013, BIOMATERIALS, V34, P4602, DOI 10.1016/j.biomaterials.2013.03.012
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Phelps EA, 2009, REGEN MED, V4, P65, DOI 10.2217/17460751.4.1.65
   Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   SCHARP DW, 1994, DIABETES, V43, P1167, DOI 10.2337/diabetes.43.9.1167
   Shah S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038368
   Shimoda M, 2010, DIABETOLOGIA, V53, P1669, DOI 10.1007/s00125-010-1745-5
   Stendahl JC, 2008, TRANSPLANTATION
   Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195
   Su J, 2010, BIOMATERIALS, V31, P308, DOI 10.1016/j.biomaterials.2009.09.045
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   Thomas F, 2001, SURGERY, V130, P333, DOI 10.1067/msy.2001.116413
   Weber LM, 2008, MATRIX BIOL, V27, P667, DOI 10.1016/j.matbio.2008.08.001
   Weber LM, 2008, TISSUE ENG A
   Yeung TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038189
   Zhang N, 2006, DIABETES, V55, P2429, DOI 10.2337/db06-0173
NR 57
TC 23
Z9 24
U1 0
U2 21
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
EI 1879-0429
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD OCT
PY 2013
VL 24
IS 5
BP 900
EP 908
DI 10.1016/j.copbio.2013.05.004
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 241BP
UT WOS:000326141700012
PM 23769320
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bitar, KN
   Zakhem, E
AF Bitar, Khalil N.
   Zakhem, Elie
TI Tissue engineering and regenerative medicine as applied to the
   gastrointestinal tract
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID GASTRIC ELECTRICAL-STIMULATION; SMOOTH-MUSCLE; IN-VITRO; SMALL-BOWEL;
   MECHANICAL-PROPERTIES; SMALL-INTESTINE; STEM-CELLS; EPITHELIUM
   REGENERATION; ESOPHAGEAL EPITHELIUM; BARRETTS-ESOPHAGUS
AB The gastrointestinal (GI) tract is a complex system characterized by multiple cell types with a determined architectural arrangement. Tissue engineering of the GI tract aims to reinstate the architecture and function of all structural layers. The key point for successful tissue regeneration includes the use of cells/biomaterials that elucidate minimal immune response after implantation. Different biomaterial choices and cell sources have been proposed to engineer the GI tract. This review summarizes the recent advances in bioengineering the GI tract with emphasis on cell sources and scaffolding biomaterials.
C1 [Bitar, Khalil N.; Zakhem, Elie] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.
   [Bitar, Khalil N.; Zakhem, Elie] Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Winston Salem, NC 27101 USA.
RP Bitar, KN (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.
EM kbitar@wakehealth.edu
FU NIH [RO1 DK 042876, R01DK 071614]
FX This work was supported by NIH RO1 DK 042876 and R01DK 071614.
CR Ackbar R, 2012, TECHNOL HEALTH CARE, V20, P215, DOI 10.3233/THC-2012-0672
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Basu J, 2012, MED HYPOTHESES, V78, P231, DOI 10.1016/j.mehy.2011.10.032
   Beyer-Berjot L, 2012, ANN SURG, V256, P739, DOI 10.1097/SLA.0b013e31827387f5
   Braghetto I, 2011, INT SURG, V96, P95, DOI 10.9738/CC29.1
   Camilleri M, 2012, CLIN GASTROENT-SER, P37, DOI 10.1007/978-1-60761-552-1_4
   Chen G, 2012, J BIOMED MATER RES A, V101, P44
   Chennazhi KP, 2012, TISSUE ENG PART A, V19, P849
   Chu HK, 2012, J GASTROEN HEPATOL, V27, P1017, DOI 10.1111/j.1440-1746.2011.06999.x
   Fuller MK, 2012, J SURG RES, V178, P48, DOI 10.1016/j.jss.2012.03.037
   Grikscheit TC, 2004, ANN SURG, V240, P748, DOI 10.1097/01.sla.0000143246.07277.73
   Grikscheit TC, 2003, ANN SURG, V238, P35, DOI 10.1097/01.SLA.0000074964.77367.4a
   Guerci B, 2012, DIABETES METAB, V38, P393, DOI 10.1016/j.diabet.2012.05.001
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Hong Y, 2010, BIOMATERIALS, V31, P4249, DOI 10.1016/j.biomaterials.2010.02.005
   Hori Y, 2002, J SURG RES, V102, P156, DOI 10.1006/jsre.2001.6294
   Jeong CG, 2010, J BIOMED MATER RES B, V93B, P141, DOI 10.1002/jbm.b.31568
   Kim HI, 2011, BIOMATERIALS, V32, P2241, DOI 10.1016/j.biomaterials.2010.11.067
   Kovesi T, 2004, CHEST, V126, P915, DOI 10.1378/chest.126.3.915
   Ladd MR, 2011, BIOMATERIALS, V32, P1549, DOI 10.1016/j.biomaterials.2010.10.038
   Lee KY, 2000, NATURE, V408, P998
   Levitt MA, 2010, SEMIN PEDIAT SURG, V19, P146, DOI 10.1053/j.sempedsurg.2009.11.013
   Li YY, 2012, J BIOMED MATER RES B, V100B, P265, DOI 10.1002/jbm.b.31949
   Liang JH, ASAIO J
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lu GY, 2009, J BIOMATER APPL, V23, P435, DOI 10.1177/0885328208091661
   Maemura T, 2012, ARTIF ORGANS, V36, P409, DOI 10.1111/j.1525-1594.2011.01360.x
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Pan WK, 2011, J SURG RES, V167, pE221, DOI 10.1016/j.jss.2011.01.016
   Prasad GA, 2009, GASTROENTEROLOGY, V137, P815, DOI 10.1053/j.gastro.2009.05.059
   Pu XM, 2012, INT J BIOL MACROMOL, V51, P868, DOI 10.1016/j.ijbiomac.2012.07.008
   Qin HH, 2011, J SURG RES, V171, pE21, DOI 10.1016/j.jss.2011.08.001
   Raghavan S, 2010, TISSUE ENG PART C-ME, V16, P999, DOI 10.1089/ten.TEC.2009.0394
   Raghavan S, 2011, GASTROENTEROLOGY, V141, P310, DOI 10.1053/j.gastro.2011.03.056
   Rodrigues MT, 2012, TISSUE ENG PT A, V18, P2518, DOI 10.1089/ten.tea.2011.0672
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Sachdeva P, 2011, DIGEST DIS SCI, V56, P1138, DOI 10.1007/s10620-011-1635-9
   Sala FG, 2011, TISSUE ENG PT A, V17, P1841, DOI [10.1089/ten.tea.2010.0564, 10.1089/ten.TEA.2010.0564]
   Sala FG, 2009, J SURG RES, V156, P205, DOI 10.1016/j.jss.2009.03.062
   Sampietro GM, 2009, CLIN GASTROENTEROL H, V7, P183, DOI 10.1016/j.cgh.2008.10.008
   Saxena AK, 2009, J GASTROINTEST SURG, V13, P1037, DOI 10.1007/s11605-009-0836-4
   Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X
   Speer AL, 2011, J SURG RES, V171, P6, DOI 10.1016/j.jss.2011.03.062
   Tan B, 2012, J SURG RES
   Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012
   Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   White LJ, 2012, ACTA BIOMATER, V8, P61, DOI 10.1016/j.actbio.2011.07.032
   Williams C, 2012, TISSUE ENG PT A, V18, P986, DOI [10.1089/ten.TEA.2011.0172, 10.1089/ten.tea.2011.0172]
   Yoshida A, 2012, J PEDIATR SURG, V47, P329, DOI 10.1016/j.jpedsurg.2011.11.027
   Zakhem E, 2012, BIOMATERIALS, V33, P4810, DOI 10.1016/j.biomaterials.2012.03.051
   Zhu YB, 2007, BIOMATERIALS, V28, P861, DOI 10.1016/j.biomaterials.2006.09.051
   Zhu YB, 2009, MAT SCI ENG C-BIO S, V29, P1046, DOI 10.1016/j.msec.2008.09.004
NR 56
TC 10
Z9 10
U1 0
U2 22
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
EI 1879-0429
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD OCT
PY 2013
VL 24
IS 5
BP 909
EP 915
DI 10.1016/j.copbio.2013.03.021
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 241BP
UT WOS:000326141700013
PM 23583170
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Cimetta, E
   Godier-Furnemont, A
   Vunjak-Novakovic, G
AF Cimetta, Elisa
   Godier-Furnemont, Amandine
   Vunjak-Novakovic, Gordana
TI Bioengineering heart tissue for in vitro testing
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID EMBRYONIC STEM-CELLS; CARDIAC-MUSCLE; ELECTRICAL-STIMULATION; CULTURE
   ARRAY; DIFFERENTIATION; CARDIOMYOCYTES; GROWTH; HYDROGEL; HYPERTROPHY;
   MYOCARDIUM
AB A classical paradigm of tissue engineering is to grow tissues for implantation by using human stem cells in conjunction with biomaterial scaffolds (templates for tissue formation) and bioreactors (culture systems providing environmental control). A reverse paradigm is now emerging through microphysiological platforms for preclinical tasting of drugs and modeling of disease that contain large numbers of very small human tissues. We discuss the biomimetic approach as a common underlying principle and some of the specifics related to the design and utilization of platforms with heart micro-tissues for high-throughput screening in vitro.
C1 [Cimetta, Elisa; Godier-Furnemont, Amandine; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Biomed Engn, 622 West 168th St,VC12-234, New York, NY 10032 USA.
EM gv2131@columbia.edu
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574; CIMETTA,
   Elisa/0000-0002-8632-3999
FU NIH [UH2 EB 17103]
FX We gratefully acknowledge NIH funding (grant UH2 EB 17103 to GVN)
   supporting some of the work described in this paper.
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a
   Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chung C, 2012, SOFT MATTER, V8, P10141, DOI 10.1039/c2sm26082d
   Cimetta E, 2013, LAB CHIP, V13, P355, DOI 10.1039/c2lc40836h
   Cimetta E, 2009, METHODS, V47, P81, DOI 10.1016/j.ymeth.2008.10.015
   Dahl S. L., 2011, SCI TRANSL MED, V3
   Davis RP, 2011, TRENDS MOL MED, V17, P475, DOI 10.1016/j.molmed.2011.05.001
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105
   Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0
   Eng G, 2013, P NATL ACAD SCI USA, V110, P4551, DOI 10.1073/pnas.1300569110
   Freund JB, 2012, DEVELOPMENT, V139, P1229, DOI 10.1242/dev.073593
   Gilbert PM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt44
   Hirt MN, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0307-z
   Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h
   Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104
   Hung PJ, 2005, LAB CHIP, V5, P44, DOI 10.1039/b410743h
   INGBER DE, 2003, ANN MED, V35, P1
   Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Lorenzen JM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0245-9
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166
   Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411
   Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68
   Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008
   Nunes SS, 2013, NAT METHODS, DOI [10.1038/nmeth.2524, DOI 10.1038/NMETH.2524.[EPUB]
   Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467
   Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6
   Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397
   Serena E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048483
   Serena E, 2009, EXP CELL RES, V315, P3611, DOI 10.1016/j.yexcr.2009.08.015
   Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018
   Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Tiburcy M, 2011, CIRC RES, V109, P1105, DOI 10.1161/CIRCRESAHA.111.251843
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   Unternaehrer JJ, 2011, PHILOS T R SOC B, V366, P2274, DOI 10.1098/rstb.2011.0017
   Voronov DA, 2002, DEV DYNAM, V224, P413, DOI 10.1002/dvdy.10121
   Vunjak-Novakovic G, 2011, CELL STEM CELL, V8, P252, DOI 10.1016/j.stem.2011.02.014
   Wheeler-Jones CPD, 2005, HEART, V91, P1366, DOI 10.1136/hrt.2005.072280
   Wong SSY, 2010, REGEN MED, V5, P763, DOI [10.2217/rme.10.52, 10.2217/RME.10.52]
   Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894
   Zhang D, TISSUE ENG CARDIAC P
   Zhang YS, 2013, STEM CELLS, V31, P1806, DOI 10.1002/stem.1468
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
NR 54
TC 16
Z9 16
U1 4
U2 49
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
EI 1879-0429
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD OCT
PY 2013
VL 24
IS 5
BP 926
EP 932
DI 10.1016/j.copbio.2013.07.002
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 241BP
UT WOS:000326141700015
PM 23932513
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Xing, JY
   Bai, B
   Xue, WJ
   Yang, MY
AF Xing, Jian-Yu
   Bai, Bo
   Xue, Wen-Jiao
   Yang, Ming-Yan
TI Effect of UV on Stability of Collagen with Consideration of Hydratation
   and Fibrillogenesis
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE ultraviolet irradiation; collagen; Fourier transform infrared
   spectroscopy; fibrillogenesis
ID DENATURATION; CHAINS
AB Collagen is an abundant extracellular matrix protein that is widely used in the biomaterial, food, and medical fields. Most extracted collagen is soluble in acids and assembles into fibrils under neutral pH conditions. In order to study the effect of UV irradiation on the stability of collagen with consideration of hydratation and fibrillogenesis, UV irradiation of collagen under acid and neutral pH conditions was investigated using electrophoresis, turbidity analysis, and Fourier transform infrared spectroscopy. The relationship between the collagen structure and sensitivity to UV radiation was assessed by studying the effect of UV on collagen under different pH conditions. Results showed that structural changes in collagen caused by UV depend on the degree of hydratation. Soluble collagen completely loses fibrillogeneic ability after exposure to UV for 40 min. Fibrillogenesis of collagen can relieve the UV effect to some degree.
C1 [Xing, Jian-Yu; Bai, Bo; Yang, Ming-Yan] Changan Univ, Sch Environm Sci & Engn, Xian 710054, Shaanxi, Peoples R China.
   [Xue, Wen-Jiao] Shaanxi Prov Inst Microbiol, Xian 710043, Shaanxi, Peoples R China.
   [Xing, Jian-Yu] Changan Univ, Opening Res Lab Water Resources & Land Environm A, Minist Land Resources, Xian 710054, Shaanxi, Peoples R China.
RP Xing, JY (reprint author), Changan Univ, Sch Environm Sci & Engn, Xian 710054, Shaanxi, Peoples R China.
EM xingjy@chd.edu.cn
OI xue, wenjiao/0000-0002-8867-1575
FU Special Fund for Basic Scientific Research of Central Colleges, Chang'an
   University, Shaanxi, China [CHD2011JC113, 2013G2291015]; National
   Natural Science Foundation of China [31000019]; Research and Development
   Program of Science and Technology of Shaanxi Province [2012GY2-35]; Open
   foundation of Opening Research Laboratory of Water Resources and Land
   Environment in Arid and Semiarid Regions of the Ministry of Land
   Resources of China
FX The project was supported by the Special Fund for Basic Scientific
   Research of Central Colleges, Chang'an University, Shaanxi, China
   (CHD2011JC113 and 2013G2291015), the National Natural Science Foundation
   of China (31000019), the Research and Development Program of Science and
   Technology of Shaanxi Province (2012GY2-35), and the Open foundation of
   Opening Research Laboratory of Water Resources and Land Environment in
   Arid and Semiarid Regions of the Ministry of Land Resources of China.
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3
   Deyl Z, 2000, J CHROMATOGR B, V739, P3, DOI 10.1016/S0378-4347(99)00515-0
   Kaminska A, 1996, POLYM DEGRAD STABIL, V51, P19, DOI 10.1016/0141-3910(95)00159-X
   Lachezar R, 2011, PROCESS APPL CERAM, V5, P161
   Metreveli N, 2008, J PHOTOCH PHOTOBIO B, V93, P61, DOI 10.1016/j.jphotobiol.2008.06.003
   Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006
   Noitup P., 2005, Journal of Aquatic Food Product Technology, V14, P17, DOI 10.1300/J030v14n01_03
   PARKINSON J, 1995, J MOL BIOL, V247, P823, DOI 10.1016/S0022-2836(05)80157-3
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Sionkowska A, 2005, INT J BIOL MACROMOL, V35, P145, DOI 10.1016/j.ijbiomac.2005.01.009
   Usha R, 2004, THERMOCHIM ACTA, V409, P201, DOI 10.1016/S0040-6031(03)00335-6
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
NR 13
TC 2
Z9 2
U1 0
U2 7
PU KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST
PI SEOUL
PA #605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL,
   135-703, SOUTH KOREA
SN 1226-7708
EI 2092-6456
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD OCT
PY 2013
VL 22
IS 5
BP 1217
EP 1221
DI 10.1007/s10068-013-0204-8
PG 5
WC Food Science & Technology
SC Food Science & Technology
GA 239RZ
UT WOS:000326044400005
DA 2018-10-20
ER

PT J
AU Ma, JS
   Liu, ZN
   Wang, F
   Zhou, QH
   Feng, C
   Li, F
AF Ma, Jinshu
   Liu, Zhenning
   Wang, Fang
   Zhou, Qinghai
   Feng, Chao
   Li, Fan
TI Preparation of a New Radiolabeled Biomaterial and Its Biodistribution in
   Mice
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE biomaterial; poly-propylene carbonate; PPC; biodistribution
ID CARBON-DIOXIDE; LIVER-REGENERATION; PROPYLENE-OXIDE; IN-VIVO; BLENDS;
   BIOCOMPATIBILITY; COPOLYMERIZATION; HOMOPOLYMER; DEGRADATION; SCAFFOLDS
AB Biomaterials have attracted more attention from biomedical research in recent years. Yet there are still unmet demands for current biomaterials, such as the reduction of local inflammation of the implantation site. Poly-Propylene Carbonate (PPC), a polymer with ester bonds on CO2 backbone, degrades to CO2 and water, which are natural components of human body, yielding less inflammatory response than traditional biomaterials. However, the tensile strength and heat resistance properties of PPC are less ideal. In order to improve the properties of PPC, we have developed a new PPC (M-PPC), modified by mixing with Poly-3-Hydroxybutyrate (PIM). Here, we report the biodistribution profiles of PPC and M-PPC, their biocompatibility arid toxicity. I-125-radiolabeled PPC and M-PPC were prepared and their biodistribution in Balb/c mice were investigated. Then acute systemic toxicity and haemolysis assays were conducted to study their toxicity and biocompatibility 'respectively. Results show that M-PPC has a good potential to be used as bone repair materials because it possesses typical biodistribution pattern in major organs, minimal toxicity and good biocompatibility.
C1 [Ma, Jinshu; Wang, Fang; Li, Fan] Jilin Univ, Norman Bethune Coll Med, Dept Pathogenobiol, Changchun 130021, Peoples R China.
   [Liu, Zhenning] Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun 130022, Peoples R China.
   [Zhou, Qinghai] Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
   [Feng, Chao] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130021, Peoples R China.
RP Li, F (reprint author), Jilin Univ, Norman Bethune Coll Med, Dept Pathogenobiol, Changchun 130021, Peoples R China.
EM fanli_liu@sina.com
FU National Hig-tech R&D Program of China (863 Program) [2007BAE42B06];
   Talent Development Fund of Jilin Province [JTF[2012]04]
FX This work was supported by National Hig-tech R&D Program of China (863
   Program) (Grant no. 2007BAE42B06) and Talent Development Fund of Jilin
   Province (Grant no. JTF[2012]04)
CR Bridges JF, 2000, BIOMATERIALS, V21, P199, DOI 10.1016/S0142-9612(99)00172-6
   Cenni E, 2008, BIOMATERIALS, V29, P1400, DOI 10.1016/j.biomaterials.2007.12.022
   Chen LB, 2001, POLYM ADVAN TECHNOL, V12, P687, DOI 10.1002/pat.89
   Doi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049051
   Du LC, 2004, J APPL POLYM SCI, V92, P1840, DOI 10.1002/app.20165
   Erdmann N, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-63
   Felfel RM, 2011, J MECH BEHAV BIOMED, V4, P1462, DOI 10.1016/j.jmbbm.2011.05.016
   Haba Yvonne, 2012, Open Orthop J, V6, P458, DOI 10.2174/1874325001206010458
   Han N, 2013, J BIOMATER APPL, V27, P990, DOI 10.1177/0885328211431855
   Hasan MS, 2013, J BIOMATER APPL, V28, P354, DOI 10.1177/0885328212453634
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   Huang YN, 2010, MUTAT RES-GEN TOX EN, V696, P101, DOI 10.1016/j.mrgentox.2009.12.016
   INOUE S, 1969, J POLYM SCI POL LETT, V7, P287, DOI 10.1002/pol.1969.110070408
   Jung JH, 2006, CATAL TODAY, V115, P283, DOI 10.1016/j.cattod.2006.02.060
   Kim G, 2008, MACROMOL RES, V16, P473, DOI 10.1007/BF03218547
   Kruse A, 2011, CLIN ORAL IMPLAN RES, V22, P506, DOI 10.1111/j.1600-0501.2010.02039.x
   Li YJ, 2009, ACS APPL MATER INTER, V1, P1650, DOI 10.1021/am900314k
   Lin DJ, 2011, J MECH BEHAV BIOMED, V4, P1186, DOI 10.1016/j.jmbbm.2011.04.001
   Ma J S, 2012, P 2 INT C WMME HONG, P21
   Pang H, 2002, J APPL POLYM SCI, V86, P2140, DOI 10.1002/app.11018
   Qin Y S, 2008, J POLYM SCI A, V46, P5959
   Sun CH, 2012, MACROMOL BIOSCI, V12, P761, DOI 10.1002/mabi.201200004
   Taki-Eldin A, 2012, EUR SURG RES, V48, P139, DOI 10.1159/000337865
   Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489
   Valappil SP, 2006, EXPERT REV MED DEVIC, V3, P853, DOI 10.1586/17434440.3.6.853
   Wang XY, 2005, COLLOID POLYM SCI, V284, P167, DOI 10.1007/s00396-005-1353-y
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
NR 27
TC 1
Z9 1
U1 3
U2 10
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD OCT
PY 2013
VL 10
IS 4
BP 514
EP 521
DI 10.1016/S1672-6529(13)60245-0
PG 8
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 244AE
UT WOS:000326358700013
DA 2018-10-20
ER

PT J
AU Nascimento, GCR
   de Miranda, CA
   Machado, SMM
   Brandao, GAM
   de Almeida, HA
   Silva, CM
AF Rodrigues Nascimento, Glaucia Cristina
   de Miranda, Cyndi Albuquerque
   Mendes Machado, Sissy Maria
   Martins Brandao, Gustavo Antonio
   de Almeida, Haroldo Amorim
   Silva, Cecy Martins
TI Does the time interval after bleaching influence the adhesion of
   orthodontic brackets?
SO KOREAN JOURNAL OF ORTHODONTICS
LA English
DT Article
DE Bracket; Bonding; Biomaterial science; Bleaching
ID SHEAR BOND STRENGTH; ENAMEL MICROHARDNESS; BOVINE ENAMEL; RESIN; TEETH;
   DENTIN; GELS
AB Objective: To test the null hypothesis that no difference exists between the effects of at-home bleaching and in-office bleaching on shear bond strength (SBS) with bracket bonding at 4 different time intervals after dental bleaching. Methods: Ninety extracted human premolars were randomly divided into 9 groups (n = 10) according to the bleaching methods used (at-home bleaching and in-office bleaching) and the storage time in artificial saliva (30 min, 1 day, 2 weeks, and 3 weeks before bonding). The control group was stored in artificial saliva for 7 days. Brackets were bonded with the Transbond XT adhesive system, and SBS testing was performed. The adhesive remnant index (ARI) was used to assess the amount of resin remaining on the enamel surfaces after debonding. The SBS data were analyzed by analysis of variance (ANOVA) and the Tukey test. For the ARI, the Kruskal-Wallis test was performed. Significance for all statistical tests was predetermined to be p < 0.05. Results: The SBS of the unbleached group was significantly higher (p < 0.05) than that of the bleached groups (except for the group bonded 30 min after at-home bleaching). Conclusions: The null hypothesis was not totally rejected. All bleaching groups tested had decreased SBS of the brackets to the enamel, except for the group bonded 30 min after at-home bleaching. The SBS returned to values close to those of the unbleached enamel within 3 weeks following bleaching.
C1 [Rodrigues Nascimento, Glaucia Cristina; de Miranda, Cyndi Albuquerque; Mendes Machado, Sissy Maria; Martins Brandao, Gustavo Antonio; de Almeida, Haroldo Amorim; Silva, Cecy Martins] Fed Univ Para, Sch Dent, Dept Dent, BR-6602566 Belem, Para, Brazil.
RP Silva, CM (reprint author), Fed Univ Para, Sch Dent, Rua Mundurucus 822-903, BR-6602566 Belem, Para, Brazil.
EM cecymsilva@gmail.com
OI Silva, Cecy/0000-0002-7870-8848
FU Para Foundation for Supporting Science (FAPESPA)
FX This research was financially supported by Para Foundation for
   Supporting Science (FAPESPA).
CR 1R Reynolds, 1975, BR J ORTHOD, V2, P171
   Al-Salehi SK, 2007, J DENT, V35, P845, DOI 10.1016/j.jdent.2007.08.001
   ARTUN J, 1984, AM J ORTHOD DENTOFAC, V85, P333, DOI 10.1016/0002-9416(84)90190-8
   Attin T, 2004, DENT MATER, V20, P852, DOI 10.1016/j.dental.2004.04.002
   Attin T, 2007, J DENT, V35, P755, DOI 10.1016/j.jdent.2007.06.005
   Bishara SE, 2007, ANGLE ORTHOD, V77, P711, DOI 10.2319/070606-280.1
   Bishara SE, 2005, AM J ORTHOD DENTOFAC, V128, P755, DOI 10.1016/j.ajodo.2004.07.044
   Borges AB, 2010, OPER DENT, V35, P180, DOI 10.2341/09-117-L
   Borges AB, 2009, OPER DENT, V34, P593, DOI 10.2341/08-081-L
   Borges AB, 2007, REV ODONTOL UNESP, V36, P77
   Breschi L, 2009, J ADHES SCI TECHNOL, V23, P1053, DOI 10.1163/156856109X440957
   Bulut H, 2005, EUR J ORTHODONT, V27, P466, DOI 10.1093/ejo/cji044
   Cacciafesta V, 2006, AM J ORTHOD DENTOFAC, V130, P83, DOI 10.1016/j.ajodo.2004.10.017
   Eliades T, 2000, EUR J ORTHODONT, V22, P13, DOI 10.1093/ejo/22.1.13
   Kimyai S, 2006, OPER DENT, V31, P496, DOI 10.2341/05-85
   MILES PG, 1994, AM J ORTHOD DENTOFAC, V106, P371, DOI 10.1016/S0889-5406(94)70058-3
   Mullins JM, 2009, ANGLE ORTHOD, V79, P777, DOI 10.2319/042308-226.1
   Oesterle LJ, 2008, AM J ORTHOD DENTOFAC, V133, P716, DOI 10.1016/j.ajodo.2006.04.042
   Oliveira R, 2005, BRAZ DENT J, V16, P103
   Ozoe R, 2012, QUINTESSENCE INT, V43, pE60
   Patusco VC, 2009, ANGLE ORTHOD, V79, P122, DOI 10.2319/072507-345.1
   Phan X, 2012, ANGLE ORTHOD, V82, P546, DOI 10.2319/052711-353.1
   PREVOST AP, 1982, J DENT RES, V61, P412, DOI 10.1177/00220345820610021001
   Ray Saugat, 2012, Orthodontics (Chic.), V13, pe181
   TITLEY KC, 1992, J DENT RES, V71, P20, DOI 10.1177/00220345920710010301
   TITLEY KC, 1993, J ENDODONT, V19, P112, DOI 10.1016/S0099-2399(06)80504-2
   Uysal T, 2003, AM J ORTHOD DENTOFAC, V123, P628, DOI 10.1016/S0889-5406(03)00051-3
NR 27
TC 5
Z9 6
U1 0
U2 5
PU KOREAN ASSOC ORTHODONTISTS
PI SEOUL
PA 603 TRAPALACE II, 1327 SEOCHO-DONG, SEOCHO-GU, SEOUL, 137-070, SOUTH
   KOREA
SN 2234-7518
EI 2005-372X
J9 KOREAN J ORTHOD
JI Korean J. Orthod.
PD OCT
PY 2013
VL 43
IS 5
BP 242
EP 247
DI 10.4041/kjod.2013.43.5.242
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 243LP
UT WOS:000326318200006
PM 24228239
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Yan, Q
   Li, AM
   Deng, LJ
   Liu, SD
AF Yan, Qun
   Li, Aimin
   Deng, Lijuan
   Liu, Side
TI Establishment and characterization of new bioartificial liver cell
   material
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Meeting Abstract
DE bioartificial liver; biomaterial; liver function; cell line
C1 [Yan, Qun; Li, Aimin; Deng, Lijuan; Liu, Side] Southern Med Univ, Nan Fang Hosp, Guangzhou, Guangdong, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD OCT
PY 2013
VL 28
SU 3
BP 608
EP 609
PG 2
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 226ER
UT WOS:000325017803377
DA 2018-10-20
ER

PT J
AU Sharma, R
   Singh, B
AF Sharma, Reena
   Singh, Baljinder
TI Removal of Ni (II) ions from aqueous solutions using modified rice straw
   in a fixed bed column
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Modified rice straw powder; Fixed bed column; Ni (II) ions; Adsorption
ID HEAVY-METALS; ADSORPTION; SAWDUST; BIOSORPTION; ADSORBENT; BIOMASS;
   CR(VI); LEAD
AB This paper investigates the ability of modified rice straw, an agricultural biomaterial, to remove Ni (II) ions from aqueous solution in a fixed-bed column. The experiments were performed with different bed heights (1.5 and 2.0 cm), influent Ni (II) concentrations (50, 75 and 100 mg/L) using flow rates (500 mu l/min) in order to obtain experimental breakthrough curves. The maximum adsorption capacity of rice straw powder (RSP) was 43 mg/L at 75 mg/L influent concentration of divalent Ni (II) ions at 2 cm bed depth. Adams-Bohart model, Thomas model and Yoon and Nelson kinetic models were used to analyze the column performance. The value of rate constant for Adams-Bohart and Yoon and Nelson model decreased with increase of influent concentration, but increased with increasing bed depth. The rate constant for Thomas model increased with initial influent Ni (II) ions concentration, decreased with increase in bed depth. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Sharma, Reena; Singh, Baljinder] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India.
RP Singh, B (reprint author), Panjab Univ, Dept Biotechnol, Chandigarh 160014, India.
EM anji14dec@gmail.com; gilljwms2@gmail.com
CR Adedirin O., 2011, Der Chemica Sinica, V2, P173
   Ahmad AA, 2010, J HAZARD MATER, V175, P298, DOI 10.1016/j.jhazmat.2009.10.003
   Aksu Z, 2004, PROCESS BIOCHEM, V39, P599, DOI 10.1016/S0032-9592(03)00132-8
   Banerjee K., 2012, J ENV HLTH SCI ENG, V3, P143
   Baral SS, 2009, J HAZARD MATER, V161, P1427, DOI 10.1016/j.jhazmat.2008.04.127
   Bohart GS, 1920, J AM CHEM SOC, V42, P523, DOI 10.1021/ja01448a018
   Calero M, 2009, J HAZARD MATER, V171, P886, DOI 10.1016/j.jhazmat.2009.06.082
   Chen SH, 2012, BIORESOURCE TECHNOL, V113, P114, DOI 10.1016/j.biortech.2011.11.110
   Gupta S, 2009, BIORESOURCE TECHNOL, V100, P5633, DOI 10.1016/j.biortech.2009.06.025
   Kadirvelu K, 2001, BIORESOURCE TECHNOL, V76, P63, DOI 10.1016/S0960-8524(00)00072-9
   Kadirvelu K, 2001, SEP PURIF TECHNOL, V24, P497, DOI 10.1016/S1383-5866(01)00149-6
   Keng P.S., 2013, ENV CHEM LETT
   Kogel-Knabner I, 2010, GEODERMA, V157, P1, DOI 10.1016/j.geoderma.2010.03.009
   Kumar D, 2012, BIORESOURCE TECHNOL, V104, P202, DOI 10.1016/j.biortech.2011.11.002
   Kumar U., 2006, BIORESOURCE TECHNOL, V97, P104
   Kundu S, 2005, J COLLOID INTERF SCI, V290, P52, DOI 10.1016/j.jcis.2005.04.006
   Lehmann M, 1999, CHEMOSPHERE, V39, P881, DOI 10.1016/S0045-6535(99)00031-4
   Malkoc E, 2006, J HAZARD MATER, V138, P142, DOI 10.1016/j.jhazmat.2006.05.051
   Malkoc E, 2006, J HAZARD MATER, V137, P899, DOI 10.1016/j.jhazmat.2006.03.004
   Oguz E, 2010, CHEM ENG J, V164, P56, DOI 10.1016/j.cej.2010.08.016
   Pahlavanzadeh H, 2010, J HAZARD MATER, V175, P304, DOI 10.1016/j.jhazmat.2009.10.004
   Sekhon G.S., 2013, INDIA EARTH RESOUR, V1, P1
   Shukla A, 2002, J HAZARD MATER, V95, P137, DOI 10.1016/S0304-3894(02)00089-4
   Subbaiah MV, 2011, J TAIWAN INST CHEM E, V42, P965, DOI 10.1016/j.jtice.2011.04.007
   Tarley CRT, 2004, MICROCHEM J, V77, P163, DOI 10.1016/j.microc.2004.02.019
   Thomas H. C., 1944, J AM CHEM SOC, V66, P1466
   Yadav S, 2013, ENVIRON SCI POLLUT R, V20, P558, DOI 10.1007/s11356-012-0892-2
   YOON YH, 1984, AM IND HYG ASSOC J, V45, P509, DOI 10.1080/15298668491400197
   Yu B, 2001, J HAZARD MATER, V84, P83, DOI 10.1016/S0304-3894(01)00198-4
NR 29
TC 47
Z9 47
U1 1
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
EI 1873-2976
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD OCT
PY 2013
VL 146
BP 519
EP 524
DI 10.1016/j.biortech.2013.07.146
PG 6
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 231TZ
UT WOS:000325442600068
PM 23973969
DA 2018-10-20
ER

PT J
AU Sa, MW
   Kim, JY
AF Sa, Min-Woo
   Kim, Jong Young
TI Design of multi-scaffold fabrication system for various 3D scaffolds
SO JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Conference on Manufacturing, Machine Design, and Tribology
   (ICMDT)
CY MAY, 2013
CL Busan, SOUTH KOREA
DE Solid free-form fabrication; Multi-scaffold fabrication system;
   Scaffold; Biomaterial
ID TISSUE ENGINEERING APPLICATIONS; FREE-FORM FABRICATION; DEPOSITION
   SYSTEM; BONE REGENERATION; PHOSPHATE; PCL; NANOFIBERS; COMPLEX
AB Three-dimensional (3D) porous scaffolds have been fabricated recently for tissue engineering applications through solid free-form fabrication (SFF) technologies. A multi-scaffold fabrication system for the fabrication of scaffolds, such as polymer, polymer/ceramic, ceramic, and nanofiber, was designed in this study. The various components, including a dispenser with a maximum pressure of 750 kPa, a thermostat with a maximum temperature of 250A degrees C, a high-voltage power supply with a maximum output of 60 kV, and a syringe pump with small flow control, play important roles in determining the process characteristics of scaffolds. The system can process applicable biomaterials with extremely high accuracy with a precision nozzle. Several 3D scaffolds, including PCL, PCL/PLGA/beta-TCP, beta-TCP, and PCL nanofibers, were fabricated. The morphology and pore size of fabricated scaffolds were observed through scanning electron microscopy. Results show that the scaffolds manufactured in this study can be effectively utilized as bone regeneration scaffolds.
C1 [Sa, Min-Woo; Kim, Jong Young] Andong Natl Univ, Dept Mech Engn, Andong 760749, South Korea.
RP Kim, JY (reprint author), Andong Natl Univ, Dept Mech Engn, Andong 760749, South Korea.
EM jykim@anu.ac.kr
CR Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Cruz F., 2010, BIOPOLYMERS, V28
   설영준, 2011, [Transactions of the KSME, B, 대한기계학회논문집 B], V35, P1237
   Gaikwad V. V., 2008, INT J PHARM SCI NANO, V1, P113
   Gauvin R, 2012, BIOMATERIALS, V33, P3824, DOI 10.1016/j.biomaterials.2012.01.048
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Hamadouche M, 2000, J BONE JOINT SURG BR, V82B, P1095, DOI 10.1302/0301-620X.82B8.11744
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang S, 2012, J MECH SCI TECHNOL, V26, P1999, DOI 10.1007/s12206-012-0502-8
   Kang HW, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/1/015011
   Kim HJ, 2012, TISSUE ENG REGEN MED, V9, P63, DOI 10.1007/s13770-012-0022-8
   Kim JY, 2008, TISSUE ENG REGEN MED, V5, P506
   Kim JY, 2010, TISSUE ENG PT A, V16, P2229, DOI [10.1089/ten.tea.2009.0644, 10.1089/ten.TEA.2009.0644]
   Korpela J, 2013, J BIOMED MATER RES B, V101B, P610, DOI 10.1002/jbm.b.32863
   Lee JW, 2011, BIOMATERIALS, V32, P744, DOI 10.1016/j.biomaterials.2010.09.035
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Martinez-Vazquez FJ, 2010, ACTA BIOMATER, V6, P4361, DOI 10.1016/j.actbio.2010.05.024
   Michna S, 2005, BIOMATERIALS, V26, P5632, DOI 10.1016/j.biomaterials.2005.02.040
   Mour M, 2010, MATERIALS, V3, P2947, DOI 10.3390/ma3052947
   Nwe N, 2009, MATERIALS, V2, P374, DOI 10.3390/ma2020374
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Park JY, 2008, J IND ENG CHEM, V14, P707, DOI 10.1016/j.jiec.2008.03.006
   Park JK, 2011, ADV FUNCT MATER, V21, P2906, DOI 10.1002/adfm.201100612
   Park SH, 2008, ACTA BIOMATER, V4, P1198, DOI 10.1016/j.actbio.2008.03.019
   Ryu HS, 2002, BIOMATERIALS, V23, P909, DOI 10.1016/S0142-9612(01)00201-0
   Sa MW, 2013, INT J PRECIS ENG MAN, V14, P649, DOI 10.1007/s12541-013-0087-x
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Samani F, 2009, INT J NANOTECHNOL, V6, P1031, DOI 10.1504/IJNT.2009.027565
   Seol YJ, 2013, BIOTECHNOL BIOENG, V110, P1444, DOI 10.1002/bit.24794
   Shim JH, 2013, TISSUE ENG PT A, V19, P317, DOI [10.1089/ten.TEA.2011.0730, 10.1089/ten.tea.2011.0730]
   Sohn YS, 2011, TISSUE ENG REGEN MED, V8, P66
   Su J, 2012, AFR J BIOTECHNOL, V11, P694
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Xu SL, 2012, J MECH SCI TECHNOL, V26, P2857, DOI 10.1007/s12206-012-0732-9
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0
NR 37
TC 4
Z9 4
U1 1
U2 23
PU KOREAN SOC MECHANICAL ENGINEERS
PI SEOUL
PA KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703,
   SOUTH KOREA
SN 1738-494X
EI 1976-3824
J9 J MECH SCI TECHNOL
JI J. Mech. Sci. Technol.
PD OCT
PY 2013
VL 27
IS 10
BP 2961
EP 2966
DI 10.1007/s12206-013-0810-7
PG 6
WC Engineering, Mechanical
SC Engineering
GA 236SG
UT WOS:000325818900010
DA 2018-10-20
ER

PT J
AU Ito, T
   Yoshida, C
   Murakami, Y
AF Ito, Tomoki
   Yoshida, Chikara
   Murakami, Yoshihiko
TI Design of novel sheet-shaped chitosan hydrogel for wound healing: A
   hybrid biomaterial consisting of both PEG-grafted chitosan and
   crosslinkable polymeric micelles acting as drug containers
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Polymeric micelle; Hydrogel; PEG modification; Chitosan; Wound dressing;
   Wound healing
ID INCORPORATE HYDROPHILIC COMPOUNDS; AMPHIPHILIC BLOCK-COPOLYMERS;
   TISSUE-ADHESIVE HYDROGEL; ANHYDROUS ISOOCTANE; PROTEIN DELIVERY;
   COMPLEX; DERIVATIVES; RELEASE; SURFACE; EGF
AB In this study, we successfully prepared a novel "sheet-shaped" chitosan hydrogel for wound healing consisting of both PEG-g-chitosan and a crosslinkable polymeric micelle. The study's findings clarify that the PEG modification percentage (PMP) of PEG-g-chitosan increased proportionally as the weight ratio of PEG/chitosan increased. Furthermore, the positive second virial coefficient of PEG-g-chitosans from a Debye plot strongly suggests that the PEG modification greatly improved the solubility of the water-insoluble chitosan. Finally, the "sheet-shaped" "flexible" hydrogel formed by mixing solutions containing either PEG-g-chitosan with moderate PMP or polymeric micelles exhibited the highest storage modulus. The sheet itself exhibited an attractive feature insofar as polymeric micelles, which can act as drug containers facilitating the incorporation and the gradual release of drugs, are covalently immobilized in the polymeric network of the hydrogel. The results obtained in the present study show that the hybrid PEG-g-chitosan hydrogel containing crosslinkable polymeric micelles has the potential to address the need for novel functional biomaterials. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Ito, Tomoki; Yoshida, Chikara; Murakami, Yoshihiko] Tokyo Univ Agr & Technol, Fac Engn, Dept Organ & Polymer Mat Chem, Koganei, Tokyo 1848588, Japan.
RP Murakami, Y (reprint author), Tokyo Univ Agr & Technol, Fac Engn, Dept Organ & Polymer Mat Chem, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.
EM muray@cc.tuat.ac.jp
RI Murakami, Yoshihiko/C-9485-2013
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   (MEXT); Industrial Technology Research Grant Program from the New Energy
   and Industrial Technology Development Organization (NEDO) of Japan
FX This study was funded, in part, by Grants-in-Aid for Scientific Research
   from the Ministry of Education, Culture, Sports, Science and Technology
   of Japan (MEXT) and the Industrial Technology Research Grant Program
   from the New Energy and Industrial Technology Development Organization
   (NEDO) of Japan.
CR Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   BROWN GL, 1988, ANN SURG, V208, P788, DOI 10.1097/00000658-198812000-00019
   DEBYE P, 1947, J PHYS COLLOID CHEM, V51, P18, DOI 10.1021/j150451a002
   El-Sherbiny IM, 2010, CARBOHYD RES, V345, P2004, DOI 10.1016/j.carres.2010.07.026
   Feng YW, 2011, CARBOHYD POLYM, V83, P1169, DOI 10.1016/j.carbpol.2010.09.026
   GONUL B, 1995, BURNS, V21, P7, DOI 10.1016/0305-4179(95)90773-S
   Hu YQ, 2005, CARBOHYD POLYM, V61, P472, DOI 10.1016/j.carbpol.2005.06.022
   Kanakubo Y, 2010, COLLOID SURFACE B, V78, P85, DOI 10.1016/j.colsurfb.2010.02.017
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Ma GP, 2009, CARBOHYD POLYM, V75, P390, DOI 10.1016/j.carbpol.2008.07.035
   McCarthy DW, 1996, J INVEST DERMATOL, V106, P49, DOI 10.1111/1523-1747.ep12327214
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Murakami Y, 2005, BIOMACROMOLECULES, V6, P2927, DOI 10.1021/bm0504330
   Murakami Y, 2005, MACROMOLECULES, V38, P1535, DOI 10.1021/ma047803h
   Murakami Y, 2003, J MOL CATAL B-ENZYM, V22, P79, DOI 10.1016/S1381-1177(03)00009-2
   Murakami Y, 1998, SEIBUTSU-KOGAKU KAIS, V76, P238
   Murakami Y, 1999, BIOTECHNOL TECH, V13, P545, DOI 10.1023/A:1008987431361
   Murakami Y, 2001, BIOTECHNOL LETT, V23, P125, DOI 10.1023/A:1010345318275
   Murakami Y, 1999, J BIOSCI BIOENG, V88, P441, DOI 10.1016/S1389-1723(99)80224-2
   Murakami Y, 2008, COLLOID SURFACE B, V65, P186, DOI 10.1016/j.colsurfb.2008.04.005
   Murakami Y, 2007, J BIOMED MATER RES A, V80A, P421, DOI 10.1002/jbm.a.30911
   Murakami Y, 2009, J BIOMED MATER RES B, V91B, P102, DOI 10.1002/jbm.b.31378
   Nishihara M, 2008, CHEM LETT, V37, P1214, DOI 10.1246/cl.2008.1214
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Renbutsu E, 2007, CARBOHYD POLYM, V69, P697, DOI 10.1016/j.carbpol.2007.02.018
   Shantha KL, 2002, CARBOHYD POLYM, V48, P247, DOI 10.1016/S0144-8617(01)00244-2
   Sugimoto M, 1998, CARBOHYD POLYM, V36, P49, DOI 10.1016/S0144-8617(97)00235-X
   Takami T, 2011, COLLOID SURFACE B, V87, P433, DOI 10.1016/j.colsurfb.2011.06.004
   Uchida Y, 2013, J POLYM SCI POL PHYS, V51, P124, DOI 10.1002/polb.23187
   Uchida Y, 2011, COLLOID SURFACE B, V84, P346, DOI 10.1016/j.colsurfb.2011.01.025
   Uchida Y, 2010, COLLOID SURFACE B, V79, P198, DOI 10.1016/j.colsurfb.2010.03.047
   Vekilov PG, 2002, BIOPHYS J, V83, P1147, DOI 10.1016/S0006-3495(02)75238-7
   Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d
   Vinigradov S.V., 2002, ADV DRUG DELIV REV, V54, P135
   Zhang JT, 2010, ACTA BIOMATER, V6, P3890, DOI 10.1016/j.actbio.2010.05.009
   Zhang Q, 2002, J BIOMED MATER RES, V60, P502, DOI 10.1002/jbm.1294
   Zimm B.H., 1948, CHEM PHYS, V6, P1093
NR 40
TC 26
Z9 26
U1 4
U2 109
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2013
VL 33
IS 7
BP 3697
EP 3703
DI 10.1016/j.msec.2013.04.056
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 231VE
UT WOS:000325445700016
PM 23910266
DA 2018-10-20
ER

PT J
AU Ji, CD
   Shi, J
AF Ji, Chengdong
   Shi, Jeffrey
TI Thermal-crosslinked porous chitosan scaffolds for soft tissue
   engineering applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Chitosan porous scaffolds; Steam sterilization; Thermal-crosslinking;
   Soft tissue engineering
ID ETHYLENE-OXIDE; GAMMA-IRRADIATION; HYDROGELS; SKIN; BIOMATERIALS;
   POROSITY; HEAT
AB The aim of this study was to demonstrate the feasibility of using a steam autoclave process for sterilization and simultaneously thermal-crosslinking of lyophilized chitosan scaffolds. This process is of great interest in biomaterial development due to its simplicity and low toxicity. The steam autoclave process had no significant effect on the average pore diameter (similar to 70 mu m) and overall porosity (>80%) of the resultant chitosan scaffolds, while the sterilized scaffolds possessed more homogenous pore size distribution. The sterilized chitosan scaffolds exhibited an enhanced compressive modulus (109.8 kPa) and comparable equilibrium swelling ratio (23.3). The resultant chitosan scaffolds could be used directly for in vitro cell culture without extra sterilization. The data of in vitro studies demonstrated that the scaffolds facilitated cell attachment and proliferation, indicating great potential for soft tissue engineering applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Ji, Chengdong; Shi, Jeffrey] Univ Sydney, Sch Chem & Biomol Engn, Sydney, NSW 2006, Australia.
RP Ji, CD (reprint author), Univ Sydney, Chem Engn Bldg J01, Sydney, NSW 2006, Australia.
EM chengdong.jicd@gmail.com
CR Abraham GA, 1997, J APPL POLYM SCI, V65, P1193, DOI 10.1002/(SICI)1097-4628(19970808)65:6<1193::AID-APP15>3.0.CO;2-V
   Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639
   BOUSQUET J, 1991, CLIN REV ALLERG, V9, P357
   BRUCK S D, 1971, Journal of Biomedical Materials Research, V5, P139, DOI 10.1002/jbm.820050303
   Chen KY, 2009, BIOMACROMOLECULES, V10, P1642, DOI 10.1021/bm900238b
   CHU CC, 1983, J BIOMED MATER RES, V17, P1029, DOI 10.1002/jbm.820170612
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hoffmann B, 2009, J MATER SCI-MATER M, V20, P1495, DOI 10.1007/s10856-009-3707-3
   Hooper KA, 1997, J APPL POLYM SCI, V63, P1499, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1499::AID-APP12>3.0.CO;2-Y
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   HUGO WB, 1991, J APPL BACTERIOL, V71, P9
   Ji CD, 2012, MATER LETT, V72, P110, DOI 10.1016/j.matlet.2011.12.116
   Ji CD, 2010, INT J PHARMACEUT, V391, P187, DOI 10.1016/j.ijpharm.2010.03.006
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lim LY, 1999, J BIOMED MATER RES, V48, P111
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Ma L., 2003, BIOMATER SCI POLYM E, V14, P861
   Osman Z, 2003, ELECTROCHIM ACTA, V48, P993, DOI 10.1016/S0013-4686(02)00812-5
   Pillai C.K.S., 2009, TRENDS BIOMATER ARTI, V22, P179
   Romeo T., 1996, AUST ELECT MICROSC N, V52, P16
   Shang J, 2008, POLYMER, V49, P5520, DOI 10.1016/j.polymer.2008.09.067
   Shin H, 2011, ACTA BIOMATER, V7, P106, DOI 10.1016/j.actbio.2010.07.014
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Steenland K, 2004, OCCUP ENVIRON MED, V61, P2
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Tiera MJ, 2006, BIOMACROMOLECULES, V7, P3151, DOI 10.1021/bm060381u
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 30
TC 15
Z9 15
U1 0
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2013
VL 33
IS 7
BP 3780
EP 3785
DI 10.1016/j.msec.2013.05.010
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 231VE
UT WOS:000325445700027
PM 23910277
DA 2018-10-20
ER

PT J
AU Sader, MS
   Martins, VCA
   Gomez, S
   LeGeros, RZ
   Soares, GA
AF Sader, Marcia S.
   Martins, Virginia C. A.
   Gomez, Santiago
   LeGeros, Racquel Z.
   Soares, Gloria A.
TI Production and in vitro characterization of 3D porous scaffolds made of
   magnesium carbonate apatite (MCA)/anionic collagen using a biomimetic
   approach
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Substituted apatite; Collagen; Biomimetic approach; 3D scaffold
ID BONE-FORMATION; PHYSICOCHEMICAL PROPERTIES; COMPOSITE; MATRICES;
   MINERALIZATION; NANOCRYSTALS; SUBSTITUTION; BIOMATERIAL; TEMPERATURE;
   FLUORIDE
AB 3D porous scaffolds are relevant biomaterials to bone engineering as they can be used as templates to tissue reconstruction. The aim of the present study was to produce and characterize in vitro 3D magnesium-carbonate apatite/collagen (MCA/col) scaffolds. They were prepared by using biomimetic approach, followed by cross-linking with 0.25% glutaraldehyde solution (GA) and liofilization. Results obtained with Fourier-transform infrared spectroscopy (FT-IR) confirmed the type-B carbonate substitution, while by X-ray diffraction (XRD), a crystallite size of similar to 10 nm was obtained. Optical and electron microscopy showed that the cylindrical samples exhibited an open-porous morphology, with apatite nanocrystals precipitated on collagen fibrils. The cross-linked 3D scaffolds showed integrity when immersed in culture medium up to 14 days. Also, the immersion of such samples into an acid buffer solution, to mimic the osteoclastic resorption environment, promotes the release of important ions for bone repair, such as calcium, phosphorus and magnesium. Bone cells (SaOs2) adhered, and proliferated on the 3D composite scaffolds, showing that synthesis and the cross-linking processes did not induce cytotoxicity. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Sader, Marcia S.; Soares, Gloria A.] COPPE UFRJ, Prog Engn Met & Mat, Rio De Janeiro, RJ, Brazil.
   [Martins, Virginia C. A.] IQSC USP, Depto Quim & Fis Mol, Sao Paulo, SP, Brazil.
   [Gomez, Santiago] Univ Cadiz, Dept Anat Patol, Cadiz, Spain.
   [LeGeros, Racquel Z.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10003 USA.
RP Sader, MS (reprint author), COPPE UFRJ, Prog Engn Met & Mat, Rio De Janeiro, RJ, Brazil.
EM msader@metalmat.ufrj.br
RI Martins, Virginia/H-5832-2012
OI Martins, Virginia/0000-0001-7565-9641
FU FAPERJ; CNPq; CAPES of Brazil; NIAMS/NIH [AR056208]
FX This study was supported by FAPERJ, CNPq and CAPES of Brazil (G. Soares,
   PI) and by research grant AR056208 from the NIAMS/NIH (R. LeGeros, PI).
CR AI-Munajjed AA, 2009, J MECH BEHAV BIOMED, V2, P138, DOI 10.1016/j.jmbbm.2008.05.001
   AOKI H, 1991, SCI MED APPL HYDROXY
   Batista T.M., 2009, J THERM ANAL CALORIM, V95, P45
   Bertazzo S, 2010, COLLOID SURFACE B, V78, P177, DOI 10.1016/j.colsurfb.2010.02.027
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   BOSKEY AL, 1992, J ORTHOP RES, V10, P774, DOI 10.1002/jor.1100100605
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   Dood J.R., 1967, J PALEONTOL, V46, P1313
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521
   Ehrlich H, 2010, J BIOMED MATER RES B, V92B, P542, DOI 10.1002/jbm.b.31551
   Ficai A., 2011, ADV COMPOSITE MAT ME
   FUJIMORI Y, 1998, BIOCERAMICS, V11, P335
   Gatti AM, 1998, BIOCERAMICS, V11, P399
   Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029
   Goissis G, 2003, ARTIF ORGANS, V27, P437, DOI 10.1046/j.1525-1594.2003.07252.x
   Gronowicz Gloria, 1996, P1253
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   Lacerda C, 1998, QUIM NOVA, V21, P267, DOI 10.1590/S0100-40421998000300006
   Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017
   LeGeros R Z, 1996, Adv Dent Res, V10, P225
   LeGeros R Z, 1995, Connect Tissue Res, V33, P203, DOI 10.3109/03008209509017003
   LEGEROS RZ, 1989, MAGNESIUM HLTH DIS, P11
   LeGeros RZ, 1971, ADV XRAY ANALYSIS, V14, P57
   Liao S, 2005, J BIOMED MATER RES B, V74B, P817, DOI 10.1002/jbm.b.30315
   Liu CZ, 2009, ACTA BIOMATER, V5, P661, DOI 10.1016/j.actbio.2008.09.022
   Marchi J, 2007, MATER RES BULL, V42, P1040, DOI 10.1016/j.materresbull.2006.09.015
   Miguel FB, 2006, J BIOMED MATER RES B, V78B, P334, DOI 10.1002/jbm.b.30492
   Rhee SH, 2000, J AM CERAM SOC, V83, P2890
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001
   Sader Marcia S., 2012, Key Engineering Materials, V493-494, P844, DOI 10.4028/www.scientific.net/KEM.493-494.844
   Sakae T, 2003, KEY ENG MAT, V240-2, P395, DOI 10.4028/www.scientific.net/KEM.240-242.395
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Tampieri A, 2005, ANAL BIOANAL CHEM, V381, P568, DOI 10.1007/s00216-004-2943-0
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Wah D.A., 2006, EUR CELLS MATER, V11, P43
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yao F, 2009, ACTA BIOMATER, V5, P2169, DOI 10.1016/j.actbio.2009.02.007
NR 45
TC 11
Z9 11
U1 1
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2013
VL 33
IS 7
BP 4188
EP 4196
DI 10.1016/j.msec.2013.06.006
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 231VE
UT WOS:000325445700082
PM 23910332
DA 2018-10-20
ER

PT J
AU Drevet, R
   Benhayoune, H
AF Drevet, Richard
   Benhayoune, Hicham
TI Pulsed electrodeposition for the synthesis of strontium-substituted
   calcium phosphate coatings with improved dissolution properties
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Electrodeposition; Biomaterial; Titanium alloy; Calcium phosphate
   coating; Strontium substitution; Physiological solution
ID HYDROXYAPATITE COATINGS; ELECTROPHORETIC DEPOSITION; TI6AL4V SUBSTRATE;
   LASER DEPOSITION; IN-VITRO; TITANIUM; CERAMICS; APATITE; TEMPERATURE;
   PARAMETERS
AB Strontium-substituted calcium phosphate coatings are synthesized by pulsed electrodeposition on titanium alloy (Ti6Al4V) substrates. Experimental conditions of the process are optimized in order to obtain a coating with a 5% atomic substitution of calcium by strontium which corresponds to the best observations on the osteoblast cells activity and on the osteoclast cells proliferation. The physical and chemical characterizations of the obtained coating are carried out by scanning electron microscopy associated to energy dispersive X-ray spectroscopy (EDXS) for X-ray microanalysis and the structural characterization of the coating. is carried out by X-ray diffraction. The in vitro dissolution/precipitation properties of the coated substrates are investigated by immersion into Dulbecco's Modified Eagle Medium (DMEM) from 1 h to 14 days. The calcium, phosphorus and strontium concentrations variations in the biological liquid are assessed by Induced Coupled Plasma Atomic Emission Spectroscopy for each immersion time. The results show that under specific experimental conditions, the electrodeposition process is suitable to synthesize strontium-substituted calcium phosphate coatings. Moreover, the addition of hydrogen peroxide (H2O2) into the electrolytic solution used in the process allows us to observe a control of the strontium release during the immersion of the prosthetic materials into DMEM. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Drevet, Richard; Benhayoune, Hicham] Univ Reims, LISM EA 4695, F-51685 Reims 02, France.
RP Drevet, R (reprint author), Univ Reims, LISM EA 4695, 21 Rue Clement ADER,BP 138, F-51685 Reims 02, France.
EM richard.drevet@univ-reims.fr
RI DREVET, Richard/A-8878-2016
OI DREVET, Richard/0000-0002-7425-4885
CR [Anonymous], 2008, 137793 ISO
   Antoniow JS, 2012, INT J THERMOPHYS, V33, P1960, DOI 10.1007/s10765-012-1287-9
   Benhayoune H, 2010, ADV ENG MATER, V12, pB192, DOI 10.1002/adem.200980058
   Boanini E, 2011, J MATER SCI-MATER M, V22, P2079, DOI 10.1007/s10856-011-4379-3
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bracci B, 2009, J INORG BIOCHEM, V103, P1666, DOI 10.1016/j.jinorgbio.2009.09.009
   Braem A, 2012, MAT SCI ENG C-MATER, V32, P2267, DOI 10.1016/j.msec.2012.06.013
   Cacciotti I, 2009, J EUR CERAM SOC, V29, P2969, DOI 10.1016/j.jeurceramsoc.2009.04.038
   Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   Corni I, 2008, J EUR CERAM SOC, V28, P1353, DOI 10.1016/j.jeurceramsoc.2007.12.011
   Dagang G., 2008, J BIOMED MATER RES A, V86, P947
   Drevet R, 2013, APPL SURF SCI, V268, P343, DOI 10.1016/j.apsusc.2012.12.093
   Drevet R, 2012, J SOLID STATE ELECTR, V16, P3069, DOI 10.1007/s10008-012-1742-3
   Drevet R, 2012, J NANOSCI NANOTECHNO, V12, P4956, DOI 10.1166/jnn.2012.4888
   Drevet R, 2011, J MATER SCI-MATER M, V22, P753, DOI 10.1007/s10856-011-4251-5
   Drevet R, 2012, ADV ENG MATER, V14, P377, DOI 10.1002/adem.201100331
   Dumelie N, 2007, J PHYS D APPL PHYS, V40, P2124, DOI 10.1088/0022-3727/40/7/040
   Dyshlovenko S, 2004, SURF COAT TECH, V179, P110, DOI 10.1016/S0257-8972(03)00799-0
   Eliaz N, 2007, J BIOMED MATER RES A, V80A, P621, DOI 10.1002/jbm.a.30944
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Grynpas MD, 1996, BONE, V18, P253, DOI 10.1016/8756-3282(95)00484-X
   Hanifi A, 2010, J MATER SCI-MATER M, V21, P2601, DOI 10.1007/s10856-010-4123-4
   He G, 2006, MAT SCI ENG C-BIO S, V26, P14, DOI 10.1016/j.msec.2005.03.007
   Hesse C, 2008, J MATER SCI-MATER M, V19, P3235, DOI 10.1007/s10856-008-3462-x
   Ismail RA, 2013, MAT SCI ENG C-MATER, V33, P47, DOI 10.1016/j.msec.2012.08.002
   Kim HW, 2004, J MATER SCI-MATER M, V15, P1129, DOI 10.1023/B:JMSM.0000046395.76435.60
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   LEGEROS RZ, 1977, CALC TISS RES, V22, P362
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Lin SJ, 2003, J BIOMED MATER RES A, V66A, P819, DOI 10.1002/jbm.a.10072
   Matsunaga K, 2009, J PHYS CHEM B, V113, P3584, DOI 10.1021/jp808713m
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Oliveira AL, 2007, J BIOMED MATER RES B, V83B, P258, DOI 10.1002/jbm.b.30791
   Ouadiay A, 2003, PHOSPHORUS SULFUR, V178, P2225, DOI 10.1080/10426500390234515
   Pan HB, 2009, ACTA BIOMATER, V5, P1678, DOI 10.1016/j.actbio.2008.11.032
   Pereiro I, 2012, APPL SURF SCI, V258, P9192, DOI 10.1016/j.apsusc.2012.04.063
   Shirkhanzadeh M, 2005, J MATER SCI-MATER M, V16, P37, DOI 10.1007/s10856-005-6444-2
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   Tkalcec E, 2001, J MATER SCI, V36, P5253, DOI 10.1023/A:1012462332440
   Zhitomirsky I, 2002, ADV COLLOID INTERFAC, V97, P279, DOI 10.1016/S0001-8686(01)00068-9
NR 42
TC 13
Z9 14
U1 0
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2013
VL 33
IS 7
BP 4260
EP 4265
DI 10.1016/j.msec.2013.06.019
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 231VE
UT WOS:000325445700091
PM 23910341
DA 2018-10-20
ER

PT J
AU Blum, MM
   Ovaert, TC
AF Blum, Michelle M.
   Ovaert, Timothy C.
TI Low friction hydrogel for articular cartilage repair: Evaluation of
   mechanical and tribological properties in comparison with natural
   cartilage tissue
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomimetic; Boundary lubricant; Biomaterial; Hydrogel; Mechanical
   properties; Tribology properties
ID POLYVINYL-ALCOHOL; LUBRICATION
AB The mechanical and tribological properties of a novel biomaterial, a boundary lubricant functionalized hydrogel, were investigated and compared to natural cartilage tissue. This low friction hydrogel material was developed for use as a synthetic replacement for focal defects in articular cartilage. The hydrogel was made by functionalizing the biocompatible polymer polyvinyl alcohol with a carboxylic acid derivative boundary lubricant molecule. Two different gel processing techniques were used to create the hydrogels. The first method consisted of initially functionalizing the boundary lubricant to the polyvinyl alcohol and then creating hydrogels by physically crosslinking the reacted polymer. The second method consisted of creating non-functionalized polyvinyl alcohol hydrogels and then performing the functionalization reaction on the fully formed gel. Osteochondral bovine samples were collected and replicate experiments were conducted to compare the mechanical and tribological performance of the boundary lubricant functionalized hydrogels to non-functionalized hydrogels and native cartilage. Friction experiments displayed a maximum decrease in friction coefficient of 70% for the functionalized hydrogels compared to neat polyvinyl alcohol. Indentation investigated the elastic modulus of the hydrogels, demonstrating that stability of the hydrogel was affected by processing method. Hydrogel performance was within the lower ranges of natural cartilage tested under the exact same conditions, showing the potential of the boundary lubricant functionalized hydrogels to perform as a biomimetic synthetic articular cartilage replacement. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Blum, Michelle M.; Ovaert, Timothy C.] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA.
   [Blum, Michelle M.] Syracuse Univ, Mech & Aerosp Dept, Syracuse, NY 13244 USA.
RP Blum, MM (reprint author), Syracuse Univ, Mech & Aerosp Dept, 239 Link Hall, Syracuse, NY 13244 USA.
EM mmblum@syr.edu
OI Blum, Michelle/0000-0002-3188-772X
FU US Army Medical Research and Materiel Command [W81XWH-09-1-0741]
FX This research was supported by the US Army Medical Research and Materiel
   Command; contract W81XWH-09-1-0741.
CR Adhyaryu A., 2006, IND ENG CHEM RES, V45, P3735
   Bhushan B., 1999, PRINCIPLES APPL TRIB
   Blum M.M., 2012, WEAR, DOI DOI 10.1016/J.WEAR.2012.1011.1042
   Blum MM, 2012, J BIOMED MATER RES B, V100B, P1755, DOI 10.1002/jbm.b.32742
   Dowson D, 1991, Proc Inst Mech Eng H, V205, P1, DOI 10.1243/PIME_PROC_1991_205_255_02
   Foster H., 1996, P I MECH ENG G-J AER, V210, P109
   FOSTER H, 1999, P I MECH ENG H, V213, P329
   GHADIALLY FN, 1982, J ANAT, V135, P685
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Dowson D, 1992, Proc Inst Mech Eng H, V206, P185, DOI 10.1243/PIME_PROC_1992_206_279_02
   Johnson K. L., 1985, CONTACT MECH
   Katta K., 2007, J BIOMED MATER RES A, V83, P471
   Leone G, 2011, J BIOMED MATER RES B, V97B, P278, DOI 10.1002/jbm.b.31813
   Li F, 2010, J MATER SCI-MATER M, V21, P147, DOI 10.1007/s10856-009-3863-5
   Ma R., 2009, J BIOMED MATER RES A, V123, P1016
   Mansour J M, 2003, BIOMECHANICS CARTILA, P66
   McGann M.E., 2009, T ASME SUMM BIOENG C
   Nakashima K, 2005, JSME INT J C-MECH SY, V48, P555, DOI 10.1299/jsmec.48.555
   Nakashima K., 2007, TRIBOL INT, V40, P1223
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Orienti I, 2001, J MICROENCAPSUL, V18, P77
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   Pan YS, 2008, J TRIBOL-T ASME, V130, DOI 10.1115/1.2908895
   PEPPAS NA, 1980, BIOMATERIALS, V1, P158, DOI 10.1016/0142-9612(80)90039-3
   PEPPAS NA, 1977, POLYM PREP AM CHEM S, V18, P794
   Reush W., 2008, CARBOXYLIC ACID DERI
   SAKAR AD, 1980, FRICTION WEAR
   Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446
   Sneddon I. N., 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Thomas J, 2003, J BIOMED MATER RES A, V67A, P1329, DOI 10.1002/jbm.a.10119
   Thongphud A, 2008, ADV MATER RES-SWITZ, V55-57, P625, DOI 10.4028/www.scientific.net/AMR.55-57.625
   Yarimitsu S., 2001, TRIBOL ONLINE, V2, P114
NR 33
TC 12
Z9 12
U1 2
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2013
VL 33
IS 7
BP 4377
EP 4383
DI 10.1016/j.msec.2013.06.035
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 231VE
UT WOS:000325445700106
PM 23910356
DA 2018-10-20
ER

PT J
AU Main, ERG
   Phillips, JJ
   Millership, C
AF Main, Ewan R. G.
   Phillips, Jonathan J.
   Millership, Charlotte
TI Repeat protein engineering: creating functional
   nanostructures/biomaterials from modular building blocks
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article
DE beta-roll motif; engineering biomaterial; protein design; repeat
   protein; tetratricopeptide repeat
ID FOLDING ENERGY LANDSCAPE; LEUCINE-RICH REPEAT; ANKYRIN-REPEAT; DESIGN;
   CONSENSUS; BINDING; STABILITY; PATHWAY; DOMAIN; MOTIF
AB There is enormous interest in molecular self-assembly and the development of biological systems to form smart nanostructures for biotechnology (so-called 'bottom-up fabrications'). Repeat proteins are ideal choices for development of such systems as they: (i) possess a relatively simple relationship between sequence, structure and function; (ii) are modular and non-globular in structure; (iii) act as diverse scaffolds for the mediation of a diverse range of protein-protein interactions; and (iv) have been extensively studied and successfully engineered and designed. In the present review, we summarize recent advances in the use of engineered repeat proteins in the self-assembly of novel materials, nanostructures and biosensors. In particular, we show that repeat proteins are excellent monomeric programmable building blocks that can be triggered to associate into a range of morphologies and can readily be engineered as stimuli-responsive biofunctional materials.
C1 [Main, Ewan R. G.; Phillips, Jonathan J.; Millership, Charlotte] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.
RP Main, ERG (reprint author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.
EM e.main@qmul.ac.uk
RI Phillips, Jonathan/I-7817-2015
OI Phillips, Jonathan/0000-0002-5361-9582
FU Biotechnology and Biological Sciences Research Council studentship;
   Biotechnology and Biological Sciences Research Council [BB/E005187/1]
FX C.M. is supported by a Biotechnology and Biological Sciences Research
   Council studentship.
CR Aksel T, 2009, METHOD ENZYMOL, V455, P95, DOI 10.1016/S0076-6879(08)04204-3
   Aksel T, 2011, STRUCTURE, V19, P349, DOI 10.1016/j.str.2010.12.018
   Bang D, 2005, P NATL ACAD SCI USA, V102, P5014, DOI 10.1073/pnas.0407648102
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218
   Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107
   Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200
   Cortajarena AL, 2008, J MOL BIOL, V379, P617, DOI 10.1016/j.jmb.2008.02.046
   Cortajarena AL, 2008, ACS CHEM BIOL, V3, P161, DOI 10.1021/cb700260z
   Cortajarena AL, 2011, PROTEIN SCI, V20, P336, DOI 10.1002/pro.564
   Cortajarena AL, 2010, ACS CHEM BIOL, V5, P545, DOI 10.1021/cb9002464
   Courtemanche N, 2008, STRUCTURE, V16, P705, DOI 10.1016/j.str.2008.02.015
   Crookes WJ, 2004, SCIENCE, V303, P235, DOI 10.1126/science.1091288
   Dooley K, 2012, BIOMACROMOLECULES, V13, P1758, DOI 10.1021/bm3002446
   Eisenberg M, 2013, BIOORGAN MED CHEM, V21, P3450, DOI 10.1016/j.bmc.2013.03.007
   Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7
   Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008
   Grove TZ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0051
   Grove TZ, 2010, J AM CHEM SOC, V132, P14024, DOI 10.1021/ja106619w
   Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9
   Itzhaki LS, 2012, ADV EXP MED BIOL, V747, P153, DOI 10.1007/978-1-4614-3229-6_10
   Javadi Y, 2009, P NATL ACAD SCI USA, V106, P17383, DOI 10.1073/pnas.0907455106
   Kajander T, 2005, J AM CHEM SOC, V127, P10188, DOI 10.1021/ja0524494
   Kloss E, 2008, ARCH BIOCHEM BIOPHYS, V469, P83, DOI 10.1016/j.abb.2007.08.034
   Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4
   Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100
   Krachler AM, 2010, PROTEINS, V78, P2131, DOI 10.1002/prot.22726
   Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437
   Lee SC, 2012, P NATL ACAD SCI USA, V109, P3299, DOI 10.1073/pnas.1113193109
   Lowe AR, 2007, P NATL ACAD SCI USA, V104, P2679, DOI 10.1073/pnas.0604653104
   Main ERG, 2005, CURR OPIN STRUC BIOL, V15, P464, DOI 10.1016/j.sbi.2005.07.003
   Main ERG, 2005, P NATL ACAD SCI USA, V102, P5721, DOI 10.1073/pnas.0404530102
   Main ERG, 2003, CURR OPIN STRUC BIOL, V13, P482, DOI 10.1016/S0959-440X(03)00105-2
   Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5
   Mello CC, 2004, P NATL ACAD SCI USA, V101, P14102, DOI 10.1073/pnas.0403386101
   Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899
   Phillips JJ, 2012, PROTEIN SCI, V21, P327, DOI 10.1002/pro.2018
   Phillips JJ, 2012, ANGEW CHEM INT EDIT, V51, P13132, DOI 10.1002/anie.201203795
   Sawyer N, 2013, BIOCHEM SOC T, V41, P1131, DOI 10.1042/BST20130112
   Scotter AJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-63
   Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7
   Simon M, 2012, BIOCONJUGATE CHEM, V23, P279, DOI 10.1021/bc200591x
   Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085
   Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7
   Tripp KW, 2008, J AM CHEM SOC, V130, P5681, DOI 10.1021/ja0763201
   Tripp KW, 2004, J MOL BIOL, V344, P169, DOI 10.1016/j.jmb.2004.09.038
   Urvoas A, 2010, J MOL BIOL, V404, P307, DOI 10.1016/j.jmb.2010.09.048
   Varadamsetty G, 2012, J MOL BIOL, V424, P68, DOI 10.1016/j.jmb.2012.08.029
   Werbeck ND, 2007, P NATL ACAD SCI USA, V104, P7863, DOI 10.1073/pnas.0610315104
   Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775
NR 50
TC 9
Z9 9
U1 1
U2 33
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0300-5127
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD OCT
PY 2013
VL 41
BP 1152
EP 1158
DI 10.1042/BST20130102
PN 5
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 224SR
UT WOS:000324910200006
PM 24059501
OA Bronze
DA 2018-10-20
ER

PT J
AU Elwood, CN
   Lo, J
   Chou, E
   Crowe, A
   Arsovska, O
   Adomat, H
   Miyaoka, R
   Tomlinson-Guns, E
   Monga, M
   Chew, BH
   Lange, D
AF Elwood, Chelsea N.
   Lo, Joey
   Chou, Emily
   Crowe, Adam
   Arsovska, Olga
   Adomat, Hans
   Miyaoka, Ricardo
   Tomlinson-Guns, Emma
   Monga, Manoj
   Chew, Ben H.
   Lange, Dirk
TI Understanding urinary conditioning film components on ureteral stents:
   profiling protein components and evaluating their role in bacterial
   colonization
SO BIOFOULING
LA English
DT Article
DE ureteral stents; bacterial adhesion; urinary conditioning film; protein
   adsorption; E. coli C1214; S. aureus Newman
ID ALPHA-1-MICROGLOBULIN; ENCRUSTATION; PATTERNS; SURFACES; GROWTH
AB Ureteral stents are fraught with problems. A conditioning film attaches to the stent surface within hours of implantation; however, differences between stent types and their role in promoting encrustation and bacterial adhesion and colonization remain to be elucidated. The present work shows that the most common components do not differ between stent types or patients with the same indwelling stent, and contain components that may drive stent encrustation. Furthermore, unlike what was previously thought, the presence of a conditioning film does not increase bacterial adhesion and colonization of stents by uropathogens. Genitourinary cytokeratins are implicated in playing a significant role in conditioning film formation. Overall, stent biomaterial design to date has been unsuccessful in discovering an ideal coating to prevent encrustation and bacterial adhesion. This current study elucidates a more global understanding of urinary conditioning film components. It also supports specific focus on the importance of physical characteristics of the stent and how they can prevent encrustation and bacterial adhesion.
C1 [Elwood, Chelsea N.; Lo, Joey; Chou, Emily; Crowe, Adam; Arsovska, Olga; Chew, Ben H.; Lange, Dirk] Univ British Columbia, Vancouver Gen Hosp, Stone Ctr, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada.
   [Elwood, Chelsea N.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada.
   [Adomat, Hans; Tomlinson-Guns, Emma] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada.
   [Miyaoka, Ricardo] Univ Estadual Campinas, State Hosp Sumare, Div Urol, Sao Paulo, Brazil.
   [Monga, Manoj] Cleveland Clin, Streem Ctr Endourol & Stone Dis, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA.
RP Lange, D (reprint author), Univ British Columbia, Vancouver Gen Hosp, Stone Ctr, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada.
EM dirk.lange@ubc.ca
CR ACHTSTATTER T, 1985, J HISTOCHEM CYTOCHEM, V33, P415, DOI 10.1177/33.5.2580881
   Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x
   Canales BK, 2009, J ENDOUROL, V23, P1437, DOI 10.1089/end.2009.0389
   Chew BH, 2006, J ENDOUROL, V20, P949, DOI 10.1089/end.2006.20.949
   GARNETT J, 1990, BIOCHEM J, V266, P863
   Lange D, 2009, J UROLOGY, V182, P1194, DOI 10.1016/j.juro.2009.05.008
   Pechey A, 2009, J UROLOGY, V182, P1628, DOI 10.1016/j.juro.2009.06.008
   QUINLAN RA, 1985, ANN NY ACAD SCI, V455, P282, DOI 10.1111/j.1749-6632.1985.tb50418.x
   Santin M, 1999, BIOMATERIALS, V20, P1245, DOI 10.1016/S0142-9612(99)00026-5
   Santin M, 1997, BIOMATERIALS, V18, P823, DOI 10.1016/S0142-9612(97)00004-5
   Wassall MA, 1998, J BIOMED MATER RES, V40, P365, DOI 10.1002/(SICI)1097-4636(19980605)40:3<365::AID-JBM4>3.0.CO;2-D
   Wassall MA, 1997, J BIOMED MATER RES, V36, P325, DOI 10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.3.CO;2-L
NR 12
TC 7
Z9 7
U1 1
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
J9 BIOFOULING
JI Biofouling
PD OCT 1
PY 2013
VL 29
IS 9
BP 1115
EP 1122
DI 10.1080/08927014.2013.829049
PG 8
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA 224LO
UT WOS:000324887500007
PM 24047458
DA 2018-10-20
ER

PT J
AU Zhu, C
   He, NA
   Cheng, T
   Tan, HL
   Guo, YY
   Chen, DS
   Cheng, MQ
   Yang, Z
   Zhang, XL
AF Zhu, Chen
   He, Nianan
   Cheng, Tao
   Tan, Honglue
   Guo, Yongyuan
   Chen, Desheng
   Cheng, Mengqi
   Yang, Zhi
   Zhang, Xianlong
TI Ultrasound-Targeted Microbubble Destruction Enhances Human beta-Defensin
   3 Activity Against Antibiotic-Resistant Staphylococcus Biofilms
SO INFLAMMATION
LA English
DT Article
DE ultrasound; microbubbles; Staphylococcus; biofilm; beta-defensin
ID LOW-INTENSITY ULTRASOUND; HUMAN BETA-DEFENSIN-3; IN-VITRO;
   PSEUDOMONAS-AERUGINOSA; BACTERICIDAL ACTIVITY; IMPLANT INFECTIONS;
   EPIDERMIDIS; AUREUS; SONOPORATION; MECHANISMS
AB The infection of orthopedic implantation devices with Staphylococcus is a serious concern within the biomaterial community. Treatments are not always successful because of antibiotic-resistant bacteria and serious biofilm infections. Human beta-defensin 3 (hBD-3) is considered to be the most promising class of defensin antimicrobial peptides and its effect on antibiotic-resistant Staphylococcus biofilms, combined with ultrasound (US)-targeted microbubble (MB) destruction (UTMD), has not been reported. In the study, we found that biofilm densities, the percentage of live cells and the viable counts of two tested Staphylococcus recovered from the biofilm were significantly decreased in the maximum concentration hBD-3 combined with UTMD compared with those of any other groups. Furthermore, results suggested that UTMD could also enhance 1MIC hBD-3 activity inhibiting the biofilm-associated genes expression of icaAD and the methicillin-resistance genes expression of MecA by simultaneously promoting the icaR expression. UTMD may have great potential for improving antibiotic activity against biofilm infections.
C1 [Zhu, Chen; Cheng, Tao; Guo, Yongyuan; Chen, Desheng; Cheng, Mengqi; Yang, Zhi; Zhang, Xianlong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthopaed Surg, Sch Med, Shanghai 200233, Peoples R China.
   [He, Nianan] Anhui Med Univ, Dept Ultrasound, Anhui Prov Hosp, Hefei 230001, Peoples R China.
   [Tan, Honglue] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Orthopaed Surg, Sch Med, Shanghai 200011, Peoples R China.
RP Zhang, XL (reprint author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthopaed Surg, Sch Med, 600 Yishan Rd, Shanghai 200233, Peoples R China.
EM zxl40@vip.sina.com
FU Interdisciplinary (Engineering-Medical) Research Fund of Shanghai Jiao
   Tong University [YG2011MS30]; Shanghai Municipal Health Bureau Science
   Fund for Young Scholars [2010QJ036A]; Opening Project of State Key
   Laboratory of High Performance Ceramics and Superfine Microstructure
   [SKL201206SIC]; National Natural Science Foundation of China [81171688]
FX This work was supported by the Interdisciplinary (Engineering-Medical)
   Research Fund of Shanghai Jiao Tong University (Grant No. YG2011MS30),
   Shanghai Municipal Health Bureau Science Fund for Young Scholars (Grant
   No. 2010QJ036A), the Opening Project of State Key Laboratory of High
   Performance Ceramics and Superfine Microstructure (Grant No.
   SKL201206SIC), and the National Natural Science Foundation of China
   (Grant No. 81171688).
CR Arciola CR, 2006, J BIOMED MATER RES A, V76A, P425, DOI 10.1002/jbm.a.30552
   Bjerkan G, 2009, ACTA ORTHOP, V80, P245, DOI 10.3109/17453670902947457
   Blum-Menezes D, 2009, BRAZ J MED BIOL RES, V42, P294, DOI 10.1590/S0100-879X2009000300011
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Carmen John C., 2004, Journal of Infection and Chemotherapy, V10, P193
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dijkmans P A, 2004, Eur J Echocardiogr, V5, P245, DOI 10.1016/j.euje.2004.02.001
   Gibson AL, 2012, WOUND REPAIR REGEN, V20, P414, DOI 10.1111/j.1524-475X.2012.00786.x
   Han YW, 2007, APPL ENVIRON MICROB, V73, P3677, DOI 10.1128/AEM.00428-07
   Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7
   Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200
   He NA, 2011, ANTIMICROB AGENTS CH, V55, P5331, DOI 10.1128/AAC.00542-11
   Hengge UR, 2006, GENE THER, V13, P1555, DOI 10.1038/sj.gt.3302855
   Hirsch T, 2009, J GENE MED, V11, P220, DOI 10.1002/jgm.1287
   Huang Q, 2012, ORTHOPEDICS, V35, pE53, DOI 10.3928/01477447-20111122-11
   Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176
   Juffermans LJM, 2006, AM J PHYSIOL-HEART C, V291, pH1595, DOI 10.1152/ajpheart.01120.2005
   Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000
   Kim HJ, 1996, HUM GENE THER, V7, P1339, DOI 10.1089/hum.1996.7.11-1339
   Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x
   Li P, 2012, J CONTROL RELEASE, V162, P349, DOI 10.1016/j.jconrel.2012.07.009
   Maisetta G, 2006, ANTIMICROB AGENTS CH, V50, P806, DOI 10.1128/AAC.50.2.806.809.2006
   Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013
   Maisetta G, 2011, PEPTIDES, V32, P1073, DOI 10.1016/j.peptides.2011.02.003
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Nejad SM, 2011, BIOCHEM BIOPH RES CO, V413, P218, DOI 10.1016/j.bbrc.2011.08.072
   Nihonyanagi S, 2012, INFLAMMATION, V35, P927, DOI 10.1007/s10753-011-9395-4
   Nishikawa T, 2010, GERODONTOLOGY, V27, P199, DOI 10.1111/j.1741-2358.2009.00325.x
   Patel ZM, 2012, INT FORUM ALLERGY RH, V2, P303, DOI 10.1002/alr.21039
   Peng ZX, 2011, ANTIMICROB AGENTS CH, V55, P860, DOI 10.1128/AAC.01005-10
   Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0
   Quaia E, 2004, RADIOLOGY, V232, P420, DOI 10.1148/radiol.2322031401
   Rohde H., 2011, EUROPEAN J CELL BIOL, V89, P103
   Runyan CM, 2006, J GEN APPL MICROBIOL, V52, P295, DOI 10.2323/jgam.52.295
   Santamato A, 2009, PHYS THER, V89, P643, DOI 10.2522/ptj.20080139
   Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   van der Plas MJA, 2008, J ANTIMICROB CHEMOTH, V61, P117, DOI 10.1093/jac/dkm407
   Warnke PH, 2006, BONE, V38, P400, DOI 10.1016/j.bone.2005.09.003
   Xu J, 2012, ULTRASONICS, V52, P668, DOI 10.1016/j.ultras.2012.01.013
   Yu H, 2012, ULTRASON SONOCHEM, V19, P377, DOI 10.1016/j.ultsonch.2011.11.010
   Yu QT, 2000, J BIOL CHEM, V275, P3943, DOI 10.1074/jbc.275.6.3943
   Zhu C, 2013, J SURG RES, V183, P204, DOI 10.1016/j.jss.2012.11.048
NR 43
TC 16
Z9 16
U1 1
U2 25
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0360-3997
J9 INFLAMMATION
JI Inflammation
PD OCT
PY 2013
VL 36
IS 5
BP 983
EP 996
DI 10.1007/s10753-013-9630-2
PG 14
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA 223CF
UT WOS:000324780600001
PM 23519963
DA 2018-10-20
ER

PT J
AU Bergmann, M
   Zeniieh, D
   Ledernez, L
   Dame, G
   Urban, G
AF Bergmann, Michael
   Zeniieh, Dani
   Ledernez, Loic
   Dame, Gregory
   Urban, Gerald
TI Swelling and Water Uptake Behavior of Nanofilms Obtained by a Magnetron
   Enhanced Plasma-Polymerization Process
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE biocompatibility; dynamic contact angle (DCA); modeling; nanolayers;
   waveguide mode spectroscopy (WAMS)
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; CONTACT-ANGLE HYSTERESIS;
   WAVE-GUIDE SPECTROSCOPY; SURFACE MODIFICATION; PROTEIN ADSORPTION;
   AQUEOUS-SOLUTION; FILMS; LENSES; ELECTRODE; CONSTANT
AB This work deals with the water uptake and swelling behavior of magnetron-enhanced plasma-polymerized nanofilms in an aqueous medium. Those coatings are used in biomedical applications such as implants or contact lenses. The role of water in biomaterial surface science is considered to be of great importance. Water is not only the major molecule in most living organisms (70%) and the carrier of cells but it is also the medium in which biochemical processes take place. Because of its small size and mobility, water is the first molecule to come in contact with a biomaterial in any clinical application. It is believed, that the degree of polymer swelling strongly affects the interaction of proteins with the surface of the polymer, which determines its biocompatibility. Polymers with a high swelling degree show weak enthalpic interactions with proteins, resulting in a protein-repellency. A new approach is applied, which combines three characterization techniques: dynamic contact angle measurements, optical waveguide spectroscopy, and electrochemical impedance spectroscopy. A relation between the composition of the films and the water and salt transport phenomena through the nanofilm was observed. A higher amount of oxygen in the precursor gas ratio in the polymerization process leads to a higher wettability as well as a higher water and salt intrusion. Based on this observation an electrical model was introduced and helped to interpret the experimental results.
C1 [Bergmann, Michael; Zeniieh, Dani; Ledernez, Loic; Dame, Gregory; Urban, Gerald] Univ Freiburg, Dept Microsyst Engn, D-79110 Freiburg, Germany.
RP Bergmann, M (reprint author), Univ Freiburg, Dept Microsyst Engn, Georges Kohler Allee 103, D-79110 Freiburg, Germany.
EM michael.bergmann@imtek.de
RI URBAN, Gerald/H-7893-2014
OI Zeniieh, Dani/0000-0003-0919-422X
CR Aulasevich A, 2009, MACROMOL RAPID COMM, V30, P872, DOI 10.1002/marc.200800747
   Barsoukov E., 2000, J NEW MAT ELECTR SYS, V3, P303
   Bisquert J, 1998, J ELECTROANAL CHEM, V452, P229, DOI 10.1016/S0022-0728(98)00115-6
   Caia K., 2006, COLLOID SURFACE B, V50, P1
   Castela ASL, 2000, PROG ORG COAT, V38, P1, DOI 10.1016/S0300-9440(99)00076-4
   CHATELIER RC, 1995, LANGMUIR, V11, P2576, DOI 10.1021/la00007a042
   CHATELIER RC, 1995, LANGMUIR, V11, P2585, DOI 10.1021/la00007a043
   Chen W, 1997, MACROMOLECULES, V30, P78, DOI 10.1021/ma961096d
   Chen WC, 2002, ELECTROCHIM ACTA, V47, P1305, DOI 10.1016/S0013-4686(01)00849-0
   Choukourov A., 2010, PLASMA PROCESS POLYM, P445
   Chu LQ, 2006, LANGMUIR, V22, P2822, DOI 10.1021/la0530283
   Czelslik C., 2006, CHEM IN UNSERER Z, V40, P238
   Dygas JR, 2003, SOLID STATE IONICS, V157, P249, DOI 10.1016/S0167-2738(02)00217-5
   Fadeev AY, 1999, LANGMUIR, V15, P3759, DOI 10.1021/la981486o
   GOLANDER CG, 1993, J APPL POLYM SCI, V49, P39, DOI 10.1002/app.1993.070490106
   Grundmeier G., 2000, ELECTROCHIM ACTA, V45, P2512
   HO CP, 1988, J BIOMED MATER RES, V22, P919, DOI 10.1002/jbm.820221007
   Jorcin JB, 2006, ELECTROCHIM ACTA, V51, P1473, DOI 10.1016/j.electacta.2005.02.128
   Kim CH, 2003, ELECTROCHIM ACTA, V48, P3455, DOI 10.1016/S0013-4686(03)00464-X
   Lam CNC, 2002, ADV COLLOID INTERFAC, V96, P169, DOI 10.1016/S0001-8686(01)00080-X
   Ledernez L., 2007, PLASMA CHEM PLASMA P, P659
   Ledernez L., 2008, J APPL PHYS
   Ledernez L., 2007, PLASMA PROCESS POLYM, P769
   Liu C, 2003, CORROS SCI, V45, P1257, DOI 10.1016/S0010-938X(02)00214-7
   Loveday D., 2004, JCT COATINGSTECH, P46
   Morra M, 2001, WATER BIOMATERIALS S
   Oldham KB, 2004, ELECTROCHEM COMMUN, V6, P210, DOI 10.1016/j.elecom.2003.12.002
   Orazem ME, 2008, ELECTROCHEMICAL IMPE
   Palumbo F., 2001, Plasmas and Polymers, V6, P163, DOI 10.1023/A:1013144612953
   Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029
   Pavlacky D.A., 2011, INT J MAT SCI, V1, P23
   Philippe LVS, 2003, J ELECTROCHEM SOC, V150, pB111, DOI 10.1149/1.1554913
   Ratner B. D., 2004, BIOMATERIALS SCI INT, V2, P867
   Ratner BD, 1993, J BIOMAT SCI-POLYM E, V4, P3
   Schiller CA, 2001, ELECTROCHIM ACTA, V46, P3619, DOI 10.1016/S0013-4686(01)00644-2
   Sedev RV, 1996, J COLLOID INTERF SCI, V180, P36, DOI 10.1006/jcis.1996.0271
   Srinivasan S., 2006, FUEL CELLS FUNDAMENT
   Weikart CM, 2001, J BIOMED MATER RES, V54, P597, DOI 10.1002/1097-4636(20010315)54:4<597::AID-JBM170>3.3.CO;2-J
   Weikart CM, 1999, J COLLOID INTERF SCI, V211, P28, DOI 10.1006/jcis.1998.5964
   Worz A, 2012, J MATER CHEM, V22, P19547, DOI 10.1039/c2jm30820g
   Xiao P, 2007, ELECTROCHEM COMMUN, V9, P2441, DOI 10.1016/j.elecom.2007.07.020
   Yasuda H, 2006, MACROMOL BIOSCI, V6, P121, DOI 10.1002/mabi.200500153
   YASUDA H, 1975, J BIOMED MATER RES, V9, P629, DOI 10.1002/jbm.820090609
   Yasuda H., 2005, LUMINOUS CHEM VAPOR
   Yasuda HK, 2001, CORROSION, V57, P29, DOI 10.5006/1.3290326
   Young K., 2004, EQUIVALENT CIRCUIT M
   Youngblood JP, 1999, MACROMOLECULES, V32, P6800, DOI 10.1021/ma9903456
   Zhang Z, 2003, SURF COAT TECH, V174, P588, DOI 10.1016/S0257-8972(03)00806-5
   Zhang ZH, 2011, PLASMA PROCESS POLYM, V8, P923, DOI 10.1002/ppap.201000156
NR 49
TC 1
Z9 1
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD OCT
PY 2013
VL 10
IS 10
BP 904
EP 911
DI 10.1002/ppap.201300009
PG 8
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 232ND
UT WOS:000325499700010
DA 2018-10-20
ER

PT J
AU Morris, OJ
   Smith, S
   Draganic, B
AF Morris, O. J.
   Smith, S.
   Draganic, B.
TI Comparison of bulking agents in the treatment of fecal incontinence: a
   prospective randomized clinical trial
SO TECHNIQUES IN COLOPROCTOLOGY
LA English
DT Article
DE Silicone; PTQ (R); Durasphere (R); Anal sphincter; Fecal incontinence;
   Quality of life
ID INJECTABLE SILICONE BIOMATERIAL; MANAGEMENT; INJECTION; EFFICACY;
   IMPLANTS
AB Background We sought to compare two synthetic injectable bulking agents, with known efficacy (PTQ (TM): a silicone biomaterial and Durasphere(A (R)): pyrolytic carbon-coated beads), in the form of a randomised clinical trial.
   Circumferential injection of either agent was performed under local anesthesia and sedation as a day-case procedure. The primary outcome measure was the Wexner incontinence scale. Secondary measures were the short-form 36 (SF-36) quality of life assessment and manometry (maximum resting and squeeze pressures). Follow-up was at 6 weeks, 6 and 12 months.
   Thirty-five patients were randomised, 17 to PTQ(A (R)) and 18 to Durasphere(A (R)). Early closure of the trial occurred, due to the removal of the agent PTQ(A (R)), from the Australian Pharmaceutical Benefits scheme. Wexner incontinence scores were significantly better than baseline, in both groups, at 6 weeks and 6 months (P < 0.05), although the improvements were not significant at 12 months. There was no significant improvement for either agent, from baseline, in mean SF-36 scores at any follow-up sessions. There was no significant difference between the two bulking agents, with regard to both Wexner and SF-36 scores, at any of the follow-up sessions. Complications occurred in one patient in the PTQ group (perianal abscess) and did not occur in any of the patients in the Durasphere group.
   This trial appears to show that both synthetic agents PTQ(A (R)) and Durasphere(A (R)) are effective and safe, although long-term improvement is limited. In this trial, there appears to be no difference in efficacy between the two agents, over a 12-month follow-up period.
C1 [Morris, O. J.; Smith, S.; Draganic, B.] Newcastle Hosp Private Suites, Hunter Colorectal Res, New Lambton Hts, NSW 2305, Australia.
   [Morris, O. J.] Hunter New England Area Hlth, New Lambton Hts, NSW, Australia.
RP Morris, OJ (reprint author), Hunter New England Area Hlth, New Lambton Hts, NSW, Australia.
EM owenjamesmorris@hotmail.com
OI Smith, Stephen/0000-0002-1104-133X
CR Chan MK, 2009, DIS COLON RECTUM, V9, P433
   Cheetham M, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858]
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   De la Portilla F, 2007, COLORECTAL DIS, V10, P89
   Feretis C, 2001, DIS COLON RECTUM, V44, P1605, DOI 10.1007/BF02234379
   Garcia V, 2005, AM J OBSTET GYNECOL, V192, P1697, DOI 10.1016/j.ajog.2004.11.045
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Kumar D, 1998, BRIT J SURG, V85, P978
   Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Ratto C, 2011, BRIT J SURG, V98, P1644, DOI 10.1002/bjs.7699
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
NR 20
TC 8
Z9 8
U1 0
U2 1
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1123-6337
J9 TECH COLOPROCTOL
JI Tech. Coloproctology
PD OCT
PY 2013
VL 17
IS 5
BP 517
EP 523
DI 10.1007/s10151-013-1000-4
PG 7
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 227QM
UT WOS:000325128600009
PM 23525964
DA 2018-10-20
ER

PT J
AU Gassling, V
   Douglas, TEL
   Purcz, N
   Schaubroeck, D
   Balcaen, L
   Bliznuk, V
   Declercq, HA
   Vanhaecke, F
   Dubruel, P
AF Gassling, Volker
   Douglas, Timothy E. L.
   Purcz, Nicolai
   Schaubroeck, David
   Balcaen, Lieve
   Bliznuk, Vitaliy
   Declercq, Heidi A.
   Vanhaecke, Frank
   Dubruel, Peter
TI Magnesium-enhanced enzymatically mineralized platelet-rich fibrin for
   bone regeneration applications
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID IN-VITRO; OSTEOBLAST ADHESION; ALKALINE-PHOSPHATASE; NANOPHASE CERAMICS;
   CALCIUM-PHOSPHATE; DIFFERENTIATION; PROLIFERATION; SCAFFOLDS; COMPOSITE;
   PRF
AB Membranes of the autologous blood-derived biomaterial platelet-rich fibrin (PRF) were mineralized enzymatically with calcium phosphate (CaP) by the incorporation of alkaline phosphatase (ALP) followed by incubation for 3 days in solutions of either 0.1 M calcium glycerophosphate (CaGP) or a combination of CaGP and magnesium glycerophosphate (CaGP:MgGP; both 0.05 M), resulting in the formation of two different PRF-mineral composites. Fourier transform infrared spectroscopy, transmission electron microscopy and selected area electron diffraction examinations showed that the CaP formed was amorphous. Inductively coupled plasma optical emission spectroscopy analysis revealed similar amounts of Ca and P in both composite types, while a smaller amount of Mg (Ca:Mg molar ratio = 10) was detected in the composites formed in the CaGP:MgGP solution, which was supported by the results of energy-dispersive x-ray spectroscopy-based elemental mapping. Scanning electron microscopy (SEM) imaging showed that the mineral deposits in PRF incubated in the CaGP: MgGP solution were markedly smaller. The mass percentage attributable to the mineral phase was similar in both composite types. MTT and WST tests with SAOS-2 cells revealed that incubation in the CaGP: MgGP solution had no negative effect on cytocompatibility and cell proliferation compared to the CaGP solution. Cells on all samples displayed a well-spread morphology as revealed by SEM imaging. In conclusion, the incorporation of Mg reduces mineral deposit dimensions and promotes cell proliferation.
C1 [Gassling, Volker; Purcz, Nicolai] Univ Hosp Schleswig Holstein, Clin Oral & Maxillofacial Surg, D-24105 Kiel, Germany.
   [Douglas, Timothy E. L.; Dubruel, Peter] Univ Ghent, Dept Organ Chem, Polymer Chem & Biomat PBM Grp, B-9000 Ghent, Belgium.
   [Schaubroeck, David] IMEC, ELIS, CMST, B-9052 Ghent, Belgium.
   [Balcaen, Lieve] Univ Ghent, Dept Analyt Chem, B-9000 Ghent, Belgium.
   [Bliznuk, Vitaliy] Dept Mat Sci & Engn, B-9052 Zwijnaarde, Belgium.
   [Declercq, Heidi A.] Univ Ghent, Tissue Engn Grp, Dept Basic Med Sci, B-9000 Ghent, Belgium.
RP Douglas, TEL (reprint author), Univ Ghent, Dept Organ Chem, Polymer Chem & Biomat PBM Grp, Krijgslaan 28 S4, B-9000 Ghent, Belgium.
EM Timothy.Douglas@UGent.be
RI Vanhaecke, Frank/F-5341-2014; Balcaen, Lieve/H-5129-2015; Gassling,
   Volker/E-4671-2016
OI Vanhaecke, Frank/0000-0002-1884-3853; Balcaen,
   Lieve/0000-0002-1800-6932; Gassling, Volker/0000-0002-0096-6142;
   Schaubroeck, David/0000-0001-9576-3091; Bliznuk,
   Vitaliy/0000-0002-6402-4066; Douglas, Timothy/0000-0002-6661-3120
FU Research Foundation Flanders (FWO)
FX This research was financed by the postdoctoral fellowships of Research
   Foundation Flanders (FWO) of TELD and LB. The authors thank Renaat
   Dasseville and G Otto for technical assistance.
CR AOBA T, 1992, CALCIFIED TISSUE INT, V51, P143, DOI 10.1007/BF00298503
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Boanini E, 2012, J INORG BIOCHEM, V107, P65, DOI 10.1016/j.jinorgbio.2011.11.003
   BOSKEY AL, 1974, MATER RES BULL, V9, P907, DOI 10.1016/0025-5408(74)90169-X
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Bracci B, 2009, J INORG BIOCHEM, V103, P1666, DOI 10.1016/j.jinorgbio.2009.09.009
   Bramanti E, 1997, BIOPOLYMERS, V41, P545
   Brandl FP, 2010, BIOMATERIALS, V31, P3957, DOI 10.1016/j.biomaterials.2010.01.128
   Cai YL, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054114
   Charrier J B, 2008, Rev Laryngol Otol Rhinol (Bord), V129, P313
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J I, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P27
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan Ehrenfest D M, 2010, CLIN ORAL IMPLAN RES, V55, P185
   Douglas T, 2012, J TISSUE EN IN PRESS
   Douglas T, 2009, J MATER SCI-MATER M, V20, P1909, DOI 10.1007/s10856-009-3756-7
   Douglas TEL, 2012, MACROMOL BIOSCI, V12, P1077, DOI 10.1002/mabi.201100501
   Douglas TEL, 2012, J BIOMED MATER RES A, V100A, P1335, DOI 10.1002/jbm.a.34073
   Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306
   Ehrenfest DMD, 2009, ORAL SURG ORAL MED O, V108, P341, DOI 10.1016/j.tripleo.2009.04.020
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Filmon R, 2002, BONE, V30, P152, DOI 10.1016/S8756-3282(01)00634-2
   Filmon R, 2000, J BIOMAT SCI-POLYM E, V11, P849, DOI 10.1163/156856200744057
   Gassling V, 2010, CLIN ORAL IMPLAN RES, V21, P543, DOI 10.1111/j.1600-0501.2009.01900.x
   He L, 2009, ORAL SURG ORAL MED O, V108, P707, DOI 10.1016/j.tripleo.2009.06.044
   Landi E, 2006, J EUR CERAM SOC, V26, P2593, DOI 10.1016/j.jeurceramsoc.2005.06.040
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Leeuwenburgh SCG, 2010, ACTA BIOMATER, V6, P836, DOI 10.1016/j.actbio.2009.09.005
   Leeuwenburgh SCG, 2007, J BIOMAT SCI-POLYM E, V18, P1547
   Litvinov RI, 2012, BIOPHYS J, V103, P1020, DOI 10.1016/j.bpj.2012.07.046
   Martin RI, 1997, CALCIFIED TISSUE INT, V60, P538, DOI 10.1007/s002239900277
   Mazor Z, 2009, J PERIODONTOL, V80, P2056, DOI 10.1902/jop.2009.090252
   Noorjahan SE, 2005, J BIOMED MATER RES B, V75B, P343, DOI 10.1002/jbm.b.30309
   Perumcherry SR, 2011, TISSUE ENG PART C-ME, V17, P1121, DOI [10.1089/ten.tec.2010.0734, 10.1089/ten.TEC.2010.0734]
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Sader MS, 2009, J MATER SCI-MATER M, V20, P521, DOI 10.1007/s10856-008-3610-3
   Simonpieri A, 2009, IMPLANT DENT, V18, P102, DOI 10.1097/ID.0b013e318198cf00
   Spoerke ED, 2009, ADV MATER, V21, P425, DOI 10.1002/adma.200802242
   Tamimi F, 2011, ACTA BIOMATER, V7, P2678, DOI 10.1016/j.actbio.2011.02.007
   Warnke PH, 2010, J BIOMED MATER RES B, V93B, P212, DOI 10.1002/jbm.b.31577
   Warnke PH, 2009, CLIN ORAL IMPLAN RES, V20, P761, DOI 10.1111/j.1600-0501.2009.01709.x
   Warnke PH, 2009, TISSUE ENG PART C-ME, V15, P115, DOI 10.1089/ten.tec.2008.0288
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Wu CL, 2012, AUST DENT J, V57, P207, DOI 10.1111/j.1834-7819.2012.01686.x
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Zhao S., 2011, CLIN ORAL IMPLAN RES, V24, P34
NR 51
TC 11
Z9 11
U1 1
U2 29
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD OCT
PY 2013
VL 8
IS 5
AR 055001
DI 10.1088/1748-6041/8/5/055001
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 224WL
UT WOS:000324922200001
PM 23945076
DA 2018-10-20
ER

PT J
AU Guo, YY
   Chen, DS
   Lu, WJ
   Jia, YH
   Wang, LQ
   Zhang, XL
AF Guo, Yongyuan
   Chen, Desheng
   Lu, Weijie
   Jia, Yuhua
   Wang, Liqiang
   Zhang, Xianlong
TI Corrosion resistance and in vitro response of a novel Ti35Nb2Ta3Zr alloy
   with a low Young's modulus
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; TITANIUM-ALLOYS; ELECTROCHEMICAL-BEHAVIOR;
   MECHANICAL-PROPERTIES; IMPLANT APPLICATIONS; HANKS-SOLUTION; SURFACE;
   OSTEOBLASTS; TANTALUM; BONE
AB beta type titanium alloys have attracted much attention in the biomedical field because they consist of non-cytotoxic elements, show high corrosion resistance, and are biologically compatible. In this study, a novel beta type titanium alloy (Ti35Nb3Zr2Ta) with a Young's modulus of 48 GPa was fabricated and the alloy's corrosion resistance and in vitro response were determined. The results indicate that the novel alloy exhibits comparable corrosion resistance when compared with Ti6Al4V, but in vitro experiments show that osteoblasts attach, spread, proliferate, and differentiate better on Ti35Nb2Ta3Zr than on Ti6Al4V. The high corrosion resistance and satisfactory biocompatibility make the novel Ti35Nb3Zr2Ta alloy a promising biomaterial for surgical implants.
C1 [Guo, Yongyuan; Jia, Yuhua] Shandong Univ, Qilu Hosp, Dept Orthopaed, Jinan 250012, Peoples R China.
   [Guo, Yongyuan; Chen, Desheng; Zhang, Xianlong] Jiao Tong Univ, Med Sch ShangHai, Dept Orthopaed, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.
   [Chen, Desheng] Ningxia Med Univ, Gen Hosp, Dept Orthopaed, Yinchuan 750004, Peoples R China.
   [Lu, Weijie; Wang, Liqiang] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
   [Wang, Liqiang] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
RP Wang, LQ (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
EM orthopedics2012@163.com; Wang_liqiang@sjtu.edu.cn
FU National Natural Science Foundation of China [81271962, 81171688];
   Shanghai Municipal Science and Technology Commission Foundation
   [12JC1407302]; Interdisciplinary (Engineering-Medical) Research Fund of
   Shanghai Jiao Tong University [YG2011MS30]; Shanghai Municipal Health
   Bureau Science Fund for Young Scholars [2010QJ036A]; Opening Project of
   State Key Laboratory of High Performance Ceramics and Superfine
   Microstructure [SKL201206SIC]; Shanghai Natural Science Foundation
   [12ZR1445500]; New Teachers' Fund for Doctor Stations, Ministry of
   Education [20120073120007]
FX This work was supported by the National Natural Science Foundation of
   China (grant no 81271962), the National Natural Science Foundation of
   China (grant no 81171688), Shanghai Municipal Science and Technology
   Commission Foundation (grant no 12JC1407302), the Interdisciplinary
   (Engineering-Medical) Research Fund of Shanghai Jiao Tong University
   (grant no YG2011MS30), Shanghai Municipal Health Bureau Science Fund for
   Young Scholars (grant no 2010QJ036A), and the Opening Project of State
   Key Laboratory of High Performance Ceramics and Superfine Microstructure
   (grant no SKL201206SIC), Shanghai Natural Science Foundation (grant no:
   12ZR1445500), New Teachers' Fund for Doctor Stations, Ministry of
   Education (grant no: 20120073120007).
CR Barranco V, 2011, ACTA BIOMATER, V7, P2716, DOI 10.1016/j.actbio.2011.02.040
   Bertrand E, 2010, J MECH BEHAV BIOMED, V3, P559, DOI 10.1016/j.jmbbm.2010.06.007
   Cabrini R L, 1993, Implant Dent, V2, P264, DOI 10.1097/00008505-199312000-00008
   Cai Z, 2003, BIOMATERIALS, V24, P213, DOI 10.1016/S0142-9612(02)00293-4
   Eriksson C, 2004, BIOMATERIALS, V25, P4759, DOI 10.1016/j.biomaterials.2003.12.006
   Fandridis J, 2008, IMPLANT DENT, V17, P91, DOI [10.1097/ID.0b013e318166d9ac, 10.1097/lD.0b013e318166d9ac]
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Jung TK, 2010, MATER SCI FORUM, V631-632, P205, DOI 10.4028/www.scientific.net/MSF.631-632.205
   Karthega M, 2007, ACTA BIOMATER, V3, P1019, DOI 10.1016/j.actbio.2007.02.009
   Kulakov O B, 2005, Morfologiia, V127, P52
   Lavos-Valereto IC, 2004, J MATER SCI-MATER M, V15, P55, DOI 10.1023/B:JMSM.0000010097.86245.74
   Lin DJ, 2007, BIOMATERIALS, V28, P2582, DOI 10.1016/j.biomaterials.2007.02.005
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mareci D, 2009, ACTA BIOMATER, V5, P3625, DOI 10.1016/j.actbio.2009.05.037
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Olivares-Navarrete R, 2011, ACTA BIOMATER, V7, P2740, DOI 10.1016/j.actbio.2011.02.030
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Padial-Molina M, 2011, ACTA BIOMATER, V7, P771, DOI 10.1016/j.actbio.2010.08.024
   Park CH, 2011, CLIN ORAL IMPLAN RES, V22, P735, DOI 10.1111/j.1600-0501.2010.02053.x
   PILLIAR RM, 1991, BIOMATERIALS, V12, P95, DOI 10.1016/0142-9612(91)90185-D
   Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251
   Saji VS, 2009, ACTA BIOMATER, V5, P2303, DOI 10.1016/j.actbio.2009.02.017
   Samuel S, 2010, J BIOMED MATER RES A, V94A, P1251, DOI 10.1002/jbm.a.32782
   Scacchi M, 2000, CLIN ORAL IMPLAN RES, V11, P22, DOI 10.1034/j.1600-0501.2000.011S1022.x
   Shukla AK, 2006, CORROS SCI, V48, P1696, DOI 10.1016/j.corsci.2005.06.003
   SNYDER SM, 1991, J ORTHOPAED RES, V9, P422, DOI 10.1002/jor.1100090315
   Swaminathan V, 2011, J BIOMED MATER RES B, V98B, P369, DOI 10.1002/jbm.b.31861
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Wang LQ, 2008, MATER TRANS, V49, P1791, DOI 10.2320/matertrans.MRA2008040
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Yang HP, 2011, T NONFERR METAL SOC, V21, P179, DOI 10.1016/S1003-6326(11)60696-1
   Yu WQ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065012
   Zhao G, 2006, CLIN ORAL IMPLAN RES, V17, P258, DOI 10.1111/j.1600-0501.2005.01195.x
NR 37
TC 4
Z9 5
U1 0
U2 18
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD OCT
PY 2013
VL 8
IS 5
AR 055004
DI 10.1088/1748-6041/8/5/055004
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 224WL
UT WOS:000324922200004
PM 24002775
DA 2018-10-20
ER

PT J
AU Wilson, JM
   Jones, N
   Jin, L
   Shin, YC
AF Wilson, J. Michael
   Jones, Nolan
   Jin, Li
   Shin, Yung C.
TI Laser deposited coatings of Co-Cr-Mo onto Ti-6Al-4V and SS316L
   substrates for biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE Ti-6Al-4V; Co-Cr-Mo; biomaterial; functionally graded material; laser
   direct deposition
ID METAL-ON-METAL; STAINLESS-STEEL; WEAR PROPERTIES; POLYETHYLENE;
   IMPLANTS; TITANIUM; MICROSTRUCTURE; MANUFACTURE; FABRICATION; JOINTS
AB Functionally gradient bio-coating material was built by laser deposition. Co-Cr-Mo material was deposited on a Ti-6Al-4V substrate transitioning from 0% to 100%. Control over the cooling rate is shown to be a key to reduce the effects of thermal expansion differences of the materials. The microstructures and composition of the functionally gradient material (FGM) were characterized using an optical microscope, SEM, EDS, and XRD. EDS results showed a gradual transition to 50% Co-Cr-Mo and approximate to 100% Co-Cr-Mo on the top layer. XRD analysis showed the absence of a brittle intermetallic phase that forms between Titanium and Cobalt. As the amount of Co-Cr-Mo increased, the microhardness of the FGM samples significantly increased. A comparison was made between Co-Cr-Mo deposited on SS316L substrates as well as Ti-6Al-4V. The bonding strength of the coatings on both substrates was tested and found to meet the ASTM standard requirement. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 101B: 1124-1132, 2013.
C1 [Wilson, J. Michael; Jones, Nolan; Jin, Li; Shin, Yung C.] Purdue Univ, Sch Mech Engn, Ctr Laser Based Mfg, W Lafayette, IN 47907 USA.
RP Shin, YC (reprint author), Purdue Univ, Sch Mech Engn, Ctr Laser Based Mfg, W Lafayette, IN 47907 USA.
EM shin@purdue.edu
OI Shin, Yung/0000-0003-3157-9345
CR ASTM International, F114705 ASTM INT
   Balla VK, 2011, BIOMATERIALS SCI PRO, V228
   Bandyopadhyay A, 2009, J MATER SCI-MATER M, V20, P29, DOI 10.1007/s10856-008-3478-2
   Dinda GP, 2008, METALL MATER TRANS A, V39A, P2914, DOI 10.1007/s11661-008-9634-y
   Dowson D, 2004, J ARTHROPLASTY, V19, P118, DOI 10.1016/j.arth.2004.09.015
   EATON HE, 1986, SURF COAT TECH, V27, P197, DOI 10.1016/0257-8972(86)90130-1
   Espey GB, ASTM STP, V287, P7
   Hao L, 2007, P R SOC A, V463, P1857, DOI 10.1098/rspa.2007.1854
   Hao L, 2006, P I MECH ENG H, V220, P521, DOI 10.1243/09544119JEIM67
   HARRYSSON O, 2005, ADV MATER PROCESS, V163, P72
   Jones N, 2011, P MAT SCI TECHN COL
   Komistek RD, 2002, J BONE JOINT SURG AM, V84A, P1836, DOI 10.2106/00004623-200210000-00015
   Krishna BV, 2008, JOM-US, V60, P45
   Li SX, 2005, MAT SCI ENG A-STRUCT, V407, P250, DOI 10.1016/j.msea.2005.07.003
   Majumdar JD, 2009, J MATER PROCESS TECH, V209, P2237, DOI 10.1016/j.jmatprotec.2008.05.017
   Majumdar JD, 2011, J ADV MAT, V2011, P4
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Murray J.L., 1981, B ALLOY PHASE DIAGRA, V2, P185
   Murray J.L., 1990, BINARY ALLOY PHASE D, VII, P1250
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Oh KT, 2002, J ELECTROCHEM SOC, V149, pB146, DOI 10.1149/1.1457984
   Okamoto H, 2002, J PHASE EQUILIB, V23, P382, DOI 10.1361/105497102770331659
   Park J., 2007, BIOMATERIALS INTRO
   Ram G. D. J., 2008, J MANUF SCI E-T ASME, V130, P1
   Ram GDJ, 2008, J MATER SCI-MATER M, V19, P2105, DOI 10.1007/s10856-007-3078-6
   Rimell JT, 2000, J BIOMED MATER RES, V53, P414, DOI 10.1002/1097-4636(2000)53:4<414::AID-JBM16>3.0.CO;2-M
   Rodriguez B, 2004, BIOMATERIALS ORTHOPE
   Savalani MM, 2007, P I MECH ENG H, V221, P873, DOI 10.1243/09544119JEIM232
   Special Metals Corporation Products, STELL 21, P36
   Tkaczyk Cathy, 2010, Open Orthop J, V4, P221, DOI 10.2174/1874325001004010221
   WALKER PS, 1972, WEAR, V21, P377, DOI 10.1016/0043-1648(72)90011-7
   Wang FJ, 2008, APPL SURF SCI, V255, P3267, DOI 10.1016/j.apsusc.2008.09.039
   Wu XH, 2004, MATER DESIGN, V25, P137, DOI 10.1016/j.matdes.2003.09.009
   Xia Y, 2011, J MATER SCI-MATER M, V22, P317, DOI 10.1007/s10856-010-4212-4
   Xue Y, 2005, APPL SURF SCI, V243, P278, DOI 10.1016/j.apsusc.2004.09.073
NR 35
TC 6
Z9 6
U1 0
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2013
VL 101
IS 7
BP 1124
EP 1132
DI 10.1002/jbm.b.32921
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 216RQ
UT WOS:000324302100002
PM 23564675
DA 2018-10-20
ER

PT J
AU Marques, L
   Holgado, LA
   Simoes, RD
   Pereira, JDAS
   Floriano, JF
   Mota, LSLS
   Graeff, CFO
   Constantino, CJL
   Rodriguez-Perez, MA
   Matsumoto, M
   Kinoshita, A
AF Marques, Leonardo
   Holgado, Leandro A.
   Simoes, Rebeca D.
   Pereira, Joao D. A. S.
   Floriano, Juliana F.
   Mota, Ligia S. L. S.
   Graeff, Carlos F. O.
   Constantino, Carlos J. L.
   Rodriguez-Perez, Miguel A.
   Matsumoto, Mariza
   Kinoshita, Angela
TI Subcutaneous tissue reaction and cytotoxicity of polyvinylidene fluoride
   and polyvinylidene fluoride-trifluoroethylene blends associated with
   natural polymers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biomaterial; piezoelectricity; tissue reaction; cytotoxicity; PVDF
ID MINERAL TRIOXIDE AGGREGATE; IN-VITRO BIOCOMPATIBILITY; PVDF; BONE;
   RESPONSES; STARCH; RUBBER; MESHES; PIEZOELECTRICITY; BIOMATERIALS
AB Cytotoxicity and subcutaneous tissue reaction of innovative blends composed by polyvinylidene fluoride and polyvinylidene fluoride-trifluoroethylene associated with natural polymers (natural rubber and native starch) forming membranes were evaluated, aiming its applications associated with bone regeneration. Cytotoxicity was evaluated in mouse fibroblasts culture cells (NIH3T3) using trypan blue staining. Tissue response was in vivo evaluated by subcutaneous implantation of materials in rats, taking into account the presence of necrosis and connective tissue capsule around implanted materials after 7, 14, 21, 28, 35, 60, and 100 days of surgery. The pattern of inflammation was evaluated by histomorphometry of the inflammatory cells. Chemical and morphological changes of implanted materials after 60 and 100 days were evaluated by Fourier transform infrared (FTIR) absorption spectroscopy and scanning electron microscopy (SEM) images. Cytotoxicity tests indicated a good tolerance of the cells to the biomaterial. The in vivo tissue response of all studied materials showed normal inflammatory pattern, characterized by a reduction of polymorphonuclear leukocytes and an increase in mononuclear leukocytes over the time (p < 0.05 Kruskal-Wallis). On day 60, microscopic analysis showed regression of the chronic inflammatory process around all materials. FTIR showed no changes in chemical composition of materials due to implantation, whereas SEM demonstrated the delivery of starch in the medium. Therefore, the results of the tests performed in vitro and in vivo show that the innovative blends can further be used as biomaterials. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 101B: 1284-1293, 2013.
C1 [Marques, Leonardo; Holgado, Leandro A.; Matsumoto, Mariza; Kinoshita, Angela] Univ Sagrado Coracao USC, Sao Paulo, Brazil.
   [Simoes, Rebeca D.; Pereira, Joao D. A. S.; Constantino, Carlos J. L.] UNESP Univ Estadual Paulista, Fac Ciencias & Tecnol, Sao Paulo, Brazil.
   [Floriano, Juliana F.; Graeff, Carlos F. O.] UNESP Univ Estadual Paulista, Fac Ciencias, Sao Paulo, Brazil.
   [Mota, Ligia S. L. S.] UNESP Univ Estadual Paulista, Inst Biociencias, Sao Paulo, Brazil.
   [Rodriguez-Perez, Miguel A.] Univ Valladolid, CellMat Lab, Fac Sci, Dept Condensed Matter Phys, Valladolid, Spain.
RP Kinoshita, A (reprint author), Univ Sagrado Coracao USC, Sao Paulo, Brazil.
EM angela.kinoshita@usc.br
RI RODRIGUEZ PEREZ, MIGUEL ANGEL/I-3538-2015; Nanotecnologias,
   Inct/I-2407-2013; Kinoshita, Angela/C-6946-2012; Mota,
   Ligia/C-4583-2013; FAPESP, CDMF/J-3591-2015; Graeff, Carlos/C-6703-2012;
   Floriano, Juliana Ferreira/D-9207-2014
OI RODRIGUEZ PEREZ, MIGUEL ANGEL/0000-0002-3607-690X; Kinoshita,
   Angela/0000-0002-5057-1667; Mota, Ligia/0000-0003-4513-753X; FAPESP,
   CDMF/0000-0002-4464-0937; Graeff, Carlos/0000-0003-0162-8273; Matsumoto,
   Mariza Akemi/0000-0001-5389-0105
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAP/USC
   (Fundacao de Amparo a Pesquisa da Universidade Sagrado Coracao)
FX Contract grant sponsors: FAPESP (Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo), CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior), FAP/USC (Fundacao de Amparo a Pesquisa da Universidade
   Sagrado Coracao)
CR [Anonymous], 1099322006 ISO
   [Anonymous], 1973, J BIOMECH, V6, P69
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Beloti MM, 2006, J BIOMED MATER RES A, V79A, P282, DOI 10.1002/jbm.a.30801
   Bloemers FW, 2003, J BIOMED MATER RES B, V66B, P526, DOI 10.1002/jbm.b.10045
   Bouaziz A, 1997, BIOMATERIALS, V18, P107, DOI 10.1016/S0142-9612(96)00114-7
   Callegari Bianca, 2004, Acta ortop. bras., V12, P160, DOI 10.1590/S1413-78522004000300005
   Cao T, 2005, J APPL TOXICOL, V25, P101, DOI 10.1002/jat.1041
   Carsten S., 2004, BIOMATERIALS, V25, P1239
   Conze J, 2008, J BIOMED MATER RES B, V87B, P321, DOI 10.1002/jbm.b.31106
   Dawlee S, J BIOMATER APPL, DOI 10.1177/0885328211434090
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   FUKADA E, 1981, ULTRASONICS, V19, P31, DOI 10.1016/0041-624X(81)90030-5
   Gimenes R, 2004, P SOC PHOTO-OPT INS, V5385, P539, DOI 10.1117/12.548647
   Hench LL, 1973, J BIOMED MATER RES, V7, P35
   Hong CC, 2012, MACROMOLECULES, V45, P1580, DOI 10.1021/ma202481t
   ISO International Organization for Standardization, 1099312009 ISO
   Janet CG, 2011, GUIDE CARE USE LAB A
   Junge K, 2005, BIOMATERIALS, V26, P787, DOI 10.1016/j.biomaterials.2004.02.070
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   Klink CD, 2011, J INVEST SURG, V24, P292, DOI 10.3109/08941939.2011.589883
   Lang SB, 2006, APPL PHYS A-MATER, V85, P125, DOI 10.1007/s00339-006-3688-8
   LAROCHE G, 1995, ARTIF ORGANS, V19, P1190, DOI 10.1111/j.1525-1594.1995.tb02282.x
   Lee YS, 2011, ACTA BIOMATER, V7, P3877, DOI 10.1016/j.actbio.2011.07.013
   Li CY, 2008, J MICROELECTROMECH S, V17, P334, DOI 10.1109/JMEMS.2007.911375
   Mano JF, 2004, MAT SCI ENG A-STRUCT, V370, P321, DOI 10.1016/j.msea.2003.08.088
   MARINO AA, 1988, J ELECTROSTAT, V21, P347, DOI 10.1016/0304-3886(88)90036-8
   Mendonca RJ, 2010, PHYTOTHER RES, V24, P764, DOI 10.1002/ptr.3043
   Minnen B., 2005, J MATER SCI-MATER M, V16, P221
   MUHAMMAD IS, 2009, J MATER SCI, V44, P5713
   Nalwa HS, 1995, FERROELECTRIC POLYM
   Olsson B, 1981, J Endod, V7, P355, DOI 10.1016/S0099-2399(81)80057-X
   Parirokh M, 2011, INT ENDOD J, V44, P283, DOI 10.1111/j.1365-2591.2010.01808.x
   Park JW, 2000, POLYM ENG SCI, V40, P2539, DOI 10.1002/pen.11384
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   SAFAVI KE, 1983, J ENDODONT, V9, P421, DOI 10.1016/S0099-2399(83)80257-X
   Simoes RD, 2010, J THERM ANAL CALORIM, V99, P621, DOI 10.1007/s10973-009-0285-z
   Simoes RD, 2009, POLYM ENG SCI, V49, P2150, DOI 10.1002/pen.21455
   Simoes RD, 2005, J RAMAN SPECTROSC, V36, P1118, DOI [10.1002/jrs.1416, 10.1002/jrs.l416]
   Strober W, 2003, CURRENT PROTOCOLS IM, pA
   Teixeira LN, 2011, J MATER SCI-MATER M, V22, P151, DOI 10.1007/s10856-010-4189-z
   Teixeira LN, 2010, ACTA BIOMATER, V6, P979, DOI 10.1016/j.actbio.2009.08.024
   Warren SM, 2003, OPERAT TECHN PLASTIC, V9, P10
   Wataha JC, 2012, DENT MATER, V28, P23, DOI 10.1016/j.dental.2011.08.595
   Yaltirik M, 2004, J ENDODONT, V30, P95, DOI 10.1097/00004770-200402000-00008
NR 47
TC 5
Z9 6
U1 2
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2013
VL 101
IS 7
BP 1284
EP 1293
DI 10.1002/jbm.b.32941
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 216RQ
UT WOS:000324302100020
PM 23661490
DA 2018-10-20
ER

PT J
AU Edgington, RJ
   Thalhammer, A
   Welch, JO
   Bongrain, A
   Bergonzo, P
   Scorsone, E
   Jackman, RB
   Schoepfer, R
AF Edgington, R. J.
   Thalhammer, A.
   Welch, J. O.
   Bongrain, A.
   Bergonzo, P.
   Scorsone, E.
   Jackman, R. B.
   Schoepfer, R.
TI Patterned neuronal networks using nanodiamonds and the effect of varying
   nanodiamond properties on neuronal adhesion and outgrowth
SO JOURNAL OF NEURAL ENGINEERING
LA English
DT Article
ID NANOCRYSTALLINE DIAMOND; CELL-ADHESION; NEURAL CELLS; SURFACE;
   NANOPARTICLES; POWDER; GROWTH; POLYLYSINE; DETONATION; CHEMISTRY
AB Objective. Detonation nanodiamond monolayer coatings are exceptionally biocompatible substrates for in vitro cell culture. However, the ability of nanodiamond coatings of different origin, size, surface chemistry and morphology to promote neuronal adhesion, and the ability to pattern neurons with nanodiamonds have yet to be investigated. Approach. Various nanodiamond coatings of different type are investigated for their ability to promote neuronal adhesion with respect to surface coating parameters and neurite extension. Nanodiamond tracks are patterned using photolithography and reactive ion etching. Main results. Universal promotion of neuronal adhesion is observed on all coatings tested and analysis shows surface roughness to not be a sufficient metric to describe biocompatibility, but instead nanoparticle size and curvature shows a significant correlation with neurite extension. Furthermore, neuronal patterning is achieved with high contrast using patterned nanodiamond coatings down to at least 10 mu m. Significance. The results of nanoparticle size and curvature being influential upon neuronal adhesion has great implications towards biomaterial design, and the ability to pattern neurons using nanodiamond tracks shows great promise for applications both in vitro and in vivo.
C1 [Edgington, R. J.; Welch, J. O.; Jackman, R. B.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England.
   [Edgington, R. J.; Welch, J. O.; Jackman, R. B.] UCL, Dept Elect & Elect Engn, London WC1H 0AH, England.
   [Thalhammer, A.] IIT, I-16163 Genoa, Italy.
   [Bongrain, A.; Bergonzo, P.; Scorsone, E.] CEA, LIST, Diamond Sensors Lab, F-91191 Gif Sur Yvette, France.
   [Schoepfer, R.] UCL, NPP, Mol Pharmacol Lab, London WC1E 6BT, England.
RP Edgington, RJ (reprint author), UCL, London Ctr Nanotechnol, 17-19 Gordon St, London WC1H 0AH, England.
EM r.edgington@ucl.ac.uk; r.jackman@ucl.ac.uk;
   publications@schoepferlab.org
RI Bergonzo, Philippe/A-6567-2015; Scorsone, Emmanuel/B-9993-2009
OI Bergonzo, Philippe/0000-0002-0647-9134; 
FU UK's Engineering and Physical Sciences Research Council (EPSRC)
   [EP/F026110]; EU Framework 6 STREP programme 'DREAMS' [FP6-NMP-033345];
   EU Framework 7 programme 'Neurocare' [FP7-NMP-280433]; Engineering and
   Physical Sciences Research Council [EP/F026110/1]
FX The work was financially supported by awards to RBJ and RS by the UK's
   Engineering and Physical Sciences Research Council (EPSRC, EP/F026110),
   an EU Framework 6 STREP programme 'DREAMS' (FP6-NMP-033345) and EU
   Framework 7 programme 'Neurocare' (FP7-NMP-280433). Dr Oliver A Williams
   (IAF, Freiburg, Germany now at University of Cardiff, UK) is thanked for
   his skilful preparation of the dispersed ND solutions that were used
   throughout. Dr Madeline Pool (McGill University, Canada) is thanked for
   her kind provision of the modified NeuriteTracer software. At UCL Dr
   Steve Hudziak is acknowledged for his assistance with the AFM
   measurements.
CR Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Bergonzo P, 2011, IRBM, V32, P91, DOI 10.1016/j.irbm.2011.01.032
   Branch DW, 2000, IEEE T BIO-MED ENG, V47, P290, DOI 10.1109/10.827289
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204
   Fan YW, 2002, APPL SURF SCI, V187, P313, DOI 10.1016/S0169-4332(01)01046-7
   Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4
   Fricke R, 2011, BIOMATERIALS, V32, P2070, DOI 10.1016/j.biomaterials.2010.11.036
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Girard HA, 2009, ACS APPL MATER INTER, V1, P2738, DOI 10.1021/am900458g
   Hees J, 2011, CHEM PHYS LETT, V509, P12, DOI 10.1016/j.cplett.2011.04.083
   Jang MJ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/23/235102
   Jiang T, 1995, CARBON, V33, P1663, DOI 10.1016/0008-6223(95)00115-1
   Khan SP, 2005, NANOMED-NANOTECHNOL, V1, P125, DOI 10.1016/j.nano.2005.03.007
   Kotov NA, 2010, SCIENCE, V330, P188, DOI 10.1126/science.1190094
   Lechleitner T, 2008, BIOMATERIALS, V29, P4275, DOI 10.1016/j.biomaterials.2008.07.023
   Lorenzoni M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01954
   Pool M, 2008, J NEUROSCI METH, V168, P134, DOI 10.1016/j.jneumeth.2007.08.029
   Rainaldi G, 1998, J MATER SCI-MATER M, V9, P755, DOI 10.1023/A:1008915305681
   Rao S. S., 2009, FRONT NEUROENG, V2, P1, DOI 10.3389/neuro.16.006.2009
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Shenderova O, 2011, J PHYS CHEM C, V115, P9827, DOI 10.1021/jp1102466
   Specht CG, 2004, BIOMATERIALS, V25, P4073, DOI 10.1016/j.biomaterials.2003.11.006
   Specht CG, 2005, MOL CELL NEUROSCI, V28, P326, DOI 10.1016/j.mcn.2004.09.017
   Sun KW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912029
   Thalhammer A, 2010, BIOMATERIALS, V31, P2097, DOI 10.1016/j.biomaterials.2009.11.109
   Wasdo SC, 2008, INT J NANOTECHNOL, V5, P92, DOI 10.1504/IJNT.2008.016550
   Williams OA, 2011, DIAM RELAT MATER, V20, P621, DOI 10.1016/j.diamond.2011.02.015
   Williams OA, 2010, CHEM PHYS LETT, V495, P84, DOI 10.1016/j.cplett.2010.06.054
   Yeung CK, 2001, NEUROSCI LETT, V301, P147, DOI 10.1016/S0304-3940(01)01628-7
   Zang JB, 2007, DIAM RELAT MATER, V16, P16, DOI 10.1016/j.diamond.2006.03.010
NR 31
TC 27
Z9 27
U1 1
U2 48
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1741-2560
J9 J NEURAL ENG
JI J. Neural Eng.
PD OCT
PY 2013
VL 10
IS 5
AR 056022
DI 10.1088/1741-2560/10/5/056022
PG 9
WC Engineering, Biomedical; Neurosciences
SC Engineering; Neurosciences & Neurology
GA 224DN
UT WOS:000324862400022
PM 24045617
DA 2018-10-20
ER

PT J
AU Tamuly, C
   Hazarika, M
   Bordoloi, M
AF Tamuly, Chandan
   Hazarika, Moushumi
   Bordoloi, Manobjyoti
TI Biosynthesis of Au nanoparticles by Gymnocladus assamicus and its
   catalytic activity
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Green synthesis; Nanoparticles; Catalytic activity
AB Here we first report synthesis of gold (Au) nanoparticles by using Gymnocladus assamicus pod extract in aqueous medium. Transmission electron microscopy (TEM) and X-ray diffraction (XRD) analysis revealed that the Au nanoparticles predominantly formed planar structure and size range 4.5 +/- 0.23-22.5 +/- 1.24 nm with 2 theta values at 38.22 degrees, 44.38 degrees, 64.34 degrees, 77.6 degrees and 81.24 degrees for lattice plane. The formation of pure metallic nanoparticles by reduction of the metal ions is possibly facilitated by reducing by phenolic acids like gallic acid, protocatechuic acid and kaempferol present in the G. assamicus pod extract. The Au solution shows potential catalytic activity in reduction of 4-nitrophenol to 4-aminophenol. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Tamuly, Chandan; Hazarika, Moushumi] CSIR North East Instst Sci & Technol, Branch Itanagar 791110, Arunachal Prade, India.
   [Bordoloi, Manobjyoti] CSIR North East Instst Sci & Technol, Jorhat 785006, Assam, India.
RP Tamuly, C (reprint author), CSIR North East Instst Sci & Technol, Branch Itanagar 791110, Arunachal Prade, India.
EM c.tamuly@gmail.com
FU SEED Division, DST, New Delhi
FX The authors thank the Director, CSIR-NEIST, Jorhat, Assam for providing
   facilities and SEED Division, DST, New Delhi for financial support.
CR Choudhury B. I., 2007, Natural Product Radiance, V6, P427
   Choudhury BI, 2007, CURR SCI INDIA, V93, P1489
   Jae YS, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI DOI 10.1007/S00449-008-0224-6
   Mahmouda MA, 2009, S AFRICAN J SCI, V105
   Singh S, 2007, J NANOSCI NANOTECHNO, V7, P3048, DOI 10.1166/jnn.2007.922
   Tamuly C., 2013, NANOSCI NANOTECHNOL, V5, P754
   Tamuly C, 2013, MATER LETT, V102, P1, DOI 10.1016/j.matlet.2013.03.090
   Tamuly C, 2013, COLLOID SURFACE B, V102, P627, DOI 10.1016/j.colsurfb.2012.09.007
   Wu F, 2011, NANO RES, V4, P861, DOI 10.1007/s12274-011-0142-9
NR 9
TC 8
Z9 8
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD OCT 1
PY 2013
VL 108
BP 276
EP 279
DI 10.1016/j.matlet.2013.07.020
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 220DT
UT WOS:000324562900074
DA 2018-10-20
ER

PT J
AU Tanaka, M
AF Tanaka, Motomu
TI Physics of interactions at biological and biomaterial interfaces
SO CURRENT OPINION IN COLLOID & INTERFACE SCIENCE
LA English
DT Review
DE Supported membrane; Grazing incidence; X-ray fluorescence; Offspecular
   scattering; Cell adhesion; Cell migration
ID X-RAY-FLUORESCENCE; SUPPORTED MEMBRANES; STERIC INTERACTIONS;
   LIPID-BILAYERS; MONTE-CARLO; THIN-FILM; CELLS; SCATTERING; SYSTEMS;
   SURFACE
AB Soft interlayers based on membranes and biopolymers define the spatial boundaries between different phases in biological systems. Physical interactions of soft matter under biologically relevant conditions (in aqueous media containing various ions) are governed by complex interplays of generic and specific interfacial interactions, which are clearly different from those acting at the interface between hard matter. This review aims at providing a comprehensive overview on: (a) models of cell-cell and cell-tissue interfaces with aid of defined building blocks, (b) new X-ray and neutron scattering techniques to probe fine structures, electrostatics, and mechanics of soft interfaces, and (c) control of dynamic cell morphology and migration of cells using tailor-made, soft interfaces. (C) 2013 The Author. Published by Elsevier Ltd. All rights reserved.
C1 [Tanaka, Motomu] Heidelberg Univ, Inst Phys Chem, D-69120 Heidelberg, Germany.
   [Tanaka, Motomu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068501, Japan.
RP Tanaka, M (reprint author), Heidelberg Univ, Inst Phys Chem, D-69120 Heidelberg, Germany.
EM tanaka@uni-heidelberg.de
RI Tanaka, Motomu/S-5949-2016
FU German Science Foundation [SFB 873]; BMBF; JSPS; Humboldt Foundation;
   World Premier International Research Center Initiative (WPI), MEXT,
   Japan
FX The author thanks all the post-doc and graduate students for their
   enormous contributions, especially, F. Rossetti, S. Kaufmann, R.
   Oliveira, E. Schneck, T. Kaindl, P. Seitz, H. Yoshikawa, W. Abuillan, A.
   Korner, T. Schubert, O. Purrucker, F. Rehfeldt, and M. Tutus. The author
   also appreciates the collaborating partners, It Schmidt C. Gege, R.
   Jordan, K. Brandenburg, D.A. Pink, J.P. Sleeman, I.M. Weiss, A.D. Ho,
   and S.P. Armes for their tackling of common scientific problems. The
   author is thankful to ESRF and ILL for the synchrotron and neutron beam
   times and to staff scientists, O. Konovalov and B. Deme, for the
   supports. The works of the author's group presented in this review were
   supported by the German Science Foundation (SFB 873), BMBF, JSPS, and
   Humboldt Foundation. The author is a member of the German Excellence
   Cluster "Cell Network" and Helmholtz Program "BioInterface". The iCeMS
   is supported by World Premier International Research Center Initiative
   (WPI), MEXT, Japan.
CR Abuillan W, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4767569
   BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159
   BROCHARDWYART F, 1992, ADV COLLOID INTERFAC, V39, P1, DOI 10.1016/0001-8686(92)80052-Y
   Cassier T, 1999, COLLOID SURFACE B, V15, P215, DOI 10.1016/S0927-7765(99)00090-9
   CRIADO M, 1982, BIOCHEMISTRY-US, V21, P5750, DOI 10.1021/bi00266a004
   DERJAGUIN BV, 1987, SURFACE FORCES
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   EGGENS I, 1989, J BIOL CHEM, V264, P9476
   EVANS E, 1988, J FLUID MECH, V194, P553, DOI 10.1017/S0022112088003106
   Gabius H. J., 1997, GLYCOSCIENCE
   GOMPPER G, 1989, EUROPHYS LETT, V9, P59, DOI 10.1209/0295-5075/9/1/011
   Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221
   Groves JT, 2003, J IMMUNOL METHODS, V278, P19, DOI 10.1016/S0022-1759(03)00193-5
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   HARDT SL, 1979, BIOPHYS CHEM, V10, P239, DOI 10.1016/0301-4622(79)85012-7
   HELFRICH W, 1978, Z NATURFORSCH A, V33, P305
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961
   Israelachvili J. N., 2007, INTERMOLECULAR SURFA
   Kaindl T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042991
   Katsaras J, 1997, BIOPHYS J, V73, P2924, DOI 10.1016/S0006-3495(97)78320-6
   Langevin D, 1998, CURR OPIN COLLOID IN, V3, P600, DOI 10.1016/S1359-0294(98)80086-1
   LEIKIN S, 1993, ANNU REV PHYS CHEM, V44, P369, DOI 10.1146/annurev.pc.44.100193.002101
   LIPOWSKY R, 1986, PHYS REV LETT, V56, P2541, DOI 10.1103/PhysRevLett.56.2541
   Liu YF, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.040901
   Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734
   Matsuda N, 2007, ADV MATER, V19, P3089, DOI 10.1002/adma.200701978
   Mora S, 2004, EUROPHYS LETT, V66, P694, DOI 10.1209/epl/i2003-10252-6
   Novikova NN, 2005, J SYNCHROTRON RADIAT, V12, P511, DOI 10.1107/S0909049505013579
   Oliveira RG, 2009, CR CHIM, V12, P209, DOI 10.1016/j.crci.2008.06.020
   Oliveira RG, 2009, PHYS REV E, V81
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Purrucker O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.078102
   Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807
   Reiter G, 1999, LANGMUIR, V15, P2551, DOI 10.1021/Ia981470y
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111
   SAFINYA CR, 1986, PHYS REV LETT, V57, P2718, DOI 10.1103/PhysRevLett.57.2718
   Salditt T, 2000, CURR OPIN COLLOID IN, V5, P19, DOI 10.1016/S1359-0294(00)00030-3
   Schneck E, 2011, BIOPHYS J, V100, P2151, DOI 10.1016/j.bpj.2011.03.011
   Schneck E, 2010, P NATL ACAD SCI USA, V107, P9147, DOI 10.1073/pnas.0913737107
   Schneck E, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041929
   Schneck E, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061924
   Seantier B, 2004, NANO LETT, V4, P5, DOI 10.1021/nl0345901
   Seitz PC, 2009, CHEMPHYSCHEM, V10, P2876, DOI 10.1002/cphc.200900553
   SINHA SK, 1994, J PHYS III, V4, P1543, DOI 10.1051/jp3:1994221
   SPITZNAGEL J, 1961, J EXP MED, V114, P1063, DOI 10.1084/jem.114.6.1063
   Tanaka M, 2001, PHYS CHEM CHEM PHYS, V3, P4091, DOI 10.1039/b105007a
   Tanaka M, 2004, J AM CHEM SOC, V126, P3257, DOI 10.1021/ja038981d
   Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164
   Tanaka M, 2005, J PHYS-CONDENS MAT, V17, pS649, DOI 10.1088/0953-8984/17/9/022
   Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2
   Yoshikawa HY, 2011, J AM CHEM SOC, V133, P1367, DOI 10.1021/ja1060615
   YUN WB, 1990, J APPL PHYS, V68, P1421, DOI 10.1063/1.346668
   ZILKER A, 1987, J PHYS-PARIS, V48, P2139, DOI 10.1051/jphys:0198700480120213900
NR 55
TC 5
Z9 5
U1 4
U2 88
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1359-0294
EI 1879-0399
J9 CURR OPIN COLLOID IN
JI Curr. Opin. Colloid Interface Sci.
PD OCT
PY 2013
VL 18
IS 5
BP 432
EP 439
DI 10.1016/j.cocis.2013.07.002
PG 8
WC Chemistry, Physical
SC Chemistry
GA 217JS
UT WOS:000324356400006
OA Other Gold
DA 2018-10-20
ER

PT J
AU Schweikl, H
   Hiller, KA
   Carl, U
   Schweiger, R
   Eidt, A
   Ruhl, S
   Muller, R
   Schmalz, G
AF Schweikl, Helmut
   Hiller, Karl-Anton
   Carl, Ulrich
   Schweiger, Rainer
   Eidt, Andreas
   Ruhl, Stefan
   Mueller, Rainer
   Schmalz, Gottfried
TI Salivary protein adsorption and Streptococccus gordonii adhesion to
   dental material surfaces
SO DENTAL MATERIALS
LA English
DT Article
DE Dental materials; Protein absorption; Bacterial adhesion; Saliva
ID BACTERIAL ADHESION; IN-VITRO; BIOMATERIAL SURFACES; BIOFILM FORMATION;
   IONIC-STRENGTH; MUTANS; MECHANISMS; BINDING; FORCES; RESIN
AB Objectives. The initial adhesion of microorganisms to clinically used dental biomaterials is influenced by physico-chemical parameters like hydrophobicity and pre-adsorption of salivary proteins. Here, polymethyl methacrylate (PMMA), polyethylene (PE), polytetrafluoroethylene (PTFE), silicone (Mucopren soft), silorane-based (Filtek Silorane) and methacrylate-based (Tetric EvoCeram) dental composites, a conventional glassionomer cement as well as cobalt-chromium-molybdenum (Co28Cr6Mo) and titanium (Ti6Al4V) were tested for adsorption of salivary proteins and adhesion of Streptococcus gordonii DL1.
   Methods. Wettability of material surfaces precoated with salivary proteins or left in phosphate-buffered saline was determined by the measurement of water contact angles. Amounts of adsorbed proteins were determined directly on material surfaces after biotinylation of amino groups and detection by horseradish peroxidase-conjugated avidin-D. The same technique was used to analyze for the binding of biotinylated bacteria to material surfaces.
   Results. The highest amount of proteins (0.18 mu g/cm(2)) adsorbed to hydrophobic PTFE samples, and the lowest amount (0.025 mu g/cm(2)) was detected on silicone. The highest number of S. gordonii (3.2 x 10(4) CFU/mm(2)) adhered to the hydrophilic glassionomer cement surface coated with salivary proteins, and the lowest number (4 x 10(3) CFU/mm(2)) was found on the hydrophobic silorane-based composite. Hydrophobicity of pure material surfaces and the number of attached microorganisms were weakly negatively correlated. No such correlation between hydrophobicity and the number of bacteria was detected when surfaces were coated with salivary proteins.
   Significance. Functional groups added by the adsorption of specific salivary proteins to material surfaces are more relevant for initial bacterial adhesion than hydrophobicity as a physical property. (C) 2013 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Schweikl, Helmut; Hiller, Karl-Anton; Carl, Ulrich; Schweiger, Rainer; Eidt, Andreas; Schmalz, Gottfried] Univ Regensburg, Med Ctr, Dept Operat Dent & Periodontol, D-93042 Regensburg, Germany.
   [Ruhl, Stefan] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA.
   [Mueller, Rainer] Univ Regensburg, Inst Phys & Theoret Chem, D-93053 Regensburg, Germany.
RP Schweikl, H (reprint author), Univ Regensburg, Med Ctr, Dept Operat Dent & Periodontol, D-93042 Regensburg, Germany.
EM helmut.schweikl@klinik.uni-regensburg.de
RI Mueller, Rainer/D-3326-2009
OI Mueller, Rainer/0000-0001-9641-7780; Ruhl, Stefan/0000-0003-3888-4908
FU Medical Faculty of the University of Regensburg
FX We would like to thank G. Ferstl for excellent technical assistance
   (SEM), and the Medical Faculty of the University of Regensburg for
   financial support.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   Burgers R, 2009, DENT MATER, V25, P269
   Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644
   Busscher HJ, 2008, LANGMUIR, V24, P10968, DOI 10.1021/la8016968
   Carlen A, 2001, BIOMATERIALS, V22, P481, DOI 10.1016/S0142-9612(00)00204-0
   Gocke Reinhard, 2002, Clin Oral Investig, V6, P227, DOI 10.1007/s00784-002-0176-1
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Hahnel S, 2008, J MATER SCI-MATER M, V19, P2619, DOI 10.1007/s10856-007-3352-7
   Hahnel S, 2010, J MATER SCI-MATER M, V21, P823, DOI 10.1007/s10856-009-3894-y
   Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3
   Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687
   Lindh L, 2002, SWED DENT J S, P1
   McNab R, 1999, J BACTERIOL, V181, P3087
   Montanaro L, 2004, BIOMATERIALS, V25, P4457, DOI 10.1016/j.biomaterials.2003.11.031
   Muller R, 2007, APPL ENVIRON MICROB, V73, P2653, DOI 10.1128/AEM.02884-06
   Muller R, 2006, ANAL BIOCHEM, V359, P194, DOI 10.1016/j.ab.2006.09.032
   OLSSON J, 1992, CARIES RES, V26, P428, DOI 10.1159/000261482
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Rosentritt M, 2008, J BIOMED MATER RES B, V86B, P36, DOI 10.1002/jbm.b.30985
   Ruhl S, 2004, J DENT RES, V83, P505, DOI 10.1177/154405910408300614
   SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Svendsen IE, 2009, BIOFOULING, V25, P255, DOI 10.1080/08927010802712861
   Takahashi Y, 2002, INFECT IMMUN, V70, P1209, DOI 10.1128/IAI.70.3.1209-1218.2002
   van Oss CJ, 2003, J MOL RECOGNIT, V16, P177, DOI 10.1002/jmr.618
   VASSILAKOS N, 1992, SCAND J DENT RES, V100, P346
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Walz A, 2006, PROTEOMICS, V6, P1631, DOI 10.1002/pmic.200500125
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
NR 30
TC 9
Z9 10
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD OCT
PY 2013
VL 29
IS 10
BP 1080
EP 1089
DI 10.1016/j.dental.2013.07.021
PG 10
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 215VA
UT WOS:000324237700013
PM 23953738
DA 2018-10-20
ER

PT J
AU Xu, LL
   Tremblay, ML
   Orrell, KE
   Leclerc, J
   Meng, Q
   Liu, XQ
   Rainey, JK
AF Xu, Lingling
   Tremblay, Marie-Laurence
   Orrell, Kathleen E.
   Leclerc, Jeremie
   Meng, Qing
   Liu, Xiang-Qin
   Rainey, Jan K.
TI Nanoparticle self-assembly by a highly stable recombinant spider
   wrapping silk protein subunit
SO FEBS LETTERS
LA English
DT Article
DE Biomaterial; Spider silk protein; Argiope trifasciata AcSp1;
   Nanoparticle
ID REPETITIVE DOMAIN; FIBROIN; FLUORESCENCE; MECHANISM; DELIVERY; SEQUENCE;
   FIBERS; ACSP1; PH
AB Artificial spider silk proteins may form fibers with exceptional strength and elasticity. Wrapping silk, or aciniform silk, is the toughest of the spider silks, and has a very different protein composition than other spider silks. Here, we present the characterization of an aciniform protein (AcSp1) subunit named W-1, consisting of one AcSp1 199 residue repeat unit from Argiope trifasciata. The structural integrity of recombinant W-1 is demonstrated in a variety of buffer conditions and time points. Furthermore, we show that W-1 has a high thermal stability with reversible denaturation at similar to 71 degrees C and forms self-assembled nanoparticle in near-physiological conditions. W-1 therefore represents a highly stable and structurally robust module for protein-based nanoparticle formation. (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
C1 [Xu, Lingling; Meng, Qing] Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai 201620, Peoples R China.
   [Xu, Lingling; Tremblay, Marie-Laurence; Orrell, Kathleen E.; Liu, Xiang-Qin; Rainey, Jan K.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.
   [Leclerc, Jeremie] Univ Laval, PROTEO, Quebec City, PQ G1V 0A6, Canada.
   [Rainey, Jan K.] Dalhousie Univ, Dept Chem, Halifax, NS B3H 4R2, Canada.
RP Meng, Q (reprint author), Inst Biol Sci & Biotechnol, 2999 North Renmin Rd, Shanghai, Peoples R China.
EM mengqing@dhu.edu.cn; paul.liu@dal.ca; jan.rainey@dal.ca
RI Rainey, Jan/C-1927-2008
OI Rainey, Jan/0000-0003-0793-5573
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   NSERC; Canadian Foundation for Innovation; Dalhousie Medical Research
   Foundation; National High Technology Research and Development Program
   863 [2006AA03Z451]; National Natural Science Foundation of China
   [31070698]; Ph. D. Programs Foundation of Ministry of Education of China
   [20120075110007]; CIHR; Nova Scotia Health Research Foundation
FX Thanks to Dr. Stephen Bearne for CD spectropolarimeter access, Mary Ann
   Trevors for SEM sample fixation, Ping Li for SEM sample preparation,
   Patricia Scallion for SEM imaging, and Bruce Stewart for technical
   assistance. This work was supported by Discovery Grants from the Natural
   Sciences and Engineering Research Council of Canada (NSERC) to J.K.R.
   and X. Q. L.; an NSERC Research Tools & Instruments Grant (to J.K.R.), a
   Leaders Opportunity Fund award from the Canadian Foundation for
   Innovation (to J.K.R.), a Dalhousie Medical Research Foundation Capital
   Equipment Grant (to J.K.R.), and research grants (to Q. M.) from the
   National High Technology Research and Development Program 863 (No.
   2006AA03Z451), the National Natural Science Foundation of China (No.
   31070698), and the Ph. D. Programs Foundation of Ministry of Education
   of China (No. 20120075110007). J.K.R. is supported by a CIHR New
   Investigator Award; M. L. T. by studentships from the Nova Scotia Health
   Research Foundation and a Postgraduate Scholarship from NSERC; and,
   K.E.O. by an NSERC Undergraduate Student Research Award.
CR Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Anand U, 2011, J COLLOID INTERF SCI, V364, P400, DOI 10.1016/j.jcis.2011.08.047
   Ayoub NA, 2013, MOL BIOL EVOL, V30, P589, DOI 10.1093/molbev/mss254
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   DONG DC, 1982, PHOTOCHEM PHOTOBIOL, V35, P17, DOI 10.1111/j.1751-1097.1982.tb03805.x
   Figueira-Gonzalez M, 2013, J PHYS CHEM B, V117, P2926, DOI 10.1021/jp3117962
   Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f
   Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084
   Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204
   Hofer M, 2012, BIOMATERIALS, V33, P1554, DOI 10.1016/j.biomaterials.2011.10.053
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640
   Leclerc J, 2013, BIOPOLYMERS, V99, P582, DOI 10.1002/bip.22218
   Leclerc J, 2012, BIOPOLYMERS, V97, P337, DOI 10.1002/bip.21717
   Liang MN, 2013, MAT SCI ENG C-MATER, V33, P1409, DOI 10.1016/j.msec.2012.12.044
   Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Matsumoto A, 2008, MACROMOL BIOSCI, V8, P1006, DOI 10.1002/mabi.200800020
   Menard N, 2012, PHARM RES-DORDR, V29, P1882, DOI 10.1007/s11095-012-0714-8
   Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704
   Pritchard EM, 2013, ADV FUNCT MATER, V23, P854, DOI 10.1002/adfm.201201636
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Seib F.P., ADV HEALTHC IN PRESS
   Togashi DM, 2008, J FLUORESC, V18, P519, DOI 10.1007/s10895-007-0294-x
   Wang SJ, 2012, J BIOMOL NMR, V54, P415, DOI 10.1007/s10858-012-9679-5
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833
   Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227
   Xu LL, 2012, BIOMOL NMR ASSIGN, V6, P147, DOI 10.1007/s12104-011-9344-z
   Yewale C., EXPERT OPIN IN PRESS
NR 34
TC 11
Z9 11
U1 0
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD OCT 1
PY 2013
VL 587
IS 19
BP 3273
EP 3280
DI 10.1016/j.febslet.2013.08.024
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 218ZM
UT WOS:000324472200018
PM 23994530
OA Bronze
DA 2018-10-20
ER

PT J
AU Djellouli, R
   Mahserejian, S
   Mokrane, A
   Moussaoui, M
   Laleg-Kirati, TM
AF Djellouli, R.
   Mahserejian, S.
   Mokrane, A.
   Moussaoui, M.
   Laleg-Kirati, T. M.
TI Theoretical study of the fibrous capsule tissue growth around a
   disk-shaped implant
SO JOURNAL OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Biomaterial implants; Fibrous capsule formation; Stability estimates;
   Maximum principle; Contraction semigroups; Elliptic equations; Parabolic
   equations; Inverse identification problem; Ill-posed problem
ID IN-VIVO; POLYMERS; RATS
AB We analyze the mathematical properties of the fibrous capsule tissue concentration around a disk-shaped implant. We establish stability estimates as well as monotonicity results that illustrate the sensitivity of this growth to the biocompatibility index parameters of the implant. In addition, we prove that the growth of the tissue increases exponentially in time toward an asymptotic regime. We also study the mathematical properties of the solution of the inverse problem consisting in the determination of the values of the biocompatibility index parameters from the knowledge of some fibrous capsule tissue measurements. We prove that this model calibration problem admits a unique solution, and establish a characterization of the index parameters. Furthermore, we demonstrate analytically that such a solution is not continuous with respect to the data, and therefore the considered inverse problem is ill-posed due to the lack of the stability requirement.
C1 [Djellouli, R.; Mahserejian, S.] Calif State Univ Northridge, Dept Math, Northridge, CA 91330 USA.
   [Djellouli, R.; Mahserejian, S.] Calif State Univ Northridge, IRIS, Interdisciplinary Res Inst Sci, Northridge, CA 91330 USA.
   [Mokrane, A.] Ecole Normale Super, Lab Equat Derivees Partielles Non Lineaires & His, Kouba, Algeria.
   [Moussaoui, M.] Ecole Cent Lyon, Kouba, Algeria.
   [Moussaoui, M.] Ecole Normale Super, Kouba, Algeria.
   [Laleg-Kirati, T. M.] KAUST, Math & Computat Sci & Engn Div, Thuwal, Saudi Arabia.
RP Djellouli, R (reprint author), Calif State Univ Northridge, Dept Math, Northridge, CA 91330 USA.
EM rabia.djellouli@csun.edu; shant.mahserejian.95@my.csun.edu;
   abdelhafid.mokrane@ens-kouba.dz; mmohand47@gmail.com;
   taousmeriem.laleg@kaust.edu.sa
RI Laleg-kirati, Taous Meriem/H-7316-2016
OI Laleg-kirati, Taous Meriem/0000-0001-5944-0121
FU MiniMed/Medtronic; office of Graduate Studies at CSUN [E1515]
FX The first author acknowledges the support of MiniMed/Medtronic and the
   office of Graduate Studies at CSUN under grant# E1515. Some of this work
   was conducted while the first author was visiting the Mathematical and
   Computer Sciences and Engineering Division at the King Abdullah
   University of Science and Technology. He also would like to thank KAUST
   for its generous hospitality. Any opinions, findings, conclusions, or
   recommendations expressed in this material are those of the authors and
   do not necessarily reflect the views of MiniMed/Medtronic or of the
   office of Graduate Studies at CSUN, or KAUST.
CR Adams R.A., 1975, SOBOLEV SPACES
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Berger M., 1977, NONLINEARITY FUNCTIO
   Brezis H., 1983, ANAL FONCTIONNELLE T
   Hadamard J., 1923, LECT CAUCH PROBL LIN
   Kontio R, 2005, INT J ORAL MAX SURG, V34, P766, DOI 10.1016/j.ijom.2005.04.027
   Lehle K, 2004, BIOMATERIALS, V25, P5457, DOI 10.1016/j.biomaterials.2003.12.055
   Li DJ, 1999, J BIOMED MATER RES, V45, P322, DOI 10.1002/(SICI)1097-4636(19990615)45:4<322::AID-JBM6>3.3.CO;2-U
   Lions J.-L., 1971, NONHOMOGENEOUS BOUND
   Pazy A, 1983, APPL MATH SERIES, V44
   Rauch J., 1991, PARTIAL DIFFERENTIAL
   Ravin AG, 2001, J BIOMED MATER RES, V58, P313, DOI 10.1002/1097-4636(2001)58:3<313::AID-JBM1023>3.0.CO;2-O
   RYAN P, 2007, THESIS CALIFORNIA ST
   Ryan P, 2008, J MATH BIOL, V57, P675, DOI 10.1007/s00285-008-0184-0
   Sanders JE, 2002, J BIOMED MATER RES, V62, P222, DOI 10.1002/jbm.10285
   Taylor M., 1997, PARTIAL DIFFERENTIAL
   Tikhonov AN, 1977, SOLUTIONS ILL POSED
   Tikhonov AN, 1963, SOV MATH DOKL, V4, P1624
   Weinberger HF, 1967, MAXIMUM PRINCIPLE DI
   Zhu Chun-Sheng, 1999, Journal of Medical Investigation, V46, P97
NR 20
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0303-6812
J9 J MATH BIOL
JI J. Math. Biol.
PD OCT
PY 2013
VL 67
IS 4
BP 833
EP 867
DI 10.1007/s00285-012-0566-1
PG 35
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 215ZH
UT WOS:000324249600004
PM 22903582
DA 2018-10-20
ER

PT J
AU Xie, MK
   Song, LJ
   Wang, JH
   Fan, SN
   Zhang, YP
   Xu, YM
AF Xie, Minkai
   Song, Lujie
   Wang, Jihong
   Fan, Suna
   Zhang, Yaopeng
   Xu, Yuemin
TI Evaluation of stretched electrospun silk fibroin matrices seeded with
   urothelial cells for urethra reconstruction
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE Urethra reconstruction; Tissue engineering; Silk fibroin; Biomaterial
ID IN-VITRO; INTESTINAL SUBMUCOSA; AQUEOUS-SOLUTIONS; SCAFFOLDS;
   STRICTURES; GRAFTS; BIOMATERIALS; MUCOSA; VIVO; URETHROPLASTY
AB Background: We investigated the feasibility of urethral reconstruction using stretched electrospun silk fibroin matrices.
   Materials and methods: A novel electrospun silk fibroin matrix was prepared. The structure of the material was assessed by scanning electron microscopy and a porosity test. Canine urothelial cells were isolated, expanded, and seeded onto the material for 1 wk to obtain a tissue-engineered graft. The tissue-engineered graft was assessed using hematoxylin and eosin staining and scanning electron microscopy. A dorsal urethral mucosal defect was created in nine female beagle dogs. In the experimental group, tissue-engineered mucosa was used to repair urethra mucosa defects in six dogs. No substitute was used in the three dogs of the control group. Retrograde urethrography was performed at 1, 2, and 6 mo after grafting. The urethral grafts were analyzed grossly and histologically.
   Results: Scanning electron microscope and a porosity test revealed that the material had a three-dimensional porous structure. Urothelial cells grew on the material and showed good biocompatibility with the stretched silk fibroin matrices. Canines implanted with tissue-engineered mucosa voided without difficulty. Retrograde urethrography revealed no signs of stricture. Histologic staining showed gradual epithelial cell development and stratified epithelial layers at 1, 2, and 6 mo. The canines in the control group showed difficulty in voiding. Retrograde urethrography showed urethra stricture. Histologic staining showed that no or only one layer of epithelial cells developed. A severe inflammatory reaction was also observed in the control group.
   Conclusions: Stretched electrospun silk fibroin matrices have good biocompatibility with urothelial cells, which could prove to be a potential material for use in urethra reconstruction. Crown Copyright (C) 2013 Published by Elsevier Inc. All rights reserved.
C1 [Xie, Minkai; Song, Lujie; Wang, Jihong; Xu, Yuemin] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Urol, Shanghai 200030, Peoples R China.
   [Fan, Suna; Zhang, Yaopeng] Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Coll Mat Sci & Engn, Shanghai, Peoples R China.
RP Xu, YM (reprint author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Urol, Shanghai 200030, Peoples R China.
EM zyp@dhu.edu.cn; yueminxu@hotmail.com
OI Zhang, Yaopeng/0000-0002-7175-6150
FU National Natural Science Foundation of China [81170641]; Doctor
   Innovation Fund of Shanghai Jiaotong University School of Medicine
   [BXJ201239]
FX The authors gratefully acknowledge financial support from the National
   Natural Science Foundation of China (grant no. 81170641) and the Doctor
   Innovation Fund of Shanghai Jiaotong University School of Medicine
   (grant no. BXJ201239).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   Atala A, 2009, CURR OPIN BIOTECH, V20, P575, DOI 10.1016/j.copbio.2009.10.003
   Billiar K, 2001, J BIOMED MATER RES, V56, P101, DOI 10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Fan SN, 2013, INT J BIOL MACROMOL, V56, P83, DOI 10.1016/j.ijbiomac.2013.01.033
   Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Gonzalez C, 2011, J UROLOGY, V186, P376, DOI 10.1016/j.juro.2011.05.013
   Guan GP, 2010, BIO-MED MATER ENG, V20, P295, DOI 10.3233/BME-2010-0643
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Hu XY, 2011, J SURG RES, V169, P162, DOI 10.1016/j.jss.2009.10.032
   Isotalo T, 1998, J UROLOGY, V160, P2033, DOI 10.1016/S0022-5347(01)62236-5
   Kluge JA, 2010, J MECH BEHAV BIOMED, V3, P278, DOI 10.1016/j.jmbbm.2009.12.001
   Li C, 2008, J UROLOGY, V180, P1538, DOI 10.1016/j.juro.2008.06.013
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ozgok Y, 2000, INT J UROL, V7, P355, DOI 10.1046/j.1442-2042.2000.00210.x
   Patterson JM, 2008, EUR UROL, V53, P1162, DOI 10.1016/j.eururo.2007.10.011
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Selim M, 2011, BJU INT, V107, P296, DOI 10.1111/j.1464-410X.2010.09310.x
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Song LJ, 2008, BJU INT, V101, P739, DOI 10.1111/j.1464-410X.2007.07230.x
   Tang X, 2012, BIOMATERIALS, V33, P3860, DOI 10.1016/j.biomaterials.2012.02.008
   Turner AM, 2008, EUR UROL, V54, P1423, DOI 10.1016/j.eururo.2008.03.068
   Wadbua P, 2010, INT J BIOL MACROMOL, V46, P493, DOI 10.1016/j.ijbiomac.2010.03.007
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Waxman SW, 2006, LANCET, V367, P1379, DOI 10.1016/S0140-6736(06)68592-9
   Wei W, 2011, MAT SCI ENG C-MATER, V31, P1602, DOI 10.1016/j.msec.2011.07.013
   Xu YM, 2004, J UROLOGY, V171, P220, DOI 10.1097/01.ju.0000094810.60093.bc
   Yin JW, 2010, BIOMACROMOLECULES, V11, P2890, DOI 10.1021/bm100643q
   Zhang Yuanyuan, 2013, Methods Mol Biol, V945, P383, DOI 10.1007/978-1-62703-125-7_23
   Zhou GQ, 2009, ADV MATER, V21, P366, DOI 10.1002/adma.200800582
   Zhu JX, 2007, INT J BIOL MACROMOL, V41, P469, DOI 10.1016/j.ijbiomac.2007.06.006
NR 39
TC 17
Z9 18
U1 1
U2 29
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD OCT
PY 2013
VL 184
IS 2
BP 774
EP 781
DI 10.1016/j.jss.2013.04.016
PG 8
WC Surgery
SC Surgery
GA 215XE
UT WOS:000324243500014
PM 23706393
DA 2018-10-20
ER

PT J
AU Li, MM
   Li, XB
   Meikle, MC
   Islam, I
   Cao, T
AF Li, Mingming
   Li, Xiaobing
   Meikle, Murray C.
   Islam, Intekhab
   Cao, Tong
TI Short Periods of Cyclic Mechanical Strain Enhance Triple-Supplement
   Directed Osteogenesis and Bone Nodule Formation by Human Embryonic Stem
   Cells In Vitro
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID SIGNAL-TRANSDUCTION PATHWAYS; OSTEOBLAST DIFFERENTIATION; DYNAMIC LOADS;
   DEXAMETHASONE; OSTEOCALCIN; GENE; MECHANOTRANSDUCTION; DERIVATION;
   CULTURE; PROTEIN
AB Human embryonic stem cells (hESCs) are uniquely endowed with a capacity for both self-renewal and multilineage differentiation. The aim of this investigation was to determine if short periods of cyclic mechanical strain enhanced dexamethasone, ascorbic acid, and -glycerophosphate (triple-supplement)-induced osteogenesis and bone nodule formation by hESCs. Colonies were cultured for 21 days and divided into control (no stretch) and three treatment groups; these were subjected to in-plane deformation of 2% for 5s (0.2 Hertz) every 60s for 1h on alternate days in BioFlex plates linked to a Flexercell strain unit over the following periods (day 7-13), (day 15-21), and (day 7-21). Numerous bone nodules were formed, which stained positively for osteocalcin and type I collagen; in addition, MTS assays for cell number as well as total collagen assays showed a significant increase in the day 7-13 group compared to controls and other treatment groups. Alizarin Red staining further showed that cyclic mechanical stretching significantly increased the nodule size and mineral density between days 7-13 compared to control cultures and the other two experimental groups. We then performed a real-time polymerase chain reaction (PCR) microarray on the day 7-13 treatment group to identify mechanoresponsive osteogenic genes. Upregulated genes included the transcription factors RUNX2 and SOX9, bone morphogenetic proteins BMP1, BMP4, BMP5, and BMP6, transforming growth factor- family members TGFB1, TGFB2, and TGFB3, and three genes involved in mineralizationALPL, BGLAP, and VDR. In conclusion, this investigation has demonstrated that four 1-h episodes of cyclic mechanical strain acted synergistically with triple supplement to enhance osteogenesis and bone nodule formation by cultured hESCs. This suggests the development of methods to engineer three-dimensional constructs of mineralized bone in vitro, could offer an alternative approach to osseous regeneration by producing a biomaterial capable of providing stable surfaces for osteoblasts to synthesize new bone, while at the same time able to be resorbed by an osteoclastic activityin other words, one that can recapitulate the remodeling dynamics of a naturally occurring bone matrix.
C1 [Li, Mingming; Meikle, Murray C.; Islam, Intekhab; Cao, Tong] Natl Univ Singapore, Fac Dent, Singapore 119083, Singapore.
   [Li, Xiaobing] Sichuan Univ, West China Coll Stomatol, Dept Pediat Dent, Chengdu 610064, Peoples R China.
RP Cao, T (reprint author), Natl Univ Singapore, Fac Dent, Singapore 119083, Singapore.
EM tong_cao@nuhs.edu.sg
RI CAO, Tong/B-1008-2008
OI CAO, Tong/0000-0002-7994-9627
FU Singapore Ministry of Education [R221-000-023-112, R221-000-024-133];
   National University Health System [R221000053515]
FX This research was partially funded by the following grants from
   Singapore Ministry of Education: R221-000-023-112, R221-000-024-133 and
   National University Health System: R221000053515.
CR ANDERSON HC, 1973, DEV BIOL, V34, P211, DOI 10.1016/0012-1606(73)90351-5
   Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161
   Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   Cao T, 2005, TISSUE CELL, V37, P325, DOI 10.1016/j.tice.2005.03.008
   Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   CORY AH, 1991, CANCER COMMUN, V3, P207
   DAVIDSON RM, 1990, PFLUG ARCH EUR J PHY, V416, P646, DOI 10.1007/BF00370609
   DeMali K. A., 2003, CURRENT OPINION CELL, V15, P72
   Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139
   Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4
   HARELL A, 1977, CALC TISS RES, V22, P202
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Heng BC, 2004, J BONE MINER RES, V19, P1379, DOI 10.1359/JBMR.040714
   Heng BC, 2007, BIOSCIENCE REP, V27, P257, DOI 10.1007/s10540-007-9051-2
   HERT J, 1971, Folia Morphologica (Prague), V19, P290
   Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7
   Jagodzinski M, 2004, Eur Cell Mater, V7, P35
   Jukes JM, 2010, J TISSUE ENG REGEN M, V4, P165, DOI 10.1002/term.234
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4
   Lee EJ, 2010, TISSUE ENG PT A, V16, P705, DOI 10.1089/ten.tea.2008.0596
   Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420
   Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214
   McDonald F, 1996, ARCH BIOCHEM BIOPHYS, V326, P31, DOI 10.1006/abbi.1996.0043
   Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7
   Owen M, 1985, J CELL SCI S, V10, P63
   Pekkanen-Mattila M, 2010, HISTOCHEM CELL BIOL, V133, P595, DOI 10.1007/s00418-010-0689-7
   RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012
   Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028
   SANDY JR, 1989, BIOCHIM BIOPHYS ACTA, V1010, P265, DOI 10.1016/0167-4889(89)90171-7
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294
   Sittichokechaiwut A, 2010, EUR CELLS MATER, V20, P45
   Sottile V, 2003, CLONING STEM CELLS, V5, P149, DOI 10.1089/153623003322234759
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Vande Geeste J. P., 2004, J BIOMECH, V40, P173
   Viereck V, 2002, J CELL BIOCHEM, V86, P348, DOI 10.1002/jcb.10220
   Wall ME, 2007, J BIOMECH, V40, P173, DOI 10.1016/j.jbiomech.2005.10.032
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Wu RR, 2013, HUM CELL, V26, P19, DOI 10.1007/s13577-011-0022-3
   YEH CK, 1984, CALCIFIED TISSUE INT, V36, pS67, DOI 10.1007/BF02406136
NR 48
TC 14
Z9 15
U1 1
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD OCT 1
PY 2013
VL 19
IS 19-20
BP 2130
EP 2137
DI 10.1089/ten.tea.2012.0308
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 211TI
UT WOS:000323933400005
PM 23614666
OA Green Published
DA 2018-10-20
ER

PT J
AU Raman, RKS
   Choudhary, L
AF Raman, R. K. Singh
   Choudhary, Lokesh
TI Cracking of magnesium-based biodegradable implant alloys under the
   combined action of stress and corrosive body fluid: a review
SO EMERGING MATERIALS RESEARCH
LA English
DT Article
DE biodegradable; biomaterial; magnesium alloys; metallic; stress-corrosion
   cracking; temporary implants
AB The mechanical and chemical stabilities of implant materials when used in the human body are critically important. While exposed to corrosive human body fluid, implants simultaneously experience considerable loadings and thus, may undergo environmentally assisted cracking (such as stress-corrosion cracking). This article summarizes the current research on stress-corrosion cracking of magnesium alloys and then, presents a review on their stress-corrosion cracking in simulated human body environments.
C1 [Raman, R. K. Singh; Choudhary, Lokesh] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia.
   [Raman, R. K. Singh] Monash Univ, Dept Chem Engn, Melbourne, Vic 3004, Australia.
RP Raman, RKS (reprint author), Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia.
EM raman.singh@monash.edu
CR Atrens A., 2011, STRESS CORROSION CRA
   Baker H., 1999, MAGNESIUM MAGNESIUM
   Ben-Hamu G, 2008, CORROS SCI, V50, P1505, DOI 10.1016/j.corsci.2008.02.012
   BOMBARA G, 1977, CORROS SCI, V17, P77, DOI 10.1016/0010-938X(77)90010-5
   BUNDY KJ, 1983, J BIOMED MATER RES, V17, P467, DOI 10.1002/jbm.820170307
   CHAKRAPANI DG, 1975, METALL TRANS A, V6, P1155, DOI 10.1007/BF02641898
   CHAKRAPANI DG, 1976, METALL TRANS A, V7, P173, DOI 10.1007/BF02644454
   Choudhary L, 2012, CORROSION, V68, P499, DOI 10.5006/i0010-9312-68-6-499
   Choudhary L, 2012, ACTA BIOMATER, V8, P916, DOI 10.1016/j.actbio.2011.10.031
   CRAPPER DR, 1976, BRAIN, V99, P67, DOI 10.1093/brain/99.1.67
   EBTEHAJ K, 1988, CORROS SCI, V28, P811, DOI 10.1016/0010-938X(88)90119-9
   FAIRMAN L, 1971, CORROS SCI, V11, P533, DOI 10.1016/S0010-938X(71)80020-3
   FORBES WF, 1995, EXP GERONTOL, V30, P23, DOI 10.1016/0531-5565(94)00050-D
   Granchi D, 1999, BIOMATERIALS, V20, P1079, DOI 10.1016/S0142-9612(99)00004-6
   Gu XN, 2010, ACTA BIOMATER, V6, P4605, DOI 10.1016/j.actbio.2010.07.026
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Jones R. H., 1992, STRESS CORROSION CRA
   Kannan MB, 2008, SCRIPTA MATER, V59, P175, DOI 10.1016/j.scriptamat.2008.03.001
   Kannan MB, 2008, MAT SCI ENG A-STRUCT, V480, P529, DOI 10.1016/j.msea.2007.07.070
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kannan MB, 2007, SCRIPTA MATER, V57, P579, DOI 10.1016/j.scriptamat.2007.06.019
   Kannan MB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045003
   Kannan MB, 2011, J BIOMED MATER RES B, V96B, P303, DOI 10.1002/jbm.b.31766
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kirkland NT, 2011, JOM-US, V63, P28, DOI 10.1007/s11837-011-0089-z
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   KUMAR MS, 1994, J MATER SCI LETT, V13, P142
   LYNCH SP, 1988, CORROSION, V44, P113, DOI 10.5006/1.3583907
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   McCormack BAO, 1998, INT J FATIGUE, V20, P581, DOI 10.1016/S0142-1123(98)00026-7
   MELETIS EI, 1984, CORROSION, V40, P39, DOI 10.5006/1.3579294
   Narayanan R, 2006, SURF COAT TECH, V200, P4720, DOI 10.1016/j.surfcoat.2005.04.040
   Padekar BS, 2013, CORROS SCI, V71, P1, DOI 10.1016/j.corsci.2013.01.001
   PARKINS RN, 1980, CORROS SCI, V20, P147, DOI 10.1016/0010-938X(80)90128-6
   PERRYMAN ECW, 1951, J I MET, V78, P621
   PULEO DA, 1995, J APPL BIOMATER, V6, P109, DOI 10.1002/jab.770060205
   Raman RKS, 2004, METALL MATER TRANS A, V35A, P2525
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   SIERADZKI K, 1985, PHILOS MAG A, V51, P95, DOI 10.1080/01418618508245272
   SIVAKUMAR M, 1992, J MATER SCI LETT, V11, P1039, DOI 10.1007/BF00729754
   Song G, 1997, CORROS SCI, V39, P855, DOI 10.1016/S0010-938X(96)00172-2
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song Y, 2010, ACTA BIOMATER, V6, P1736, DOI 10.1016/j.actbio.2009.12.020
   Srinivasan PB, 2008, CORROS SCI, V50, P2415, DOI 10.1016/j.corsci.2008.05.018
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   STAMPELLA RS, 1984, CORROS SCI, V24, P325, DOI 10.1016/0010-938X(84)90017-9
   Timonova M. A., 1962, INTERCRYSTALLINE COR
   Uematsu Y, 2012, MAT SCI ENG A-STRUCT, V531, P171, DOI 10.1016/j.msea.2011.10.052
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   WEARMOUTH WR, 1973, CORROSION-US, V29, P251, DOI 10.5006/0010-9312-29.6.251
   Winzer N, 2008, MAT SCI ENG A-STRUCT, V488, P339, DOI 10.1016/j.msea.2007.11.064
   Winzer N, 2008, MAT SCI ENG A-STRUCT, V472, P97, DOI 10.1016/j.msea.2007.03.021
   Winzer N, 2005, ADV ENG MATER, V7, P659, DOI 10.1002/adem.200500071
   Winzer N, 2008, METALL MATER TRANS A, V39A, P1157, DOI 10.1007/s11661-008-9475-8
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F., 2011, ACTA BIOMATER, V6, P1680
   Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Yuen CK, 2010, ACTA BIOMATER, V6, P1808, DOI 10.1016/j.actbio.2009.11.036
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhang EL, 2008, MAT SCI ENG A-STRUCT, V497, P111, DOI 10.1016/j.msea.2008.06.019
   Zhou W, 2010, CORROS SCI, V52, P1035, DOI 10.1016/j.corsci.2009.11.030
NR 69
TC 3
Z9 3
U1 2
U2 3
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2046-0147
EI 2046-0155
J9 EMERG MATER RES
JI Emerg. Mater. Res.
PD OCT
PY 2013
VL 2
IS 5
BP 219
EP 228
DI 10.1680/emr.13.00033
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA V41HU
UT WOS:000209538100002
DA 2018-10-20
ER

PT J
AU Seitz, JM
   Fau, DR
   Eifler, R
   Kietzmann, M
   Weber, C
   Durisin, M
   Bach, FW
AF Seitz, Jan-Marten
   Fau, Danielle R.
   Eifler, Rainer
   Kietzmann, Manfred
   Weber, Constantin
   Durisin, Martin
   Bach, Friedrich-Wilhelm
TI MgNd2: a future resorbable magnesium-based implant material?
SO EMERGING MATERIALS RESEARCH
LA English
DT Article
DE biomaterial; implant; mechanical properties; magnesium; neodymium; stent
AB At present, resorbable materials for implant applications are of great interest in biomedical engineering. Furthermore, the magnesium alloy MgNd2 provides unique mechanical and corrosive characteristics combined with appropriate biocompatibility, making it an ideal candidate for resorbable biomedical applications. MgNd2 provides low strength, enabling plastic deformation at similar to 80 MPa and a tensile elongation of similar to 30%, which is exceptional for magnesium alloys. Mass-loss analyses using simulated body fluid have exhibited a slow and homogeneous corrosion behavior in vitro, revealing a corrosion rate of less than 1 mm/year. Using cell viability and cytocompatibility tests, a general biocompatibility determined for MgNd2 showed no negative impact on cells. Due to excellent characteristics of MgNd2, it was successfully introduced as a resorbable stenting material within biological air-ducting tubuli and, furthermore, demonstrated desired in situ deformation characteristics.
C1 [Seitz, Jan-Marten; Eifler, Rainer; Bach, Friedrich-Wilhelm] Univ Hannover, Inst Werkstoffkunde, Garbsen, Germany.
   [Fau, Danielle R.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Kietzmann, Manfred] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany.
   [Weber, Constantin; Durisin, Martin] Hannover Med Sch, Klin & Poliklin Hals Nasen Ohrenheilkunde, D-30623 Hannover, Germany.
RP Seitz, JM (reprint author), Univ Hannover, Inst Werkstoffkunde, Garbsen, Germany.
EM seitz@iw.uni-hannover.de
FU German Research Foundation (DFG)
FX All the experiments carried out in this study were conducted within the
   Collaborative Research Centre 599 'Sustainable bioresorbable and
   permanent implants of metallic and ceramic materials' Subproject R1,
   which was funded by the German Research Foundation (DFG). The authors
   also thank Heinz Hake, Harald Kernbach, Matthew Vaughan and Anja
   Krabbenhoft for their assistance.
CR Bohlen J, 2010, MAT SCI ENG A-STRUCT, V527, P7092, DOI 10.1016/j.msea.2010.07.081
   Bostman OM, 2000, CLIN ORTHOP RELAT R, P216
   BRUCKNER L, 1978, ZBL CHIR, V103, P108
   Chlumsky V., 1900, ZENTRALBL CHIR, V27, P921
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Drynda A, 2009, J BIOMED MATER RES A, V91A, P360, DOI 10.1002/jbm.a.32235
   Eppley B L, 1996, J Craniomaxillofac Trauma, V2, P56
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P850, DOI 10.1097/01.FRS.0000132856.69391.43
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Exner E, 2004, BIONIK AKTUELLE SCHU, P351
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   FLICK H, 1977, A GRAEF ARCH KLIN EX, V205, P1, DOI 10.1007/BF00413457
   Ghali E, 2004, J MATER ENG PERFORM, V13, P7, DOI 10.1361/10599490417533
   Gorsse S, 2005, J ALLOY COMPD, V392, P253, DOI 10.1016/j.jallcom.2004.09.040
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hanzi AC, 2009, ACTA BIOMATER, V5, P162, DOI 10.1016/j.actbio.2008.07.034
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P123, DOI 10.1007/BF00443385
   Hoher J., 2004, TRAUMA BERUFSKRANKHE, V6, P285
   Hopfner E., 1903, UEBER GEFASSNACHT GE
   Huang Jingjing, 2007, Frontiers of Materials Science in China, V1, P405, DOI 10.1007/s11706-007-0074-1
   Im JN, 2007, POLYM DEGRAD STABIL, V92, P667, DOI 10.1016/j.polymdegradstab.2006.12.011
   Kopp V, 2011, J PHASE EQUILIB DIFF, V32, P298, DOI 10.1007/s11669-011-9882-1
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Lyon P., 2007, P 7 INT C MAGN ALL T, P20
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   Mayama T, 2009, COMP MATER SCI, V47, P448, DOI 10.1016/j.commatsci.2009.09.009
   Moses PA, 2002, AUST VET J, V80, P336, DOI 10.1111/j.1751-0813.2002.tb14781.x
   Muller D, 2001, BIOMED TECH, V46, P290
   Nordlien JH, 1997, CORROS SCI, V39, P1397, DOI 10.1016/S0010-938X(97)00037-1
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Park J.J., 1957, PHASE RELATIONSHIPS
   Payr E, 1905, ARCH KLIN CHIR, V77, P962
   Qi GC, 2008, APPL SURF SCI, V255, P304, DOI 10.1016/j.apsusc.2008.06.106
   RAIHA J E, 1992, Clinical Materials, V10, P35, DOI 10.1016/0267-6605(92)90082-5
   REHM KE, 1997, DER ORTHOPADE, V26, P489
   Rokhlin LL, 1995, J PHASE EQUILIB, V16, P504, DOI 10.1007/BF02646719
   Seitz JM, 2012, ACTA BIOMATER, V8, P3852, DOI 10.1016/j.actbio.2012.05.024
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   WITTENBERG JM, 1991, J ORAL MAXIL SURG, V49, P512, DOI 10.1016/0278-2391(91)90178-O
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
NR 46
TC 4
Z9 4
U1 2
U2 3
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2046-0147
EI 2046-0155
J9 EMERG MATER RES
JI Emerg. Mater. Res.
PD OCT
PY 2013
VL 2
IS 5
BP 239
EP 247
DI 10.1680/emr.13.00034
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA V41HU
UT WOS:000209538100004
DA 2018-10-20
ER

PT J
AU van Oosten, M
   Schafer, T
   Gazendam, JAC
   Ohlsen, K
   Tsompanidou, E
   de Goffau, MC
   Harmsen, HJM
   Crane, LMA
   Lim, E
   Francis, KP
   Cheung, L
   Olive, M
   Ntziachristos, V
   van Dijl, JM
   van Dam, GM
AF van Oosten, Marleen
   Schaefer, Tina
   Gazendam, Joost A. C.
   Ohlsen, Knut
   Tsompanidou, Eleni
   de Goffau, Marcus C.
   Harmsen, Hermie J. M.
   Crane, Lucia M. A.
   Lim, Ed
   Francis, Kevin P.
   Cheung, Lael
   Olive, Michael
   Ntziachristos, Vasilis
   van Dijl, Jan Maarten
   van Dam, Gooitzen M.
TI Real-time in vivo imaging of invasive- and biomaterial-associated
   bacterial infections using fluorescently labelled vancomycin
SO NATURE COMMUNICATIONS
LA English
DT Article
ID STAPHYLOCOCCUS-AUREUS; IRDYE 800CW; ANTIBIOTICS; CANCER; INFLAMMATION;
   DIAGNOSIS; PROBES; MICE
AB Invasive and biomaterial-associated infections in humans are often difficult to diagnose and treat. Here, guided by recent advances in clinically relevant optical imaging technologies, we explore the use of fluorescently labelled vancomycin (vanco-800CW) to specifically target and detect infections caused by Gram-positive bacteria. The application potential of vanco800CW for real-time in vivo imaging of bacterial infections is assessed in a mouse myositis model and a human post-mortem implant model. We show that vanco-800CW can specifically detect Gram-positive bacterial infections in our mouse myositis model, discriminate bacterial infections from sterile inflammation in vivo and detect biomaterial-associated infections in the lower leg of a human cadaver. We conclude that vanco-800CW has a high potential for enhanced non-invasive diagnosis of infections with Gram-positive bacteria and is a promising candidate for early-phase clinical trials.
C1 [van Oosten, Marleen; Gazendam, Joost A. C.; Tsompanidou, Eleni; de Goffau, Marcus C.; Harmsen, Hermie J. M.; van Dijl, Jan Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands.
   [van Oosten, Marleen; Crane, Lucia M. A.; van Dam, Gooitzen M.] Univ Groningen, Univ Med Ctr Groningen, BioOpt Imaging Ctr, Div Surg Oncol,Dept Surg, NL-9700 RB Groningen, Netherlands.
   [Schaefer, Tina; Ohlsen, Knut] Univ Wurzburg, Inst Mol Infekt Biol, D-97080 Wurzburg, Germany.
   [Gazendam, Joost A. C.] Med Ctr Alkmaar, Dept Surg, NL-1815 JD Alkmaar, Netherlands.
   [Lim, Ed; Francis, Kevin P.] Caliper, Alameda, CA 94501 USA.
   [Cheung, Lael; Olive, Michael] LI COR Biosci, Lincoln, NE 68504 USA.
   [Ntziachristos, Vasilis] Tech Univ Munich, D-85764 Neuherberg, Germany.
   [Ntziachristos, Vasilis] Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany.
RP van Dijl, JM (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.
EM j.m.van.dijl01@umcg.nl
FU CEU project [LSHGCT-2006-037469]; DFG [TR-34, Z3]
FX We thank Klaas van Linschoten, Sip Zwever, Bhanu Sinha, Federico Iovino,
   Jurgen Glatz and Rick G. Pleijhuis for expert technical support. Funding
   was provided by the authors' employers. T.S., K.O. and J.M.v.D. were in
   parts supported by the CEU project LSHGCT-2006-037469 (StaphDynamics)
   and DFG TR-34 project Z3.
CR AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919
   FORD CW, 1989, J MED MICROBIOL, V28, P259, DOI 10.1099/00222615-28-4-259
   Goh AC, 2009, WORLD J UROL, V27, P301, DOI 10.1007/s00345-009-0387-z
   Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246
   Histed SN, 2012, NUCL MED COMMUN, V33, P349, DOI 10.1097/MNM.0b013e32834ec8a5
   Israel O, 2011, ANN NY ACAD SCI, V1228, P150, DOI 10.1111/j.1749-6632.2011.06026.x
   Jalilian AR, 2008, NUCL MED REV, V11, P1
   Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107
   Konig C, 1998, J ANTIMICROB CHEMOTH, V42, P227, DOI 10.1093/jac/42.2.227
   Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050
   Kumar V, 2005, Q J NUCL MED MOL IM, V49, P325
   Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710
   Lawson TS, 2012, LETT APPL MICROBIOL, V54, P263, DOI 10.1111/j.1472-765X.2011.03197.x
   Linder KE, 2011, BIOCONJUGATE CHEM, V22, P1287, DOI 10.1021/bc100457s
   Love C, 2005, RADIOGRAPHICS, V25, P1357, DOI 10.1148/rg.255045122
   Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x
   MOELLERING RC, 1981, REV INFECT DIS, V3, pS230
   Ning XH, 2011, NAT MATER, V10, P602, DOI [10.1038/NMAT3074, 10.1038/nmat3074]
   Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/nmeth.1483, 10.1038/NMETH.1483]
   Oyen WJG, 2005, EUR J NUCL MED MOL I, V32, P151, DOI 10.1007/s00259-004-1722-7
   Panizzi P, 2011, NAT MED, V17, P1142, DOI 10.1038/nm.2423
   Parvizi J, 2010, J ARTHROPLASTY, V25, P103, DOI 10.1016/j.arth.2010.04.011
   Scheuer W, 2012, SCI TRANSL MED, V4
   Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003
   Themelis G, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259362
   Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472
NR 28
TC 76
Z9 76
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD OCT
PY 2013
VL 4
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 245NM
UT WOS:000326470400028
PM 24129412
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Panseri, S
   Russo, A
   Sartori, M
   Giavaresi, G
   Sandri, M
   Fini, M
   Maltarello, MC
   Shelyakova, T
   Ortolani, A
   Visani, A
   Dediu, V
   Tampieri, A
   Marcacci, M
AF Panseri, S.
   Russo, A.
   Sartori, M.
   Giavaresi, G.
   Sandri, M.
   Fini, M.
   Maltarello, M. C.
   Shelyakova, T.
   Ortolani, A.
   Visani, A.
   Dediu, V.
   Tampieri, A.
   Marcacci, M.
TI Modifying bone scaffold architecture in vivo with permanent magnets to
   facilitate fixation of magnetic scaffolds
SO BONE
LA English
DT Article
DE Magnetic field; Fixation; Scaffold; Bone; Oriented architecture
ID PULSED ELECTROMAGNETIC-FIELDS; HYBRID CONSTRUCTS; REGENERATION; VITRO;
   HYDROXYAPATITE; RECONSTRUCTION; STIMULATION; ORIENTATION; COLLAGEN;
   MODEL
AB The fundamental elements of tissue regeneration are cells, biochemical signals and the three-dimensional microenvironment. In the described approach, biomineralized-collagen biomaterial functions as a scaffold and provides biochemical stimuli for tissue regeneration. In addition superparamagnetic nanoparticles were used to magnetize the biomaterials with direct nucleation on collagen fibres or impregnation techniques. Minimally invasive surgery was performed on 12 rabbits to implant cylindrical NdFeB magnets in close proximity to magnetic scaffolds within the lateral condyles of the distal femoral epiphyses.
   Under this static magnetic field we demonstrated, for the first time in vivo, that the ability to modify the scaffold architecture could influence tissue regeneration obtaining a well-ordered tissue. Moreover, the association between NdFeB magnet and magnetic scaffolds represents a potential technique to ensure scaffold fixation avoiding micromotion at the tissue/biomaterial interface. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Panseri, S.; Shelyakova, T.; Ortolani, A.; Visani, A.; Marcacci, M.] Rizzoli Orthopaed Inst, Lab Biomech & Technol Innovat, I-40136 Bologna, Italy.
   [Panseri, S.; Sandri, M.; Tampieri, A.] CNR, Inst Sci & Technol Ceram, ISTEC, Faenza, RA, Italy.
   [Russo, A.; Shelyakova, T.] Rizzoli Orthopaed Inst, Lab Nanobiotechnol, I-40136 Bologna, Italy.
   [Sartori, M.; Giavaresi, G.; Fini, M.] Rizzoli Orthopaed Inst, Lab Biocompatibil Innovat Technol & Adv Therapies, I-40136 Bologna, Italy.
   [Giavaresi, G.; Fini, M.] Rizzoli Orthopaed Inst, Lab Preclin & Surg Studies, I-40136 Bologna, Italy.
   [Maltarello, M. C.] Rizzoli Orthopaed Inst, Lab Musculoskeletal Cell Biol, I-40136 Bologna, Italy.
   [Dediu, V.] CNR, Inst Nanostruct Mat, ISMN, I-40126 Bologna, Italy.
   [Marcacci, M.] Univ Bologna, Dept Human Anat & Physiopathol Locomotor Apparatu, I-40136 Bologna, Italy.
RP Panseri, S (reprint author), Rizzoli Orthopaed Inst, Lab Biomech & Technol Innovat, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM s.panseri@biomec.ior.it
RI Fini, Milena/J-4808-2016; DEDIU, Valentin/F-5365-2011
OI Fini, Milena/0000-0002-3732-3570; DEDIU, Valentin/0000-0001-9567-5112;
   Giavaresi, Gianluca/0000-0001-7843-5969; Sandri,
   Monica/0000-0001-5782-3137; Panseri, Silvia/0000-0002-8099-7132
FU European Project MAGISTER [NMP3-LA-2008-214685]
FX We would like to acknowledge European Project MAGISTER
   (NMP3-LA-2008-214685) for funding our research.
CR ASCENZI A, 1988, J BIOMECH ENG-T ASME, V110, P357, DOI 10.1115/1.3108454
   Assiotis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-24
   Ba XL, 2011, BIOMATERIALS, V32, P7831, DOI 10.1016/j.biomaterials.2011.06.053
   Bakbak S, 2011, J BIOMECH, P11
   Barnaba SA, 2012, RHEUMATOL INT, V32, P1025, DOI 10.1007/s00296-010-1724-7
   Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Colbert AP, 2009, EVID-BASED COMPL ALT, V6, P133, DOI 10.1093/ecam/nem131
   Cunha C., 2012, AM J BIOMED ENG, V2, P263, DOI DOI 10.5923/J.AJBE.20120206.05
   Darendeliler M A, 1997, Int J Adult Orthodon Orthognath Surg, V12, P43
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Fini M, 2008, BIOMED PHARMACOTHER, V62, P709, DOI 10.1016/j.biopha.2007.03.001
   FRIEDMAN MJ, 1985, CLIN ORTHOP RELAT R, P9
   Handoll HHG, 2008, COCHRANE REV, P1
   Hopp M, 2003, J MATER SCI-MATER M, V14, P335, DOI 10.1023/A:1022931915709
   Huang HM, 2006, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000203464.35561.be
   Inoue N, 2002, J ORTHOP RES, V20, P1106, DOI 10.1016/S0736-0266(02)00031-1
   Kim SH, 2006, BIOELECTROMAGNETICS, V27, P105, DOI 10.1002/bem.20182
   Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814
   Kotani H, 2000, J APPL PHYS, V87, P6191, DOI 10.1063/1.372652
   Kruyt MC, 2004, BIOMATERIALS, V25, P1463, DOI 10.1016/S0142-9612(03)00490-3
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin HY, 2011, BIOELECTROMAGNETICS, V32, P552, DOI 10.1002/bem.20668
   Lu HH, 2006, ADV BIOCHEM ENG BIOT, V102, P91, DOI 10.1007/b138509
   Lu HH, 2010, ANN BIOMED ENG, V38, P2142, DOI 10.1007/s10439-010-0046-y
   Markov MS, 2007, ELECTROMAGN BIOL MED, V26, P257, DOI 10.1080/15368370701580806
   Markov MS, 2007, ELECTROMAGN BIOL MED, V26, P1, DOI 10.1080/15368370600925342
   Moffat KL, 2009, CLIN SPORT MED, V28, P157, DOI 10.1016/j.csm.2008.08.006
   Noar J H, 1999, Br J Orthod, V26, P29
   Panseri S, 2012, J BIOMED MATER RES A, V100A, P2278, DOI 10.1002/jbm.a.34167
   Panseri S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-32
   Panseri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038710
   Panseri S, 2012, KNEE SURG SPORT TR A, V20, P1182, DOI 10.1007/s00167-011-1655-1
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Russo A, 2012, MED ENG PHYS, V34, P1287, DOI 10.1016/j.medengphy.2011.12.019
   SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021
   Singh P, 2006, INDIAN J BIOCHEM BIO, V43, P167
   Smartt JM, 2004, ANN PLAS SURG, V52, P592, DOI 10.1097/01.sap.0000123484.27287.2d
   Sprio S, 2012, J NANOMATER, V2012, P10
   Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104
   Tampieri A, 2012, ACTA BIOMATER, V8, P843, DOI 10.1016/j.actbio.2011.09.032
   Willie BM, 2010, SOFT MATTER, V6, P4976, DOI 10.1039/c0sm00262c
   Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205
   Yan QC, 1998, MED ENG PHYS, V20, P397, DOI 10.1016/S1350-4533(98)00051-4
   Young CS, 2005, TISSUE ENG, V11, P1599, DOI 10.1089/ten.2005.11.1599
   Zelle S, 2007, ARTHROSCOPY, V23, P1073, DOI 10.1016/j.arthro.2007.05.015
NR 48
TC 28
Z9 28
U1 2
U2 40
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD OCT
PY 2013
VL 56
IS 2
BP 432
EP 439
DI 10.1016/j.bone.2013.07.015
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 210VX
UT WOS:000323864000029
PM 23876980
DA 2018-10-20
ER

PT J
AU Hunt, JA
   Fok, M
   Bryan, N
AF Hunt, John A.
   Fok, Matthew
   Bryan, Nicholas
TI Impact of cell purification technique of autologous human adult stem
   cells on inflammatory reaction
SO BIOMATERIALS
LA English
DT Article
DE Autologous cell implantation; Adult stem cells; Immunoglobulin; F-c
   receptor; Reactive oxygen species; In vitro
ID ADIPOSE-TISSUE; HUMAN-NEUTROPHILS; MOLECULAR-BASIS; NADPH OXIDASE;
   FC-RECEPTORS; BONE-MARROW; MOUSE IGG1; PHOLASIN; DIFFERENTIATION;
   ACTIVATION
AB Adult stem cells have shown fantastic regenerative potential as the cellular components of biomaterial mediated tissue engineering. Realising the biomedical potential of human adult stem cells (hASCs) however will require delivery in an ultra- purified format, without competing cells which may mediate inflammation, fibrosis or tumorigenesis. Purifying ASCs involves exhuming cells from primary tissue using immunoaffinity; which isolates pure populations with the complication of retained immunoglobulin (Ig); the clinical impact of which is currently not known. One of the negative outcomes of retained surface Ig is exacerbation of inflammation by leucocyte F-c receptor (FcR) activation, with consequences ranging from inflammatory cytokine and ROS release to chronic inflammation. The balance of ROS within a tissue will impact the efficacy of a stem cell therapy as ROS play an important role in stem cell self renewal and differentiation. In this study we utilised a chemiluminescent monitoring technique based on a ROS excitable photoprotein Pholasin, to quantify leucocyte ROS production in response to xenogeneic and recombinant human Ig of varying class and isotype with applications in stem cell selection. We were able to demonstrate inter-class differences in leucocyte ROS response to Ig which also varied between donors. This study highlighted the potential for utilising this technique for personalisation of autologous ASC therapies. This would allow clinicians to perform a rapid pre-operative screen to maximise the probability for success of an ASC intervention based on cell isolation using an Ig most appropriate for a specific patient. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Hunt, John A.; Fok, Matthew; Bryan, Nicholas] Univ Liverpool, Inst Ageing & Chron Dis, UKCTE, Liverpool L69 3GA, Merseyside, England.
RP Bryan, N (reprint author), Univ Liverpool, Inst Ageing & Chron Dis, UKCTE, Liverpool L69 3GA, Merseyside, England.
EM n.bryan@liv.ac.uk
RI Hunt, John/G-6366-2012
OI Hunt, John/0000-0002-5168-4778
CR Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979
   Banas A, 2007, DEV DYNAM, V236, P3228, DOI 10.1002/dvdy.21330
   Carriere A, 2009, ARTERIOSCL THROM VAS, V29, P1093, DOI 10.1161/ATVBAHA.109.188318
   CEUPPENS JL, 1989, CELL IMMUNOL, V118, P136, DOI 10.1016/0008-8749(89)90363-8
   Crossley LJ, 2003, J LEUKOCYTE BIOL, V74, P583, DOI 10.1189/jlb.0103020
   Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5
   Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259
   Flake AW, 2004, BLOOD CELL MOL DIS, V32, P58, DOI 10.1016/j.bcmd.2003.09.015
   Glebska J, 2005, FREE RADICAL BIO MED, V38, P1014, DOI 10.1016/j.freeadbiomed.2004.12.028
   Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3
   Gupta S, 2011, ADV PARASIT, V76, P153, DOI 10.1016/B978-0-12-385895-5.00007-4
   Henderson M, 1996, BIOCHIM BIOPHYS ACTA, V1273, P87
   Higurashi S, 2012, BIOCHEM BIOPH RES CO, V417, P794, DOI 10.1016/j.bbrc.2011.12.038
   INDIK ZK, 1995, BLOOD, V86, P4389
   Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kim JS, 2007, EXP GERONTOL, V46, P500
   Knight J, 1996, BR J RHEUMATOL S2, V35
   Knight J, 1997, IMMUNOL NEWS, V4, P26
   Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107
   Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x
   Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027
   MULLER T, 1989, J BIOLUM CHEMILUM, V3, P105, DOI 10.1002/bio.1170030304
   Musina RA, 2005, B EXP BIOL MED+, V139, P504, DOI 10.1007/s10517-005-0331-1
   Naik E, 2011, J EXP MED, V31, P519
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003
   Park SG, 2011, EXPERT OPIN THER TAR, V15, P1297, DOI 10.1517/14728222.2011.628315
   Reichl S, 2001, FREE RADICAL RES, V35, P723, DOI 10.1080/10715760100301231
   Reichl S, 2000, FREE RADICAL BIO MED, V28, P1555, DOI 10.1016/S0891-5849(00)00268-9
   RODBELL M, 1966, J BIOL CHEM, V241, P130
   Romanov YA, 2005, B EXP BIOL MED+, V140, P138, DOI 10.1007/s10517-005-0430-z
   Schmielau J, 2001, CANCER RES, V61, P4756
   TAX WJM, 1985, TRANSPLANT P, V17, P794
   TAX WJM, 1984, J IMMUNOL, V133, P1185
   TSAN MF, 1980, INFLAMMATION, V4, P371, DOI 10.1007/BF00916048
   Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093
   Waller RA, 1969, J AM STAT ASSOC, V64, P1483
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 41
TC 2
Z9 2
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2013
VL 34
IS 31
BP 7626
EP 7631
DI 10.1016/j.biomaterials.2013.06.065
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 205QI
UT WOS:000323459100007
PM 23871537
DA 2018-10-20
ER

PT J
AU Hortensius, RA
   Harley, BAC
AF Hortensius, Rebecca A.
   Harley, Brendan A. C.
TI The use of bioinspired alterations in the glycosaminoglycan content of
   collagen-GAG scaffolds to regulate cell activity
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Scaffold; Tendon; Growth factors; Biomimetic material;
   Mesenchymal stem cell
ID GROWTH-FACTOR SUPPLEMENTATION; EXTRACELLULAR-MATRIX; TENOCYTE
   BIOACTIVITY; CHONDROITIN SULFATE; FACTOR DELIVERY; CROSS-LINKING;
   ROTATOR CUFF; IN-VITRO; TENDON; REGENERATION
AB The design of biomaterials for regenerative medicine can require biomolecular cues such as growth factors to induce a desired cell activity. Signal molecules are often incorporated into the biomaterial in either freely-diffusible or covalently-bound forms. However, biomolecular environments in vivo are often complex and dynamic. Notably, glycosaminoglycans (GAGs), linear polysaccharides found in the extracellular matrix, are involved in transient sequestration of growth factors via charge interactions. Biomaterials mimicking this phenomenon may offer the potential to amplify local biomolecular signals, both endogenously produced and exogenously added. GAGs of increasing sulfation (hyaluronic acid, chondroitin sulfate, heparin) were incorporated into a collagen-GAG (CG) scaffold under development for tendon tissue engineering. Manipulating the degree of GAG sulfation significantly impacts sequestration of growth factors from the media. Increasing GAG sulfation improved equine tenocyte metabolic activity in normal serum (10% FBS), low serum (1% FBS), and IGF-1 supplemented media conditions. Notably, previously reported dose-dependent changes in tenocyte bioactivity to soluble IGF-1 within the CG scaffold were replicated by using a single dose of soluble IGF-1 in scaffolds containing increasingly sulfated GAGs. Collectively, these results suggest that CG scaffold GAG content can be systematically manipulated to regulate the sequestration and resultant enhanced bioactivity of growth factor signals on cell behavior within the matrix. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Hortensius, Rebecca A.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Inst Genom Biol, Roger Adams Lab 110, 600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Harley, Brendan/0000-0001-5458-154X
FU U.S. Department of Energy [DE-FG02-07ER46453, DE-FG02-07ER46471];
   National Science Foundation [1105300]; NSF Graduate Research Fellowship
   [DGE 11-44245 FLLW]; Chemical and Biomolecular Engineering Dept.;
   Institute for Genomic Biology at the University of Illinois at
   Urbana-Champaign
FX The authors would like to acknowledge Dr. Allison Stewart (Veterinary
   Sciences, UIUC) for the equine tenocytes, Karen Doty (Veterinary
   Sciences, UIUC) for sectioning for pore size analysis, Dr. Sandra
   McMasters (SCS, UIUC) for culture media preparation, and the IGB Core
   Facilities for assistance with real-time PCR. This research was carried
   out in part in the Frederick Seitz Materials Research Laboratory Central
   Facilities, University of Illinois, which is partially supported by the
   U.S. Department of Energy under grants DE-FG02-07ER46453 and
   DE-FG02-07ER46471. This material is based upon work supported by the
   National Science Foundation under Grant No.1105300. We are grateful for
   the funding for this study provided by the NSF Graduate Research
   Fellowship DGE 11-44245 FLLW (RAH), the Chemical and Biomolecular
   Engineering Dept. (BAH), and the Institute for Genomic Biology (BAH) at
   the University of Illinois at Urbana-Champaign.
CR Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955
   Costa MA, 2006, TISSUE ENG, V12, P1937, DOI 10.1089/ten.2006.12.1937
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810
   Gulotta LV, 2009, CLIN SPORT MED, V28, P13, DOI 10.1016/j.csm.2008.09.002
   Hanson JA, 2008, NATURE, V455, P85, DOI 10.1038/nature07197
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, BIOPHYS J, V93, P2911, DOI 10.1529/biophysj.106.095471
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Hempel U, 2012, ACTA BIOMATER, V8, P659, DOI 10.1016/j.actbio.2011.10.026
   Hudalla GA, 2011, ADV MATER, V23, P5415, DOI 10.1002/adma.201103046
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   James R, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025011
   James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007
   Kapoor A, 2010, ACTA BIOMATER, V6, P2580, DOI 10.1016/j.actbio.2009.12.047
   Klenkler BJ, 2006, BIOTECHNOL BIOENG, V95, P1158, DOI 10.1002/bit.21083
   Lim JJ, 2013, BIOMATERIALS, V34, P5007, DOI 10.1016/j.biomaterials.2013.03.037
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Park A, 2010, TISSUE ENG PT A, V16, P2941, DOI 10.1089/ten.tea.2009.0710
   Pauly S, 2010, EUR CELLS MATER, V20, P84, DOI 10.22203/eCM.v020a08
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020
   Rawat M, 2008, J AM CHEM SOC, V130, P2959, DOI 10.1021/ja709993p
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Schubert M., 1965, METHODS CARBOHYDRATE, P109
   Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040
   Sohier J, 2006, J CONTROL RELEASE, V111, P95, DOI 10.1016/j.conrel.2005.11.016
   SPILLMANN D, 1994, CURR OPIN STRUC BIOL, V4, P677, DOI 10.1016/S0959-440X(94)90165-1
   Taylor SE, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-27
   Thomopoulos S, 2005, J HAND SURG-AM, V30A, P441, DOI 10.1016/j.jhsa.2004.12.006
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhang L, 2006, J CONTROL RELEASE, V114, P130, DOI 10.1016/j.jconrel.2006.06.005
NR 48
TC 38
Z9 40
U1 1
U2 89
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2013
VL 34
IS 31
BP 7645
EP 7652
DI 10.1016/j.biomaterials.2013.06.056
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 205QI
UT WOS:000323459100009
PM 23871542
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Salbach-Hirsch, J
   Kraemer, J
   Rauner, M
   Samsonov, SA
   Pisabarro, MT
   Moeller, S
   Schnabelrauch, M
   Scharnweber, D
   Hofbauer, LC
   Hintze, V
AF Salbach-Hirsch, Juliane
   Kraemer, Julia
   Rauner, Martina
   Samsonov, Sergey A.
   Pisabarro, M. Teresa
   Moeller, Stephanie
   Schnabelrauch, Matthias
   Scharnweber, Dieter
   Hofbauer, Lorenz C.
   Hintze, Vera
TI The promotion of osteoclastogenesis by sulfated hyaluronan through
   interference with osteoprotegerin and receptor activator of NF-kappa B
   ligand/osteoprotegerin complex formation
SO BIOMATERIALS
LA English
DT Article
DE Osteoprotegerin (OPG); Receptor activator of NF-kappa B ligand (RANKL);
   Hyaluronic acid/hyaluronan (HA) sulfate; Surface plasmon resonance
   (SPR); Osteoclast (OC)
ID CHONDROITIN SULFATE; DERMATAN SULFATE; BONE-RESORPTION; HEPARIN;
   GLYCOSAMINOGLYCANS; OSTEOPOROSIS; DERIVATIVES; BINDING; LIGAND; RANKL
AB In order to improve bone regeneration, in particular in aged and multimorbid patients, the development of new adaptive biomaterials and their characterization in terms of their impact on bone biology is warranted. Glycosaminoglycans (GAGs) such as hyaluronan (HA) are major extracellular matrix (ECM) components in bone and may display osteogenic properties that are potentially useful for biomaterial coatings. Using native and synthetically derived sulfate-modified HA, we evaluated how GAG sulfation modulates the activity of two main regulators of osteoclast function: receptor activator of NF-kappa B ligand (RANKL) and osteoprotegerin (OPG). GAGs were tested for their capability to bind to OPG and RANKL using surface plasmon resonance (SPR), ELISA and molecular modeling techniques. Results were validated in an in vitro model of osteoclastogenesis. Sulfated GAGs bound OPG but not RANKL in a sulfate-dependent manner. Furthermore, OPG pre-incubated with different GAGs displayed a sulfate- and dose-dependent loss in bioactivity, possibly due to competition of GAGs for the RANKL/OPG binding site revealing a potential GAG interaction site at the RANKL/OPG interface. In conclusion, high-sulfated GAGs might significantly control osteoclastogenesis via interference with the physiological RANKL/OPG complex formation. Whether these properties can be utilized to improve bone regeneration and fracture healing needs to be validated in vivo. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Salbach-Hirsch, Juliane; Rauner, Martina; Hofbauer, Lorenz C.] Tech Univ Dresden, Med Ctr, Dept Med 3, Div Endocrinol Diabet & Bone Dis, D-01307 Dresden, Germany.
   [Kraemer, Julia; Scharnweber, Dieter; Hintze, Vera] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Samsonov, Sergey A.; Pisabarro, M. Teresa] Tech Univ Dresden, BIOTEC, D-01307 Dresden, Germany.
   [Moeller, Stephanie; Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, D-07745 Jena, Germany.
   [Scharnweber, Dieter; Hofbauer, Lorenz C.] Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany.
RP Hintze, V (reprint author), Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
EM Vera.Hintze@tu-dresden.de
RI Salbach-Hirsch, Juliane/H-9409-2013; Hofbauer, Lorenz/G-2490-2010;
   Rauner, Martina/A-1665-2015; Samsonov, Sergey/P-6280-2015; Pisabarro, M.
   Teresa/D-4270-2012
OI Salbach-Hirsch, Juliane/0000-0001-7097-9953; Hofbauer,
   Lorenz/0000-0002-8691-8423; 
FU Deutsche Forschungsgemeinschaft [Transregio-67]
FX We wish to acknowledge support from the Deutsche Forschungsgemeinschaft
   [Transregio-67, projects A2, A3, A7, B2].
CR Ariyoshi W, 2008, J CELL BIOCHEM, V103, P1707, DOI 10.1002/jcb.21559
   Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018
   FULLER K, 1991, J CELL PHYSIOL, V147, P208, DOI 10.1002/jcp.1041470204
   GOLDHABER P, 1965, SCIENCE, V147, P407, DOI 10.1126/science.147.3656.407
   GRIFFITH GC, 1965, J AMER MED ASSOC, V193, P91, DOI 10.1001/jama.1965.03090020005001
   Hempel U, 2012, ACTA BIOMATER, V8, P659
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Irie A, 2007, BONE, V41, P165, DOI 10.1016/j.bone.2007.04.190
   JAFFE MD, 1965, J AMER MED ASSOC, V193, P158, DOI 10.1001/jama.1965.03090020072024
   Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050
   Kunze R, 2010, GLYCOCONJUGATE J, V27, P151, DOI 10.1007/s10719-009-9270-9
   Lamoureux F, 2009, CANCER RES, V69, P526, DOI 10.1158/0008-5472.CAN-08-2648
   Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Miller WE, 1966, OSTEOPOROSIS, V33, P31
   Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499
   Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120
   PRINCE CW, 1983, J NUTR, V113, P1576
   Salbach J, 2012, BIOMATERIALS, V33, P8418, DOI 10.1016/j.biomaterials.2012.08.028
   Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2
   Satoh A, 1998, ANAL BIOCHEM, V260, P96, DOI 10.1006/abio.1998.2668
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shinmyouzu K, 2007, BIOCHEM BIOPH RES CO, V354, P447, DOI 10.1016/j.bbrc.2006.12.221
   Soares-Schanoski A, 2007, J LEUKOCYTE BIOL, V82, P700, DOI 10.1189/jlb.1106673
   Theoleyre S, 2006, BIOCHEM BIOPH RES CO, V347, P460, DOI 10.1016/j.bbrc.2006.06.120
   Velasco CR, 2011, GLYCOBIOLOGY, V21, P781, DOI 10.1093/glycob/cwr002
   Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282
NR 31
TC 17
Z9 17
U1 4
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2013
VL 34
IS 31
BP 7653
EP 7661
DI 10.1016/j.biomaterials.2013.06.053
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 205QI
UT WOS:000323459100010
PM 23871544
DA 2018-10-20
ER

PT J
AU Guziewicz, NA
   Massetti, AJ
   Perez-Ramirez, BJ
   Kaplan, DL
AF Guziewicz, Nicholas A.
   Massetti, Andrew J.
   Perez-Ramirez, Bernardo J.
   Kaplan, David L.
TI Mechanisms of monoclonal antibody stabilization and release from silk
   biomaterials
SO BIOMATERIALS
LA English
DT Article
DE Protein; Antibody; Stability; Sustained delivery; Silk; Hydrogel
ID CONTROLLED DRUG-RELEASE; DELIVERY-SYSTEMS; SUSTAINED-RELEASE; PROTEIN
   DELIVERY; FIBROIN; DEGRADATION; TEMPERATURE; FILMS; WATER; FABRICATION
AB The availability of stabilization and sustained delivery systems for antibody therapeutics remains a major clinical challenge, despite the growing development of antibodies for a wide range of therapeutic applications due to their specificity and efficacy. A mechanistic understanding of protein-matrix interactions is critical for the development of such systems and is currently lacking as a mode to guide the field. We report mechanistic insight to address this need by using well-defined matrices based on silk gels, in combination with a monoclonal antibody. Variables including antibody loading, matrix density, charge interactions, hydrophobicity and water access were assessed to clarify mechanisms involved in the release of antibody from the biomaterial matrix. The results indicate that antibody release is primarily governed by hydrophobic interactions and hydration resistance, which are controlled by silk matrix chemistry, peptide domain distribution and protein density. Secondary ionic repulsions are also critical in antibody stabilization and release. Matrix modification by free methionine incorporation was found to be an effective strategy for mitigating encapsulation induced antibody oxidation. Additionally, these studies highlight a characterization approach to improve the understanding and development of other protein sustained delivery systems, with broad applicability to the rapidly developing monoclonal antibody field. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Guziewicz, Nicholas A.; Massetti, Andrew J.; Perez-Ramirez, Bernardo J.] Genzyme Corp, BioFormulat Dev, Framingham, MA 01701 USA.
   [Kaplan, David L.] Tufts Univ, Sch Engn, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Sch Engn, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU Genzyme; NIH [EB002520]
FX The authors would like to acknowledge Carmen Preda and Jonathan Kluge
   for sharing their expertise in silk preparation and sonication,
   respectively. We are also grateful to Robert Simler and Robert
   Mattaliano for critically reviewing the manuscript and Alison Schroeer
   for editing the figures and producing the artwork used in Fig. 6. We
   also acknowledge funding of this work, which was provided by Genzyme and
   NIH grant EB002520.
CR Bee JS, 2011, J PHARM SCI, V100, P4158
   Brouwers JRBJ, 1996, PHARM WORLD SCI, V18, P153, DOI 10.1007/BF00820726
   Casi G, 2012, J CONTROL RELEASE, V161, P422, DOI 10.1016/j.jconrel.2012.01.026
   Chang LQ, 2009, J PHARM SCI-US, V98, P2886, DOI 10.1002/jps.21825
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022
   DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407
   Dyakonov T, 2012, DRUG DELIV, V2012
   Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P28, DOI 10.4161/onci.1.1.17938
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Hawe A, 2012, J PHARM SCI-US, V101, P895, DOI 10.1002/jps.22812
   Hines DJ, 2011, BIOMACROMOLECULES, V12, P804, DOI 10.1021/bm101421r
   Hofer M, 2012, BIOMATERIALS, V33, P1554, DOI 10.1016/j.biomaterials.2011.10.053
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2010, BIOMACROMOLECULES
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Jiskoot W, 2012, J PHARM SCI-US, V101, P946, DOI 10.1002/jps.23018
   LANGER R, 1980, CHEM ENG COMMUN, V6, P1, DOI 10.1080/00986448008912519
   Langer R, 1998, NATURE, V392, P5
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Liu HC, 2006, J CHROMATOGR B, V837, P35, DOI 10.1016/j.jchromb.2006.03.053
   Lu Q, 2010, ACTA BIOMATER, V6, P1380
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566
   Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6
   Milowska K, 2007, BIOMOL ENG, V24, P263, DOI 10.1016/j.bioeng.2007.02.001
   Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Piggee C, 2008, ANAL CHEM, V80, P2305, DOI 10.1021/ac086033v
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Rapoza ML, 2006, J IMMUNOL METHODS, V316, P18, DOI 10.1016/j.jim.2006.07.009
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9
   Sohn S, 2004, BIOMACROMOLECULES, V5, P751, DOI 10.1021/bm034393
   Tsioris K, 2012, ADV FUNCT MATER, V22, P330, DOI 10.1002/adfm.201102012
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vepari C, 2010, J BIOMED MATER RES A, V93A, P595, DOI 10.1002/jbm.a.32565
   Wang SD, 2011, INT J BIOL MACROMOL, V48, P345, DOI 10.1016/j.ijbiomac.2010.12.008
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Zhang JE, 2012, P NATL ACAD SCI USA, V109, P11981, DOI 10.1073/pnas.1206210109
   Zhong TY, 2012, J BIOMED MATER RES A, V100A, P1983, DOI 10.1002/jbm.a.33307
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
NR 45
TC 26
Z9 30
U1 8
U2 100
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2013
VL 34
IS 31
BP 7766
EP 7775
DI 10.1016/j.biomaterials.2013.06.039
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 205QI
UT WOS:000323459100021
PM 23859659
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lindhe, J
   Araujo, MG
   Bufler, M
   Liljenberg, B
AF Lindhe, J.
   Araujo, M. G.
   Bufler, M.
   Liljenberg, B.
TI Biphasic alloplastic graft used to preserve the dimension of the
   edentulous ridge: an experimental study in the dog
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE alveolar socket; graft; hydroxyapatite; -TCP; ridge preservation
ID CONTROLLED CLINICAL-TRIAL; HUMAN EXTRACTION SOCKETS; TOOTH EXTRACTION;
   BIO-OSS(R) COLLAGEN; ALVEOLAR BONE; OSTEOPONTIN; TISSUE; RAT;
   PHOSPHOPROTEIN; EXPRESSION
AB Background Loss of teeth results in marked qualitative and quantitative alterations of the alveolar process at the edentulous site. It was observed that a graft comprised of bovine bone mineral placed in the fresh extraction socket delayed tissue modeling, but preserved the dimension of the ridge at edentulous sites.
   Objective To analyze the influence of a biphasic synthetic graft on tissue modeling and remodeling during healing of extraction wounds.
   Material and methods Five beagle dogs were used. Two premolars in the maxilla and two in the mandible were included. Full thickness flaps were elevated and the distal roots were removed. An alloplastic graft (BPCAP; -TCP core coated with nanocrystalline biomimetic hydroxyapatite) embedded in porcine collagen was placed to fill the fresh extraction socket of the premolar sites. Flaps were replaced to cover the entrance of the extraction sockets during early healing. The extraction and grafting procedures were scheduled to allow for the study of 1, 2, and 3months socket healing. The biopsies from the maxillary sites were decalcified, embedded in paraffin, and stained to allow the study of various aspects of hard tissue formation. The biopsies from the mandibular sites were processed for ground sectioning and used to evaluate alterations of ridge dimensions after 3months of socket healing.
   Results and conclusion It was documented that the biphasic alloplastic graft did not undergo marked resorption during tissue modeling and remodeling, but allowed large amounts of bone to form within the post-extraction site. Grafting the experimental sites with this biomaterial furthermore counteracted ridge resorption that otherwise occurs following tooth extraction.
C1 [Araujo, M. G.] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
   [Bufler, M.] Geistlich Pharma, Wolhusen, Switzerland.
   [Lindhe, J.; Liljenberg, B.] Univ Gothenburg, Inst Odontol, Sahlgrenska Acad, Gothenburg, Sweden.
RP Araujo, MG (reprint author), Rua Silva Jardim,15 Sala 03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
CR Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   BERGMAN B, 1985, J PROSTHET DENT, V53, P56, DOI 10.1016/0022-3913(85)90066-6
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Donath K., 1988, PRAPARATOR, V34, P197
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   KAWAGUCHI H, 1993, CELL MATER, V3, P337
   Mardas N, 2011, CLIN ORAL IMPLAN RES, V22, P416, DOI 10.1111/j.1600-0501.2010.02154.x
   Mardas N, 2010, CLIN ORAL IMPLAN RES, V21, P688, DOI 10.1111/j.1600-0501.2010.01918.x
   MARK MP, 1987, J HISTOCHEM CYTOCHEM, V35, P707, DOI 10.1177/35.7.3295029
   MARK MP, 1988, DIFFERENTIATION, V37, P123, DOI 10.1111/j.1432-0436.1988.tb00804.x
   NODA M, 1995, ANN NY ACAD SCI, V760, P242, DOI 10.1111/j.1749-6632.1995.tb44634.x
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   ROSS FP, 1993, J BIOL CHEM, V268, P9901
   Sanz M, 2010, CLIN ORAL IMPLAN RES, V21, P13, DOI 10.1111/j.1600-0501.2009.01824.x
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tomasi C, 2010, CLIN ORAL IMPLAN RES, V21, P30, DOI 10.1111/j.1600-0501.2009.01848.x
NR 27
TC 19
Z9 19
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD OCT
PY 2013
VL 24
IS 10
BP 1158
EP 1163
DI 10.1111/j.1600-0501.2012.02527.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 210MS
UT WOS:000323838400014
PM 22804845
DA 2018-10-20
ER

PT J
AU Ansone, L
   Klavins, M
   Viksna, A
AF Ansone, Linda
   Klavins, Maris
   Viksna, Arturs
TI Arsenic removal using natural biomaterial-based sorbents
SO ENVIRONMENTAL GEOCHEMISTRY AND HEALTH
LA English
DT Article
DE Arsenic; Peat; Biomass sorbents; Sorption
ID MODIFIED FUNGAL BIOMASS; AQUEOUS-SOLUTION; HUMIC-ACID; IRON; ADSORPTION;
   SORPTION; KINETICS; WATER; PEAT; ADSORBENTS
AB Arsenic contamination of water is a major problem worldwide. A possible solution can be approached through developing new sorbents based on cost-effective and environmentally friendly natural biomaterials. We have developed new sorbents based on biomaterial impregnation with iron oxyhydroxide. In this study, raw peat material, iron-modified peat, iron-modified biomass (shingles, straw, sands, cane and moss) as well as iron humate were used for the removal of arsenate from contaminated water. The highest sorption capacity was observed in iron-modified peat, and kinetic studies indicated that the amount of arsenic sorbed on this material exceeds 90 % in 5 h. Arsenate sorption on iron-modified peat is characterised by the pseudo-second-order mechanism. The results of arsenic sorption in the presence of competing substances indicated that sulphate, nitrate, chloride and tartrate anions have practically no influence on As(V) sorption onto Fe-modified peat, whereas the presence of phosphate ions and humic acid significantly lowers the arsenic removal efficiency.
C1 [Ansone, Linda; Klavins, Maris] Univ Latvia, Dept Environm Sci, LV-1586 Riga, Latvia.
   [Viksna, Arturs] Univ Latvia, Fac Chem, LV-1586 Riga, Latvia.
RP Ansone, L (reprint author), Univ Latvia, Dept Environm Sci, Raina Blvd 19, LV-1586 Riga, Latvia.
EM linda_ansone@inbox.lv
FU National Research Programme NatRes; European Social Fund within the
   project "Support for Doctoral Studies at the University of Latvia"
FX This work was supported by the National Research Programme NatRes and by
   the European Social Fund within the project "Support for Doctoral
   Studies at the University of Latvia".
CR Anirudhan TS, 2007, CHEMOSPHERE, V66, P60, DOI 10.1016/j.chemosphere.2006.05.031
   Ansari R., 2007, E-J CHEM, V4, P103
   Ansone L, 2012, ECOL CHEM ENG S, V19, P513, DOI 10.2478/v10216-011-0037-4
   Coates J., 2000, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A5606
   DeMarco MJ, 2003, WATER RES, V37, P164, DOI 10.1016/S0043-1354(02)00238-5
   Dupont L, 2007, ENVIRON CHEM LETT, V5, P125, DOI 10.1007/s10311-007-0092-3
   Escudero C, 2009, J HAZARD MATER, V164, P533, DOI 10.1016/j.jhazmat.2008.08.042
   Ghimire KN, 2002, SEPAR SCI TECHNOL, V37, P2785, DOI 10.1081/SS-120005466
   Giasuddin ABM, 2007, ENVIRON SCI TECHNOL, V41, P2022, DOI 10.1021/es0616534
   Gu ZM, 2005, ENVIRON SCI TECHNOL, V39, P3833, DOI 10.1021/es048179r
   Gundogan R, 2004, J COLLOID INTERF SCI, V269, P303, DOI 10.1016/S0021-9797(03)00762-8
   Guo HM, 2007, SCI TOTAL ENVIRON, V377, P142, DOI 10.1016/j.scitotenv.2007.02.001
   Henke K., 2009, ARSENIC ENV CHEM HLT
   Ho YS, 2005, PROCESS BIOCHEM, V40, P3455, DOI 10.1016/j.procbio.2005.02.017
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Katsoyiannis IA, 2002, WATER RES, V36, P5141, DOI 10.1016/S0043-1354(02)00236-1
   Ko I, 2004, COLLOID SURFACE A, V234, P43, DOI 10.1016/j.colsurfa.2003.12.001
   Kuriakose S, 2004, WATER QUAL RES J CAN, V39, P258
   Loukidou MX, 2003, WATER RES, V37, P4544, DOI 10.1016/S0043-1354(03)00415-9
   Maji SK, 2007, J SURF SCI TECHNOL, V22, P161
   Manna B, 2005, WATER QUAL RES J CAN, V40, P82
   Mikutta C, 2011, ENVIRON SCI TECHNOL, V45, P9550, DOI 10.1021/es202300w
   Mohan D, 2007, J HAZARD MATER, V142, P1, DOI 10.1016/j.jhazmat.2007.01.006
   Negrea A., 2011, CHEM B POLITEHNICA U, V56, P1
   Nemade PD, 2009, J ENVIRON BIOL, V30, P499
   Pokhrel D, 2006, WATER RES, V40, P549, DOI 10.1016/j.watres.2005.11.040
   Rodriguez-Lucena P., 2009, P INT PLANT NUTR C 1
   Tan K.H., 2005, SOIL SAMPLING PREPAR
   Thirunavkukkarasu OS, 2001, WATER QUAL RES J CAN, V36, P55
   Zhang FS, 2005, CHEMOSPHERE, V60, P319, DOI 10.1016/j.chemosphere.2004.12.019
   Zhang Y, 2003, CHEMOSPHERE, V51, P945, DOI 10.1016/S0045-6535(02)00850-0
NR 32
TC 10
Z9 11
U1 2
U2 78
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0269-4042
EI 1573-2983
J9 ENVIRON GEOCHEM HLTH
JI Environ. Geochem. Health
PD OCT
PY 2013
VL 35
IS 5
SI SI
BP 633
EP 642
DI 10.1007/s10653-013-9546-7
PG 10
WC Engineering, Environmental; Environmental Sciences; Public,
   Environmental & Occupational Health; Water Resources
SC Engineering; Environmental Sciences & Ecology; Public, Environmental &
   Occupational Health; Water Resources
GA 207YK
UT WOS:000323640600009
PM 23793448
DA 2018-10-20
ER

PT J
AU Balasubramanian, P
   Prabhakaran, MP
   Kai, D
   Ramakrishna, S
AF Balasubramanian, Preethi
   Prabhakaran, Molamma P.
   Kai, Dan
   Ramakrishna, Seeram
TI Human cardiomyocyte interaction with electrospun fibrinogen/gelatin
   nanofibers for myocardial regeneration
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE electrospinning; cross-linking; mechanical properties; infarction;
   tissue engineering
ID DRUG-DELIVERY; GROWTH-FACTOR; GELATIN MICROSPHERES; CELL-PROLIFERATION;
   CROSS-LINKING; IN-VITRO; FIBRIN; INFARCTION; COLLAGEN; SCAFFOLDS
AB Myocardial infarction is the major cause of death in many industrialized nations as it leads to end-stage heart failure. Tissue engineering (TE) approaches for treatment of the infarcted tissue have gained huge attention over the recent years and research in this direction mainly aims for the optimization of a biomaterial scaffold with suitable cell source for tissue regeneration. In this regard, we fabricated completely natural polymeric scaffolds using fibrinogen and gelatin in two different weight ratios and performed cross-linking [Fib/Gel(1:4)-CL; Fib/Gel(2:3)-CL] while cross-linked fibrinogen scaffolds were used as the control. The fiber diameters of the fabricated scaffolds were obtained in the range of 150-300nm. Chemical characterization of the scaffolds confirmed the presence of both the proteins and showed the absence of any chemical reactions between them. The tensile strength and the stiffness values of Fib/Gel(1:4)-CL matrices were found to be 0.0125 and 0.46MPa, respectively, which were much similar to the innate properties of the native myocardium. Cell culture studies using human cardiomyocytes revealed higher cell proliferation on Fib/Gel(1:4)-CL scaffolds compared to cell proliferation on Fib/Gel(2:3)-CL scaffolds, which was even higher than the cell proliferation on cross-linked fibrinogen scaffolds. Moreover, the cardiomyocytes seeded on composite substrates expressed the typical functional cardiac proteins such as alpha-actinin, troponin I, connexin-43, and myosin heavy chain, and could be potential for application in cardiac TE.
C1 [Balasubramanian, Preethi; Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
   [Prabhakaran, Molamma P.; Ramakrishna, Seeram] Natl Univ Singapore, Ctr Nanofibers & Nanotechnol, BFaculty Engn, Nanosci & Nanotechnol Initiat, Singapore 117576, Singapore.
   [Kai, Dan] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117576, Singapore.
RP Prabhakaran, MP (reprint author), Natl Univ Singapore, Ctr Nanofibers & Nanotechnol, BFaculty Engn, Nanosci & Nanotechnol Initiat, 2 Engn Dr 3, Singapore 117576, Singapore.
EM nnimpp@nus.edu.sg
RI Prabhakaran, Molamma/M-8630-2013
FU Singapore National Research Foundation under CREATE programme: The
   Regenerative Medicine Initiative in Cardiac Restoration Therapy
   (NRF-Technion WBS) [R-398-001-065-592]; Nanoscience and Nanotechnology
   Initiative, Faculty of Engineering, National University of Singapore,
   Singapore
FX This research was supported by the Singapore National Research
   Foundation under CREATE programme: The Regenerative Medicine Initiative
   in Cardiac Restoration Therapy (NRF-Technion WBS No: R-398-001-065-592)
   and the Nanoscience and Nanotechnology Initiative, Faculty of
   Engineering, National University of Singapore, Singapore.
CR Balasubramanian P, 2011, J BIOMATER TISS ENG, V1, P149, DOI 10.1166/jbt.2011.1021
   Barsotti MC, 2011, BIOTECHNOL APPL BIOC, V58, P301, DOI 10.1002/bab.49
   BLOMBACK B, 1972, ANN NY ACAD SCI, V202, P77, DOI 10.1111/j.1749-6632.1972.tb16323.x
   Boengler K, 2006, EXP GERONTOL, V41, P485, DOI 10.1016/j.exger.2006.01.011
   Caiado F, 2011, BIOMATERIALS, V32, P7096, DOI 10.1016/j.biomaterials.2011.06.022
   CARR ME, 1980, MACROMOLECULES, V13, P1473, DOI 10.1021/ma60078a022
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Coirault C, 1998, J APPL PHYSIOL, V85, P1762
   DANG CV, 1989, AM J MED, V87, P567
   Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003
   Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Kai D, 2011, J BIOMED MATER RES B, V98B, P379, DOI 10.1002/jbm.b.31862
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Lee J, 2008, BIOMATERIALS, V29, P1872, DOI 10.1016/j.biomaterials.2007.12.029
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Ma J, 1999, J AM COLL CARDIOL, V33, P1347, DOI 10.1016/S0735-1097(99)00007-8
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Prabhakaran MP, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055001
   Rybarczyk BJ, 2003, BLOOD, V102, P4035, DOI 10.1182/blood-2003-03-0822
   Sahni A, 2000, BLOOD, V96, P3772
   Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030
   SHEKHONIN BV, 1990, J MOL CELL CARDIOL, V22, P533, DOI 10.1016/0022-2828(90)90955-2
   SPEISER B, 1991, CARDIOSCIENCE, V2, P225
   Vacanti JP, 1999, LANCET, V354, pSI32
   Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5
   Weis SM, 2000, CIRC RES, V87, P663, DOI 10.1161/01.RES.87.8.663
   Wess TJ, 2005, ADV PROTEIN CHEM, V70, P341, DOI 10.1016/S0065-3233(05)70010-3
   Wiedemann D, 2010, TRANSPLANTATION, V89, P824, DOI 10.1097/TP.0b013e3181ccd822
   WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804
   Willems IEMG, 1996, J PATHOL, V179, P321
   Wu SC, 2011, J BIOACT COMPAT POL, V26, P565, DOI 10.1177/0883911511423563
   Xing Yu, 2003, Fa Yi Xue Za Zhi, V19, P242
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
NR 43
TC 17
Z9 18
U1 5
U2 67
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD OCT 1
PY 2013
VL 24
IS 14
BP 1660
EP 1675
DI 10.1080/09205063.2013.789958
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 207VJ
UT WOS:000323632500005
PM 23611504
DA 2018-10-20
ER

PT J
AU Lozano, RM
   Perez-Maceda, BT
   Carboneras, M
   Onofre-Bustamante, E
   Garcia-Alonso, MC
   Escudero, ML
AF Maria Lozano, Rosa
   Teresa Perez-Maceda, Blanca
   Carboneras, Monica
   Onofre-Bustamante, Edgar
   Cristina Garcia-Alonso, Maria
   Lorenza Escudero, Maria
TI Response of MC3T3-E1 osteoblasts, L929 fibroblasts, and J774 macrophages
   to fluoride surface-modified AZ31 magnesium alloy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE MC3T3-E1 osteoblasts; L929 fibroblasts; J774 macrophages; AZ31 magnesium
   fluoride
ID CORROSION BEHAVIOR; RESPIRATORY BURST; BIOCOMPATIBILITY; IMPLANTS; BONE;
   DIFFERENTIATION; BIODEGRADATION; BIOMATERIALS; ACTIVATION; PROTECTION
AB The present work evaluates the biocompatibility of a fluoride surface-modified AZ31 magnesium alloy (AZ31HF) with different cell lines that coexist in the implant environment to test its potential use as a biodegradable and absorbable biomaterial for bone repair. A clear stimulation of cell proliferation and an enhancement of the mitochondrial respiratory activity were observed when mouse osteoblasts (MC3T3-E1), fibroblasts (L929), and macrophages (J774) cell lines were cultured with the modified alloy. No significant change in apoptosis or viability rates was observed when osteoblasts and fibroblasts cultures were grown in the presence of this alloy. A proteomic analysis of the MC3T3-E1 cell extracts cultured in the presence of AZ31HF showed an overexpression of proteins related with the mineralization process, which is a necessary step for bone repair. An increase in the lactate dehydrogenase activity was observed in the MC3T3-E1 and J774 cell cultures that could be a response of the oxidative stress produced by the presence of the material. This stress could be related to the increase observed in the respiratory mitochondrial activity or respiratory burst measured in theses cultures that indicate damage in the cell membranes and subsequently some cell death. Results reported here, for and against AZ31HF, should be taken into account when considering the potential use of this modified alloy in bone repair applications. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 2753-2762, 2013.
C1 [Maria Lozano, Rosa; Teresa Perez-Maceda, Blanca] Ctr Invest Biol CIB CSIC, Dept Cellular & Mol Biol, Cell Biomat Recognit Lab, Madrid 28040, Spain.
   [Carboneras, Monica; Onofre-Bustamante, Edgar; Cristina Garcia-Alonso, Maria; Lorenza Escudero, Maria] Ctr Nacl Invest Met CENIM CSIC, Dept Surface Engn Corros & Durabil, Madrid 28040, Spain.
RP Lozano, RM (reprint author), Ctr Invest Biol CIB CSIC, Dept Cellular & Mol Biol, Cell Biomat Recognit Lab, C Ramiro de Maeztu 9, Madrid 28040, Spain.
EM rlozano@cib.csic.es
RI Escudero, Maria Lorenza/L-7113-2014; Garcia-Alonso, Maria
   Cristina/K-3779-2014
OI Escudero, Maria Lorenza/0000-0002-2181-448X; Garcia-Alonso, Maria
   Cristina/0000-0003-0275-4626; Fresno Escudero,
   Manuel/0000-0002-9223-5477
FU Ministerio de Ciencia e Innovacion [MAT2008-06719-C03-01-02]; Ministerio
   de Economia y Competitividad from Spain [MAT2011-29152-C02-02]
FX Contract grant sponsor: Ministerio de Ciencia e Innovacion; contract
   grant number: MAT2008-06719-C03-01-02; Contract grant sponsor: The
   Ministerio de Economia y Competitividad from Spain; contract grant
   number: MAT2011-29152-C02-02
CR Al-Abdullat Y, 2001, MATER TRANS, V42, P1777, DOI 10.2320/matertrans.42.1777
   Alcaide M, 2012, J BIOMED MATER RES A, V100A, P64, DOI 10.1002/jbm.a.33229
   Alvarez-Lopez M, 2010, ACTA BIOMATER, V6, P1763, DOI 10.1016/j.actbio.2009.04.041
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   BERRIDGE MV, 1996, BIOCHEMICA, V4, P15
   Carboneras M, 2011, MATER LETT, V65, P3020, DOI 10.1016/j.matlet.2011.06.041
   Carboneras M, 2011, REV METAL MADRID, V47, P212, DOI 10.3989/revmetalm.1065
   Carboneras M, 2011, CORROS SCI, V53, P1433, DOI 10.1016/j.corsci.2011.01.014
   Carboneras M, 2010, J ALLOY COMPD, V496, P442, DOI 10.1016/j.jallcom.2010.02.043
   Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Iles KE, 2002, IMMUNOL RES, V26, P95, DOI 10.1385/IR:26:1-3:095
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Jacobs JJ, 2001, CLIN ORTHOP RELAT R, P71
   Jo JH, 2011, J MATER SCI-MATER M, V22, P2437, DOI 10.1007/s10856-011-4431-3
   Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143-4160(02)00188-4
   Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6
   MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT
   Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317
   Murphy MB, 2011, J FUNCT BIOMATER, V2, P39, DOI 10.3390/jfb2020039
   NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Reifenrath J, 2011, MAGNESIUM ALLOYS COR, P94, DOI 10.5772/14143
   Roach HI, 1999, HISTOCHEM J, V31, P53, DOI 10.1023/A:1003519104980
   Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468
   Silerova M, 2007, GENE, V397, P169, DOI 10.1016/j.gene.2007.04.035
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3
   TSUNAWAKI S, 1984, J BIOL CHEM, V259, P4305
   VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7
   Wang W, 2005, EXP CELL RES, V305, P156, DOI 10.1016/j.yexcr.2004.12.002
   Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b
   Williams D.F, 2001, TITANIUM MED, P15
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   YEOWELL HN, 1991, ARCH BIOCHEM BIOPHYS, V289, P399, DOI 10.1016/0003-9861(91)90430-Q
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
NR 43
TC 16
Z9 18
U1 4
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2013
VL 101
IS 10
BP 2753
EP 2762
DI 10.1002/jbm.a.34579
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 208AV
UT WOS:000323648300001
PM 23427136
DA 2018-10-20
ER

PT J
AU Jiang, YP
   Jia, TH
   Gong, WM
   Wooley, PH
   Yang, SY
AF Jiang, Yunpeng
   Jia, Tanghong
   Gong, Weiming
   Wooley, Paul H.
   Yang, Shang-You
TI Effects of Ti, PMMA, UHMWPE, and Co-Cr wear particles on differentiation
   and functions of bone marrow stromal cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE aseptic loosening; wear debris; osteoblast; bone marrow stromal cells;
   gene expression
ID MESENCHYMAL STEM-CELLS; DEBRIS-INDUCED OSTEOLYSIS; REVISION TOTAL HIP;
   MURINE MODEL; TITANIUM PARTICLES; UNITED-STATES; GENE-TRANSFER;
   ARTHROPLASTY; OSTEOBLASTS; EXPRESSION
AB This study investigates the roles of orthopedic biomaterial particles [Ti-alloy, poly(methyl methacrylate) (PMMA), ultrahigh-molecular-weight polyethylene (UHMWPE), Co-Cr alloy] on the differentiation and functions of bone marrow stromal cells (BMSCs). Cells were isolated from femurs of BALB/c mice and cultured in complete osteoblast-induction medium in presence of micron-sized biomaterial particles at various doses. 3-(4,5)-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and lactate dehydrogenase assay were performed for cell proliferation and cytotoxicity. Differentiation and function of osteoblasts were evaluated by alkaline phosphatase (ALP), osteocalcin, RANKL, OSX, and Runx2 expressions. Murine interleukin-1 (IL-1), IL-6, and tumor necrosis factor- in culture media were determined by enzyme-linked immunosorbent assay. Challenge with low doses of Ti, UHMWPE, or Co-Cr particles markedly promoted the bone marrow cell proliferation while high dose of Co-Cr significantly inhibited cell growth (p < 0.05). Cells challenged with low dose of PMMA or UHMWPE particles (0.63 mg/mL) exhibited strong ALP activity, whereas Ti and Co-Cr groups showed minimal effects (p < 0.05). UHMWPE and Ti particles also promoted higher expression of proinflammatory cytokines. Real-time polymerase chain reaction data suggested that cells treated with low dose (0.5 mg/mL) particles resulted in distinctly diminished RANKL expression compared to those exposed to high concentrated (3 mg/mL) particles. In conclusion, various types of wear debris particles behaved differently in the differentiation, maturation, and functions of osteogenic cells; and the particulate debris-interacted BMSCs may play an important role in the pathogenesis and process of the debris-associated aseptic prosthetic loosening. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 2817-2825, 2013.
C1 [Jiang, Yunpeng; Wooley, Paul H.; Yang, Shang-You] Via Christi Wichita Hosp, Orthopaed Res Inst, Wichita, KS USA.
   [Jiang, Yunpeng; Jia, Tanghong; Gong, Weiming] Shandong Univ, Jinan Cent Hosp, Jinan 250100, Shandong, Peoples R China.
   [Jiang, Yunpeng; Wooley, Paul H.; Yang, Shang-You] Wichita State Univ, Dept Biol Sci, Wichita, KS 67208 USA.
RP Yang, SY (reprint author), Via Christi Wichita Hosp, Orthopaed Res Inst, Wichita, KS USA.
EM shang-You.Yang@via-christi.org
OI Yang, Shang-You/0000-0002-8835-5302
FU National Institutes of Health [5R03AR054929]; Orthopaedic Research
   Institute, Via Christi Health
FX Contract grant sponsor: National Institutes of Health; contract grant
   number: 5R03AR054929 (S-YY); Contract grant sponsor: Orthopaedic
   Research Institute, Via Christi Health
CR Abu-Amer Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2170
   Bauer TW, 2002, CLIN ORTHOP RELAT R, P138, DOI 10.1097/01.blo.00000038467.05771.90
   Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   Chiu R, 2010, J ORTHOP RES, V28, P571, DOI 10.1002/jor.21035
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   Granchi D, 2005, BIOMATERIALS, V26, P2371, DOI 10.1016/j.biomaterials.2004.07.0145
   Hundric-Haspl Z, 2006, CLIN ORTHOP RELAT R, P299, DOI 10.1097/01.blo.0000229365.57985.96
   KASUGAI S, 1990, JPN J PHARMACOL, V52, P95, DOI 10.1254/jjp.52.95
   KIM KJ, 1994, J BONE JOINT SURG AM, V76A, P172, DOI 10.2106/00004623-199402000-00002
   Koreny T, 2006, ARTHRITIS RHEUM, V54, P3221, DOI 10.1002/art.22134
   Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441
   Lassus J, 1998, CLIN ORTHOP RELAT R, P7
   Liu YL, 2010, BONE, V47, P916, DOI 10.1016/j.bone.2010.07.022
   Mandelin J, 2003, J BONE JOINT SURG BR, V85B, P1196, DOI 10.1302/0301-620X.85B8.13311
   Manolagas S.C., 1993, OSTEOPOROS INT S1, V3, P114
   MARGEVICIUS KJ, 1994, J BONE JOINT SURG AM, V76A, P1664, DOI 10.2106/00004623-199411000-00010
   Okafor CC, 2006, J ORTHOP RES, V24, P461, DOI 10.1002/jor.20075
   Rader CP, 1999, J ARTHROPLASTY, V14, P840, DOI 10.1016/S0883-5403(99)90035-9
   Ren WP, 2003, BIOMATERIALS, V24, P4819, DOI 10.1016/S0142-9612(03)00384-3
   Schaefer CJ, 1997, ARTHRITIS RHEUM-US, V40, P1064, DOI 10.1002/art.1780400611
   Schmiedberg SK, 2007, BIOMED SCI INSTRUM, V43, P104
   Sethi RK, 2003, BIOMATERIALS, V24, P2561, DOI 10.1016/S0142-9612(03)00056-5
   Stea S, 2000, CYTOKINE, V12, P1575, DOI 10.1006/cyto.2000.0753
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Vermes C, 2001, J BONE JOINT SURG AM, V83A, P201, DOI 10.2106/00004623-200102000-00007
   Vermes C, 2000, J BONE MINER RES, V15, P1756, DOI 10.1359/jbmr.2000.15.9.1756
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
   Yang SY, 2011, J ORTHOP RES, V29, P781, DOI 10.1002/jor.21287
   Yang SY, 2005, J BONE JOINT SURG AM, V87A, P1088, DOI 10.2106/JBJS.D.02052
   Yang SY, 2004, GENE THER, V11, P483, DOI 10.1038/sj.gt.3302192
   Yang SY, 2002, BIOMATERIALS, V23, P3535, DOI 10.1016/S0142-9612(02)00032-7
   Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047
   Zhang T, 2009, BIOMATERIALS, V30, P6102, DOI 10.1016/j.biomaterials.2009.07.032
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 37
TC 18
Z9 19
U1 1
U2 40
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2013
VL 101
IS 10
BP 2817
EP 2825
DI 10.1002/jbm.a.34595
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 208AV
UT WOS:000323648300007
PM 24039045
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ruiz, A
   Flanagan, CE
   Masters, KS
AF Ruiz, Amaliris
   Flanagan, Claire E.
   Masters, Kristyn S.
TI Differential support of cell adhesion and growth by copolymers of
   polyurethane with hyaluronic acid
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyurethane; hyaluronic acid; hemocompatibility; endothelialization;
   electrospinning
ID IN-VITRO HEMOCOMPATIBILITY; VASCULAR GRAFTS; PROLIFERATION;
   BIOMATERIALS; SURFACE; SCAFFOLD; FIBROBLASTS; INFECTIONS; MACROPHAGE;
   MANAGEMENT
AB Mechanical mismatch, along with inadequate hemocompatibility and endothelialization, contribute to the high failure rate of many synthetic vascular grafts. However, due to the dueling nature of these requirements (i.e., inhibiting platelet adhesion frequently means inhibiting endothelial cell (EC) adhesion), the creation of materials that simultaneously satisfy the mechanical and biological design criteria needed for small diameter vascular grafts has been an elusive goal. In this work, we demonstrate the ability of polyurethane (PU) containing hyaluronic acid (HA) in its backbone structure to reduce protein adsorption, platelet and bacterial adhesion, and fibroblast and macrophage proliferation while allowing the retention of both ECs and vascular-appropriate mechanics. Irrespective of HA molecular weight (MW), PU-HA materials selectively supported the growth of ECs relative to fibroblasts, reduced platelet adhesion, and performed comparably to negative controls with respect to bactericidal activity. The extent of EC growth on the PU-HA materials did differ with HA MW, with a lower HA MW yielding improved EC growth in both two-dimensional (2-D) films and 3-D electrospun fibrous scaffolds. These findings illustrate that HA incorporated into the backbone of a synthetic polymer structure can retain bioactivity, with subtle differences in HA MW significantly impacting the physical and biological properties of the biomaterial; in particular, PU modified with low-MW HA appears promising for vascular graft applications. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 2870-2882, 2013.
C1 [Ruiz, Amaliris; Masters, Kristyn S.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
   [Flanagan, Claire E.; Masters, Kristyn S.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA.
RP Masters, KS (reprint author), Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
EM kmasters@wisc.edu
FU Graduate Engineering Research Scholars Program; W.H. Coulter Foundation
FX Contract grant sponsors: Graduate Engineering Research Scholars Program
   and the W.H. Coulter Foundation
CR Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   Ambrosio L, 1999, J MACROMOL SCI PURE, VA36, P991, DOI 10.1080/10601329908951195
   Baumgartner JN, 1996, ASAIO J, V42, pM476, DOI 10.1097/00002480-199609000-00033
   BERGAN JJ, 1982, SURGERY, V92, P921
   Bisdas T, 2012, EUR J VASC ENDOVASC
   Bisharat N, 2012, AM J MED SCI
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Brigham MD, 2009, TISSUE ENG PT A, V15, P1645, DOI 10.1089/ten.tea.2008.0441
   Carlson GA, 2004, BIOCHEM BIOPH RES CO, V321, P472, DOI 10.1016/j.bbrc.2004.06.165
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Chuang TW, 2009, BIOMATERIALS, V30, P5341, DOI 10.1016/j.biomaterials.2009.06.029
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   De S, 2005, J BIOMAT SCI-POLYM E, V16, P973, DOI 10.1163/1568562054414612
   DEROSE G, 1984, J CARDIOVASC SURG, V25, P51
   DEVANATHAN T, 1980, BIOMATER ARTIF CELL, V8, P369, DOI 10.3109/10731198009118990
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551
   FEINBERG RN, 1983, SCIENCE, V220, P1177, DOI 10.1126/science.6857242
   Giudiceandrea A, 1998, EUR J VASC ENDOVASC, V15, P147, DOI 10.1016/S1078-5884(98)80136-6
   GOLDBERG RL, 1987, ARTHRITIS RHEUM, V30, P769, DOI 10.1002/art.1780300707
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   Ibrahim S, 2008, J TISSUE ENG REGEN M, V2, P22, DOI 10.1002/term.61
   Imamura E., 1981, ARTIF ORGANS, V10, P590
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   Iwasaki K, 2008, CIRCULATION, V118, pS52, DOI 10.1161/CIRCULATIONAHA.107.757369
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Joddar B, 2006, BIOMATERIALS, V27, P2994, DOI 10.1016/j.biomaterials.2006.01.020
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Krijgsman B, 2002, TISSUE ENG, V8, P673, DOI 10.1089/107632702760240580
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   Laser A, 2011, J VASC SURG, V54, P58, DOI 10.1016/j.jvs.2010.11.111
   Lee DG, 2010, UROLOGY, V75, P949, DOI 10.1016/j.urology.2009.05.047
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Li JX, 2006, MACROMOL RAPID COMM, V27, P114, DOI 10.1002/marc.200500726
   Li W. J., 2009, CURR PROTOC CELL BIO
   Liu RH, 2012, J BIOMED MATER RES A, V100A, P2750, DOI 10.1002/jbm.a.34211
   Liu WJ, 2002, J APPL POLYM SCI, V86, P2145, DOI 10.1002/app.11023
   MAST BA, 1993, MATRIX, V13, P441, DOI 10.1016/S0934-8832(11)80110-1
   Morra M, 2005, BIOMACROMOLECULES, V6, P1205, DOI 10.1021/bm049346i
   National Institutes of Health, 2002, IN VITR CYT TEST MET, V2012
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   PATRICE T, 1989, DIGEST DIS SCI, V34, P1681, DOI 10.1007/BF01540044
   Pirnazar P, 1999, J PERIODONTOL, V70, P370, DOI 10.1902/jop.1999.70.4.370
   Pottecher T, 1984, Eur J Anaesthesiol, V1, P361
   Ratcliffe A, 2000, MATRIX BIOL, V19, P353, DOI 10.1016/S0945-053X(00)00080-9
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Roy-Chaudhury P, 2009, NEPHROL DIAL TRANSPL, V24, P2786, DOI 10.1093/ndt/gfn708
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Sheehan KM, 2004, LIFE SCI, V75, P3087, DOI 10.1016/j.lfs.2004.02.038
   Shi Y, 1996, CIRCULATION, V94, P1655, DOI 10.1161/01.CIR.94.7.1655
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315
   Soletti L, 2010, ACTA BIOMATER, V6, P110, DOI 10.1016/j.actbio.2009.06.026
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504
   VEITH FJ, 1979, SURGERY, V85, P253
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   Xu F, 2008, BIOMATERIALS, V29, P150, DOI 10.1016/j.biomaterials.2007.09.028
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Zeltsman D, 1999, AM SURGEON, V65, P331
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
NR 66
TC 9
Z9 9
U1 1
U2 80
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2013
VL 101
IS 10
BP 2870
EP 2882
DI 10.1002/jbm.a.34597
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 208AV
UT WOS:000323648300013
PM 23505036
DA 2018-10-20
ER

PT J
AU Singh, AV
AF Singh, Ajay Vikram
TI Biotechnological applications of supersonic cluster beam-deposited
   nanostructured thin films: Bottom-up engineering to optimize
   cell-protein-surface interactions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE nanocluster; AFM; microarray; cell-surface interactions; high throughput
ID ATOMIC-FORCE MICROSCOPY; BOVINE SERUM-ALBUMIN; CARBON-FILMS; ALLOY
   NANOPARTICLES; FUNCTION SCREENS; FLAME SYNTHESIS; GENE-FUNCTION;
   MICROARRAYS; TIO2; TECHNOLOGY
AB Technological innovations in biomaterial sciences harness nanoparticle (NP) production, manipulation, and deposition with supreme precision, enabling the development of industrial processes. This review first discusses the basic components of this approach, introducing cluster sources, experimental apparatus, and growth mechanisms for NP formation. The second part of this review provides an overview of how the nanoscale bottom-up engineering can control protein adsorption, which in turn determines the fate of nanostructured coating for prokaryotic and mammalian (primary and stem) cell interactions. In addition, we briefly address the implications of the cluster beam deposition technique for nanostructuration of biocompatible microdevices and its potential as a facile coating method to promote protein-surface interactions for microarray applications in biotechnology. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:2994-3008, 2013.
C1 [Singh, Ajay Vikram] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Singh, Ajay Vikram] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
RP Singh, AV (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
EM singha8@rpi.edu
FU Department of Biomedical Engineering (BME), Rensselaer Polytechnic
   Institute (RPI)
FX Contract grant sponsors: Department of Biomedical Engineering (BME),
   Rensselaer Polytechnic Institute (RPI; AVS)
CR Andersen N., 1988, ATOMIC MOL BEAM METH, V1, P206
   [Anonymous], 2005, NAT MATER, V4, P575, DOI 10.1038/nmat1445
   Ariga K, 2006, J NANOSCI NANOTECHNO, V6, P2278, DOI 10.1166/jnn.2006.503
   Bailey SN, 2006, NAT METHODS, V3, P117, DOI 10.1038/NMETH848
   BARABASI AL, 1995, FRACTAL CONCEPTS SUR
   Barborini E, 2000, APPL PHYS LETT, V77, P1059, DOI 10.1063/1.1289040
   Barborini E, 2005, ADV MATER, V17, P1842, DOI 10.1002/adma.200401169
   Barborini E, 1999, J PHYS D APPL PHYS, V32, pL105, DOI 10.1088/0022-3727/32/21/102
   Barborini E, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/5/055015
   Barborini E, 1999, CHEM PHYS LETT, V300, P633, DOI 10.1016/S0009-2614(98)01449-3
   Belicchi M, 2010, BIOMATERIALS, V31, P5385, DOI 10.1016/j.biomaterials.2010.03.021
   Bertone P, 2005, FEBS J, V272, P5400, DOI 10.1111/j.1742-4658.2005.04970.x
   Boccaccini AR, 2010, J R SOC INTERFACE, V7, pS581, DOI 10.1098/rsif.2010.0156.focus
   BRAUN JH, 1992, PROG ORG COAT, V20, P105, DOI 10.1016/0033-0655(92)80001-D
   Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826
   Carbone R, 2006, BIOMATERIALS, V27, P3221, DOI 10.1016/j.biomaterials.2006.01.056
   Carbone R, 2007, BIOMATERIALS, V28, P2244, DOI 10.1016/j.biomaterials.2006.12.026
   Carbone R, 2009, ANAL BIOCHEM, V394, P7, DOI 10.1016/j.ab.2009.07.005
   Caruso T, 2007, SURF SCI, V601, P2688, DOI 10.1016/j.susc.2006.12.025
   Cassina V, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115422
   Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139
   Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102
   Chiappini C, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2746824
   De Marni ML, 2012, METHODS, V56, P317, DOI 10.1016/j.ymeth.2011.06.008
   Della Foglia F, 2009, J NANOPART RES, V11, P1339, DOI 10.1007/s11051-009-9691-1
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Eaton MAW, 2011, NANOMED-NANOTECHNOL, V7, P371, DOI 10.1016/j.nano.2011.05.015
   Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836
   Eran B., 2004, COMBINING TOP DOWN B, P46
   Fabre RM, 2009, LANGMUIR, V25, P12644, DOI 10.1021/la901920y
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fioretti F, 2010, ACS NANO, V4, P3277, DOI 10.1021/nn100713m
   Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030
   Galli C, 2001, SURF SCI, V474, pL180, DOI 10.1016/S0039-6028(00)01054-2
   Giorgetti L, 2008, LANGMUIR, V24, P11637, DOI 10.1021/la801910p
   Giorgetti L, 2007, EXPERT REV PROTEOMIC, V4, P609, DOI 10.1586/14789450.4.5.609
   Guilleaume B, 2005, PROTEOMICS, V5, P4705, DOI 10.1002/pmic.200401324
   Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916
   Haouzi D, 2005, J CELL SCI, V118, P2763, DOI 10.1242/jcs.02403
   Harrison PM, 2002, NUCLEIC ACIDS RES, V30, P1083, DOI 10.1093/nar/30.5.1083
   Hook AL, 2006, TRENDS BIOTECHNOL, V24, P471, DOI 10.1016/j.tibtech.2006.08.001
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Kammler HK, 2001, CHEM ENG TECHNOL, V24, P583, DOI 10.1002/1521-4125(200106)24:6<583::AID-CEAT583>3.0.CO;2-H
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kasemo B, 1998, CURR OPIN SOLID ST M, V3, P451, DOI 10.1016/S1359-0286(98)80006-5
   Koegler P, 2012, ADV DRUG DELIVER REV, V64, P1820, DOI 10.1016/j.addr.2012.06.001
   Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993
   Lenardi C, 2006, J NANOSCI NANOTECHNO, V6, P3718, DOI 10.1166/jnn.2006.619
   Li J, 2010, ADV TOP SCI TECH CHI, P1, DOI 10.1007/978-3-642-05012-1
   Ling MM, 2007, EXPERT REV MOL DIAGN, V7, P87, DOI 10.1586/14737159.7.1.87
   Liotta LA, 2001, JAMA-J AM MED ASSOC, V286, P2211, DOI 10.1001/jama.286.18.2211
   Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617
   Mazza T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2035874
   Milani P, 2001, J VAC SCI TECHNOL A, V19, P2025, DOI 10.1116/1.1331289
   Milani P, 1999, EUR PHYS J D, V9, P63, DOI 10.1007/s100530050400
   Neher E, 2001, NAT BIOTECHNOL, V19, P114, DOI 10.1038/84359
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Oliver RG, 2001, ORTHODONTIC MAT SCI, P310
   Olson CL, 2006, J PHYS CHEM B, V110, P9995, DOI 10.1021/jp0572611
   Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709
   Perry JL, 2011, ACCOUNTS CHEM RES, V44, P990, DOI 10.1021/ar2000315
   Petricoin EF, 2005, J CLIN ONCOL, V23, P3614, DOI 10.1200/JCO.2005.02.509
   Piseri P, 2001, REV SCI INSTRUM, V72, P2261, DOI 10.1063/1.1361082
   Piseri P, CURR OPIN SOLID STAT, V8, P195
   Ratner B., 2011, J CARDIOVASTRANSL RE, P1
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5
   Rocker C, 2009, NAT NANOTECHNOL, V4, P577, DOI [10.1038/NNANO.2009.195, 10.1038/nnano.2009.195]
   Ronzoni S, 2005, CYTOM PART A, V66A, P52, DOI 10.1002/cyto.a.20151
   Saerens Dirk, 2008, Briefings in Functional Genomics & Proteomics, V7, P275, DOI 10.1093/bfgp/eln028
   Santamaria Annette, 2012, Methods Mol Biol, V926, P1, DOI 10.1007/978-1-62703-002-1_1
   Schmidt SR, 2009, IEEE INT C EM TECHN, P1, DOI DOI 10.1109/ETFA.2009.5347197
   Scopelliti PE, 2009, BIOPHYS J, V96, p50A
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Sevecka M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005363
   Singh AV, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/47/475101
   Singh AV, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/11/115028
   Singh AV, 2009, COLLOID SURFACE B, V69, P239, DOI 10.1016/j.colsurfb.2008.11.021
   Singh AV, 2011, MAT SCI ENG C-MATER, V31, P892, DOI 10.1016/j.msec.2011.02.006
   Singh AV, 2013, J NANOSCI NANOTECHNO, V13, P77, DOI 10.1166/jnn.2013.6727
   Singh AV, 2012, J NEUROSCI RURAL PRA, V3, P301, DOI 10.4103/0976-3147.102611
   Singh AV, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025001
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Singh AV, 2005, J MATER CHEM, V15, P5115, DOI 10.1039/b510398c
   Singh AV, 2012, AUTOIMMUNE DIS, V2012, P1
   Singh Y, 2002, J AEROSOL SCI, V33, P1309, DOI 10.1016/S0021-8502(02)00072-1
   Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179
   Stark WJ, 2002, POWDER TECHNOL, V126, P103, DOI 10.1016/S0032-5910(02)00077-3
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tafreshi HV, 2006, J NANOSCI NANOTECHNO, V6, P1140, DOI 10.1166/jnn.2006.139
   Tafreshi HV, 2002, AEROSOL SCI TECH, V36, P593, DOI 10.1080/02786820252883838
   Tomilin NV, 2001, RADIAT RES, V156, P347, DOI 10.1667/0033-7587(2001)156[0347:VOFNSO]2.0.CO;2
   Vandamme N, 2001, APPL PHYS A-MATER, V72, pS177, DOI 10.1007/s003390100660
   Vendra VK, 2010, POLYM THIN FILMS BIO, P54
   Vyas V, 2011, J NANOSCI NANOTECHNO, V11, P4739, DOI 10.1166/jnn.2011.4113
   Wegner K, 2006, J PHYS D APPL PHYS, V39, pR439, DOI 10.1088/0022-3727/39/22/R02
   Wegner K, 2003, CHEM ENG SCI, V58, P4581, DOI 10.1016/j.ces.2003.07.010
   Wegner K, 2003, AICHE J, V49, P1667, DOI 10.1002/aic.690490707
   Wheeler DB, 2005, NAT GENET, V37, pS25, DOI 10.1038/ng1560
   Wheeler DB, 2004, NAT METHODS, V1, P127, DOI 10.1038/NMETH711
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu RZ, 2002, TRENDS CELL BIOL, V12, P485, DOI 10.1016/S0962-8924(02)02354-1
   Yarmush ML, 2009, ANNU REV BIOMED ENG, V11, P235, DOI 10.1146/annurev.bioeng.10.061807.160502
   Zanardi A, 2007, MOL CELL PROTEOMICS, V6, P939, DOI 10.1074/mcp.T600051-MCP200
   Zanardi A, 2010, BIOTECHNIQUES, V49, P497, DOI 10.2144/000113445
   Zhou J, 2011, 2011 INT C MOD PYR C, P472
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 109
TC 12
Z9 12
U1 3
U2 42
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2013
VL 101
IS 10
BP 2994
EP 3008
DI 10.1002/jbm.a.34601
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 208AV
UT WOS:000323648300025
PM 23519999
DA 2018-10-20
ER

PT J
AU Lieder, R
   Petersen, PH
   Sigurjonsson, OE
AF Lieder, Ramona
   Petersen, Petur Henry
   Sigurjonsson, Olafur Eysteinn
TI Endotoxins-the Invisible Companion in Biomaterials Research
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; TOTAL HIP-REPLACEMENT; TOLL-LIKE RECEPTOR-4;
   LPS-BINDING-PROTEIN; TITANIUM PARTICLES; OSTEOCLAST DIFFERENTIATION;
   IN-VITRO; POLYETHYLENE PARTICLES; BACTERIAL-ENDOTOXINS; ADHERENT
   ENDOTOXIN
AB Metal implants and polymeric devices for the application in the clinical treatment of orthopedic tissue injuries are increasingly coated with bioactive biomaterials derived from natural substances to induce desirable biological effects. Many metals and polymers used in biomaterials research show high affinity for endotoxins, which are abundant in the environment. Endotoxin contamination is indicated in the pathology of periodontitis and aseptic implant loosening, but may also affect the evaluation of a biomaterial's bioactivity by inducing strong inflammatory reactions. In this review, we discuss the high affinity of three commonly used implant biomaterials for endotoxins and how the contamination can affect the outcome of the orthopedic fixation. The chemical nature of bacterial endotoxins and some of the clinical health implications are described, as this knowledge is critically important to tackle the issues associated with the measurement and removal of endotoxins from medical devices. Commonly used methods for endotoxin testing and removal from natural substances are examined and the lack of standard guidelines for the in vitro evaluation of biomaterials is discussed.
C1 [Lieder, Ramona; Sigurjonsson, Olafur Eysteinn] Landspitali Univ Hosp, Blood Bank, IS-105 Reykjavik, Iceland.
   [Lieder, Ramona; Sigurjonsson, Olafur Eysteinn] Reykjavik Univ, Sch Sci & Engn, Reykjavik, Iceland.
   [Petersen, Petur Henry; Sigurjonsson, Olafur Eysteinn] Univ Iceland, Biomed Ctr, Reykjavik, Iceland.
   [Petersen, Petur Henry] Univ Iceland, Fac Med, Reykjavik, Iceland.
RP Sigurjonsson, OE (reprint author), Landspitali Univ Hosp, Blood Bank, Snorrabraut 60, IS-105 Reykjavik, Iceland.
EM oes@landspitali.is
OI Sigurjonsson, Olafur/0000-0002-4968-842X
FU Technology Development Fund; Icelandic Research Fund; Landspitali
   University Hospital
FX We like to acknowledge the Technology Development Fund and the Icelandic
   Research Fund, managed by the Icelandic Centre for Research and the
   Landspitali University Hospital research fund for funding.
CR AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U
   Amaral IF, 2007, J BIOMAT SCI-POLYM E, V18, P469, DOI 10.1163/156856207780425068
   ANSPACH FB, 1995, J CHROMATOGR A, V711, P81, DOI 10.1016/0021-9673(95)00126-8
   Ashwood P, 2007, EXP BIOL MED, V232, P107
   Bauer TW, 2002, CLIN ORTHOP RELAT R, P138, DOI 10.1097/01.blo.00000038467.05771.90
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   BENDE S, 1986, CIRC SHOCK, V19, P239
   Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004
   Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Bi YM, 2002, J ORTHOPAED RES, V20, P696, DOI 10.1016/S0736-0266(01)00176-0
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Breger JC, 2009, J BIOMED MATER RES B, V91B, P755, DOI 10.1002/jbm.b.31452
   Bryans Trabue D., 2004, Biomedical Instrumentation & Technology, V38, P73, DOI 10.2345/0899-8205(2004)38[73:BETARO]2.0.CO;2
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734
   BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139
   Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010
   Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X
   CHESTER IR, 1975, EUR J BIOCHEM, V58, P273, DOI 10.1111/j.1432-1033.1975.tb02373.x
   Cho DR, 2002, J ORTHOPAED RES, V20, P704, DOI 10.1016/S0736-0266(01)00179-6
   Cinquemani C, 2011, J IND MICROBIOL BIOT, V38, P29, DOI 10.1007/s10295-010-0824-4
   COOPERSTOCK MS, 1975, LANCET, V1, P1272
   CORRADIN SB, 1992, J LEUKOCYTE BIOL, V52, P363
   Darkow R, 1999, BIOMATERIALS, V20, P1277, DOI 10.1016/S0142-9612(99)00022-8
   Davydova VN, 2000, BIOCHEMISTRY-MOSCOW+, V65, P1082
   Dean DD, 1999, J BONE JOINT SURG AM, V81A, P452, DOI 10.2106/00004623-199904000-00002
   Dean DD, 1999, J ORTHOPAED RES, V17, P9, DOI 10.1002/jor.1100170104
   DEVLEESCHOUWER MJ, 1985, APPL ENVIRON MICROB, V50, P1509
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541
   Engesaeter LB, 2003, ACTA ORTHOP SCAND, V74, P644, DOI 10.1080/00016470310018135
   Ermak IM, 2004, B EXP BIOL MED+, V137, P379, DOI 10.1023/B:BEBM.0000035136.61014.c2
   Fang H, 2004, BIOMATERIALS, V25, P5433, DOI 10.1016/j.biomaterials.2003.12.035
   Gagnon F, 1994, J Prosthodont, V3, P228, DOI 10.1111/j.1532-849X.1994.tb00160.x
   GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z
   Goodman SB, 2009, J BIOMED MATER RES A, V90A, P603, DOI 10.1002/jbm.a.32063
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Gruber R, 2010, WIEN MED WOCHENSCHR, V160, P438, DOI 10.1007/s10354-010-0809-y
   Gutsmann T, 2007, INT J MED MICROBIOL, V297, P341, DOI 10.1016/j.ijmm.2007.03.004
   Hallan G, 2010, J BONE JOINT SURG BR, V92B, P196, DOI 10.1302/0301-620X.92B2.22179
   Hamann L, 2005, INFECT IMMUN, V73, P193, DOI 10.1128/IAI.73.1.193-200.2005
   Hasiwa M, 2007, BIOMATERIALS, V28, P1367, DOI 10.1016/j.biomaterials.2006.11.016
   Hirayama C, 2002, J CHROMATOGR B, V781, P419, DOI 10.1016/S1570-0232(02)00430-0
   Hitchins VM, 1999, J BIOMED MATER RES, V46, P434
   Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313
   Horn DL, 1996, SCAND J INFECT DIS, P9
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   HOU KC, 1990, J PARENT SCI TECHN, V44, P204
   HOU KC, 1990, BIOTECHNOL APPL BIOC, V12, P315
   INADA K, 1991, MICROBIOL IMMUNOL, V35, P303, DOI 10.1111/j.1348-0421.1991.tb01559.x
   ISSEKUTZ AC, 1983, J IMMUNOL METHODS, V61, P275, DOI 10.1016/0022-1759(83)90221-1
   Itoh K, 2003, J IMMUNOL, V170, P3688, DOI 10.4049/jimmunol.170.7.3688
   JANN B, 1975, EUR J BIOCHEM, V60, P239, DOI 10.1111/j.1432-1033.1975.tb20996.x
   Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320
   JOINER KA, 1984, INFECT IMMUN, V45, P113
   Kanayama Y, 2007, BIOL PHARM BULL, V30, P237, DOI 10.1248/bpb.30.237
   KARPLUS TE, 1987, J IMMUNOL METHODS, V105, P211, DOI 10.1016/0022-1759(87)90268-7
   KAWAGUCHI H, 1995, RES COMMUN MOL PATH, V89, P317
   Knoernschild K L, 1994, Int J Prosthodont, V7, P22
   Kumbar SG, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065005
   Lassus J, 2000, ARCH ORTHOP TRAUM SU, V120, P328, DOI 10.1007/s004020050475
   Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4
   Li YM, 1999, ANAL BIOCHEM, V267, P121, DOI 10.1006/abio.1998.2989
   Li ZX, 2011, J ARTIF ORGANS, V14, P163, DOI 10.1007/s10047-011-0585-5
   Lieder R, 2013, ACTA BIOMATER, V9, P4771, DOI 10.1016/j.actbio.2012.08.043
   Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x
   Liu CL, 1998, J CHROMATOGR B, V711, P127, DOI 10.1016/S0378-4347(98)00013-9
   Llewelyn M, 2001, CURR CLIN TOPICS INF, V21, P148
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LOPPNOW H, 1989, J IMMUNOL, V142, P3229
   Lynn WA, 1998, J ANTIMICROB CHEMOTH, V41, P71, DOI 10.1093/jac/41.suppl_1.71
   Machado RL, 2006, PROCESS BIOCHEM, V41, P2252, DOI 10.1016/j.procbio.2006.05.015
   Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388
   Maitz MF, 2009, J BIOMED MATER RES B, V90B, P18, DOI 10.1002/jbm.b.31247
   Marshall JC, 2004, J INFECT DIS, V190, P527, DOI 10.1086/422254
   MATSUMAE H, 1990, BIOTECHNOL APPL BIOC, V12, P129
   Mazzola PG, 2006, BIOTECHNOL BIOENG, V93, P998, DOI 10.1002/bit.20806
   MENDIOLA LR, 1972, INFECT IMMUN, V6, P27
   Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007
   Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x
   Munford RS, 2005, J ENDOTOXIN RES, V11, P69, DOI 10.1179/096805105X35161
   Muroi M, 2002, INFECT IMMUN, V70, P6043, DOI 10.1128/IAI.70.11.6043-6047.2002
   Naberezhnykh GA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P432, DOI 10.1134/S0006297908040081
   Nakagawa Y, 2003, J BIOMED MATER RES B, V66B, P347, DOI 10.1002/jbm.b.10020
   Nalepka JL, 2006, CLIN ORTHOP RELAT R, P229, DOI 10.1097/01.blo.0000224050.94248.38
   Nalepka JL, 2004, BIOTECHNIQUES, V37, P413, DOI 10.2144/04373ST06
   NEIDHARDT EA, 1992, J CHROMATOGR, V590, P255, DOI 10.1016/0021-9673(92)85389-B
   Nelson CL, 2005, CLIN ORTHOP RELAT R, P25, DOI 10.1097/01.blo.0000175715.68624.3d
   Nelson SK, 1997, J PROSTHET DENT, V77, P76, DOI 10.1016/S0022-3913(97)70210-5
   OPAL SM, 1994, LANCET, V344, P429, DOI 10.1016/S0140-6736(94)91767-1
   Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006
   Orishimo KF, 2003, J BONE JOINT SURG AM, V85A, P1095, DOI 10.2106/00004623-200306000-00018
   OROSZLAN SI, 1963, BIOCHEM BIOPH RES CO, V12, P345, DOI 10.1016/0006-291X(63)90102-5
   Persing DH, 2002, TRENDS MICROBIOL, V10, pS32, DOI 10.1016/S0966-842X(02)02426-5
   Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6
   PRINGLE JH, 1986, APPL ENVIRON MICROB, V51, P1321
   Pyo SH, 2001, PROTEIN EXPRES PURIF, V23, P38, DOI 10.1006/prep.2001.1471
   QAWNICZEKWALCZY.A, 2010, ANN AGR ENV MED, V17, P193
   Radon K, 2006, OCCUP ENVIRON MED, V63, P73, DOI 10.1136/oem.2004.017616
   RAETZ CRH, 1993, J BACTERIOL, V175, P5745
   Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Rangel-Yagui CO, 2003, BIOTECHNOL BIOENG, V82, P445, DOI 10.1002/bit.10586
   Rietschel ET, 1996, CURR TOP MICROBIOL, V216, P39
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689
   Schwab LP, 2006, J BIOMED MATER RES B, V79B, P66, DOI 10.1002/jbm.b.30512
   SHIBATANI T, 1983, THROMB HAEMOSTASIS, V49, P91
   SHIBAYAMA Y, 1987, J PATHOL, V151, P133, DOI 10.1002/path.1711510206
   SHIBAYAMA Y, 1987, J PATHOL, V151, P315, DOI 10.1002/path.1711510412
   Skoglund B, 2002, J BONE JOINT SURG BR, V84B, P767, DOI 10.1302/0301-620X.84B5.11775
   Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Suri RM, 1998, J IMMUNOL METHODS, V214, P149, DOI 10.1016/S0022-1759(98)00048-9
   SWEADNER KJ, 1977, APPL ENVIRON MICROB, V34, P382
   Takagi M, 2007, J BIOMED MATER RES A, V81A, P1017, DOI 10.1002/jbm.a.31235
   Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062
   Takemoto Y, 2003, ARTIF ORGANS, V27, P1134, DOI 10.1111/j.1525-1594.2003.07156.x
   Taki N, 2007, BONE, V40, P1276, DOI 10.1016/j.bone.2006.12.053
   Tam SK, 2006, BIOMATERIALS, V27, P1296, DOI 10.1016/j.biomaterials.2005.08.027
   Tatro JM, 2007, J ORTHOP RES, V25, P361, DOI 10.1002/jor.20289
   TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X
   Udagawa N, 2007, PERIODONTOL 2000, V43, P56, DOI 10.1111/j.1600-0757.2006.00167.x
   van Putten SM, 2011, J BIOMED MATER RES A, V98A, P527, DOI 10.1002/jbm.a.33144
   van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336
   Vermes C, 2001, J BONE JOINT SURG AM, V83A, P201, DOI 10.2106/00004623-200102000-00007
   Wandrey C, 2001, ANN NY ACAD SCI, V944, P187
   WANG D, 1995, J LEUKOCYTE BIOL, V57, P865
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002
   WEBER C, 1995, ASAIO J, V41, pM430, DOI 10.1097/00002480-199507000-00046
   WEISER MM, 1968, J BIOL CHEM, V243, P1320
   Williams David, 2003, Med Device Technol, V14, P8
   Wilson Michael, 1995, Science Progress, V78, P19
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   Xing ZQ, 2006, J ORTHOP RES, V24, P959, DOI 10.1002/jor.20038
   Yao JL, 1997, J BONE JOINT SURG AM, V79A, P107, DOI 10.2106/00004623-199701000-00011
   Yermak IM, 2006, BIOCHIMIE, V88, P23, DOI 10.1016/j.biochi.2005.07.004
NR 141
TC 27
Z9 27
U1 1
U2 40
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD OCT
PY 2013
VL 19
IS 5
BP 391
EP 402
DI 10.1089/ten.teb.2012.0636
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 207NJ
UT WOS:000323608000001
PM 23350734
DA 2018-10-20
ER

PT J
AU Xiao, YH
   Friis, EA
   Gehrke, SH
   Detamore, MS
AF Xiao, Yinghua
   Friis, Elizabeth A.
   Gehrke, Stevin H.
   Detamore, Michael S.
TI Mechanical Testing of Hydrogels in Cartilage Tissue Engineering: Beyond
   the Compressive Modulus
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID DOUBLE-NETWORK HYDROGELS; BOVINE PATELLAR CARTILAGE; ATOMIC-FORCE
   MICROSCOPY; PLATE-BENDING METHOD; ARTICULAR-CARTILAGE;
   FRACTURE-TOUGHNESS; INDEPENDENT CONTROL; ELASTIC-MODULUS;
   CONTACT-LENSES; DRUG-DELIVERY
AB Injuries to articular cartilage result in significant pain to patients and high medical costs. Unfortunately, cartilage repair strategies have been notoriously unreliable and/or complex. Biomaterial-based tissue-engineering strategies offer great promise, including the use of hydrogels to regenerate articular cartilage. Mechanical integrity is arguably the most important functional outcome of engineered cartilage, although mechanical testing of hydrogel-based constructs to date has focused primarily on deformation rather than failure properties. In addition to deformation testing, as the field of cartilage tissue engineering matures, this community will benefit from the addition of mechanical failure testing to outcome analyses, given the crucial clinical importance of the success of engineered constructs. However, there is a tremendous disparity in the methods used to evaluate mechanical failure of hydrogels and articular cartilage. In an effort to bridge the gap in mechanical testing methods of articular cartilage and hydrogels in cartilage regeneration, this review classifies the different toughness measurements for each. The urgency for identifying the common ground between these two disparate fields is high, as mechanical failure is ready to stand alongside stiffness as a functional design requirement. In comparing toughness measurement methods between hydrogels and cartilage, we recommend that the best option for evaluating mechanical failure of hydrogel-based constructs for cartilage tissue engineering may be tensile testing based on the single edge notch test, in part because specimen preparation is more straightforward and a related American Society for Testing and Materials (ASTM) standard can be adopted in a fracture mechanics context.
C1 [Xiao, Yinghua; Friis, Elizabeth A.; Gehrke, Stevin H.; Detamore, Michael S.] Univ Kansas, Lawrence, KS 66045 USA.
RP Detamore, MS (reprint author), Univ Kansas, Dept Chem & Petr Engn, 1530 W 15th St,4132 Learned Hall, Lawrence, KS 66045 USA.
EM detamore@ku.edu
RI Gehrke, Stevin/A-5265-2014
FU NIH/NIBIB [R21 EB008783]
FX The authors would like to acknowledge funding from the NIH/NIBIB (R21
   EB008783).
CR Abdurrahmanoglu S, 2009, POLYMER, V50, P5449, DOI 10.1016/j.polymer.2009.09.042
   Adams DJ, 2003, J BIOMECH ENG-T ASME, V125, P927, DOI 10.1115/1.1635405
   Ahsan T, 1999, OSTEOARTHR CARTILAGE, V7, P29, DOI 10.1053/joca.1998.0160
   Azuma C, 2007, J BIOMED MATER RES A, V81A, P373, DOI 10.1002/jbm.a.31043
   Bae WC, 2003, ARTHRITIS RHEUM-US, V48, P3382, DOI 10.1002/art.11347
   Bruce AS, 2001, BIOMATERIALS, V22, P3249, DOI 10.1016/S0142-9612(01)00162-4
   Cha C, 2009, ADV FUNCT MATER, V19, P3056, DOI 10.1002/adfm.200900865
   ChinPurcell MV, 1996, J BIOMECH ENG-T ASME, V118, P545, DOI 10.1115/1.2796042
   CLARKE JC, 1971, J ANAT, V108, P23
   DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761
   Erman B., 1997, STRUCTURES PROPERTIE
   Farshad M, 1998, ENG FRACT MECH, V60, P597, DOI 10.1016/S0013-7944(98)00020-4
   GLENISTER TW, 1976, J ANAT, V122, P323
   Gong JP, 2010, ADV POLYM SCI, V236, P203, DOI 10.1007/12_2010_91
   Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Hegedus C, 2010, ACTA PHYSIOL HUNG, V97, P84
   Huang AH, 2008, OSTEOARTHR CARTILAGE, V16, P1074, DOI 10.1016/j.joca.2008.02.005
   JACKSON AP, 1990, BIOMATERIALS, V11, P403, DOI 10.1016/0142-9612(90)90095-8
   Jaramillo-Botero A, 2010, J COMPUT THEOR NANOS, V7, P1238, DOI 10.1166/jctn.2010.1477
   Julkunen P, 2008, MED ENG PHYS, V30, P506, DOI 10.1016/j.medengphy.2007.05.012
   Knecht S, 2006, CLIN BIOMECH, V21, P999, DOI 10.1016/j.clinbiomech.2006.07.001
   Kong HJ, 2003, MACROMOLECULES, V36, P4582, DOI 10.1021/ma034137w
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Korhonen RK, 2002, MED ENG PHYS, V24, P99, DOI 10.1016/S1350-4533(01)00123-0
   Kundu S, 2009, SOFT MATTER, V5, P3963, DOI 10.1039/b909237d
   LAWN B, 1975, J MATER SCI, V10, P1049, DOI 10.1007/BF00823224
   Lewis JL, 2001, J ANAT, V199, P483, DOI 10.1046/j.1469-7580.2001.19940483.x
   Liang SM, 2011, MACROMOLECULES, V44, P3016, DOI 10.1021/ma2000527
   Little CJ, 2011, TISSUE ENG PART B-RE, V17, P213, DOI [10.1089/ten.teb.2010.0572, 10.1089/ten.TEB.2010.0572]
   Loparic M, 2010, BIOPHYS J, V98, P2731, DOI 10.1016/j.bpj.2010.02.013
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z
   Miller GJ, 2010, OSTEOARTHR CARTILAGE, V18, P1051, DOI 10.1016/j.joca.2010.04.007
   Miller KL, 2003, INVEST OPHTH VIS SCI, V44, P60, DOI 10.1167/iovs.02-0348
   Monclus MA, 2010, J MATER SCI, V45, P3190, DOI 10.1007/s10853-010-4326-6
   Nakajima T, 2009, MACROMOLECULES, V42, P2184, DOI 10.1021/ma802148p
   Nakajima T, 2009, CHINESE J POLYM SCI, V27, P1, DOI 10.1142/S0256767909003601
   Oss-Ronen L, 2011, ACTA BIOMATER, V7, P163, DOI 10.1016/j.actbio.2010.07.017
   Park S, 2009, P I MECH ENG H, V223, P339, DOI 10.1243/09544119JEIM516
   Paugh JR, 2001, INVEST OPHTH VIS SCI, V42, P2813
   Podczeck F, 2001, INT J PHARM, V227, P39, DOI 10.1016/S0378-5173(01)00783-9
   Sant S, 2010, CAN J CHEM ENG, V88, P899, DOI 10.1002/cjce.20411
   Simha NK, 2007, J BIOMECH ENG-T ASME, V129, P767, DOI 10.1115/1.2768110
   Simha NK, 2004, J MATER SCI-MATER M, V15, P631, DOI 10.1023/B:JMSM.0000026104.30607.c7
   Smith KE, 2009, J APPL POLYM SCI, V114, P2711, DOI 10.1002/app.30565
   Stok K, 2007, CLIN BIOMECH, V22, P725, DOI 10.1016/j.clinbiomech.2007.03.005
   Stok K, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390200256
   Suekama TC, 2013, ACS MACRO LETT, V2, P137, DOI 10.1021/mz3006318
   Tanaka Y, 2005, J PHYS CHEM B, V109, P11559, DOI 10.1021/jp0500790
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 50
TC 20
Z9 21
U1 4
U2 137
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD OCT
PY 2013
VL 19
IS 5
BP 403
EP 412
DI 10.1089/ten.teb.2012.0461
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 207NJ
UT WOS:000323608000002
PM 23448091
OA Green Published
DA 2018-10-20
ER

PT J
AU Zakaria, SM
   Sharif, SH
   Othman, MR
   Yang, F
   Jansen, JA
AF Zakaria, Siti Maisurah
   Sharif, Sharif Hussein
   Othman, Mohd Roslee
   Yang, Fang
   Jansen, John A.
TI Nanophase Hydroxyapatite as a Biomaterial in Advanced Hard Tissue
   Engineering: A Review
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID OSTEOBLAST-LIKE CELLS; BOVINE SERUM-ALBUMIN; SOL-GEL SYNTHESIS;
   CALCIUM-PHOSPHATE; IN-VITRO; SURFACE MODIFICATION; NANOSTRUCTURED
   HYDROXYAPATITE; ELECTROPHORETIC DEPOSITION; GELATIN-HYDROXYAPATITE;
   COLLOIDAL STABILITY
AB Hydroxyapatite is a biocompatible material that is extensively used in the replacement and regeneration of bone material. In nature, nanostructured hydroxyapatite is the main component present in hard body tissues. Hence, the state of the art in nanotechnology can be exploited to synthesize nanophase hydroxyapatite that has similar properties with natural hydroxyapatite. Sustainable methods to mass-produce synthetic hydroxyapatite nanoparticles are being developed to meet the increasing demand for these materials and to further develop the progress made in hard tissue regeneration, especially for orthopedic and dental applications. This article reviews the current developments in nanophase hydroxyapatite through various manufacturing techniques and modifications.
C1 [Zakaria, Siti Maisurah; Sharif, Sharif Hussein; Othman, Mohd Roslee] Univ Sains Malaysia, Sch Chem Engn, Nibong Tebal 14300, Penang, Malaysia.
   [Yang, Fang; Jansen, John A.] Radboud Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, NL-6525 ED Nijmegen, Netherlands.
RP Sharif, SH (reprint author), Univ Sains Malaysia, Sch Chem Engn, Engn Campus, Nibong Tebal 14300, Penang, Malaysia.
EM chhussein@eng.usm.my
RI Jansen, John/H-8055-2014; Yang, Fang/E-1937-2011
OI Yang, Fang/0000-0002-4022-7643
FU Short Term Research University Grants by the Universiti Sains Malaysia
FX The authors gratefully acknowledge support from the Short Term Research
   University Grants provided by the Universiti Sains Malaysia.
CR Alivisatos AP, 2000, SCIENCE, V289, P736, DOI 10.1126/science.289.5480.736
   Barrere F, 2003, J BIOMED MATER RES A, V64A, P378, DOI 10.1002/jbm.a.10291
   Barrere F., 1999, BIOCERAMICS, V12, P125
   Benmesli S., 2008, INT J POLYM MATER, V11, P1045
   Billotte W., 2002, BIOMATERIALS, P21
   Bishop A, 2006, POLYM ADVAN TECHNOL, V17, P902, DOI 10.1002/pat.787
   Borum L, 2003, BIOMATERIALS, V24, P3681, DOI 10.1016/S0142-9612(03)00240-0
   Boskey AL, 2003, OSTEOPOROS INT S5, V14, P16
   Cao LY, 2005, CERAM INT, V31, P1041, DOI 10.1016/j.ceramint.2004.11.002
   Cengiz B, 2008, COLLOID SURFACE A, V322, P29, DOI 10.1016/j.colsurfa.2008.02.011
   Cerroni L, 2002, BIOMOL ENG, V19, P119, DOI 10.1016/S1389-0344(02)00027-8
   Chen F, 2007, J BIOMED MATER RES B, V82B, P183, DOI 10.1002/jbm.b.30720
   Cheng LJ, 2010, ACTA BIOMATER, V6, P1569, DOI 10.1016/j.actbio.2009.10.050
   CHRISTOFFERSEN J, 1991, WATER RES, V25, P227, DOI 10.1016/0043-1354(91)90033-M
   Cui WG, 2010, BIOMATERIALS, V31, P4620, DOI 10.1016/j.biomaterials.2010.02.050
   Cunniffe GM, 2010, J BIOMED MATER RES A, V95A, P1142, DOI 10.1002/jbm.a.32931
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Dai XS, 2007, MATER LETT, V61, P2735, DOI 10.1016/j.matlet.2006.07.195
   Dean-Mo L, 2002, BIOMATERIALS, V23, P1679
   DEB S, 1995, BIOMATERIALS, V16, P1095, DOI 10.1016/0142-9612(95)98906-U
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   FOLTYN SR, 1991, APPL PHYS LETT, V59, P594, DOI 10.1063/1.106386
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Ganguli D., 1997, CERAMIC POWDER PREPA
   GORBUNOFF MJ, 1984, ANAL BIOCHEM, V136, P440, DOI 10.1016/0003-2697(84)90241-0
   Grafe T., 2002, INT NONW TECHN C ATL
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Heimke G., 1991, ADV MATER, V14
   Hench L.L., 1998, HDB BIOMATERIAL PROP, P355, DOI 10.1007/978-1-4615-5801-9_22
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Heness G., 2004, MATER FORUM, V27, P104
   Huang J, 2007, J MATER SCI-MATER M, V18, P2151, DOI 10.1007/s10856-007-3201-8
   JANSEN JA, 1995, J MATER SCI-MATER M, V6, P653, DOI 10.1007/BF00123447
   Jhpraz A. M., 1996, BIOMED MAT RES, V30, P231
   Ji W, 2012, BIOMATERIALS, V33, P6604, DOI 10.1016/j.biomaterials.2012.06.018
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P643, DOI 10.1002/jbm.a.30866
   Kim HM, 2000, BIOMATERIALS, V21, P1129, DOI 10.1016/S0142-9612(99)00265-3
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim HW, 2006, J BIOMED MATER RES B, V77B, P323, DOI 10.1002/jbm.b.30376
   Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116
   Kim IS, 2004, MAT SCI ENG B-SOLID, V111, P232, DOI 10.1016/j.mseb.2004.04.011
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   Kong LB, 2002, J MATER SCI, V37, P1131, DOI 10.1023/A:1014355103125
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Kothapalli CR, 2005, ACTA BIOMATER, V1, P653, DOI 10.1016/j.actbio.2005.06.005
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Krajewski A., 1991, BIOCERAMICS
   Kundu B., 2010, J BIOMED MATER RES, V62, P600
   Le Geros R. Z., 1993, DENSE HYDROXYAPATITE, P139
   Lee HJ, 2006, CHEM MATER, V18, P5111, DOI 10.1021/cm061139x
   Lewandrowski KU, 2003, BIO-MED MATER ENG, V13, P115
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Liao S., 2006, BIOMED MATER, V1, P45
   Linhart W, 2001, J BIOMED MATER RES, V54, P162, DOI 10.1002/1097-4636(200102)54:2<162::AID-JBM2>3.0.CO;2-3
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Liu HS, 1997, CERAM INT, V23, P19, DOI 10.1016/0272-8842(95)00135-2
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu Q., 1997, SURFACE MODIFICATION
   Liu Y, 1997, J PHYS CHEM B, V101, P3464, DOI 10.1021/jp962403k
   Liu YL, 2001, J BIOMED MATER RES, V57, P327, DOI 10.1002/1097-4636(20011205)57:3<327::AID-JBM1175>3.0.CO;2-J
   Loty C, 2000, J BIOMED MATER RES, V49, P423, DOI 10.1002/(SICI)1097-4636(20000315)49:4<423::AID-JBM1>3.3.CO;2-Z
   Loty C., 1997, PREFABRICATED BIOL A, P219
   Ma ZL, 2008, J APPL POLYM SCI, V107, P1000, DOI 10.1002/app.27173
   Manuel C., 2003, KEY ENG MATER, V8, P240
   Massaru S., 2009, MAT T, V6, P1318
   Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081
   Monmaturapoj N, 2008, J MET MAT MINER, V18, P15
   Murugan R., 2005, J CRYST GROWTH, V274, P1
   Oliveira V, 2001, ADV ENG MATER, V3, P75, DOI 10.1002/1527-2648(200101)3:1/2<75::AID-ADEM75>3.0.CO;2-Z
   Ooi C. Y., 2007, CERAM INT, V33, P1172
   Queiroz AC, 2004, BIOMATERIALS, V25, P4607, DOI 10.1016/j.biomaterials.2003.11.054
   Roy ME, 2002, BONE, V31, P296, DOI 10.1016/S8756-3282(02)00821-9
   Ryu SC, 2009, B KOREAN CHEM SOC, V30, P887
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Samsudin M. R., 2005, J SOLID ST SCI TECHN, V12, P360
   Serra P., 1997, APPL SURF SCI, V8, P109
   Serra P., 1998, THIN SOLID FILMS, V8, P335
   Shi ZL, 2010, J BIOMATER APPL, V25, P19, DOI 10.1177/0885328209339396
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   SOBOL EN, 1995, PHASE TRANSFORMATION
   Stigter M, 2002, BIOMATERIALS, V23, P4143, DOI 10.1016/S0142-9612(02)00157-6
   Suchanek W., 1997, MAT RES, V13, P94
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   Tang X.-J., 2008, BIOMED MATER, V3, P1
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Teng SH, 2008, MATER LETT, V62, P3055, DOI 10.1016/j.matlet.2008.01.104
   UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317
   Venugopal J., 2005, NANOENG NANOSYST, V218, P35
   Verheyen C. C. P. M., 1992, BONE BONDING BIOMATE, P153
   WALSH WR, 1994, BIOMATERIALS, V15, P137, DOI 10.1016/0142-9612(94)90263-1
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang X. M., 2007, MATER ENG, V1, P26
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wei M, 2001, J SOL-GEL SCI TECHN, V21, P39, DOI 10.1023/A:1011201414651
   Wen HB, 1999, J BIOMED MATER RES, V46, P245, DOI 10.1002/(SICI)1097-4636(199908)46:2<245::AID-JBM14>3.0.CO;2-A
   Wilson OC, 2008, MAT SCI ENG C-BIO S, V28, P434, DOI 10.1016/j.msec.2007.04.005
   Wu YQ, 2004, J AM CERAM SOC, V87, P1988
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
   YOSHIMURA M, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P45
   Yu-Song P, 2011, MICRO NANO LETT, V6, P129, DOI 10.1049/mnl.2010.0187
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
   Yubao L, 1994, J MATER SCI-MATER M, V5, P326
   Yubao L., 1993, MORPHOLOGY PHASE STR
   Zakaria S. M., 2012, BIOMED MAT RES A, DOI [10.1002/jbm.a.34506, DOI 10.1002/JBM.A.34506]
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhu W., 2012, MICRO NANO LETT, V5, P19
NR 114
TC 80
Z9 84
U1 4
U2 179
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD OCT
PY 2013
VL 19
IS 5
BP 431
EP 441
DI 10.1089/ten.teb.2012.0624
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 207NJ
UT WOS:000323608000005
PM 23557483
DA 2018-10-20
ER

PT J
AU Huang, JY
   Lu, YM
   Wang, H
   Liu, J
   Liao, MH
   Hong, LJ
   Tao, RR
   Ahmed, MM
   Liu, P
   Liu, SS
   Fukunaga, K
   Du, YZ
   Han, F
AF Huang, Ji-yun
   Lu, Ying-mei
   Wang, Huan
   Liu, Jun
   Liao, Mei-hua
   Hong, Ling-juan
   Tao, Rong-rong
   Ahmed, Muhammad Masood
   Liu, Ping
   Liu, Shuang-shuang
   Fukunaga, Kohji
   Du, Yong-zhong
   Han, Feng
TI The effect of lipid nanoparticle PEGylation on neuroinflammatory
   response in mouse brain
SO BIOMATERIALS
LA English
DT Article
DE Lipid nanoparticles; PEGylation; Brain; Microglia; P2X(7) receptor;
   Neuroinflammatory response
ID MICROGLIAL ACTIVATION; INTRACELLULAR CALCIUM; ENDOTHELIAL-CELLS;
   SPINAL-CORD; CYTOTOXICITY; RECEPTOR; DELIVERY; THERAPY; INJURY; ACID
AB Nanocarrier-based drug delivery systems have attracted wide interest for the treatment of brain disease. However, neurotoxicity of nanoparticle has limited their therapeutic application. Here we demonstrated that lipid nanoparticles (LNs) accumulated in the brain parenchyma within 3 h of intravenous injection to mice and persisted for more than 24 weeks, coinciding with a dramatic activation of brain microglia. Morphological characteristic of microglial activation also observed in LNs-treated Cx3cr1(GFP/+) mice. In vivo study with two-photon confocal microscopy revealed abnormal Ca2+ waves in microglia following LNs injection. The correlated activation of caspase-1, IL-1 beta and neurovascular damage following LNs injection was attenuated in P2X(7)(-/-) mice. PEGylation of LNs reduced correlated nanoparticles aggregation. Moreover, PEGylation of LNs ameliorated the P2X(7)/caspase-1/IL-1 beta signalling-dependent microglia activation and neurovascular damage. In conclusion, PEGylation of LNs is a promising biomaterial for brain-targeted therapy that inhibits P2X(7)-dependent neuroinflammatory response. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Huang, Ji-yun; Wang, Huan; Liao, Mei-hua; Hong, Ling-juan; Tao, Rong-rong; Ahmed, Muhammad Masood; Han, Feng] Zhejiang Univ, Inst Pharmacol Toxicol & Biochem Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China.
   [Lu, Ying-mei] Zhejiang Univ City Coll, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.
   [Liu, Jun; Liu, Ping; Du, Yong-zhong] Zhejiang Univ, Coll Pharmaceut Sci, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
   [Liu, Shuang-shuang] Zhejiang Univ, Sch Med, Core Facil, Imaging Ctr, Hangzhou 310058, Zhejiang, Peoples R China.
   [Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan.
RP Du, YZ (reprint author), Zhejiang Univ, Coll Pharmaceut Sci, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
EM duyongzhong@zju.edu.cn; changhuahan@zju.edu.cn
FU National Natural Science Foundations of China [81120108023, 91232705,
   81202533]; National Basic Research Program of China (973 Program)
   [2009CB930300]; The Science and Technology Planning Project of Zhejiang
   Province [2012F82G2010024]
FX This work was supported in part by National Natural Science Foundations
   of China (81120108023, 91232705, 81202533); National Basic Research
   Program of China (973 Program, 2009CB930300); The Science and Technology
   Planning Project of Zhejiang Province (2012F82G2010024).
CR Albanese A, 2010, ACS NANO, V4, P2490, DOI 10.1021/nn100776z
   Andrews AM, 2012, ACS NANO, V6, P8463, DOI 10.1021/nn304724q
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Avgoustakis Konstantinos, 2004, Current Drug Delivery, V1, P321, DOI 10.2174/1567201043334605
   Bae JE, 2011, BIOMATERIALS, V32, P9401, DOI 10.1016/j.biomaterials.2011.08.075
   Barandeh F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029424
   Bocca C, 1998, INT J PHARM, V175, P185, DOI 10.1016/S0378-5173(98)00282-8
   Bondi ML, 2010, NANOMEDICINE-UK, V5, P25, DOI 10.2217/NNM.09.67
   Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715
   Cardoso ALC, 2010, J CONTROL RELEASE, V142, P392, DOI 10.1016/j.jconrel.2009.11.004
   Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10
   Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106
   FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119
   Gao Y, 2008, BIOMATERIALS, V29, P4129, DOI 10.1016/j.biomaterials.2008.07.008
   Gilmore JL, 2008, J NEUROIMMUNE PHARM, V3, P83, DOI 10.1007/s11481-007-9099-6
   Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055
   Han F, 2011, J PINEAL RES, V50, P281, DOI 10.1111/j.1600-079X.2010.00838.x
   Harde H, 2011, EXPERT OPIN DRUG DEL, V8, P1407, DOI 10.1517/17425247.2011.604311
   Hoffmann A, 2003, J NEUROSCI, V23, P4410
   Hu FQ, 2012, MOL PHARMACEUT, V9, P2469, DOI 10.1021/mp300002v
   Hu RP, 2010, BIOMATERIALS, V31, P8043, DOI 10.1016/j.biomaterials.2010.07.011
   Hutter E, 2010, ACS NANO, V4, P2595, DOI 10.1021/nn901869f
   Kaur IP, 2008, J CONTROL RELEASE, V127, P97, DOI 10.1016/j.jconrel.2007.12.018
   Kim GW, 2003, J NEUROSCI, V23, P8733
   Lanza GM, 2010, STROKE, V41, pS42, DOI 10.1161/STROKEAHA.110.598656
   Lattarulo C, 2011, METHODS MOL BIOL, V793, P377, DOI 10.1007/978-1-61779-328-8_25
   Lu YM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-172
   Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271
   Ma LL, 2010, BIOMATERIALS, V31, P99, DOI 10.1016/j.biomaterials.2009.09.028
   Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009
   Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4
   Pardridge WM, 2007, STROKE, V38, P686, DOI 10.1161/01.STR.0000247887.61831.74
   Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106
   Peracchia MT, 1999, BIOMATERIALS, V20, P1269, DOI 10.1016/S0142-9612(99)00021-6
   Puzyn T, 2011, NAT NANOTECHNOL, V6, P175, DOI 10.1038/NNANO.2011.10
   Ryan SM, 2008, EXPERT OPIN DRUG DEL, V5, P371, DOI [10.1517/17425247.5.4.371, 10.1517/17425247.5.4.371 ]
   Sanders NN, 2007, J CONTROL RELEASE, V122, P226, DOI 10.1016/j.jconrel.2007.05.004
   Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027
   Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje
   Shi NY, 2001, P NATL ACAD SCI USA, V98, P12754, DOI 10.1073/pnas.221450098
   Siddiqi NJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-123
   Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100
   Trickler WJ, 2012, NANOMEDICINE-UK, V7, P835, DOI [10.2217/NNM.11,154, 10.2217/nnm.11.154]
   Tvrdy K, 2012, NAT NANOTECHNOL, V7, P8, DOI 10.1038/nnano.2011.241
   Wang JY, 2009, NEUROTOXICOLOGY, V30, P926, DOI 10.1016/j.neuro.2009.09.005
   Wang Y, 2011, TOXICOL LETT, V205, P26, DOI 10.1016/j.toxlet.2011.05.001
   Weiss PS, 2011, NATURE, V479, P187, DOI 10.1038/479187a
   Weiss PS, 2010, ACS NANO, V4, P1771, DOI 10.1021/nn100710n
   Wu J, 2011, ACS NANO, V5, P4476, DOI 10.1021/nn103530b
   Yu T, 2011, ACS NANO, V5, P5717, DOI 10.1021/nn2013904
   Yuan H, 2007, COLLOID SURFACE B, V58, P157, DOI 10.1016/j.colsurfb.2007.03.002
   Zhou HY, 2012, J PINEAL RES, V52, P120, DOI 10.1111/j.1600-079X.2011.00926.x
NR 53
TC 17
Z9 18
U1 2
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2013
VL 34
IS 32
BP 7960
EP 7970
DI 10.1016/j.biomaterials.2013.07.009
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 205US
UT WOS:000323470900015
PM 23880338
DA 2018-10-20
ER

PT J
AU Sonnet, C
   Simpson, CL
   Olabisi, RM
   Sullivan, K
   Lazard, Z
   Gugala, Z
   Peroni, JF
   Weh, JM
   Davis, AR
   West, JL
   Olmsted-Davis, EA
AF Sonnet, Corinne
   Simpson, C. LaShan
   Olabisi, Ronke M.
   Sullivan, Kayleigh
   Lazard, ZaWaunyka
   Gugala, Zbigniew
   Peroni, John F.
   Weh, J. Michael
   Davis, Alan R.
   West, Jennifer L.
   Olmsted-Davis, Elizabeth A.
TI Rapid healing of femoral defects in rats with low dose sustained BMP2
   expression from PEGDA hydrogel microspheres
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE BMP2; bone healing; critical size defect; microencapsulation; PEGDA
ID BONE MORPHOGENETIC PROTEIN-2; GENE-THERAPY; HETEROTOPIC OSSIFICATION;
   STROMAL CELLS; IN-VITRO; DIFFERENTIATION; REGENERATION; IMAGES; REPAIR
AB Current strategies for bone regeneration after traumatic injury often fail to provide adequate healing and integration. Here, we combined the poly (ethylene glycol) diacrylate (PEGDA) hydrogel with allogeneic carrier cells transduced with an adenovirus expressing BMP2. The system is unique in that the biomaterial encapsulates the cells, shielding them and thus suppressing destructive inflammatory processes. Using this system, complete healing of a 5mm-long femur defect in a rat model occurs in under 3 weeks, through secretion of 100-fold lower levels of protein as compared to doses of recombinant BMP2 protein used in studies which lead to healing in 2-3 months. New bone formation was evaluated radiographically, histologically, and biomechanically at 2, 3, 6, 9, and 12 weeks after surgery. Rapid bone formation bridged the defect area and reliably integrated into the adjacent skeletal bone as early as 2 weeks. At 3 weeks, biomechanical analysis showed the new bone to possess 79% of torsional strength of the intact contralateral femur. Histological evaluation showed normal bone healing, with no infiltration of inflammatory cells with the bone being stable approximately 1 year later. We propose that these osteoinductive microspheres offer a more efficacious and safer clinical option over the use of rhBMP2. (c) 2013 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 31:1597-1604, 2013
C1 [Sonnet, Corinne; Sullivan, Kayleigh; Lazard, ZaWaunyka; Davis, Alan R.; Olmsted-Davis, Elizabeth A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.
   [Simpson, C. LaShan; Olabisi, Ronke M.; West, Jennifer L.] Rice Univ, Dept Bioengn, Houston, TX 77030 USA.
   [Gugala, Zbigniew] Univ Texas Med Branch, Dept Orthoped Surg & Rehabil, Galveston, TX 77555 USA.
   [Peroni, John F.; Weh, J. Michael] Univ Georgia, Coll Vet Med, Athens, GA 30602 USA.
   [Davis, Alan R.; Olmsted-Davis, Elizabeth A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Davis, Alan R.; Olmsted-Davis, Elizabeth A.] Baylor Coll Med, Dept Orthoped Surg, Houston, TX 77030 USA.
RP Olmsted-Davis, EA (reprint author), Baylor Coll Med, Ctr Cell & Gene Therapy, 1 Baylor Plaza,Alkek Bldg,Room N1010, Houston, TX 77030 USA.
EM edavis@bcm.edu
RI West, Jennifer/A-4582-2008
OI West, Jennifer/0000-0001-8550-2875; Gugala,
   Zbigniew/0000-0003-2331-7660; Simpson, C. LaShan/0000-0002-2908-7977;
   Olabisi, Ronke/0000-0003-3738-5250
FU Defense Advanced Research Agency (DARPA) [W911NF-09-1-0040]; Department
   of Defense Orthopedic Extremities Program (DAMD) [W81XWH-07-1-0215]
FX Grant sponsor: Defense Advanced Research Agency (DARPA); Grant number:
   W911NF-09-1-0040; Grant sponsor: Department of Defense Orthopedic
   Extremities Program (DAMD); Grant number: W81XWH-07-1-0215.
CR Bikram M, 2007, ANN BIOMED ENG, V35, P796, DOI 10.1007/s10439-007-9263-4
   Blum JS, 2001, J CELL BIOCHEM, V80, P532, DOI 10.1002/1097-4644(20010315)80:4<532::AID-JCB1007>3.0.CO;2-B
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Chen Y, 2003, GENE THER, V10, P1345, DOI 10.1038/sj.gt.3301999
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Dilling CF, 2010, J BONE MINER RES, V25, P1147, DOI 10.1359/jbmr.091031
   Donegan DJ, 2011, ORTHOPEDICS, V34, pE730, DOI 10.3928/01477447-20110922-16
   Fouletier-Dilling CM, 2005, HUM GENE THER, V16, P1287, DOI 10.1089/hum.2005.16.1287
   Franco CL, 2011, ACTA BIOMATER, V7, P3267, DOI 10.1016/j.actbio.2011.06.011
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Hoff BA, 2012, BONE, V51, P78, DOI 10.1016/j.bone.2012.04.005
   Hsu CW, 2011, J BIOMED MATER RES A, V98A, P53, DOI 10.1002/jbm.a.33076
   Hutmacher DW, 2012, METHODS MOL BIOL, V868, P327, DOI 10.1007/978-1-61779-764-4_20
   Hwang CJ, 2009, J NEUROSURG-SPINE, V10, P443, DOI 10.3171/2009.1.SPINE08473
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Kang JD, 2011, SPINE J, V11, P517, DOI 10.1016/j.spinee.2011.03.022
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291
   Mumaw J, 2012, INT J BIOMATER, V2012
   Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1
   Olabisi RM, 2010, TISSUE ENG PT A, V16, P3727, DOI 10.1089/ten.TEA.2010.0234
   Olmsted EA, 2001, J CELL BIOCHEM, V82, P11, DOI 10.1002/jcb.1106
   Olmsted-Davis E, 2007, AM J PATHOL, V170, P620, DOI 10.2353/ajpath.2007.060692
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   Ratner BD, 2004, BIOMATER SCI, P100
   Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6
   Salisbury E, 2011, J CELL BIOCHEM, V112, P2748, DOI 10.1002/jcb.23225
   Salisbury EA, 2012, STEM CELL TRANSL MED, V1, P874, DOI 10.5966/sctm.2012-0090
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   Winn SR, 2000, ADV DRUG DELIVER REV, V42, P121, DOI 10.1016/S0169-409X(00)00057-0
NR 36
TC 20
Z9 21
U1 1
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD OCT
PY 2013
VL 31
IS 10
BP 1597
EP 1604
DI 10.1002/jor.22407
PG 8
WC Orthopedics
SC Orthopedics
GA 203PL
UT WOS:000323305000014
PM 23832813
OA Bronze
DA 2018-10-20
ER

PT J
AU Yuan, YF
   Altalhi, WA
   Ng, JJ
   Courtman, DW
AF Yuan, Yifan
   Altalhi, Wafa A.
   Ng, Jeannette J.
   Courtman, David W.
TI Derivation of human peripheral blood derived endothelial progenitor
   cells and the role of osteopontin surface modification and eNOS
   transfection
SO BIOMATERIALS
LA English
DT Article
DE Endothelium; Progenitor cell; Osteopontin; Cell adhesion; Gene
   expression
ID COLONY-STIMULATING FACTOR; ACUTE MYOCARDIAL-INFARCTION; IN-VITRO;
   NITRIC-OXIDE; MARROW; NEOVASCULARIZATION; TRANSPLANTATION; INFLAMMATION;
   MIGRATION; DISEASE
AB Endothelial coverage of blood-contacting biomaterial surfaces has been difficult to achieve. A readily available autologous source of endothelium combined with an appropriate attachment substrate would improve the chances of developing functional surfaces. Here we describe methods to derive high quantities of human endothelial progenitor cells (EPCs) from peripheral blood monocytes (PBMCs) obtained by leukapheresis. These cells are morphologically and phenotypically similar to human umbilical vein endothelial cells (HUVECs); however, their expression of the key vascular factor - endothelial nitric oxide synthase (eNOS) - is markedly lower than that observed in HUVECs. We demonstrate that eNOS levels can be restored with plasmid-based transfection. To promote EPC adherence we examined substrate enhancement with a matricellular protein associated with vascular repair, osteopontin (OPN). We observed dose- and time-dependent responses of OPN in EPC adhesion, spreading, and haptotactic migration of EPCs in Boyden chamber assays. In addition, the combination of the OPN coating and enhanced eNOS expression in EPCs maximally enhanced cell adhesion (39.6 +/- 1.7 and 49.4 +/- 2.4 cells/field for 0 and 1 nM OPN) and spreading (84.7 +/- 3.5% and 92.1 +/- 3.9% for 0 nM and 1 nM OPN). These data highlight the direct effects of OPN on peripheral blood derived EPCs, suggesting that OPN works by mediating progenitor cell adhesion during vascular injury. The combination of autologous EPCs and OPN coatings could be a promising method of developing functional endothelialized surfaces. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Yuan, Yifan; Altalhi, Wafa A.; Ng, Jeannette J.; Courtman, David W.] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada.
   [Yuan, Yifan; Altalhi, Wafa A.; Ng, Jeannette J.; Courtman, David W.] Univ Ottawa, Dept Med & Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.
RP Courtman, DW (reprint author), Ottawa Hosp, Res Inst, Gen Campus,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.
EM dcourtman@ohri.ca
FU King Abdullah Scholarship Program, Saudi Arabia
FX We are grateful to King Abdullah Scholarship Program, Saudi Arabia for
   financial support. We gratefully acknowledge Cre Comanita for her
   technical assistance with Western blot.
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964
   Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005
   Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002
   Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994
   Boyer M, 2000, J VASC SURG, V31, P181, DOI 10.1016/S0741-5214(00)70080-2
   Cui B, 2011, MICROVASC RES, V81, P143, DOI 10.1016/j.mvr.2010.09.009
   Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723
   Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980
   DREGER P, 1995, BLOOD, V86, P3970
   Gehling UM, 2000, BLOOD, V95, P3106
   Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6
   Gulati R, 2003, CIRC RES, V93, P1023, DOI 10.1161/01.RES.0000105569.77539.21
   Hall A, 1999, BRIT J CANCER, V80, P25
   Hernandez DA, 2000, AM SURGEON, V66, P355
   Hill JM, 2005, J AM COLL CARDIOL, V46, P1643, DOI 10.1016/j.jacc.2005.01.067
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Kalka C, 2000, CIRC RES, V86, P1198, DOI 10.1161/01.RES.86.12.1198
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Kong D, 2004, CIRCULATION, V109, P1769, DOI 10.1161/01.CIR.0000121732.85572.6F
   Korbling M, 2006, TRANSFUSION, V46, P1795, DOI 10.1111/j.1537-2995.2006.00985.x
   LASKY LC, 1989, TRANSFUSION, V29, P323, DOI 10.1046/j.1537-2995.1989.29489242798.x
   Leali D, 2007, J BIOL CHEM, V282, P19676, DOI 10.1074/jbc.M606938200
   Leen LLS, 2008, ARTERIOSCL THROM VAS, V28, P2131, DOI 10.1161/ATVBAHA.108.167965
   LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214
   Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071
   Masuda H, 2000, Hum Cell, V13, P153
   Mauricio R, 2005, TRANSFUS APHER SCI, V33, P351, DOI 10.1016/j.transci.2005.08.005
   Molin DGM, 2008, ARTERIOSCL THROM VAS, V28, P2099, DOI 10.1161/ATVBAHA.108.176446
   MONCADA S, 1992, ACTA PHYSIOL SCAND, V145, P201, DOI 10.1111/j.1748-1716.1992.tb09359.x
   Moog R, 2004, TRANSFUS APHER SCI, V31, P207, DOI 10.1016/j.transci.2004.09.006
   Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156, DOI 10.1161/01.ATV.19.5.1156
   Ormiston ML, 2010, AM J RESP CELL MOL, V43, P546, DOI 10.1165/rcmb.2009-0152OC
   Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676
   Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072
   Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824
   Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5
   Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122
   Stroncek JD, 2012, ACTA BIOMATER, V8, P201, DOI 10.1016/j.actbio.2011.09.002
   Taljaard M, 2010, AM HEART J, V159, P354, DOI 10.1016/j.ahj.2009.12.021
   Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828
   Tura O, 2010, J THROMB HAEMOST, V8, P1614, DOI 10.1111/j.1538-7836.2010.03900.x
   Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509
   Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328
   Yu M, 2011, J CELL BIOCHEM, V112, P1730, DOI 10.1002/jcb.23071
NR 50
TC 7
Z9 7
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2013
VL 34
IS 30
BP 7292
EP 7301
DI 10.1016/j.biomaterials.2013.06.003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 198OJ
UT WOS:000322931900008
PM 23810253
DA 2018-10-20
ER

PT J
AU Georgiou, M
   Bunting, SCJ
   Davies, HA
   Loughlin, AJ
   Golding, JP
   Phillips, JB
AF Georgiou, Melanie
   Bunting, Stephen C. J.
   Davies, Heather A.
   Loughlin, Alison J.
   Golding, Jonathan P.
   Phillips, James B.
TI Engineered neural tissue for peripheral nerve repair
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Schwann cell; Nerve guide; Nerve regeneration; Nerve tissue
   engineering; Hydrogel
ID PLASTIC COMPRESSION; NEURITE OUTGROWTH; IN-VITRO; CELL ALIGNMENT;
   COLLAGEN GELS; STEM-CELLS; REGENERATION; SCAFFOLDS; CONDUIT; CHANNELS
AB A new combination of tissue engineering techniques provides a simple and effective method for building aligned cellular biomaterials. Self-alignment of Schwann cells within a tethered type-1 collagen matrix, followed by removal of interstitial fluid produces a stable tissue-like biomaterial that recreates the aligned cellular and extracellular matrix architecture associated with nerve grafts. Sheets of this engineered neural tissue supported and directed neuronal growth in a co-culture model, and initial in vivo tests showed that a device containing rods of rolled-up sheets could support neuronal growth during rat sciatic nerve repair (5 mm gap). Further testing of this device for repair of a critical-sized 15 mm gap showed that, at 8 weeks, engineered neural tissue had supported robust neuronal regeneration across the gap. This is, therefore, a useful new approach for generating anisotropic engineered tissues, and it can be used with Schwann cells to fabricate artificial neural tissue for peripheral nerve repair. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Georgiou, Melanie; Davies, Heather A.; Loughlin, Alison J.; Golding, Jonathan P.; Phillips, James B.] Open Univ, Milton Keynes MK7 6AA, Bucks, England.
   [Bunting, Stephen C. J.] UCL, London WC1E 6BT, England.
RP Phillips, JB (reprint author), Open Univ, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.
EM james.b.phillips@open.ac.uk
RI Golding, Jon/L-2700-2017; Phillips, James/G-7926-2014
OI Golding, Jon/0000-0002-7910-7382; Phillips, James/0000-0001-8117-3074
FU Medical Research Council [G113/31]
CR Angius D, 2012, BIOMATERIALS, V33, P8034, DOI 10.1016/j.biomaterials.2012.07.056
   Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055
   Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Bitar M, 2007, J MATER SCI-MATER M, V18, P237, DOI 10.1007/s10856-006-0685-1
   Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017
   Braziulis E, 2012, TISSUE ENG PART C-ME, V18, P464, DOI [10.1089/ten.TEC.2011.0561, 10.1089/ten.tec.2011.0561]
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   BROWN RA, 2004, Patent No. 2004087231
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017
   East E, 2009, J TISSUE ENG REGEN M, V3, P634, DOI 10.1002/term.209
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Hadjipanayi E, 2011, J CONTROL RELEASE, V153, P217, DOI 10.1016/j.jconrel.2011.03.029
   Hsu SH, 2009, ARTIF ORGANS, V33, P26, DOI 10.1111/j.1525-1594.2008.00671.x
   Ikeda M, 2012, BRAIN BEHAV, V2, P382, DOI 10.1002/brb3.61
   Kalbermatten DF, 2008, J HAND SURG-EUR VOL, V33E, P587, DOI 10.1177/1753193408090755
   Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029
   Levis HJ, 2010, BIOMATERIALS, V31, P7726, DOI 10.1016/j.biomaterials.2010.07.012
   Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Mantovani Cristina, 2012, Methods Mol Biol, V916, P47, DOI 10.1007/978-1-61779-980-8_5
   Micol LA, 2011, BIOMATERIALS, V32, P1543, DOI 10.1016/j.biomaterials.2010.10.028
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Pabari A, 2011, J CONTROL RELEASE, V156, P2, DOI 10.1016/j.jconrel.2011.07.001
   Park H, 2007, TISSUE ENG, V13, P1867, DOI 10.1089/ten.2006.0198
   Phillips JB, 2011, METHODS MOL BIOL, V695, P183, DOI 10.1007/978-1-60761-984-0_12
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007
   Richardson JA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046015
   Seggio AM, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046001
   Szynkaruk M, 2012, TISSUE ENG B
   Thompson DM, 2006, ANN BIOMED ENG, V34, P161, DOI 10.1007/s10439-005-9013-4
   Wright KE, 2009, BRIT J CANCER, V101, P658, DOI 10.1038/sj.bjc.6605197
   Zhang YJ, 2010, BIOMATERIALS, V31, P5312, DOI 10.1016/j.biomaterials.2010.03.029
NR 37
TC 82
Z9 84
U1 1
U2 154
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2013
VL 34
IS 30
BP 7335
EP 7343
DI 10.1016/j.biomaterials.2013.06.025
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 198OJ
UT WOS:000322931900012
PM 23834895
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Nair, AM
   Tsai, YT
   Shah, KM
   Shen, JH
   Weng, H
   Zhou, J
   Sun, XK
   Saxena, R
   Borrelli, J
   Tang, LP
AF Nair, Ashwin M.
   Tsai, Yi-Ting
   Shah, Krishna M.
   Shen, Jinhui
   Weng, Hong
   Zhou, Jun
   Sun, Xiankai
   Saxena, Ramesh
   Borrelli, Joseph, Jr.
   Tang, Liping
TI The effect of erythropoietin on autologous stem cell-mediated bone
   regeneration
SO BIOMATERIALS
LA English
DT Article
DE Autologous stem cells; Scaffold; Erythropoietin; Stromal derived
   factor-1 alpha; Bone morphogenetic protein-2; Bone tissue engineering
ID MESENCHYMAL STROMAL CELLS; SIZE DEFECT MODEL; IN-VITRO; MORPHOGENETIC
   PROTEIN-2; DUAL DELIVERY; GROWTH-FACTOR; GM-CSF; MARROW;
   DIFFERENTIATION; SCAFFOLDS
AB Mesenchymal stern cells (MSCs) although used for bone tissue engineering are limited by the requirement of isolation and culture prior to transplantation. Our recent studies have shown that biomaterial implants can be engineered to facilitate the recruitment of MSCs. In this study, we explore the ability of these implants to direct the recruitment and the differentiation of MSCs in the setting of a bone defect. We initially determined that both stromal derived factor-1alpha (SDF-1 alpha) and erythropoietin (Epo) prompted different degrees of MSC recruitment. Additionally, we found that Epo and bone morphogenetic protein-2 (BMP-2), but not SDF-1 alpha, triggered the osteogenic differentiation of MSCs in vitro. We then investigated the possibility of directing autologous MSC-mediated bone regeneration using a murine calvaria model. Consistent with our in vitro observations, Epo-releasing scaffolds were found to be more potent in bridging the defect than BMP-2 loaded scaffolds, as determined by computed tomography (CT) scanning, fluorescent imaging and histological analyses. These results demonstrate the tremendous potential, directing the recruitment and differentiation of autologous MSCs has in the field of tissue regeneration. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Nair, Ashwin M.; Tsai, Yi-Ting; Shah, Krishna M.; Shen, Jinhui; Weng, Hong; Zhou, Jun; Tang, Liping] Univ Texas Southwestern Med Ctr, Bioengn Dept, Arlington, TX 76019 USA.
   [Nair, Ashwin M.; Tsai, Yi-Ting; Shah, Krishna M.; Shen, Jinhui; Weng, Hong; Zhou, Jun; Tang, Liping] Univ Texas Arlington, Arlington, TX 76019 USA.
   [Sun, Xiankai] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA.
   [Saxena, Ramesh] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.
   [Borrelli, Joseph, Jr.] Texas Hlth Arlington Mem Hosp, Texas Hlth Phys Grp, Arlington, TX 76012 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Bioengn Dept, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
FU NIH [EB007271]
FX The authors would like to acknowledge NIH Grant EB007271. The authors
   would also like to thank and acknowledge Mr. Patrick Thomas for his help
   with a scanning.
CR Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Betz RR, 2002, ORTHOPEDICS, V25, pS561
   Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101
   Burger D, 2006, CARDIOVASC RES, V72, P51, DOI 10.1016/j.cardiores.2006.06.026
   Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chen CL, 2010, EXP CELL RES, V316, P1109, DOI 10.1016/j.yexcr.2010.02.022
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Copland IB, 2008, CARDIOVASC RES, V79, P405, DOI 10.1093/cvr/cvn090
   Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015
   Diao HJ, 2009, TISSUE ENG PT A, V15, P2687, DOI [10.1089/ten.tea.2008.0621, 10.1089/ten.TEA.2008.0621]
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803
   Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   GRONTHOS S, 1994, BLOOD, V84, P4164
   Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3
   Holstein JH, 2007, LIFE SCI, V80, P893, DOI 10.1016/j.lfs.2006.11.023
   Jang S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-25
   Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200
   Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kato S, 2010, J PHARMACOL SCI, V112, P167, DOI 10.1254/jphs.09262FP
   Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025
   Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60
   Lin GT, 2011, STEM CELLS DEV, V20, P1747, DOI 10.1089/scd.2010.0564
   Liu NM, 2011, EXP BIOL MED, V236, P1093, DOI 10.1258/ebm.2011.011001
   Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Mudalagiri NR, 2008, BRIT J PHARMACOL, V153, P50, DOI 10.1038/sj.bjp.0707461
   Muller-Ehmsen J, 2006, AM J PHYSIOL-HEART C, V290, pH331, DOI 10.1152/ajpheart.01269.2004
   Nair A, 2011, ACTA BIOMATER, V7, P3887, DOI 10.1016/j.actbio.2011.06.050
   Nair A, 2010, TISSUE ENG PART C-ME, V16, P23, DOI 10.1089/ten.TEC.2009.0094
   Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599
   Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433
   Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060
   Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC
   Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105
   Schneider RK, 2010, PATHOLOGE, V31, P138, DOI 10.1007/s00292-010-1329-7
   Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Shiozawa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010853
   Thevenot P, 2008, TISSUE ENG PART C-ME, V14, P319, DOI 10.1089/ten.tec.2008.0221
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   von Lindern M, 2000, J BIOL CHEM, V275, P34719, DOI 10.1074/jbc.M007042200
   Washio A, 2012, INT J DENT, V2012
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648
   WODNARFILIPOWICZ A, 1989, NATURE, V339, P150, DOI 10.1038/339150a0
   Xu B, 2009, J DENT RES, V88, P1003, DOI 10.1177/0022034509346928
   Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510
   Yu B, 2012, J BONE MINER RES, V27, P2001, DOI 10.1002/jbmr.1663
   Zhao Z, 2007, J DENT RES, V86, P1207, DOI 10.1177/154405910708601213
   Zwezdaryk KJ, 2007, EXP HEMATOL, V35, P640, DOI 10.1016/j.exphem.2007.01.044
NR 63
TC 21
Z9 22
U1 2
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2013
VL 34
IS 30
BP 7364
EP 7371
DI 10.1016/j.biomaterials.2013.06.031
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 198OJ
UT WOS:000322931900015
PM 23831188
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Francisco, AT
   Mancino, RJ
   Bowles, RD
   Brunger, JM
   Tainter, DM
   Chen, YT
   Richardson, WJ
   Guilak, F
   Setton, LA
AF Francisco, Aubrey T.
   Mancino, Robert J.
   Bowles, Robby D.
   Brunger, Jonathan M.
   Tainter, David M.
   Chen, Yi-Te
   Richardson, William J.
   Guilak, Farshid
   Setton, Lori A.
TI Injectable laminin-functionalized hydrogel for nucleus pulposus
   regeneration
SO BIOMATERIALS
LA English
DT Article
DE Laminin; Nucleus pulposus; Intervertebral disc; Polyethylene glycol;
   Injectable; Organ culture
ID MESENCHYMAL STEM-CELLS; INTERVERTEBRAL DISC CELLS; IN-VIVO; CHONDROCYTE
   TRANSPLANTATION; MATRIX INTERACTIONS; MODEL; DEGENERATION; EXPRESSION;
   THERAPY; REPAIR
AB Cell delivery to the pathological intervertebral disc (IVD) has significant therapeutic potential for enhancing IVD regeneration. The development of injectable biomaterials that retain delivered cells, promote cell survival, and maintain or promote an NP cell phenotype in vivo remains a significant challenge. Previous studies have demonstrated NP cell - laminin interactions in the nucleus pulposus (NP) region of the IVD that promote cell attachment and biosynthesis. These findings suggest that incorporating laminin ligands into carriers for cell delivery may be beneficial for promoting NP cell survival and phenotype. Here, an injectable, laminin-111 functionalized poly(ethylene glycol) (PEG-LM111) hydrogel was developed as a biomaterial carrier for cell delivery to the IVD. We evaluated the mechanical properties of the PEG-LM111 hydrogel, and its ability to retain delivered cells in the IVD space. Gelation occurred in approximately 20 min without an initiator, with dynamic shear moduli in the range of 0.9-1.4 kPa. Primary NP cell retention in cultured IVD explants was significantly higher over 14 days when cells were delivered within a PEG-LM111 carrier, as compared to cells in liquid suspension. Together, these results suggest this injectable laminin-functionalized biomaterial may be an easy to use carrier for delivering cells to the IVD. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Francisco, Aubrey T.; Mancino, Robert J.; Bowles, Robby D.; Brunger, Jonathan M.; Guilak, Farshid; Setton, Lori A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
   [Brunger, Jonathan M.; Chen, Yi-Te; Richardson, William J.; Guilak, Farshid; Setton, Lori A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC USA.
   [Tainter, David M.] Duke NUS Grad Med Sch, Singapore, Singapore.
   [Chen, Yi-Te] Shin Kong Wu Ho Su Mem Hosp, Dept Orthoped, Taipei, Taiwan.
   [Chen, Yi-Te] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan.
   [Chen, Yi-Te] Natl Yang Ming Univ, Dept Orthoped, Taipei 112, Taiwan.
RP Setton, LA (reprint author), Dept Biomed Engn, 136 Hudson Hall,Box 90281, Durham, NC 27708 USA.
EM lori.setton@duke.edu
OI Guilak, Farshid/0000-0001-7380-0330; Richardson,
   William/0000-0001-9608-199X
FU NIH [R01AR047442, R01EB002263, T32GM008555, F32AR063012, R01AR048852];
   Duke-NUS Medical Student Scholarship
FX This work was completed with support from NIH Grants R01AR047442,
   R01EB002263, T32GM008555, F32AR063012, R01AR048852, and a Duke-NUS
   Medical Student Scholarship. The authors thank Devin T. Bridgen, Gregory
   M. Palmer and Stephen Johnson for their assistance with the surgical
   procedures.
CR Bertram H, 2005, BIOCHEM BIOPH RES CO, V331, P1185, DOI 10.1016/j.bbrc.2005.04.034
   Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108
   Boyd LM, 2006, EUR SPINE J, V15, pS414, DOI 10.1007/s00586-006-0172-2
   Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x
   Chen J, 2002, BIOCHEM BIOPH RES CO, V293, P932, DOI 10.1016/S0006-291X(02)00314-5
   Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925
   Cheng YH, 2010, TISSUE ENG PT A, V16, P695, DOI 10.1089/ten.TEA.2009.0229
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   Chou AI, 2009, J BIOMED MATER RES A, V91A, P187, DOI 10.1002/jbm.a.32191
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Ferletta M, 2003, MOL BIOL CELL, V14, P2088, DOI 10.1091/mbc.E03-01-0852
   Ganey T, 2003, SPINE, V28, P2609, DOI 10.1097/01.BRS.0000097891.63063.78
   Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39
   Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343
   Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170
   Gruber HE, 2002, SPINE, V27, P1626, DOI 10.1097/01.BRS.0000018788.88555.21
   HABEEB AFS, 1966, BIOCHIM BIOPHYS ACTA, V115, P440, DOI 10.1016/0304-4165(66)90442-9
   Hunter CJ, 2003, TISSUE ENG, V9, P667, DOI 10.1089/107632703768247368
   Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009
   Iatridis JC, 1997, J BIOMECH, V30, P1005, DOI 10.1016/S0021-9290(97)00069-9
   Leckie SK, 2013, SPINE J, V13, P263, DOI 10.1016/j.spinee.2012.12.004
   Leo BM, 2004, SPINE, V29, P838, DOI 10.1097/00007632-200404150-00004
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   LYONS G, 1981, BIOCHIM BIOPHYS ACTA, V673, P443, DOI 10.1016/0304-4165(81)90476-1
   Marquardt L, 2011, J BIOMED MATER RES A, V98A, P1, DOI 10.1002/jbm.a.33044
   Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002
   Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Nettles DL, 2010, TISSUE ENG PT A, V16, P11, DOI 10.1089/ten.tea.2009.0134
   Nettles DL, 2004, J ANAT, V204, P515, DOI 10.1111/j.0021-8782.2004.00306.x
   O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608
   Oegema TR, 2002, BIOCHEM SOC T, V30, P839, DOI 10.1042/bst0300839
   Omlor GW, 2010, EUR SPINE J, V19, P601, DOI 10.1007/s00586-009-1255-7
   Peroglio Marianna, 2012, Eur Spine J, V21 Suppl 6, pS839, DOI 10.1007/s00586-011-1976-2
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Phillips FM, 2002, J BONE JOINT SURG BR, V84B, P289, DOI 10.1302/0301-620X.84B2.11937
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Revell PA, 2007, J MATER SCI-MATER M, V18, P303, DOI 10.1007/s10856-006-0693-6
   Risbud MV, 2010, DEV DYNAM, V239, P2141, DOI 10.1002/dvdy.22350
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5
   Saldanha KJ, 2008, EUR CELLS MATER, V16, P17, DOI 10.22203/eCM.v016a03
   Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37
   Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688
   Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004
   WALMSLEY R, 1953, Edinb Med J, V60, P341
   Wang BC, 2012, J BIOMED MATER RES A, V100A, P646, DOI 10.1002/jbm.a.33300
   WOLFE HUBERT J., 1965, CLIN ORTHOP RELAT RES, V39, P205
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 59
TC 42
Z9 44
U1 3
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2013
VL 34
IS 30
BP 7381
EP 7388
DI 10.1016/j.biomaterials.2013.06.038
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 198OJ
UT WOS:000322931900017
PM 23849345
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Orellana, BR
   Thomas, MV
   Dziubla, TD
   Shah, NM
   Hilt, JZ
   Puleo, DA
AF Orellana, Bryan R.
   Thomas, Mark V.
   Dziubla, Thomas D.
   Shah, Nihar M.
   Hilt, J. Zach
   Puleo, David A.
TI Bioerodible calcium sulfate/poly(beta-amino ester) hydrogel composites
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Calcium sulfate; Composite; Bioerodible; Biodegradable; Bone
   regeneration; Controlled release
ID BONE-GRAFT SUBSTITUTES; PHOSPHATE-BASED BONE; RIDGE AUGMENTATION;
   CONTROLLED-RELEASE; ALVEOLAR RIDGE; DRUG-RELEASE; SULFATE; CURCUMIN;
   CEMENTS; RAT
AB The capacity to quickly regenerate or augment bone lost as a result of resorption is crucial to ensure suitable application of prosthetics for restoring masticatory function. Calcium sulfate hemihydrate (CS)-based bone graft substitute composites containing poly(p-amino ester) (PBAE) biodegradable hydrogel particles were developed to act as a 'tenting' barrier to soft tissue infiltration, potentially providing adequate space to enable vertical bone regeneration. CS has long been recognized as an osteoconductive biomaterial with an excellent reputation as a biocompatible substance. Composite samples were fabricated with varying amounts (1 or 10 wt%) and sizes (53-150 or 150-250 mu m) of gel particles embedded in CS. The swelling and degradation rates of PBAE gels alone were rapid, resulting in complete degradation in less than 24 h, an important characteristic to aid in controlled release of drug. MicroCT images revealed a homogeneous distribution of gel particles within the CS matrix. All CS samples degraded via surface erosion, with the amount of gel particles (i.e., 10 wt% gel particles) having only a small, but significant, effect on the dissolution rate (4% vs. 5% per day). Compression testing determined that the amount, but not the size, of gel particles had a significant effect on the overall strength of the composites. As much as a 75% drop in strength was seen with a 10 wt% loading of particles. A pilot study using PBAE particles loaded with the multipotential drug curcumin demonstrated sustained release of drug from CS composites. By adjusting the amount and/or size of the biodegradable gel particles embedded in CS, mechanical strength and degradation rates of the composites, as well as the drug release kinetics, can be tuned to fabricate, multi-functional 'space-making' bone grafting substitutes. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Orellana, Bryan R.; Puleo, David A.] Univ Kentucky, Ctr Biomed Engn, Wenner Gren Res Lab, Lexington, KY 40506 USA.
   [Thomas, Mark V.] Univ Kentucky, Coll Dent, Lexington, KY 40536 USA.
   [Dziubla, Thomas D.; Shah, Nihar M.; Hilt, J. Zach] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.
RP Puleo, DA (reprint author), Univ Kentucky, Ctr Biomed Engn, 209 Wenner Gren Lab, Lexington, KY 40506 USA.
EM puleo@uky.edu
FU National Institutes of Health [DE019645]; Kentucky NASA EPSCoR
   [NNX08BA13A]; National Science Foundation [EPS-0814194]
FX This research supported by the National Institutes of Health (DE019645),
   Kentucky NASA EPSCoR (NNX08BA13A), and the National Science Foundation
   (EPS-0814194).
CR Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   Chiapasco M., 2009, BONE AUGMENTATION PR
   Chiapasco M, 2007, CLIN ORAL IMPLAN RES, V18, P432, DOI 10.1111/j.1600-0501.2007.01351.x
   Cho DC, 2012, ACTA NEUROCHIR, V154, P2215, DOI 10.1007/s00701-012-1516-9
   Choi BH, 2004, J CRANIO MAXILL SURG, V32, P51, DOI 10.1016/j.jcms.2003.08.006
   Clavero Jaime, 2003, Clin Implant Dent Relat Res, V5, P154, DOI 10.1111/j.1708-8208.2003.tb00197.x
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P203, DOI 10.1034/j.1600-0501.2002.130211.x
   Gao CJ, 2007, J BIOMAT SCI-POLYM E, V18, P799, DOI 10.1163/156856207781367710
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Gu QL, 2012, PHARMACOGN MAG, V8, P202, DOI 10.4103/0973-1296.99285
   Guarnieri R, 2006, INT J PERIODONT REST, V26, P79
   Guarnieri R, 2004, J PERIODONTOL, V75, P902, DOI 10.1902/jop.2004.75.6.902
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   Handschel J, 2002, BIOMATERIALS, V23, P1689, DOI 10.1016/S0142-9612(01)00296-4
   Hawkins AM, 2011, J APPL POLYM SCI, V122, P1420, DOI 10.1002/app.34093
   Hawkins AM, 2009, PHARM RES-DORD, V26, P667, DOI 10.1007/s11095-008-9804-z
   Hesaraki S, 2009, J BIOMED MATER RES B, V91B, P651, DOI 10.1002/jbm.b.31441
   Hitti RA, 2011, OPEN PATHOL J, V5, P33
   Jamali A, 2002, CALCIFIED TISSUE INT, V71, P172, DOI 10.1007/s00223-001-1087-x
   Karadag E, 2002, POLYM BULL, V48, P299, DOI 10.1007/s00289-002-0029-8
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   Kim SY, 2012, J IND ENG CHEM, V18, P128, DOI 10.1016/j.jiec.2011.11.001
   Lewis KN, 2006, J MATER SCI-MATER M, V17, P531, DOI 10.1007/s10856-006-8936-0
   Ozaki K, 2000, BIOCHEM PHARMACOL, V59, P1577, DOI 10.1016/S0006-2952(00)00277-X
   Pecora G, 1997, ORAL SURG ORAL MED O, V84, P424, DOI 10.1016/S1079-2104(97)90043-3
   Shimazu C, 2006, J ORAL REHABIL, V33, P609, DOI 10.1111/j.1365-2842.2005.01593.x
   Simion M, 2007, CLIN ORAL IMPLAN RES, V18, P620, DOI 10.1111/j.1600-0501.2007.01389.x
   Strietzel FP, 2007, CLIN ORAL IMPLAN RES, V18, P743, DOI 10.1111/j.1600-0501.2007.01416.x
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   Thomas Mark V, 2005, J Long Term Eff Med Implants, V15, P599
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Triplett RG, 1996, J ORAL MAXIL SURG, V54, P486, DOI 10.1016/S0278-2391(96)90126-3
   Urban RM, 2007, CLIN ORTHOP RELAT R, P110, DOI 10.1097/BLO.0b013e318059b902
   Wattamwar PP, 2012, ACTA BIOMATER, V8, P2529, DOI 10.1016/j.actbio.2012.03.022
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   Zhou WJ, 1996, J APPL POLYM SCI, V62, P911, DOI 10.1002/(SICI)1097-4628(19961107)62:6<911::AID-APP7>3.3.CO;2-G
NR 39
TC 8
Z9 10
U1 1
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD OCT
PY 2013
VL 26
BP 43
EP 53
DI 10.1016/j.jmbbm.2013.05.021
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 198NP
UT WOS:000322929900005
PM 23811276
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Galeotti, F
   Andicsova, A
   Bertini, F
   Botta, C
AF Galeotti, Francesco
   Andicsova, Anita
   Bertini, Fabio
   Botta, Chiara
TI A versatile click-grafting approach to surface modification of silk
   fibroin films
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID POLY(ETHYLENE GLYCOL); MECHANICAL-PROPERTIES; CONJUGATE FILMS;
   DRUG-DELIVERY; CHEMISTRY; POLYMER; BIOMATERIAL; CELLS; REGENERATION;
   DEVICES
AB Silk fibroin is a biocompatible, mechanically robust protein polymer that can be made optically transparent, and is widely used and studied as biomaterial for different applications. Its chemical modification is a fascinating way for tuning the properties and widening its application field. Herein, PEG grafting on the surface of regenerated silk fibroin films is obtained by direct linking based on a click reaction between the azido activated silk surface and an alkyne terminated PEG. The so obtained PEGylated films exhibit modified surface properties in comparison with the unmodified films. Through the same click approach, we also show that arrays of ordered fluorescent spots are steadily printed onto the film surface. This expands the versatility of our silk modification to different molecules and polymers, hence allowing for the realization of new functional hybrid materials.
C1 [Galeotti, Francesco; Andicsova, Anita; Bertini, Fabio; Botta, Chiara] CNR, Ist Studio Macromol, I-20133 Milan, Italy.
RP Galeotti, F (reprint author), CNR, Ist Studio Macromol, Via Bassini 15, I-20133 Milan, Italy.
EM f.galeotti@ismac.cnr.it
RI Botta, Chiara/B-8301-2015; galeotti, francesco/A-4813-2012
OI Botta, Chiara/0000-0001-8722-0417; galeotti,
   francesco/0000-0003-4793-9827; BERTINI, FABIO/0000-0003-0199-4767
FU Regione Lombardia, GreenCosmetic ATP Project; Regione/CNR [4]
FX The authors are grateful for the financial support to Regione Lombardia,
   GreenCosmetic ATP Project and to agreement Regione/CNR, project 4:
   "Nanoscienze per materiali e applicazioni biomediche". The authors also
   thank Guido Scavia (ISMAC-CNR) for AFM analysis.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Binder WH, 2007, MACROMOL RAPID COMM, V28, P15, DOI 10.1002/marc.200600625
   Bolognesi A, 2010, MACROMOL CHEM PHYS, V211, P1488, DOI 10.1002/macp.201000063
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Galeotti F, 2012, SOFT MATTER, V8, P4815, DOI 10.1039/c2sm25089f
   Galeotti F, 2009, EUR POLYM J, V45, P3027, DOI 10.1016/j.eurpolymj.2009.08.009
   Gassensmith JJ, 2012, ADV MATER, V25, P223
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 1997, POLYMER, V38, P487, DOI 10.1016/S0032-3861(96)00665-9
   GOTOH Y, 1993, BIOCONJUGATE CHEM, V4, P554, DOI 10.1021/bc00024a020
   Hines DJ, 2011, BIOMACROMOLECULES, V12, P804, DOI 10.1021/bm101421r
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   INADA Y, 1995, TRENDS BIOTECHNOL, V13, P86, DOI 10.1016/S0167-7799(00)88912-X
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Le Droumaguet B, 2008, MACROMOL RAPID COMM, V29, P1073, DOI 10.1002/marc.200800155
   Lu WY, 2010, TETRAHEDRON, V66, P750, DOI 10.1016/j.tet.2009.11.044
   MAROUDAS NG, 1975, NATURE, V254, P695, DOI 10.1038/254695a0
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   MENICAGLI R, 1994, SYNTHETIC COMMUN, V24, P2153, DOI 10.1080/00397919408010229
   Mulhaupt R, 2013, MACROMOL CHEM PHYS, V214, P159, DOI 10.1002/macp.201200439
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Rogers JA, 2009, APPL PHYS LETT, V95
   Rozkiewicz DI, 2007, CHEMBIOCHEM, V8, P1997, DOI 10.1002/cbic.200700402
   Sampaio S, 2011, POLYM INT, V60, P1737, DOI 10.1002/pi.3143
   Smitha VS, 2011, J AM CERAM SOC, V94, P1731, DOI 10.1111/j.1551-2916.2010.04326.x
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari C, 2010, J BIOMED MATER RES A, V93A, P595, DOI 10.1002/jbm.a.32565
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
NR 46
TC 4
Z9 4
U1 6
U2 97
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD OCT
PY 2013
VL 48
IS 20
BP 7004
EP 7010
DI 10.1007/s10853-013-7509-0
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 189OX
UT WOS:000322277700017
DA 2018-10-20
ER

PT J
AU Xu, DW
   Yang, WH
   Hu, Y
   Luo, Z
   Li, JH
   Hou, YH
   Liu, Y
   Cai, KY
AF Xu, Dawei
   Yang, Weihu
   Hu, Yan
   Luo, Zhong
   Li, Jinghua
   Hou, Yanhua
   Liu, Yun
   Cai, Kaiyong
TI Surface functionalization of titanium substrates with cecropin B to
   improve their cytocompatibility and reduce inflammation responses
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Titanium; Cecropin B; Osteoblast; Inflammation response; Antibacterial
   property
ID MESENCHYMAL STEM-CELLS; STRUCTURAL BASIS; TNF-ALPHA; IN-VITRO;
   DIFFERENTIATION; ANTIBACTERIAL; PEPTIDES; IMPLANTS; NANOPARTICLES;
   BIOMATERIAL
AB Bacteria-related inflammation is a common postoperative complication in orthopedic implantation. In this study, cecropin B (CecB), a cationic peptide, was immobilized onto the surfaces of titanium substrates to improve their cytocompatibility and reduce inflammation responses. Polydopamine film was coated onto the surfaces of titanium substrates as an intermediate layer for the further immobilization of the CecB, which was confirmed by scanning electron microscopy (SEM), atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS) and water contact angle measurement, respectively. Osteoblasts grown onto the CecB-immobilized titanium substrates displayed significantly higher (p < 0.01) cell viability than that of native titanium substrates (controls). Gram-positive bacteria - Bacillus subtilis, Staphylococcus aureus and Gram-negative bacteria - Escherichia coli, Pseudomonas aeruginosa were employed for antibacterial characterization. Media-borne assay and anti-biofilm formation showed that CecB-immobilized titanium substrates inhibited the adhesion and growth of bacteria. Macrophages cultured onto CecB-immobilized titanium substrates demonstrated statistically lower (p < 0.01) levels of tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) than those of the control groups. The results indicated that the immobilization of CecB onto titanium substrates was responsible for improved cytocompatibility and reduced inflammation responses. The approach presented here has great potential in the development of antibacterial titanium-based implants in clinical applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Xu, Dawei; Yang, Weihu; Hu, Yan; Luo, Zhong; Li, Jinghua; Hou, Yanhua; Liu, Yun; Cai, Kaiyong] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China.
RP Yang, WH (reprint author), Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China.
EM yangweihu@cqu.edu.cn; kaiyong_cai@cqu.edu.cn
RI 蔡, 开勇/G-1233-2011
FU China Ministry of Science and Technology (973 Project) [2009CB930000];
   Natural Science Foundation of Chongqing Municipal Government (CSTC)
   [2011JJJQ10004]; Natural Science Foundation of China [31170923,
   51173216]; National Key Technology R&D Program of the Ministry of
   Science and Technology [2012BAI18B04]; Chongqing University [S-09104]
FX We gratefully acknowledge the financial support from China Ministry of
   Science and Technology (973 Project No. 2009CB930000), Natural Science
   Foundation of Chongqing Municipal Government (CSTC, 2011JJJQ10004),
   Natural Science Foundation of China (31170923 and 51173216), National
   Key Technology R&D Program of the Ministry of Science and Technology
   (2012BAI18B04) and Chongqing University Innovative Talent Training
   Project of the Third Stage of "211 Project" (#S-09104).
CR Andra J, 2001, MED MICROBIOL IMMUN, V189, P169, DOI 10.1007/s430-001-8025-x
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610
   Broggini N, 2003, J DENT RES, V82, P232, DOI 10.1177/154405910308200316
   Cai KY, 2005, APPL SURF SCI, V250, P252, DOI 10.1016/j.apsusc.2005.01.013
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chen HM, 2003, MICROSC RES TECHNIQ, V62, P423, DOI 10.1002/jemt.10406
   Chen HM, 2003, EUR J BIOCHEM, V270, P911, DOI 10.1046/j.1432-1033.2003.03451.x
   Chien CY, 2013, J BIOMED MATER RES A, V101, P740, DOI 10.1002/jbm.a.34376
   Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Gao Y, 2009, BIOMATERIALS, V30, P1790, DOI 10.1016/j.biomaterials.2008.12.025
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Grellner W, 2000, FORENSIC SCI INT, V113, P251, DOI 10.1016/S0379-0738(00)00218-8
   Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200
   Gu YX, 2013, J BIOMED MATER RES A, V101, P748, DOI 10.1002/jbm.a.34377
   Hamlet S, 2012, CLIN ORAL IMPLAN RES, V23, P584, DOI 10.1111/j.1600-0501.2011.02325.x
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hu Y, 2012, BIOMATERIALS, V33, P3515, DOI 10.1016/j.biomaterials.2012.01.040
   Hu Y, 2010, ADV ENG MATER, V12, pB18, DOI 10.1002/adem.200980006
   Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020
   Koyanagi T, 2013, J CLIN PERIODONTOL, V40, P218, DOI 10.1111/jcpe.12047
   Lai M, 2011, BIOMACROMOLECULES, V12, P1097, DOI 10.1021/bm1014365
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Li SB, 2012, J BIOMED MATER RES B, V100B, P1587, DOI 10.1002/jbm.b.32727
   Morra M, 2004, BIOMED PHARMACOTHER, V58, P418, DOI 10.1016/j.biopha.2004.08.002
   Pennekamp PH, 2006, J ORTHOP RES, V24, P531, DOI 10.1002/jor.20066
   Quirynen M., 2002, CLIN ORAL IMPLANTS R, V13
   Rim NG, 2012, COLLOID SURFACE B, V91, P189, DOI 10.1016/j.colsurfb.2011.10.057
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041
   Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077
   Singh R, 2012, INT J RADIAT BIOL, V88, P661, DOI 10.3109/09553002.2012.700166
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Suttmann Henrik, 2008, BMC Urol, V8, P5, DOI 10.1186/1471-2490-8-5
   TAKAGI M, 2001, J CLIN EXP HEMATOPAT, V41, P81
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946
   Wu JM, 2009, PEPTIDES, V30, P839, DOI 10.1016/j.peptides.2009.02.004
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
NR 43
TC 19
Z9 19
U1 4
U2 135
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2013
VL 110
BP 225
EP 235
DI 10.1016/j.colsurfb.2013.04.050
PG 11
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 185BM
UT WOS:000321940200030
PM 23732798
DA 2018-10-20
ER

PT J
AU Yalcin, O
   Bayrakdar, H
   Ozum, S
AF Yalcin, Orhan
   Bayrakdar, Harun
   Ozum, Songul
TI Spin-flop transition, magnetic and microwave absorption properties of
   alpha-Fe2O4 spinel type ferrite nanoparticles
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE XRD; Microwave property; Microwave absorption; Dielectric property;
   Magnetic property; Spin-flop transition
ID NANOCRYSTALLINE NICKEL FERRITE; NI-ZN FERRITES; COMPOSITE NANOPARTICLES;
   ZINC FERRITE; PHOTOCATALYTIC SHELL; BIOMATERIAL SYSTEM; ANTIMICROBIAL
   ACTIVITY; PRECURSOR METHOD; PARTICLE-SIZE; CORE
AB We have prepared NiFe2O4, CoFe2O4, Ni0.6Zn0.4Fe2O4 and ZnFe2O4 spinel type ferrite nanoparticles by surfactant-assisted hydrothermal process using cetyltrimethylammonium bromide (CTAB). The spin-flop transition, magnetic, dielectric and permittivity characterizations have been investigated. The spin-flop transition occurs from antiferromagnetic state to mixed state and then ferromagnetic state for Zn doped samples. The spin-flop transition occurs in the temperature range of 50-250 K. The ionic conduction, dipolar relaxation, atomic polarization and electronic polarization are the main mechanisms that contribute to the permittivity of a dielectric material. The permittivity increases with increasing frequency. This suggests a resonance behavior, which is expected when the ferrite samples are highly conductive and skin effect become significant. These samples will provide great benefits for electromagnetic applications and electromagnetic interference shielding characteristics. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Yalcin, Orhan] Nigde Univ, Dept Phys, TR-51240 Nigde, Turkey.
   [Bayrakdar, Harun] Canakkale Onsekiz Mart Univ, TR-17100 Canakkale, Turkey.
   [Ozum, Songul] Nigde Univ, Inst Grad Sch Nat & Appl Sci, TR-51240 Nigde, Turkey.
RP Yalcin, O (reprint author), Nigde Univ, Dept Phys, TR-51240 Nigde, Turkey.
EM o.yalcin@nigde.edu.tr
FU Scientific and Technological Research Council of Turkey (TUBITAK)
   [112E044]
FX The authors are grateful to the Scientific and Technological Research
   Council of Turkey (TUBITAK, Contract no. 112E044) for financial support
   of this study. We would like to thank Sahin Unluer of Nigde University
   for valuable discussions and the critical reading of the paper.
CR Ahmed YMZ, 2009, J MAGN MAGN MATER, V321, P181, DOI 10.1016/j.jmmm.2008.08.100
   ARIT G, 1985, J APPL PHYS, V58, P1619
   Atif M, 2006, SOLID STATE COMMUN, V138, P416, DOI 10.1016/j.ssc.2006.03.023
   Babin V, 2003, J APPL PHYS, V94, P4244, DOI 10.1063/1.1604932
   Baykal A, 2008, J ALLOY COMPD, V464, P514, DOI [10.1016/j.jallcom.2007.10.041, 10.1016/j.jallcom.2007.10.41]
   Bayrakdar H., 2011, TURKISH J CHEM
   Bayrakdar H, 2011, J MAGN MAGN MATER, V323, P1882, DOI 10.1016/j.jmmm.2011.02.030
   Bayrakdar H, 2010, J APPL PHYS, V107, DOI 10.1063/1.3305333
   Brusentsov NA, 2001, J MAGN MAGN MATER, V225, P113, DOI 10.1016/S0304-8853(00)01238-5
   Chen L. F., 2004, MICROWAVE ELECT MEAS
   Cruickshank D, 2003, J EUR CERAM SOC, V23, P2721, DOI 10.1016/S0955-2219(03)00145-6
   Damnjanovic M, 2006, IEEE T MAGN, V42, P270, DOI 10.1109/TMAG.2005.860485
   Ding LL, 1999, SYNTHETIC MET, V104, P73, DOI 10.1016/S0379-6779(99)00035-1
   El-Sayed AM, 2002, CERAM INT, V28, P363, DOI 10.1016/S0272-8842(01)00103-1
   Fortin JP, 2008, EUR BIOPHYS J BIOPHY, V37, P223, DOI 10.1007/s00249-007-0197-4
   Gill CS, 2009, CATAL LETT, V131, P425, DOI 10.1007/s10562-009-0099-4
   GLEITER H, 1992, ADV MATER, V4, P474, DOI 10.1002/adma.19920040704
   Goldman A., 2006, MODERN FERRITE TECHN
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   Guertin RP, 2007, J MAGN MAGN MATER, V308, P97, DOI 10.1016/j.jmmm.2006.05.010
   HASHIMOTO O, 1997, INTRO WAVE ABSORBER
   Hashimoto O., 2003, TECHNOLOGIES APPL WA
   He X, 2008, PROG ELECTROM RES LE, V3, P1, DOI 10.2528/PIERL08011501
   Hessien MM, 2008, J MAGN MAGN MATER, V320, P1615, DOI 10.1016/j.jmmm.2008.01.025
   Hochepied JF, 2000, J PHYS CHEM B, V104, P905, DOI 10.1021/jp991626i
   Huang XH, 2004, J MAGN MAGN MATER, V280, P37, DOI 10.1016/j.jmmm.2004.02.020
   Ikenaga N, 2004, FUEL, V83, P661, DOI 10.1016/j.fuel.2003.08.019
   Ji GB, 2004, J CRYST GROWTH, V270, P156, DOI [10.1016/j.jcrysgro.2004.06.025, 10.1016/j.j.crysgro.2004.06.025]
   Jiang JZ, 1999, NANOSTRUCT MATER, V12, P737, DOI 10.1016/S0965-9773(99)00228-7
   Joy PA, 2000, J MAGN MAGN MATER, V222, P33, DOI 10.1016/S0304-8853(00)00572-2
   JUNG CW, 1995, MAGN RESON IMAGING, V13, P661, DOI 10.1016/0730-725X(95)00024-B
   Kale A, 2004, J MAGN MAGN MATER, V277, P350, DOI 10.1016/j.jmmm.2003.11.015
   Kartopu G., 2010, ELECTRODEPOSITED NAN
   Kasapoglu N, 2007, SCRIPTA MATER, V57, P441, DOI 10.1016/j.scriptamat.2007.04.042
   KEFFER F, 1973, PHYS REV LETT, V31, P1061, DOI 10.1103/PhysRevLett.31.1061
   Kim DY, 1996, IEEE T MAGN, V32, P555, DOI 10.1109/20.486547
   Lakshmi K, 2009, ACTA MATER, V57, P371, DOI 10.1016/j.actamat.2008.09.018
   Li D, 2009, J APPL PHYS, V106, DOI 10.1063/1.3213100
   Li H, 2010, POWDER TECHNOL, V198, P157, DOI 10.1016/j.powtec.2009.11.005
   Lian LX, 2007, J ALLOY COMPD, V441, P301, DOI 10.1016/j.jallcom.2006.09.101
   Lim KM, 2003, IEEE T MAGN, V39, P1836, DOI 10.1109/TMAG.2003.810619
   Liu J P, 2009, NANOSCALE MAGNETIC M
   Maeda T, 2001, MATER TRANS, V42, P446, DOI 10.2320/matertrans.42.446
   Mansour S.F., 2010, CERAM INT, V37, P1175
   Mastai Y., ADV CRYSTALLIZATION
   Matsumoto M., 1998, J MAGN SOC JPN, V22, P885
   MILLS DL, 1968, PHYS REV LETT, V20, P18, DOI 10.1103/PhysRevLett.20.18
   Mohamed RM, 2010, J MAGN MAGN MATER, V322, P2058, DOI 10.1016/j.jmmm.2010.01.034
   Mornet S, 2006, PROG SOLID STATE CH, V34, P237, DOI 10.1016/j.progsolidstchem.2005.11.010
   MURTHY VRK, 1989, SOLID STATE COMMUN, V70, P847, DOI 10.1016/0038-1098(89)90510-3
   NAITO Y, 1971, IEEE T MICROW THEORY, VMT19, P65, DOI 10.1109/TMTT.1971.1127446
   NAITO Y, 1987, ELECTROMAGNETIC WAVE
   Ohlan A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2969400
   OZIN GA, 1992, ADV MATER, V4, P612, DOI 10.1002/adma.19920041003
   Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rashad MM, 2008, J MATER PROCESS TECH, V198, P139, DOI 10.1016/j.jmatprotec.2007.07.012
   Rashad MM, 2009, J ALLOY COMPD, V486, P759, DOI 10.1016/j.jallcom.2009.07.051
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Saito A., 1999, MAT JAPAN, V38, P46
   Sertoglu M., 2009, TURK J CHEM, V33, P33
   Shenoy SD, 2004, J MAGN MAGN MATER, V269, P217, DOI 10.1016/S0304-8853(03)00596-1
   Shim JH, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064404
   Shirsath SE, 2011, J MAGN MAGN MATER, V323, P3104, DOI 10.1016/j.jmmm.2011.06.065
   Sivakumar N, 2010, J ALLOY COMPD, V504, P395, DOI 10.1016/j.jallcom.2010.05.125
   Sugimoto S, 1998, MATER T JIM, V39, P1080, DOI 10.2320/matertrans1989.39.1080
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Upadhyay C, 2004, APPL PHYS LETT, V85, P2074, DOI 10.1063/1.1786368
   Upadhyay C, 2004, J APPL PHYS, V95, P5746, DOI 10.1063/1.1699501
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Verma A, 2003, J MAGN MAGN MATER, V263, P228, DOI 10.1016/S0304-8853(02)01569-X
   Wang J, 2004, ADV MATER, V16, P137, DOI 10.1002/adma.200306136
   WANG RW, 1994, PHYS REV LETT, V72, P920, DOI 10.1103/PhysRevLett.72.920
   Yalcin O., 2012, NANORODS, DOI [10.5772/2046, DOI 10.5772/2046]
   Yalcin O., 2012, SMART NANOPARTICLES
   Yoshida S, 1999, J APPL PHYS, V85, P4636, DOI 10.1063/1.370432
   Zhang DE, 2005, J MAGN MAGN MATER, V292, P79, DOI 10.1016/j.jmmm.2004.10.097
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
   Zhao DL, 2009, J ALLOY COMPD, V469, P215, DOI 10.1016/j.jallcom.2008.01.083
   Zysler RD, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.212408
NR 85
TC 12
Z9 12
U1 3
U2 95
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD OCT
PY 2013
VL 343
BP 157
EP 162
DI 10.1016/j.jmmm.2013.05.009
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 173VK
UT WOS:000321109500027
DA 2018-10-20
ER

PT J
AU Colledge, FMA
   Elger, BS
   Shaw, DM
AF Colledge, Flora M. A.
   Elger, Bernice S.
   Shaw, David M.
TI "Conferring Authorship": Biobank Stakeholders' Experiences with
   Publication Credit in Collaborative Research
SO PLOS ONE
LA English
DT Article
ID SCIENTIFIC MISCONDUCT; NETWORKS; CONTRIBUTORS; BIORESOURCES; ARTICLES;
   JOURNALS; VIEWS; ORDER; COIN; NEED
AB Background: Multi-collaborator research is increasingly becoming the norm in the field of biomedicine. With this trend comes the imperative to award recognition to all those who contribute to a study; however, there is a gap in the current "gold standard" in authorship guidelines with regards to the efforts of those who provide high quality biosamples and data, yet do not play a role in the intellectual development of the final publication.
   Methods and findings: We carried out interviews with 36 individuals working in, or with links to, biobanks in Switzerland, in order to understand how they interpret, apply and value authorship criteria in studies involving biosamples. The majority of respondents feel that authorship is an important motivating factor in working and publishing collaboratively. However, our findings suggest that in some cases, authorship guidelines are being ignored in favor of departmental standards which recognize "scientific work" as meriting authorship.
   Conclusions: Our results support the current calls in the literature for an alternative method of crediting biomaterial contributions, in order to ensure appropriate authorship inclusion and promote collaborative research involving biobanks.
C1 [Colledge, Flora M. A.; Elger, Bernice S.; Shaw, David M.] Univ Basel, Inst Biomed Eth, Basel, Switzerland.
RP Colledge, FMA (reprint author), Univ Basel, Inst Biomed Eth, Basel, Switzerland.
EM flora.colledge@unibas.ch
RI Elger, Bernice/V-7265-2017
OI Elger, Bernice/0000-0002-4249-7399
FU University of Basel; Kathe-Zingg Schwichtenberg Fund of the Swiss
   Academy of Medical Science
FX The salaries of all authors are paid by the University of Basel. Flora
   Colledge's doctoral research is funded in part by the Kathe-Zingg
   Schwichtenberg Fund of the Swiss Academy of Medical Science. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a
   [Anonymous], 2011, COD AC INT GOOD PRAC
   Barrett Kirsten A, 2005, Account Res, V12, P193, DOI 10.1080/08989620500217321
   Bennett Dianne M, 2003, Emerg Med (Fremantle), V15, P263, DOI 10.1046/j.1442-2026.2003.00432.x
   Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1605, DOI 10.2106/00004623-200308000-00024
   Bhopal R, 1997, BRIT MED J, V314, P1009, DOI 10.1136/bmj.314.7086.1009
   Cambon-Thomsen A, 2011, NAT GENET, V43, P503, DOI 10.1038/ng.831
   Erlen JA, 1997, J PROF NURS, V13, P262, DOI 10.1016/S8755-7223(97)80097-X
   Geggie D, 2001, J MED ETHICS, V27, P344
   Glanzel W, 2005, HDB QUANTITATIVE SCI, P257, DOI DOI 10.1007/1-4020-2755-9_12
   ICoMJ Editors, 2009, BIOMEDICAL J UNPUB
   Jacob MA, 2011, AM J BIOETHICS, V11, P28, DOI 10.1080/15265161.2011.603812
   Jones AH, 2003, SCI ENG ETHICS, V9, P243, DOI 10.1007/s11948-003-0011-3
   King JT, 2000, NEUROSURGERY, V47, P435, DOI 10.1097/00006123-200008000-00032
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Laudel G, 2001, INT J TECHNOL MANAGE, V22, P762, DOI 10.1504/IJTM.2001.002990
   Leopold SS, 2013, CLIN ORTHOP RELAT R, V471, P701, DOI 10.1007/s11999-013-2796-y
   Mabile L, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-7
   Marris E, 2006, NATURE, V439, P768, DOI 10.1038/439768b
   Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1
   Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266
   Pignatelli B, 2005, J MED ETHICS, V31, P578, DOI 10.1136/jme.2004.009449
   Riegman PHJ, 2008, MOL ONCOL, V2, P213, DOI 10.1016/j.molonc.2008.07.004
   RIESENBERG D, 1990, JAMA-J AM MED ASSOC, V264, P1857, DOI 10.1001/jama.264.14.1857
   Shickle D, 2010, PATHOBIOLOGY, V77, P181, DOI 10.1159/000292651
   Smith J, 2005, BRIT MED J, V331, P245, DOI 10.1136/bmj.331.7511.245
   Smith R, 1997, BRIT MED J, V314, P992, DOI 10.1136/bmj.314.7086.992
   Smith R, 1997, BRIT MED J, V315, P696, DOI 10.1136/bmj.315.7110.696
   Strange K, 2008, AM J PHYSIOL-CELL PH, V295, pC567, DOI 10.1152/ajpcell.00208.2008
   Thomas GA, 2011, CLIN ONCOL-UK, V23, P276, DOI 10.1016/j.clon.2011.01.503
   Vaught J, 2009, BIOPRESERV BIOBANK, V7, P143, DOI 10.1089/bio.2010.0003
   Wager E, 2006, J ROY SOC MED, V99, P542, DOI 10.1258/jrsm.99.11.542
   Wilcox LJ, 1998, JAMA-J AM MED ASSOC, V280, P216, DOI 10.1001/jama.280.3.216
   Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128
NR 34
TC 5
Z9 5
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 30
PY 2013
VL 8
IS 9
AR e76686
DI 10.1371/journal.pone.0076686
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 231NL
UT WOS:000325423500174
PM 24098803
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Dubey, AK
   Yamada, H
   Kakimoto, K
AF Dubey, Ashutosh Kumar
   Yamada, Hiroaki
   Kakimoto, Ken-ichi
TI Space charge polarization induced augmented in vitro bioactivity of
   piezoelectric (Na, K) NbO3
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID FERROELECTRIC BATIO3 CERAMICS; APATITE-FORMING ABILITY; SIMULATED
   BODY-FLUID; TITANIUM METAL; TI METAL; CALCIUM-PHOSPHATE;
   SURFACE-STRUCTURE; CRYSTAL-GROWTH; HEAT-TREATMENT; HYDROXYAPATITE
AB The present study reports the influence of chemical and electrical treatments (CET) of Li-modified sodium potassium niobate [Li-0.06(Na0.5K0.5)(0.94)NbO3, LNKN] piezo-biomaterial on in vitro bioactivity. The chemical treatment of LNKN substrate was performed by Ti sputtering, followed by immersion in NaOH aqueous solution for various time durations and subsequently, the heat treatment. The chemically treated LNKN substrates were then corona poled. The in vitro biomineralization study suggested that the integrated effect of chemical as well as electrical treatments of LNKN piezoceramics stimulates the early stage apatite crystallization as compared to that of the mere chemical treatment. To reveal the mechanism of polarization on crystal formation, the thermally stimulated depolarization currents (TSDC) were measured before and after the chemically as well as electrically treated substrates being soaked in simulated body fluid for various time durations. It has been observed that the release of surface charge in the low temperature region (similar to 60 degrees C) has significant effect on apatite formation and growth. The surface charge density decreases with increase in the soaking period and hence, the influence of surface charge on apatite crystallization can be realized. The dielectric relaxation in the low frequency region as well as TSDC analysis suggests that the space charge polarization is dominant polarization mechanism in the CET piezo-biomaterial. (C) 2013 AIP Publishing LLC.
C1 [Dubey, Ashutosh Kumar; Yamada, Hiroaki; Kakimoto, Ken-ichi] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Dubey, AK (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
EM akdubey@nitech.ac.jp
FU JSPS;  [2365400];  [24-2377]
FX This work was supported by Grant-in-Aids for JSPS Challenging
   Exploratory Research (No. 2365400) and for JSPS Fellows (No. 24-2377).
   A. K. D. gratefully acknowledge JSPS for the fellowship.
CR Almond DP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.157601
   Baxter FR, 2010, ANN BIOMED ENG, V38, P2079, DOI 10.1007/s10439-010-9977-6
   Calvert P, 1997, NATURE, V386, P127, DOI 10.1038/386127a0
   Dreyer C. J., 1961, NATURE, V190, P1217
   Dubey AK, 2011, FERROELECTRICS, V423, P63, DOI 10.1080/00150193.2011.618382
   Dubey AK, 2011, J BIOMED MATER RES B, V98B, P18, DOI 10.1002/jbm.b.31827
   Dubey AK, 2010, J BIOMED MATER RES B, V95B, P320, DOI 10.1002/jbm.b.31716
   EI Messiery M. A., 1979, J BIOMED ENG, V1, P63
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Gonzalez-Abreu Y, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729918
   Guo YP, 2004, APPL PHYS LETT, V85, P4121, DOI 10.1063/1.1813636
   HASTINGS GW, 1988, J BIOMED ENG, V10, P515, DOI 10.1016/0141-5425(88)90109-4
   Hwang KS, 2002, J MATER SCI-MATER M, V13, P133, DOI 10.1023/A:1013671526975
   Kakimoto K, 2010, J AM CERAM SOC, V93, P2423, DOI 10.1111/j.1551-2916.2010.03748.x
   Kim HM, 1999, J BIOMED MATER RES, V45, P100, DOI 10.1002/(SICI)1097-4636(199905)45:2<100::AID-JBM4>3.0.CO;2-0
   Kim HM, 2003, J BIOMED MATER RES A, V67A, P1305, DOI 10.1002/jbm.a.20039
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LANG SIDNEY B., 1966, NATURE, V212, P704, DOI 10.1038/212704a0
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   Nilsson K, 2003, U. S. patent, Patent No. [6,526,984, 6526984]
   Obata A, 2003, J BIOMED MATER RES A, V67A, P413, DOI 10.1002/jbm.a.10069
   Olivares-Navarrete R, 2011, COATINGS, V1, P72, DOI 10.3390/coatings1010072
   Ong J L, 2000, Crit Rev Biomed Eng, V28, P667
   Paks G. A., 1965, CHEM REV, V65, P177
   Park YJ, 2002, BIOMATERIALS, V23, P3859, DOI 10.1016/S0142-9612(02)00123-0
   PRUSI AR, 1992, CORROS SCI, V33, P153, DOI 10.1016/0010-938X(92)90024-W
   Sato K, 2005, ANAL SCI, V21, P21, DOI 10.2116/analsci.21.21
   Takadama H, 2001, J BIOMED MATER RES, V55, P185, DOI 10.1002/1097-4636(200105)55:2<185::AID-JBM1005>3.3.CO;2-G
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Yamaguchi S, 2009, J CERAM SOC JPN, V117, P1126, DOI 10.2109/jcersj2.117.1126
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
NR 37
TC 3
Z9 3
U1 4
U2 47
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD SEP 28
PY 2013
VL 114
IS 12
AR 124701
DI 10.1063/1.4822022
PG 10
WC Physics, Applied
SC Physics
GA 231CR
UT WOS:000325391100075
DA 2018-10-20
ER

PT J
AU Krishnan, R
   Arora, R
   Lamb, M
   White, SM
   Storrs, R
   Dorian, R
   King, S
   Foster, CE
   Botvinick, E
   Choi, B
   Lakey, JRT
AF Krishnan, Rahul
   Arora, Rajan
   Lamb, Morgan
   White, Sean M.
   Storrs, Rick
   Dorian, Randy
   King, Scott
   Foster, Clarence E., III
   Botvinick, Elliot
   Choi, Bernard
   Lakey, Jonathan R. T.
TI Noninvasive Quantification of Vascular Hemodynamics in Subcutaneous
   Transplantation of Biomaterial Encapsulated Islets.
SO TRANSPLANTATION
LA English
DT Meeting Abstract
CT 14th World Congress of the
   International-Pancreas-and-Islet-Transplant-Association (IPITA)
CY SEP 24-27, 2013
CL Monterey, CA
SP Int Pancreas & Islet Transplant Assoc
C1 [Krishnan, Rahul; Lamb, Morgan; Foster, Clarence E., III; Botvinick, Elliot; Choi, Bernard; Lakey, Jonathan R. T.] Univ Calif Irvine, Orange, CA 92668 USA.
   [Arora, Rajan; White, Sean M.; Botvinick, Elliot; Choi, Bernard] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92715 USA.
   [White, Sean M.; Botvinick, Elliot; Choi, Bernard; Lakey, Jonathan R. T.] Univ Calif Irvine, Irvine, CA USA.
   [Storrs, Rick; Dorian, Randy; King, Scott] Islet Sheet Med, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD SEP 27
PY 2013
VL 96
IS 6
SU S
BP S106
EP S106
PG 1
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 300DB
UT WOS:000330443500193
DA 2018-10-20
ER

PT J
AU Lee, JA
   Lee, WK
AF Lee, Jung A.
   Lee, Woo-Kul
TI Calcium phosphate-mediated surface modification of titanium oxide and
   its effects on surface potential and fibrinogen adsorption
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE Titanium oxide; Fibrinogen; Calcium phosphate; Zeta potential; Protein
   adsorption
ID SIMULATED BODY-FLUID; METHYLATED SILICON SURFACES; SERUM-ALBUMIN
   ADSORPTION; PROTEIN ADSORPTION; CONFORMATIONAL-CHANGES; ADSORBED
   FIBRINOGEN; CELL-PROLIFERATION; APATITE FORMATION; TIO2 SURFACES;
   IN-VITRO
AB Surface modification is one of major concerns in biomaterial research for the improvement of biocompatibility. This study examined the effects of calcium phosphate (CaP) formation on TiO2 particle on the surface properties and adsorption of fibrinogen (FBN). CaP coating was formed by incubating the particles in an ionic solution. The properties of CaP-coated TiO2 (cpTiO(2)) were analyzed using various analytical methods. CaP coating was calcium-deficient showing a highly porous 3D structure and decreased the negativity of zeta potential of the particle. Fibrinogen (FBN) adsorption decreased the negativity of the surface charge of particles dependent on FBN adsorption time and concentration. (c) 2013 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
C1 [Lee, Jung A.; Lee, Woo-Kul] Dankook Univ, Coll Engn, Inst Tissue Regenerat Engn, Dept Chem Engn,Lab Biointerfaces Tissue Engn, Yongin, Gyeonggi Do, South Korea.
RP Lee, WK (reprint author), Dankook Univ, Coll Engn, Inst Tissue Regenerat Engn, Dept Chem Engn,Lab Biointerfaces Tissue Engn, Yongin, Gyeonggi Do, South Korea.
EM leewo@dankook.ac.kr
FU Dankook University
FX The present research was conducted by the research fund of Dankook
   University in 2010.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Arvidsson S, 2007, BIOMATERIALS, V28, P1346, DOI 10.1016/j.biomaterials.2006.11.005
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Bai ZJ, 2009, SURF SCI, V603, P839, DOI 10.1016/j.susc.2009.01.040
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   BERNABEU P, 1988, ELECTROCHIM ACTA, V33, P1129, DOI 10.1016/0013-4686(88)80204-4
   Botelho CM, 2002, J MATER SCI-MATER M, V13, P1123, DOI 10.1023/A:1021177601899
   Cai KY, 2006, COLLOID SURFACE B, V50, P1, DOI 10.1016/j.colsurfb.2006.03.016
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Chen YL, 1999, J COLLOID INTERF SCI, V214, P38
   COHEN C, 1983, ANN NY ACAD SCI, V408, P194, DOI 10.1111/j.1749-6632.1983.tb23245.x
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   David L, 2005, J CRANIOFAC SURG, V16, P129, DOI 10.1097/00001665-200501000-00026
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Dolatshahi-Pirouz A, 2008, COLLOID SURFACE B, V66, P53, DOI 10.1016/j.colsurfb.2008.05.010
   Fang F, 2005, BIOPHYS J, V89, P1516, DOI 10.1529/biophysj.104.055079
   Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   GORBUNOFF MJ, 1984, ANAL BIOCHEM, V136, P440, DOI 10.1016/0003-2697(84)90241-0
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Ha SW, 1997, J MATER SCI-MATER M, V8, P881, DOI 10.1023/A:1018557922690
   Han Y, 1999, J MATER SCI-MATER M, V10, P243, DOI 10.1023/A:1008914330004
   Hantgan R. R., 1994, HEMOSTASIS THROMBOSI
   Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n
   Hein TW, 2001, AM J PHYSIOL-HEART C, V281, pH2378
   Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Jeffcoat MK, 2003, INT J ORAL MAX IMPL, V18, P406
   Jung JY, 2009, J MATER SCI-MATER M, V20, P2441, DOI 10.1007/s10856-009-3817-y
   KAVANAUGH JS, 1993, BIOCHEMISTRY-US, V32, P2509, DOI 10.1021/bi00061a007
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Kobson K. D., 1997, LANGMUIR, V13, P2614
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kurrat R, 1997, J COLLOID INTERF SCI, V185, P1, DOI 10.1006/jcis.1996.4528
   Lang Q., 2001, CHEM ENG J, V81, P179
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leonor IB, 2005, KEY ENG MAT, V284-286, P453, DOI 10.4028/www.scientific.net/KEM.284-286.453
   Lia J., 2007, BIOMATERIALS, V28, P781
   Lin JH, 2007, COMPOS PART A-APPL S, V38, P535, DOI 10.1016/j.compositesa.2006.02.013
   Lu HH, 2000, J BIOMED MATER RES, V51, P80, DOI 10.1002/(SICI)1097-4636(200007)51:1<80::AID-JBM11>3.0.CO;2-6
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Martins AM, 2009, ACTA BIOMATER, V5, P3328, DOI 10.1016/j.actbio.2009.05.027
   Mohsen-Nia M, 2012, PROTEIN J, V31, P150, DOI 10.1007/s10930-011-9384-3
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Pasche S, 2005, J PHYS CHEM B, V109, P17545, DOI 10.1021/jp050431+
   Raffaini G, 2010, LANGMUIR, V26, P5679, DOI 10.1021/la903769c
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Roddick-Lanzilotta AD, 1998, LANGMUIR, V14, P6479, DOI 10.1021/la980425n
   Shi DL, 2000, J BIOMED MATER RES, V53, P457
   Simi CK, 2009, COLLOID SURFACE B, V71, P319, DOI 10.1016/j.colsurfb.2009.02.019
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Sousa SR, 2007, LANGMUIR, V23, P7046, DOI 10.1021/la062956e
   Steiner G, 2007, ANAL CHEM, V79, P1311, DOI 10.1021/ac061341j
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Teixeira S, 2009, MAT SCI ENG C-BIO S, V29, P1510, DOI 10.1016/j.msec.2008.09.052
   Tunc S, 2005, COLLOID SURFACE B, V42, P219, DOI 10.1016/j.colsurfb.2005.03.004
   WALIVAARA B, 1995, J COLLOID INTERF SCI, V174, P53, DOI 10.1006/jcis.1995.1363
   Wang XH, 2003, COLLOID SURFACE B, V30, P111, DOI 10.1016/S0927-7765(03)00078-X
   WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058
   Werner C, 1999, COLLOID SURFACE A, V156, P3, DOI 10.1016/S0927-7757(99)00007-2
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
   Yang Q, 2007, ANAL CHIM ACTA, V597, P58, DOI 10.1016/j.aca.2007.06.025
NR 69
TC 6
Z9 7
U1 1
U2 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD SEP 25
PY 2013
VL 19
IS 5
BP 1448
EP 1456
DI 10.1016/j.jiec.2013.01.008
PG 9
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 198SW
UT WOS:000322943600005
DA 2018-10-20
ER

PT J
AU Kaufman, JJ
   Ottman, R
   Tao, GM
   Shabahang, S
   Banaei, EH
   Liang, XD
   Johnson, SG
   Fink, Y
   Chakrabarti, R
   Abouraddy, AF
AF Kaufman, Joshua J.
   Ottman, Richard
   Tao, Guangming
   Shabahang, Soroush
   Banaei, Esmaeil-Hooman
   Liang, Xiangdong
   Johnson, Steven G.
   Fink, Yoel
   Chakrabarti, Ratna
   Abouraddy, Ayman F.
TI In-fiber production of polymeric particles for biosensing and
   encapsulation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID DRUG-DELIVERY; SILVER NANOPARTICLES; CANCER-THERAPY; PROTEIN;
   TECHNOLOGIES; NANOSPHERES; INSTABILITY; STABILITY; EMULSIONS; CARRIERS
AB Polymeric micro- and nanoparticles are becoming a mainstay in biomedicine, medical diagnostics, and therapeutics, where they are used in implementing sensing mechanisms, as imaging contrast agents, and in drug delivery. Current approaches to the fabrication of such particles are typically finely tuned to specific monomer or polymer species, size ranges, and structures. We present a general scalable methodology for fabricating uniformly sized spherical polymeric particles from a wide range of polymers produced with complex internal architectures and continuously tunable diameters extending from the millimeter scale down to 50 nm. Controllable access to such a wide range of sizes enables broad applications in cancer treatment, immunology, and vaccines. Our approach harnesses thermally induced, predictable fluid instabilities in composite core/cladding polymer fibers drawn from a macroscopic scaled-up model called a "preform." Through a stack-and-draw process, we produce fibers containing a multiplicity of identical cylindrical cores made of the polymers of choice embedded in a polymer cladding. The instability leads to the breakup of the initially intact cores, independent of the polymer chemistry, into necklaces of spherical particles held in isolation within the cladding matrix along the entire fiber length. We demonstrate here surface functionalization of the extracted particles for biodetection through specific protein-protein interactions, volumetric encapsulation of a biomaterial in spherical polymeric shells, and the combination of both surface and volumetric functionalities in the same particle. These particles used in distinct modalities may be produced from the desired biocompatible polymer by changing only the geometry of the macroscopic preform from which the fiber is drawn.
C1 [Kaufman, Joshua J.; Tao, Guangming; Shabahang, Soroush; Abouraddy, Ayman F.] Univ Cent Florida, CREOL, Coll Opt & Photon, Orlando, FL 32816 USA.
   [Ottman, Richard; Chakrabarti, Ratna] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.
   [Banaei, Esmaeil-Hooman] Univ Cent Florida, Dept Elect Engn & Comp Sci, Orlando, FL 32816 USA.
   [Liang, Xiangdong; Johnson, Steven G.] MIT, Dept Math, Cambridge, MA 02139 USA.
   [Fink, Yoel] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
RP Abouraddy, AF (reprint author), Univ Cent Florida, CREOL, Coll Opt & Photon, Orlando, FL 32816 USA.
EM raddy@creol.ucf.edu
RI Liang, Xiangdong/C-5903-2016
OI Tao, Guangming/0000-0002-1371-7735; Johnson, Steven/0000-0001-7327-4967
FU Air Force Office of Scientific Research [FA-9550-12-1-0148]; National
   Institutes of Health [S10RR027142]; Materials Research Science and
   Engineering Program of the US National Science Foundation [DMR-0819762]
FX This work was supported by the Air Force Office of Scientific Research
   under Contract FA-9550-12-1-0148; National Institutes of Health Shared
   Instrument Grant S10RR027142 (to R.C.); and, in part, by the Materials
   Research Science and Engineering Program of the US National Science
   Foundation under Award DMR-0819762.
CR Abouraddy AF, 2007, NAT MATER, V6, P336, DOI 10.1038/nmat1889
   Agemy L, 2011, P NATL ACAD SCI USA, V108, P17450, DOI 10.1073/pnas.1114518108
   Alarcon EI, 2012, BIOMATERIALS, V33, P4947, DOI 10.1016/j.biomaterials.2012.03.033
   Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519
   [Anonymous], 2001, ENCY HDB EMULSION TE
   Bai MY, 2012, ADV FUNCT MATER, V22, P764, DOI 10.1002/adfm.201102582
   Bhavsar MD, 2007, EXPERT OPIN DRUG DEL, V4, P197, DOI 10.1517/17425247.4.3.197
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Chen HW, 2008, J CONTROL RELEASE, V128, P209, DOI 10.1016/j.jconrel.2008.03.010
   Chen KY, 2009, BIOMACROMOLECULES, V10, P1642, DOI 10.1021/bm900238b
   Chen Z, 2012, ACS NANO, V6, P7752, DOI 10.1021/nn301725w
   Cramer C, 2004, CHEM ENG SCI, V59, P3045, DOI 10.1016/j.ces.2004.04.006
   Deng DS, 2011, OPT EXPRESS, V19, P16273, DOI 10.1364/OE.19.016273
   Deng DS, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3275751
   Deng DS, 2008, NANO LETT, V8, P4265, DOI 10.1021/nl801979w
   Derveaux S, 2008, ANAL BIOANAL CHEM, V391, P2453, DOI 10.1007/s00216-008-2062-4
   Doiron AL, 2011, BIOTECHNOL BIOENG, V108, P2988, DOI 10.1002/bit.23253
   Eggers J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/3/036601
   ElKaoutit M, 2012, COLLOID SURFACE B, V92, P42, DOI 10.1016/j.colsurfb.2011.11.023
   Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103
   Ganan-Calvo AM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.274501
   Gong Y, 2009, C P IEEE ENG MED BIO, DOI [10.1109/IEMBS.2009.5333441, DOI 10.1109/IEMBS.2009.5333441]
   Greenhalgh K, 2009, NANOMED-NANOTECHNOL, V5, P46, DOI 10.1016/j.nano.2008.07.004
   Haley B, 2008, UROL ONCOL-SEMIN ORI, V26, P57, DOI 10.1016/j.urolonc.2007.03.015
   Helary C, 2010, BIOMATERIALS, V31, P481, DOI 10.1016/j.biomaterials.2009.09.073
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]
   Hudson D, 2014, CRIT REV BIOTECHNOL, V34, P161, DOI 10.3109/07388551.2012.743503
   Imoto T, 2010, MACROMOL BIOSCI, V10, P271, DOI 10.1002/mabi.200900272
   Jena RK, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3682098
   Kai J, 2003, P 7 INT C MICR AN SY, P1101
   Kaufman JJ, 2012, NATURE, V487, P463, DOI 10.1038/nature11215
   Kaufman JJ, 2011, NANO LETT, V11, P4768, DOI 10.1021/nl202583g
   Kelly JY, 2008, J AM CHEM SOC, V130, P5438, DOI 10.1021/ja8014428
   Liang X, 2011, J FLUID MECH, V683, P235, DOI 10.1017/jfm.2011.260
   Liang X, 2013, THESIS MIT CAMBRIDGE
   Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068
   Liu JN, 2012, BIOMATERIALS, V33, P7282, DOI 10.1016/j.biomaterials.2012.06.035
   Nisisako T, 2002, LAB CHIP, V2, P24, DOI 10.1039/b108740c
   Nunes PS, 2010, MICROFLUID NANOFLUID, V9, P145, DOI 10.1007/s10404-010-0605-4
   Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y
   Plateau J.A.F., 1873, STATIQUE EXPT THEORI, V2
   Rayleigh L., 1879, P R SOC LONDON, V29, P71, DOI DOI 10.1098/RSPL.1879.0015
   Sakai K, 2011, DENT MATER J, V30, P913, DOI 10.4012/dmj.2011-126
   Shabahang S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3653247
   Sheng Y, 2009, BIOMATERIALS, V30, P2340, DOI 10.1016/j.biomaterials.2008.12.070
   Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004
   Souto E. B., 2008, International Journal of Cosmetic Science, V30, P157, DOI 10.1111/j.1468-2494.2008.00433.x
   Tao GM, 2012, INT J APPL GLASS SCI, V3, P349, DOI 10.1111/ijag.12007
   Tao GM, 2012, OPT LETT, V37, P2751, DOI 10.1364/OL.37.002751
   Thoma DS, 2012, J CLIN PERIODONTOL, V39, P157, DOI 10.1111/j.1600-051X.2011.01823.x
   Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163
   Tomotika S., 1935, Proceedings of the Royal Society of London, Series A (Mathematical and Physical Sciences), V150, P322, DOI 10.1098/rspa.1935.0104
   Tsai MJ, 2012, INT J PHARMACEUT, V423, P461, DOI 10.1016/j.ijpharm.2011.12.009
   Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164
   Volkhard H, 2008, PRINCIPLES COMPUTATI
   Vollath D., 2008, NANOMATERIALS INTRO
   Wong C, 2011, P NATL ACAD SCI USA, V108, P2426, DOI 10.1073/pnas.1018382108
   Wu J, 2010, NAT COMMUN, DOI [10.1038/ncomms1035, DOI 10.1038/NC0MMS1035]
   Xu HY, 2011, BIOMATERIALS, V32, P9758, DOI 10.1016/j.biomaterials.2011.08.076
   Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109
   You J, 2012, CANCER RES, V72, P4777, DOI 10.1158/0008-5472.CAN-12-1003
   Zhang YQ, 2010, J MED CHEM, V53, P3262, DOI 10.1021/jm901910j
NR 63
TC 20
Z9 20
U1 4
U2 57
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 24
PY 2013
VL 110
IS 39
BP 15549
EP 15554
DI 10.1073/pnas.1310214110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 222XE
UT WOS:000324765100022
PM 24019468
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Potyrailo, RA
   Starkey, TA
   Vukusic, P
   Ghiradella, H
   Vasudev, M
   Bunning, T
   Naik, RR
   Tang, ZX
   Larsen, M
   Deng, T
   Zhong, S
   Palacios, M
   Grande, JC
   Zorn, G
   Goddard, G
   Zalubovsky, S
AF Potyrailo, Radislav A.
   Starkey, Timothy A.
   Vukusic, Peter
   Ghiradella, Helen
   Vasudev, Milana
   Bunning, Timothy
   Naik, Rajesh R.
   Tang, Zhexiong
   Larsen, Michael
   Deng, Tao
   Zhong, Sheng
   Palacios, Manuel
   Grande, James C.
   Zorn, Gilad
   Goddard, Gregory
   Zalubovsky, Sergey
TI Discovery of the surface polarity gradient on iridescent Morpho
   butterfly scales reveals a mechanism of their selective vapor response
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE multivariable sensing; spectral analysis; surface characterization;
   transmission electron microscopy; image analysis
ID POROUS SILICON; PHOTONIC CRYSTALS; COLOR CHANGES; WING SCALES;
   INTERFERENCE; FLUORESCENCE; EPICUTICLE; INSECTS; CUTICLE; ARRAYS
AB For almost a century, the iridescence of tropical Morpho butterfly scales has been known to originate from 3D vertical ridge structures of stacked periodic layers of cuticle separated by air gaps. Here we describe a biological pattern of surface functionality that we have found in these photonic structures. This pattern is a gradient of surface polarity of the ridge structures that runs from their polar tops to their less-polar bottoms. This finding shows a biological pattern design that could stimulate numerous technological applications ranging from photonic security tags to self-cleaning surfaces, gas separators, protective clothing, sensors, and many others. As an important first step, this biomaterial property and our knowledge of its basis has allowed us to unveil a general mechanism of selective vapor response observed in the photonic Morpho nanostructures. This mechanism of selective vapor response brings a multivariable perspective for sensing, where selectivity is achieved within a single chemically graded nanostructured sensing unit, rather than from an array of separate sensors.
C1 [Potyrailo, Radislav A.; Tang, Zhexiong; Larsen, Michael; Deng, Tao; Zhong, Sheng; Palacios, Manuel; Grande, James C.; Zorn, Gilad; Goddard, Gregory; Zalubovsky, Sergey] Gen Elect Global Res Ctr, Niskayuna, NY 12309 USA.
   [Starkey, Timothy A.; Vukusic, Peter] Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.
   [Ghiradella, Helen] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA.
   [Vasudev, Milana; Bunning, Timothy; Naik, Rajesh R.] Air Force Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.
   [Deng, Tao] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.
RP Potyrailo, RA (reprint author), Gen Elect Global Res Ctr, Niskayuna, NY 12309 USA.
EM potyrailo@crd.ge.com
FU DARPA [W911NF-10-C-0069]; GE's Advanced Technology research funds;
   Biotechnology and Biological Sciences Research Council [JF16983,
   BB/E000177/1]
FX We thank H. Grade, M. Pietrzykowski, R. Schnoor, W. Shang, and V.
   Smentkowski (General Electric, GE), D. Gallagher and P. Lloyd (Air Force
   Research Laboratory), R. Bonam and J. Hartley (University at Albany), S.
   N. Gorb (University of Kiel), and V. Greanya and J. Abo-Shaeer (Defense
   Advanced Research Projects Agency, DARPA) for fruitful discussions. This
   work has been supported in part from DARPA Contract W911NF-10-C-0069 and
   from GE's Advanced Technology research funds.
CR Aryal M, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4759461
   Baklanov MR, 2000, J VAC SCI TECHNOL B, V18, P1385, DOI 10.1116/1.591390
   Bechger L, 2005, J PHYS CHEM B, V109, P9980, DOI 10.1021/jp047489t
   BIELANSKI A, 1957, NATURE, V179, P668, DOI 10.1038/179668a0
   Bjorklund RB, 1996, APPL PHYS LETT, V69, P3001, DOI 10.1063/1.116819
   Burgess IB, 2012, ACS NANO, V6, P1427, DOI 10.1021/nn204220c
   Claussen KU, 2012, MACROMOL MATER ENG, V297, P938, DOI 10.1002/mame.201200032
   De Stefano L, 2009, J APPL PHYS, V106, DOI 10.1063/1.3177344
   GHIRADELLA H, 1972, SCIENCE, V178, P1214, DOI 10.1126/science.178.4066.1214
   GHIRADELLA H, 1994, MICROSC RES TECHNIQ, V27, P429, DOI 10.1002/jemt.1070270509
   GREENSPAN P, 1985, J LIPID RES, V26, P781
   Hierlemann A, 2008, CHEM REV, V108, P563, DOI 10.1021/cr068116m
   Huber G, 2005, P NATL ACAD SCI USA, V102, P16293, DOI 10.1073/pnas.0506328102
   Janata J, 2009, PRINCIPLES OF CHEMICAL SENSORS, SECOND EDITION, P1, DOI 10.1007/978-0-387-69931-8_1
   Kennaway R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002071
   Kolle M, 2010, NAT NANOTECHNOL, V5, P511, DOI [10.1038/NNANO.2010.101, 10.1038/nnano.2010.101]
   Lee SY, 2010, P NATL ACAD SCI USA, V107, P12086, DOI 10.1073/pnas.1002849107
   Li YY, 2003, SCIENCE, V299, P2045, DOI 10.1126/science.1081298
   LOCKE M, 1966, J MORPHOL, V118, P461, DOI 10.1002/jmor.1051180403
   Mason CW, 1926, J PHYS CHEM-US, V30, P383, DOI 10.1021/j150261a009
   Neville A. C., 1975, BIOL ARTHROPOD CUTIC
   Otto M., 1999, CHEMOMETRICS STAT CO
   Pedrini N, 2007, COMP BIOCHEM PHYS C, V146, P124, DOI 10.1016/j.cbpc.2006.08.003
   Peisker H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2576
   PERSAUD K, 1982, NATURE, V299, P352, DOI 10.1038/299352a0
   Potyrailo RA, 2007, NAT PHOTONICS, V1, P123, DOI 10.1038/nphoton.2007.2
   Potyrailo RA, 2011, CHEM REV, V111, P7315, DOI 10.1021/cr2000477
   Pryor MGM, 1940, PROC R SOC SER B-BIO, V128, P393, DOI 10.1098/rspb.1940.0018
   Rassart M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031910
   Ruminski AM, 2008, ADV FUNCT MATER, V18, P3418, DOI 10.1002/adfm.200701494
   Sanchis MR, 2007, J APPL POLYM SCI, V105, P1077, DOI 10.1002/app.26250
   Snow PA, 1999, J APPL PHYS, V86, P1781, DOI 10.1063/1.370968
   Tamaska I, 2013, KEY ENG MATER, V543, P18, DOI 10.4028/www.scientific.net/KEM.543.18
   Voigt D, 2009, APPL SCANNING PROBE, P1
   Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794
   Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941
   Wanekaya AK, 2005, SENSOR ACTUAT B-CHEM, V110, P41, DOI 10.1016/j.snb.2005.01.025
   Watanabe K, 2005, JPN J APPL PHYS 2, V44, pL48, DOI 10.1143/JJAP.44.L48
   Yang HT, 2012, J COLLOID INTERF SCI, V370, P11, DOI 10.1016/j.jcis.2011.12.058
   Yang HT, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3535977
   Yoshioka S., 2005, STRUCTURAL COLORS BI
   Zhou SL, 2000, ANAL CHEM, V72, P963, DOI 10.1021/ac990912n
   Zuccarello G, 2002, ADV MATER, V14, P1261, DOI 10.1002/1521-4095(20020916)14:18<1261::AID-ADMA1261>3.0.CO;2-N
NR 43
TC 44
Z9 44
U1 5
U2 102
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 24
PY 2013
VL 110
IS 39
BP 15567
EP 15572
DI 10.1073/pnas.1311196110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 222XE
UT WOS:000324765100025
PM 24019497
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Shen, CY
   Lazouskaya, V
   Zhang, HY
   Li, BG
   Jin, Y
   Huang, YF
AF Shen, Chongyang
   Lazouskaya, Volha
   Zhang, Hongyan
   Li, Baoguo
   Jin, Yan
   Huang, Yuanfang
TI Influence of surface chemical heterogeneity on attachment and detachment
   of microparticles
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article
DE Colloid; Attachment; Detachment; Transport; Chemical heterogeneity
ID ATOMIC-FORCE MICROSCOPY; COLLOID-FACILITATED TRANSPORT; MICROMETER-SCALE
   PARTICLES; SATURATED POROUS-MEDIA; DLVO INTERACTION; ROUGH SURFACES;
   IRREVERSIBLE ADSORPTION; CHARGE HETEROGENEITIES; SPHERICAL-PARTICLES;
   BROWNIAN PARTICLES
AB This study theoretically examined attachment/detachment of negatively charged microparticles onto/from a negative planar surface carrying a positively charged square patch of different sizes. The surface element integration technique was used to calculate Derjaguin-Landau-Verwey-Overbeek (DLVO) interaction energies at different ionic strengths. Results show that a critical patch size is needed to attach a particle at a given ionic strength. The critical size decreases with increasing ionic strength and decreasing particle size. Colloid attachment on the patch via primary-minimum association is irreversible to reduction of ionic strength, in contrast to the experimental observations in the literature. We attributed the discrepancy to the fact that chemical heterogeneity is commonly accompanied with topographical variation. To account for the coupled effects on colloid detachment, the collector surface was modeled as a negative planar surface carrying a square prism. If the size of the prism is <= 5 nm x 5 nm x 5 nm, whether the prism surface is positively or negatively charged does not have significant influence on the interaction energy curves at <= 0.01 M. These tiny asperities mainly play a role in eliminating the primary minima of interaction energy curves at the low ionic strengths, causing detachment of colloids from primary minima. For larger prisms, the primary-minimum depths can be increased significantly if the prism surfaces are positively charged, resulting in more irreversible attachments in primary minima. Findings from this study have implications to understanding particle-surface interactions that involve only one ligand-receptor bond (e.g., cell-biomaterial interactions via a single contact). (C) 2013 Elsevier B.V. All rights reserved.
C1 [Shen, Chongyang; Li, Baoguo; Huang, Yuanfang] China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China.
   [Lazouskaya, Volha; Jin, Yan] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA.
   [Zhang, Hongyan] China Agr Univ, Dept Appl Chem, Beijing 100193, Peoples R China.
RP Shen, CY (reprint author), China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China.
EM chongyang.shen@gmail.com; yfhuang@cau.edu.cn
FU National Natural Science Foundation of China [41271009]; Beijing Natural
   Science Foundation [6123034]; National Key Technology RD Program
   [2012BAD05B02]
FX We acknowledge the financial support provided by the National Natural
   Science Foundation of China (no. 41271009), Beijing Natural Science
   Foundation (no. 6123034), and National Key Technology R&D Program (no.
   2012BAD05B02).
CR Acuna SM, 2008, LANGMUIR, V24, P4881, DOI 10.1021/la703866g
   Adamczyk Z, 2005, ADV COLLOID INTERFAC, V118, P25, DOI 10.1016/j.cis.2005.03.003
   Adamczyk Z, 2004, J CHEM PHYS, V120, P11155, DOI 10.1063/1.1712967
   Adamczyk Z, 2003, COLLOID SURFACE A, V214, P219, DOI 10.1016/S0927-7757(02)00411-9
   AMIRTHARAJAH A, 1993, COLLOID SURFACE A, V73, P211, DOI 10.1016/0927-7757(93)80017-9
   Assemi S, 2006, COLLOID SURFACE A, V286, P70, DOI 10.1016/j.colsurfa.2006.03.024
   Bekhit HM, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003262
   Bendersky M, 2011, J COLLOID INTERF SCI, V353, P87, DOI 10.1016/j.jcis.2010.09.058
   Bergendahl J, 1999, AICHE J, V45, P475, DOI 10.1002/aic.690450305
   Bergendahl J, 2000, CHEM ENG SCI, V55, P1523, DOI 10.1016/S0009-2509(99)00422-4
   Bhattacharjee S, 1997, J COLLOID INTERF SCI, V193, P273, DOI 10.1006/jcis.1997.5076
   Bhattacharjee S, 1998, LANGMUIR, V14, P3365, DOI 10.1021/la971360b
   Bhattacharjee S, 1998, CROAT CHEM ACTA, V71, P883
   Bhattacharjee S, 2002, J CONTAM HYDROL, V57, P161, DOI 10.1016/S0169-7722(02)00007-4
   Bradford SA, 2012, LANGMUIR, V28, P13643, DOI 10.1021/la3029929
   Bradford SA, 2012, J CONTAM HYDROL, V138, P83, DOI 10.1016/j.jconhyd.2012.06.007
   Brant JA, 2002, ENVIRON ENG SCI, V19, P413, DOI 10.1089/109287502320963409
   Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176
   CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518
   Considine RF, 2001, LANGMUIR, V17, P7777, DOI 10.1021/la0017227
   Cooper K, 2001, J COLLOID INTERF SCI, V234, P284, DOI 10.1006/jcis.2000.7276
   Drelich J, 2011, ADV COLLOID INTERFAC, V165, P91, DOI 10.1016/j.cis.2010.12.009
   Duffadar R, 2009, J COLLOID INTERF SCI, V337, P396, DOI 10.1016/j.jcis.2009.05.046
   Duffadar RD, 2008, J COLLOID INTERF SCI, V326, P18, DOI 10.1016/j.jcis.2008.07.004
   Duffadar RD, 2007, J COLLOID INTERF SCI, V308, P20, DOI 10.1016/j.jcis.2006.12.068
   Elimelech M, 2000, ENVIRON SCI TECHNOL, V34, P2143, DOI 10.1021/es9910309
   ELIMELECH M, 1990, LANGMUIR, V6, P1153, DOI 10.1021/la00096a023
   ELIMELECH M, 1990, ENVIRON SCI TECHNOL, V24, P1528, DOI 10.1021/es00080a012
   Elimelech M, 2003, LANGMUIR, V19, P6594, DOI 10.1021/la034516i
   Faure MH, 1997, J CONTAM HYDROL, V26, P169, DOI 10.1016/S0169-7722(96)00066-6
   Foppen JWA, 2005, WATER RES, V39, P3082, DOI 10.1016/j.watres.2005.05.023
   Fuerstenau DW, 2005, ADV COLLOID INTERFAC, V114, P9, DOI 10.1016/j.cis.2004.08.006
   Grolimund D, 1996, ENVIRON SCI TECHNOL, V30, P3118, DOI 10.1021/es960246x
   Hahn M.W., 2004, ENVIRON SCI TECHNOL, V38, P5919
   Hahn MW, 2004, ENVIRON SCI TECHNOL, V38, P210, DOI 10.1021/es030416n
   Hamaker HC, 1937, PHYSICA, V4, P1058, DOI 10.1016/S0031-8914(37)80203-7
   Hoek EMV, 2006, J COLLOID INTERF SCI, V298, P50, DOI 10.1016/j.jcis.2005.12.031
   HOGG R, 1966, T FARADAY SOC, V62, P1638, DOI 10.1039/tf9666201638
   Johnson PR, 1996, ENVIRON SCI TECHNOL, V30, P3284, DOI 10.1021/es960053+
   Katainen J, 2006, J COLLOID INTERF SCI, V304, P524, DOI 10.1016/j.jcis.2006.09.015
   Kemps JAL, 2005, LANGMUIR, V21, P11710, DOI 10.1021/la051292q
   Kozlova N, 2006, LANGMUIR, V22, P1135, DOI 10.1021/la0515221
   Loveland JP, 2003, J CONTAM HYDROL, V65, P161, DOI 10.1016/S0169-7722(02)00238-3
   Ma HL, 2011, LANGMUIR, V27, P14982, DOI 10.1021/la203587j
   Martines E, 2008, COLLOID SURFACE A, V318, P45, DOI 10.1016/j.colsurfa.2007.11.035
   MCDOWELLBOYER LM, 1992, ENVIRON SCI TECHNOL, V26, P586, DOI 10.1021/es00027a023
   Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622
   Na CZ, 2008, ENVIRON SCI TECHNOL, V42, P6883, DOI 10.1021/es800839a
   Nazemifard N, 2006, LANGMUIR, V22, P9879, DOI 10.1021/la061702q
   NocitoGobel J, 1996, COLLOID SURFACE A, V107, P223, DOI 10.1016/0927-7757(95)03340-8
   Rabinovich YI, 2000, J COLLOID INTERF SCI, V232, P17, DOI 10.1006/jcis.2000.7168
   Roy SB, 1997, ENVIRON SCI TECHNOL, V31, P656, DOI 10.1021/es9600643
   RUCKENSTEIN E, 1976, AICHE J, V22, P276, DOI 10.1002/aic.690220209
   Ryan JN, 1999, ENVIRON SCI TECHNOL, V33, P63, DOI 10.1021/es980350+
   Ryan JN, 1996, COLLOID SURFACE A, V107, P1, DOI 10.1016/0927-7757(95)03384-X
   Santore MM, 2007, LANGMUIR, V23, P4782, DOI 10.1021/la063546t
   Santore MM, 2009, LANGMUIR, V25, P84, DOI 10.1021/la802554s
   Sarda S, 2004, BIOPHYS J, V86, P3291, DOI 10.1016/S0006-3495(04)74377-5
   Shellenberger K, 2002, ENVIRON SCI TECHNOL, V36, P184, DOI 10.1021/es015515k
   Shen CY, 2007, ENVIRON SCI TECHNOL, V41, P6976, DOI 10.1021/es070210c
   Shen CY, 2012, LANGMUIR, V28, P14681, DOI 10.1021/la303163c
   Shen CY, 2012, COLLOID SURFACE A, V410, P98, DOI 10.1016/j.colsurfa.2012.06.025
   Shen CY, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0057
   Shen CY, 2012, J CONTAM HYDROL, V134, P1, DOI 10.1016/j.jconhyd.2012.04.003
   Shen CY, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006580
   SONG LF, 1994, J COLLOID INTERF SCI, V167, P301, DOI 10.1006/jcis.1994.1365
   SONG LF, 1994, ENVIRON SCI TECHNOL, V28, P1164, DOI 10.1021/es00055a030
   Sparks DL, 2003, ENV SOIL CHEM
   Sun N, 2001, J CONTAM HYDROL, V49, P173, DOI 10.1016/S0169-7722(00)00193-5
   Suresh L, 1996, J COLLOID INTERF SCI, V183, P199, DOI 10.1006/jcis.1996.0535
   Taboada-Serrano P, 2005, ENVIRON SCI TECHNOL, V39, P6352, DOI 10.1021/es050100a
   Torkzaban S, 2010, ENVIRON SCI TECHNOL, V44, P1662, DOI 10.1021/es903277p
   Tufenkji N, 2004, LANGMUIR, V20, P10818, DOI 10.1021/la0486638
   Tufenkji N, 2005, LANGMUIR, V21, P841, DOI 10.1021/la048102g
   Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104
   Walz JY, 1998, ADV COLLOID INTERFAC, V74, P119, DOI 10.1016/S0001-8686(97)00042-0
   Weiss M, 1998, J COLLOID INTERF SCI, V206, P322, DOI 10.1006/jcis.1998.5636
   Zhang J, 2008, LANGMUIR, V24, P6404, DOI 10.1021/la800857v
NR 78
TC 31
Z9 33
U1 2
U2 51
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD SEP 20
PY 2013
VL 433
BP 14
EP 29
DI 10.1016/j.colsurfa.2013.04.048
PG 16
WC Chemistry, Physical
SC Chemistry
GA 179RD
UT WOS:000321538100003
DA 2018-10-20
ER

PT J
AU Roehrich, A
   Drobny, G
AF Roehrich, Adrienne
   Drobny, Gary
TI Solid-State NMR Studies of Biomineralization Peptides and Proteins
SO ACCOUNTS OF CHEMICAL RESEARCH
LA English
DT Review
AB Nature has evolved sophisticated strategies for engineering hard tissues through the interaction of proteins, and ultimately cells, with inorganic mineral phases. This process, called biomineralization, is how living organisms transform inorganic materials such as hydroxyapatite, calcite, and silica into highly intricate and organized structures. The remarkable material properties of shell, bone, and teeth come from the activities of proteins that function at the organic inorganic interface. A better understanding of the biomolecular mechanisms used to promote or retard the formation of mineral-based structures could provide important design principles for the development of calcification inhibitors and promoters in orthopedics, cardiology, urology, and dentistry. With the knowledge of the structural basis for control of hard tissue growth by proteins, scientists could potentially develop materials using biomimetic principles with applications in catalysis, biosensors, electronic devices, and chromatographic separations, to name a few. Additionally, biomineralization also has potential applications in electronics, catalysis, magnetism, sensory devices, and mechanical design. Where man-made hard materials require the use of extreme temperatures, high pressure, and pH, biological organisms can accomplish these feats at ambient temperature and at physiological pH.
   Despite the fact that many researchers want to identify and control the structure of proteins at material and biomineral interfaces, there is a decided lack of molecular-level structure information available for proteins at biomaterial interfaces in general. In particular, this holds for mammalian proteins that directly control calcification processes in hard tissue. The most fundamental questions regarding the secondary and tertiary structures of proteins adsorbed to material surfaces, how proteins catalyze the formation of biomineral composites, or how proteins interact at biomaterial interfaces remain unanswered. This is largely due to a lack of methods capable of providing high-resolution structural information for proteins adsorbed to material surfaces under physiologically relevant conditions.
   In this Account, we highlight recent work that is providing insight into the structure and crystal recognition mechanisms of a salivary protein model system, as well as the structure and interactions of a peptide that catalyzes the formation of biosilica composites. To develop a better understanding of the structure and interactions of proteins in biomaterials, we have used solid-state NMR techniques to determine the molecular structure and dynamics of proteins and peptides adsorbed onto inorganic crystal surfaces and embedded within biomineral composites. This work adds to the understanding of the structure and crystal recognition mechanisms of an acidic human salivary phosphoprotein, statherin.
C1 [Roehrich, Adrienne; Drobny, Gary] Univ Washington, Dept Chem, Seattle, WA 98195 USA.
RP Drobny, G (reprint author), Univ Washington, Dept Chem, Box 351700, Seattle, WA 98195 USA.
FU NIDCR NIH HHS [R01 DE 12554]
NR 0
TC 36
Z9 36
U1 6
U2 101
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0001-4842
EI 1520-4898
J9 ACCOUNTS CHEM RES
JI Accounts Chem. Res.
PD SEP 17
PY 2013
VL 46
IS 9
BP 2136
EP 2136
DI 10.1021/ar300321e
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 294BO
UT WOS:000330017600024
PM 23932180
DA 2018-10-20
ER

PT J
AU Mangindaan, D
   Kuo, WH
   Kurniawan, H
   Wang, MJ
AF Mangindaan, Dave
   Kuo, Wei-Hsuan
   Kurniawan, Hengky
   Wang, Meng-Jiy
TI Creation of biofunctionalized plasma polymerized allylamine gradients
SO JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS
LA English
DT Article
DE allylamine; amine functionality; biocompatibility; biofunctionalization;
   biological applications of polymers; biopolymers; chemical gradient;
   functionalization of polymers; plasma polymerization; surface
   characterizations
ID WETTABILITY GRADIENT; CHEMICAL GRADIENTS; BIOMEDICAL APPLICATIONS;
   COVALENT IMMOBILIZATION; CELL MOTILITY; GAS-PLASMA; SURFACE; FILMS;
   DEPOSITION; AMINE
AB A chemical gradient possessing gradual change of amine concentration for every 100 carbon atoms (NHx/100 C) from 4.03 to 1.98 was prepared by plasma polymerization of allylamine on polypropylene films. Electron spectroscopy for chemical analysis and water contact angle (WCA) measurements revealed that the nitrogen incorporation resulted in the amine functionality (CN binding) and, therefore, the formation of the wettability gradient. The gradient showed the WCAs varied from 15 degrees to 90 degrees as the change of amine concentration on the gradient from the nitrogen rich end to the nitrogen deprived end. Furthermore, the interactions between the gradient with mammalian cells revealed that more than twofold cell density was found at the nitrogen rich end when compared with the nitrogen deprived end. Plasma polymerization was demonstrated as an effective method to create controllable chemical gradient and the obtained allylamine gradient was useful for biomaterial applications. (c) 2013 Wiley Periodicals, Inc. J. Polym. Sci., Part B: Polym. Phys. 2013, 51, 1361-1367
C1 [Mangindaan, Dave; Kuo, Wei-Hsuan; Kurniawan, Hengky; Wang, Meng-Jiy] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 106, Taiwan.
RP Wang, MJ (reprint author), Natl Taiwan Univ Sci & Technol, Dept Chem Engn, 43 Keelung Rd,Sec 4, Taipei 106, Taiwan.
EM mjwang@mail.ntust.edu.tw
OI Mangindaan, Dave/0000-0001-8657-1709
FU National Science Council; National Taiwan University of Science and
   Technology [NSC100-2621-M-011-002]
FX The authors express great appreciation to the National Science Council
   and National Taiwan University of Science and Technology for their
   financial supports (NSC100-2621-M-011-002).
CR Alexander MR, 2004, J MATER CHEM, V14, P408, DOI 10.1039/b311256j
   Apple D J, 1984, J Am Intraocul Implant Soc, V10, P53
   Ballav N, 2007, ADV MATER, V19, P998, DOI 10.1002/adma.200602168
   Beamson G., 1992, HIGH RESOLUTION XPS
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0
   Choee JH, 2004, J APPL POLYM SCI, V92, P599, DOI 10.1002/app.20048
   Choukourov A, 2005, J PHYS CHEM B, V109, P23086, DOI 10.1021/jp0535691
   Choukourov A, 2004, VACUUM, V75, P195, DOI 10.1016/j.vacuum.2004.02.006
   Choukourov A, 2004, J APPL POLYM SCI, V92, P979, DOI 10.1002/app.13387
   Chuang WH, 2007, J BIOMED MATER RES A, V82A, P820, DOI 10.1002/jbm.a.31193
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Goreham RV, 2011, J PHYS CHEM C, V115, P3429, DOI 10.1021/jp111221g
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Hiratsuka A, 1999, ELECTROANAL, V11, P1098, DOI 10.1002/(SICI)1521-4109(199911)11:15<1098::AID-ELAN1098>3.0.CO;2-N
   Hook AL, 2008, SURF SCI, V602, P1883, DOI 10.1016/j.susc.2008.03.029
   Hossain MM, 2007, PLASMA PROCESS POLYM, V4, P471, DOI 10.1002/ppap.200600214
   Junge K, 2005, Hernia, V9, P212, DOI 10.1007/s10029-004-0315-5
   Kang CE, 2004, J BIOMED MATER RES A, V71A, P403, DOI 10.1002/jbm.a.30137
   Khung YL, 2008, EXP CELL RES, V314, P789, DOI 10.1016/j.yexcr.2007.10.015
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Kunzler TP, 2006, APPL SURF SCI, V253, P2148, DOI 10.1016/j.apsusc.2006.04.014
   Kurniawan H, 2012, CELLULOSE, V19, P1975, DOI 10.1007/s10570-012-9785-2
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   LEE JH, 1992, J COLLOID INTERF SCI, V151, P563, DOI 10.1016/0021-9797(92)90504-F
   Lin Y S, 1995, Colloids Surf B Biointerfaces, V4, P65, DOI 10.1016/0927-7765(94)01150-4
   Mangindaan D, 2012, J BIOMED MATER RES A, V100A, P3177, DOI 10.1002/jbm.a.34251
   Mangindaan D, 2011, SURF COAT TECH, V206, P1299, DOI 10.1016/j.surfcoat.2011.08.046
   Mangindaan D, 2010, PLASMA PROCESS POLYM, V7, P754, DOI 10.1002/ppap.201000021
   Michelmore A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/41/415601
   Morgenthaler S, 2008, SOFT MATTER, V4, P419, DOI 10.1039/b715466f
   Nakamura R, 1997, ANAL CHEM, V69, P4649, DOI 10.1021/ac970571i
   Nakanishi K, 1996, ANAL CHEM, V68, P1695, DOI 10.1021/ac950756u
   PITT WG, 1989, J COLLOID INTERF SCI, V133, P223, DOI 10.1016/0021-9797(89)90295-6
   Plummer ST, 2003, LANGMUIR, V19, P7528, DOI 10.1021/la030075r
   Spijker HT, 1999, COLLOID SURFACE B, V15, P89, DOI 10.1016/S0927-7765(99)00056-9
   Truica-Marasescu F, 2008, PLASMA PROCESS POLYM, V5, P44, DOI 10.1002/ppap.200700077
   Vasilev K, 2010, BIOMATERIALS, V31, P392, DOI 10.1016/j.biomaterials.2009.09.056
   WAHLGREN M, 1995, COLLOID SURFACE B, V4, P23
   Walker RA, 2009, LANGMUIR, V25, P4243, DOI 10.1021/la803775m
   Wells N, 2009, BIOMATERIALS, V30, P1066, DOI 10.1016/j.biomaterials.2008.10.027
   Whittle JD, 2003, CHEM COMMUN, P1766, DOI 10.1039/b305445b
   Yang ZL, 2010, BIOMATERIALS, V31, P2072, DOI 10.1016/j.biomaterials.2009.11.091
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zelzer M, 2009, J PHYS CHEM B, V113, P8487, DOI 10.1021/jp902137y
   Zhu Y, 2013, RSC ADV, V3, P2509, DOI 10.1039/c2ra22358a
   Zhu Y, 2013, BIOMACROMOLECULES, V14, P342, DOI 10.1021/bm301523p
NR 52
TC 4
Z9 4
U1 0
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-6266
EI 1099-0488
J9 J POLYM SCI POL PHYS
JI J. Polym. Sci. Pt. B-Polym. Phys.
PD SEP 15
PY 2013
VL 51
IS 18
BP 1361
EP 1367
DI 10.1002/polb.23341
PG 7
WC Polymer Science
SC Polymer Science
GA 238BM
UT WOS:000325915400007
DA 2018-10-20
ER

PT J
AU Kurniawan, H
   Ye, YS
   Kuo, WH
   Lai, JT
   Wang, MJ
   Liu, HS
AF Kurniawan, Hengky
   Ye, Yun-Sheng
   Kuo, Wei-Hsuan
   Lai, Jinn-Tsyy
   Wang, Meng-Jiy
   Liu, Hwai-Shen
TI Improvement of biofouling resistance on bacterial cellulose membranes
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Acetobacter; Antifouling; Cellulose; Bioinert; Immobilization; Tissue
   cell culture
ID SELF-ASSEMBLED MONOLAYERS; ION MASS-SPECTROMETRY; PROTEIN ADSORPTION;
   POLY(ETHYLENE GLYCOL); SURFACE MODIFICATION; MICROBIAL CELLULOSE;
   POTENTIAL SCAFFOLD; XPS; IMMOBILIZATION; CARTILAGE
AB Bacterial cellulose possesses excellent biocompatibility and mechanical strength that show great potentials for biomaterial applications. In this study, the surface modifications of bacterial cellulose (BC) membranes were facilitated using either simple coating or chemical grafting methods. The surface coating method is to simply immobilize BC membranes with poly(ethylene glycol) (PEG) solutions of concentration from I to 10%, followed by post-treatment with argon (Ar) plasma. The chemical method involved grafting mPEG (monofunctional methyl ether PEG) on BCs. The outcomes of surface modifications were characterized by surface chemical compositions (electron spectroscopy for chemical analysis (ESCA), Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), thermogravimetry analysis (TGA), and surface morphology (atomic force microscopy (AFM) and scanning electron microscopy (SEM)). The effects of resistance to biofouling were verified by quantifying the adsorption of proteins and mammalian cells. The results showed that the PEG coating on BCs improved the resistance to cell adhesion by more than 30%. On the other hand, the specific chemical grafting resulted in a particularly high resistance to biofouling that the density of adherent cells reduced by more than 70% when compared to that on pristine BC. We have demonstrated that the two proposed methods were effective for the preparation of bioinert BC membranes with great potentials for applications in biomaterials and tissue engineering. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Kurniawan, Hengky; Ye, Yun-Sheng; Kuo, Wei-Hsuan; Wang, Meng-Jiy] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 106, Taiwan.
   [Lai, Jinn-Tsyy] Food Ind Res & Dev Inst FIRDI, Hsinchu 300, Taiwan.
   [Liu, Hwai-Shen] Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
RP Wang, MJ (reprint author), Natl Taiwan Univ Sci & Technol, Dept Chem Engn, 43,Keelung Rd,Sec 4, Taipei 106, Taiwan.
EM mjwang@mail.ntust.edu.tw; hsliu@ntu.edu.tw
FU Food Industry Research and Development Institute (FIRDI); National
   Science Council, Taiwan [99-2621-M-011-003]
FX The authors would like to demonstrate great appreciation to the
   financial supports from the Food Industry Research and Development
   Institute (FIRDI) and National Science Council, Taiwan
   (99-2621-M-011-003).
CR Balamurugan S, 2005, J AM CHEM SOC, V127, P14548, DOI 10.1021/ja054156g
   Brown EE, 2007, BIOMACROMOLECULES, V8, P3074, DOI 10.1021/bm700448x
   Browne MM, 2004, SURF SCI, V553, P155, DOI 10.1016/j.susc.2004.01.046
   Cai X, 2009, BIORESOURCE TECHNOL, V100, P4164, DOI 10.1016/j.biortech.2009.04.005
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Galtayries A, 2006, SURF INTERFACE ANAL, V38, P186, DOI 10.1002/sia.2295
   Gao SH, 2009, APPL SURF SCI, V255, P6017, DOI 10.1016/j.apsusc.2009.01.057
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   HESSELINK FT, 1971, J PHYS CHEM-US, V75, P2094, DOI 10.1021/j100683a005
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Huang HC, 2010, BIORESOURCE TECHNOL, V101, P6084, DOI 10.1016/j.biortech.2010.03.031
   Ifuku S, 2007, BIOMACROMOLECULES, V8, P1973, DOI 10.1021/bm070113b
   Ishihara K., BIOMATERIALS, V16
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim J., 2010, J NANOTECHNOL ENG ME, V1
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Lin SB, 2009, FOOD HYDROCOLLOID, V23, P2195, DOI 10.1016/j.foodhyd.2009.05.011
   Liu PS, 2010, J MEMBRANE SCI, V350, P387, DOI 10.1016/j.memsci.2010.01.015
   Lloyd A., 2004, MAT TODAY, V7, P28
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Luo X, 2010, J MATER SCI-MATER M, V21, P597, DOI 10.1007/s10856-009-3903-1
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nge TT, 2007, J BIOMED MATER RES A, V81A, P124, DOI 10.1002/jbm.a.31020
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Phisalaphong M, 2008, CARBOHYD POLYM, V74, P482, DOI 10.1016/j.carbpol.2008.04.004
   Piehler J, 2000, BIOSENS BIOELECTRON, V15, P473, DOI 10.1016/S0956-5663(00)00104-4
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Ruegsegger M.A., 2001, J BIOMED MATER RES, V56, P24
   Schilp S., 2007, BIOINTERPHASES, V2
   SCHMITT DF, 1991, J AM COLL TOXICOL, V10, P541, DOI 10.3109/10915819109078651
   Schoenfisch MH, 1998, J AM CHEM SOC, V120, P4502, DOI 10.1021/ja974301t
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6
   Sokolnicki AM, 2006, J MEMBRANE SCI, V272, P15, DOI 10.1016/j.memsci.2005.06.065
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   TARLOV MJ, 1992, LANGMUIR, V8, P1398, DOI 10.1021/la00041a026
   Tsai WB, 2009, ACTA BIOMATER, V5, P1442, DOI 10.1016/j.actbio.2009.01.002
   Vallon S, 1996, J VAC SCI TECHNOL A, V14, P3194, DOI 10.1116/1.580212
   VERLHAC C, 1990, J POLYM SCI POL CHEM, V28, P1171, DOI 10.1002/pola.1990.080280517
   Wagner MS, 2002, J BIOMAT SCI-POLYM E, V13, P407, DOI 10.1163/156856202320253938
   Wang P, 2002, J MEMBRANE SCI, V195, P103, DOI 10.1016/S0376-7388(01)00548-8
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
   Werner C., 2008, POLYM SURF INTERF, P299
   Yamanaka S, 2000, CELLULOSE, V7, P213, DOI 10.1023/A:1009208022957
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   Yang ZH, 1999, LANGMUIR, V15, P8405, DOI 10.1021/la990260y
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
   ZHANG TH, 1994, MACROMOLECULES, V27, P7302, DOI 10.1021/ma00103a011
   Zhang X, 2008, J BIOMED MATER RES A, V84A, P795, DOI 10.1002/jbm.a.31343
   Zhou LL, 2007, J IND MICROBIOL BIOT, V34, P483, DOI 10.1007/s10295-007-0218-4
NR 56
TC 7
Z9 7
U1 4
U2 85
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1369-703X
EI 1873-295X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD SEP 15
PY 2013
VL 78
SI SI
BP 138
EP 145
DI 10.1016/j.bej.2013.03.021
PG 8
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA 217IF
UT WOS:000324352500022
DA 2018-10-20
ER

PT J
AU Cheng, Y
   Cai, HX
   Yin, BO
   Yao, P
AF Cheng, Ye
   Cai, Huanxin
   Yin, Baoru
   Yao, Ping
TI Cholic acid modified N-(2-hydroxy)-propyl-3-trimethylammonium chitosan
   chloride for superoxide dismutase delivery
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Chitosan; Drug delivery; Nanoparticles; Protein
ID DEOXYCHOLIC-ACID; OXIDATIVE STRESS; IN-VITRO; NANOPARTICLES; PROTEIN;
   SYSTEMS; SOD; FLUORESCENCE; BIOMATERIAL; DERIVATIVES
AB A series of novel amphiphilic chitosan derivatives, cholic acid modified N-(2-hydroxy)-propyl-3-trimethylammonium chitosan chloride (HTCC-CA) with different quaternization degrees and cholic acid substitutions were synthesized in this study. HTCC-CA is biocompatible and forms particles in aqueous solution. The binding with superoxide dismutase (SOD) at pH 6.8 destroys the original aggregates of HTCC-CA and produces smaller SOD/HTCC-CA complex nanoparticles via electrostatic and hydrophobic interactions. The SOD loading efficiency and loading capacity of HTCC-CA can reach to more than 90% and 45%, respectively. Confocal laser scanning microscopy observation and flow cytometry analysis reveal that SOD/HTCC-CA complex nanoparticles greatly enhance the cellular internalization of the loaded SOD. The SOD activities and malonaldehyde concentrations in the serum and organs of the rats, administrated intravenously with free SOD, free HTCC-CA, and SOD/HTCC-CA nanoparticles, were assayed to evaluate the antioxidant efficiency in vivo. The results demonstrate that free HTCC-CA is effective to scavenge superoxide radicals in the blood circulation and SOD/HTCC-CA nanoparticles have better antioxidant efficiency than free SOD as well as free HTCC-CA. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Cheng, Ye; Cai, Huanxin; Yin, Baoru; Yao, Ping] Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Shanghai 200433, Peoples R China.
RP Yao, P (reprint author), Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Shanghai 200433, Peoples R China.
EM yaoping@fudan.edu.cn
FU Ministry of Science and Technology of China (973 Program) [2009CB930402,
   2011CB932503]; innovative team of Ministry of Education of China
   [IRT0911]; National Natural Science Foundation of China (NSFC)
   [21274026, 20874016]
FX The financial supports of Ministry of Science and Technology of China
   (973 Program 2009CB930402 and 2011CB932503), the innovative team of
   Ministry of Education of China (IRT0911), National Natural Science
   Foundation of China (NSFC Project 21274026 and 20874016) are gratefully
   acknowledged. The authors are grateful to Professor Weiwei Qiao of
   Experimental Animal Center of Fudan University for the technical
   assistance in the animal experiments.
CR Amidi M, 2010, ADV DRUG DELIVER REV, V62, P59, DOI 10.1016/j.addr.2009.11.009
   Bafana A, 2011, J MOL CATAL B-ENZYM, V68, P129, DOI 10.1016/j.molcatb.2010.11.007
   Chen G, 2011, INT J BIOL MACROMOL, V49, P543, DOI 10.1016/j.ijbiomac.2011.06.009
   Chiu YL, 2010, J CONTROL RELEASE, V146, P152, DOI 10.1016/j.jconrel.2010.05.023
   Cho J, 2006, BIOMACROMOLECULES, V7, P2845, DOI 10.1021/bm060436s
   Ghosh P, 2010, J AM CHEM SOC, V132, P2642, DOI 10.1021/ja907887z
   Harada A, 1999, J AM CHEM SOC, V121, P9241, DOI 10.1021/ja9919175
   Jeon TI, 2003, TOXICOLOGY, V187, P67, DOI 10.1016/S0300-483X(03)00003-9
   KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004
   Kaminski K, 2010, J MED CHEM, V53, P4141, DOI 10.1021/jm1001666
   Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x
   Kim S, 2005, DRUG DEVELOP RES, V64, P129, DOI 10.1002/ddr.10423
   Kim S, 2010, BIOMATERIALS, V31, P4157, DOI 10.1016/j.biomaterials.2010.01.139
   Kim S, 2009, BIOMATERIALS, V30, P4743, DOI 10.1016/j.biomaterials.2009.05.010
   Li M, 1997, J POLYM SCI POL PHYS, V35, P1593, DOI 10.1002/(SICI)1099-0488(19970730)35:10<1593::AID-POLB11>3.0.CO;2-5
   Li TS, 2010, J CONTROL RELEASE, V144, P101, DOI 10.1016/j.jconrel.2010.01.021
   Lim SH, 2004, CARBOHYD RES, V339, P313, DOI 10.1016/j.carres.2003.10.024
   Liu HT, 2009, PHARMACOL RES, V59, P167, DOI 10.1016/j.phrs.2008.12.001
   Liu JF, 2009, MOL CELL BIOCHEM, V327, P219, DOI 10.1007/s11010-009-0060-2
   Liu Y, 2011, ANGEW CHEM INT EDIT, V50, P3058, DOI 10.1002/anie.201005740
   Luo JT, 2009, LANGMUIR, V25, P10913, DOI 10.1021/la9013703
   MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x
   McCord JM, 2005, BIOMED PHARMACOTHER, V59, P139, DOI 10.1016/j.biopha.2005.03.005
   Mukhopadhyay S, 2004, CURR SCI INDIA, V87, P1666
   Nam HY, 2009, J CONTROL RELEASE, V135, P259, DOI 10.1016/j.jconrel.2009.01.018
   Ordonez YN, 2010, ANAL CHEM, V82, P2387, DOI 10.1021/ac902624b
   ODLIND B, 1988, PHARMACOL TOXICOL, V62, P95, DOI 10.1111/j.1600-0773.1988.tb01853.x
   Ratnam DV, 2006, J CONTROL RELEASE, V113, P189, DOI 10.1016/j.jconrel.2006.04.015
   REITER RJ, 1995, FASEB J, V9, P526
   Rengel RG, 2002, EUR J PHARM SCI, V15, P441, DOI 10.1016/S0928-0987(02)00030-1
   SALIN ML, 1975, J CLIN INVEST, V56, P1319, DOI 10.1172/JCI108208
   Seshadri G, 2010, BIOMATERIALS, V31, P1372, DOI 10.1016/j.biomaterials.2009.10.045
   Simoes SI, 2005, J CONTROL RELEASE, V103, P419, DOI 10.1016/j.jconrel.2004.12.008
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sonaje K, 2010, BIOMATERIALS, V31, P3384, DOI 10.1016/j.biomaterials.2010.01.042
   Sonia TA, 2011, CARBOHYD POLYM, V84, P103, DOI 10.1016/j.carbpol.2010.10.070
   Sun T, 2004, CARBOHYD POLYM, V58, P379, DOI 10.1016/j.carbpol.2004.06.042
   SUN Y, 1988, CLIN CHEM, V34, P497
   Sun Y, 2007, J APPL POLYM SCI, V105, P552, DOI 10.1002/app.26038
   Tan ML, 2010, PEPTIDES, V31, P184, DOI 10.1016/j.peptides.2009.10.002
   Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375
   Uzar E, 2006, MOL CELL BIOCHEM, V291, P63, DOI 10.1007/s11010-006-9196-5
   Valdivia A, 2009, J PHYSIOL BIOCHEM, V65, P195, DOI 10.1007/BF03179070
   Veronese FM, 2002, ADV DRUG DELIVER REV, V54, P587, DOI 10.1016/S0169-409X(02)00029-7
   Wu J, 2006, INT J PHARM, V315, P1, DOI 10.1016/j.ijpharm.2006.01.045
   Xiang Y. B., 2012, MACROMOL BIOSCI, V12, P515
   Xiao B, 2012, COLLOID SURFACE B, V91, P168, DOI 10.1016/j.colsurfb.2011.10.053
   Xu YM, 2003, BIOMATERIALS, V24, P5015, DOI 10.1016/S0142-9612(03)00408-3
   Zhang X, 2012, CARBOHYD POLYM, V89, P486, DOI 10.1016/j.carbpol.2012.03.032
   Zhao SH, 2010, INT J PHARMACEUT, V393, P268, DOI 10.1016/j.ijpharm.2010.04.034
   Zhou HF, 2010, BIOMACROMOLECULES, V11, P3480, DOI 10.1021/bm100989x
NR 51
TC 16
Z9 17
U1 1
U2 51
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD SEP 15
PY 2013
VL 454
IS 1
BP 425
EP 434
DI 10.1016/j.ijpharm.2013.06.056
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 210SK
UT WOS:000323854600049
PM 23830946
DA 2018-10-20
ER

PT J
AU Chen, MH
   Soda, Y
   Izawa, K
   Kobayashi, S
   Tani, K
   Maruyama, K
   Tojo, A
   Asano, S
AF Chen, Ming-Han
   Soda, Yasushi
   Izawa, Kiyoko
   Kobayashi, Seiichiro
   Tani, Kenzaburo
   Maruyama, Kazuo
   Tojo, Arinobu
   Asano, Shigetaka
TI A versatile drug delivery system using streptavidin-tagged pegylated
   liposomes and biotinylated biomaterials
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Drug delivery system; Immunoliposome; Tumor-targeting; Internalization;
   Streptavidin; Biotin
ID ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; TARGETED DELIVERY;
   CELL-LINES; IMMUNOLIPOSOMES; RECEPTOR; CANCER; INTERNALIZATION;
   TRANSLOCATION; IMMUNOTOXINS
AB Here we have developed a versatile liposome-mediated drug delivery system (DDS) allowing a strong bridge between the streptavidin-tagged liposome (SAL) and biotin (Bi)-tagged biomaterials which has strong affinity to surface proteins expressed in restricted cell lineages. This DDS was effective and specific for many leukemia cells in vitro and in vivo. When examining 6 human leukemia cell lines using calcein-encapsulated SALs in combination with Bi-granulocyte colony-stimulating factor (G-CSF), Bi-anti-CD33 monoclonal antibody (MAb) or Bi-anti-CD7 MAb, the fluorescent positive rate of each cell line was in almost proportion to degree of G-CSF receptor, CD33 or CD7 expression, respectively. More importantly, the binding ability was shown to be well maintained in a mouse xenograft model. Furthermore the cytosine arabinoside (AraC)-encapsulated SALs could kill the corresponding cells much more effectively in combination with Bi-biomaterials than free AraC, as expected. These findings strongly indicate that our SAL/Bi-biomaterial system could allow various types of medical agents to be delivered reliably and stably to the cells targeted. (C) 2013 Published by Elsevier B.V.
C1 [Chen, Ming-Han] Natl Yang Ming Univ, Dept Med, Ilan, Taiwan.
   [Chen, Ming-Han] Natl Yang Ming Univ, Dept Med, Taipei, Taiwan.
   [Soda, Yasushi] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA.
   [Izawa, Kiyoko; Kobayashi, Seiichiro; Tojo, Arinobu] Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Mol Therapy, Tokyo, Japan.
   [Tani, Kenzaburo] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Div Mol & Clin Genet, Fukuoka 812, Japan.
   [Maruyama, Kazuo] Teikyo Univ, Fac Pharma Sci, Dept Drug Delivery Res, Tokyo 173, Japan.
   [Asano, Shigetaka] Waseda Univ, Sch Sci & Engn, Dept Chem Biol Chem, Tokyo 1698555, Japan.
RP Asano, S (reprint author), Waseda Univ, Sch Sci & Engn, Dept Chem Biol Chem, Shinjuku Ku, 3-4-1 Olcubo, Tokyo 1698555, Japan.
EM asgtkmd@waseda.jp
CR AHMAD I, 1993, CANCER RES, V53, P1484
   Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903
   Allen TM, 1997, DRUGS, V54, P8, DOI 10.2165/00003495-199700544-00004
   ASOU H, 1991, BLOOD, V77, P2031
   Awasthi V, 1998, J NUCL MED, V39, P1089
   DIAMANDIS EP, 1991, CLIN CHEM, V37, P625
   Drexler HG, 2000, LEUKEMIA RES, V24, P881, DOI 10.1016/S0145-2126(00)00070-9
   Drexler HG, 1998, LEUKEMIA LYMPHOMA, V31, P305, DOI 10.3109/10428199809059223
   Eliaz RE, 2001, CANCER RES, V61, P2592
   Forraz N, 2004, STEM CELLS, V22, P100, DOI 10.1634/stemcells.22-1-100
   Haniu M, 1996, BIOCHEMISTRY-US, V35, P13040, DOI 10.1021/bi960213u
   Harata M, 2004, BLOOD, V104, P1442, DOI 10.1182/blood-2004-02-0588
   Hertlein E, 2010, BLOOD, V116, P2554, DOI 10.1182/blood-2009-11-253203
   Jiang J., 2013, EUR J PHARM BIOPHARM, V76, P170
   JUNG LKL, 1989, J IMMUNOL METHODS, V116, P137, DOI 10.1016/0022-1759(89)90322-0
   Knox SJ, 2000, CLIN CANCER RES, V6, P406
   Lesch HP, 2010, EXPERT OPIN DRUG DEL, V7, P551, DOI 10.1517/17425241003677749
   Maruyama K, 2002, BIOSCIENCE REP, V22, P251, DOI 10.1023/A:1020138622686
   MARUYAMA K, 1995, BBA-BIOMEMBRANES, V1234, P74, DOI 10.1016/0005-2736(94)00263-O
   Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003
   Minko T, 2004, CURR DRUG TARGETS, V5, P389, DOI 10.2174/1389450043345443
   Pan XQ, 2002, BLOOD, V100, P594, DOI 10.1182/blood.V100.2.594
   Park JW, 2002, CLIN CANCER RES, V8, P1172
   Pea F, 2000, CANCER CHEMOTH PHARM, V46, P279, DOI 10.1007/s002800000163
   PREIJERS FWMB, 1988, BRIT J HAEMATOL, V70, P289, DOI 10.1111/j.1365-2141.1988.tb02484.x
   Rowlinson-Busza Gail, 1992, Current Opinion in Oncology, V4, P1142, DOI 10.1097/00001622-199212000-00020
   Sadzuka Y, 2000, CURR DRUG METAB, V1, P31, DOI 10.2174/1389200003339225
   Sapra P, 2003, PROG LIPID RES, V42, P439, DOI 10.1016/S0163-7827(03)00032-8
   Setoyama M, 1998, BLOOD, V92, P1454
   SIMMONS D, 1988, J IMMUNOL, V141, P2797
   STONG RC, 1985, BLOOD, V66, P627
   Sugano M, 2000, CANCER RES, V60, P6942
   Tsuji K, 2001, LEUKEMIA LYMPHOMA, V42, P1351, DOI 10.3109/10428190109097763
   van der Velden VHJ, 2001, BLOOD, V97, P3197, DOI 10.1182/blood.V97.10.3197
   Weiden PL, 2000, CANCER BIOTHER RADIO, V15, P15, DOI 10.1089/cbr.2000.15.15
   Xu L, 2002, MOL CANCER THER, V1, P337
NR 36
TC 6
Z9 7
U1 3
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD SEP 15
PY 2013
VL 454
IS 1
BP 478
EP 485
DI 10.1016/j.ijpharm.2013.06.031
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 210SK
UT WOS:000323854600055
PM 23806815
DA 2018-10-20
ER

PT J
AU VanWagner, M
   Rhadigan, J
   Lancina, M
   Lebovsky, A
   Romanowicz, G
   Holmes, H
   Brunette, MA
   Snyder, KL
   Bostwick, M
   Lee, BP
   Frost, MC
   Rajachar, RM
AF VanWagner, Michael
   Rhadigan, Jessica
   Lancina, Michael
   Lebovsky, Allison
   Romanowicz, Genevieve
   Holmes, Hal
   Brunette, Margaret A.
   Snyder, Katherine L.
   Bostwick, Michael
   Lee, Bruce P.
   Frost, Megan C.
   Rajachar, Rupak M.
TI S-Nitroso-N-acetylpenicillamine (SNAP) Derivatization of Peptide Primary
   Amines to Create Inducible Nitric Oxide Donor Biomaterials
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE biodegradable; fibrin; hydrogel; inducible; nitric oxide; tissue
   engineering
ID STAPHYLOCOCCUS-EPIDERMIDIS; BIOMEDICAL APPLICATIONS; ANTIMICROBIAL
   AGENT; FIBRIN GEL; HYDROGELS; RELEASE; NANOPARTICLES; BIOCOMPATIBILITY;
   PROLIFERATION; REGENERATION
AB An S-nitroso-N-acetylpenicillarnine (SNAP) derivatization approach was used to modify existing free primary amines found in fibrin (a natural protein-based biomaterial) to generate a controlled nitric oxide (NO) releasing scaffold material. The duration of the derivatization reaction affects the NO release kinetics, the induction of controlled NO-release, hydrophobicity, swelling behavior, elastic moduli, rheometric character, and degradation behavior. These "properties were quantified to determine changes in fibrin hydrogels following covalent attachment of SNAP. NO-releasing materials exhibited minimal cytotoxicity when cultured with fibroblasts or osteoblasts. Cells maintained viability and proliferative character on derivatized materials as demonstrated by Live/Dead cell staining and counting. In addition, SNAP-derivatized hydrogels exhibited an antimicrobial character indicative of NO-releasing materials. SNAP derivatization of natural polymeric biomaterials containing free primary amines offers a means to generate inducible NO-releasing biomaterials for use as an antimicrobial and regenerative support for tissue engineering.
C1 [VanWagner, Michael; Rhadigan, Jessica; Lancina, Michael; Lebovsky, Allison; Romanowicz, Genevieve; Holmes, Hal; Brunette, Margaret A.; Snyder, Katherine L.; Bostwick, Michael; Lee, Bruce P.; Frost, Megan C.; Rajachar, Rupak M.] Michigan Technol Univ, Coll Engn, Dept Biomed Engn, Houghton, MI 49931 USA.
RP Rajachar, RM (reprint author), Michigan Technol Univ, Coll Engn, Dept Biomed Engn, 1400 Townsend Dr, Houghton, MI 49931 USA.
EM rupakr@mtu.edu
OI Lee, Bruce/0000-0002-6529-0032
FU National Science Foundation, Division of Materials Research
   [DMR-0906709-2009]
FX The authors gratefully acknowledge partial funding support from the
   National Science Foundation, Division of Materials Research
   DMR-0906709-2009.
CR Armour KJ, 2001, ARTHRITIS RHEUM, V44, P2790, DOI 10.1002/1529-0131(200112)44:12<2790::AID-ART466>3.0.CO;2-X
   Benhardt HA, 2009, TISSUE ENG PART B-RE, V15, P467, DOI 10.1089/ten.TEB.2008.0687
   Benson DE, 1996, ASAIO J, V42, pM655, DOI 10.1097/00002480-199609000-00069
   Bernatchez SF, 2013, WOUND REPAIR REGEN, V21, P410, DOI 10.1111/wrr.12048
   Bruns H, 2005, TISSUE ENG, V11, P1718, DOI 10.1089/ten.2005.11.1718
   Cha C, 2011, ACTA BIOMATER, V7, P3719, DOI 10.1016/j.actbio.2011.06.017
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chen DTN, 2010, ANNU REV CONDEN MA P, V1, P301, DOI 10.1146/annurev-conmatphys-070909-104120
   CHUGH TD, 1990, INFECT IMMUN, V58, P315
   Coban AY, 2008, SALUD CIENC, V16, P1340
   Coneski PN, 2011, ACS APPL MATER INTER, V3, P426, DOI 10.1021/am101010e
   Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73
   Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104
   Damodaran VB, 2012, J MATER CHEM, V22, P5990, DOI 10.1039/c2jm16554f
   Damodaran VB, 2011, J MATER CHEM, V21, P5870, DOI 10.1039/c1jm10315f
   Deupree SM, 2009, ACTA BIOMATER, V5, P1405, DOI 10.1016/j.actbio.2009.01.025
   DICKS AP, 1996, J CHEM SOC PERK T, V2, P481
   DONG LC, 1991, J CONTROL RELEASE, V15, P141, DOI 10.1016/0168-3659(91)90072-L
   Dong SS, 1999, J CELL BIOCHEM, V73, P478, DOI 10.1002/(SICI)1097-4644(19990615)73:4<478::AID-JCB6>3.0.CO;2-T
   FRIEDMAN AJ, 2011, BIOL CHEM, V25, P381
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Ghaffari A, 2006, NITRIC OXIDE-BIOL CH, V14, P21, DOI 10.1016/j.niox.2005.08.003
   Gonzalez N, 2003, J POLYM SCI POL CHEM, V41, P395, DOI 10.1002/pola.10584
   Han G, 2012, AM J PATHOL, V180, P1465, DOI 10.1016/j.ajpath.2011.12.013
   Hetrick EM, 2009, BIOMATERIALS, V30, P2782, DOI 10.1016/j.biomaterials.2009.01.052
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hou YC, 1999, CURR PHARM DESIGN, V5, P417
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Isenberg JS, 2005, MICROSURG, V25, P442, DOI 10.1002/micr.20166
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Kim J, 2011, BIOCONJUGATE CHEM, V22, P1031, DOI 10.1021/bc100405c
   Kirsch M, 2009, ORG BIOMOL CHEM, V7, P1954, DOI 10.1039/b901046g
   Li Y, 2010, MOL PHARMACEUT, V7, P254, DOI [10.1021/mp900237f, 10.1021/mp900237t]
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Mason MN, 2010, J BIOMED MATER RES A, V95A, P283, DOI 10.1002/jbm.a.32825
   Masters KSB, 2005, J BIOMAT SCI-POLYM E, V16, P659, DOI 10.1163/1568562053783722
   McManus MC, 2006, ACTA BIOMATER, V2, P19, DOI 10.1016/j.actbio.2005.09.008
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Moynihan HA, 1994, J CHEM SOC P1, V1, P797
   Murrell G. A., 2007, J SPORTS MED, V41, P227
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Piechocka IK, 2010, BIOPHYS J, V98, P2281, DOI 10.1016/j.bpj.2010.01.040
   Sabanai Ken, 2009, Clin Calcium, V19, P1133, DOI CliCa090811331141
   Sarvestani AS, 2007, POLYMER, V48, P7113, DOI 10.1016/j.polymer.2007.10.007
   Scorza G, 1997, FREE RADICAL BIO MED, V22, P633, DOI 10.1016/S0891-5849(96)00378-4
   Scutt N, 2006, J ORTHOP RES, V24, P173, DOI 10.1002/jor.20030
   Shin JH, 2006, ANALYST, V131, P609, DOI 10.1039/b600129g
   Shishido SM, 2003, BIOMATERIALS, V24, P3543, DOI 10.1016/S0142-9612(03)00153-4
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Soon ASC, 2011, BIOMATERIALS, V32, P4406, DOI 10.1016/j.biomaterials.2011.02.050
   Stubauer G, 1999, J BIOL CHEM, V274, P28128, DOI 10.1074/jbc.274.40.28128
   Sun B., 2011, ABSTR PAP AM CHEM S, P242
   Swartz D. D., 2005, AM J PHYSIOL-HEART C, V288, pH1451
   Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020
   Varu VN, 2009, VASC ENDOVASC SURG, V43, P121, DOI 10.1177/1538574408322752
   Weller RB, 2009, J INVEST DERMATOL, V129, P2335, DOI 10.1038/jid.2009.149
   Wold KA, 2012, ACS APPL MATER INTER, V4, P3022, DOI 10.1021/am300383w
   Xia W, 2006, J ORTHOP RES, V24, P159, DOI 10.1002/jor.20060
NR 62
TC 4
Z9 4
U1 5
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP 11
PY 2013
VL 5
IS 17
BP 8430
EP 8439
DI 10.1021/am4017945
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 294BJ
UT WOS:000330017100027
PM 23964741
DA 2018-10-20
ER

PT J
AU Martinez, S
   Kuhn, ML
   Russell, JT
   Holz, RC
   Elgren, TE
AF Martinez, Salette
   Kuhn, Misty L.
   Russell, James T.
   Holz, Richard C.
   Elgren, Timothy E.
TI Hydration of nitriles by a nitrile hydratase biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 246th National Meeting of the American-Chemical-Society (ACS)
CY SEP 08-12, 2013
CL Indianapolis, IN
SP Amer Chem Soc
C1 [Russell, James T.; Elgren, Timothy E.] Hamilton Coll, Clinton, NY 13323 USA.
   [Martinez, Salette; Kuhn, Misty L.; Holz, Richard C.] Loyola Univ, Chicago, IL 60660 USA.
EM smartinez5@luc.edu
NR 0
TC 0
Z9 0
U1 1
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 8
PY 2013
VL 246
MA 167-INOR
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 288NJ
UT WOS:000329618404204
DA 2018-10-20
ER

PT J
AU Vielreicher, M
   Schurmann, S
   Detsch, R
   Schmidt, MA
   Buttgereit, A
   Boccaccini, A
   Friedrich, O
AF Vielreicher, M.
   Schuermann, S.
   Detsch, R.
   Schmidt, M. A.
   Buttgereit, A.
   Boccaccini, A.
   Friedrich, O.
TI Taking a deep look: modern microscopy technologies to optimize the
   design and functionality of biocompatible scaffolds for tissue
   engineering in regenerative medicine
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE multiphoton imaging; second harmonic generation; autofluorescence;
   biomaterials; artificial tissues; extracellular matrix
ID OPTICAL COHERENCE TOMOGRAPHY; RAMAN SCATTERING MICROSCOPY; 2ND-HARMONIC
   GENERATION MICROSCOPY; MESENCHYMAL STEM-CELLS; IN-VITRO EVALUATION;
   MULTIFOCAL MULTIPHOTON MICROSCOPY; 3-DIMENSIONAL COLLAGEN MATRICES;
   BACTERIAL CELLULOSE SCAFFOLDS; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX
AB This review focuses on modern nonlinear optical microscopy (NLOM) methods that are increasingly being used in the field of tissue engineering (TE) to image tissue non-invasively and without labelling in depths unreached by conventional microscopy techniques. With NLOM techniques, biomaterial matrices, cultured cells and their produced extracellular matrix may be visualized with high resolution. After introducing classical imaging methodologies such as mu CT, MRI, optical coherence tomography, electron microscopy and conventional microscopy two-photon fluorescence (2-PF) and second harmonic generation (SHG) imaging are described in detail (principle, power, limitations) together with their most widely used TE applications. Besides our own cell encapsulation, cell printing and collagen scaffolding systems and their NLOM imaging the most current research articles will be reviewed. These cover imaging of autofluorescence and fluorescence-labelled tissue and biomaterial structures, SHG-based quantitative morphometry of collagen I and other proteins, imaging of vascularization and online monitoring techniques in TE. Finally, some insight is given into state-of-the-art three-photon-based imaging methods (e. g. coherent anti-Stokes Raman scattering, third harmonic generation). This review provides an overview of the powerful and constantly evolving field of multiphoton microscopy, which is a powerful and indispensable tool for the development of artificial tissues in regenerative medicine and which is likely to gain importance also as a means for general diagnostic medical imaging.
C1 [Vielreicher, M.; Schuermann, S.; Schmidt, M. A.; Buttgereit, A.; Friedrich, O.] Univ Erlangen Nurnberg, Inst Med Biotechnol, Dept Chem & Biol Engn, D-91052 Erlangen, Germany.
   [Detsch, R.; Schmidt, M. A.; Boccaccini, A.] Univ Erlangen Nurnberg, Inst Biomat WW7, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
RP Vielreicher, M (reprint author), Univ Erlangen Nurnberg, Inst Med Biotechnol, Dept Chem & Biol Engn, Paul Gordan Str 3, D-91052 Erlangen, Germany.
EM martin.vielreicher@mbt.uni-erlangen.de
RI Vielreicher, Martin/L-1768-2013
OI Vielreicher, Martin/0000-0002-7515-1431
FU Emerging Fields Initiative (EFI) project TOPbiomat from
   Friedrich-Alexander University of Erlangen-Nuremberg
FX This work was supported by the Emerging Fields Initiative (EFI) project
   TOPbiomat from the Friedrich-Alexander University of Erlangen-Nuremberg.
CR Abbah SA, 2006, BIOCHEM BIOPH RES CO, V347, P185, DOI 10.1016/j.bbrc.2006.06.072
   Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072
   Ballyns JJ, 2009, J CELL MOL MED, V13, P1428, DOI 10.1111/j.1582-4934.2009.00836.x
   Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008
   Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783
   Boos AM, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1457, DOI 10.1002/TERM.1457)]
   Boppart SA, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2008974
   BOYD GD, 1968, J APPL PHYS, V39, P3597, DOI 10.1063/1.1656831
   Brackmann C, 2012, TISSUE ENG PART C-ME, V18, P227, DOI [10.1089/ten.tec.2011.0211, 10.1089/ten.TEC.2011.0211]
   Brackmann C, 2012, J BIOPHOTONICS, V5, P404, DOI 10.1002/jbio.201100141
   Brackmann C, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505024
   Brezinski ME, 2006, INT J CARDIOL, V107, P154, DOI 10.1016/j.ijcard.2005.07.066
   Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Carriles R, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3184828
   Casalis P, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1582, DOI 10.1002/TERM.1582)]
   Chen B, 2008, LANGMUIR, V24, P11866, DOI 10.1021/la802048s
   Chen LD, 2008, BIOMATERIALS, V29, P4170, DOI 10.1016/j.biomaterials.2008.07.025
   Chen WL, 2010, TISSUE ENG PART C-ME, V16, P913, DOI [10.1089/ten.tec.2009.0596, 10.1089/ten.TEC.2009.0596]
   Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009
   Cheng JX, 2001, OPT LETT, V26, P1341, DOI 10.1364/OL.26.001341
   Chim H, 2012, CELL TISSUE RES, V350, P89, DOI 10.1007/s00441-012-1449-x
   Chu SW, 2005, MICROSC RES TECHNIQ, V66, P193, DOI 10.1002/jemt.20160
   Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008
   Conovaloff A, 2009, ORGANOGENESIS, V5, P231, DOI 10.4161/org.5.4.10404
   Cristino S, 2005, J BIOMED MATER RES A, V73A, P275, DOI 10.1002/jbm.a.30261
   Dalby MJ, 1999, J MATER SCI-MATER M, V10, P793, DOI 10.1023/A:1008907218330
   Dawes C.J., 1979, BIOL TECHNIQUES TRAN
   Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813
   Delehanty JB, 2009, ANAL BIOANAL CHEM, V393, P1091, DOI 10.1007/s00216-008-2410-4
   Dempsey WP, 2012, BIOESSAYS, V34, P351, DOI 10.1002/bies.201100106
   Deng Y, 2003, BIOMATERIALS, V24, P4273, DOI 10.1016/S0142-9612(03)00367-3
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]
   Diaspro A, 2005, Q REV BIOPHYS, V38, P97, DOI 10.1017/S0033583505004129
   Diaspro A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-36
   Dittmar R, 2012, TISSUE ENG PART C-ME, V18, P198, DOI [10.1089/ten.tec.2011.0334, 10.1089/ten.TEC.2011.0334]
   Doroski DM, 2007, BIOMATERIALS, V28, P187, DOI 10.1016/j.biomaterials.2006.08.040
   Drexler W, 2001, NAT MED, V7, P502, DOI 10.1038/86589
   DUNCAN MD, 1982, OPT LETT, V7, P350, DOI 10.1364/OL.7.000350
   Erol MM, 2012, ACTA BIOMATER, V8, P792, DOI 10.1016/j.actbio.2011.10.013
   Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102
   Fedorovich NE, 2008, TISSUE ENG PT A, V14, P127, DOI 10.1089/ten.a.2007.0158
   Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI 10.1088/0034-4885/66/2/204
   Filova E, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3509112
   Fischer RS, 2011, TRENDS CELL BIOL, V21, P682, DOI 10.1016/j.tcb.2011.09.008
   FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X
   Friedrich O, 2010, BIOPHYS J, V98, P606, DOI 10.1016/j.bpj.2009.11.005
   Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248
   Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032
   Goppert-Mayer M., 1931, J R SOC INTERFACE, V9, P273, DOI [10.1002/andp.19314010303, DOI 10.1002/ANDP.19314010303)]
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Grandfield K, 2012, PHILOS T R SOC A, V370, P1337, DOI 10.1098/rsta.2011.0253
   Hegen A, 2011, J TISSUE ENG REGEN M, V5, pE52, DOI 10.1002/term.336
   Hockaday LA, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035005
   Hu JJ, 2009, TISSUE ENG PT A, V15, P1553, DOI 10.1089/ten.tea.2008.0287
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Iqbal K, 2012, INDIAN J ORTHOP, V46, P391, DOI 10.4103/0019-5413.98826
   ISHII K, 2007, P SOC PHOTO-OPT INS, V6439, P64390
   Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   KAISER W, 1961, PHYS REV LETT, V7, P229, DOI 10.1103/PhysRevLett.7.229
   Kajiwara H, 2005, BIOMATERIALS, V26, P581, DOI 10.1016/j.biomaterials.2004.02.072
   Kaushalya SK, 2008, J NEUROSCI RES, V86, P3469, DOI 10.1002/jnr.21794
   Kiernan J.A., 1999, HISTOLOGICAL HISTOCH
   Kinikoglu B, 2009, BIOMATERIALS, V30, P6418, DOI 10.1016/j.biomaterials.2009.08.010
   KLEINMAN DA, 1962, PHYS REV, V126, P1977, DOI 10.1103/PhysRev.126.1977
   Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721
   Konig K, 2005, BIOMATERIALS, V26, P495, DOI 10.1016/j.biomaterials.2004.02.059
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lee PF, 2009, EXP CELL RES, V315, P396, DOI 10.1016/j.yexcr.2008.10.040
   Liang MS, 2011, BIOMATERIALS, V32, P8684, DOI 10.1016/j.biomaterials.2011.07.079
   Liang X, 2009, J BIOPHOTONICS, V2, P643, DOI 10.1002/jbio.200910048
   Liu B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753410
   Liu E, 2007, J BIOMED MATER RES B, V82B, P284, DOI 10.1002/jbm.b.30732
   Liu XC, 2012, INT J NANOMED, V7, P1239, DOI 10.2147/IJN.S28098
   Lu KC, 2009, SKIN RES TECHNOL, V15, P489, DOI 10.1111/j.1600-0846.2009.00395.x
   Luderer F, 2012, J BIOMATER APPL, DOI [10.1177/0885328212443393, DOI 10.1177/0885328212443393)]
   Madani SY, 2012, INT J NANOMED, V7, P905, DOI 10.2147/IJN.S25035
   Maiti S, 1997, SCIENCE, V275, P530, DOI 10.1126/science.275.5299.530
   Marelli B, 2011, BIOMATERIALS, V32, P8915, DOI 10.1016/j.biomaterials.2011.08.016
   Marelli B, 2010, BIOMACROMOLECULES, V11, P1470, DOI 10.1021/bm1001087
   Martinez H, 2012, J BIOMED MATER RES A, V100A, P948, DOI 10.1002/jbm.a.34035
   McBane JE, 2012, ACTA BIOMATER, V8, P488, DOI 10.1016/j.actbio.2011.09.018
   McNally EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029258
   Meng DC, 2011, J BIOMED MATER RES A, V99A, P435, DOI 10.1002/jbm.a.33185
   Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939
   Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171
   MILLER K, 2002, THEORY PRACTICE HIST, P421
   Mouras R., 2011, P SOC PHOTO-OPT INS, P8086, DOI [10.1117/12.889780, DOI 10.1117/12.889780)]
   Muller M., 2006, INTRO CONFOCAL FLUOR
   Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202
   Muller-Borer Barbara J., 2007, Journal of Nanobiotechnology, V5, P9, DOI 10.1186/1477-3155-5-9
   Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010
   Nadiarnykh O, 2007, OPT EXPRESS, V15, P3348, DOI 10.1364/OE.15.003348
   Nehal KS, 2008, SEMIN CUTAN MED SURG, V27, P37, DOI 10.1016/j.sder.2008.01.006
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nielsen T, 2001, J MICROSC-OXFORD, V201, P368, DOI 10.1046/j.1365-2818.2001.00852.x
   Niesner RA, 2011, CYTOM PART A, V79A, P789, DOI 10.1002/cyto.a.21140
   Niklason LE, 2010, P NATL ACAD SCI USA, V107, P3335, DOI 10.1073/pnas.0907813106
   Nucciotti V, 2010, P NATL ACAD SCI USA, V107, P7763, DOI 10.1073/pnas.0914782107
   Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1
   Oliveira SM, 2010, J BIOMED MATER RES A, V94A, P371, DOI 10.1002/jbm.a.32694
   Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428
   Orsini G, 2008, EUR J HISTOCHEM, V52, P215
   Pancrazio JJ, 2007, BIOSENS BIOELECTRON, V22, P2803, DOI 10.1016/j.bios.2006.12.023
   Pandit A, 1999, J INVEST SURG, V12, P89
   Pawlicki M, 2009, ANGEW CHEM INT EDIT, V48, P3244, DOI 10.1002/anie.200805257
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211
   Potma EO, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3558735
   Quentmeier S, 2009, J FLUORESC, V19, P1037, DOI 10.1007/s10895-009-0503-x
   Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024
   Rai MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025749
   Raub CB, 2010, ACTA BIOMATER, V6, P4657, DOI 10.1016/j.actbio.2010.07.004
   Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   Rice WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010075
   RODRIGUES SC, 2012, J BIOMED MATER RES, V101, P1, DOI DOI 10.1002/JBM.A.34394)
   Roldan JC, 2010, J CRANIO MAXILL SURG, V38, P580, DOI 10.1016/j.jcms.2010.01.004
   Rubbens MP, 2009, ANN BIOMED ENG, V37, P1263, DOI 10.1007/s10439-009-9698-x
   Saidha S, 2010, OPHTHALMOLOGY, V20, P77, DOI DOI 10.1155/2011/472790)
   Sanyal A, 2012, J BIOMECH, V45, P2513, DOI 10.1016/j.jbiomech.2012.07.023
   Schenke-Layland K, 2007, ANN THORAC SURG, V83, P1641, DOI 10.1016/j.athoracsur.2006.12.005
   Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004
   Schenke-Layland K, 2009, BIOMATERIALS, V30, P4665, DOI 10.1016/j.biomaterials.2009.05.033
   Schenke-Layland K, 2008, J BIOPHOTONICS, V1, P451, DOI 10.1002/jbio.200810045
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Schurmann S, 2010, BIOPHYS J, V99, P1842, DOI 10.1016/j.bpj.2010.07.005
   Shao LJ, 2011, SENSORS-BASEL, V11, P11736, DOI 10.3390/s111211736
   Shiels S, 2012, J BIOMED MATER RES B, V100B, P1782, DOI 10.1002/jbm.b.32745
   Skardal A, 2010, TISSUE ENG PT A, V16, P2675, DOI [10.1089/ten.tea.2009.0798, 10.1089/ten.TEA.2009.0798]
   Smith AM, 2006, ANN BIOMED ENG, V34, P3, DOI 10.1007/s10439-005-9000-9
   Smith LE, 2010, J TISSUE ENG REGEN M, V4, P652, DOI 10.1002/term.281
   Smith LE, 2010, MICROSC RES TECHNIQ, V73, P1123, DOI 10.1002/jemt.20859
   Strachan CJ, 2011, INT J PHARMACEUT, V417, P163, DOI 10.1016/j.ijpharm.2010.12.017
   Sun Y, 2008, MICROSC RES TECHNIQ, V71, P140, DOI 10.1002/jemt.20537
   Tan HY, 2006, INVEST OPHTH VIS SCI, V47, P5251, DOI 10.1167/iovs.06-0386
   Tan W, 2006, OPT EXPRESS, V14, P7159, DOI 10.1364/OE.14.007159
   Teng SW, 2007, ARCH OPHTHALMOL-CHIC, V125, P977, DOI 10.1001/archopht.125.7.977
   Thrasivoulou C, 2011, BIOMED OPT EXPRESS, V2, P1282, DOI 10.1364/BOE.2.001282
   Torkian Behrooz A, 2004, Arch Facial Plast Surg, V6, P180, DOI 10.1001/archfaci.6.3.180
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Ustione A, 2011, J MICROSC-OXFORD, V243, P221, DOI 10.1111/j.1365-2818.2011.03532.x
   Vande Velde G, 2009, Q J NUCL MED MOL IM, V53, P565
   Watt SM, 2010, J R SOC INTERFACE, V7, pS731, DOI [10.1098/rsif.2010.0377.focus, 10.1098/rsif.2010.0377.focas]
   Wessels JT, 2010, CYTOM PART A, V77A, P667, DOI 10.1002/cyto.a.20931
   Wu SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012643
   Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763
   Xu HH, 2008, J BIOSCI BIOENG, V106, P515, DOI 10.1263/jbb.106.515
   Xu JL, 2012, BIOMATERIALS, V33, P6965, DOI 10.1016/j.biomaterials.2012.06.010
   Yang XC, 2012, J CELL BIOCHEM, V113, P669, DOI 10.1002/jcb.23396
   Yang Y, 2006, PHYS MED BIOL, V51, P1649, DOI 10.1088/0031-9155/51/7/001
   Yang Y, 2007, J R SOC INTERFACE, V4, P1169, DOI 10.1098/rsif.2007.1044
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   Yeh AT, 2008, TISSUE ENG PT B-REV, V14, P119, DOI 10.1089/teb.2007.0284
   Young S, 2008, TISSUE ENG PT B-REV, V14, P295, DOI 10.1089/ten.teb.2008.0153
   Yue SH, 2012, BIOPHYS J, V102, P1215, DOI 10.1016/j.bpj.2012.01.023
   Zheng K, 2009, Open Tissue Eng Regen Med J, V2, P8
   Zheng Y, 2012, J DENT RES, V91, P676, DOI 10.1177/0022034512449834
   Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899
   Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100
NR 169
TC 28
Z9 29
U1 2
U2 37
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD SEP 6
PY 2013
VL 10
IS 86
AR UNSP 20130263
DI 10.1098/rsif.2013.0263
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AB5BT
UT WOS:000331804600003
PM 23864499
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Joly, P
   Duda, GN
   Schone, M
   Welzel, PB
   Freudenberg, U
   Werner, C
   Petersen, A
AF Joly, Pascal
   Duda, Georg N.
   Schoene, Martin
   Welzel, Petra B.
   Freudenberg, Uwe
   Werner, Carsten
   Petersen, Ansgar
TI Geometry-Driven Cell Organization Determines Tissue Growths in Scaffold
   Pores: Consequences for Fibronectin Organization
SO PLOS ONE
LA English
DT Article
ID EXTRACELLULAR-MATRIX; ASCORBIC-ACID; COLLAGEN; FIBROBLASTS; DYNAMICS;
   MODEL; POLYMERIZATION; SUBSTRATE; HYDROGELS; STIFFNESS
AB To heal tissue defects, cells have to bridge gaps and generate new extracellular matrix (ECM). Macroporous scaffolds are frequently used to support the process of defect filling and thus foster tissue regeneration. Such biomaterials contain micro-voids (pores) that the cells fill with their own ECM over time. There is only limited knowledge on how pore geometry influences cell organization and matrix production, even though it is highly relevant for scaffold design. This study hypothesized that 1) a simple geometric description predicts cellular organization during pore filling at the cell level and that 2) pore closure results in a reorganization of ECM. Scaffolds with a broad distribution of pore sizes (macroporous starPEG-heparin cryogel) were used as a model system and seeded with primary fibroblasts. The strategies of cells to fill pores could be explained by a simple geometrical model considering cells as tensioned chords. The model matched qualitatively as well as quantitatively by means of cell number vs. open cross-sectional area for all pore sizes. The correlation between ECM location and cell position was higher when the pores were not filled with tissue (Pearson's coefficient rho = 0.45 +/- 0.01) and reduced once the pores were closed (rho = 0.26 +/- 0.04) indicating a reorganization of the cell/ECM network. Scaffold pore size directed the time required for pore closure and furthermore impacted the organization of the fibronectin matrix. Understanding how cells fill micro-voids will help to design biomaterial scaffolds that support the endogenous healing process and thus allow a fast filling of tissue defects.
C1 [Joly, Pascal; Duda, Georg N.; Schoene, Martin; Petersen, Ansgar] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Joly, Pascal; Duda, Georg N.; Schoene, Martin] Charite, Berlin Brandenburg Sch Regenerat Therapies, D-13353 Berlin, Germany.
   [Duda, Georg N.; Petersen, Ansgar] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany.
   [Joly, Pascal; Duda, Georg N.; Schoene, Martin; Petersen, Ansgar] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany.
   [Welzel, Petra B.; Freudenberg, Uwe; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat Dresden, Dresden, Germany.
   [Welzel, Petra B.; Freudenberg, Uwe; Werner, Carsten] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany.
RP Joly, P (reprint author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
EM pascal.joly@charite.de
RI Duda, Georg/H-2085-2016; Werner, Carsten/F-8127-2010; Petersen,
   Ansgar/O-1945-2015; Umlauf, Ursula/D-3356-2014
OI Duda, Georg/0000-0001-7605-3908; Werner, Carsten/0000-0003-0189-3448; 
FU Berlin-Brandenburg Center for Regenerative Therapies (BCRT);
   Berlin-Brandenburg School for Regenerative Therapies (BSRT)
FX This work has been funded by the Berlin-Brandenburg Center for
   Regenerative Therapies (BCRT) and the Berlin-Brandenburg School for
   Regenerative Therapies (BSRT). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bai F, 2011, BIOMEDICAL MAT, V6
   Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X
   Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102
   Bidan CM, 2013, ADV HEALTHC MATER, V2, P186, DOI 10.1002/adhm.201200159
   Bidan CM, 2012, PLOS ONE, V7
   Carlson MA, 2004, WOUND REPAIR REGEN, V12, P134, DOI 10.1111/j.1067-1927.2004.012208.x
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cheng G, 2009, BIOPHYS J, V97, P401, DOI 10.1016/j.bpj.2009.03.067
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   Edwards SL, 2011, TISSUE ENG PART C-ME, V17, P123, DOI [10.1089/ten.tec.2010.0182, 10.1089/ten.TEC.2010.0182]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Freudenberg U, 2012, ADV FUNCT MATER, V22, P1391, DOI 10.1002/adfm.201101868
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Fujie T, 2011, LANGMUIR, V27, P13173, DOI 10.1021/la203140a
   Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI [10.1089/ten.tea.2010.0273, 10.1089/ten.TEA.2010.0273]
   HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jeon YK, 2010, WOUND REPAIR REGEN, V18, P655, DOI 10.1111/j.1524-475X.2010.00636.x
   Knychala J, 2013, ANN BIOMED ENG, V41, P917, DOI 10.1007/s10439-013-0748-z
   Kollmannsberger P, 2011, SOFT MATTER, V7, P9549, DOI 10.1039/c1sm05588g
   Lozinsky VI, 2002, USP KHIM+, V71, P559
   MANDERS EMM, 1992, J CELL SCI, V103, P857
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   O'Dea RD, 2012, J MATH BIOL
   Petersen A, 2012, TISSUE ENG PT A, V18, P1804, DOI [10.1089/ten.tea.2011.0514, 10.1089/ten.TEA.2011.0514]
   Ramtani S, 2004, J BIOMECH, V37, P1709, DOI 10.1016/j.jbiomech.2004.01.028
   Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Schindler M, 2006, CELL BIOCHEM BIOPHYS, V45, P215, DOI 10.1385/CBB:45:2:215
   Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009
   Shimizu M, 1997, BBA-PROTEIN STRUCT M, V1339, P53, DOI 10.1016/S0167-4838(96)00214-2
   Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007
   Stolarska MA, 2009, PHILOS T R SOC A, V367, P3525, DOI 10.1098/rsta.2009.0095
   Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200
   Vidal G, 2011, CARBON, V49, P2318, DOI 10.1016/j.carbon.2011.01.064
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Welzel PB, 2012, BIOMACROMOLECULES, V13, P2349, DOI 10.1021/bm300605s
   Welzel PB, 2011, POLYMERS-BASEL, V3, P602, DOI 10.3390/polym3010602
   Zhou LL, 1998, CURR EYE RES, V17, P211, DOI 10.1076/ceyr.17.2.211.5608
NR 46
TC 31
Z9 31
U1 0
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 5
PY 2013
VL 8
IS 9
AR e73545
DI 10.1371/journal.pone.0073545
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 219CG
UT WOS:000324481600086
PM 24039979
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bronze-Uhle, ES
   Batagin-Neto, A
   Xavier, PHP
   Fernandes, NI
   de Azevedo, ER
   Graeff, CFO
AF Bronze-Uhle, Erika S.
   Batagin-Neto, Augusto
   Xavier, Pedro H. P.
   Fernandes, Nicole I.
   de Azevedo, Eduardo R.
   Graeff, Carlos F. O.
TI Synthesis and characterization of melanin in DMSO
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE Biomaterial; Solubility; Structural characterization; Spectroscopy
   methods; Organic synthesis
ID THIN-FILMS; ELECTRONIC-PROPERTIES; DIMETHYL-SULFOXIDE; OXIDATION;
   EUMELANIN; KINETICS; ACID; NMR; MECHANISM; AMINES
AB Recently soluble melanin derivatives have been obtained by a synthetic procedure carried out in DMSO (D-melanin). In this work a comparative study of the structural characteristics of synthetic melanin derivatives obtained by oxidation of L-DOPA in H2O and DMSO are presented. To this end, Fourier-transform infrared spectroscopy as well as proton and carbon nuclear magnetic resonance techniques has been employed. In addition, aging effects have been investigated for a-melanin. The results suggest that sulfonate groups (-SO2CH3) from the oxidation of DMSO, are incorporated into melanin, which confers protection to the phenolic hydroxyl group present in its structure. The solubility of a-melanin in DMSO is attributed to the presence of these groups. When a-melanin is left in air for long time periods, the sulfonate groups leave the structure, and an insoluble compound is obtained. NaOH and water have been used, in order to accelerate the release of the sulfonate groups attached to a-melanin, thereby corroborating the proposed structure and the synthesis mechanism. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Bronze-Uhle, Erika S.; Graeff, Carlos F. O.] Univ Estadual Paulista, UNESP, DF FC, BR-17033360 Bauru, SP, Brazil.
   [Batagin-Neto, Augusto; Xavier, Pedro H. P.; Fernandes, Nicole I.] Univ Estadual Paulista, UNESP, POSMAT, Programa Posgrad Ciencia & Tecnol Mat, BR-17033360 Bauru, SP, Brazil.
   [de Azevedo, Eduardo R.] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
RP Bronze-Uhle, ES (reprint author), Univ Estadual Paulista, UNESP, DF FC, Av Eng Luiz Edmundo Carrijo Coube 14-01, BR-17033360 Bauru, SP, Brazil.
EM eriuhle@fc.unesp.br
RI Nanotecnologias, Inct/I-2407-2013; Sao Carlos Institute of Physics,
   IFSC/USP/M-2664-2016; FAPESP, CDMF/J-3591-2015; Batagin-Neto,
   Augusto/F-8624-2012; Graeff, Carlos/C-6703-2012
OI FAPESP, CDMF/0000-0002-4464-0937; Batagin-Neto,
   Augusto/0000-0003-4609-9002; Graeff, Carlos/0000-0003-0162-8273
FU CAPES; FAPESP (INCTMN); CNPq
FX We would like to thank the Brazilian agencies CAPES, FAPESP (INCTMN),
   and CNPq for financial support; Professor Kleber Thiago de Oliveira
   (UFSCAR-Brazil) for the <SUP>1</SUP>H NMR spectrum; Professor Paulo
   Noronha Lisboa (UNESP-Brazil) for the FTIR measurements; and Professor
   Marc Dubois (Universite Blaise Pascal-France) for the <SUP>13</SUP>C
   CP/MAS spectra discussions.
CR Abbas M, 2009, EUR PHYS J E, V28, P285, DOI 10.1140/epje/i2008-10437-9
   Adhyaru BB, 2003, MAGN RESON CHEM, V41, P466, DOI 10.1002/mrc.1193
   [Anonymous], 2006, CHEM DRAW ULTR CHEM
   Arsene C, 2002, ENVIRON SCI TECHNOL, V36, P5155, DOI 10.1021/es020035u
   Berggren M, 2007, ADV MATER, V19, P3201, DOI 10.1002/adma.200700419
   Borghetti P, 2010, LANGMUIR, V26, P19007, DOI 10.1021/la102973u
   Bothma JP, 2008, ADV MATER, V20, P3539, DOI 10.1002/adma.200703141
   Bridelli MG, 2010, J PHYS CHEM B, V114, P9381, DOI 10.1021/jp101833k
   BUSFIELD WK, 1961, T FARADAY SOC, V57, P1044, DOI 10.1039/tf9615701044
   CORRADINI MG, 1986, TETRAHEDRON, V42, P2083, DOI 10.1016/S0040-4020(01)87625-0
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   da Silva MIN, 2004, J APPL PHYS, V96, P5803, DOI 10.1063/1.1803629
   Deziderio SN, 2004, J NON-CRYST SOLIDS, V338, P634, DOI [10.1016/j.jnoncrysol.2004.03.058, 10.1016/j.jnonerysol.2004.03.058]
   DUFF GA, 1988, BIOCHEMISTRY-US, V27, P7112, DOI 10.1021/bi00418a067
   Goncalves PJ, 2006, J APPL PHYS, V99, DOI 10.1063/1.2201691
   Grant PM, 1997, FORENSIC SCI INT, V87, P219, DOI 10.1016/S0379-0738(97)00076-5
   Guo JS, 2006, J ORG CHEM, V71, P8302, DOI 10.1021/jo061295n
   KARGER MH, 1971, J ORG CHEM, V36, P528
   LAMBERT C, 1989, BIOCHIM BIOPHYS ACTA, V993, P12, DOI 10.1016/0304-4165(89)90136-0
   Lawrie KJ, 2008, PHOTOCHEM PHOTOBIOL, V84, P632, DOI 10.1111/j.1751-1097.2007.00295.x
   Lorite GS, 2006, J APPL PHYS, V99, DOI 10.1063/1.2200401
   Lyavinets AS, 2004, RUSS J GEN CHEM+, V74, P885, DOI 10.1023/B:RUGC.0000042424.78088.7f
   Mathes C., 2010, U.S. Patent, Patent No. 20100168229
   Meredith P, 2006, SOFT MATTER, V2, P37, DOI 10.1039/b511922g
   Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x
   Naito H, 2010, ORG LETT, V12, P1228, DOI 10.1021/ol100086j
   PALUMBO P, 1987, TETRAHEDRON LETT, V28, P467, DOI 10.1016/S0040-4039(00)95758-7
   Pezzella A, 2010, PHOTOCHEM PHOTOBIOL, V86, P533, DOI 10.1111/j.1751-1097.2010.00730.x
   Prasad A, 2005, J SCI IND RES INDIA, V64, P756
   PROTA G, 1992, MELANINS MELANOGENES
   Rosenau T, 2004, ORG LETT, V6, P541, DOI 10.1021/ol036319g
   Seally R. C., 1980, RADICALS BIOL
   Smith M. B, 2001, MARCHS ADV ORGANIC C
   Socrates G., 2004, INFRARED RAMAN CHARA
   Sridhar M, 1998, TETRAHEDRON LETT, V39, P2847, DOI 10.1016/S0040-4039(98)00314-1
   Teasdale A, 2010, ORG PROCESS RES DEV, V14, P999, DOI 10.1021/op900301n
   YOUNG TE, 1974, J ORG CHEM, V39, P1980, DOI 10.1021/jo00927a057
   YOUNG TE, 1980, J ORG CHEM, V45, P2899, DOI 10.1021/jo01302a029
   Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r
NR 39
TC 17
Z9 17
U1 0
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
J9 J MOL STRUCT
JI J. Mol. Struct.
PD SEP 5
PY 2013
VL 1047
BP 102
EP 108
DI 10.1016/j.molstruc.2013.04.061
PG 7
WC Chemistry, Physical
SC Chemistry
GA 190RF
UT WOS:000322357200015
DA 2018-10-20
ER

PT J
AU Lu, YW
   Chien, CW
   Lin, PC
   Huang, LD
   Chen, CY
   Wu, SW
   Han, CL
   Khoo, KH
   Lin, CC
   Chen, YJ
AF Lu, Ying-Wei
   Chien, Chih-Wei
   Lin, Po-Chiao
   Huang, Li-De
   Chen, Chang-Yang
   Wu, Sz-Wei
   Han, Chia-Li
   Khoo, Kay-Hooi
   Lin, Chun-Cheng
   Chen, Yu-Ju
TI BAD-Lectins: Boronic Acid-Decorated Lectins with Enhanced Binding
   Affinity for the Selective Enrichment of Glycoproteins
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID SURFACE-PLASMON RESONANCE; MASS-SPECTROMETRY; HEPATOCELLULAR-CARCINOMA;
   MULTIPLEXED IMMUNOASSAY; GLYCOSYLATION PATTERN; CARBOHYDRATE-BINDING;
   GOLD NANOPARTICLES; CORE-FUCOSE; GLYCANS; CANCER
AB The weak and variable binding affinities exhibited by lectin carbohydrate interactions have often compromised the practical utility of lectin in capturing glycoproteins for glycoproteomic applications. We report here the development and applications of a new type of hybrid biomaterial, namely a boronic acid-decorated lectin (BAD-lectin), for efficient bifunctional glycoprotein labeling and enrichment. Our binding studies showed an enhanced affinity by BAD-lectin, likely to be mediated via the formation of boronate ester linkages between the lectin and glycan subsequent to the initial recognition process and thus preserving its glycan-specificity. Moreover, when attached to magnetic nanoparticles (BAD-lectin@MNPs), 2 to 60-fold improvement on detection sensitivity and enrichment efficiency for specific glycoproteins was observed over the independent use of either lectin or BA. Tested at the level of whole cell lysates for glycoproteomic applications, three different types of BAD-lectin@MNPs exhibited excellent specificities with only 6% overlapping among the 295 N-linked glycopeptides identified. As many as 236 N-linked glycopeptides (80%) were uniquely identified by one of the BAD-lectin@MNPs. These results indicated that the enhanced glycan-selective recognition and binding affinity of BAD-lectin@MNPs will facilitate a complementary identification of the under-explored glycoproteome.
C1 [Lu, Ying-Wei; Chien, Chih-Wei; Huang, Li-De; Lin, Chun-Cheng] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30071, Taiwan.
   [Lin, Po-Chiao] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 804, Taiwan.
   [Chen, Chang-Yang] Natl Taiwan Normal Univ, Dept Chem, Taipei 106, Taiwan.
   [Wu, Sz-Wei; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.
   [Han, Chia-Li; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei 115, Taiwan.
   [Chen, Yu-Ju] Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan.
RP Lin, CC (reprint author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30071, Taiwan.
EM cclin66@mx.nthu.edu.tw; yujuchen@gate.sinica.edu.tw
RI Chen, Yu-Ju/E-9481-2015
FU National Tsing Hua University; Academia Sinica; National Science
   Council, Taiwan
FX This research was financially supported by the National Tsing Hua
   University, Academia Sinica, and the National Science Council, Taiwan.
CR Arndt NX, 2011, J CELL BIOCHEM, V112, P2230, DOI 10.1002/jcb.23139
   Bellapadrona G, 2012, ANAL CHEM, V84, P232, DOI 10.1021/ac202363t
   Blake TA, 2009, ANAL CHEM, V81, P3109, DOI 10.1021/ac900095h
   CERAMI A, 1979, METABOLISM, V28, P431, DOI 10.1016/0026-0495(79)90051-9
   Chen HX, 2007, SENSORS-BASEL, V7, P1480, DOI 10.3390/s7081480
   Chen ML, 2008, ANGEW CHEM INT EDIT, V47, P8627, DOI 10.1002/anie.200803377
   Chien YY, 2008, CHEMBIOCHEM, V9, P1100, DOI 10.1002/cbic.200700590
   CODDEVILLE B, 1992, CARBOHYD RES, V236, P145, DOI 10.1016/0008-6215(92)85013-P
   CONBOY JJ, 1992, J AM SOC MASS SPECTR, V3, P804, DOI 10.1016/1044-0305(92)80003-4
   Cummings R. D., 2009, ESSENTIALS GLYCOBIOL, P633
   Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751
   Edwards PR, 1997, ANAL BIOCHEM, V246, P1, DOI 10.1006/abio.1996.9922
   El-Dakdouki MH, 2012, BIOMACROMOLECULES, V13, P1144, DOI 10.1021/bm300046h
   Han CL, 2008, MOL CELL PROTEOMICS, V7, P1983, DOI 10.1074/mcp.M800068-MCP200
   Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340
   Hirabayashi Jun, 2002, J Biomol Tech, V13, P205
   Hollenbaugh D., 1998, BIOORGANIC CHEM CARB, P313
   Hsiao HY, 2011, CHEM COMMUN, V47, P1187, DOI 10.1039/c0cc03816d
   Hsu KL, 2006, NAT PROTOC, V1, P543, DOI 10.1038/nprot.2006.76
   HUDDLESTON MJ, 1993, ANAL CHEM, V65, P877, DOI 10.1021/ac00055a009
   Imberty A, 2005, CURR OPIN STRUC BIOL, V15, P525, DOI 10.1016/j.sbi.2005.08.003
   Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345
   Kaji H, 2006, NAT PROTOC, V1, P3019, DOI 10.1038/nprot.2006.444
   Kim SK, 2010, TETRAHEDRON LETT, V51, P3286, DOI 10.1016/j.tetlet.2010.04.067
   Lee JH, 2005, J AM SOC MASS SPECTR, V16, P1456, DOI 10.1016/j.jasms.2005.04.005
   Li D, 2001, CLIN CHIM ACTA, V313, P15, DOI 10.1016/S0009-8981(01)00644-1
   Lin CC, 2003, CHEM COMMUN, P2920, DOI 10.1039/b308995a
   Lin PC, 2006, SMALL, V2, P485, DOI 10.1002/smll.200500387
   Lin PC, 2013, BIOMACROMOLECULES, V14, P160, DOI 10.1021/bm301567w
   Lin PC, 2009, ANAL CHEM, V81, P8774, DOI 10.1021/ac9012122
   Lin SY, 2008, J PROTEOME RES, V7, P3293, DOI 10.1021/pr800093b
   Linman MJ, 2008, ANAL CHEM, V80, P4007, DOI 10.1021/ac702566e
   Lopez M, 1997, GLYCOBIOLOGY, V7, P635, DOI 10.1093/glycob/7.5.635
   LORAND JP, 1959, J ORG CHEM, V24, P769, DOI 10.1021/jo01088a011
   Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739
   MALMQVIST M, 1993, NATURE, V361, P186, DOI 10.1038/361186a0
   Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200
   Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019
   PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0
   Peracaula R, 2003, GLYCOBIOLOGY, V13, P457, DOI 10.1093/glycob/cwg041
   Pilobello KT, 2007, P NATL ACAD SCI USA, V104, P11534, DOI 10.1073/pnas.0704954104
   Prien JM, 2009, J AM SOC MASS SPECTR, V20, P539, DOI 10.1016/j.jasms.2008.11.012
   Qiu YH, 2008, J PROTEOME RES, V7, P1693, DOI 10.1021/pr700706s
   Ramakrishnan B, 2011, METHODS MOL BIOL, V751, P281, DOI 10.1007/978-1-61779-151-2_17
   Reichardt NC, 2013, CHEM SOC REV, V42, P4358, DOI 10.1039/c2cs35427f
   Ritchie MA, 2002, J AM SOC MASS SPECTR, V13, P1065, DOI 10.1016/S1044-0305(02)00421-X
   SHIBUYA N, 1987, J BIOL CHEM, V262, P1596
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Sparbier Katrin, 2005, J Biomol Tech, V16, P407
   Springsteen G, 2001, CHEM COMMUN, P1608, DOI 10.1039/b104895n
   Tajiri M, 2005, GLYCOBIOLOGY, V15, P1332, DOI 10.1093/glycob/cwj019
   TAKETA K, 1993, CANCER RES, V53, P5419
   Tao SC, 2008, GLYCOBIOLOGY, V18, P761, DOI 10.1093/glycob/cwn063
   Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016
   Ueda K, 2010, MOL CELL PROTEOMICS, V9, P1819, DOI 10.1074/mcp.2010/000893
   Wang KY, 2008, ANAL CHEM, V80, P6159, DOI 10.1021/ac800354u
   Yang BY, 1996, CARBOHYD RES, V287, P203, DOI 10.1016/0008-6215(96)00073-0
NR 57
TC 23
Z9 23
U1 2
U2 83
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD SEP 3
PY 2013
VL 85
IS 17
BP 8268
EP 8276
DI 10.1021/ac401581u
PG 9
WC Chemistry, Analytical
SC Chemistry
GA 294BL
UT WOS:000330017300036
PM 23895469
DA 2018-10-20
ER

PT J
AU Langer, R
AF Langer, Robert
TI Biomaterials and biotechnology: From the discovery of the first
   angiogenesis inhibitors to the development of controlled drug delivery
   systems and the foundation of tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE drug delivery; biomaterial; tissue; engineering
ID ENDOTHELIAL-CELL-GROWTH; EMBRYONIC STEM-CELLS; CONTROLLED-RELEASE;
   INTERSTITIAL CHEMOTHERAPY; TUMOR ANGIOGENESIS; RECURRENT GLIOMAS; SIRNA
   DELIVERY; SPINAL-CORD; IN-VIVO; POLYMERS
AB This paper describes the discovery of the first inhibitors of angiogenesis; the discoveries that led to the development of the first biocompatible controlled release systems for macromolecules, and findings that helped to create the field of tissue engineering. In addition, new paradigms for creating biomaterials, early work on nanotechnology in medicine and intelligent drug delivery systems are discussed. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 2449-2455, 2013.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Langer, R (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM rlanger@mit.edu
CR Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Ball P, 1997, MADE MEASURE NEW MAT, P240
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BREM H, 1991, J NEUROSURG, V74, P441, DOI 10.3171/jns.1991.74.3.0441
   BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6
   Cao YH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000399
   CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322
   Cramer DA, 1998, ANN INTERN MED, V129, P841, DOI 10.7326/0003-4819-129-10-199811150-00029
   Dolgin E, 2011, NAT MED, V17, P1032, DOI 10.1038/nm0911-1032
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Farra R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003276
   FISCHELGHODSIAN F, 1988, P NATL ACAD SCI USA, V85, P2403, DOI 10.1073/pnas.85.7.2403
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115
   GLASER BM, 1980, J CELL BIOL, V84, P298, DOI 10.1083/jcb.84.2.298
   GOSPODAROWICZ D, 1979, EXP EYE RES, V28, P501, DOI 10.1016/0014-4835(79)90038-1
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Hansbrough John F., 1992, Journal of Burn Care and Rehabilitation, V13, P519, DOI 10.1097/00004630-199209000-00004
   HSIEH DST, 1983, J PHARM SCI-US, V72, P17, DOI 10.1002/jps.2600720105
   HSU TTP, 1985, J BIOMED MATER RES, V19, P445, DOI 10.1002/jbm.820190409
   John M, 2007, NATURE, V449, P745, DOI 10.1038/nature06179
   KALB RG, 1990, SCIENCE, V250, P294, DOI 10.1126/science.2145629
   KOST J, 1989, P NATL ACAD SCI USA, V86, P7663, DOI 10.1073/pnas.86.20.7663
   LANGER R, 1980, J MEMBRANE SCI, V7, P333, DOI 10.1016/S0376-7388(00)80477-9
   LANGER R, 1976, SCIENCE, V193, P70, DOI 10.1126/science.935859
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer RS, 2012, CHEM ENG NEWS, V90, P20
   Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   LING JJ, 1995, DEV BRAIN RES, V86, P354, DOI 10.1016/0165-3806(95)00035-C
   MCAUSLAN BR, 1980, T OPHTHAL SOC UK, V100, P354
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Michaelson IC, 1948, T OPHTHAL SOC UK, V68, P137
   Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645
   MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   PARK CM, 1993, INT REV CYTOL, V146, P49, DOI 10.1016/S0074-7696(08)60379-4
   Pearson H, 2009, NATURE, V458, P22, DOI 10.1038/458022a
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PLISKIN ME, 1980, TRANSPLANTATION, V29, P255, DOI 10.1097/00007890-198003000-00019
   POLVERINI PJ, 1977, NATURE, V269, P804, DOI 10.1038/269804a0
   REH TA, 1985, J NEUROSCI, V5, P1132
   RHINE WD, 1980, J PHARM SCI, V69, P265, DOI 10.1002/jps.2600690305
   ROSEN HB, 1983, BIOMATERIALS, V4, P131, DOI 10.1016/0142-9612(83)90054-6
   Santini JT, 1999, NATURE, V397, P335
   SCHOR AM, 1979, INT J CANCER, V24, P225, DOI 10.1002/ijc.2910240215
   Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180
   Service RF, 2010, SCIENCE, V330, P314, DOI 10.1126/science.330.6002.314
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844
   SILBERSTEIN GB, 1982, DEV BIOL, V93, P272, DOI 10.1016/0012-1606(82)90259-7
   SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593
   Stannett V, 1979, ADV POLYM SCI, V32, P69
   Tenenbaum D, 1999, POLYM PEOPLE DISCOVE
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   Valtonen S, 1997, NEUROSURGERY, V41, P44, DOI 10.1097/00006123-199707000-00011
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
NR 66
TC 12
Z9 13
U1 0
U2 79
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2013
VL 101
IS 9
BP 2449
EP 2455
DI 10.1002/jbm.a.34811
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 186RN
UT WOS:000322061900001
PM 23723136
DA 2018-10-20
ER

PT J
AU Lim, PN
   Teo, EY
   Ho, B
   Tay, BY
   Thian, ES
AF Lim, Poon Nian
   Teo, Erin Yiling
   Ho, Bow
   Tay, Bee Yen
   Thian, Eng San
TI Effect of silver content on the antibacterial and bioactive properties
   of silver-substituted hydroxyapatite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE antibacterial; bioactivity; hydroxyapatite; mesenchymal stem cell;
   silver
ID OSTEOBLAST ADHESION; ROUTE; IONS; CYTOTOXICITY; MECHANISMS; INFECTION;
   COATINGS; RELEASE; NITRATE; SURFACE
AB The long-term success of a biomaterial used during surgery may be compromised by infection. A possible effective solution is to make the biomaterial osteoconductive and antibacterial. A range of silver-substituted hydroxyapatite (AgHA) of up to 1.1 wt. % of Ag was synthesized. AgHA displayed a rod-like morphology of dimensions approximate to 50 nm in length and approximate to 15 nm in width. Phase-pure AgHA was demonstrated in the X-ray diffraction patterns and Fourier transform infrared spectroscopy spectra. Comparing with hydroxyaptite (HA), 0.5AgHA exhibited a 3-log reduction in the number of bacteria. Diffusion of the entrapped Ag+ ions towards the crystal structure surface was revealed by an increase of 6 at. % Ag in the X-ray photoelectron spectroscopy results. Furthermore, less than 0.5 ppm of Ag+ ions being released from 0.5AgHA into the deionized water medium was evidenced from the inductively coupled plasma mass spectrometry results. AgHA produced by co-precipitation gave rise to minimal release of Ag+ ions. It was hypothesized that the diffused surface Ag+ ions damaged the bacteria cell membrane and impede its replication. With the culturing time, significant increase in the number of human mesenchymal stem cells (p < 0.05) was demonstrated on 0.5AgHA. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 2456-2464, 2013.
C1 [Lim, Poon Nian; Thian, Eng San] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
   [Teo, Erin Yiling] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore.
   [Ho, Bow] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 119757, Singapore.
   [Tay, Bee Yen] Singapore Inst Mfg Technol, Singapore 638075, Singapore.
RP Thian, ES (reprint author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
EM mpetes@nus.edu.sg
OI Thian, Eng San/0000-0001-6925-6811
FU Ministry of Education Academic Research, Singapore [R-265-000-311-133];
   Singapore Institute of Manufacturing Technology, A*STAR [U10-F-003SU]
FX Contract grant sponsor: Ministry of Education Academic Research,
   Singapore; contract grant number: R-265-000-311-133; Contract grant
   sponsor: Singapore Institute of Manufacturing Technology, A*STAR;
   contract grant number: U10-F-003SU
CR Badrour L, 1998, ANN CHIM-SCI MAT, V23, P61, DOI 10.1016/S0151-9107(98)80012-3
   BARR TL, 1995, J VAC SCI TECHNOL A, V13, P1239, DOI 10.1116/1.579868
   Bellantone M, 2000, J BIOMED MATER RES, V51, P484, DOI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
   BENGHUZZI HA, 1992, BIOMED SCI INSTRUM, V28, P179
   CAPANNA R, 1994, J BONE JOINT SURG BR, V76B, P178
   Chen YK, 2010, SURF COAT TECH, V205, P1892, DOI 10.1016/j.surfcoat.2010.08.073
   Chung RJ, 2005, J SOL-GEL SCI TECHN, V33, P229, DOI 10.1007/s10971-005-5618-1
   Darouiche R. O., 2004, INFECT DIS CLIN PRAC, V12, P258
   Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hidalgo E, 1998, TOXICOL LETT, V98, P169, DOI 10.1016/S0378-4274(98)00114-3
   Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542
   Hwang KS, 2008, J NANOPART RES, V10, P1337, DOI 10.1007/s11051-008-9404-1
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4
   Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x
   Oh KS, 2004, KEY ENG MAT, V264-268, P2111, DOI 10.4028/www.scientific.net/KEM.264-268.2111
   Oh KS, 2004, MATER SCI FORUM, V449-4, P1233, DOI 10.4028/www.scientific.net/MSF.449-452.1233
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Saravanapavan P, 2004, KEY ENG MATER, V254-2, P1087, DOI 10.4028/www.scientific.net/KEM.254-256.1087
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Stanic V, 2011, APPL SURF SCI, V257, P4510, DOI 10.1016/j.apsusc.2010.12.113
   UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Winkelmann M, 2003, BIOMATERIALS, V24, P1133, DOI 10.1016/S0142-9612(02)00449-0
   Wu X., 2010, BIOMED MAT, V5
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
NR 32
TC 42
Z9 44
U1 1
U2 56
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2013
VL 101
IS 9
BP 2456
EP 2464
DI 10.1002/jbm.a.34544
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 186RN
UT WOS:000322061900002
PM 23349126
DA 2018-10-20
ER

PT J
AU Hronik-Tupaj, M
   Raja, WK
   Tang-Schomer, M
   Omenetto, FG
   Kaplan, DL
AF Hronik-Tupaj, Marie
   Raja, Waseem Khan
   Tang-Schomer, Min
   Omenetto, Fiorenzo G.
   Kaplan, David L.
TI Neural responses to electrical stimulation on patterned silk films
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE neuron; silk; biomaterial; electrical stimulation; tissue engineering
ID MESENCHYMAL STEM-CELLS; NERVE GROWTH-FACTOR; ACCELERATES AXON
   REGENERATION; PULSED ELECTROMAGNETIC-FIELD; RAT SCIATIC-NERVE; NEURONAL
   DIFFERENTIATION; NEUROTROPHIC FACTORS; EMBRYONAL CARCINOMA;
   SIGNAL-TRANSDUCTION; NEURITE OUTGROWTH
AB Peripheral nerve injury is a critical issue for patients with trauma. Following injury, incomplete axon regeneration or misguided axon innervation into tissue will result in loss of sensory and motor functions. The objective of this study was to examine axon outgrowth and axon alignment in response to surface patterning and electrical stimulation. To accomplish our objective, metal electrodes with dimensions of 1.5 mm x 4 cm, were sputter coated onto micropatterned silk protein films, with surface grooves 3.5 m wide x 500 nm deep. P19 neurons were seeded on the patterned electronic silk films and stimulated at 120 mV, 1 kHz, for 45 min each day for 7 days. Responses were compared with neurons on flat electronic silk films, patterned silk films without stimulation, and flat silk films without stimulation. Significant alignment was found on the patterned film groups compared with the flat film groups. Axon outgrowth was greater (p < 0.05) on electronic films on days 5 and 7 compared with the unstimulated groups. In conclusion, electrical stimulation, at 120 mV, 1 kHz, for 45 min daily, in addition to surface patterning, of 3.5 m wide x 500 nm deep grooves, offered control of nerve axon outgrowth and alignment. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 2559-2572, 2013.
C1 [Hronik-Tupaj, Marie; Raja, Waseem Khan; Tang-Schomer, Min; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU Armed Forces Institute of Regenerative Medicine (AFIRM); Tissue
   Engineering Resource Center (TERC) through the NIH from the National
   Institute of Biomedical Imaging and Bioengineering [P41EB002520];
   National Science Foundation [ECS-0335765]
FX Contract grant sponsor: Armed Forces Institute of Regenerative Medicine
   (AFIRM); Contract grant sponsor: The Tissue Engineering Resource Center
   (TERC) through the NIH from the National Institute of Biomedical Imaging
   and Bioengineering; contract grant number: P41EB002520; Contract grant
   sponsor: National Science Foundation under NSF award no. ECS-0335765
CR Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812
   Akanji OO, 2008, BIORHEOLOGY, V45, P229, DOI 10.3233/BIR-2008-0473
   Alrashdan MS, 2011, ACTA NEUROCHIR, V153, P2021, DOI 10.1007/s00701-011-1054-x
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arien-Zakay H, 2007, J MOL NEUROSCI, V32, P179, DOI 10.1007/s12031-007-0027-2
   Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Benfenati V, 2010, BIOMATERIALS, V31, P7883, DOI 10.1016/j.biomaterials.2010.07.013
   Blumenthal NC, 1997, BIOELECTROMAGNETICS, V18, P264, DOI 10.1002/(SICI)1521-186X(1997)18:3<264::AID-BEM10>3.0.CO;2-P
   Brighton CT, 2006, BIOCHEM BIOPH RES CO, V342, P556, DOI 10.1016/j.bbrc.2006.01.171
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Clarke JC, 2011, HEARING RES, V278, P96, DOI 10.1016/j.heares.2011.05.004
   Diniz P, 2002, BIOELECTROMAGNETICS, V23, P398, DOI 10.1002/bem.10032
   Dube J, 2005, USRI
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Fozdar DY, 2011, INT J NANOMED, V6, P45, DOI 10.2147/IJN.S12376
   Fozdar DY, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035005
   Ghasemi-Mobarakeh L, 2009, TISSUE ENG PT A, V15, P3605, DOI 10.1089/ten.TEA.2008.0689
   Ghaznavi AM, 2011, ANN PLAS SURG, V66, P273, DOI 10.1097/SAP.0b013e3181e6cff7
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020
   Gordon T, 2009, MOTOR CONTROL, V13, P412, DOI 10.1123/mcj.13.4.412
   Gordon T, 2009, INT REV NEUROBIOL, V87, P433, DOI 10.1016/S0074-7742(09)87024-4
   Graves MS, 2011, ANN BIOMED ENG, V39, P1759, DOI 10.1007/s10439-011-0259-8
   Greenebaum B, 2007, BIOELECTROMAGNETICS, V28, P488, DOI 10.1002/bem.20331
   Hill PS, 2011, TISSUE ENG PT A, V17, P1499, DOI 10.1089/ten.tea.2010.0184
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Hong S, 2010, J BIOMED MATER RES B, V94B, P421, DOI 10.1002/jbm.b.31670
   Hronik-Tupaj M, 2012, TISSUE ENG PART B-RE, V18, P167, DOI [10.1089/ten.TEB.2011.0244, 10.1089/ten.teb.2011.0244]
   Hronik-Tupaj M, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-9
   Huang JH, 2010, GLIA, V58, P622, DOI 10.1002/glia.20951
   Huang YJ, 2012, SMALL, V8, P2869, DOI 10.1002/smll.201200715
   Ijiri K, 1996, ANTICANCER RES, V16, P2853
   Ishikawa E, 1997, J FERMENT BIOENG, V83, P222, DOI 10.1016/S0922-338X(97)80983-X
   Kandel E. R., 2000, PRINCIPLES NEURAL SC
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1
   Kemp SWP, 2008, NEUROL RES, V30, P1030, DOI 10.1179/174313208X362505
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim DH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238552
   Kim JA, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/16/165102
   Kim U, 2005, BIOMATERIALS, P26
   Kipke D, 2010, MICROFABRICATED SILI
   Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015
   Klein JP, 2003, J NEUROSCI RES, V74, P192, DOI 10.1002/jnr.10768
   Koppes AN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046023
   Lari H, 2001, NERVE REGENERATION
   Larson B, 2011, BIOMED OPT EXPRESS, V2, P2055, DOI 10.1364/BOE.2.002055
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Leach M, 2011, J VIS EXP, P48
   Lee HK, 2005, PROC IEEE MICR ELECT, P642, DOI 10.1109/MEMSYS.2005.1454011
   Lee JY, 2012, IEEE T NANOBIOSCI, V11, P15, DOI 10.1109/TNB.2011.2159621
   Lin YC, 2011, ANN PLAS SURG, V67, P147, DOI 10.1097/SAP.0b013e3182240346
   Lu C.-H., 2012, BIOCH BIOPHYS ACTA, DOI 10.1016/j.bbagen.2012.08.028
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Madduri S, 2010, J CONTROL RELEASE, V143, P168, DOI 10.1016/j.jconrel.2009.12.017
   Mani S, 2000, BRAIN RES, V853, P384, DOI 10.1016/S0006-8993(99)02042-9
   Mathie A, 2003, RADIAT PROT DOSIM, V106, P311, DOI 10.1093/oxfordjournals.rpd.a006365
   MCCAIG CD, 1989, J CELL SCI, V93, P723
   Mehta AK, 2012, HUM EXP TOXICOL, V31, P51, DOI 10.1177/0960327111417908
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Murakami T, 2003, BRAIN RES, V974, P17, DOI 10.1016/S0006-8993(03)02539-3
   Oe T, 2006, NEUROPHARMACOLOGY, V50, P1041, DOI 10.1016/j.neuropharm.2006.02.004
   Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008
   Pan HC, 2006, J CLIN NEUROSCI, V13, P570, DOI 10.1016/j.jocn.2005.06.007
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Peignot P, 2004, Med Device Technol, V15, P22
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   POLLOCK M, 1995, CURR OPIN NEUROL, V8, P354, DOI 10.1097/00019052-199510000-00005
   Potucek R, 2009, PERIPHERAL NERVE INJ
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Saygili E, 2010, J MOL CELL CARDIOL, V49, P79, DOI 10.1016/j.yjmcc.2010.01.019
   Shen YP, 2004, MOL CELL NEUROSCI, V26, P390, DOI 10.1016/j.mcn.2004.03.004
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sun JS, 2009, MICROFLUID NANOFLUID, V6, P589, DOI 10.1007/s10404-008-0331-3
   Sun LY, 2009, BIOELECTROMAGNETICS, V30, P251, DOI 10.1002/bem.20472
   Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com
   Sun S, 2006, BIOELECTROCHEMISTRY, V69, P133, DOI 10.1016/j.bioelechem.2005.11.007
   Sundar S, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014104
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Tandon N., 2009, C P IEEE ENG MED BIO, V1, P6517
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Tsioris K, 2012, ADV FUNCT MATER, V22, P330, DOI 10.1002/adfm.201102012
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Ulrich H, 2006, CELL PROLIFERAT, V39, P281, DOI 10.1111/j.1365-2184.2006.00385.x
   Waetzig V, 2005, MOL CELL NEUROSCI, V30, P67, DOI 10.1016/j.mcn.2005.06.001
   Wan LD, 2010, J NEUROSCI RES, V88, P2578, DOI 10.1002/jnr.22426
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Witzel C, 2005, J COMP NEUROL, V485, P183, DOI 10.1002/cne.20436
   Xu J, 2009, OSTEOARTHR CARTILAGE, V17, P397, DOI 10.1016/j.joca.2008.07.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yucel T, 2010, J STRUCT BIOL, V170, P406, DOI 10.1016/j.jsb.2009.12.012
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 94
TC 14
Z9 14
U1 2
U2 72
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2013
VL 101
IS 9
BP 2559
EP 2572
DI 10.1002/jbm.a.34565
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 186RN
UT WOS:000322061900012
PM 23401351
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Love, RJ
   Jones, KS
AF Love, Ryan J.
   Jones, Kim S.
TI The recognition of biomaterials: Pattern recognition of medical polymers
   and their adsorbed biomolecules
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE biomaterial; pattern recognition; scavenger receptors; toll-like
   receptors; leukocyte activation
ID MACROPHAGE SCAVENGER RECEPTOR; TOLL-LIKE RECEPTOR-4; ACUTE INFLAMMATORY
   RESPONSES; GIANT-CELL FORMATION; CLASS-A SCAVENGER;
   LOW-DENSITY-LIPOPROTEIN; MOLECULAR-WEIGHT KININOGEN; INNATE IMMUNE
   RECOGNITION; AORTIC ENDOTHELIAL-CELLS; GLYCATION END-PRODUCT
AB All biomedical materials are recognized as foreign entities by the host immune system despite the substantial range of different materials that have been developed by material scientists and engineers. Hydrophobic biomaterials, hydrogels, biomaterials with low protein binding surfaces, and those that readily adsorb a protein layer all seem to incite similar host responses in vivo that may differ in magnitude, but ultimately result in encapsulation by fibrotic tissue. The recognition of medical materials by the host is explained by the very intricate pattern recognition system made up of integrins, toll-like receptors, scavenger receptors, and other surface proteins that enable leukocytes to perceive almost any foreign body. In this review, we describe the various pattern recognition receptors and processes that occur on biomedical material surfaces that permit detection of a range of materials within the host. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 2740-2752, 2013.
C1 [Love, Ryan J.; Jones, Kim S.] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.
   [Jones, Kim S.] McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RP Jones, KS (reprint author), McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.
EM kjones@mcmaster.ca
RI Love, Ryan/I-8597-2012
OI Love, Ryan/0000-0003-1759-2957
CR Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217
   AIDA Y, 1984, J BIOCHEM-TOKYO, V95, P1067, DOI 10.1093/oxfordjournals.jbchem.a134694
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Al-Saffar N, 1998, J MATER SCI-MATER M, V9, P849, DOI 10.1023/A:1008952329788
   ALTIERI DC, 1993, J BIOL CHEM, V268, P1847
   ALTIERI DC, 1988, J BIOL CHEM, V263, P7007
   ALTIERI DC, 1988, P NATL ACAD SCI USA, V85, P7462, DOI 10.1073/pnas.85.20.7462
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622
   ARAKI N, 1995, EUR J BIOCHEM, V230, P408, DOI 10.1111/j.1432-1033.1995.0408h.x
   Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058
   Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200
   Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266
   BAKER DP, 1984, ARTERIOSCLEROSIS, V4, P248, DOI 10.1161/01.ATV.4.3.248
   Barbucci R, 2003, BIOMACROMOLECULES, V4, P1506, DOI 10.1021/bm0340366
   Becker M, 2006, EUR J IMMUNOL, V36, P950, DOI 10.1002/eji.200535660
   Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164
   Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565
   Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x
   Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   Chen HA, 2010, BIOMATERIALS, V31, P8172, DOI 10.1016/j.biomaterials.2010.07.056
   Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22
   Christensen L, 2005, AESTHET PLAST SURG, V29, P34, DOI 10.1007/s00266-004-0113-6
   COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Cotena A, 2004, J IMMUNOL, V173, P6427, DOI 10.4049/jimmunol.173.10.6427
   Curtin JF, 2009, PLOS MED, V6, P83, DOI 10.1371/journal.pmed.1000010
   Daugherty A, 1997, ARTERIOSCL THROM VAS, V17, P2369, DOI 10.1161/01.ATV.17.11.2369
   de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237
   ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Fernandez-Cossio S, 2006, PLAST RECONSTR SURG, V117, P1789, DOI 10.1097/01.prs.0000214656.07273.b0
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103
   GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333
   Gorbet MB, 2005, J BIOMED MATER RES A, V74A, P511, DOI 10.1002/jbm.a.30354
   GOVERNA M, 1988, CELL BIOL TOXICOL, V4, P187, DOI 10.1007/BF00119245
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651
   Grolleau A, 2003, J IMMUNOL, V171, P2879, DOI 10.4049/jimmunol.171.6.2879
   GUIDOIN R, 1984, ANN THORAC SURG, V37, P457, DOI 10.1016/S0003-4975(10)61131-9
   Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989
   Hamad OA, 2012, IMMUNOBIOLOGY, V217, P1191, DOI 10.1016/j.imbio.2012.08.178
   HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0
   Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302
   HED J, 1984, IMMUNOL LETT, V8, P295, DOI 10.1016/0165-2478(84)90013-0
   Hodgkinson CP, 2008, ARTERIOSCL THROM VAS, V28, P2275, DOI 10.1161/ATVBAHA.108.175992
   Horiuchi S, 2005, ANN NY ACAD SCI, V1043, P671, DOI 10.1196/annals.1333.076
   Hoshino K, 1999, J IMMUNOL, V162, P3749
   Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501
   HUGHES DA, 1995, EUR J IMMUNOL, V25, P466, DOI 10.1002/eji.1830250224
   HUNTER R, 1981, J IMMUNOL, V127, P1244
   HUNTER RL, 1984, J IMMUNOL, V133, P3167
   HUNTER RL, 1986, SCAND J IMMUNOL, V23, P287, DOI 10.1111/j.1365-3083.1986.tb01970.x
   Itabe H, 2003, BIOL PHARM BULL, V26, P1, DOI 10.1248/bpb.26.1
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Ji YY, 2009, CELL PHYSIOL BIOCHEM, V23, P265, DOI 10.1159/000218173
   Jiang Y, 2006, J BIOL CHEM, V281, P9058, DOI 10.1074/jbc.M507874200
   Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233
   Jozefowski S, 2005, J IMMUNOL, V175, P8032, DOI 10.4049/jimmunol.175.12.8032
   Jozefowski S, 2004, J LEUKOCYTE BIOL, V76, P1066, DOI 10.1189/jlb.0504270
   Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010
   Kim WS, 2003, BIOCHEM BIOPH RES CO, V310, P542, DOI 10.1016/j.bbrc.2003.09.049
   KOBZIK L, 1995, J IMMUNOL, V155, P367
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Lee J, 2011, P NATL ACAD SCI USA, V108, P14055, DOI 10.1073/pnas.1105777108
   Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128
   Lim DJ, 2011, TISSUE ENG PT A, V17, P399, DOI [10.1089/ten.tea.2010.0151, 10.1089/ten.TEA.2010.0151]
   Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x
   Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987
   Mukhopadhyay S, 2004, J LEUKOCYTE BIOL, V76, P577, DOI 10.1189/jlb.0104014
   Mukhopadhyay S, 2004, IMMUNOBIOLOGY, V209, P39, DOI 10.1016/j.imbio.2004.02.004
   Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036
   Nilsson B, 1998, BLOOD, V92, P1661
   Nilsson UR, 2001, MOL IMMUNOL, V38, P151, DOI 10.1016/S0161-5890(01)00039-6
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558
   Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200
   Oji MO, 1999, J MATER SCI-MATER M, V10, P869, DOI 10.1023/A:1008933318756
   Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200
   Orenstein SB, 2010, HERNIA, V14, P511, DOI 10.1007/s10029-010-0680-1
   OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007
   OTTERLEI M, 1993, INFECT IMMUN, V61, P1917
   Ozeki Y, 2006, MICROB PATHOGENESIS, V40, P171, DOI 10.1016/j.micpath.2005.12.006
   Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7
   Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005
   Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200
   Peiser L, 2002, INFECT IMMUN, V70, P5346, DOI 10.1128/IAI.70.10.5346-5354.2002
   Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7
   Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574
   PERKINS SJ, 1989, BIOCHEM J, V263, P463, DOI 10.1042/bj2630463
   Pikkarainen T, 1999, J BIOL CHEM, V274, P10975, DOI 10.1074/jbc.274.16.10975
   Plescia J, 1996, BIOCHEM J, V319, P873, DOI 10.1042/bj3190873
   Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019
   Rezzani R, 2004, ARCH HISTOL CYTOL, V67, P211, DOI 10.1679/aohc.67.211
   Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04
   Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203
   Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JC123755
   Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272
   Schmidt S, 2003, J BIOMED MATER RES A, V66A, P491, DOI 10.1002/jbm.a.10031
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Sheng N, 2000, BLOOD, V95, P3788
   Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tamayo I, 2010, CLIN VACCINE IMMUNOL, V17, P1356, DOI 10.1128/CVI.00164-10
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   TANG LP, 1993, CLIN RES, V41, pA164
   TANNER FC, 1991, CIRCULATION, V83, P2012, DOI 10.1161/01.CIR.83.6.2012
   Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200
   Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680
   Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519
   Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200
   van der Laan LJW, 1999, J IMMUNOL, V162, P939
   VANBERKEL TJC, 1991, J BIOL CHEM, V266, P2282
   vanderLaan LJW, 1997, IMMUNOL LETT, V57, P203, DOI 10.1016/S0165-2478(97)00077-1
   Volle JM, 2000, INFLAMMATION, V24, P571, DOI 10.1023/A:1007081508211
   VROMAN L, 1980, BLOOD, V55, P156
   Walivaara B, 1997, J COLLOID INTERF SCI, V187, P121, DOI 10.1006/jcis.1996.4673
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0
   Yang D, 2009, J BIOMED MATER RES A, V90A, P411, DOI 10.1002/jbm.a.32096
   Yang RB, 1998, NATURE, V395, P284
   Yu DQ, 2010, LANGMUIR, V26, P924, DOI 10.1021/la902395v
   Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zhou F, 2012, COLLOID SURFACE B, V90, P97, DOI 10.1016/j.colsurfb.2011.10.016
   Zhu FG, 2001, IMMUNOLOGY, V103, P226, DOI 10.1046/j.1365-2567.2001.01222.x
NR 164
TC 15
Z9 15
U1 1
U2 63
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2013
VL 101
IS 9
BP 2740
EP 2752
DI 10.1002/jbm.a.34577
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 186RN
UT WOS:000322061900029
PM 23613455
DA 2018-10-20
ER

PT J
AU Li, ZH
   Ji, SC
   Wang, YZ
   Shen, XC
   Liang, H
AF Li, Zi-Heng
   Ji, Shi-Chen
   Wang, Ya-Zhen
   Shen, Xing-Can
   Liang, Hong
TI Silk fibroin-based scaffolds for tissue engineering
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Review
DE silk fibroin (SF); scaffold; tissue engineering; biomaterial; tissue
   repair
ID MESENCHYMAL STEM-CELLS; CONTROLLED DRUG-DELIVERY; SPIDER DRAGLINE SILK;
   HUMAN-LIKE COLLAGEN; SOLID-STATE NMR; BOMBYX-MORI;
   MECHANICAL-PROPERTIES; CONFORMATIONAL TRANSITION; NEPHILA-CLAVIPES;
   VASCULAR GRAFTS
AB Silk fibroin (SF) from the Bombyx mori silkworm exhibits attractive potential applications as biomechanical materials, due to its unique mechanical and biological properties. This review outlines the structure and properties of SF, including of its biocompatibility and biodegradability. It highlights recent researches on the fabrication of various SF-based composites scaffolds that are promising for tissue engineering applications, and discusses synthetic methods of various SF-based composites scaffolds and valuable approaches for controlling cell behaviors to promote the tissue repair. The function of extracellular matrices and their interaction with cells are also reviewed here.
C1 [Li, Zi-Heng; Ji, Shi-Chen; Wang, Ya-Zhen; Shen, Xing-Can; Liang, Hong] Guangxi Normal Univ, Key Lab Chem & Mol Engn Med Resources, Sch Chem & Pharmaceut Sci, Guilin 541004, Peoples R China.
   [Wang, Ya-Zhen] Guilin Univ Elect Technol, Sch Mat Sci & Engn, Guilin 541004, Peoples R China.
RP Shen, XC (reprint author), Guangxi Normal Univ, Key Lab Chem & Mol Engn Med Resources, Sch Chem & Pharmaceut Sci, Guilin 541004, Peoples R China.
EM xcshen@mailbox.gxnu.edu.cn
FU National Natural Science Foundation of China [21161003]; Guangxi Natural
   Science Foundation of China [2013GXNSFGA019001, 2012GXNSFDA053007,
   2011GXNSFA018044]; New Century National Hundred, Thousand and Ten
   Thousand Talent Project of Guangxi, State Key Laboratory Cultivation
   Base for the Chemistry and Molecular Engineering of Medicinal Resources
   [CMEMR2012-A12]; Talent Highland Project for Guangxi Pharmaceutical
   Industry [1304]
FX This work was supported by the National Natural Science Foundation of
   China (Grant No. 21161003), Guangxi Natural Science Foundation of China
   (Grant Nos. 2013GXNSFGA019001, 2012GXNSFDA053007 and 2011GXNSFA018044),
   the New Century National Hundred, Thousand and Ten Thousand Talent
   Project of Guangxi, State Key Laboratory Cultivation Base for the
   Chemistry and Molecular Engineering of Medicinal Resources (Grant No.
   CMEMR2012-A12), and Talent Highland Project for Guangxi Pharmaceutical
   Industry (Grant No. 1304).
CR AKAI H, 1993, INT J INSECT MORPHOL, V22, P497, DOI 10.1016/0020-7322(93)90036-Z
   Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   AMBROSE EJ, 1951, NATURE, V167, P264, DOI 10.1038/167264a0
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   ASAKURA T, 1984, MACROMOLECULES, V17, P2421, DOI 10.1021/ma00141a036
   Lun B, 2007, J MATER SCI-MATER M, V18, P1917, DOI 10.1007/s10856-007-3105-7
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Carlisle C H, 1955, ANN REP CHEM SOC, V52, P380
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Cruz DH, 2006, BIOMACROMOLECULES, V7, P836, DOI 10.1021/bm050943u
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   DEMURA M, 1989, BIOSENSORS, V4, P361, DOI 10.1016/0265-928X(89)80002-1
   Demura M, 1998, J AM CHEM SOC, V120, P1300, DOI 10.1021/ja972069l
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Foss C, 2013, BIOMACROMOLECULES, V14, P38, DOI 10.1021/bm301174x
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Gil ES, 2007, BIOMACROMOLECULES, V8, P258, DOI 10.1021/bm060543m
   Gunatillake PA, 2003, EUR CELLS MATER, V20, P1
   Ha SW, 2005, BIOMACROMOLECULES, V6, P2563, DOI 10.1021/bm050294m
   Harris M, 1930, IND ENG CHEM, V22, P965, DOI 10.1021/ie50249a018
   Harris M, 1930, IND ENG CHEM, V22, P539, DOI 10.1021/ie50245a030
   Heslot H, 1998, BIOCHIMIE, V80, P19, DOI 10.1016/S0300-9084(98)80053-9
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu BW, 2006, J PHYS CHEM B, V110, P18046, DOI 10.1021/jp062461y
   Hu K, 2007, J BIOACT COMPAT POL, V22, P395, DOI 10.1177/0883911507079893
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Hu K, 2008, J BIOMED MATER RES A, V84A, P483, DOI 10.1002/jbm.a.31440
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   KAY LM, 1956, J AM CHEM SOC, V78, P2430, DOI 10.1021/ja01592a023
   KAY LM, 1954, J AM CHEM SOC, V76, P3564, DOI 10.1021/ja01642a063
   Kong XD, 2006, MAT SCI ENG C-BIO S, V26, P639, DOI 10.1016/j.msec.2005.09.097
   KRATKY O, 1950, NATURE, V165, P319, DOI 10.1038/165319a0
   KRATKY O, 1956, MONATSH CHEM, V87, P269
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li XG, 2008, BIOPOLYMERS, V89, P497, DOI 10.1002/bip.20905
   Liivak O, 1998, MACROMOLECULES, V31, P2947, DOI 10.1021/ma971626l
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Lu Q, 2008, J MATER SCI-MATER M, V19, P629, DOI 10.1007/s10856-007-3180-9
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Lv Q, 2009, MAT SCI ENG C, V29, P2239
   Lv Q, 2008, J BIOMED MATER RES A, V84A, P198, DOI 10.1002/jbm.a.31366
   Lv Q, 2007, COMPOS SCI TECHNOL, V67, P3023, DOI 10.1016/j.compscitech.2007.05.003
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   MERCER EH, 1954, TEXT RES J, V24, P135, DOI 10.1177/004051755402400208
   Mondal M., 2007, Caspian Journal of Environmental Sciences, V5, P63
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Nakazawa Y, 2011, J BIOMAT SCI-POLYM E, V22, P195, DOI 10.1163/092050609X12586381656530
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   O'Connor SM, 2000, BIOSENS BIOELECTRON, V14, P871
   Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019
   Ohgo K, 2008, J AM CHEM SOC, V130, P4182, DOI 10.1021/ja710011d
   Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7
   PELEG H, 1986, THORAC CARDIOV SURG, V34, P384, DOI 10.1055/s-2007-1022179
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Porter D, 2009, ADV MATER, V21, P487, DOI 10.1002/adma.200801332
   Ren YJ, 2009, INT J BIOL MACROMOL, V44, P372, DOI 10.1016/j.ijbiomac.2009.02.004
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Rousseau ME, 2006, BIOMACROMOLECULES, V7, P2512, DOI 10.1021/bm060280w
   Rusa CC, 2005, MACROMOLECULES, V38, P5640, DOI 10.1021/ma050340a
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   SCHROEDER WA, 1955, J AM CHEM SOC, V77, P3908, DOI 10.1021/ja01619a066
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   Sirichaisit J, 2000, POLYMER, V41, P1223, DOI 10.1016/S0032-3861(99)00293-1
   Sohn S, 2004, BIOMACROMOLECULES, V5, P751, DOI 10.1021/bm034393
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Tanaka C, 2008, MACROMOLECULES, V41, P796, DOI 10.1021/ma7021875
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vollrath F, 2005, CURR BIOL, V15, P364
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0
   Wei YJ, 2011, J MATER SCI-MATER M, V22, P1947, DOI 10.1007/s10856-011-4370-z
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Whitesides GM, 2006, MRS BULL, V31, P19, DOI 10.1557/mrs2006.2
   Yang MC, 2010, BIOMATERIALS, V31, P854, DOI 10.1016/j.biomaterials.2009.09.096
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Zhang JG, 2013, FRONT MATER SCI, V7, P129, DOI 10.1007/s11706-013-0206-8
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XH, 2009, BIOMATERIALS, V30, P3213, DOI 10.1016/j.biomaterials.2009.02.002
   Zhao CX, 2011, INT J BIOL MACROMOL, V48, P249, DOI 10.1016/j.ijbiomac.2010.11.004
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
NR 105
TC 16
Z9 16
U1 3
U2 52
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD SEP
PY 2013
VL 7
IS 3
BP 237
EP 247
DI 10.1007/s11706-013-0214-8
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH9BG
UT WOS:000336433200003
DA 2018-10-20
ER

PT J
AU Wang, MD
   Zhai, P
   Schreyer, DJ
   Zheng, RS
   Sun, XD
   Cui, FZ
   Chen, XB
AF Wang, Min-Dan
   Zhai, Peng
   Schreyer, David J.
   Zheng, Ruo-Shi
   Sun, Xiao-Dan
   Cui, Fu-Zhai
   Chen, Xiong-Biao
TI Novel crosslinked alginate/hyaluronic acid hydrogels for nerve tissue
   engineering
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Article
DE hyaluronic acid (HA); alginate; hydrogel scaffold; nerve injury; tissue
   engineering
ID SCHWANN-CELL TRANSPLANTATION; NOGO-66 RECEPTOR ANTIBODY; INJURED
   SPINAL-CORD; HYALURONIC-ACID; EXTRACELLULAR-MATRIX; ALGINATE GEL; ADULT
   RATS; REGENERATION; SCAFFOLDS; BRAIN
AB Artificial tissue engineering scaffolds can potentially provide support and guidance for the regrowth of severed axons following nerve injury. In this study, a hybrid biomaterial composed of alginate and hyaluronic acid (HA) was synthesized and characterized in terms of its suitability for covalent modification, biocompatibility for living Schwann cells and feasibility to construct three dimensional (3D) scaffolds. Carbodiimide mediated amide formation for the purpose of covalent crosslinking of the HA was carried out in the presence of calciumions that ionically crosslink alginate. Amide formation was found to be dependent on the concentrations of carbodiimide and calcium chloride. The double-crosslinked composite hydrogels display biocompatibility that is comparable to simple HA hydrogels, allowing for Schwann cell survival and growth. No significant difference was found between composite hydrogels made from different ratios of alginate and HA. A 3D BioPlotterTM rapid prototyping system was used to fabricate 3D scaffolds. The result indicated that combining HA with alginate facilitated the fabrication process and that 3D scaffolds with porous inner structure can be fabricated from the composite hydrogels, but not from HA alone. This information provides a basis for continuing in vitro and in vivo tests of the suitability of alginate/HA hydrogel as a biomaterial to create living cell scaffolds to support nerve regeneration.
C1 [Wang, Min-Dan; Zhai, Peng; Schreyer, David J.; Chen, Xiong-Biao] Univ Saskatchewan, Div Biomed Engn, Saskatoon, SK S7N5A9, Canada.
   [Schreyer, David J.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK S7N5E5, Canada.
   [Zheng, Ruo-Shi; Sun, Xiao-Dan; Cui, Fu-Zhai] Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China.
   [Chen, Xiong-Biao] Univ Saskatchewan, Dept Mech Engn, Saskatoon, SK S7N5A9, Canada.
RP Wang, MD (reprint author), Univ Saskatchewan, Div Biomed Engn, 57 Campus Dr, Saskatoon, SK S7N5A9, Canada.
EM miw554@mail.usask.ca
FU Canadian Institutes of Health Research (CIHR) [00827001]; College of
   Graduate Studies and Research of the University of Saskatchecwan
FX The project was supported by a research funding from the Canadian
   Institutes of Health Research (CIHR, No. 00827001). M. D. Wang was
   supported by a scholarship from the College of Graduate Studies and
   Research of the University of Saskatchecwan. We are grateful for Dr. Ian
   Burgess and Dr. Catherine Niu for providing us with insightful comments
   and research instruments.
CR ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200
   BURD DAR, 1991, BRIT J PLAST SURG, V44, P579, DOI 10.1016/0007-1226(91)90093-Y
   Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018
   Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030
   DANISHEF.I, 1971, CARBOHYD RES, V16, P199, DOI 10.1016/S0008-6215(00)86114-5
   Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Goto E, 2010, J BIOSCI BIOENG, V109, P512, DOI 10.1016/j.jbiosc.2009.11.002
   HAUG A, 1963, ACTA CHEM SCAND, V17, P1653, DOI 10.3891/acta.chem.scand.17-1653
   Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Ikeda K, 2003, BRIT J PLAST SURG, V56, P342, DOI 10.1016/S0007-1226(03)00197-8
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   Lee HS, 1996, CORNEA, V15, P517
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Maharjan A S, 2011, PLOS ONE, V6
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Ozgenel GY, 2003, MICROSURG, V23, P575, DOI 10.1002/micr.10209
   Papastefanaki F, 2007, BRAIN, V130, P2159, DOI 10.1093/brain/awm155
   Peattie RA, 2004, BIOMATERIALS, V25, P2789, DOI 10.1016/j.biomaterials.2003.09.054
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P339, DOI 10.1021/bc00028a010
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sherman L, 1995, J NEURO-ONCOL, V26, P171, DOI 10.1007/BF01052620
   Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Suzuki K, 1999, NEUROREPORT, V10, P2891, DOI 10.1097/00001756-199909290-00003
   Suzuki Y, 2002, NEUROSCI LETT, V318, P121, DOI 10.1016/S0304-3940(01)02359-X
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Tobias CA, 2001, J NEUROTRAUM, V18, P287, DOI 10.1089/08977150151070937
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
NR 39
TC 11
Z9 11
U1 1
U2 56
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD SEP
PY 2013
VL 7
IS 3
BP 269
EP 284
DI 10.1007/s11706-013-0211-y
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH9BG
UT WOS:000336433200006
DA 2018-10-20
ER

PT J
AU Neagu, E
   Paun, G
   Alecu, A
   Radu, GL
AF Neagu, Elena
   Paun, Gabriela
   Alecu, Andreia
   Radu, Gabriel Lucian
TI CHITOSAN-POLYVINILPYRROLIDONE/ELLAGIC ACID BASED MEMBRANES WITH
   CONTROLLED ANTIOXIDANT PROPERTIES
SO REVUE ROUMAINE DE CHIMIE
LA English
DT Article
DE membrane; chitosan; ellagic acid; FTIR; entrapping; antioxidant
ID DRUG-DELIVERY; HUMAN COLON; ENCAPSULATION; CANCER; BEADS; NANOPARTICLES;
   RELEASE; APOPTOSIS; BEHAVIOR; EXTRACT
AB They were characterized by Fourier transform infrared spectroscopy (FTIR). The efficiency of EA entrapment revealed values >= 50%. The released ellagic acid quantities were spectrophotometrically determined at various time intervals: 1, 2, 3, 7 days, and various pH: 3.0, 7.5, 8.0, 9.0. The best cumulative release of ellagic acid from membranes was obtained at lowest pH, pH=3. The antioxidant capacity of EA released from membranes was evaluated by inhibition percent of 2,2-diphenyl-1-picrylhydrazyl (DPPH). The best result was found also at pH=3.0, 20% DPPH inhibition (at 48h). The properties of such membranes recommend them as biomaterial with controlled antioxidant biological activity.
C1 [Neagu, Elena; Paun, Gabriela; Alecu, Andreia] Natl Inst Res Dev Biol Sci, Ctr Bioanal, Bucharest 060031 6, Romania.
   [Radu, Gabriel Lucian] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 060042, Romania.
RP Neagu, E (reprint author), Natl Inst Res Dev Biol Sci, Ctr Bioanal, 296 Spl Independentei,POB 17-16, Bucharest 060031 6, Romania.
EM lucineagu2006@yahoo.com
RI Alecu, Andreia/G-6702-2011; RADU, Gabriel-Lucian/E-8560-2011; Paun,
   Gabriela/F-7551-2011; Radu, GL/F-7766-2011; Neagu, Elena/F-7797-2011
OI Alecu, Andreia/0000-0003-2999-6027; RADU,
   Gabriel-Lucian/0000-0002-4385-1177; Radu, GL/0000-0002-4385-1177; 
FU Roumanian National Center for Program Management [PN 09-360101/2009]
FX This research was supported by the Roumanian National Center for Program
   Management - PN 09-360101/2009 projects.
CR Augustin MA, 2009, CHEM SOC REV, V38, P902, DOI 10.1039/b801739p
   Avgeropoulos N G, 1999, Oncologist, V4, P209
   BARNABYA NS, 2012, COLLOID SURFACE B, V95, P154
   Belscak-Cvitanovic A, 2011, FOOD RES INT, V44, P1094, DOI 10.1016/j.foodres.2011.03.030
   Bondet V, 1997, FOOD SCI TECHNOL-LEB, V30, P609
   Deladino L, 2008, CARBOHYD POLYM, V71, P126, DOI 10.1016/j.carbpol.2007.05.030
   Desai KGH, 2005, DRY TECHNOL, V23, P1361, DOI 10.1081/DRT-200063478
   DeYao K, 1996, J APPL POLYM SCI, V60, P279, DOI 10.1002/(SICI)1097-4628(19960411)60:2<279::AID-APP16>3.0.CO;2-0
   DIPLOCK AT, 1999, J NUTR, V81, P1
   Fang ZX, 2010, TRENDS FOOD SCI TECH, V21, P510, DOI 10.1016/j.tifs.2010.08.003
   Gibbs BF, 1999, INT J FOOD SCI NUTR, V50, P213, DOI 10.1080/096374899101256
   Gupta KC, 2000, BIOMATERIALS, V21, P1115, DOI 10.1016/S0142-9612(99)00263-X
   Hostanska K, 2007, CANCER DETECT PREV, V31, P129, DOI 10.1016/j.cdp.2007.03.001
   Hu B, 2008, J AGR FOOD CHEM, V56, P7451, DOI 10.1021/jf801111c
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   Khan TA, 2002, J PHARM PHARM SCI, V5, P205
   Kim S, 2009, BIOMATERIALS, V30, P4743, DOI 10.1016/j.biomaterials.2009.05.010
   Lakshmanan VK, 2011, ADV POLYM SCI, V243, P55, DOI 10.1007/12_2011_132
   Landete JM, 2011, FOOD RES INT, V44, P1150, DOI 10.1016/j.foodres.2011.04.027
   Larrosa M, 2006, J NUTR BIOCHEM, V17, P611, DOI 10.1016/j.nutbio.2005.09.004
   Madrigal-Carballo S, 2010, J FUNCT FOODS, V2, P99, DOI 10.1016/j.jff.2010.01.002
   Malik A, 2011, ASIAN PAC J TROP MED, V4, P550, DOI 10.1016/S1995-7645(11)60144-2
   Mi FL, 2002, POLYMER, V43, P757, DOI 10.1016/S0032-3861(01)00580-8
   MINGWEI L, 2012, CARBOHYD POLYM, V87, P1749
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   Mourtzinos I, 2007, J AGR FOOD CHEM, V55, P8088, DOI 10.1021/jf0709698
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   PAZ R, 2012, FOOD CHEM, V134, P1
   Santos C, 2006, EUR POLYM J, V42, P3277, DOI 10.1016/j.eurpolymj.2006.09.001
   Sezer AD, 1999, J MICROENCAPSUL, V16, P195, DOI 10.1080/026520499289176
   Shantha LK, 2006, CARBOHYD POLYM, V64, P163
   Siripatrawan U, 2010, FOOD HYDROCOLLOID, V24, P770, DOI 10.1016/j.foodhyd.2010.04.003
   Tangsadthakun C, 2006, J MET MAT MINER, V16, P37
   TZUHUI W, 2008, INT J PHARMACEUT, V346, P160
   Voos P., 2010, INT DAIRY J, V20, P292
   Wu TH, 2008, INT J PHARM, V346, P160, DOI 10.1016/j.ijpharm.2007.06.036
   Xu YM, 2007, INT J PHARM, V336, P329, DOI 10.1016/j.ijpharm.2006.12.019
NR 38
TC 0
Z9 0
U1 0
U2 7
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 0035-3930
J9 REV ROUM CHIM
JI Rev. Roum. Chim.
PD SEP-OCT
PY 2013
VL 58
IS 9-10
BP 791
EP +
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA AG7UK
UT WOS:000335624100009
DA 2018-10-20
ER

PT J
AU Ellis, CE
   Vulesevic, B
   Suuronen, E
   Yeung, T
   Seeberger, K
   Korbutt, GS
AF Ellis, Cara E.
   Vulesevic, Branka
   Suuronen, Erik
   Yeung, Telford
   Seeberger, Karen
   Korbutt, Gregory S.
TI Bioengineering a highly vascularized matrix for the ectopic
   transplantation of islets
SO ISLETS
LA English
DT Article
DE islet transplantation; cell delivery; diabetes; vascularization;
   collagen; chitosan; chondroitin
ID MESENCHYMAL STEM-CELLS; EDMONTON PROTOCOL; OMENTAL POUCH; BIOARTIFICIAL
   PANCREAS; INSULIN-SECRETION; SURVIVAL; SITE; GROWTH; ANGIOGENESIS;
   STEATOSIS
AB Islet transplantation is a promising treatment for Type 1 diabetes; however limitations of the intra-portal site and poor revascularization of islets must be overcome. We hypothesize that engineering a highly vascularized collagen-based construct will allow islet graft survival and function in alternative sites. In this study, we developed such a collagen-based biomaterial. Neonatal porcine islets (NPIs) were embedded in collagen matrices crosslinked with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide containing combinations of chondroitin-6-sulfate, chitosan, and laminin, and compared with controls cultured in standard media. Islets were examined for insulin secretory activity after 24 h and 4 d and for apoptotic cell death and matrix integrity after 7 d in vitro. These same NPI/collagen constructs were transplanted subcutaneously in immunoincompetent B6.Rag(-/-) mice and then assessed for islet survival and vascularization. At all time points assessed during in vitro culture there were no significant differences in insulin secretory activity between control islets and those embedded in the collagen constructs, indicating that the collagen matrix had no adverse effect on islet function. Less cell death was observed in the matrix with all co-polymers compared with the other matrices tested. Immunohistochemical analysis of the grafts post-transplant confirmed the presence of intact insulin-positive islets; grafts were also shown to be vascularized by von Willebrand factor staining. This study demonstrates that a collagen, chondroitin-6-sulfate, chitosan, and laminin matrix supports islet function in vitro and moreover allows islet survival and vascularization post-transplantation; therefore, this bio-engineered vascularized construct is capable of supporting islet survival.
C1 [Ellis, Cara E.; Yeung, Telford; Seeberger, Karen; Korbutt, Gregory S.] Univ Alberta, Dept Surg, Edmonton, AB, Canada.
   [Ellis, Cara E.; Yeung, Telford; Seeberger, Karen; Korbutt, Gregory S.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada.
   [Vulesevic, Branka; Suuronen, Erik] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON, Canada.
RP Korbutt, GS (reprint author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.
EM korbutt@ualberta.ca
FU Juvenile Diabetes Research Foundation [41-2009-771]; Canadian Institutes
   of Health Research [MOP 119500]; Alberta Innovates Health Solutions
   Studentship
FX This study is supported by the Juvenile Diabetes Research Foundation
   (Grant #41-2009-771) and the Canadian Institutes of Health Research
   (Grant #MOP 119500). Ellis CE is a recipient of an Alberta Innovates
   Health Solutions Studentship. We would like to thank the Clinical Islet
   Laboratory (University of Alberta and Alberta Health Services) and
   Alberta Diabetes Institute IsletCore (University of Alberta) for
   providing human islet preparations; Dr Kunimasa Suzuki (Alberta Diabetes
   Institute Molecular Biology Core, University of Alberta) for assistance
   with the Meso Scale Discovery Assays; the University of Alberta Swine
   Research Centre for the neonatal piglets; the Alberta Diabetes Institute
   Histology Core including Sheena Maxwell for assistance with histology;
   and Deb Dixon for assistance with isolating the NPIs. The funders had no
   role in study design, data collection and analysis, decision to publish
   or publication of manuscript. Portions of this manuscript have been
   previously presented at the 13th World Congress of IPITA in Prague,
   Czech Republic (June 2011).
CR AO ZL, 1993, TRANSPLANTATION, V56, P524, DOI 10.1097/00007890-199309000-00007
   Balamurugan AN, 2003, PANCREAS, V26, P279, DOI 10.1097/00006676-200304000-00012
   Bhargava R, 2004, DIABETES, V53, P1311, DOI 10.2337/diabetes.53.5.1311
   Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375
   Cavallari G, 2012, CELL TRANSPLANT, V21, P2771, DOI 10.3727/096368912X637046
   DeVos P, 1997, TRANSPLANTATION, V63, P824, DOI 10.1097/00007890-199703270-00006
   Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317
   Duffy GP, 2011, EUR CELLS MATER, V21, P15, DOI 10.22203/eCM.v021a02
   Edamura K, 2003, CELL TRANSPLANT, V12, P439, DOI 10.3727/000000003108746867
   Hosseini-Tabatabaei A, 2013, CAN J DIABETES, V37, P27, DOI 10.1016/j.jcjd.2012.10.011
   Hou YT, 2011, J BIOSCI BIOENG, V112, P265, DOI 10.1016/j.jbiosc.2011.05.003
   Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4
   Jalili RB, 2011, J CELL PHYSIOL, V226, P1813, DOI 10.1002/jcp.22515
   Kin T, 2003, AM J TRANSPLANT, V3, P281, DOI 10.1034/j.1600-6143.2003.00049.x
   Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649
   Kuraitis D, 2011, EUR CELLS MATER, V22, P109, DOI 10.22203/eCM.v022a09
   Liang WH, 2010, J BIOMED MATER RES A, V94A, P1050, DOI 10.1002/jbm.a.32774
   Madhavan K, 2010, ACTA BIOMATER, V6, P1413, DOI 10.1016/j.actbio.2009.09.028
   Markmann JF, 2003, DIABETES, V52, P1591, DOI 10.2337/diabetes.52.7.1591
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88
   Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Sakurai T, 2004, PANCREAS, V28, pE70, DOI 10.1097/00006676-200404000-00028
   Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Stiegler P, 2010, XENOTRANSPLANTATION, V17, P379, DOI 10.1111/j.1399-3089.2010.00606.x
   Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107
   Suuronen EJ, 2006, CIRCULATION, V114, pI138, DOI 10.1161/CIRCULATIONAHA.105.001081
   Suuronen EJ, 2004, FASEB J, V18, P170, DOI 10.1096/fj.03-0043fje
   Suuronen EJ, 2008, CAN J CARDIOL SE, V24
   Villiger P, 2005, AM J TRANSPLANT, V5, P2992, DOI 10.1111/j.1600-6143.2005.01108.x
   Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085
   Vulesevic B, 2011, J BIOMAT SCI-POLYM E, V23, P1467
   Wang WJ, 2003, TRANSPLANTATION, V76, P290, DOI 10.1097/01.TP.0000073613.25658.4D
   YASUNAMI Y, 1983, TRANSPLANTATION, V36, P181, DOI 10.1097/00007890-198308000-00014
   Yeung TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038189
   Zhou YF, 2011, PROTOPLASMA, V248, P683, DOI 10.1007/s00709-010-0229-2
NR 38
TC 8
Z9 9
U1 2
U2 6
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1938-2014
EI 1938-2022
J9 ISLETS
JI Islets
PD SEP-DEC
PY 2013
VL 5
IS 5
BP 216
EP 225
DI 10.4161/isl.27175
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 299GN
UT WOS:000330384200006
PM 24262950
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Nakamura, J
   Kasuga, T
AF Nakamura, Jin
   Kasuga, Toshihiro
TI Preparation of siloxane-containing vaterite particles with
   red-blood-cell-like morphologies and incorporation of calcium-salt
   polylactide for bone regenerative medicine
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Biomaterial; Ion release; Calcium carbonate; Siloxane; Vaterite;
   gamma-aminopropyltriethoxysilane
ID SUPERSTRUCTURES; MINERALIZATION; INFECTION
AB Siloxane-containing vaterite (SiV) particles with red-blood-cell-like morphologies were prepared by a CO2 gas carbonation process for application as osteogenic devices in bone tissue engineering. The particles release soluble silica species and calcium ions, which are expected to genetically stimulate osteoblasts to enhance bone reconstruction. The released particles possessed the mean diameter of 2 mu m Phi with the thickness of approximately 0.7 mu m. The Brenauer-Emmett-Teller surface area was estimated to be 76m(2).g(-1). In addition, the shape of the nitrogen adsorption-desorption hysteresis of the particles indicated the presence of slit-or wedge-shaped mesoporous structures. The particles were primarily composed of vaterite with aminopropyl-functionalised siloxanes in the silicon mass percentage of approximately 2wt%. Soluble silica species and a trace amount of calcium ion were released into the physiological pH buffer solution (pH 7.4) during the initial 1 h of soaking. To estimate its potential for loading functional molecules, polylactide (PLA) was used as the model molecule and the SiV particles were prepared in their presence. Fourier transform infrared spectrometry of the sample revealed that PLA formed a carboxylate salt with the calcium ions and was loaded into the mesoporous structures. Upon contact with the buffer solution, the calcium-salt PLA and siloxane were released simultaneously within the initial 1 h of soaking. (C)2013 The Ceramic Society of Japan. All rights reserved.
C1 [Nakamura, Jin; Kasuga, Toshihiro] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
EM kasuga.toshihiro@nitech.ac.jp
FU Japan Society for Promotion of Science
FX The authors are indebted to Dr Yoshio Ota of Yabashi Industries, Co.
   Ltd. and Mr Anthony Ma~on of Imperial College London for their helpful
   discussions. We acknowledge the support of the ITP program of the
   Institute of Ceramics Research and Education (ICRE) administered by
   Nagoya Institute of Technology. This work was supported in part by a
   Grant-in-Aid for Scientific Research from the Japan Society for
   Promotion of Science.
CR Alt V, 2006, BIOMATERIALS, V27, P4627, DOI 10.1016/j.biomaterials.2006.04.035
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Carrasco F, 2010, POLYM DEGRAD STABIL, V95, P116, DOI 10.1016/j.polymdegradstab.2009.11.045
   Chen SF, 2006, CHEM MATER, V18, P115, DOI 10.1021/cm0519028
   CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501
   Fujikura K, 2012, J BIOMAT SCI-POLYM E, V23, P1369, DOI 10.1163/092050611X582867
   Gehrke N, 2005, CRYST GROWTH DES, V5, P1317, DOI 10.1021/cg050051d
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Kawai T, 2007, MACROMOLECULES, V40, P9463, DOI 10.1021/ma070082c
   Li M, 2003, ADV MATER, V15, P2032, DOI 10.1002/adma.200305589
   MAYER U, 1975, MONATSH CHEM, V106, P1235, DOI 10.1007/BF00913599
   Nablo BJ, 2005, BIOMATERIALS, V26, P6984, DOI 10.1016/j.biomaterials.2005.05.017
   Obata A, 2010, ACTA BIOMATER, V6, P1248, DOI 10.1016/j.actbio.2009.11.013
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Wakita T, 2011, DENT MATER J, V30, P232, DOI 10.4012/dmj.2010-141
   Wang WS, 2009, J PHYS CHEM C, V113, P16414, DOI 10.1021/jp9059278
   Xu AW, 2006, ADV FUNCT MATER, V16, P903, DOI 10.1002/adfm.200500716
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
NR 21
TC 3
Z9 3
U1 1
U2 11
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD SEP
PY 2013
VL 121
IS 1417
BP 792
EP 796
DI 10.2109/jcersj2.121.792
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 296VF
UT WOS:000330212800010
OA Bronze
DA 2018-10-20
ER

PT J
AU Yeon, B
   Park, MH
   Moon, HJ
   Kim, SJ
   Cheon, YW
   Jeong, B
AF Yeon, Bora
   Park, Min Hee
   Moon, Hyo Jung
   Kim, Seung-Jin
   Cheon, Young Woo
   Jeong, Byeongmoon
TI 3D Culture of Adipose-Tissue-Derived Stem Cells Mainly Leads to
   Chondrogenesis in Poly(ethylene glycol)-Poly(L-alanine) Diblock
   Copolymer Thermogel
SO BIOMACROMOLECULES
LA English
DT Article
ID OXIDE) TRIBLOCK COPOLYMER; SOL-GEL TRANSITION; STROMAL CELLS;
   AQUEOUS-SOLUTIONS; BLOCK-COPOLYMERS; MACROPHAGE PHENOTYPE; INJECTABLE
   HYDROGEL; DRUG-DELIVERY; THERMOREVERSIBLE GELATION; MICROPATTERNED
   SURFACES
AB Poly(ethylene glycol)-b-poly(L-alanine) (PEG-L-PA)s with L-PA molecular weights of 620, 1100, and 2480 Da and a fixed molecular weight of PEG at 5000 Da were synthesized to compare the thermosensitive behavior, and to investigate their potential as a three-dimensional (3D) culture matrix of adipose-tissue-derived stem cells (ADSCs). The sol-to-gel transition temperature and the concentration ranges where the transition was observed decreased as the L-PA molecular weight increased. ADSCs were cultured in the 3D matrixes of in situ formed PEG-L-PA hydrogels, which were produced by increasing the temperature of cell-suspended PEG-L-PA aqueous solutions. The spherical morphology was maintained in the PEG-L-PA hydrogel, while the cells underwent fibroblastic morphological changes in the Matrigel over 14 days of incubation. ADSCs exhibited high expression of type II collagen in the PEG-L-PA thermogel. In addition, they also moderately expressed the biomarker of myogenic differentiation factor 1 as the same mesodermal lineages, as well as the type III beta-tubulin as a cross-differentiation biomarker. Similar to the in vitro study, the ADSCs predominantly exhibited chondrogenic biomarkers in the in vivo study. The study demonstrates that the polypeptide thermogel of PEG-L-PA is promising as a 3D culture matrix of ADSCs and as an injectable tissue engineering biomaterial.
C1 [Yeon, Bora; Park, Min Hee; Moon, Hyo Jung; Kim, Seung-Jin; Jeong, Byeongmoon] Ewha Womans Univ, Dept Chem & Nano Sci, Ewha Global Top Res Program 5, Seoul 120750, South Korea.
   [Cheon, Young Woo] Gachon Univ, Gil Med Ctr, Dept Plast & Reconstruct Surg, Inchon, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem & Nano Sci, Ewha Global Top Res Program 5, 52 Ewhayeodae Gil, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
FU National Research Foundation of Korea; Korean Government (MSIP)
   [2009-0080447, 2012M3A9C6049784]
FX This work was supported by the National Research Foundation of Korea
   Grant funded by the Korean Government (MSIP; 2009-0080447 and
   2012M3A9C6049784).
CR Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   BROWN W, 1991, J PHYS CHEM-US, V95, P1850, DOI 10.1021/j100157a064
   Cau F, 1996, MACROMOLECULES, V29, P170, DOI 10.1021/ma950976+
   Chandler EM, 2011, BIOTECHNOL BIOENG, V108, P1683, DOI 10.1002/bit.23079
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chang JC, 2009, BIOMATERIALS, V30, P6265, DOI 10.1016/j.biomaterials.2009.07.064
   Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067
   Choi YY, 2010, J MATER CHEM, V20, P3416, DOI 10.1039/b922956f
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Chung YM, 2002, BIOMACROMOLECULES, V3, P511, DOI 10.1021/bm0156431
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81
   Hans M, 2005, BIOMACROMOLECULES, V6, P2708, DOI 10.1021/bm050188k
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2000, MACROMOLECULES, V33, P8317, DOI 10.1021/ma000638v
   Jeong BM, 1999, J POLYM SCI POL CHEM, V37, P751
   Jeong Y, 2009, J CONTROL RELEASE, V137, P25, DOI 10.1016/j.jconrel.2009.03.008
   Jung HH, 2010, J CONTROL RELEASE, V147, P84, DOI 10.1016/j.jconrel.2010.06.020
   Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X
   Kim MH, 2010, BIOMATERIALS, V31, P1213, DOI 10.1016/j.biomaterials.2009.10.057
   Kim SY, 2007, MACROMOLECULES, V40, P5519, DOI 10.1021/ma070190z
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Klok HA, 2002, ANGEW CHEM INT EDIT, V41, P1509, DOI 10.1002/1521-3773(20020503)41:9<1509::AID-ANIE1509>3.0.CO;2-K
   Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lee HR, 2012, J CONTROL RELEASE, V159, P332, DOI 10.1016/j.jconrel.2012.02.008
   Li H, 2003, LANGMUIR, V19, P1075, DOI 10.1021/la026464n
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Lim YB, 2008, J MATER CHEM, V18, P2909, DOI 10.1039/b802639d
   Lin YF, 2006, MOL CELL BIOCHEM, V285, P69, DOI 10.1007/s11010-005-9056-8
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Lu H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1209
   McCullen SD, 2010, TISSUE ENG PT A, V16, P1971, DOI [10.1089/ten.tea.2009.0691, 10.1089/ten.TEA.2009.0691]
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Moon HJ, 2011, BIOMACROMOLECULES, V12, P1234, DOI 10.1021/bm101518c
   Ning HX, 2008, DIFFERENTIATION, V76, P488, DOI 10.1111/j.1432-0436.2007.00240.x
   Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504
   Parisi-Amon A, 2013, ADV HEALTHC MATER, V2, P428, DOI 10.1002/adhm.201200293
   Park MH, 2012, ACCOUNTS CHEM RES, V45, P424, DOI 10.1021/ar200162j
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Schacht E, 2006, J CONTROL RELEASE, V116, P219, DOI 10.1016/j.jconrel.2006.07.026
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Shinde UP, 2012, J MATER CHEM, V22, P6072, DOI 10.1039/c2jm15419f
   Singh A, 2013, ADV FUNCT MATER, V23, P575, DOI 10.1002/adfm.201201902
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Tous E, 2012, ACTA BIOMATER, V8, P3218, DOI 10.1016/j.actbio.2012.05.027
   Wang J, 2009, MACROMOL RAPID COMM, V30, P845, DOI 10.1002/marc.200800744
   Wang YY, 2012, J MATER CHEM, V22, P25217, DOI 10.1039/c2jm35186b
   Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yan C, 2011, BIOMATERIALS, V32, P3931, DOI 10.1016/j.biomaterials.2011.01.078
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   Zhang H, 2008, MACROMOLECULES, V41, P6493, DOI 10.1021/ma7026484
   Zhang Z, 2012, J BIOMED MATER RES B, V100B, P1599, DOI 10.1002/jbm.b.32728
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
NR 72
TC 49
Z9 49
U1 1
U2 83
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2013
VL 14
IS 9
BP 3256
EP 3266
DI 10.1021/bm400868j
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 295CZ
UT WOS:000330095500034
PM 23909492
DA 2018-10-20
ER

PT J
AU Liu, Y
   Yin, Y
   Wang, LY
   Zhang, WF
   Chen, XM
   Yang, XX
   Xu, JJ
   Ma, GH
AF Liu, Yuan
   Yin, Ying
   Wang, Lianyan
   Zhang, Weifeng
   Chen, Xiaoming
   Yang, Xiaoxiao
   Xu, Junjie
   Ma, Guanghui
TI Engineering Biomaterial-Associated Complement Activation to Improve
   Vaccine Efficacy
SO BIOMACROMOLECULES
LA English
DT Article
ID T-CELL IMMUNITY; INNATE IMMUNITY; IN-VIVO; CHITOSAN; NANOPARTICLES;
   ADJUVANTS; DELIVERY; SURFACES; SYSTEM; MODEL
AB The complement system plays an important role in innate and adaptive immunity, which suggests that complement activation could be exploited as a potential strategy for vaccine adjuvants. Here we explored the potential of chitosan-based microparticles (CS-NH2 MPs) as a vaccine adjuvant with an active surface for complement activation due to the abundance of amino groups. In vaccination studies, using recombinant anthrax protective antigen as a model antigen, compared with the control microparticles (amino-cross-linked MPs), we found that microparticles (MPs) with abundant amino groups significantly enhanced higher antigen-specific IgG titers in vivo and enhanced the production of IL-4 and IFN-gamma with ex vivo restimulation. Furthermore, proliferative responses of splenocytes to ex vivo antigen restimulation were enhanced following immunization with MPs with amino groups. Overall, these results indicated that CS-NH2 MPs with a high surface density of amino groups were favorable for complement activation and immune responses. Our data provide further design principles for studies on complement-activating MPs as a vaccine platform.
C1 [Liu, Yuan; Wang, Lianyan; Zhang, Weifeng; Chen, Xiaoming; Yang, Xiaoxiao; Ma, Guanghui] Chinese Acad Sci, Inst Proc Engn, PLA Key Lab Biopharmaceut Prod & Formulat Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.
   [Liu, Yuan; Zhang, Weifeng; Chen, Xiaoming] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Yin, Ying; Xu, Junjie] Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 100071, Peoples R China.
RP Wang, LY (reprint author), Chinese Acad Sci, Inst Proc Engn, PLA Key Lab Biopharmaceut Prod & Formulat Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.
EM wanglianyan@home.ipe.ac.cn; xujunlie@sina.com; ghma@home.ipe.ac.cn
RI Zhang, Weifeng/E-4780-2013
OI Zhang, Weifeng/0000-0002-9238-7198
FU 863 Program [2012AA02A406]; Special Fund for Agroscientific Research in
   the Public Interest [201303046]; Chinese Academy of Sciences
   [KSCX2-EW-R-19]
FX This work was financially supported by the 863 Program (Grant No.
   2012AA02A406), Special Fund for Agroscientific Research in the Public
   Interest (Grant No. 201303046), and the Knowledge Innovation Program of
   the Chinese Academy of Sciences (Grant No. KSCX2-EW-R-19).
CR Auten MW, 2012, VACCINE, V30, P2768, DOI 10.1016/j.vaccine.2012.02.020
   Camacho AI, 2011, VACCINE, V29, P7130, DOI 10.1016/j.vaccine.2011.05.072
   Carroll M. C., 2008, VACCINE, V26, P128
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Fischer M, 2010, BIOMATERIALS, V31, P2498, DOI 10.1016/j.biomaterials.2009.12.016
   Gadjeva M, 1998, J IMMUNOL, V161, P985
   Garcia-Fuentes M, 2012, J CONTROL RELEASE, V161, P496, DOI 10.1016/j.jconrel.2012.03.017
   Heeger PS, 2012, IMMUNOBIOLOGY, V217, P216, DOI 10.1016/j.imbio.2011.06.004
   Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967
   Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010
   Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994
   Klinman DM, 2009, ADV DRUG DELIVER REV, V61, P248, DOI 10.1016/j.addr.2008.12.012
   Kolla R. V., 2007, PLOS ONE, V2
   Kumar M, 2001, J ALLERGY CLIN IMMUN, V108, P402, DOI 10.1067/mai.2001.117261
   Leleux J, 2013, ADV HEALTHC MATER, V2, P72, DOI 10.1002/adhm.201200268
   Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863
   Lv PP, 2009, IND ENG CHEM RES, V48, P8819, DOI 10.1021/ie801758e
   Lyubchenko T, 2007, J IMMUNOL, V179, P2695, DOI 10.4049/jimmunol.179.5.2695
   Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004
   Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442
   Merkel OM, 2011, BIOMATERIALS, V32, P4936, DOI 10.1016/j.biomaterials.2011.03.035
   Mizrahy S, 2011, J CONTROL RELEASE, V156, P231, DOI 10.1016/j.jconrel.2011.06.031
   Moghimi SM, 2011, ADV DRUG DELIVER REV, V63, P1000, DOI 10.1016/j.addr.2011.06.002
   Pekkarinen PT, 2011, IMMUNOBIOLOGY, V216, P737, DOI 10.1016/j.imbio.2010.10.004
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Salvador-Morales C, 2009, BIOMATERIALS, V30, P2231, DOI 10.1016/j.biomaterials.2009.01.005
   Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001
   Thasneem YM, 2011, J BIOMED MATER RES A, V99A, P607, DOI 10.1002/jbm.a.33220
   Thomas SN, 2011, BIOMATERIALS, V32, P2194, DOI 10.1016/j.biomaterials.2010.11.037
   Toda M, 2008, BIOMATERIALS, V29, P407, DOI 10.1016/j.biomaterials.2007.10.005
   Villiers MB, 1999, J IMMUNOL, V162, P3647
   Zhang YL, 2011, EUR J PHARM BIOPHARM, V77, P11, DOI 10.1016/j.ejpb.2010.09.016
NR 38
TC 16
Z9 17
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2013
VL 14
IS 9
BP 3321
EP 3328
DI 10.1021/bm400930k
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 295CZ
UT WOS:000330095500041
PM 23875970
DA 2018-10-20
ER

PT J
AU Kamath, AF
   Evangelista, PJ
   Nelson, CL
AF Kamath, Atul F.
   Evangelista, Perry J.
   Nelson, Charles L.
TI Total hip arthroplasty with porous metal cups following acetabular
   fracture
SO HIP INTERNATIONAL
LA English
DT Article
DE Acetabular fracture; Total hip replacement (arthroplasty); Porous metal;
   Tantalum; Cementless
ID TANTALUM BIOMATERIAL; REPLACEMENT; OSTEOARTHRITIS; RECONSTRUCTION;
   DISLOCATION; COMPONENTS; INTERFACE; ARTHRITIS; INGROWTH; DEFECTS
AB Total hip arthroplasty (THA) after acetabular fracture presents unique challenges, including acetabular fixation. Twelve patients with a history of acetabular fracture underwent THA with porous metal cups. The average age was 57 years (range 24-88). THA was performed at an average 20 months from initial fracture. Average follow-up was 39 months (range 24-49). Average WOMAC scores improved from 32 to 79; UCLA scores improved from 1.75 to 5.25. There was one case of acetabular loosening in a renal transplant patient with rheumatoid arthritis. No other patients showed progressive radiolucent lines. At average three-year follow-up, porous metal components afforded improved clinical and radiographic outcomes in the majority of patients. Longer follow-up will determine whether porous metal is a durable option in the management of prior acetabular fracture.
C1 [Kamath, Atul F.; Evangelista, Perry J.; Nelson, Charles L.] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
RP Kamath, AF (reprint author), Mayo Clin, 200 1st St SW,Gonda 14, Rochester, MN 55902 USA.
EM akamath@post.harvard.edu
CR AMSTUTZ HC, 1984, J BONE JOINT SURG AM, V66A, P228, DOI 10.2106/00004623-198466020-00010
   Bellabarba C, 2001, J BONE JOINT SURG AM, V83A, P868, DOI 10.2106/00004623-200106000-00008
   Berry DJ, 2002, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000038470.05771.eb
   BOARDMAN KP, 1978, J BONE JOINT SURG BR, V60, P495
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BOBYN JD, 1981, ACTA ORTHOP SCAND, V52, P145, DOI 10.3109/17453678108991775
   BOBYN JD, 1984, ORTHOPEDICS, V7, P1410, DOI 10.3928/0147-7447-19840901-05
   BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629
   COVENTRY MB, 1974, J BONE JOINT SURG AM, VA 56, P1128, DOI 10.2106/00004623-197456060-00002
   Del Gaizo DJ, 2012, CLIN ORTHOP RELAT R, V470, P395, DOI 10.1007/s11999-011-2170-x
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Joglekar SB, 2012, CLIN ORTHOP RELAT R, V470, P3041, DOI 10.1007/s11999-012-2382-8
   Klassbo M, 2003, SCAND J RHEUMATOL, V32, P46
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   Kremers Hilal Maradit, 2012, J Bone Joint Surg Am, V94, pe82, DOI 10.2106/JBJS.K.00549
   Lai OJ, 2011, J ARTHROPLASTY, V26, P1008, DOI 10.1016/j.arth.2011.02.026
   MALKIN C, 1985, CLIN ORTHOP RELAT R, P57
   Mears DC, 2002, J BONE JOINT SURG AM, V84A, P1
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P741, DOI 10.1016/j.arth.2009.04.025
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P337, DOI 10.1016/j.arth.2009.03.003
   Mortazavi SMJ, 2012, J ARTHROPLASTY, V27, P31, DOI 10.1016/j.arth.2011.05.014
   Mulier Michiel, 2006, Acta Orthop Belg, V72, P326
   Ranawat A, 2009, J ARTHROPLASTY, V24, P759, DOI 10.1016/j.arth.2008.04.004
   ROMNESS DW, 1990, J BONE JOINT SURG BR, V72, P761
   Schreurs BW, 2005, CLIN ORTHOP RELAT R, P145, DOI 10.1097/01.blo.0000164408.86710.dc
   Sporer SM, 2006, J ARTHROPLASTY, V21, P83, DOI 10.1016/j.arth.2006.05.008
   Weber M, 1998, J BONE JOINT SURG AM, V80A, P1295, DOI 10.2106/00004623-199809000-00008
   Zhang L, 2011, J ARTHROPLASTY, V26, P1189, DOI 10.1016/j.arth.2011.02.024
NR 31
TC 5
Z9 6
U1 0
U2 2
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1120-7000
EI 1724-6067
J9 HIP INT
JI Hip Int.
PD SEP-OCT
PY 2013
VL 23
IS 5
BP 465
EP 471
DI 10.5301/hipint.5000037
PG 7
WC Orthopedics
SC Orthopedics
GA 286VM
UT WOS:000329497300007
PM 23813176
DA 2018-10-20
ER

PT J
AU Oteyaka, MO
   Unal, HH
   Bilici, N
   Tasci, E
AF Oteyaka, Mustafa Ozgur
   Unal, Hasan Huseyin
   Bilici, Namik
   Tasci, Eda
TI Characterization of powdered fish heads for bone graft biomaterial
   applications
SO ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA
LA English
DT Article
DE Biomaterials; bone graft; calcium carbonate; characterization
ID SUBSTITUTES; CORAL; CUTTLEFISH
AB Objective: The aim of this study was to define the chemical composition, morphology and crystallography of powdered fish heads of the species Argyrosomus regius for bone graft biomaterial applications.
   Methods: Two sizes of powder were prepared by different grinding methods; Powder A (coarse, d(50)=68.5 mu m) and Powder B (fine, d(50)=19.1 mu m). Samples were analyzed using X-ray diffraction (XRD), X-ray fluorescence (XRF), scanning electron microscopy (SEM), thermogravimetry (TG), and energy dispersive X-ray spectroscopy (EDS).
   Results: The powder was mainly composed of aragonite (CaCO3) and calcite (CaCO3). The XRD pattern of Powder A and B matched standard aragonite and calcite patterns. In addition, the calcium oxide (CaO) phase was found after the calcination of Powder A. Thermogravimetry analysis confirmed total mass losses of 43.6% and 47.3% in Powders A and B, respectively.
   Conclusion: The microstructure of Powder A was mainly composed of different sizes and tubular shape, whereas Powder B showed agglomerated particles. The high quantity of CaO and other oxides resemble the chemical composition of bone. In general, the powder can be considered as bone graft after transformation to hydroxyapatite phase.
C1 [Oteyaka, Mustafa Ozgur] Dumlupinar Univ, Fac Engn, Dept Mech Engn, Kutahya, Turkey.
   [Unal, Hasan Huseyin] Pendik Vet Control & Res Inst, Istanbul, Turkey.
   [Bilici, Namik] Bahcelievler Municipal, Directorate Vet Affairs, Istanbul, Turkey.
   [Tasci, Eda] Dumlupinar Univ, Fac Engn, Dept Ceram Engn, Kutahya, Turkey.
RP Oteyaka, MO (reprint author), Dumlupinar Univ, Muhendislik Fak, Makine Muhendisligi Bolumu, Evliya Celebi Yerleskesi, Kutahya, Turkey.
EM mozgur.oteyaka@dpu.edu.tr
OI Oteyaka, Mustafa Ozgur/0000-0002-1488-6098
CR BARRIGA C, 1985, J MATER SCI, V20, P941, DOI 10.1007/BF00585738
   Becker A, 2003, DALTON T, P551, DOI 10.1039/b210529b
   BEGLEY CT, 1995, BIOMATERIALS, V16, P1181, DOI 10.1016/0142-9612(95)93584-Z
   Ben-Nissan B, 2003, CURR OPIN SOLID ST M, V7, P283, DOI 10.1016/j.cossms.2003.10.001
   Bertazzo S, 2006, KEY ENG MAT, V309-311, P3, DOI 10.4028/www.scientific.net/KEM.309-311.3
   Cartwright JHE, 2007, J R SOC INTERFACE, V4, P491, DOI 10.1098/rsif.2006.0188
   Damien E, 2004, J Appl Biomater Biomech, V2, P65
   DUPOIRIEUX L, 1994, INT J ORAL MAX SURG, V23, P395, DOI 10.1016/S0901-5027(05)80028-1
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   LEGEROS RZ, 1983, J DENT RES, V62, P138, DOI 10.1177/00220345830620021101
   Lemos AF, 2006, J EUR CERAM SOC, V26, P3639, DOI 10.1016/j.jeurceramsoc.2005.12.011
   Lopez E, 2005, BIOFUTUR, P30
   Luz GM, 2010, COMPOS SCI TECHNOL, V70, P1777, DOI 10.1016/j.compscitech.2010.05.013
   Manoli F, 2000, J CRYST GROWTH, V217, P422, DOI 10.1016/S0022-0248(00)00515-7
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Tuyel U, 2007, J BIOTECHNOL, V131, pS65, DOI 10.1016/j.biotec.2007.07.113
NR 17
TC 1
Z9 1
U1 1
U2 17
PU TURKISH ASSOC ORTHOPAEDICS TRAUMATOLOGY
PI ISTANBUL
PA TIP FAKULTESI ORTOPEDI VE TRAVMATOLOJI KLINIGI, ISTANBUL, TOPKAPI 34390,
   TURKEY
SN 1017-995X
J9 ACTA ORTHOP TRAUMATO
JI Acta Orthop. Traumatol. Turc.
PD SEP-OCT
PY 2013
VL 47
IS 5
BP 359
EP 365
DI 10.3944/AOTT.2013.2688
PG 7
WC Orthopedics
SC Orthopedics
GA 285RQ
UT WOS:000329413100012
PM 24164947
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Chen, M
   Yu, QS
   Sun, HM
AF Chen, Meng
   Yu, Qingsong
   Sun, Hongmin
TI Novel Strategies for the Prevention and Treatment of Biofilm Related
   Infections
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE biofilm; antimicrobial; small molecule; biomaterial
ID STAPHYLOCOCCUS-EPIDERMIDIS BIOFILM; CENTRAL VENOUS CATHETERS;
   BLOOD-STREAM INFECTION; SILVER NANOPARTICLES; IN-VIVO; BACTERIAL
   ADHESION; SURFACE-ROUGHNESS; ANTIBIOTIC-RESISTANCE; BIOLOGICAL-ACTIVITY;
   AUREUS INFECTIONS
AB Biofilm formation by human bacterial pathogens on implanted medical devices causes major morbidity and mortality among patients, and leads to billions of dollars in healthcare cost. Biofilm is a complex bacterial community that is highly resistant to antibiotics and human immunity. As a result, novel therapeutic solutions other than the conventional antibiotic therapies are in urgent need. In this review, we will discuss the recent research in discovery of alternative approaches to prevent or treat biofilms. Current anti-biofilm technologies could be divided into two groups. The first group focuses on targeting the biofilm forming process of bacteria based on our understanding of the molecular mechanism of biofilm formation. Small molecules and enzymes have been developed to inhibit or disrupt biofilm formation. Another group of anti-biofilm technologies focuses on modifying the biomaterials used in medical devices to make them resistant to biofilm formation. While these novel anti-biofilm approaches are still in nascent phases of development, efforts devoted to these technologies could eventually lead to anti-biofilm therapies that are superior to the current antibiotic treatment.
C1 [Chen, Meng] Nanova Inc, Columbia, MO 65211 USA.
   [Yu, Qingsong] Univ Missouri, Dept Mech & Aerosp Engn, Columbia, MO 65211 USA.
   [Sun, Hongmin] Univ Missouri, Dept Internal Med, Div Cardiovasc Med, Columbia, MO 65212 USA.
RP Sun, HM (reprint author), Univ Missouri, Dept Internal Med, Div Cardiovasc Med, Columbia, MO 65212 USA.
EM chenmeng@nanovamed.com; yuq@missouri.edu; sunh@health.missouri.edu
FU NIH [P01HL573461, 1R44HL097485-01A2]
FX The works of the authors are supported by NIH Grant P01HL573461 to HS,
   and NIH Grant 1R44HL097485-01A2 to MC. We would also like to thank all
   our colleagues on the works discussed in the review. We apologize to all
   colleagues whose works could not be cited due to space limitations.
CR Abraham NM, 2012, J MED MICROBIOL, V61, P1062, DOI 10.1099/jmm.0.040758-0
   Agarwal A, 2010, FEMS IMMUNOL MED MIC, V58, P147, DOI 10.1111/j.1574-695X.2009.00601.x
   Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051
   Boks NP, 2009, J COLLOID INTERF SCI, V331, P60, DOI 10.1016/j.jcis.2008.11.025
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644
   Casey AL, 2008, LANCET INFECT DIS, V8, P763, DOI 10.1016/S1473-3099(08)70280-9
   Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y
   Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08
   Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3
   Harris J. M., 1992, POLYETHYLENE GLYCOL, P283
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Hockenhull JC, 2009, CRIT CARE MED, V37, P702, DOI 10.1097/CCM.0b013e3181958915
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Hume EBH, 2004, BIOMATERIALS, V25, P5023, DOI 10.1016/j.biomaterials.2004.01.048
   Ivanova EP, 2008, MICRON, V39, P1197, DOI 10.1016/j.micron.2008.04.009
   Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07
   Jena P, 2012, INT J NANOMED, V7, P1805, DOI 10.2147/IJN.S28077
   Jenal U, 2009, CURR OPIN MICROBIOL, V12, P125, DOI 10.1016/j.mib.2009.02.002
   Jiang HQ, 2004, J APPL POLYM SCI, V93, P1411, DOI 10.1002/app.20561
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Khan MSY, 2002, PHARMAZIE, V57, P448
   Kiedrowski MR, 2011, ANN NY ACAD SCI, V1241, P104, DOI 10.1111/j.1749-6632.2011.06281.x
   Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763
   Klibanov AM, 2007, J MATER CHEM, V17, P2479, DOI 10.1039/b702079a
   Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628
   KOZMINYKH VO, 1993, PHARMAZIE, V48, P99
   Ma Y., 2012, PLOS ONE, V7
   Ma YB, 2012, ANTIMICROB AGENTS CH, V56, P5923, DOI 10.1128/AAC.01739-12
   Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159
   Mann EE, 2009, PLOS ONE, V4, pe5822, DOI DOI 10.1371/J0URNAL.P0NE.0005822
   Martinez JL, 2002, CLIN MICROBIOL REV, V15, P647, DOI 10.1128/CMR.15.4.647-679.2002
   Mathews SM, 2006, CORNEA, V25, P806, DOI 10.1097/01.ico.0000224636.57062.90
   McConnell SA, 2003, CLIN INFECT DIS, V37, P65, DOI 10.1086/375227
   McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x
   Mei L, 2011, DENT MATER, V27, P770, DOI 10.1016/j.dental.2011.03.017
   Menzies BE, 2003, CURR OPIN INFECT DIS, V16, P225, DOI 10.1097/01.qco.0000073771.11390.75
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Ni Eidhin Deirdre, 1998, Molecular Microbiology, V30, P245, DOI 10.1046/j.1365-2958.1998.01050.x
   Niel-Weise BS, 2007, INTENS CARE MED, V33, P2058, DOI 10.1007/s00134-007-0897-3
   OLSSON J, 1992, CARIES RES, V26, P428, DOI 10.1159/000261482
   Opperman TJ, 2009, ANTIMICROB AGENTS CH, V53, P4357, DOI 10.1128/AAC.00077-09
   Otto M, 2008, CURR TOP MICROBIOL, V322, P207
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Panmanee W, 2013, J BIOMOL SCREEN, V18, P820, DOI 10.1177/1087057113481499
   Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003
   PerezGiraldo C, 1997, J ANTIMICROB CHEMOTH, V39, P643, DOI 10.1093/jac/39.5.643
   Privett BJ, 2011, LANGMUIR, V27, P9597, DOI 10.1021/la201801e
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Roe D, 2008, J ANTIMICROB CHEMOTH, V61, P869, DOI 10.1093/jac/dkn034
   Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   Roosjen A, 2006, PROG COLL POL SCI S, V132, P138, DOI 10.1007/2882_026
   Sambanthamoorthy K, 2011, ANTIMICROB AGENTS CH, V55, P4369, DOI 10.1128/AAC.00583-11
   Song J, 2011, COLLOID SURFACE B, V82, P651, DOI 10.1016/j.colsurfb.2010.10.027
   Stallard CP, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0031-0
   Stevens KNJ, 2009, BIOMATERIALS, V30, P3682, DOI 10.1016/j.biomaterials.2009.03.054
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Stobie N, 2008, BIOMATERIALS, V29, P963, DOI 10.1016/j.biomaterials.2007.10.057
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705
   Sun HM, 2012, P NATL ACAD SCI USA, V109, P3469, DOI 10.1073/pnas.1201031109
   SWITALSKI LM, 1993, MOL MICROBIOL, V7, P99, DOI 10.1111/j.1365-2958.1993.tb01101.x
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   Tran PL, 2012, ANTIMICROB AGENTS CH, V56, P972, DOI 10.1128/AAC.05680-11
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Uckay I, 2009, ANN MED, V41, P109, DOI 10.1080/07853890802337045
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 85
TC 100
Z9 104
U1 2
U2 91
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2013
VL 14
IS 9
BP 18488
EP 18501
DI 10.3390/ijms140918488
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 274RN
UT WOS:000328623900066
PM 24018891
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Barros, J
   Grenho, L
   Manuel, CM
   Ferreira, C
   Melo, LF
   Nunes, OC
   Monteiro, FJ
   Ferraz, MP
AF Barros, Joana
   Grenho, Liliana
   Manuel, Candida M.
   Ferreira, Carla
   Melo, Luis F.
   Nunes, Olga C.
   Monteiro, Fernando J.
   Ferraz, Maria P.
TI A modular reactor to simulate biofilm development in orthopedic
   materials
SO INTERNATIONAL MICROBIOLOGY
LA English
DT Article
DE orthopedic materials; orthopedic conditions; modular reactors;
   continuous flow; biomaterials; biofilm formation
ID REINFORCED HYDROXYAPATITE COMPOSITES; STAPHYLOCOCCUS-EPIDERMIDIS
   BIOFILM; QUANTITATIVE-ANALYSIS; ADHESION; SURFACE; NANOHYDROXYAPATITE;
   KINETICS; MODEL; BONE
AB Surfaces of medical implants are generally designed to encourage soft- and/or hard-tissue adherence, eventually leading to tissue- or osseo-integration. Unfortunately, this feature may also encourage bacterial adhesion and biofilm formation. To understand the mechanisms of bone tissue infection associated with contaminated biomaterials, a detailed understanding of bacterial adhesion and subsequent biofilm formation on biomaterial surfaces is needed. In this study, a continuous-flow modular reactor composed of several modular units placed in parallel was designed to evaluate the activity of circulating bacterial suspensions and thus their predilection for biofilm formation during 72 h of incubation. Hydroxyapatite discs were placed in each modular unit and then removed at fixed times to quantify biofilm accumulation. Biofilm formation on each replicate of material, unchanged in structure, morphology, or cell density, was reproducibly observed. The modular reactor therefore proved to be a useful tool for following mature biofilm formation on different surfaces and under conditions similar to those prevailing near human-bone implants.
C1 [Barros, Joana; Grenho, Liliana; Monteiro, Fernando J.; Ferraz, Maria P.] INEB Inst Engn Biomed, Oporto, Portugal.
   [Barros, Joana; Grenho, Liliana; Monteiro, Fernando J.; Ferraz, Maria P.] Univ Porto, Dept Engn Met & Mat, Fac Engn, FEUP, P-4150180 Oporto, Portugal.
   [Ferraz, Maria P.] Univ Fernando Pessoa, CEBIMED, Ctr Estudos Biomed, Oporto, Portugal.
   [Barros, Joana; Manuel, Candida M.; Ferreira, Carla; Melo, Luis F.; Nunes, Olga C.] Univ Porto, Dept Chem Engn, LEPABE, Lab Proc Engn Environm Biotechnol & Energy, P-4150180 Oporto, Portugal.
   [Manuel, Candida M.] Univ Lusofona Porto, Oporto, Portugal.
RP Barros, J (reprint author), Univ Porto, INEB, Inst Biomed Engn, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM joanabarros@fe.up.pt
RI Ferraz, Maria/M-6316-2013; Grenho, Liliana/I-4540-2015; Melo,
   Luis/F-8119-2011
OI Ferraz, Maria/0000-0002-0274-106X; Grenho, Liliana/0000-0001-9476-2839;
   Melo, Luis/0000-0002-8469-4462; Duarte Manuel, Candida
   Maria/0000-0002-7030-1525; Monteiro, Fernando/0000-0002-1361-4605;
   Barros, Joana/0000-0002-8205-5675; Nunes, Olga/0000-0003-4742-2537
FU FEDER funds through COMPETE; FCT-Fundacao para a Ciencia e a Tecnologia
   [PTDC/SAU-BMA/111233/2009]
FX The authors acknowledge financial support for this work by a research
   grant to J. Banos from the FEDER funds through COMPETE and by
   FCT-Fundacao para a Ciencia e a Tecnologia in the framework of the
   project NanoBiofilm (PTDC/SAU-BMA/111233/2009). Also, the provision of
   nanoHA (nanoXIM) by FLUIDINOVA, SA (Maia-Portugal) is greatly
   acknowledged.
CR An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   Barros J, 2014, J BIOMATER APPL, V28, P1325, DOI 10.1177/0885328213507300
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   CHEATLE MD, 1991, ORTHOP CLIN N AM, V22, P539
   Costerton W, 2007, J CLIN INVEST, V11, P1466
   Cotter JJ, 2010, J APPL MICROBIOL, V109, P2105, DOI 10.1111/j.1365-2672.2010.04842.x
   Creach V, 2003, J MICROBIOL METH, V52, P19, DOI 10.1016/S0167-7012(02)00128-8
   Cvitkovitch DG, 2001, CRIT REV ORAL BIOL M, V12, P217, DOI 10.1177/10454411010120030201
   Darley ESR, 2004, J ANTIMICROB CHEMOTH, V53, P928, DOI 10.1093/jac/dkh191
   Ferraz MP, 2007, J BIOMED MATER RES A, V81A, P994, DOI 10.1002/jbm.a.31151
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Gattlen J, 2011, BIOFOULING, V27, P979, DOI 10.1080/08927014.2011.619657
   Gilmore BF, 2010, J BIOMED MATER RES B, V93B, P128, DOI 10.1002/jbm.b.31567
   Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0
   Grenho L, 2012, J BIOMED MATER RES A, V100A, P1823, DOI 10.1002/jbm.a.34139
   HUANG CT, 1992, BIOTECHNOL TECH, V6, P193
   Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0
   Lawrence JR, 2000, J MICROBIOL METH, V42, P215, DOI 10.1016/S0167-7012(00)00195-0
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   Manuel CM, 2007, WATER RES, V41, P551, DOI 10.1016/j.watres.2006.11.007
   Mittelman M.W., 1992, BIOFOULING, V6, P39
   Pereira MO, 2002, LETT APPL MICROBIOL, V34, P22, DOI 10.1046/j.1472-765x.2002.01030.x
   SANTOS JD, 1994, BIOMATERIALS, V15, P5, DOI 10.1016/0142-9612(94)90188-0
   Schetz J.A., 1999, FUNDAMENTALS FLUID M
   Shapiro JA, 2011, J MED MICROBIOL, V60, P950, DOI 10.1099/jmm.0.026013-0
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Simoes M, 2007, WATER SCI TECHNOL, V55, P437, DOI 10.2166/wst.2007.288
   Stoodley P, 2012, BIOMATERIALS SCI INT, P565
   Williams DL, 2011, CURR MICROBIOL, V62, P1657, DOI 10.1007/s00284-011-9908-2
   Williams DL, 2010, MICROSC MICROANAL, V16, P143, DOI 10.1017/S143192760999136X
NR 31
TC 7
Z9 7
U1 2
U2 10
PU VIGUERA EDITORES, S L
PI BARCELONA
PA PLAZA TETUAN, 7, BARCELONA, E-08010, SPAIN
SN 1139-6709
EI 1618-1905
J9 INT MICROBIOL
JI Int. Microbiol.
PD SEP
PY 2013
VL 16
IS 3
BP 191
EP 198
DI 10.2436/20.1501.01.193
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 275WM
UT WOS:000328709900006
PM 24568034
DA 2018-10-20
ER

PT J
AU Zustiak, SP
   Pubill, S
   Ribeiro, A
   Leach, JB
AF Zustiak, Silviya P.
   Pubill, Stephanie
   Ribeiro, Andreia
   Leach, Jennie B.
TI Hydrolytically Degradable Poly(ethylene glycol) Hydrogel Scaffolds as a
   Cell Delivery Vehicle: Characterization of PC12 Cell Response
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE neurotransplantation; stem cells; cell viability; neurite extension;
   differentiation
ID NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEURITE EXTENSION; PROGENITOR
   CELLS; SPINAL-CORD; IN-VITRO; GLYCOL)/POLY(L-LYSINE) HYDROGELS;
   PHEOCHROMOCYTOMA CELLS; MECHANICAL-PROPERTIES; PROCESS OUTGROWTH
AB The central nervous system (CNS) has a low intrinsic potential for regeneration following injury and disease, yet neural stem/progenitor cell (NPC) transplants show promise to provide a dynamic therapeutic in this complex tissue environment. Moreover, biomaterial scaffolds may improve the success of NPC-based therapeutics by promoting cell viability and guiding cell response. We hypothesized that a hydrogel scaffold could provide a temporary neurogenic environment that supports cell survival during encapsulation, and degrades completely in a temporally controlled manner to allow progression of dynamic cellular processes such as neurite extension. We utilized PC12 cells as a model cell line with an inducible neuronal phenotype to define key properties of hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds that impact cell viability and differentiation following release from the degraded hydrogel. Adhesive peptide ligands (RGDS, IKVAV, or YIGSR), were required to maintain cell viability during encapsulation; as compared to YIGSR, the RGDS, and IKVAV ligands were associated with a higher percentage of PC12 cells that differentiated to the neuronal phenotype following release from the hydrogel. Moreover, among the hydrogel properties examined (e.g., ligand type, concentration), total polymer density within the hydrogel had the most prominent effect on cell viability, with densities above 15% w/v leading to decreased cell viability likely due to a higher shear modulus. Thus, by identifying key properties of degradable hydrogels that affect cell viability and differentiation following release from the hydrogel, we lay the foundation for application of this system towards future applications of the scaffold as a neural cell delivery vehicle. (c) 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29:1255-1264, 2013
C1 [Zustiak, Silviya P.; Pubill, Stephanie; Ribeiro, Andreia; Leach, Jennie B.] UMBC, Dept Chem & Biochem Engn, Baltimore, MD 21250 USA.
RP Leach, JB (reprint author), UMBC, Dept Chem & Biochem Engn, 1000 Hilltop Circle, Baltimore, MD 21250 USA.
EM jleach@umbc.edu
FU NIH-NINDS [R01NS065205]; Henry Luce Foundation; UMBC-Wyeth Fellowship
FX We thank Shelby Vargo and Helena Gaifem for assistance with studies.
   This work was supported by NIH-NINDS (R01NS065205), the Henry Luce
   Foundation, and a UMBC-Wyeth Fellowship to Andreia Ribeiro.
CR An YH, 2006, BIOMED MATER, V1, pR38, DOI 10.1088/1748-6041/1/2/R02
   BADOYANNIS HC, 1991, MOL BRAIN RES, V11, P79, DOI 10.1016/0169-328X(91)90024-R
   Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Franks W, 2007, BIOSENS BIOELECTRON, V22, P1426, DOI 10.1016/j.bios.2006.06.031
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Hill CE, 2007, EUR J NEUROSCI, V26, P1433, DOI 10.1111/j.1460-9568.2007.05771.x
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Hynes SR, 2009, J BIOMED MATER RES A, V89A, P499, DOI 10.1002/jbm.a.31987
   Hynes SR, 2007, J BIOMAT SCI-POLYM E, V18, P1017, DOI 10.1163/156856207781494368
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Lepore A C, 2006, Neuroscience, V142, P287, DOI 10.1016/j.neuroscience.2005.12.067
   Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2
   Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7
   Nakaji-Hirabayashi T, 2008, BIOMACROMOLECULES, V9, P1411, DOI 10.1021/bm701423d
   Namba RM, 2009, ACTA BIOMATER, V5, P1884, DOI 10.1016/j.actbio.2009.01.036
   Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje
   Park KH, 2004, J BIOSCI BIOENG, V97, P374, DOI 10.1263/jbb.97.374
   Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649
   Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347
   Warchol ME, 2002, J NEUROSCI, V22, P2607, DOI 10.1523/JNEUROSCI.22-07-02607.2002
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Wilson JT, 2008, ADV DRUG DELIVER REV, V60, P124, DOI 10.1016/j.addr.2007.08.034
   Young TH, 2000, J BIOMED MATER RES, V52, P748, DOI 10.1002/1097-4636(20001215)52:4<748::AID-JBM20>3.0.CO;2-1
   Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291
   Zustiak SP, 2010, ACTA BIOMATER, V6, P3404, DOI 10.1016/j.actbio.2010.03.040
   Zustiak SP, 2010, SOFT MATTER, V6, P3609, DOI [10.1039/c0sm00111b, 10.1039/C0SM00111B]
   Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q
NR 64
TC 16
Z9 17
U1 1
U2 36
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8756-7938
EI 1520-6033
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD SEP
PY 2013
VL 29
IS 5
BP 1255
EP 1264
DI 10.1002/btpr.1761
PG 10
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 241OM
UT WOS:000326176600020
PM 24474590
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Liu, WT
   Cai, Q
   Zhang, F
   Wei, Y
   Zhang, XH
   Wang, Y
   Deng, XM
   Deng, XL
AF Liu, Wentao
   Cai, Qing
   Zhang, Feng
   Wei, Yan
   Zhang, Xuehui
   Wang, Ying
   Deng, Xuming
   Deng, Xuliang
TI Dose-dependent enhancement of bone marrow stromal cells adhesion,
   spreading and osteogenic differentiation on atmospheric plasma-treated
   poly(l-lactic acid) nanofibers
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE plasma treatment; poly(l-lactic acid) nanofibers; Biocompatibility;
   surface modification; osteogenic differentiation
ID MESENCHYMAL STEM-CELLS; DIELECTRIC BARRIER DISCHARGE; SURFACE
   MODIFICATION; CYTOSKELETAL TENSION; INTEGRIN BINDING; SCAFFOLDS; SHAPE;
   PERFORMANCE; SUBSTRATE; DESIGN
AB Although poly(l-lactic acid) nanofibers are known to promote osteogenic differentiation of bone marrow stromal cells, their relative hydrophobicity and surface inertia tend to hinder their biomedical application. We explored a feasible and effective technique to improve the bioactivity and biocompatibility of poly(l-lactic acid) fibers for further application in regenerative medicine. A low-temperature atmospheric plasma was used to treat poly(l-lactic acid) nanofibers for 1, 5, and 10 min, and the surface properties and dose-dependent effects on the behavior of bone marrow stromal cells were studied. Both the amino group content and surface hydrophilicity of the nanofibers increased with treatment time, whereas the spreading and proliferation of bone marrow stromal cells were greatest on nanofibers which had been treated for 5 min, followed by samples treated for 1 and 10 min. The quantitative reverse transcription-polymerase chain reaction analysis of the bone marrow stromal cells on the 5-min-treated nanofibers had the highest expression level of osteogenic marker genes including RUNX2, BMP2, ALP, COL1A1, OPN, and OCN. The nanofibers treated for 5 min also promoted the high levels of alkaline phosphatase activity. These results suggest the exertion of dose-dependent effects by atmospheric plasma treatment on the surface of poly(l-lactic acid) nanofibers, and that this treatment is a feasible and effective technique to improve biomaterial biocompatibility and promotion of osteogenic differentiation of bone marrow stromal cells.
C1 [Liu, Wentao; Wei, Yan; Wang, Ying; Deng, Xuliang] Peking Univ, Sch & Hosp Stomatol, Dept Geriatr Dent, Beijing 100081, Peoples R China.
   [Liu, Wentao; Deng, Xuming] Jilin Univ, Coll Vet Med, Changchun 130023, Peoples R China.
   [Cai, Qing] Beijing Univ Chem Technol, Minist Educ, Key Lab Carbon Fiber & Funct Polymers, Beijing 100029, Peoples R China.
   [Zhang, Feng] Beijing Armed Police Force, Hosp 2, Oral Clin, Beijing, Peoples R China.
   [Zhang, Xuehui] Tsinghua Univ, Dept Mat Sci & Engn, Beijing, Peoples R China.
RP Deng, XL (reprint author), Peking Univ, Sch & Hosp Stomatol, Dept Geriatr Dent, Beijing 100081, Peoples R China.
EM kqdengxuliang@bjmu.edu.cn
RI Wei, Yen/H-5329-2012
FU National Basic Research Program of China [2012CB933900]; National
   Natural Science Foundation of China [81171000]; National High Technology
   Research and Development Program of China [2012AA022501]
FX This study was supported by the National Basic Research Program of China
   (2012CB933900), National Natural Science Foundation of China (81171000),
   and the National High Technology Research and Development Program of
   China (2012AA022501).
CR ANDRADE J D, 1991, Journal of Biomaterials Science Polymer Edition, V2, P161
   Barradas AMC, 2012, ACTA BIOMATER, V8, P2969, DOI 10.1016/j.actbio.2012.04.021
   Beskardes IG, 2009, J BIOACT COMPAT POL, V24, P507, DOI 10.1177/0883911509349311
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   Byun Y, 2009, CHEMOSPHERE, V75, P815, DOI 10.1016/j.chemosphere.2009.01.040
   Chen WL, 2007, EXP EYE RES, V85, P259, DOI 10.1016/j.exer.2007.04.012
   Chim H, 2003, J BIOMED MATER RES A, V65A, P327, DOI 10.1002/jbm.a.10478
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   D'Sa RA, 2010, ACTA BIOMATER, V6, P2609, DOI 10.1016/j.actbio.2010.01.015
   Dong KY, 2012, TALANTA, V89, P33, DOI 10.1016/j.talanta.2011.11.040
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Faeda RS, 2009, J ORAL MAXIL SURG, V67, P1706, DOI 10.1016/j.joms.2009.03.046
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Gamboa-Martinez TC, 2011, J BIOACT COMPAT POL, V26, P464, DOI 10.1177/0883911511419834
   Guarino V, 2011, J BIOACT COMPAT POL, V26, P144, DOI 10.1177/0883911511399410
   Hosseinkhani H, 2006, J BIOACT COMPAT POL, V21, P277, DOI 10.1177/0883911506066934
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Li SJ, 2009, J BIOACT COMPAT POL, V24, P84, DOI 10.1177/0883911509103357
   Ma JY, 2011, ANN BIOMED ENG, V39, P14, DOI 10.1007/s10439-010-0106-3
   Ma X, 2011, J BIOACT COMPAT POL, V26, P335, DOI 10.1177/0883911511407402
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mwale F, 2006, BIOMATERIALS, V27, P2258, DOI 10.1016/j.biomaterials.2005.11.006
   Pavlica S, 2009, BIOMATERIALS, V30, P6514, DOI 10.1016/j.biomaterials.2009.08.024
   Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Re'em T, 2012, ADV BIOCHEM ENG BIOT, V126, P227, DOI 10.1007/10_2011_118
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   Shah A, 2011, J TISSUE ENG REGEN M, V5, P301, DOI 10.1002/term.316
   Tamargo-Martinez K, 2011, J CHROMATOGR A, V1218, P3781, DOI 10.1016/j.chroma.2011.04.028
   Tseng PC, 2012, BIOMATERIALS, V33, P556, DOI 10.1016/j.biomaterials.2011.09.090
   Wan YQ, 2006, BIOMATERIALS, V27, P2699, DOI 10.1016/j.biomaterials.2005.12.007
   Wang B, 2011, J MECH BEHAV BIOMED, V4, P600, DOI 10.1016/j.jmbbm.2011.01.008
   Wang HY, 2012, ADV MATER, V24, P3315, DOI 10.1002/adma.201104967
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Zhu HB, 2011, BIOMATERIALS, V32, P4744, DOI 10.1016/j.biomaterials.2011.03.030
NR 38
TC 5
Z9 6
U1 0
U2 30
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD SEP
PY 2013
VL 28
IS 5
BP 453
EP 467
DI 10.1177/0883911513494623
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 217YG
UT WOS:000324398600004
DA 2018-10-20
ER

PT J
AU Yu, Y
   Zhang, YH
   Martin, JA
   Ozbolat, IT
AF Yu, Yin
   Zhang, Yahui
   Martin, James A.
   Ozbolat, Ibrahim T.
TI Evaluation of Cell Viability and Functionality in Vessel-like
   Bioprintable Cell-Laden Tubular Channels
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE bioprinting; cell-laden hydrogels; vascular constructs; tissue
   engineering
ID FREEFORM FABRICATION; MAMMALIAN-CELLS; STEM-CELLS; TISSUE; DEPOSITION;
   TECHNOLOGY; CHALLENGES; SCAFFOLDS; HYDROGELS; SYSTEM
AB Organ printing is a novel concept recently introduced in developing artificial three-dimensional organs to bridge the gap between transplantation needs and organ shortage. One of the major challenges is inclusion of blood-vessellike channels between layers to support cell viability, postprinting functionality in terms of nutrient transport, and waste removal. In this research, we developed a novel and effective method to print tubular channels encapsulating cells in alginate to mimic the natural vascular system. An experimental investigation into the influence on cartilage progenitor cell (CPCs) survival, and the function of printing parameters during and after the printing process were presented. CPC functionality was evaluated by checking tissue-specific genetic marker expression and extracellular matrix production. Our results demonstrated the capability of direct fabrication of cell-laden tubular channels by our newly designed coaxial nozzle assembly and revealed that the bioprinting process could induce quantifiable cell death due to changes in dispensing pressure, coaxial nozzle geometry, and biomaterial concentration. Cells were able to recover during incubation, as well as to undergo differentiation with high-level cartilage-associated gene expression. These findings may not only help optimize our system but also can be applied to biomanufacturing of 3D functional cellular tissue engineering constructs for various organ systems.
C1 [Yu, Yin; Zhang, Yahui; Ozbolat, Ibrahim T.] Univ Iowa, BioMfG Lab, Ctr Comp Aided Design, Iowa City, IA 52242 USA.
   [Yu, Yin] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.
   [Yu, Yin; Martin, James A.] Univ Iowa, Dept Orthopaed & Rehabil, Iowa City, IA 52242 USA.
   [Zhang, Yahui; Ozbolat, Ibrahim T.] Univ Iowa, Dept Mech & Ind Engn, Iowa City, IA 52242 USA.
RP Ozbolat, IT (reprint author), Univ Iowa, BioMfG Lab, Ctr Comp Aided Design, Iowa City, IA 52242 USA.
EM ibrahim-ozbolat@uiowa.edu
RI Yu, Yin/K-9865-2013; zhang, yahui/F-7983-2018
OI Yu, Yin/0000-0002-0381-1437; zhang, yahui/0000-0002-0436-1634
FU National Institutes of Health (NIH); Institute for Clinical and
   Translational Science (ICTS) [ULIRR024979]
FX This research has been supported by the National Institutes of Health
   (NIH) and the Institute for Clinical and Translational Science (ICTS)
   grant number ULIRR024979. The authors also would like to thank Mr. John
   Bierman for his expertise and help in confocal imaging.
CR Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Barron JA, 2004, THIN SOLID FILMS, V453, P383, DOI 10.1016/j.tsf.2003.11.161
   Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f
   Boland T, 2003, ANAT REC PART A, V272A, P497, DOI 10.1002/ar.a.10059
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004
   Chhabra RP, 2008, NON-NEWTONIAN FLOW AND APPLIED RHEOLOGY: ENGINEERING APPLICATIONS, 2ND EDITION, P1
   Cohen DL, 2006, TISSUE ENG, V12, P1325, DOI 10.1089/ten.2006.12.1325
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]
   Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762
   Duan B, 2012, J BIOMED MATER RES A, V101A, P1255
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Khalil S, 2007, MAT SCI ENG C-BIO S, V27, P469, DOI 10.1016/j.msec.2006.05.023
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Lin Y., 2009, J APPL PHYS, V106
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Mironov V, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022001
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004
   Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Norton I. T., 2011, PRACTICAL FOOD RHEOL
   Odde DJ, 1999, TRENDS BIOTECHNOL, V17, P385, DOI 10.1016/S0167-7799(99)01355-4
   Ozawa F, 2013, J BIOSCI BIOENG, V115, P459, DOI 10.1016/j.jbiosc.2012.10.014
   Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912
   Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843
   Tang QO, 2012, EXPERT OPIN BIOL TH, V12, P1361, DOI 10.1517/14712598.2012.707182
   Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83
   Wu PK, 2001, THIN SOLID FILMS, V398, P607, DOI 10.1016/S0040-6090(01)01347-5
   Xiang L, 2012, ANN PLAS SURG, V68, P229, DOI 10.1097/SAP.0b013e3182384068
   Xu CX, 2012, BIOTECHNOL BIOENG, V109, P3152, DOI 10.1002/bit.24591
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yan YN, 2003, MATER LETT, V57, P2623, DOI 10.1016/S0167-577X(02)01339-3
   Yu Y., 2012, THESIS U IOWA IOWA C
   Zhang Y., 2013, ASME J NANO IN PRESS
   Zhang YH, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025004
NR 38
TC 42
Z9 45
U1 3
U2 81
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
EI 1528-8951
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD SEP
PY 2013
VL 135
IS 9
AR 091011
DI 10.1115/1.4024575
PG 9
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 240HJ
UT WOS:000326085700011
PM 23719889
OA Green Published
DA 2018-10-20
ER

PT J
AU Eslaminejad, MB
   Bordbar, S
   Nazarian, H
AF Eslaminejad, Mohamadreza Baghaban
   Bordbar, Sima
   Nazarian, Hamid
TI Odontogenic differentiation of dental pulp-derived stem cells on
   tricalcium phosphate scaffolds
SO JOURNAL OF DENTAL SCIENCES
LA English
DT Article
DE alkaline phosphatase; dental pulp stem cells; gene expression;
   mineralization; odontoblast; tricalcium phosphate
ID IMPERFECTA TYPE-II; IN-VITRO; ALKALINE-PHOSPHATASE; BONE REGENERATION;
   TISSUE FORMATION; DENTINOGENESIS; PHOSPHOPROTEIN; CULTURE; GENE;
   SEQUENCE
AB Background/purpose: The regeneration of dental-related tissue is a major problem in dentistry. Thus, it is beneficial to develop dental constructs that are fabricated with dental pulp stem cells (DPSCs) and an appropriate scaffold. The present study investigates the level of odontogenic differentiation of human DPSCs on tricalcium phosphate (TCP) scaffolds.
   Materials and methods: We isolated pulp stem cells from human third molars and culture-expanded them through several successive subcultures. The cells from passage 3 were then loaded onto TCP scaffolds and treated with odontogenic supplements (OSs) that included vitamin D3 for a period of 21 days. DPSCs cultivated on TCP without OS, a monolayer culture treated with OS, and normal pulp tissue were the controls. We compared the groups in terms of odontogenic differentiation markers.
   Results: Alkaline phosphatase (ALP) activity and the amount of culture mineralization, as well as the expression levels of dentin sialophosphoprotein (DSPP) and dentin matrix acidic phosphoprotein 1 (DMP1) genes tended to be significantly higher in the three-dimensional (3D) cultures treated with OS compared to those 3D cultures without OS and the monolayer culture with OS (P < 0.05). The differentiation level in 3D cultures was considerably lower than that in pulp tissue extracted from third molars (P < 0.05). 3D culture on TCP without OS showed a level of differentiation indicating an odontogenic property of the TCP biomaterial.
   Conclusion: The 3D culture system improves odontogenic differentiation of DPSCs. The differentiation level of the cells in 3D culture is significantly lower than that of odontoblasts present in pulp tissue. TCP biomaterial possesses an odontogenic-inducing property. Copyright (C) 2013, Association for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.
C1 [Eslaminejad, Mohamadreza Baghaban; Bordbar, Sima; Nazarian, Hamid] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran.
RP Eslaminejad, MB (reprint author), Royan Inst, POB 19395-4644, Tehran, Iran.
EM eslami@royaninstitute.org
RI Baghaban Eslaminejad, Mohamadreza/S-3645-2017
OI Baghaban Eslaminejad, Mohamadreza/0000-0002-1036-0072; Nazarian,
   Hamid/0000-0001-9920-5054
CR About I, 2000, EXP CELL RES, V258, P33, DOI 10.1006/excr.2000.4909
   Alliot-Licht B, 2001, ARCH ORAL BIOL, V46, P221, DOI 10.1016/S0003-9969(00)00115-1
   APLIN HM, 1995, GENOMICS, V30, P347, DOI 10.1006/geno.1995.9867
   Batouli S, 2003, J DENT RES, V82, P976, DOI 10.1177/154405910308201208
   Butler WT, 1998, EUR J ORAL SCI, V106, P204, DOI 10.1111/j.1600-0722.1998.tb02177.x
   Couble ML, 2000, CALCIFIED TISSUE INT, V66, P129, DOI 10.1007/PL00005833
   d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Eslaminejad Mr Baghaban, 2010, J Dent (Tehran), V7, P185
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hirst KL, 1997, GENOMICS, V42, P38, DOI 10.1006/geno.1997.4700
   KASUGAI S, 1993, ARCH ORAL BIOL, V38, P769, DOI 10.1016/0003-9969(93)90073-U
   Khojasteh A, 2008, ORAL SURG ORAL MED O, V106, P356, DOI 10.1016/j.tripleo.2007.10.017
   Kitamura C, 1999, J DENT RES, V78, P673, DOI 10.1177/00220345990780020701
   LINDE A, 1978, J BIOL BUCCALE, V6, P293
   MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835
   Onishi T, 1999, ARCH ORAL BIOL, V44, P361, DOI 10.1016/S0003-9969(99)00007-2
   Panagakos FS, 1998, J ENDODONT, V24, P171, DOI 10.1016/S0099-2399(98)80177-5
   Ruch JV, 1998, BIOCHEM CELL BIOL, V76, P923, DOI 10.1139/bcb-76-6-923
   Shiba H, 1998, J CELL PHYSIOL, V174, P194
   SMITH AJ, 1995, INT J DEV BIOL, V39, P273
   THESLEFF I, 1995, INT J DEV BIOL, V39, P35
   Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034
   Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009
   Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759
   WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439
   Wiltfang Joerg, 2003, Clin Oral Implants Res, V14, P213, DOI 10.1034/j.1600-0501.2003.140212.x
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
   Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357
   Zhang WB, 2006, TISSUE ENG, V12, P2813, DOI 10.1089/ten.2006.12.2813
   Zheng LQ, 2011, BIOMATERIALS, V32, P7053, DOI [10.1016/j.biomaterials.2011.06.094, 10.1016/j.biomaterials.2011.06.004]
NR 31
TC 7
Z9 7
U1 0
U2 9
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1991-7902
J9 J DENT SCI
JI J. Dental Sci.
PD SEP
PY 2013
VL 8
IS 3
BP 306
EP 313
DI 10.1016/j.jds.2013.03.005
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 237BM
UT WOS:000325843200012
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Rae, M
   Folch, H
   Moniz, MBJ
   Wolff, CW
   McCormack, GP
   Rindi, F
   Johnson, MP
AF Rae, Margaret
   Folch, Helka
   Moniz, Monica B. J.
   Wolff, Carsten W.
   McCormack, Grace P.
   Rindi, Fabio
   Johnson, Mark P.
TI Marine bioactivity in Irish waters
SO PHYTOCHEMISTRY REVIEWS
LA English
DT Review
DE Marine biodiscovery; Biodiscovery; Bioprospecting; Biomaterial; Drug
ID SECONDARY METABOLITES; INVASIVE HISTORY; IRELAND; BIOLUMINESCENCE;
   RHODOPHYTA; TRACKING; REVEALS; SPONGES; ISLAND
AB In 2009, the Marine Biodiscovery Laboratory was set-up at the Marine Institute with funds from the Marine Institute and the Beaufort Marine Biodiscovery Research Programme. The Marine Biodiscovery Laboratory has already processed over 130 marine specimens from coastal zones and from the Deep Sea (a parts per thousand currency sign3,000 m) within the Marine Irish Exclusive Economic Zone. Beaufort Biodiscovery funded taxonomists are involved in species identification and elucidation of evolutionary relationships. The project approach links sampling, systematics, extraction, microbial metagenomics and biomaterials. The Laboratory consists of approximately 56 m(2) including an extraction and a bioassay suite. The Laboratory samples and assesses marine biological diversity geared towards developing natural products for drug discovery, advanced material applications and bio-medical devices. Samples are tracked from sample log-into right through to extraction and bioassay using a customised Marine Biodiscovery Database. The extraction procedure is described along with the anti-bacterial bioassay selected for routine use. The Marine Biodiscovery Database manages the data generated and links the data collected by the project's stakeholders to existing biodiversity, genetic and chemical resources. The system uses in-house developed software tools to merge biodiscovery data collected with other MI resources and external databases and for the data mining and visualisation of biogeographical, genetic and chemical information aimed at the identification of potential biodiversity and bioactivity "hotspots".
C1 [Rae, Margaret; Moniz, Monica B. J.; Wolff, Carsten W.; McCormack, Grace P.; Johnson, Mark P.] Natl Univ Ireland, Ryan Inst, Galway, Ireland.
   [Rae, Margaret; Folch, Helka] Inst Marine, Marine Biodiscovery Lab, Oranmore, Galway, Ireland.
   [Folch, Helka] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.
   [Rindi, Fabio] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.
RP Rae, M (reprint author), Natl Univ Ireland, Ryan Inst, Galway, Ireland.
EM margaret.rae@nuigalway.ie
RI Johnson, Mark/B-5017-2009
OI Johnson, Mark/0000-0002-5078-1410; McCormack, Grace/0000-0003-4960-5185
CR Amante C., 2009, NGDC24 NOAA NESDIS
   Baumgartner V, 2007, BIOACTIVITY BASED AN
   Bell JJ, 2007, J MAR BIOL ASSOC UK, V87, P1655, DOI 10.1017/S0025315407058171
   Bell JJ, 2000, HYDROBIOLOGIA, V440, P55, DOI 10.1023/A:1004145011422
   Blight AJ, 2009, MAR ECOL PROG SER, V396, P235, DOI 10.3354/meps08379
   COTTON AD, 1912, P R IR ACAD, V31, P1
   Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483
   De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462
   Ebada SS, 2008, NAT PROTOC, V3, P1820, DOI 10.1038/nprot.2008.182
   Guiry M, 1998, SEAWEED RESOURCES WO, P210
   Guiry MD, 2011, SPECIES VERSION 1 0
   Hardy FG, 2003, PHYCOLOGIA BRITANNIC, P1
   Harvey W. H., 1849, PHYCOLOGIA BRITANNIC, P217
   Harvey WH, 1847, PHYCOLOGIA BRIT, P73
   Harvey WH, 1850, PLATES, P295
   HARVEY WH, 1841, MANUAL BRIT ALGAE
   Harvey WH, 1848, PHYCOLOGIA BRIT, P147
   Harvey WH, 1844, ANN MAG NAT HIST, V14, P27
   Holdt SL, 2011, J APPL PHYCOL, V23, P543, DOI 10.1007/s10811-010-9632-5
   Houssen W. E., 2006, METHODS BIOTECHNOLOG, V20
   Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025
   Hu ZM, 2010, J PHYCOL, V46, P889, DOI 10.1111/j.1529-8817.2010.00877.x
   Kelly NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013832
   Kim JH, 2007, J PHYCOL, V43, P1310, DOI 10.1111/j.1529-8817.2007.00410.x
   Kloppel A, 2008, JPC-J PLANAR CHROMAT, V21, P431, DOI 10.1556/JPC.21.2008.6.7
   KONNECKER G, 1973, P ROY IRISH ACAD B, V73, P451
   Kreiss W, 2010, ANAL BIOANAL CHEM, V398, P2081, DOI 10.1007/s00216-010-4086-9
   Loughnane CJ, 2008, PHYCOLOGIA, V47, P416, DOI 10.2216/07-61.1
   McIvor L, 2001, MOL ECOL, V10, P911, DOI 10.1046/j.1365-294X.2001.01240.x
   Mohrle V, 2007, ANAL BIOANAL CHEM, V388, P1117, DOI 10.1007/s00216-007-1300-5
   Picton B, 2007, SPONGE BIODIVERSITY
   Provan J, 2005, MOL ECOL, V14, P793, DOI 10.1111/j.1365-294X.2005.02447.x
   Provan J, 2005, MOL ECOL, V14, P189, DOI 10.1111/j.1365-294X.2004.02384.x
   Provan J, 2008, DIVERS DISTRIB, V14, P343, DOI 10.1111/j.1472-4642.2007.00420.x
   Provan J, 2012, P ROY SOC B-BIOL SCI, V279, P39, DOI 10.1098/rspb.2011.0536
   Rindi F, 2004, BIODIVERS CONSERV, V13, P471, DOI 10.1023/B:BIOC.0000009496.32334.82
   Rindi F, 2011, MARINE BIOACTIVE COM, P1
   Smit AJ, 2004, J APPL PHYCOL, V16, P245, DOI 10.1023/B:JAPH.0000047783.36600.ef
   Stephens J., 1912, P ROY IRISH ACAD, V31, P1
   Tierney MS, 2010, BOT MAR, V53, P387, DOI 10.1515/BOT.2010.044
   Van Soest RWM, 1981, SPONGES ROARING WATE, V12, P35
   Van Soest RWM, 1980, CO CORK IRISH NAT J, V20, P1
   VANSOEST RWM, 1994, SPONGES IN TIME AND SPACE, P213
   VLAAMS INSTITUUT VOOR DE ZEE (VLIZ), 2011, MAR BOUND GEOD VERS
   WHO, 2003, WHO GUID GOOD AGR CO
   Wilkes RJ, 2005, EUR J PHYCOL, V40, P53, DOI 10.1080/09670260400024634
NR 46
TC 7
Z9 7
U1 3
U2 33
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1568-7767
EI 1572-980X
J9 PHYTOCHEM REV
JI Phytochem. Rev.
PD SEP
PY 2013
VL 12
IS 3
BP 555
EP 565
DI 10.1007/s11101-012-9227-7
PG 11
WC Plant Sciences
SC Plant Sciences
GA 221JE
UT WOS:000324653400015
DA 2018-10-20
ER

PT J
AU Bigham-Sadegh, A
   Shadkhast, M
   Khalegi, MR
AF Bigham-Sadegh, Amin
   Shadkhast, Mohammad
   Khalegi, Mahmoud-Reza
TI Demineralized calf foetal growth plate effects on experimental bone
   healing in rabbit model
SO VETERINARSKI ARHIV
LA English
DT Article
DE demineralized calf fetal growth plate; bone healing; rabbit
ID ARTICULAR-CARTILAGE; GRAFT SUBSTITUTES; BIOMECHANICAL EVALUATION;
   HYDROXYAPATITE; XENOGRAFT; BIOLOGY; REPAIR
AB The following study was designed to evaluate demineralized calf foetal growth plate (DCFGP) effects on bone healing process. A critical size defect (10 mm) was created in the radial diaphysis of 20 rabbits and then supplied with DCFGP (treatment group, n = 10) or the defect was left empty (control group, n = 10). Radiographs of each forelimb were taken postoperatively on the 1st day and at the 2nd, 4th, 6th and 8th weeks post injury to evaluate bone formation, union and remodeling of the defect. The operated radiuses were removed on the 56th postoperative day and were evaluated for histopathological criteria. This study demonstrated that DCFGP, as a xenogenic biomaterial, could promote bone regeneration in critical size defects with a high regenerative capacity, and could be an attractive alternative for reconstruction of the major diaphyseal defects of the long bones in animal models.
C1 [Bigham-Sadegh, Amin; Khalegi, Mahmoud-Reza] Shahrekord Univ, Fac Vet Med, Dept Vet Surg & Radiol, Shahrekord, Iran.
   [Shadkhast, Mohammad] Shahrekord Univ, Fac Vet Med, Dept Vet Anat & Embryol, Shahrekord, Iran.
RP Bigham-Sadegh, A (reprint author), Shahrekord Univ, Fac Vet Med, Dept Vet Surg & Radiol, Shahrekord, Iran.
EM dr.bigham@gmail.com
FU Veterinary School, Shahrekord University
FX The authors would like to thank the authorities of the Veterinary
   School, Shahrekord University for their financial support and
   cooperation.
CR An YH, 1999, ANIMAL MODELS ORTHOP
   Anderson HC, 2000, J HISTOCHEM CYTOCHEM, V48, P1493, DOI 10.1177/002215540004801106
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Bigham AS, 2011, RES VET SCI, V91, P306, DOI 10.1016/j.rvsc.2010.12.001
   Bigham AS, 2009, CELL TISSUE BANK, V10, P33, DOI 10.1007/s10561-008-9107-y
   BOLANDER ME, 1986, J BONE JOINT SURG AM, V68A, P1264, DOI 10.2106/00004623-198668080-00018
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Dehghani SN, 2008, CELL TISSUE BANK, V9, P91, DOI 10.1007/s10561-008-9062-7
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Flecknell P. A., 2009, LAB ANIMAL ANAESTHES
   Fleming JE, 2000, ORTHOP CLIN N AM, V31, P357, DOI 10.1016/S0030-5898(05)70156-5
   FRIEDLAENDER G E, 1987, Journal of Bone and Joint Surgery American Volume, V69, P786
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   HEIPLE KG, 1987, ORTHOP CLIN N AM, V18, P179
   Inoue K, 1997, J BONE MINER RES, V12, P989, DOI 10.1359/jbmr.1997.12.6.989
   Jin DD, 1991, CHUNG HUA WAI KO TSA, V29, P312
   Karaismailoglu Turgut Nedim, 2002, Acta Orthop Traumatol Turc, V36, P147
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   Loredo GA, 1996, AM J VET RES, V57, P554
   Moghadam HG, 2004, J ORAL MAXIL SURG, V62, P202, DOI 10.1016/j.joms.2003.10.002
   Oshin AO, 2007, VET COMP ORTHOPAED, V20, P151, DOI 10.1160/VCOT-07-02-0018
   Parikh SN, 2002, ORTHOPEDICS, V25, P1301
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   Rigalli A, 2009, EXPERIMENTAL SURGICAL MODELS IN THE LABORATORY RAT, P1, DOI 10.1201/9781420093278
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   Rosier RN, 1998, CLIN ORTHOP RELAT R, pS294
   TANAKA T, 1995, J ORTHOPAED RES, V13, P464, DOI 10.1002/jor.1100130322
   URIST M. F., 1983, P SOC EXP BIOL MED, P194
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
NR 31
TC 6
Z9 6
U1 0
U2 1
PU UNIV ZAGREB VET FACULTY
PI ZAGREB
PA P O BOX 190, 41001 ZAGREB, CROATIA
SN 0372-5480
EI 1331-8055
J9 VET ARHIV
JI Vet. Arh.
PD SEP-OCT
PY 2013
VL 83
IS 5
BP 525
EP 536
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA 237ZO
UT WOS:000325910400006
DA 2018-10-20
ER

PT J
AU Hassert, R
   Beck-Sickinger, AG
AF Hassert, Rayk
   Beck-Sickinger, Annette G.
TI Tuning peptide affinity for biofunctionalized surfaces
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Article
DE Peptide; Surface coating; Biomaterial; Biomimetic; Bioinert; Mussel;
   GEPI; Immobilization; Phage display
ID COATED TITANIUM IMPLANTS; BONE MORPHOGENETIC PROTEIN-2; SELF-ASSEMBLED
   MONOLAYERS; COLI CELL-SURFACE; IN-VIVO; ESCHERICHIA-COLI; BINDING
   PEPTIDES; ADHESIVE PROTEIN; OXIDE BINDING; REPEATING POLYPEPTIDES
AB The control of the interaction between biological systems and surfaces plays a major role in the development of bioactive implants. Random absorbance of different compounds of the body liquids attach at the implant site after surgery. This protein layer triggers the activation of immune cells and is a breeding ground for pathogens, which may induce inflammation processes. Many efforts have been made to block these fouling processes such as PEGylation and unspecific coatings. These systems lead to bioinert implant surfaces that lower the inflammation potential of implanted materials. In contrast, the biomimetic approach attempts the functionalization of implant surfaces with compounds such as peptides, proteins, or sugars that form an artificial layer on the implant that corresponds to the naturally occurring extracellular matrix. This enables the controlled recruitment of cells that improve the healing processes or enhance the osseointegration into the implanted material. An improved connection of implants with cells that enhances the healing processes or tightens the connection of implants with the surrounding tissue is obtained by this approach. However, for bioactive functionalization of implant materials, efficient and robust immobilization techniques are required. Peptides. owing to their low-toxicity and their multifunctionality are interesting agents that can act as molecular glue to surfaces. Here, an overview is provided of the development of surface binding peptides, the molecular mechanisms of peptide-surface interactions, and the application of surface binding peptides in the development of multifunctional biomaterials that facilitate beneficial characteristics in vitro and in vivo. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Hassert, Rayk; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany.
RP Beck-Sickinger, AG (reprint author), Univ Leipzig, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.
EM beck-sickinger@uni-leipzig.de
FU DFG [TRR67, A4]; Graduate School BuildMona; European Union; Free State
   of Saxony (ESF)
FX The financial support of the DFG (TRR67, A4) and the Graduate School
   BuildMona is kindly acknowledged. The project was funded by the European
   Union and the Free State of Saxony (ESF).
CR Ahrens VM, 2012, FUTURE MED CHEM, V4, P1567, DOI [10.4155/FMC.12.76, 10.4155/fmc.12.76]
   Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h
   Bachmann M, 2010, ANGEW CHEM INT EDIT, V49, P9530, DOI 10.1002/anie.201000984
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Baneyx F, 2007, CURR OPIN BIOTECH, V18, P312, DOI 10.1016/j.copbio.2007.04.008
   Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927
   Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049
   Blauenstein P, 2004, CANCER BIOTHER RADIO, V19, P181, DOI 10.1089/108497804323071959
   Borghouts C, 2005, EXPERT OPIN BIOL TH, V5, P783, DOI 10.1517/14712598.5.6.783
   Brady D, 2009, BIOTECHNOL LETT, V31, P1639, DOI 10.1007/s10529-009-0076-4
   Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269
   BROWN S, 1992, P NATL ACAD SCI USA, V89, P8651, DOI 10.1073/pnas.89.18.8651
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   Cha T, 2005, PROTEOMICS, V5, P416, DOI 10.1002/pmic.200400948
   Chen H., 2008, LANGMUIR, V25, P1588
   Chen HB, 2008, LANGMUIR, V24, P6852, DOI 10.1021/la800314p
   Choe WS, 2007, LANGMUIR, V23, P11347, DOI 10.1021/la702414m
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   DOORBAR J, 1994, J MOL BIOL, V244, P361, DOI 10.1006/jmbi.1994.1736
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Elmengaard B, 2005, J BIOMED MATER RES A, V75A, P249, DOI 10.1002/jbm.a.30301
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   FRANKEL RB, 1979, SCIENCE, V203, P1355, DOI 10.1126/science.203.4387.1355
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Gentilucci L, 2010, CURR PHARM DESIGN, V16, P3185, DOI 10.2174/138161210793292555
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Goede K, 2004, NANO LETT, V4, P2115, DOI 10.1021/nl048829p
   Greene AH, 2008, CLIN ORTHOP RELAT R, V466, P1699, DOI 10.1007/s11999-008-0269-5
   Gunawan RC, 2007, LANGMUIR, V23, P10635, DOI 10.1021/1a701415z
   Guyomard A, 2008, ADV FUNCT MATER, V18, P758, DOI 10.1002/adfm.200700793
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   Hassert R, 2012, CHEM BIODIVERS, V9, P2648, DOI 10.1002/cbdv.201200290
   Hassert R, 2012, BIOCONJUGATE CHEM, V23, P2129, DOI 10.1021/bc3003875
   Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hnilova M, 2008, LANGMUIR, V24, P12440, DOI 10.1021/la801468c
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Hwang DS, 2010, BIOMATERIALS, V31, P1080, DOI 10.1016/j.biomaterials.2009.10.041
   Jennissen HP, 2007, MATERIALWISS WERKST, V38, P1035, DOI 10.1002/mawe.200700247
   Jung YS, 2012, BIOMATERIALS, V33, P295, DOI 10.1016/j.biomaterials.2011.09.051
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Khatayevich D, 2010, ACTA BIOMATER, V6, P4634, DOI 10.1016/j.actbio.2010.06.004
   Khoo X, 2010, BIOMATERIALS, V31, P9285, DOI 10.1016/j.biomaterials.2010.08.031
   Khoo XJ, 2009, J AM CHEM SOC, V131, P10992, DOI 10.1021/ja9020827
   Krauland EM, 2007, BIOTECHNOL BIOENG, V97, P1009, DOI 10.1002/bit.21341
   Kristensen J. B., 2009, BIOFOULING, V26, P141
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Kuboyama M, 2012, BIOCHEM ENG J, V66, P73, DOI 10.1016/j.bej.2012.04.019
   Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172
   Lai M, 2011, BIOMACROMOLECULES, V12, P1097, DOI 10.1021/bm1014365
   Lawson MC, 2009, BIOMACROMOLECULES, V10, P2221, DOI 10.1021/bm900410a
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee DW, 2012, BONE, V50, P974, DOI 10.1016/j.bone.2012.01.007
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Liang MN, 2000, P NATL ACAD SCI USA, V97, P13092, DOI 10.1073/pnas.230451697
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   LU ZJ, 1995, BIO-TECHNOL, V13, P366, DOI 10.1038/nbt0495-366
   Luckarift HR, 2006, SMALL, V2, P640, DOI 10.1002/smll.200500376
   MANN S, 1990, NATURE, V343, P258, DOI 10.1038/343258a0
   Masuko T, 2005, BIOMATERIALS, V26, P5339, DOI 10.1016/j.biomaterials.2005.01.062
   Matinlinna JP, 2004, INT J PROSTHODONT, V17, P155
   McCusker CF, 2002, BIOORG MED CHEM LETT, V12, P547, DOI 10.1016/S0960-894X(01)00799-5
   Messersmith PB, 2010, SCIENCE, V328, P180, DOI 10.1126/science.1187598
   Meyers SR, 2012, CHEM REV, V112, P1615, DOI 10.1021/cr2000916
   Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716
   Noberini R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028611
   Oh EJ, 2008, BIOCONJUGATE CHEM, V19, P2401, DOI 10.1021/bc800255y
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Park KM, 2011, J MATER CHEM, V21, P15906, DOI 10.1039/c1jm13869c
   Patwardhan SV, 2012, J AM CHEM SOC, V134, P6244, DOI 10.1021/ja211307u
   Petrie TA, 2008, BIOMATERIALS, V29, P2849, DOI 10.1016/j.biomaterials.2008.03.036
   PHIZICKY EM, 1995, MICROBIOL REV, V59, P94
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Sano K, 2005, SMALL, V1, P826, DOI 10.1002/smll.200500010
   Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Schlenoff JB, 1995, J AM CHEM SOC, V117, P12528, DOI 10.1021/ja00155a016
   Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209
   SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028
   Seker UOS, 2009, BIOMACROMOLECULES, V10, P250, DOI 10.1021/bm8009895
   Seker UOS, 2007, LANGMUIR, V23, P7895, DOI 10.1021/la700446g
   Seker UOS, 2011, MOLECULES, V16, P1426, DOI 10.3390/molecules16021426
   Sengupta A, 2008, LANGMUIR, V24, P2000, DOI 10.1021/la702079e
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   Steinhagen M, 2011, CHEMBIOCHEM, V12, P2426, DOI 10.1002/cbic.201100434
   Tamerler C, 2010, BIOPOLYMERS, V94, P78, DOI 10.1002/bip.21368
   Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   Terskikh AV, 1997, P NATL ACAD SCI USA, V94, P1663, DOI 10.1073/pnas.94.5.1663
   Thai CK, 2004, BIOTECHNOL BIOENG, V87, P129, DOI 10.1002/bit.20149
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   WAITE JH, 1987, CHEMTECH, V17, P692
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   Whaley SR, 2000, NATURE, V405, P665
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yoshinari M., 2009, BIOFOULING, V26, P103
NR 117
TC 7
Z9 7
U1 3
U2 61
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0939-6411
EI 1873-3441
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD SEP
PY 2013
VL 85
IS 1
SI SI
BP 69
EP 77
DI 10.1016/j.ejpb.2013.02.006
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 215RF
UT WOS:000324227300011
PM 23454053
DA 2018-10-20
ER

PT J
AU Nakaoka, R
   Hirano, Y
   Mooney, DJ
   Tsuchiya, T
   Matsuoka, A
AF Nakaoka, Ryusuke
   Hirano, Yoshiaki
   Mooney, David J.
   Tsuchiya, Toshie
   Matsuoka, Atsuko
TI Study on the potential of RGD- and PHSRN-modified alginates as
   artificial extracellular matrices for engineering bone
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Bone tissue engineering; Polymeric scaffolds; Peptide modification; Cell
   differentiation; 3D Cell culture
ID SER-ARG-ASN; CELL-ADHESION; SYNERGY SITE; IN-VITRO; FIBRONECTIN;
   HYDROGELS; DIFFERENTIATION; SURFACES; IMMOBILIZATION; BIOMATERIALS
AB Alginate is a polysaccharide that can be crosslinked by divalent cations, such as calcium ions, to form a gel. Chemical modification is typically used to improve its cell adhesive properties for tissue engineering applications. In this study, alginates were modified with peptides containing RGD (arginine-glycine-aspartic acid) or PHSRN (proline-histidine-serine-arginine-asparagine) sequences from fibronectin to study possible additive and synergistic effects on adherent cells. Alginates modified with each peptide were mixed at different ratios to form gels containing various concentrations and spacing between the RGD and PHSRN sequences. When normal human osteoblasts (NHOsts) were cultured on or in the gels, the ratio of RGD to PHSRN was found to influence cell behaviors, especially differentiation. NHOsts cultured on gels composed of RGD- and PHSRN-modified alginates showed enhanced differentiation when the gels contained > 33 % RGD-alginate, suggesting the relative distribution of the peptides and the presentation to cells are important parameters in this regulation. NHOsts cultured in gels containing both RGD- and PHSRN-alginates also demonstrated a similar enhancement tendency of calcium deposition that was dependent on the peptide ratio in the gel. However, calcium deposition was greater when cells were cultured in the gels, as compared to on the gels. These results suggest that modifying this biomaterial to more closely mimic the chemistry of natural cell adhesive proteins, (e.g., fibronectin) may be useful in developing scaffolds for bone tissue engineering and provide three-dimensional cell culture systems which more closely mimic the environment of the human body.
C1 [Nakaoka, Ryusuke; Tsuchiya, Toshie; Matsuoka, Atsuko] Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan.
   [Hirano, Yoshiaki] Kansai Univ, Fac Chem Mat & Bioengn, Dept Chem & Mat Engn, Suita, Osaka 5648680, Japan.
   [Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
RP Nakaoka, R (reprint author), Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.
EM nakaoka@nihs.go.jp; matsuoka@nihs.go.jp
FU Health and Labour Sciences Research Grants for Research on Regulatory
   Science of Pharmaceuticals and Medical Devices by Ministry of Health,
   Labour and Welfare [H24-Iyaku-Shitei-018]
FX This work was partly supported by Health and Labour Sciences Research
   Grants for Research on Regulatory Science of Pharmaceuticals and Medical
   Devices by Ministry of Health, Labour and Welfare
   (H24-Iyaku-Shitei-018). The authors are also grateful to Dr. Kuen Yong
   Lee (Hanyang University, South Korea), Dr. Hyun-Joon Kong (University of
   Illinois, USA), and Dr. Takuya Matsumoto (Okayama University, Japan) for
   many helpful discussions.
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Comisar WA, 2006, BIOMATERIALS, V27, P2322, DOI 10.1016/j.biomaterials.2005.10.037
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1
   HIRANO Y, 1993, J BIOMAT SCI-POLYM E, V4, P235, DOI 10.1163/156856293X00546
   Hishikawa K, 2004, BIOCHEM BIOPH RES CO, V317, P1103, DOI 10.1016/j.bbrc.2004.03.165
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee MH, 2007, J BIOMED MATER RES A, V81A, P2007
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mardilovich A, 2006, LANGMUIR, V22, P3259, DOI 10.1021/la052756n
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   Mooney DJ, 1999, SCI AM, V280, P38
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Ochsenhirt SE, 2006, BIOMATERIALS, V27, P3863, DOI 10.1016/j.biomaterials.2005.12.012
   Ohyama M, 2002, J PERIODONTOL, V73, P543, DOI 10.1902/jop.2002.73.5.543
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Shibasaki Y, 2011, BIOPOLYMERS, V96, P302, DOI 10.1002/bip.21551
   Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Winters BS, 2006, MOL BIOL CELL, V17, P3386, DOI 10.1091/mbc.E05-09-0849
NR 33
TC 22
Z9 22
U1 2
U2 46
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1434-7229
J9 J ARTIF ORGANS
JI J. Artif. Organs
PD SEP
PY 2013
VL 16
IS 3
BP 284
EP 293
DI 10.1007/s10047-013-0703-7
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 228JY
UT WOS:000325183500003
PM 23512309
DA 2018-10-20
ER

PT J
AU Honda, H
   Tamai, N
   Naka, N
   Yoshikawa, H
   Myoui, A
AF Honda, Hirotsugu
   Tamai, Noriyuki
   Naka, Norifumi
   Yoshikawa, Hideki
   Myoui, Akira
TI Bone tissue engineering with bone marrow-derived stromal cells
   integrated with concentrated growth factor in Rattus norvegicus calvaria
   defect model
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Concentrated growth factors; Bone tissue engineering; Rat calvaria
   defect; Bone marrow stromal cells; hTERT-E6/E7
ID PLATELET-RICH PLASMA; FIBRIN PRF; IN-VITRO; STEM-CELLS; PROLIFERATION;
   DIFFERENTIATION; REGENERATION; OSTEOBLASTS; BIOLOGY
AB Concentrated growth factor (CGF) is an autologous leukocyte-rich and platelet-rich fibrin (L-PRF) biomaterial termed "second-generation platelet concentrate". CGF contains autologous osteoinductive platelet growth factors and an osteoconductive fibrin matrix. The purpose of this study was to assess the ability of CGF combined with bone marrow stromal cells (BMSCs) to heal critical-size rat calvaria defects in vivo and to modulate the proliferation and osteogenic differentiation of mesenchymal stem cells (MSCs) in vitro. In the in-vivo study, the CGF group regenerated bone better than the control group, and combined therapy with CGF and BMSCs almost completely repaired critical-size bone defects within 12 weeks after surgery. In the in-vitro study, the CGF extract, at concentrations between 1 and 10 %, promoted proliferation, osteogenic maturation, and mineralization of hTERT-E6/E7 human MSCs in a dose-dependent manner but had an inhibitory effect at higher concentrations. In conclusion, a CGF extract promoted the proliferation, osteogenic maturation, and mineralization of mesenchymal stem cells in vitro, and combination therapy with CGF and BMSCs resulted in excellent healing of critical-size bone defects in vivo.
C1 [Honda, Hirotsugu; Myoui, Akira] Osaka Univ Hosp, Dept Med Innovat, Med Ctr Translat & Clin Res, Suita, Osaka 5650871, Japan.
   [Tamai, Noriyuki; Naka, Norifumi; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed, Suita, Osaka 5650871, Japan.
RP Myoui, A (reprint author), Osaka Univ Hosp, Dept Med Innovat, Med Ctr Translat & Clin Res, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.
EM hhonda@ort.med.osaka-u.ac.jp; myoi@hp-mctr.med.osaka-u.ac.jp
RI Myoui, Akira/E-8296-2010
FU Ministry of Education, Culture, Sports, Science, and Technology, Japan
   [23390364]; Terumo Life Science Foundation
FX We thank Dr Junya Toguchida, Kyoto University, for kindly providing the
   hTERT-E6/E7 cells and Mrs Mari Shinkawa for technical assistance with
   the histological study. This study was supported by a Grant-in-Aid for
   Scientific Research (no. 23390364) from the Ministry of Education,
   Culture, Sports, Science, and Technology, Japan, and by a special
   research subsidy from Terumo Life Science Foundation. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR BROWN LF, 1993, AM J PATHOL, V142, P273
   Choi BH, 2005, INT J ORAL MAX SURG, V34, P420, DOI 10.1016/j.ijom.2004.10.018
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Freymiller EG, 2004, J ORAL MAXIL SURG, V62, P484, DOI 10.1016/j.joms.2003.08.021
   Graziani F, 2006, CLIN ORAL IMPLAN RES, V17, P212, DOI 10.1111/j.1600-0501.2005.2005.01203.x
   He L, 2009, ORAL SURG ORAL MED O, V108, P707, DOI 10.1016/j.tripleo.2009.06.044
   Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7
   Pietrzak WS, 2005, J CRANIOFAC SURG, V16, P1043, DOI 10.1097/01.scs.0000186454.07097.bf
   Plachokova AS, 2008, CLIN ORAL IMPLAN RES, V19, P539, DOI 10.1111/j.1600-0501.2008.01525.x
   Retamoso LB, 2010, ANAT REC, V293, P195, DOI 10.1002/ar.21035
   Schmitz JP, 2001, J ORAL MAXIL SURG, V59, P1119, DOI 10.1053/joms.2001.26801
   Sohn DS, 2011, IMPLANT DENT, V20, P389, DOI 10.1097/ID.0b013e31822f7a70
   Sverzut CE, 2008, INT J EXP PATHOL, V89, P91, DOI 10.1111/j.1365-2613.2007.00569.x
   Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010
NR 22
TC 19
Z9 28
U1 6
U2 23
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1434-7229
EI 1619-0904
J9 J ARTIF ORGANS
JI J. Artif. Organs
PD SEP
PY 2013
VL 16
IS 3
BP 305
EP 315
DI 10.1007/s10047-013-0711-7
PG 11
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 228JY
UT WOS:000325183500005
PM 23700004
DA 2018-10-20
ER

PT J
AU Montanari, E
   Meier, RPH
   Mahou, R
   Borcard, F
   Bollinger, A
   Wandrey, C
   Muller, Y
   Gonelle-Gispert, C
   Seebach, JD
   Buhler, LH
AF Montanari, Elisa
   Meier, Raphael P. H.
   Mahou, Redouan
   Borcard, Francoise
   Bollinger, Annalena
   Wandrey, Christine
   Muller, Yannick
   Gonelle-Gispert, Carmen
   Seebach, Joerg D.
   Buhler, Leo H.
TI Alginate-PEG biomaterial for cell microencapsulation and
   xenotransplantation
SO XENOTRANSPLANTATION
LA English
DT Meeting Abstract
CT Joint Congress of 12th International-Xenotransplantation-Association and
   Organ Transplantation in ABO-incompatible and Hyperimmunized Recipients
CY NOV 10-13, 2013
CL Osaka, JAPAN
SP Int Xenotransplantat Assoc, Transplantat Soc, Int Xenotransplantat Assoc
C1 [Montanari, Elisa; Meier, Raphael P. H.; Bollinger, Annalena; Gonelle-Gispert, Carmen; Buhler, Leo H.] Univ Hosp, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland.
   [Montanari, Elisa; Meier, Raphael P. H.; Bollinger, Annalena; Muller, Yannick; Gonelle-Gispert, Carmen; Seebach, Joerg D.; Buhler, Leo H.] Fac Med, Geneva, Switzerland.
   [Mahou, Redouan; Borcard, Francoise; Wandrey, Christine] Ecole Polytech Fed Lausanne, Lab Chem Biotechnol, Lausanne, Switzerland.
   [Muller, Yannick; Seebach, Joerg D.] Univ Hosp, Div Immunol & Allergy, Geneva, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0908-665X
EI 1399-3089
J9 XENOTRANSPLANTATION
JI Xenotransplantation
PD SEP
PY 2013
VL 20
IS 5
SI SI
BP 355
EP 355
PG 1
WC Medicine, Research & Experimental; Transplantation
SC Research & Experimental Medicine; Transplantation
GA 224YG
UT WOS:000324928400122
DA 2018-10-20
ER

PT J
AU Kishida, A
AF Kishida, Akio
TI Decellularized xenogeneic tissues as a novel biomaterial
SO XENOTRANSPLANTATION
LA English
DT Meeting Abstract
CT Joint Congress of 12th International-Xenotransplantation-Association and
   Organ Transplantation in ABO-incompatible and Hyperimmunized Recipients
CY NOV 10-13, 2013
CL Osaka, JAPAN
SP Int Xenotransplantat Assoc, Transplantat Soc, Int Xenotransplantat Assoc
C1 [Kishida, Akio] Tokyo Med & Dent Univ, Tokyo, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0908-665X
EI 1399-3089
J9 XENOTRANSPLANTATION
JI Xenotransplantation
PD SEP
PY 2013
VL 20
IS 5
SI SI
BP 362
EP 362
PG 1
WC Medicine, Research & Experimental; Transplantation
SC Research & Experimental Medicine; Transplantation
GA 224YG
UT WOS:000324928400141
DA 2018-10-20
ER

PT J
AU Kim, GD
   Yang, H
   Park, HR
   Park, CS
   Park, YS
   Lee, SE
AF Kim, Gun-Dong
   Yang, Hana
   Park, Hye Rim
   Park, Cheung-Seog
   Park, Yong Seek
   Lee, Seung Eun
TI Evaluation of immunoreactivity of in vitro and in vivo models against
   bacterial synthesized cellulose to be used as a prosthetic biomaterial
SO BIOCHIP JOURNAL
LA English
DT Article
DE Gluconacetobacter xylinus; Bacterial cellulose (BC); Biomaterials;
   Immunoreactivity; Human umbilical vein endothelial cells (HUVECs);
   Lipopolysaccharide (LPS)
ID HUMAN ENDOTHELIAL-CELLS; MICROBIAL CELLULOSE; CYTOKINE PRODUCTION;
   INTERFERON-GAMMA; UP-REGULATION; ROLES; BIOSYNTHESIS; MICROSURGERY;
   STIMULATION; APOPTOSIS
AB Prosthetic biomaterials are required to be non-toxic, non-thrombogenic, and non-immunogenic. Bacterial cellulose (BC) synthesized by Gluconacetobacter xylinus has recently been studied as a biocompatible material due to its unique features such as high purity, crystallinity, biodegradability, and tensile strength as compared to plant cellulose. Although BC has high potential to be used as biomaterial, its toxicity and immunoreactivity have not been properly studied yet. In this report, we investigated the immunoreactivity of BC in vitro in human umbilical vein endothelial cells (HUVECs) and in vivo using BALB/c mice. We report that BC does not induce apoptosis and necrosis in HUVECs and does not stimulate immune response in both HUVECs and BALB/c mice models. These results suggest that BC may be widely used as a biocompatible biomaterial for tissue engineering and biosensors.
C1 [Kim, Gun-Dong; Yang, Hana; Park, Hye Rim; Park, Cheung-Seog; Park, Yong Seek; Lee, Seung Eun] Kyung Hee Univ, Sch Med, Dept Microbiol, Seoul 130701, South Korea.
RP Park, YS (reprint author), Kyung Hee Univ, Sch Med, Dept Microbiol, Seoul 130701, South Korea.
EM yongseek@khu.ac.kr; eunlee@khu.ac.kr
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science and Technology [2011-0011748]
FX This work was supported Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education, Science and Technology (No. 2011-0011748).
CR Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   DEBEAUX AC, 1995, J INTERF CYTOK RES, V15, P441, DOI 10.1089/jir.1995.15.441
   Dimmeler S, 2000, CIRC RES, V87, P434
   Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478
   Falcao SC, 2008, ACTA CIR BRAS, V23, P184, DOI 10.1590/S0102-86502008000200012
   Fink H, 2011, J BIOMED MATER RES A, V97A, P52, DOI 10.1002/jbm.a.33031
   GALANOS C, 1977, INFECT IMMUN, V16, P407
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Jeong SI, 2010, MOL CELL TOXICOL, V6, P373, DOI 10.1007/s13273-010-0049-7
   Jeong SI, 2012, MOL CELL TOXICOL, V8, P119, DOI 10.1007/s13273-012-0015-7
   Jeong SI, 2011, MOL CELL TOXICOL, V7, P127, DOI 10.1007/s13273-011-0017-x
   Kim SY, 2006, APPL BIOCHEM BIOTECH, V131, P705, DOI 10.1385/ABAB:131:1:705
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Lau RKL, 2007, J NANOSCI NANOTECHNO, V7, P452, DOI 10.1166/jnn.2007.110
   LE JM, 1986, J IMMUNOL, V136, P4525
   Lee SE, 2011, TOXICOL LETT, V201, P240, DOI 10.1016/j.toxlet.2011.01.006
   Liang Y, 2009, ELECTROCHEM COMMUN, V11, P1018, DOI 10.1016/j.elecom.2009.03.001
   MACKENSEN A, 1991, BLOOD, V78, P3254
   Muller D, 2013, CARBOHYD POLYM, V94, P655, DOI 10.1016/j.carbpol.2013.01.041
   MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493
   OSULLIVAN ST, 1995, ANN SURG, V222, P482
   Park YS, 2007, ARTERIOSCL THROM VAS, V27, P1319, DOI 10.1161/ATVBAHA.106.132837
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0
   Schumann DA, 2005, ABSTR PAP AM CHEM S, V229, pU300
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   Teeri TT, 2007, TRENDS BIOTECHNOL, V25, P299, DOI 10.1016/j.tibtech.2007.05.002
   Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089
   Wang BQ, 2000, TALANTA, V51, P565, DOI 10.1016/S0039-9140(99)00315-X
   Wang L, 2012, CELL IMMUNOL, V274, P98, DOI 10.1016/j.cellimm.2012.01.006
   Yang H, 2011, J GINSENG RES, V35, P352, DOI 10.5142/jgr.2011.35.3.352
   YANG HY, 1989, J IMMUNOL, V142, P1710
   Zhao QT, 2012, CHIN J NAT MEDICINES, V10, P53, DOI [10.1016/S1875-5364(12)60012-0, 10.3724/SP.J.1009.2012.00053]
NR 40
TC 10
Z9 10
U1 0
U2 18
PU KOREAN BIOCHIP SOCIETY-KBCS
PI SEOUL
PA KOREA SCI & TECHNOL CENT, #310, 635-4, YEOGSAM-DONG, KANGNAM-GU, SEOUL,
   135-703, SOUTH KOREA
SN 1976-0280
J9 BIOCHIP J
JI BioChip J.
PD SEP
PY 2013
VL 7
IS 3
BP 201
EP 209
DI 10.1007/s13206-013-7302-9
PG 9
WC Biochemical Research Methods; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 221BF
UT WOS:000324631500002
DA 2018-10-20
ER

PT J
AU Osman, RB
   Elkhadem, AH
   Ma, SY
   Swain, MV
AF Osman, Reham B.
   Elkhadem, Amr H.
   Ma, Sunyoung
   Swain, Michael V.
TI Titanium Versus Zirconia Implants Supporting Maxillary Overdentures:
   Three-Dimensional Finite Element Analysis
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE finite element analysis; implant materials; implant overdentures;
   maxilla; titanium; zirconia
ID CRYSTAL SAPPHIRE IMPLANTS; COMMERCIALLY PURE TITANIUM; DENTAL IMPLANTS;
   IN-VITRO; MANDIBULAR OVERDENTURES; BONE PHYSIOLOGY; STRESS-ANALYSIS;
   FOLLOW-UP; PERSPECTIVES; BIOMATERIAL
AB Purpose: The purpose of this study was to compare the stress and strain occurring in peri-implant bone and implants used to support maxillary overdentures. Three-dimensional finite element analysis (3D FEA) was used to compare one-piece zirconia and titanium implants. Materials and Methods: Two types of implants were simulated using a 3D FEA model: one-piece zirconia and titanium implants (diameter, 3.8 x 11.5 mm) with 2.25-mm diameter ball abutments. In each simulation four implants were placed bilaterally in the canine/premolar region of an edentulous maxillary model. Static loads were applied axially and 20 degrees buccolingually on the buccal slope of the lingual cusps of posterior teeth of the first quadrant. Von Mises stresses and equivalent strains generated in peri-implant bone and first principal stresses in the implants were calculated. Results: Comparable stress and strain values were shown in the peri-implant bone for both types of implants. The maximum equivalent strain produced in the peri-implant region was mostly within the range for bone augmentation. Under oblique loading, maximum von Mises stresses and equivalent strain were more evident at the neck of the most distal implant on the loaded side. Under axial load, the stress and strain were transferred to the peri-implant bone around the apex of the implant. Maximum tensile stresses that developed for either material were well below their fracture strength. The highest stresses were mainly located at the distobuccal region of the neck for the two implant materials under both loading conditions. Conclusions: From a biomechanical point of view, ceramic implants made from yttrium-stabilized tetragonal polycrystalline zirconia may be a potential alternative to conventional titanium implants for the support of overdentures. This is particularly relevant for a select group of patients with a proven allergy to titanium. Prospective clinical studies are still required to confirm these in vitro results. Different simulations presenting various cortical bone thicknesses and implant designs are required to provide a better understanding of the biomechanics of zirconia implants.
C1 [Osman, Reham B.; Ma, Sunyoung; Swain, Michael V.] Univ Otago, Sir John Walsh Res Inst, Sch Dent, Oral Implantol Res Grp, Dunedin, New Zealand.
   [Osman, Reham B.; Elkhadem, Amr H.] Cairo Univ, Dept Removable Prosthodont, Cairo, Egypt.
RP Swain, MV (reprint author), Univ Otago, Sir John Walsh Res Inst, Sch Dent, 280 Great King St, Dunedin, New Zealand.
EM michael.swain@otago.ac.nz
RI Swain, Michael/J-7266-2017
CR Akagawa Y, 1998, J PROSTHET DENT, V80, P551, DOI 10.1016/S0022-3913(98)70031-9
   AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   Berge TI, 2000, CLIN ORAL IMPLAN RES, V11, P154, DOI 10.1034/j.1600-0501.2000.011002154.x
   Black J., 1998, HDB BIOMATERIAL PROP, P340
   Caglar A, 2011, INT J ORAL MAX IMPL, V26, P961
   Caglar A, 2010, INT J ORAL MAX IMPL, V25, P95
   Chaturvedi T P, 2009, Indian J Dent Res, V20, P91
   Cheng YY, 2010, J PROSTHET DENT, V103, P309, DOI 10.1016/S0022-3913(10)60064-9
   Choi AH, 2012, ACTA ODONTOL SCAND, V70, P353, DOI 10.3109/00016357.2011.600723
   Chun HJ, 2005, J ORAL REHABIL, V32, P193, DOI 10.1111/j.1365-2842.2004.01407.x
   Clelland N L, 1993, J Prosthodont, V2, P183, DOI 10.1111/j.1532-849X.1993.tb00405.x
   Degidi M, 2006, J PERIODONTOL, V77, P73, DOI 10.1902/jop.2006.77.1.73
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Depprich Rita, 2008, Head Face Med, V4, P25, DOI 10.1186/1746-160X-4-25
   du Preez L A, 2007, SADJ, V62, P24
   Egusa H, 2008, J PROSTHET DENT, V100, P344, DOI 10.1016/S0022-3913(08)60233-4
   FARTASH B, 1995, CLIN ORAL IMPLAN RES, V6, P181, DOI 10.1034/j.1600-0501.1995.060307.x
   Fartash B, 1996, CLIN ORAL IMPLAN RES, V7, P220, DOI 10.1034/j.1600-0501.1996.070304.x
   Flatebo RS, 2006, J PERIODONTOL, V77, P1201, DOI 10.1902/jop.2006.050406
   Frost HM, 2004, ANGLE ORTHOD, V74, P3
   Frost HM, 2001, ANAT RECORD, V262, P398, DOI 10.1002/ar.1049
   FROST HM, 1992, BONE MINER, V19, P257, DOI 10.1016/0169-6009(92)90875-E
   Gahlert M, 2009, CLIN ORAL IMPLAN RES, V20, P1247, DOI 10.1111/j.1600-0501.2009.01734.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Geng JP, 2001, J PROSTHET DENT, V85, P585, DOI 10.1067/mpr.2001.115251
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Grossner-Schreiber B, 2006, CLIN ORAL IMPLAN RES, V17, P736, DOI 10.1111/j.1600-0501.2006.01277.x
   Gross MD, 2001, J PROSTHET DENT, V85, P442, DOI 10.1067/mpr.2001.115253
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Hoffmann O, 2008, INT J ORAL MAX IMPL, V23, P691
   ICHIKAWA Y, 1992, J PROSTHET DENT, V68, P322, DOI 10.1016/0022-3913(92)90338-B
   Javed F, 2013, CLIN IMPLANT DENT R, V15, P47, DOI 10.1111/j.1708-8208.2010.00330.x
   Jemt T, 1992, Int J Oral Maxillofac Implants, V7, P162
   Johns R B, 1992, Int J Oral Maxillofac Implants, V7, P513
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   KAMPOSIORA P, 1994, J PROSTHET DENT, V71, P435, DOI 10.1016/0022-3913(94)90179-1
   KAWAHARA H, 1980, J BIOMED MATER RES, V14, P597, DOI 10.1002/jbm.820140506
   Koca OL, 2005, J PROSTHET DENT, V93, P38, DOI 10.1016/j.prosdent.2004.10.001
   Kohal RJ, 2009, CLIN IMPLANT DENT R, V11, P323, DOI 10.1111/j.1708-8208.2008.00116.x
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Kohal RJ, 2004, INT J PERIODONT REST, V24, P147
   Kohal RJ, 2002, INT J PROSTHODONT, V15, P189
   KOTH DL, 1988, J PROSTHET DENT, V60, P226, DOI 10.1016/0022-3913(88)90321-6
   Koutayas SO, 2009, INT J ESTHET DENT, V4, P348
   Meyer U, 2001, J CRANIO MAXILL SURG, V29, P100, DOI 10.1054/jcms.2001.0198
   Narhi TO, 2001, INT J ORAL MAX IMPL, V16, P259
   Okumura N, 2010, J PROSTHODONT RES, V54, P133, DOI 10.1016/j.jpor.2009.12.004
   Oliva J, 2007, INT J ORAL MAX IMPL, V22, P430
   Oliva J, 2008, INT J PERIODONT REST, V28, P609
   Osman RB, 2013, INT J ORAL MAX IMPL, V28, pE1, DOI 10.11607/jomi.2303
   Ozkurt Z, 2011, J ORAL IMPLANTOL, V37, P367, DOI 10.1563/AAID-JOI-D-09-00079
   Payer M, 2013, CLIN ORAL IMPLAN RES, V24, P569, DOI 10.1111/j.1600-0501.2012.02425.x
   Payne AGT, 2001, CLIN ORAL IMPLAN RES, V12, P179, DOI 10.1034/j.1600-0501.2001.012002179.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Saab EX, 2007, J PROSTHET DENT, V97, P85
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   SCLAROFF A, 1990, ORAL SURG ORAL MED O, V70, P141, DOI 10.1016/0030-4220(90)90106-3
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, P13
   Shinya A, 2011, J ORAL IMPLANTOL, V37, P133, DOI 10.1563/AAID-JOI-D-09-00046
   Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x
   Siddiqi A, 2011, CLIN ORAL IMPLAN RES, V22, P673, DOI 10.1111/j.1600-0501.2010.02081.x
   Steflik DE, 1995, J ORAL IMPLANTOL, V11, P8
   Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   van Steenberghe D, 2001, J CLIN PERIODONTOL, V28, P628, DOI 10.1034/j.1600-051x.2001.028007628.x
NR 68
TC 9
Z9 10
U1 1
U2 10
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD SEP-OCT
PY 2013
VL 28
IS 5
BP E198
EP E208
DI 10.11607/jomi.3019
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 222LY
UT WOS:000324733800001
PM 24066336
OA Bronze
DA 2018-10-20
ER

PT J
AU Sclar, AG
   Best, SP
AF Sclar, Anthony G.
   Best, Steven P.
TI The Combined Use of rhBMP-2/ACS, Autogenous Bone Graft, a Bovine Bone
   Mineral Biomaterial, Platelet-Rich Plasma, and Guided Bone Regeneration
   at Nonsubmerged Implant Placement for Supracrestal Bone Augmentation. A
   Case Report
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE autogenous bone graft; bovine bone biomaterial; cross-linked collagen
   barrier membrane; guided bone regeneration; nonsubmerged implant
   placement; platelet-rich plasma; recombinant human bone morphogenetic
   protein-2; vertical bone augmentation
ID MORPHOGENETIC PROTEIN-2 RHBMP-2; RECONSTRUCTION; DEFECTS; COMBINATION;
   INDUCTION; HUMANS; DOG
AB This case report presents the clinical application and outcomes of the use of a combined approach to treat a patient with a severe alveolar defect. Recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge carrier, along with autogenous bone graft, bovine bone mineral, platelet-rich plasma, and guided bone regeneration, were used simultaneous with nonsubmerged implant placement. At 1 year postsurgery, healthy peri-implant soft tissues and radiographically stable peri-implant crestal bone levels were observed along with locally increased radiographic bone density. In addition, a cone beam computed tomography (CBCT) scan demonstrated apparent supracrestal peri-implant bone augmentation with the appearance of normal alveolar ridge contours, including the facial bone wall.
C1 [Sclar, Anthony G.; Best, Steven P.] Nova Southeastern Coll Dent Med, Dept Oral & Maxillofacial Surg, Ft Lauderdale, FL USA.
   [Sclar, Anthony G.] Sclar Oral Surg & Implant Dent Ctr, Miami, FL USA.
RP Sclar, AG (reprint author), 7600 Red Rd,101, Miami, FL 33143 USA.
EM anthonysclar@aol.com
CR Baldini N, 2011, DENT MATER, V27, P61, DOI 10.1016/j.dental.2010.10.017
   Barboza EP, 2000, J PERIODONTOL, V71, P488, DOI 10.1902/jop.2000.71.3.488
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018
   Boyne PJ, 2001, INT J PERIODONT REST, V21, P333
   Carter TG, 2008, J ORAL MAXIL SURG, V66, P1417, DOI 10.1016/j.joms.2008.01.058
   Cochran DL, 1997, INT J ORAL MAX IMPL, V12, P739
   Howell TH, 1997, INT J PERIODONT REST, V17, P125
   Jovanovic SA, 2007, CLIN ORAL IMPLAN RES, V18, P224, DOI 10.1111/j.1600-0501.2006.01324.x
   Jung RE, 2005, CLIN ORAL IMPLAN RES, V16, P676, DOI 10.1111/j.1600-0501.2005.01183.x
   Jung RE, 2003, CLIN ORAL IMPLAN RES, V14, P556, DOI 10.1034/j.1600-0501.2003.00921.x
   Jung RE, 2009, CLIN ORAL IMPLAN RES, V20, P660, DOI 10.1111/j.1600-0501.2008.01648.x
   Kang PD, 2007, CONNECT TISSUE RES, V48, P171, DOI 10.1080/01926230701221295
   Konishi S, 2002, J SPINAL DISORD TECH, V15, P237, DOI 10.1097/01.BSD.000018290.84059.64
   Park EJ, 2008, INT J ORAL MAX IMPL, V23, P818
   Schuckert KH, 2009, TISSUE ENG PT A, V15, P493, DOI 10.1089/ten.tea.2008.0033
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   Tarnow DP, 2010, INT J PERIODONT REST, V30, P139
   Triplett R, 2008, TISSUE ENG, P186
   Wikesjo Ulf M E, 2003, Clin Implant Dent Relat Res, V5, P112, DOI 10.1111/j.1708-8208.2003.tb00192.x
   Wikesjo UME, 2009, ORTHOD CRANIOFAC RES, V12, P263, DOI 10.1111/j.1601-6343.2009.01461.x
NR 22
TC 3
Z9 3
U1 0
U2 5
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD SEP-OCT
PY 2013
VL 28
IS 5
BP E272
EP E276
DI 10.11607/jomi.te07
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 222LY
UT WOS:000324733800010
PM 24066344
OA Bronze
DA 2018-10-20
ER

PT J
AU Metzler, P
   von Wilmoyvsky, C
   Stadlinger, B
   Zemann, W
   Schlegel, KA
   Rosiwal, S
   Rupprecht, S
AF Metzler, Philipp
   von Wilmoyvsky, Cornelius
   Stadlinger, Bernd
   Zemann, Wolfgang
   Schlegel, Karl Andreas
   Rosiwal, Stephan
   Rupprecht, Stephan
TI Nano-crystalline diamond-coated titanium dental implants - A
   histomorphometric study in adult domestic pigs
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Titanium-alloy; Titanium; Diamond; Nano-modified surface; MWP-CVD
ID BONE-METAL INTERFACE; NANOCRYSTALLINE DIAMOND; NANOSTRUCTURED DIAMOND;
   ORTHOPEDIC IMPLANTS; WEAR BEHAVIOR; IN-VITRO; COATINGS; PARTICLES;
   SURFACE; TISSUE
AB Promising biomaterial characteristics of diamond-coatings in biomedicine have been described in the literature. However, there is a lack of knowledge about implant osseointegration of this surface modification compared to the currently used sandblasted acid-etched Ti-Al6-V4 implants. The aim of this study was to investigate the osseointegration of microwave plasma-chemical-vapour deposition (MWP-CVD) diamond-coated Ti-Al6-V4 dental implants after healing periods of 2 and 5 months.
   Twenty-four MWP-CVD diamond-coated and 24 un-coated dental titanium-alloy implants (Ankylos (R)) were placed in the frontal skull of eight adult domestic pigs. To evaluate the effects of the nano-structured surfaces on bone formation, a histomorphometric analysis was performed after 2 and 5 months of implant healing. Histomorphometry analysed the bone-to-implant contact (BIC). No significant difference in BIC for the diamond-coated implants in comparison to reference implants could be observed for both healing periods. Scanning electron microscopy revealed an adequate interface between the bone and the diamond surface. No delamination or particle-dissociation due to shearing forces could be detected. In this study, diamond-coated dental titanium-alloy implants and sandblasted acid-etched implants showed a comparable degree of osseointegration. (C) 2012 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Metzler, Philipp; Stadlinger, Bernd; Zemann, Wolfgang] Univ Zurich Hosp, Dept Craniomaxillofacial & Oral Surg, CH-8091 Zurich, Switzerland.
   [von Wilmoyvsky, Cornelius; Schlegel, Karl Andreas] Univ Erlangen Nurnberg, Dept Oral & Maxillofacial Surg, D-91054 Erlangen, Germany.
   [Rosiwal, Stephan] Univ Erlangen Nurnberg, Dept Mat Sci, D-91058 Erlangen, Germany.
   [Rupprecht, Stephan] Private Clin Oral & Maxillofacial Surg, D-91054 Erlangen, Germany.
RP Metzler, P (reprint author), Univ Zurich Hosp, Dept Craniomaxillofacial & Oral Surg, Frauenklin Str 24, CH-8091 Zurich, Switzerland.
EM Philipp.Metzler@usz.ch
OI Stadlinger, Bernd/0000-0001-5044-7052
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Amaral M, 2008, J BIOMED MATER RES A, V87A, P91, DOI 10.1002/jbm.a.31742
   Amaral M, 2009, ACTA BIOMATER, V5, P755, DOI 10.1016/j.actbio.2008.08.015
   Aparicio Carlos, 2003, Clin Implant Dent Relat Res, V5, P57, DOI 10.1111/j.1708-8208.2003.tb00183.x
   Aspenberg P, 1996, BIOMATERIALS, V17, P807, DOI 10.1016/0142-9612(96)81418-9
   Bi YM, 2001, J BONE JOINT SURG AM, V83A, P501, DOI 10.2106/00004623-200104000-00004
   Bornstein MM, 2005, CLIN ORAL IMPLAN RES, V16, P631, DOI 10.1111/j.1600-0501.2005.01209.x
   Cadosch D, 2009, J NEUROSCI METH, V178, P182, DOI 10.1016/j.jneumeth.2008.12.008
   Chaturvedi T P, 2009, Indian J Dent Res, V20, P91
   Clem WC, 2008, BIOMATERIALS, V29, P3461, DOI 10.1016/j.biomaterials.2008.04.045
   De Maeztu MA, 2007, INT J ORAL MAX IMPL, V22, P273
   Deppe H, 2004, J CRANIO MAXILL SURG, V32, P211, DOI 10.1016/S1010-5182(04)00045-9
   Drees P, 2008, BIOMED TECH, V53, P93, DOI 10.1515/BMT.2008.021
   Drees P, 2007, NAT CLIN PRACT RHEUM, V3, P165, DOI 10.1038/ncprheum0428
   Flemmig TF, 2006, CLIN ORAL IMPLAN RES, V17, P160
   Guglielmotti M B, 1999, Implant Dent, V8, P303, DOI 10.1097/00008505-199903000-00016
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   Heinrich G, 1998, Biomed Tech (Berl), V43 Suppl, P382, DOI 10.1515/bmte.1998.43.s1.382
   Hill MR, 2008, J BIOMED MATER RES B, V85B, P140, DOI 10.1002/jbm.b.309.26
   Jaatinen JJP, 2011, ACTA ORTHOP, V82, P499, DOI 10.3109/17453674.2011.579522
   Kalbacova M, 2009, ACTA BIOMATER, V5, P3076, DOI 10.1016/j.actbio.2009.04.020
   Kim JG, 2008, J BIOMED MATER RES A, V86A, P41, DOI 10.1002/jbm.a.31632
   Kloss FR, 2007, J NANOSCI NANOTECHNO, V7, P4581, DOI 10.1166/jnn.2007.004
   Koldsland OC, 2009, J PERIODONTOL, V80, P1069, DOI 10.1902/jop.2009.080594
   LAIBLIN C, 1979, BERL MUNCH TIERARZTL, V92, P124
   Laine P, 2005, J CRANIO MAXILL SURG, V33, P212, DOI 10.1016/j.jcms.2004.12.004
   Levon J, 2009, J BIOMED MAT RES A
   Mandelin J, 2003, J BONE JOINT SURG BR, V85B, P1196, DOI 10.1302/0301-620X.85B8.13311
   Mandelin J, 2003, J RHEUMATOL, V30, P2033
   Mombelli A, 2006, CLIN ORAL IMPLAN RES, V17, P97, DOI 10.1111/j.1600-0501.2006.01354.x
   Nordsletten L, 1996, BIOMATERIALS, V17, P1521, DOI 10.1016/0142-9612(96)89777-8
   Papo MJ, 2004, J MATER SCI-MATER M, V15, P773, DOI 10.1023/B:JMSM.0000032817.05997.d2
   Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b
   Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P283, DOI 10.1111/j.1600-051X.2006.00907.x
   Rupprecht S, 2005, CLIN ORAL IMPLAN RES, V16, P98, DOI 10.1111/j.1600-0501.2004.01079.x
   Rupprecht S, 2002, INT J ORAL MAX IMPL, V17, P778
   Santavirta S, 2003, ACTA ORTHOP SCAND, V74
   Santavirta SS, 1999, CLIN ORTHOP RELAT R, P92
   Schlegel KA, 2009, ORAL SURG ORAL MED O, V108, pE37, DOI 10.1016/j.tripleo.2009.05.037
   Silva FG, 2009, J NANOSCI NANOTECHNO, V9, P3938, DOI 10.1166/jnn.2009.NS93
   Specht CG, 2004, BIOMATERIALS, V25, P4073, DOI 10.1016/j.biomaterials.2003.11.006
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Valles G, 2008, J BIOMED MATER RES A, V84A, P324, DOI 10.1002/jbm.a.31315
   Valles G, 2008, BIOMATERIALS, V29, P2326, DOI 10.1016/j.biomaterials.2008.02.011
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   Yang L, 2009, J BIOMED MATER RES A, V91A, P548, DOI 10.1002/jbm.a.32227
   Yang L, 2009, BIOMATERIALS, V30, P3458, DOI 10.1016/j.biomaterials.2009.03.014
NR 48
TC 15
Z9 15
U1 2
U2 18
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD SEP
PY 2013
VL 41
IS 6
BP 532
EP 538
DI 10.1016/j.jcms.2012.11.020
PG 7
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 223YS
UT WOS:000324849000013
PM 23266005
DA 2018-10-20
ER

PT J
AU Fan, XZ
   Pomerantseva, E
   Gnerlich, M
   Brown, A
   Gerasopoulos, K
   McCarthy, M
   Culver, J
   Ghodssi, R
AF Fan, Xiao Z.
   Pomerantseva, Ekaterina
   Gnerlich, Markus
   Brown, Adam
   Gerasopoulos, Konstantinos
   McCarthy, Matthew
   Culver, James
   Ghodssi, Reza
TI Tobacco mosaic virus: A biological building block for micro/nano/bio
   systems
SO JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A
LA English
DT Review
ID ATOMIC LAYER DEPOSITION; LITHIUM-ION BATTERIES; RAY FIBER DIFFRACTION;
   ELECTROCHEMICAL ENERGY-STORAGE; NUCLEIC-ACID HYBRIDIZATION;
   CHEMICAL-VAPOR-DEPOSITION; NANOWIRE ARRAYS; PHAGE-DISPLAY;
   MECHANICAL-PROPERTIES; TEMPLATED SYNTHESIS
AB Tobacco mosaic virus (TMV) has the potential to be an ideal candidate for a building block of the next-generation micro/nano/bio systems. The TMV virion is a high-aspect ratio rigid nanotube that is robust and compatible with some conventional microfabrication processes. TMV can be chemically and genetically modified to enhance its physical properties and tailor them to specific applications. This review covers the use of TMV nanostructures in a wide range of micro/nano/bio systems. TMV has been utilized in the production of nanowires, nanostructured thin films, biomimetic surfaces, novel sensors, high performance microbatteries, solid-state electronics, and engineered biosystems. The work highlighted here is meant to give a perspective of the entire breadth of the properties of these virions, from their synthesis and functionalization to assembly and patterning, as well as feature works that represent key milestones in the field of biofabrication and biomaterial integration. The advantages already demonstrated by the integration of TMV nanostructures, even at this early stage of development, suggest that the applications for this micro/nano/bio systems building block will continue to grow. (C) 2013 American Vacuum Society.
C1 [Fan, Xiao Z.; Pomerantseva, Ekaterina; Gnerlich, Markus; Gerasopoulos, Konstantinos; Ghodssi, Reza] Univ Maryland, MEMS Sensors & Actuators Lab MSAL, Dept Elect & Comp Engn, College Pk, MD 20742 USA.
   [Fan, Xiao Z.; Pomerantseva, Ekaterina; Gnerlich, Markus; Gerasopoulos, Konstantinos; Ghodssi, Reza] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA.
   [Brown, Adam; Ghodssi, Reza] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Brown, Adam; Culver, James] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.
   [McCarthy, Matthew] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
   [Culver, James] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.
RP Ghodssi, R (reprint author), Univ Maryland, MEMS Sensors & Actuators Lab MSAL, Dept Elect & Comp Engn, College Pk, MD 20742 USA.
EM ghodssi@umd.edu
FU NSF Nanomanufacturing Program [NSF-CMMI 0927693]; Department of Energy
   [FG0202ER45975]; Nanostructures for Electrical Energy Storage, an Energy
   Frontier Research Center; U.S. Department of Energy, Office of Science,
   Office of Basic Energy Sciences [12DESC0001160]; Biochemistry Program of
   the Army Research Office [W911NF1110138]
FX This work was supported by the NSF Nanomanufacturing Program (NSF-CMMI
   0927693) and Department of Energy (FG0202ER45975), the Nanostructures
   for Electrical Energy Storage, an Energy Frontier Research Center funded
   by the U.S. Department of Energy, Office of Science, Office of Basic
   Energy Sciences (12DESC0001160), and the Biochemistry Program of the
   Army Research Office (W911NF1110138). The authors would like to
   acknowledge the staff at the Maryland Nanocenter clean-room facilities
   and Nanoscale Imaging Spectroscopy and Properties Lab.
CR Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368
   Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a
   Arthur TS, 2011, MRS BULL, V36, P523, DOI 10.1557/mrs.2011.156
   Atanasova P, 2011, ADV MATER, V23, P4918, DOI 10.1002/adma.201102900
   Balci S, 2006, ELECTROCHIM ACTA, V51, P6251, DOI 10.1016/j.electacta.2006.04.007
   Balci S, 2009, ELECTROCHIM ACTA, V54, P5149, DOI 10.1016/j.electacta.2009.03.036
   Balci S, 2008, ADV MATER, V20, P2195, DOI 10.1002/adma.200602879
   Balci S, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/4/045603
   Bittner AM, 2005, EUR J INORG CHEM, P3717, DOI 10.1002/ejic.200500388
   Bolisay LD, 2007, BIOMACROMOLECULES, V8, P3893, DOI 10.1021/bm7008526
   Bruckman MA, 2013, J MATER CHEM B, V1, P1482, DOI 10.1039/c3tb00461a
   Bruckman MA, 2011, ACS NANO, V5, P1606, DOI 10.1021/nn1025719
   Bruckman MA, 2010, J MATER CHEM, V20, P5715, DOI 10.1039/c0jm00634c
   Bruin R. D., 1999, NAT BIOTECHNOL, V17, P397
   Cai H, 2003, ANAL BIOANAL CHEM, V375, P287, DOI 10.1007/s00216-002-1652-9
   Chen XL, 2012, J POWER SOURCES, V211, P129, DOI 10.1016/j.jpowsour.2012.03.070
   Chen XL, 2011, ELECTROCHIM ACTA, V56, P5210, DOI 10.1016/j.electacta.2011.03.037
   Chen XL, 2010, ACS NANO, V4, P5366, DOI 10.1021/nn100963j
   Chen XY, 2013, RSC ADV, V3, P4294, DOI 10.1039/c3ra23031g
   Chen XY, 2012, CHEM MATER, V24, P1255, DOI 10.1021/cm202901z
   Chiang CY, 2012, NANO LETT, V12, P6005, DOI 10.1021/nl303579z
   Crowell JE, 2003, J VAC SCI TECHNOL A, V21, pS88, DOI 10.1116/1.1600451
   CULVER J N, 1989, Molecular Plant-Microbe Interactions, V2, P209, DOI 10.1094/MPMI-2-209
   Culver JN, 2002, ANNU REV PHYTOPATHOL, V40, P287, DOI 10.1146/annurev.phyto.40.120301.102400
   CULVER JN, 1995, VIROLOGY, V206, P724, DOI 10.1016/S0042-6822(95)80096-4
   DAWSON WO, 1986, P NATL ACAD SCI USA, V83, P1832, DOI 10.1073/pnas.83.6.1832
   Deng ZX, 2003, NANO LETT, V3, P1545, DOI 10.1021/nl034720q
   Dujardin E, 2003, NANO LETT, V3, P413, DOI 10.1021/nl034004o
   DURHAM ACH, 1971, NATURE-NEW BIOL, V229, P37
   Durrer L, 2008, SENSOR ACTUAT B-CHEM, V132, P485, DOI 10.1016/j.snb.2007.11.007
   Evans DJ, 2008, J MATER CHEM, V18, P3746, DOI 10.1039/b804305a
   Falvo MR, 1997, BIOPHYS J, V72, P1396, DOI 10.1016/S0006-3495(97)78786-1
   Fan X. Z., 2010, IEEE SENS 2010 C WAI
   Feng XJ, 2008, NANO LETT, V8, P3781, DOI 10.1021/nl802096a
   Fowler CE, 2001, ADV MATER, V13, P1266, DOI 10.1002/1521-4095(200108)13:16<1266::AID-ADMA1266>3.0.CO;2-9
   Fu H, 2010, BIORESOURCE TECHNOL, V101, P2034, DOI 10.1016/j.biortech.2009.10.045
   Fujikawa S, 2003, LANGMUIR, V19, P6545, DOI 10.1021/la026979e
   George SM, 2010, CHEM REV, V110, P111, DOI 10.1021/cr900056b
   Gerasopoulos K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/5/055304
   Gerasopoulos K., 2008, IEEE MEMS 2008 C TUC
   Gerasopoulos K, 2012, ACS NANO, V6, P6422, DOI 10.1021/nn301981p
   Gerasopoulos K, 2010, CHEM COMMUN, V46, P7349, DOI 10.1039/c0cc01689f
   Gerasopoulos K, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/10/104003
   Ghoshal T, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/6/065606
   Gorzny ML, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/16/165704
   Gu Q, 2006, NANOTECHNOLOGY, V17, pR14, DOI 10.1088/0957-4484/17/1/R02
   Han ZZ, 1999, SCI CHINA SER C, V42, P43, DOI 10.1007/BF02881746
   Hashimoto Y, 2005, CHEM LETT, V34, P112, DOI 10.1246/cl.2005.112
   Holder PG, 2010, LANGMUIR, V26, P17383, DOI 10.1021/la1039305
   Horn A, 2009, FARADAY DISCUSS, V143, P143, DOI 10.1039/b902721a
   Ide T, 2003, BIOSCI BIOTECH BIOCH, V67, P1335, DOI 10.1271/bbb.67.1335
   Janotti A, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126501
   Kalinin SV, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2194008
   Kegel WK, 2006, BIOPHYS J, V91, P1501, DOI 10.1529/biophysj.105.072603
   Kelly KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000665
   Khan AS, 2003, BIOTECHNOL LETT, V25, P1671, DOI 10.1023/A:1025618032335
   Kinsella JM, 2007, LANGMUIR, V23, P3886, DOI 10.1021/la0628571
   Klug A, 1999, PHILOS T ROY SOC B, V354, P531, DOI 10.1098/rstb.1999.0404
   Knez M, 2003, NANO LETT, V3, P1079, DOI 10.1021/nl0342545
   Knez M, 2006, NANO LETT, V6, P1172, DOI 10.1021/nl060413j
   Knez M, 2004, ADV FUNCT MATER, V14, P116, DOI 10.1002/adfm.200304376
   Knez M, 2002, J ELECTROANAL CHEM, V522, P70, DOI 10.1016/S0022-0728(01)00728-8
   Kobayashi M, 2010, CHEM LETT, V39, P616, DOI 10.1246/cl.2010.616
   Kobayashi M, 2010, NANO LETT, V10, P773, DOI 10.1021/nl902405s
   Kordas K, 2005, APPL SURF SCI, V252, P1471, DOI 10.1016/j.apsusc.2005.02.120
   Kudo H, 2006, IEEE T NANOTECHNOL, V5, P90, DOI 10.1109/TNANO.2006.869691
   Kum MC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/32/325711
   Kumara MT, 2007, J PHYS CHEM C, V111, P5276, DOI 10.1021/jp067479n
   LEBEURIER G, 1977, P NATL ACAD SCI USA, V74, P149, DOI 10.1073/pnas.74.1.149
   Lee LA, 2011, ORG BIOMOL CHEM, V9, P6189, DOI 10.1039/c1ob05700f
   Lee SY, 2005, NANOTECHNOLOGY, V16, pS435, DOI 10.1088/0957-4484/16/7/019
   Leskela M, 2003, ANGEW CHEM INT EDIT, V42, P5548, DOI 10.1002/anie.200301652
   Lewis CL, 2010, LANGMUIR, V26, P13436, DOI 10.1021/la102446n
   Liang X, 2008, MATER LETT, V62, P2999, DOI 10.1016/j.matlet.2008.01.094
   Lim JS, 2010, NANO LETT, V10, P3863, DOI 10.1021/nl101375f
   Lim JS, 2010, J NANOMATER, DOI 10.1155/2010/620505
   Lim JS, 2010, J COLLOID INTERF SCI, V342, P455, DOI 10.1016/j.jcis.2009.10.028
   Liu WL, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1952587
   Loset GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017433
   Ma HZ, 2006, TOXICON, V47, P901, DOI 10.1016/j.toxicon.2006.03.003
   Ma YF, 2004, J AM CHEM SOC, V126, P7097, DOI 10.1021/ja039621t
   Machado PA, 2010, BIORESOURCE TECHNOL, V101, P1091, DOI 10.1016/j.biortech.2009.09.009
   Manocchi AK, 2011, LANGMUIR, V27, P7052, DOI 10.1021/la2005453
   Manocchi AK, 2010, LANGMUIR, V26, P7516, DOI 10.1021/la904324h
   Manocchi AK, 2010, LANGMUIR, V26, P3670, DOI 10.1021/la9031514
   McCarthy M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729935
   Mogul R, 2006, MATER LETT, V60, P19, DOI 10.1016/j.matlet.2005.07.066
   Mueller A, 2011, ACS NANO, V5, P4512, DOI 10.1021/nn103557s
   NAMBA K, 1989, J MOL BIOL, V208, P307, DOI 10.1016/0022-2836(89)90391-4
   Niu Z, 2007, NANO LETT, V7, P3729, DOI 10.1021/nl072134h
   Niu ZW, 2007, LANGMUIR, V23, P6719, DOI 10.1021/la070096b
   O'Brien S, 2001, J AM CHEM SOC, V123, P12085, DOI 10.1021/ja011414a
   Okada Y, 1986, Adv Biophys, V22, P95, DOI 10.1016/0065-227X(86)90004-3
   Oudenhoven JFM, 2011, ADV ENERGY MATER, V1, P10, DOI 10.1002/aenm.201000002
   PATTANAYEK R, 1992, J MOL BIOL, V228, P516, DOI 10.1016/0022-2836(92)90839-C
   Petrenko VA, 2003, J MICROBIOL METH, V53, P253, DOI 10.1016/S0167-7012(03)00029-0
   Pomerantseva E, 2012, J POWER SOURCES, V206, P282, DOI 10.1016/j.jpowsour.2012.01.127
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Royston E, 2006, J COLLOID INTERF SCI, V298, P706, DOI 10.1016/j.jcis.2005.12.068
   Royston E, 2008, LANGMUIR, V24, P906, DOI 10.1021/la7016424
   Royston ES, 2009, J COLLOID INTERF SCI, V332, P402, DOI 10.1016/j.jcis.2008.12.064
   Samuelson P, 2000, APPL ENVIRON MICROB, V66, P1243, DOI 10.1128/AEM.66.3.1243-1248.2000
   Schweikart A., 2010, ADV POLYM SCI, V227, P24
   Sneh O, 2002, THIN SOLID FILMS, V402, P248, DOI 10.1016/S0040-6090(01)01678-9
   Soykut EA, 2008, BIOCHEM BIOPH RES CO, V370, P104, DOI 10.1016/j.bbrc.2008.03.065
   Srinivasan K., 2005, NANOMATERIAL SENSING
   Sun S, 2007, CHEM MATER, V19, P6376, DOI 10.1021/cm7022949
   Tan WS, 2008, LANGMUIR, V24, P12483, DOI 10.1021/la802089q
   Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644
   Teki R, 2009, SMALL, V5, P2236, DOI 10.1002/smll.200900382
   Tiitta M, 1997, CHEM VAPOR DEPOS, V3, P167, DOI 10.1002/cvde.19970030404
   Tseng RJ, 2006, NAT NANOTECHNOL, V1, P72, DOI 10.1038/nnano.2006.55
   Tsukamoto R, 2007, CHEM MATER, V19, P2389, DOI 10.1021/cm062187k
   Wang H, 1997, J MOL BIOL, V269, P769, DOI 10.1006/jmbi.1997.1048
   WANG H, 1994, J MOL BIOL, V239, P371, DOI 10.1006/jmbi.1994.1379
   Wang J, 1997, ANAL CHIM ACTA, V347, P1, DOI 10.1016/S0003-2670(96)00598-3
   Wang JH, 2005, ELECTROCHEM SOLID ST, V8, pC9, DOI 10.1149/1.1836112
   Wang XY, 2005, J POWER SOURCES, V140, P211, DOI 10.1016/j.jpowsour.2004.07.033
   Wargacki SP, 2008, LANGMUIR, V24, P5439, DOI 10.1021/la7040778
   Wu LY, 2011, J MATER CHEM, V21, P8550, DOI 10.1039/c1jm00078k
   Xiang B, 2007, NANO LETT, V7, P323, DOI 10.1021/nl062410c
   Yang CX, 2011, J MATER CHEM, V21, P187, DOI 10.1039/c0jm03145c
   Yang CX, 2010, BIOCHEM ENG J, V52, P160, DOI 10.1016/j.bej.2010.08.002
   Yang CX, 2010, APPL CATAL B-ENVIRON, V93, P282, DOI 10.1016/j.apcatb.2009.10.001
   Yi HM, 2005, NANO LETT, V5, P1931, DOI 10.1021/nl051254r
   Yi H, 2007, LANGMUIR, V23, P2663, DOI 10.1021/la062493c
   Zang H. B.-Y. Faheng, 2013, 10 INT WORKSH NAN SE
   Zhang BJ, 2000, CHEM COMMUN, P781, DOI 10.1039/b001528h
   Zhang WJ, 2011, J POWER SOURCES, V196, P13, DOI 10.1016/j.jpowsour.2010.07.020
   Zhao YN, 2007, MATER LETT, V61, P384, DOI 10.1016/j.matlet.2006.04.067
NR 130
TC 24
Z9 25
U1 0
U2 122
PU A V S AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0734-2101
EI 1520-8559
J9 J VAC SCI TECHNOL A
JI J. Vac. Sci. Technol. A
PD SEP
PY 2013
VL 31
IS 5
AR 050815
DI 10.1116/1.4816584
PG 24
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 217UZ
UT WOS:000324388800015
DA 2018-10-20
ER

PT J
AU Gunn, JM
   Rekola, J
   Hirvonen, J
   Aho, AJ
AF Gunn, Jarmo M.
   Rekola, Jami
   Hirvonen, Jussi
   Aho, Allan J.
TI Comparison of the osteoconductive properties of three particulate bone
   fillers in a rabbit model: Allograft, calcium carbonate (Biocoral (R))
   and S53P4 bioactive glass
SO ACTA ODONTOLOGICA SCANDINAVICA
LA English
DT Article
DE bone; bioactive glass; biocoral; allograft
ID IN-VIVO; DEFECTS; RECONSTRUCTION; IMPLANTS; GRAFTS
AB Aim. The aim of this study was to compare the osteoconductivity and suitability of three biomaterials used as particulate fillers; S53P4 bioactive glass, allogeneic fresh frozen bone and coral-derived calcium carbonate. Materials and methods. Materials were implanted into drill-holes in the femoral condyles of adult rabbits. Follow-ups were performed at 3, 6, 12 and 24 weeks. Host-response, osteoconductivity, bonding and filler-effect were evaluated by SEM, EDXA and histology and histomorphometry to evaluate. Results. All three materials were found to be biocompatible and osteoconductive. Defects filled with allograft seemed to have more bone at 24 weeks, although no statistically significant difference in new bone growth was found. In earlier time points, coral, however, was observed to degrade more quickly, leaving more empty space in the defects, thus making it a less suitable filler for cavitary defects. Conclusion. At all time points there was less filler material (i.e. biomaterial and new bone) in coral-filled defects than in BAG or allograft filled defects (p < 0.05).
C1 [Gunn, Jarmo M.] Univ Turku, Turku, Finland.
   [Gunn, Jarmo M.] Turku Univ Hosp, Dept Cardiothorac Surg, FIN-20520 Turku, Finland.
   [Rekola, Jami] Turku Univ Hosp, Dept Otorhinolaryngol, FIN-20520 Turku, Finland.
   [Hirvonen, Jussi] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland.
   [Aho, Allan J.] Turku Univ Hosp, Dept Orthopaed & Traumatol, FIN-20520 Turku, Finland.
RP Gunn, JM (reprint author), Turku Univ Hosp, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland.
EM jarmo.gunn@tyks.fi
OI Gunn, Jarmo/0000-0002-6996-0726
CR Aho AJ, 2004, J MATER SCI-MATER M, V15, P1165, DOI 10.1023/B:JMSM.0000046401.50406.9b
   Aitasalo KMJ, 2007, PLAST RECONSTR SURG, V120, P1963, DOI 10.1097/01.prs.0000287319.34425.27
   Arnaud E, 1999, BIOMATERIALS, V20, P1909, DOI 10.1016/S0142-9612(99)00090-3
   BURCHARDT H, 1978, J BONE JOINT SURG AM, V60, P1082, DOI 10.2106/00004623-197860080-00011
   Calixto RFE, 2007, IMPLANT DENT, V16, P260, DOI 10.1097/ID.0b013e3180500b95
   Choi JY, 2011, CLIN ORAL IMPLAN RES, V22, P343, DOI 10.1111/j.1600-0501.2010.01978.x
   Cunin G, 2000, SPINE, V25, P1070, DOI 10.1097/00007632-200005010-00006
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   GROSS AE, 1985, CLIN ORTHOP RELAT R, P115
   Haddad FS, 2000, J BONE JOINT SURG BR, V82B, P830, DOI 10.1302/0301-620X.82B6.10485
   Ilharreborde B, 2008, J PEDIATR ORTHOPED, V28, P347, DOI 10.1097/BPO.0b013e318168d1d4
   Lindfors NC, 2009, J BIOMED MATER RES B, V90B, P131, DOI 10.1002/jbm.b.31263
   Peltola M, 2008, J ORAL MAXIL SURG, V66, P639, DOI 10.1016/j.joms.2007.11.019
   Turunen T, 1997, CLIN ORAL IMPLAN RES, V8, P96, DOI 10.1034/j.1600-0501.1997.080204.x
   Xie ZP, 2009, J BIOMED MATER RES B, V90B, P195, DOI 10.1002/jbm.b.31273
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
NR 17
TC 8
Z9 8
U1 1
U2 13
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0001-6357
J9 ACTA ODONTOL SCAND
JI Acta Odontol. Scand.
PD SEP
PY 2013
VL 71
IS 5
BP 1238
EP 1242
DI 10.3109/00016357.2012.757642
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 216CH
UT WOS:000324258100032
PM 23294163
DA 2018-10-20
ER

PT J
AU Brand, E
   Pavenstadt, H
   Schmieder, RE
   Engelbertz, C
   Fobker, M
   Pinnschmidt, HO
   Wegscheider, K
   Breithardt, G
   Reinecke, H
AF Brand, Eva
   Pavenstaedt, Hermann
   Schmieder, Roland E.
   Engelbertz, Christiane
   Fobker, Manfred
   Pinnschmidt, Hans O.
   Wegscheider, Karl
   Breithardt, Guenter
   Reinecke, Holger
TI The Coronary Artery Disease and Renal Failure (CAD-REF) registry: Trial
   design, methods, and aims
SO AMERICAN HEART JOURNAL
LA English
DT Article
ID CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE;
   MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; HEART-FAILURE;
   INSUFFICIENCY; ASSOCIATION; DYSFUNCTION; OUTCOMES; TIMI
AB Background During the past 10 years, chronic kidney disease (CKD) has been recognized as a major global health problem. Factors leading to decreased renal function are closely related to cardiovascular disease and vice versa. Cardiovascular morbidity and mortality are substantially increased in patients with CKD, even in those with only mild or moderate renal impairment. A better understanding of pathogenesis, risk factors, and genetic conditions is strongly required for more specific treatment strategies in CKD because until now, knowledge is very limited.
   Methods The German CAD-REF registry is a prospective observational multicenter national registry. It aims at including >3,300 white patients with angiographically documented coronary artery disease (coronary artery disease [CAD]; >= 50% stenosis in at least 1 coronary artery) being enrolled at 32 centers and assigned to 6 different groups according to their estimated glomerular filtration rate and/or proteinuria. Baseline characteristics, treatment data, and biomaterial including serum, plasma, urine, and DNA samples are collected. Follow-ups are performed at 6, 12, 24, 36, 48, and 60 months.
   Conclusions The CAD-REF registry will establish one of the largest ethnically homogeneous cohorts, to date, of clinically and angiographically well-characterized patients with CAD who have all stages of CKD. This approach offers great opportunities for an improved understanding of the underlying pathophysiologic mechanism and clinical impact of CKD in patients with CAD, especially including the identification of clinically relevant risk factors and (genetic and other bio-) markers as a basis to ameliorate future treatment strategies.
C1 [Brand, Eva; Pavenstaedt, Hermann; Engelbertz, Christiane] Univ Hosp Muenster, Dept Nephrol Hypertens & Rheumatol, Munster, Germany.
   [Schmieder, Roland E.] Univ Erlangen Nuernberg, Dept Nephrol & Hypertens, Erlangen, Germany.
   [Engelbertz, Christiane; Breithardt, Guenter; Reinecke, Holger] Univ Hosp Muenster, Dept Cardiovasc Med, Div Vasc Med, Munster, Germany.
   [Fobker, Manfred] Univ Hosp Muenster, Inst Clin Chem & Lab Med, Munster, Germany.
   [Pinnschmidt, Hans O.; Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany.
RP Reinecke, H (reprint author), Dept Kardiol & Angiol, Abt Angiol, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany.
EM holger.reinecke@ukmuenster.de
FU Deutsche Forschungsgemeinschaft [Br1589/8-2]
FX Eva Brand is supported by a Heisenberg Professorship from the Deutsche
   Forschungsgemeinschaft (Br1589/8-2).
CR Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
   Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835
   CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0
   Cerasola G, 2010, J HYPERTENS, V28, P2357, DOI 10.1097/HJH.0b013e32833ec377
   D'Ascenzo F, 2012, CONTEMP CLIN TRIALS, V33, P507, DOI 10.1016/j.cct.2012.01.001
   Eckardt KU, 2012, NEPHROL DIAL TRANSPL, V27, P1454, DOI 10.1093/ndt/gfr456
   El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7
   Ezekowitz J, 2004, J AM COLL CARDIOL, V44, P1587, DOI 10.1016/j.jacc.2004.06.072
   Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE
   Ghali WA, 2000, CAN J CARDIOL, V16, P1225
   Glassock RJ, 2008, NEPHRON CLIN PRACT, V110, pC39, DOI 10.1159/000151244
   Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
   Imai E, 2008, HYPERTENS RES, V31, P1101, DOI 10.1291/hypres.31.1101
   Imai E, 2010, CLIN EXP NEPHROL, V14, P558, DOI 10.1007/s10157-010-0328-6
   Levey AS, 2010, KIDNEY INT, V78, P19, DOI [10.1038/ki.2010.115, 10.1038/ki.2010.483]
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013
   National KF, 2002, AM J KIDNEY DIS, V39, pS1, DOI DOI 10.1016/S0272-6386(02)70081-4]
   PARRA HJ, 1992, ARTERIOSCLER THROMB, V12, P701, DOI 10.1161/01.ATV.12.6.701
   Reffelmann T, 2010, ATHEROSCLEROSIS, V211, P660, DOI 10.1016/j.atherosclerosis.2010.03.023
   Reinecke H, 2003, NEPHROLOGY, V8, P110, DOI 10.1046/j.1440-1797.2003.00148.x
   Reinecke H, 2003, KIDNEY INT, V63, P696, DOI 10.1046/j.1523-1755.2003.00784.x
   Reinecke H, 2009, J AM SOC NEPHROL, V20, P705, DOI 10.1681/ASN.2007111207
   Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807
   Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066
NR 25
TC 5
Z9 5
U1 0
U2 6
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-8703
EI 1097-5330
J9 AM HEART J
JI Am. Heart J.
PD SEP
PY 2013
VL 166
IS 3
BP 449
EP +
DI 10.1016/j.ahj.2013.06.010
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 214UZ
UT WOS:000324163600018
PM 24016493
DA 2018-10-20
ER

PT J
AU Wanyonyi, WC
   Onyari, JM
   Shiundu, PM
AF Wanyonyi, Wycliffe Chisutia
   Onyari, John Mmari
   Shiundu, Paul Mwanza
TI Adsorption of Methylene Blue Dye from Aqueous Solutions Using Eichhornia
   crassipes
SO BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY
LA English
DT Article
DE Eichhornia crassipes; Methylene blue; Kinetics; Adsorption
ID WASTE-WATER; BASIC DYE; EQUILIBRIUM; REMOVAL; BIOSORPTION; SORPTION;
   PARAMETERS; EFFLUENT; KINETICS
AB Adsorption of methylene blue (MB) from aqueous solution using dried roots, stems, and leaves of Eichhornia crassipes biomass obtained from Lake Victoria was studied. Batch experimental results revealed that the adsorption process was highly dependent on adsorbent dosage, initial MB concentration, E. crassipes particle size and aqueous solution temperature. The isotherm data fitted Freundlich mathematical models with maximum dye adsorption of 35.37 mg g(-1). Roots adsorbed over 99 % of the MB in < 5 min. Sorption kinetics followed a pseudo-second-order model. Results provide evidence that E. crassipes is an effective and inexpensive biomaterial for dye removal from aqueous dye solutions and industrial effluents.
C1 [Wanyonyi, Wycliffe Chisutia; Onyari, John Mmari; Shiundu, Paul Mwanza] Univ Nairobi, Sch Phys Sci, Dept Chem, Nairobi, Kenya.
RP Wanyonyi, WC (reprint author), Univ Nairobi, Sch Phys Sci, Dept Chem, POB 30197-00100, Nairobi, Kenya.
EM wchisutia@yahoo.com
OI Onyari, john Mmari/0000-0002-7289-6550
CR Akar T, 2008, BIORESOURCE TECHNOL, V99, P3057, DOI 10.1016/j.biortech.2007.06.029
   Bulut Y, 2006, DESALINATION, V194, P259, DOI 10.1016/j.desal.2005.10.032
   Chanzu HA, 2012, J POLYM ENVIRON, V20, P665, DOI 10.1007/s10924-012-0479-5
   Crini G, 2008, DYES PIGMENTS, V77, P415, DOI 10.1016/j.dyepig.2007.07.001
   Dogan M, 2009, J HAZARD MATER, V164, P172, DOI 10.1016/j.jhazmat.2008.07.155
   Garg VK, 2004, DYES PIGMENTS, V63, P243, DOI 10.1016/j.dyepig.2004.03.005
   Hameed BH, 2008, J HAZARD MATER, V154, P204, DOI 10.1016/j.jhazmat.2007.10.010
   Hameed BH, 2008, COLLOID SURFACE A, V316, P78, DOI 10.1016/j.colsurfa.2007.08.033
   Hu ZH, 2010, J HAZARD MATER, V173, P292, DOI 10.1016/j.jhazmat.2009.08.082
   Li Y, 2003, B ENVIRON CONTAM TOX, V70, P1112, DOI 10.1007/s00128-003-0097-y
   Low KS, 1999, B ENVIRON CONTAM TOX, V62, P428, DOI 10.1007/s001289900893
   Mondal S, 2008, ENVIRON ENG SCI, V25, P383, DOI 10.1089/ees.2007.0049
   Ncibi MC, 2007, J HAZARD MATER, V139, P280, DOI 10.1016/j.jhazmat.2006.06.029
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Seddigi ZS, 2010, B ENVIRON CONTAM TOX, V84, P564, DOI 10.1007/s00128-010-9995-y
   Viraraghavan T, 1998, J HAZARD MATER, V57, P59, DOI 10.1016/S0304-3894(97)00062-9
   Wang XS, 2008, SEPAR SCI TECHNOL, V43, P3712, DOI 10.1080/01496390802222640
   Zhang WJ, 2011, B ENVIRON CONTAM TOX, V87, P86, DOI 10.1007/s00128-011-0304-1
NR 18
TC 13
Z9 15
U1 1
U2 23
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4861
J9 B ENVIRON CONTAM TOX
JI Bull. Environ. Contam. Toxicol.
PD SEP
PY 2013
VL 91
IS 3
BP 362
EP 366
DI 10.1007/s00128-013-1053-0
PG 5
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 204BT
UT WOS:000323340600021
PM 23839152
DA 2018-10-20
ER

PT J
AU Mensah-Darkwa, K
   Gupta, RK
   Kumar, D
AF Mensah-Darkwa, K.
   Gupta, R. K.
   Kumar, D.
TI Mechanical and Corrosion Properties of Magnesium-Hydroxyapatite (Mg-HA)
   Composite Thin Films
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE Magnesium; Hydroxyapatite; Scanning electron microscopy; Pulsed laser
   deposition; Corrosion; Impedance spectroscopy
ID PULSED-LASER DEPOSITION; ION-BEAM IMPLANTATION; HANKS SOLUTION; ALLOY;
   COATINGS; BIOMATERIAL; RESISTANCE; BEHAVIOR; ELECTRODEPOSITION; MATRIX
AB Magnesium (Mg)-hydroxyapatite (Ca-10(PO4)(6)(OH)(2), abbreviated as HA) composite films have been grown on Mg plates using a pulsed laser deposition technique. Mechanical property measurements and analysis have indicated that hardness and Young's modulus of nMg-(100-n)HA composite coatings increase with Mg content in the coatings and reach a maximum at a 70Mg-30HA composition. n and 100-n in the nMg-(100-n) HA represent the relative number of laser pulses impinging on Mg and HA targets, respectively. Direct current potentiodynamic polarization studies have shown that the corrosion of Mg plate (control) decreases with an increase in the HA ratio in the composite films. For example, the corrosion current density of Mg plate reduces by similar to 350 times after coating the Mg plate with 10Mg-90HA composite film. The reduction in corrosion current density of Mg plates was also accompanied by a positive shift in the corrosion potential (similar to 6%) due to this coating. The mechanism behind the reduction in corrosion behavior of Mg plates due to nMg-(100-n) HA composite coatings has been understood by electrochemical impedance spectroscopy.
C1 [Mensah-Darkwa, K.; Kumar, D.] N Carolina Agr & Tech State Univ, Dept Mech Engn, Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC 27411 USA.
   [Gupta, R. K.] Pittsburg State Univ, Dept Chem, Pittsburg, KS 66762 USA.
RP Gupta, RK (reprint author), Pittsburg State Univ, Dept Chem, 1601 East Market St, Pittsburg, KS 66762 USA.
EM ramguptamsu@gmail.com
FU National Science Foundation through Engineering Research Center of
   Revolutionizing Metallic Biomaterials at NCAT
FX This research was financially supported by the National Science
   Foundation through Engineering Research Center of Revolutionizing
   Metallic Biomaterials at NCAT. Authors thank Dr. J. Sankar, Dr. Y. Yun,
   and Dr. S. Neralla for useful discussion and providing access to their
   research facilities.
CR Al-Abdullat Y, 2001, MATER TRANS, V42, P1777, DOI 10.2320/matertrans.42.1777
   Arias JL, 2003, BIOMATERIALS, V24, P3403, DOI 10.1016/S0142-9612(03)00202-3
   Bao QH, 2006, MAT SCI ENG A-STRUCT, V429, P25, DOI 10.1016/j.msea.2006.04.003
   Chamos AN, 2010, FATIGUE FRACT ENG M, V33, P252, DOI 10.1111/j.1460-2695.2009.01434.x
   Chen XB, 2011, CORROS SCI, V53, P2263, DOI 10.1016/j.corsci.2011.03.008
   Chen XB, 2011, CORROSION-US, V67, DOI 10.5006/1.3563639
   Dinda GP, 2009, ACTA BIOMATER, V5, P1821, DOI 10.1016/j.actbio.2009.01.027
   Eason R., 2007, PULSED LASER DEPOSIT
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Gu XN, 2010, MAT SCI ENG C-MATER, V30, P827, DOI 10.1016/j.msec.2010.03.016
   Hahn BD, 2011, SURF COAT TECH, V205, P3112, DOI 10.1016/j.surfcoat.2010.11.029
   Hiromoto S, 2009, ELECTROCHIM ACTA, V54, P7085, DOI 10.1016/j.electacta.2009.07.033
   HONIG RE, 1962, RCA REV, V23, P567
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Kim H, 2010, ACTA BIOMATER, V6, P3234, DOI 10.1016/j.actbio.2010.02.031
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Landkof B, 2003, MATERIALWISS WERKST, V34, P395, DOI 10.1002/mawe.200390082
   Ma HY, 2003, ELECTROCHIM ACTA, V48, P4277, DOI 10.1016/j.electacta.2003.08.003
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI DOI 10.2174/1877610801002010040
   Meifeng H., 2008, CORROS SCI, V50, P3267
   Mizutani Y, 2003, SURF COAT TECH, V169, P143, DOI 10.1016/S0257-8972(03)00214-7
   Mroz W, 2010, J MOL STRUCT, V977, P145, DOI 10.1016/j.molstruc.2010.05.025
   Nelea V, 2004, THIN SOLID FILMS, V453, P208, DOI 10.1016/j.tsf.2003.11.119
   Nelea V, 2002, APPL SURF SCI, V186, P483, DOI 10.1016/S0169-4332(01)00754-1
   Neralla S, 2004, COMPOS PART B-ENG, V35, P157, DOI 10.1016/j.compositesb.2003.08.005
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   STERN M, 1957, J ELECTROCHEM SOC, V104, P559, DOI 10.1149/1.2428653
   Wang J, 2010, J ALLOY COMPD, V494, P271, DOI 10.1016/j.jallcom.2010.01.007
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Wen CL, 2009, APPL SURF SCI, V255, P6433, DOI 10.1016/j.apsusc.2008.09.078
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Wu GS, 2006, APPL SURF SCI, V252, P7422, DOI 10.1016/j.apsusc.2005.08.095
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Zhang S, 2011, APPL SURF SCI, V257, P9213, DOI 10.1016/j.apsusc.2011.06.006
   Zhang XP, 2007, J MATER SCI, V42, P8523, DOI 10.1007/s10853-007-1738-z
NR 37
TC 16
Z9 16
U1 3
U2 63
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD SEP
PY 2013
VL 29
IS 9
BP 788
EP 794
DI 10.1016/j.jmst.2013.04.019
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 214VK
UT WOS:000324164900002
DA 2018-10-20
ER

PT J
AU Saxena, M
   Sarkar, S
AF Saxena, Manav
   Sarkar, Sabyasachi
TI Fluorescence imaging of human erythrocytes by carbon nanoparticles
   isolated from food stuff and their fluorescence enhancement by blood
   plasma
SO MATERIALS EXPRESS
LA English
DT Article
DE Carbon Nanoparticles; Fluorescence Imaging; Human Erythrocytes;
   Haemolysis; Blood Plasma
ID SEMICONDUCTOR QUANTUM DOTS; IN-VIVO; NANO-ONIONS; LOW CYTOTOXICITY;
   BRIGHT; CDSE; PHOTOLUMINESCENCE; GRAPHITE; ROUTE; OXIDE
AB We have isolated carbon nanoparticles (CNPs) from bread. A simple oxidative treatment make them water soluble and fluorescent. CNPs exhibit fluorescence over a broad range of excitation wavelengths. These fluorescent CNPs have been susscessfully used for fluorescence imaging of human erythrocytes under 488 and 561 nm bandpass filters. Upon direct interaction with human erythrocytes, these CNPs show similar to 6% haemolysis in 5 h. In the presence of blood plasma, the quantum yield of these water soluble carbon nanoparticles enhances from 2 to 4.5% leading to rise a new phenomenon of auto passivation of CNPs by bio-fluids. Therefore, these fluorescent CNPs can be used as a unique and new type of biomaterial for bioimaging and other biomedical applications.
C1 [Saxena, Manav] Indian Inst Technol Kanpur, Dept Chem, Kanpur 208016, Uttar Pradesh, India.
   [Sarkar, Sabyasachi] Bengal Engn & Sci Univ, Dept Chem, Howrah 711103, India.
RP Sarkar, S (reprint author), Bengal Engn & Sci Univ, Dept Chem, Howrah 711103, India.
EM abya@iitk.ac.in
OI Sarkar, Sabyasachi/0000-0002-8954-4375
FU Department of Science and Technology India; Council of Scientific and
   Industrial Research New Delhi, India
FX Manav Saxena thanks to Council of Scientific and Industrial Research New
   Delhi, India for senior research fellowship and Sabyasachi Sarkar thanks
   the Department of Science and Technology India for financial assistance
   for procuring the optical fluorescence microscope. Manav Saxena thanks
   to Ms. Sunita, Department of Chemistry, IIT Kanpur for her assistance in
   blood related experiment.
CR Baker SN, 2010, ANGEW CHEM INT EDIT, V49, P6726, DOI 10.1002/anie.200906623
   Batalov A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195506
   Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u
   Bourlinos AB, 2008, CHEM MATER, V20, P4539, DOI 10.1021/cm800506r
   Cao L, 2007, J AM CHEM SOC, V129, P11318, DOI 10.1021/ja073527l
   Chandra S, 2011, NANOSCALE, V3, P1533, DOI 10.1039/c0nr00735h
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Dubey P, 2005, PRAMANA-J PHYS, V65, P681, DOI 10.1007/BF03010456
   da Silva JCGE, 2011, TRAC-TREND ANAL CHEM, V30, P1327, DOI 10.1016/j.trac.2011.04.009
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Galeone A, 2012, NANOSCALE, V4, P6401, DOI 10.1039/c2nr31826a
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Ghosh M, 2011, SMALL, V7, P3170, DOI 10.1002/smll.201101158
   Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284
   HOFFMANN R, 1968, J AM CHEM SOC, V90, P1475, DOI 10.1021/ja01008a016
   Iijima S, 1999, CHEM PHYS LETT, V309, P165, DOI 10.1016/S0009-2614(99)00642-9
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780
   Li HT, 2012, J MATER CHEM, V22, P24230, DOI 10.1039/c2jm34690g
   Li HT, 2011, CARBON, V49, P605, DOI 10.1016/j.carbon.2010.10.004
   Li HT, 2010, ANGEW CHEM INT EDIT, V49, P4430, DOI 10.1002/anie.200906154
   Liu HP, 2007, ANGEW CHEM INT EDIT, V46, P6473, DOI 10.1002/anie.200701271
   Liu RL, 2009, ANGEW CHEM INT EDIT, V48, P4598, DOI 10.1002/anie.200900652
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907
   Ming H, 2012, DALTON T, V41, P9526, DOI 10.1039/c2dt30985h
   Neugart F, 2007, NANO LETT, V7, P3588, DOI 10.1021/nl0716303
   Ow H, 2005, NANO LETT, V5, P113, DOI [10.1021/nl0482478, 10.1012/nl0482478]
   Pan DY, 2010, ADV MATER, V22, P734, DOI 10.1002/adma.200902825
   Panessa-Warren BJ, 2006, J PHYS CONDENS MATT, V18, P2185
   Pu SC, 2006, SMALL, V2, P1308, DOI 10.1002/smll.200600157
   Purewal J., 2010, THESIS CALTECH CALIF
   Qiao ZA, 2010, CHEM COMMUN, V46, P8812, DOI 10.1039/c0cc02724c
   Ray SC, 2009, J PHYS CHEM C, V113, P18546, DOI 10.1021/jp905912n
   ROY S, 1994, J CHEM SOC CHEM COMM, P275, DOI 10.1039/c39940000275
   Saxena M, 2012, DIAM RELAT MATER, V24, P11, DOI 10.1016/j.diamond.2012.01.035
   Selvi BR, 2008, NANO LETT, V8, P3182, DOI 10.1021/nl801503m
   Sonkar SK, 2012, MATER EXPRESS, V2, P105, DOI 10.1166/mex.2012.1064
   Sonkar SK, 2012, NANOSCALE, V4, P7670, DOI 10.1039/c2nr32408c
   Sonkar SK, 2010, J NANOSCI NANOTECHNO, V10, P4064, DOI 10.1166/jnn.2010.2007
   Sramkova Z., 2009, ACTA CHIM SLOV, V2, P115
   Srivastava S, 2011, CHEMPHYSCHEM, V12, P2624, DOI 10.1002/cphc.201100188
   Sun YP, 2006, J AM CHEM SOC, V128, P7756, DOI 10.1021/ja062677d
   Tan DZ, 2012, NANOSCALE, V4, P6664, DOI 10.1039/c2nr31398g
   Tripathi S, 2011, NANOSCALE, V3, P1176, DOI 10.1039/c0nr00722f
   Wang QL, 2011, CARBON, V49, P3134, DOI 10.1016/j.carbon.2011.03.041
   Yang ST, 2009, J PHYS CHEM C, V113, P18110, DOI 10.1021/jp9085969
   Yang ST, 2009, J AM CHEM SOC, V131, P11308, DOI 10.1021/ja904843x
   Yu SJ, 2005, J AM CHEM SOC, V127, P17604, DOI 10.1021/ja0567081
   Zhao QL, 2008, CHEM COMMUN, P5116, DOI 10.1039/b812420e
NR 49
TC 12
Z9 13
U1 3
U2 38
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2158-5849
J9 MATER EXPRESS
JI Mater. Express
PD SEP
PY 2013
VL 3
IS 3
BP 201
EP 209
DI 10.1166/mex.2013.1126
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 219AC
UT WOS:000324474300002
DA 2018-10-20
ER

PT J
AU Tachaboonyakiat, W
   Ajiro, H
   Akashi, M
AF Tachaboonyakiat, Wanpen
   Ajiro, Hiroharu
   Akashi, Mitsuru
TI Synthesis of a thermosensitive polycation by random copolymerization of
   N-vinylformamide and N-vinylbutyramide
SO POLYMER JOURNAL
LA English
DT Article
DE concentration dependence; lower critical solution temperature;
   N-vinylbutyramide; N-vinylformamide; pH dependence; thermoresponsive;
   vinylamine
ID GENE DELIVERY VECTORS; TRANSFECTION EFFICIENCY; STAR POLYMER; IN-VITRO;
   TEMPERATURE; POLY(N-ISOPROPYLACRYLAMIDE); DNA; POLY(N-VINYLALKYLAMIDE);
   FUNCTIONALITIES; SEPARATION
AB The novel thermoresponsive polycations poly(N-vinylbutyramide-co-vinylamide) (poly(NVBA-co-VAm)), with different mole ratios of poly(VAm) (PVAm): poly(NVBA) (PNVBA), were synthesized as a biomaterial by free radical copolymerization of poly (N-vinylbutyramide-co-N-vinylformamide) (poly(NVBA-co-NVF), followed by acid hydrolysis. Such poly(N-vinylamide)s do not generate toxic low-molecular-weight amine compounds by hydrolysis, although the poly(acrylamide) structural isomers do. The mole ratio of PVAm and PNVBA was varied by adjusting the NVF:NVBA mol% feeding ratio used in the copolymerization. The lower critical solution temperature (LCST) of the obtained copolymers was investigated and compared with that of PNVBA. PNVBA showed an LCST of 32 degrees C, while that for poly(NVBA-co-VAm) increased as the VAm mole ratio increased (due to the increasing hydrophilicity), and the more physiologically relevant temperature (for humans) of 36.5 degrees C was obtained at a VAm mole ratio of 5%. Furthermore, the LCST of these copolymers not only depended on the VAm mole ratios but also on the pH, the concentration of the copolymer solution and ionic strength. Variation in the copolymer LCST could lead to several applications, especially for copolymers with an LCST value around physiological temperature that would potentially be of merit for a controlled drug or biomolecule delivery system.
C1 [Tachaboonyakiat, Wanpen] Chulalongkorn Univ, Dept Mat Sci, Fac Sci, Bangkok, Thailand.
   [Ajiro, Hiroharu; Akashi, Mitsuru] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan.
   [Ajiro, Hiroharu; Akashi, Mitsuru] Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka 5650871, Japan.
RP Akashi, M (reprint author), Osaka Univ, Dept Appl Chem, Grad Sch Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.
EM akashi@chem.eng.osaka-u.ac.jp
FU Arai Scientific Technology Promoting Foundation; MEXT project, 'Creating
   Hybrid Organs of the future' at Osaka University; Hitachi Scholarship
   Foundation
FX We would like to express our appreciation to The Hitachi Scholarship
   Foundation for the research fellowship to W Tachaboonyakiat. This work
   was also supported in part by Arai Scientific Technology Promoting
   Foundation and the MEXT project, 'Creating Hybrid Organs of the future'
   at Osaka University.
CR Ajiro H, 2012, MACROMOLECULES, V45, P2668, DOI 10.1021/ma300183t
   AKASHI M, 1990, J POLYM SCI POL CHEM, V28, P3487, DOI 10.1002/pola.1990.080281224
   AKASHI M, 1993, J POLYM SCI POL CHEM, V31, P1153, DOI 10.1002/pola.1993.080310509
   Bisht HS, 2006, BIOMACROMOLECULES, V7, P1169, DOI 10.1021/bm0509927
   Caykara T, 2006, EUR POLYM J, V42, P348, DOI 10.1016/j.eurpolymj.2005.07.006
   Cheng H, 2008, BIOCONJUGATE CHEM, V19, P1368, DOI 10.1021/bc700478s
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Choi C, 2006, POLYMER, V47, P4571, DOI 10.1016/j.polymer.2006.05.011
   Coughlan DC, 2006, INT J PHARMACEUT, V313, P163, DOI 10.1016/j.ijpharm.2006.02.005
   Graziano G, 2000, INT J BIOL MACROMOL, V27, P89, DOI 10.1016/S0141-8130(99)00122-1
   Griffiths PC, 2008, BIOMACROMOLECULES, V9, P1170, DOI 10.1021/bm701096p
   Kanazawa H, 2008, J CHROMATOGR A, V1191, P157, DOI 10.1016/j.chroma.2008.01.056
   Kanazawa H, 2011, J CHROMATOGR A, V1218, P8738, DOI 10.1016/j.chroma.2011.04.015
   Kim JH, 2002, POLYMER, V43, P7549, DOI 10.1016/S0032-3861(02)00675-4
   Kratz K, 2000, COLLOID SURFACE A, V170, P137, DOI 10.1016/S0927-7757(00)00490-8
   Kuckling D, 2000, MACROMOL CHEM PHYSIC, V201, P273, DOI 10.1002/(SICI)1521-3935(20000201)201:2<273::AID-MACP273>3.0.CO;2-E
   Kurisawa M, 2000, J CONTROL RELEASE, V69, P127, DOI 10.1016/S0168-3659(00)00297-2
   Li J, 2009, J POLYM SCI POL CHEM, V47, P1450, DOI 10.1002/pola.23254
   Li M, 2008, J POLYM SCI POL CHEM, V46, P5093, DOI 10.1002/pola.22837
   Liu SQ, 2005, BIOMATERIALS, V26, P5064, DOI 10.1016/j.biomaterials.2005.01.030
   Ma YZ, 2010, MACROMOL BIOSCI, V10, P202, DOI 10.1002/mabi.200900230
   Mao ZW, 2007, BIOMATERIALS, V28, P4488, DOI 10.1016/j.biomaterials.2007.06.033
   Miyazaki H, 1996, POLYMER, V37, P681, DOI 10.1016/0032-3861(96)83156-9
   Mori T, 2004, LANGMUIR, V20, P313, DOI 10.1021/la0356194
   Nagase K, 2008, BIOMACROMOLECULES, V9, P1340, DOI 10.1021/bm701427m
   Nuopponen M, 2004, POLYMER, V45, P3643, DOI 10.1016/j.polymer.2004.03.083
   OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J
   Oupicky D, 2003, MACROMOLECULES, V36, P6863, DOI 10.1021/ma034039a
   Pinkrah VT, 2003, LANGMUIR, V19, P585, DOI 10.1021/la0262831
   Qin SH, 2006, ADV MATER, V18, P2905, DOI 10.1002/adma.200601019
   Schilli CM, 2004, MACROMOLECULES, V37, P7861, DOI 10.1021/ma035838w
   Suwa K, 1997, J POLYM SCI POL CHEM, V35, P3087, DOI 10.1002/(SICI)1099-0518(19971115)35:15<3087::AID-POLA1>3.3.CO;2-Z
   Takai Y. G., 1993, BIOCONJ CHEM, V4, P341
   Twaites BR, 2005, J CONTROL RELEASE, V108, P472, DOI 10.1016/j.jconrel.2005.08.009
   Twaites BR, 2004, J CONTROL RELEASE, V97, P551, DOI 10.1016/j.jconrel.2004.03.032
   Virtanen J, 2000, MACROMOLECULES, V33, P336, DOI 10.1021/ma990978k
   Wei H, 2006, BIOMATERIALS, V27, P2028, DOI 10.1016/j.biomaterials.2005.09.028
   Yamamoto K, 2003, MACROMOL CHEM PHYS, V204, P1027, DOI 10.1002/macp.200390073
   Yamamoto K, 2001, MACROMOLECULES, V34, P8014, DOI 10.1021/ma0102969
   Yamamoto K, 2000, J POLYM SCI POL CHEM, V38, P3674, DOI 10.1002/1099-0518(20001001)38:19<3674::AID-POLA210>3.0.CO;2-N
   Yang H, 2003, POLYMER, V44, P7175, DOI 10.1016/j.polymer.2003.09.008
   Yin X, 2006, BIOMACROMOLECULES, V7, P1381, DOI 10.1021/bm0507812
   Zhang J., 2000, MACROMOLECULES, V33, P1102
   Zhou YM, 2007, J CONTROL RELEASE, V123, P239, DOI 10.1016/j.jconrel.2007.08.026
   Zintchenko A, 2006, BIOCONJUGATE CHEM, V17, P766, DOI 10.1021/bc050292z
NR 45
TC 3
Z9 3
U1 2
U2 26
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0032-3896
J9 POLYM J
JI Polym. J.
PD SEP
PY 2013
VL 45
IS 9
BP 971
EP 978
DI 10.1038/pj.2013.12
PG 8
WC Polymer Science
SC Polymer Science
GA 214YK
UT WOS:000324175300013
DA 2018-10-20
ER

PT J
AU Monticelli, O
   Bocchini, S
   Gardella, L
   Cavallo, D
   Cebe, P
   Germelli, G
AF Monticelli, Orietta
   Bocchini, Sergio
   Gardella, Lorenza
   Cavallo, Dario
   Cebe, Peggy
   Germelli, Gabriele
TI Impact of synthetic talc on PLLA electrospun fibers
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Electrospinning; PLLA; Talc; Wettability
ID POLY(L-LACTIC ACID); POLY(LACTIC ACID); INFRARED-SPECTROSCOPY; CRYSTAL
   MODIFICATIONS; ALPHA-FORM; NANOFIBERS; MEMBRANES; POLYMER; POLYLACTIDE;
   BEHAVIOR
AB Poly(L-lactic acid) (PLLA) is an important biomaterial with application as surgical meshes, sutures, and in artificial tissue. Here we prepared novel fibers by electrospinning solutions containing PLLA and a specially synthesized talc (ts), characterized by the presence of aliphatic chains in the structure and completely soluble in the electrospinning solutions. Even a small amount of ts (2 wt.%) in the toluene/chloroform solvent increases the solution viscosity, most likely because of specific interactions between talc and PLLA. Morphological characterization demonstrated that homogenous fibers, of neat PLLA and PLLA/ts, are obtained by proper choice of electrospinning conditions. Among the parameters studied, relative humidity (Rh) was found significantly to affect fiber morphology. Morphological homogeneity increases by increasing Rh. In contrast to fibers containing a commercial talc, which is insoluble in the electrospinning mixture, and whose aggregates render the fiber irregular, in the case of PLLA/ts fibers the dispersion of the synthetic talc is achieved at the nanometric length scale. Electrospun mats based on PLLA/ts showed a much higher water contact angle than the neat PLLA mats, the contact angle increasing from 92 degrees to ca. 140 degrees, thus highlighting that a superhydrophobic PLLA surface is obtained by dispersing synthetic talc into PLLA fibers, widening the potential for biomedical applications of this material. Fiber properties of superhydrophobic PLLA were studied by means of differential scanning calorimetry (DSC), static and real-time wide angle X-ray diffraction (WAXD), and water contact angle measurements. Talc was found to promote the development of a small amount of crystallinity during the electrospinning process, and to favor the development of the alpha crystallographic form during annealing. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Monticelli, Orietta; Gardella, Lorenza; Germelli, Gabriele] Univ Genoa, Dipartimento Chim & Chim Ind, I-16146 Genoa, Italy.
   [Bocchini, Sergio] Ist Italian Tecnol, Ctr Space Human Robot PoliTo, I-10129 Turin, Italy.
   [Cavallo, Dario] Eindhoven Univ Technol, Dept Mech Engn, NL-5600 MB Eindhoven, Netherlands.
   [Cebe, Peggy] Tufts Univ, Dept Phys & Astron, Ctr Nanoscop Phys, Medford, MA 02155 USA.
RP Monticelli, O (reprint author), Univ Genoa, Dipartimento Chim & Chim Ind, Via Dodecaneso 31, I-16146 Genoa, Italy.
EM orietta.monticelli@unige.it
RI Cavallo, Dario/G-6012-2012; Bocchini, Sergio/B-7797-2010
OI Cavallo, Dario/0000-0002-3274-7067; Bocchini,
   Sergio/0000-0003-2876-2317; Cebe, Peggy/0000-0002-8721-644X
CR Afifi AM, 2009, MACROMOL MATER ENG, V294, P658, DOI 10.1002/mame.200900101
   Aleman C, 2001, MACROMOLECULES, V34, P4795, DOI 10.1021/ma001630o
   Alvarez-Perez MA, 2010, BIOMACROMOLECULES, V11, P2238, DOI 10.1021/bm100221h
   Areias AC, 2012, SOFT MATTER, V8, P5818, DOI 10.1039/c2sm25557j
   Ballester-Beltran J, 2011, SOFT MATTER, V7, P10803, DOI 10.1039/c1sm06102j
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Cozza ES, 2013, POLYM INT, V62, P41, DOI 10.1002/pi.4314
   Cozza ES, 2012, POLYM ADVAN TECHNOL, V23, P1252, DOI 10.1002/pat.2037
   Cozza ES, 2012, ACS APPL MATER INTER, V4, P604, DOI 10.1021/am201766r
   Cozza ES, 2010, MACROMOL MATER ENG, V295, P791, DOI 10.1002/mame.201000214
   Fisher E. W., 1973, COLLOID POLYM SCI, V251, P980
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hughes J, 2012, CARBOHYD POLYM, V88, P165, DOI 10.1016/j.carbpol.2011.11.078
   Inai R, 2005, NANOTECHNOLOGY, V16, P208, DOI 10.1088/0957-4484/16/2/005
   Lee YH, 2005, BIOMATERIALS, V26, P3165, DOI 10.1016/j.biomaterials.2004.08.018
   Lim GT, 2011, BIOMACROMOLECULES, V12, P1795, DOI 10.1021/bm200157b
   Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004
   Megelski S, 2002, MACROMOLECULES, V35, P8456, DOI 10.1021/ma020444a
   Mel F, 2007, BIOMACROMOLECULES, V8, P3729
   Michalak I, 2012, CARBOHYD POLYM, V87, P2432, DOI 10.1016/j.carbpol.2011.11.013
   Monticelli O, 2011, J POLYM SCI POL CHEM, V49, P4794, DOI 10.1002/pola.24926
   Najmunnisa N, 2007, EUR RESPIR J, V29, P761, DOI 10.1183/09031936.00061606
   Nguyen T. T. T., 2011, CARBOHYD POLYM, V86, P1799, DOI DOI 10.1016/J.CARBP0L.2011.07.014
   Noh KT, 2010, MATER LETT, V64, P802, DOI 10.1016/j.matlet.2010.01.014
   Pan PJ, 2008, MACROMOLECULES, V41, P4296, DOI 10.1021/ma800343g
   Pan P, 2008, J APPL POLYM SCI, V107, P54, DOI 10.1002/app.27102
   Pan P, 2007, MACROMOLECULES, V40, P6898, DOI 10.1021/ma071258d
   Pan P, 2009, PROG POLYM SCI, V34, P605, DOI 10.1016/j.progpolymsci.2009.01.003
   Patel HA, APPL CLAY S IN PRESS, DOI DOI 10.1016/J.CLAY.2013.05.010
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Sasaki S, 2003, MACROMOLECULES, V36, P8385, DOI 10.1021/ma0348674
   Shao SJ, 2011, BIOMATERIALS, V32, P2821, DOI 10.1016/j.biomaterials.2011.01.051
   Stoclet G, 2010, MACROMOLECULES, V43, P1488, DOI 10.1021/ma9024366
   Touny AH, 2010, MAT SCI ENG C-MATER, V30, P1304, DOI 10.1016/j.msec.2010.07.015
   Tripatanasuwan S, 2007, POLYMER, V48, P5742, DOI 10.1016/j.polymer.2007.07.045
   Tsuji H, 2006, BIOMACROMOLECULES, V7, P3316, DOI 10.1021/bm060786e
   Wang C, 2009, POLYMER, V50, P6100, DOI 10.1016/j.polymer.2009.10.025
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Xu JZ, 2010, MACROMOLECULES, V43, P5000, DOI 10.1021/ma100304n
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
   Yang T, 2011, POLYM COMPOSITE, V32, P1280, DOI 10.1002/pc.21149
   You Y, 2006, MATER LETT, V60, P1331, DOI 10.1016/j.matlet.2005.11.022
   Zhang JM, 2006, MACROMOL SYMP, V242, P274, DOI 10.1002/masy.200651038
   Zhang JM, 2010, MACROMOLECULES, V43, P4240, DOI 10.1021/ma100301h
   Zhang JM, 2005, MACROMOLECULES, V38, P8012, DOI 10.1021/ma051232r
   Zhang TP, 2011, J PHYS CHEM B, V115, P13835, DOI 10.1021/jp2087863
   Zhao NQ, 2008, J PHYS CHEM SOLIDS, V69, P1564, DOI 10.1016/j.jpcs.2007.10.046
   Zong XH, 2004, ANN SURG, V240, P910, DOI 10.1097/0l.sla.0000143302.48223.7e
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 51
TC 34
Z9 34
U1 1
U2 59
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
J9 EUR POLYM J
JI Eur. Polym. J.
PD SEP
PY 2013
VL 49
IS 9
SI SI
BP 2572
EP 2583
DI 10.1016/j.eurpolymj.2013.05.017
PG 12
WC Polymer Science
SC Polymer Science
GA 210BC
UT WOS:000323803300020
DA 2018-10-20
ER

PT J
AU Prasad, R
   Al-Kheraif, AA
AF Prasad, Rahul
   Al-Kheraif, Abdulaziz Abdullah
TI Three-Dimensional Accuracy of CAD/CAM Titanium and Ceramic
   Superstructures for Implant Abutments Using Spiral Scan Microtomography
SO INTERNATIONAL JOURNAL OF PROSTHODONTICS
LA English
DT Article
ID MARGINAL FIT; IN-VITRO; CROWN SYSTEMS; INTERNAL FIT; MICRO-CT; COPINGS;
   FRAMEWORKS; ZIRCONIA; RESTORATIONS; DISCREPANCY
AB Purpose: To introduce a new three-dimensional (3D) method of evaluating the fit of implant superstructures made using computer-aided design/computer-assisted manufacture (CAD/CAM) technology and conventional casting and to determine which biomaterial would produce optimal fit for the long-term clinical longevity of dental implant restorations. Materials and Methods: Five groups of materials were used to make 50 copings (n = 10) using CAD/CAM technology for titanium, partially sintered zirconia, fully sintered zirconia, and leucite-reinforced glass-ceramic materials and a conventional casting technique for the nickel-chromium group. The vertical marginal gap was measured at 16 equidistant points using a traveling microscope and compared with the 3D spatial gap values obtained by using spiral scan microtomography. Multivariate analysis of variance and Tukey post hoc tests were used for statistical analysis. Results: The vertical marginal gap width ranged from 13.21 to 75.26 mu m for the CAD/CAM groups and 64.89 to 115.27 mu m for the conventionally casted group. The spatial gap ranged from 0.22 to 0.67 mm(3) for CAD/CAM groups and 0.75 to 0.89 mm(3) for the conventionally casted group. The highest accuracy of fit was observed in the titanium group, followed by the leucite-reinforced glass-ceramic, partially sintered zirconia, fully sintered zirconia, and nickel-chromium groups. Conclusion: When used in combination with the CAD/CAM technique, titanium produces the most accurate implant superstructure. Spiral scan microtomography can be used to measure the accuracy of fit of dental implant superstructures and restorations as it provides a 3D measurement with less chance of errors compared with conventional methods of measurement.
C1 [Prasad, Rahul; Al-Kheraif, Abdulaziz Abdullah] King Saud Univ, Riyadh 11433, Saudi Arabia.
RP Prasad, R (reprint author), King Saud Univ, Ad Diriyah Campus,POB 10219, Riyadh 11433, Saudi Arabia.
EM rprasad@ksu.edu.sa
FU Research Center, College of Applied Medical Sciences and Deanship of
   Scientific Research at King Saud University
FX The authors extend their appreciation to the following: (1) Research
   Center, College of Applied Medical Sciences and Deanship of Scientific
   Research at King Saud University for funding this research, (2) Engineer
   Abdullah Bagshan Research Chair for Growth Factors and Bone Regeneration
   (GFBR), King Saud University, and (3) Physical Laboratory, College of
   Dentistry Research Center (CDRC), King Saud University. The authors
   reported no conflicts of interest related to this study.
CR Al-Amleh B, 2010, J ORAL REHABIL, V37, P641, DOI 10.1111/j.1365-2842.2010.02094.x
   Amano M, 2006, J DENT, V34, P503, DOI 10.1016/j.jdent.2005.12.001
   Baig MR, 2010, J PROSTHET DENT, V104, P216, DOI 10.1016/S0022-3913(10)60128-X
   Beschnidt SM, 1999, J ORAL REHABIL, V26, P582, DOI 10.1046/j.1365-2842.1999.00449.x
   Besimo C, 1997, INT J PROSTHODONT, V10, P541
   Beuer F, 2009, DENT MATER, V25, P94, DOI 10.1016/j.dental.2008.04.018
   Beuer F, 2009, CLIN ORAL INVEST, V13, P343, DOI 10.1007/s00784-008-0224-6
   Oyague RC, 2012, J DENT, V40, P123, DOI 10.1016/j.jdent.2011.11.007
   Coli P, 2004, INT J PROSTHODONT, V17, P577
   Conrad HJ, 2007, J PROSTHET DENT, V98, P389, DOI 10.1016/S0022-3913(07)60124-3
   de Torres EM, 2007, J DENT, V35, P800, DOI 10.1016/j.jdent.2007.07.013
   DURET F, 1988, J AM DENT ASSOC, V117, P715, DOI 10.14219/jada.archive.1988.0096
   Eden E, 2008, AM J DENT, V21, P393
   Fasbinder DJ, 2005, J AM DENT ASSOC, V136, P1714, DOI 10.14219/jada.archive.2005.0116
   Fonseca JC, 2003, DENT MATER, V19, P686, DOI 10.1016/S0109-5641(03)00014-9
   GELBARD S, 1994, J PROSTHET DENT, V71, P1, DOI 10.1016/0022-3913(94)90246-1
   GOLL GE, 1991, J PROSTHET DENT, V66, P377, DOI 10.1016/0022-3913(91)90266-Y
   Groten M, 1997, J ORAL REHABIL, V24, P871, DOI 10.1046/j.1365-2842.1997.00592.x
   Groten M, 2000, J PROSTHET DENT, V83, P40, DOI 10.1016/S0022-3913(00)70087-4
   Hamilton MJ, 2010, J PROSTHODONT, V19, P478, DOI 10.1111/j.1532-849X.2010.00599.x
   Han HS, 2011, J PROSTHET DENT, V106, P191, DOI 10.1016/S0022-3913(11)60120-0
   Holand W, 2006, J MATER SCI-MATER M, V17, P1037, DOI 10.1007/s10856-006-0441-y
   HOLMES JR, 1989, J PROSTHET DENT, V62, P405, DOI 10.1016/0022-3913(89)90170-4
   Jemt T, 1996, Int J Oral Maxillofac Implants, V11, P620
   Kan JYK, 1999, J PROSTHET DENT, V81, P7, DOI 10.1016/S0022-3913(99)70229-5
   Karatasli O, 2011, DENT MATER J, V30, P97, DOI 10.4012/dmj.2010-063
   KARLSSON S, 1993, ACTA ODONTOL SCAND, V51, P129, DOI 10.3109/00016359309041158
   Kelly JR, 2007, CLIN ORAL IMPLAN RES, V18, P205, DOI 10.1111/j.1600-0501.2007.01443.x
   Lee HS, 2008, AM J DENT, V21, P129
   Lee KB, 2008, DENT MATER J, V27, P422, DOI 10.4012/dmj.27.422
   Martinez-Rus F, 2011, J PROSTHET DENT, V105, P108, DOI 10.1016/S0022-3913(11)60009-7
   Mitha T, 2009, INT J PROSTHODONT, V22, P248
   Papazoglou E, 2001, J PROSTHET DENT, V85, P133, DOI 10.1067/mpr.2001.113707
   Quintas AF, 2004, J PROSTHET DENT, V92, P250, DOI 10.1016/j.prosdent.2004.06.023
   Romero GG, 2000, J PROSTHET DENT, V84, P602, DOI 10.1067/mpr.2000.111494
   Sahin S, 2001, Implant Dent, V10, P85
   SCHWARTZ IS, 1986, J PROSTHET DENT, V56, P279, DOI 10.1016/0022-3913(86)90003-X
   SONES AD, 1989, J PROSTHET DENT, V62, P581, DOI 10.1016/0022-3913(89)90084-X
   Song XF, 2010, J ORAL REHABIL, V37, P680, DOI 10.1111/j.1365-2842.2010.02099.x
   Sulaiman F, 1997, INT J PROSTHODONT, V10, P478
   Tan Philip L, 2008, J Prosthodont, V17, P378, DOI 10.1111/j.1532-849X.2008.00302.x
   Wang R R, 1996, Quintessence Int, V27, P401
   Weinberg L A, 1993, Int J Oral Maxillofac Implants, V8, P19
   Witkowski S, 2006, J PROSTHET DENT, V96, P47, DOI 10.1016/j.prosdent.2006.05.013
   Yeo IS, 2003, J PROSTHET DENT, V90, P459, DOI 10.1016/j.prosdent.2003.08.005
   Yilmaz H, 2007, J PROSTHET DENT, V98, P120, DOI 10.1016/S0022-3913(07)60045-6
NR 46
TC 7
Z9 7
U1 2
U2 20
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0893-2174
EI 1942-4426
J9 INT J PROSTHODONT
JI Int. J. Prosthodont.
PD SEP-OCT
PY 2013
VL 26
IS 5
BP 451
EP 457
DI 10.11607/ijp.3302
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 212YO
UT WOS:000324019200008
PM 23998143
OA Bronze
DA 2018-10-20
ER

PT J
AU Oudadesse, H
   Wers, E
   Bui, XV
   Roiland, C
   Bureau, B
   Akhiyat, I
   Mostafa, A
   Chaair, H
   Benhayoune, H
   Faure, J
   Pellen-Mussi, P
AF Oudadesse, Hassane
   Wers, Eric
   Bui, Xuang Vuong
   Roiland, Claire
   Bureau, Bruno
   Akhiyat, Imane
   Mostafa, Amany
   Chaair, Hassan
   Benhayoune, Hicham
   Faure, Joel
   Pellen-Mussi, Pascal
TI Chitosan effects on glass matrices evaluated by biomaterial. MAS-NMR and
   biological investigations
SO KOREAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Bioactive Glass; Chitosan; Composite; Bioactivity; Hydroxyapatite; P-31
   MAS NMR; Si-29 MAS NMR; Immortalized Cell; 3D Cells Viability
ID SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; BIOACTIVE GLASS; P-31;
   APATITE; SPECTROSCOPY; PHOSPHATE; GROWTH; TISSUE; SI-29
AB Bioactive glass 46S6 and biodegradable therapeutic polymer (Chitosan: CH) have been elaborated to form 46S6-CH composite by freeze-drying process. The kinetics of chemical reactivity and bioactivity at the surface were investigated by using physicochemical techniques, particularly solid-state MAS-NMR. Immortalized cell line used to construct multicellular spheroids was employed as three-dimensional (3D) cell cultures for in vitro studies. Obtained results showed a novel structure of the composite; the chemical treatment (ultrasound, magnetic stirring, freeze drying process and lyophilization) led the bioactive glass particles to be loaded in the chitosan-based materials. Si-29 and 311) MAS-NMR results showed the emergence of two new species, Q(st),(3)(OH) and Q(st)(4), which are characteristic of the vitreous network dissolution in simulated body fluid (SBF). MAS-NMR also confirmed the formation of amorphous calcium phosphate (ACP) at the surface of the initial 46S6-CH. Three-dimensional (3D) cell cultures highlighted the effect of chitosan, where the cell viability reached up to 78% in 46S6-CH composite and up to 67% in 46S6. The association of (CH) and bioactive glass (BG) matrix promotes a highly significant bioactivity, demonstrating surface bone formation and satisfactory behavior in biological environment.
C1 [Oudadesse, Hassane; Wers, Eric; Bui, Xuang Vuong; Roiland, Claire; Bureau, Bruno; Akhiyat, Imane; Mostafa, Amany; Pellen-Mussi, Pascal] Univ Rennes 1, SCR, UMR CNRS 6226, F-35042 Rennes, France.
   [Mostafa, Amany] Natl Res Ctr, Biomat Dept, Cairo 12622, Egypt.
   [Benhayoune, Hicham; Faure, Joel] LISM URCA, F-51685 Reims 02, France.
RP Oudadesse, H (reprint author), Univ Rennes 1, SCR, UMR CNRS 6226, 263 Av Gen Leclerc, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
OI Mostafa, Amany/0000-0003-4013-0742; roiland, claire/0000-0001-9587-1340
CR ALNO N, MAT RES A, DOI DOI 10.1002/JBM.A.32818
   ANDERSSON OH, 1991, J NON-CRYST SOLIDS, V129, P145, DOI 10.1016/0022-3093(91)90090-S
   Angelopoulou A, 2008, J NON-CRYST SOLIDS, V354, P333, DOI 10.1016/j.jnoncrysol.2007.08.091
   AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032
   BELTON PS, 1988, J PHYS CHEM SOLIDS, V49, P21, DOI 10.1016/0022-3697(88)90129-1
   BOYAN BD, 1996, Patent No. 5492697
   BRANDENBERG G, 1984, NEUROSURGERY, V15, P9, DOI 10.1227/00006123-198407000-00004
   Bui XV, 2012, KOREAN J CHEM ENG, V29, P215, DOI 10.1007/s11814-011-0151-0
   BUI XV, 2011, 4421 U RENN 1, V171
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   Dietrich E., 2008, J BIOMED MATER RES A, V88, P1087
   DIETRICH E, 2008, 3767 U RENN 1, V205
   Elgayar I, 2005, J NON-CRYST SOLIDS, V351, P173, DOI 10.1016/j.jnoncrysol.2004.07.067
   Gunawidjaja PN, 2010, J PHYS CHEM C, V114, P19345, DOI 10.1021/jp105408c
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HINEDI ZR, 1992, J COLLOID INTERF SCI, V152, P141, DOI 10.1016/0021-9797(92)90015-E
   HIRANO S, 1980, RES CARBOHYD, V8, P103
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   JOELBUMGARDNER D, 2007, Patent No. 0254007
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Leonor IB, 2008, ACTA BIOMATER, V4, P1349, DOI 10.1016/j.actbio.2008.03.003
   Lin KSK, 2005, CHEM MATER, V17, P4493, DOI 10.1021/cm0505654c
   LOCKYER MWG, 1995, J NON-CRYST SOLIDS, V188, P207, DOI 10.1016/0022-3093(95)00188-3
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   MATHEW P, 2009, CARBOHYD POLYM, V79, P281
   MUZZARELLI RAA, 1984, CARBOHYD RES, V126, P225, DOI 10.1016/0008-6215(84)85380-X
   OESTRIKE R, 1987, GEOCHIM COSMOCHIM AC, V51, P2199, DOI 10.1016/0016-7037(87)90269-9
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   OUDADESSE H, 2011, USTV
   Rich J, 2002, BIOMATERIALS, V23, P2143, DOI 10.1016/S0142-9612(01)00345-3
   Smith M. E., 2002, MULTINUCLEAR SOLID S
   Thein-Han W.W., 2008, ACTA BIOMATER, V5, P1182
   Walsh D, 2001, BIOMATERIALS, V22, P1205, DOI 10.1016/S0142-9612(00)00268-4
   Zhao L, 2004, J MATER SCI-MATER M, V15, P625, DOI 10.1023/B:JMSM.0000026103.44687.d0
NR 36
TC 5
Z9 5
U1 2
U2 20
PU KOREAN INSTITUTE CHEMICAL  ENGINEERS
PI SEOUL
PA F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA
SN 0256-1115
EI 1975-7220
J9 KOREAN J CHEM ENG
JI Korean J. Chem. Eng.
PD SEP
PY 2013
VL 30
IS 9
BP 1775
EP 1783
DI 10.1007/s11814-013-0104-x
PG 9
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 211OA
UT WOS:000323916500016
DA 2018-10-20
ER

PT J
AU Swaminathan, S
   Harris, T
   McClellan, D
   Cui, Y
AF Swaminathan, Swathi
   Harris, Thomas
   McClellan, Dan
   Cui, Yue
TI Bio-inspired mammalian hair-fabricated microfluidics
SO MATERIALS LETTERS
LA English
DT Article
DE Microfluidic channels; Mammalian hair; Immunoassay; Cell assay;
   Microwire synthesis
ID THREAD
AB The development of a simple approach for the generation of microstructures could expand opportunities in both fundamental studies and practical applications. Mammalian hair is a filamentous biomaterial which is mechanically strong, flexible, abundant, and easily harvested. Here, we demonstrate for the first time a simple generation of microfluidic channels from mammalian hairs. Our results show that hairs with different widths result in the generation of microfluidic channels with different widths. Furthermore, with different textures of hairs, the shape of microfluidic channels can be varied. Finally, we demonstrate the utility of this microfluidic channel for bioassays and microwire synthesis. We anticipate that these results could open exciting opportunities for investigating a variety of biological materials to fabricate micro/nano-structures and devices for fundamental studies, as well as applications ranging from biological analysis to materials synthesis. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Swaminathan, Swathi; Harris, Thomas; McClellan, Dan; Cui, Yue] Utah State Univ, Dept Biol Engn, Logan, UT 84322 USA.
RP Cui, Y (reprint author), Utah State Univ, Dept Biol Engn, Logan, UT 84322 USA.
EM yue.cui@usu.edu
FU Utah State University
FX We acknowledge Utah State University for the financial support of this
   work.
CR Ashley JF, 2011, LAB CHIP, V11, P2772, DOI 10.1039/c1lc20189a
   Chen CS, 2008, LAB CHIP, V8, P622, DOI 10.1039/b719029h
   Kim DR, 2009, NANO LETT, V9, P1984, DOI 10.1021/nl900238a
   Kim J, 2011, LAB CHIP, V11, P1946, DOI 10.1039/c1lc20079h
   Li X, 2010, ACS APPL MATER INTER, V2, P1, DOI 10.1021/am9006148
   MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144
   Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84
   Reches M, 2010, ACS APPL MATER INTER, V2, P1722, DOI 10.1021/am1002266
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sessions BD, 2009, J NAT HIST, V43, P489, DOI 10.1080/00222930802267187
   Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584
   Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389
   Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064
   Yuan B, 2010, ADV FUNCT MATER, V20, P3715, DOI 10.1002/adfm.201001298
NR 14
TC 4
Z9 4
U1 2
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD SEP 1
PY 2013
VL 106
BP 208
EP 212
DI 10.1016/j.matlet.2013.05.006
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 195DM
UT WOS:000322682500056
DA 2018-10-20
ER

PT J
AU Hu, Q
   Chen, XF
   Zhao, NR
   Li, YL
AF Hu, Qing
   Chen, Xiaofeng
   Zhao, Naru
   Li, Yuli
TI Facile synthesis and in vitro bioactivity of monodispersed mesoporous
   bioactive glass sub-micron spheres
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterials; Sol-gel preparation; Bioactive glass; Monodispersed;
   Mesoporous sub-micron spheres
ID BONE TISSUE REGENERATION; SOL-GEL; MICROSPHERES; SILICA; CELLS
AB This paper reports a facile method for fabricating monodispersed mesoporous bioactive glass sub-micron spheres (MBGS) using dodecylamine (DDA) as a catalyst and template agent in sal gel process. The morphology, structure and in vitro bioactivity of MBGS were investigated by various methods. The results indicate that using DDA as the structure directing agent and hydrolysis catalyst is in favor of preparing the MBGS with mesoporous surface structure, large specific surface area (362.073 m(2) g(-1)), relatively homogeneous particle size (similar to 560 nm) and good apatite-forming activity. The unique structure and properties may turn MBGS into a good candidate as a drug delivery carrier or an injectable biomaterial for bone tissue regeneration. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Hu, Qing; Chen, Xiaofeng; Zhao, Naru; Li, Yuli] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
RP Chen, XF (reprint author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
EM chenxf@scut.edu.cn
FU National Natural Science Foundation of China [50830101, 51072055,
   51172073, 51202069]; National 973 project of China [2011CB606204];
   Research Fund for the Doctoral Program of Higher Education of China
   [20110172110002]; Fundamental Research Funds for the Central University
   [2012ZP0001]
FX This work was supported by the Key Project of the National Natural
   Science Foundation of China (Grant no. 50830101), National Natural
   Science Foundation of China (Grant no. 51072055, Grant no. 51172073,
   Grant no. 51202069), the National 973 project of China (2011CB606204),
   Research Fund for the Doctoral Program of Higher Education of China
   (20110172110002) and the Fundamental Research Funds for the Central
   University (2012ZP0001).
CR Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Chen XF, 2009, J NON-CRYST SOLIDS, V355, P791, DOI 10.1016/j.jnoncrysol.2009.02.005
   Coleman NJ, 2000, CERAM INT, V26, P171, DOI 10.1016/S0272-8842(99)00037-1
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hong ZK, 2010, J BIOMED MATER RES A, V95A, P747, DOI 10.1002/jbm.a.32898
   Hong ZK, 2009, J NON-CRYST SOLIDS, V355, P368, DOI 10.1016/j.jnoncrysol.2008.12.003
   Hum J, 2012, J MATER SCI-MATER M, V23, P2317, DOI 10.1007/s10856-012-4580-z
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Labbaf S, 2011, BIOMATERIALS, V32, P1010, DOI 10.1016/j.biomaterials.2010.08.082
   Lei B, 2012, J BIOMED MATER RES B, V100B, P967, DOI 10.1002/jbm.b.32659
   Lei B, 2012, J AM CERAM SOC, V95, P30, DOI 10.1111/j.1551-2916.2011.04918.x
   Lei B, 2011, J MATER CHEM, V21, P12725, DOI 10.1039/c1jm11547b
   Lei B, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054103
   Lei B, 2009, MATER LETT, V63, P1719, DOI 10.1016/j.matlet.2009.04.041
   Ryoo R, 2001, J AM CHEM SOC, V123, P1650, DOI 10.1021/ja0038326
   Shi XT, 2008, J MATER SCI-MATER M, V19, P2933, DOI 10.1007/s10856-008-3424-3
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   TANEV PT, 1995, SCIENCE, V267, P865, DOI 10.1126/science.267.5199.865
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Yu JG, 2006, J SOLID STATE CHEM, V179, P226, DOI 10.1016/j.jssc.2005.10.036
NR 21
TC 31
Z9 31
U1 2
U2 48
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD SEP 1
PY 2013
VL 106
BP 452
EP 455
DI 10.1016/j.matlet.2013.04.075
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 195DM
UT WOS:000322682500118
DA 2018-10-20
ER

PT J
AU Weis, S
   Lee, TT
   del Campo, A
   Garcia, AJ
AF Weis, Simone
   Lee, Ted T.
   del Campo, Aranzazu
   Garcia, Andres J.
TI Dynamic cell-adhesive microenvironments and their effect on myogenic
   differentiation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Integrin; RGD; Biomaterial; Fibronectin; Cell adhesion
ID SELF-ASSEMBLED MONOLAYERS; PHOTOCAGED RGDS PEPTIDES; STEM-CELLS;
   FIBRONECTIN; INTEGRIN; BIOMATERIALS; PROLIFERATION; DENSITY;
   CHEMISTRIES; HYDROGELS
AB Integrin-mediated cell adhesion plays a central role in cell behavior on biomaterial surfaces and influences various cell functions. Photoactivatable RGD adhesive peptides were used to investigate the effect of the density and time point of bioadhesive ligand presentation on cell adhesion, proliferation and differentiation. PEGylated self-assembled monolayers were functionalized with RGD and caged RGD ligands and seeded with C2C12 myoblasts. The cultures were irradiated at various time points between 1 and 48 h after cell seeding in order to increase RGD surface concentration at defined time points. Attachment, spreading and myogenic differentiation of C2C12 myoblasts strongly varied with the density of RGD at the surface. Proliferation and myogenesis were further regulated by the time point at which RGD was presented to the cell, reaching highest levels when RGD exposure occurred <= 6 h after cell seeding. These results provide fundamental insights in cell-biomaterial interactions of C2C12 myoblasts in terms of temporal integrin-mediated cell responses. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Weis, Simone; del Campo, Aranzazu] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Lee, Ted T.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP del Campo, A (reprint author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
EM delcampo@mpip-mainz.mpg.de; andres.garcia@me.gatech.edu
OI del Campo, Aranzazu/0000-0001-5725-2135
FU Materials World Network [DFG AOBJ 569628, NSF DMR-0909002];
   Max-Planck-Graduate Center
FX The authors thank M. Wirkner and T.A. Petrie for assistance with pilot
   experiments on peptide modified SAMs. The authors thank the Materials
   World Network (DFG AOBJ 569628, NSF DMR-0909002) for financial support.
   S.W. thanks the Max-Planck-Graduate Center for financial support.
CR Altrock E, 2012, BIOMATERIALS, V33, P3107, DOI 10.1016/j.biomaterials.2012.01.002
   Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657
   Beebe D. J., 2011, TRENDS BIOTECHNOL, V29, P399, DOI DOI 10.1016/ J. TIBTECH. 2011. 03. 006, S0167- 7799
   Capadona JR, 2003, LANGMUIR, V19, P1847, DOI 10.1021/la026244
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Eisenberg JL, 2009, LANGMUIR, V25, P13942, DOI 10.1021/la901528c
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Goubko CA, 2013, J BIOMED MATER RES A, V101, P787, DOI 10.1002/jbm.a.34381
   Goubko CA, 2010, BIOMED MICRODEVICES, V12, P555, DOI 10.1007/s10544-010-9412-7
   Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126
   Kilian KA, 2012, ANGEW CHEM INT EDIT, V51, P4891, DOI 10.1002/anie.201108746
   Kim J, 2012, TRENDS BIOTECHNOL, V30, P426, DOI 10.1016/j.tibtech.2012.04.003
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kustra S, 2012, MRS BULL, V37, P836, DOI 10.1557/mrs.2012.185
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Ohmuro-Matsuyama Y, 2008, ANGEW CHEM INT EDIT, V47, P7527, DOI 10.1002/anie.200802731
   Petersen S, 2008, ANGEW CHEM INT EDIT, V47, P3192, DOI 10.1002/anie.200704857
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Raynor JE, 2007, ADV MATER, V19, P1724, DOI 10.1002/adma.200602129
   Robertus J, 2010, CHEM SOC REV, V39, P354, DOI 10.1039/b906608j
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x
   Salierno MJ, 2013, ADV FUNCT MATER, V23, P5974, DOI 10.1002/adfm.201300902
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306
   Tanaka K, 2011, MUSCLE NERVE, V44, P968, DOI 10.1002/mus.22224
   Wade RJ, 2012, MATER TODAY, V15, P454, DOI 10.1016/S1369-7021(12)70197-9
   Wirkner M, 2011, CHEMBIOCHEM, V12, P2623, DOI 10.1002/cbic.201100437
   Wirkner M, 2011, ADV MATER, V23, P3907, DOI 10.1002/adma.201100925
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
NR 38
TC 23
Z9 23
U1 2
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2013
VL 9
IS 9
BP 8059
EP 8066
DI 10.1016/j.actbio.2013.06.019
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204WS
UT WOS:000323402600003
PM 23791677
DA 2018-10-20
ER

PT J
AU Samal, SK
   Dash, M
   Chiellini, F
   Kaplan, DL
   Chiellini, E
AF Samal, Sangram K.
   Dash, Mamoni
   Chiellini, Federica
   Kaplan, David L.
   Chiellini, Emo
TI Silk microgels formed by proteolytic enzyme activity
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk fibroin protein; alpha-Chymotrypsin; Self-assemble; Peptide;
   Microgels
ID BOMBYX-MORI; DRUG-DELIVERY; FIBROIN; MECHANISM; RELEASE; MICROSPHERES;
   SCAFFOLDS; MICROFLUIDICS; ENCAPSULATION; SYSTEM
AB The proteolytic enzyme alpha-chymotrypsin selectively cleaves the amorphous regions of silk fibroin protein (SFP) and allows the crystalline regions to self-assemble into silk microgels (SMGs) at physiological temperature. These microgels consist of lamellar crystals in the micrometer scale, in contrast to the nanometer-scaled crystals in native silkworm fibers. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and zeta potential results demonstrated that alpha-chymotrypsin utilized only the non-amorphous domains or segments of the heavy chain of SFP to form negatively charged SMGs. The SMGs were characterized in terms of size, charge, structure, morphology, crystallinity, swelling kinetics, water content and thermal properties. The results suggest that the present technique of preparing SMGs by alpha-chymotrypsin is simple and efficient, and that the prepared SMGs have useful features for studies related to biomaterial and pharmaceutical needs. This process is also an easy way to obtain the amorphous peptide chains for further study. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Samal, Sangram K.; Dash, Mamoni; Chiellini, Federica; Chiellini, Emo] Univ Pisa, BioLab UdR INSTM, I-1291 Pisa, Italy.
   [Samal, Sangram K.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Samal, Sangram K.; Dash, Mamoni] Univ Ghent, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
RI Chiellini, Federica/F-3233-2010; Samal, Sangram/H-5442-2013; Dash,
   Mamoni/H-5450-2013
OI Chiellini, Federica/0000-0003-4680-9975; Dash,
   Mamoni/0000-0001-6930-6495
FU Bimolecular Sciences School, University of Pisa, Italy; NIH [EB002520];
   AFOSR
FX Authors would like to thank Xiaoqin Wang, Carmen Preda and Guokui Qin
   for their technical help. The authors would also like to thank
   Bimolecular Sciences School, University of Pisa, Italy, the NIH
   (EB002520) and the AFOSR for financial support.
CR An HZ, 2012, ADV MATER, V24, P3838, DOI 10.1002/adma.201200214
   Asakura T, 2002, BIOCHEMISTRY-US, V41, P4415, DOI 10.1021/bi0119013
   Athamneh AI, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/10/104024
   BENDER ML, 1965, ANNU REV BIOCHEM, V34, P49, DOI 10.1146/annurev.bi.34.070165.000405
   Berg J M, 2002, BIOCHEMISTRY
   Breslauer DN, 2010, BIOMACROMOLECULES, V11, P643, DOI 10.1021/bm901209u
   Dendukuri D, 2009, ADV MATER, V21, P4071, DOI 10.1002/adma.200803386
   Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7
   Donna W, 2000, BIOPHYS J, V78, P2690
   HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324
   Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x
   Hino Tomoaki, 2000, Pharmacy and Pharmacology Communications, V6, P335
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Ostrowska-Czubenko J, 2009, CARBOHYD POLYM, V77, P590, DOI 10.1016/j.carbpol.2009.01.036
   Piras AM, 2008, INT J PHARMACEUT, V357, P260, DOI 10.1016/j.ijpharm.2008.01.035
   Samal SK, 2009, J THERM ANAL CALORIM, V97, P859, DOI 10.1007/s10973-009-0337-4
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Wang AH, 2012, ADV FUNCT MATER, V22, P2673, DOI 10.1002/adfm.201102907
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wen XG, 2011, INT J PHARMACEUT, V416, P195, DOI 10.1016/j.ijpharm.2011.06.041
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Ying H, 2011, 5 INT C BIOINF BIOM, DOI DOI 10.1109/ICBBE.2011.5780318
   Yonemura N, 2009, J MOL EVOL, V68, P641, DOI 10.1007/s00239-009-9234-5
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 34
TC 9
Z9 9
U1 4
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2013
VL 9
IS 9
BP 8192
EP 8199
DI 10.1016/j.actbio.2013.05.027
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204WS
UT WOS:000323402600016
PM 23756227
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hsiao, YC
   Chen, CN
   Chen, YT
   Yang, TL
AF Hsiao, Ya-Chuan
   Chen, Chun-Nan
   Chen, Yoy-Tzung
   Yang, Tsung-Lin
TI Controlling branching structure formation of the salivary gland by the
   degree of chitosan deacetylation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Branching; Structure formation; Salivary gland; Chitosan; Deacetylation
ID TISSUE ENGINEERING APPLICATIONS; HETEROGENEOUS N-DEACETYLATION; CRUCIATE
   LIGAMENT CELLS; IN-VITRO; MOLECULAR-WEIGHT; SUBMANDIBULAR-GLAND;
   BIOLOGICAL-PROPERTIES; ALKALINE-SOLUTION; GENE-EXPRESSION; MORPHOGENESIS
AB The salivary gland is characterized by ramified epithelial branches, a specific tissue structure responsible for saliva production and regulation. To regenerate the salivary gland function, it is important to establish the tissue structure. Chitosan is a deacetylated derivative of chitin with wide biomedical applications. Because of its deacetylated nature, chitosan has different properties when prepared with different degrees of deacetylation (DDA). However, the impact of chitosan DDA on the effect of regulating tissue structure formation remains unexplored. In this study, the embryonic murine submandibular gland (SMG) was used as a model to investigate the role of chitosan DDA in regulating tissue structure formation of the salivary gland. When chitin substrates with different DDA were used, the branching numbers of cultured SMG explants changed. Similar effects were observed in the culture with chitosan prepared using different degrees of acetylation. The mRNA expressions of type land type III collagen were elevated in SMG explants with enhanced branching morphogenesis, as was the protein level. In addition to the amounts of collagen, type land type III collagen fibers were spatially present in the epithelial mesenchymal junction of developing branches in the culture with chitosan of a specific range of DDA. The branch-promoting effect of chitosan DDA was abolished when SMG explants were treated with collagenase, both early in the stage of branch initiation and with the establishment of the branching structure. The branch-promoting effect of chitosan DDA disappeared when antisense oligonucleotides were applied to specifically block type III collagen. This study demonstrates for the first time that DDA of chitosan affects tissue structure formation. The different proportions of side-chain components of chitin derivatives regulate structural formation of cultured SMG, indicating that DDA is an important parameter using chitosan as a biomaterial for tissue structure formation of the salivary glands. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hsiao, Ya-Chuan; Chen, Chun-Nan; Yang, Tsung-Lin] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.
   [Hsiao, Ya-Chuan; Chen, Chun-Nan; Yang, Tsung-Lin] Coll Med, Taipei, Taiwan.
   [Hsiao, Ya-Chuan] Taipei City Hosp, Dept Ophthalmol, Zhongxing Branch, Taipei, Taiwan.
   [Hsiao, Ya-Chuan] Natl Yang Ming Univ, Coll Med, Dept Ophthalmol, Taipei 112, Taiwan.
   [Chen, Chun-Nan; Chen, Yoy-Tzung] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan.
   [Chen, Yoy-Tzung] Natl Taiwan Univ, Grad Inst Med Genom & Prote, Coll Med, Taipei 10764, Taiwan.
   [Yang, Tsung-Lin] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan.
RP Yang, TL (reprint author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.
EM yangtl@ntu.edu.tw
OI YANG, TSUNG-LIN/0000-0001-6521-8631; CHEN, YOU-TZUNG/0000-0001-6510-3420
FU National Science Council of the Republic of China; National Taiwan
   University Hospital; National Health Research Institutes
FX The authors thank National Science Council of the Republic of China,
   National Taiwan University Hospital and National Health Research
   Institutes for their financial support. The authors also thank the staff
   of the Eighth Core Lab, Department of Medical Research, and the
   Institute of Biomedical Engineering, National Taiwan University for
   technical support.
CR AIBA S, 1994, CARBOHYD RES, V265, P323, DOI 10.1016/0008-6215(94)00243-6
   Amaral IF, 2007, J BIOMAT SCI-POLYM E, V18, P469, DOI 10.1163/156856207780425068
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Benesch J, 2002, BIOMATERIALS, V23, P2561, DOI 10.1016/S0142-9612(01)00391-X
   Cantara SI, 2012, BIOMATERIALS, V33, P8372, DOI 10.1016/j.biomaterials.2012.08.021
   Chang KLB, 1997, CARBOHYD RES, V303, P327, DOI 10.1016/S0008-6215(97)00179-1
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen WL, 2010, TISSUE ENG C
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Elsabee MZ, 2009, COLLOID SURFACE B, V74, P1, DOI 10.1016/j.colsurfb.2009.06.021
   FUKUDA Y, 1988, DEVELOPMENT, V103, P259
   GROBSTEIN C, 1965, SCIENCE, V150, P626, DOI 10.1126/science.150.3696.626
   Hayakawa T, 1992, Matrix Suppl, V1, P344
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172
   Horie S, 2000, PATHOL INT, V50, P937, DOI 10.1046/j.1440-1827.2000.01146.x
   Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Hsiao YC, 2011, BIOMATERIALS, V32, P4424, DOI 10.1016/j.biomaterials.2011.02.057
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   KALLMAN F, 1965, DEV BIOL, V11, P169, DOI 10.1016/0012-1606(65)90055-2
   Kiang T, 2004, BIOMATERIALS, V25, P5293, DOI 10.1016/j.biomaterials.2003.12.036
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Lieder R, 2012, J BIOMED MATER RES A, V100A, P3392, DOI 10.1002/jbm.a.34283
   Methacanon P, 2003, CARBOHYD POLYM, V52, P119, DOI 10.1016/S0144-8617(02)00300-4
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   NAKANISHI Y, 1988, DEVELOPMENT, V104, P51
   Nishimura K, 1984, Vaccine, V2, P93, DOI 10.1016/S0264-410X(98)90039-1
   Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x
   Porporatto C, 2003, BIOCHEM BIOPH RES CO, V304, P266, DOI 10.1016/S0006-291X(03)00579-5
   Prabaharan M, 2008, J BIOMATER APPL, V23, P5, DOI 10.1177/0885328208091562
   Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Shao HJ, 2010, BIOMATERIALS, V31, P4695, DOI 10.1016/j.biomaterials.2010.02.037
   Shao HJ, 2010, J BIOMED MATER RES A, V93A, P1297, DOI 10.1002/jbm.a.32629
   Simard P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2703
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   SPOONER BS, 1980, DEV BIOL, V77, P84, DOI 10.1016/0012-1606(80)90458-3
   Suphasiriroj W, 2009, J MATER SCI-MATER M, V20, P309, DOI 10.1007/s10856-008-3575-2
   Tangsadthakun C, 2007, J BIOMAT SCI-POLYM E, V18, P147, DOI 10.1163/156856207779116694
   Thein-Han WW, 2007, J BIOMED MATER RES B, V80B, P92, DOI 10.1002/jbm.b.30573
   Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Vachoud L, 2000, CARBOHYD RES, V326, P295, DOI 10.1016/S0008-6215(00)00038-0
   Varum KM, 1996, BBA-GEN SUBJECTS, V1291, P5, DOI 10.1016/0304-4165(96)00038-4
   Yang TL, 2008, BIOMATERIALS, V29, P2501, DOI 10.1016/j.biomaterials.2008.02.014
   Yang TL, 2008, BIOMED ENG-APP BAS C, V20, P287, DOI [10.1142/S1016237208000908, 10.4015/S1016237208000908]
   Yang TL, 2012, TISSUE ENG PT A, V18, P2220, DOI [10.1089/ten.tea.2011.0527, 10.1089/ten.TEA.2011.0527]
   Yang TL, 2011, INT J MOL SCI, V12, P1936, DOI 10.3390/ijms12031936
   Yang TL, 2010, BIOMATERIALS, V31, P288, DOI 10.1016/j.biomaterials.2009.09.052
   Yang TL, 2009, J CELL MOL MED, V13, P2853, DOI 10.1111/j.1582-4934.2008.00425.x
   Yang TL, 2009, BIOCHEM BIOPH RES CO, V381, P466, DOI 10.1016/j.bbrc.2008.10.116
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
   Zhu CH, 2009, J BIOMED MATER RES A, V89A, P829, DOI 10.1002/jbm.a.32256
NR 58
TC 6
Z9 6
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2013
VL 9
IS 9
BP 8214
EP 8223
DI 10.1016/j.actbio.2013.06.002
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204WS
UT WOS:000323402600018
PM 23770221
DA 2018-10-20
ER

PT J
AU Holmberg, KV
   Abdolhosseini, M
   Li, YP
   Chen, X
   Gorr, SU
   Aparicio, C
AF Holmberg, Kyle V.
   Abdolhosseini, Mahsa
   Li, Yuping
   Chen, Xi
   Gorr, Sven-Ulrik
   Aparicio, Conrado
TI Bio-inspired stable antimicrobial peptide coatings for dental
   applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biofunctionalization; Antimicrobial coating; Peptides; Parotid secretory
   protein; Titanium
ID TITANIUM SURFACES; PERI-IMPLANTITIS; BACTERIAL ADHESION; ATTACHMENT;
   PREVENTION; BIOMATERIAL; STRATEGIES; DISEASES; PROTEIN; TISSUE
AB We developed a novel titanium coating that has applications for preventing infection-related implant failures in dentistry and orthopedics. The coating incorporates an antimicrobial peptide, GL13K, derived from parotid secretory protein, which has been previously shown to be bactericidal and bacteriostatic in solution. We characterized the resulting physicochemical properties, resistance to degradation, activity against Porphyromonas gingivalis and in vitro cytocompatibility. Porphyromonas gingivalis is a pathogen associated with dental peri-implantitis, an inflammatory response to bacteria resulting in bone loss and implant failure. Our surface modifications obtained a homogeneous, highly hydrophobic and strongly anchored GL13K coating that was resistant to mechanical, thermochemical and enzymatic degradation. The GL13K coatings had a bactericidal effect and thus significantly reduced the number of viable bacteria compared to control surfaces. Finally, adequate proliferation of osteoblasts and human gingival fibroblasts demonstrated the GL13K coating's cytocompatibility. The robustness, antimicrobial activity and cytocompatibility of GL13K-biofunctionalized titanium make it a promising candidate for sustained inhibition of bacterial biofilm growth. This surface chemistry provides a basis for development of multifunctional bioactive surfaces to reduce patient morbidities and improve long-term clinical efficacy of metallic dental and orthopedic implants. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Holmberg, Kyle V.; Li, Yuping; Chen, Xi; Aparicio, Conrado] Univ Minnesota, Sch Dent, Minnesota Dent Res Ctr Biomat & Biomech, Minneapolis, MN 55455 USA.
   [Abdolhosseini, Mahsa; Gorr, Sven-Ulrik] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA.
   [Aparicio, Conrado] Univ Minnesota, Sch Dent, Dept Restorat Sci, Minneapolis, MN 55455 USA.
RP Aparicio, C (reprint author), Univ Minnesota, Sch Dent, Minnesota Dent Res Ctr Biomat & Biomech, Moos Tower,515 Delaware St SE, Minneapolis, MN 55455 USA.
EM apari003@umn.edu
RI Aparicio, Conrado/J-9903-2012; Li, Yuping/H-5259-2013; Vining,
   Kyle/I-9256-2017
OI Aparicio, Conrado/0000-0003-2969-6067; Li, Yuping/0000-0002-2506-1155;
   Vining, Kyle/0000-0002-4009-879X
FU 3M Non-tenured Faculty Award; UMN-SOD Summer Fellowship; PHS grant from
   the NIDCR [R01DE017989]; NSF through the MRSEC program
FX The authors thank Drs. R. Chen, E. Jensen, B. Luo and R. Hegde, and Mr.
   Y. Maazouz for their technical assistance. Funding: 3M Non-tenured
   Faculty Award (C.A.), UMN-SOD Summer Fellowship (K.V.H.) and PHS grant
   R01DE017989 from the NIDCR (S.U.G.). Parts of this work were carried out
   in the Characterization Facility, University of Minnesota, which
   receives partial support from NSF through the MRSEC program.
CR Abdolhosseini M, 2012, PEPTIDES, V35, P231, DOI 10.1016/j.peptides.2012.03.017
   Abrahamsson I, 1998, J CLIN PERIODONTOL, V25, P721, DOI 10.1111/j.1600-051X.1998.tb02513.x
   An N, 2012, DENT MATER, V28, P1207, DOI 10.1016/j.dental.2012.08.007
   Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502
   Aparicio C, 2007, J BIOMED MATER RES A, V82A, P521, DOI 10.1002/jbm.a.31164
   Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x
   Bumgardner JD, 2011, INT J ORAL MAX IMPL, V26, P553
   Chen RX, 2012, ACTA BIOMATER, V8, P4371, DOI 10.1016/j.actbio.2012.07.029
   Chen X, 2013, COLLOID SURFACE B, V107, P189, DOI 10.1016/j.colsurfb.2013.02.005
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Dubruel P, 2006, SURF SCI, V600, P2562, DOI 10.1016/j.susc.2006.04.021
   Esposito M., 2012, COCHRANE DATABASE SY
   Gorr SU, 2011, BIOCHEM SOC T, V39, P1028, DOI 10.1042/BST0391028
   Gorr SU, 2008, PEPTIDES, V29, P2118, DOI 10.1016/j.peptides.2008.09.019
   Graziani F, 2012, J CLIN PERIODONTOL, V39, P224, DOI 10.1111/j.1600-051X.2011.01832.x
   Green JBD, 2011, BIOINTERPHASES, V6, pMR13, DOI 10.1116/1.3645195
   Hallstrom H, 2012, J CLIN PERIODONTOL, V39, P574, DOI 10.1111/j.1600-051X.2012.01884.x
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kloss FR, 2011, CLIN ORAL IMPLAN RES, V22, P699, DOI 10.1111/j.1600-0501.2010.02038.x
   Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x
   Mombelli A, 2002, PERIODONTOL 2000, V28, P177, DOI 10.1034/j.1600-0757.2002.280107.x
   Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x
   Myshin HL, 2005, J PROSTHET DENT, V94, P440, DOI 10.1016/j.prosdent.2005.08.021
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Renvert S, 2007, CLIN ORAL IMPLAN RES, V18, P509, DOI 10.1111/j.1600-0501.2007.01378.x
   Rossi S, 2008, CLIN ORAL IMPLAN RES, V19, P348, DOI 10.1111/j.1600-0501.2007.01478.x
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Yoshinari M, 2010, BIOFOULING, V26, P103, DOI 10.1080/08927010903216572
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 32
TC 61
Z9 61
U1 10
U2 118
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2013
VL 9
IS 9
BP 8224
EP 8231
DI 10.1016/j.actbio.2013.06.017
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204WS
UT WOS:000323402600019
PM 23791670
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Seeto, WJ
   Tian, Y
   Lipke, EA
AF Seeto, W. J.
   Tian, Y.
   Lipke, E. A.
TI Peptide-grafted poly(ethylene glycol) hydrogels support dynamic adhesion
   of endothelial progenitor cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hydrogel; Peptide; Shear stress; Endothelial colony forming cell;
   Endothelialization
ID SHEAR-STRESS; IN-VIVO; TUMOR ANGIOGENESIS; CAPTURE STENTS; BALLOON
   INJURY; P-SELECTIN; RECEPTOR; TISSUE; SURFACES; ALPHA-4-BETA-1
AB This study investigated the dynamic adhesion of endothelial progenitor cells (EPCs) to peptide-grafted poly(ethylene glycol) diacrylate (PEGDA) hydrogels and determined the relative ability of RGDS, REDV and YIGSRG peptides to reduce the velocity of EPC rolling. Circulating EPCs are key mediators of endothelium repair and have been shown to accelerate re-endothelialization, which is important in reducing the incidence of restenosis following stent placement and occlusion of small diameter vascular grafts. However, to exploit these capabilities for tissue engineering applications, more knowledge is needed about EPC binding to the vascular wall under shear and, in particular, whether the incorporation of peptide ligands into biomaterials can support the process of EPC rolling or maintain EPC adhesion. This study specifically examined one type of EPCs endothelial colony forming cells (ECFCs), based on their ability to be expanded in culture and differentiate into mature endothelial cells. The amount of grafted PEG-peptide was shown to be dependent on the concentration of PEG-peptide grafting solution photopolymerized onto the hydrogel surface. The ECFC strength of adhesion on PEG-RDGS grafted hydrogels exceeded 350 dyn cm(-2) for 85% of adherent cells. PEG-RGDS grafted hydrogels supported ECFC rolling, whereas ECFC velocity on the negative control PEG-RGES grafted hydrogels and on the "blank slate" PEGDA hydrogels was substantially higher than the cutoff velocity for cell rolling. The ECFC rolling velocity on PEG-RDGS grafted hydrogels depended on the shear rate; as shear rate was increased from 20 s(-1) to 120 s(-1), ECFC rolling velocity increased from 103 +/- 3 mu m s(-1) to 741 +/- 28 mu m s(-1). REDV and YIGSRG, which are known to preferentially support endothelial cell adhesion, also supported ECFC rolling. Interestingly, the rolling velocity of ECFCs on PEG-REDV grafted hydrogels was significantly lower than on PEG-YIGSRG or on PEG-RGDS grafted hydrogels. Understanding the dynamic adhesion of ECFCs to peptide-grafted hydrogels is the first step towards understanding the similarities and differences of EPCs from mature endothelial cells and improving the ability to sequester EPCs to biomaterial surfaces in order to promote intravascular re-endothelialization. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Seeto, W. J.; Tian, Y.; Lipke, E. A.] Auburn Univ, Dept Chem Engn, Auburn, AL 36849 USA.
   [Tian, Y.] NYU, Polytech Inst, Dept Chem & Biomol Engn, New York, NY 10003 USA.
RP Lipke, EA (reprint author), Auburn Univ, Dept Chem Engn, 212 Ross Hall, Auburn, AL 36849 USA.
EM ea10003@auburn.edu
OI Lipke, Elizabeth/0000-0002-3465-5609
FU Auburn University;  [NSF-EPS-0814103];  [1158862];  [NSF-EEC-1063107]; 
   [NSF-CBET-1150854]
FX This work was supported by an Auburn University Intramural Grant for
   Interdisciplinary Equipment and by NSF-EPS-0814103 and 1158862 (W.S.),
   NSF-EEC-1063107 (Y.T.) and NSF-CBET-1150854 (W.S. and E.A.L.).
CR Angelos MG, 2010, BIOPHYS J, V99, P3545, DOI 10.1016/j.bpj.2010.10.004
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941
   Beijk MAM, 2010, EUR HEART J, V31, P1055, DOI 10.1093/eurheartj/ehp476
   Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x
   Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989
   Brown MA, 2007, BIOMATERIALS, V28, P3928, DOI 10.1016/j.biomaterials.2007.05.009
   Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185
   Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950
   Choi WS, 2009, MACROMOL RES, V17, P458, DOI 10.1007/BF03218892
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386
   Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0
   Garg S, 2010, EUR HEART J, V31, P1032, DOI 10.1093/eurheartj/ehp591
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gonzalez AL, 2004, TISSUE ENG, V10, P1775, DOI 10.1089/ten.2004.10.1775
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   Ham AS, 2009, LANGMUIR, V25, P10038, DOI 10.1021/la900966h
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Jun H, 2003, J BIOMAT SCI-POLYM E, V15, P73
   Jun HW, 2005, J BIOMED MATER RES B, V72B, P131, DOI 10.1002/jbm.b.30135
   Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da
   Levenberg S, 2005, CURR OPIN BIOTECH, V16, P516, DOI 10.1016/j.copbio.2005.08.007
   LEY K, 1991, BLOOD, V77, P2553
   Lipke EA, 2005, ACTA BIOMATER, V1, P597, DOI 10.1016/j.actbio.2005.07.010
   Lipke EA, 2012, ADV POL BIO, P117
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Mellick AS, 2010, CANCER RES, V70, P7273, DOI 10.1158/0008-5472.CAN-10-1142
   Moldovan NI, 2003, NOVEL ANGIOGENIC MEC
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Obi S, 2012, AM J PHYSIOL-CELL PH, V303, P595
   Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008
   Park EYH, 2002, BIOPHYS J, V82, P1835, DOI 10.1016/S0006-3495(02)75534-3
   Paschall CD, 2008, BIOPHYS J, V94, P1034, DOI 10.1529/biophysj.106.098707
   PATRICK CW, 1995, BLOOD PURIFICAT, V13, P112
   Rinker KD, 2001, BIOPHYS J, V80, P1722, DOI 10.1016/S0006-3495(01)76143-7
   Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schmedlen RH, 2003, CLIN PLAST SURG, V30, P507, DOI 10.1016/S0094-1298(03)00069-5
   Seeto WJ, 2012, PEPTIDE GRAFTED POLY
   SLEPIAN MJ, 1995, CIRCULATION, V92, P1823
   Slepian MJ, 1997, ADV DRUG DELIVER REV, V24, P11, DOI 10.1016/S0169-409X(96)00479-6
   Tabachnick B. G., 1996, USING MULTIVARIATE S
   Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Vajkoczy P, 2003, J EXP MED, V197, P1755, DOI 10.1084/jem.20021659
   Veleva AN, 2008, BIOMATERIALS, V29, P3656, DOI 10.1016/j.biomaterials.2008.05.022
   Veleva AN, 2007, BIOTECHNOL BIOENG, V98, P306, DOI 10.1002/bit.21420
   Vickers DAL, 2010, LAB CHIP, V10, P2380, DOI 10.1039/c004870d
   Wang X, 2013, TISSUE ENG PART A, V19, P1
   Wei Y, 2013, BIOMATERIALS, V34, P2588, DOI 10.1016/j.biomaterials.2012.12.036
   Wendel HP, 2010, INT J CARDIOL, V145, P115, DOI 10.1016/j.ijcard.2009.06.020
   West JL, 1996, P NATL ACAD SCI USA, V93, P13188, DOI 10.1073/pnas.93.23.13188
   West JL, 2004, ENCY BIOMATERIALS BI, V7
   Xia WH, 2012, HYPERTENSION, V59, P1225, DOI 10.1161/HYPERTENSIONAHA.111.179820
   Zeng LY, 2012, CELL BIOCHEM BIOPHYS, V64, P213, DOI 10.1007/s12013-012-9387-5
NR 57
TC 24
Z9 25
U1 3
U2 106
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2013
VL 9
IS 9
BP 8279
EP 8289
DI 10.1016/j.actbio.2013.05.023
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204WS
UT WOS:000323402600025
PM 23770139
DA 2018-10-20
ER

PT J
AU Andriani, Y
   Morrow, IC
   Taran, E
   Edwards, GA
   Schiller, TL
   Osman, AF
   Martin, DJ
AF Andriani, Yosephine
   Morrow, Isabel C.
   Taran, Elena
   Edwards, Grant A.
   Schiller, Tara L.
   Osman, Azlin F.
   Martin, Darren J.
TI In vitro biostability of poly(dimethyl siloxane/hexamethylene
   oxide)-based polyurethane/layered silicate nanocomposites
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polyurethane; Organoclay; Nanocomposite; Biostability; Biomaterial
ID VIVO BIOSTABILITY; SEGMENTED POLYURETHANES; SILVER NANOPARTICLES;
   LAYERED SILICATES; ELASTOMERS; MORPHOLOGY; BIOCOMPATIBILITY; OXIDATION;
   MICROSTRUCTURE; BIODEGRADATION
AB We have prepared a number of silicone-based thermoplastic polyurethane (TPU) nanocomposites and demonstrated an enhancement of in vitro biostability against metal-ion-induced oxidation for potential use in long-term implantable medical devices. Organoclays based on both low-aspect-ratio hectorites and high-aspect-ratio fluoromicas were evaluated after being dual-modified with two quaternary alkyl ammonium salts with differing degrees of polarity. The resultant nanocomposites were tested for in vitro biostability using physiologically relevant oxidizing conditions. Subsequently, the effects of oxidative treatment on the surface degradation and bulk mechanical integrity of the nanocomposites were investigated and compared with the parent TPUs to identify nanocomposites with the most desirable features for long-term implantation. Here, we demonstrate that the low-aspect-ratio organohectorite was delaminated and well dispersed in the nanocomposites. Importantly, these factors gave rise to the enhanced oxidative stability. In addition, the mechanical properties of all nanocomposites were less adversely affected by the oxidative treatment compared to their parent TPUs. These results suggest the potential for improved mechanical integrity and biostability when suitable dual modified organoclays are incorporated in a silicone-based TPU. (c) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Andriani, Yosephine; Morrow, Isabel C.; Edwards, Grant A.; Schiller, Tara L.; Osman, Azlin F.; Martin, Darren J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
   [Taran, Elena] Univ Queensland, Australian Natl Fabricat Facil Queensland Node, Brisbane, Qld 4072, Australia.
   [Martin, Darren J.] Univ Queensland, Sch Chem Engn, Brisbane, Qld 4072, Australia.
RP Martin, DJ (reprint author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
EM darren.martin@uq.edu.au
RI Taran, Elena/C-5833-2009; Schiller, Tara/C-5675-2009
OI Taran, Elena/0000-0001-7575-5545; Schiller, Tara/0000-0002-3973-1308;
   OSMAN, AZLIN FAZLINA/0000-0002-9090-936X; Martin,
   Darren/0000-0002-8537-6765
FU Aortech Biomaterials Pty Ltd.; Cochlear(TM) Ltd.
FX The authors thank Aortech Biomaterials Pty Ltd. and Cochlear (TM) Ltd.
   for providing research materials and financial support. The facilities
   and technical assistance from Australian National Fabrication Facility
   Queensland Node at The University of Queensland are acknowledged. The
   authors acknowledge the facilities and technical assistance from the
   Australian Microscopy & Microanalysis Research Facility at the Centre
   for Microscopy and Microanalysis, The University of Queensland. We also
   would like to thank Dr. Ajay Padsalgikar and Ms jadwiga Weksler for
   valued discussions.
CR Campbell KT, 2005, THESIS U QUEENSLAND
   Chandy T, 2009, J BIOMED MATER RES B, V89B, P314, DOI 10.1002/jbm.b.31218
   Choi T, 2009, POLYMER, V50, P2320, DOI 10.1016/j.polymer.2009.03.024
   Choi T, 2009, AUST J CHEM, V62, P794, DOI 10.1071/CH09096
   Chou CW, 2008, J BIOMED MATER RES A, V84A, P785, DOI 10.1002/jbm.a.31387
   Chou CW, 2006, POLYM DEGRAD STABIL, V91, P1017, DOI 10.1016/j.polymdegradstab.2005.08.001
   Christenson EM, 2007, CORROS ENG SCI TECHN, V42, P312, DOI 10.1179/174327807X238909
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Edwards GA, 2007, THESIS U QUEENSLAND
   Finnigan B, 2005, MACROMOLECULES, V38, P7386, DOI 10.1021/ma0508911
   Finnigan B, 2005, J APPL POLYM SCI, V97, P300, DOI 10.1002/app.21718
   Finnigan B, 2004, POLYMER, V45, P2249, DOI 10.1016/j.polymer.2004.01.049
   Finnigan B, 2006, J APPL POLYM SCI, V102, P128, DOI 10.1002/app.23347
   Fong N, 2010, ACTA BIOMATER, V6, P2554, DOI 10.1016/j.actbio.2010.01.005
   Hernandez R, 2008, J BIOMED MATER RES A, V87A, P546, DOI 10.1002/jbm.a.31823
   Hernandez R, 2007, MACROMOLECULES, V40, P5441, DOI 10.1021/ma070767c
   Hernandez R, 2008, MACROMOLECULES, V41, P9767, DOI 10.1021/ma8014454
   Kang J, 2010, J POLYM SCI POL CHEM, V48, P2194, DOI 10.1002/pola.23989
   Khan M, 2005, BIOMATERIALS, V26, P633, DOI 10.1016/j.biomaterials.2004.02.064
   Khan M, 2005, BIOMATERIALS, V26, P621, DOI 10.1016/j.biomaterials.2004.02.065
   Korley LTJ, 2006, MACROMOLECULES, V39, P7030, DOI 10.1021/ma061383+
   LeBaron PC, 1999, APPL CLAY SCI, V15, P11, DOI 10.1016/S0169-1317(99)00017-4
   Mahomed A, 2010, MAT SCI ENG C-MATER, V30, P1298, DOI 10.1016/j.msec.2010.07.014
   Martin DJ, 2000, BIOMATERIALS, V21, P1021, DOI 10.1016/S0142-9612(99)00271-9
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   Mishra A, 2012, J PHYS CHEM C, V116, P2260, DOI 10.1021/jp210560s
   Osman AF, 2012, THESIS U QUEENSLAND
   Osman AF, 2012, RSC ADV, V2, P9151, DOI 10.1039/c2ra21420b
   Osman AF, 2012, MACROMOLECULES, V45, P198, DOI 10.1021/ma202189e
   Paul DR, 2008, POLYMER, V49, P3187, DOI 10.1016/j.polymer.2008.04.017
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Simmons A, 2004, BIOMATERIALS, V25, P4887, DOI 10.1016/j.biomaterials.2004.01.004
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Styan KE, 2012, ACTA BIOMATER, V8, P2243, DOI 10.1016/j.actbio.2012.03.004
   Thomas S., 2010, RUBBER NANOCOMPOSITE
   Tran NH, 2006, LANGMUIR, V22, P6696, DOI 10.1021/la060737n
   Tseng HJ, 2011, J BIOMED MATER RES A, V99A, P192, DOI 10.1002/jbm.a.33175
   Vermette P., 2001, BIOMEDICAL APPL POLY
   Ward B, 2006, J BIOMED MATER RES A, V77A, P380, DOI 10.1002/jbm.a.30553
   Xu LC, 2007, J BIOMAT SCI-POLYM E, V18, P353, DOI 10.1163/156856207780425013
   Xu LC, 2010, ACTA BIOMATER, V6, P1938, DOI 10.1016/j.actbio.2009.11.031
   Yu L, 2009, POLYMER, V50, P2133, DOI 10.1016/j.polymer.2009.03.003
NR 42
TC 18
Z9 18
U1 6
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2013
VL 9
IS 9
BP 8308
EP 8317
DI 10.1016/j.actbio.2013.05.021
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204WS
UT WOS:000323402600028
PM 23727246
DA 2018-10-20
ER

PT J
AU Canal, C
   Pastorino, D
   Mestres, G
   Schuler, P
   Ginebra, MP
AF Canal, Cristina
   Pastorino, David
   Mestres, Gemma
   Schuler, Philipp
   Ginebra, Maria-Pau
TI Relevance of microstructure for the early antibiotic release of fresh
   and pre-set calcium phosphate cements
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Calcium phosphate cement; Drug release; Hydroxyapatite; Antibiotic;
   Doxycycline
ID IN-VITRO; BONE-CEMENT; TRICALCIUM PHOSPHATE; GENTAMICIN RELEASE; SETTING
   REACTION; MATRICES; DOXYCYCLINE; POLYMETHYLMETHACRYLATE; TETRACYCLINE;
   VANCOMYCIN
AB Calcium phosphate cements (CPCs) have great potential as carriers for controlled release and vectoring of drugs in the skeletal system. However, a lot of work still has to be done in order to obtain reproducible and predictable release kinetics. A particular aspect that adds complexity to these materials is that they cannot be considered as stable matrices, since their microstructure evolves during the setting reaction. The aims of the present work were to analyze the effect of the microstructural evolution of the CPC during the setting reaction on the release kinetics of the antibiotic doxycycline hyclate and to assess the effect of the antibiotic on the microstructural development of the CPC. The incorporation of the drug in the CPC modified the textural and microstructural properties of the cements by acting as a nucleating agent for the heterogeneous precipitation of hydroxyapatite crystals, but did not affect its antibacterial activity. In vitro release experiments were carried out on readily prepared cements (fresh CPCs), and compared to those of pre-set CPCs. No burst release was found in any formulation. A marked difference in release kinetics was found at the initial stages; the evolving microstructure of fresh CPCs led to a two-step release. Initially, when the carrier was merely a suspension of alpha-TCP particles in water, a faster release was recorded, which rapidly evolved to a zero-order release. In contrast, pre-set CPCs released doxycycline following non-Fickian diffusion. The final release percentage was related to the total porosity and entrance pore size of each biomaterial. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Canal, Cristina; Pastorino, David; Mestres, Gemma; Schuler, Philipp; Ginebra, Maria-Pau] Tech Univ Catalonia UPC, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn Grp, Barcelona 08028, Spain.
   [Canal, Cristina; Pastorino, David; Mestres, Gemma; Ginebra, Maria-Pau] Tech Univ Catalonia UPC, Ctr Res Nanoengn, Barcelona 08028, Spain.
   [Canal, Cristina; Pastorino, David; Mestres, Gemma; Ginebra, Maria-Pau] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza 50118, Spain.
RP Ginebra, MP (reprint author), Tech Univ Catalonia UPC, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn Grp, Av Diagonal 647, Barcelona 08028, Spain.
EM maria.pau.ginebra@upc.edu
RI Ginebra, Maria-Pau/J-8149-2017
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Mestres,
   Gemma/0000-0001-7462-4236
FU MICINN [MAT 2009-13547]; Juan de la Cierva fellowship; ICREA Academia;
   Generalitat de Catalunya
FX The authors acknowledge the MICINN, the financial support in the MAT
   2009-13547 project and the Juan de la Cierva fellowship of CC. Support
   for the research of MPG was received through the prize "ICREA Academia"
   for excellence in research, funded by the Generalitat de Catalunya. The
   authors are grateful to M. Molmeneu and M. Fernandez for their help with
   SSA and MIP tests.
CR BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bohner M, 2000, J PHARM SCI, V89, P1262, DOI 10.1002/1520-6017(200010)89:10<1262::AID-JPS4>3.3.CO;2-Z
   Chen CHD, 2011, MAT SCI ENG C-MATER, V31, P334, DOI 10.1016/j.msec.2010.10.002
   Espanol M, 2009, ACTA BIOMATER, V5, P2752, DOI 10.1016/j.actbio.2009.03.011
   Ethell MT, 2000, VET SURG, V29, P375, DOI 10.1053/jvet.2000.7535
   Gbureck U, 2007, J CONTROL RELEASE, V122, P173, DOI 10.1016/j.jconrel.2007.06.022
   Gbureck U, 2007, ADV MATER, V19, P795, DOI 10.1002/adma.200601370
   GIBALDI M, 1967, J PHARM SCI, V56, P1238, DOI 10.1002/jps.2600561005
   Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   Ginebra MP, 1999, J AM CERAM SOC, V82, P2808
   Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049
   Alkhraisat MH, 2010, ACTA BIOMATER, V6, P1522, DOI 10.1016/j.actbio.2009.10.043
   Hofmann MP, 2009, ACTA BIOMATER, V5, P43, DOI 10.1016/j.actbio.2008.08.005
   Jiang PJ, 2010, J BIOMED MATER RES B, V93B, P51, DOI 10.1002/jbm.b.31557
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Kisanuki O, 2007, J ORTHOP SCI, V12, P281, DOI 10.1007/s00776-007-1124-3
   Le Nihouannen D, 2008, EUR J PHARM BIOPHARM, V70, P813, DOI 10.1016/j.ejpb.2008.07.018
   Montufar EB, 2013, ACTA BIOMATER, V9, P6188, DOI 10.1016/j.actbio.2012.11.028
   Montufar EB, 2010, ACTA BIOMATER, V6, P876, DOI 10.1016/j.actbio.2009.10.018
   Parfitt K, 1999, COMPLETE DRUG REFERE, P203
   Perez RA, 2011, J BIOMED MATER RES B, V97B, P156, DOI 10.1002/jbm.b.31798
   Ratier A, 2004, INT J PHARM, V274, P261, DOI 10.1016/j.ijpharm.2004.01.021
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Siepmann J, 2011, INT J PHARMACEUT, V418, P6, DOI 10.1016/j.ijpharm.2011.03.051
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Stallmann HP, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-18
   Sunaric SM, 2009, J ANAL CHEM+, V64, P231, DOI 10.1134/S1061934809030046
   Takechi M, 2002, J MATER SCI-MATER M, V13, P973, DOI 10.1023/A:1019816830793
   Takechi M, 1998, J BIOMED MATER RES, V39, P308, DOI 10.1002/(SICI)1097-4636(199802)39:2<308::AID-JBM19>3.3.CO;2-F
   Tamimi F, 2008, J BIOMED MATER RES A, V85A, P707, DOI 10.1002/jbm.a.31610
   Urabe K, 2009, J ORTHOP SCI, V14, P784, DOI 10.1007/s00776-009-1397-9
   Vorndran E, 2010, ADV FUNCT MATER, V20, P1585, DOI 10.1002/adfm.200901759
NR 36
TC 26
Z9 26
U1 1
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2013
VL 9
IS 9
BP 8403
EP 8412
DI 10.1016/j.actbio.2013.05.016
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204WS
UT WOS:000323402600038
PM 23707499
DA 2018-10-20
ER

PT J
AU Sreejit, P
   Verma, RS
AF Sreejit, P.
   Verma, R. S.
TI Enhanced cardiomyogenic lineage differentiation of adult
   bone-marrow-derived stem cells grown on cardiogel
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Stem cells; Differentiation; Cardiogel; Cardiomyogenic induction; Mouse
ID EXTRACELLULAR-MATRIX; IN-VITRO; MYOCARDIAL-INFARCTION; HEART-FAILURE;
   STROMAL CELLS; CARDIAC MYOCYTES; MULTILINEAGE DIFFERENTIATION;
   CARDIOMYOCYTES; THERAPY; REGENERATION
AB The extracellular matrix (ECM) and its components are known to promote growth and cellular differentiation in vitro. Cardiogel, a three-dimensional extracellular matrix derived from cardiac fibroblasts, is evaluated for its cardiomyogenic-differentiation-inducing potential on bone-marrow-derived stem cells (BMSC). BMSC from adult mice were grown on cardiogel and induced to differentiate into specific lineages that were validated by morphological, phenotypic and molecular assays. The data revealed that the cardiogel enhanced cardiomyogenic and adipogenic differentiation and relegated osteogenic differentiation following specific induction. More importantly, increased cardiomyogenic differentiation was also observed following BMSC growth on cardiogel without specific chemical (5-azacytidine) induction. This is the first report of an attempt to use cardiogel as a biomaterial on which to achieve cardiomyogenic differentiation of BMSC without chemical induction. Our study suggests that cardiogel is an efficient extracellular matrix that enhances the cardiomyogenic differentiation of BMSC and that it can therefore be used as a scaffold for cardiac tissue regeneration.
C1 [Sreejit, P.; Verma, R. S.] Indian Inst Technol, Stem Cell & Mol Biol Lab, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
RP Verma, RS (reprint author), Indian Inst Technol, Stem Cell & Mol Biol Lab, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
EM vermars@iitm.ac.in
OI Verma, Rama/0000-0001-7287-7803
FU Department of Biotechnology, Government of India
   [BT/PR7951/MED/14/1193/2006]; Indian Council for Medical Research
   [3/1/3/JRF/37/MPD/2004(32402)]
FX This work was supported by grants (to R. S. V.) from the Department of
   Biotechnology, Government of India (BT/PR7951/MED/14/1193/2006) and by a
   fellowship (to S. P.) from the Indian Council for Medical Research (no.
   3/1/3/JRF/37/MPD/2004(32402)).
CR Abbate A, 2009, AM J PHYSIOL-HEART C, V296, pH563, DOI 10.1152/ajpheart.00066.2009
   Adler ED, 2010, FASEB J, V24, P1073, DOI 10.1096/fj.09-135426
   Baharvand H, 2005, J MOL CELL CARDIOL, V38, P495, DOI 10.1016/j.yjmcc.2004.12.011
   Bettiol E, 2007, REV PHYSIOL BIOCH P, V157, P1, DOI 10.1007/s112_0508
   Bick RJ, 1998, CELL ADHES COMMUN, V6, P301, DOI 10.3109/15419069809010789
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Castells-Sala C, 2012, CURR OPIN ORGAN TRAN, V17, P681, DOI 10.1097/MOT.0b013e32835a34a6
   Chang W, 2007, TISSUE ENG REGEN MED, V4, P370
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Choi SC, 2008, BIOTECHNOL LETT, V30, P835, DOI 10.1007/s10529-007-9631-z
   Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Condorelli G, 2001, P NATL ACAD SCI USA, V98, P10733, DOI 10.1073/pnas.191217898
   COSTANZO MR, 1995, CIRCULATION, V92, P3593, DOI 10.1161/01.CIR.92.12.3593
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Dimarakis I, 2005, EUR J CARDIO-THORAC, V28, P665, DOI 10.1016/j.ejcts.2005.08.013
   Dimarakis I., 2006, J CARDIOTHORAC RENAL, V1, P107
   Dimarakis I, 2006, J CARDIOTHORAC RENAL, V1, P115
   DONALD GP, 2007, STEM CELLS, V25, P2896
   Engel FB, 2006, J MOL CELL CARDIOL, V41, P601, DOI 10.1016/j.yjmcc.2006.06.012
   Eshghi S., 2008, STEMBOOK
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Fukuda K, 2003, BONE MARROW TRANSPL, V32, pS25, DOI 10.1038/sj.bmt.1703940
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   Grepin C, 1997, DEVELOPMENT, V124, P2387
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hattan N, 2005, CARDIOVASC RES, V65, P334, DOI 10.1016/j.cardiores.2004.10.004
   Heng BC, 2004, CARDIOVASC RES, V62, P34, DOI 10.1016/j.cardiores.2003.12.022
   Higuchi S, 2013, J BIOSCI BIOENG, V115, P320, DOI 10.1016/j.jbiosc.2012.10.004
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Ishii O, 2005, J THORAC CARDIOV SUR, V130, P1358, DOI 10.1016/j.jtcvs.2005.05.048
   Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018
   Ji YR, 2010, J BIOL CHEM, V285, P28627, DOI 10.1074/jbc.M109.073718
   Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60
   Kurdi Mazen, 2010, Congest Heart Fail, V16, P132, DOI 10.1111/j.1751-7133.2010.00145.x
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Maulik N, 2008, J MOL CELL CARDIOL, V44, P219, DOI 10.1016/j.yjmcc.2007.11.012
   McNamara LE, 2010, J TISSUE ENG, V2010
   Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023
   Menasche P, 2009, CIRCULATION, V119, P2735, DOI 10.1161/CIRCULATIONAHA.108.812693
   Miner EC, 2006, MAYO CLIN PROC, V81, P71, DOI 10.4065/81.1.71
   Mummery CL, 2010, SCI TRANSL MED, V2, P17
   Nesselmann C, 2008, J CELL MOL MED, V12, P1795, DOI 10.1111/j.1582-4934.2008.00457.x
   Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193
   Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0
   Pasumarthi KBS, 1996, CIRC RES, V78, P126, DOI 10.1161/01.RES.78.1.126
   Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070
   Perin Emerson C, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS110, DOI 10.1038/ncpcardio0447
   Perin EC, 2006, TEX HEART I J, V33, P204
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Rosca AM, 2011, STEM CELLS DEV, V20, P1213, DOI 10.1089/scd.2010.0433
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Siegel G, 2012, STEM CELLS DEV, V21, P2457, DOI 10.1089/scd.2011.0626
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Song H, 2007, STEM CELLS, V25, P1431, DOI 10.1634/stemcells.2006-0467
   Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302
   Sreejit P, 2008, IN VITRO CELL DEV-AN, V44, P45, DOI 10.1007/s11626-007-9079-4
   Sreejit P, 2013, STEM CELL REV REP, V9, P158, DOI 10.1007/s12015-013-9427-6
   Sreejit P, 2012, CELL TISSUE RES, V350, P55, DOI 10.1007/s00441-012-1458-9
   Sreejit P, 2011, EUR CELLS MATER, V21, P107, DOI 10.22203/eCM.v021a09
   Sreejit P, 2011, ANAL BIOCHEM, V416, P186
   Swain SM, 2012, STEM CELL RES, V9, P59, DOI 10.1016/j.scr.2012.04.005
   Tang Yao Liang, 2007, Ann Thorac Surg, V83, P1499, DOI 10.1016/j.athoracsur.2006.11.054
   Tong M, 2010, CHINESE MED J-PEKING, V123, P1571, DOI 10.3760/cma.j.issn.0366-6999.2010.12.017
   Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309
   van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X
   van Laake LW, 2010, CELL MOL LIFE SCI, V67, P277, DOI 10.1007/s00018-009-0179-z
   VanWinkle WB, 1996, IN VITRO CELL DEV-AN, V32, P478
   Wang JS, 2001, J THORAC CARDIOV SUR, V122, P699, DOI 10.1067/mtc.2001.116317
   Wei-xin L, 2004, WUHAN U J NAT SCI, V9, P513
   Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1
   Wu KH, 2006, EUR J CARDIO-THORAC, V30, P770, DOI 10.1016/j.ejcts.2006.08.003
   Zhang FB, 2005, BIOCHEM BIOPH RES CO, V336, P784, DOI 10.1016/j.bbrc.2005.08.177
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 84
TC 8
Z9 8
U1 0
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD SEP
PY 2013
VL 353
IS 3
BP 443
EP 456
DI 10.1007/s00441-013-1661-3
PG 14
WC Cell Biology
SC Cell Biology
GA 207RI
UT WOS:000323620800009
PM 23771778
DA 2018-10-20
ER

PT J
AU Marchi, J
   Amorim, EM
   Lazar, DRR
   Ussui, V
   Bressiani, AHA
   Cesar, PF
AF Marchi, Juliana
   Amorim, Eric M.
   Lazar, Dolores R. R.
   Ussui, Valter
   Bressiani, Ana Helena A.
   Cesar, Paulo Francisco
TI Physico-chemical characterization of zirconia-titania composites coated
   with an apatite layer for dental implants
SO DENTAL MATERIALS
LA English
DT Article
DE Dental implant; Ceramic composite; Y-TZP; Titania; Biomimetic coating
ID BIOMIMETIC METHOD; CERAMICS; HYDROXYAPATITE; OSSEOINTEGRATION;
   BIOMATERIAL; ENVIRONMENT; COATINGS; POWDERS
AB Objectives. To investigate the crystalline phases, morphological features and functional groups on the surface of sintered Y:TZP/TiO2 composite ceramics before and after the application of a biomimetic bone-like apatite layer. The effect of TiO2 content on the composite's characteristics was also evaluated.
   Methods. Samples of Y:TZP containing 0-30 mol% TiO2 were synthesized by co-precipitation, followed by filtration, drying and calcination. The powders were uniaxially pressed and sintered at 1500 degrees C/1 h. To obtain biomimetic coatings the samples were exposed to sodium silicate solution and then to a concentrated simulated body fluid solution. The surfaces, before and after coating, were characterized by diffuse reflectance infrared Fourier transformed spectroscopy, X-ray diffraction analysis and scanning electron microscopy.
   Results. The surfaces of all Y:TZP/TiO2 samples were covered with a dense and uniform calcium phosphate layer with a globular microstructure. This layer was crystalline for specimens with 30% of TiO2 and amorphous for specimens with 0 and 10% of TiO2. Chemical analysis indicated that this layer was composed of type A carbonate apatite. Among the materials tested, the composite with 10% of TiO2 showed the best overall chemical and physical features, such as higher density and more cohesive amorphous apatite layer.
   Significance. Y-TZP-based materials obtained in the present investigation by means of the successful association of a calcium phosphate biomimetic layer with small amounts TiO2 should be further explored as an option for ceramic dental implants with improved bioactivity. (C) 2013 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Marchi, Juliana; Amorim, Eric M.] Univ Fed Abc, CCNH, BR-09210170 Santo Andre, SP, Brazil.
   [Lazar, Dolores R. R.; Ussui, Valter; Bressiani, Ana Helena A.] Inst Pesquisas Energet & Nucl, Ctr Ciencia & Tecnol Mat, Sao Paulo, Brazil.
   [Cesar, Paulo Francisco] Univ Sao Paulo, Dept Biomat & Biol Oral, Fac Odontol, Sao Paulo, Brazil.
RP Marchi, J (reprint author), Univ Fed Abc, CCNH, Rua Santa Adelia 166, BR-09210170 Santo Andre, SP, Brazil.
EM juliana.marchi@ufabc.edu.br
RI Cesar, Paulo/L-3917-2016; Marchi, Juliana/C-4864-2012; Bressiani,
   Ana/I-1402-2012; Lazar, Dolores/F-2904-2012
OI Marchi, Juliana/0000-0002-0663-0463; Lazar, Dolores/0000-0001-7384-304X;
   Cesar, Paulo/0000-0001-5834-105X
FU FAPESP; CNPq; UFABC; Laboratorio de Microscopia do Centro de Ciencia e
   Tecnologia de Materiais do Instituto de Pesquisas Energeticas e
   Nucleares
FX This investigation was financial supported by FAPESP, CNPq and UFABC.;
   The authors thank Laboratorio de Microscopia do Centro de Ciencia e
   Tecnologia de Materiais do Instituto de Pesquisas Energeticas e
   Nucleares for their support with microstructure analyses and da Silva AC
   for help in DRITF experiments.
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   Ananta S, 2003, MATER LETT, V57, P2637, DOI 10.1016/S0167-577X(02)01342-3
   Bianco A, 1998, J EUR CERAM SOC, V18, P1235, DOI 10.1016/S0955-2219(98)00048-X
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chiang YM, 1997, PRINCIPLES CERAMIC S
   Egusa H, 2008, J PROSTHET DENT, V100, P344, DOI 10.1016/S0022-3913(08)60233-4
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Silva CCGE, 2008, MATER RES-IBERO-AM J, V11, P47, DOI 10.1590/S1516-14392008000100009
   Hao L, 2005, MAT SCI ENG C-BIO S, V25, P496, DOI 10.1016/j.msec.2005.03.003
   Haynes W. M., 2011, CRC HDB CHEM PHYS, P92
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Kim HW, 2004, BIOMATERIALS, V25, P4203, DOI 10.1016/j.biomaterials.2003.10.094
   Ko HC, 2007, DENT MATER, V23, P1349, DOI 10.1016/j.dental.2006.11.023
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Marchi J, 2010, J BIOMED MATER RES B, V94B, P305, DOI 10.1002/jbm.b.31652
   Marchi J, 2009, INT J APPL CERAM TEC, V6, P60, DOI 10.1111/j.1744-7402.2008.02254.x
   Merkus HG, 2009, PART TECHNOL SER, V17, P1, DOI 10.1007/978-1-4020-9015-8_1
   Pelaez-Vargas A, 2011, DENT MATER, V27, P581, DOI 10.1016/j.dental.2011.02.014
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Pierri J, 2006, J NON-CRYST SOLIDS, V352, P5279, DOI 10.1016/j.jnoncrysol.2006.08.036
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   REY C, 1991, CALCIFIED TISSUE INT, V49, P259, DOI 10.1007/BF02556215
   Rigo ECS, 2003, MATER SCI FORUM, V416-4, P658
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   Shibli JA, 2007, IMPLANT DENT, V16, P252, DOI 10.1097/ID.0b013e3180de4d64
   Shibli JA, 2007, J BIOMED MATER RES B, V80B, P377, DOI 10.1002/jbm.b.30608
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Uchida M., 1999, BIOCERAMICS, V12, P149
   Ussui V, 2003, MATER SCI FORUM, V416-4, P681, DOI 10.4028/www.scientific.net/MSF.416-418.681
   Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
NR 35
TC 9
Z9 9
U1 0
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD SEP
PY 2013
VL 29
IS 9
BP 954
EP 962
DI 10.1016/j.dental.2013.07.002
PG 9
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 206YB
UT WOS:000323561600012
PM 23891476
DA 2018-10-20
ER

PT J
AU Akar, T
   Arslan, S
   Akar, ST
AF Akar, Tamer
   Arslan, Sercan
   Akar, Sibel Tunali
TI Utilization of Thamnidium elegans fungal culture in environmental
   cleanup: A reactive dye biosorption study
SO ECOLOGICAL ENGINEERING
LA English
DT Article
DE Biosorption; Thamnidium elegans; RR198; Column; Regeneration
ID AQUEOUS TIO2 SUSPENSIONS; AZO DYES; PHOTOCATALYTIC DEGRADATION;
   ADSORPTION; SORPTION; ISOTHERMS; KINETICS; THERMODYNAMICS; EQUILIBRIUM;
   REMOVAL
AB In this study, the potential of biomaterial obtained from filamentous fungi, Thamnidium elegans was investigated for the batch and dynamic flow mode biosorption of Reactive Red 198 (RR198). The effects of pH, biosorbent amount, contact time, initial dye concentration and ionic strength were evaluated in addition to the investigation of its biosorption performance in the presence of other dyes in the biosorption medium. High biosorption yields were recorded by using small amount of biosorbent in a relatively short time. The biosorption process followed by the pseudo-second-order kinetic and the Langmuir isotherm models. Maximum monolayer dye biosorption capacity of biosorbent was found as 234.24 mg g(-1) in batch conditions. Biosorption-desorption studies indicated that T. elegans has relatively good regeneration ability. Also the suggested biomaterial exhibited high biosorption yield in competitive and real wastewater conditions. The dye removal mechanism was evaluated by IR, SEM and zeta potential analysis. Overall, batch and dynamic-flow mode studies indicated that this environmentally friendly biosorbent may be an alternative for the removal of reactive dyes from contaminated media. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Akar, Tamer; Akar, Sibel Tunali] Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
   [Arslan, Sercan] Eskisehir Osmangazi Univ, Grad Sch Nat & Appl Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
RP Akar, T (reprint author), Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
EM takar@ogu.edu.tr
CR Akar ST, 2010, CHEM ENG J, V162, P591, DOI 10.1016/j.cej.2010.06.001
   Akar T., 2013, CHEM ENG J IN PRESS
   Akar T, 2011, J CHEM TECHNOL BIOT, V86, P1332, DOI 10.1002/jctb.2639
   Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441
   Chatzifragkou A, 2011, ENERGY, V36, P1097, DOI 10.1016/j.energy.2010.11.040
   Chen Z, 2008, J HAZARD MATER, V155, P327, DOI 10.1016/j.jhazmat.2007.11.064
   Dubinin M, 1947, CHEM ZENTR, V1, P875
   ELSHARKAWY S, 1987, J NAT PROD, V50, P520, DOI 10.1021/np50051a038
   Fagundes-Klen MR, 2007, BIOCHEM ENG J, V34, P136, DOI 10.1016/j.bej.2006.11.023
   Fan T, 2008, J HAZARD MATER, V160, P655, DOI 10.1016/j.jhazmat.2008.03.038
   Freundlich H., 1906, ABSORPTION LOSUNGEN, P98
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Hasan Hassimi Abu, 2012, J Environ Manage, V111, P34, DOI 10.1016/j.jenvman.2012.06.027
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Ho YS, 2003, PROCESS BIOCHEM, V38, P1047, DOI 10.1016/S0032-9592(02)00239-X
   Hu C, 2003, APPL CATAL B-ENVIRON, V42, P47, DOI 10.1016/S0926-3373(02)00214-X
   Kapoor A., 1997, BIOSORBENTS METAL IO, P67
   Kara I, 2012, CHEM ENG J, V211, P442, DOI 10.1016/j.cej.2012.09.086
   Khani MH, 2008, J HAZARD MATER, V150, P612, DOI 10.1016/j.jhazmat.2007.05.010
   Kuhnt M, 1997, ENZYME MICROB TECH, V21, P405, DOI 10.1016/S0141-0229(97)00013-6
   Kuyucak N., 1990, BIOSORPTION HEAVY ME, P372
   LAGERGREN S, 1989, KUNGLIGA SVENSKA VET, V24, P1
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Liu Y, 2008, SEP PURIF TECHNOL, V61, P229, DOI 10.1016/j.seppur.2007.10.002
   Ofomaja AE, 2010, BIORESOURCE TECHNOL, V101, P5868, DOI 10.1016/j.biortech.2010.03.033
   Padmesh TVN, 2006, DYES PIGMENTS, V71, P77, DOI 10.1016/j.dyepig.2005.06.003
   Park D, 2010, BIOTECHNOL BIOPROC E, V15, P86, DOI 10.1007/s12257-009-0199-4
   Roulia M, 2008, MICROPOR MESOPOR MAT, V116, P732, DOI 10.1016/j.micromeso.2008.03.017
   Saravanan D, 2013, INT J BIOL MACROMOL, V53, P67, DOI 10.1016/j.ijbiomac.2012.11.005
   Solis M, 2012, PROCESS BIOCHEM, V47, P1723, DOI 10.1016/j.procbio.2012.08.014
   Stredansky M, 2000, BIORESOURCE TECHNOL, V73, P41, DOI 10.1016/S0960-8524(99)00132-7
   Stylidi M, 2003, APPL CATAL B-ENVIRON, V40, P271, DOI 10.1016/S0926-3373(02)00163-7
   Vijayaraghavan K, 2008, DYES PIGMENTS, V76, P726, DOI 10.1016/j.dyepig.2007.01.013
   Wang DP, 2007, J EUKARYOT MICROBIOL, V54, P110, DOI 10.1111/j.1550-7408.2006.00136.x
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
NR 35
TC 20
Z9 21
U1 1
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-8574
J9 ECOL ENG
JI Ecol. Eng.
PD SEP
PY 2013
VL 58
BP 363
EP 370
DI 10.1016/j.ecoleng.2013.06.026
PG 8
WC Ecology; Engineering, Environmental; Environmental Sciences
SC Environmental Sciences & Ecology; Engineering
GA 207OD
UT WOS:000323610200045
DA 2018-10-20
ER

PT J
AU Seery, TJ
   Sinha, P
   Zurakowski, D
   Jonas, RA
AF Seery, Thomas J.
   Sinha, Pranava
   Zurakowski, David
   Jonas, Richard A.
TI Femoral vein homograft for neoaortic reconstruction in the Norwood stage
   1 operation: A follow-up study
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID LEFT-HEART SYNDROME; EXPERIENCE; PATCH; ARCH
AB Objective: The aim of this study was to analyze our experience with the cryopreserved femoral vein homograft in comparison with standard biomaterials for neoaortic reconstruction in the Norwood stage 1 operation.
   Methods: All patients who underwent the Norwood operation from September 2004 to April 2011 were analyzed retrospectively (n = 107). Patients were grouped into group A(cryopreserved femoral vein homograft; n = 72) or group B (other; n = 35). Intergroup comparisons and dimensional analyses of all available angiograms were performed. Two surgical techniques, "standard homograft cuff" and "homograft tube," were compared.
   Results: Multivariable Cox regression analysis revealed use of biomaterial other than femoral vein (P = .01; hazard ratio, 3.0; 95% confidence interval [CI], 1.4-6.4), weight less than 2.5 kg at the time of stage 1 (P - .01; hazard ratio, 3.7; 95% CI, 1.7-7.8), and need for extracorporeal membrane oxygenator support after stage 1 (P < .001; hazard ratio, 13.8; 95% CI, 5.9-31.9) as significant independent predictors of overall mortality. Improved late survival at 48 months was seen with the femoral vein homograft compared with other biomaterials when a "homograft tube with end-to-side ascending aortic reimplantation technique" was used (group A [75%] vs group B [44%]; P = .03). With the use of the "homograft cuff technique," survival was similar for femoral vein homografts and other biomaterials (group A [67%] vs group B [61%]; P = .85). Similar neoaortic coarctation rates were seen in both groups (A: 25/59 [42%] vs B: 12/26 [46%]; P = .81). A progressive increase in the diameter of the neoaorta was seen over time in both groups with both technical modifications (tube grafts pre-stage 2 vs pre-stage 3: group A [10.61 mm +/- 1.93 vs 13.74 mm +/- 3.16] [P < .001] and group B [13.93 mm +/- 6.71 vs 17.38 mm +/- 5.92] [P = .049]); cuff repair pre-stage 2 to pre-stage 3: group A [13.98 mm +/- 2.13 vs 19.09 mm +/- 4.18] [P = .002] and group B [16.06 mm +/- 3.05 vs 19.73 mm +/- 2.93] [P < .001]). The neoaortic Z-scores were generous with the use of homograft cuffs and modest when homograft tubes were used and maintained in range over the follow-up time.
   Conclusions: Survivals are improved with the use of femoral vein homograft for neoaortic reconstruction for Norwood stage 1 operation, especially when used as a homograft tube with end-to-side aortic reimplantation. Femoral vein homografts have similar recoarctation rates compared with standard biomaterials. Progressive growth/dilation of the neoaorta in proportion to somatic growth is seen with femoral vein tube grafts.
C1 [Seery, Thomas J.] Childrens Natl Med Ctr, Dept Cardiol, Washington, DC 20010 USA.
   [Sinha, Pranava; Jonas, Richard A.] Childrens Natl Med Ctr, Dept Cardiovasc Surg, Washington, DC 20010 USA.
   [Zurakowski, David] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Anesthesia & Surg, Boston, MA USA.
RP Jonas, RA (reprint author), Childrens Natl Med Ctr, Childrens Natl Heart Inst, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM lyoung@cnmc.org
CR Bautista-Hernandez V, 2007, J THORAC CARDIOV SUR, V133, P1540, DOI 10.1016/j.jtcvs.2006.12.067
   Gargiulo G, 1999, ANN THORAC SURG, V68, P1873, DOI 10.1016/S0003-4975(99)01013-9
   Healy DG, 2007, J THORAC CARDIOV SUR, V133, P567, DOI 10.1016/j.jtcvs.2006.08.072
   Jonas RA., 2004, COMPREHENSIVE SURG M
   Lemler MS, 2000, AM J CARDIOL, V86, P697, DOI 10.1016/S0002-9149(00)01058-4
   Mahle WT, 2000, CIRCULATION, V102, P136
   Morell VO, 2007, ANN THORAC SURG, V84, P1312, DOI 10.1016/j.athoracsur.2007.05.036
   Ravishankar C, 2006, PEDIATR CRIT CARE ME, V7, P319, DOI 10.1097/01.PCC.0000227109.82323.CE
   Sinha P, 2009, ANN THORAC SURG, V87, P1309, DOI 10.1016/j.athoracsur.2008.09.007
   Warren AE, 2006, HEART, V92, P1496, DOI 10.1136/hrt.2005.081539
NR 10
TC 7
Z9 7
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD SEP
PY 2013
VL 146
IS 3
BP 550
EP 556
DI 10.1016/j.jtcvs.2012.12.010
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 207MV
UT WOS:000323605800015
PM 23312981
OA Bronze
DA 2018-10-20
ER

PT J
AU Tsuchida, AI
   Bekkers, JEJ
   Beekhuizen, M
   Vonk, LA
   Dhert, WJA
   Saris, DBF
   Creemers, LB
AF Tsuchida, Anika I.
   Bekkers, Joris E. J.
   Beekhuizen, Michiel
   Vonk, Lucienne A.
   Dhert, Wouter J. A.
   Saris, Daniel B. F.
   Creemers, Laura B.
TI Pronounced biomaterial dependency in cartilage regeneration using
   nonexpanded compared with expanded chondrocytes
SO REGENERATIVE MEDICINE
LA English
DT Article
DE cartilage tissue engineering; chondrocyte; cytokine; growth factors;
   hydrogel
ID HUMAN ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; DOMAIN RECEPTOR 2;
   SYNOVIAL-FLUID; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; ACTIN
   CYTOSKELETON; SOLUBLE MEDIATORS; MONOLAYER-CULTURE; TISSUE
AB Aim: We aimed to investigate freshly isolated compared with culture-expanded chondrocytes with respect to early regenerative response, cytokine production and cartilage formation in response to four commonly used biomaterials. Materials & methods: Chondrocytes were both directly and after expansion to passage 2, incorporated into four biomaterials: Polyactive, Beriplast((R)), HyStem((R)) and a type II collagen gel. Early cartilage matrix gene expression, cytokine production and glycosaminoglycan (GAG) and DNA content in response to these biomaterials were evaluated. Results: HyStem induced more GAG production, compared with all other biomaterials (p 0.001). Nonexpanded cells did not always produce more GAGs than expanded chondrocytes, as this was biomaterial-dependent. Cytokine production and early gene expression were not predictive for final regeneration. Conclusion: For chondrocyte-based cartilage treatments, the biomaterial best supporting cartilage matrix production will depend on the chondrocyte differentiation state and cannot be predicted from early gene expression or cytokine profile.
C1 [Tsuchida, Anika I.; Bekkers, Joris E. J.; Beekhuizen, Michiel; Vonk, Lucienne A.; Dhert, Wouter J. A.; Saris, Daniel B. F.; Creemers, Laura B.] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands.
   [Dhert, Wouter J. A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands.
   [Saris, Daniel B. F.] Univ Twente, MIRA Inst, NL-7500 AE Enschede, Netherlands.
RP Creemers, LB (reprint author), Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands.
EM l.b.creemers@umcutrecht.nl
OI Creemers, Laura/0000-0002-1585-3052
FU Smith Nephew; The Netherlands Ministry of Economic Affairs; The
   Netherlands Ministry of Education, Culture and Science; Dutch Arthritis
   Foundation; Sanofi/Genzyme; Tigenix
FX The work of AI Tsuchida was supported by an institutional research grant
   from Smith & Nephew. The work of LA Vonk was supported by the TeRM Smart
   Mix Program of The Netherlands Ministry of Economic Affairs and The
   Netherlands Ministry of Education, Culture and Science. LB Creemers is
   funded by the Dutch Arthritis Foundation. DBF Saris receives trial
   support from Sanofi/Genzyme and consultancy and teaching fees from
   Tigenix and Smith & Nephew. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004
   Albrecht C, 2009, INT J MOL MED, V23, P253, DOI 10.3892/ijmm_00000124
   Attur MG, 2000, J IMMUNOL, V164, P2684, DOI 10.4049/jimmunol.164.5.2684
   Beekhuizen M, 2013, OSTEOARTHR CARTILAGE, V21, P918, DOI 10.1016/j.joca.2013.04.002
   Beekhuizen M, 2011, ARTHRITIS RHEUM-US, V63, P1918, DOI 10.1002/art.30364
   Bekkers JEJ, 2010, OSTEOARTHR CARTILAGE, V18, P266, DOI 10.1016/j.joca.2009.09.001
   Brodkin KR, 2004, BIOMATERIALS, V25, P5929, DOI 10.1016/j.biomaterials.2004.01.044
   Buser Z, 2012, J TISSUE ENG REGEN M, DOI 10.1002/term.1503
   Campo GM, 2012, BIOFACTORS, V38, P69, DOI 10.1002/biof.202
   Chemin K, 2012, J IMMUNOL, V189, P2159, DOI 10.4049/jimmunol.1200156
   Chiang HS, 2010, TISSUE ENG PART C-ME, V16, P291, DOI 10.1089/ten.tec.2009.0298
   Coates EE, 2012, J ORTHOP RES, V30, P1886, DOI 10.1002/jor.22166
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009
   de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003
   Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16
   Hoshiba T, 2012, J BIOMED MATER RES A, V100A, P694, DOI 10.1002/jbm.a.34003
   Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146
   Julovi SM, 2011, J ORTHOP RES, V29, P258, DOI 10.1002/jor.21216
   Kang SW, 2007, BIO-MED MATER ENG, V17, P269
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Klatt AR, 2009, J PATHOL, V218, P241, DOI 10.1002/path.2529
   Knudson W, 2000, ARTHRITIS RHEUM, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H
   Kustermans G, 2008, BIOCHEM PHARMACOL, V76, P1214, DOI 10.1016/j.bcp.2008.08.017
   Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405
   Lowin T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3464
   Ma B, 2013, OSTEOARTHR CARTILAGE, V21, P599, DOI 10.1016/j.joca.2013.01.014
   Malicev E, 2007, BIOTECHNOL BIOENG, V96, P364, DOI 10.1002/bit.21038
   Novakofski KD, 2012, J ORTHOP RES, V30, P246, DOI 10.1002/jor.21515
   Park JS, 2011, BIOMATERIALS, V32, P8139, DOI 10.1016/j.biomaterials.2011.07.043
   Rohner E, 2012, IMMUNOL RES, V52, P169, DOI 10.1007/s12026-011-8247-5
   Rutgers M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3050
   Rutgers M, 2009, IMMUNOTHERAPY, V1, P435, DOI 10.2217/IMT.09.14
   Salzmann GM, 2011, BIOMATERIALS, V32, P5810, DOI 10.1016/j.biomaterials.2011.04.073
   Schagemann JC, 2010, J BIOMED MATER RES A, V93A, P454, DOI 10.1002/jbm.a.32521
   Schagemann JC, 2010, BIOMATERIALS, V31, P2798, DOI 10.1016/j.biomaterials.2009.12.037
   Schlegel W, 2008, INT J MOL MED, V22, P691, DOI 10.3892/ijmm_00000074
   Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001
   Spicer PP, 2010, J CONTROL RELEASE, V148, P49, DOI 10.1016/j.jconrel.2010.06.025
   Takahashi N, 2010, ARTHRITIS RHEUM-US, V62, P1338, DOI 10.1002/art.27410
   Toh WS, 2011, MOL PHARMACEUT, V8, P994, DOI 10.1021/mp100437a
   Tsuchida AI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4107
   Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185
   Vonk LA, 2011, RHEUMATOLOGY, V50, P463, DOI 10.1093/rheumatology/keq305
   Welsch GH, 2010, AM J SPORT MED, V38, P934, DOI 10.1177/0363546509354971
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110
   Yasuda T, 2012, MOD RHEUMATOL, DOI 10.1007/s10165-012-0804-9
   Yatabe T, 2009, ANN RHEUM DIS, V68, P1051, DOI 10.1136/ard.2007.086884
   ZHENG SX, 2004, BIOMATERIALS, V25, P1339, DOI DOI 10.1016/J.BIOMATERIALS.2003.08.014
NR 52
TC 3
Z9 3
U1 1
U2 13
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
J9 REGEN MED
JI Regen. Med.
PD SEP
PY 2013
VL 8
IS 5
BP 583
EP 595
DI 10.2217/rme.13.44
PG 13
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 209DU
UT WOS:000323735200010
PM 23998752
DA 2018-10-20
ER

PT J
AU Chang, XJ
   Gorbet, M
AF Chang, Xiaojian
   Gorbet, Maud
TI The effect of shear on invitro platelet and leukocyte material-induced
   activation
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Leukocyte activation; cardiovascular material; invitro model; shear;
   platelet
ID VON-WILLEBRAND-FACTOR; TISSUE FACTOR EXPRESSION; FLOW CONDITIONS;
   MICROPARTICLE FORMATION; PROTEIN PREADSORPTION; BIOMATERIAL SURFACES;
   DISTURBED FLOW; WHOLE-BLOOD; ADHESION; STRESS
AB The failure to understand the mechanisms of biomaterial-associated thrombosis prevents us from improving the blood compatibility of stents and mechanical heart valves. Blood-material interactions trigger a complex series of events and anticoagulant and anti-platelet therapies are needed to reduce the risks of thrombotic complications with most cardiovascular materials. While material interaction with platelets has been widely studied, little is currently known on material-induced leukocyte activation in the presence of shear. Invitro experiments were performed to assess the effect of flow on blood cell activation induced by medical grade metals, ST316L and TiAl6V4. Blood was circulated in flow chambers preloaded with or without metal wires at shear rates of 100, 500, and 1500s(-1). Platelet and leukocyte activation, leukocyte-platelet aggregation, and tissue factor expression on monocytes were measured by flow cytometry. Metal surfaces were characterized by scanning electron microscopy. Under physiological shear rates, no significant platelet microparticle formation was observed. However, significant CD11b up-regulation, leukocyte-platelet aggregates, and tissue factor expression were observed at 100s(-1). As shear rate increased to 1500s(-1), leukocyte activation reduced to control values. TiAl6V4-induced leukocyte activation was generally lower than that of ST316L. Adhesion significantly decreased with increasing shear rate to 1500s(-1). In blood, increase within physiological shear rates led to a significant reduction in invitro material-induced leukocyte activation, suggesting that difference between material biocompatibility may be better identified at low shear rates or under pathological shear conditions.
C1 [Chang, Xiaojian; Gorbet, Maud] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada.
RP Gorbet, M (reprint author), Univ Waterloo, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
EM mgorbet@uwaterloo.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Gorbet's start-up funds
FX This work was supported by a grant from the Natural Sciences and
   Engineering Research Council of Canada (NSERC) and Gorbet's start-up
   funds.
CR Ahn KC, 2005, BIOCHEM BIOPH RES CO, V329, P345, DOI 10.1016/j.bbrc.2005.01.146
   Alcaide P, 2009, MICROCIRCULATION, V16, P43, DOI 10.1080/10739680802273892
   Bayram C, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/055007
   Boreda R, 1995, J VASC INVEST, P26
   Chiu JJ, 2003, J BIOMECH, V36, P1883, DOI 10.1016/S0021-9290(03)00210-0
   Dopheide SM, 2002, BLOOD, V99, P159, DOI 10.1182/blood.V99.1.159
   Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3
   Fischer M, 2010, BIOMATERIALS, V31, P2498, DOI 10.1016/j.biomaterials.2009.12.016
   Fuchs B, 2010, THROMB RES, V125, P239, DOI 10.1016/j.thromres.2009.08.020
   Garg S, 2010, J AM COLL CARDIOL, V56, pS43, DOI 10.1016/j.jacc.2010.06.008
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   Goto S, 2000, INT ANGIOL, V19, P147
   Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30
   Holme PA, 1997, ARTERIOSCL THROM VAS, V17, P646, DOI 10.1161/01.ATV.17.4.646
   Hu H, 2003, THROMB HAEMOSTASIS, V90, P679, DOI 10.1160/TH03-05-0274
   Inoue T, 2003, CIRCULATION, V107, P1757, DOI 10.1161/01.CIR.0000060487.15126.56
   Jimenez JM, 2009, ANN BIOMED ENG, V37, P1483, DOI 10.1007/s10439-009-9719-9
   Kao WYJ, 2000, BIOMATERIALS, V21, P2295, DOI 10.1016/S0142-9612(00)00156-3
   Makino A, 2007, BIORHEOLOGY, V44, P221
   Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742
   Miyazaki Y, 1996, BLOOD, V88, P3456
   Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955
   Otto M, 2004, J MATER SCI-MATER M, V15, P35, DOI 10.1023/B:JMSM.0000010095.19693.67
   Otto M, 2003, J MATER SCI-MATER M, V14, P263, DOI 10.1023/A:1022840909038
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Park KH, 2007, J ORAL REHABIL, V34, P517, DOI 10.1111/j.1365-2842.2006.01688.x
   Patel JD, 2003, J BIOMAT SCI-POLYM E, V14, P279, DOI 10.1163/156856203763572725
   Reininger AJ, 2006, BLOOD, V107, P3537, DOI 10.1182/blood-2005-02-0618
   Schmehl JM, 2008, CARDIOVASC REVASCULA, V9, P255, DOI 10.1016/j.carrev.2008.03.004
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   Skilbeck CA, 2004, BRIT J HAEMATOL, V126, P418, DOI 10.1111/j.1365-2141.2004.05057.x
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   Tanaka Y, 2009, J ARTIF ORGANS, V12, P182, DOI 10.1007/s10047-009-0468-1
   Tepe G, 2002, J VASC INTERV RADIOL, V13, P1029, DOI 10.1016/S1051-0443(07)61868-5
   Uchida M, 2005, BIOMATERIALS, V26, P6924, DOI 10.1016/j.biomaterials.2005.04.066
NR 36
TC 11
Z9 11
U1 3
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD SEP
PY 2013
VL 28
IS 3
BP 407
EP 415
DI 10.1177/0885328212454689
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 205ZC
UT WOS:000323482500009
PM 22832217
DA 2018-10-20
ER

PT J
AU Araque-Monros, MC
   Vidaurre, A
   Gil-Santos, L
   Bernabe, SG
   Monleon-Pradas, M
   Mas-Estelles, J
AF Araque-Monros, Maria C.
   Vidaurre, Ana
   Gil-Santos, Luis
   Girones Bernabe, Sagrario
   Monleon-Pradas, Manuel
   Mas-Estelles, Jorge
TI Study of the degradation of a new PLA braided biomaterial in buffer
   phosphate saline, basic and acid media, intended for the regeneration of
   tendons and ligaments
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Prosthesis; Tendon; Ligament; Hydrolytic degradation
ID MOLECULAR-WEIGHT POLY(L-LACTIDE); EXTENDED-CHAIN CRYSTALLITES; IN-VITRO
   HYDROLYSIS; ENZYMATIC DEGRADATION; ALKALINE-SOLUTION; ACHILLES-TENDON;
   MORPHOLOGY; SCAFFOLD; FILM; MECHANISMS
AB The purpose of this study was to evaluate the effects of hydrolytic degradation on the properties of a PLA hollow braid designed as a new concept of biodegradable prosthesis for the regeneration of tendons and ligaments. The main function of the braided material is to bear mechanical loads while it is being replaced by the newly-generated tissue. The kinetics of braided material degradation is thus an important factor in determining the success of the product. In order to study this mechanism, PLA braid was subjected to a 12-month degradation process at 37 degrees C in PBS at pH 7.4 (to simulate the human physiological medium) and to accelerated degradation for one month in pH 12 and pH 3 solutions. Degradation of the braid subjected to hydrolysis was evaluated by weight loss, molecular weight distribution, mechanical properties, and calorimetric and morphologic analyses. The weight loss in a basic medium reached 21%, versus no significant change in the other media. Average molecular weight was reduced by approximately 50% in the three media, with loss of mechanical properties in all cases. The morphological changes were more evident in the PLA degraded in the basic medium. The crystallinity of the material increased at the first stages of degradation, regardless of the medium used. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Araque-Monros, Maria C.; Vidaurre, Ana; Monleon-Pradas, Manuel] Univ Politecn Valencia, Ctr Biomat & Ingn Tisular, Valencia 46022, Spain.
   [Araque-Monros, Maria C.; Vidaurre, Ana; Gil-Santos, Luis; Monleon-Pradas, Manuel; Mas-Estelles, Jorge] CIBER Bioingn Biomat & Nanomed CIBER BBN, Valencia, Spain.
   [Gil-Santos, Luis] Hosp Intermutual Levante, Valencia, Spain.
   [Gil-Santos, Luis] Univ Catolica Valencia San Vicente Martir, Inst Univ Invest Enfermedades Musculoesquelet, Valencia, Spain.
   [Girones Bernabe, Sagrario] Asociac Invest Ind Text AITEX, Alcoy, Alicante, Spain.
RP Araque-Monros, MC (reprint author), Univ Politecn Valencia, Ctr Biomat & Ingn Tisular, Valencia 46022, Spain.
EM marmon@upvnet.upv.es
RI Vidaurre, Ana/L-3457-2013; Mas-Estelles, Jorge/H-5331-2015
OI Vidaurre, Ana/0000-0003-3394-1176; Mas-Estelles,
   Jorge/0000-0001-8446-6737; MONLEON PRADAS, MANUEL/0000-0001-6457-0414
FU AITEX (Valencia, Spain)
FX This work has been carried out thanks to the financial support of AITEX
   (Valencia, Spain).
CR Araque Monnis MC, PROCEDIMIENTO OBTENC
   Araque-Monros MC, 2013, J BIOMEDICAL MAT R A, DOI DOI 10.1002/IBM.A.34633
   CAM D, 1995, BIOMATERIALS, V16, P833, DOI 10.1016/0142-9612(95)94144-A
   CHU CC, 1981, J APPL POLYM SCI, V26, P1727, DOI 10.1002/app.1981.070260527
   Chung S, 1995, J CONTROL RELEASE, V34, P9
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Iwata T, 1998, MACROMOLECULES, V31, P2461, DOI 10.1021/ma980008h
   Kikkawa Y, 2002, BIOMACROMOLECULES, V3, P350, DOI 10.1021/bm015623z
   Maurus PB, 2004, OPER TECHN SPORT MED, V12, P158, DOI 10.1053/j.otsm.2004.07.015
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ouyang HW, 2002, ANN NY ACAD SCI, V961, P126, DOI 10.1111/j.1749-6632.2002.tb03064.x
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Saha SK, 2006, POLYM DEGRAD STABIL, V91, P1665, DOI 10.1016/j.polymdegradstab.2005.12.009
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Surrao DC, 2012, ACTA BIOMATER, V8, P3704, DOI 10.1016/j.actbio.2012.06.016
   Tsuji H, 2000, POLYM DEGRAD STABIL, V67, P179, DOI 10.1016/S0141-3910(99)00111-1
   Tsuji H, 1998, J POLYM SCI POL CHEM, V36, P59, DOI 10.1002/(SICI)1099-0518(19980115)36:1<59::AID-POLA9>3.0.CO;2-X
   Tsuji H, 2000, J APPL POLYM SCI, V77, P1452, DOI 10.1002/1097-4628(20000815)77:7<1452::AID-APP7>3.0.CO;2-S
   Tsuji H, 2005, J POLYM SCI POL PHYS, V43, P1064, DOI 10.1002/polb.20399
   TSUJI H, 1995, POLYMER, V36, P2709, DOI 10.1016/0032-3861(95)93647-5
   Tsuji H, 2003, J APPL POLYM SCI, V87, P1628, DOI 10.1002/app.11605
   Tsuji H, 2002, J APPL POLYM SCI, V86, P186, DOI 10.1002/app.10813
   Tsuji H, 2004, BIOMACROMOLECULES, V5, P1021, DOI 10.1021/bm034523i
   Tsuji H, 2004, POLYM DEGRAD STABIL, V84, P515, DOI 10.1016/j.polymdegradstab.2004.01.010
   Vasanthan N, 2009, POLYM DEGRADATION ST, V94, P2364
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Yuan XY, 2002, POLYM DEGRAD STABIL, V75, P45, DOI 10.1016/S0141-3910(01)00203-8
   Yuan XY, 2003, POLYM DEGRAD STABIL, V79, P45, DOI 10.1016/S0141-3910(02)00237-9
   Zhang XF, 2007, POLYMER, V48, P1005, DOI 10.1016/j.polymer.2006.12.028
NR 31
TC 13
Z9 13
U1 1
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD SEP
PY 2013
VL 98
IS 9
BP 1563
EP 1570
DI 10.1016/j.polymdegradstab.2013.06.031
PG 8
WC Polymer Science
SC Polymer Science
GA 205SD
UT WOS:000323464200003
DA 2018-10-20
ER

PT J
AU Reid, B
   Afzal, JM
   McCartney, AM
   Abraham, R
   O'Rourke, B
   Elisseeff, JH
AF Reid, Branden
   Afzal, Junaid M.
   McCartney, Annemarie M.
   Abraham, Roselle
   O'Rourke, Brian
   Elisseeff, Jennifer H.
TI Enhanced Tissue Production through Redox Control in Stem Cell-Laden
   Hydrogels
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID OSTEOGENIC DIFFERENTIATION; AEROBIC GLYCOLYSIS; ENERGY-PRODUCTION;
   OXIDATIVE STRESS; COMPLEX-III; L-CARNITINE; MITOCHONDRIA; ANTIOXIDANT;
   ADHESION; ANOIKIS
AB Cellular bioenergetics and redox (reduction-oxidation) play an important role in cell proliferation and differentiation, key aspects of building new tissues. In the present study, we examined the metabolic characteristics of human adipose-derived stem cells (hASCs) during proliferation and differentiation in both monolayer and three-dimensional biomaterial scaffolds. In monolayer, hASCs exhibited higher glycolysis and lower ox-phos as compared to both adipogenic and osteogenic differentiated cells, and hASCs demonstrated the Warburg effect (aerobic glycolysis). However, reactive oxygen species (ROS) levels increased during adipogenic differentiation, but decreased during osteogenic differentiation. Similarly, a decrease in ROS levels along with a higher mitochondrial membrane potential and viability was observed in hASCs encapsulated in poly(ethylene glycol) (PEG) hydrogels containing an adhesion peptide (RGD), compared to PEG hydrogels with a scrambled control peptide (GRD), demonstrating that adhesion-dependent signaling can also regulate ROS production and bioenergetics. As a result, we hypothesized that we could modulate osteogenesis in PEG hydrogels containing the adhesion peptide (RGD) by further reducing ROS levels using a small therapeutic molecule, L-carnitine, a metabolite with purported antioxidant effects. We observed reduced ROS levels, no effect on mitochondrial membrane potential, and increased osteogenic differentiation and tissue production in cells in the presence of L-carnitine. These results suggest the potential to manipulate tissue production by modulating cellular metabolism.
C1 [Reid, Branden; McCartney, Annemarie M.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
   [Reid, Branden; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21231 USA.
   [Afzal, Junaid M.; Abraham, Roselle; O'Rourke, Brian] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Smith Bldg Rm 5033,400 N Broadway, Baltimore, MD 21231 USA.
EM jhe@jhu.edu
FU NIDCR [3R01DE016887-03S]; NIAMS [R01AR054005]
FX The authors gratefully acknowledge funding NIDCR 3R01DE016887-03S and
   NIAMS R01AR054005. We also thank Warren Grayson for helpful discussions.
CR Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Benoit DSW, 2007, J BIOMED MATER RES A, V81A, P259, DOI 10.1002/jbm.a.31292
   Brand KA, 1997, FASEB J, V11, P388
   Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   Calo LA, 2006, INT J CARDIOL, V107, P54, DOI 10.1016/j.ijcard.2005.02.053
   Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509
   Chen CT, 2012, BBA-GEN SUBJECTS, V1820, P571, DOI 10.1016/j.bbagen.2011.09.013
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Chung S., 2007, NAT CLIN PRACT CA S1, V4, pS60
   Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484
   D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256
   Dahl JA, 2008, INT J DEV BIOL, V52, P1033, DOI 10.1387/ijdb.082663jd
   Fang B, 2007, TRANSPL P, V39, P3358, DOI 10.1016/j.transproceed.2007.08.103
   Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104
   Garcia-Olmo D, 2008, EXPERT OPIN BIOL TH, V8, P1417, DOI [10.1517/14712590802321613, 10.1517/14712598.8.9.1417 ]
   Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478
   Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gulcin I, 2006, LIFE SCI, V78, P803, DOI 10.1016/j.lfs.2005.05.103
   Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200
   Halim H, 2012, CELL BIOL INT, V36, P1055, DOI 10.1042/CBI20120111
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Imhoff BR, 2011, CELL MOL BIOL LETT, V16, P149, DOI 10.2478/s11658-010-0042-0
   Kim KS, 2010, J BIOL CHEM, V285, P40294, DOI 10.1074/jbc.M110.126821
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z
   Meza-Zepeda LA, 2008, J CELL MOL MED, V12, P553, DOI 10.1111/j.1582-4934.2007.00146.x
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   NICHOLLS DG, 2002, BIOENERGETICS, V3
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040
   Rungtabnapa P, 2011, AM J PHYSIOL-CELL PH, V300, pC235, DOI 10.1152/ajpcell.00249.2010
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Shyh-Chang N, 2011, EMBO J, V30, P4851, DOI 10.1038/emboj.2011.436
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Stoppel W.L., 2012, ENG BIOMATERIALS REG, P41
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007
   Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914
   Willerth SM, 2008, COMBINING STEM CELLS
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
NR 58
TC 4
Z9 5
U1 0
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2013
VL 19
IS 17-18
BP 2014
EP 2023
DI 10.1089/ten.tea.2012.0515
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 190ES
UT WOS:000322322600013
PM 23627869
OA Green Published
DA 2018-10-20
ER

PT J
AU Blegvad, C
   Skjolding, AD
   Broholm, H
   Laursen, H
   Juhler, M
AF Blegvad, C.
   Skjolding, A. D.
   Broholm, H.
   Laursen, H.
   Juhler, M.
TI Pathophysiology of shunt dysfunction in shunt treated hydrocephalus
SO ACTA NEUROCHIRURGICA
LA English
DT Article
DE Hydrocephalus; Shunt dysfunction; Valve; Catheter; Pathophysiology
ID CEREBROSPINAL-FLUID EOSINOPHILIA; LATERAL PERIVENTRICULAR TISSUE;
   ETHYLENE-OXIDE ALLERGY; CENTRAL-NERVOUS-SYSTEM; VENTRICULAR CATHETERS;
   VENTRICULOPERITONEAL SHUNTS; TUBING IMPLANTS; SPINA-BIFIDA; VALVE
   DESIGN; MALFUNCTIONS
AB We hypothesized that shunt dysfunction in the ventricular catheter and the shunt valve is caused by different cellular responses. We also hypothesized that the cellular responses depend on different pathophysiological mechanisms.
   Removed shunt material was collected. Macroscopic tissue in the catheters was paraffin-embedded and HE-stained. Valves were incubated with trypsin-EDTA in order to detach macroscopically invisible biomaterial, which was then cytospinned and HE-stained. Associated aetiological and surgical data were collected by reviewing patient files, and ventricular catheter position was examined using preoperative radiology (CT scans).
   We examined eleven ventricular catheters and ten shunt valves. Catheters: 6/11 catheters contained intraluminal tissue consisting of vascularised glial tissue and inflammatory cells (macrophages/giant cells and a few eosinophils). Catheter adherence correlated with the presence of intraluminal tissue, and all tissue containing catheters had some degree of ventricle wall contact. All obstructed catheters contained intraluminal tissue, except one catheter that was dysfunctional because of lost ventricular contact. Valves: Regardless of intraoperative confirmation of valve obstruction, all ten valves contained an almost uniform cellular response of glial cells (most likely ependymal cells), macrophages/giant cells, and lymphomonocytic cells. Some degree of ventricle wall catheter contact was present in all examined valves with available radiology (9/10).
   The same cellular responses (i.e., glial cells and inflammatory cells) cause both catheter obstruction and valve obstruction. We propose two synergistic pathophysiological mechanisms. (1) Ventricle wall/parenchymal contact by the catheter causes mechanical irritation of the parenchyma including ependymal exfoliation. (2) The shunt material provokes an inflammatory reaction, either nonspecific or specific. In combination, these mechanisms cause obstructive tissue ingrowth (glial and inflammatory) in the catheter and clogging of the valve by exfoliated glial cells and reactive inflammatory cells.
C1 [Blegvad, C.; Skjolding, A. D.; Juhler, M.] Rigshosp, Copenhagen Univ Hosp, Univ Clin Neurosurg 2092, DK-2100 Copenhagen O, Denmark.
   [Blegvad, C.; Skjolding, A. D.; Broholm, H.; Laursen, H.] Rigshosp, Copenhagen Univ Hosp, Neuropathol Lab, DK-2100 Copenhagen O, Denmark.
RP Blegvad, C (reprint author), Rigshosp, Copenhagen Univ Hosp, Univ Clin Neurosurg 2092, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.
EM christoffer.blegvad@gmail.com
CR AOKI N, 1990, SURG NEUROL, V33, P256, DOI 10.1016/0090-3019(90)90045-Q
   Bache S, 2011, ACTA ANAESTH SCAND, V55, P1279, DOI 10.1111/j.1399-6576.2011.02504.x
   BIERBRAUER K S, 1990, Pediatric Neurosurgery, V16, P287, DOI 10.1159/000120544
   BIGNER SH, 1985, ACTA CYTOL, V29, P391
   BORGBJERG BM, 1995, ACTA NEUROCHIR, V136, P189, DOI 10.1007/BF01410625
   Browd SR, 2006, PEDIATR NEUROL, V34, P171, DOI 10.1016/j.pediatrneurol.2005.05.021
   BRUNI JE, 1986, NEUROSURGERY, V19, P337, DOI 10.1227/00006123-198609000-00001
   Brydon HL, 1996, BRIT J NEUROSURG, V10, P245, DOI 10.1080/02688699650040098
   Brydon HL, 1998, J NEUROL NEUROSUR PS, V64, P643, DOI 10.1136/jnnp.64.5.643
   COLLINS P, 1978, J NEUROSURG, V48, P609, DOI 10.3171/jns.1978.48.4.0609
   Czernicki Z, 2010, ACTA NEUROCHIR SUPPL, V106, P81, DOI 10.1007/978-3-211-98811-4_13
   Del Bigio MR, 1998, NEUROSURGERY, V42, P319, DOI 10.1097/00006123-199802000-00064
   DELBIGIO MR, 1986, J NEUROSURG, V64, P932, DOI 10.3171/jns.1986.64.6.0932
   Drake JM, 1998, NEUROSURGERY, V43, P294, DOI 10.1097/00006123-199808000-00068
   Ellis MJ, 2008, J NEUROS-PEDIATR, V1, P237, DOI 10.3171/PED/2008/1/3/237
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   GEDIKOGLU Y, 1993, ACTA NEUROCHIR, V122, P266, DOI 10.1007/BF01405540
   GO KG, 1981, CLIN NEUROL NEUROSUR, V83, P47, DOI 10.1016/0303-8467(81)90001-9
   GOLDBLUM RM, 1992, LANCET, V340, P510, DOI 10.1016/0140-6736(92)91710-P
   GOWER DJ, 1984, J NEUROSURG, V61, P1079, DOI 10.3171/jns.1984.61.6.1079
   GUEVARA JA, 1981, CHILD BRAIN, V8, P284
   Harris CA, 2012, NEUROSURGERY, V70, P1589, DOI 10.1227/NEU.0b013e318244695f
   Heidemann SM, 2010, PEDIATR NEUROSURG, V46, P255, DOI 10.1159/000320130
   Koga Hisashi, 1992, Neurologia Medico-Chirurgica, V32, P824, DOI 10.2176/nmc.32.824
   KOSSOVSKY N, 1989, J BIOMED MATER RES-A, V23, P73, DOI 10.1002/jbm.820231308
   Lundberg F, 1999, J NEUROSURG, V90, P101, DOI 10.3171/jns.1999.90.1.0101
   Lundberg F, 1997, ACTA NEUROCHIR, V139, P734, DOI 10.1007/BF01420046
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MONERETVAUTRIN DA, 1990, ANESTHESIOLOGY, V73, P556, DOI 10.1097/00000542-199009000-00032
   PIATT JH, 1993, PEDIATR NEUROSURG, V19, P233, DOI 10.1159/000120738
   PITTMAN T, 1994, BRIT J NEUROSURG, V8, P41, DOI 10.3109/02688699409002391
   PITTMAN T, 1995, J ALLERGY CLIN IMMUN, V96, P486, DOI 10.1016/S0091-6749(95)70291-1
   SAINTE-ROSE C, 1991, Pediatric Neurosurgery, V17, P2, DOI 10.1159/000120557
   SEKHAR LN, 1982, J NEUROSURG, V56, P411, DOI 10.3171/jns.1982.56.3.0411
   Sgouros S, 2004, J NEUROSURG, V100, P534, DOI 10.3171/jns.2004.100.3.0534
   Singh D, 2012, BR J NEUROSURG
   SNOW RB, 1989, SURG NEUROL, V31, P209, DOI 10.1016/0090-3019(89)90119-5
   Takahashi Y, 1998, NEUROL MED-CHIR, V38, P399, DOI 10.2176/nmc.38.399
   Thomale UW, 2010, CHILD NERV SYST, V26, P781, DOI 10.1007/s00381-009-1055-8
   TRAYNELIS VC, 1988, NEUROSURGERY, V23, P645, DOI 10.1227/00006123-198811000-00019
   TRAYNELIS VC, 1991, NEUROSURGERY, V28, P848, DOI 10.1227/00006123-199106000-00010
   VandeVord PJ, 2004, BIOMATERIALS, V25, P3853, DOI 10.1016/j.biomaterials.2003.10.024
   Wan KR, 2011, J CLIN NEUROSCI, V18, P485, DOI 10.1016/j.jocn.2010.06.018
   Wilson TJ, 2013, J NEUROSURG, V119, P66, DOI 10.3171/2012.11.JNS111384
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 45
TC 8
Z9 8
U1 1
U2 14
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0001-6268
J9 ACTA NEUROCHIR
JI Acta Neurochir.
PD SEP
PY 2013
VL 155
IS 9
BP 1763
EP 1772
DI 10.1007/s00701-013-1729-6
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 202JW
UT WOS:000323212300026
PM 23645322
DA 2018-10-20
ER

PT J
AU Li, JY
   Ho, YC
   Chung, YC
   Lin, FC
   Liao, WL
   Tsai, WB
AF Li, J-Y
   Ho, Y-C
   Chung, Y-C
   Lin, F-C
   Liao, W-L
   Tsai, W-B
TI Preparation of micron/submicron hybrid patterns via a two-stage
   UV-imprint technique and their dimensional effects on cell adhesion and
   alignment
SO BIOFABRICATION
LA English
DT Article
ID CAPILLARY-FORCE LITHOGRAPHY; TOPOGRAPHICAL CONTROL; NANOTOPOGRAPHY;
   SURFACES; BEHAVIOR; NANOGROOVE; MODULATION; SUBMICRON; GUIDANCE; CULTURE
AB Cell adhesion, movement and proliferation on a biomaterial have been broadly explored and known to be induced by the morphology and structure of material surfaces. In order to explore the effects of hybrid structures (combination of micro- and nanofeatures on a pattern) on cell adhesion and alignment, a micro-featured mold was firstly prepared using partial UV-irradiation and the protruding top of the mold was then imprinted with nano-featured templates via successive UV irradiation. An oxygen inhibition effect was utilized in the course of UV curing and a two-step molding process, to form multiscale hybrid structures. The poly(dimethyl siloxane) (PDMS) replica of the hybrid mold was manufactured and employed to fabricate hybrid polymeric patterns for cell attachment. The underlying micro-feature was chosen to be a 25-mu m-wide pattern and the nanostructures on the protrusions of the micropattern were different ruled nanogrooves, either parallel or perpendicular to the micro- featured pattern. In cell attachment measurement, 3T3 fibroblasts attached to poly(methyl methacrylate) (PMMA) samples seemed to be preferentially located on the recessed area of the hybrid patterns; however, 3T3 fibroblasts were aligned with nano-features, no matter if the nanogrooves were parallel or perpendicular to the micro-featured patterns. The nanogroove size was found to determine the effectiveness of cell alignment.
C1 [Li, J-Y; Chung, Y-C; Lin, F-C; Liao, W-L] Natl Univ Kaohsiung, Dept Chem & Mat Engn, Kaohsiung 811, Taiwan.
   [Ho, Y-C; Chung, Y-C] Natl Univ Kaohsiung, Inst Biotechnol, Kaohsiung 811, Taiwan.
   [Chung, Y-C] Natl Cheng Kung Univ, Res Ctr Energy Technol & Strategy, Tainan 701, Taiwan.
   [Tsai, W-B] Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
RP Chung, YC (reprint author), Natl Univ Kaohsiung, Dept Chem & Mat Engn, 700 Kaohsiung Univ Rd, Kaohsiung 811, Taiwan.
EM ycchung@nuk.edu.tw
RI Tsai, Wei-Bor/B-7953-2011
OI Tsai, Wei-Bor/0000-0002-2316-5751
FU Ministry of Economics in Taiwan [95-EC-17-A-07-S1-0018]
FX The authors appreciate the financial support from the Ministry of
   Economics in Taiwan, with the grant no 95-EC-17-A-07-S1-0018 and the
   proof-reading work of Mr Bryan Van Biesbrouck, who has been working in
   editing for years.
CR Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d
   Borenstein JT, 2007, TISSUE ENG, V13, P1837, DOI 10.1089/ten.2006.0156
   Buyukhatipoglu K, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/3/035003
   Chaberska Hanna, 2007, Polim Med, V37, P13
   Chou SY, 1996, J VAC SCI TECHNOL B, V14, P4129, DOI 10.1116/1.588605
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 2006, NANOMEDICINE-UK, V1, P67, DOI 10.2217/17435889.1.1.67
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159
   Fraser SA, 2008, J BIOMED MATER RES A, V86A, P725, DOI 10.1002/jbm.a.31519
   Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918
   Goubko CA, 2009, MAT SCI ENG C-MATER, V29, P1855, DOI 10.1016/j.msec.2009.02.016
   Hsu SH, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/3/035008
   Hu W, 2005, J VAC SCI TECHNOL B, V23, P2984, DOI 10.1116/1.2121729
   Jeong HE, 2009, NANOSCALE, V1, P331, DOI 10.1039/b9nr00106a
   Jeong HE, 2008, SMALL, V4, P1913, DOI 10.1002/smll.200800151
   Kim MS, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494017
   Kwak R, 2009, SMALL, V5, P790, DOI 10.1002/smll.200900219
   Kwon KW, 2011, LANGMUIR, V27, P3238, DOI 10.1021/la2000156
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lin Y C, 2013, SURF COAT T IN PRESS
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Nam J, 2007, J BIOCH, V29, P20
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Rim NG, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014102
   Rogers J A, 2009, UNCONVENTIONAL NANOP, P7
   Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001
   Tsai WB, 2009, J MATER SCI-MATER M, V20, P1367, DOI 10.1007/s10856-008-3687-8
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   Walboomers X F, 2001, Odontology, V89, P2, DOI 10.1007/s10266-001-8178-z
   Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021
   Wang PY, 2010, BIOTECHNOL BIOENG, V106, P285, DOI 10.1002/bit.22697
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
NR 42
TC 11
Z9 11
U1 5
U2 40
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
J9 BIOFABRICATION
JI Biofabrication
PD SEP
PY 2013
VL 5
IS 3
AR 035003
DI 10.1088/1758-5082/5/3/035003
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 201IJ
UT WOS:000323133600003
PM 23714853
DA 2018-10-20
ER

PT J
AU Camilleri, J
   Formosa, L
   Damidot, D
AF Camilleri, J.
   Formosa, L.
   Damidot, D.
TI The setting characteristics of MTA Plus in different environmental
   conditions
SO INTERNATIONAL ENDODONTIC JOURNAL
LA English
DT Article
DE chemical characterization; hydration; physiological solution; mineral
   trioxide aggregate; root end filling material
ID MINERAL TRIOXIDE AGGREGATE; TRICALCIUM SILICATE CEMENT;
   PHOSPHATE-CONTAINING FLUID; FETAL BOVINE SERUM; PORTLAND-CEMENT; DENTAL
   BIOMATERIAL; WHITE; MICROSTRUCTURE; SURFACE; BLOOD
AB Aim Characterization and assessment of the hydration reaction of mineral trioxide aggregate (MTA) Plus exposed to different environmental conditions.
   Methodology The specific surface area, surface morphology and characterization of un-hydrated MTA Plus (Avalon Biomed Inc. Bradenton, FL, USA) were investigated. The specific surface area was compared with that of ProRoot MTA (Dentsply International, Tulsa Dental Specialties, Johnson City, TN, USA). The reaction rate was determined using calorimetry, and the hydrated cement was assessed for setting time (determined using an indentation technique), and the set material was characterized using X-ray diffraction analysis, scanning electron microscopy and X-ray energy-dispersive analysis. Atomic ratio plots were drawn to establish the relationship of the hydration products. Three different environmental conditions namely dry or immersed in either water or Hank's balanced salt solution (HBSS) were used.
   Results Mineral trioxide aggregate Plus had a higher specific surface area than ProRoot MTA. The hydration reaction was exothermic. The setting time of MTA Plus was retarded when in contact with fluids (P<0.001). The setting time was longer when MTA Plus was in contact with HBSS than when in contact with water (P<0.001). Hydration of MTA Plus resulted in the formation of calcium silicate hydrate, calcium hydroxide, ettringite and monosulfate phases. Bismuth was incorporated in the calcium silicate hydrate structure. The hydration of the core material was not affected by contact with the different solutions but the periphery exhibited microcracking, leaching of calcium hydroxide, partial decalcification of calcium silicate hydrate, inhibition of hydration in contact with the physiological solution.
   Conclusions The novel MTA Plus was finer than ProRoot MTA but had a similar chemical composition. MTA Plus in direct contact with fluids exhibited partial decalcification of calcium silicate hydrate in contact with the solution, microcracking and leaching of calcium hydroxide. Interaction with a physiological solution resulted in inhibition of hydration.
C1 [Camilleri, J.] Univ Malta, Fac Dent Surg, Dept Restorat Dent, Msida 2090, MSD, Malta.
   [Formosa, L.] Univ Malta, Fac Engn, Dept Met & Mat Engn, Msida 2090, MSD, Malta.
   [Damidot, D.] Univ Lille Nord France, Lille, France.
   [Damidot, D.] LGCgE GCE, EM Douai, Douai, France.
RP Camilleri, J (reprint author), Univ Malta, Sch Med, Mater Dei Hosp, Dept Restorat Dent,Fac Dent Surg, Msida 2090, MSD, Malta.
EM josette.camilleri@um.edu.mt
RI Damidot, Denis/G-3215-2011; Camilleri, Josette/N-9409-2015
OI Damidot, Denis/0000-0001-6630-9607; Camilleri,
   Josette/0000-0003-3556-6365
FU Faculty of Dental Surgery; Research Grant Committee University of Malta;
   ERDF (Malta) [012]
FX The Faculty of Dental Surgery and the Research Grant Committee
   University of Malta for funding; Dr Carolyn Primus for the materials;
   Ing. J. Camilleri of the Faculty of Engineering, University of Malta for
   his assistance; ERDF (Malta) for the financing of the testing equipment
   through the project: 'Developing an Interdisciplinary Material Testing
   and Rapid Prototyping R&D Facility (Ref. no. 012)'.
CR Asgary S, 2006, J MATER SCI-MATER M, V17, P187, DOI 10.1007/s10856-006-6823-3
   Belio-Reyes IA, 2009, J ENDODONT, V35, P875, DOI 10.1016/j.joen.2009.03.004
   Bozeman TB, 2006, J ENDODONT, V32, P425, DOI 10.1016/j.joen.2005.08.009
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x
   Camilleri J, 2007, INT ENDOD J, V40, P462, DOI 10.1111/j.1365-2591.2007.01248.x
   Camilleri J, 2005, DENT MATER, V21, P297, DOI 10.1016/j.dental.2004.05.010
   Camilleri J, 2011, DENT MATER, V27, P836, DOI 10.1016/j.dental.2011.04.010
   Camilleri J, 2011, DENT MATER, V27, P845, DOI 10.1016/j.dental.2011.04.011
   Camilleri J, 2010, INT ENDOD J, V43, P21, DOI 10.1111/j.1365-2591.2009.01621.x
   Camilleri J, 2011, J ENDODONT, V37, P239, DOI 10.1016/j.joen.2010.11.012
   Chen CC, 2009, J ENDODONT, V35, P1554, DOI 10.1016/j.joen.2009.08.006
   Duarte MAH, 2003, ORAL SURG ORAL MED O, V95, P345, DOI 10.1067/moe.2003.12
   European Standard,, 2000, 12 M EUR EYE BANK AS, P1
   Formosa LM, 2012, INT ENDOD J, V45, P326, DOI 10.1111/j.1365-2591.2011.01980.x
   Kim Y, 2012, J ENDODONT, V38, P536, DOI 10.1016/j.joen.2011.12.005
   Komabayashi T, 2008, J ENDODONT, V34, P94, DOI 10.1016/j.joen.2007.10.013
   Lee YL, 2004, BIOMATERIALS, V25, P787, DOI 10.1016/S0142-9612(03)00591-X
   Nekoofar MH, 2011, INT ENDOD J, V44, P1011, DOI 10.1111/j.1365-2591.2011.01909.x
   Nekoofar MH, 2010, INT ENDOD J, V43, P849, DOI 10.1111/j.1365-2591.2010.01750.x
   Oliveira Marília Gerhardt de, 2007, Braz. Dent. J., V18, P3, DOI 10.1590/S0103-64402007000100002
   Ramachandran VS, 1995, APPL ADMIXTURES CONC, P1
   Reyes-Carmona JF, 2009, J ENDODONT, V35, P731, DOI 10.1016/j.joen.2009.02.011
   Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41
   Storm B, 2008, J ENDODONT, V34, P80, DOI 10.1016/j.joen.2007.10.006
   Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008
   Tingey MC, 2008, J ENDODONT, V34, P45, DOI 10.1016/j.joen.2007.09.013
   Wang XP, 2007, J BIOMED MATER RES B, V81B, P410, DOI 10.1002/jbm.b.30678
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
NR 29
TC 33
Z9 37
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0143-2885
EI 1365-2591
J9 INT ENDOD J
JI Int. Endod. J.
PD SEP
PY 2013
VL 46
IS 9
BP 831
EP 840
DI 10.1111/iej.12068
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 198IZ
UT WOS:000322917500006
PM 23441890
DA 2018-10-20
ER

PT J
AU Stoecklin-Wasmer, C
   Rutjes, AWS
   da Costa, BR
   Salvi, GE
   Juni, P
   Sculean, A
AF Stoecklin-Wasmer, C.
   Rutjes, A. W. S.
   da Costa, B. R.
   Salvi, G. E.
   Jueni, P.
   Sculean, A.
TI Absorbable Collagen Membranes for Periodontal Regeneration: A Systematic
   Review
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE periodontal disease(s); periodontitis; surgery; meta-analysis;
   biomaterial(s); guided tissue regeneration; clinical studies/trials
ID GUIDED TISSUE REGENERATION; DEFECTS FOLLOWING TREATMENT; CONTROLLED
   CLINICAL-TRIAL; HUMAN INTRABONY DEFECTS; BOVINE-DERIVED XENOGRAFT;
   SURGICAL-TREATMENT; BONY DEFECTS; BARRIER MEMBRANES; HEALING RESPONSE;
   ACCESS FLAP
AB Guided tissue regeneration (GTR) with bioabsorbable collagen membranes (CM) is commonly used for the treatment of periodontal defects. The objective of this systematic review of randomized clinical trials was to assess the clinical efficacy of GTR procedures with CM, with or without bone substitutes, in periodontal infrabony defects compared with that of open flap debridement (OFD) alone. Primary outcomes were tooth loss and gain in clinical attachment level (CAL). Screening of records, data extraction, and risk-of-bias assessments were performed by two reviewers. Weighted mean differences were estimated by random effects meta-analysis. We included 21 reports on 17 trials. Risk of bias was generally high. No data were available for the primary outcome tooth loss. The summary treatment effect for change in CAL for GTR with CM compared with OFD was 1.58 mm (95% CI, 1.27 to 1.88). Despite large between-trial heterogeneity (I-2 = 75%, p< .001), all trials favored GTR over OFD. No differences in treatment effects were detected between trials of GTR with CM alone and trials of GTR with CM in combination with bone substitutes (p for interaction, .31). GTR with CM, with or without substitutes, may result in improved clinical outcomes compared with those achieved with OFD alone. Our findings support GTR with CM for the treatment of infrabony periodontal defects.
C1 [Stoecklin-Wasmer, C.; Salvi, G. E.; Sculean, A.] Univ Bern, Dept Periodontol, CH-3010 Bern, Switzerland.
   [Rutjes, A. W. S.; da Costa, B. R.; Jueni, P.] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland.
   [Rutjes, A. W. S.] Univ G dAnnunzio, Ctr Aging Sci Ce SI, I-66100 Chieti, Italy.
   [da Costa, B. R.; Jueni, P.] Univ Bern, CTU Bern, Dept Clin Res, CH-3012 Bern, Switzerland.
RP Sculean, A (reprint author), Univ Bern, Dept Periodontol, Freiburgstr 7, CH-3010 Bern, Switzerland.
EM anton.sculean@zmk.unibe.ch
RI Rutjes, Anne/L-8750-2017
OI Rutjes, Anne/0000-0001-9782-779X
CR ALARRAYED F, 1995, J CLIN PERIODONTOL, V22, P371, DOI 10.1111/j.1600-051X.1995.tb00163.x
   BLUMENTHAL N, 1990, J PERIODONTOL, V61, P319, DOI 10.1902/jop.1990.61.6.319
   Boynuegri D, 2009, J BIOMED MATER RES B, V90B, P461, DOI 10.1002/jbm.b.31307
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Camargo PM, 2005, INT J PERIODONT REST, V25, P49
   Camargo PM, 2000, J CLIN PERIODONTOL, V27, P889, DOI 10.1034/j.1600-051x.2000.027012889.x
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   CHUNG KM, 1990, J PERIODONTOL, V61, P732, DOI 10.1902/jop.1990.61.12.732
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cortellini P, 2005, J PERIODONTOL, V76, P341, DOI 10.1902/jop.2005.76.3.341
   Cortellini P, 2004, J PERIODONTOL, V75, P672, DOI 10.1902/jop.2004.75.5.672
   GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x
   Heitz-Mayfield L, 2006, J CLIN PERIODONTOL, V33, P62, DOI 10.1111/j.1600-051X.2005.00872.x
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hujoel PP, 2004, PERIODONTOL 2000, V36, P196, DOI 10.1111/j.1600-0757.2004.03681.x
   Juni P, 2001, BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42
   Lekovic V, 2001, J PERIODONTOL, V72, P583, DOI 10.1902/jop.2001.72.5.583
   Linares A, 2006, J CLIN PERIODONTOL, V33, P351, DOI 10.1111/j.1600-051X.2006.00911.x
   Ling LJ, 2003, J PERIODONTAL RES, V38, P57, DOI 10.1034/j.1600-0765.2003.01641.x
   Murphy Kevin G, 2003, Ann Periodontol, V8, P266, DOI 10.1902/annals.2003.8.1.266
   Needleman IG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001724.pub2
   NOWZARI H, 1995, J CLIN PERIODONTOL, V22, P469, DOI 10.1111/j.1600-051X.1995.tb00179.x
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   Paolantonio M, 2002, J PERIODONTOL, V73, P158, DOI 10.1902/jop.2002.73.2.158
   Paolantonio M, 2008, J PERIODONTOL, V79, P1886, DOI [10.1902/jop.2008.080076, 10.1902/jop.2008.080076 ]
   Paolantonio M, 2010, J PERIODONTOL, V81, P1587, DOI 10.1902/jop.2010.100094
   Papapanou PN, 2000, PERIODONTOL 2000, V22, P8, DOI 10.1034/j.1600-0757.2000.2220102.x
   Parodi R, 1997, Int J Periodontics Restorative Dent, V17, P282
   PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892
   PIHLSTROM BL, 1983, J CLIN PERIODONTOL, V10, P524, DOI 10.1111/j.1600-051X.1983.tb02182.x
   QUTEISH D, 1992, J CLIN PERIODONTOL, V19, P476, DOI 10.1111/j.1600-051X.1992.tb01160.x
   Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009
   Rucker G, 2008, BMC MED RES METHODOL, V8, P79
   Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473
   Sculean A, 2005, J CLIN PERIODONTOL, V32, P720, DOI 10.1111/j.1600-051X.2005.00758.x
   Sculean A, 2004, Clin Oral Investig, V8, P70
   Sculean A, 2003, J CLIN PERIODONTOL, V30, P73, DOI 10.1034/j.1600-051X.2003.10192.x
   Sculean A, 2007, J CLIN PERIODONTOL, V34, P72, DOI 10.1111/j.1600-051X.2006.01007.x
   SELVIG KA, 1992, J PERIODONTOL, V63, P974, DOI 10.1902/jop.1992.63.12.974
   Singh Vijendra P, 2012, J Indian Soc Periodontol, V16, P562, DOI 10.4103/0972-124X.106912
   Singh Vijendra P, 2012, Dent Res J (Isfahan), V9, P60, DOI 10.4103/1735-3327.92945
   Sowmya N K, 2010, J Indian Soc Periodontol, V14, P23, DOI 10.4103/0972-124X.65432
   STAHL SS, 1990, J CLIN PERIODONTOL, V17, P191, DOI 10.1111/j.1600-051X.1990.tb01085.x
   Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8
   Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761
   Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V
   Tonetti MS, 2004, J CLIN PERIODONTOL, V31, P770, DOI 10.1111/j.1600-051X.2004.00562.x
   Tonetti MS, 1996, J CLIN PERIODONTOL, V23, P548, DOI 10.1111/j.1600-051X.1996.tb01823.x
   TONETTI MS, 1993, J PERIODONTOL, V64, P934, DOI 10.1902/jop.1993.64.10.934
   Trombelli L, 2010, J PERIODONTOL, V81, P1256, DOI 10.1902/jop.2010.100113
   Vouros I, 2004, J CLIN PERIODONTOL, V31, P908, DOI 10.1111/j.1600-051X.2004.00583.x
NR 52
TC 25
Z9 26
U1 3
U2 33
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD SEP
PY 2013
VL 92
IS 9
BP 773
EP 781
DI 10.1177/0022034513496428
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 201JK
UT WOS:000323136300002
PM 23842107
DA 2018-10-20
ER

PT J
AU Tsuda, Y
   Hattori, H
   Tanaka, Y
   Ishihara, M
   Kishimoto, S
   Amako, M
   Arino, H
   Nemoto, K
AF Tsuda, Yoshifumi
   Hattori, Hidemi
   Tanaka, Yoshihiro
   Ishihara, Masayuki
   Kishimoto, Satoko
   Amako, Masatoshi
   Arino, Hiroshi
   Nemoto, Koichi
TI Ultraviolet light-irradiated photocrosslinkable chitosan hydrogel to
   prevent bone formation in both rat skull and fibula bone defects
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE chitin; chitosan; hydrogel; photopolymerization; synostosis; bone;
   fibrous tissue formation
ID TRAUMATIC RADIOULNAR SYNOSTOSIS; FIBROBLAST GROWTH FACTOR-2; HETEROTOPIC
   BONE; HEALING-PROCESS; ACCELERATOR; ADHESIVE; CHITIN; REGENERATION;
   INHIBITION; MEMBRANE
AB In the field of orthopaedic surgery, an orthopaedic surgeon sometimes requires to suppress excessive bone formation, such as ectopic bone formation, ossifying myositis and radio-ulnar synostosis, etc. Ultraviolet (UV) light irradiation of a photocrosslinkable chitosan (Az-CH-LA) generates an insoluble hydrogel within 30s. The purpose of this study was to evaluate the ability of the photocrosslinked chitosan hydrogel (PCH) to inhibit bone formation in an experimental model of bone defect. Rat calvarium and fibula were surgically injured and PCH was implanted into the resultant bone defects. The PCH implants significantly prevented bone formation in the bone defects during the 4 and 8week observation periods. In the PCH-treated defects, fibrous tissues infiltrated by inflammatory cells were formed by day 7, completely filling the bone defects. In addition to these findings, expression of osteocalcin and runt-related gene 2 (RUNX2) mRNA, both markers of bone formation, was lower in the PCH-treated defects than in the controls. In contrast, collagen type 12 and -smooth muscle actin (-SMA) mRNA levels were significantly higher in the PCH-treated defects after 1week. PCH stimulated the formation of fibrous tissue in bone defects while inhibiting bone formation. Thus, PCH might be a promising new therapeutic biomaterial for the prevention of bone formation in orthopaedic surgery. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Tsuda, Yoshifumi; Amako, Masatoshi; Arino, Hiroshi; Nemoto, Koichi] Natl Def Med Coll, Dept Orthopaed Surg, Tokorozawa, Saitama 3598513, Japan.
   [Hattori, Hidemi; Tanaka, Yoshihiro; Ishihara, Masayuki; Kishimoto, Satoko] Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan.
   [Kishimoto, Satoko] Japan Soc Promot Sci, Tokyo, Japan.
RP Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Div Biomed Engn, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
EM ishihara@ndmc.ac.jp
CR Beingessner DM, 2000, J HAND SURG-AM, V25A, P483, DOI 10.1053/jhsu.2000.6922
   BREIT R, 1983, CLIN ORTHOP RELAT R, P149
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76
   Einborn TA, 1999, CLIN ORTHOP RELAT R, V367S, pS59
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245
   Hattori H, 2010, ANN BIOMED ENG, V38, P3724, DOI 10.1007/s10439-010-0121-4
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jupiter JB, 1998, J BONE JOINT SURG AM, V80A, P248, DOI 10.2106/00004623-199802000-00012
   Kamakura S, 2004, J BIOMED MATER RES A, V71A, P299, DOI 10.1002/jbm.a.30157
   Kanineni S, 2002, J BONE JOINT SURG AM, V84A, P745
   Kiyozumi T, 2007, BURNS, V33, P642, DOI 10.1016/j.burns.2006.09.010
   Kiyozumi T, 2006, J BIOMED MATER RES B, V79B, P129, DOI 10.1002/jbm.b.30522
   KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554
   Kuo SM, 2006, J BIOMED MATER RES A, V76A, P408, DOI 10.1002/jbm.a.30534
   MAEMPEL FZ, 1984, CLIN ORTHOP RELAT R, P182
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4
   Rossomacha E, 2004, J HISTOTECHNOL, V27, P31, DOI 10.1179/his.2004.27.1.31
   SACHAR K, 1994, HAND CLIN, V10, P399
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Tominaga K, 1998, JPN J ORAL MAXILLOFA, V44, P29
   Tsuda Y, 2009, ARTIF ORGANS, V33, P74, DOI 10.1111/j.1525-1594.2008.00676.x
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   VanLaeken N, 1989, J BURN CARE REHABIL, V10, P331
   VINCE KG, 1987, J BONE JOINT SURG AM, V69A, P640, DOI 10.2106/00004623-198769050-00002
   WARREN SB, 1992, J BONE JOINT SURG AM, V74A, P201, DOI 10.2106/00004623-199274020-00006
   Yang-Hing K, 1983, J BONE JOINT SURG BR, V65, P433
NR 38
TC 6
Z9 7
U1 1
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2013
VL 7
IS 9
BP 720
EP 728
DI 10.1002/term.1462
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 201SY
UT WOS:000323164500005
PM 22408001
DA 2018-10-20
ER

PT J
AU Reich, MS
   Akkus, O
AF Reich, Michael S.
   Akkus, Ozan
TI Sporicidal efficacy of genipin: a potential theoretical alternative for
   biomaterial and tissue graft sterilization
SO CELL AND TISSUE BANKING
LA English
DT Article
DE Allograft; Bacillus pumilus; Bacillus subtilis; Genipin; Geobacillus
   stearothermophilus; Sterilization
ID TENDON-BONE ALLOGRAFTS; IN-VITRO EVALUATION; CROSS-LINKING;
   BIOMECHANICAL PROPERTIES; GAMMA-IRRADIATION; OSTEOCHONDRAL ALLOGRAFTS;
   MECHANICAL-PROPERTIES; IONIZING-RADIATION; BIOLOGICAL TISSUES; FORMALIN
   FIXATION
AB Terminal sterilization of musculoskeletal allografts by gamma radiation minimizes the risk of disease transmission but impairs allograft mechanical properties. Commonly employed crosslinking agents can sterilize tissues without affecting mechanical properties adversely; however, these agents are toxic. Genipin is reported to be a benign crosslinking agent that strengthens mechanical properties of tissues; however, the antimicrobial capacity of genipin is largely unknown. The present study's aims were: (1) to assess the sporicidal potential of genipin, (2) to improve antimicrobial capacity by changing chemical and physical treatment conditions. To establish genipin's sterilization potential Bacillus subtilis var. niger spore strips were treated with 0-10 % genipin in PBS or in 1:1 DMSO:PBS up to 72 h at room temperature (RT). Sterilizing doses and concentrations of genipin were used to treat B. pumilus and Geobacillus stearothermophilus spores to assess broader spectrum sporicidal activity of genipin. Scanning electron microscopy (SEM) was performed to evaluate gross morphological changes after genipin treatment. Optimal sterilization conditions were determined by evaluating the effects of temperature (RT-50 A degrees C), DMSO:PBS ratio (0:100-100:0), and treatment duration (24-72 h) on B. subtilis. Genipin penetration of full thickness bovine patellar tendon and cortical bone specimens was observed to assess the feasibility of the agent for treating grafts. Initial studies showed that after 72 h of treatment at RT with 0.63-10 % genipin/DMSO:PBS B. subtilis spore strips were sterilized; 0.63 % genipin/PBS did not sterilize spore strips at 72 h at RT. Genipin doses and concentrations that sterilized B. subtilis spore strips sterilized B. pumilus and G. stearothermophilus spore strips. SEM revealed no gross morphological differences between untreated and treated spores. Treatment optimization resulted in sterilization within 24 h with 100 % PBS, and DMSO facilitated sporicidal activity. Genipin penetrated full thickness patellar tendon specimens and 3.72 +/- A 0.58 mm in cortical bone specimens. Genipin sterilizes B. subtilis, B. pumilus, and G. stearothermophilus spore strips. It penetrates soft and hard tissues at doses previously shown to be non-toxic and to improve mechanical strength in collagen-rich soft tissues. Further studies are indicated to assess genipin's effects on the mechanical properties of genipin-sterilized grafts, the ability of genipin to eradicate infectious species other than spores, and to assess whether sterilant activity persists after penetrating tissues and biomaterials.
C1 [Reich, Michael S.; Akkus, Ozan] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
   [Akkus, Ozan] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA.
   [Akkus, Ozan] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Akkus, O (reprint author), Case Western Reserve Univ, Dept Mech & Aerosp Engn, 10900 Euclid Ave,Glennan Bldg Room 615, Cleveland, OH 44106 USA.
EM oxa@case.edu
OI Akkus, Ozan/0000-0003-3523-3421; Reich, Michael/0000-0002-5113-1321
FU AOTrauma North America
FX This research was funded by AOTrauma North America.
CR ANCHORDOGUY TJ, 1992, BIOCHIM BIOPHYS ACTA, V1104, P117, DOI 10.1016/0005-2736(92)90139-D
   [Anonymous], 2006, ISO111392006
   Avila MY, 2010, J CATARACT REFR SURG, V36, P659, DOI 10.1016/j.jcrs.2009.11.003
   BAILEY AJ, 1967, RADIAT RES, V31, P206, DOI 10.2307/3572321
   BASCH H, 1968, APPL MICROBIOL, V16, P1953
   BERTELLI G, 1995, J CLIN ONCOL, V13, P2851, DOI 10.1200/JCO.1995.13.11.2851
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   Bright RW, 1983, OSTEOCHONDRAL ALLOGR, P241
   BROBYN RD, 1975, ANN NY ACAD SCI, V243, P497, DOI 10.1111/j.1749-6632.1975.tb25394.x
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Burkhart KJ, 2010, BIOMED TECH, V55, P361, DOI 10.1515/BMT.2010.043
   Campbell DG, 1999, AUST NZ J SURG, V69, P517, DOI 10.1046/j.1440-1622.1999.01615.x
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   Cohen SB, 2007, CLIN SPORT MED, V26, P597, DOI 10.1016/j.csm.2007.06.003
   Colwell A, 1996, EUR J CLIN INVEST, V26, P1107, DOI 10.1046/j.1365-2362.1996.460602.x
   CONRAD EU, 1995, J BONE JOINT SURG AM, V77A, P214, DOI 10.2106/00004623-199502000-00007
   Curran AR, 2004, AM J SPORT MED, V32, P1131, DOI 10.1177/0363546503260030
   Currey JD, 1997, J ORTHOP RES, V15, P111, DOI 10.1002/jor.1100150116
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Fassel TA, 1997, BIOTECH HISTOCHEM, V72, P268, DOI 10.3109/10520299709082251
   FDA, 2002, UPD 510K STER REV GU
   Ferretti M, 2006, TISSUE ENG, V12, P2657, DOI 10.1089/ten.2006.12.2657
   FIDELER BM, 1995, AM J SPORT MED, V23, P643, DOI 10.1177/036354659502300521
   FRIEDLAENDER GE, 1983, CLIN ORTHOP RELAT R, P58
   Friedlander GE, 1999, ORTHOP CLIN N AM, V30, P583, DOI 10.1016/S0030-5898(05)70111-5
   FUJIKAWA S, 1987, BIOTECHNOL LETT, V9, P697, DOI 10.1007/BF01024600
   Gillis JR, 2010, PHARM TECH, V34
   Gurkan UA, 2010, J BIOMED MATER RES A, V94A, P1070, DOI 10.1002/jbm.a.32783
   Halvorson HO, 1933, J BACTERIOL, V25, P101
   HENDERSON TR, 1975, ANN NY ACAD SCI, V243, P38, DOI 10.1111/j.1749-6632.1975.tb25342.x
   HERNIGOU P, 1993, J BONE JOINT SURG BR, V75, P904
   Jackson DW, 1996, CLIN ORTHOP RELAT R, P126
   JACOB SW, 1986, CRYOBIOLOGY, V23, P14, DOI 10.1016/0011-2240(86)90014-3
   Joyce MJ, 2008, AAOS 75 ANN M SAN FR
   Kishore V, 2012, J BIOMED MATER RES B, V100B, P400, DOI 10.1002/jbm.b.31962
   Kishore V, 2012, BIOMATERIALS, V33, P2137, DOI 10.1016/j.biomaterials.2011.11.066
   Klesper B, 2000, J CRANIO MAXILL SURG, V28, P110, DOI 10.1054/jcms.2000.0122
   Komender A, 1976, Mater Med Pol, V8, P13
   Lelono R A A, 2009, Pak J Biol Sci, V12, P949
   Li W, 2004, TETRAHEDRON LETT, V45, P1071, DOI 10.1016/j.tetlet.2003.11.072
   Lietman SA, 2000, CLIN ORTHOP RELAT R, P214
   Liu BS, 2003, J BIOMED MATER RES A, V67A, P1163, DOI 10.1002/jbm.a.20017
   Loshon CA, 1999, J APPL MICROBIOL, V87, P8, DOI 10.1046/j.1365-2672.1999.00783.x
   LUDWIG CU, 1987, EUR J CANCER CLIN ON, V23, P327, DOI 10.1016/0277-5379(87)90077-0
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147
   Moon SH, 2000, USA Patent, Patent No. 6162826
   Moore DR, 2006, AM J SPORT MED, V34, P392, DOI 10.1177/0363546505281237
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Myoung H, 2001, ORAL SURG ORAL MED O, V92, P23, DOI 10.1067/moe.2001.115027
   Ng KW, 2013, CELL TISSUE BANK, V14, P21, DOI 10.1007/s10561-012-9295-3
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Rappe M, 2007, AM J SPORT MED, V35, P1653, DOI 10.1177/0363546507302926
   Sagripanti JL, 1996, APPL ENVIRON MICROB, V62, P545
   Salehpour A, 1995, J ORTHOP RES, V13, P898, DOI 10.1002/jor.1100130614
   SCHERBEL AL, 1967, ANN NY ACAD SCI, V141, P613, DOI 10.1111/j.1749-6632.1967.tb34931.x
   Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x
   SIMONDS RJ, 1992, NEW ENGL J MED, V326, P726, DOI 10.1056/NEJM199203123261102
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Sun K, 2009, KNEE SURG SPORT TR A, V17, P464, DOI 10.1007/s00167-008-0714-8
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Sung HW, 2000, J BIOMED MATER RES, V52, P77, DOI 10.1002/1097-4636(200010)52:1<77::AID-JBM10>3.0.CO;2-6
   The S D, 1975, J Endod, V1, P300
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P668
   TSAI TH, 1994, J LIQ CHROMATOGR, V17, P2199
   UPTON J, 1992, J HAND SURG-AM, V17A, P704, DOI 10.1016/0363-5023(92)90321-F
   USPC, 2002, 25 USPC, P233
   Van Kleunen JP, 2003, SUMM BIOENG C KEY BI
   WHO, 2011, QUAL CONTR STER
   Wilke HJ, 1996, J BIOMECH, V29, P1629, DOI 10.1016/0021-9290(96)00085-1
   Windrum P, 2005, BONE MARROW TRANSPL, V36, P601, DOI 10.1038/sj.bmt.1705100
   Yerramalli CS, 2007, BIOMECH MODEL MECHAN, V6, P13, DOI 10.1007/s10237-006-0043-0
NR 73
TC 12
Z9 13
U1 2
U2 28
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
EI 1573-6814
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD SEP
PY 2013
VL 14
IS 3
BP 381
EP 393
DI 10.1007/s10561-012-9335-z
PG 13
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA 195CB
UT WOS:000322677900006
PM 22875200
DA 2018-10-20
ER

PT J
AU Irshad, M
   Scheres, N
   Crielaard, W
   Loos, BG
   Wismeijer, D
   Laine, ML
AF Irshad, Muhammad
   Scheres, Nina
   Crielaard, Wim
   Loos, Bruno G.
   Wismeijer, Daniel
   Laine, Marja L.
TI Influence of titanium on in vitro fibroblast-Porphyromonas gingivalis
   interaction in peri-implantitis
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE biomaterial; cytokines; fibroblast; inflammation; Porphyromonas
   gingivalis
ID 3-YEAR CLINICAL-TRIAL; SHAPED ORAL IMPLANTS; TISSUE-RESPONSE; RESECTIVE
   SURGERY; IMMUNE-RESPONSE; DENTAL IMPLANTS; CYTOKINE LEVELS;
   WEAR-PARTICLES; PURE TITANIUM; DISEASES
AB Aim: Titanium wear particles have been found in peri-implant tissues, but their role in the pathogenesis of peri-implantitis remains unclear. We aimed to determine the in vitro inflammatory responses of peri-implant granulation tissue fibroblasts (PIGFs) to titanium particles alone and in the presence of viable Porphyromonas gingivalis.
   Materials & Methods: Peri-implant granulation tissue fibroblasts were challenged either with TiO2 particles, P. gingivalis or a combination of TiO2 particles and P. gingivalis. Gene expression and protein production of pro-inflammatory mediators by PIGFs were measured with PCR and ELISA, respectively.
   Results: Higher doses of TiO2 were toxic to PIGFs and in sub-toxic doses, TiO2 caused an increase in gene expression of tumour necrosis factor (TNF)-A and increased protein production of TNF-alpha, interleukin (IL)-6 and IL-8. A challenge with P. gingivalis alone induced gene expression of TNF-A, IL-1, IL-6 and IL-8. A combined challenge with TiO2 and P. gingivalis caused a stronger increase in gene expression of TNF-A and protein production of TNF-alpha and MCP-1 than P. gingivalis alone.
   Conclusions: TiO2 particles and P. gingivalis, individually, can induce pro-inflammatory responses in PIGFs. Furthermore, TiO2 particles and viable P. gingivalis further enhance gene expression and production of TNF-alpha by PIGFs. Therefore, Ti wear particles in the peri-implant tissues in combination with P. gingivalis infection may contribute to the pathogenesis of peri-implantitis by enhancing the inflammation in peri-implant tissues.
C1 [Irshad, Muhammad; Scheres, Nina; Crielaard, Wim] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Prevent Dent, NL-1081 LA Amsterdam, Netherlands.
   [Irshad, Muhammad; Scheres, Nina; Crielaard, Wim; Loos, Bruno G.; Wismeijer, Daniel; Laine, Marja L.] Vrije Univ Amsterdam, Amsterdam, Netherlands.
   [Loos, Bruno G.; Laine, Marja L.] Univ Amsterdam, ACTA, Dept Periodontol, NL-1081 LA Amsterdam, Netherlands.
   [Wismeijer, Daniel] Univ Amsterdam, ACTA, Res Inst MOVE, Dept Oral Funct & Restorat Dent,Sect Oral Implant, NL-1081 LA Amsterdam, Netherlands.
RP Laine, ML (reprint author), Univ Amsterdam, ACTA, Dept Periodontol, Gustav Mahlerlaan 3004, NL-1081 LA Amsterdam, Netherlands.
EM m.laine@acta.nl
OI Irshad, Muhammad/0000-0002-9910-2159
FU Higher Education Commission of Pakistan; University of Amsterdam
FX The authors declare that they have no conflict of interest. MI has been
   supported by the "Higher Education Commission of Pakistan" with a
   scholarship for the research studies. The Academic Centre for Dentistry
   Amsterdam (ACTA) is supported in part by a grant from the University of
   Amsterdam for research into the focal point "Oral Infections and
   Inflammation".
CR Banbula A, 1999, BIOCHEM BIOPH RES CO, V261, P598, DOI 10.1006/bbrc.1999.1075
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Bi YM, 2001, J BONE JOINT SURG AM, V83A, P501, DOI 10.2106/00004623-200104000-00004
   Bordin S, 2009, INT J ORAL MAX IMPL, V24, P197
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-5
   Deo Vikas, 2010, Dent Today, V29, P60
   Duarte PM, 2009, J PERIODONTOL, V80, P234, DOI [10.1902/jop.2009.070672, 10.1902/jop.2009.070672 ]
   Enersen M., 2013, J ORAL MICROBIOLOGY, V6, P5
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   Evrard L, 2010, Rev Med Brux, V31, P44
   Fiorellini JP, 1998, PERIODONTOL 2000, V17, P125, DOI 10.1111/j.1600-0757.1998.tb00130.x
   Fletcher J, 1998, CURR MICROBIOL, V36, P216, DOI 10.1007/s002849900297
   Forte Giovanni, 2008, Inflammation & Allergy Drug Targets, V7, P145, DOI 10.2174/187152808785748146
   Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873
   Hirayama T, 2011, J ORTHOP RES, V29, P984, DOI 10.1002/jor.21369
   Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x
   Irshad M., 2013, J PERIODONTAL RES, DOI 10.1111/jre.12051
   Irshad M, 2012, ARCH IMMUNOL THER EX, V60, P469, DOI 10.1007/s00005-012-0196-8
   Islam AS, 2011, J ORTHOP RES, V29, P211, DOI 10.1002/jor.21199
   Kim YK, 1997, J ORAL MAXIL SURG, V55, P322, DOI 10.1016/S0278-2391(97)90115-4
   Konittinen YT, 2006, INT J PERIODONT REST, V26, P135
   Krajewski AC, 2009, APMIS, V117, P746, DOI 10.1111/j.1600-0463.2009.02532.x
   Kreisler M, 2003, INT J ORAL MAX IMPL, V18, P706
   Lai JCK, 2008, INT J NANOMED, V3, P533
   Laine ML, 1997, J DENT RES, V76, P1840, DOI 10.1177/00220345970760120601
   Lang NP, 2011, J CLIN PERIODONTOL, V38, P178, DOI 10.1111/j.1600-051X.2010.01674.x
   Lekic PC, 1997, CRIT REV ORAL BIOL M, V8, P253, DOI 10.1177/10454411970080030201
   Meulman T, 2011, J PERIODONTAL RES, V46, P629, DOI 10.1111/j.1600-0765.2011.01385.x
   Meyer U, 2006, CLIN ORAL IMPLAN RES, V17, P206, DOI 10.1111/j.1600-0501.2005.01184.x
   Mikolajczyk-Pawlinska J, 1998, FEBS LETT, V440, P282, DOI 10.1016/S0014-5793(98)01461-6
   Mine Y, 2010, J PROSTHODONT RES, V54, P1, DOI 10.1016/j.jpor.2009.07.003
   Mombelli A, 2001, CLIN ORAL IMPLAN RES, V12, P287, DOI 10.1034/j.1600-0501.2001.012004287.x
   Mostardi RA, 2002, J BIOMED MATER RES, V59, P605, DOI 10.1002/jbm.10009
   Mostardi RA, 1999, J BIOMED MATER RES, V47, P60, DOI 10.1002/(SICI)1097-4636(199910)47:1<60::AID-JBM8>3.0.CO;2-X
   Nakagawa M, 2002, DENT MATER J, V21, P83, DOI 10.4012/dmj.21.83
   Nowzari H, 2008, CLIN IMPLANT DENT R, V10, P166, DOI 10.1111/j.1708-8208.2007.00076.x
   Olmedo DG, 2012, J PERIODONTOL, V83, P973, DOI 10.1902/jop.2011.110392
   Pioletti DP, 1999, J BIOMED MATER RES, V46, P399, DOI 10.1002/(SICI)1097-4636(19990905)46:3<399::AID-JBM13>3.3.CO;2-2
   Roitt I. M., 2001, ROITTS ESSENTIAL IMM, p[xi, 481]
   Romeo E, 2005, CLIN ORAL IMPLAN RES, V16, P9, DOI 10.1111/j.1600-0501.2004.01084.x
   Romeo E, 2007, CLIN ORAL IMPLAN RES, V18, P179, DOI 10.1111/j.1600-0501.2006.01318.x
   Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P283, DOI 10.1111/j.1600-051X.2006.00907.x
   Rossi S, 2008, CLIN ORAL IMPLAN RES, V19, P348, DOI 10.1111/j.1600-0501.2007.01478.x
   Scheres N, 2010, J PERIODONTAL RES, V45, P262, DOI 10.1111/j.1600-0765.2009.01229.x
   Schlegel KA, 2002, BIOMATERIALS, V23, P2939, DOI 10.1016/S0142-9612(01)00423-9
   Schwarz F, 2006, CLIN ORAL INVEST, V10, P279, DOI 10.1007/s00784-006-0070-3
   Sharon E, 2013, CLIN IMPLANT DENT R, V15, P292, DOI 10.1111/j.1708-8208.2011.00366.x
   Shibli JA, 2008, CLIN ORAL IMPLAN RES, V19, P975, DOI 10.1111/j.1600-0501.2008.01566.x
   Siddiqi A, 2011, CLIN ORAL IMPLAN RES, V22, P673, DOI 10.1111/j.1600-0501.2010.02081.x
   Soskolne WA, 2002, CLIN ORAL IMPLAN RES, V13, P86, DOI 10.1034/j.1600-0501.2002.130111.x
   St Pierre CA, 2010, J ORTHOP RES, V28, P1418, DOI 10.1002/jor.21149
   Steffen MJ, 2000, ORAL MICROBIOL IMMUN, V15, P172, DOI 10.1034/j.1399-302x.2000.150305.x
   Taira M, 2010, J MATER SCI-MATER M, V21, P267, DOI 10.1007/s10856-009-3834-x
   Taylor JJ, 2010, PERIODONTOL 2000, V54, P160, DOI 10.1111/j.1600-0757.2009.00344.x
   Trindade MCD, 2000, J BIOMED MATER RES, V51, P360, DOI 10.1002/1097-4636(20000905)51:3<360::AID-JBM9>3.0.CO;2-E
   Venza I, 2010, J PERIODONTOL, V81, P99, DOI 10.1902/jop.2009.090358
   Wataha JC, 1996, J ORAL REHABIL, V23, P79, DOI 10.1111/j.1365-2842.1996.tb01214.x
   Wu-Yuan C D, 1995, J Oral Implantol, V21, P207
   Zhang DD, 2002, EXP LUNG RES, V28, P641, DOI 10.1080/01902140290108337
   Zhou J, 2007, J PERIODONTAL RES, V42, P77, DOI 10.1111/j.1600-0765.2006.00918.x
NR 61
TC 7
Z9 10
U1 1
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD SEP
PY 2013
VL 40
IS 9
BP 841
EP 849
DI 10.1111/jcpe.12136
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 196KS
UT WOS:000322774300003
PM 23875835
DA 2018-10-20
ER

PT J
AU Xu, B
   Rollo, B
   Stamp, LA
   Zhang, DC
   Fang, XY
   Newgreen, DF
   Chen, QZ
AF Xu, Bing
   Rollo, Ben
   Stamp, Lincon A.
   Zhang, Dongcheng
   Fang, Xiya
   Newgreen, Donald F.
   Chen, Qizhi
TI Non-linear elasticity of core/shell spun PGS/PLLA fibres and their
   effect on cell proliferation
SO BIOMATERIALS
LA English
DT Article
DE Nonlinear elasticity; Poly(glycerol sebacate); Poly(lactic acid);
   Core/shell electrospinning; Hirschsprung disease; Enteric nervous system
   progenitor cells
ID TISSUE-ENGINEERING SCAFFOLDS; ENTERIC NERVOUS-SYSTEM; POLY(GLYCEROL
   SEBACATE); MECHANICAL-PROPERTIES; LEFT-VENTRICLE; BIOMATERIALS;
   STIFFNESS; ELASTOMER; MOTILITY; NEURONS
AB An efficient delivery system is critical for the success of cell therapy. To deliver cells to a dynamic organ, the biomaterial vehicle should mechanically match with the non-linearly elastic host tissue. In this study, nonlinearly elastic biomaterials have been fabricated from a chemically crosslinked elastomeric poly(glycerol sebacate) (PGS) and thermoplastic poly(L-lactic add) (PLLA) using the core/shell electrospinning technique. The spun fibrous materials containing a PGS core and PLLA shell demonstrate J-shaped stress-strain curves, having ultimate tensile strength (UTS), rupture elongation and stiffness constants of 1 +/- 0.2 MPa, 25 +/- 3% and 12 +/- 2, respectively, which are comparable to skin tissue properties reported previously. Our ex vivo and in vivo trials have shown that the elastomeric mesh supports and fosters the growth of enteric neural crest (ENC) progenitor cells, and that the cell-seeded elastomeric fibrous sheet physically remains in intimate contact with guts after grafting, providing the effective delivery of the progenitor cells to an embryonic and post-natal gut environment. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Xu, Bing; Fang, Xiya; Chen, Qizhi] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
   [Xu, Bing; Fang, Xiya; Chen, Qizhi] Monash Univ, Monash Ctr Electron Microscope, Clayton, Vic 3800, Australia.
   [Rollo, Ben; Zhang, Dongcheng; Newgreen, Donald F.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   [Stamp, Lincon A.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.
RP Chen, QZ (reprint author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
EM qizhi.chen@monash.edu
OI Stamp, Lincon/0000-0002-8925-7894
FU Australian National Health Medical Research Council [APP1050692,
   ARCDP130101384]; Victorian Government
FX We would like to thank Dr Matthew Burton from the Murdoch Childrens
   Research Institute, Victoria, Australia for his support with confocal
   microscopy and flow cytometry; Dr Stefan Gfroerer from the Department of
   Paediatric Surgery, University of Frankfurt, Frankfurt, Germany, for
   expert assistance with in vivo mouse assays, and Ms Karla Contreras for
   her technical assistance in the conduction the tissue culture work at
   Monash University. The EdnrBKikume mice were kindly supplied by Dr
   Hideki Enomoto, Laboratory for Neuronal Differentiation and
   Regeneration, RIKEN Center for Developmental Biology, Kobe City, Japan.
   The work was supported by Australian National Health Medical Research
   Council grant APP1050692, ARCDP130101384, and the Victorian Government's
   Operational Infrastructure Support Program.
CR Achilleos A, 2012, CELL RES, V22, P288, DOI 10.1038/cr.2012.11
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   Caruso RA, 2001, ADV MATER, V13, P1577, DOI 10.1002/1521-4095(200110)13:20<1577::AID-ADMA1577>3.0.CO;2-S
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2010, ACTA BIOMATER, V6, P4143, DOI 10.1016/j.actbio.2010.04.022
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Chen QZ, 2011, SOFT MATTER, V7, P6484, DOI 10.1039/c1sm05350g
   Chen QZ, 2010, SOFT MATTER, V6, P4715, DOI 10.1039/c0sm00213e
   FESTER A, 1974, CIRCULATION, V50, P609, DOI 10.1161/01.CIR.50.3.609
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Hackett-Jones EJ, 2011, J THEOR BIOL, V287, P148, DOI 10.1016/j.jtbi.2011.07.013
   Hotta R, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01411.x
   Li Y, 2012, RSC ADV, V2, P8229, DOI 10.1039/c2ra20736b
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Liang SL, 2012, POLYM INT, V61, P17, DOI 10.1002/pi.3165
   LU LC, 1999, POLYM DATA HDB, P527
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Malberg S, 2010, J POLYM SCI POL CHEM, V48, P1214, DOI 10.1002/pola.23884
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIRSKY I, 1974, CIRCULATION, V50, P128, DOI 10.1161/01.CIR.50.1.128
   MIRSKY I, 1973, CIRC RES, V33, P233, DOI 10.1161/01.RES.33.2.233
   MIRSKY I, 1976, PROG CARDIOVASC DIS, V18, P277, DOI 10.1016/0033-0620(76)90023-2
   Nishiyama C, 2012, NAT NEUROSCI, V15, P1211, DOI 10.1038/nn.3184
   Ou KL, 2011, EUR POLYM J, V47, P882, DOI 10.1016/j.eurpolymj.2011.02.001
   Ravichandran R, 2011, TISSUE ENG PT A, V17, P1363, DOI [10.1089/ten.tea.2010.0441, 10.1089/ten.TEA.2010.0441]
   Roberts RR, 2007, AM J PHYSIOL-GASTR L, V292, pG930, DOI 10.1152/ajpgi.00444.2006
   Roberts RR, 2010, J PHYSIOL-LONDON, V588, P1153, DOI 10.1113/jphysiol.2009.185421
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Stuckey DJ, 2010, TISSUE ENG PT A, V16, P3395, DOI 10.1089/ten.TEA.2010.0213
   Sun ZJ, 2009, MAT SCI ENG C-BIO S, V29, P178, DOI 10.1016/j.msec.2008.06.010
   Takaoka H, 2002, AM J PHYSIOL-HEART C, V282, pH2190, DOI 10.1152/ajpheart.00759.2001
   Tsuji H, 2006, BIOMACROMOLECULES, V7, P3316, DOI 10.1021/bm060786e
   Veress AI, 2005, J BIOMECH ENG-T ASME, V127, P1195, DOI 10.1115/1.2073677
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
NR 45
TC 22
Z9 25
U1 0
U2 124
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2013
VL 34
IS 27
BP 6306
EP 6317
DI 10.1016/j.biomaterials.2013.05.009
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 178CF
UT WOS:000321421000002
PM 23747009
OA Other Gold
DA 2018-10-20
ER

PT J
AU Lake, J
   Zaniolo, K
   Gaudreault, M
   Carrier, P
   Deschambault, A
   Bazin, R
   Germain, L
   Salesse, C
   Guerin, SL
AF Lake, Jennifer
   Zaniolo, Karine
   Gaudreault, Manon
   Carrier, Patrick
   Deschambault, Alexandre
   Bazin, Richard
   Germain, Lucie
   Salesse, Christian
   Guerin, Sylvain L.
TI Expression of the alpha 5 integrin gene in corneal epithelial cells
   cultured on tissue-engineered human extracellular matrices
SO BIOMATERIALS
LA English
DT Article
DE Transcription factors; Extracellular matrix; Corneal wound healing;
   Integrin; Tissue engineering; Biomaterial substitute
ID TRANSCRIPTION FACTORS SP1; IN-VITRO; UP-REGULATION; RADIAL KERATOTOMY;
   STATISTICAL-MODEL; BASEMENT-MEMBRANE; SUBUNIT GENE; PROMOTER; COLLAGEN;
   FIBRONECTIN
AB The integrin alpha 5 beta 1 plays a major role in corneal wound healing by promoting epithelial cell adhesion and migration over the fibronectin matrix secreted as a cellular response to corneal damage. Expression of alpha 5 is induced when rabbit corneal epithelial cells (RCECs) are grown in the presence of fibronectin. Here, we examined whether alpha 5 expression is similarly altered when RCECs or human corneal epithelial cells (HCECs) are grown on a reconstructed stromal matrix used as an underlying biomaterial. Mass spectrometry and immunofluorescence analyses revealed that the biomaterial matrix produced by culturing human corneal fibroblasts with ascorbic acid (ECM/35d) contains several types of collagens, fibronectin, tenascin and proteoglycans. Results from transfection of CAT/alpha 5-promoter plasmids, Western blot and EMSA analyses indicated that ECM/35d significantly increase expression of alpha 5 in HCECs as a result of alteration in the expression and DNA binding of the transcription factors NFI, Sp1, AP-1 and PAX6. The biological significance of this biomaterial substitute on the expression of the alpha 5 gene may therefore contribute to better understand the function played by the alpha 5 beta 1 integrin during corneal wound healing. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Lake, Jennifer; Zaniolo, Karine; Gaudreault, Manon; Salesse, Christian; Guerin, Sylvain L.] CHU Quebec, Ctr Rech FRQS, CUO Rech, Quebec City, PQ, Canada.
   [Lake, Jennifer; Zaniolo, Karine; Gaudreault, Manon; Carrier, Patrick; Deschambault, Alexandre; Germain, Lucie; Salesse, Christian; Guerin, Sylvain L.] CHU Quebec, Ctr Rech FRQS, Quebec City, PQ, Canada.
   [Lake, Jennifer; Zaniolo, Karine; Gaudreault, Manon; Carrier, Patrick; Deschambault, Alexandre; Germain, Lucie; Salesse, Christian; Guerin, Sylvain L.] Univ Laval, CHU Quebec, Hop St Sacrement, Ctr LOEX, Quebec City, PQ, Canada.
   [Bazin, Richard] CHU Quebec, Ctr Univ Ophtalmol, Hop St Sacrement, Quebec City, PQ, Canada.
   [Bazin, Richard; Salesse, Christian; Guerin, Sylvain L.] Univ Laval, Fac Med, Dept Ophthalmol, Quebec City, PQ G1K 7P4, Canada.
   [Germain, Lucie] Univ Laval, Fac Med, Dept Chirurg, Quebec City, PQ G1K 7P4, Canada.
RP Guerin, SL (reprint author), CHU Quebec, Ctr Rech, Hop St Sacrement, CUO Rech, Quebec City, PQ, Canada.
EM Sylyain.Guerin@fmed.ulayal.ca
FU ' Canadian Institutes of Health Research' (CIHR); Reseau de Recherche en
   Sante de la Vision from the ' Fonds de Recherche du Quebec-Sante' (FRQS)
FX This study was supported by grants from the ' Canadian Institutes of
   Health Research' (CIHR) to C.S. and S.L.G, and to L.G., S.L.G. and
   F.A.A. The Banque d'yeux Nationale is partly supported by the Reseau de
   Recherche en Sante de la Vision from the ' Fonds de Recherche du
   Quebec-Sante' (FRQS). J.L. was supported by a studentship from the CIHR.
   L.G. is the recipient of a Canadian Research Chair on Stem Cell and
   Tissue Engineering.
CR Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Beliveau A, 1999, EUR J BIOCHEM, V261, P585, DOI 10.1046/j.1432-1327.1999.00362.x
   BIRKENMEIER TM, 1991, J BIOL CHEM, V266, P20544
   BOISJOLY HM, 1993, EXP EYE RES, V57, P293, DOI 10.1006/exer.1993.1127
   Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904
   Carrier P, 2009, INVEST OPHTH VIS SCI, V50, P2645, DOI 10.1167/iovs.08-2001
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   Doillon CJ, 2003, INT J ARTIF ORGANS, V26, P764
   Duncan MK, 2000, J CELL SCI, V113, P3173
   Duval C, 2012, J MOL BIOL, V418, P281, DOI 10.1016/j.jmb.2012.01.021
   GARANA RMR, 1992, INVEST OPHTH VIS SCI, V33, P3271
   Gaudreault M, 2003, INVEST OPHTH VIS SCI, V44, P1447, DOI 10.1167/iovs.02-0707
   Gaudreault M, 2008, INVEST OPHTH VIS SCI, V49, P3758, DOI 10.1167/iovs.08-1913
   Gaudreault M, 2007, INVEST OPHTH VIS SCI, V48, P3490, DOI 10.1167/iovs.07-0016
   Germain L, 1999, PATHOBIOLOGY, V67, P140, DOI 10.1159/000028064
   Germain LGC, 2004, ENCY BIOMATERIALS BI, P1534
   Gingras ME, 2009, INVEST OPHTH VIS SCI, V50, P57, DOI 10.1167/iovs.08-2059
   Gingras ME, 2003, INVEST OPHTH VIS SCI, V44, P3742, DOI 10.1167/iovs.03-0191
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Kang SJ, 1999, OPHTHALMOLOGICA, V213, P20, DOI 10.1159/000027388
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kesanakurti D, 2013, ONCOGENE, V32, P327, DOI 10.1038/onc.2012.52
   Larouche K, 2000, J BIOL CHEM, V275, P39182, DOI 10.1074/jbc.M002945200
   LAUWERYNS B, 1991, INVEST OPHTH VIS SCI, V32, P2079
   Liu Y, 2006, EXP EYE RES, V83, P1196, DOI 10.1016/j.exer.2006.06.008
   Ljubimov AV, 1996, INVEST OPHTH VIS SCI, V37, P997
   Ljubimov AV, 1998, EXP EYE RES, V67, P265, DOI 10.1006/exer.1998.0511
   Lu L, 2001, EXP BIOL MED, V226, P653
   Maguen E, 1997, CORNEA, V16, P675
   Maguen E, 2002, CORNEA, V21, P95, DOI 10.1097/00003226-200201000-00020
   MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cb.03.110187.000421
   McCall-Culbreath KD, 2011, J INNATE IMMUN, V3, P459, DOI 10.1159/000324832
   MINAMI Y, 1993, INVEST OPHTH VIS SCI, V34, P2316
   MURAKAMI J, 1992, J LAB CLIN MED, V120, P86
   NAKAYASU K, 1986, OPHTHALMIC RES, V18, P1, DOI 10.1159/000265406
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Nishida T, 1996, Curr Opin Ophthalmol, V7, P2, DOI 10.1097/00055735-199608000-00002
   NISHIDA T, 1990, J CELL PHYSIOL, V145, P549, DOI 10.1002/jcp.1041450323
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Poree B, 2008, J BIOL CHEM, V283, P4850, DOI 10.1074/jbc.M706387200
   POTHIER F, 1992, DNA CELL BIOL, V11, P83, DOI 10.1089/dna.1992.11.83
   Proulx S, 2010, MOL VIS, V16, P2192
   ROY RJ, 1991, BIOTECHNIQUES, V11, P770
   Schneider AI, 1999, IN VITRO CELL DEV-AN, V35, P515
   SCHNEIDER R, 1986, NUCLEIC ACIDS RES, V14, P1303, DOI 10.1093/nar/14.3.1303
   SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173
   Stepp MA, 1997, J HISTOCHEM CYTOCHEM, V45, P189, DOI 10.1177/002215549704500205
   Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010
   Suhr KB, 2003, ARCH DERMATOL RES, V294, P433, DOI 10.1007/s00403-002-0357-4
   Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3
   Tanaka T, 1999, JPN J OPHTHALMOL, V43, P348, DOI 10.1016/S0021-5155(99)00097-0
   Tuori A, 1996, CORNEA, V15, P286, DOI 10.1097/00003226-199605000-00010
   Vigneault F, 2007, PROG RETIN EYE RES, V26, P99, DOI 10.1016/j.preteyeres.2006.10.004
   Vrana NE, 2008, INVEST OPHTH VIS SCI, V49, P5325, DOI 10.1167/iovs.07-1599
   Werner A, 2008, VET OPHTHALMOL, V11, P280, DOI 10.1111/j.1463-5224.2008.00646.x
   Zieske JD, 2001, CURR OPIN OPHTHALMOL, V12, P237, DOI 10.1097/00055735-200108000-00001
   ZIMMERMANN DR, 1986, FEBS LETT, V197, P55, DOI 10.1016/0014-5793(86)80297-6
NR 59
TC 9
Z9 11
U1 2
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2013
VL 34
IS 27
BP 6367
EP 6376
DI 10.1016/j.biomaterials.2013.05.007
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 178CF
UT WOS:000321421000007
PM 23727260
DA 2018-10-20
ER

PT J
AU Galea, L
   Bohner, M
   Thuering, J
   Doebelin, N
   Aneziris, CG
   Graule, T
AF Galea, Laetitia
   Bohner, Marc
   Thuering, Juerg
   Doebelin, Nicola
   Aneziris, Christos G.
   Graule, Thomas
TI Control of the size, shape and composition of highly uniform,
   non-agglomerated, sub-micrometer beta-tricalcium phosphate and dicalcium
   phosphate platelets
SO BIOMATERIALS
LA English
DT Article
DE Calcium phosphate; Monodisperse; Monetite; Growth mechanism;
   Biomaterial; Ethylene glycol-assisted synthesis
ID BONE-GRAFT SUBSTITUTES; HYDROXYAPATITE WHISKERS; HYDROTHERMAL SYNTHESIS;
   CRYSTALLIZATION MECHANISMS; SINGLE-CRYSTAL; NANOCRYSTALS; MORPHOLOGY;
   CALCIUM; NANOCOMPOSITES; BIOCERAMICS
AB Calcium phosphates (Caps) are widely used as bone graft substitutes but are inherently brittle, hence restricting their use to mechanically protected environments. Combining them with a tough polymer matrix could potentially lead to a composite with load-bearing properties. However, the highest mechanical properties can only be achieved if the CaP particles possess very precise features: they should be uniform in size and shape, non-agglomerated, elongated and thin. The aim of the present study therefore was to assess a novel method to produce such particles. This involved the precipitation of CaP particles in ethylene glycol at moderate temperatures (90-170 degrees C) and the variation of different reaction parameters (temperature, concentration, pH, etc) to study their influence on particle composition, size, shape and dispersion was studied. As a result, two main CaP phases were obtained as well-dispersed and highly uniform platelets in the form of: (i) beta-tricalcium phosphate (beta-TCP) hexagonal prisms and (ii) monetite (DCP) flat parallelepipeds. The size dispersion was the narrowest for beta-TCP (standard deviation/mean < 5%) whereas the aspect ratio was the highest for DCP (up to 25). In both cases, the thickness of the platelets was below 300 nm which should be ideal for the synthesis of strong Cap-based composites. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Galea, Laetitia; Bohner, Marc; Thuering, Juerg; Doebelin, Nicola] RMS Fdn, CH-2544 Bettlach, Switzerland.
   [Galea, Laetitia; Aneziris, Christos G.; Graule, Thomas] Tech Univ Bergakad Freiberg, Inst Ceram Glass & Construct Mat, D-09596 Freiberg, Germany.
   [Thuering, Juerg] Swiss Fed Inst Technol, Dept Mat, Lab Multifunct Mat, CH-8093 Zurich, Switzerland.
   [Graule, Thomas] EMPA, Swiss Fed Labs Mat Sci & Technol, Lab High Performance Ceram, CH-8600 Dubendorf, Switzerland.
RP Bohner, M (reprint author), RMS Fdn, Bischmattstr 12, CH-2544 Bettlach, Switzerland.
EM marc.bohner@rms-foundation.ch
RI Bohner, Marc/F-3828-2011; Thuring, Jurg/J-2484-2013
OI Bohner, Marc/0000-0002-5079-3286; Thuring, Jurg/0000-0002-3179-0477
CR Addadi L, 2012, Z KRIST-CRYST MATER, V227, P711, DOI 10.1524/zkri.2012.1524
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barnard A.S., 2010, REP PROG PHYS, V73
   Bohner M, 2003, BIOMATERIALS, V24, P3463, DOI 10.1016/S0142-9612(03)00234-5
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   BOISTELLE R, 1988, J CRYST GROWTH, V90, P14, DOI 10.1016/0022-0248(88)90294-1
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Chenot CF, 1975, USA patent US Patent, Patent No. 3927180
   DICKENS B, 1974, J SOLID STATE CHEM, V10, P232, DOI 10.1016/0022-4596(74)90030-9
   Dickens B., 1971, ACTA CRYSTALLOGR B, V28, P797
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Feldmann C, 2003, ADV FUNCT MATER, V13, P101, DOI 10.1002/adfm.200390014
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   Gibson IR, 2001, J MATER SCI-MATER M, V12, P163, DOI 10.1023/A:1008930313194
   Gopi D, 2011, CURR APPL PHYS, V11, P590, DOI 10.1016/j.cap.2010.10.003
   Griffith A.A., 1920, Philosophical Transactions of the Royal Society of London, V221, P163
   Inukai S, 2001, CHEM ENG RES DES, V79, P901, DOI 10.1205/02638760152721730
   Jana NR, 2004, CHEM MATER, V16, P3931, DOI 10.1021/cm049221k
   JARCHO M, 1979, J MATER SCI, V14, P142, DOI 10.1007/BF01028337
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Jinawath S, 2001, INT J INORG MATER, V3, P997, DOI 10.1016/S1466-6049(01)00199-4
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5
   Knetsch D., 1973, INORG CHIM ACTA, V7, P81
   Kwon SG, 2011, SMALL, V7, P2685, DOI 10.1002/smll.201002022
   LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   LAYROLLE P, 1994, CHEM MATER, V6, P1996, DOI 10.1021/cm00047a019
   Layrolle P, 1996, CHEM MATER, V8, P134, DOI 10.1021/cm950326k
   LeGeros RZ, 2003, KEY ENG MAT, V240-2, P3, DOI 10.4028/www.scientific.net/KEM.240-242.3
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Liang L, 2010, ACTA BIOMATER, V6, P3763, DOI 10.1016/j.actbio.2010.03.033
   McNaught AD, 1997, COMPENDIUM CHEM TERM
   MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025
   Neira IS, 2008, J MATER SCI, V43, P2171, DOI 10.1007/s10853-007-2032-9
   Neira IS, 2009, CRYST GROWTH DES, V9, P466, DOI 10.1021/cg800738a
   Nichols G, 2002, J PHARM SCI, V91, P2103, DOI 10.1002/jps.10191
   Peng XG, 2000, NATURE, V404, P59
   Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176
   REXER J, 1979, POLYM ENG SCI, V19, P1, DOI 10.1002/pen.760190102
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rodriguez-Carvajal J., 2001, COMMISSION POWDER DI, V26, P12
   Rodriguez-Hornedo N, 1999, J PHARM SCI, V88, P651, DOI 10.1021/js980490h
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Tamimi F, 2012, ACTA BIOMATER, V8, P3161, DOI 10.1016/j.actbio.2012.04.025
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Tao AR, 2008, SMALL, V4, P310, DOI 10.1002/smll.200701295
   Tao JH, 2008, CRYST GROWTH DES, V8, P2227, DOI 10.1021/cg700808h
   Tao JH, 2009, CRYST GROWTH DES, V9, P3154, DOI 10.1021/cg801130w
   Thornton C, 1996, J PHYS D APPL PHYS, V29, P424, DOI 10.1088/0022-3727/29/2/021
   VEREECKE G, 1990, J CRYST GROWTH, V104, P820, DOI 10.1016/0022-0248(90)90108-W
   Wang PP, 2010, POWDER TECHNOL, V203, P315, DOI 10.1016/j.powtec.2010.05.023
   Weng W, 1997, J EUR CERAM SOC, V17, P1151, DOI 10.1016/S0955-2219(96)00215-4
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zhang HB, 2009, J PHYS CHEM SOLIDS, V70, P243, DOI 10.1016/j.jpcs.2008.10.011
   Zhang HQ, 2010, ACTA BIOMATER, V6, P3216, DOI 10.1016/j.actbio.2010.02.011
   Zhang HQ, 2010, J EUR CERAM SOC, V30, P2041, DOI 10.1016/j.jeurceramsoc.2010.04.013
   Zhang XF, 2010, ELECTROCHIM ACTA, V55, P2414, DOI 10.1016/j.electacta.2009.12.001
   Zhang Y, 2012, APPL SURF SCI, V258, P2098, DOI 10.1016/j.apsusc.2011.03.151
NR 60
TC 24
Z9 24
U1 5
U2 113
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2013
VL 34
IS 27
BP 6388
EP 6401
DI 10.1016/j.biomaterials.2013.05.026
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 178CF
UT WOS:000321421000009
PM 23755834
DA 2018-10-20
ER

PT J
AU Zhang, Z
   Wu, HP
   Hao, WN
   Bao, YM
   Chai, GZ
AF Zhang, Zheng
   Wu, Huaping
   Hao, Weina
   Bao, Yumei
   Chai, Guozhong
TI A systematic AMF-FEM coupled method for the thermo-elasto-plastic
   contact analysis of the plasma sprayed HA-coated biocomposite
SO INTERNATIONAL JOURNAL OF MECHANICS AND MATERIALS IN DESIGN
LA English
DT Article
DE HA coating; Coupled adaptive meshfree method and finite element method;
   Thermo-elasto-plastic contact; Biocomposite
ID FINITE-ELEMENT; ELASTOPLASTIC CONTACT; ASPERITY CONTACTS; MESHLESS
   METHODS; COMPUTATION; STRESSES
AB Hydroxyapatite (HA) coated Ti-6Al-4V alloy biocomposite has been accepted as one of the most promising implant materials for orthopaedic and dental applications because of its favorable biocompatibility and mechanical properties. After the plasma sprayed HA composite coating on titanium alloy substrate biocomposite was prepared, a novel meshless numerical analysis method of the coupled adaptive meshfree method and finite element method (AMF-FEM) is developed for the simulation of the thermo-elasto-plastic contact problems of the biocomposites in this paper. The adaptive meshfree method based on strain energy gradient is used in the concerned contact domain, and FEM is used in the non-contact domain to overcome the difficulties of the meshfree method and improve the calculation efficiency. The thermo-elasto-plastic contact model using the incremental-initial stiffness method, error estimation and the local adaptive refinement strategy for the AMF-FEM method are combined. The AMF-FEM thermo-elasto-plastic model takes into account the temperature variation, micro plastic flow, the thermo-elasto-plastic coupling behavior and the strain-hardening property of the materials. The examples of the elastic/thermal-elastic contact of real HA-coated rough surfaces using the AMF-FEM is studied for two biomaterial models, respectively. The results all show that the AMF-FEM solutions are accurate, efficient, and can be widely applied to different thermo-elasto-plastic contact multi-layer biomaterial models considering different geometric parameter, material parameter, thermal and friction properties.
C1 [Zhang, Zheng; Wu, Huaping; Hao, Weina; Bao, Yumei; Chai, Guozhong] Zhejiang Univ Technol, Key Lab E&M, Minist Educ & Zhejiang Prov, Hangzhou 310014, Zhejiang, Peoples R China.
RP Zhang, Z (reprint author), Zhejiang Univ Technol, Key Lab E&M, Minist Educ & Zhejiang Prov, Hangzhou 310014, Zhejiang, Peoples R China.
EM zzhangme@zjut.edu.cn
FU National Natural Science Foundation of China [51205355, 11002126];
   Zhejiang Provincial Natural Science Foundation of China [Y1100108,
   Y6100425]; Research Fund for the Doctoral Program of Higher Education of
   China [20123317120003]; Zhejiang University of Technology Foundation for
   Science Research [20100207]
FX The project was supported by the National Natural Science Foundation of
   China (Grant Nos. 51205355, 11002126), Zhejiang Provincial Natural
   Science Foundation of China (Grant Nos. Y1100108, Y6100425), Research
   Fund for the Doctoral Program of Higher Education of China (Grant No.
   20123317120003), and the Zhejiang University of Technology Foundation
   for Science Research (Grant No. 20100207).
CR Belytschko T, 1995, COMPUT MECH, V17, P186
   BELYTSCHKO T, 1994, INT J NUMER METH ENG, V37, P229, DOI 10.1002/nme.1620370205
   Belytschko T, 1996, COMPUT METHOD APPL M, V139, P3, DOI 10.1016/S0045-7825(96)01078-X
   Chou BY, 2002, SURF COAT TECH, V153, P84, DOI 10.1016/S0257-8972(01)01532-8
   Chung HJ, 1998, COMPUT MECH, V21, P91, DOI 10.1007/s004660050286
   Combe UH, 1998, COMPUT METHODS APPL, V162, P203
   Crcan Y., 2001, J THERMAL STRESSES, V24, P1097
   Duarte CA, 1996, COMPUT METHOD APPL M, V139, P237, DOI 10.1016/S0045-7825(96)01085-7
   Eraslan A.N., 2007, INT J THERM SCI, V47, P136
   Eraslan AN, 2002, J THERM STRESSES, V25, P559, DOI 10.1080/01495730290074298
   Espinosa HD, 1998, MECH MATER, V29, P275, DOI 10.1016/S0167-6636(98)00018-0
   Gu YW, 2004, BIOMATERIALS, V25, P3177, DOI 10.1016/j.biomaterials.2003.09.101
   Ju DY, 1999, J MATER PROCESS TECH, V93, P243, DOI 10.1016/S0924-0136(99)00227-7
   Kou XY, 2007, MATER DESIGN, V28, P2549, DOI 10.1016/j.matdes.2006.10.024
   Liu G, 2001, TRIBOL T, V44, P437, DOI 10.1080/10402000108982478
   Liu G, 2000, J TRIBOL-T ASME, V122, P300, DOI 10.1115/1.555357
   Liu GR, 2002, COMPUT METHOD APPL M, V191, P1923, DOI 10.1016/S0045-7825(01)00360-7
   Liu TX, 2006, J TRIBOL-T ASME, V128, P1, DOI 10.1115/1.1843134
   Michael G., 2003, MESHFREE METHODS PAR, P267
   Shi F., 2005, P WORLD TRIB C 3 WTC, P353
   Sladek J, 2005, COMP MATER SCI, V32, P532, DOI 10.1016/j.commatsci.2004.09.011
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Wang Q, 1999, TRIBOL T, V42, P763, DOI 10.1080/10402009908982280
   Wriggers P, 1998, COMPUT METHOD APPL M, V151, P593, DOI 10.1016/S0045-7825(97)00169-2
   Wriggers P., 2002, COMPUTATIONAL CONTAC
   Xiao JR, 2005, ENG ANAL BOUND ELEM, V29, P95, DOI 10.1016/j.enganabound.2004.12.004
   Yu H, 2004, TRIBOL LETT, V17, P155, DOI 10.1023/B:TRIL.0000032440.19767.17
   Zhang Z, 2007, TRIBOL-MATER SURF IN, V1, P87, DOI 10.1179/175158407X231367
   Zhang Z, 2008, INT J COMPUT METHODS, V5, P433, DOI 10.1142/S0219876208001595
NR 29
TC 2
Z9 2
U1 3
U2 36
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1569-1713
J9 INT J MECH MATER DES
JI Int. J. Mech. Mater. Des.
PD SEP
PY 2013
VL 9
IS 3
BP 227
EP 238
DI 10.1007/s10999-012-9211-9
PG 12
WC Engineering, Civil; Engineering, Mechanical; Materials Science,
   Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 192NI
UT WOS:000322491300004
DA 2018-10-20
ER

PT J
AU Deshayes, S
   Kasko, AM
AF Deshayes, Stephanie
   Kasko, Andrea M.
TI Polymeric biomaterials with engineered degradation
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE enzymolysis; hydrolysis; oxidation; photolysis; polymeric biomaterials;
   stimuli-sensitive polymers; degradation; bioengineering
ID RING-OPENING POLYMERIZATION; CONTROLLED DRUG-RELEASE; TYROSINE-DERIVED
   POLYCARBONATES; PHOTOLABILE PROTECTING GROUPS; CRITICAL SOLUTION
   TEMPERATURE; BLOCK-COPOLYMER MICELLES; CYCLIC ORTHOESTER GROUPS;
   UNCAGING CROSS-SECTIONS; NONVIRAL GENE DELIVERY; PH-RESPONSIVE POLYMERS
AB Polymeric biomaterials are widely used as carriers for cells and therapeutic agents. Until recently, most research has been limited to a relatively narrow number of monomers and chemistries. A fundamental challenge in developing clinically relevant polymeric biomaterials is to independently control their chemical and physical properties across multiple scales in both time and space. Control over a biomaterial's chemical and physical properties is critical to recapitulate the complex cascades of signals and complex microenvironments found in nature. Typically, dynamically responsive biomaterials either degrade in the presence of a stimulus (i.e., water induces hydrolysis) or experience a change in solubility on application of the stimulus (i.e., temperature induces gelation via lower critical solution temperature LCST). This highlight discusses recent advances in stimulated and controlled degradation of polymeric biomaterials. The goal of this review is to provide a broad overview of physiologically relevant stimuli used to control the degradation of a wide range of polymeric biomaterials with varying architectures and physical forms. (c) 2013 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2013, 51, 3531-3566
C1 [Deshayes, Stephanie; Kasko, Andrea M.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
RP Kasko, AM (reprint author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
EM akasko@ucla.edu
OI Deshayes, Stephanie/0000-0002-7306-0077
FU National Institutes of Health through the NIH Director's New Innovator
   Award Program [1-DP2-OD008533]
FX The authors gratefully acknowledge financial support from the National
   Institutes of Health through the NIH Director's New Innovator Award
   Program, 1-DP2-OD008533. The authors also acknowledge D.Y. Wong for
   assistance in editing the manuscript.
CR Agarwal S, 2010, MACROMOL CHEM PHYS, V211, P905, DOI 10.1002/macp.200900579
   AGRAWAL CM, 1994, J BIOMED MATER RES, V28, P851, DOI 10.1002/jbm.820280803
   Allen BL, 2011, ACS NANO, V5, P5263, DOI 10.1021/nn201477y
   AMICI A, 1989, J BIOL CHEM, V264, P3341
   AOKI T, 1994, MACROMOLECULES, V27, P947, DOI 10.1021/ma00082a010
   Aujard I, 2006, CHEM-EUR J, V12, P6865, DOI 10.1002/chem.200501393
   Azagarsamy MA, 2012, BIOMACROMOLECULES, V13, P2219, DOI 10.1021/bm300646q
   Bachelder EM, 2008, J AM CHEM SOC, V130, P10494, DOI 10.1021/ja803947s
   Bae Y, 2003, ANGEW CHEM INT EDIT, V42, P4640, DOI 10.1002/anie.200250653
   Bae Y, 2007, BIOCONJUGATE CHEM, V18, P1131, DOI 10.1021/bc060401p
   BAILEY WJ, 1982, MACROMOLECULES, V15, P711, DOI 10.1021/ma00231a006
   BAILEY WJ, 1982, J POLYM SCI POL CHEM, V20, P3021, DOI 10.1002/pol.1982.170201101
   Bar-Cohen Y, 2004, ELECTROACTIVE POLYM
   Bar-Cohen Y., 2007, BIOINSPIR BIOMIM, V2, pE01
   Beaudette TT, 2009, J AM CHEM SOC, V131, P10360, DOI 10.1021/ja903984s
   Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031
   Biddiss E, 2006, MED ENG PHYS, V28, P568, DOI 10.1016/j.medenglpy.2005.09.009
   Binauld S, 2013, CHEM COMMUN, V49, P2082, DOI 10.1039/c2cc36589h
   Bonner DK, 2013, J CONTROL RELEASE, V167, P101, DOI 10.1016/j.jconrel.2012.09.004
   BRETT HWW, 1954, J POLYM SCI, V13, P441, DOI 10.1002/pol.1954.120137103
   Broaders KE, 2011, J AM CHEM SOC, V133, P756, DOI 10.1021/ja110468v
   Broaders KE, 2009, P NATL ACAD SCI USA, V106, P5497, DOI 10.1073/pnas.0901592106
   Carampin P, 2012, MACROMOL CHEM PHYS, V213, P2052, DOI 10.1002/macp.201200264
   Chen J, 2011, BIOMACROMOLECULES, V12, P3601, DOI 10.1021/bm200804j
   Chen W, 2010, J CONTROL RELEASE, V142, P40, DOI 10.1016/j.jconrel.2009.09.023
   Cheng JJ, 2006, PHARM RES, V23, P557, DOI 10.1007/s11095-005-9444-5
   Cho HY, 2011, BIOMACROMOLECULES, V12, P3478, DOI 10.1021/bm2006455
   Choi SK, 2010, CHEM COMMUN, V46, P2632, DOI 10.1039/b927215c
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   Cui LN, 2011, BIOCONJUGATE CHEM, V22, P949, DOI 10.1021/bc100596w
   Dai J, 2011, ANGEW CHEM INT EDIT, V50, P9404, DOI 10.1002/anie.201103806
   Davis FF, 2002, ADV DRUG DELIVER REV, V54, P457, DOI 10.1016/S0169-409X(02)00021-2
   De Geest BG, 2007, SMALL, V3, P804, DOI 10.1002/smll.200600441
   De orest C. A., 2012, ANGEW CHEM INT EDIT, V51, P1816
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DEMANUELE A, 1992, MACROMOLECULES, V25, P511, DOI 10.1021/ma00028a002
   Dewit MA, 2010, J POLYM SCI POL CHEM, V48, P3977, DOI 10.1002/pola.24180
   Ding CX, 2009, BIOCONJUGATE CHEM, V20, P1163, DOI 10.1021/bc800563g
   Docherty-Skogh AC, 2010, PLAST RECONSTR SURG, V125, P1383, DOI 10.1097/PRS.0b013e3181d629dc
   Doh J, 2004, J AM CHEM SOC, V126, P9170, DOI 10.1021/ja048261m
   Du FS, 2010, MACROMOLECULES, V43, P2474, DOI 10.1021/ma902227g
   Du YF, 2012, BIOMATERIALS, V33, P7291, DOI 10.1016/j.biomaterials.2012.06.034
   Eby JK, 2012, ACTA BIOMATER, V8, P3210, DOI 10.1016/j.actbio.2012.06.007
   El-Sherif DM, 2004, J BIOMED MATER RES A, V68A, P71, DOI 10.1002/jbm.a.20032
   El-Sherif DM, 2003, J BIOMED MATER RES A, V66A, P347, DOI 10.1002/jbm.a.10586
   Erdmann L, 2000, BIOMATERIALS, V21, P2507, DOI 10.1016/S0142-9612(00)00118-6
   Erdmann L, 2000, BIOMATERIALS, V21, P1941, DOI 10.1016/S0142-9612(00)00073-9
   Esser-Kahn AP, 2011, MACROMOLECULES, V44, P5539, DOI 10.1021/ma201014n
   Etrych T, 2010, MOL PHARMACEUT, V7, P1015, DOI 10.1021/mp100119f
   Federico C., 2011, BIOINSPIR BIOMIMETIC, V6
   FIELDS RD, 1974, J APPL POLYM SCI, V18, P3571, DOI 10.1002/app.1974.070181207
   FIFE TH, 1965, J ORG CHEM, V30, P1492, DOI 10.1021/jo01016a036
   Fomina N, 2010, J AM CHEM SOC, V132, P9540, DOI 10.1021/ja102595j
   Fu Y, 2010, EXPERT OPIN DRUG DEL, V7, P429, DOI 10.1517/17425241003602259
   Fuhrer R, 2009, SMALL, V5, P383, DOI 10.1002/smll.200801091
   Fujiwara T, 2001, J POLYM SCI POL CHEM, V39, P4249, DOI 10.1002/pola.10080
   Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193
   Gillies ER, 2004, J AM CHEM SOC, V126, P11936, DOI 10.1021/ja0463738
   Griffin DR, 2013, BIOMACROMOLECULES, V14, P1199, DOI 10.1021/bm400169d
   Griffin DR, 2012, ACS MACRO LETT, V1, P1330, DOI 10.1021/mz300366s
   Griffin DR, 2012, J AM CHEM SOC, V134, P13103, DOI 10.1021/ja305280w
   Griffin DR, 2010, BIOTECHNOL BIOENG, V107, P1012, DOI 10.1002/bit.22882
   Gu JX, 2008, BIOMACROMOLECULES, V9, P255, DOI 10.1021/bm701084w
   Guo QY, 2012, BIOMATERIALS, V33, P8040, DOI 10.1016/j.biomaterials.2012.07.013
   Gupta MK, 2012, J CONTROL RELEASE, V162, P591, DOI 10.1016/j.jconrel.2012.07.042
   Hafeman AE, 2011, BIOMATERIALS, V32, P419, DOI 10.1016/j.biomaterials.2010.08.108
   Han DH, 2012, LANGMUIR, V28, P2327, DOI 10.1021/la204930n
   Hawkins AM, 2009, PHARM RES-DORD, V26, P667, DOI 10.1007/s11095-008-9804-z
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   HELLER J, 1980, J POLYM SCI POL LETT, V18, P293, DOI 10.1002/pol.1980.130180410
   Heller J, 2004, BIOMACROMOLECULES, V5, P1625, DOI 10.1021/bm040049n
   Heller J, 2002, ADV DRUG DELIVER REV, V54, P1015, DOI 10.1016/S0169-409X(02)00055-8
   Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   HORNE RA, 1971, J COLLOID INTERF SCI, V35, P77, DOI 10.1016/0021-9797(71)90187-1
   Hruby M, 2005, J CONTROL RELEASE, V103, P137, DOI 10.1016/j.jconrel.2004.11.017
   Hruby M, 2007, J CONTROL RELEASE, V119, P25, DOI 10.1016/j.jconrel.2007.02.009
   Hu FQ, 2012, MOL PHARMACEUT, V9, P2469, DOI 10.1021/mp300002v
   Hu FQ, 2009, BIOMATERIALS, V30, P6955, DOI 10.1016/j.biomaterials.2009.09.008
   Hu P, 2011, REACT FUNCT POLYM, V71, P303, DOI 10.1016/j.reactfunctpolym.2010.10.010
   Hu SH, 2008, LANGMUIR, V24, P11811, DOI 10.1021/la801138e
   Hu SH, 2011, CHEM COMMUN, V47, P1776, DOI 10.1039/c0cc03998e
   Huang XN, 2007, MACROMOL RAPID COMM, V28, P597, DOI 10.1002/marc.200600798
   Huang XN, 2009, MACROMOLECULES, V42, P783, DOI 10.1021/ma802138r
   Husseini GA, 2005, J CONTROL RELEASE, V107, P253, DOI 10.1016/j.jconrel.2005.06.015
   Husseini GA, 2008, ADV DRUG DELIVER REV, V60, P1137, DOI 10.1016/j.addr.2008.03.008
   Husseini GA, 2007, J NANOSCI NANOTECHNO, V7, P1028, DOI 10.1166/jnn.2007.218
   Husseini GA, 2007, TECHNOL CANCER RES T, V6, P49, DOI 10.1177/153303460700600107
   Husseini GA, 2009, J CONTROL RELEASE, V138, P45, DOI 10.1016/j.jconrel.2009.04.018
   Husseini GA, 2009, J PHARM SCI-US, V98, P795, DOI 10.1002/jps.21444
   Idziak I, 1999, MACROMOLECULES, V32, P1260, DOI 10.1021/ma981171f
   Jain R, 2007, MACROMOLECULES, V40, P452, DOI 10.1021/ma062319v
   Jang WD, 2009, PROG POLYM SCI, V34, P1, DOI 10.1016/j.progpolymsci.2008.08.003
   Jeong MJ, 2002, J POLYM SCI POL CHEM, V40, P4493, DOI 10.1002/pola.10537
   Jia YH, 2012, INT J NANOMED, V7, P1697, DOI 10.2147/IJN.S28629
   Jiang XL, 2011, MACROMOL CHEM PHYS, V212, P64, DOI 10.1002/macp.201000448
   Johnson JA, 2007, MACROMOLECULES, V40, P3589, DOI 10.1021/ma062862b
   Johnson JA, 2010, MACROMOLECULES, V43, P10326, DOI 10.1021/ma1021506
   Kale AA, 2007, BIOCONJUGATE CHEM, V18, P363, DOI 10.1021/bc060228x
   Kang HC, 2011, BIOMATERIALS, V32, P1193, DOI 10.1016/j.biomaterials.2010.08.079
   KATONO H, 1991, J CONTROL RELEASE, V16, P215, DOI 10.1016/0168-3659(91)90045-F
   Katz JS, 2010, MACROMOL BIOSCI, V10, P339, DOI 10.1002/mabi.200900297
   Kauffman KJ, 2012, ACS APPL MATER INTER, V4, P4149, DOI 10.1021/am3008888
   Khutoryanskiy VV, 2008, PURE APPL CHEM, V80, P1703, DOI 10.1351/pac200880081703
   Kim H, 2003, BIOMATERIALS, V24, P4671, DOI 10.1016/S0142-9612(03)00358-2
   Kim H. C., 2006, J BIOMED OPT, P11
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Kim YH, 2005, J CONTROL RELEASE, V103, P209, DOI 10.1016/j.jconrel.2004.11.008
   Kirschner CM, 2013, SMALL, V9, P578, DOI 10.1002/smll.201201841
   Kloxin AM, 2012, INTEGR BIOL-UK, V4, P1540, DOI 10.1039/c2ib20212c
   Kloxin AM, 2010, ADV MATER, V22, P61, DOI 10.1002/adma.200900917
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Knorr V, 2008, BIOCONJUGATE CHEM, V19, P1625, DOI 10.1021/bc8001858
   Knorr V, 2008, PHARM RES-DORDR, V25, P2937, DOI 10.1007/s11095-008-9700-6
   KODA S, 1994, POLYMER, V35, P30, DOI 10.1016/0032-3861(94)90045-0
   KOST J, 1988, MAKROMOL CHEM-M SYMP, V19, P275, DOI 10.1002/masy.19880190122
   KOST J, 1989, P NATL ACAD SCI USA, V86, P7663, DOI 10.1073/pnas.86.20.7663
   Kostkova H, 2011, J BIOACT COMPAT POL, V26, P270, DOI 10.1177/0883911511406326
   Kulkarni RV, 2007, J APPL BIOMATER BIOM, V5, P125
   KWON IC, 1994, J CONTROL RELEASE, V30, P155, DOI 10.1016/0168-3659(94)90262-3
   KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0
   Lavon I, 1998, J CONTROL RELEASE, V54, P1, DOI 10.1016/S0168-3659(97)00112-0
   Lee CC, 2006, P NATL ACAD SCI USA, V103, P16649, DOI 10.1073/pnas.0607705103
   LEONG KW, 1986, BIOMATERIALS, V7, P364, DOI 10.1016/0142-9612(86)90007-4
   Li WJ, 2005, J GENE MED, V7, P67, DOI 10.1002/jgm.634
   Li YW, 2010, CHEM COMMUN, V46, P7739, DOI 10.1039/c0cc02628j
   Li YL, 2009, ANGEW CHEM INT EDIT, V48, P9914, DOI 10.1002/anie.200904260
   Li YP, 2011, BIOMATERIALS, V32, P6633, DOI 10.1016/j.biomaterials.2011.05.050
   Li YH, 2013, ADV FUNCT MATER, V23, P660, DOI 10.1002/adfm.201201708
   Lin YL, 2010, BIOMATERIALS, V31, P7150, DOI 10.1016/j.biomaterials.2010.05.048
   Liu G, 2012, BIOMACROMOLECULES, V13, P1573, DOI 10.1021/bm300304t
   Liu JY, 2011, BIOMACROMOLECULES, V12, P1567, DOI 10.1021/bm200275j
   LIU LS, 1992, MACROMOLECULES, V25, P123, DOI 10.1021/ma00027a020
   Liu TY, 2009, NANO TODAY, V4, P52, DOI 10.1016/j.nantod.2008.10.011
   Liu TY, 2009, ADV FUNCT MATER, V19, P616, DOI 10.1002/adfm.200801304
   LoPresti C, 2009, J MATER CHEM, V19, P3576, DOI 10.1039/b818869f
   Lu JS, 2010, POLYMER, V51, P1709, DOI 10.1016/j.polymer.2009.12.034
   Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005
   Lu ZH, 2005, LANGMUIR, V21, P2042, DOI 10.1021/la047629q
   Lundberg P, 2012, ACS MACRO LETT, V1, P1240, DOI 10.1021/mz300477t
   Lux CD, 2012, J AM CHEM SOC, V134, P15758, DOI 10.1021/ja303372u
   Madras G, 2001, AICHE J, V47, P2341, DOI 10.1002/aic.690471018
   Magno MHR, 2010, J MATER CHEM, V20, P8885, DOI 10.1039/c0jm00868k
   Mahmoud EA, 2011, BIOCONJUGATE CHEM, V22, P1416, DOI 10.1021/bc200141h
   Maji S, 2011, MACROMOL CHEM PHYS, V212, P2573, DOI 10.1002/macp.201100375
   MALHOTRA SL, 1982, J MACROMOL SCI CHEM, VA18, P455, DOI 10.1080/00222338208056515
   Martinez-Sanz E, 2011, J CONTROL RELEASE, V152, P232, DOI 10.1016/j.jconrel.2011.02.003
   McBane JE, 2007, J BIOMED MATER RES A, V82A, P984, DOI 10.1002/jbm.a.31263
   Meng FH, 2009, BIOMATERIALS, V30, P2180, DOI 10.1016/j.biomaterials.2009.01.026
   Meng H, 2010, J INTEL MAT SYST STR, V21, P859, DOI 10.1177/1045389X10369718
   Mercanzini A, 2010, J CONTROL RELEASE, V145, P196, DOI 10.1016/j.jconrel.2010.04.025
   Mikheeva LM, 1997, MACROMOLECULES, V30, P2693, DOI 10.1021/ma9615112
   Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.mythe.2005.02.010
   Murdan S, 2003, J CONTROL RELEASE, V92, P1, DOI 10.1016/S0168-3659(03)00303-1
   Murthy N, 2003, BIOCONJUGATE CHEM, V14, P412, DOI 10.1021/bc020056d
   Murthy N, 2003, J CONTROL RELEASE, V89, P365, DOI 10.1016/S0168-3659(03)00099-3
   Murthy N, 2002, J AM CHEM SOC, V124, P12398, DOI 10.1021/ja026925r
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081
   Napoli A, 2004, LANGMUIR, V20, P3487, DOI 10.1021/la0357054
   Narayanan RP, 2012, BIOMACROMOLECULES, V13, P2465, DOI 10.1021/bm300707a
   Neradovic D, 2004, BIOMATERIALS, V25, P2409, DOI 10.1016/j.biomaterials.2003.09.024
   Neradovic D, 2003, MACROMOLECULES, V36, P7491, DOI 10.1021/ma034381n
   Ouimet MA, 2013, BIOMACROMOLECULES, V14, P854, DOI 10.1021/bm3018998
   Park JH, 2006, COLLOID POLYM SCI, V284, P763, DOI 10.1007/s00396-005-1438-7
   Patterson J, 2011, BIOMATERIALS, V32, P1301, DOI 10.1016/j.biomaterials.2010.10.016
   Paulino AT, 2012, CARBOHYD POLYM, V90, P1216, DOI 10.1016/j.carbpol.2012.06.051
   Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8
   Pernaut JM, 2000, J PHYS CHEM B, V104, P4080, DOI 10.1021/jp994274o
   Peterson GI, 2012, MACROMOLECULES, V45, P7317, DOI 10.1021/ma300817v
   Pileni MP, 2001, ADV FUNCT MATER, V11, P323, DOI 10.1002/1616-3028(200110)11:5<323::AID-ADFM323>3.0.CO;2-J
   Prabaharan M, 2009, BIOMATERIALS, V30, P5757, DOI 10.1016/j.biomaterials.2009.07.020
   Prudencio A, 2009, MACROMOL RAPID COMM, V30, P1101, DOI 10.1002/marc.200900059
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Qiao ZY, 2010, MACROMOLECULES, V43, P6485, DOI 10.1021/ma101090g
   Qin SH, 2006, ADV MATER, V18, P2905, DOI 10.1002/adma.200601019
   Rapoport N, 2012, INT J HYPERTHER, V28, P374, DOI 10.3109/02656736.2012.665567
   Reddy NN, 2011, J APPL POLYM SCI, V122, P1364, DOI 10.1002/app.34016
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Rehor A, 2005, LANGMUIR, V21, P411, DOI 10.1021/la0478043
   Rehor A, 2005, J MATER CHEM, V15, P4006, DOI 10.1039/b510998a
   Rehor A, 2008, BIOMATERIALS, V29, P1958, DOI 10.1016/j.biomaterials.2007.12.035
   Reid M, 2001, CURR OPIN CLIN NUTR, V4, P65, DOI 10.1097/00075197-200101000-00012
   Ren TB, 2011, SOFT MATTER, V7, P11547
   Riachi C, 2009, MACROMOLECULES, V42, P8076, DOI 10.1021/ma901537x
   Rosario-Melendez R, 2012, J CONTROL RELEASE, V162, P538, DOI 10.1016/j.jconrel.2012.07.033
   Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0
   Sarig-Nadir O, 2009, BIOPHYS J, V96, P4743, DOI 10.1016/j.bpj.2009.03.019
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Schmitt E. E., 1967, U. S. Patent, Patent No. [3,297,033, 3297033]
   Sedlacek O, 2012, BIOORGAN MED CHEM, V20, P4056, DOI 10.1016/j.bmc.2012.05.007
   Sershen S, 2002, ADV DRUG DELIVER REV, V54, P1225, DOI 10.1016/S0169-409X(02)00090-X
   Seuring J, 2012, MACROMOL RAPID COMM, V33, P1898, DOI 10.1002/marc.201200433
   Shamis M, 2004, J AM CHEM SOC, V126, P1726, DOI 10.1021/ja039052p
   Shchukin DG, 2006, LANGMUIR, V22, P7400, DOI 10.1021/la061047m
   SHEN WC, 1981, BIOCHEM BIOPH RES CO, V102, P1048, DOI 10.1016/0006-291X(81)91644-2
   Shim MS, 2009, BIOCONJUGATE CHEM, V20, P488, DOI 10.1021/bc800436v
   Singh A, 2013, ACS MACRO LETT, V2, P269, DOI 10.1021/mz300591m
   Son S, 2010, BIOMATERIALS, V31, P6344, DOI 10.1016/j.biomaterials.2010.04.047
   Son YJ, 2003, J CONTROL RELEASE, V91, P135, DOI 10.1016/S0168-3659(03)00231-1
   Sun HL, 2010, BIOMACROMOLECULES, V11, P848, DOI 10.1021/bm1001069
   Sun HL, 2009, BIOMATERIALS, V30, P6358, DOI 10.1016/j.biomaterials.2009.07.051
   Sun SY, 2012, ACS MACRO LETT, V1, P1184, DOI 10.1021/mz3002947
   Szabo D, 1998, MACROMOLECULES, V31, P6541, DOI 10.1021/ma980284w
   Tang RP, 2011, POLYMER, V52, P921, DOI 10.1016/j.polymer.2010.12.057
   TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tokatlian T, 2010, BIOMATERIALS, V31, P8072, DOI 10.1016/j.biomaterials.2010.07.030
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   Tomatsu I, 2011, ADV DRUG DELIVER REV, V63, P1257, DOI 10.1016/j.addr.2011.06.009
   Tomlinson R, 2003, BIOCONJUGATE CHEM, V14, P1096, DOI 10.1021/bc030028a
   Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0
   Trenor SR, 2004, MACROMOL CHEM PHYSIC, V205, P715, DOI 10.1002/macp.200300168
   Tu L, 2013, IEEE T MAGN, V49, P227, DOI 10.1109/TMAG.2012.2224853
   Uhrich K., 2008, United States Patent Office, Patent No. 7396527
   Ulijn RV, 2006, J MATER CHEM, V16, P2217, DOI 10.1039/b601776m
   Undin J, 2012, POLYM CHEM-UK, V3, P1260, DOI 10.1039/c2py20034a
   Van Durme K, 2004, MACROMOLECULES, V37, P1054, DOI 10.1021/ma035319t
   Varghese OP, 2010, MACROMOL RAPID COMM, V31, P1175, DOI 10.1002/marc.200900906
   Varghese OP, 2009, J AM CHEM SOC, V131, P8781, DOI 10.1021/ja902857b
   Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011
   Vicent MJ, 2004, J DRUG TARGET, V12, P491, DOI 10.1080/10611860400011885
   de Paz MV, 2010, BIOMACROMOLECULES, V11, P269, DOI 10.1021/bm9011216
   Walker GF, 2005, MOL THER, V11, P418, DOI 10.1016/j.ymthe.2004.11.006
   Wang L, 2007, MACROMOL BIOSCI, V7, P987, DOI 10.1002/mabi.200700109
   Wang YC, 2011, BIOCONJUGATE CHEM, V22, P1939, DOI 10.1021/bc200139n
   Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215
   Wei H, 2009, PROG POLYM SCI, V34, P893, DOI 10.1016/j.progpolymsci.2009.05.002
   Wen HY, 2011, CHEM COMMUN, V47, P3550, DOI 10.1039/c0cc04983b
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wich PR, 2012, AUST J CHEM, V65, P15, DOI 10.1071/CH11370
   Wilson DS, 2010, NAT MATER, V9, P923, DOI [10.1038/NMAT2859, 10.1038/nmat2859]
   Wong DY, 2010, MACROMOLECULES, V43, P2824, DOI 10.1021/ma9023679
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
   Wu YL, 2012, J CONTROL RELEASE, V164, P338, DOI 10.1016/j.jconrel.2012.07.011
   Wylie RG, 2008, J MATER CHEM, V18, P2716, DOI 10.1039/b718431j
   Xuan JA, 2011, MACROMOL CHEM PHYS, V212, P498, DOI 10.1002/macp.201000624
   Yoo HS, 2002, J CONTROL RELEASE, V82, P17, DOI 10.1016/S0168-3659(02)00088-3
   Yoo MK, 2000, POLYMER, V41, P5713, DOI 10.1016/S0032-3861(99)00779-X
   Yow HN, 2006, SOFT MATTER, V2, P940, DOI 10.1039/b606965g
   Yu C, 1999, BIOMATERIALS, V20, P265, DOI 10.1016/S0142-9612(98)00170-7
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
   Yu SS, 2011, BIOMACROMOLECULES, V12, P4357, DOI 10.1021/bm201328k
   Yuan L, 2012, J POLYM SCI POL CHEM, V50, P4579, DOI 10.1002/pola.26273
   Yuan QA, 2010, BIOMACROMOLECULES, V11, P1940, DOI 10.1021/bm100589g
   Zhang HJ, 2009, J CONTROL RELEASE, V139, P31, DOI 10.1016/j.jconrel.2009.05.037
   Zhang WQ, 2005, MACROMOLECULES, V38, P5743, DOI 10.1021/ma0509199
   Zhang Y, 2012, POLYM CHEM-UK, V3, P2752, DOI 10.1039/c2py20403g
   Zhao H, 2012, MACROMOLECULES, V45, P1723, DOI 10.1021/ma201924h
   Zhao YR, 2004, J AM CHEM SOC, V126, P4653, DOI 10.1021/ja036958m
   Zhao Y, 2012, MACROMOLECULES, V45, P3647, DOI 10.1021/ma300094t
   Zheng YJ, 2002, MACROMOLECULES, V35, P5228, DOI 10.1021/ma012263z
   Zhou L, 2011, BIOMACROMOLECULES, V12, P1460, DOI 10.1021/bm101340u
   Zhou LJ, 2012, BIOMATERIALS, V33, P2734, DOI 10.1016/j.biomaterials.2011.11.009
   Zhu SJ, 2010, BIOMATERIALS, V31, P1360, DOI 10.1016/j.biomaterials.2009.10.044
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
   Zrinyi M, 2000, COLLOID POLYM SCI, V278, P98, DOI 10.1007/s003960050017
NR 259
TC 38
Z9 38
U1 3
U2 154
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-624X
EI 1099-0518
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD SEP 1
PY 2013
VL 51
IS 17
BP 3531
EP 3566
DI 10.1002/pola.26765
PG 36
WC Polymer Science
SC Polymer Science
GA 185ZO
UT WOS:000322010800001
OA Bronze
DA 2018-10-20
ER

PT J
AU Thrivikraman, G
   Mallik, PK
   Basu, B
AF Thrivikraman, Greeshma
   Mallik, Prafulla K.
   Basu, Bikramjit
TI Substrate conductivity dependent modulation of cell proliferation and
   differentiation in vitro
SO BIOMATERIALS
LA English
DT Article
DE Substrate conductivity; Cell proliferation and differentiation; Myoblast
   and myotube alignment; Biomaterial; Cell and myotube density
ID MUSCLE-CELLS; MYOGENESIS; MYOTUBES; MYOBLASTS; BEHAVIOR; CONTRACTILE;
   EXPRESSION; SURFACES; ADHESION; FUSION
AB In designing and developing various biomaterials, the influence of substrate properties, like surface topography, stiffness and wettability on the cell functionality has been investigated widely. However, such study to probe into the influence of the substrate conductivity on cell fate processes is rather limited. In order to address this issue, spark plasma sintered HA-CaTiO3 (Hydroxyapatite-Calcium titanate) has been used as a model material system to showcase the effect of varying conductivity on cell functionality. Being electroactive in nature, mouse myoblast cells (C2C12) were selected as a model cell line in this study. It was inferred that myoblast adhesion/growth systematically increases with substrate conductivity due to CaTiO3 addition to HA. Importantly, parallel arrangement of myoblast cells on higher CaTiO3 containing substrates indicate that self-adjustable cell patterning can be achieved on conductive biomaterials. Furthermore, enhanced myoblast assembly and myotube formation were recorded after 5 days of serum starvation. Overall, the present study conclusively establishes the positive impact of the substrate conductivity towards cell proliferation and differentiation as well as confirms the efficacy of HA-CaTiO3 biocomposites as conductive platforms to facilitate the growth, orientation and fusion of myoblasts, even when cultured in the absence of external electric field. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Thrivikraman, Greeshma; Mallik, Prafulla K.; Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
   [Thrivikraman, Greeshma] Indian Inst Sci, Ctr Nano Sci & Engn, Bangalore 560012, Karnataka, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
OI T, Greeshma/0000-0002-0870-5369
FU Department of Science & Technology (DST); Department of Biotechnology
   (DBT), Government of India
FX The authors would like to thank Department of Science & Technology (DST)
   and Department of Biotechnology (DBT), Government of India for the
   financial support. The authors are also grateful to Dr. Girish Kunte,
   Suma, Venkatesh (MNCF facility, CeNSE, BSc) and Srinivas (AFM facility,
   MRC, IISc) for their assistance in using the research facilities.
CR Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657
   Basu B, 2009, ADV BIOMATERIALS FUN
   Baxter FR, 2010, ANN BIOMED ENG, V38, P2079, DOI 10.1007/s10439-010-9977-6
   Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627
   Burattini S, 2004, EUR J HISTOCHEM, V48, P223
   Cooper ST, 2004, CELL MOTIL CYTOSKEL, V58, P200, DOI 10.1002/cm.20010
   Coreno J, 2005, J BIOMED MATER RES A, V75A, P478, DOI 10.1002/jbm.a.30447
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Griffin MA, 2004, J CELL SCI, V117, P5855, DOI 10.1242/jcs.01496
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Itoh S, 2006, CALCIFIED TISSUE INT, V78, P133, DOI 10.1007/s00223-005-0213-6
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   Kang JS, 2010, CURR OPIN CLIN NUTR, V13, P243, DOI 10.1097/MCO.0b013e328336ea98
   KITCHEN S, 2002, ELECTROTHERAPY EVIDE
   Magnani A, 2003, MAT SCI ENG C-BIO S, V23, P315, DOI 10.1016/S0928-4931(02)00284-9
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   McCaig CD, 1997, BIOESSAYS, V19, P819, DOI 10.1002/bies.950190912
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   McKeon-Fischer KD, 2012, NANO LIFE, V2, DOI 10.1142/S1793984412300117
   Nuccitelli R, 2003, RADIAT PROT DOSIM, V106, P375, DOI 10.1093/oxfordjournals.rpd.a006375
   OZAWA E, 1972, BIOL BULL, V143, P431, DOI 10.2307/1540064
   Poltawski L, 2009, PHYS THER REV, V14, P104, DOI 10.1179/174328809X405973
   Ricotti L, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035010
   Rowlands AS, 2008, BIOMATERIALS, V29, P4510, DOI 10.1016/j.biomaterials.2008.07.052
   Sadleir Rosalind J, 2012, Front Psychiatry, V3, P90, DOI 10.3389/fpsyt.2012.00090
   Santos Maria Helena, 2004, Mat. Res., V7, P625, DOI 10.1590/S1516-14392004000400017
   SASTRE A, 1976, P NATL ACAD SCI USA, V73, P1355, DOI 10.1073/pnas.73.4.1355
   Shimizu K, 2009, BIOTECHNOL BIOENG, V103, P631, DOI 10.1002/bit.22268
   SINGH S, 1984, CLIN ORTHOP RELAT R, P249
   Sun JS, 1997, J BIOMED MATER RES, V34, P227, DOI 10.1002/(SICI)1097-4636(199702)34:2<227::AID-JBM12>3.0.CO;2-F
   WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7
NR 34
TC 34
Z9 34
U1 3
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2013
VL 34
IS 29
BP 7073
EP 7085
DI 10.1016/j.biomaterials.2013.05.076
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 186OA
UT WOS:000322052700006
PM 23796580
DA 2018-10-20
ER

PT J
AU Long, TJ
   Takeno, M
   Sprenger, CC
   Plymate, SR
   Ratner, BD
AF Long, Thomas J.
   Takeno, Marc
   Sprenger, Cynthia C.
   Plymate, Stephen R.
   Ratner, Buddy D.
TI Capillary Force Seeding of Sphere-Templated Hydrogels for
   Tissue-Engineered Prostate Cancer Xenografts
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID SCAFFOLDS; PROLIFERATION
AB Biomaterial-based tissue-engineered tumor models are now widely used in cancer biology studies. However, specific methods for efficient and reliable cell seeding into these and tissue-engineering constructs used for regenerative medicine often remain poorly defined. Here, we describe a capillary force-based method for seeding the human prostate cancer cell lines M12 and LNCaP C4-2 into sphere-templated poly(2-hydroxyethyl methacrylate) hydrogels. The capillary force seeding method improved the cell number and distribution within the porous scaffolds compared to well-established protocols such as static and centrifugation seeding. Seeding efficiency was found to be strongly dependent on the rounded cell diameter relative to the pore diameter and pore interconnect size, parameters that can be controllably modulated during scaffold fabrication. Cell seeding efficiency was evaluated quantitatively using a PicoGreen DNA assay, which demonstrated some variation in cell retention using the capillary force method. When cultured within the porous hydrogels, both cell lines attached and proliferated within the network, but histology showed the formation of a necrotic zone by 7 days likely due to oxygen and nutrient diffusional limitations. The necrotic zone thickness was decreased by dynamically culturing cells in an orbital shaker. Proliferation analysis showed that despite a variable seeding efficiency, by 7 days in culture, scaffolds contained a roughly consistent number of cells as they proliferated to fill the pores of the scaffold. These studies demonstrate that sphere-templated polymeric scaffolds have the potential to serve as an adaptable cell culture substrate for engineering a three-dimensional prostate cancer model.
C1 [Long, Thomas J.; Takeno, Marc; Ratner, Buddy D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Sprenger, Cynthia C.; Plymate, Stephen R.] Univ Washington, Dept Med, Seattle, WA 98195 USA.
   [Plymate, Stephen R.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA.
RP Ratner, BD (reprint author), Univ Washington, Dept Bioengn, Box 355061,3720 15th Ave NE, Seattle, WA 98195 USA.
EM ratner@uweb.engr.washington.edu
FU Nanotechnology and Physical Science in Cancer Research Training Program
   NIH [T32CA138312, TMEN-U54CA126540, PO1 CA085859]; Veterans Affairs
   Research Service
FX This work was supported by the Nanotechnology and Physical Science in
   Cancer Research Training Program NIH T32CA138312 (T.J.L. and B. D. R.),
   TMEN-U54CA126540 (S. R. P.), PO1 CA085859 (S. R. P.), and the Veterans
   Affairs Research Service (S.R.P.).
CR American Cancer Society, 2012, DET GUID PROST CANC
   [Anonymous], 2011, [No title captured], Patent No. [US 20110256628, 20110256628]
   Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G
   Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI [10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676]
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Ewald AJ, 2002, DEV DYNAM, V225, P369, DOI 10.1002/dvdy.10169
   Galperin A, 2010, BIOMACROMOLECULES, V11, P2583, DOI 10.1021/bm100521x
   Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI [10.1089/ten.tea.2010.0135, 10.1089/ten.TEA.2010.0135]
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619
   Isenhath SN, 2007, J BIOMED MATER RES A, V83A, P915, DOI 10.1002/jbm.a.31391
   Kievit FM, 2010, BIOMATERIALS, V31, P5903, DOI 10.1016/j.biomaterials.2010.03.062
   Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470
   Li Y, 2001, BIOTECHNOL PROGR, V17, P935, DOI 10.1021/bp0100878
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Marshall A. J., 2004, ACS POLYM PREPR, V45, P100
   Ng KW, 2005, TISSUE ENG, V11, P182, DOI 10.1089/ten.2005.11.182
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Shanbhag S, 2005, SMALL, V1, P1208, DOI 10.1002/smll.200500191
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002
   Tan PHS, 2011, BIOMATERIALS, V32, P6131, DOI 10.1016/j.biomaterials.2011.04.084
NR 22
TC 7
Z9 7
U1 1
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD SEP
PY 2013
VL 19
IS 9
BP 738
EP 744
DI 10.1089/ten.tec.2012.0388
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 187KS
UT WOS:000322117900008
PM 23373788
OA Green Published
DA 2018-10-20
ER

PT J
AU Povlich, LK
   Cho, JC
   Leach, MK
   Corey, JM
   Kim, J
   Martin, DC
AF Povlich, Laura K.
   Cho, Jae Cheol
   Leach, Michelle K.
   Corey, Joseph M.
   Kim, Jinsang
   Martin, David C.
TI Synthesis, copolymerization and peptide-modification of carboxylic
   acid-functionalized 3,4-ethylenedioxythiophene (EDOTacid) for neural
   electrode interfaces
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Conjugated polymer; Electrochemical; Biomaterial; RGD; Neuron; Adhesion
ID CONDUCTING POLYMER; IN-VITRO; SURFACES; BIOCOMPATIBILITY; FIBRONECTIN;
   SCAFFOLDS; DENSITY
AB Background: Conjugated polymers have been developed as effective materials for interfacing prosthetic device electrodes with neural tissue. Recent focus has been on the development of conjugated polymers that contain biological components in order to improve the tissue response upon implantation of these electrodes.
   Methods: Carboxylic acid-functionalized 3,4-ethylenedioxythiophene (EDOTacid) monomer was synthesized in order to covalently bind peptides to the surface of conjugated polymer films. EDOTacid was copolymerized with EDOT monomer to form stable, electrically conductive copolymer films referred to as PEDOT-PEDOTacid. The peptide GGGGRGDS was bound to PEDOT-PEDOTacid to create peptide functionalized PEDOT films.
   Results: The PEDOT-PEDOTacid-peptide films increased the adhesion of primary rat motor neurons between 3 and 9 times higher than controls, thus demonstrating that the peptide maintained its biological activity.
   Conclusions: The EDOT-acid monomer can be used to create functionalized PEDOT-PEDOTacid copolymer films that can have controlled bioactivity.
   General Significance: PEDOT-PEDOTacid-peptide films have the potential to control the behavior of neurons and vastly improve the performance of implanted electrodes. This article is part of a Special Issue entitled Organic Bioelectronics Novel Applications in Biomedicine. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Povlich, Laura K.; Kim, Jinsang] Univ Michigan, Macromol Sci & Engn Ctr, Ann Arbor, MI 48109 USA.
   [Cho, Jae Cheol; Kim, Jinsang] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Leach, Michelle K.; Corey, Joseph M.; Kim, Jinsang] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Corey, Joseph M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.
   [Corey, Joseph M.] Vet Affairs Ann Arbor Healthcare Ctr, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI 48105 USA.
   [Kim, Jinsang] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Povlich, Laura K.; Martin, David C.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   [Martin, David C.] Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA.
RP Kim, J (reprint author), Univ Michigan, Macromol Sci & Engn Ctr, Ann Arbor, MI 48109 USA.
EM jinsang@umich.edu; milty@udel.edu
RI Martin, David/B-1838-2008; Kim, Jinsang/G-3928-2011
OI Martin, David/0000-0003-1195-3838; Kim, Jinsang/0000-0002-1235-3327
FU Army MURI on Bio-Integrating Structural and Neural Prosthetic Materials
   [W911NF-06-1-0218]; NSF DMR [0644864]
FX The authors thank Dr. Robert Opila, Fang Fang and Dan Yang for their
   assistance with XPS and Kathleen Feldman for helpful discussions
   regarding this work. This research was supported by the Army MURI on
   Bio-Integrating Structural and Neural Prosthetic Materials
   (W911NF-06-1-0218) and NSF DMR (Career 0644864). DCM is a co-founder and
   Chief Scientific Officer for Biotectix, a University of Michigan
   spin-off company that is actively working to develop polymer coatings
   for electronic biomedical devices.
CR Albericio F, 1998, J ORG CHEM, V63, P9678, DOI 10.1021/jo980807y
   Ali EM, 2007, MACROMOLECULES, V40, P6025, DOI 10.1021/ma0708949
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Azemi E, 2008, ACTA BIOMATER, V4, P1208, DOI 10.1016/j.actbio.2008.02.028
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Kim J., 2010, US Patent, Patent No. [7,708,908, 7708908]
   Leach M. K., 2011, J VIS EXP, V48
   Lee JW, 2006, LANGMUIR, V22, P9816, DOI 10.1021/la062129d
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   PIERSCHBACHER MD, 1985, J CELL BIOCHEM, V28, P115, DOI 10.1002/jcb.240280205
   Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   STENGER DA, 1993, BRAIN RES, V630, P136, DOI 10.1016/0006-8993(93)90651-3
   Yang JY, 2006, J MATER RES, V21, P1124, DOI 10.1557/JMR.2006.0145
   Zhang ZP, 2005, BIOMATERIALS, V26, P47, DOI 10.1016/j.biomaterials.2004.02.004
NR 21
TC 28
Z9 28
U1 0
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD SEP
PY 2013
VL 1830
IS 9
SI SI
BP 4288
EP 4293
DI 10.1016/j.bbagen.2012.10.017
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 177WG
UT WOS:000321405500003
PM 23103748
DA 2018-10-20
ER

PT J
AU Li, JA
   Yang, J
   Zhong, XZ
   He, FR
   Wu, XW
   Shen, GX
AF Li, Jianan
   Yang, Juan
   Zhong, Xiaozhong
   He, Fengrong
   Wu, Xiongwen
   Shen, Guanxin
TI Demineralized dentin matrix composite collagen material for bone tissue
   regeneration
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE demineralized dentin matrix; collagen sponge; bone defect; bone repair
ID STROMAL CELLS; DIFFERENTIATION; OSTEOARTHRITIS; BIOACTIVITY; MODELS
AB Demineralized dentin matrix (DDM) had been successfully used in clinics as bone repair biomaterial for many years. However, particle morphology of DDM limited it further applications. In this study, DDM and collagen were prepared to DDM composite collagen material. The surface morphology of the material was studied by scanning electron microscope (SEM). MC3T3-E1 cells responses in vitro and tissue responses in vivo by implantation of DDM composite collagen material in bone defect of rabbits were also investigated. SEM analysis showed that DDM composite collagen material evenly distributed and formed a porous scaffold. Cell culture and animal models results indicated that DDM composite collagen material was biocompatible and could support cell proliferation and differentiation. Histological evaluation showed that DDM composite collagen material exhibited good biocompatibility, biodegradability and osteoconductivity with host bone in vivo. The results suggested that DDM composite collagen material might have a significant clinical advantage and potential to be applied in bone and orthopedic surgery.
C1 [Li, Jianan; Zhong, Xiaozhong] Jianghan Univ, Life Sci Coll, Dept Biotechnol, Wuhan 430056, Peoples R China.
   [Li, Jianan; Yang, Juan; He, Fengrong; Wu, Xiongwen; Shen, Guanxin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430030, Peoples R China.
RP Wu, XW (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430030, Peoples R China.
EM xiongwenwu@hotmail.com; shenguanxin@mail.hust.edu.cn
RI shen, Guanxin/F-7441-2011
FU Wuhan City local government [201051099415-07]
FX The project supported by Wuhan City local government (No:
   201051099415-07).
CR Brandt KD, 2008, RHEUM DIS CLIN N AM, V34, P531, DOI 10.1016/j.rdc.2008.05.011
   Brauer DS, 2007, J BIOMED MATER RES A, V80A, P410, DOI 10.1002/jbm.a.30902
   Chalidis B, 2011, INT J IMMUNOPATH PH, V24, P17, DOI 10.1177/03946320110241S204
   Fernandes H, 2010, TISSUE ENG PT A, V16, P1693, DOI 10.1089/ten.TEA.2009.0341
   Gal P, 2009, ACTA CHIR ORTHOP TR, V76, P495
   Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033
   Hannink G, 2011, INJURY S2, p[S22, 42]
   Huan Z, 2007, ACTA BIOMATER, V3, P952, DOI 10.1016/j.actbio.2007.05.003
   Kim M, 2011, BMB REP, V44, P619, DOI 10.5483/BMBRep.2011.44.10.619
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Mills LA, 2012, J BONE JOINT SURG BR, V94B, P865, DOI 10.1302/0301-620X.94B7.27370
   Reinholz GG, 2004, BIOMATERIALS, V25, P1511, DOI 10.1016/S0142-9612(03)00498-8
   Richette P, 2009, ARTHRITIS RHEUM, V60, P824, DOI 10.1002/art.24301
   Santin M, 2007, BIOMACROMOLECULES, V8, P2706, DOI 10.1021/bm0703362
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Van de Putte K A, 1965, Clin Orthop Relat Res, V43, P257
   Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001
   Yagihashi K, 2009, CALCIFIED TISSUE INT, V84, P210, DOI 10.1007/s00223-008-9205-7
NR 19
TC 6
Z9 7
U1 0
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD SEP 1
PY 2013
VL 24
IS 13
BP 1519
EP 1528
DI 10.1080/09205063.2013.777227
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 182GZ
UT WOS:000321731000002
PM 23848446
DA 2018-10-20
ER

PT J
AU Leszczak, V
   Smith, BS
   Popat, KC
AF Leszczak, Victoria
   Smith, Barbara S.
   Popat, Ketul C.
TI Hemocompatibility of polymeric nanostructured surfaces
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE hemocompatibility; nanowire surfaces; nanofiber surfaces; platelets
ID TISSUE ENGINEERING APPLICATIONS; IN-VIVO BIOCOMPATIBILITY;
   CARDIOVASCULAR IMPLANTS; POLYURETHANE MEMBRANE; BLOOD COMPATIBILITY;
   NANOFIBER SCAFFOLDS; FIBROUS SCAFFOLDS; VITRO;
   POLY(EPSILON-CAPROLACTONE); POLYCAPROLACTONE
AB Tissue integration is an important property when inducing transplant tolerance, however, the hemocompatibility of the biomaterial surface also plays an important role in the ultimate success of the implant. Therefore, in order to induce transplant tolerance, it is critical to understand the interaction of blood components with the material surfaces. In this study, we have investigated the adsorption of key blood serum proteins, in vitro adhesion and activation of platelets and clotting kinetics of whole blood on flat polycaprolactone (PCL) surfaces, nanowire (NW) surfaces and nanofiber (NF) surfaces. Previous studies have shown that polymeric nanostructured surfaces improve cell adhesion, proliferation and viability; however it is unclear how these polymeric nanostructured surfaces interact with the blood and its components. Protein adsorption results indicate that while there were no significant differences in total albumin (ALB) adsorption on PCL, NW and NF surfaces, NW surfaces had higher total fibrinogen (FIB) and immunoglobulin-G (IgG) adsorption compared to NF and PCL surfaces. In contrast, NF surfaces had higher surface FIB and IgG adsorption compared to PCL and NW surfaces. Platelet adhesion and viability studies show more adhesion and clustering of platelets on the NF surfaces as compared to PCL and NW surfaces. Platelet activation studies reveal that NW surfaces have the highest percentage of unactivated platelets, whereas NF surfaces have the highest percentage of fully activated platelets. Whole blood clotting results indicate that NW surfaces maintain an increased amount of free hemoglobin during the clotting process compared to PCL and NF surface, indicating less clotting and slower rate of clotting on their surfaces.
C1 [Leszczak, Victoria; Popat, Ketul C.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
   [Smith, Barbara S.; Popat, Ketul C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP Popat, KC (reprint author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
EM Ketul.Popat@ColoState.EDU
RI Leszczak, Victoria/A-3707-2014
OI Popat, Ketul C./0000-0002-2417-7789
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [5-R21-AR057341-02]
FX Research reported in this publication was supported by the National
   Institute of Arthritis and Musculoskeletal and Skin Diseases of the
   National Institutes of Health under Award Number 5-R21-AR057341-02. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Ajili SH, 2009, ACTA BIOMATER, V5, P1519, DOI 10.1016/j.actbio.2008.12.014
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864
   Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013
   Baker DW, 2011, BIOMACROMOLECULES, V12, P997, DOI 10.1021/bm1013487
   Bechara S, 2011, ACTA BIOMATER, V7, P2892, DOI 10.1016/j.actbio.2011.04.009
   Bechara SL, 2010, BIOMATERIALS, V31, P3492, DOI 10.1016/j.biomaterials.2010.01.084
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   Buijs J, 1996, J COLLOID INTERF SCI, V178, P594, DOI 10.1006/jcis.1996.0156
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Christopher X.F.L., 2008, BIOMED MATER, V3
   Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008
   de Jonge L, 2008, PHARM RES, V25, P2357
   De Santis R, 2011, J APPL POLYM SCI, V122, P3599, DOI 10.1002/app.34771
   Ekblad T, 2010, CURR OPIN COLLOID IN, V15, P499, DOI 10.1016/j.cocis.2010.07.008
   Faria M, 2011, COLLOID SURFACE B, V86, P21, DOI 10.1016/j.colsurfb.2011.03.021
   Feng Y., 2010, FRONT CHEM ENG CHINA, V4, P372, DOI [DOI 10.1007/S11705-010-0005-Z, 10.1007/s11705-010-0005-z]
   He LM, 2009, EUR CELLS MATER, V18, P63, DOI 10.22203/eCM.v018a06
   Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Cerda-Cristerna BI, 2011, J CONTROL RELEASE, V153, P269, DOI 10.1016/j.jconrel.2011.04.016
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Kim H. N., 2012, ADV DRUG DELIV REV
   Kim HI, 2011, BIOMATERIALS, V32, P2241, DOI 10.1016/j.biomaterials.2010.11.067
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Lee W, 2012, ACTA BIOMATER, V8, P2986, DOI 10.1016/j.actbio.2012.04.032
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Liu L, 2008, J BIOMED MATER RES B, V87B, P244, DOI 10.1002/jbm.b.31103
   Maegdefessel L, 2010, THROMB RES, V126, pE196, DOI 10.1016/j.thromres.2010.06.011
   Major TC, 2011, BIOMATERIALS, V32, P5957, DOI 10.1016/j.biomaterials.2011.03.036
   Mavis B., 2011, J BIOMECH, V44, P7
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Motlagh D, 2007, J BIOMED MATER RES A, V82A, P907, DOI 10.1002/jbm.a.31211
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Muthusubramaniam L, 2011, ANN BIOMED ENG, V39, P1296, DOI 10.1007/s10439-011-0256-y
   Nagaoka S., 2001, J ARTIF ORGANS, V4, P107
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Popat KC, 2003, J VAC SCI TECHNOL B, V21, P645, DOI 10.1116/1.1545733
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Redenti Stephen, 2008, J Ocul Biol Dis Infor, V1, P19, DOI 10.1007/s12177-008-9005-3
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sangsanoh P, 2007, BIOMACROMOLECULES, V8, P1587, DOI 10.1021/bm061152a
   Seidlits SK, 2008, NANOMEDICINE-UK, V3, P183, DOI 10.2217/17435889.3.2.183
   Seyednejad H, 2012, BIOMATERIALS, V33, P4309, DOI 10.1016/j.biomaterials.2012.03.002
   Shinoka T, 1996, CIRCULATION, V94, P164
   Smith SC, 2012, J AM COLL CARDIOL, V60, P2343, DOI 10.1016/j.jacc.2012.08.962
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   VANERP R, 1992, J IMMUNOL METHODS, V152, P191, DOI 10.1016/0022-1759(92)90140-O
   Wan LS, 2009, J BIOMED MATER RES A, V89A, P168, DOI 10.1002/jbm.a.31907
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xiang P, 2011, INT J BIOL MACROMOL, V49, P281, DOI 10.1016/j.ijbiomac.2011.05.004
   Xm H, 1992, NATURE, V358, P209
   Ye L, 2010, J BIOMAT SCI-POLYM E, V21, P21
   Ye L, 2012, J BIOMED MATER RES A, V100A, P3251, DOI 10.1002/jbm.a.34270
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 64
TC 19
Z9 19
U1 2
U2 43
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD SEP 1
PY 2013
VL 24
IS 13
BP 1529
EP 1548
DI 10.1080/09205063.2013.777228
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 182GZ
UT WOS:000321731000003
PM 23848447
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Xu, LX
   Zhang, XY
   Zhu, CY
   Zhang, YL
   Fu, CK
   Yang, B
   Tao, L
   Wei, Y
AF Xu, Liangxin
   Zhang, Xiaoyong
   Zhu, Chongyu
   Zhang, Yaling
   Fu, Changkui
   Yang, Bin
   Tao, Lei
   Wei, Yen
TI Nonionic polymer cross-linked chitosan hydrogel: preparation and
   bioevaluation
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE chitosan; polyacrylamide; hydrogel; physical blending; biocompatibility
ID BIOMEDICAL APPLICATIONS; GRAPHENE OXIDE; DELIVERY; DRUG; HEMORRHAGE;
   GELATION; RELEASE; CHITIN; BIOCOMPATIBILITY; NANOPARTICLES
AB A straightforward method to prepare nonionic polymer (polyacrylamide, PAM) cross-linked chitosan hydrogel has been developed. The chitosan-polyacrylamide (CS-PAM) hydrogel could be quickly obtained by simply mixing of chitosan and polyacrylamide solutions under very benign condition (room temperature, <30s). The cytotoxicity and hemocompatibility of the CS-PAM hydrogel were subsequently investigated. Cells retained normal morphology even when the concentration of CS-PAM hydrogel in culture system was as high as 640gmL(-1), indicating the CS-PAM hydrogel has minimal cytotoxicity to A549 and HeLa cells. Meanwhile, no hemolysis was observed after incubating the CS-PAM hydrogel with red blood cells for 6h, further suggesting excellent biocompatibility of the hydrogel. Scanning electron microscopy images illustrated that the CS-PAM hydrogel can absorb red blood cells through the interaction between the protonated amine groups on chitosan and the negative charged residues on red blood cell membranes. Given its low cost, simple preparation, and excellent biocompatibility, this CS-PAM hydrogel might be a potential biomaterial for future healthcare and biomedical applications.
C1 [Tao, Lei] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.
   Tsinghua Univ, Tsinghua Ctr Frontier Polymer Res, Beijing 100084, Peoples R China.
RP Tao, L (reprint author), Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.
EM leitao@mail.tsinghua.edu.cn; weiyen@mail.tsinghua.edu.cn
RI zhang, xiaoyong/D-9539-2011; Fu, Changkui/M-3326-2018; tao,
   lei/A-1078-2012; Xu, Liangxin/G-4524-2012; Wei, Yen/H-5329-2012
OI Fu, Changkui/0000-0002-2444-607X; tao, lei/0000-0002-1735-6586; Xu,
   Liangxin/0000-0001-7398-0976; Zhang, Yaling/0000-0003-1174-6599; Zhu,
   Chongyu/0000-0001-6337-178X
FU National Science Foundation of China [21134004, 21104039]; National 973
   Project [2011CB935700]
FX We thank Dr Ximin Guo and Mr Zhiyong Qian (Chinese Academy of Military
   Medical Sciences) for their kind cooperation. This work was supported by
   the National Science Foundation of China (nos. 21134004, 21104039), and
   the National 973 Project (no. 2011CB935700).
CR Aliaghaie M, 2012, SOFT MATTER, V8, P7128, DOI 10.1039/c2sm25254f
   Anirudhan TS, 2011, POLYM CHEM-UK, V2, P2052, DOI 10.1039/c1py00059d
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Bhat KA, 2012, CARBOHYD RES, V352, P143
   Boddohi S, 2009, BIOMACROMOLECULES, V10, P1402, DOI 10.1021/bm801513e
   Brack HP, 1997, POLYMER, V38, P2351, DOI 10.1016/S0032-3861(96)00780-X
   Cascone MG, 1999, J MATER SCI-MATER M, V10, P431, DOI 10.1023/A:1008983215833
   Cerchiara T, 2002, J PHARM PHARMACOL, V54, P1453, DOI 10.1211/00223570281
   Dai CL, 2010, BIOMATERIALS, V31, P7620, DOI 10.1016/j.biomaterials.2010.06.049
   Dambies L, 2001, BIOMACROMOLECULES, V2, P1198, DOI 10.1021/bm010083r
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   De Castro GP, 2012, J TRAUMA ACUTE CARE, V72, P899, DOI 10.1097/TA.0b013e318248baa1
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Dowling MB, 2011, BIOMATERIALS, V32, P3351, DOI 10.1016/j.biomaterials.2010.12.033
   Gu RL, 2010, BIOMATERIALS, V31, P1270, DOI 10.1016/j.biomaterials.2009.10.023
   Hattori H, 2010, ANN BIOMED ENG, V38, P3724, DOI 10.1007/s10439-010-0121-4
   Jiang T, 2010, BIOMACROMOLECULES, V11, P1254, DOI 10.1021/bm100050d
   Kim SK, 2005, CARBOHYD POLYM, V62, P357, DOI 10.1016/j.carbpol.2005.08.012
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Ladet S, 2008, NATURE, V452, P76, DOI 10.1038/nature06619
   Li X, 2012, SOFT MATTER, V8, P3781, DOI 10.1039/c2sm06994f
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Martin L, 2003, EUR J PHARM BIOPHARM, V55, P35, DOI 10.1016/S0939-6411(02)00118-2
   Messing R, 2011, POLYM CHEM-UK, V2, P18, DOI 10.1039/c0py00129e
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Noble L, 1999, INT J PHARM, V192, P173, DOI 10.1016/S0378-5173(99)00306-3
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Pusateri AE, 2003, J TRAUMA, V54, P177, DOI 10.1097/01.TA.0000032512.04647.C6
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Risbud MV, 2000, DRUG DELIV, V7, P69
   Sa-Lima H, 2010, SOFT MATTER, V6, P5184, DOI 10.1039/c0sm00041h
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Shu XZ, 2002, INT J PHARM, V233, P217, DOI 10.1016/S0378-5173(01)00943-7
   Valmikinathan CM, 2012, SOFT MATTER, V8, P1964, DOI 10.1039/c1sm06629c
   Xin Y, 2012, POLYM CHEM-UK, V3, P3045, DOI 10.1039/c2py20290e
   Yang B, 2012, POLYM CHEM-UK, V3, P3235, DOI 10.1039/c2py20627g
   Zhang XY, 2012, TOXICOL RES-UK, V1, P62, DOI 10.1039/c2tx20006f
   Zhang XY, 2012, POLYM CHEM-UK, V3, P2716, DOI 10.1039/c2py20457f
   Zhang XY, 2012, NANOSCALE, V4, P5581, DOI 10.1039/c2nr31281f
   Zhang XY, 2011, CARBON, V49, P986, DOI 10.1016/j.carbon.2010.11.005
   Zhang YL, 2011, BIOMACROMOLECULES, V12, P2894, DOI 10.1021/bm200423f
NR 45
TC 17
Z9 18
U1 4
U2 132
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD SEP 1
PY 2013
VL 24
IS 13
BP 1564
EP 1574
DI 10.1080/09205063.2013.781934
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 182GZ
UT WOS:000321731000005
PM 23560850
DA 2018-10-20
ER

PT J
AU Mhuka, V
   Dube, S
   Nindi, MM
   Torto, N
AF Mhuka, Vimbai
   Dube, Simiso
   Nindi, Mathew Muzi
   Torto, Nelson
TI Fabrication and structural characterization of electrospun nanofibres
   from Gonometa Postica and Gonometa Rufobrunnae regenerated silk fibroin
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE biopolymer; electrospinning; fibroin; Gonometa species
ID AQUEOUS-SOLUTION; SCAFFOLDS; BIOMATERIAL; MEMBRANES; DELIVERY; FIBERS
AB We report the fabrication and characterization of electrospun nanofibres from Gonometa postica and Gonometa rufobrunnae silk fibroin indigenous to Southern Africa. Nanofibres were electrospun from regenerated silk fibroin (RSF) powders obtained by freeze drying or via rotary evaporation using methanol as a desiccant. Optimal electrospinning conditions employed trifluoroacetic acid as a solvent. The solution of RSF powder prepared by rotary evaporation was electrospun at a lower concentration (27% w/v) than that of freeze dried RSF powder (40% w/v). Concentration of the fibroin solution had the most influence on electrospinnability whereas voltage and flow rate mainly affected the fibre morphology. Scanning electron microscopy (SEM) showed that nanofibres from freeze dried and rotary evaporator dried RSF powders had diameters ranging from 300-760 and 400-1,000 nm respectively. Fourier transform infrared (FTIR) analysis revealed that the RSF powders were mainly composed of beta-sheets, similar to degummed silk fibroin. The nanofibres, however, exhibited predominantly random coil/alpha-helical structure showing degradation of the native silk structure. beta-sheet structure in the nanofibres was restored upon solvent treatment resulting in improved water stability. The extent of structural transformation was dependent on the type of solvent used. This study confirms the feasibility of fabricating Gonometa fibroin into stable nanofibrous structures that could be used as scaffolds in biotechnological and biomedical applications.
C1 [Mhuka, Vimbai; Dube, Simiso; Nindi, Mathew Muzi] Univ S Africa, Dept Chem, Coll Sci Engn & Technol, ZA-0003 Pretoria, South Africa.
   [Torto, Nelson] Rhodes Univ, Dept Chem, ZA-6140 Grahamstown, South Africa.
RP Dube, S (reprint author), Univ S Africa, Dept Chem, Coll Sci Engn & Technol, POB 392, ZA-0003 Pretoria, South Africa.
EM dubes@unisa.ac.za
RI Dube, Simiso/S-1771-2017
OI Dube, Simiso/0000-0003-1225-5812
FU National Research Foundation (NRF) [69081]; University of South Africa
   (UNISA); Organization for Women in Science for the Developing World
   (OWSDW)
FX The authors gratefully acknowledge the National Research Foundation
   (NRF) (Grant number 69081) and University of South Africa (UNISA) for
   financially supporting this project. We also acknowledge Rhodes
   University for providing facilities for the electrospinning work and
   analyses. We are also indebted to the Organization for Women in Science
   for the Developing World (OWSDW) for awarding Ms Mhuka with a
   postgraduate fellowship. We are also indebted to Dr. S. Chigome for his
   suggestions and comments on the research and preparation of the
   manuscript. We would also like to acknowledge Mr. J. A. Nyati, Prof C.
   H. Scholtz and Elster Vermeulen for their assistance in sourcing
   varieties of silkworm cocoons.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Andrady A. L., 2007, SCI TECHNOLOGY POLYM, P105
   BOMMARIUS AS, 2004, BIOCATALYSIS FUNDAME
   Collins KD, 2004, METHODS, V34, P300, DOI 10.1016/j.ymeth.2004.03.021
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Der A, 2007, J PHYS CHEM B, V111, P5344, DOI 10.1021/jp066206p
   Dhandayuthapani B, 2011, MATER RES-IBERO-AM J, V14, P317, DOI 10.1590/S1516-14392011005000064
   FREDDI G, 1993, J APPL POLYM SCI, V48, P99, DOI 10.1002/app.1993.070480110
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Jayaraman J. K., 2004, J NANOSCI NANOTECHNO, V4, P52
   Kenawy ER, 2003, BIOMATERIALS, V24, P907, DOI 10.1016/S0142-9612(02)00422-2
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kweon H, 2001, J APPL POLYM SCI, V82, P750, DOI 10.1002/app.1901
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Marelli B, 2010, ACTA BIOMATER, V6, P4019, DOI 10.1016/j.actbio.2010.05.008
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Mhuka V., 2012, INT J BIOL MACROMOL, DOI [10.1016/j.ijbiomac.2012.09.010, DOI 10.1016/J.IJBI0MAC.2012.09.010]
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Min M, 2006, MACROMOL BIOSCI, V6, P285
   Miyaguchi Y., 2005, FOOD SCI TECHNOL RES, V11, P3742
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Reneker D. H., 1996, NANOTECHNOLOGY, V7, P36
   Schiffman JD, 2008, POLYM REV, V48, P317, DOI 10.1080/15583720802022182
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Srisuwan Y., 2009, Journal of Applied Sciences, V9, P978, DOI 10.3923/jas.2009.978.982
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tan SH, 2005, POLYMER, V46, P6128, DOI 10.1016/j.polymer.2005.05.068
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1407, DOI 10.1002/polb.1994.090320812
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wadbua P, 2010, INT J BIOL MACROMOL, V46, P493, DOI 10.1016/j.ijbiomac.2010.03.007
   Wei W, 2011, J MATER RES, V26, P1100, DOI 10.1557/jmr.2011.47
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Zhang F, 2009, POLYMER, V50, P279, DOI 10.1016/j.polymer.2008.10.053
   Zhang W. N. L., 2001, J CHIN I FOOD SCI TE, V1, P56
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhou Z. W., 2011, OPEN MAT SCI J, V5, P51
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 39
TC 4
Z9 4
U1 1
U2 61
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD SEP
PY 2013
VL 21
IS 9
BP 995
EP 1003
DI 10.1007/s13233-013-1127-1
PG 9
WC Polymer Science
SC Polymer Science
GA 155TW
UT WOS:000319772100008
DA 2018-10-20
ER

EF